
<html lang="en"     class="pb-page"  data-request-id="c38bfc3f-c92f-46ba-89c5-62eb42fa035d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-24;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c01449;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones" /></meta><meta name="dc.Creator" content="Yulin  Ren" /></meta><meta name="dc.Creator" content="A. Douglas  Kinghorn" /></meta><meta name="dc.Description" content="Naturally occurring terpenoid lactones and their synthetic derivatives have attracted increasing interest for their promising antitumor activity and potential utilization in the discovery and desig..." /></meta><meta name="Description" content="Naturally occurring terpenoid lactones and their synthetic derivatives have attracted increasing interest for their promising antitumor activity and potential utilization in the discovery and desig..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 8, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01449" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01449" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01449" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01449" /></link>
        
    
    

<title>Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01449" /></meta><meta property="og:title" content="Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0032.jpeg" /></meta><meta property="og:description" content="Naturally occurring terpenoid lactones and their synthetic derivatives have attracted increasing interest for their promising antitumor activity and potential utilization in the discovery and design of new antitumor agents. In the present perspective article, selected plant-derived five-membered γ-lactones and six-membered δ-lactones that occur with terpenoid scaffolds are reviewed, with their structures, cancer cell line cytotoxicity and in vivo antitumor activity, structure–activity relationships, mechanism of action, and the potential for developing cancer chemotherapeutic agents discussed in each case. The compounds presented include artemisinin (ART, 1), parthenolide (PTL, 2), thapsigargin (TPG, 3), andrographolide (AGL, 4), ginkgolide B (GKL B, 5), jolkinolide B (JKL B, 6), nagilactone E (NGL E, 7), triptolide (TPL, 8), bruceantin (BRC, 9), dichapetalin A (DCT A, 10), and limonin (LMN, 11), and their naturally occurring analogues and synthetic derivatives. It is hoped that this contribution will be supportive of the future development of additional efficacious anticancer agents derived from natural products." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Naturally occurring terpenoid lactones and their synthetic derivatives have attracted increasing interest for their promising antitumor activity and potential utilization in the discovery and design of new antitumor agents. In the present perspective article, selected plant-derived five-membered γ-lactones and six-membered δ-lactones that occur with terpenoid scaffolds are reviewed, with their structures, cancer cell line cytotoxicity and in vivo antitumor activity, structure–activity relationships, mechanism of action, and the potential for developing cancer chemotherapeutic agents discussed in each case. The compounds presented include artemisinin (ART, 1), parthenolide (PTL, 2), thapsigargin (TPG, 3), andrographolide (AGL, 4), ginkgolide B (GKL B, 5), jolkinolide B (JKL B, 6), nagilactone E (NGL E, 7), triptolide (TPL, 8), bruceantin (BRC, 9), dichapetalin A (DCT A, 10), and limonin (LMN, 11), and their naturally occurring analogues and synthetic derivatives. It is hoped that this contribution will be supportive of the future development of additional efficacious anticancer agents derived from natural products." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0032.jpeg" /></meta><meta name="twitter:title" content="Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01449"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01449">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01449&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01449&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01449&amp;href=/doi/10.1021/acs.jmedchem.0c01449" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 15410-15448</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01378" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c01502" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yulin Ren</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yulin Ren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 1-(740) 707-1263. Email: <a href="/cdn-cgi/l/email-protection#582a3d36766c6918372b2d763d3c2d"><span class="__cf_email__" data-cfemail="4f3d2a21617b7e0f203c3a612a2b3a">[email protected]</span></a>. Fax: (614) 247-8094.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yulin++Ren">Yulin Ren</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3667-1466" title="Orcid link">http://orcid.org/0000-0003-3667-1466</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">A. Douglas Kinghorn</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">A. Douglas Kinghorn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 1(614) 247-8094. Email: <a href="/cdn-cgi/l/email-protection#1b7072757c73746975352f5b74686e357e7f6e"><span class="__cf_email__" data-cfemail="c0aba9aea7a8afb2aeeef480afb3b5eea5a4b5">[email protected]</span></a>. Fax: (614) 247-8094.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=A.+Douglas++Kinghorn">A. Douglas Kinghorn</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6647-8707" title="Orcid link">http://orcid.org/0000-0002-6647-8707</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01449&amp;href=/doi/10.1021%2Facs.jmedchem.0c01449" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 15410–15448</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 August 2020</li><li><span class="item_label"><b>Published</b> online</span>8 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01449" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01449</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15410%26pageCount%3D39%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYulin%2BRen%252C%2BA.%2BDouglas%2BKinghorn%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D24%26contentID%3Dacs.jmedchem.0c01449%26title%3DDevelopment%2Bof%2BPotential%2BAntitumor%2BAgents%2Bfrom%2Bthe%2BScaffolds%2Bof%2BPlant-Derived%2BTerpenoid%2BLactones%26numPages%3D39%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15448%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01449"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1310</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01449" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yulin&quot;,&quot;last_name&quot;:&quot;Ren&quot;},{&quot;first_name&quot;:&quot;A.&quot;,&quot;last_name&quot;:&quot;Douglas Kinghorn&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15410-15448&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01449&quot;},&quot;abstract&quot;:&quot;Naturally occurring terpenoid lactones and their synthetic derivatives have attracted increasing interest for their promising antitumor activity and potential utilization in the discovery and design of new antitumor agents. In the present perspective article, selected plant-derived five-membered γ-lactones and six-membered δ-lactones that occur with terpenoid scaffolds are reviewed, with their structures, cancer cell line cytotoxicity and in vivo antitumor activity, structure–activity relationships, mechanism of action, and the potential for developing cancer chemotherapeutic agents discussed in each case. The compounds presented include artemisinin (ART, 1), parthenolide (PTL, 2), thapsigargin (TPG, 3), andrographolide (AGL, 4), ginkgolide B (GKL B, 5), jolkinolide B (JKL B, 6), nagilactone E (NGL E, 7), triptolide (TPL, 8), bruceantin (BRC, 9), dichapetalin A (DCT A, 10), and limonin (LMN, 11), and their naturally occurring analogues and synthetic derivatives. It is hoped that this contribution will be supp&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01449&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01449" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01449&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01449" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01449&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01449" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01449&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01449&amp;href=/doi/10.1021/acs.jmedchem.0c01449" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01449" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01449" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01449%26sid%3Dliteratum%253Aachs%26pmid%3D33289552%26genre%3Darticle%26aulast%3DRen%26date%3D2020%26atitle%3DDevelopment%2Bof%2BPotential%2BAntitumor%2BAgents%2Bfrom%2Bthe%2BScaffolds%2Bof%2BPlant-Derived%2BTerpenoid%2BLactones%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D24%26spage%3D15410%26epage%3D15448%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/24" title="Go to Volume 63, Issue 24"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/jmcmar.2020.63.issue-24/20201224/jmcmar.2020.63.issue-24.largecover.jpg" alt="Go to Volume 63, Issue 24"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Naturally occurring terpenoid lactones and their synthetic derivatives have attracted increasing interest for their promising antitumor activity and potential utilization in the discovery and design of new antitumor agents. In the present perspective article, selected plant-derived five-membered γ-lactones and six-membered δ-lactones that occur with terpenoid scaffolds are reviewed, with their structures, cancer cell line cytotoxicity and in vivo antitumor activity, structure–activity relationships, mechanism of action, and the potential for developing cancer chemotherapeutic agents discussed in each case. The compounds presented include artemisinin (ART, <b>1</b>), parthenolide (PTL, <b>2</b>), thapsigargin (TPG, <b>3</b>), andrographolide (AGL, <b>4</b>), ginkgolide B (GKL B, <b>5</b>), jolkinolide B (JKL B, <b>6</b>), nagilactone E (NGL E, <b>7</b>), triptolide (TPL, <b>8</b>), bruceantin (BRC, <b>9</b>), dichapetalin A (DCT A, <b>10</b>), and limonin (LMN, <b>11</b>), and their naturally occurring analogues and synthetic derivatives. It is hoped that this contribution will be supportive of the future development of additional efficacious anticancer agents derived from natural products.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer results from an abnormally excessive growth of tissue or a neoplasia, and develops through the stages of carcinoma in situ, invasion, angiogenesis, and metastasis. Cancer may be characterized by all of aggressive cellular growth, relapse, metastasis, and resistance to existing cancer chemotherapeutic agents, and thus is one of the most serious diseases known.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, cancer is a genetic disease, with a mutator phenotype found ubiquitously in cancer cells. The repair of DNA damage becomes skewed in cancer cells, which results in multiple mutations, and the genome of cancer cells is unstable, leading to cascades of mutations and then the development of tumor resistance to drug therapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, theoretically, drugs that are directed to cancer cells, DNA, or tumor genomes may not be totally effective in treating cancer, so it seems preferable that further anticancer drug design should focus on lead compounds with multiple molecular targets.</div><div class="NLM_p">Many currently available cancer chemotherapy regimens are insufficient for treating cancer, and several problems, including the occurrence of adverse effects and the development of multidrug resistance (MDR), have been observed with their use in cancer clinics. For more than 50 years, natural products (NPs) have played a key role in the discovery of anticancer agents, as evidenced by the increasing numbers of new anticancer drugs that are developed from diverse natural sources. These naturally derived drugs mediate their activity through different cellular mechanisms, of which some are novel or unusual, and thus, developing promising agents from NPs to treat cancer effectively has become well accepted.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a></div><div class="NLM_p">The natural terpenoids are derived from five-carbon (C<sub>5</sub>) units of isoprene (2-methyl-1,3-butadiene) via “head-to-head” or “head-to-tail” addition and are characterized mainly as monoterpene (C<sub>10</sub>), sesquiterpene (C<sub>15</sub>), diterpene (C<sub>20</sub>), and triterpene (C<sub>30</sub>) subgroups, based on the number of C<sub>5</sub> isoprene units contained. These NPs are involved in various cellular processes and have a number of biotechnological applications.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> As plant-signaling hormones, terpenoids show important physiological properties,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and they also exhibit a broad range of the biological activities that may benefit human health, including having antitumor, antimicrobial, antifungal, antiviral, antihyperglycemic, antiinflammatory, and antiparasitic properties.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Of these compounds, natural terpene lactones (NTLs) are a large group, with a γ-lactone (five-membered tetrahydrofuran ring system) or a δ-lactone (six-membered tetrahydropyran ring system) occurring commonly in different types of terpenoids. NTLs exhibit a variety of potent biological activities, as described recently in an extensive review on sesquiterpene lactones in 2018,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> as well as in several of our laboratory contributions on goyazensolides (SQLs) in 2016 and on dichapetalins (triterpene lactones) in 2018 and 2019.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a></div><div class="NLM_p">As an extension of the previous literature, in the present perspective, selected plant-derived terpenoids that contain either a five-membered γ-lactone or a six-membered δ-lactone unit and development work toward their possible utilization in cancer chemotherapy are discussed. Included, herein, are examples of sesquiterpene [artemisinin (<b>1</b>), parthenolide (<b>2</b>), and thapsigargin (<b>3</b>)], diterpene [(andrographolide (<b>4</b>), ginkgolide B (<b>5</b>), jolkinolide B (<b>6</b>), nagilactone E (<b>7</b>), and triptolide (<b>8</b>)], and triterpene [bruceantin (<b>9</b>), dichapetalin A (<b>10</b>), and limonin (<b>11</b>)] lactones. These representative compounds (<b>1</b>–<b>11</b>) have been selected based on their potent inhibitory activity toward cancer cell growth, the predominant interactions with their molecular targets, or their potential promise for the development of antitumor agents in cancer clinical trials. Thus far, several compounds discussed or their derivatives (<b>1</b>–<b>4</b>, <b>8</b>, and <b>9</b>) have been evaluated in phase I or II clinical trials (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Certain other terpenoid lactones that show potential antitumor activity have not been included in the present perspective, owing to space limitations.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Plant-Derived Terpenoid Lactones with Potential Antitumor Activity</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">plant origin</th><th class="colsep0 rowsep0" align="center">antitumor potential</th><th class="colsep0 rowsep0" align="center">major target</th><th class="colsep0 rowsep0" align="center">ref.</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">artemisinin (<b>1</b>, ART)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Artemisia annua</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">phase I cancer clinical trial</td><td class="colsep0 rowsep0" align="left">Akt</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref11 ref14 ref19 ref21 ref24'); return false;" href="javascript:void(0);" class="ref ref11 ref14 ref19 ref21 ref24">(11,14,19,21,24)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AR</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NF-κB</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">parthenolide (<b>2</b>, PTL)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Chrysanthemum parthenium</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">phase I cancer clinical trial</td><td class="colsep0 rowsep0" align="left">NF-κB</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref11 ref40'); return false;" href="javascript:void(0);" class="ref ref11 ref40">(11,40)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HIF</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">thapsigargin (<b>3</b>, TPG)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Thapsia garganica</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">IC<sub>50</sub> = 30 nM (S180 sarcoma cells), with an analogue mipsagargin (<b>3b</b>) tested in phases I and II cancer clinical trials</td><td class="colsep0 rowsep0" align="left">AMPK</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref62 ref67 ref69 ref71 ref75 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref62 ref67 ref69 ref71 ref75 ref82 ref83">(62,67,69,71,75,82,83)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SERCA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">andrographolide (<b>4</b>, AGL)</td><td class="colsep0 rowsep0" rowspan="4" align="left"><i>Andrographis paniculata</i></td><td class="colsep0 rowsep0" rowspan="4" align="left">IC<sub>50</sub> = 2.4 μM (HL-60 human leukemia cells), tested in phase I cancer clinical trial</td><td class="colsep0 rowsep0" align="left">Akt/mTOR</td><td class="colsep0 rowsep0" rowspan="4" align="left"><a onclick="showRef(event, 'ref84 ref85 ref87 ref90 ref91 ref93'); return false;" href="javascript:void(0);" class="ref ref84 ref85 ref87 ref90 ref91 ref93">(84,85,87,90,91,93)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">COX2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PGE2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR4/NF-κB/MMP</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">ginkgolide B (<b>5</b>, GKL B)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Ginkgo biloba</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">IC<sub>50</sub> > 50 μM (OVCA429 human ovarian cancer cells) IC<sub>50</sub> 0.13 μM (antiplatelet aggregation)</td><td class="colsep0 rowsep0" align="left">P53</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref107 ref114 ref118 ref119 ref121'); return false;" href="javascript:void(0);" class="ref ref107 ref114 ref118 ref119 ref121">(107,114,118,119,121)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAFR</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ZEB1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">jolkinolide B (<b>6</b>, JKL B)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Euphorbia jolkini</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">IC<sub>50</sub> = 2.8 μM (UACC-62 human melanoma cells)</td><td class="colsep0 rowsep0" align="left">Akt/STAT3/mTOR</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref128 ref130 ref133 ref134 ref135 ref136 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref128 ref130 ref133 ref134 ref135 ref136 ref138 ref139">(128,130,133−136,138,139)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HK2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3K/Akt/mTOR</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">nagilactone E (<b>7</b>, NGL E)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Podocarpus nagi Podocarpus macrophyllus</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">IC<sub>50</sub> = 0.72 μM (P-388 mouse leukemia cells)</td><td class="colsep0 rowsep0" align="left">caspases</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref143 ref144 ref147 ref149'); return false;" href="javascript:void(0);" class="ref ref143 ref144 ref147 ref149">(143,144,147,149)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cyclin B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RIOK2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">triptolide (<b>8</b>, TPL)</td><td class="colsep0 rowsep0" rowspan="4" align="left"><i>Tripterygium wilfordii</i></td><td class="colsep0 rowsep0" rowspan="4" align="left">IC<sub>50</sub>= 0.01 μM (HCT116 human colon cancer cells), with an analogue Minnelide (<b>8h</b>) tested in phases I and II cancer clinical trials</td><td class="colsep0 rowsep0" align="left">ERK</td><td class="colsep0 rowsep0" rowspan="4" align="left"><a onclick="showRef(event, 'ref163 ref165 ref169 ref183'); return false;" href="javascript:void(0);" class="ref ref163 ref165 ref169 ref183">(163,165,169,183)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hsp70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAPK</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NF-κB</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">bruceantin (<b>9</b>, BRC)</td><td class="colsep0 rowsep0" rowspan="3" align="left"><i>Brucea antidysenterica</i></td><td class="colsep0 rowsep0" rowspan="3" align="left">IC<sub>50</sub> = 0.067 μM (HCT116 human colon cancer cells) phases I and II cancer clinical trials</td><td class="colsep0 rowsep0" align="left">c-Myc</td><td class="colsep0 rowsep0" rowspan="3" align="left"><a onclick="showRef(event, 'ref210 ref213 ref216 ref217 ref219 ref220 ref221 ref239'); return false;" href="javascript:void(0);" class="ref ref210 ref213 ref216 ref217 ref219 ref220 ref221 ref239">(210,213,216,217,219−221,239)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Notch pathway</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STAT3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">dichapetalin A (<b>10</b>, DCT A)</td><td class="colsep0 rowsep0" align="left"><i>Dichapetalum madagascariense</i></td><td class="colsep0 rowsep0" align="left">EC<sub>90</sub> < 0.17 nM (L1210 murine leukemia cells)</td><td class="colsep0 rowsep0" rowspan="2" align="left">not determined yet</td><td class="colsep0 rowsep0" rowspan="2" align="left"><a onclick="showRef(event, 'ref256 ref259 ref260 ref261'); return false;" href="javascript:void(0);" class="ref ref256 ref259 ref260 ref261">(256,259−261)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Dichapetalum gelonioides</i></td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 0.25 μM (HCT116 human colon cancer cells)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">limonin (<b>11</b>, LMN)</td><td class="colsep0 rowsep0" rowspan="4" align="left"><i>Citrus limon</i></td><td class="colsep0 rowsep0" rowspan="4" align="left">IC<sub>50</sub> = 4.3 μM (MCF-7 human breast cancer cells)</td><td class="colsep0 rowsep0" align="left">PI3K/Akt</td><td class="colsep0 rowsep0" rowspan="4" align="left"><a onclick="showRef(event, 'ref274 ref278 ref279 ref280 ref282 ref283'); return false;" href="javascript:void(0);" class="ref ref274 ref278 ref279 ref280 ref282 ref283">(274,278−280,282,283)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ROS</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wnt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">YAP</td></tr></tbody></table></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Sesquiterpene Lactones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sesquiterpene lactones (SQLs) have been well investigated for their potential antitumor activity through several pertinent mechanisms, including inhibition of the SERCA pump and NF-κB activation and modulation of signal transducers and activators of transcription 3 (STAT3).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus far, several SQLs have been evaluated in cancer clinical trials, including artesunate, dimethylaminoparthenolide, and mipsagargin (G-202).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The structure determination and antitumor potential of artemisinin (<b>1</b>), parthenolide (<b>2</b>), thapsigargin (<b>3</b>), and some of their naturally occurring or synthetic analogues have been summarized in 2016 in our previous review,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and in this update, more recent progress only of the development of these SQLs as new antitumor agents is discussed in the following paragraphs.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Artemisinin</h3><div class="NLM_p">Artemisinin (ART, <b>1</b>), having the (3<i>R</i>,5a<i>S</i>,6<i>R</i>,8a<i>S</i>,9<i>R</i>,12<i>S</i>,12a<i>R</i>) absolute configuration (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), is an important naturally occurring endoperoxide-containing sesquiterpene lactone extracted from <i>Artemisia annua</i> L. (Asteraceae).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although superseded by several clinically used semisynthetic derivatives today, ART has been used for the treatment of malaria for several decades, for which the 2015 Nobel Prize in Physiology or Medicine was shared by Professor Youyou Tu for her contribution to the field (<a href="http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.html" class="extLink">http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.html</a>). ART (<b>1</b>) has shown also selective antitumor efficacy toward several tumor xenograft models, with multiple molecular targets characterized. These include the interactions between its essential endoperoxide bridge and ferrous iron for generating free radicals to lead to cancer cell death, as discussed in reviews published in 2016 and 2017.<a onclick="showRef(event, 'ref11 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref15">(11,15)</a> ART was found recently to suppress hepatocellular carcinoma (HCC) cell growth, migration, and invasion by inactivation of Hippo-YAP signal transduction,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and it inhibited SKOV3 human ovarian epithelial cancer cell growth via autophagy-mediated cell cycle arrest.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of artemisinin (ART, <b>1</b>) and its derivatives <b>1a</b>–<b>1e</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>MCF-7 and <sup><i>b</i></sup>MDA-MB-231 breast, <sup><i>c</i></sup>C33A cervical, and <sup><i>d</i></sup>SMMC-7721 liver cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the case of a 51-year-old male patient who suffered adrenocortical carcinoma (ACC) with liver and peritoneal metastases and after the failure of several prior antineoplastic therapies, a durable disease response was observed by an up to two-year-treatment with oral dosing by artemisinin tablets (ART 99%) (600 mg dose for 5 days, followed by 5 days without therapy).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The patient did not suffer from any symptoms or clinical signs of toxicity. Although only one patient was involved in this clinical investigation, further preclinical and clinical studies for a better understanding of the mechanism and clinical anti-ACC efficacy were recommended for ART.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Mechanistically, ART has been found to inhibit UMRC-2 and CAKI-2 human clear cell renal cell carcinoma (ccRCC) cell growth through inhibition of the Akt [protein kinase B (PKB)] signaling pathway.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It interacted with P-glycoprotein (P-gp) to reverse P-gp-mediated MDR to support the design of proposed rational ART-based combination cancer chemotherapies.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> ART prevented <i>Helicobacter pylori</i>-induced gastric carcinogenesis via inhibition of nuclear factor kappa B (NF-κB) signaling.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Interestingly, ART was found to enhance significantly the cytolytic activity of natural killer (NK) cells and the antitumor immune response in 4T1 breast cancer cells.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> It selectively induced the ubiquitin-26S proteasome-mediated degradation of androgen receptor (AR) without altering receptor transcript levels in androgen-responsive LNCaP and PC-3 human prostate cancer cells.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The ART-induced loss of AR prevented the cell proliferation and ablated total AR transcriptional activity, in which PI3K (phosphoinositide 3-kinase)/Akt-1 signaling played an important role. Thus, the potential of AR-targeted prostate cancer chemotherapy was suggested for ART (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition, two synthetic derivatives of ART, dihydroartemisinin (DHA, <b>1a</b>) and artesunate (ARS, <b>1b</b>), were found to suppress transforming growth factor-β (TGF-β, a recruiter and activator of fibroblasts in many cancers) signaling to inactivate cancer-associated fibroblasts (CAFs). This resulted in the inhibition of CAF mouse fibroblast L-929 cell growth and metastasis.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cellular signaling for the mediation of cytotoxicity of artemisinin (<b>1</b>) and actions against human cancer cells of five synthetic derivatives (<b>1a</b>–<b>1e</b>) of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of ART, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d480b2f999879a949596">[email protected]</a>, a cathepsin B-controllable nanoformulation, employing transferrin (Tf)-peptide-modified mesoporous silica (MSN) to codeliver ART and buthionine-sulfoximine (BSO), a glutathione scavenger, was designed and prepared. Using this system, the Tf-peptide targeted MCF-7 human breast cancer cells to supply additional Fe<sup>2+</sup>, which catalyzes ART, to produce extra reactive oxygen species (ROS) to kill MCF-7 cells efficiently.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, its generally low potency and the generation of MDR have both limited the promise of ART for potential development as an anticancer drug.<a onclick="showRef(event, 'ref19 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref19 ref25 ref26">(19,25,26)</a> To combat these challenges, increasing numbers of ART synthetic derivatives showing improved antitumor activity have been prepared, with some of these having been evaluated in cancer clinical trials, including dihydroartemisinin (DHA, <b>1a</b>) and artesunate (ARS, <b>1b</b>).<a onclick="showRef(event, 'ref15 ref27'); return false;" href="javascript:void(0);" class="ref ref15 ref27">(15,27)</a> Among these derivatives, dimerization and hybridization have proved to be of interest for further oncolytic drug development.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> For example, a nonacetal-type amide-linked deoxoartemisinin dimer, 10-(2′-aminoethyl)deoxoartemisinin dimer <b>(1c</b>), exhibited pronounced activity against MCF-7 human breast cancer cells, with an IC<sub>50</sub> value of 8 nM.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Several fused ART-piperazine-dithioformates were found to be active against human cancer cells, of which the compound 4-cyanobenzyl-ART-piperazinecarbodithioate (<b>1d</b>) showed the most potent activity, with IC<sub>50</sub> values of 2.5 and 14 nM against the SMMC-7721 liver and MCF-7 breast human cancer cell lines, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, both changing the C-10 carbonyl group to a hydroxy group and dimerization of the molecule resulted in the cytotoxicity of <b>1</b> being enhanced (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key SAR conclusions for the synthetic modification of artemisinin (<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Currently, the MDR of oncolytic agents has limited the efficient treatment of many types of cancer, so combination chemotherapy with more than one molecular target is a promising approach to overcome this problem, as evidenced by ART and several of its derivatives.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, a number of ART-estrogen hybrids have been synthesized, and they all exhibited cytotoxicity against human MCF-7, MDA-MB-231, MDA-MB-361, and T47D breast and C33A cervical cancer cells, with the activity improved around 10-fold when compared with their respective parent compounds. Of these, benzylestrondiol-ART nonacetal hybrid (<b>1e</b>) was the most potent, showing IC<sub>50</sub> values of 0.45, 0.86, and 0.15 μM against MCF-7, MDA-MB-231, and C33A cells, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), indicating that hybridization of ART may have translational potential for developing innovative anticancer agents.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">In addition, B-cell lymphoma 2 (Bcl-2) proteins are the key regulators of apoptosis and are overexpressed in tumors, and selective blockade of Bcl-2 represents an attractive cancer target. Several series of compounds synthesized from ART were found to display inhibitory activity against Bcl-2, of which some compounds showed high potency, with IC<sub>50</sub> values being less than 2.0 nM,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> indicating that ART could be a potential lead for the design of Bcl-2-targeted anticancer agents.</div><div class="NLM_p last">In a Phase I, dose-escalation study to assess the safety and efficacy of self-administered artesunate (ARS) vaginal inserts, a total of 28 biopsy-confirmed cervical intraepithelial neoplasia 2/3 (CIN2/3) patients received 1, 2, or 3 five-day treatment cycles (200 mg inserts/time) at study weeks 0, 2, and 4, for 15 weeks. A modified intention-to-treat analysis showed that an overall histologic regression to CIN1 or less was observed in 19 patients, and clearance of HPV genotypes detected at baseline occurred in nine subjects for whom the lesions underwent histologic regression. These findings supported proceeding to Phase II clinical studies for the treatment of CIN2/3 with the topical use of ARS and further indicate the promise for the development of ART-based anticancer agents.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Parthenolide</h3><div class="NLM_p">As summarized previously from the period of 2013–2020, (4<i>R</i>,5<i>S</i>,6<i>S</i>,7<i>S</i>)-parthenolide (PTL, <b>2</b>), an epoxylated germacranolide isolated from <i>Chrysanthemum parthenium</i> L. [syn. <i>Tanacetum parthenium</i> L. (Asteraceae)] (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), has shown cytotoxicity against various human cancer cells and inhibited selectively cancer stem cell (CSC) growth in leukemia and solid tumors, by interacting with multiple molecular targets.<a onclick="showRef(event, 'ref11 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref11 ref35 ref36">(11,35,36)</a> PTL (<b>2</b>) is known to target acute myelogenous leukemia (AML) progenitor and leukemia stem cells (LSCs) that are essential to the growth and potential relapse of acute and chronic myelogenous leukemia (AML and CML) to induce selective robust apoptosis in primary human AML cells and blast crisis CML cells. Such LSC apoptosis induction is mediated by inhibition of nuclear factor kappa B (NF-κB), proapoptotic activation of p53, and by the generation of increased ROS. Thus, PTL shows promise for the design of LSC-targeted antileukemic agents.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Also, it inhibited Panc-1 and BxPC3 human pancreatic cancer cell growth by inducing autophagy-mediated apoptosis, which suggests that PTL could be a potential pancreatic cancer chemotherapeutic agent.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of parthenolide (PTL, <b>2</b>) and its analogues <b>2a</b>–<b>2f</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HepG2 liver cancer, <sup><i>b</i></sup>MCF-7 breast cancer, <sup><i>c</i></sup>MOLM-13, <sup><i>d</i></sup>EOL-1, and <sup><i>e</i></sup>AML leukemia, <sup><i>f</i></sup>HCT116 and <sup><i>j</i></sup>HT-29 colon cancer, <sup><i>g</i></sup>Panc-1 pancreatic, <sup><i>h</i></sup>A549 nonsmall cell lung, and <sup><i>i</i></sup>Bel-7402 human hepatocellular carcinoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, PTL was found to inhibit the proliferation of multidrug-resistant cancer cells. The sensitivity of SGC-7901 human gastric cancer cells to DDP (cisplatin) was enhanced by PTL, and significant apoptosis was induced in drug-resistant SGC-7901/DDP human gastric cancer cells treated with PTL. The proliferation, migration, and invasion of SGC-7901/DDP cells were inhibited by PTL through inhibition of the STAT3 signaling pathway.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> It also inhibited multidrug-resistant MDA-MB-231-BCRP cell growth through the NF-κB and hypoxia-inducible factor (HIF) pathways directly or indirectly. BCRP is a member of the adenosine triphosphate (ATP) binding cassette proteins of efflux transporters responsible for drug disposition and distribution, and expression of BCRP is associated with the tumor response to chemotherapy and resistance. Moreover, PTL has been found to inhibit histone deacetylase (HDAC) activity, which stabilizes HIF-α by decreasing the expression of the von Hippel-Lindau (VHL) tumor suppressor and the tumor protein p53 (p53).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">HIF-1 promotes cancer progression partially by inducing the epithelial-mesenchymal transition (EMT), a phenotypic change in which epithelial cells are transformed to spindle-like motile cells that express mesenchymal markers, and through which cancer cells undergo migration and invasion leading to cancer progression and metastasis. Both HIF and hypoxia-induced EMT play key roles in tumor metastasis, and hence, they are regarded as promising targets for the development of new and effective anticancer therapies. The 2019 Nobel Prize in Physiology or Medicine was awarded jointly to William G. Kaelin, Peter J. Ratcliffe, and Gregg L. Semenza, for their discoveries of how cells sense and adapt to oxygen availability (<a href="https://www.nobelprize.org/prizes/medicine/2019/summary" class="extLink">https://www.nobelprize.org/prizes/medicine/2019/summary</a>). PTL was found to inhibit HIF-1α and hypoxia-mediated EMT through blockade of NF-κB activation to mediate its cytotoxicity toward human colorectal cancer (CRC) HT-29, DLD-1, and HCT116 cells.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Thus, PTL shows promise also for development as a novel HIF-1α inhibitor to treat cancer.</div><div class="NLM_p">Furthermore, PTL activates p53-mediated caspase-dependent apoptosis and inhibits angiogenesis to suppress the proliferation of human A549 nonsmall-cell and H526 small-cell lung cancer cells, and it also inhibited the tumor-promoting effects of nicotine in A549 and H526 cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> It was found recently to target C427 of focal adhesion kinase 1 (FAK1) to inhibit FAK1 activity and its downstream signaling, which leads to impairment of breast cancer cell proliferation, survival, and motility.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> By targeting ribosome proteins L10 (RPL10) that regulate selectively T-cell factor 4 (TCF4)/lymphoid enhancer factor 1 (LEF1) synthesis without affecting β-catenin translation and blocking TCF4/LEF1 synthesis, PTL inhibited Wnt (Wingless-related integration site)/β-catenin signaling and decreased the TCF4/LEF1 protein levels in HEK293 human embryonic kidney cells. It also significantly reduced the TCF4 levels in human SW480, Caco2, and HT-29 colon cancer cells and inhibited expression of the Wnt target gene <i>NKD1</i> to suppress proliferation of these colon cancer cells.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The Wnt/β-catenin pathway plays an essential role in both embryo development and adult tissue homeostasis, and overactivation of this signaling pathway is related closely to tumor formation and progression. Thus, PTL potentially could be used to treat Wnt-driven tumors.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">However, even though PTL shows some promise for development as a novel CSC-targeted anticancer drug with lowered MDR occurrence, its low potency and poor water solubility are limiting factors in this regard. A preliminary SAR (structure–activity relationship) study showed that saturation of the C-11/C-13 double bond or introduction of an additional epoxy group at the C-1 and C-10 positions of PTL resulted in abolished inhibitory activity against Wnt/β-catenin signaling in HEK293 cells, indicating the importance of these pharmacophores.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Following these conclusions, two novel hybrid molecules, namely, parthabine (<b>2a</b>) and parthalan (<b>2b</b>), were synthesized from PTL and two water-soluble anticancer drugs, cytarabine, an antimetabolic agent used for the treatment of AML and acute lymphocytic leukemia (ALL), and melphalan, a drug used against various types of cancers, respectively. The aqueous solubility of <b>2a</b> and <b>2b</b> was increased when compared with PTL, and both prodrugs showed more potent cytotoxicity than PTL, cytarabine, melphalan, PTL plus cytarabine, or PTL plus melphalan toward human HepG2 liver, LNCaP prostate, and MCF-7 breast cancer cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In turn, a water-soluble amino derivative of PTL, dimethylaminoparthenolide (DMAPT or LC-1, <b>2c</b>), was prepared, which showed potent cytotoxicity against AML cells.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> DMAPT inhibited CWR22Rv1 and PC3 human prostate cancer cell growth through generating ROS and inhibition of NF-κB activity.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> It was cytotoxic toward AsPC-1, BxPC-3, MiaPaca-2, and Panc-1 human pancreatic cancer cells and decreased the expression of RPL10 and either p65 or IKKγ to inhibit the NF-κB pathway in Panc-1 and MiaPaca-2 cells.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Radiation therapy (RT) is a critical treatment for advanced nonsmall cell lung carcinoma (NSCLC), but it may result in toxic lesions as characterized by DNA double-strand breaks (DSBs). DMAPT was found to inhibit NF-κB binding activity and DNA DSB repair, which increased the radiation-induced NSCLC cell death,<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> and it radioprotected normal tissues and sensitized prostate tumors to radiation-induced damage.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Thus, DMAPT could be used as a radioprotector in conjunction with cancer radiotherapy or as a NSCLC radiosensitizer for use clinically.</div><div class="NLM_p">A triple drug regimen termed PDT was designed and prepared. This contained PTL to target LSC, 2-deoxyglucose to inhibit dihydronicotinamide-adenine dinucleotide phosphate (NADPH) production from the pentose phosphate pathway (PPP), and temsirolimus to inhibit the nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated oxidative stress responses in AML cells. PDT was more potently toxic than PTL toward both bulk and stem/progenitor populations of primary AML cells, and it showed very limited toxicity toward normal hematopoietic cells. Also, PDT was effective against AML cells that are relatively resistant to PTL, and it mediated antileukemic activity through inducing oxidative stress but without activating the compensatory Nrf2 and PPP responses in primary AML cells.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Following this, increased antitumor efficacy was observed for a cocktail liposome therapy (CLT) when nude mice were inoculated with A549 NSCLC cells, and tumors were formed. The tumor-bearing mice were treated (i.v., every 3 days) with a cocktail therapy (CT) of betulinic acid (20.3 mg/kg), ginsenoside Rh2 (20.0 mg/kg), honokiol (20.7 mg/kg), plus parthenolide (20.5 mg/kg), which synergize with each other or this CLT, with the doses of the four natural products being identical with the doses used for the CT, for nine treatment cycles.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">A series of triazole derivatives of melampomagnolide B (14-hydroxy-PTL) has been synthesized, of which 4-nitrophenoxytriazolmethylmelapomagnolide B (<b>2d</b>) showed the most potent activity toward the cancer cells tested, with up to a 10-fold enhancement compared to PTL (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compound <b>2d</b> induced apoptosis and inhibited proliferation and migration of HCT116 cells, and thus, it was considered as a promising lead compound candidate.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Several other synthetic products with melampomagnolide B conjugated with cinnamic acid or its derivatives have been prepared, of which most compounds showed more potent cytotoxicity than the parent natural product toward MDA-MB-231 human triple-negative breast cancer (TNBC) cells.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Also, several parthenolide-5-fluorouracil (5-FU) (PTL-5-FU) conjugates were synthesized and evaluated against human Bel-7402 HCC cells and the 5-FU-resistant HCC cell line, Bel-7402/5-FU. Some compounds showed enhanced cytotoxicity against both Bel-7402 and Bel-7402/5-FU cells when compared with PTL or 5-FU, including compound <b>2e</b>, indicating promise for the development of PTL-based anti-HCC drugs.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Previously, a furano-analogue of PTL, (+)-goyazensolide (<b>2f</b>), containing a furan ring between the C-3 and C-10 positions, a carbonyl group at the C-1 position, and an ester group at the C-8 position, was isolated and identified as a cytotoxic principle compound from the leaves of <i>Piptocoma rufescens</i> Cass. (Asteraceae).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The complete structure of this compound with a (6<i>R</i>,7<i>R</i>,8<i>S</i>,10<i>R</i>) absolute configuration was confirmed by analysis of its single-crystal X-ray diffraction and NMR and ECD spectroscopic data, inclusive of values of −0.04(13) defined from the Flack parameter and −0.03(4) as determined from the Hooft y parameter, in our recent investigations on this compound.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> (+)-Goyazensolide (<b>2f</b>) was highly cytotoxic toward HT-29 human colon cancer cells and MOLM-13 and EOL-1 human leukemia cells.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> In an vivo study, it exhibited antitumor efficacy when immunodeficient NCr <i>nu</i>/<i>nu</i> mice implanted with hollow fibers containing HT-29 cells were treated intraperitoneally (i.p.) daily with (+)-goyazensolide (<b>2f</b>) at doses of 12.5 mg/kg for 4 days.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Similar to PTL, (+)-goyazensolide (<b>2f</b>) inhibited colon tumor growth by targeting selectively NF-κB,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and it prohibited the proliferation of Sch10545 and Ben-Men cells by reducing the levels of cyclins A and E, phospho-Akt, and NF-κB. Thus, it may have potential for treating neurofibromatosis type 2 (NF2)-associated schwannomas and meningiomas.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Also, (+)-goyazensolide (<b>2f</b>) showed superior in vitro antileukemic potency when compared with PTL, and it was synergistic with midostaurin against both MOLM-13 and EOL-1 cells. Thus, (+)-goyazensolide could be a promising NF-κB-targeted antileukemic lead.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Recently, PTL was characterized as a potential pyruvate kinase M2 (PKM2) activator, and several PTL-related dimers were synthesized and tested against PKM2, of which compound <b>2g</b> was found to show the greatest PKM2-activator activity, showing an IC<sub>50</sub> value of 15 nM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Also, this dimer (<b>2g</b>) was found to be the most potently cytotoxic, and it inhibited proliferation and metastasis of glioblastoma multiforme (GBM) cells. A preliminary SAR study showed that the length of the linker between the two melampomagnolide B units present is important, with derivatives containing longer linkers exhibiting less potent cytotoxicity against U118 GBM cells. To improve on water solubility, a prodrug, <b>2h</b>, was synthesized from <b>2g</b>, which was found to show an ability to penetrate the blood–brain barrier (BBB) and potent antitumor efficacy. Thus, GBM tumor growth was inhibited when 5–6-week-old Bar b/c nude mice were inoculated by U118 GBM cells (1 day) and treated (i.p.) with <b>2h</b> (50 mg/kg, twice a week) for 3 weeks.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> On the basis of these modifications of <b>2</b>, introducing a N-containing substituent at C-13 or dimerization of the molecule appears to enhance the cytotoxicity of <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of parthenolide dimeric derivatives <b>2g</b> and <b>2h</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>PKM2 protein and <sup><i>b</i></sup>U118 human glioma cells and the <sup><i>c</i></sup>dose used in an animal model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Key SAR conclusions for the synthetic modification of parthenolide (PTL, <b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">PKM2 acts as a key metabolic regulator to support cancer cells to maintain a balance of energy and biomolecule precursor requirements, and activation of PKM2 has emerged as a useful target for the discovery of new anticancer agents. Compound <b>2g</b> functions as a potent PKM2 activator, with its prodrug <b>2h</b> showing the potential to penetrate the BBB, and thus, the PTL dimer <b>2h</b> was proposed as an anti-GBM lead compound.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> This indicates that dimerization of PTL could be a reasonable strategy for the design and discovery of novel PTL-based anti-GBM agents.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Thapsigargin</h3><div class="NLM_p">(1<i>R</i>,2<i>S</i>,3<i>S</i>,6<i>S</i>,7<i>R</i>,8<i>S</i>,10<i>S</i>,11<i>S</i>)-Thapsigargin (TPG, <b>3</b>), a SQL isolated originally from the roots of <i>Thapsia garganica</i> L. (Apiaceae), was identified as a skin-irritant principle of this plant (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref11 ref62'); return false;" href="javascript:void(0);" class="ref ref11 ref62">(11,62)</a> It has been characterized as a potent sarco/endoplasmic reticulum (ER) calcium ATPase (SERCA) inhibitor and also exhibits cytotoxicity toward human cancer cell lines.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> Phytochemical information, synthesis methodology, and SAR observations for the inhibitory activities against the SERCA pump and human cancer cell growth of TPG and its derivatives have been summarized from 2015 to 2018,<a onclick="showRef(event, 'ref11 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref11 ref62 ref63 ref64">(11,62−64)</a> and discussed below is an update of these previous reviews on this compound.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of thapsigargin (TPG, <b>3</b>) and an analogue (<b>3a</b>) and a prodrug (<b>3b</b>) and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>EL4 murine lymphoma, <sup><i>b</i></sup>S180 sarcoma, <sup><i>c</i></sup>MCF-7 human breast cancer, <sup><i>d</i></sup>TSU-Pr1, and <sup><i>e</i></sup>LNCaP human prostate cancer cells, and <sup><i>f</i></sup>inhibition of SERCA pump.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">TPG was identified by Christensen and colleagues in 1980.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> It was demonstrated later as a weak tumor-promoting agent when 7–8-week-old female CD-I mice were treated topically with 5 μg of TPG twice a week for 30 weeks, and papillomas and carcinomas were counted every 2 weeks for 52 weeks. Also, a low risk for conversion of these papillomas to malignancies was indicated by the rapid regression of these TPG-promoted papillomas after a 40-week treatment.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Further biological studies showed that TPG is potently cytotoxic toward murine EL4 lymphoma (IC<sub>50</sub> = 0.1 μM) and S180 sarcoma (IC<sub>50</sub> = 0.03 μM) cells, but it showed a lesser activity against MCF-7 human breast cancer cells (IC<sub>50</sub> = 2.3 μM) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> TPG resulted in a loss of clonogenic survival of TSU-Pr1 human prostate cancer cells, while it inhibited skeletal muscle Ca<sup>2+</sup>-ATPase (SERCA), with a low IC<sub>50</sub> value of 3.9 nM.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">As a potent SERCA inhibitor, TPG discharges intracellular Ca<sup>2+</sup> stores in rat hepatocytes by specific inhibition of the endoplasmic reticulum (ER) Ca<sup>2+</sup>-ATPase, and it provides a powerful laboratory tool to test the biochemical functions of SERCA.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> For example, an overall correlation was observed between the inhibition of SERCA and the induction of LNCaP and PC3 human prostate cancer cell death by TPG. Both ER Ca<sup>2+</sup> drainage and sustained unfolded protein response (UPR) were found important for TPG to induce LNCaP and PC3 cell apoptosis at a low concentration.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Influx of Ca<sup>2+</sup> caused by the treatment of human DLD-1 colorectal and SK-OV-3 ovarian cancer cells with TPG enhanced oncolytic adenovirus enadenotucirev (EnAd) replication and cell killing through PKCα (protein kinase C-α) activation. This indicates a signaling pathway between PKC and adenovirus early region 1A (E1A), as well as the possibility of Ca<sup>2+</sup> flux-involved potentiation of oncolytic virotherapies.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> In addition, the level of S100A4 protein in MDA-MB-231 human TNBC cells was found to be decreased significantly by the treatment of cells with TPG, but the cell viability was not inhibited, suggesting that <i>S100A4</i> gene transcription may be regulated by Ca<sup>2+</sup> signaling pathways.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> S100A4, known as metastasin-1, is a calcium-binding protein known to regulate cancer development, while TPG inhibits effectively SERCA to increase Ca<sup>2+</sup> levels in the cytoplasm of cells. Thus, the mechanism of SERCA inhibition by TPG could be supportive of the design of novel anticancer agents targeting tumor metastasis.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p">In addition, TPG induced endoplasmic reticulum (ER) stress that may invoke apoptosis to prohibit the proliferation of PC3 human prostate cancer cells. This could be mediated through the Akt-mTOR and F-actin/cofilin-1/paxillin pathways, as shown by its inhibition of Akt activity and expression of m-TOR, F-actin, and paxillin and induction of caspase-3/9 activities and cofilin-1 expression in PC3 cells.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Induction of ER stress can lead to the formation of autophagic vehicles, which triggers subsequently autophagic or apoptotic cell death. Thus, TPG was found to inhibit MCF-7 human breast cancer cell growth through induction of sequential expression of autophagy and apoptosis-related proteins in cells.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Also, TPG-induced ER stress increased the expression of the cytosine-cytosine-adenosine-adenosine-thymidine (CCAAT)-enhancer-binding protein (C/EBP) homologous protein (CHOP) and the subsequent upregulation of the death receptor 5 (DR5) to promote human esophageal squamous cell carcinoma (ESCC) cell apoptosis. In turn, it inhibited selectively EC109 and TE12 ESCC cell growth, migration, adhesion, and invasion through induction of CHOP in ESCC cells to induce cell apoptosis. TPG also sensitized EC109 and TE12 esophageal cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis via AMPK activation, indicating that activation of ER stress by TPG may support TRAIL-based cancer chemotherapy.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">In mammalian cells, Sec62, a membrane protein of the ER, interacts with the ribosomal tunnel exit to support cotranslational protein entry to regulate ER calcium homeostasis, and the siRNA-mediated depletion of Sec62 was found to sensitize the cancer cells to TPG treatment. Addition of the calmodulin (a multifunctional intermediate calcium-binding messenger protein) antagonist trifluoperazine, an antipsychotic used to treat schizophrenia, was found to mimic the <i>Sec62</i> depletion phenotype to sensitize cancer cells to TPG, indicating a potential therapeutic option of treating <i>Sec62</i>-overproducing tumors with a combination therapy of TPG plus trifluoperazine. Such a possible approach was substantiated by an in vivo investigation, where tumor growth was inhibited when eight-week-old athymic nude mice were inoculated by FaDu human hypopharyngeal squamous cell carcinoma cells, and the tumor-bearing mice were treated (i.p., three times a week) with TPG (1.6 mg/kg) or TPG (1.6 mg/kg) plus trifluoperazine (0.5 mg/kg) for 5 weeks, after solid tumors occurred.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">Mechanistically, TPG induces HCT116 human colon cancer cell apoptosis by activating Bax, a crucial mediator of the mitochondrial pathway, through a caspase-8-dependent pathway. This leads to the release of Smac and Omi into the cytosol to amplify the caspase-8 signal for the activation of caspase-3 and apoptosis.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> In addition, Bax downregulates interleukin-8 (IL-8) expression, and both IL-8 and Hsp60 promote apoptosis resistance in cancer. As a noncompetitive SERCA inhibitor, TPG was found to induce the robust expression of IL-8, since a nanomolar combination of TPG with the histone deacetylase (HDAC) inhibitor apicidin (Api) reduced IL-8 expression and induced apoptosis in human HCT116 colon and LNCaP prostate cancer cells. Interestingly, Bax reconstitution induced cancer cell death in response to the combination treatment of Api and TPG, and IL-8 release was reduced drastically upon Hsp60 knockdown, which inhibits the TGF-β expression that was decreased in LNCaP cells treated with TPG or TPG plus Api. Thus, Hsp60 could regulate IL-8 expression and its upstream regulator TGF-β in cancer cells, and a combination of TPG and Api may abrogate the Hsp60-IL-8-TGF-β axis to overcome apoptotic resistance, which could potentiate the therapeutic outcome in colorectal and prostate malignancies.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">To develop TPG as an effective anticancer agent, a derivative, namely, L12ADT (<b>3a</b>), showing potent activity toward LNCaP cells (IC<sub>50</sub> 14 nM) comparable to TPG (IC<sub>50</sub> 10 nM), was produced by successfully coupling a 12-aminododecanoyl side-chain analogue of TPG to leucine. L12ADT was hydrolyzed efficiently by prostate-specific antigen (PSA), and it was selectively toxic to PSA-producing prostate cancer cells. This indicates the potential for the development of PSA-activated TPG prodrugs for the treatment of metastatic prostate cancer<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> and introducing a large substituent at the C-8 position seems to enhance the antitumor potential of <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Thus, a promising TPG prodrug, mipsagargin (<b>3b</b>, also named G-202), was produced by solid-phase synthesis protocols (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), which is based on the hypothesis that the extracellular prostate-specific membrane antigen (PSMA) may be used to cleave the masking peptide to deliver mipsagargin into tumors specifically.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Key SAR conclusions for the synthetic modification of thapsigargin (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The maximum tolerated dose (MTD), the dose-limiting toxicities (DLTs), the pharmacokinetics, and the recommended phase II dose of mipsagargin (<b>3b</b>) have been determined in a phase I clinical trial study. Altogether, 44 patients (28 patients in the dose escalation phase and 16 patients in an expansion cohort), with different types of locally advanced or metastatic solid tumors, were treated (i.v.) continuously with mipsagargin on days 1, 2, and 3 of 28-day cycles at doses ranging from 1.2 to 88 mg/m<sup>2</sup> until evidence was shown of disease progression or unacceptable toxicity. Mipsagargin was generally well tolerated and demonstrated a favorable pharmacokinetic profile in the patients, and a prolonged disease stabilization was observed in the advanced HCC patients. The recommended phase II dose (RP2D) of 40 mg/m<sup>2</sup> on day 1 and that of 66.8 mg/m<sup>2</sup> on days 2 and 3 with prophylactic premedications and hydration on each day of infusion to help ameliorate the infusion-related reaction (IRR) were established.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p">A phase II multicenter and single-arm study, with mipsagargin used as a second-line therapy following sorafenib, has been completed. Altogether, 19 patients with progressive advanced HCC after treatment with sorafenib or intolerant of sorafenib were treated (i.v.) with mipsagargin at a dose of 40 mg/m<sup>2</sup> on days 1–3 of each 28-day cycle. Mipsagargin was found to be relatively well tolerated and promoted prolonged disease stabilization in patients. Importantly, a significant decrease in <i>K</i><sub>trans</sub> upon the treatment was observed, suggesting that mipsagargin could reduce blood flow in hepatic lesions, and thus, it may have the necessary activity to be evaluated in a larger clinical study.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p last">From being a skin-irritant plant component and a tumor promoter to a tumor inhibitor and then an anticancer prodrug, TPG functions as a potent SERCA inhibitor to prevent the reuptake of calcium from the cytosol to the ER to induce cancer cell apoptosis. The detailed continued investigations of this compound and its derivatives provide a good example of the mechanism-guided development a tumor-targeted agent of natural origin.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Diterpene Lactones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Diterpenes are one of the largest groups of NPs and are composed of two monoterpene units derived from four isoprene subunits (C<sub>20</sub>), of which an increasing number found are diterpene lactones, with either a five-membered γ-lactone or six-membered δ-lactone unit being present. Several compounds of this type of NPs have been investigated for their potent antitumor activity, as exemplified by andrographolide (<b>4</b>), ginkgolide (<b>5</b>), jolkinolide (<b>6</b>), nagilactone (<b>7</b>), and triptolide (<b>8</b>), which will be discussed in turn below.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Andrographolide</h3><div class="NLM_p">Andrographolide (<b>4</b>, AGL) is a bitter-tasting labdane-type diterpene lactone derived from a medicinal plant, <i>Andrographis paniculata</i> (Burm.f.) Nees (Acanthaceae), and it has shown moderate but selective cytotoxicity against human cancer cells.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The (3<i>R</i>,4<i>R</i>,5<i>S</i>,9<i>R</i>,10<i>S</i>,14<i>S</i>) absolute configuration was determined recently by the refinement of the Flack parameter to 0.21(19) from its single-crystal X-ray diffraction data (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Since the potential antitumor activity of AGL and its derivatives has been discussed in two recent review articles in 2018,<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> the following paragraphs provide an update to these previous reviews.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of andrographolide (AGL, <b>4</b>) and its analogues <b>4a</b>–<b>4g</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>A2058 melanoma, <sup><i>b</i></sup>HCT116 colon cancer, <sup><i>c</i></sup>HL-60 leukemia, <sup><i>d</i></sup>HT-29 colon cancer, <sup><i>e</i></sup>MCF-7 and <sup><i>f</i></sup>MDA-MB-231 breast cancer, and <sup><i>h</i></sup>CCRF-CEM leukemia cells and <sup><i>g</i></sup>P-388 murine leukemia cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AGL showed cytotoxicity toward U87 MG human glioma cells, and it inhibited U87 MG cell migration, indicating a possibility of use against glioblastoma multiforme (GBM, the most common and aggressive primary brain tumor in adults).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> It induced apoptosis in HepG2CR cisplatin-resistant human hepatoma cells through the PKA/PP 2A/IKK pathway, demonstrating that AGL may reverse the resistance observed in cisplatin-resistant HepG2CR cells.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div><div class="NLM_p">Recently, a combination of AGL with anti-PD-1 (programmed cell death protein 1) antibody was found to show more potent antitumor activity than either individual agent alone, when 6–8 week-old female BALB/c mice were inoculated by CT26 mouse colon carcinoma cells (3 days) and treated (i.p.) with AGL (5 mg/kg, every day) with or without anti-PD-1 (i.p., 5 mg/kg, every 3 days) for 15 days. This AGL and anti-PD-1 combined therapy increased the infiltration and function of CD<sup>4+</sup> and CD<sup>8+</sup> T cells and tumor suppression cytokine interferon gamma (IFN-γ), perforin, granzyme, and Fas ligand (FasL) expression in tumor tissues. Thus, a combination of a PD-1 blockade with AGL might be a promising strategy for cancer immunotherapy.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p">AGL mediates its antitumor potential through several signaling pathways. For example, it protected SH-SY5Y human neuroblastoma cells from bupivacaine-induced cytotoxicity via inhibition of apoptosis, increasing the antioxidative status, and activation of the Akt–mTOR signaling pathway.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> AGL treatment inhibited cyclooxygenase-2 (COX2, overexpressed in colon cancer to inhibit apoptotic activity, to stimulate adhesion and invasion, and to induce angiogenesis) activity and prostaglandin E<sub>2</sub>(PGE2) release in CT26 mouse colon cancer cells, and thus, it may contribute to reduction of the immune suppressive microenvironment in tumors.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> The docking profiles between AGL or meloxicam, a COX2 blocker, and COX2 showed that AGL has a stronger affinity and more stable bonds than meloxicam when binding to COX2.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> AGL augmented cytotoxicity in SW620 human colon cancer cells through evoking cell apoptosis via suppression of the Toll-like receptor 4 (TLR4)/NF-κB/MMP (matrix metalloproteinase)-9 signaling pathway.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Also, AGL exhibited antiproliferative effects against HT-29 human colon cancer cells by augmentation of intracellular ROS levels and disruption of mitochondrial transmembrane potential (MTP).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> It inhibited PC-3 human prostate cancer cell growth by inducing cell apoptosis and decreasing the vascular endothelial growth factor (VEGF) level in cells.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">Thus, far, andrographolide (<b>4</b>) has been tested in a phase I open-label, randomized, controlled clinical trial. This involved the study of andrographolide with or without capecitabine to treat colorectal cancer (AGCRC-013) (NCT01993472), with 308 participants with unresectable, advanced, recurrent, or metastatic colorectal cancer included. However, this trial study eventually had to be terminated, owing to the low accrual rate (<a href="https://clinicaltrials.gov/ct2/show/NCT01993472" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01993472</a>).</div><div class="NLM_p">Since nanotechnology has offered an opportunity to improve cancer treatments by site-specific and target-directed drug delivery, several new delivery systems have been developed for AGL. Of these, a cell-penetrating peptide (CPP)-assisted liposomal codelivery system (Lipo-CPP) was prepared for AGL plus doxorubicin (DOX), which effectively increased the resultant intratumor infiltration, cellular uptake, and intranuclear accumulation. This Lipo-CPP system exhibited more potent cytotoxicity and inhibitory effects on cell migration and invasion against 4T1 murine breast cancer cells than the free combination of AGL and DOX.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Solid lipid nanoparticles to deliver AGL into the brain were prepared using Compritol 888 ATO as a solid lipid and Brij 78 as a surfactant, and these nanoparticles improved the permeability of AGL to cross the blood-brain barrier (BBB) when compared with free AGL.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> In addition, AGL-loaded regenerated silk fibroin (RSF) as a drug-carrier to encapsulate AGL was prepared successfully, of which the average volume size was about 300 nm, which could be beneficial for lymphatic chemotherapy. These AGL-loaded RSF nanoparticles were shown to adhere to human HeLa cervical and MDA-MB-231 breast cancer cells readily, and they inhibited cell growth more potently than free AGL at concentrations of 50 and 100 μM.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> More recently, an optimized self-microemulsifying drug delivery system (SMEDDS) was prepared for AGL. It increased significantly the overall solubility and cytotoxicity against MCF-7 human breast cancer cells of AGL and is supportive of the oral drug delivery potential of this compound.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><div class="NLM_p">The relatively weak cytotoxic potency observed against cancer cells is another challenge for the development of AGL as a possible new anticancer agent (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Thus, various AGL derivatives were produced by transforming its α-alkylidene-γ-butyrolactone moiety into a C-12-substituted-14-deoxylactone unit. This was completed in each case through a Michael addition reaction, with aminoalkyl, thiophenyl, and substituted aminoaryl groups introduced at the C-12 position of AGL. The cytotoxicity of these synthetic derivatives was evaluated against the NCI60 cell line panel, and those analogues containing a thiophenyl or an aminoaryl group substituted with sulfonamide were found to exhibit the most potent activity toward the majority of the cancer cell lines used. Of these derivatives, 12(α/β)-phenylthio-14-deoxyandrographolide (<b>4a</b>) and 12(α/β)-(<i>N</i>-acetylsulfamoyl)phenylamino)-14-deoxyandrographolide (<b>4b</b>) showed greater activity against HCT116 human colon cancer cells than AGL, with an IC<sub>50</sub> value of 0.85 and 1.7 μM, respectively.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Also, the 12(α/β)-<i>N</i>-sulfamoylphenylamino-14-deoxyandrographolides <b>4c</b> and <b>4d</b> were synthesized, and both compounds showed activity against CCRF-CEM human leukemia cells, with IC<sub>50</sub> values of 0.73 and 0.0073 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Two structurally similar naturally occurring labdane diterpenoids, chlorolissoclimide (<b>4e</b>) and dichlorolissoclimide (<b>4f</b>), were found to be powerful cytotoxins toward P-388 murine leukemia cells, with IC<sub>50</sub> values of 0.004 and 0.002 μM, respectively.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> On the basis of the SAR observations as discussed above, the cytotoxicity of <b>4</b> could be enhanced by introducing a thiophenyl group at the C-12 position, along with removal of the C-14 hydroxy group followed by introducing a double bond at the C-13/C-14 positions and acetylation of hydroxy group at the C-3 and C-19 positions (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Key SAR conclusions for the synthetic modification of andrographolide (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition, a fluorescent AGL derivative, with a nitrobenzoxadiazole (NBD) fluorophore connected at its C-19 hydroxy group, namely, ANDRO-NBD (<b>4g</b>) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), was synthesized. This ANDRO-NBD fluorescent conjugate showed more potent activity than AGL toward human cancer cells, and it was used to analyze the uptake kinetics and cellular distribution and to identify the molecular targets of AGL. This fluorescent conjugate should provide a promising tool for the further investigation of the mechanisms of action of AGL and supports the development of this diterpene lactone and its derivatives as antitumor leads.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Ginkgolide B</h3><div class="NLM_p"><i>Ginkgo biloba</i> L. (Ginkgoaceae), known as ginkgo, is regarded as a living fossil plant that has existed for more than 250 million years, and the leaf extract acts as a free-radical scavenger of nearly all ROS types and is well tolerated and apparently safe when ingested by humans. Thus, ginkgo is used widely to improve mental alertness and memory and also for enhanced vasodilation for improved blood flow.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Recently, ginkgo has become of interest for the treatment and prevention of retinal diseases associated with neurodegeneration, in which the retinal ganglion cells have poor antioxidant capacities and insufficient nucleic acid repair mechanisms.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In addition, ginkgo leaves possess antitumor properties, which results from their antioxidant, antiangiogenic, and gene-regulatory activities.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> For example, a ginkgo leaf extract exhibited cytotoxicity against HepG2 and Hep3B HCC cells,<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> and it suppressed the proliferation of OVCA429 human ovarian cancer cells.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Ginkgolides B (GKL B, <b>5</b>), A (GKL A, <b>5a</b>), and C (GKL C, <b>5b</b>), the caged diterpene trilactones comprising six five-membered rings, were isolated as the major bitter principles from the leaves of ginkgo,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> and their structures were established by single-crystal X-ray diffraction analysis (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(109,110)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of ginkgolide B (GKL B, <b>5</b>) and its analogues <b>5a</b>–<b>5e</b> and IC<sub>50</sub> (μM) values for the inhibition of PAF-induced platelet aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The (1<i>R</i>,2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>,8<i>S</i>,9<i>S</i>,10<i>R</i>,12<i>R</i>,14<i>S</i>) absolute configuration of GKL B (<b>5</b>) was determined by analysis of its NMR spectroscopic data and comparison with those of GKL A (<b>5a</b>), for which the (2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>,8<i>S</i>,9<i>S</i>,10<i>R</i>,12<i>R</i>,14<i>S</i>) absolute configuration was established from the Flack parameter of −0.02(12) measured by the single-crystal X-ray diffraction with Cu Kα radiation at 296 K for ginkgolide A monohydrate. Following these studies, the (1<i>R</i>,2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>,7<i>R</i>,8<i>S</i>,9<i>S</i>,10<i>R</i>,12<i>R</i>,14<i>S</i>) absolute configuration was determined for ginkgolide C (<b>5b</b>) sesquihydrate.<a onclick="showRef(event, 'ref108 ref111'); return false;" href="javascript:void(0);" class="ref ref108 ref111">(108,111)</a></div><div class="NLM_p">The early biological investigations on GKLs focused on their activity toward platelet-activating factor (PAF or PAF-acether), a naturally occurring etherphospholipid generated by specific activation of rabbit basophils, human and rabbit polymorphonuclears, and human macrophages and eosinophils to potentially mediate anaphylaxis and shock. In 1985, Braquet and colleagues identified GKLs A–C as specific PAF inhibitors, which inhibited both the binding of [<sup>3</sup>H] PAF-acether to its receptor, with IC<sub>50</sub> values (μM) of 0.94 (GKL A), 0.25 (GKL B), and 17 (GKL C), and PAF-dependent platelet aggregation. Of these compounds, GKL B (<b>5</b>) was found to be the most potently active, indicating the importance of the hydroxy groups occurring at the C-6 and C-10 positions.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> These conclusions were confirmed by investigations of the binding of GKLs and their synthetic derivatives to a cloned PAF receptor (PAFR), which showed that several GKL derivatives containing aromatic photoactivatable substituents at the C-10 position were active PAFR antagonists.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Following these observations, more potent PAFR inhibitors, namely, 10-<i>O</i>-(((anthracen-2-yloxy)methyl)-1<i>H</i>-1,2,3-triazole) ginkgolide B (<b>5c</b>), 10-<i>O</i>-(((anthracen-2-yloxy)methyl)-1<i>H</i>-1,2,3-triazole) ginkgolide A (<b>5d</b>), and 10-<i>O</i>-(((anthracen-2-yloxy)methyl)-1<i>H</i>-1,2,3-triazole) ginkgolide C (<b>5e</b>), were synthesized from GKLs B (<b>5</b>), A (<b>5a</b>), and C (<b>5b</b>), respectively, through an azide–alkyne Huisgen cycloaddition reaction. These ginkgolide derivatives showed considerably enhanced PAFR inhibitory activity when compared to their parent compounds (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), and they did not exhibit any toxicity toward cardiomyocytes and platelets. Of these, the derivative <b>5c</b> inhibited PAF-induced platelet aggregation at the nanomolar level (IC<sub>50</sub> = 5.7 nM).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> These indicate that introducing a hydroxy group at the C-7 position decreases the PAF inhibitory activity of <b>5</b>, but substituting a triazole-containing substituent at the C-10 position may increase this effect (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Key SAR conclusions for the synthetic modification of ginkgolide B (<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The role of PAF/PAFR in tumors has been well-documented recently. The tumor microenvironment (TME) is essential for the development of tumors, where PAF-like phospholipids are generated because of the increased apoptotic cells under hypoxia. The overexpressed PAFR may thus induce a regulatory/tolerogenic phenotype to protect cancer cells from death induced by chemotherapy, and hence a combination of PAFR antagonists with other chemotherapeutic agents may benefit cancer treatment.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Hence, the upregulation of PAFR was observed in SKOV-3 and CAOV-3 human ovarian cancer cells treated with cisplatin (CDDP), and inhibition of PAFR sensitized the ovarian cancer cells to CDDP.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> In a recent study, mesenchymal stem cells (MSCs) were found to induce the TME to secrete high concentrations of PAF, of which the receptor PAFR was overexpressed in ovarian cancer cells (OCC). Therefore, the tumor-promoting effect of MSCs in OCCs via their interaction in the TME seems, at least in part, to be mediated by the PAF/PAFR pathway, indicating that inhibition of PAFR can suppress ovarian tumor growth.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><div class="NLM_p">As a potent PAF inhibitor, GKL B exhibits multiple bioactivities, including potential anti-Alzheimer’s (i.e., protective effects on neuronal degeneration), anti-inflammatory, antitumor, and antiviral activities, as summarized in 2007 in a review article.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Even though GKL B showed no discernible cytotoxicity against OVCA429 human ovarian cancer cells (IC<sub>50</sub> > 50 μM),<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> it was found to decrease the level of the zinc finger E-box-binding homeobox 1 (ZEB1) in T24 human bladder cancer cells (IC<sub>50</sub> = ∼0.5 μM) to suppress T24 cell invasion via upregulating miR-223-3p.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> ZEB1 is a protein encoded by the <i>ZEB1</i> gene and a key promoter of EMT initiation for maintaining the adapted mesenchymal phenotype, which triggers EMT to allow cancer cells to adapt to a phenotype favoring invasiveness and metastases, and thus GKL B may possess some therapeutic potential to reduce bladder cancer metastases.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p">Although GKL B did not show any evident growth inhibitory activity against BxPC-3, Capan-1, MiaPaCa-2, and Panc-1 human pancreatic cancer cells, it enhanced the sensitivity, proliferation inhibition, and apoptosis induction of gemcitabine in these cells. This indicates that GKL B might have some therapeutic potential to combat MDR observed in the treatment of pancreatic cancer with gemcitabine.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> In addition, in HEI-OC1 (the house ear institute-organ of Corti 1) mouse auditory cells, GKL B decreased superoxide generation through down-regulation of p53 and the downstream targets, NOX4 and p66shc regulated by miR214, to inhibit cisplatin-induced cytotoxicity in these cochlear cells,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> suggesting that GKL B may decrease the side effects on auditory perception of cisplatin in the treatment of cancer.</div><div class="NLM_p">In vivo studies have shown that the antiovarian tumor efficacy of CDDP was enhanced markedly by GKL B when four- to six-week-old female athymic <i>nu</i>/<i>nu</i> mice injected by human ovarian cancer SKOV-3-luc cells, with the region of interest of tumor tissues being reached around 1 × 10<sup>9</sup>, and then the mice were treated (i.p.) with GKL B (10 mg per mouse, daily), CDDP (5 mg/kg, once a week), or GKL B (10 mg per mouse, daily) plus CDDP (5 mg/kg, once a week) for 3 weeks.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Also, the antipancreatic tumor activity of gemcitabine was potentiated by GKL B when six-week-old nude mice were inoculated by Capan-1 human pancreatic cancer cells (2 weeks) and treated (i.p. every 3 days) with gemcitabine (100 mg/kg), GKL B (40 mg/kg), or gemcitabine (100 mg/kg) plus GKL B (40 mg/kg) for 4 weeks.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">In addition, diethylnitrosamine (DEN)-induced HCC was inhibited by GKL B nanocapsules when adult male Swiss Albino rats were injected intraperitoneally by three doses of DEN (200 mg/kg, in olive oil), with 15-day intervals between doses, and treated (orally by gavage, once a week) with PEG-containing GKL B nanocapsules (5 mg/kg), or GKL B nanocapsules without PEG (5 mg/kg) for 16 weeks.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Colitis-associated tumorigenesis and angiogenesis were inhibited significantly when eight-week-old female C57/BL6 mice were injected (i.p.) with azoxymethane (AOM) on day 1, followed by three cycles of 2% dextran sulfate sodium (DSS) in the drinking water for 7 days and treated (i.p., daily) with GKL B (10 mg/kg) for 2 weeks.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> These results indicate that GKL B may suppress tumorigenesis.</div><div class="NLM_p last">The tumor-promoting effect of PAF could be mediated by acting against both tumor and host cells, for which activation of PAFR at the cellular level may increase cell resistance to injury induced by chemotherapeutic drugs, while that at the tissue level could promote the clearance of dying cells, apoptotic bodies, or cell debris to trigger a loop for tumor cell repopulation.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Several 10-triazole synthetic derivatives of GKL B, including <b>5c</b>, <b>5d</b>, and <b>5e</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) exhibited more potent PAFR inhibitory activity than GKL B itself, and thus, these compounds could be investigated for their in vivo antitumor potential and mechanism of action. Following this, GKL B and its derivatives <b>5c</b>–<b>5e</b> might be evaluated in cancer clinical trials as an adjuvant therapy, with the development of ginkgolide drug conjugates being supportive of established cancer treatments.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Jolkinolide B</h3><div class="NLM_p">Jolkinolide B (JKL B, <b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) was isolated originally from the fresh roots of <i>Euphorbia jolkini</i> Boiss. (Euphorbiaceae) in the early 1970s,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> and it was characterized later as a major bioactive component of the dried roots of <i>Euphorbia fischeriana</i> Steud (Euphorbiaceae).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The structure of JKL B was confirmed by single-crystal X-ray diffraction data,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> with the (5<i>R</i>,8<i>S</i>,9<i>R</i>,10<i>R</i>,11<i>R</i>,12<i>R</i>,14<i>R</i>) absolute configuration determined by comparison of its spectroscopic data with those of a closely related analogue, fischeriabietane E (<b>6a</b>), for which the configuration was assigned by analysis of the experimental and calculated ECD spectra.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of jolkinolide B (JKL B, <b>6</b>) and its analogues <b>6a</b>–<b>6f</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>C4–2B human prostate cancer, <sup><i>b</i></sup>HCT-15 human colon cancer, <sup><i>c</i></sup>MCF-7 and <sup><i>d</i></sup>MDA-MB-231 human breast cancer, <sup><i>e</i></sup>UACC62 human melanoma, <sup><i>f</i></sup>Bel-7402 human lung cancer, <sup><i>g</i></sup>HT-29 human colon cancer, <sup><i>h</i></sup>Panc-28 human pancreatic cancer, and <sup><i>i</i></sup>Ramos B human Burkitt’s lymphoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An early study showed JKL B to be cytotoxic against HeLa human cervical cancer cells (IC<sub>50</sub> 7.0 μM),<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and, as summarized recently in 2018, it exhibited inhibitory effects on cell growth against a panel of human cancer cells, with IC<sub>50</sub> values being in the range 10–250 μM.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> For example, it suppressed the proliferation of human A549 and HepG2 liver cancer cells and induced apoptosis in these cells and in HUVECs (human umbilical vein endothelial cells).<a onclick="showRef(event, 'ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref128 ref129">(128,129)</a> It inhibited the adhesion of MDA-MB-231 human breast cancer cells to fibronectin and thus showed a potential antimetastatic effect on breast cancer.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> In an in vivo study, JKL B was found to suppress melanoma growth through induction of apoptosis in B16F10 mouse melanoma cells when C57BL/6 mice were inoculated by B16F10 cells (1 week) and treated daily (i.g.) with JKL B at doses of 10, 20, and 40 mg/kg for a week, with the tumor growth inhibition rates being 17.3%, 34.6% and 54.4%, respectively.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">JKL B (<b>6</b>) mediates its potential antitumor activity by multiple mechanisms demonstrated so far. It reduces the expression of the VEGF protein in A549 cell xenograft lung tumors by inhibiting the Akt/STAT3/mTOR signaling,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> while it attenuated the attachment of MDA-MB-231 human breast cancer cells to fibronectin by modulation of the integrin/focal adhesion kinase (FAK) and ERK (extracellular signal-regulated kinases) pathways.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> It reduces cell viability and induced apoptosis in HL-60 and THP-1 human leukemic cells, at least in part, through the downregulation of Janus kinases2 (JAK2)/STAT3,<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> and it was found to induce MCF-7 breast cancer cell apoptosis by inhibition of the PI3K/Akt/mTOR signaling pathway.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><div class="NLM_p">In addition, JKL B induced apoptosis in HT-29 and SW620 human colon cancer cells through a ROS-ER stress-Ca<sup>2+</sup>-mitochondrial dependent pathway. The generation of invoked ROS and ER stress by JKL B triggered Ca<sup>2+</sup> release from the ER and mitochondrial Ca<sup>2+</sup> uptake that led to mitochondrial depolarization, and thus JKL B was proposed as a potential anticolon tumor agent.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Intriguingly, JKL B inhibited A549 and H1299 NSCLC cell viability through reduction of the glucose consumption, lactate production, and hexokinase 2 (HK2) expression in cells by targeting the Akt/mTOR pathway.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Similarly, it mediated its antimelanoma activity through downregulation of the mRNA expression of genes of glucose transporters (GLUTs 1, 3, and 4) and glycolysis-related kinase [HK2 and LDHA (lactate dehydrogenase A)] in B16F10 mouse melanoma cells.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">It has been necessary to identify the pharmacophores of JKL B through SAR investigations with the objective of improving its antitumor potential. Comparison of the cytotoxicity of JKL B and several naturally occurring analogues showed that 17-hydroxyjolkinolide B (<b>6b</b>) was less potently active than JKL B itself, indicating that introducing a hydroxy group at the C-17 position diminishes the resultant potency.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Quite potent inhibitory activity against Ramos B human Burkitt’s lymphoma cells (IC<sub>50</sub> 0.059 μM) was observed for 17-acetoxyjolkinolide B (<b>6c</b>),<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> suggesting that 17-acetylation may improve the cytotoxicity of <b>6</b>. De-epoxylation at the C-11 and C-12 positions resulted in the cytotoxic potency being decreased, as shown for fischeriabietane E (<b>6a</b>), which did not display any activity toward human Bel-7402 lung, HT-29 colon, and Panc-28 pancreatic cancer cells, and jolkinolide A (<b>6d</b>) that was much less active than <b>6</b>.<a onclick="showRef(event, 'ref125 ref136'); return false;" href="javascript:void(0);" class="ref ref125 ref136">(125,136)</a> Further hydroxylation at C-17 of <b>6d</b> increased its activity, as indicated by caudicifolin (<b>6e</b>) (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>),<a onclick="showRef(event, 'ref125 ref136'); return false;" href="javascript:void(0);" class="ref ref125 ref136">(125,136)</a> and introducing a conjugated system over C-8 and C-13–C-15 and a C-17 hydroxy group enhanced the cytotoxicity of JKL B against ANA-1 murine macrophages and Jurkat human T lymphoma cells.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Thus, the natural product mangiolide (<b>6f</b>) was more active than <b>6</b>, showing cytotoxicity against human MCF-7 breast cancer and UACC62 melanoma cells, with IC<sub>50</sub> values of 0.13 and 0.08 μM, respectively.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> These SAR conclusions suggest that the cancer cell cytotoxicity of JKL B may be improved by modifications at the C-8, C-11–C-14, and C-17 positions, and a conjugated C-14 carbonyl group seems important for the mediation of this type of activity. Removal of the epoxy group at the C-11 and C-12 positions decreases the cytotoxic potency of <b>6</b>, but introducing a C-14 carbonyl group conjugated with double bonds at C-7(8) and C13(15) positions potentiates the cytotoxicity of <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Key SAR conclusions for the synthetic modification of jolkinolide B (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is worthy noting that while 17-hydroxyjolkinolide B (<b>6b</b>) showed a only weak tumor cell cytotoxicity,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> it inhibited strongly IL-6-induced STAT3 activation by directing the JAK family kinases and induced apoptosis in HepG2 hepatoma cells,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> while 17-acetoxyjolkinolide B (<b>6c</b>) was found to inhibit NF-κB signaling by directly interacting with IKK-β.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Thus, both <b>6b</b> and <b>6c</b> show some promise as antitumor agents by targeting the JAK/STAT3 and NF-κB pathways.</div><div class="NLM_p last">Cancer cells require large amounts of glucose transported by glucose transporters (GLUTs) to meet their rapid proliferation rate, and GLUTs have attracted wide interest for the potential treatment or diagnosis of cancer. Many plant-derived glucose transport inhibitors have been found to show potential antitumor activity, and some of these may have use in addressing the management of toxicity and MDR observed with current anticancer drugs.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> As discussed above, JKL B inhibited glycolysis in human NSCLC and mouse melanoma cells and showed antitumor activity,<a onclick="showRef(event, 'ref131 ref135'); return false;" href="javascript:void(0);" class="ref ref131 ref135">(131,135)</a> and several of its analogues showed more potent tumor cell cytotoxicity than JKL B. Thus, the development of JKL B as a new anticancer agent by targeting GLUTs to lower side effects could be a promising future strategy, and this is supported by its high nontoxic i.p. dose of 40 mg/kg that was able to be used in an animal model.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Nagilactone E</h3><div class="NLM_p">Nagilactone E (NGL E, <b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) is a labdane-type C<sub>19</sub>-norditerpene dilactone isolated and identified from the leaves and seeds of <i>Podocarpus nagi</i> Zoll. et Moritzi and the roots and bark of <i>Podocarpus macrophyllus</i> D. Don (Podocarpaceae).<a onclick="showRef(event, 'ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref143 ref144">(143,144)</a> The structure of NGL E was supported from single-crystal X-ray diffraction data of its close natural analogues makilactone I (<b>7a</b>) and 3-deoxy-2β-hydroxynagilactone E (<b>7b</b>).<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144,145)</a> The (3<i>S</i>,4<i>R</i>,5<i>R</i>,6<i>S</i>,7<i>R</i>,8<i>R</i>,10<i>S</i>,14<i>R</i>) absolute configuration was proposed originally by analysis of the ECD spectrum of NGL E<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> and confirmed by single-crystal X-ray diffraction experiments for <b>7b</b> and 1-deoxy-2β-hydroxynagilactone A (<b>7c</b>), of which the absolute configuration was determined by analysis of the Flack parameter [0.06 (3)] for <b>7b</b> and the graphite-monochromated Cu Kα radiation for <b>7c</b>.<a onclick="showRef(event, 'ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref145 ref146">(145,146)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of nagilactone E (NGL E, <b>7</b>) and its analogues <b>7a</b>–<b>7g</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>A549 and <sup><i>b</i></sup>NCI-H1975 human nonsmall cell lung cancer, <sup><i>c</i></sup>P-388 murine leukemia, <sup><i>d</i></sup>A431 human epidermoid carcinoma, <sup><i>e</i></sup>AGS human gastric cancer, <sup><i>f</i></sup>HeLa human cervical cancer, <sup><i>g</i></sup>HepG2 human hepatoma, <sup><i>h</i></sup>MDA-MB-231 human breast cancer, <sup><i>i</i></sup>Panc-1 human pancreatic cancer, <sup><i>j</i></sup>U87 human glioma, and <sup><i>k</i></sup>A2780 and <sup><i>l</i></sup>HEY human ovarian carcinoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">NGL E was found to be cytotoxic against P-388 murine leukemia cells (IC<sub>50</sub> 0.72 μM) and showed moderate growth inhibitory activity in A549 (IC<sub>50</sub> 5.2 μM) and NCI-H1975 (IC<sub>50</sub> 3.6 μM) human NSCLC cells (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref144 ref147'); return false;" href="javascript:void(0);" class="ref ref144 ref147">(144,147)</a> It also inhibited TGF-β1-induced EMT, migration, and invasion in NSCLC A549 cells.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> An in vivo study demonstrated that lung tumor growth was suppressed significantly when male CB-17/SCID mice (14–16 g) were inoculated by A549 cells (1 week) and treated (i.p.) daily with NGL E (10 mg/kg) for 3 weeks, with no obvious adverse effects being observed in the test mice.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Mechanistic studies indicated that NGL E inhibits proliferation in A549 and NCI-H1975 cells through induction of G2 phase cell cycle arrest and caspase-dependent cell apoptosis, and it decreases the protein levels of cyclin B1, as well as the nuclear localization in these cells.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> As a potential protein synthesis inhibitor, NGL E targets RIOK2 [RIO (right open reading frame) kinase 2] to inhibit lung tumor growth.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div><div class="NLM_p">Investigation of the cytotoxicity of NGL E and its analogues showed that various substituents seem essential in this regard. Removal of the C-3 hydroxy group [e.g., as in nagilactone G (<b>7d</b>)] increased slightly the cytotoxicity of NGL E (<b>7</b>), but introducing further hydroxy groups at the C-1 and C-16 positions [e.g., as in makilactone I (<b>7a</b>)] resulted in the activity being decreased,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> indicating that these hydroxy groups might not be required for maximal cytotoxicity. A switch of the hydroxy group from C-3 to C-2 [e.g., as in 3-deoxy-2β-hydroxynagilactone E (<b>7b</b>)] potentiated activity, but this did not change greatly when the pyrone ring was altered to a dihydropyrone unit followed by a replacement of the C-17/C-18 epoxy group with a C-7 hydroxy group [e.g., 1-deoxy-2β-hydroxynagilactone A (<b>7c</b>)].<a onclick="showRef(event, 'ref145 ref146 ref150'); return false;" href="javascript:void(0);" class="ref ref145 ref146 ref150">(145,146,150)</a></div><div class="NLM_p">In addition, the activity of <b>7</b> against A549 cells was improved slightly by hydroxylation at the C-16 position [16-hydroxynagilactone E (<b>7e</b>)], but such a change as exemplified by 3-deoxy-2β,16-dihydroxynagilactone E (<b>7f</b>) reduced the potency of <b>7b</b>.<a onclick="showRef(event, 'ref145 ref147 ref150'); return false;" href="javascript:void(0);" class="ref ref145 ref147 ref150">(145,147,150)</a> However, substitution of a glucose unit at the C-16 hydroxy group of <b>7e</b> [e.g., 16-<i>O</i>-β-<span class="smallcaps smallerCapital">d</span>-glucopyranosylnagilactone E (<b>7g</b>)] resulted in the cytotoxicity being abolished for all of human A431 epidermoid carcinoma, A549 NSCLC, and U87 glioma cells (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> While the C-7/C-8 epoxy group seems not critical for the mediation of the cytotoxicity of these norditerpene dilactones, as suggested by the similar cytotoxic potencies against P-388 cells observed for <b>7d</b> and nagilactone F (<b>7h</b>) and those against HeLa cells for <b>7b</b> and 2β-hydroxynagilactone F (<b>7i</b>), introduction of a 2β-hydroxy group still leads to the activity of <b>7h</b> being retained (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref144 ref145 ref151'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref151">(144,145,151)</a> Replacing the C-ring with a pyrone unit plus changing the 2β-hydroxy group to a C-1/C-2 epoxy moiety followed by introduction of hydroxy group at the C-3 and C-7 positions [e.g., nagilactone C (<b>7j</b>)] diminished the activity of <b>7i</b> considerably.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of nagilactone E analogues <b>7h</b>–<b>7r</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>AGS human gastric cancer, <sup><i>b</i></sup>HeLa human cervical cancer, <sup><i>c</i></sup>HepG2 human hepatoma, <sup><i>d</i></sup>MDA-MB-231 human breast cancer, <sup><i>e</i></sup>P-388 murine leukemia, <sup><i>f</i></sup>Panc-1 human pancreatic cancer, <sup><i>g</i></sup>NCI H460 human large-cell and <sup><i>k</i></sup>NCI H446 human small-cell lung cancer, <sup><i>h</i></sup>SMMC-7721 human hepatocarcinoma, <sup>i</sup>SW1990 human pancreatic cancer, and <sup><i>j</i></sup>MCF-7 human breast cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, removal of the C-17 methyl group from <b>7h</b> [e.g., makilactone A (<b>7k</b>), a C<sub>18</sub>-bisnorditerpene dilactone] or further substitutions of the C-2/C-3 and C-7/C-8 epoxy and C-3 hydroxy groups [e.g., as in inumakilactone B (<b>7l</b>)] did not change greatly the resultant potency. However, addition of a water molecule at the Δ<sup>15(16)</sup> double bond [inumakilactone A (<b>7m</b>)] decreased potency, while further introduction of a C-16 hydroxy group resulted in formation of an inactive compound, makilactone M (<b>7n</b>) (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> These observations indicate that the 17-methyl and 1,2- and 7,8-epoxy groups are not required for nagilactone F (<b>7h</b>) to mediate its cytotoxicity, while the introduction of a 15,16-diol unit abrogated this type of activity. Thus, modification at the C-14 side chain could be important to improve on the cancer cell cytotoxic potencies of the nagilactone derivatives.</div><div class="NLM_p">Therefore, it is pertinent to note that wentilactone A (<b>7o</b>), a C<sub>16</sub>-tetranorlabdane diterpene dilactone derived from the fungus <i>Aspergillus wentii</i> (Trichocomaceae), with the C-14 side chain being absent, exhibited weak cytotoxicity toward human cancer cells (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152,153)</a> Wentilactone A (<b>7o</b>) was found to induce apoptosis and G2/M arrest in human NCI H460 large-cell and NCI H446 small-cell lung cancer cells via the Ras/Raf/ERK pathway, targeting HRas-guanosine-5′-triphosphate (GTP). Lung tumor growth was inhibited when five-week-old male BALB/<i>c</i> athymic mice were inoculated with NCI H460 and NCI H446 cells and treated daily (i.p.) with wentilactone A (5 mg/kg) for 20 days after solid tumors appeared.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><div class="NLM_p">Investigation of the cytotoxicity of wentilactone A (<b>7o</b>) and its close analogues, asperolide E (<b>7p</b>), wentilactone B (<b>7q</b>), and asperolide A (<b>7r</b>), showed that all of these tetranorditerpene dilactones exhibited comparable low activity, with IC<sub>50</sub> values being in the range 10–70 μM (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref153 ref155'); return false;" href="javascript:void(0);" class="ref ref153 ref155">(153,155)</a> This indicates that the C-1/C-2 epoxy group and the position of the hydroxy group connected to the A-ring do not affect greatly the cytotoxicity of these compounds. Similar to wentilactone A (<b>7o</b>), wentilactone B (<b>7q</b>), a tetranorditerpene dilactone isolated from <i>Aspergillus wentii</i>,<a onclick="showRef(event, 'ref152 ref156'); return false;" href="javascript:void(0);" class="ref ref152 ref156">(152,156)</a> induced efficiently apoptosis in SMMC-7721 human hepatoma cells to suppress cell proliferation, and it also inhibited migration of SMMC-7721 cells by interacting with the cell-surface receptors, CD44 and EGFR.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Liver tumor growth was inhibited significantly when nude mice were inoculated by SMMC-7721 cells (1 week) and treated (i.p.) once every 2 days with wentilactone B (<b>7q</b>, 10 mg/kg) for 3 weeks, and no obvious adverse effects were observed in these mice.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Mechanistically, wentilactone B binds directly to Ras–GTP to induce cell cycle arrest at the G2 phase and mitochondrial-related apoptosis in SMMC-7721 cells through the Ras/Raf/ERK and Ras/Raf/JNK signaling pathways.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><div class="NLM_p">Asperolide A (<b>7r</b>) suppressed lung tumor growth when six-week-old BALB/<i>c</i> male athymic mice were inoculated with NCI-H460 human large-cell lung cancer cells and treated (i.v.) with asperolide A (5 mg/kg) once every 2 days for 20 days after solid tumors were formed. No obvious changes were observed in the body weights of the treated mice.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> This dilactone (<b>7r</b>) mediates its antitumor activity by inhibition of cell-cycle progression at the G2/M phase through decreasing the levels of CDC2, cdc25c, and cyclin B, as well as by induction of G2/M arrest mediated by p53-dependent p21 induction and regulated by the Ras/Raf/MEK/ERK signaling pathway.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><div class="NLM_p">Investigation of the cytotoxicity reported for nagilactone E (NGL E, <b>7</b>) and its analogues indicates that a switch of the hydroxy group from C-3 to C-2 potentiated the cytotoxicity of <b>7</b> against A549 cells, but introducing a glucopyranosyl group at the C-17 position resulted in such activity being abolished (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Key SAR conclusions for the synthetic modification of nagilactone E (<b>7</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The RIO family of atypical serine protein kinases has been characterized recently based on the gene <i>RIO</i>, with its representatives occurring widely among organisms, from archaea to humans. The ubiquitous presence and enzymatic activity involving ribosome biogenesis, a fundamental process in all living cells, suggest that RIOK could be novel targets for drug design.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> More recently, RIOK2 was found to be highly expressed in A549, H1299, H1975 and H1650 NSCLC cancer cells and tissues from NSCLC patients, and the expression of RIOK2 and NOB1 (Nin one binding) was associated significantly with tumor and lymph node metastasis and differentiation and patient survival rates, suggesting that these proteins could be potential targets for NSCLC therapy.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p last">NGL E (<b>7</b>) targeted RIOK2 to inhibit protein synthesis to subsequently suppress A549 NSCLC tumor growth in mice.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Treatment (i.p.) with all of compounds <b>7</b>, <b>7o</b>, <b>7q</b>, and <b>7r</b> did not result in any toxicity in mice,<a onclick="showRef(event, 'ref149 ref154 ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref149 ref154 ref158 ref159">(149,154,158,159)</a> and 3-deoxy-2β,16-dihydroxynagilactone E (<b>7f</b>) mediates its cancer cell cytotoxicity through inhibiting JAK2/STAT3 signaling.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> All of the analogues of <b>7</b> presented herein are natural products, and novel agents produced from the synthetic derivatization of NGL E (<b>7</b>) could contribute to the control of cancer by inhibition of tumor metastasis, and targeting RIOK2. In this regard, introducing a triazole unit as used in the modification of GKL B (<b>5</b>) at the C-14 position of <b>7</b> might enhance such a possibility.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Triptolide</h3><div class="NLM_p">Triptolide (TPL, <b>8</b>), along with its analogues tripdiolide (<b>8a</b>) and triptonide (<b>8b</b>), which are 18(4 → 3) <i>abeo</i>-abietane-type diterpenoid triepoxide lactones, were isolated originally from the roots of <i>Tripterygium wilfordii</i> Hook.f. (Celastraceae), a traditional Chinese medicine, namely, “Lei Gong Teng” (Thunder God Vine), by Kupchan and his associates at University of Virginia in 1972. Subsequently, the complete structure and stereochemistry were determined by analysis of its single-crystal X-ray diffraction data and those of <b>8a</b> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>), and the consistent absolute configuration [(5<i>S</i>,7<i>S</i>,8<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>S</i>,12<i>S</i>,13<i>R</i>,14<i>R</i>) for <b>8</b> and (3<i>S</i>,5<i>S</i>,7<i>S</i>,8<i>S</i>,9<i>S</i>,10<i>S</i>,11<i>S</i>,12<i>S</i>,13<i>R</i>,14<i>R</i>) for <b>8a</b>] was also defined by the Hamilton’s <i>R</i>-factor ratio test and the measurement of intensity differences in selected Friedel pairs of reflections.<a onclick="showRef(event, 'ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref163 ref164">(163,164)</a> In their early investigation, both <b>8</b> and <b>8a</b> were found to show potent cytotoxicity against KB human oral epidermoid carcinoma cells (IC<sub>50</sub> 0.27–2.8 nM) and significant antileukemic activity against the L1210 and P-388 murine leukemias at a dose of 0.1 mg/kg.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of triptolide (TPL, <b>8</b>) and its analogues <b>8a</b>–<b>8h</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>B16F10 mouse melanoma, <sup><i>b</i></sup>BGC-823 human gastric cancer, <sup><i>c</i></sup>HCT116 human colon cancer, <sup><i>d</i></sup>HepG2 human hepatoma, <sup><i>e</i></sup>NCI-H1650 human bronchoalveolar carcinoma, <sup><i>f</i></sup>Panc-1 human pancreatic cancer, and <sup><i>g</i></sup>PC3 and <sup><i>h</i></sup>DU-145 human prostate cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar to the traditional medicinal use of the roots of <i>T. wilfordii</i> for the treatment of rheumatoid arthritis, cancer, and other inflammatory and autoimmune diseases, TPL exhibits analogous bioactivities in the laboratory, targeting the IL-6/8, MMPs, PGE2, and TLR2/4 through the p38 and ERK, MAPK, and NF-κB pathways.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Previously, the potential therapeutic effects of TPL toward human malignancies by the induction of cancer cell apoptosis and inhibition of cell invasion and migration and tumor vascularization have been reviewed in 2018.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> The regulation of pro- and antiapoptotic proteins by TPL to induce breast cancer cell apoptosis through interacting with Akt, ERK, FAK, NF-κB, VEGF and other related signaling pathways to suppress breast tumor growth,<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> as well its antipancreatic cancer properties in different experimental models through the angiogenic, apoptosis, and autophagic pathways, also have been summarized in 2017.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> As an update to these reviews, the present perspective article focuses on the structural requirements and molecular targets of TPL to provide important indicators for the design of further TPL-type antitumor agents.</div><div class="NLM_p">TPL exhibited potent cytotoxicity against B16F10 mouse melanoma and human BGC-823 gastric, HCT116 colon, HepG2 liver, and NCI-H1650 bronchoalveolar cancer cells, with IC<sub>50</sub> values in the range 2–15 nM.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> It decreased the viability of human Panc-1 pancreatic and PC3 prostate cancer cells, with IC<sub>50</sub> values being around 200 and 43 nM, respectively.<a onclick="showRef(event, 'ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref170 ref171">(170,171)</a> Also, TPL induced apoptosis and showed cytotoxicity in CD133<sup>+</sup>/CD44<sup>+</sup> colon CSCs and inhibited cell migration.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a></div><div class="NLM_p">In in vivo studies, TPL suppressed breast tumor xenograft growth when 4–5-week-old female BALB/<i>c</i> athymic mice were inoculated with MDA-MB-231 human breast cancer cells and treated (i.p.) daily with TPL (0.15 mg/kg) for 2 weeks, after solid tumors occurred.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Colon tumor growth was inhibited significantly, and the life span of the test animals was increased when ICR-1 mice bearing colon tumors induced by azoxymethane (AOM) and dextran sulfate sodium (DSS) were treated daily with TPL (0.2 mg/kg, by gavage) for 4 weeks.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Also, ovarian tumor growth was inhibited when Balb/<i>c</i>-<i>nu</i> mice were inoculated by SKOV3 human ovarian cancer cells (1 week) and treated (i.p.) daily with TPL (0.15 mg/kg) for 2 weeks.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div><div class="NLM_p">Furthermore, TPL has demonstrated an ability to circumvent cancer cell resistance, targeting ATP-binding cassette transporters, apoptosis induction, tumor suppressors, oncogenic factors, the RNA polymerase II complex, CSC, and TME.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> For example, TPL sensitized SKOV3/DDP human cisplatin (DDP)-resistant ovarian cancer cells to treatment with DDP by inhibiting Akt.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> It enhanced the sensitivity of Panc-1 human pancreatic cancer cells to gemcitabine (GEM) treatment by targeting inhibition of TLR4/NF-κB signaling.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> A combined treatment with TPL and a tyrosine kinase inhibitor enhanced synergistically apoptosis in H1975 but not H1299 human NSCLC cells, due to partial inhibition of the EGFR/Akt pathway.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> As one of the most serious challenges to a successful cancer chemotherapeutic regimen, MDR is a comprehensive result of multiple complex cellular process, and focusing only on one target is rarely effective in resolving this problem. TPL inhibits the resistance of cancer cells to cancer chemotherapy through multiple mechanisms, and it or its derivatives could thus be promising clinically if used in combination with existing anticancer drugs.</div><div class="NLM_p">Over the period of 2016–2020, numerous investigations have demonstrated that TPL mediates its antitumor activity through interacting with multiple molecular targets, including the ERK/Akt, HIF-1α, Hsp70, MAPK, c-Myc, and NF-κB signaling pathways.<a onclick="showRef(event, 'ref166 ref167 ref168 ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref166 ref167 ref168 ref180 ref181">(166−168,180,181)</a> Of these, its stimulation of autophagy to induce neuroblastoma, leukemia, and colon, lung, and pancreatic cancer cell death and inhibition of Hsp70 have been investigated extensively.<a onclick="showRef(event, 'ref180 ref182'); return false;" href="javascript:void(0);" class="ref ref180 ref182">(180,182)</a> As an evolutionarily conserved intracellular catabolic process to converge on the delivery of cargos to the lysosome for degradation and recycling, the autophagic pathway is a widely investigated anticancer target. In addition, Hsp70 is a cancer cell survival promoter, and inhibition of this protein can kill cancer cells effectively. The functionality of TPL as both an autophagy modulator and a Hsp70 inhibitor in mesothelioma cells indicates that this diterpene triepoxide could be a potential candidate for the treatment of malignant mesothelioma.<a onclick="showRef(event, 'ref182 ref183'); return false;" href="javascript:void(0);" class="ref ref182 ref183">(182,183)</a></div><div class="NLM_p">To improve on its antitumor parameters, many TPL-targeted delivery systems have been developed, including conjugation of TPL to a sugar, peptide, oligonucleotide, or antibody ligand, or encapsulation of TPL with well-designed nanovehicle.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> More recently, TPL-loaded tumor acid-triggered micelles that were modified by a CRPPR peptide delivery system were prepared, which increased the therapeutic effects of TPL against pancreatic ductal adenocarcinoma, one of the most devastating malignancies, and reduced the damage to the main animal organs that resulted from TPL treatment.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a></div><div class="NLM_p">Although TPL has shown potent cytotoxicity at nanomolar concentrations and is a promising sensitizer to circumvent anticancer drug resistance, exposure to this diterpenoid may result in membrane damage, mitochondrial disruption, metabolism dysfunction, endoplasmic reticulum and oxidative stress, apoptosis and autophagy on the cellular level, as well as injury to various organs, including the liver, kidney, testes, ovary, and heart in test animals.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> These adverse effects have hindered the further clinical development of TPL, and thus various synthetic modifications of TPL have been conducted. As a foundation for further work, TPL has been synthesized, using tetralone, L-abietic acid, and/or L-dehydroabietic acid as starting materials and by processing Diels–Alder or metal-catalyzed reactions or polyene cyclization to construct the core structure.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> These synthetic approaches have not only resolved the problem of the lack natural abundant supply of TPL but also form a basis for SAR investigations, synthetic optimization, and further development of this antitumor diterpene triepoxide.</div><div class="NLM_p">Previous SAR investigations have shown that a hydrogen-bonded hydroxy group at the C-14 position, the three epoxy groups, and the α,β-unsaturated-five-membered lactone unit (D ring) are the key groups for TPL to mediate its antitumor activity.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Following these conclusions, the water solubility and cytotoxicity of TPL was enhanced by derivatization at the 14β-hydroxy group, and its toxicity was reduced while retaining the immunosuppressive and antitumor potential by introduction of suitable groups at the C-5 and C-6 positions.<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188,189)</a> As summarized in a 2019 review article, several of these derivatives and TPL itself showed a broad spectrum of activity against a variety of types of cancer cells through multiple pathways that are commonly deregulated in cancer, such as apoptosis, autophagy, EMT, and regulation of gene expression.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Additional SAR studies have suggested that the C-13 position could be another site for potential modification,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> as indicated by the diminished cytotoxicity observed when a hydroxy group was introduced at the C-15 position of TPL [e.g., as in the plant-derived triptolidenol or 15-hydroxytriptolide (<b>8c</b>)], and by the inactive natural product analogue, triptriolide (<b>8d</b>) that contains a 12,13-diol rather than a 12,13-epoxy group. Also, the cytotoxicity of <b>8</b> was decreased when an additional C-2 hydroxy group was introduced [e.g., tripdiolide (<b>8a</b>)], suggesting that C-2 could be another potential position for the modification of TPL (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Furthermore, the cytotoxicity of TPL was decreased when an extra epoxy group was introduced at the C-14 position [e.g., the synthetic derivative, (14<i>S</i>)-14,21-epoxytriptolide (<b>8e</b>)],<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> indicating that TPL might be modified at this position, and a tetra-epoxy system is probably not required. However, the cytotoxic potency of TPL was found not to change greatly when the C-14 hydroxy group was oxidized to a carbonyl group [e.g., triptonide (<b>8b</b>)].<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></div><div class="NLM_p">Different from TPL (<b>8</b>) that targets the Wnt3a-CM-induced β-catenin protein, triptonide (<b>8b</b>) did not downregulate this protein, while it inhibited effectively canonical Wnt/β-catenin signaling by acting at the C-terminal transcription domain of β-catenin or its associated nuclear component. This indicates that <b>8b</b> inhibits Wnt/β-catenin signaling through a mechanism different from that of <b>8</b>. Abnormal activation of canonical Wnt/β-catenin signaling is implicated in cancer, and thus triptonide (<b>8b</b>) was found to induce apoptosis in Wnt-dependent human RKO and SW480 colon cancer cells and thus to inhibit cell growth, with IC<sub>50</sub> values of 15 nM and 17 nM, respectively.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> In addition, triptonide (<b>8b</b>) showed potent cytotoxicity toward AGS, HGC-27, MGC-803, N87, and SGC-7901 human gastric cancer cells (IC<sub>50</sub> < 20 nM),<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> AsPC-1, BxPC-3, CFPAC-1, Panc-1, PaTu8988, and SW1990 human pancreatic cancer cells (IC<sub>50</sub> < 20 nM),<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> DU-145, LNCaP, and PC3 human prostate cancer cells (IC<sub>50</sub> 10–12 nM),<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> and Raji and Jurkat human lymphoma cells (IC<sub>50</sub> 4–6 nM).<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a></div><div class="NLM_p">In animal models, triptonide (<b>8b</b>) suppressed effectively gastric tumor growth and gastric cancer cell metastasis to the lung when six-week-old female BALB/<i>c</i> nude mice were inoculated by HGC-27 cells followed by daily treatments (i.p.) with <b>8b</b> (5 mg/kg) for 38 days. The tumors in four of the five tumor-bearing mice treated with <b>8b</b> disappeared completely, with those in the other mouse being reduced markedly, with no obvious body weight changes occurring among the test animals.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> Pancreatic tumor growth was inhibited effectively, with the inhibition rate being 97.5%, when eight-week-old female NOD/SCID mice were inoculated by PaTu8988 cells followed by daily treatments (i.p.) with <b>8b</b> (5 mg/kg) for 60 days, with no significant changes observed in the mouse body weights.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Also, triptonide exerted a strong antilymphoma activity when eight-week-old female NOD/SCID mice were inoculated by Raji cells followed by daily treatments (i.p.) with triptonide (<b>8b</b>) (5 mg/kg) for 35 days, without any evidence of toxicity being obtained.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a></div><div class="NLM_p">Mechanistic investigations have indicated that triptonide (<b>8b</b>) activates the tumor-suppressive MEKK4-MKK4-p38 MAPK pathway in pancreatic cancer cells and mediates antiprostate tumor activity through inhibiting mTOR signaling.<a onclick="showRef(event, 'ref193 ref196'); return false;" href="javascript:void(0);" class="ref ref193 ref196">(193,196)</a> In turn, it suppressed effectively gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways, and it induced colon cancer cell apoptosis by targeting Wnt/β-catenin signaling.<a onclick="showRef(event, 'ref194 ref195'); return false;" href="javascript:void(0);" class="ref ref194 ref195">(194,195)</a> Moreover, triptonide was found to repress oncogenic Lyn expression, Lyn phosphorylation, and the Lyn downstream ERK and AKT signal pathways in lymphoma cells. Overexpression of Lyn, Lck/Yes novel tyrosine kinase or v-yes-1 Yamaguchi sarcoma viral related oncogene homologue, promotes lymphoma cell proliferation and metastasis. Thus, Lyn has recently become an important target for novel antilymphoma drug discovery. Triptonide targets Lyn to mediate its antileukemic activity, suggesting that this diterpene lactone may function as a probe to explore other related new targets for Lyn-targeted lymphoma treatment.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a></div><div class="NLM_p">In addition, a TPL conjugate has been synthesized, namely, CX-23 (<b>8f</b>, <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>), which contains a quinone unit attached to its C-14 hydroxy group through a linker, propionic acid, with reference to NAD(P)H:quinone oxidoreductase 1 (NQO1) that catalyzes the two-electron reduction of other substrates and is overexpressed in HCC. Molecular modeling showed that the quinone of CX-23 binds to NQO1 at its active site and flavin adenine dinucleotide (FAD), with the TPL component itself kept outside the substrate binding pocket, indicating that the interaction between the quinone unit of CX-23 and NQO1 is not affected by the TPL moiety.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> In vitro studies showed that CX-23 inhibited HepG2 HCC cell growth (IC<sub>50</sub> 54 nM), which is comparable in potency with that of TPL, but such activity was found to be lost partially when cells were treated with a combination of CX-23 and dicoumarol, a NQO1 inhibitor, indicating that CX-23 may depend on NQO1 to mediate its cytotoxicity.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">In an in vivo study, hepatoma growth was inhibited significantly when 7–9 week-old female Balb/<i>c</i> nude mice were inoculated by HepG2 cells, and solid tumors were formed. The tumor-bearing mice were treated (i.p.) daily with TPL (0.2 mg/kg) or CX-23 (0.3 mg/kg) for 15 days. No obvious toxic effects were observed in mice treated with CX-23, but an abnormal renal function was indicated in the TPL treatment group from the increased levels of creatinine and BUN when compared with those of the control or the CX-23 treatment group. Therefore, CX-23 could be a promising lead for the discovery of anti-HCC TPLs with reduced renal toxicity, and NQO1 may serve as a targeted delivery system to release CX-23 in HCC cells.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">When a furoxan-based NO-donating moiety was introduced directly at the C-14 hydroxy group of TPL, a novel triptolide/furoxan hybrid molecule (<b>8g</b>) was synthesized. This hybrid exhibited cytotoxicity against a small panel of cancer cell lines, with IC<sub>50</sub> values in the nanomolar range, which was less potent cytotoxic than PTL itself. In a melanoma xenograft mouse model, tumor growth was inhibited significantly when female C57BL/6 mice (18–20 g) were inoculated by B16F10 mouse melanoma cells and treated daily with <b>8g</b> (0.3 mg/kg, orally) for 20 days, after solid tumors occurred. Importantly, <b>8g</b> showed evidence of low acute toxicity [median lethal dose (LD<sub>50</sub>) = 160.9 mg/kg], which was decreased up to 200-fold when compared with TPL itself (LD<sub>50</sub> 0.79 mg/kg), demonstrating that the toxicity of TPL can be lowered greatly through modification of its C-14 hydroxy group.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><div class="NLM_p">Following this, a water-soluble derivative of TPL, 14-<i>O</i>-phosphonooxymethyltriptolide disodium salt, namely, Minnelide (<b>8h</b>), was synthesized, with an estimated approximately two-year shelf life (<i>t</i><sub>90</sub>) observed for hydrolysis to occur.<a onclick="showRef(event, 'ref171 ref199'); return false;" href="javascript:void(0);" class="ref ref171 ref199">(171,199)</a> This novel TPL prodrug was found to decrease the viability of S2-013, MiaPaCa-2, and Panc-1 human pancreatic cancer cells in the presence of phosphatase, with IC<sub>50</sub> values being around 200 nM, comparable with those of TPL.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> An initial in vivo study showed that Minnelide (<b>8h</b>) inhibited pancreatic tumor growth when 4–6-week-old female athymic mice were inoculated with MIA PaCa-2 cells, and the solid tumor-bearing mice were treated (i.p.) with TPL (0.2 mg/kg, daily), or Minnelide (0.1–0.6 mg/kg, twice a day) for 60 days, followed by 30 days of absence of treatment. Also, the antipancreatic tumor efficacy of <b>8h</b> was found to be more effective than that of gemcitabine, a first-line FDA-approved pancreatic cancer chemotherapeutic agent, when 4- to 6-week-old female athymic mice bearing MIA PaCa-2 pancreatic tumors were treated (i.p.) with gemcitabine (100 mg/kg, twice a week) or Minnelide (0.28 mg/kg, daily) for 60 days. Further toxicity studies using this same animal model showed that Minnelide was not toxic after a 29-day treatment at a dose of 0.3 mg/kg (i.p.), and no overt signs of toxicity were observed over a 385-day treatment at a dose of 0.42 mg/kg (i.p.).<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><div class="NLM_p">The potential antipancreatic and antihepatic tumor activities of Minnelide (<b>8h</b>) have been described in a previous review in 2015.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> Both pancreatic adenocarcinoma and hepatoma are among the most lethal malignancies, with no effective treatments available, with the 5-year survival rate of pancreatic cancer being extremely poor. Thus, Minnelide could become a novel chemotherapeutic agent for the treatment of both pancreatic and liver cancer.<a onclick="showRef(event, 'ref171 ref200'); return false;" href="javascript:void(0);" class="ref ref171 ref200">(171,200)</a> In addition, Minnelide has shown promising inhibitory effects on other types of tumor models. For example, colon tumor growth was inhibited when 7- to 9-week-old female athymic nude mice were inoculated with HT-29 human colon cancer cells and treated (i.p.) daily with Minnelide (0.3 mg/kg) for 4 weeks, after solid tumors occurred. No toxic signs were observed in mice.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> HPV-positive head-and-neck tumor progression was decreased effectively when 4–6-week-old female nude mice bearing the xenografts developed from inoculation of UM-SCC 47 human papillomavirus (HPV) head and neck squamous cell carcinoma (HNSCC) cells or young adult SCID mice implanted with human oropharyngeal HPV-positive tumors were treated (i.p.) daily with Minnelide (0.42 mg/kg) for 6 weeks.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Also, lung tumor growth was slowed significantly when 4–6-week-old <i>nu</i>/<i>nu</i> nude mice were inoculated by A549 NSCLC or NCI-H460 large cell lung cancer cells (5 days) and treated (i.p.) daily with Minnelide (0.42 mg/kg) for 28 days, with no obvious toxic effects observed in mice.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> In addition, survival in two orthotopic ovarian tumor models was increased significantly when 6-week-old female athymic mice were inoculated by human platinum-sensitive (A2780) or -resistant (C200) ovarian cancer cells (7–12 days) and treated (i.p.) daily with Minnelide (0.42 and 0.6 mg/kg in A2780 and C200 animal models, respectively) for 28 days.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a></div><div class="NLM_p">The androgen receptor (AR) is expressed throughout prostate cancer progression, and androgen-deprivation therapy (ADT) has been a key treatment of prostate cancer, although this treatment may eventually fail, owing to the occurrence of castration-resistant prostate cancer (CRPC). Encouragingly, tumors derived from CRPC cells were found to be sensitive to Minnelide, which showed superior anti-CRPC activity when compared with docetaxel and enzalutamide, two standard prostate cancer chemotherapy drugs, when 4–6-week-old athymic male nude mice were inoculated with 22RV1 human CRPC cells, and solid tumors were formed. The tumor-bearing mice were treated with Minnelide (0.21 mg/kg, daily, i.p.), docetaxel (10 mg/kg, weekly, i.p.), or enzalutamide (10 mg/kg, daily, oral gavage) for 5 weeks. This indicates that Minnelide is promising for further evaluation against other AR-dependent prostate cancers for the potential control of CRPC.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> This derivative also exerts a potent antileukemic effect, as a result of which the tumor burden was reduced dramatically when NRGS mice were inoculated by THP-1 AML cells expressed by the luciferase reporter gene and treated (i.p.) daily with Minnelide (0.1 mg/kg) for 45 days.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a></div><div class="NLM_p">Similar to the parent compound, Minnelide (<b>8h</b>) targets several molecular signaling pathways to repress tumor progression, including inducing apoptosis to slow NSCLC tumor growth, reducing the expression of androgen receptor and its splice variants to inhibit androgen dependent castration-resistant prostate tumor growth, and activating wild-type p53 to retard HNSCC growth.<a onclick="showRef(event, 'ref201 ref202 ref205'); return false;" href="javascript:void(0);" class="ref ref201 ref202 ref205">(201,202,205)</a></div><div class="NLM_p">Thus far, Minnelide has been tested in several clinical trials for the treatment of cancer patients. A phase I, multicenter, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of Minnelide given (i.v.) daily for 21 days followed by 7 days off-schedule in patients with advanced gastrointestinal tumors from August 2013 to December 2016 has been completed, from which the MTD and DLT of Minnelide were established, with the dose for a future phase II protocol determined (Study of Minnelide in Patients With Advanced GI Tumors, <a href="https://ichgcp.net/clinical-trials-registry/NCT01927965" class="extLink">https://ichgcp.net/clinical-trials-registry/NCT01927965</a>). Also, a phase I, multicenter, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of Minnelide capsules given (orally) alone or in combination with protein-bound paclitaxel to patients with advanced solid tumors, including breast, colorectal, gastric, pancreatic, metastatic prostate, and stomach tumors is recruiting from October 2017 to December 2021 (<a href="https://ichgcp.net/clinical-trials-registry/NCT03129139" class="extLink">https://ichgcp.net/clinical-trials-registry/NCT03129139</a>).</div><div class="NLM_p">Even though a very recent phase I pilot study of Minnelide designed as a novel Hsp70 inhibitor in adult patients with relapsed or refractory acute myeloid leukemia was withdrawn (<a href="https://ichgcp.net/clinical-trials-registry/NCT03347994" class="extLink">https://ichgcp.net/clinical-trials-registry/NCT03347994</a>), a phase I/Ib dose escalation study of Minnelide in relapsed or refractory acute myeloid leukemia to determine its safety and recommended phase II oral dose in AML is underway (<a href="https://ichgcp.net/clinical-trials-registry/NCT03760523" class="extLink">https://ichgcp.net/clinical-trials-registry/NCT03760523</a>). Following these phase I clinical trials, a phase II, international open label trial of Minnelide in patients with refractory pancreatic cancer from April 2017 to May 2020 is currently active but not recruiting, in which Minnelide is being administered at the dose of 0.67 mg/m<sup>2</sup> as a 30 min infusion intravenously daily on days 1–21 of each cycle followed by a 7-day rest period (<a href="https://ichgcp.net/clinical-trials-registry/NCT03117920" class="extLink">https://ichgcp.net/clinical-trials-registry/NCT03117920</a>).</div><div class="NLM_p">Thus far, the diterpene triepoxide lactone triptolide (TPL, <b>8</b>) has been investigated extensively for its antitumor effects, including its activity toward cancer cells and tumor xenograft models, and for the mechanisms of action involved, MDR reversal, synergy with other modes of cancer chemotherapy, and the development of synthetic derivatives and novel delivery systems to improve on potency. SAR investigations indicate that introducing a hydroxy group at the C-2 or C-15 position decreases cytotoxic potency of <b>8</b>, while substitution of a phosphonooxymethyl group at the C-14 position improves the antitumor potential of <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>). The TPL prodrug, Minnelide, has been developed successfully for phase I and phase II clinical trial applications, which indicates also that introducing a water-soluble phosphonooxymethyl group could be a promising strategy for developing other NPs as novel anticancer agents.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Key SAR conclusions for the synthetic modification of triptolide (<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Triterpene Lactones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The triterpenoids are a large group of natural products derived from C<sub>30</sub> precursors and are of interest for their diverse structures and bioactivities, particularly in terms of their antitumor potential.<a onclick="showRef(event, 'ref13 ref206'); return false;" href="javascript:void(0);" class="ref ref13 ref206">(13,206)</a> Of these, pristimerin, a quinone methide triterpenoid isolated from species of the Celastraceae and Hippocrateaceae plant families, has been investigated extensively for its potential anticancer activities that involve apoptosis, autophagy, migration and invasion, vasculogenesis, and drug resistance, by targeting the cyclins, MAPK, microRNA, NF-κB, PI3K/Akt/mTOR, and ROS pathways.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Bardoxolone methyl (CDDO-Me or RTA 402), a synthetic oleanane-type triterpenoid, has reached a clinical trial for the potential treatment of cancer.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, several triterpene lactones that contain either a five-membered γ-lactone or a six-membered δ-lactone group have been found to show promising antitumor properties, including bruceantin (BRC, <b>9</b>), dichapetalin A (DCT, <b>10</b>), and limonin (LMN <b>11</b>), as detailed in the following paragraphs.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Bruceantin</h3><div class="NLM_p">Quassinoids (simaroubolides) are a group of degraded natural products derived from tetracyclic triterpenoids and comprised mainly of the C<sub>18</sub>, C<sub>19</sub>, C<sub>20</sub>, C<sub>22</sub>, C<sub>25</sub>, and C<sub>26</sub> skeletal types. These NPs have been purified mostly from plants in the family Simaroubaceae and found to exhibit multiple potent bioactivities.<a onclick="showRef(event, 'ref208 ref209'); return false;" href="javascript:void(0);" class="ref ref208 ref209">(208,209)</a> Of these, bruceantin (BRC, <b>9</b>), a C<sub>20</sub>-quassinoid containing a δ-lactone unit between C-7 and C-16, was isolated originally as one of the major antileukemic components from <i>Brucea antidysenterica</i> Mill. (Simaroubaceae).<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> The (5<i>R</i>,7<i>R</i>,8<i>R</i>,9<i>R</i>,10<i>S</i>,11<i>R</i>,12<i>S</i>,13<i>S</i>,14<i>S</i>,15<i>R</i>) absolute configuration of BRC was determined by comparison of its spectroscopic data with those of its closely similar natural product analogues, brusatol (<b>9a</b>) and bruceine A (<b>9b</b>) (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>), for which their complete structures were established using single-crystal X-ray diffraction data.<a onclick="showRef(event, 'ref211 ref212'); return false;" href="javascript:void(0);" class="ref ref211 ref212">(211,212)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures of bruceantin (BRC, <b>9</b>) and its analogues <b>9a</b>–<b>9i</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HL-60 leukemia, <sup><i>b</i></sup>HT-29, <sup><i>d</i></sup>HCT116, and <sup><i>i</i></sup>HCT-8 colon cancer, <sup><i>c</i></sup>HeLa cervical cancer, <sup><i>e</i></sup>Panc-1 and <sup><i>f</i></sup>SW1990 pancreatic cancer, <sup><i>g</i></sup>MCF-7 and <sup><i>h</i></sup>MDA-MB-231 breast cancer, <sup><i>j</i></sup>HepG2 hepatoma, <sup><i>k</i></sup>BGC-823 gastric cancer, and <sup><i>l</i></sup>A549 lung cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As reviewed previously in 2004, BRC down-regulates c-<i>myc</i> to exhibit activity against hematological malignancies.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> It showed potent cytotoxicity toward HL-60 human leukemia cells (IC<sub>50</sub> = 40 nM)<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> and inhibited human HCT116 (IC<sub>50</sub> = 67 nM) and HT-29 (IC<sub>50</sub> = 22 nM) colon and HeLa cervical (IC<sub>50</sub> = 29 nM) cancer cell growth effectively.<a onclick="showRef(event, 'ref215 ref216'); return false;" href="javascript:void(0);" class="ref ref215 ref216">(215,216)</a> At a low concentration (25 nM), BRC suppressed the proliferation of human multiple myeloma stem cells, which are highly resistant to conventional cancer chemotherapeutic agents.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> It was also potently cytotoxic against the KB-VIN, KB-7d, and KB-CPT human MDR cancer cell lines.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a></div><div class="NLM_p">An in vivo study showed that leukemia was regressed significantly when 13-week-old female severe-combined immunodeficiency (SCID) mice were inoculated with RPMI 8226 human leukemia cells (46 days) and treated (i.p.) with BRC (2.5 mg/kg, every 3 days) for 17 days.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> Mechanistic investigations showed that BRC exhibited cytotoxicity toward human cancer cells through down-regulation of c-Myc<a onclick="showRef(event, 'ref213 ref219'); return false;" href="javascript:void(0);" class="ref ref213 ref219">(213,219)</a> and inhibition of STAT3.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> It suppressed multiple myeloma stem cell proliferation through the Notch pathway.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a></div><div class="NLM_p">In a phase I clinical trial, 18 patients with metastatic cancer divided into separate normal to mildly abnormal liver functions and hepatic dysfunction groups were treated with BRC (infused intravenously for 3 h) at doses ranging from 1 to 3.6 mg/m<sup>2</sup> per day for 5 days. The dose-limiting toxicity found was hypotension that occurred in the abnormal liver function group, and an individualized therapy was recommended.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> A Phase II study was carried out in 22 patients with advanced malignant melanoma, who were infused with BRC at a dose of 5.5 mg/m<sup>2</sup> over 2 h, with the infusions repeated weekly for 4 weeks and then resumed after a two-week break. The treatment was continued for four full courses if a complete response occurred or as long as acceptable toxicity permitted for the partial responses. However, patients were removed from the study if progression of the disease occurred. From this phase II study, no objective cancer regressions were observed, and thus BRC was not suggested to be of use for the systemic therapy of melanoma, either as a single agent or in combination with other cytotoxic drugs.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> In turn, other clinical trials for BRC were terminated,<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> and scientific interest has shifted to the development of BRC analogues as possible antitumor agents.</div><div class="NLM_p">Earlier SAR studies indicated that a substituent at the C-15 position is important for the mediation of the antileukemic activity of BRC, of which both the length and presence of the C-1′–C-3′ α,ß-unsaturated carbonyl unit contribute greatly to the resultant activity.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> Thus, bruceantin (BRC, <b>9</b>) and brusatol (<b>9a</b>), which each contain a C-15 α,ß-unsaturated ester, were found to be more potent than their naturally occurring analogues, bruceine A (<b>9b</b>) or bruceine B (<b>9c</b>).</div><div class="NLM_p">Compound <b>9</b> was more active than <b>9a</b>, and <b>9b</b> showed a more potent activity than <b>9c</b> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>),<a onclick="showRef(event, 'ref214 ref215 ref216 ref222 ref223'); return false;" href="javascript:void(0);" class="ref ref214 ref215 ref216 ref222 ref223">(214−216,222,223)</a> indicating that a large C-15 substituent might be preferable in this regard. Comparison of the activity of <b>9</b> with that of its natural analogue, bruceine C (<b>9d</b>), implied that substitution of a hydroxy group at the C-5′ position of <b>9</b> decreased cytotoxic potency against HCT116 human colon cancer cells, but acetylation of this hydroxy group improved such activity greatly, as shown by bruceantinol (<b>9e</b>).<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> However, changing the location of the α,β-unsaturated carbonyl group along the C-1–C-4 positions followed by glucosylation at the hydroxy group at C-2 resulted in the activity abolished, as exhibited by the naturally occurring bruceantinoside A (<b>9f</b>), bruceoside A (<b>9g</b>), and yadanzioside A (<b>9h</b>) (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a></div><div class="NLM_p">A more detailed SAR study of brusatol (<b>9a</b>) and its synthetic derivatives and their activity against P-388 murine leukemia cells indicated that the length of the C-21 ester side chain has a slight effect on the cytotoxic activity, but either methylation or removal of the C-3 hydroxy group decreases activity markedly.<a onclick="showRef(event, 'ref224'); return false;" href="javascript:void(0);" class="ref ref224">(224)</a> These trends have been confirmed by cell growth inhibition screening against the NCI 60-cell line panel and by using MCF-7 and MDA-MB-231 breast cancer cells, but the direction of the ether bridge either from C-11 to C-20 or from C-13 to C-20 did not affect the overall inhibitory effects on cancer cell growth (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a> and <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>),<a onclick="showRef(event, 'ref225 ref226'); return false;" href="javascript:void(0);" class="ref ref225 ref226">(225,226)</a> However, cleavage of C-2 and C-3, which forms a 2,3-dicarboxylic acid unit, resulted in an inactive natural product, javanic acid A (<b>9i</b>, IC<sub>50</sub> > 10 μM toward all the cancer cell lines tested),<a onclick="showRef(event, 'ref227'); return false;" href="javascript:void(0);" class="ref ref227">(227)</a> while modification of the C-2–C-4 enone group seems not to affect the activity very much, as indicated by the comparable cytotoxicity observed for natural products bruceine D (<b>9j</b>) and bruceine H (<b>9k</b>), as well for the plant-derived bruceanols D (<b>9l</b>), F (<b>9m</b>), and E (<b>9n</b>) (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref227 ref228'); return false;" href="javascript:void(0);" class="ref ref227 ref228">(227,228)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of bruceantin analogues <b>9j</b>–<b>9u</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HCT-8 colon cancer, <sup><i>b</i></sup>HepG2 and <sup><i>k</i></sup>Hep3B hepatoma, <sup><i>c</i></sup>BGC-823 gastric cancer, <sup><i>d</i></sup>A549 lung cancer, <sup><i>e</i></sup>Panc-1 and <sup><i>f</i></sup>SW1990 pancreatic cancer, <sup><i>g</i></sup>MCF-7 and <sup><i>h</i></sup>MDA-MB-231 breast cancer, <sup><i>i</i></sup>KB human oral epidermoid cancer, <sup><i>j</i></sup>P-388 murine leukemia, <sup><i>l</i></sup>HL-60 leukemia, and <sup><i>m</i></sup>L1210 murine leukemia cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the SAR investigations for BRC (<b>9</b>), the ester unit connected at the C-15 position seems important for this compound to mediate its cytotoxicity. Either removal of the dimethyl group from C-5′ or introducing a hydroxy group at this position decreases its cytotoxicity (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Key SAR conclusions for the synthetic modification of bruceantin (<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, one of the analogues of BRC, brusatol (<b>9a</b>), was found to show more potent cytotoxic activity against several pancreatic cancer cell lines than the positive control, camptothecin (CPT).<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> As reviewed previously in 2019, brusatol (<b>9a</b>) exhibited cytotoxicity toward human leukemia and solid adenocarcinoma, colon and hepatic cancer cell lines, as well as mammospheres.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a> It inhibited several short-lived proteins in A549 human lung cancer cells to overcome potentially chemoresistance,<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> while it decreased the viability of Bel7404, Hep3B, Huh7, LM3 human liver cancer cells and suppressed cell proliferation and invasion and migration capacity in Bel7404 cells.<a onclick="showRef(event, 'ref231'); return false;" href="javascript:void(0);" class="ref ref231">(231)</a> Also, it induced BXPC-3, Panc-1, and PATU-8988 human pancreatic cancer cell apoptosis, and abrogated gemcitabine-induced Nrf2 activation to potentiate the gemcitabine-induced growth inhibition in these cancer cells.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a></div><div class="NLM_p">In vivo studies have shown that brusatol inhibited significantly the growth of hepatocellular tumors when 6-week-old BALB/C-<i>nu</i>/<i>nu</i> nude mice were inoculated by Bel7404 cells (14 days) and treated (i.p.) with brusatol (<b>9a</b>) (2 mg/kg, every 2 days) for 28 days, with no significant toxic effects being observed in mice. Immunohistochemical analysis demonstrated that Ki67, MMP2, and MMP9 expression levels in the Bel7404 xenograft tissues were diminished, indicating that brusatol reduced tumor growth by inhibiting proliferation and tumor cell invasion and metastasis.<a onclick="showRef(event, 'ref231'); return false;" href="javascript:void(0);" class="ref ref231">(231)</a> It also enhanced the antitumor activity of gemcitabine when 4–6-week-old male BALB/c homozygous nude mice were inoculated by Panc-1 cancer cells (1 week) and treated (i.p.) with brusatol (2 mg/kg, daily), gemcitabine (100 mg/kg, twice a week), or brusatol (2 mg/kg, daily) plus gemcitabine (100 mg/kg, twice a week) for 26 days. However, considerably lower body weights were observed in the nude mice treated with brusatol plus gemcitabine, demonstrating that this combination treatment exerted adverse effects in these test animals.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a></div><div class="NLM_p">The Nrf2 pathway is a major target for brusatol to mediate its antitumor activity. Activation of Nrf2 supports cell survival under detrimental environments to promote cancer formation and to contribute to chemoresistance, and, hence, suppressing Nrf2 can inhibit tumor progression and enhance the effectiveness of cancer treatments.<a onclick="showRef(event, 'ref233 ref234'); return false;" href="javascript:void(0);" class="ref ref233 ref234">(233,234)</a> Brusatol inhibited the Nrf2 signaling pathway effectively to augment the antitumor effects of gemcitabine,<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> and it also sensitized cancer cells and xenografts to cisplatin and increased the chemotherapeutic efficacy of cisplatin through specific inhibition of Nrf2-dependent cellular defense mechanisms.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> Through inhibition of Nrf2, brusatol showed dual antihepatitis C virus (HCV) and hepatic cancer cell growth inhibitory activities, as well enhancing the dual effects on sorafenib.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> These results suggest that brusatol can be used as an adjuvant chemotherapeutic agent for the treatment of cancer. Moreover, brusatol inhibited neurotoxicity induced by amyloid-β through activation of the Nrf2/HO-1 pathway, which resulted from inhibition of the PI3K/Akt/mTOR pathway, indicating the potential use of this agent in the treatment of gliomas.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a></div><div class="NLM_p">Another major mechanism demonstrated for brusatol is its modulation of c-Myc. The c-Myc oncogene is a “master regulator” to control cellular growth and metabolism, a collection of metabolic pathways largely involved in energy production. c-Myc is overexpressed in the majority of human cancers to drive cell proliferation, to stimulate glycolysis, and to contribute to the development of some tumors, and thus, it has become an attractive cancer chemotherapeutic target.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> Brusatol inhibited c-Myc expression in colorectal hypoxic cancer cells and mouse xenograft tumors, which induced hypoxia-inducing factor 1α (HIF-1α) degradation and cancer cell death,<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a> and both brusatol and BRC down-regulated <i>c</i>-<i>myc</i> to induce leukemic cell differentiation and G1 arrest.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> In addition, brusatol blocked potently the STAT3 signaling pathway in head and neck squamous cell carcinoma (HNSCC) cells, and it was found to reduce the cell viability of human UD SCC2 HPV16-positive hypopharyngeal, JMAR floor-of-mouth squamous cell, and YD-10B oral squamous carcinoma cells, and induced apoptosis in these cells.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a> Furthermore, brusatol inhibited the cell growth of PaTu 8988 and Panc-1 human pancreatic cancer cells and induced apoptosis in these cells through the JNK (<i>c</i>-Jun N-terminal kinase)/p38 MAPK (mitogen-activated protein kinase)/NF-κB/STAT3/Bcl2 signaling pathway.<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a></div><div class="NLM_p">A further nonesterified analogue of BRC, bruceine D (<b>9j</b>), also has attracted interest for its antitumor potential. It was found to inhibit human breast and lung cancer cell growth and suppressed the viability, metastasis, and EMT of MDA-MB-231 human breast cancer cells.<a onclick="showRef(event, 'ref242 ref243'); return false;" href="javascript:void(0);" class="ref ref242 ref243">(242,243)</a> Bruceine D (<b>9j</b>) induces mitochondria-dependent apoptosis and autophagy in A549 and NCI-H292 human lung cancer cells to inhibit cell growth,<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> and it exhibited potent cytotoxicity against Capan-1, Capan-2, Panc-1, and SW-1990 human pancreatic cancer cells.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> In addition, bruceine D (<b>9j</b>) inhibits cell proliferation and migration and induced cell cycle arrest and apoptosis in osteosarcoma cells. It suppresses the sphere-forming and self-renewal ability of osteosarcoma stem cells, which could contribute to osteosarcoma relapse, metastasis, and resistance to chemotherapy.<a onclick="showRef(event, 'ref245'); return false;" href="javascript:void(0);" class="ref ref245">(245)</a></div><div class="NLM_p">In in vivo studies, the growth of A549 lung xenograft tumors was inhibited significantly when 4-week-old female BALB/c-<i>nu</i> mice were inoculated by A549 human lung cancer cells, which was followed by the occurrence of solid tumors, and then the tumor-bearing mice were treated (i.p.) with bruceine D (<b>9j</b>) (40 mg/kg, every 2 days) for 15 days. No significant toxicity observed in mice.<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> Bruceine D suppressed effectively pancreatic tumor growth without causing mortality or other obvious side effects when 5–7-week-old male athymic <i>nu</i>/<i>nu</i> mice were inoculated by Capan-2 human pancreatic cancer cells (1 week) and treated (i.p.) with this quassinoid (1.5 mg/kg, once daily) for 28 days.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> Osteosarcoma growth was inhibited when four-week-old female BALB/c-<i>nu</i> mice were inoculated by MNNG/HOS human osteosarcoma cells (3 days) and treated (i.p.) with bruceine D (2.5 or 5 mg/kg, every alternate day) or cisplatin (2 mg/kg, twice a week) for 12 days. Neither discernible changes in body weights nor any pathological changes in the major organs of mice were observed. In addition, bruceine D (i.p., 5 mg/kg, every alternate day) showed more potent antiosteosarcoma activity than cisplatin (i.p., 2 mg/kg, twice a week) in a BALB/c-<i>nu</i> mouse MNNG/HOS xenograft osteosarcoma model.<a onclick="showRef(event, 'ref245'); return false;" href="javascript:void(0);" class="ref ref245">(245)</a></div><div class="NLM_p">Mechanistically, bruceine D induces A549 and NCI-H292 human lung cancer cell apoptosis and autophagy mainly through the activation of the ROS-mediated MAPK pathways,<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> and the bruceine D-induced Panc-1 cell apoptotic effects were dependent on the accumulated ROS and the inactivation of the PI3K/Akt signaling pathway.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> Also, bruceine D inhibited MNNG/HOS human osteosarcoma stem cell growth through inhibition of STAT3, and it induced H460 and A549 NSCLC cell apoptosis by activation of the JNK pathway.<a onclick="showRef(event, 'ref245 ref246'); return false;" href="javascript:void(0);" class="ref ref245 ref246">(245,246)</a> Accordingly, bruceine D may be a promising therapeutic lead compound candidate for the treatment of NSCLC, pancreatic cancer, and osteosarcoma.<a onclick="showRef(event, 'ref243 ref244 ref245 ref246'); return false;" href="javascript:void(0);" class="ref ref243 ref244 ref245 ref246">(243−246)</a></div><div class="NLM_p">A natural analogue of bruceine D (<b>9j</b>), ailanthone (<b>9o</b>) containing an ether bridge between C-11 and C-20, was found to be potently cytotoxic against Hep3B and HepG2 human hepatoma cells. The C-2–C-4 enone group, the Δ<sup>13(21)</sup> double bond, and the C-15 hydroxy group all seem to contribute positively to such activity, as indicated by natural products shinjulactone A (<b>9p</b>),<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a> glaucarubolone (<b>9q</b>), and glaucarubol (<b>9r</b>).<a onclick="showRef(event, 'ref214 ref248'); return false;" href="javascript:void(0);" class="ref ref214 ref248">(214,248)</a> In addition, the C-11/C-20 ether bridge appears critical for the activity observed, as exhibited by the natural analogue amarolide (<b>9s</b>), which did not show any growth inhibitory effects against Hep3B and HepG2 cells (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a></div><div class="NLM_p">Ailanthone (<b>9o</b>) induced apoptosis in HL-60, KG1, OCI-AML2, THP-1, and U-937 human acute myeloid leukemia cells,<a onclick="showRef(event, 'ref249'); return false;" href="javascript:void(0);" class="ref ref249">(249)</a> as well in MCF-7 human breast solid cancer cells,<a onclick="showRef(event, 'ref250'); return false;" href="javascript:void(0);" class="ref ref250">(250)</a> and it inhibited the viability of SGC-7901 human gastric cancer cells<a onclick="showRef(event, 'ref251'); return false;" href="javascript:void(0);" class="ref ref251">(251)</a> and induced G0/G1-phase cell cycle arrest to inhibit the proliferation of Huh7 human hepatocellular carcinoma (HCC) cells.<a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">(252)</a> The growth of liver tumors was inhibited significantly when 4–6-week-old male BALB/c <i>nu</i>/<i>nu</i> mice were inoculated by Huh7 cells (14 days) and treated (i.p.) with ailanthone (5 mg/kg, daily) for 16 days. No obvious toxicity was observed in mice, and decreased angiogenesis marker CD31 and p-VEGFR2 levels were observed in the tumors, indicating that ailanthone suppresses tumor growth in part by disrupting tumor vascularity.<a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">(252)</a></div><div class="NLM_p">Mechanistic studies have shown that ailanthone (<b>9o</b>) induces autophagy-mediated apoptosis through up-regulation of the expression of beclin-1 and LC3-II protein levels and down-regulation of the expression of LC3-I and p62 in HL-60 human leukemia cells.<a onclick="showRef(event, 'ref253'); return false;" href="javascript:void(0);" class="ref ref253">(253)</a> It inhibited HL-60 cell growth, migration, and invasion through up-regulation of miR-449a and deactivation of the Notch and PI3K/Akt signaling pathways.<a onclick="showRef(event, 'ref249'); return false;" href="javascript:void(0);" class="ref ref249">(249)</a> In addition, ailanthone induced MCF-7 and SGC-7901 cell apoptosis by upregulating Bax protein and mRNA,<a onclick="showRef(event, 'ref250 ref251'); return false;" href="javascript:void(0);" class="ref ref250 ref251">(250,251)</a> and it decreased the expression levels of cyclins and CDKs while increasing the expression of p21 and p27 to induce cell cycle arrest in Huh7 cells, which was mitochondrially mediated and involved the PI3K/Akt signaling pathway.<a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">(252)</a></div><div class="NLM_p">Two synthetic derivatives of ailanthone, namely, SUN2071 (<b>9t</b>) and SUN0237 (<b>9u</b>), were found to show potent cytotoxicity toward L1210 murine leukemia cells, comparable to both BRC and vincristine. Leukemia development was inhibited, while the lifespan of tumor-bearing mice was increased significantly, when female C57BL/6 X DBA/2 mice were inoculated by P-388 or L1210 leukemia cells (1 day) and treated (i.p.) daily with SUN2071 (5 mg/kg), SUN0237 (5 mg/kg), or vincristine (0.25 mg/kg) for 9 days. The antileukemic effects of both SUN2071 and SUN0237 were similarly as potent as that of vincristine.<a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">(254)</a> However, both the mechanism of action and the further development of these compounds have not been reported.</div><div class="NLM_p last">Thus far, except for BRC, none of its simaroubolide analogues has been evaluated in cancer clinical trials, owing mainly to the fact that no objective cancer regressions observed in phase II clinical testing on BRC.<a onclick="showRef(event, 'ref213 ref221'); return false;" href="javascript:void(0);" class="ref ref213 ref221">(213,221)</a> However, brusatol (<b>9a</b>), bruceine D (<b>9j</b>), and ailanthone (<b>9o</b>) all have shown potent antitumor activities in animal models, and thus they may have some type of clinical application, based on the mechanism of action involving the c-Myc and STAT3 proteins and the Notch pathway as reported for quassinoids.<a onclick="showRef(event, 'ref216 ref217 ref219'); return false;" href="javascript:void(0);" class="ref ref216 ref217 ref219">(216,217,219)</a> In this regard, synthetic modifications, the introduction of conjugated drug units, and the development of novel drug delivery system for these compounds may be advantageous for future work.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Dichapetalin A (DCT A, <b>10</b>)</h3><div class="NLM_p">Dichapetalin-type triterpenoids are a small group of 13,30-cyclo-dammarane-type tetracyclic triterpene lactones derived mainly from the plant family Dichapetalaceae, containing in common a phenethyl group linked through a pyran ring at the C-3, C-4, and C-29 positions, a C-17 five-membered lactone unit, a C-7 hydroxy group, and two Δ<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> and Δ<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> double bonds.<a onclick="showRef(event, 'ref255'); return false;" href="javascript:void(0);" class="ref ref255">(255)</a> The first member of this group of NPs, dichapetalin A (DCT A, <b>10</b>) was isolated originally in 1995 as a new constituent from the roots of <i>Dichapetalum madagascariense</i> Poir. (Dichapetalaceae) collected in Legon, Ghana (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref256'); return false;" href="javascript:void(0);" class="ref ref256">(256)</a> The complete structure of DCT A was confirmed later by analysis of its single-crystal X-ray diffraction data, and the (4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>R</i>,9<i>R</i>,10<i>S</i>,13<i>S</i>,14<i>S</i>,17<i>S</i>,20<i>S</i>,23<i>R</i>,7′<i>S</i>) absolute configuration was determined by refining the Flack parameter [<i>x</i> = −0.1(0.3)].<a onclick="showRef(event, 'ref257'); return false;" href="javascript:void(0);" class="ref ref257">(257)</a> Subsequently, additional dichapetalins were identified from this plant (<i>D. madagascariense</i>).<a onclick="showRef(event, 'ref258'); return false;" href="javascript:void(0);" class="ref ref258">(258)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structures of dichapetalin A (DCT A, <b>10</b>) and its analogues <b>10a</b>–<b>10g</b> and IC<sub>50</sub> values for <sup><i>a</i></sup>CEM human T-lymphoblast-like leukemia, <sup><i>b</i></sup>HCT116 and <sup><i>i</i></sup>HT-29 human colon cancer, <sup><i>c</i></sup>HL-60 human acute promyelocytic leukemia, <sup><i>d</i></sup>Jurkat human T-lymphocytic leukemia, <sup><i>e</i></sup>LNCaP human prostate cancer, <sup><i>f</i></sup>Lu-1 human lung cancer, <sup><i>g</i></sup>SW626 human ovarian cancer, and <sup><i>h</i></sup>WM 266–4 human melanoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the original investigation, DCT A (<b>10</b>) was found to show selectively potent cytotoxicity toward cancer cells, with the EC<sub>90</sub> value being less than 0.17 nM when tested against L1210 murine leukemia cells.<a onclick="showRef(event, 'ref256'); return false;" href="javascript:void(0);" class="ref ref256">(256)</a> Later, it was found also to be cytotoxic toward human HCT116 colon cancer and WM 266–4 melanoma cells, with EC<sub>50</sub> values of 0.25 and 17 μM, respectively.<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> When tested against a small panel of human cancer cell lines, DCT A was found to show some selectivity. For example, it was potently active against SW626 human ovarian cancer cells (IC<sub>50</sub> = 0.34 μM) but inactive toward BC1 human breast cancer cells (IC<sub>50</sub> > 20 μM).<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a> DCT A inhibited human CEM, HL-60, and Jurkat leukemia cell growth, with IC<sub>50</sub> values in the range of 3.0–12 μM.<a onclick="showRef(event, 'ref261'); return false;" href="javascript:void(0);" class="ref ref261">(261)</a> However, when tested in an in vivo hollow fiber assay, dichapetalin A (DCT A, <b>10</b>) did not show evident inhibitory activity when 5–6-week-old female athymic NCr <i>nu</i>/<i>nu</i> mice were implanted with hollow fibers containing human LNCaP prostate, Lu1 lung, MCF-7 breast, or SW626 ovarian cancer cells and treated (i.p.) daily with DCT A (1, 2, 4, and 6 mg/kg) for 4 days.<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a></div><div class="NLM_p">Investigation of the cytotoxicity of DCT A and its analogues has indicated that changing the primary C-26 hydroxy group to an aldehyde [e.g., dichapetalin N (<b>10a</b>)] increases the cytotoxicity of DCT A against HCT116 and WM 266-4 cells.<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> Saturation of the Δ<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> double bond [e.g., dichapetalin L (<b>10b</b>)] results in the activity against human LNCaP prostate and Lu-1 lung cancer cells being enhanced slightly and that toward SW626 human ovarian cancer cells decreased greatly. However, addition of a water (H<sub>2</sub>O) molecule to the double bond between C-11 and C-12 [e.g., dichapetalin I (<b>10c</b>)] diminishes cytotoxicity against LNCaP and Lu-1 cells but potentiates the activity against SW626 cells (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>),<a onclick="showRef(event, 'ref259 ref260'); return false;" href="javascript:void(0);" class="ref ref259 ref260">(259,260)</a> indicating that the selectivity against cancer cells of DCT A may be enhanced by derivatization at the C-11 and C-12 positions. Surprisingly, when a hydroxy group was introduced at the C-22 position of DCT A (<b>10</b>) [e.g., dichapetalin B (<b>10d</b>)], cytotoxicity of <b>10</b> against both HCT116 and WM 266–4 cells was improved considerably,<a onclick="showRef(event, 'ref259 ref260'); return false;" href="javascript:void(0);" class="ref ref259 ref260">(259,260)</a> implying that the C-22 position might be a key site for the modification of DCT A. In addition, substitution of a methoxy group at the C-4′ position [e.g., dichapetalin K (<b>10e</b>)] enhanced slightly the cytotoxic potency against LNCaP and Lu-1 cells but weakened substantially such an effect on SW626 cells, while further addition of a water molecule at the Δ<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> double bond [e.g., dichapetalin J (<b>10f</b>)] resulted in the potency against LNCaP and Lu-1 cells being decreased and that toward SW626 cells being enhanced (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>).<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a> Discovery of an inactive compound, songbodichapetalin (<b>10g</b>), containing a 3′,4′-methylenedioxy, a C-22 hydroxy, and a C-26 methoxy group, when evaluated against HT-29 human colon cancer cells, indicated that the substituents at all of the C-12, C-22, C-26, and C-7′ positions are important for <b>10</b> to mediate its cytotoxicity. As discussed previously in 2019, the presence of a primary C-26 hydroxy group seems important in determining the cytotoxic potency of the dichapetalin-type triterpenes.<a onclick="showRef(event, 'ref13 ref262'); return false;" href="javascript:void(0);" class="ref ref13 ref262">(13,262)</a></div><div class="NLM_p">Even though the C-17 lactone unit is important for the mediation of the cytotoxicity of DCT A, it is not essential, as indicated by DCT A derivatives that contain a C-17 hemiacetal rather than a lactone side chain, including <b>10h</b>, dichapetalin O (<b>10i</b>), and dichapetalin Q (<b>10j</b>) (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). When the C-17 lactone unit of DCT A was reduced to a 21-hydroxytetrahydrofuran ring (e.g., <b>10h</b>), the cytotoxicity against WM 266-4 cells was increased but that toward HCT116 cells was found to be decreased. Saturation of the Δ<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> double bond [e.g., dichapetalin O (<b>10i</b>)] reduced slightly the activity of <b>10h</b> against both cell lines. However, the activity of <b>10i</b> declined greatly when the 13,14,30-cyclopropane unit was opened followed by introduction of a Δ<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> double bond [e.g., dichapetalin Q (<b>10j</b>)], indicating that this cyclopropane ring plays a critical role in the determination of such an effect. In addition, the activity was not abolished when the C-17 tetrahydrofuran was replaced by a linear side chain or a tetrahydropyran ring, as shown by <b>10k</b>, dichapetalin C (<b>10l</b>), and dichapetalin R (<b>10m</b>) (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>),<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> suggesting that a cyclic substitution at the C-17 position of DCT A is not critical for mediation of its cytotoxicity.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of dichapetalin A analogues <b>10h</b>–<b>10m</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HCT116 colon cancer and <sup><i>b</i></sup>WM 266–4 human melanoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several novel analogues of DCT A containing a spiroketal moiety formed by connecting C-23 and C-26 with an oxygen were found to be cytotoxic, of which dichapetalin S (<b>10n</b>) exhibited more potent activity than DCT A against WM 266–4 cells,<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> while the potency toward CEM and HL-60 cells was lessened when a hydroxy group is introduced to the C-22 position of <b>10n</b>, followed by acetylation of its C-25 hydroxy group [e.g., 7-hydroxydichapetalin P (<b>10o</b>)].<a onclick="showRef(event, 'ref261'); return false;" href="javascript:void(0);" class="ref ref261">(261)</a> The activity against these leukemia cells was potentiated when the C-25 acetoxy group of <b>10o</b> is modified to a β-hydroxybutyrate unit [e.g., dichapetalin X (<b>10p</b>)],<a onclick="showRef(event, 'ref261 ref263'); return false;" href="javascript:void(0);" class="ref ref261 ref263">(261,263)</a> and the potency toward HCT116 and WM 266-4 cells was improved greatly when the C-7 hydroxy group of <b>10o</b> is changed to a carbonyl group [e.g., dichapetalin P (<b>10q</b>)]. Such an effect was further increased when a hydroxy group is introduced to the C-6 position of <b>10q</b> [e.g., dichapetalin M (<b>10r</b>)] (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>),<a onclick="showRef(event, 'ref259 ref264'); return false;" href="javascript:void(0);" class="ref ref259 ref264">(259,264)</a> showing that a 6-hydroxy-7-carbonyl unit is required by spiro-DCTs to exhibit maximal cytotoxic potency.</div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of dichapetalin A analogues <b>10n</b>–<b>10v</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HCT116, <sup><i>i</i></sup>SW480, and <sup><i>j</i></sup>Col-2 colon cancer, <sup><i>b</i></sup>WM 266-4 melanoma, <sup><i>c</i></sup>CEM T-lymphoblast-like leukemia, <sup><i>d</i></sup>HL-60 acute promyelocytic leukemia, <sup><i>e</i></sup>Jurkat T-lymphocytic leukemia, <sup><i>f</i></sup>A549 non-small-cell lung cancer, <sup><i>g</i></sup>MCF-7 breast cancer, <sup><i>h</i></sup>SMMC-7721 human hepatocarcinoma, <sup><i>k</i></sup>KB oral epidermoid carcinoma cells, and <sup><i>l</i></sup>P-388 murine leukemia cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, much less potent activity toward a small panel of human cancer cells was observed when the C-25 acetoxy group of <b>10r</b> or its analogues was replaced by a 3-hydroxy-3-(4-hydroxyphenyl)propanoate unit [e.g., dichapetalin U (<b>10s</b>), dichapetalin V (<b>10t</b>), and dichapetalin W (<b>10u</b>)]. Substitution of a hydroxy group at the C-22 position of <b>10s</b> (e.g., <b>10t</b>) enhanced the activity slightly, but the switching of this hydroxy group to the C-24 position and removal of that at the C-3″ position followed by introduction of a methoxy group at the C-4′ position (e.g., <b>10u</b>) resulted in activity being abolished (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref265'); return false;" href="javascript:void(0);" class="ref ref265">(265)</a></div><div class="NLM_p">These observations indicate that a C-25 hydroxy group is important, but a bulky ester substituent at the C-25 position may not be preferable for the mediation of cytotoxicity of the spiro-DCTs. Thus, the most potently cytotoxic DCT yet discovered is acutissimatriterpene E (<b>10v</b>), containing a satuated C-11 and C-12 bond and C-22 hydroxy, C-25 methoxy, and 3′,4′-methylenedioxy groups, which showed inhibitory activity against P-388 murine leukemia cell growth, with an IC<sub>50</sub> value of 7.4 nM.<a onclick="showRef(event, 'ref266'); return false;" href="javascript:void(0);" class="ref ref266">(266)</a> The preliminary SAR investigations as discussed above show that all of the substituents at the C-6, C-7, C-12, C-22–C-26, and C-7′ positions contribute to the cytotoxicity of DCTs, and the C-22 hydroxy group and the 6-hydroxy-7-carbonyl unit are preferred for this type of activity, indicating that the potential antitumor activity of DCTs could be improved by synthetic modifications at these positions. Introducing a hydroxy group at the C-22 position increases the cytotoxicity of <b>10</b>, while changing the C-21 carbonyl group to a hydroxy group decreases such activity (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>). Thus, the potently active compounds acutissimatriterpene E [<b>10v</b>, IC<sub>50</sub> = 7.4 nM (P-388 cells)] and dichapetalin B [<b>10d</b>, IC<sub>50</sub> = 81 nM (HCT116 cells)] could be modified by changing their C-7 hydroxy group to a 6-hydroxy-7-carbonyl unit, while the cytotoxicity of dichapetalin M [<b>10r</b>, IC<sub>50</sub> = 9.9 nM (HCT116 cells)] may be enhanced by a change of the C-25 acetoxy group to a methoxy group.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Key SAR conclusions for the synthetic modification of dichapetalin A (<b>10</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">DCT A (<b>10</b>) and all of its analogues (<b>10a</b>–<b>10v</b>) discussed above are plant-derived triterpenoids, of which, except for DCT A, none of the other DCTs has thus far been tested for their potential antitumor activity in an animal model, and the mechanism of action of all of these compounds has not been determined. On the basis of the SAR conclusions obtained for DCTs, some derivatives showing more potent activity could be synthesized in future investigations on this type of triterpenoid. In addition, compounds <b>10d</b>, <b>10r</b>, and <b>10v</b> all exhibit potent activities against certain cancer cells, and hence more detailed investigations seem advisable for their possible further development, including in vivo antineoplastic efficacy evaluation, molecular target determination, and novel drug delivery system preparation.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Limonin (LMN <b>11</b>)</h3><div class="NLM_p">As reported in a 2014 review article, limonoids, a group of secondary metabolites confined to the families Rutaceae and Meliaceae, are modified euphane-type tetracyclic furanotetranortriterpenoids, with the loss of the terminal four carbon atoms (C-24–C-27), followed by cyclization of a furan ring, of which one of the four rings (A, B, C, or D) may be opened by oxidation.<a onclick="showRef(event, 'ref267'); return false;" href="javascript:void(0);" class="ref ref267">(267)</a> The term “limonoid” is derived from limonin (LMN, <b>11</b>), the first member of the limonoid group identified as the bitter constituent of the seeds of a <i>Citrus</i> species, for which the molecular structure was established by an X-ray crystallographic investigation,<a onclick="showRef(event, 'ref268'); return false;" href="javascript:void(0);" class="ref ref268">(268)</a> and the (1<i>S</i>,5<i>R</i>,8<i>R</i>,9<i>R</i>,10<i>R</i>,13<i>S</i>,14<i>R</i>,15<i>S</i>,17<i>S</i>) absolute configuration was determined by application of the heavy-atom method and a full three-dimensional analysis of the single-crystal X-ray diffraction data of epilimonol iodoacetate.<a onclick="showRef(event, 'ref269'); return false;" href="javascript:void(0);" class="ref ref269">(269)</a> Limonin (LMN, <b>11</b>) is a major component of the seeds of lemon [<i>Citrus limon</i> (L.) Osbek (Rutaceae)],<a onclick="showRef(event, 'ref270'); return false;" href="javascript:void(0);" class="ref ref270">(270)</a> and it has been named previously as citrolimonin, dictamnolactone, evodin, and obaculactone.<a onclick="showRef(event, 'ref271'); return false;" href="javascript:void(0);" class="ref ref271">(271)</a> Thus far, several other limonoids have been characterized from lemon seeds, including limonexic acid, isolimonexic acid, limonin glucoside, nomilin, obacunone, and obacunone glucoside (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref272'); return false;" href="javascript:void(0);" class="ref ref272">(272)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of limonin (LMN, <b>11</b>) and its analogues <b>11a</b>–<b>11h</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>MCF-7 breast cancer, <sup><i>b</i></sup>MDA-MB-435 melanoma, <sup><i>c</i></sup>Panc-28 pancreatic cancer, and <sup><i>d</i></sup>SW480 colon cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Lemons are used widely as a <i>Citrus</i> crop of benefit to human health, and lemon-derived limonoids have been reported for their potential pharmaceutical properties, including antibacterial, antifungal, antimalarial, antineoplastic, and antiviral activities,<a onclick="showRef(event, 'ref267'); return false;" href="javascript:void(0);" class="ref ref267">(267)</a> as a result of which LMN was found to show potential antitumor activity.<a onclick="showRef(event, 'ref273'); return false;" href="javascript:void(0);" class="ref ref273">(273)</a> For example, LMN (<b>11</b>) inhibited human MCF-7 breast cancer and MDA-MB-435 melanoma cell proliferation, with its IC<sub>50</sub> values being 4.3 and 26 μM, respectively,<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> and it also inhibited the growth of Panc-28 human pancreatic cancer cells (IC<sub>50</sub> = 42 μM) (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref275'); return false;" href="javascript:void(0);" class="ref ref275">(275)</a> Although LMN did not show any activity toward P-388 murine leukemia cells,<a onclick="showRef(event, 'ref276'); return false;" href="javascript:void(0);" class="ref ref276">(276)</a> it was found to suppress hexokinase 2 (HK2) activity to inhibit tumor glycolysis in HCC cells, which induced cell apoptosis to inhibit cell proliferation.<a onclick="showRef(event, 'ref277'); return false;" href="javascript:void(0);" class="ref ref277">(277)</a> Interestingly, LMN was recently found to attenuate the stemness of cancer cells, including breast cancer,<a onclick="showRef(event, 'ref278'); return false;" href="javascript:void(0);" class="ref ref278">(278)</a> cervical cancer,<a onclick="showRef(event, 'ref279'); return false;" href="javascript:void(0);" class="ref ref279">(279)</a> hepatoma,<a onclick="showRef(event, 'ref280'); return false;" href="javascript:void(0);" class="ref ref280">(280)</a> and nasopharyngeal cancer stem cells.<a onclick="showRef(event, 'ref281'); return false;" href="javascript:void(0);" class="ref ref281">(281)</a></div><div class="NLM_p">The potential antitumor activity, toxicity, and pharmacokinetics of LMN have been summarized recently in 2019,<a onclick="showRef(event, 'ref273'); return false;" href="javascript:void(0);" class="ref ref273">(273)</a> and discussed below is updated information to this previous review. In an vivo study, benzo(a)pyrene[B(a)P]-induced lung carcinogenesis was inhibited when C57BL/6J mice that weighed around 20–25 g were fed (twice a week) with B(a)P (50 mg/kg) for 4 weeks, followed by a six-week oral treatment with LMN (50 mg/kg).<a onclick="showRef(event, 'ref282'); return false;" href="javascript:void(0);" class="ref ref282">(282)</a> Mechanistically, LMN inhibited HCC proliferation through the suppression of HK-2 activity, from which the glycolytic level in HCC cells was substantially reduced, and mitochondria-mediated apoptosis was induced by the resultant release of cytochrome c. A decrease of HK-2 phosphorylation was observed mainly due to the inhibition of Akt activity,<a onclick="showRef(event, 'ref277'); return false;" href="javascript:void(0);" class="ref ref277">(277)</a> and thus LMN was found to attenuate the stemness of HCC cells through activating the PI3K/Akt signaling pathway.<a onclick="showRef(event, 'ref280'); return false;" href="javascript:void(0);" class="ref ref280">(280)</a> In MCF-7 and MDA-MB-231 human breast cancer cells, LMN decreased MIR216A methylation levels and thus increased miR-216a-3p expression to inactivate the Wnt/β-catenin pathway, which resulted in attenuation of the stemness of these cancer cells (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>).<a onclick="showRef(event, 'ref278'); return false;" href="javascript:void(0);" class="ref ref278">(278)</a> In addition, LMN induced apoptosis in A549 human lung cancer cells by enhancing ROS production,<a onclick="showRef(event, 'ref282'); return false;" href="javascript:void(0);" class="ref ref282">(282)</a> and it attenuated the stemness of HeLa cervical cancer cells and inhibited the progression of oral tongue squamous cell cancer cells via inhibiting YAP (Yes-associated protein, the root of cancer) transcriptional regulatory activity through promoting YAP nuclear-cytoplasmic translocation.<a onclick="showRef(event, 'ref279 ref283'); return false;" href="javascript:void(0);" class="ref ref279 ref283">(279,283)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Cellular signaling pathways for the mediation of cytotoxicity of limonin (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, a zein-alginate encapsulation system to produce highly dispersible limonin nanoparticles has been developed. The release of LMN in simulated gastric fluid, and, preferentially, in simulated intestinal fluid, was delayed and minimized by this nanodelivery system. Simultaneously, this zein-alginate encapsulated LMN exhibited significantly improved glutathione <i>S</i>-transferase-inducing, free radical-scavenging, and antiangiogenic activity, indicating the potential of effective oral delivery system to enhance the bioavailability of LMN.<a onclick="showRef(event, 'ref284'); return false;" href="javascript:void(0);" class="ref ref284">(284)</a> However, the relatively weak cytotoxic potency of LMN seems to limit its potential drug use, and thus, SAR-guided synthetic modification may facilitate the development of its modified derivatives as useful cancer chemotherapeutic agents.</div><div class="NLM_p">SAR investigations for different types of limonoids and their potential antitumor activity have been reviewed recently in 2018, and both the furan ring and substitution at the C-7 position were found to be required for LMN to induce phase II detoxification enzymes.<a onclick="showRef(event, 'ref285'); return false;" href="javascript:void(0);" class="ref ref285">(285)</a> Inspection of the inhibitory activity toward Panc-28 human pancreatic cancer cells by LMN (<b>11</b>, IC<sub>50</sub> = 42 μM), limonexic acid (<b>11a</b>, IC<sub>50</sub> = 22 μM), isolimonexic acid (<b>11b</b>, IC<sub>50</sub> = 18 μM), and limonin glucoside (<b>11c</b>, IC<sub>50</sub> = 20 μM) (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>)<a onclick="showRef(event, 'ref275'); return false;" href="javascript:void(0);" class="ref ref275">(275)</a> showed that the natural products <b>11a</b>–<b>11c</b> all exhibited comparable activities, with their potencies being somewhat greater than that of <b>11</b>. These data indicate that changing the furan ring to a lactone unit or opening the six-membered δ-lactone unit followed by introducing a glucosyl moiety at the C-17 hydroxy group increases slightly the growth inhibitory activity of LMN against Panc-28 cells.</div><div class="NLM_p">However, when tested toward MCF-7 estrogen receptor-positive human breast cancer and MDA-MB-435 estrogen receptor-negative human breast cancer cells (revised later as MDA-MB-435 human melanoma cells), the respective proliferation inhibition of limonin glucoside (<b>11c</b>, IC<sub>50</sub> = 55 and 119 μM) was found to be much less potent than that of LMN (<b>11</b>, IC<sub>50</sub> = 4.3 and 26 μM),<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> demonstrating that opening the δ-lactone unit followed by C-17 glucosylation diminishes greatly the activity of LMN against these cancer cells. While the naturally occurring deoxylimonin (<b>11d</b>) exhibited an activity against MCF-7 cells (IC<sub>50</sub> = 5.5 μM) that was comparable with LMN, its activity toward MDA-MB-435 cells (1.7 μM) was more pronounced than that of LMN (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>),<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> leading to the conclusion that the C-14–C-15 epoxy group is not essential for LMN to mediate its cytotoxicity toward these cancer cell types.</div><div class="NLM_p">Interestingly, the activities of LMN toward both MCF-7 and MDA-MB-435 cells are enhanced more than 30 times when the C-1–C-5 bicyclic system is changed to a seven-membered lactone monocyclic unit [e.g., in the plant-derived nomilin (<b>11e</b>, IC<sub>50</sub> = 0.097 and 0.78 μM against MCF-7 and MDA-MB-435 cells, respectively],<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> suggesting that the C-1–C-5 monocyclic ring is preferred for enhancing the activity of LMN. Also, deacetylation [e.g., deacetylnomilin (<b>11f</b>, IC<sub>50</sub> = 0.01 μM)] or deacetoxylation [e.g., obacunone (<b>11g</b>, IC<sub>50</sub> = 0.02 μM)] of nomilin resulted in the activity against MCF-7 cells being increased greatly,<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> indicating that the presence of a C-1 acetoxy group reduces the cytotoxic potency of nomilin. Obacunone glucoside (<b>11h</b>, IC<sub>50</sub> = 3.2 μM) showed a much less potent activity than obacunone itself (<b>11g</b>, IC<sub>50</sub> = 0.02 μM) (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>) against MCF-7 cells,<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> demonstrating that the C-13–C-17 δ-lactone unit is required, but introduction of a glucosyl group may not be preferred for such an activity. In addition, all of the potently active compounds, <b>11e</b> (IC<sub>50</sub> = 0.097 and 0.78 μM), <b>11f</b> (IC<sub>50</sub> = 0.01 and 0.15 μM), and <b>11g</b> (IC<sub>50</sub> = 0.02 and 6.8 μM) in this series showed a greater sensitivity toward MCF-7 cells than against MDA-MB-435 cells, suggesting that these compounds could be useful in the design of selective anticancer agents.</div><div class="NLM_p">Of these analogues, nomilin (<b>11e</b>), isolated originally from lemon seeds, showed cell proliferation inhibitory activities against human breast cancer and melanoma cells,<a onclick="showRef(event, 'ref270 ref274'); return false;" href="javascript:void(0);" class="ref ref270 ref274">(270,274)</a> and it has exhibited some promise in the inhibition of tumor metastasis and angiogenesis. Metastatic lung tumor nodule formation was inhibited when 6–8-week-old male C57BL/6 mice were inoculated by BI6F-10 melanoma cells followed by daily treatments (i.p.) with nomilin (6 mg/kg) for 10 days, followed by 11 days of the absence of the treatment.<a onclick="showRef(event, 'ref286'); return false;" href="javascript:void(0);" class="ref ref286">(286)</a> Tumor-specific angiogenesis was suppressed significantly when 4–6-week-old male C57BL/6 mice were inoculated by B16F-10 melanoma cells, followed immediately with daily treatments (i.p.) with nomilin (6 mg/kg) for 5 days.<a onclick="showRef(event, 'ref287'); return false;" href="javascript:void(0);" class="ref ref287">(287)</a></div><div class="NLM_p">Obacunone (<b>11g</b>, IC<sub>50</sub> = 0.02 μM) was found to be more active than nomilin (<b>11e</b>, IC<sub>50</sub> 0.097 μM) against the MCF-7 estrogen receptor-positive human breast cancer cell line in an early investigation.<a onclick="showRef(event, 'ref274'); return false;" href="javascript:void(0);" class="ref ref274">(274)</a> However, its activity against SW480 colon and LNCaP human prostate cancer cells was much less potent, with IC<sub>50</sub> values of 56 and around 12 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>),<a onclick="showRef(event, 'ref288 ref289'); return false;" href="javascript:void(0);" class="ref ref288 ref289">(288,289)</a> with a lack of evident cytotoxicity (IC<sub>50</sub> > 50 μM) observed when evaluated against MCF-7 cells.<a onclick="showRef(event, 'ref290'); return false;" href="javascript:void(0);" class="ref ref290">(290)</a> Interestingly, obacunone was found to induce apoptosis in LNCaP and SW480 cells through activation of the intrinsic pathway.<a onclick="showRef(event, 'ref288 ref289'); return false;" href="javascript:void(0);" class="ref ref288 ref289">(288,289)</a> It up-regulated the expression of Bax and down-regulated Bcl2 expression to induce apoptosis in MCF-7 cells, while it decreased the expression of NF-κB and COX-2 by activation of the MAPK signaling pathway, indicating its inhibitory effects on estrogen-responsive breast cancer through the inhibition of inflammatory pathways.<a onclick="showRef(event, 'ref290'); return false;" href="javascript:void(0);" class="ref ref290">(290)</a></div><div class="NLM_p">Gedunin (<b>11i</b>), an analogue of obacunone with the absence of an oxygen atom between C-3 and C-4, was isolated originally from the heartwood of <i>Entandrophragma angolense</i> (Welw.) C.DC. (Meliaceae) in 1960,<a onclick="showRef(event, 'ref291'); return false;" href="javascript:void(0);" class="ref ref291">(291)</a> with the structure determined by analysis of the single-crystal X-ray data of dihydrogedun-3β-yl iodoacetate.<a onclick="showRef(event, 'ref292'); return false;" href="javascript:void(0);" class="ref ref292">(292)</a> Gedunin (<b>11i</b>) was determined as being inactive against A549 human lung cancer cells,<a onclick="showRef(event, 'ref293'); return false;" href="javascript:void(0);" class="ref ref293">(293)</a> while it exhibited moderate cytotoxicity toward human MCF-7 and SK-BR-3 breast cancer and HL-60 leukemia cells, with IC<sub>50</sub> values in the range 3–9 μM (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref293 ref294'); return false;" href="javascript:void(0);" class="ref ref293 ref294">(293,294)</a> Tumor incidence was inhibited completely when the right buccal pouches of two-month-old male Syrian hamsters were painted by 7,12-dimethylbenz[<i>a</i>]anthracene (DMBA), and the animals were treated (intragastrically) with gedunin (0.1 mg/kg, three times a week) for 14 weeks.<a onclick="showRef(event, 'ref295'); return false;" href="javascript:void(0);" class="ref ref295">(295)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of limonin analogues <b>11i</b>–<b>11n</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>A549 lung cancer, <sup><i>b</i></sup>MCF-7 and <sup><i>d</i></sup>SK-BR-3 breast cancer, <sup><i>c</i></sup>HL-60 leukemia, <sup><i>e</i></sup>HeLa cervical, <sup><i>f</i></sup>HepG2 hepatoma, and <sup><i>g</i></sup>IMR32 neuroblastoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mechanistically, gedunin inhibited the proliferation of PA-1 and OVCAR-3 human ovarian cancer cells through G2/M-phase arrest and ROS-mediated intrinsic apoptosis, which involved the MAPK and JAK/STAT3 pathways.<a onclick="showRef(event, 'ref296'); return false;" href="javascript:void(0);" class="ref ref296">(296)</a> It induced apoptotic death of MCF-7, MDA-MB-231, T47D, and Hs578T human breast cancer cells through inactivation of the cochaperone p23 protein, from which its cellular interaction with Hsp90 is blocked,<a onclick="showRef(event, 'ref297'); return false;" href="javascript:void(0);" class="ref ref297">(297)</a> and it prohibited the growth and metastasis of HPAC human pancreatic cancer cells through inhibition of sonic hedgehog signaling.<a onclick="showRef(event, 'ref298'); return false;" href="javascript:void(0);" class="ref ref298">(298)</a> Administration of gedunin suppressed the development of hamster buccal pouch carcinomas by inhibiting the PI3K/Akt and NF-κB pathways, and it blocked angiogenesis by downregulating the expression of miR-21, VEGF, and HIF-1α.<a onclick="showRef(event, 'ref295'); return false;" href="javascript:void(0);" class="ref ref295">(295)</a></div><div class="NLM_p">Investigation of the cytotoxicity of gedunin (<b>11i</b>) and its analogues showed that deacetylation [e.g., 7-desacetylgedunin (<b>11j</b>)] decreased the activity against MCF-7 and SK-BR-3 human breast cancer cells, and introducing an additional epoxy group at the C-1 and C-2 position [e.g., 1,2-dihydro-7-desacetyl-1,2-epoxygedunin (<b>11k</b>)] resulted in the activity being abolished,<a onclick="showRef(event, 'ref294'); return false;" href="javascript:void(0);" class="ref ref294">(294)</a> while changing C-7 acetyl to a benzoyl group [e.g., 7-deacetyl-7-benzoylgedunin (<b>11l</b>)] enhanced the activity against HL-60 cells slightly.<a onclick="showRef(event, 'ref293'); return false;" href="javascript:void(0);" class="ref ref293">(293)</a> These observations suggest that the C-1–C-3 enone group seems critical in the mediation of the cytotoxicity of gedunin, and that activity can be improved by modifications at the C-7 position. Surprisingly, cleavage of the C-7 and C-8 bond and the oxygen-bridge between the C-1 and C-14 carbons resulted in the activity against IMR32 human neuroblastoma cells being enhanced substantially, as shown by cipaferen G (<b>11m</b>), which was potently cytotoxic against IMR cells, with an IC<sub>50</sub> value of 22 nM (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref299'); return false;" href="javascript:void(0);" class="ref ref299">(299)</a> Also, the cytotoxicity against HepG2 human hepatoma cells of cipaferen G (<b>11m</b>) was enhanced more than 10 000-fold, when a <i>N</i>-benzoylpiperazine unit was linked synthetically to its acetyl group [e.g., <b>11n</b>, IC<sub>50</sub> = 0.01 μM (HepG2 cells)]. Both <b>11m</b> and <b>11n</b> showed some selectivity among the cancer cells tested,<a onclick="showRef(event, 'ref299'); return false;" href="javascript:void(0);" class="ref ref299">(299)</a> and thus, they seem to be promising lead compounds for further investigation.</div><div class="NLM_p">Furthermore, removal of the oxygen atom between C-16 and C-17 of gedunin leads to the azadirone-type limonoids, of which nimbolide (<b>11o</b>), containing a 6,28-lactone unit, a C-7 and C-15 oxygen-bridged tetrahydrofuran ring, and a cleaved C-12 and C-13 bond (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>), is an important limonoid member that shows potential antitumor properties. Nimbolide (<b>11o</b>) was isolated originally from the fresh leaves of the neem tree [<i>Azadirachta indica</i> A. Juss. (Meliaceae)] in 1967,<a onclick="showRef(event, 'ref300'); return false;" href="javascript:void(0);" class="ref ref300">(300)</a> with the structure determined by analysis of its single-crystal X-ray diffraction data.<a onclick="showRef(event, 'ref301'); return false;" href="javascript:void(0);" class="ref ref301">(301)</a> On the basis of prior literature reports in 2014 and 2016, this limonoid affects tumor cell proliferation and apoptosis and tumor angiogenesis and metastasis through different mechanisms.<a onclick="showRef(event, 'ref302 ref303'); return false;" href="javascript:void(0);" class="ref ref302 ref303">(302,303)</a> Nimbolide (<b>11o</b>) was found to be potently cytotoxic against P-388 murine leukemia cells (IC<sub>50</sub> = 0.14 μM), while it showed a lower potency toward other cancer cell lines (IC<sub>50</sub> = 0.43–1.3 μM),<a onclick="showRef(event, 'ref304'); return false;" href="javascript:void(0);" class="ref ref304">(304)</a> with a moderate activity observed also against the MCF-7 (IC<sub>50</sub> = 4.0 μM) and MDA-MB-231 (IC<sub>50</sub> = 6.0 μM) human breast cancer cell lines (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>).<a onclick="showRef(event, 'ref305'); return false;" href="javascript:void(0);" class="ref ref305">(305)</a> Also, nimbolide induces cancer cell apoptosis,<a onclick="showRef(event, 'ref305'); return false;" href="javascript:void(0);" class="ref ref305">(305)</a> and its apoptotic effects were found selectively for cancer cell lines but not for normal cells.<a onclick="showRef(event, 'ref306'); return false;" href="javascript:void(0);" class="ref ref306">(306)</a> Importantly, it induced mitochondrial apoptosis in pancreatic ductal adenocarcinoma cells, with the potency being greater than that of gemcitabine, the first-line agent to treat pancreatic cancer, and other agents, including sorafenib and curcumin.<a onclick="showRef(event, 'ref307'); return false;" href="javascript:void(0);" class="ref ref307">(307)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structures of limonin analogues <b>11o</b>–<b>11v</b> and IC<sub>50</sub> values (μM) for <sup><i>a</i></sup>Col-2 and <sup><i>g</i></sup>HCT15 human colon cancer, <sup><i>b</i></sup>KB human oral epidermoid carcinoma, <sup><i>c</i></sup>MCF-7 and <sup><i>d</i></sup>MDA-MB-231 human breast cancer, <sup><i>e</i></sup>P-388 murine leukemia, and human <sup><i>f</i></sup>A549 lung cancer, <sup><i>h</i></sup>SK-MEL-2 melanoma, <sup><i>i</i></sup>SK-OV-3 ovarian cancer, and <sup><i>j</i></sup>XF-498 glioblastoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In in vivo investigations, nimbolide (<b>11o</b>) showed positive results. Colon tumor growth was inhibited when four-week-old athymic <i>nu</i>/<i>nu</i> mice were inoculated by HCT116 human colon cancer cells (1 week) and treated (i.p.) daily with nimbolide (5 mg/kg) for 10 days.<a onclick="showRef(event, 'ref308'); return false;" href="javascript:void(0);" class="ref ref308">(308)</a> Also, liver tumor growth was retarded when five-week-old male BALB/c nude mice were inoculated by Huh7 human liver cancer cells (12 days) and treated (orally) three times per week with nimbolide (10 mg/kg) for 5 weeks.<a onclick="showRef(event, 'ref309'); return false;" href="javascript:void(0);" class="ref ref309">(309)</a> Moreover, the growth of oral tumors was delayed significantly when the right buccal pouches of eight-ten-week-old male Syrian hamsters were painted with DMBA, and the animals were treated (i.g.) daily with nimbolide (0.1 mg/kg) for 4 weeks.<a onclick="showRef(event, 'ref310'); return false;" href="javascript:void(0);" class="ref ref310">(310)</a></div><div class="NLM_p">Nimbolide (<b>11o</b>) targets different signaling pathways to mediate its antitumor effects. It induced mitochondrial apoptosis in Huh-7 HCC cells through activation of the MAPK pathway, which involves activating the inhibition of c-IAP1 (c-inhibitor of apoptosis 1) expression.<a onclick="showRef(event, 'ref309'); return false;" href="javascript:void(0);" class="ref ref309">(309)</a> It activated autophagy-mediated apoptotic cell death in MDA-MB-231 and MCF-7 breast cancer cells, for which apoptosis signaling was induced via downregulation of Bcl-2 proteins and activation of caspases, with the autophagy signaling being activated by increasing Beclin 1 and LC3B (MAP1-LC3B, microtubule-associated protein 1 light chain 3), along with decreased p62 and mTOR protein expression that resulted from inhibition of HDAC-2.<a onclick="showRef(event, 'ref311'); return false;" href="javascript:void(0);" class="ref ref311">(311)</a> Also, nimbolide induced initially autophagy leading to apoptosis in SCC131 and SCC4 human oral cancer cells, which resulted in inhibition of cell growth. The decreased expression of LC-3 II, Beclin-1, and autophagy related 5 (ATG5), which function as molecular links between autophagy and apoptosis, and the enhanced expression of Bax, cytosolic cytochrome c, and cleaved caspase-3 indicated a cytoprotective effect of the autophagy induced by nimbolide. Moreover, nimbolide mediates autophagy-dependent apoptosis via downregulation of homeobox transcript antisense intergenic RNA (HOTAIR), a competing endogenous RNA that sponges miR-126, an activator of GSK (glycogen synthase kinase)-3β. This may increase the expression of miR-126 leading to activation of GSK-3β to contribute to inactivation of PI3K/Akt/GSK3 signaling by nimbolide.<a onclick="showRef(event, 'ref310'); return false;" href="javascript:void(0);" class="ref ref310">(310)</a> In addition, nimbolide (<b>11o</b>) inhibited the proliferation and invasion of HCT116 human colon cancer cells through inhibition of NF-κB activation.<a onclick="showRef(event, 'ref308'); return false;" href="javascript:void(0);" class="ref ref308">(308)</a></div><div class="NLM_p">Concurrent regulation of autophagy, an evolutionarily conserved form of programmed cell death, and apoptosis is desired to improve cancer chemotherapeutic outcomes through retarding cancer cell MDR. Thus, nimbolide (<b>11o</b>) was proposed as being worthy of evaluation for its safety and efficacy in cancer clinical testing, based on its potent autophagy/apoptosis-targeted antitumor efficacy.<a onclick="showRef(event, 'ref308 ref310'); return false;" href="javascript:void(0);" class="ref ref308 ref310">(308,310)</a> This was supported by a pharmacokinetic investigation reported recently, when male Sprague–Dawley rats were administered i.v. (10 mg/kg) or orally (10, 30, and 50 mg/kg) by nimbolide, with the blood samples of rats being collected through the retro-orbital sinus at different time points and tested using the LC/QTOF/MS method. The maximum plasma concentrations of nimbolide were determined as around 15.3 and 5555.2 ng/mL at 10 mg/kg by oral and i.v. administration, respectively, which indicated a poor oral absorption that may delay the therapeutic translation of this compound.<a onclick="showRef(event, 'ref312'); return false;" href="javascript:void(0);" class="ref ref312">(312)</a> Thus, structural optimization followed by novel delivery system development for nimbolide seems to be required for the development of promising antitumor candidate.<a onclick="showRef(event, 'ref312'); return false;" href="javascript:void(0);" class="ref ref312">(312)</a></div><div class="NLM_p">Nimbolide (<b>11o</b>) showed more potent activity than 28-deoxonimbolide (<b>11p</b>) against Col-2 and HCT15 human colon cancer and P-388 murine leukemia cells (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>),<a onclick="showRef(event, 'ref304'); return false;" href="javascript:void(0);" class="ref ref304">(304)</a> indicating that the C-6/C-28 oxygen-bridged lactone unit is important in the modulation of its cytotoxicity. A greatly enhanced cytotoxic potency toward murine P-388 cells was observed when the lactone unit of <b>11o</b> is replaced by a tetrahydropyran ring composed of C-4, C-5, C-10, C-19, and C-28, with its oxygen-bridged C-7 and C-15 tetrahydrofuran ring modified to a 14,15-epoxy group followed by a direct connection of C-12 and C-13 [e.g., amoorastatin (<b>11q</b>)].<a onclick="showRef(event, 'ref313'); return false;" href="javascript:void(0);" class="ref ref313">(313)</a> The natural product <b>11q</b> exhibited potent activity against P-388 cells, with the IC<sub>50</sub> value being less than 1.9 nM,<a onclick="showRef(event, 'ref313'); return false;" href="javascript:void(0);" class="ref ref313">(313)</a> but its close natural analogue, amoorastatone (<b>11r</b>), containing a C-15 carbonyl group, was found to be inactive (IC<sub>50</sub> = 58 μM),<a onclick="showRef(event, 'ref314'); return false;" href="javascript:void(0);" class="ref ref314">(314)</a> indicating that the 14,15-epoxy group is critically important for amoorastatin (<b>11q</b>) to mediate its activity against P-388 cells. The activity of <b>11q</b> did not change greatly when a hydroxy group was substituted at the C-12 position [e.g., 12-hydroxyamoorastatin (<b>11s</b>)], but the activity against SK-MEL-2 human melanoma cells of <b>11s</b> was enhanced more than 10-fold when its 12-hydroxy group was acetylated [e.g., 12-acetoxyamoorastatin (<b>11t</b>, IC<sub>50</sub> = 1.2 nM].<a onclick="showRef(event, 'ref314 ref315'); return false;" href="javascript:void(0);" class="ref ref314 ref315">(314,315)</a> Further acetylation of the C-28 hydroxy group of <b>11t</b> [e.g., sendanin (<b>11u</b>)] did not increase the activity, but changing the 14,15-epoxy group of <b>11s</b> to a carbonyl group [e.g., 12-hydroxyamoorastatone (<b>11v</b>)] decreased the potency greatly (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>),<a onclick="showRef(event, 'ref314 ref315'); return false;" href="javascript:void(0);" class="ref ref314 ref315">(314,315)</a> suggesting that both the 3,12-diacetyl and 14,15-epoxy groups are required in order for 12-acetoxyamoorastatin (<b>11t</b>) to mediate its cancer cell cytotoxicity, and that its activity might be improved by further modifications at the C-12 position. Thus, additional work could be focused on detailed investigations on the in vivo antitumor efficacy and mechanism of action of this limonoid (<b>11t</b>) for the discovery of a possible autophagy-targeted antitumor agent.</div><div class="NLM_p">Limonin (LMN, <b>11</b>) is a major component of the seeds of lemon and other <i>Citrus</i> species and shows a broad spectrum of bioactivities of potential benefit to human health. Numerous naturally occurring limonoids that represent different skeletons and related to limonin (<b>11</b>) have thus far characterized. Of these compounds, nomilin (<b>11e</b>), obacunone (<b>11g</b>), gedunin (<b>11i</b>), nimbolide (<b>11o</b>), and LMN (<b>11</b>) itself have attracted wide attention due to their potential antitumor activities, and <b>11o</b> was found to target autophagy/apoptosis to mediate its antitumor property. However, except for compound <b>11n</b>, all of the other analogues of LMN (<b>11</b>) are plant-derived natural products, and thus, synthetic modifications of these compounds could be performed in future investigations. SAR investigations for limonin (LMN, <b>11</b>) and its analogues as discussed above indicate that changing C-1–C-5, C-10, and C-19 bicyclic system to a monolactone unit enhanced cytotoxicity of <b>11</b> (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>). Thus, the antitumor activity of limonoids may be enhanced greatly when a tetrahydropyran ring is introduced to a gedunin-type molecule with C-1 and C-14 bridged by an oxygen atom, or to an azadirone-type limonoid containing oxygen-linked to the C-19 and C-28 carbons, as represented by <b>11n</b> and <b>11t</b>, respectively. Accordingly, these potent antitumor leads could be investigated further to develop autophagy-targeted agents to combat MDR in cancer.</div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Key SAR conclusions for the synthetic modification of limonin (LMN, <b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Summary and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this Perspective, 11 antitumor terpenoid lactones (<b>1</b>–<b>11</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), along with over 100 of their analogues, representing plant-derived sesquiterpene, diterpene, and triterpene lactones and their derivatives, have been reviewed for their potential antineoplastic activity, with SAR information, mechanisms of action, and clinical possibilities highlighted. Among them, ART (<b>1</b>), PTL (<b>2</b>), AGL (<b>4</b>), and BRC (<b>9</b>), along with the prodrugs, mipsagargin (<b>3b</b>) and Minnelide (<b>8h</b>) of TPG (<b>3</b>) and TPL (<b>8</b>), respectively, have been evaluated in cancer clinical trials. The structures of these compounds may be used as valuable scaffolds for the design and development of novel agents for the effective treatment of cancer.</div><div class="NLM_p">The complete structures of compounds <b>1</b>–<b>11</b> have been determined by either analysis of their single-crystal X-ray diffraction data or by total synthesis of these molecules or their related derivatives, and these determinations have been supported in many cases by further analysis of their electronic circular dichroism (ECD) spectra. This structural information will be critically important for the possible further development of these compounds as anticancer agents.</div><div class="NLM_p">Sesquiterpene lactones (SQLs) are a large group of natural products, with many members being found to show potential antitumor activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> SQLs <b>1</b>–<b>3</b> presented herein, have been evaluated in cancer clinical trials, of which derivatives of ART (<b>1</b>) are used clinically to treat malaria, and PTL (<b>2</b>) and TPG (<b>3</b>) are potent inhibitors of NF-κB and SERCA, respectively. Some other SQLs, including arglabin, micheliolide, and α-santonin that show potential antitumor activity, have been summarized previously<a onclick="showRef(event, 'ref316 ref317 ref318'); return false;" href="javascript:void(0);" class="ref ref316 ref317 ref318">(316−318)</a> and so are not included in the present Perspective.</div><div class="NLM_p">The α,β-unsaturated γ-lactone moiety has been defined as important for SQLs to show cancer cell cytotoxicity.<a onclick="showRef(event, 'ref319'); return false;" href="javascript:void(0);" class="ref ref319">(319)</a> However, the importance of a lactone unit in the mediation of cytotoxicity of the terpenoid lactones <b>1</b>–<b>9</b> has not been demonstrated definitively thus far, and this unit seems not critical in the exhibition of cytotoxicity by analogues of dichapetalin A (DCT, <b>10</b>) and limonin (LMN, <b>11</b>). For example, all of the compounds <b>10h</b>–<b>10m</b> exhibited cytotoxicity against WM 266–4 human melanoma cells, at comparable levels to that of dichapetalin A (DCT, <b>10</b>) (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a> and <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>).<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> In turn, nimbolide (<b>11o</b>) showed less potent activity than amoorastatin (<b>11q</b>) toward P-388 murine leukemia cells (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>).<a onclick="showRef(event, 'ref304 ref313'); return false;" href="javascript:void(0);" class="ref ref304 ref313">(304,313)</a> Thus, additional synthetic modifications focused on the lactone unit of compounds <b>1</b>–<b>11</b> could be performed in future investigations.</div><div class="NLM_p">The potential antitumor activity of dihydroartemisinin (DHA, <b>1a</b>) has been improved when compared with that of artemisinin (ART, <b>1</b>),<a onclick="showRef(event, 'ref15 ref27'); return false;" href="javascript:void(0);" class="ref ref15 ref27">(15,27)</a> and a water-soluble amino derivative of parthenolide (PTL, <b>2</b>), dimethylaminoparthenolide (DMAPT or LC-1, <b>2c</b>), was found to show potent cytotoxicity against AML cells.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> In addition, Minnelide (<b>8h</b>), a water-soluble prodrug of triptolide (TPL, <b>8</b>) and a 14-<i>O</i>-phosphonooxymethyltriptolide disodium salt, has been developed as a promising agent evaluated in cancer clinical trials.<a onclick="showRef(event, 'ref171 ref199'); return false;" href="javascript:void(0);" class="ref ref171 ref199">(171,199)</a> These successful examples indicate that the terpenoid lactones (<b>1</b>–<b>11</b>) could be modified at their lactone unit, through reduction of the carbonyl group, followed by introduction of a dimethylamino or a phosphonooxymethyl group. Such modifications may be supportive of the development of novel anticancer agents from terpenoid lactones.</div><div class="NLM_p">The pharmacophores of the terpenoid lactones discussed have been characterized by SAR investigations, and the isoprenoid core, the enone and lactone units, and the oxygen-bridged multiple ring systems have been found to be important for the mediation of the antitumor properties of compounds <b>1</b>–<b>11</b>. Following the SAR conclusions made, a number of derivatives that display improved antitumor potencies have been prepared, which indicate that acetylation, dimerization, and introduction of an α-hydroxy-substituted carbonyl group, an enone or related longer conjugated system, an epoxy group, a lactone unit, a pyran ring, or a drug conjugate, may enhance the potential antitumor activity of a terpenoid lactone. These observations should be supportive of the design and development of future natural product anticancer agents of this type. However, it is worth noting that most SAR conclusions that have been discussed in the present contribution are based on relatively limited numbers of the natural product analogues or their synthetic derivatives. Thus, an enlarged number of the analogues of these lead compounds should be investigated in the future to support or to modify the SAR conclusions made herein.</div><div class="NLM_p">To overcome factors that have limited antitumor efficacy of the compounds presented, including undesired toxicity and poor bioavailability observed in preclinical investigations, synthetic modifications, including introducing water-soluble moieties and drug conjugation or hybrid molecule formation have been carried out for several of the examples discussed. Overall, the modified products obtained have shown an improved antitumor potential when compared with their parent compounds. In addition, novel drug delivery systems developed for several of the compounds discussed were found to enhance their aqueous solubility and bioavailability, while other formulations have been designed to deliver the active compounds to tumor tissues directly to kill the malignant cells more effectively. These scientific accomplishments form a firm foundation for the further development of the lactones based on terpenoid scaffolds as new cancer chemotherapeutic agents.</div><div class="NLM_p">Cancer is a genetic disease, with multiple complex biological processes involved. The occurrence of a mutator phenotype in cancer cells indicates the possibility of the development of adaptive resistance in tumors, and thus, it may be rationalized that the design of further effective anticancer drugs should focus on compounds with multiple rather than single molecular targets. In this regard, mechanism-based anticancer drug discovery seems highly desirable. As discussed in this perspective article, terpenoid lactones can be quite structurally complex, and they have been shown to interact with diverse molecular targets to mediate their potential antitumor activity. These include the major targets of AR for ART (<b>1</b>), NF-κB for PTL (<b>2</b>), SERCA for TPG (<b>3</b>), COX2 for AGL (<b>4</b>), PAFR for GKL B (<b>5</b>), HK2 for JKL B (<b>6</b>), RIOK2 for NGL E (<b>7</b>), Hsp70 for TPL (<b>8</b>), c-Myc for BRC (<b>9</b>), and YAP for LMN (<b>11</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These targets and their triggered signaling pathways control cancer cell proliferation, invasion, and migration, MDR against chemotherapeutic treatments, and tumor growth by interfering with cancer cell autophagy, apoptosis, necrosis, and cancer stem cell proliferation, as well as interacting with the tumor genomes, the inflammatory response, the microenvironment, cellular metabolism, and immune destruction.</div><div class="NLM_p">Indeed, several of the compounds discussed herein have attracted attention for their antitumor properties as a result of their activity against the molecular targets rather than their growth inhibitory potency toward cancer cells. For example, thapsigargin (TPG, <b>3</b>) was found to inhibit SERCA (IC<sub>50</sub> = 3.9 nM) to increase Ca<sup>2+</sup> levels in the cytoplasm of cancer cells,<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> which led to the development of the prodrug mipsagargin (<b>3b</b>, G-202) that was evaluated in phase I and II cancer clinical trials.<a onclick="showRef(event, 'ref62 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref62 ref82 ref83">(62,82,83)</a> Ginkgolide B (GKL B, <b>6</b>) was identified as a specific PAF inhibitor that induces tumor cell apoptosis, and thus the antiovarian tumor efficacy of cisplatin was found to be improved by combination treatment of this drug with GKL B.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> These results indicate that mechanism-targeted discovery of anticancer agents is promising, and those novel bitarget cancer drug conjugates could be preferential candidates in this regard.</div><div class="NLM_p">Moreover, several compounds presented, including ART (<b>1</b>), TPG (<b>3</b>), TPL (<b>8</b>), bruceine D (<b>9j</b>), and nimbolide (<b>11o</b>), showed autophagy modulatory activity. Autophagy is a naturally regulated cellular mechanism for the control of important physiological functions, and it contributes to cancer as both a tumor survival promoter and suppressor. There is crosstalk between autophagy and apoptosis through several signaling pathways, which could contribute to the reversal of the cancer MDR.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Thus, compounds modulating autophagy could improve current cancer chemotherapy by decreasing MDR effects.</div><div class="NLM_p">In addition, cancers are also complex matrices composed of malignant and nonmalignant cells, which together create a tumor microenvironment (TME). Communication between the stroma and malignant cells enables cancer cells to invade normal adjacent tissues, and interaction with the TME contribute critically to the successful treatment of cancer.<a onclick="showRef(event, 'ref1 ref320'); return false;" href="javascript:void(0);" class="ref ref1 ref320">(1,320)</a> As discussed in the present perspective, several TME-related targets, including autophagy, cancer stem cells, PI3K/Akt/mTOR, HIF-1α, HK2, and Wnt2, have been reported as the cellular signaling mechanisms of <b>1</b>–<b>11</b>. Thus, it could be a promising strategy to design and discover some TME-targeted anticancer agents based on the terpenoid lactones, <b>1</b>–<b>11</b>.</div><div class="NLM_p">Frequently, the genotoxicity of any anticancer agents may prevent their development toward clinical trial investigations. Of the lead compounds discussed, three SQLs, ART (<b>1</b>), PTL (<b>2</b>), and TPG (<b>3</b>), a diterpene [TPL (<b>8</b>)], and a triterpene [LMN (<b>11</b>)] lactone have been reported for their potential genotoxicity.<a onclick="showRef(event, 'ref186 ref321 ref322'); return false;" href="javascript:void(0);" class="ref ref186 ref321 ref322">(186,321,322)</a> However, no genotoxic effects have been demonstrated for compounds <b>4</b>–<b>7</b>, <b>9</b>, and <b>10</b> to date. Thus, more detailed information about potential mutagenic or immunogenic adverse effects of these terpenoid lactones could be reported in future investigations, and this will probably lead to the discovery of some novel terpenoid lactone derivative, with decreased genotoxic potency.</div><div class="NLM_p last">Historically, plants are known to produce complex specialized metabolite organic compounds with the desired structural diversity to potentially interact with multiple cellular targets, and plant-derived natural products have played a key role in the discovery of new anticancer agents over the last several decades.<a onclick="showRef(event, 'ref5 ref323 ref324 ref325'); return false;" href="javascript:void(0);" class="ref ref5 ref323 ref324 ref325">(5,323−325)</a> Further searches for plant-derived lead compounds as new antineoplastic agents could lead to the characterization of additional interesting compounds based on new structural types. These novel molecules may act on cancer cells through unusual mechanisms to afford possible new approaches for cancer treatment. In this context, the discovery of novel plant-derived terpenoid lactones and their derivatives may be of great importance. It is hoped that the information provided in the present contribution will be supportive of further work being performed on the discovery of antitumor agents from terpenoid lactones purified from higher plants.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01449" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yulin Ren</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry and
Pharmacognosy, College of Pharmacy, The
Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3667-1466" title="Orcid link">http://orcid.org/0000-0003-3667-1466</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89fbece7a7bdb8c9e6fafca7ecedfc"><span class="__cf_email__" data-cfemail="493b2c27677d7809263a3c672c2d3c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">A. Douglas Kinghorn</span> - <span class="hlFld-Affiliation affiliation">Division of Medicinal Chemistry and
Pharmacognosy, College of Pharmacy, The
Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6647-8707" title="Orcid link">http://orcid.org/0000-0002-6647-8707</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c7acaea9a0afa8b5a9e9f387a8b4b2e9a2a3b2"><span class="__cf_email__" data-cfemail="ef8486818887809d81c1dbaf809c9ac18a8b9a">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87371" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87371" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Yulin Ren</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=BIO-d7e6791-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yulin Ren</b> received her Ph.D. degree in Medicinal Chemistry and Pharmacognosy in 2001 from Peking Union Medical College, Beijing, People’s Republic of China, under the supervision of Prof. Junshan Yang. After being trained as a postdoctoral researcher in both Organic Synthesis and Biomedical Sciences in United States, she joined the group of Prof. A. Douglas Kinghorn at College of Pharmacy, The Ohio State University. Her research interests focus on design and discovery of anticancer agents based on the plant-derived compounds. These include the isolation and identification of the antitumor constituents of higher plants, the structural determination of natural products, and the synthetic modification of the potential anticancer lead compounds.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="33" class="article__inlineFigure"><h2 class="fig-label">A. Douglas Kinghorn</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=BIO-d7e6796-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>A. Douglas Kinghorn</b> received his Ph.D. (1975) and D.Sc. (1990) degrees from The School of Pharmacy, University of London. He is currently Emeritus Editor of the <i>Journal of Natural Products</i> and Series Editor of <i>Progress in the Chemistry of Organic Natural Products</i> (Springer Nature, Cham, Switzerland). Since 2004, he has held the position of Professor and Jack L. Beal Chair at the College of Pharmacy, The Ohio State University. His research interests include the isolation and structural characterization of bioactive natural products from higher plants. He received the Norman R. Farnsworth Research Achievement Award from the American Society of Pharmacognosy in 2010 and the Egon Stahl Award in Gold from GA (Society for Medicinal Plant and Natural Products Research) in 2020.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Certain laboratory studies conducted by the authors and cited in this Perspective were supported by program project CA125066, funded by the National Cancer Institute, NIH, Bethesda, MD, USA. We wish to thank many present and former faculty and staff colleagues, postdoctoral associates, and graduate and undergraduate students who have participated in this collaborative project.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACC</td><td class="NLM_def"><p class="first last">adrenocortical carcinoma</p></td></tr><tr><td class="NLM_term">ADP</td><td class="NLM_def"><p class="first last">adenosine diphosphate</p></td></tr><tr><td class="NLM_term">ADT</td><td class="NLM_def"><p class="first last">androgen deprivation therapy</p></td></tr><tr><td class="NLM_term">AGL</td><td class="NLM_def"><p class="first last">andrographolide</p></td></tr><tr><td class="NLM_term">Akt or PKB</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">ALL</td><td class="NLM_def"><p class="first last">acute lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">AOM</td><td class="NLM_def"><p class="first last">azoxymethane</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">ARS</td><td class="NLM_def"><p class="first last">artesunate</p></td></tr><tr><td class="NLM_term">ART</td><td class="NLM_def"><p class="first last">artemisinin</p></td></tr><tr><td class="NLM_term">ATG5</td><td class="NLM_def"><p class="first last">autophagy related 5</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BAG3</td><td class="NLM_def"><p class="first last">Bcl-2-associated athanogene domain 3</p></td></tr><tr><td class="NLM_term">B(a)P</td><td class="NLM_def"><p class="first last">benzo(a)pyrene</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood brain barrier</p></td></tr><tr><td class="NLM_term">Bcl-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">BRC</td><td class="NLM_def"><p class="first last">bruceantin</p></td></tr><tr><td class="NLM_term">CAF</td><td class="NLM_def"><p class="first last">cancer-associated fibroblast</p></td></tr><tr><td class="NLM_term">CCAAT</td><td class="NLM_def"><p class="first last">cytosine-cytosine-adenosine-adenosine-thymidine</p></td></tr><tr><td class="NLM_term">CDDP or DDP</td><td class="NLM_def"><p class="first last"><i>cis</i>-diaminodichloroplatinum (cisplatin)</p></td></tr><tr><td class="NLM_term">CHOP</td><td class="NLM_def"><p class="first last">C/EBP homologous protein</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">COX2</td><td class="NLM_def"><p class="first last">cyclooxygenase-2</p></td></tr><tr><td class="NLM_term">CPP</td><td class="NLM_def"><p class="first last">cell-penetrating peptide</p></td></tr><tr><td class="NLM_term">CPT</td><td class="NLM_def"><p class="first last">camptothecin</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">colorectal cancer</p></td></tr><tr><td class="NLM_term">CSC</td><td class="NLM_def"><p class="first last">cancer stem cells</p></td></tr><tr><td class="NLM_term">DCT</td><td class="NLM_def"><p class="first last">dichapetalin</p></td></tr><tr><td class="NLM_term">DEN</td><td class="NLM_def"><p class="first last">diethylnitrosamine</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">dihydroartemisinin</p></td></tr><tr><td class="NLM_term">DLT</td><td class="NLM_def"><p class="first last">dose-limiting toxicity</p></td></tr><tr><td class="NLM_term">DMBA</td><td class="NLM_def"><p class="first last">7,12-dimethylbenz[<i>a</i>]anthracene</p></td></tr><tr><td class="NLM_term">DOX</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">DR</td><td class="NLM_def"><p class="first last">death receptor</p></td></tr><tr><td class="NLM_term">DSB</td><td class="NLM_def"><p class="first last">double-strand breaks</p></td></tr><tr><td class="NLM_term">EBP</td><td class="NLM_def"><p class="first last">enhancer-binding proteins</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial-mesenchymal transition</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinases</p></td></tr><tr><td class="NLM_term">ESCC</td><td class="NLM_def"><p class="first last">esophageal squamous cell carcinoma</p></td></tr><tr><td class="NLM_term">FAK</td><td class="NLM_def"><p class="first last">focal adhesion kinase</p></td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluorouracil</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma multiforme</p></td></tr><tr><td class="NLM_term">GEM</td><td class="NLM_def"><p class="first last">gemcitabine</p></td></tr><tr><td class="NLM_term">GKL</td><td class="NLM_def"><p class="first last">ginkgolide</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">glycogen synthase kinase</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">guanosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducing factor 1α</p></td></tr><tr><td class="NLM_term">HK2</td><td class="NLM_def"><p class="first last">hexokinase 2</p></td></tr><tr><td class="NLM_term">HNSCC</td><td class="NLM_def"><p class="first last">head and neck squamous cell carcinoma</p></td></tr><tr><td class="NLM_term">HPV</td><td class="NLM_def"><p class="first last">human papillomavirus</p></td></tr><tr><td class="NLM_term">Hsp70</td><td class="NLM_def"><p class="first last">70 kDa heat shock proteins</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cells</p></td></tr><tr><td class="NLM_term">IAP</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">the concentration required for 50% inhibition of cell viability</p></td></tr><tr><td class="NLM_term">IL-8</td><td class="NLM_def"><p class="first last">interleukin-8</p></td></tr><tr><td class="NLM_term">i.g.</td><td class="NLM_def"><p class="first last">intragastrically</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneally</p></td></tr><tr><td class="NLM_term">IRR</td><td class="NLM_def"><p class="first last">infusion-related reaction</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinases</p></td></tr><tr><td class="NLM_term">JKL</td><td class="NLM_def"><p class="first last">jolkinolide</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last"><i>c</i>-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">LC3 (MAP1-LC3A,B and C)</td><td class="NLM_def"><p class="first last">microtubule-associated protein 1 light chain 3</p></td></tr><tr><td class="NLM_term">LD<sub>50</sub>, median lethal dose</td><td class="NLM_def"><p class="first last">the dose required to kill 50% of the members of a tested population</p></td></tr><tr><td class="NLM_term">LEF1</td><td class="NLM_def"><p class="first last">lymphoid enhancer factor 1</p></td></tr><tr><td class="NLM_term">LMN</td><td class="NLM_def"><p class="first last">limonin</p></td></tr><tr><td class="NLM_term">LSC</td><td class="NLM_def"><p class="first last">leukemic stem cells</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinases</p></td></tr><tr><td class="NLM_term">MSC</td><td class="NLM_def"><p class="first last">mesenchymal stem cells</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">MTP</td><td class="NLM_def"><p class="first last">mitochondrial transmembrane potential</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">dihydronicotinamide-adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor kappa B</p></td></tr><tr><td class="NLM_term">NGL</td><td class="NLM_def"><p class="first last">nagilactone</p></td></tr><tr><td class="NLM_term">NK</td><td class="NLM_def"><p class="first last">natural killer</p></td></tr><tr><td class="NLM_term">NP</td><td class="NLM_def"><p class="first last">natural product</p></td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H:quinone oxidoreductase 1</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">NTL</td><td class="NLM_def"><p class="first last">natural terpene lactones</p></td></tr><tr><td class="NLM_term">OCC</td><td class="NLM_def"><p class="first last">ovarian cancer cells</p></td></tr><tr><td class="NLM_term">PAF</td><td class="NLM_def"><p class="first last">platelet-activating factor</p></td></tr><tr><td class="NLM_term">PAFR</td><td class="NLM_def"><p class="first last">platelet-activating factor receptor</p></td></tr><tr><td class="NLM_term">PD-1</td><td class="NLM_def"><p class="first last">programmed cell death protein 1</p></td></tr><tr><td class="NLM_term">PGE2</td><td class="NLM_def"><p class="first last">prostaglandin E<sub>2</sub></p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">PKM2</td><td class="NLM_def"><p class="first last">pyruvate kinase M2</p></td></tr><tr><td class="NLM_term">PP</td><td class="NLM_def"><p class="first last">protein phosphatase</p></td></tr><tr><td class="NLM_term">PPP</td><td class="NLM_def"><p class="first last">pentose phosphate pathway</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">prostate-specific antigen</p></td></tr><tr><td class="NLM_term">PTL</td><td class="NLM_def"><p class="first last">parthenolide</p></td></tr><tr><td class="NLM_term">RIO</td><td class="NLM_def"><p class="first last">right open reading frame</p></td></tr><tr><td class="NLM_term">RIOK2</td><td class="NLM_def"><p class="first last">RIO kinase 2</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency</p></td></tr><tr><td class="NLM_term">SERCA</td><td class="NLM_def"><p class="first last">sarco/endoplasmic reticulum (ER) calcium ATPase</p></td></tr><tr><td class="NLM_term">SQL</td><td class="NLM_def"><p class="first last">sesquiterpene lactone</p></td></tr><tr><td class="NLM_term">STAT3</td><td class="NLM_def"><p class="first last">signal transducers and activators of transcription 3</p></td></tr><tr><td class="NLM_term">TCF4</td><td class="NLM_def"><p class="first last">T-cell factor 4</p></td></tr><tr><td class="NLM_term">TGF-β</td><td class="NLM_def"><p class="first last">transforming growth factor-β</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr><tr><td class="NLM_term">TME</td><td class="NLM_def"><p class="first last">tumor microenvironment</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">TPG</td><td class="NLM_def"><p class="first last">thapsigargin</p></td></tr><tr><td class="NLM_term">TPL</td><td class="NLM_def"><p class="first last">triptolide</p></td></tr><tr><td class="NLM_term">TRAIL</td><td class="NLM_def"><p class="first last">TNF-related apoptosis-inducing ligand</p></td></tr><tr><td class="NLM_term">UPR</td><td class="NLM_def"><p class="first last">unfolded protein response</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">Wnt</td><td class="NLM_def"><p class="first last">Wingless-related integration site</p></td></tr><tr><td class="NLM_term">YAP</td><td class="NLM_def"><p class="first last">Yes-associated protein</p></td></tr><tr><td class="NLM_term">ZEB1</td><td class="NLM_def"><p class="first last">zinc finger E-box-binding homeobox 1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 325 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: The next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+The+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0liJUEE-Rspw9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520The%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loeb, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeb, L. A.</span></span> <span> </span><span class="NLM_article-title">Significance of multiple mutations in cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1093/carcin/21.3.379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fcarcin%2F21.3.379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10688858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVeisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=379-385&author=K.+R.+Loebauthor=L.+A.+Loeb&title=Significance+of+multiple+mutations+in+cancer&doi=10.1093%2Fcarcin%2F21.3.379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of multiple mutations in cancer</span></div><div class="casAuthors">Loeb, Keith R.; Loeb, Lawrence A.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review, with 71 refs.  There is increasing evidence that in eukaryotic cells, DNA undergoes continuous damage, repair, and resynthesis.  A homeostatic equil. exists in which extensive DNA damage is counterbalanced by multiple pathways for DNA repair.  In normal cells, most DNA damage is repaired without error.  However, in tumor cells this equil. may be skewed, resulting in the accumulation of multiple mutations.  Among genes mutated are those that function in guaranteeing the stability of the genome.  Loss of this stability results in a mutator phenotype.  Evidence for a mutator phenotype in human cancers includes the frequent occurrence of gene amplification, microsatellite instability, chromosomal aberrations, and aneuploidy.  Current expts. have centered on two mechanisms for the generation of genomic instability, one focused on mutations in mismatch repair genes resulting in microsatellite instability and one focused on mutations in genes that are required for chromosomal segregation resulting in chromosomal aberrations.  This dichotomy may reflect only the ease by which these manifestations can be identified.  Underlying both pathways may be a more general phenomenon involving the selection for mutator genes during tumor progression.  During carcinogenesis there is selection for cells harboring mutations that can overcome adverse conditions that limit tumor growth.  These mutations are produced by direct DNA damage as well as secondarily as a result of mutations in genes that cause a mutator phenotype.  Thus, as tumor progression selects for cells with specific mutations, it also selects for cancer cells harboring mutations in genes that normally function in maintaining genetic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPFdsQN8bQWLVg90H21EOLACvtfcHk0liJUEE-Rspw9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVeisrg%253D&md5=45e1a6ce6cf4ea9b3ce4641d0031d97b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F21.3.379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F21.3.379%26sid%3Dliteratum%253Aachs%26aulast%3DLoeb%26aufirst%3DK.%2BR.%26aulast%3DLoeb%26aufirst%3DL.%2BA.%26atitle%3DSignificance%2520of%2520multiple%2520mutations%2520in%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2000%26volume%3D21%26spage%3D379%26epage%3D385%26doi%3D10.1093%2Fcarcin%2F21.3.379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Natural product and natural product derived drugs in clinical trials</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1039/C4NP00064A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC4NP00064A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25204227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1612-1661&author=M.+S.+Butlerauthor=A.+A.+B.+Robertsonauthor=M.+A.+Cooper&title=Natural+product+and+natural+product+derived+drugs+in+clinical+trials&doi=10.1039%2FC4NP00064A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product and natural product derived drugs in clinical trials</span></div><div class="casAuthors">Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1612-1661</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 2008-2013.  Previous review: 2008, 25, 475There are a significant no. of natural product (NP) drugs in development.  We review the 100 NP and NP-derived compds. and 33 Antibody Drug Conjugates (ADCs) with a NP-derived cytotoxic component being evaluated in clin. trials or in registration at the end of 2013. 38 of these compds. and 33 ADCs are being investigated as potential oncol. treatments, 26 as anti-infectives, 19 for the treatment of cardiovascular and metabolic diseases, 11 for inflammatory and related diseases and 6 for neurol.  There was a spread of the NP and NP-derived compds. through the different development phases (17 in phase I, 52 in phase II, 23 in phase III and 8 NDA and/or MAA filed), while there were 23 ADCs in phase I and 10 in phase II. 50 of these 100 compds. were either NPs or semi-synthetic (SS) NPs, which indicated the original NP still plays an important role.  NP and NP-derived compds. for which clin. trials have been halted or discontinued since 2008 are listed in the Supplementary Information.  The 25 NP and NP-derived drugs launched since 2008 are also reviewed, and late stage development candidates and new NP drug pharmacophores analyzed.  The short term prospect for new NP and NP-derived drug approvals is bright, with 31 compds. in phase III or in registration, which should ensure a steady stream of approvals for at least the next five years.  However, there could be future issues for new drug types as only five new drug pharmacophores discovered in the last 15 years are currently being evaluated in clin. trials.  The next few years will be crit. for NP-driven lead discovery, and a concerted effort is required to identify new biol. active pharmacophores and to progress these and existing compds. through pre-clin. drug development into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ZulhKpZ6PbVg90H21EOLACvtfcHk0lhEYuoXSSoY2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF&md5=05f9fafdbe8dd7c1407fb7b4afab0587</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2FC4NP00064A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00064A%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%2BB.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DNatural%2520product%2520and%2520natural%2520product%2520derived%2520drugs%2520in%2520clinical%2520trials%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D1612%26epage%3D1661%26doi%3D10.1039%2FC4NP00064A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b01285</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b01285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2020&pages=770-803&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+nearly+four+decades+from+01%2F1981+to+09%2F2019&doi=10.1021%2Facs.jnatprod.9b01285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">770-803</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016.  For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the first of Jan. 1981 to the 30th of Sept. 2019 for all diseases worldwide and from ∼1946 (earliest so far identified) to the 30th of Sept. 2019 for all approved antitumor drugs worldwide.  As in earlier reviews, only the first approval of any drug is counted, irresp. of how many "biosimilars" or added approvals were subsequently identified.  As in the 2012 and 2016 reviews, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions, and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from 1946 to 1980, of the 75 small mols., 40, or 53.3%, are N or ND.  In the 1981 to date time frame the equiv. figures for the N* compds. of the 185 small mols. are 62, or 33.5%, though to these can be added the 58 S* and S*/NMs, bringing the figure to 64.9%.  In other areas, the influence of natural product structures is quite marked with, as expected from prior information, the anti-infective area being dependent on natural products and their structures, though as can be seen in the review there are still disease areas (shown in Table 2) for which there are no drugs derived from natural products.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are still able to identify only two de novo combinatorial compds. (one of which is a little speculative) approved as drugs in this 39-yr time frame, though there is also one drug that was developed using the "fragment-binding methodol." and approved in 2012.  We have also added a discussion of candidate drug entities currently in clin. trials as "warheads" and some very interesting preliminary reports on sources of novel antibiotics from Nature due to the abs. requirement for new agents to combat plasmid-borne resistance genes now in the general populace.  We continue to draw the attention of readers to the recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated"; thus we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9vVZR4nleEbVg90H21EOLACvtfcHk0lhEYuoXSSoY2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D&md5=2c10c2aef98042d8bd772b6280b51d2b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b01285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b01285%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520nearly%2520four%2520decades%2520from%252001%252F1981%2520to%252009%252F2019%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2020%26volume%3D83%26spage%3D770%26epage%3D803%26doi%3D10.1021%2Facs.jnatprod.9b01285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco Carcache, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addo, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Current status and contemporary approaches to the discovery of antitumor agents from higher plants</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">107337</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2019.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biotechadv.2019.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30633954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1emtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=107337&author=G.+Agarwalauthor=P.+J.+Blanco+Carcacheauthor=E.+M.+Addoauthor=A.+D.+Kinghorn&title=Current+status+and+contemporary+approaches+to+the+discovery+of+antitumor+agents+from+higher+plants&doi=10.1016%2Fj.biotechadv.2019.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Current status and contemporary approaches to the discovery of antitumor agents from higher plants</span></div><div class="casAuthors">Agarwal, Garima; Carcache, Peter J. Blanco; Addo, Ermias Mekuria; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107337</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Higher plant constituents have afforded clin. available anticancer drugs.  These include both chem. unmodified small mols. and their synthetic derivs. currently used or those in clin. trials as antineoplastic agents, and an updated summary is provided.  In addn., botanical dietary supplements, exemplified by mangosteen and noni constituents, are also covered as potential cancer chemotherapeutic agents.  Approaches to metabolite purifn., rapid dereplication, and biol. evaluation including anal. hyphenated techniques, mol. networking, and advanced cellular and animal models are discussed.  Further, enhanced and targeted drug delivery systems for phytochems., including micelles, nanoparticles and antibody drug conjugates (ADCs) are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDKtoINxG87Vg90H21EOLACvtfcHk0ljdjWwMyYacww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1emtrc%253D&md5=094832aae5d9e3f20d6ac048bce98611</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2019.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2019.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DG.%26aulast%3DBlanco%2BCarcache%26aufirst%3DP.%2BJ.%26aulast%3DAddo%26aufirst%3DE.%2BM.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCurrent%2520status%2520and%2520contemporary%2520approaches%2520to%2520the%2520discovery%2520of%2520antitumor%2520agents%2520from%2520higher%2520plants%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2020%26volume%3D38%26spage%3D107337%26doi%3D10.1016%2Fj.biotechadv.2019.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">The methylerythritol phosphate pathway to isoprenoids</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">5675</span>– <span class="NLM_lpage">5703</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00537</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=5675-5703&author=A.+Frankauthor=M.+Groll&title=The+methylerythritol+phosphate+pathway+to+isoprenoids&doi=10.1021%2Facs.chemrev.6b00537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Methylerythritol Phosphate Pathway to Isoprenoids</span></div><div class="casAuthors">Frank, Annika; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5675-5703</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Isoprenoids constitute one of the most diverse classes of natural products.  As a compd. class they are essential to basic metabolic processes including cell wall biosynthesis, post-translational protein modifications, and signaling.  In addn., isoprenoid secondary metabolites are highly valuable natural products with a wide range of biotechnol. applications.  The biosynthesis of their 2 universal building blocks, isopentenyl diphosphate and dimethylallyl diphosphate, was thought to proceed exclusively by way of mevalonate as a key intermediate until a novel pathway involving methylerithritol phosphate (MEP) was discovered in the early 1990s.  Here, the authors describe the 7 enzymes of the MEP pathway, their discovery, 3-dimensional structures and mechanisms.  The latter include examples of remarkable enzyme catalysis including an unusual cytidilation reaction and the use of Fe-S cluster cofactors in reductive ring opening and OH group elimination.  Furthermore, isoprenoid biosynthesis shows a characteristic species distribution.  A brief overview highlights the MEP pathway's potential as a selective drug target, absent in humans but essential to the survival of many important bacterial and apicomplexan pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI7TRNfELYI7Vg90H21EOLACvtfcHk0ljdjWwMyYacww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnF&md5=4e64297438c0ea4ddbcb6d170febaefc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00537%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DA.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DThe%2520methylerythritol%2520phosphate%2520pathway%2520to%2520isoprenoids%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D5675%26epage%3D5703%26doi%3D10.1021%2Facs.chemrev.6b00537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarkowská, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, M.</span></span> <span> </span><span class="NLM_article-title">Isoprenoid-derived plant signaling molecules: Biosynthesis and biological importance</span>. <i>Planta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>247</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1007/s00425-018-2878-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs00425-018-2878-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29532163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVegtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=2018&pages=1051-1066&author=D.+Tarkowsk%C3%A1author=M.+Strnad&title=Isoprenoid-derived+plant+signaling+molecules%3A+Biosynthesis+and+biological+importance&doi=10.1007%2Fs00425-018-2878-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Isoprenoid-derived plant signaling molecules: biosynthesis and biological importance</span></div><div class="casAuthors">Tarkowska, Danuse; Strnad, Miroslav</div><div class="citationInfo"><span class="NLM_cas:title">Planta</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1051-1066</span>CODEN:
                <span class="NLM_cas:coden">PLANAB</span>;
        ISSN:<span class="NLM_cas:issn">0032-0935</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Main conclusion: The present review summarizes current knowledge of the biosynthesis and biol. importance of isoprenoid-derived plant signaling compds.  Cellular organisms use chem. signals for intercellular communication to coordinate their growth, development, and responses to environmental cues.  The skeletons of majority of plant signaling mols., mediators of plant intercellular 'broadcasting', are built from C5 units of isoprene and therefore belong to a huge and diverse group of natural substances called isoprenoids (terpenoids).  They fill many important roles in nature.  This review summarizes current knowledge of the biosynthesis and biol. importance of a group of isoprenoid-derived plant signaling compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1JRPGm7TzTLVg90H21EOLACvtfcHk0ljdjWwMyYacww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVegtLs%253D&md5=2c6e74552af2065511dd5207da227de3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00425-018-2878-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00425-018-2878-x%26sid%3Dliteratum%253Aachs%26aulast%3DTarkowsk%25C3%25A1%26aufirst%3DD.%26aulast%3DStrnad%26aufirst%3DM.%26atitle%3DIsoprenoid-derived%2520plant%2520signaling%2520molecules%253A%2520Biosynthesis%2520and%2520biological%2520importance%26jtitle%3DPlanta%26date%3D2018%26volume%3D247%26spage%3D1051%26epage%3D1066%26doi%3D10.1007%2Fs00425-018-2878-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajikumar, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phon, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephanopoulos, G.</span></span> <span> </span><span class="NLM_article-title">Terpenoids: Opportunities for biosynthesis of natural product drugs using engineered microorganisms</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1021/mp700151b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp700151b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsFGjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=167-190&author=P.+K.+Ajikumarauthor=K.+Tyoauthor=S.+Carlsenauthor=O.+Muchaauthor=T.+H.+Phonauthor=G.+Stephanopoulos&title=Terpenoids%3A+Opportunities+for+biosynthesis+of+natural+product+drugs+using+engineered+microorganisms&doi=10.1021%2Fmp700151b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms</span></div><div class="casAuthors">Ajikumar, Parayil Kumaran; Tyo, Keith; Carlsen, Simon; Mucha, Oliver; Phon, Too Heng; Stephanopoulos, Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-190</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Terpenoids represent a diverse class of mols. that provide a wealth of opportunities to address many human health and societal issues.  The expansive array of structures and functionalities that have been evolved in nature provide an excellent pool of mols. for use in human therapeutics.  While this class of mols. has members with therapeutic properties including anticancer, antiparasitic, antimicrobial, antiallergenic, antispasmodic, antihyperglycemic, anti-inflammatory, and immunomodulatory properties, supply limitations prevent the large scale use of some mols.  Many of these mols. are only found in ppm levels in nature thus requiring massive harvesting to obtain sufficient amts. of the drug.  Synthetic biol. and metabolic engineering provide innovative approaches to increase the prodn. of the desired mol. in the native organism, and most importantly, transfer the biosynthetic pathways to other hosts.  Microbial systems are well studied, and genetic manipulations allow the optimization of microbial metabs. for the prodn. of common terpenoid precursors.  Using a host of tools, unprecedented advancements in the large scale prodn. of terpenoids have been achieved in recent years.  Identification of limiting steps and pathway regulation, coupled with design strategies to minimize terpenoid byproducts with a high flux to the desired biosynthetic pathways, have yielded greater than 100-fold improvements in the prodn. of a range of terpenoids.  This review focuses on the biodiversity of terpenoids, the biosynthetic pathways involved, and engineering efforts to maximize the prodn. through these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7OFP275GvZ7Vg90H21EOLACvtfcHk0ljdjWwMyYacww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsFGjur4%253D&md5=0c7e294fa82c77e790ff46257c92a8c6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fmp700151b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp700151b%26sid%3Dliteratum%253Aachs%26aulast%3DAjikumar%26aufirst%3DP.%2BK.%26aulast%3DTyo%26aufirst%3DK.%26aulast%3DCarlsen%26aufirst%3DS.%26aulast%3DMucha%26aufirst%3DO.%26aulast%3DPhon%26aufirst%3DT.%2BH.%26aulast%3DStephanopoulos%26aufirst%3DG.%26atitle%3DTerpenoids%253A%2520Opportunities%2520for%2520biosynthesis%2520of%2520natural%2520product%2520drugs%2520using%2520engineered%2520microorganisms%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2008%26volume%3D5%26spage%3D167%26epage%3D190%26doi%3D10.1021%2Fmp700151b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paduch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandefer-Szerszeń, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trytek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiedurek, J.</span></span> <span> </span><span class="NLM_article-title">Terpenes: Substances useful in human healthcare</span>. <i>Arch. Immunol. Ther. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1007/s00005-007-0039-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs00005-007-0039-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=18219762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGqsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=315-327&author=R.+Paduchauthor=M.+Kandefer-Szersze%C5%84author=M.+Trytekauthor=J.+Fiedurek&title=Terpenes%3A+Substances+useful+in+human+healthcare&doi=10.1007%2Fs00005-007-0039-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenes: substances useful in human healthcare</span></div><div class="casAuthors">Paduch, Roman; Kandefer-Szerzen, Martyna; Trytek, Mariusz; Fiedurek, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Archivum Immunologiae et Therapiae Experimentalis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">315-327</span>CODEN:
                <span class="NLM_cas:coden">AITEAT</span>;
        ISSN:<span class="NLM_cas:issn">0004-069X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Terpenes are naturally occurring substances produced by a wide variety of plants and animals.  A broad range of the biol. properties of terpenoids is described, including cancer chemopreventive effects, antimicrobial, antifungal, antiviral, anti-hyperglycemic, anti-inflammatory, and antiparasitic activities.  Terpenes are also presented as skin penetration enhancers and agents involved in the prevention and therapy of several inflammatory diseases.  Moreover, a potential mechanism of their action against pathogens and their influence on skin permeability are discussed.  The major conclusion is that larger-scale use of terpenoids in modern medicine should be taken into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPWXrsN016JbVg90H21EOLACvtfcHk0li28m0Iojfn9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGqsLzM&md5=15f8d9199ac8af186c17a627cd593e24</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00005-007-0039-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00005-007-0039-1%26sid%3Dliteratum%253Aachs%26aulast%3DPaduch%26aufirst%3DR.%26aulast%3DKandefer-Szersze%25C5%2584%26aufirst%3DM.%26aulast%3DTrytek%26aufirst%3DM.%26aulast%3DFiedurek%26aufirst%3DJ.%26atitle%3DTerpenes%253A%2520Substances%2520useful%2520in%2520human%2520healthcare%26jtitle%3DArch.%2520Immunol.%2520Ther.%2520Exp.%26date%3D2007%26volume%3D55%26spage%3D315%26epage%3D327%26doi%3D10.1007%2Fs00005-007-0039-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estévez, F.</span></span> <span> </span><span class="NLM_article-title">Recent advances on cytotoxic sesquiterpene lactones</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4355</span>– <span class="NLM_lpage">4361</span>, <span class="refDoi"> DOI: 10.2174/1381612825666190119114323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1381612825666190119114323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=4355-4361&author=J.+Quintanaauthor=F.+Est%C3%A9vez&title=Recent+advances+on+cytotoxic+sesquiterpene+lactones&doi=10.2174%2F1381612825666190119114323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F1381612825666190119114323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612825666190119114323%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana%26aufirst%3DJ.%26aulast%3DEst%25C3%25A9vez%26aufirst%3DF.%26atitle%3DRecent%2520advances%2520on%2520cytotoxic%2520sesquiterpene%2520lactones%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2019%26volume%3D24%26spage%3D4355%26epage%3D4361%26doi%3D10.2174%2F1381612825666190119114323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Development of anticancer agents from plant-derived sesquiterpene lactones</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2420</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160510123255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F0929867323666160510123255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27160533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=2397-2420&author=Y.+Renauthor=J.+Yuauthor=A.+D.+Kinghorn&title=Development+of+anticancer+agents+from+plant-derived+sesquiterpene+lactones&doi=10.2174%2F0929867323666160510123255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones</span></div><div class="casAuthors">Ren, Yulin; Yu, Jianhua; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2397-2420</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Sesquiterpene lactones are of considerable interest due to their potent bioactivities, including cancer cell cytotoxicity and antineoplastic efficacy in in vivo studies.  Among these compds., artesunate, dimethylaminoparthenolide, and L12ADT peptide prodrug, a deriv. of thapsigargin, are being evaluated in the current cancer clin. or preclin. trials.  Based on the structures of several antitumor sesquiterpene lactones, a no. of analogs showing greater potency have been either isolated as natural products or partially synthesized, and some potential anticancer agents that have emerged from this group of lead compds. have been investigated extensively.  The present review focuses on artemisinin, parthenolide, thapsigargin, and their naturally occurring or synthetic analogs showing potential anticancer activity.  This provides an overview of the advances in the development of these types of sesquiterpene lactones as potential anticancer agents, including their structural characterization, synthesis and synthetic modification, and antitumor potential, with the mechanism of action and structure-activity relationships also discussed.  It is hoped that this will be helpful in stimulating the further interest in developing sesquiterpene lactones and their derivs. as new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_1PsbdXAYcbVg90H21EOLACvtfcHk0li28m0Iojfn9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7jF&md5=fd2a8464d69d9bec4f3fdd4d065c3c41</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160510123255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160510123255%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DDevelopment%2520of%2520anticancer%2520agents%2520from%2520plant-derived%2520sesquiterpene%2520lactones%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D2397%26epage%3D2420%26doi%3D10.2174%2F0929867323666160510123255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Potential anticancer agents characterized from selected tropical plants</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFyjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2019&pages=657-679&author=Y.+Renauthor=E.+J.+Carcache+de+Blancoauthor=J.+R.+Fuchsauthor=D.+D.+Soejartoauthor=J.+E.+Burdetteauthor=S.+M.+Swansonauthor=A.+D.+Kinghorn&title=Potential+anticancer+agents+characterized+from+selected+tropical+plants&doi=10.1021%2Facs.jnatprod.9b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potential Anticancer Agents Characterized from Selected Tropical Plants</span></div><div class="casAuthors">Ren, Yulin; de Blanco, Esperanza J. Carcache; Fuchs, James R.; Soejarto, Djaja D.; Burdette, Joanna E.; Swanson, Steven M.; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">657-679</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Higher plants are well known for their value in affording clin. useful anticancer agents, with such compds. acting against cancer cells by a range of mechanisms of action.  There remains a strong interest in the discovery and development of plant secondary metabolites as addnl. cancer chemotherapeutic lead compds.  In the present review, progress on the discovery of plant-derived compds. of the biflavonoid, lignan, sesquiterpene, steroid, and xanthone structural types is presented.  Several potential anticancer leads of these types have been characterized from tropical plants collected in three countries as part of our ongoing collaborative multi-institutional project.  Preliminary structure-activity relationships and work on in vivo testing and cellular mechanisms of action are also discussed.  In addn., the relevant work reported by other groups on the same compd. classes is included herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6wQ6YEZLhGLVg90H21EOLACvtfcHk0li28m0Iojfn9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFyjs7s%253D&md5=24dbd8b58989ad4a3c24549923f542ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b00018%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DBurdette%26aufirst%3DJ.%2BE.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DPotential%2520anticancer%2520agents%2520characterized%2520from%2520selected%2520tropical%2520plants%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2019%26volume%3D82%26spage%3D657%26epage%3D679%26doi%3D10.1021%2Facs.jnatprod.9b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Natural product triterpenoids and their semi-synthetic derivatives with potential anticancer activity</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1055/a-0832-2383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fa-0832-2383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30658371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=802-814&author=Y.+Renauthor=A.+D.+Kinghorn&title=Natural+product+triterpenoids+and+their+semi-synthetic+derivatives+with+potential+anticancer+activity&doi=10.1055%2Fa-0832-2383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity *</span></div><div class="casAuthors">Ren, Yulin; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11/12</span>),
    <span class="NLM_cas:pages">802-814</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Triterpenoids are distributed widely in higher plants and are of interest because of their structural diversity and broad range of bioactivities.  In particular, there is a very large literature on the propensity of a variety of triterpenoids to act as potential anticancer agents.  In the present review, the anticancer potential is summarized for naturally occurring triterpenoids and their semi-synthetic derivs., including examples of lupane-, oleanane-, ursane-, and cucurbitane-type pentacyclic triterpenoids, along with dammarane-type tetracyclic triterpenes including ginsenosides and their sapogenins and dichapetalins, which have been characterized as antitumor leads from higher plants.  Preliminary structure-activity relationships and reported mechanisms of the antineoplastic-related activity are included.  Prior studies for triterpenoids of plant origin are supportive of addnl. work being conducted on the more detailed biol. and mechanistic evaluation for the progression of this type of natural products as possible cancer chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp13aTkQV1DCbVg90H21EOLACvtfcHk0lh-72M_azoTYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVSisbY%253D&md5=9e8d63dcd2b07d651a231d3e7284b23b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1055%2Fa-0832-2383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fa-0832-2383%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DNatural%2520product%2520triterpenoids%2520and%2520their%2520semi-synthetic%2520derivatives%2520with%2520potential%2520anticancer%2520activity%26jtitle%3DPlanta%2520Med.%26date%3D2019%26volume%3D85%26spage%3D802%26epage%3D814%26doi%3D10.1055%2Fa-0832-2383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghantous, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gali-Muhtasib, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saliba, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwiche, N.</span></span> <span> </span><span class="NLM_article-title">What made sesquiterpene lactones reach cancer clinical trials?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.drudis.2010.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20541036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=668-678&author=A.+Ghantousauthor=H.+Gali-Muhtasibauthor=H.+Vuorelaauthor=N.+A.+Salibaauthor=N.+Darwiche&title=What+made+sesquiterpene+lactones+reach+cancer+clinical+trials%3F&doi=10.1016%2Fj.drudis.2010.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">What made sesquiterpene lactones reach cancer clinical trials?</span></div><div class="casAuthors">Ghantous, Akram; Gali-Muhtasib, Hala; Vuorela, Heikki; Saliba, Najat A.; Darwiche, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">668-678</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sesquiterpene lactones (SLs) are plant-derived compds. often used in traditional medicine against inflammation and cancer.  This review focuses on the chem. and biol. properties of SLs that lead to enhanced anticancer and anti-inflammatory effects.  The chem. properties comprise alkylating center reactivity, lipophilicity, and mol. geometry and electronic features.  SLs in clin. trials are artemisinin, thapsigargin and parthenolide and many of their synthetic derivs.  These drugs are selective toward tumor and cancer stem cells by targeting specific signaling pathways, which make them lead compds. in cancer clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSvY2k51WSrbVg90H21EOLACvtfcHk0lh-72M_azoTYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3K&md5=8e7baa64e3c226c50ac5ccc740cb79b4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DGhantous%26aufirst%3DA.%26aulast%3DGali-Muhtasib%26aufirst%3DH.%26aulast%3DVuorela%26aufirst%3DH.%26aulast%3DSaliba%26aufirst%3DN.%2BA.%26aulast%3DDarwiche%26aufirst%3DN.%26atitle%3DWhat%2520made%2520sesquiterpene%2520lactones%2520reach%2520cancer%2520clinical%2520trials%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D668%26epage%3D678%26doi%3D10.1016%2Fj.drudis.2010.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slezakova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda-Kucerova, J.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity of artemisinin and its derivatives</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">5995</span>– <span class="NLM_lpage">6003</span>, <span class="refDoi"> DOI: 10.21873/anticanres.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.21873%2Fanticanres.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29061778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVGqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=5995-6003&author=S.+Slezakovaauthor=J.+Ruda-Kucerova&title=Anticancer+activity+of+artemisinin+and+its+derivatives&doi=10.21873%2Fanticanres.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activity of Artemisinin and its derivatives</span></div><div class="casAuthors">Slezakova, Silvia; Ruda-Kucerova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5995-6003</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Artemisinin is an ext. from the plant Artemisia annua.  With its semi-synthetic derivs., they form a group of well-known and efficacious antimalarial drugs.  Recent studies have documented the potential anticancer effect of artemisinin and its derivs. (ARTs).  This review summarizes results of preclin. studies, documenting mechanisms of anticancer actions of ARTs and clin. studies focused mainly on efficacy, safely and dose-ranging of ARTs as anticancer chemotherapeutics.  The main mechanisms of action of ARTs is the prodn. of reactive oxygen species, inhibition of cell cycle in G0/G1 phase, induction of apoptosis and inhibition of angiogenesis.  Safety studies have shown no evident toxicity and low incidence of adverse effects.  ARTs potential to inhibit growth of solid tumors suggests their application in a neoadjuvant therapy.  Dihydroartemisinin and artesunate exhibit chemosensitizing effects in vivo in breast, lung, pancreas and glioma cancer cells, proposing the use of ARTs also in combination anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqffAzRp6rrh7Vg90H21EOLACvtfcHk0lh-72M_azoTYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVGqtb4%253D&md5=a266986154a4528708994039c2e646b9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.12046%26sid%3Dliteratum%253Aachs%26aulast%3DSlezakova%26aufirst%3DS.%26aulast%3DRuda-Kucerova%26aufirst%3DJ.%26atitle%3DAnticancer%2520activity%2520of%2520artemisinin%2520and%2520its%2520derivatives%26jtitle%3DAnticancer%2520Res.%26date%3D2017%26volume%3D37%26spage%3D5995%26epage%3D6003%26doi%3D10.21873%2Fanticanres.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangguan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span> <span> </span><span class="NLM_article-title">Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">3367</span>– <span class="NLM_lpage">3383</span>, <span class="refDoi"> DOI: 10.1007/s00204-019-02579-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs00204-019-02579-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31563988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKrsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2019&pages=3367-3383&author=Y.+Liauthor=J.+Luauthor=Q.+Chenauthor=S.+Hanauthor=H.+Shaoauthor=P.+Chenauthor=Q.+Jinauthor=M.+Yangauthor=F.+Shangguanauthor=M.+Feiauthor=L.+Wangauthor=Y.+Liuauthor=N.+Liuauthor=B.+Lu&title=Artemisinin+suppresses+hepatocellular+carcinoma+cell+growth%2C+migration+and+invasion+by+targeting+cellular+bioenergetics+and+Hippo-YAP+signaling&doi=10.1007%2Fs00204-019-02579-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling</span></div><div class="casAuthors">Li, Yujie; Lu, Jing; Chen, Qin; Han, Shengnan; Shao, Hua; Chen, Pingyi; Jin, Qiumei; Yang, Mingyue; Shangguan, Fugen; Fei, Mingming; Wang, Lu; Liu, Yongzhang; Liu, Naxin; Lu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3367-3383</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The primary liver cancer (PLC) is one of the leading causes of cancer-related death worldwide.  The predominant form of PLC is hepatocellular carcinoma (HCC), which accounts for about 85% of all PLC.  Artemisinin (ART) was clin. used as anti-malarial agents.  Recently, it was demonstrated to inhibit cell growth and migration in multiple cancer types.  However, the mol. mechanism underlying these anti-cancer activity remains largely unknown.  Herein, it is discovered that ART dramatically suppresses HCC cell growth in vitro through arresting cell cycle progression, and represses cell migration and invasion via regulating N-cadherin-Snail-E-cadherin axis.  In addn., the disruption of cellular bioenergetics contributed to ART-caused cell growth, migration and invasion inhibition.  Moreover, ART (100 mg/kg, i.p.) substantially inhibits HCC xenograft growth in vivo.  Importantly, Hippo-YAP signal transduction is remarkably inactivated in HCC cells upon ART administration.  Collectively, these data reveal a novel mechanism of ART in regulating HCC cell growth, migration, and invasion, which indicates that ART could be considered as a potential drug for the treatment of HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMWiMTVFvWwLVg90H21EOLACvtfcHk0ljcPOoqC5ud7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKrsrbE&md5=c44498fd3c31746c9de221b9bf502267</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00204-019-02579-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-019-02579-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DShangguan%26aufirst%3DF.%26aulast%3DFei%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DB.%26atitle%3DArtemisinin%2520suppresses%2520hepatocellular%2520carcinoma%2520cell%2520growth%252C%2520migration%2520and%2520invasion%2520by%2520targeting%2520cellular%2520bioenergetics%2520and%2520Hippo-YAP%2520signaling%26jtitle%3DArch.%2520Toxicol.%26date%3D2019%26volume%3D93%26spage%3D3367%26epage%3D3383%26doi%3D10.1007%2Fs00204-019-02579-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, D.</span></span> <span> </span><span class="NLM_article-title">Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1227</span>– <span class="NLM_lpage">1235</span>, <span class="refDoi"> DOI: 10.1093/abbs/gmy125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fabbs%2Fgmy125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30395153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlWksLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1227-1235&author=B.+Liauthor=S.+Buauthor=J.+Sunauthor=Y.+Guoauthor=D.+Lai&title=Artemisinin+derivatives+inhibit+epithelial+ovarian+cancer+cells+via+autophagy-mediated+cell+cycle+arrest&doi=10.1093%2Fabbs%2Fgmy125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest</span></div><div class="casAuthors">Li, Boning; Bu, Shixia; Sun, Junyan; Guo, Ying; Lai, Dongmei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1227-1235</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1745-7270</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Epithelial ovarian cancer (EOC) is the most fatal gynecol. malignancy due to its late diagnosis and lack of curative therapy.  The antimalaria compd. artemisinin and its derivs., such as artesunate (ART) and dihydroartemisinin (DHA), have proven to be potent anticancer drugs and act through various anticancer mechanisms.  To identify novel targets of artemisinin derivs. in EOC cells, we investigated the effects of ART and DHA on SKOV3 and primary EOC cell growth via CCK-8 assay.  Both ART and DHA inhibited EOC cell growth.  A cell cycle distribution anal. showed that ART and DHA caused G2/M cell cycle arrest.  Moreover, ART and DHA induced autophagy in EOC cells, whereas autophagy inhibitors reversed the cell growth inhibition and cell cycle arrest induced by ART and DHA.  Western blot anal. showed that ART and DHA also suppressed the cell cycle-related NF-κB-signaling pathway in EOC cells.  These data suggest that artemisinin derivs. induce autophagy, block the cell cycle, and inhibit cell growth in EOC cells.  Our research provides new targets for artemisinin derivs. for EOC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruIljEG6whuLVg90H21EOLACvtfcHk0ljcPOoqC5ud7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlWksLrJ&md5=bc325f54d554ea566ada39a924088062</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmy125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmy125%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DBu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DD.%26atitle%3DArtemisinin%2520derivatives%2520inhibit%2520epithelial%2520ovarian%2520cancer%2520cells%2520via%2520autophagy-mediated%2520cell%2520cycle%2520arrest%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2018%26volume%3D50%26spage%3D1227%26epage%3D1235%26doi%3D10.1093%2Fabbs%2Fgmy125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisanti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosentini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laganà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberio, G. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berruti, A.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic activity of artemisinin in adrenocortical carcinoma</span>. <i>Endocrine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1007/s12020-019-02077-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs12020-019-02077-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31493273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsleltbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2019&pages=425-427&author=L.+Loriniauthor=S.+Grisantiauthor=R.+Ambrosiniauthor=D.+Cosentiniauthor=M.+Lagan%C3%A0author=L.+Grazioliauthor=G.+A.+M.+Tiberioauthor=S.+Sigalaauthor=A.+Berruti&title=Antineoplastic+activity+of+artemisinin+in+adrenocortical+carcinoma&doi=10.1007%2Fs12020-019-02077-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic activity of artemisinin in adrenocortical carcinoma</span></div><div class="casAuthors">Lorini, Luigi; Grisanti, Salvatore; Ambrosini, Roberta; Cosentini, Deborah; Lagana, Marta; Grazioli, Luigi; Tiberio, Guido A. M.; Sigala, Sandra; Berruti, Alfredo</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">425-427</span>CODEN:
                <span class="NLM_cas:coden">EOCRE5</span>;
        ISSN:<span class="NLM_cas:issn">1355-008X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomoiVZOsxFpbVg90H21EOLACvtfcHk0ljcPOoqC5ud7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsleltbbE&md5=908082ba7c421c6dbd3bccb2799416a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs12020-019-02077-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12020-019-02077-7%26sid%3Dliteratum%253Aachs%26aulast%3DLorini%26aufirst%3DL.%26aulast%3DGrisanti%26aufirst%3DS.%26aulast%3DAmbrosini%26aufirst%3DR.%26aulast%3DCosentini%26aufirst%3DD.%26aulast%3DLagan%25C3%25A0%26aufirst%3DM.%26aulast%3DGrazioli%26aufirst%3DL.%26aulast%3DTiberio%26aufirst%3DG.%2BA.%2BM.%26aulast%3DSigala%26aufirst%3DS.%26aulast%3DBerruti%26aufirst%3DA.%26atitle%3DAntineoplastic%2520activity%2520of%2520artemisinin%2520in%2520adrenocortical%2520carcinoma%26jtitle%3DEndocrine%26date%3D2019%26volume%3D66%26spage%3D425%26epage%3D427%26doi%3D10.1007%2Fs12020-019-02077-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Akt enhances the anticancer effects of artemisinin in clear cell renal cell carcinoma</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">109383</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31545251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ylu73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2019&pages=109383&author=C.+Yuauthor=P.+Sunauthor=Y.+Zhouauthor=B.+Shenauthor=M.+Zhouauthor=L.+Wuauthor=M.+Kong&title=Inhibition+of+Akt+enhances+the+anticancer+effects+of+artemisinin+in+clear+cell+renal+cell+carcinoma&doi=10.1016%2Fj.biopha.2019.109383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma</span></div><div class="casAuthors">Yu, Congcong; Sun, Peiyu; Zhou, Yuehong; Shen, Bin; Zhou, Meihua; Wu, Lingzhi; Kong, Min</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109383</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Given studies have shown that Artemisinin (ART) reduces cancer cell proliferation, migration, invasion, tumorigenesis and metastasis.  In this study, we evaluated the roles of ART in clear cell renal cell carcinoma (ccRCC) progression.  We measured the eff ;ects of ART on cancer cell proliferation, colony formation, migration, invasion and tumorigenesis.  CCK-8 assay demonstrated that ART inhibited cell growth with IC50 values 31.30 ± 0.73 μM in UMRC-2 and 23.97 ± 0.92 μM in CAKI-2, resp.  Colony formation assay shown that ART inhibited cell colony formation.  Transwell migration and invasion assay shown that ART inhibited RCC migration and invasion.  Realtime-qPCR assay shown that ART decreased the mRNA levels of proliferation related genes c-Myc, cyclin D1 and PCNA, and reduced the mRNA levels of mesenchymal genes N-cadherin, Vimentin and Snail, but increased the mRNA levels of epithelial marker E-cadherin.  Moreover, ART inhibited AKT signaling pathway.  In the presence of AKT inhibitor VIII, a pan-AKT inhibitor, ART reduced more cell proliferation, migration and invasion than in the absence of AKT inhibitor VIII, suggesting combination of ART and AKT inhibitor enhanced the anti-cancer effects of ART.  Furthermore, the in vivo xenograft tumor model results suggested that ART decreased tumor size and wt., and suppressed AKT signaling.  Taken together, our results indicated that ART inhibited ccRCC cell proliferation, colony formation, migration, invasion and tumorigenesis.  Combination of ART and AKT inhibitor enhanced the anti-cancer cell proliferation, migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrad5ePyjzRS7Vg90H21EOLACvtfcHk0lg4i6dDkKAnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ylu73I&md5=c02ed450ce89bd1034262c597eee56d0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109383%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520Akt%2520enhances%2520the%2520anticancer%2520effects%2520of%2520artemisinin%2520in%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D118%26spage%3D109383%26doi%3D10.1016%2Fj.biopha.2019.109383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Interactions between artemisinin derivatives and P-glycoprotein</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">152998</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2019.152998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phymed.2019.152998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31301971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlGgu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=152998&author=Y.+Wangauthor=Y.+Liauthor=D.+Shangauthor=T.+Efferth&title=Interactions+between+artemisinin+derivatives+and+P-glycoprotein&doi=10.1016%2Fj.phymed.2019.152998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between artemisinin derivatives and P-glycoprotein</span></div><div class="casAuthors">Wang, Yulin; Li, Yongjie; Shang, Dong; Efferth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152998</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Artemisinin was isolated and identified in 1972, which was the starting point for a new era in antimalarial drug therapy.  Furthermore, numerous studies have demonstrated that artemisinin and its derivs. exhibit considerable anticancer activity both in vitro, in vivo, and even in clin. Phase I/II trials.  P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) is one of the most serious causes of chemotherapy failure in cancer treatment.  Interestingly, many artemisinin derivs. exhibit excellent ability to overcome P-gp mediated MDR and even show collateral sensitivity against MDR cancer cells.  Furthermore, some artemisinin derivs. show P-gp-mediated MDR reversal activity.  Therefore, the interaction between P-gp and artemisinin derivs. is important to develop novel combination treatment protocols with artemisinin derivs. and established anticancer drugs that are P-gp substrates.  This systematic review provides an updated overview on the interaction between artemisinin derivs. and P-gp and the effect of artemisinin derivs. on the P-gp expression level.  Artemisinin derivs. exhibit multi-specific interactions with P-gp.  The currently used artemisinin derivs. are not transported by P-gp.  However, some of novel synthesized artemisinin derivs. exhibit P-gp substrate properties.  Furthermore, many artemisinin derivs. act as P-gp inhibitors, which exhibit the potential to reverse MDR towards clin. used anticancer drugs.  Therefore, studies on the interaction between artemisinin derivs. and P-gp provide important information for the development of novel anti-cancer artemisinin derivs. to reverse P-gp mediated MDR and for the design of rational artemisinin-based combination therapies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGfzWFlwF97Vg90H21EOLACvtfcHk0lg4i6dDkKAnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlGgu73M&md5=ebc13b2395efa5573f05e925c9c709b1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2019.152998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2019.152998%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShang%26aufirst%3DD.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DInteractions%2520between%2520artemisinin%2520derivatives%2520and%2520P-glycoprotein%26jtitle%3DPhytomedicine%26date%3D2019%26volume%3D60%26spage%3D152998%26doi%3D10.1016%2Fj.phymed.2019.152998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Artemisinin and its derivatives prevent <i>Helicobacter pylori</i>-induced gastric carcinogenesis via inhibition of NF-κB signaling</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">152968</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2019.152968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phymed.2019.152968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31280140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlCiu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=152968&author=T.+Suauthor=F.+Liauthor=J.+Guanauthor=L.+Liuauthor=P.+Huangauthor=Y.+Wangauthor=X.+Qiauthor=Z.+Liuauthor=L.+Luauthor=D.+Wang&title=Artemisinin+and+its+derivatives+prevent+Helicobacter+pylori-induced+gastric+carcinogenesis+via+inhibition+of+NF-%CE%BAB+signaling&doi=10.1016%2Fj.phymed.2019.152968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling</span></div><div class="casAuthors">Su, Tao; Li, Fangyuan; Guan, Jiaji; Liu, Linxin; Huang, Ping; Wang, Ying; Qi, Xiaoxiao; Liu, Zhongqiu; Lu, Linlin; Wang, Dawei</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152968</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Gastric cancer has a high morbidity and is a leading cause of cancer-related mortality worldwide.  Helicobacter pylori (H. pylori) infection is commonly found in the early stage of gastric cancer pathogenesis, which induces chronic gastritis.  Artemisinin (ART) and its derivs. (ARTS, artesunate and DHA, dihydroartemisinin), a new class of potent antimalarials, have been reported to exert both preventive and anti-gastric cancer effects.  However, the underlying mechanisms of the chemopreventive effects of ART and its derivs. in H. pylori infection induced-gastric cancer are not fully elucidated.  We investigated the effects of H. pylori infection in gastric cancer; and the preventive mechanisms of ART, ARTS and DHA.The H. pylori growth was detd. by the broth macro-diln. method, and its adhesion to gastric cancer cells was evaluated by using the urease assay.  The protein and mRNA levels, reactive oxygen species (ROS) prodn., as well as the prodn. of inflammatory cytokines were evaluated by Western blot, real-time PCR, flow cytometry and ELISA, resp.  Moreover, an in vivo MNU (N-methyl-N-nitroso-urea) and H. pylori-induced gastric adenocarcinoma mouse model was established for the investigation of the cancer preventive effects of ART and its derivaties, and the underlying mechanisms of action.  ART, DHA and ARTS inhibited the growth of H. pylori and gastric cancer cells,suppressed H. pylori adhesion to the gastric cancer cells, and reduced the H. pylori-enhanced ROS prodn.  Moreover, ART, DHA and ARTS significantly reduced tumor incidence, no. of tumor nodules and tumor size in the mouse model.  Among these three compds., DHA exerted the most potent chemopreventive effect.  Mechanistic studies showed that ART and its derivs. potently inhibited the NF-κB activation.  ART, DHA and ARTS have potent preventive effects in H. pylori-induced gastric carcinogenesis.  These effects are, at least in part, attributed to the inhibition of NF-κB signaling pathway.  Our findings provide a mol. justification of using ART and its derivs. for the prevention and treatment of gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOvjm1jfKkQ7Vg90H21EOLACvtfcHk0lg4i6dDkKAnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlCiu7rK&md5=47586cd8b58d1aa4d7ddb6beff13294c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2019.152968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2019.152968%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DArtemisinin%2520and%2520its%2520derivatives%2520prevent%2520Helicobacter%2520pylori-induced%2520gastric%2520carcinogenesis%2520via%2520inhibition%2520of%2520NF-%25CE%25BAB%2520signaling%26jtitle%3DPhytomedicine%26date%3D2019%26volume%3D63%26spage%3D152968%26doi%3D10.1016%2Fj.phymed.2019.152968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houh, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, D.</span></span> <span> </span><span class="NLM_article-title">The effects of artemisinin on the cytolytic activity of natural killer (NK) cells</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1600</span>, <span class="refDoi"> DOI: 10.3390/ijms18071600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fijms18071600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVehsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1600&author=Y.+K.+Houhauthor=K.+E.+Kimauthor=S.+Parkauthor=D.+Y.+Hurauthor=S.+Kimauthor=D.+Kimauthor=S.+I.+Bangauthor=Y.+Yangauthor=H.+J.+Parkauthor=D.+Cho&title=The+effects+of+artemisinin+on+the+cytolytic+activity+of+natural+killer+%28NK%29+cells&doi=10.3390%2Fijms18071600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of artemisinin on the cytolytic activity of natural killer (NK) cells</span></div><div class="casAuthors">Houh, Youn Kyung; Kim, Kyung Eun; Park, Sunyoung; Hur, Dae Young; Kim, Seonghan; Kim, Daejin; Bang, Sa Ik; Yang, Yoolhee; Park, Hyun Jeong; Cho, Daeho</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1600/1-1600/11</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Artemisinin, a chem. compd. used for the treatment of malaria, has been known to show anti-cancer activity.  However, the effect of this chem. on natural killer (NK) cells, which are involved in tumor killing, remains unknown.  Here, we demonstrate that artemisinin exerts a potent anti-cancer effect by activating NK cells.  NK-92MI cells pre-treated with artemisinin were subjected to a cytotoxicity assay using K562 cells.  The results showed that artemisinin significantly enhances the cytolytic activity of NK cells in a dose-dependent manner.  Addnl., the artemisinin-enhanced cytotoxic effect of NK-92MI cells on tumor cells was accompanied by the stimulation of granule exocytosis, as evidenced by the detection of CD107a expression in NK cells.  Moreover, this enhancement of cytotoxicity by artemisinin was also obsd. in human primary NK cells from peripheral blood.  Our results suggest that artemisinin enhances human NK cell cytotoxicity and degranulation.  This is the first evidence that artemisinin exerts antitumor activity by enhancing NK cytotoxicity.  Therefore, these results provide a deeper understanding of the action of artemisinin and will contribute to the development and application of this class of compds. in cancer treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGJDQHHVQswLVg90H21EOLACvtfcHk0ljmjU1O5Tu-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVehsrvE&md5=3b303aa59a015d3d681ec0e4eef97f7a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fijms18071600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18071600%26sid%3Dliteratum%253Aachs%26aulast%3DHouh%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BE.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DHur%26aufirst%3DD.%2BY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBang%26aufirst%3DS.%2BI.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DD.%26atitle%3DThe%2520effects%2520of%2520artemisinin%2520on%2520the%2520cytolytic%2520activity%2520of%2520natural%2520killer%2520%2528NK%2529%2520cells%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1600%26doi%3D10.3390%2Fijms18071600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.-J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2019.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.intimp.2019.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30798159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1Sitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2019&pages=110-116&author=Y.+Caoauthor=Y.-H.+Fengauthor=L.-W.+Gaoauthor=X.-Y.+Liauthor=Q.-X.+Jinauthor=Y.-Y.+Wangauthor=Y.-Y.+Xuauthor=F.+Jinauthor=S.-L.+Luauthor=M.-J.+Wei&title=Artemisinin+enhances+the+anti-tumor+immune+response+in+4T1+breast+cancer+cells+in+vitro+and+in+vivo&doi=10.1016%2Fj.intimp.2019.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo</span></div><div class="casAuthors">Cao, Yu; Feng, Yong-Hui; Gao, Li-Wei; Li, Xiao-Ying; Jin, Quan-Xiu; Wang, Yu-Ying; Xu, Ying-Ying; Jin, Feng; Lu, Shi-Long; Wei, Min-Jie</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer is a prominent cause of death among women worldwide.  Recent studies have demonstrated that artemisinin (ART) displays anti-tumor activity.  Using a mouse breast cancer model, we investigated the effects of ART in vitro and in vivo to det. how it influences the anti-tumor immune response.  We measured the proliferation and apoptosis of 4T1 cells in vitro after ART treatment by MTT assay and FACS.  To examine the effects of ART in vivo, tumor vols. and survival rates were measured in 4T1 tumor-bearing mice.  FACS was used to det. the frequencies of Tregs, MDSCs, CD4+ IFN-γ+ T cells, and CTLs in the tumors and spleens of the mice. mRNA levels of the transcription factors T-bet and FOXP3 and cytokines IFN-γ, TNF-α, TGF-β, and IL-10 were also detd. by real-time RT-PCR.  ELISA was used to measure TGF-β protein levels in the cell culture supernatants.  ART supplementation significantly increased 4T1 cell apoptosis and decreased TGF-β levels in vitro.  ART also impeded tumor growth in 4T1 TB mice and extended their survival.  MDSC and Treg frequencies significantly decreased in the 4T1 TB mice after ART treatment while CD4+ IFN-γ+ T cells and CTLs significantly increased.  ART significantly increased T-bet, IFN-γ, and TNF-α mRNA levels within the tumor and significantly decreased TGF-β mRNA levels.  ART supplementation hindered 4T1 tumor growth in vivo by promoting T cell activation and quelling immunosuppression from Tregs and MDSCs in the tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc0qbJfSGPhrVg90H21EOLACvtfcHk0ljmjU1O5Tu-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1Sitb0%253D&md5=9e3a8a96b7b3de5f78422e6b5dfa8473</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2019.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2019.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DY.-H.%26aulast%3DGao%26aufirst%3DL.-W.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DJin%26aufirst%3DQ.-X.%26aulast%3DWang%26aufirst%3DY.-Y.%26aulast%3DXu%26aufirst%3DY.-Y.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DS.-L.%26aulast%3DWei%26aufirst%3DM.-J.%26atitle%3DArtemisinin%2520enhances%2520the%2520anti-tumor%2520immune%2520response%2520in%25204T1%2520breast%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2019%26volume%3D70%26spage%3D110%26epage%3D116%26doi%3D10.1016%2Fj.intimp.2019.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steely, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willoughby, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aivaliotis, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, G. L.</span></span> <span> </span><span class="NLM_article-title">Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1031</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2FCAD.0000000000000547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28708672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOrsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1018-1031&author=A.+M.+Steelyauthor=J.+A.+Willoughbyauthor=S.+N.+Sundarauthor=V.+I.+Aivaliotisauthor=G.+L.+Firestone&title=Artemisinin+disrupts+androgen+responsiveness+of+human+prostate+cancer+cells+by+stimulating+the+26S+proteasome-mediated+degradation+of+the+androgen+receptor+protein&doi=10.1097%2FCAD.0000000000000547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein</span></div><div class="casAuthors">Steely, Andrea M.; Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Aivaliotis, Vasiliki I.; Firestone, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1018-1031</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Androgen receptor (AR) expression and activity is highly linked to the development and progression of prostate cancer and is a target of therapeutic strategies for this disease.  We investigated whether the antimalarial drug artemisinin, which is a sesquiterpene lactone isolated from the sweet wormwood plant Artemisia annua, could alter AR expression and responsiveness in cultured human prostate cancer cell lines.  Artemisinin treatment induced the 26S proteasome-mediated degrdn. of the receptor protein, without altering AR transcript levels, in androgen-responsive LNCaP prostate cancer cells or PC-3 prostate cancer cells expressing exogenous wild-type AR.  Furthermore, artemisinin stimulated AR ubiquitination and AR receptor interactions with the E3 ubiquitin ligase MDM2 in LNCaP cells.  The artemisinin-induced loss of AR protein prevented androgen-responsive cell proliferation and ablated total AR transcriptional activity.  The serine/threonine protein kinase AKT-1 was shown to be highly assocd. with artemisinin-induced proteasome-mediated degrdn. of AR protein.  Artemisinin treatment activated AKT-1 enzymic activity, enhanced receptor assocn. with AKT-1, and induced AR serine phosphorylation.  Treatment of LNCaP cells with the PI3-kinase inhibitor LY294002, which inhibits the PI3-kinase-dependent activation of AKT-1, prevented the artemisinin-induced AR degrdn.  Furthermore, in transfected receptor-neg. PC-3 cells, artemisinin failed to stimulate the degrdn. of an altered receptor protein (S215A/S792A) with mutations in its two consensus AKT-1 serine phosphorylation sites.  Taken together, our results indicate that artemisinin induces the degrdn. of AR protein and disrupts androgen responsiveness of human prostate cancer cells, suggesting that this natural compd. represents a new potential therapeutic mol. that selectively targets AR levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumQe65M9qS7Vg90H21EOLACvtfcHk0ljmjU1O5Tu-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOrsLjK&md5=2d9a855334c5b253ca8a57ce88aec05a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000547%26sid%3Dliteratum%253Aachs%26aulast%3DSteely%26aufirst%3DA.%2BM.%26aulast%3DWilloughby%26aufirst%3DJ.%2BA.%26aulast%3DSundar%26aufirst%3DS.%2BN.%26aulast%3DAivaliotis%26aufirst%3DV.%2BI.%26aulast%3DFirestone%26aufirst%3DG.%2BL.%26atitle%3DArtemisinin%2520disrupts%2520androgen%2520responsiveness%2520of%2520human%2520prostate%2520cancer%2520cells%2520by%2520stimulating%2520the%252026S%2520proteasome-mediated%2520degradation%2520of%2520the%2520androgen%2520receptor%2520protein%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2017%26volume%3D28%26spage%3D1018%26epage%3D1031%26doi%3D10.1097%2FCAD.0000000000000547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, N.</span></span> <span> </span><span class="NLM_article-title">Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">282</span>, <span class="refDoi"> DOI: 10.1186/s13046-018-0960-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs13046-018-0960-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30477536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=282&author=Y.+Yaoauthor=Q.+Guoauthor=Y.+Caoauthor=Y.+Qiuauthor=R.+Tanauthor=Z.+Yuauthor=Y.+Zhouauthor=N.+Lu&title=Artemisinin+derivatives+inactivate+cancer-associated+fibroblasts+through+suppressing+TGF-%CE%B2+signaling+in+breast+cancer&doi=10.1186%2Fs13046-018-0960-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer</span></div><div class="casAuthors">Yao, Yuyuan; Guo, Qinglong; Cao, Yue; Qiu, Yangmin; Tan, Renxiang; Yu, Zhou; Zhou, Yuxin; Lu, Na</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cancer-assocd. fibroblasts (CAFs) are activated fibroblasts assocd. with cancer.  They have an important role in tumor growth and metastasis.  Artemisinin (ART) is a sesquiterpene lactone extd. from Chinese herb qinghao, and artemether (ARM), artesunate (ARS) and dihydroartemisinin (DHA) were synthesized derivs. of artemisinin, which also have anti-malarial and anti-cancer effects such as artemisinin.  Methods: In this study, we investigated the in-vitro and in-vivo effects of artemisinin derivs. on inactivating cancer-assocd. fibroblasts and uncovered its underlying mechanism.  Results: We demonstrated that ARS and DHA could revert L-929-CAFs and CAFs from activated to inactivated state in vitro.  Mech., ARS and DHA could suppress TGF-β signaling to inhibit activation of L-929-CAFs and CAFs, and decreased interaction between tumor and tumor microenvironment.  The results showed that ARS and DHA could suppress CAFs-induced breast cancer growth and metastasis in the orthotopic model.  Conformably, ARS and DHA suppressed TGF-β signaling to inactivate cancer-assocd. fibroblasts and inhibit cancer metastasis in vivo.  Conclusions: Artemisinin derivs. are potential therapeutic agents for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFnvHdNlDnr7Vg90H21EOLACvtfcHk0lhBuoEjKbz2HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWhtbc%253D&md5=4e77b1f170c94f476ae66d5304cbf19d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs13046-018-0960-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-018-0960-7%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DN.%26atitle%3DArtemisinin%2520derivatives%2520inactivate%2520cancer-associated%2520fibroblasts%2520through%2520suppressing%2520TGF-%25CE%25B2%2520signaling%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D37%26spage%3D282%26doi%3D10.1186%2Fs13046-018-0960-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-based smart nanomedicines with self-supply of ferrous ion to enhance oxidative stress for specific and efficient cancer treatment</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">29490</span>– <span class="NLM_lpage">29497</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b07390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b07390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGhs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=29490-29497&author=Y.+Luoauthor=X.+Sunauthor=L.+Huangauthor=J.+Yanauthor=B.-Y.+Yuauthor=J.+Tian&title=Artemisinin-based+smart+nanomedicines+with+self-supply+of+ferrous+ion+to+enhance+oxidative+stress+for+specific+and+efficient+cancer+treatment&doi=10.1021%2Facsami.9b07390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-Based Smart Nanomedicines with Self-Supply of Ferrous Ion to Enhance Oxidative Stress for Specific and Efficient Cancer Treatment</span></div><div class="casAuthors">Luo, Yingping; Sun, Xian; Huang, Liwei; Yan, Jin; Yu, Bo-Yang; Tian, Jiangwei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29490-29497</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Though abundant researches report that artemisinin could inhibit cancer cell growth via generating toxic reactive oxygen species (ROS), the therapeutic efficiency of artemisinin for cancer treatment is still limited owing to the insufficient intracellular ferrous ion and defensive effect of intracellular glutathione.  Herein, we report a cathepsin B-controllable smart nanomedicine based on the structural and pharmacodynamic characteristics of artemisinin, which employed transferrin-peptide-modified mesoporous silica to codeliver artemisinin and buthionine-sulfoximine, a glutathione scavenger, into cancer cells.  As a gatekeeper, the transferrin-peptide can not only target the cancer cells but also supply the extra ferrous iron to catalyze artemisinin to produce excessive ROS to kill cancer cells efficiently.  Once the designed nanomedicine attack into lysosome of tumor cells, the cargos of nanomedicine can be released in the presence of cathepsin B to immediately activate self-amplification of oxidative stress by simultaneously elevating the levels of ROS and weakening the levels of glutathione.  We anticipate that this rational design strategy provides innovative opportunities for artemisinin in the clin. application of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTGCIAJkDUq7Vg90H21EOLACvtfcHk0lhBuoEjKbz2HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGhs7rK&md5=95e2be587783d314dcba6abb4f0da81b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b07390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b07390%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DB.-Y.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DArtemisinin-based%2520smart%2520nanomedicines%2520with%2520self-supply%2520of%2520ferrous%2520ion%2520to%2520enhance%2520oxidative%2520stress%2520for%2520specific%2520and%2520efficient%2520cancer%2520treatment%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D29490%26epage%3D29497%26doi%3D10.1021%2Facsami.9b07390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capci Karagöz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsogoeva, S. B.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-derived dimers: Potent antimalarial and anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7360</span>– <span class="NLM_lpage">7388</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01380</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01380" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC28fjtlKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7360-7388&author=T.+Fr%C3%B6hlichauthor=A.+Capci+Karag%C3%B6zauthor=C.+Reiterauthor=S.+B.+Tsogoeva&title=Artemisinin-derived+dimers%3A+Potent+antimalarial+and+anticancer+agents&doi=10.1021%2Facs.jmedchem.5b01380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents</span></div><div class="casAuthors">Frohlich Tony; Capci Karagoz Aysun; Reiter Christoph; Tsogoeva Svetlana B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7360-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of new efficient therapeutics for the treatment of malaria and cancer is an important endeavor.  Over the past 15 years, much attention has been paid to the synthesis of dimeric structures, which combine two units of artemisinin, as lead compounds of interest.  A wide variety of atemisinin-derived dimers containing different linkers demonstrate improved properties compared to their parent compounds (e.g., circumventing multidrug resistance), making the dimerization concept highly compelling for development of efficient antimalarial and anticancer drugs.  The present Perspective highlights recent developments on different types of artemisinin-derived dimers and their structural and functional features.  Particular emphasis is put on the respective in vitro and in vivo studies, exploring the role of the length and nature of linkers on the activities of the dimers, and considering the future prospects of the dimerization concept for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5J9u1WsTDZK_dlEzl_fBafW6udTcc2eYou0k8FFbkp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fjtlKhsA%253D%253D&md5=0bc32b707e395961bf4a61a2c0665061</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01380%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DT.%26aulast%3DCapci%2BKarag%25C3%25B6z%26aufirst%3DA.%26aulast%3DReiter%26aufirst%3DC.%26aulast%3DTsogoeva%26aufirst%3DS.%2BB.%26atitle%3DArtemisinin-derived%2520dimers%253A%2520Potent%2520antimalarial%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7360%26epage%3D7388%26doi%3D10.1021%2Facs.jmedchem.5b01380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships</span>. <i>Arch. Pharm. Chem. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>352</i></span>, <span class="NLM_elocation-id">e1900240</span> <span class="refDoi"> DOI: 10.1002/ardp.201900240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fardp.201900240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2019&author=B.+Zhang&title=Artemisinin-derived+dimers+as+potential+anticancer+agents%3A+Current+developments%2C+action+mechanisms%2C+and+structure-activity+relationships&doi=10.1002%2Fardp.201900240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fardp.201900240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201900240%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DArtemisinin-derived%2520dimers%2520as%2520potential%2520anticancer%2520agents%253A%2520Current%2520developments%252C%2520action%2520mechanisms%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DArch.%2520Pharm.%2520Chem.%2520Life%2520Sci.%26date%3D2019%26volume%3D352%26doi%3D10.1002%2Fardp.201900240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1021/jm020119d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020119d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1SgtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=987-994&author=M.+Jungauthor=S.+Leeauthor=J.+Hamauthor=K.+Leeauthor=H.+Kimauthor=S.+K.+Kim&title=Antitumor+activity+of+novel+deoxoartemisinin+monomers%2C+dimers%2C+and+trimer&doi=10.1021%2Fjm020119d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Novel Deoxoartemisinin Monomers, Dimers, and Trimer</span></div><div class="casAuthors">Jung, Mankil; Lee, Sangmin; Ham, Jungyeob; Lee, Kyunghoon; Kim, Hanjo; Kim, Soo Kie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">987-994</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first primary amines and bromoalkyl analogs of deoxoartemisinin with nonacetal functionality at C-12 are prepd. as versatile intermediates for the synthesis of various derivs.  Eight C-12 nonacetal type dimers and one trimer of deoxoartemisinin were prepd. using novel chem.  Dimers, and trimer I, were esp. potent and selective at inhibiting the growth of certain human cancer cell lines and were comparable to that of clin. used anticancer drugs.  The linker with one amide- or one sulfur-centered two ethylene groups of the dimers is essential for high anticancer activity.  Trimer I shows very potent activity against most of the human cancer cell lines tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOlkHJl0xdGLVg90H21EOLACvtfcHk0liyHF8Ix7J86Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1SgtLc%253D&md5=02e082b1cd0fec1aab1247597e8a621a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm020119d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020119d%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520novel%2520deoxoartemisinin%2520monomers%252C%2520dimers%252C%2520and%2520trimer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D987%26epage%3D994%26doi%3D10.1021%2Fjm020119d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.-X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.02.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.02.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30852384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks12it78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=21-28&author=J.-Y.+Yuauthor=X.-Q.+Liauthor=M.-X.+Wei&title=Synthesis+and+biological+activities+of+artemisinin-piperazine-dithiocarbamate+derivatives&doi=10.1016%2Fj.ejmech.2019.02.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives</span></div><div class="casAuthors">Yu, Jia-Ying; Li, Xue-Qiang; Wei, Meng-Xue</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-28</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Twelve derivs. of artemisinin-piperazine-dithiocarbamate, I (R = CH2Ph, CH2C6H4Me-4, n-pentyl, CH2CO2CH2Ph, etc.), have been synthesized, and some of them show good in vitro cytotoxic activity.  Compd. I (R = CH2C6H4CN-4) (II) exhibits the best inhibitory activity against SMMC-7721 cell lines with an IC50 of 0.0025 ± 0.04 μM for 72 h, but the toxicity was lower against LO2 cell lines with an IC50 of 0.18 ± 0.04 μM for 72 h.  The results indicate that compd. II is more cytotoxic towards cancer cell lines than towards benign cell lines compared with vincristine in vitro.  And compd. II also has good inhibitory activity against colon, breast and prostate cancer cells.  Meanwhile, we have also proposed the six-member ring mechanism of DMSO in catalyzing the esterification of hydroxyl and acyl chloride.  Instead of using the hydroxyl, we can obtain the nucleophilic substitution prodn. simply and efficiently without a Lewis acid, which has not been reported previously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWlRfgzrd8crVg90H21EOLACvtfcHk0liyHF8Ix7J86Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks12it78%253D&md5=58a2aebce79f86c7f42ab4882b38cb42</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.02.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.02.071%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.-Y.%26aulast%3DLi%26aufirst%3DX.-Q.%26aulast%3DWei%26aufirst%3DM.-X.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520artemisinin-piperazine-dithiocarbamate%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D169%26spage%3D21%26epage%3D28%26doi%3D10.1016%2Fj.ejmech.2019.02.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khair, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yergeri, M. C.</span></span> <span> </span><span class="NLM_article-title">Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3323</span>– <span class="NLM_lpage">3338</span>, <span class="refDoi"> DOI: 10.2174/1381612825666190902155957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1381612825666190902155957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31475891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1OitLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=3323-3338&author=M.+S.+Kumarauthor=T.+T.+Yadavauthor=R.+R.+Khairauthor=G.+J.+Petersauthor=M.+C.+Yergeri&title=Combination+therapies+of+artemisinin+and+its+derivatives+as+a+viable+approach+for+future+cancer+treatment&doi=10.2174%2F1381612825666190902155957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment</span></div><div class="casAuthors">Kumar, Maushmi S.; Yadav, Tanuja T.; Khair, Rohan R.; Peters, Godefridus J.; Yergeri, Mayur C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3323-3338</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: Many anticancer drugs have been developed for clin. usage till now, but the major problem is the development of drug-resistance over a period of time in the treatment of cancer.  Anticancer drugs produce huge adverse effects, ultimately leading to death of the patient.  Researchers have been focusing on the development of novel mols. with higher efficacy and lower toxicity; the anti-malarial drug artemisinin and its derivs. have exhibited cytotoxic effects.  Methods: We have done extensive literature search for artemisinin for its new role as anti-cancer agent for future treatment.  Last two decades papers were referred for deep understanding to strengthen its role.  Result: Literature shows changes at 9, 10 position in the artemisinin structure produces anticancer activity.  Artemisinin shows anticancer activity in leukemia, hepatocellular carcinoma, colorectal and breast cancer cell lines.  Artemisinin and its derivs. have been studied as combination therapy with several synthetic compds., RNA interfaces, recombinant proteins and antibodies etc., for synergizing the effect of these drugs.  They produce an anticancer effect by causing cell cycle arrest, regulating signaling in apoptosis, angiogenesis and cytotoxicity activity on the steroid receptors.  Many novel formulations of artemisinin are being developed in the form of carbon nanotubes, polymer-coated drug particles, etc., for delivering artemisinin, since it has poor water/ oil soly. and is chem. unstable.  Conclusion: We have summarize the combination therapies of artemisinin and its derivs. with other anticancer drugs and also focussed on recent developments of different drug delivery systems in the last 10 years.  Various reports and clin. trials of artemisinin type drugs indicated selective cytotoxicity along with minimal toxicity thus projecting them as promising anti-cancer agents in future cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_yzgpTIPj07Vg90H21EOLACvtfcHk0liyHF8Ix7J86Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1OitLzF&md5=a508563e0a15e928dbbdea976bd9f138</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1381612825666190902155957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612825666190902155957%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%2BS.%26aulast%3DYadav%26aufirst%3DT.%2BT.%26aulast%3DKhair%26aufirst%3DR.%2BR.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26aulast%3DYergeri%26aufirst%3DM.%2BC.%26atitle%3DCombination%2520therapies%2520of%2520artemisinin%2520and%2520its%2520derivatives%2520as%2520a%2520viable%2520approach%2520for%2520future%2520cancer%2520treatment%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2019%26volume%3D25%26spage%3D3323%26epage%3D3338%26doi%3D10.2174%2F1381612825666190902155957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wölfling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mernyák, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulmány, Á. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minorics, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupkó, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidenberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marschall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsogoeva, S. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of artemisinin-estrogen hybrids highly active against HCMV, <i>P. falciparum</i>, and cervical and breast cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3crgtFKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1128-1133&author=T.+Fr%C3%B6hlichauthor=A.+Kissauthor=J.+W%C3%B6lflingauthor=E.+Merny%C3%A1kauthor=%C3%81.+E.+Kulm%C3%A1nyauthor=R.+Minoricsauthor=I.+Zupk%C3%B3author=M.+Leidenbergerauthor=O.+Friedrichauthor=B.+Kappesauthor=F.+Hahnauthor=M.+Marschallauthor=G.+Schneiderauthor=S.+B.+Tsogoeva&title=Synthesis+of+artemisinin-estrogen+hybrids+highly+active+against+HCMV%2C+P.+falciparum%2C+and+cervical+and+breast+cancer&doi=10.1021%2Facsmedchemlett.8b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer</span></div><div class="casAuthors">Frohlich Tony; Tsogoeva Svetlana B; Kiss Anita; Wolfling Janos; Mernyak Erzsebet; Schneider Gyula; Kulmany Agnes E; Minorics Renata; Zupko Istvan; Leidenberger Maria; Friedrich Oliver; Kappes Barbara; Hahn Friedrich; Marschall Manfred</div><div class="citationInfo"><span class="NLM_cas:title">ACS medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1128-1133</span>
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    </div><div class="casAbstract">Artemisinin-estrogen hybrids were for the first time both synthesized and investigated for their in vitro biological activity against malaria parasites (Plasmodium falciparum 3D7), human cytomegalovirus (HCMV), and a panel of human malignant cells of gynecological origin containing breast (MCF7, MDA-MB-231, MDA-MB-361, T47D) and cervical tumor cell lines (HeLa, SiHa, C33A).  In terms of antimalarial efficacy, hybrid 8 (EC50 = 3.8 nM) was about two times more active than its parent compound artesunic acid (7) (EC50 = 8.9 nM) as well as the standard drug chloroquine (EC50 = 9.8 nM) and was, therefore, comparable to the clinically used dihydroartemisinin (6) (EC50 = 2.4 nM).  Furthermore, hybrids 9-12 showed a strong antiviral effect with EC50 values in the submicromolar range (0.22-0.38 μM) and thus possess profoundly stronger anti-HCMV activity (approximately factor 25) than the parent compound artesunic acid (7) (EC50 = 5.41 μM).  These compounds also exerted a higher in vitro anti-HCMV efficacy than ganciclovir used as the standard of current antiviral treatment.  In addition, hybrids 8-12 elicited substantially more pronounced growth inhibiting action on all cancer cell lines than their parent compounds and the reference drug cisplatin.  The most potent agent, hybrid 12, exhibited submicromolar EC50 values (0.15-0.93 μM) against breast cancer and C33A cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIymkYCXITsudfST00W0BcfW6udTcc2eZZV7ALBgkrM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crgtFKiug%253D%253D&md5=01eb9e5d37e598cd409b75b63c5733eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00381%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DT.%26aulast%3DKiss%26aufirst%3DA.%26aulast%3DW%25C3%25B6lfling%26aufirst%3DJ.%26aulast%3DMerny%25C3%25A1k%26aufirst%3DE.%26aulast%3DKulm%25C3%25A1ny%26aufirst%3D%25C3%2581.%2BE.%26aulast%3DMinorics%26aufirst%3DR.%26aulast%3DZupk%25C3%25B3%26aufirst%3DI.%26aulast%3DLeidenberger%26aufirst%3DM.%26aulast%3DFriedrich%26aufirst%3DO.%26aulast%3DKappes%26aufirst%3DB.%26aulast%3DHahn%26aufirst%3DF.%26aulast%3DMarschall%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DTsogoeva%26aufirst%3DS.%2BB.%26atitle%3DSynthesis%2520of%2520artemisinin-estrogen%2520hybrids%2520highly%2520active%2520against%2520HCMV%252C%2520P.%2520falciparum%252C%2520and%2520cervical%2520and%2520breast%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D1128%26epage%3D1133%26doi%3D10.1021%2Facsmedchemlett.8b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2018.09.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30278333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVegsr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=149-165&author=X.+Liuauthor=Y.+Zhangauthor=W.+Huangauthor=J.+Luoauthor=Y.+Liauthor=W.+Tanauthor=A.+Zhang&title=Development+of+high+potent+and+selective+Bcl-2+inhibitors+bearing+the+structural+elements+of+natural+product+artemisinin&doi=10.1016%2Fj.ejmech.2018.09.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin</span></div><div class="casAuthors">Liu, Xiaohua; Zhang, Yu; Huang, Wenjing; Luo, Jia; Li, Yang; Tan, Wenfu; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">149-165</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">By taking advantage of the apoptosis-inducing capacity of artemisinin derivs., the authors developed several series of compds. by merging the basic structural elements of the natural product artemisinin into the P2 interaction pocket of the clin. prescribed Bcl-2 inhibitor venetoclax.  Most of the new compds. displayed improved biochem. potency against Bcl-2 and high selectivity over Bcl-xL.  Specifically, compds. I and II were found to be the most potent with IC50 values less than 2.0 nM.  Unfortunately, these compds. only showed moderate antiproliferative effects against Bcl-2 dependent cells.  Though further structural optimization is needed to improve the cellular absorptive permeability, the current approach represents an alternative strategy to develop novel Bcl-2 inhibitors with greater selectivity over Bcl-xL, which is related to the off-target adverse effects of venetoclax.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYsHA4drQdRLVg90H21EOLACvtfcHk0ljHGjtwqHxuEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVegsr3L&md5=39caef7357b62af6112f4d0940a3cda3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.059%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520high%2520potent%2520and%2520selective%2520Bcl-2%2520inhibitors%2520bearing%2520the%2520structural%2520elements%2520of%2520natural%2520product%2520artemisinin%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D159%26spage%3D149%26epage%3D165%26doi%3D10.1016%2Fj.ejmech.2018.09.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trimble, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plesa, M.</span></span> <span> </span><span class="NLM_article-title">A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2019.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ygyno.2019.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32005582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVensLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2020&pages=188-194&author=C.+L.+Trimbleauthor=K.+Levinsonauthor=L.+Maldonadoauthor=M.+J.+Donovanauthor=K.+T.+Clarkauthor=J.+Fuauthor=M.+E.+Shayauthor=M.+E.+Sauterauthor=S.+A.+Sandersauthor=P.+S.+Frantzauthor=M.+Plesa&title=A+first-in-human+proof-of-concept+trial+of+intravaginal+artesunate+to+treat+cervical+intraepithelial+neoplasia+2%2F3+%28CIN2%2F3%29&doi=10.1016%2Fj.ygyno.2019.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)</span></div><div class="casAuthors">Trimble, Cornelia L.; Levinson, Kimberly; Maldonado, Leonel; Donovan, Michael J.; Clark, Katharine T.; Fu, Jie; Shay, Maria E.; Sauter, Mary Elizabeth; Sanders, Stephanie A.; Frantz, Peter S.; Plesa, Mihaela</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">188-194</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Most treatment options for cervical intraepithelial neoplasia 2/3 (CIN2/3) are either excisional or ablative, and require sequential visits to health care providers.  Artesunate, a compd. that is WHO-approved for treatment of acute malaria, also has cytotoxic effect on squamous cells transformed by HPV.  We conducted a first-in-human Phase I dose-escalation study to assess the safety and efficacy of self-administered artesunate vaginal inserts in biopsy-confirmed CIN2/3.  Safety analyses were based on patients who received at least one dose, and were assessed by the severity, frequency, and duration of reported adverse events.  Tolerability was assessed as the percentage of subjects able to complete their designated dosing regimen.  Modified intention-to-treat analyses for efficacy and viral clearance were based on patients who received at least one dose for whom endpoint data were available.  Efficacy was defined as histol. regression to CIN1 or less.  Viral clearance was defined as absence of HPV genotoype (s) detected at baseline.  A total of 28 patients received 1, 2, or 3 five-day treatment cycles at study weeks 0, 2, and 4, resp., prior to a planned, std.-of-care resection at study week 15.  Reported adverse events were mild, and self-limited.  In the modified intention-to-treat anal., histol. regression was obsd. in 19/28 (67.9%) subjects.  Clearance of HPV genotypes detected at baseline occurred in 9 of the 19 (47.4%) subjects whose lesions underwent histol. regression.  Self-administered vaginal artesunate inserts were safe and well-tolerated, at clin. EDs to treat CIN2/3.  These findings support proceeding with Phase II clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCb58aUZG-grVg90H21EOLACvtfcHk0ljHGjtwqHxuEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVensLw%253D&md5=b0a84c1d666d2cf98e482ff930ce1c69</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2019.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2019.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DTrimble%26aufirst%3DC.%2BL.%26aulast%3DLevinson%26aufirst%3DK.%26aulast%3DMaldonado%26aufirst%3DL.%26aulast%3DDonovan%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DK.%2BT.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DShay%26aufirst%3DM.%2BE.%26aulast%3DSauter%26aufirst%3DM.%2BE.%26aulast%3DSanders%26aufirst%3DS.%2BA.%26aulast%3DFrantz%26aufirst%3DP.%2BS.%26aulast%3DPlesa%26aufirst%3DM.%26atitle%3DA%2520first-in-human%2520proof-of-concept%2520trial%2520of%2520intravaginal%2520artesunate%2520to%2520treat%2520cervical%2520intraepithelial%2520neoplasia%25202%252F3%2520%2528CIN2%252F3%2529%26jtitle%3DGynecol.%2520Oncol.%26date%3D2020%26volume%3D157%26spage%3D188%26epage%3D194%26doi%3D10.1016%2Fj.ygyno.2019.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghantous, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinjab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herceg, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwiche, N.</span></span> <span> </span><span class="NLM_article-title">Parthenolide: From plant shoots to cancer roots</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">905</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.drudis.2013.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23688583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=894-905&author=A.+Ghantousauthor=A.+Sinjabauthor=Z.+Hercegauthor=N.+Darwiche&title=Parthenolide%3A+From+plant+shoots+to+cancer+roots&doi=10.1016%2Fj.drudis.2013.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide: from plant shoots to cancer roots</span></div><div class="casAuthors">Ghantous, Akram; Sinjab, Ansam; Herceg, Zdenko; Darwiche, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">894-905</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Parthenolide (PTL), a sesquiterpene lactone (SL) originally purified from the shoots of feverfew (Tanacetum parthenium), has shown potent anticancer and anti-inflammatory activities.  It is currently being tested in cancer clin. trials.  Structure-activity relationship (SAR) studies of parthenolide revealed key chem. properties required for biol. activities and epigenetic mechanisms, and led to the derivatization of an orally bioavailable analog, dimethylamino-parthenolide (DMAPT).  Parthenolide is the first small mol. found to be selective against cancer stem cells (CSC), which it achieves by targeting specific signaling pathways and killing cancer from its roots.  In this review, we highlight the exciting journey of parthenolide, from plant shoots to cancer roots.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSNnHqQJd2UrVg90H21EOLACvtfcHk0lgNKUT829ATcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFGjtbw%253D&md5=e87a1ab300093f8953879ee931d3cd42</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DGhantous%26aufirst%3DA.%26aulast%3DSinjab%26aufirst%3DA.%26aulast%3DHerceg%26aufirst%3DZ.%26aulast%3DDarwiche%26aufirst%3DN.%26atitle%3DParthenolide%253A%2520From%2520plant%2520shoots%2520to%2520cancer%2520roots%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D894%26epage%3D905%26doi%3D10.1016%2Fj.drudis.2013.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freund, R. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobrecht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, H.-D.</span></span> <span> </span><span class="NLM_article-title">Advances in chemistry and bioactivity of parthenolide</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1039/C9NP00049F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC9NP00049F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31763637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ajurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2020&pages=541-565&author=R.+R.+A.+Freundauthor=P.+Gobrechtauthor=D.+Fischerauthor=H.-D.+Arndt&title=Advances+in+chemistry+and+bioactivity+of+parthenolide&doi=10.1039%2FC9NP00049F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in chemistry and bioactivity of parthenolide</span></div><div class="casAuthors">Freund, Robert R. A.; Gobrecht, Philipp; Fischer, Dietmar; Arndt, Hans-Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-565</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Review covering up to 07/2019(-)-Parthenolide is a germacrane sesquiterpene lactone, available in ample amts. from the traditional medical plant feverfew (Tanacetum parthenium).  Acting as a covalently reactive compd., it displays anti-inflammatory, redox-modulating, and epigenetic activities, as well as selective cytotoxicity towards cancer stem and progenitor cells.  Furthermore, parthenolide was found to modulate microtubule dynamics by interfering with the detyrosination of α-tubulin, a specific posttranslational modification of the cytoskeleton.  This review interfaces recently achieved parthenolide syntheses with strategies for bioactivity-based derivatization.  Furthermore, chem. probe development from parthenolide is discussed, leading to a qualified summary of reported biol. activities and implicated or identified targets.  Special emphasis is given to parthenolide-induced microtubule modulation and the recently characterized tubulin carboxypeptidase enzymes involved in nerve (re)growth, cardiac muscle cell function, and metastasis development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFup1MnWZMV7Vg90H21EOLACvtfcHk0lgNKUT829ATcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ajurbM&md5=53d831765248cbc9b8f94f7a56572350</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC9NP00049F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9NP00049F%26sid%3Dliteratum%253Aachs%26aulast%3DFreund%26aufirst%3DR.%2BR.%2BA.%26aulast%3DGobrecht%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DArndt%26aufirst%3DH.-D.%26atitle%3DAdvances%2520in%2520chemistry%2520and%2520bioactivity%2520of%2520parthenolide%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2020%26volume%3D37%26spage%3D541%26epage%3D565%26doi%3D10.1039%2FC9NP00049F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnischky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span> <span> </span><span class="NLM_article-title">The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">4163</span>– <span class="NLM_lpage">4169</span>, <span class="refDoi"> DOI: 10.1182/blood-2004-10-4135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1182%2Fblood-2004-10-4135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=15687234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks12ju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=4163-4169&author=M.+L.+Guzmanauthor=R.+M.+Rossiauthor=L.+Karnischkyauthor=X.+Liauthor=D.+R.+Petersonauthor=D.+S.+Howardauthor=C.+T.+Jordan&title=The+sesquiterpene+lactone+parthenolide+induces+apoptosis+of+human+acute+myelogenous+leukemia+stem+and+progenitor+cells&doi=10.1182%2Fblood-2004-10-4135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells</span></div><div class="casAuthors">Guzman, Monica L.; Rossi, Randall M.; Karnischky, Lilliana; Li, Xiaojie; Peterson, Derick R.; Howard, Dianna S.; Jordan, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4163-4169</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Recent studies have described malignant stem cells as central to the initiation, growth, and potential relapse of acute and chronic myelogenous leukemia (AML and CML).  Because of their important role in pathogenesis, rare and biol. distinct leukemia stem cells (LSCs) represent a crit. target for therapeutic intervention.  However, to date, very few agents have been shown to directly target the LSC population.  The present studies demonstrate that parthenolide (PTL), a naturally occurring small mol., induces robust apoptosis in primary human AML cells and blast crisis CML (bcCML) cells while sparing normal hematopoietic cells.  Furthermore, anal. of progenitor cells using in vitro colony assays, as well as stem cells using the nonobese diabetic/severe combined immunodeficient (NOD/SCID) xenograft model, show that PTL also preferentially targets AML progenitor and stem cell populations.  Notably, in comparison to the std. chemotherapy drug cytosine arabinoside (Ara-C), PTL is much more specific to leukemia cells.  The mol. mechanism of PTL-mediated apoptosis is strongly assocd. with inhibition of nuclear factor κ B (NF-κB), proapoptotic activation of p53, and increased reactive oxygen species (ROS).  On the basis of these findings, we propose that the activity of PTL triggers LSC-specific apoptosis and as such represents a potentially important new class of drugs for LSC-targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBTKT6XR3lUbVg90H21EOLACvtfcHk0lgNKUT829ATcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks12ju74%253D&md5=4436e10afc798d6c233808acc3f0c0a2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-10-4135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-10-4135%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DRossi%26aufirst%3DR.%2BM.%26aulast%3DKarnischky%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPeterson%26aufirst%3DD.%2BR.%26aulast%3DHoward%26aufirst%3DD.%2BS.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26atitle%3DThe%2520sesquiterpene%2520lactone%2520parthenolide%2520induces%2520apoptosis%2520of%2520human%2520acute%2520myelogenous%2520leukemia%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D4163%26epage%3D4169%26doi%3D10.1182%2Fblood-2004-10-4135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span> <span> </span><span class="NLM_article-title">Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.2147/OTT.S117250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2147%2FOTT.S117250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28176967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCisr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=453-461&author=W.+Liuauthor=X.+Wangauthor=J.+Sunauthor=Y.+Yangauthor=W.+Liauthor=J.+Song&title=Parthenolide+suppresses+pancreatic+cell+growth+by+autophagy-mediated+apoptosis&doi=10.2147%2FOTT.S117250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis</span></div><div class="casAuthors">Liu, Weifeng; Wang, Xinshuai; Sun, Junjun; Yang, Yanhui; Li, Wensheng; Song, Junxin</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">453-461</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive malignancy and is unresponsive to conventional chemotherapies.  Parthenolide, a sesquiterpene lactone isolated from feverfew, has exhibited potent anticancer effects against various cancers.  The purpose of this report was to investigate the effect and underlying mechanism of parthenolide in human pancreatic cancer Panc-1 and BxPC3 cells.  The results demonstrated that parthenolide suppressed the growth and induced apoptosis of Panc-1 and BxPC3 pancreatic cancer cells with the half maximal inhibitory concn. (IC♂♂) ranging between 7 and 9 μM after 24 h of treatment.  Significant autophagy was induced by parthenolide treatment in pancreatic cancer cells.  Parthenolide treatment concn.-dependently increased the percentage of autophagic cells and significantly increased the expression levels of p62/SQSTM1, Beclin 1, and LC3II in Panc-1 cells.  Punctate LC3II staining confirmed autophagy.  Furthermore, inhibiting autophagy by chloroquine, 3-methyladenine, or LC3II siRNA significantly blocked parthenolide-induced apoptosis, suggesting that parthenolide induced apoptosis through autophagy in this study.  In conclusion, these studies established that parthenolide inhibits pancreatic cell growth by autophagy-mediated apoptosis.  Data of the present study suggest that parthenolide can serve as a potential chemotherapeutic agent for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsjs7XQNtJ4rVg90H21EOLACvtfcHk0lgmyzr0mSI9Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCisr7P&md5=4d4553c3fb9de779968d21af546d2786</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2147%2FOTT.S117250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S117250%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DJ.%26atitle%3DParthenolide%2520suppresses%2520pancreatic%2520cell%2520growth%2520by%2520autophagy-mediated%2520apoptosis%26jtitle%3DOncoTargets%2520Ther.%26date%3D2017%26volume%3D10%26spage%3D453%26epage%3D461%26doi%3D10.2147%2FOTT.S117250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3572</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.7739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.7739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29467878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MrktVGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=3572-3579&author=H.+Liauthor=H.+Luauthor=M.+Lvauthor=Q.+Wangauthor=Y.+Sun&title=Parthenolide+facilitates+apoptosis+and+reverses+drug-resistance+of+human+gastric+carcinoma+cells+by+inhibiting+the+STAT3+signaling+pathway&doi=10.3892%2Fol.2018.7739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway</span></div><div class="casAuthors">Li Hua; Sun Yuping; Li Hua; Lu Hang; Lv Meng; Wang Qingsheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3572-3579</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">In the present study, SGC-7901/DDP cells were treated with different concentrations of parthenolide (PN) (2.5-15 μmol/l), cisplatin (DDP) (1.25-15 μg/ml) and PN+DDP.  The proliferation inhibition rates were measured using an MTT assay, and the synergies of PN and DDP were analyzed.  The effect of PN and DDP on SGC-7901/DDP cell proliferation demonstrated a time- and concentration-dependent association, and a synergy between PN and DDP was identified.  DAPI staining and flow cytometry results indicated that 15 μmol/l PN significantly induced SGC-7901/DDP apoptosis and G1 phase arrest compared with the untreated control group.  Western blotting analysis results indicated that among the apoptosis-associated proteins, there were dose-dependent increases in the protein expression of apoptosis regulator BAX, cellular tumor antigen p53, cleaved caspase-3 and cleaved capase-9, and decreases in apoptosis regulator Bcl-2 and Bcl-xL protein expression levels.  Among the cell cycle-associated proteins, cyclin D1 expression was significantly decreased, cyclin-dependent kinase inhibitor 1 expression was significantly increased, and signal transducer and activator of transcription 3 (STAT3) activation was inhibited.  Scratch and Transwell assay results revealed that PN significantly inhibited SGC-7901/DDP cell migration, and invasion.  The present study demonstrated that PN induces SGC-7901/DDP apoptosis, inhibits SGC-7901/DDP proliferation, migration and invasion, and enhances the drug sensitivity of the cells to DDP.  The underlying mechanisms may be associated with inhibition of the STAT3 signaling pathway and regulation of the downstream apoptotic protein and cyclin expression levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrmXdAiWRkMdFxYDaSSP8XfW6udTcc2eaPgrt_oqeTRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrktVGmtA%253D%253D&md5=efb23320870893f96ff5e3515333e01b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.7739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.7739%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLv%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DParthenolide%2520facilitates%2520apoptosis%2520and%2520reverses%2520drug-resistance%2520of%2520human%2520gastric%2520carcinoma%2520cells%2520by%2520inhibiting%2520the%2520STAT3%2520signaling%2520pathway%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D15%26spage%3D3572%26epage%3D3579%26doi%3D10.3892%2Fol.2018.7739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Collateral sensitivity of parthenolide via NF-κB and HIF-α inhibition and epigenetic changes in drug-resistant cancer cell lines</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">542</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2019.00542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31164821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGksbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=542&author=M.+Dawoodauthor=E.+Ookoauthor=T.+Efferth&title=Collateral+sensitivity+of+parthenolide+via+NF-%CE%BAB+and+HIF-%CE%B1+inhibition+and+epigenetic+changes+in+drug-resistant+cancer+cell+lines&doi=10.3389%2Ffphar.2019.00542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Collateral sensitivity of parthenolide via NF-κB and HIF-α Inhibition and epigenetic changes in drug-resistant cancer cell lines</span></div><div class="casAuthors">Dawood, Mona; Ooko, Edna; Efferth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">542</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Parthenolide (PT) is a sesquiterpene lactone isolated from Tanacetum parthenium.  In this study, PT showed varying cytotoxic effects against different solid tumor cell lines.  HCT116 (p53+/+) colon carcinoma cells and their parental HCT116 knockout p53 (p53-/-) cell lines showed a resistance degree of 2.36.  On the other hand, wild-type U87.MG cells or cells transfected with a deletion-activated EGFR cDNA (U87.MGΔEGFR) exhibited slight sensitivity toward PT.  Multidrug-resistant MDA-MB-231-BCRP cells were even more sensitive toward PT than sensitive MDA-MB-231-pcDNA cells with a resistance degree of 0.07 (collateral sensitivity).  To the best of our knowledge, hypersensitivity (collateral sensitivity) in MDA-MB-231-BCRP cell line is reported in this study for the first time.  We attempted to identify the mechanism of collateral sensitivity.  Firstly, we found that PT bound to IKK preventing I κBα degrdn. and eventually inhibition of the nuclear factor kappa B (NF-κB) pathway.  Down-regulation of hypoxia inducing factor 1-alpha (HIF-1α) in MDA-MB-231-BCRP resistant cells may be a second mechanism, since it is a target gene of NF-κB.  Moreover, PT also showed epigenetic effect by inhibition of HDAC activity as shown using both mol. docking and HDAC activity assay.  Based on COMPARE and hierarchical cluster analyses, we found gene expression profiles that predicted sensitivity or resistance of 47 tumor cell lines toward PT.  Interestingly, pathway analyses of gene expression profiles revealed NF-κB and HIF signaling as top networks of these genes, cellular functions and canonical pathways influencing the activity of PT against tumor cells.  In conclusion, PT exerted profound cytotoxic activity against various cancer cell lines mainly against BCRP-overexpressing tumor cells, suggesting PT as novel candidate for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrowSGH63_cSrVg90H21EOLACvtfcHk0lgmyzr0mSI9Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGksbzO&md5=ba66ef72b6a031ba2b027649302b4d66</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00542%26sid%3Dliteratum%253Aachs%26aulast%3DDawood%26aufirst%3DM.%26aulast%3DOoko%26aufirst%3DE.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DCollateral%2520sensitivity%2520of%2520parthenolide%2520via%2520NF-%25CE%25BAB%2520and%2520HIF-%25CE%25B1%2520inhibition%2520and%2520epigenetic%2520changes%2520in%2520drug-resistant%2520cancer%2520cell%2520lines%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D542%26doi%3D10.3389%2Ffphar.2019.00542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-W.</span></span> <span> </span><span class="NLM_article-title">Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1809</span>– <span class="NLM_lpage">1820</span>, <span class="refDoi"> DOI: 10.3892/ijo.2017.4166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fijo.2017.4166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29075793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyqtLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2017&pages=1809-1820&author=S.+L.+Kimauthor=Y.+R.+Parkauthor=S.+T.+Leeauthor=S.-W.+Kim&title=Parthenolide+suppresses+hypoxia-inducible+factor-1%CE%B1+signaling+and+hypoxia+induced+epithelial-mesenchymal+transition+in+colorectal+cancer&doi=10.3892%2Fijo.2017.4166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer</span></div><div class="casAuthors">Kim, Se Lim; Park, Young Ran; Lee, Soo Teik; Kim, Sang-Wook</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1809-1820</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Activation of hypoxia-inducible factor 1α (HIF-1α) is frequently obsd. in solid tumors and it has been assocd. with various pathophysiol. processes, including epithelial-mesenchymal transition (EMT).  Previously, we reported that parthenolide (PT), an inhibitor of nuclear factor-κB (NF-κB), is a promising anticancer agent because it promotes apoptosis of human colorectal cancer (CRC).  Here, we investigated a new mol. mechanism by which PT acts on HIF-1α and hypoxia contributing to EMT by NF-κB inhibition.  Cell viability, DNA binding activity, vascular cell tube formation and cell motility were studied after treatment of PT in hypoxic or normoxic condition.  Moreover, effects of PT on hypoxia signaling and hypoxia-induced EMT signaling were investigated.  We also examd. the inhibitory effect of PT on CRC progression in xenografts.  We demonstrated that PT markedly inhibits hypoxia dependent HIF-1α activity and angiogenesis by preventing NF-κB activation.  We also report that PT decreases the level of proteins assocd. with glucose metab., angiogenesis, development and survival that are regulated by HIF-1α.  Furthermore, we verified that PT protects the morphol. change from epithelial to mesenchymal state, inhibits matrix metalloproteinase (MMP) enzyme activity and decreases cell motility involved in the regulation of the hypoxia-induced EMT markers.  In addn., PT inhibits growth in CRC xenograft models and regulates NF-κB, HIF-1α and EMT specific marker in tissue specimens.  Our data demonstrated that PT can inhibit HIF-1α signaling and hypoxia-induced EMT, suggesting a novel mol. mechanism for HIF-1α mediated cancer progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI01oAq9n1NLVg90H21EOLACvtfcHk0lj7Fk3874R_4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyqtLzM&md5=b0ecfec45fd349a3a4c9e0190e81cc81</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3892%2Fijo.2017.4166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2017.4166%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BL.%26aulast%3DPark%26aufirst%3DY.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BT.%26aulast%3DKim%26aufirst%3DS.-W.%26atitle%3DParthenolide%2520suppresses%2520hypoxia-inducible%2520factor-1%25CE%25B1%2520signaling%2520and%2520hypoxia%2520induced%2520epithelial-mesenchymal%2520transition%2520in%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2017%26volume%3D51%26spage%3D1809%26epage%3D1820%26doi%3D10.3892%2Fijo.2017.4166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talib, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Kury, L. T.</span></span> <span> </span><span class="NLM_article-title">Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing p53-dependent apoptosis and inhibiting VEGF expression</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1495</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.08.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.08.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30257366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1ClsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2018&pages=1488-1495&author=W.+H.+Talibauthor=L.+T.+Al+Kury&title=Parthenolide+inhibits+tumor-promoting+effects+of+nicotine+in+lung+cancer+by+inducing+p53-dependent+apoptosis+and+inhibiting+VEGF+expression&doi=10.1016%2Fj.biopha.2018.08.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression</span></div><div class="casAuthors">Talib, Wamidh H.; Al Kury, Lina T.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1488-1495</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The correlation between cigarette smoking and the onset of non-small cell lung cancer is well documented.  Enhanced proliferation, angiogenesis induction, and resistance to apoptosis were reported as direct results assocd. with exposure to nicotine (the active ingredient of cigarettes).  Parthenolide is a sesquiterpene lactone with anticancer activity against different cancer types.  In this study, we tested the ability of parthenolide to inhibit the proliferating effect of nicotine in lung cancer cell lines.  MTT assay was used to measure cell survival of A549 and H526 cells treated with nicotine, parthenolide, and their combination.  Angiogenesis inhibition was measured using VEGF detection kit and apoptosis induction was evaluated by measuring caspase-3 activity.  Real time PCR assay was used to detect the change in expression of several genes assocd. with cell proliferation and apoptosis (CASP3, CASP7, CASP8, CASP9, P53, GADD45, BAX, BIM, Bcl-2, TOPO I, and TOPO II).  Parthenolide inhibited lung cancer cells in a concn.-dependent manner and decreased the proliferation stimulating effect of nicotine.  Caspase-3 activity and VEGF assays evidenced an apoptosis-inducing and VEGF- inhibiting effects of parthenolide.  The real time PCR assay demonstrated that parthenolide down-regulated the expression of Bcl-2 and up-regulated the expression of E2F1, P53, GADD45, BAX, BIM, and CASP 3,7,8,9, which indicates an activation of P53- dependent apoptosis pathway in response to parthenolide.  Furthermore, this pathway remained active in the presence of nicotine suggesting the ability of parthenolide to exclude the anti-apoptotic effect of nicotine.  Our results indicate that parthenolide inhibits nicotine proliferating effect on lung cancer.  The anticancer effect of parthenolide is mediated by angiogenesis inhibition and activation of P53- dependent apoptosis.  Parthenolide is a promising natural product for inhibiting and treating nicotine-assocd. lung cancer.  However, further studied on more lung cancer cell lines and on protein level are needed to fully understand its mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCAq1pjtnml7Vg90H21EOLACvtfcHk0lj7Fk3874R_4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1ClsL3M&md5=0129c491458ddb8c6742248c2f093cae</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.08.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.08.139%26sid%3Dliteratum%253Aachs%26aulast%3DTalib%26aufirst%3DW.%2BH.%26aulast%3DAl%2BKury%26aufirst%3DL.%2BT.%26atitle%3DParthenolide%2520inhibits%2520tumor-promoting%2520effects%2520of%2520nicotine%2520in%2520lung%2520cancer%2520by%2520inducing%2520p53-dependent%2520apoptosis%2520and%2520inhibiting%2520VEGF%2520expression%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D107%26spage%3D1488%26epage%3D1495%26doi%3D10.1016%2Fj.biopha.2018.08.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtola, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petri, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altobelli, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeulenaere, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olzmann, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Parthenolide covalently targets and inhibits focal adhesion kinase in breast cancer cells</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.chembiol.2019.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31080076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=1027-1035&author=C.+A.+Berdanauthor=R.+Hoauthor=H.+S.+Lehtolaauthor=M.+Toauthor=X.+Huauthor=T.+R.+Huffmanauthor=Y.+Petriauthor=C.+R.+Altobelliauthor=S.+G.+Demeulenaereauthor=J.+A.+Olzmannauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=Parthenolide+covalently+targets+and+inhibits+focal+adhesion+kinase+in+breast+cancer+cells&doi=10.1016%2Fj.chembiol.2019.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells</span></div><div class="casAuthors">Berdan, Charles A.; Ho, Raymond; Lehtola, Haley S.; To, Milton; Hu, Xirui; Huffman, Tucker R.; Petri, Yana; Altobelli, Chad R.; Demeulenaere, Sasha G.; Olzmann, James A.; Maimone, Thomas J.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1027-1035.e22</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Parthenolide, a natural product from the feverfew plant and member of the large family of sesquiterpene lactones, exerts multiple biol. and therapeutic activities including anti-inflammatory and anti-cancer effects.  Here, we further study the parthenolide mechanism of action using activity-based protein profiling-based chemoproteomic platforms to map addnl. covalent targets engaged by parthenolide in human breast cancer cells.  We find that parthenolide, as well as other related exocyclic methylene lactone-contg. sesquiterpenes, covalently modify cysteine 427 of focal adhesion kinase 1 (FAK1), leading to impairment of FAK1-dependent signaling pathways and breast cancer cell proliferation, survival, and motility.  These studies reveal a functional target exploited by members of a large family of anti-cancer natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBoLxdD_DwkLVg90H21EOLACvtfcHk0lh1I9oY_txWIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOrsLw%253D&md5=fd9e4ca4129156abd553d0cfe5f41c74</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DBerdan%26aufirst%3DC.%2BA.%26aulast%3DHo%26aufirst%3DR.%26aulast%3DLehtola%26aufirst%3DH.%2BS.%26aulast%3DTo%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHuffman%26aufirst%3DT.%2BR.%26aulast%3DPetri%26aufirst%3DY.%26aulast%3DAltobelli%26aufirst%3DC.%2BR.%26aulast%3DDemeulenaere%26aufirst%3DS.%2BG.%26aulast%3DOlzmann%26aufirst%3DJ.%2BA.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DParthenolide%2520covalently%2520targets%2520and%2520inhibits%2520focal%2520adhesion%2520kinase%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D1027%26epage%3D1035%26doi%3D10.1016%2Fj.chembiol.2019.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">5335</span>– <span class="NLM_lpage">5344</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.819300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M117.819300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29462785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFWqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=5335-5344&author=X.+Zhuauthor=C.+Yuanauthor=C.+Tianauthor=C.+Liauthor=F.+Nieauthor=X.+Songauthor=R.+Zengauthor=D.+Wuauthor=X.+Haoauthor=L.+Li&title=The+plant+sesquiterpene+lactone+parthenolide+inhibits+Wnt%2F%CE%B2-catenin+signaling+by+blocking+synthesis+of+the+transcriptional+regulators+TCF4%2FLEF1&doi=10.1074%2Fjbc.M117.819300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1</span></div><div class="casAuthors">Zhu, Xiaoliang; Yuan, Chunmao; Tian, Chenyang; Li, Chen; Nie, Fen; Song, Xiaomin; Zeng, Rong; Wu, Dianqing; Hao, Xiaojiang; Li, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5335-5344</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Wnt/β-catenin pathway is essential for embryonic development and homeostasis, but excessive activation of this pathway is frequently obsd. in various human diseases, including cancer.  Current therapeutic drugs targeting the Wnt pathway often lack sufficient efficacy, and new compds. targeting this pathway are therefore greatly needed.  Here the authors report that the plant-derived natural product parthenolide (PTL), a sesquiterpene lactone, inhibits Wnt signaling.  The authors found that PTL dose-dependently inhibits Wnt3a- and CHIR99021-induced transcriptional activity assessed with the T-cell factor (TCF)/lymphoid enhancer factor (LEF) firefly luciferase (TOPFlash) assay in HEK293 cells.  Further investigations revealed that PTL decreases the levels of the transcription factors TCF4/LEF1 without affecting β-catenin stability or subcellular distribution.  Moreover, this effect of PTL on TCF4/LEF1 was related to protein synthesis rather than to proteasome-mediated degrdn.  Of note, siRNA-mediated knockdown of RPL10, a ribosome protein PTL binds, substantially decreased TCF4/LEF1 protein levels and also Wnt3a-induced TOPFlash activities, suggesting a potential mechanism by which PTL may repress Wnt/β-catenin signaling.  In summary, PTL binds RPL10 and thereby potently inhibits the Wnt/β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvFi8Wxv3O8LVg90H21EOLACvtfcHk0lh1I9oY_txWIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFWqtrg%253D&md5=09d3b5085074968f14b601fa22fe4d85</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.819300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.819300%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DNie%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DThe%2520plant%2520sesquiterpene%2520lactone%2520parthenolide%2520inhibits%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520by%2520blocking%2520synthesis%2520of%2520the%2520transcriptional%2520regulators%2520TCF4%252FLEF1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D5335%26epage%3D5344%26doi%3D10.1074%2Fjbc.M117.819300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taleghani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasseri, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iranshahi, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of dual-action parthenolide prodrugs as potent anticancer agents</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bioorg.2017.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28215600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVymsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2017&pages=128-134&author=A.+Taleghaniauthor=M.+A.+Nasseriauthor=M.+Iranshahi&title=Synthesis+of+dual-action+parthenolide+prodrugs+as+potent+anticancer+agents&doi=10.1016%2Fj.bioorg.2017.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of dual-action parthenolide prodrugs as potent anticancer agents</span></div><div class="casAuthors">Taleghani, Akram; Nasseri, Mohammad Ali; Iranshahi, Mehrdad</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer stem cells are responsible for the failure of a large no. of cancer treatments and the re-emergence of cancer in patients.  Parthenolide is a potent anticancer sesquiterpene lactone that is also able to kill cancer stem cells.  The main problem with this compd. is its poor soly. in water.  To solve this problem, medicinal chemists have tried to prep. amino-derivs. of parthenolide, however, most amino-derivs. have less potency than that of parthenolide.  In this paper, the authors proposed a new approach to synthesize parthenolide derivs. with better soly. and higher potency.  The authors prepd. novel parthenolide derivs. through the aza-Michael addn. of nitrogen-contg. anticancer drug mols. (cytarabine and melphalan) to the α-methylene-γ-lactone group of parthenolide.  Different types of catalysts were used to catalyze the aza-Michael addn.  Among all the used catalysts, 1,8-diazabicyclo [5.4.0] undec-7-ene (DBU) was found to have the highest catalytic activity.  In addn., the authors examd. the effects of parthenolide-anticancer drug hybrids on the growth and proliferation of three cancer cell lines (MCF-7, LNcaP, Hep G2) and CHO.  The parthenolide prodrugs showed potent cytotoxic property with IC50 values ranging from 0.2 to 5.2 μM, higher than those of parthenolide and anticancer drugs (cytarabine and melphalan).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX51FkClDO2rVg90H21EOLACvtfcHk0lh1I9oY_txWIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVymsLk%253D&md5=91997aec756d570d2f13ded547f1efd9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DTaleghani%26aufirst%3DA.%26aulast%3DNasseri%26aufirst%3DM.%2BA.%26aulast%3DIranshahi%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520dual-action%2520parthenolide%2520prodrugs%2520as%2520potent%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Chem.%26date%3D2017%26volume%3D71%26spage%3D128%26epage%3D134%26doi%3D10.1016%2Fj.bioorg.2017.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span> <span> </span><span class="NLM_article-title">Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4346</span>– <span class="NLM_lpage">4349</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2009.05.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19505822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4346-4349&author=S.+Neelakantanauthor=S.+Nasimauthor=M.+L.+Guzmanauthor=C.+T.+Jordanauthor=P.+A.+Crooks&title=Aminoparthenolides+as+novel+anti-leukemic+agents%3A+Discovery+of+the+NF-%CE%BAB+inhibitor%2C+DMAPT+%28LC-1%29&doi=10.1016%2Fj.bmcl.2009.05.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)</span></div><div class="casAuthors">Neelakantan, Sundar; Nasim, Shama; Guzman, Monica L.; Jordan, Craig T.; Crooks, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4346-4349</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of aminoparthenolide analogs were synthesized and evaluated for their anti-leukemic activity.  Eight compds. exhibited good anti-leukemic activity with LD50's in the low μM range (1.5-3.0 μM).  Compds. I, II and III were the most potent compds. in the series, causing greater than 90% cell death at 10 μM concn. against primary AML cells in culture, with LD50 values of 1.7, 1.8 and 1.6 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzFsAppmWkqbVg90H21EOLACvtfcHk0lhhQpeD8BnqRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGmu7w%253D&md5=aff3db6b1997e882d2474e120a1419fa</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.092%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DNasim%26aufirst%3DS.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DAminoparthenolides%2520as%2520novel%2520anti-leukemic%2520agents%253A%2520Discovery%2520of%2520the%2520NF-%25CE%25BAB%2520inhibitor%252C%2520DMAPT%2520%2528LC-1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4346%26epage%3D4349%26doi%3D10.1016%2Fj.bmcl.2009.05.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumanchi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakshatri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C. J.</span></span> <span> </span><span class="NLM_article-title">A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NF-κB and generating reactive oxygen species</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1002/pros.21141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fpros.21141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20209491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1074-1086&author=R.+Shanmugamauthor=P.+Kusumanchiauthor=L.+Chengauthor=P.+Crooksauthor=S.+Neelakantanauthor=W.+Matthewsauthor=H.+Nakshatriauthor=C.+J.+Sweeney&title=A+water-soluble+parthenolide+analogue+suppresses+in+vivo+prostate+cancer+growth+by+targeting+NF-%CE%BAB+and+generating+reactive+oxygen+species&doi=10.1002%2Fpros.21141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFκB and generating reactive oxygen species</span></div><div class="casAuthors">Shanmugam, Rajasubramaniam; Kusumanchi, Praveen; Cheng, Liang; Crooks, Peter; Neelakantan, Sundar; Matthews, William; Nakshatri, Harikrishna; Sweeney, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1086</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">BACKGROUND: To characterize the mol. changes assocd. with DMAPT-induced prostate cancer cell death and its in vivo activity.  METHODS: CWR22Rv1 and PC-3 were subjected to flow cytometry, electrophoretic mobility shift assays, and Western blot studies to measure DMAPT's ability to generate reactive oxygen species (ROS), inhibit NFκB DNA binding, and cause changes in anti-apoptotic proteins.  N-acetyl cysteine (NAC) and short hairpin RNA (shRNA) were used to det. the contribution of ROS and JNK2 activation, resp.  The BrdU incorporation assay was used to measure proliferation and trypan blue studies assessed cell viability after DMAPT treatment.  The in vivo activity of DMAPT as a single agent and in combination with bicalutamide or docetaxel was assessed in a s.c. xenograft model with athymic nude female mice.  RESULTS: DMAPT generated ROS with subsequent JNK activation and inhibited NFκB DNA binding and expression of NFκB-regulated anti-apoptotic proteins.  DMAPT increased necrotic and apoptotic cell death in a cell-type-dependent manner and both types of cell death were blocked by NAC.  Addnl., shRNA JNK2 partially blocked the anti-proliferative activity of DMAPT.  DMAPT inhibited CWR22Rv1 and PC-3 cellular proliferation by 100% with 10 and 20 μM resp. and in vivo, DMAPT was more effective at inhibiting growth than bicalutamide (CWR22v1) and docetaxel (PC-3).  CONCLUSIONS: DMAPT promotes cell death by both generating ROS and inhibition of NFκB.  Its in vivo activity supports the conduct of clin. trials in patients with castrate-resistant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hRizuVUKjrVg90H21EOLACvtfcHk0lhhQpeD8BnqRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFSisbY%253D&md5=8a43622d28067a05fedf13656cc7d16a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fpros.21141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21141%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugam%26aufirst%3DR.%26aulast%3DKusumanchi%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCrooks%26aufirst%3DP.%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DW.%26aulast%3DNakshatri%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26atitle%3DA%2520water-soluble%2520parthenolide%2520analogue%2520suppresses%2520in%2520vivo%2520prostate%2520cancer%2520growth%2520by%2520targeting%2520NF-%25CE%25BAB%2520and%2520generating%2520reactive%2520oxygen%2520species%26jtitle%3DProstate%26date%3D2010%26volume%3D70%26spage%3D1074%26epage%3D1086%26doi%3D10.1002%2Fpros.21141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span> <span> </span><span class="NLM_article-title">Cooperative down-regulation of ribosomal protein L10 and NF-κB signaling pathway is responsible for the anti-proliferative effects by DMAPT in pancreatic cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">35009</span>– <span class="NLM_lpage">35018</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.16557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.16557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28388532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1cvlsleisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=35009-35018&author=C.+Shiauthor=Y.+Wangauthor=Y.+Guoauthor=Y.+Chenauthor=N.+Liu&title=Cooperative+down-regulation+of+ribosomal+protein+L10+and+NF-%CE%BAB+signaling+pathway+is+responsible+for+the+anti-proliferative+effects+by+DMAPT+in+pancreatic+cancer+cells&doi=10.18632%2Foncotarget.16557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cooperative down-regulation of ribosomal protein L10 and NF-κB signaling pathway is responsible for the anti-proliferative effects by DMAPT in pancreatic cancer cells</span></div><div class="casAuthors">Shi Chen; Wang Yang; Guo Yuna; Chen Yijun; Liu Nan</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">35009-35018</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dimethylaminoparthenolide (DMAPT), a water-soluble analogue of natural product parthenolide, possesses anti-inflammatory and anti-tumor activities.  Despite that the anti-inflammatory mechanism of DMAPT has been well studied, specific target(s) for DMPAT and its anti-tumor mechanism remain poorly understood.  In this study, to assess the anti-proliferative effects of DMAPT in pancreatic cancer cell lines and exploit its anti-tumor mechanism, serial affinity chromatograph was implemented to probe potential targets for DMAPT, revealing that ribosomal protein L10 (RPL10) is a specific binding protein of DMAPT in PANC-1 cells.  DMAPT could decrease the expression of RPL10 accompanying its anti-proliferative effects.  Mechanistically, in both PANC-1 cells and MiaPaca-2 cells, reduced expression of RPL10 triggered by DMAPT binding decreased the expression of either p65 or IKKγ through the direct binding between RPL10 and p65 or IKKγ.  Together, the present study strongly implies that RPL10 is a novel target with therapeutic potential for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpzTbGs5iFh4HWj6b1v8uTfW6udTcc2ebYeKHUysGetbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvlsleisA%253D%253D&md5=c7be90b05bc4607af14c9557cec6b576</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.16557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.16557%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26atitle%3DCooperative%2520down-regulation%2520of%2520ribosomal%2520protein%2520L10%2520and%2520NF-%25CE%25BAB%2520signaling%2520pathway%2520is%2520responsible%2520for%2520the%2520anti-proliferative%2520effects%2520by%2520DMAPT%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D35009%26epage%3D35018%26doi%3D10.18632%2Foncotarget.16557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estabrook, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin-Sinex, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgmann, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhaemers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, M. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2249</span>– <span class="NLM_lpage">2258</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.freeradbiomed.2011.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22019440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2249-2258&author=N.+C.+Estabrookauthor=H.+Chin-Sinexauthor=A.+J.+Borgmannauthor=R.+M.+Dhaemersauthor=R.+H.+Shapiroauthor=D.+Gilleyauthor=N.+Hudaauthor=P.+Crooksauthor=C.+Sweeneyauthor=M.+S.+Mendonca&title=Inhibition+of+NF-%CE%BAB+and+DNA+double-strand+break+repair+by+DMAPT+sensitizes+non-small-cell+lung+cancers+to+X-rays&doi=10.1016%2Fj.freeradbiomed.2011.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays</span></div><div class="casAuthors">Estabrook, Neil C.; Chin-Sinex, Helen; Borgmann, Anthony J.; Dhaemers, Ryan M.; Shapiro, Ronald H.; Gilley, David; Huda, Nazmul; Crooks, Peter; Sweeney, Christopher; Mendonca, Marc S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2249-2258</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated the efficacy and mechanism of dimethylaminoparthenolide (DMAPT), an NF-κB inhibitor, to sensitize human lung cancer cells to X-ray killing in vitro and in vivo.  We tested whether DMAPT increased the effectiveness of single and fractionated X-ray treatment through inhibition of NF-κB and/or DNA double-strand break (DSB) repair.  Treatment with DMAPT decreased plating efficiency, inhibited constitutive and radiation-induced NF-κB binding activity, and enhanced radiation-induced cell killing by dose modification factors of 1.8 and 1.4 in vitro.  X-ray fractionation demonstrated that DMAPT inhibited split-dose recovery/repair, and neutral DNA comet assays confirmed that DMAPT altered the fast and slow components of X-ray-induced DNA DSB repair.  Knockdown of the NF-κB family member p65 by siRNA increased radiation sensitivity and completely inhibited split-dose recovery in a manner very similar to DMAPT treatment.  The data suggest a link between inhibition of NF-κB and inhibition of DSB repair by DMAPT that leads to enhancement of X-ray-induced cell killing in vitro in non-small-cell lung cancer cells.  Studies of A549 tumor xenografts in nude mice demonstrated that DMAPT enhanced X-ray-induced tumor growth delay in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3oigOlBYJyrVg90H21EOLACvtfcHk0lg6srYKgkYAlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegu73J&md5=518eafc7d7dc05d1eb3f84061b8520ef</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DEstabrook%26aufirst%3DN.%2BC.%26aulast%3DChin-Sinex%26aufirst%3DH.%26aulast%3DBorgmann%26aufirst%3DA.%2BJ.%26aulast%3DDhaemers%26aufirst%3DR.%2BM.%26aulast%3DShapiro%26aufirst%3DR.%2BH.%26aulast%3DGilley%26aufirst%3DD.%26aulast%3DHuda%26aufirst%3DN.%26aulast%3DCrooks%26aufirst%3DP.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DMendonca%26aufirst%3DM.%2BS.%26atitle%3DInhibition%2520of%2520NF-%25CE%25BAB%2520and%2520DNA%2520double-strand%2520break%2520repair%2520by%2520DMAPT%2520sensitizes%2520non-small-cell%2520lung%2520cancers%2520to%2520X-rays%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D51%26spage%3D2249%26epage%3D2258%26doi%3D10.1016%2Fj.freeradbiomed.2011.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deraska, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reavis, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaro, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, D.</span></span> <span> </span><span class="NLM_article-title">NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1038/s41420-017-0008-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41420-017-0008-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29531807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1Mngtl2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=10&author=P.+V.+Deraskaauthor=C.+O%E2%80%99Learyauthor=H.+D.+Reavisauthor=S.+Labeauthor=T.-K.+Dinhauthor=J.-B.+Lazaroauthor=C.+Sweeneyauthor=A.+D.+D%E2%80%99Andreaauthor=D.+Kozono&title=NF-%CE%BAB+inhibition+by+dimethylaminoparthenolide+radiosensitizes+non-small-cell+lung+carcinoma+by+blocking+DNA+double-strand+break+repair&doi=10.1038%2Fs41420-017-0008-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair</span></div><div class="casAuthors">Deraska Peter V; O'Leary Colin; Reavis Hunter D; Labe Shelby; Dinh Tru-Khang; Lazaro Jean-Bernard; D'Andrea Alan D; Kozono David; Lazaro Jean-Bernard; D'Andrea Alan D; Sweeney Christopher; D'Andrea Alan D</div><div class="citationInfo"><span class="NLM_cas:title">Cell death discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn">2058-7716</span>.
    </div><div class="casAbstract">Despite optimal chemotherapy, radiotherapy (RT), and/or surgery, non-small-cell lung carcinoma (NSCLC) remains the leading cause of cancer-related death in the US and worldwide.  Thoracic RT, a mainstay in the treatment of locally advanced NSCLC, is often restricted in efficacy by a therapeutic index limited by sensitivity of tissues surrounding the malignancy.  Therefore, radiosensitizers that can improve the therapeutic index are a vital unmet need.  Inhibition of the NF-κB pathway is a proposed mechanism of radiosensitization.  Here we demonstrate that inhibition of the canonical NF-κB pathway by dimethylaminoparthenolide (DMAPT) radiosensitizes NSCLC by blocking DNA double-strand break (DSB) repair.  NF-κB inhibition results in significant impairment of both homologous recombination (HR) and non-homologous end joining (NHEJ), as well as reductions in ionizing radiation (IR)-induced DNA repair biomarkers.  NF-κB inhibition by DMAPT shows preclinical potential for further investigation as a NSCLC radiosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaynErFKLIgBOk4JA3soTqfW6udTcc2eb8ZL0ceDpMh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mngtl2hsw%253D%253D&md5=53b3ea584371bb13768877d45b6bece3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fs41420-017-0008-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41420-017-0008-3%26sid%3Dliteratum%253Aachs%26aulast%3DDeraska%26aufirst%3DP.%2BV.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DC.%26aulast%3DReavis%26aufirst%3DH.%2BD.%26aulast%3DLabe%26aufirst%3DS.%26aulast%3DDinh%26aufirst%3DT.-K.%26aulast%3DLazaro%26aufirst%3DJ.-B.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26aulast%3DKozono%26aufirst%3DD.%26atitle%3DNF-%25CE%25BAB%2520inhibition%2520by%2520dimethylaminoparthenolide%2520radiosensitizes%2520non-small-cell%2520lung%2520carcinoma%2520by%2520blocking%2520DNA%2520double-strand%2520break%2520repair%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2018%26volume%3D4%26spage%3D10%26doi%3D10.1038%2Fs41420-017-0008-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morel, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ormsby, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, P. J.</span></span> <span> </span><span class="NLM_article-title">Parthenolide selectively sensitizes prostate tumor tissue to radiotherapy while protecting healthy tissues in vivo</span>. <i>Radiat. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1667/RR14710.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1667%2FRR14710.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28398879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWru77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2017&pages=501-512&author=K.+L.+Morelauthor=R.+J.+Ormsbyauthor=E.+Bezakauthor=C.+J.+Sweeneyauthor=P.+J.+Sykes&title=Parthenolide+selectively+sensitizes+prostate+tumor+tissue+to+radiotherapy+while+protecting+healthy+tissues+in+vivo&doi=10.1667%2FRR14710.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide selectively sensitizes prostate tumor tissue to radiotherapy while protecting healthy tissues in vivo</span></div><div class="casAuthors">Morel, Katherine L.; Ormsby, Rebecca J.; Bezak, Eva; Sweeney, Christopher J.; Sykes, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Radiation Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-512</span>CODEN:
                <span class="NLM_cas:coden">RAREAE</span>;
        ISSN:<span class="NLM_cas:issn">1938-5404</span>.
    
            (<span class="NLM_cas:orgname">Radiation Research Society</span>)
        </div><div class="casAbstract">Radiotherapy is widely used in cancer treatment, however the benefits can be limited by radiation-induced damage to neighboring normal tissues.  Parthenolide (PTL) exhibits antiinflammatory and anti-tumor properties and selectively induces radiosensitivity in prostate cancer cell lines, while protecting primary prostate epithelial cell lines from radiation- induced damage.  Low doses of radiation have also been shown to protect from subsequent high-dose-radiation induced apoptosis as well as DNA damage.  These properties of PTL and low-dose radiation could be used to improve radiotherapy by killing more tumor cells and less normal cells.  Sixteen-week-old male Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) and C57BL/6J mice were treated with PTL (40 mg/kg), dimethylaminoparthenolide (DMAPT, a PTL analog with increased bioavailability) (100 mg/kg), or vehicle control three times over one week prior to combinations of low (10 mGy) and high (6 Gy) doses of whole-body X-irradn.  Tissues were analyzed for apoptosis at a range of time points up to 72 h postirradn.  Both PTL and DMAPT protected normal tissues, but not prostate tumor tissues, from a significant proportion of highdose- radiation-induced apoptosis.  DMAPT provided superior protection compared to PTL in normal dorsolateral prostate (71.7% redn., P = 0.026), spleen (48.2% redn., P = 0.0001) and colorectal tissue (38.0% redn., P = 0.0002), and doubled radiation-induced apoptosis in TRAMP prostate tumor tissue (101.3% increase, P = 0.039).  Both drugs induced the greatest radiosensitivity in TRAMP prostate tissue in areas with higher grade prostatic intraepithelial neoplasia (PIN) lesions.  A 10 mGy dose delivered 3 h prior to a 6 Gy dose induced a radioadaptive apoptosis response in normal C57Bl/6J prostate (28.4% redn., P = 0.045) and normal TRAMP spleen (13.6% redn., P = 0.047), however the low-dose-adaptive radioprotection did not significantly add to the PTL/DMAPT-induced protection in normal tissues, nor did it affect tumor kill.  These results support the use of the more bioavailable DMAPT and lowdose radiation, alone or in combination as useful radioprotectors of normal tissues to alleviate radiotherapy-induced side-effects in patients.  The enhanced radiosensitization in prostate tissues displaying high-grade PIN suggests that DMAPT also holds promise for targeted therapy of advanced prostate cancer, which may go on to become metastatic.  The redox mechanisms involved in the differential radioprotection obsd. here suggest that increased radiotherapy efficacy by DMAPT is more broadly applicable to a range of cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr4IwWEbNYN7Vg90H21EOLACvtfcHk0lg6srYKgkYAlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWru77N&md5=0b29eefce3e477485fa84c2566873038</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1667%2FRR14710.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1667%252FRR14710.1%26sid%3Dliteratum%253Aachs%26aulast%3DMorel%26aufirst%3DK.%2BL.%26aulast%3DOrmsby%26aufirst%3DR.%2BJ.%26aulast%3DBezak%26aufirst%3DE.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26aulast%3DSykes%26aufirst%3DP.%2BJ.%26atitle%3DParthenolide%2520selectively%2520sensitizes%2520prostate%2520tumor%2520tissue%2520to%2520radiotherapy%2520while%2520protecting%2520healthy%2520tissues%2520in%2520vivo%26jtitle%3DRadiat.%2520Res.%26date%3D2017%26volume%3D187%26spage%3D501%26epage%3D512%26doi%3D10.1667%2FRR14710.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minhajuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alessandro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemkov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adane, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span> <span> </span><span class="NLM_article-title">Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">21984</span>– <span class="NLM_lpage">22000</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.750653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M116.750653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27573247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=21984-22000&author=S.+Peiauthor=M.+Minhajuddinauthor=A.+D%E2%80%99Alessandroauthor=T.+Nemkovauthor=B.+M.+Stevensauthor=B.+Adaneauthor=N.+Khanauthor=F.+K.+Hagenauthor=V.+K.+Yadavauthor=S.+Deauthor=J.+M.+Ashtonauthor=K.+C.+Hansenauthor=J.+A.+Gutmanauthor=D.+A.+Pollyeaauthor=P.+A.+Crooksauthor=C.+Smithauthor=C.+T.+Jordan&title=Rational+design+of+a+parthenolide-based+drug+regimen+that+selectively+eradicates+acute+myelogenous+leukemia+stem+cells&doi=10.1074%2Fjbc.M116.750653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells</span></div><div class="casAuthors">Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo; Nemkov, Travis; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Hagen, Fred K.; Yadav, Vinod K.; De, Subhajyoti; Ashton, John M.; Hansen, Kirk C.; Gutman, Jonathan A.; Pollyea, Daniel A.; Crooks, Peter A.; Smith, Clayton; Jordan, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">21984-22000</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although multidrug approaches to cancer therapy are common, few strategies are based on rigorous scientific principles.  Rather, drug combinations are largely dictated by empirical or clin. parameters.  In the present study we developed a strategy for rational design of a regimen that selectively targets human acute myelogenous leukemia (AML) stem cells.  As a starting point, we used parthenolide, an agent shown to target crit. mechanisms of redox balance in primary AML cells.  Next, using proteomic, genomic, and metabolomic methods, we detd. that treatment with parthenolide leads to induction of compensatory mechanisms that include up-regulated NADPH prodn. via the pentose phosphate pathway as well as activation of the Nrf2-mediated oxidative stress response pathway.  Using this knowledge we identified 2-deoxyglucose and temsirolimus as agents that can be added to a parthenolide regimen as a means to inhibit such compensatory events and thereby further enhance eradication of AML cells.  We demonstrate that the parthenolide, 2-deoxyglucose, temsirolimus (termed PDT) regimen is a potent means of targeting AML stem cells but has little to no effect on normal stem cells.  Taken together our findings illustrate a comprehensive approach to designing combination anticancer drug regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofi19JgIu4zbVg90H21EOLACvtfcHk0lgyTFN4lU9E2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgsbbI&md5=f428d714f3a7a2745809ffdc86d4b55c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.750653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.750653%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DS.%26aulast%3DMinhajuddin%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DA.%26aulast%3DNemkov%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DB.%2BM.%26aulast%3DAdane%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DHagen%26aufirst%3DF.%2BK.%26aulast%3DYadav%26aufirst%3DV.%2BK.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DAshton%26aufirst%3DJ.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BC.%26aulast%3DGutman%26aufirst%3DJ.%2BA.%26aulast%3DPollyea%26aufirst%3DD.%2BA.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26atitle%3DRational%2520design%2520of%2520a%2520parthenolide-based%2520drug%2520regimen%2520that%2520selectively%2520eradicates%2520acute%2520myelogenous%2520leukemia%2520stem%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D21984%26epage%3D22000%26doi%3D10.1074%2Fjbc.M116.750653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.2217/nnm-2018-0479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2217%2Fnnm-2018-0479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31868113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVers7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=41-54&author=X.+Jinauthor=Q.+Yangauthor=N.+Caiauthor=Z.+Zhang&title=A+cocktail+of+betulinic+acid%2C+parthenolide%2C+honokiol+and+ginsenoside+Rh2+in+liposome+systems+for+lung+cancer+treatment&doi=10.2217%2Fnnm-2018-0479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment</span></div><div class="casAuthors">Jin, Xin; Yang, Qing; Cai, Ning; Zhang, Zhenhai</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1748-6963</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: Lung cancer has a very high incidence rate, and thus, there is an urgent need for novel and effective therapies.  Materials & methods: In this study, we proposed a potential treatment option by combining four natural products in liposome systems.  Results: In vitro studies indicated that the combination of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 exhibited a synergistic action.  When these four natural products were loaded into liposome systems, we obsd. an increased effect.  The relative action was also obsd. in vivo.  The cisplatin group presented obvious kidney damage, whereas both cocktail therapy and cocktail liposome therapy were safer.  Conclusion: Therefore, we propose cocktail liposome systems may provide a more efficient and safer treatment for lung cancer.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGoz1jvPVWLLVg90H21EOLACvtfcHk0lgyTFN4lU9E2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVers7zK&md5=8f9a483a2f403bfff01b7fb900e04dc5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2217%2Fnnm-2018-0479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fnnm-2018-0479%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DA%2520cocktail%2520of%2520betulinic%2520acid%252C%2520parthenolide%252C%2520honokiol%2520and%2520ginsenoside%2520Rh2%2520in%2520liposome%2520systems%2520for%2520lung%2520cancer%2520treatment%26jtitle%3DNanomedicine%26date%3D2020%26volume%3D15%26spage%3D41%26epage%3D54%26doi%3D10.2217%2Fnnm-2018-0479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anticancer activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.06.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2018.06.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30006167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlSltLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=216-229&author=Y.+Dingauthor=H.+Guoauthor=W.+Geauthor=X.+Chenauthor=S.+Liauthor=M.+Wangauthor=Y.+Chenauthor=Q.+Zhang&title=Copper%28I%29+oxide+nanoparticles+catalyzed+click+chemistry+based+synthesis+of+melampomagnolide+B-triazole+conjugates+and+their+anticancer+activities&doi=10.1016%2Fj.ejmech.2018.06.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities</span></div><div class="casAuthors">Ding, Yahui; Guo, Hongyu; Ge, Weizhi; Chen, Xinyi; Li, Shengzu; Wang, Mengmeng; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of thirty-one melampomagnolide B-triazole conjugates was synthesized via copper(I) oxide nanoparticles-catalyzed click chem.  These conjugates were evaluated for their anti-cancer activities against a panel of five human cancer cell lines.  The most active compd., I, showed high activity against HCT116 cell line with IC50 value of 0.43 μM, which demonstrated 11.5-fold improvement compared to that of the parent compd. melampomagnolide B (IC50 = 4.93 μM).  Compd. I showed significant efficacy for inducing apoptosis, inhibiting proliferation and migration of HCT116 cells.  The preliminary mol. mechanism of I was also investigated.  On the base of these results, compd. I might be considered as a promising candidate for further evaluation as a potential anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2kad9CTfb0rVg90H21EOLACvtfcHk0ljAe6L4c_kyTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlSltLnP&md5=fa0597b84688c64a2dcd6930bf69091a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.06.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.06.058%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DCopper%2528I%2529%2520oxide%2520nanoparticles%2520catalyzed%2520click%2520chemistry%2520based%2520synthesis%2520of%2520melampomagnolide%2520B-triazole%2520conjugates%2520and%2520their%2520anticancer%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D216%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2018.06.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.01.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30739826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivFygtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2019&pages=445-469&author=W.+Geauthor=X.+Haoauthor=F.+Hanauthor=Z.+Liuauthor=T.+Wangauthor=M.+Wangauthor=N.+Chenauthor=Y.+Dingauthor=Y.+Chenauthor=Q.+Zhang&title=Synthesis+and+structure-activity+relationship+studies+of+parthenolide+derivatives+as+potential+anti-triple+negative+breast+cancer+agents&doi=10.1016%2Fj.ejmech.2019.01.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents</span></div><div class="casAuthors">Ge, Weizhi; Hao, Xin; Han, Fangzhi; Liu, Zhongquan; Wang, Tianpeng; Wang, Mengmeng; Chen, Ning; Ding, Yahui; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">445-469</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is the most aggressive cancers with a high recurrence rate and rapidly acquired drug resistance among various breast cancer subtypes.  There is no specific drug for treatment of TNBC.  Discovery of therapeutic agents with unique modes of actions is urgently needed.  In this study, a series of seventy parthenolide derivs. was designed, synthesized, and evaluated for their anti-TNBC activities.  Compd. I exhibited the most potent activity against different breast cancer cells with IC50 values ranging from 0.20 μM to 0.27 μM, which demonstrated 11.6- to 18.6-fold improvement comparing to that of the parent compd. parthenolide with IC50 values of 2.68-4.63 μM.  It is worth to note that I was more active than the pos. control drug ADR.  Moreover, compd. I could induce apoptosis of SUM-159 cells through mitochondria pathway and cause G1 phase arrest of SUM-159 cells.  These findings indicate that compd. I deserves further studies as a lead compd. for ultimate discovery of effective anti-TNBC drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW97WDAuIPtLVg90H21EOLACvtfcHk0ljAe6L4c_kyTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivFygtL8%253D&md5=32965e2aa3657b697c4d23f2cf7b63ce</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DW.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520parthenolide%2520derivatives%2520as%2520potential%2520anti-triple%2520negative%2520breast%2520cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D166%26spage%3D445%26epage%3D469%26doi%3D10.1016%2Fj.ejmech.2019.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">111706</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.111706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31553932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVams7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2019&pages=111706&author=Y.+Dingauthor=S.+Liauthor=W.+Geauthor=Z.+Liuauthor=X.+Zhangauthor=M.+Wangauthor=T.+Chenauthor=Y.+Chenauthor=Q.+Zhang&title=Design+and+synthesis+of+parthenolide+and+5-fluorouracil+conjugates+as+potential+anticancer+agents+against+drug+resistant+hepatocellular+carcinoma&doi=10.1016%2Fj.ejmech.2019.111706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma</span></div><div class="casAuthors">Ding, Yahui; Li, Shengzu; Ge, Weizhi; Liu, Zhongquan; Zhang, Xuhai; Wang, Mengmeng; Chen, Tianyang; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111706</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of twenty-three parthenolide-5-fluorouracil (5-FU) conjugates were synthesized and evaluated for their anti-cancer activities against human hepatocellular carcinoma cell line Bel-7402 and 5-fluorouracil-resistant human hepatocellular carcinoma cell line Bel-7402/5-FU.  The preliminary structure-activity relationships were discussed.  The most active compd., I, showed high activity against Bel-7402/5-FU cell line with IC50 value of 2.25 μM, which demonstrated 5.8-fold improvement compared to that of the parent compd. parthenolide (IC50 = 12.98 μM).  The investigation of preliminary mol. mechanism of I revealed that I could reverse drug resistance by inhibiting MDR1, ABCC1 and ABCG2 to increase the intracellular drug accumulation and induce apoptosis of Bel-7402/5-FU cells through mitochondria mediated pathway.  On the basis of these results, compd. I deserves to be further investigated as a potential anti-HCC lead compd. for ultimate discovery of parthenolide-based anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIpi4bMKVa8LVg90H21EOLACvtfcHk0ljAe6L4c_kyTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVams7rM&md5=acfcb009bf87ed110f49c4f2a4df22f3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111706%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520parthenolide%2520and%25205-fluorouracil%2520conjugates%2520as%2520potential%2520anticancer%2520agents%2520against%2520drug%2520resistant%2520hepatocellular%2520carcinoma%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D183%26spage%3D111706%26doi%3D10.1016%2Fj.ejmech.2019.111706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz
Acuña, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejía, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallucci, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and NF-κB inhibitory sesquiterpene lactones from <i>Piptocoma rufescens</i></span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2671</span>– <span class="NLM_lpage">2678</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2012.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tet.2012.01.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22685350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2ruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=2671-2678&author=Y.+Renauthor=U.+Mu%C3%B1oz%0AAcu%C3%B1aauthor=F.+Jim%C3%A9nezauthor=R.+Garc%C3%ADaauthor=M.+Mej%C3%ADaauthor=H.-B.+Chaiauthor=J.+C.+Gallucciauthor=N.+R.+Farnsworthauthor=D.+D.+Soejartoauthor=E.+J.+Carcache+de+Blancoauthor=A.+D.+Kinghorn&title=Cytotoxic+and+NF-%CE%BAB+inhibitory+sesquiterpene+lactones+from+Piptocoma+rufescens&doi=10.1016%2Fj.tet.2012.01.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens</span></div><div class="casAuthors">Ren, Yulin; Acuna, Ulyana Munoz; Jimenez, Francisco; Garcia, Ricardo; Mejia, Melciades; Chai, Heebyung; Gallucci, Judith C.; Farnsworth, Norman R.; Soejarto, Djaja D.; Carcache de Blanco, Esperanza J.; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2671-2678</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Six new (1-6) and eight known germacranolide-type sesquiterpene lactones, along with several known phenylpropanol coumarates and methylated flavonoids, were isolated from the leaves of Piptocoma rufescens, collected in the Dominican Republic.  The new compds. were identified by anal. of their spectroscopic data, with the mol. structure of 3 being established by single-crystal x-ray diffraction.  The abs. configurations of the sesquiterpene lactones isolated were detd. from their CD and NOESY NMR spectra, together with the anal. of Mosher ester reactions.  Bioassay screening results showed the majority of the sesquiterpene lactones isolated (1-13) to be highly cytotoxic toward the HT-29 human colon cancer cell line, with the most potent compd. being 15-deoxygoyazensolide (10, IC50, 0.26 μM).  In addn., several of the sesquiterpene lactones exhibited NF-κB (p65) inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcHiA3AQ7oobVg90H21EOLACvtfcHk0lhb9Ljaxcnv2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2ruro%253D&md5=aa4ac9de414ad67710e7ebd97eb488ee</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DMu%25C3%25B1oz%2BAcu%25C3%25B1a%26aufirst%3DU.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DF.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DR.%26aulast%3DMej%25C3%25ADa%26aufirst%3DM.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DGallucci%26aufirst%3DJ.%2BC.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCytotoxic%2520and%2520NF-%25CE%25BAB%2520inhibitory%2520sesquiterpene%2520lactones%2520from%2520Piptocoma%2520rufescens%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D2671%26epage%3D2678%26doi%3D10.1016%2Fj.tet.2012.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallucci, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Crystal structures and human leukemia cell apoptosis inducible activities of parthenolide analogues isolated from <i>Piptocoma rufescens</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b01079</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b01079" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Squ7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2018&pages=554-561&author=Y.+Renauthor=J.+C.+Gallucciauthor=X.+Liauthor=L.+Chenauthor=J.+Yuauthor=A.+D.+Kinghorn&title=Crystal+structures+and+human+leukemia+cell+apoptosis+inducible+activities+of+parthenolide+analogues+isolated+from+Piptocoma+rufescens&doi=10.1021%2Facs.jnatprod.7b01079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures and human leukemia cell apoptosis inducible activities of parthenolide analogues isolated from Piptocoma rufescens</span></div><div class="casAuthors">Ren, Yulin; Gallucci, Judith C.; Li, Xinxin; Chen, Lichao; Yu, Jianhua; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-561</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The mol. structures of 3 parthenolide analogs, (-)-goyazensolide (1), (-)-15-deoxygoyazensolide (2), and (-)-ereglomerulide (3), isolated from the leaves of P. rufescens in a previous study were detd. by x-ray anal., and the abs. configuration of 1 was confirmed crystallog. using Cu Kα radiation at low temp.  Compds. 1-3, (+)-rufesolide A (4), and com. parthenolide (5) were found to be growth inhibitory toward MOLM-13 and EOL-1 human acute myeloid leukemia cells using PKC412 (midostaurin) as the pos. control, with compds. 1-3 being more active than compd. 5.  Also, compds. 1-4 exhibited synergistic effects when tested with PKC412, but 5 did not show this type of activity.  At a concn. lower than 2.0 μM, both 1 and 2 induced approx. 50% of the cells to become apoptotic at a late stage of the cell cycle, but no similar apoptotic effects were obsd. for 3, 4, or 5.  Leukemia cell apoptosis was induced by these compds. through the activation of caspase-3 and the inhibition of NF-κB, as indicated by immunoblotting anal., and compds. 1 and 2 seemed to be promising leads for development as potential antileukemic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEqlP6yzLvrVg90H21EOLACvtfcHk0lhb9Ljaxcnv2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Squ7Y%253D&md5=8e081b76c039d188ab12ea0dfda3f705</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b01079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b01079%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGallucci%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCrystal%2520structures%2520and%2520human%2520leukemia%2520cell%2520apoptosis%2520inducible%2520activities%2520of%2520parthenolide%2520analogues%2520isolated%2520from%2520Piptocoma%2520rufescens%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2018%26volume%3D81%26spage%3D554%26epage%3D561%26doi%3D10.1021%2Facs.jnatprod.7b01079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Acuña, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantvit, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span> <span> </span><span class="NLM_article-title">Goyazensolide induces apoptosis in cancer cells <i>in vitro</i> and <i>in vivo</i></span>. <i>Int. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.3923/ijcr.2013.36.53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3923%2Fijcr.2013.36.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25621077" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=36-53&author=U.+Mu%C3%B1oz-Acu%C3%B1aauthor=Q.+Shenauthor=Y.+Renauthor=D.+D.+Lantvitauthor=J.+A.+Wittwerauthor=A.+D.+Kinghornauthor=S.+M.+Swansonauthor=E.+J.+Carcache+de+Blanco&title=Goyazensolide+induces+apoptosis+in+cancer+cells+in+vitro+and+in+vivo&doi=10.3923%2Fijcr.2013.36.53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3923%2Fijcr.2013.36.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3923%252Fijcr.2013.36.53%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Acu%25C3%25B1a%26aufirst%3DU.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DLantvit%26aufirst%3DD.%2BD.%26aulast%3DWittwer%26aufirst%3DJ.%2BA.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26atitle%3DGoyazensolide%2520induces%2520apoptosis%2520in%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D9%26spage%3D36%26epage%3D53%26doi%3D10.3923%2Fijcr.2013.36.53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spear, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oblinger, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welling, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L.-S.</span></span> <span> </span><span class="NLM_article-title">Natural compounds as potential treatments of <i>NF2</i>-deficient schwannoma and meningioma: Cucurbitacin D and goyazensolide</span>. <i>Otol. Neurotol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1527</span>, <span class="refDoi"> DOI: 10.1097/MAO.0b013e3182956169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2FMAO.0b013e3182956169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23928514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC3sfotVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1519-1527&author=S.+A.+Spearauthor=S.+S.+Burnsauthor=J.+L.+Oblingerauthor=Y.+Renauthor=L.+Panauthor=A.+D.+Kinghornauthor=D.+B.+Wellingauthor=L.-S.+Chang&title=Natural+compounds+as+potential+treatments+of+NF2-deficient+schwannoma+and+meningioma%3A+Cucurbitacin+D+and+goyazensolide&doi=10.1097%2FMAO.0b013e3182956169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide</span></div><div class="casAuthors">Spear Samuel A; Burns Sarah S; Oblinger Janet L; Ren Yulin; Pan Li; Kinghorn A Douglas; Welling D Bradley; Chang Long-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1519-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">HYPOTHESIS:  Cucurbitacin D and goyazensolide, 2 plant-derived natural compounds, possess potent growth-inhibitory activity in schwannoma and meningioma cells.  BACKGROUND:  Currently, no FDA-approved drugs are available for neurofibromatosis type 2 (NF2)-associated schwannomas and meningiomas.  Selected natural compounds with antineoplastic activity, such as cucurbitacin D and goyazensolide, may be developed as potential treatments for these tumors.  METHODS:  The Nf2-deficient mouse schwannoma Sch10545 and human benign meningioma Ben-Men-1 cells were treated with various concentrations of cucurbitacin D and goyazensolide.  The effect on cell proliferation was determined using resazurin assays.  Flow cytometry was used to assess the cell cycle profiles.  Western blot analysis was performed to investigate the expression of various signaling molecules related to the cell cycle and the AKT pathway.  RESULTS:  Cucurbitacin D inhibited proliferation of Sch10545 cells (IC50 ∼ 0.75 μM) and Ben-Men-1 cells (IC50 ∼0.2 μM).  Goyazensolide also reduced cell proliferation of Sch10545 cells (IC50 ∼0.9 μM) and Ben-Men-1 cells (IC50 ∼1 μM).  The G2/M population increased in both Sch10545 and Ben-Men-1 cells treated with cucurbitacin D or goyazensolide around the IC50.  Cucurbitacin and goyazensolide substantially reduced the levels of cyclins E and A in treated Sch10545 and Ben-Men-1 cells.  Cucurbitacin D also inhibited cyclin B, phospho-AKT and phospho-PRAS40 expression.  In addition, goyazensolide reduced the levels of phospho-AKT and NFκB and increased the expression of pro-apoptotic Bim in Sch10545 and Ben-Men-1 cells.  CONCLUSION:  Both cucurbitacin D and goyazensolide effectively inhibit proliferation of NF2-deficient schwannoma and meningioma cells, suggesting that these natural compounds should be further evaluated as potential treatments for NF2-related tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9VuHkT8Q0Hdy3lHz94U-GfW6udTcc2eZVpa4WGo3xBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfotVantQ%253D%253D&md5=afbaa511e84ba0b5496d13b23d35307c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1097%2FMAO.0b013e3182956169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMAO.0b013e3182956169%26sid%3Dliteratum%253Aachs%26aulast%3DSpear%26aufirst%3DS.%2BA.%26aulast%3DBurns%26aufirst%3DS.%2BS.%26aulast%3DOblinger%26aufirst%3DJ.%2BL.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DWelling%26aufirst%3DD.%2BB.%26aulast%3DChang%26aufirst%3DL.-S.%26atitle%3DNatural%2520compounds%2520as%2520potential%2520treatments%2520of%2520NF2-deficient%2520schwannoma%2520and%2520meningioma%253A%2520Cucurbitacin%2520D%2520and%2520goyazensolide%26jtitle%3DOtol.%2520Neurotol.%26date%3D2013%26volume%3D34%26spage%3D1519%26epage%3D1527%26doi%3D10.1097%2FMAO.0b013e3182956169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Identification of parthenolide dimers as activators of pyruvate kinase M2 in xenografts of glioblastoma multiforme in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1611</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs12ks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=1597-1611&author=Y.+Dingauthor=Q.+Xueauthor=S.+Liuauthor=K.+Huauthor=D.+Wangauthor=T.+Wangauthor=Y.+Liauthor=H.+Guoauthor=X.+Haoauthor=W.+Geauthor=Y.+Zhangauthor=A.+Liauthor=J.+Liauthor=Y.+Chenauthor=Q.+Zhang&title=Identification+of+parthenolide+dimers+as+activators+of+pyruvate+kinase+M2+in+xenografts+of+glioblastoma+multiforme+in+vivo&doi=10.1021%2Facs.jmedchem.9b01328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo</span></div><div class="casAuthors">Ding, Yahui; Xue, Qingqing; Liu, Shuo; Hu, Kai; Wang, Da; Wang, Tianpeng; Li, Ye; Guo, Hongyu; Hao, Xin; Ge, Weizhi; Zhang, Yan; Li, Ang; Li, Jing; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1597-1611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we detail the discovery of a series of parthenolide dimers as activators of PKM2 and evaluation of their anti-GBM activities.  The most promising compd. 5 showed high potency to activate PKM2 with an AC50 value of 15 nM, inhibited proliferation and metastasis, and induced apoptosis of GBM cells.  Compd. 5 could promote tetramer formation of PKM2 and reduce nucleus translocation of PKM2 in GBM cells without influence on the expression of total PKM2, thereby inhibiting the STAT3 signal pathway in vitro and in vivo.  PKM2 knockdown assay demonstrated that the anti-GBM effect of 5 mainly depended on the expression of PKM2 in vitro and in vivo.  Compd. 16, a prodrug of 5, markedly suppressed U118 tumor xenograft growth and reduced the wt. of tumor.  On the basis of these investigations, we propose that 16 might be considered as a promising lead compd. for discovery of anti-GBM drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGSzLzH8RIxrVg90H21EOLACvtfcHk0lggzJUESZxNNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs12ks70%253D&md5=e4596295089acdb58caae08e05c48ad4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01328%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DIdentification%2520of%2520parthenolide%2520dimers%2520as%2520activators%2520of%2520pyruvate%2520kinase%2520M2%2520in%2520xenografts%2520of%2520glioblastoma%2520multiforme%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D1597%26epage%3D1611%26doi%3D10.1021%2Facs.jmedchem.9b01328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span> <span> </span><span class="NLM_article-title">Targeting thapsigargin towards tumors</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.steroids.2014.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.steroids.2014.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25065587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kru7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=2-7&author=N.+T.+Q.+Doanauthor=E.+S.+Paulsenauthor=P.+Sehgalauthor=J.+V.+M%C3%B8llerauthor=P.+Nissenauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacsauthor=C.+A.+Dionneauthor=S.+B.+Christensen&title=Targeting+thapsigargin+towards+tumors&doi=10.1016%2Fj.steroids.2014.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting thapsigargin towards tumors</span></div><div class="casAuthors">Doan, Nhu Thi Quynh; Paulsen, Eleonora Sandholdt; Sehgal, Pankaj; Moeller, Jesper Vuust; Nissen, Poul; Denmeade, Samuel R.; Isaacs, John T.; Dionne, Craig A.; Christensen, Soeren Broegger</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2-7</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The skin irritating principle from Thapsia garganica was isolated, named thapsigargin and the structure elucidated.  By inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) thapsigargin provokes apoptosis in almost all cells.  By conjugating thapsigargin to peptides, which are only substrates for either prostate specific antigen (PSA) or prostate specific membrane antigen (PSMA) prodrugs were created, which selectively affect prostate cancer cells or neovascular tissue in tumors.  One of the prodrug is currently tested in clin. phase II.  The prodrug under clin. trial has been named mipsagargin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo3XRhn7mC3LVg90H21EOLACvtfcHk0lggzJUESZxNNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kru7fM&md5=40b2f353210ebe88da3b061a310417f6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2014.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2014.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BT.%2BQ.%26aulast%3DPaulsen%26aufirst%3DE.%2BS.%26aulast%3DSehgal%26aufirst%3DP.%26aulast%3DM%25C3%25B8ller%26aufirst%3DJ.%2BV.%26aulast%3DNissen%26aufirst%3DP.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26atitle%3DTargeting%2520thapsigargin%2520towards%2520tumors%26jtitle%3DSteroids%26date%3D2015%26volume%3D97%26spage%3D2%26epage%3D7%26doi%3D10.1016%2Fj.steroids.2014.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quynh
Doan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, origin, chemistry, structure-activity relationships and prodrug development</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5501</span>– <span class="NLM_lpage">5517</span>, <span class="refDoi"> DOI: 10.2174/1381612821666151002112824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1381612821666151002112824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26429715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGktbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=5501-5517&author=N.+Quynh%0ADoanauthor=S.+Christensen&title=Thapsigargin%2C+origin%2C+chemistry%2C+structure-activity+relationships+and+prodrug+development&doi=10.2174%2F1381612821666151002112824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development</span></div><div class="casAuthors">Quynh Doan, Nhu Thi; Christensen, Soren Brogger</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">5501-5517</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Thapsigargin was originally isolated from the roots of the Mediterranean umbelliferous plant Thapsia garganica in order to characterize the skin irritant principle.  Characteristic chem. properties and semi-syntheses are reviewed.  The biol. activity was related to the subnanomolar affinity for the sarco/endoplasmic reticulum calcium ATPase.  Prolonged inhibition of the pump afforded collapse of the calcium homeostasis and eventually apoptosis.  Structure-activity relationships enabled design of an equipotent analog contg. a linker.  Conjugation of the analog contg. the linker with peptides, which only are substrates for either prostate specific antigen (PSA) or prostate specific membrane antigen (PSMA) enabled design of prodrugs targeting a no. of cancer diseases including prostate cancer (G115) and hepatocellular carcinoma (G202).  Prodrug G202 has under the name of mipsagargin in phase II clin. trials shown promising properties against hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFZdSp5MJs6LVg90H21EOLACvtfcHk0lh0ckpVzjItVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGktbjO&md5=8e85c0e7b3f0eaf4dd6aebcf070e5428</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F1381612821666151002112824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612821666151002112824%26sid%3Dliteratum%253Aachs%26aulast%3DQuynh%2BDoan%26aufirst%3DN.%26aulast%3DChristensen%26aufirst%3DS.%26atitle%3DThapsigargin%252C%2520origin%252C%2520chemistry%252C%2520structure-activity%2520relationships%2520and%2520prodrug%2520development%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D5501%26epage%3D5517%26doi%3D10.2174%2F1381612821666151002112824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajaj, S. O.</span></span> <span> </span><span class="NLM_article-title">Promising anticancer drug thapsigargin: A perspective toward the total synthesis</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1080/00397911.2017.1386789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F00397911.2017.1386789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyjurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=1-13&author=S.+Deyauthor=S.+O.+Bajaj&title=Promising+anticancer+drug+thapsigargin%3A+A+perspective+toward+the+total+synthesis&doi=10.1080%2F00397911.2017.1386789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Promising anticancer drug thapsigargin: A perspective toward the total synthesis</span></div><div class="casAuthors">Dey, Supriya; Bajaj, Sumit O.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The guaianolide ring contg. sesquiterpene thapsigargin is found in the roots and fruits of Mediterranean plant Thapsia garganica.  It is known for its activity as a potent antagonist for Ca2+-ATPase (sarco-endoplasmic reticulum Ca2+-ATPase) inhibition.  Recently, a prodrug mipsagargin is being investigated to target the blood vessel of the cancer cells for the treatment of tumors.  The limited natural supply (low isolation and only localized growth (Mediterranean area)) from the natural sources strongly urges for the development of chem. synthetic strategies to access these natural products.  This review pertain the various strategies used so far in the thapsigargin's synthesis, focusing on major contributions in the total synthesis till date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4DfiF8pHXR7Vg90H21EOLACvtfcHk0ljQd_II5Yc8zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyjurzK&md5=62e37c8353a72e9dc8f2ffb0628013e2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F00397911.2017.1386789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2017.1386789%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DS.%26aulast%3DBajaj%26aufirst%3DS.%2BO.%26atitle%3DPromising%2520anticancer%2520drug%2520thapsigargin%253A%2520A%2520perspective%2520toward%2520the%2520total%2520synthesis%26jtitle%3DSynth.%2520Commun.%26date%3D2018%26volume%3D48%26spage%3D1%26epage%3D13%26doi%3D10.1080%2F00397911.2017.1386789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophersen, C.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, constitution of a sesquiterpene lactone histamine liberator from <i>Thapsia garganica</i></span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3829</span>– <span class="NLM_lpage">3830</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(80)80191-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0040-4039%2880%2980191-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL3MXhvFantb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1980&pages=3829-3830&author=S.+B.+Christensenauthor=U.+Rasmussenauthor=C.+Christophersen&title=Thapsigargin%2C+constitution+of+a+sesquiterpene+lactone+histamine+liberator+from+Thapsia+garganica&doi=10.1016%2F0040-4039%2880%2980191-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin.  Constitution of a sesquiterpene lactone histamine liberator from Thapsia garganica</span></div><div class="casAuthors">Christensen, S. Broegger; Rasmussen, Ulla; Christophersen, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">3829-30</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The structure of thapsigargin (I), the major skin irritating constituent previously isolated from the root of T. garganica , was detd. by spectroscopic and chem. means.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8vMrtk06etrVg90H21EOLACvtfcHk0ljCmH0u2YPD-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhvFantb4%253D&md5=59c358a0499e1276735a7de45f3cca95</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2880%2980191-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252880%252980191-2%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DRasmussen%26aufirst%3DU.%26aulast%3DChristophersen%26aufirst%3DC.%26atitle%3DThapsigargin%252C%2520constitution%2520of%2520a%2520sesquiterpene%2520lactone%2520histamine%2520liberator%2520from%2520Thapsia%2520garganica%26jtitle%3DTetrahedron%2520Lett.%26date%3D1980%26volume%3D21%26spage%3D3829%26epage%3D3830%26doi%3D10.1016%2F0040-4039%2880%2980191-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowry, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennings, H.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, a weak skin tumor promoter, alters the growth and differentiation of mouse keratinocytes in culture</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1093/carcin/17.4.699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fcarcin%2F17.4.699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=8625480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XislCgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=699-706&author=D.+T.+Lowryauthor=L.+Liauthor=H.+Hennings&title=Thapsigargin%2C+a+weak+skin+tumor+promoter%2C+alters+the+growth+and+differentiation+of+mouse+keratinocytes+in+culture&doi=10.1093%2Fcarcin%2F17.4.699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, a weak skin tumor promoter, alters the growth and differentiation of mouse keratinocytes in culture</span></div><div class="casAuthors">Lowry, David T.; Li, Luowei; Hennings, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">699-706</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Thapsigargin (Tg), applied twice weekly to the backs of CD-1 mice initiated with 7,12-dimethylbenz[a]anthracene, promoted papillomas on the skin of ∼50% of the mice.  Tg alone induced papillomas in 10% of the mice.  Although Tg and 12-O-tetradecanoylphorbol 13-acetate (TPA) are synergistic in a keratinocyte co-culture assay for promotion, skin tumor promotion by TPA was inhibited by co-treatment with Tg.  Treatment of cultured keratinocytes with non-toxin doses of Tg increased the level of intracellular free Ca2+ and delayed Ca2+-induced stratification.  Tg blocked expression of the spinous layer differentiation marker keratin 1 (K1), while inducing cornification, a marker of differentiation in the granular layer/stratum corneum.  In medium with 1.4 mM Ca2+, Tg prolonged keratinocyte proliferation and selected foci of monolayer cells.  A Tg-independent cell line, TK-1, was developed from a single dish in which foci continued to expand after Tg removal.  Grafting TK-1 cells on to the backs of nude mice as part of a reconstituted skin resulted in the development of dysplastic papillomas with a high rate of progression to squamous cell carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zElTwqC_d7Vg90H21EOLACvtfcHk0lgJe59i9PhGzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCgsLg%253D&md5=93f63c740c8eeee5f09ee4d9ed858e13</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F17.4.699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F17.4.699%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DD.%2BT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHennings%26aufirst%3DH.%26atitle%3DThapsigargin%252C%2520a%2520weak%2520skin%2520tumor%2520promoter%252C%2520alters%2520the%2520growth%2520and%2520differentiation%2520of%2520mouse%2520keratinocytes%2520in%2520culture%26jtitle%3DCarcinogenesis%26date%3D1996%26volume%3D17%26spage%3D699%26epage%3D706%26doi%3D10.1093%2Fcarcin%2F17.4.699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søhoel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brøgger Christensen, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from <i>Thapsia garganica</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2651</span>– <span class="NLM_lpage">2658</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2006.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2006.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=17098264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CnsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=2651-2658&author=H.+Liuauthor=K.+G.+Jensenauthor=L.+M.+Tranauthor=M.+Chenauthor=L.+Zhaiauthor=C.+E.+Olsenauthor=H.+S%C3%B8hoelauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacsauthor=S.+Br%C3%B8gger+Christensen&title=Cytotoxic+phenylpropanoids+and+an+additional+thapsigargin+analogue+isolated+from+Thapsia+garganica&doi=10.1016%2Fj.phytochem.2006.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from Thapsia garganica</span></div><div class="casAuthors">Liu, Huizhen; Jensen, Kent Gunnertoft; Tran, Linh My; Chen, Ming; Zhai, Lin; Olsen, Carl Erik; Sohoel, Helmer; Denmeade, Samuel R.; Isaacs, John T.; Brogger Christensen, S.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2651-2658</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Four phenylpropanoids and a thapsigargin analog have been isolated from the fruits of Thapsia garganica.  A spectroscopic method for elucidating the relative stereochem. at the two pairs of stereogenic centers in the phenylpropanoids has been developed.  The phenylpropanoids were found to be potent cytotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC8lAHS1QQHLVg90H21EOLACvtfcHk0lg8GF0A9423Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CnsbnJ&md5=911f4a4fcd2af52aecadc7d1d33d308c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2006.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2006.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DK.%2BG.%26aulast%3DTran%26aufirst%3DL.%2BM.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DZhai%26aufirst%3DL.%26aulast%3DOlsen%26aufirst%3DC.%2BE.%26aulast%3DS%25C3%25B8hoel%26aufirst%3DH.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DBr%25C3%25B8gger%2BChristensen%26aufirst%3DS.%26atitle%3DCytotoxic%2520phenylpropanoids%2520and%2520an%2520additional%2520thapsigargin%2520analogue%2520isolated%2520from%2520Thapsia%2520garganica%26jtitle%3DPhytochemistry%26date%3D2006%26volume%3D67%26spage%3D2651%26epage%3D2658%26doi%3D10.1016%2Fj.phytochem.2006.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brøgger
Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kromann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tombal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin analogs for targeting programmed death of androgen-independent prostate cancer cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(99)00074-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0968-0896%2899%2900074-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10465403" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1273-1280&author=S.+Br%C3%B8gger%0AChristensenauthor=A.+Andersenauthor=H.+Kromannauthor=M.+Treimanauthor=B.+Tombalauthor=S.+Denmeadeauthor=J.+T.+Isaacs&title=Thapsigargin+analogs+for+targeting+programmed+death+of+androgen-independent+prostate+cancer+cells&doi=10.1016%2FS0968-0896%2899%2900074-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2899%2900074-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252899%252900074-7%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25B8gger%2BChristensen%26aufirst%3DS.%26aulast%3DAndersen%26aufirst%3DA.%26aulast%3DKromann%26aufirst%3DH.%26aulast%3DTreiman%26aufirst%3DM.%26aulast%3DTombal%26aufirst%3DB.%26aulast%3DDenmeade%26aufirst%3DS.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DThapsigargin%2520analogs%2520for%2520targeting%2520programmed%2520death%2520of%2520androgen-independent%2520prostate%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D1273%26epage%3D1280%26doi%3D10.1016%2FS0968-0896%2899%2900074-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thastrup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drøbak, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanley, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, A. P.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, a tumor promoter, discharges intracellular Ca<sup>2+</sup> stores by specific inhibition of the endoplasmic reticulum Ca<sup>2+</sup>-ATPase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2466</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1073/pnas.87.7.2466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1073%2Fpnas.87.7.2466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=2138778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=2466-2470&author=O.+Thastrupauthor=P.+J.+Cullenauthor=B.+K.+Dr%C3%B8bakauthor=M.+R.+Hanleyauthor=A.+P.+Dawson&title=Thapsigargin%2C+a+tumor+promoter%2C+discharges+intracellular+Ca2%2B+stores+by+specific+inhibition+of+the+endoplasmic+reticulum+Ca2%2B-ATPase&doi=10.1073%2Fpnas.87.7.2466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, a tumor promoter, discharges intracellular calcium stores by specific inhibition of the endoplasmic reticulum calcium ATPase</span></div><div class="casAuthors">Thastrup, Ole; Cullen, Peter J.; Drobak, Bjorn K.; Hanley, Michael R.; Dawson, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2466-70</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Thapsigargin (I), a tumor-promoting sesquiterpene lactone, discharges intracellular Ca2+ in rat hepatocytes, as it does in many vertebrate cell types.  It appears to act intracellularly, as incubation of isolated rat liver microsomes with I induces a rapid, dose-dependent release of stored Ca2+.  The I-releasable pool of microsomal Ca2+ includes the pools sensitive to inositol 1,4,5-trisphosphate and GTP.  I pretreatment of microsomes blocks subsequent loading with 45Ca2+, suggesting that its target is the ATP-dependent Ca2+ pump of endoplasmic reticulum.  This hypothesis is strongly supported by the demonstration that I causes a rapid inhibition of the Ca2+-activated ATPase activity of rat liver microsomes, with an identical dose dependence to that seen in whole cell or isolated microsome Ca2+ discharge.  The inhibition of the endoplasmic reticulum isoform of the Ca2+-ATPase is highly selective, as I has little or no effect on the Ca2+-ATPases of hepatocyte or erythrocyte plasma membrane or of cardiac or skeletal muscle sarcoplasmic reticulum.  These results suggest that I increases the concn. of cytosolic free Ca2+ in sensitive cells by an acute and highly specific arrest of the endoplasmic reticulum Ca2+ pump, followed by a rapid Ca2+ leak from at least two pharmacol. distinct Ca2+ stores.  The implications of this mechanism of action for the application of I in the anal. of Ca2+ hemostasis and possible forms of Ca2+ control are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwq70TgjRICrVg90H21EOLACvtfcHk0lg8GF0A9423Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFemurk%253D&md5=03282a990f01740f93da56eb8397a242</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.87.7.2466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.87.7.2466%26sid%3Dliteratum%253Aachs%26aulast%3DThastrup%26aufirst%3DO.%26aulast%3DCullen%26aufirst%3DP.%2BJ.%26aulast%3DDr%25C3%25B8bak%26aufirst%3DB.%2BK.%26aulast%3DHanley%26aufirst%3DM.%2BR.%26aulast%3DDawson%26aufirst%3DA.%2BP.%26atitle%3DThapsigargin%252C%2520a%2520tumor%2520promoter%252C%2520discharges%2520intracellular%2520Ca2%252B%2520stores%2520by%2520specific%2520inhibition%2520of%2520the%2520endoplasmic%2520reticulum%2520Ca2%252B-ATPase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1990%26volume%3D87%26spage%3D2466%26epage%3D2470%26doi%3D10.1073%2Fpnas.87.7.2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olesen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praetorius, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engedal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, J. V.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the sarco/endoplasmic reticulum (ER) Ca<sup>2+</sup>-ATPase by thapsigargin analogs induces cell death via ER Ca<sup>2+</sup> depletion and the unfolded protein response</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">19656</span>– <span class="NLM_lpage">19673</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.796920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M117.796920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28972171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=19656-19673&author=P.+Sehgalauthor=P.+Szalaiauthor=C.+Olesenauthor=H.+A.+Praetoriusauthor=P.+Nissenauthor=S.+B.+Christensenauthor=N.+Engedalauthor=J.+V.+M%C3%B8ller&title=Inhibition+of+the+sarco%2Fendoplasmic+reticulum+%28ER%29+Ca2%2B-ATPase+by+thapsigargin+analogs+induces+cell+death+via+ER+Ca2%2B+depletion+and+the+unfolded+protein+response&doi=10.1074%2Fjbc.M117.796920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response</span></div><div class="casAuthors">Sehgal, Pankaj; Szalai, Paula; Olesen, Claus; Praetorius, Helle A.; Nissen, Poul; Christensen, Soeren Broegger; Engedal, Nikolai; Moeller, Jesper V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19656-19673</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Calcium (Ca2+) is a fundamental regulator of cell signaling and function.  Thapsigargin (Tg) blocks the sarco/endoplasmic reticulum (ER) Ca2+-ATPase (SERCA), disrupts Ca2+ homeostasis, and causes cell death.  However, the exact mechanisms whereby SERCA inhibition induces cell death are incompletely understood.  Here, the authors report that low (0.1 μm) concns. of Tg and Tg analogs with various long-chain substitutions at the O-8 position extensively inhibit SERCA1a-mediated Ca2+ transport.  The authors also found that, in both prostate and breast cancer cells, exposure to Tg or Tg analogs for 1 day caused extensive drainage of the ER Ca2+ stores.  This Ca2+ depletion was followed by markedly reduced cell proliferation rates and morphol. changes that developed over 2-4 days and culminated in cell death.  Interestingly, these changes were not accompanied by bulk increases in cytosolic Ca2+ levels.  Moreover, knockdown of two key store-operated Ca2+ entry (SOCE) components, Orai1 and STIM1, did not reduce Tg cytotoxicity, indicating that SOCE and Ca2+ entry are not crit. for Tg-induced cell death.  However, the authors obsd. a correlation between the abilities of Tg and Tg analogs to deplete ER Ca2+ stores and their detrimental effects on cell viability.  Furthermore, caspase activation and cell death were assocd. with a sustained unfolded protein response.  The authors conclude that ER Ca2+ drainage and sustained unfolded protein response activation are key for initiation of apoptosis at low concns. of Tg and Tg analogs, whereas high cytosolic Ca2+ levels and SOCE are not required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR89n8X7wgbVg90H21EOLACvtfcHk0lg8GF0A9423Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsr3O&md5=720c1b7e01c47d5d62586ff3a800831a</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.796920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.796920%26sid%3Dliteratum%253Aachs%26aulast%3DSehgal%26aufirst%3DP.%26aulast%3DSzalai%26aufirst%3DP.%26aulast%3DOlesen%26aufirst%3DC.%26aulast%3DPraetorius%26aufirst%3DH.%2BA.%26aulast%3DNissen%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DEngedal%26aufirst%3DN.%26aulast%3DM%25C3%25B8ller%26aufirst%3DJ.%2BV.%26atitle%3DInhibition%2520of%2520the%2520sarco%252Fendoplasmic%2520reticulum%2520%2528ER%2529%2520Ca2%252B-ATPase%2520by%2520thapsigargin%2520analogs%2520induces%2520cell%2520death%2520via%2520ER%2520Ca2%252B%2520depletion%2520and%2520the%2520unfolded%2520protein%2520response%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D19656%26epage%3D19673%26doi%3D10.1074%2Fjbc.M117.796920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taverner, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobus, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champion, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paton, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei-Rossmann, J.</span></span> <span> </span><span class="NLM_article-title">Calcium influx caused by ER stress inducers enhances oncolytic adenovirus enadenotucirev replication and killing through PKCα activation</span>. <i>Mol. Ther. Oncolytics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.omto.2019.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.omto.2019.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31890865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVKqs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=117-130&author=W.+K.+Tavernerauthor=E.+J.+Jacobusauthor=J.+Christiansonauthor=B.+Championauthor=A.+W.+Patonauthor=J.+C.+Patonauthor=W.+Suauthor=R.+Cawoodauthor=L.+W.+Seymourauthor=J.+Lei-Rossmann&title=Calcium+influx+caused+by+ER+stress+inducers+enhances+oncolytic+adenovirus+enadenotucirev+replication+and+killing+through+PKC%CE%B1+activation&doi=10.1016%2Fj.omto.2019.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation</span></div><div class="casAuthors">Taverner, William K.; Jacobus, Egon J.; Christianson, John; Champion, Brian; Paton, Adrienne W.; Paton, James C.; Su, Weiheng; Cawood, Ryan; Seymour, Len W.; Lei-Rossmann, Janet</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy--Oncolytics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-130</span>CODEN:
                <span class="NLM_cas:coden">MTOHDL</span>;
        ISSN:<span class="NLM_cas:issn">2372-7705</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oncolytic viruses represent an emerging approach to cancer therapy.  However, better understanding of their interaction with the host cancer cell and approaches to enhance their efficacy are needed.  Here, we investigate the effect of chem. induced endoplasmic reticulum (ER) stress on the activity of the chimeric group B adenovirus Enadenotucirev, its closely related parental virus Ad11p, and the archetypal group C oncolytic adenovirus Ad5.  We show that treatment of colorectal and ovarian cancer cell lines with thapsigargin or ionomycin caused an influx of Ca2+, leading to an upregulation in E1A transcript and protein levels.  Increased E1A protein levels, in turn, increased levels of expression of the E2B viral DNA polymerase, genome replication, late viral protein expression, infectious virus particle prodn., and cell killing during Enadenotucirev and Ad11p, but not Ad5, infection.  This effect was not due to the induction of ER stress, but rather the influx of extracellular Ca2+ and consequent increase in protein kinase C activity.  These results underscore the importance of Ca2+ homeostasis during adenoviral infection, indicate a signaling pathway between protein kinase C and E1A, and raise the possibility of using Ca2+ flux-modulating agents in the manuf. and potentiation of oncolytic virotherapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8zYKRLDcoqLVg90H21EOLACvtfcHk0lgFBOA0sVAx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVKqs7rK&md5=0325fedb1dccfdd3620e0fe4f9a8cc35</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.omto.2019.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.omto.2019.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DTaverner%26aufirst%3DW.%2BK.%26aulast%3DJacobus%26aufirst%3DE.%2BJ.%26aulast%3DChristianson%26aufirst%3DJ.%26aulast%3DChampion%26aufirst%3DB.%26aulast%3DPaton%26aufirst%3DA.%2BW.%26aulast%3DPaton%26aufirst%3DJ.%2BC.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DCawood%26aufirst%3DR.%26aulast%3DSeymour%26aufirst%3DL.%2BW.%26aulast%3DLei-Rossmann%26aufirst%3DJ.%26atitle%3DCalcium%2520influx%2520caused%2520by%2520ER%2520stress%2520inducers%2520enhances%2520oncolytic%2520adenovirus%2520enadenotucirev%2520replication%2520and%2520killing%2520through%2520PKC%25CE%25B1%2520activation%26jtitle%3DMol.%2520Ther.%2520Oncolytics%26date%3D2019%26volume%3D15%26spage%3D117%26epage%3D130%26doi%3D10.1016%2Fj.omto.2019.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotnova, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyanova, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukhanina, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portseva, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilyin, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgieva, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepchenko, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pankratova, E. V.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, inhibitor of sarco-endoplasmic Ca<sup>2+</sup>-ATPase, effectively suppresses the expression of S100A4 protein in human breast cancer cell line</span>. <i>Dokl. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1134/S1607672919030050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1134%2FS1607672919030050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31367816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFShu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2019&pages=181-183&author=A.+P.+Kotnovaauthor=B.+M.+Lyanovaauthor=E.+A.+Dukhaninaauthor=T.+N.+Portsevaauthor=Y.+V.+Ilyinauthor=S.+G.+Georgievaauthor=A.+G.+Stepchenkoauthor=E.+V.+Pankratova&title=Thapsigargin%2C+inhibitor+of+sarco-endoplasmic+Ca2%2B-ATPase%2C+effectively+suppresses+the+expression+of+S100A4+protein+in+human+breast+cancer+cell+line&doi=10.1134%2FS1607672919030050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, inhibitor of sarco-endoplasmic calcium-ATPase, effectively suppresses expression of S100A4 protein in human breast cancer cell line</span></div><div class="casAuthors">Kotnova, A. P.; Lyanova, B. M.; Dukhanina, E. A.; Portseva, T. N.; Ilyin, Yu. V.; Georgieva, S. G.; Stepchenko, A. G.; Pankratova, E. V.</div><div class="citationInfo"><span class="NLM_cas:title">Doklady Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-183</span>CODEN:
                <span class="NLM_cas:coden">DBBOAL</span>;
        ISSN:<span class="NLM_cas:issn">1607-6729</span>.
    
            (<span class="NLM_cas:orgname">Pleiades Publishing, Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Thapsigargin (SERCA ATPase inhibitor) inhibited the S100A4 metastatic marker expression in MDA-MB231 breast cancer cells.  We found that S100A4 gene transcription is regulated by Ca2+ signaling pathways.  We found that the synthesis of S100A4 mRNA and S100A4 protein in MDA-MB231 cells was effectively suppressed by thapsigargin at a concn. of 0.4-4μM with retaining cell viability.  We assume that the change in the gene transcription in response to disturbance of Ca2+ homeostasis is directly involved in the remodeling of Ca2+ signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHIIPoKGX8brVg90H21EOLACvtfcHk0lgFBOA0sVAx7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFShu7vJ&md5=244401ad35e38a2e08de14585b06167b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1134%2FS1607672919030050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS1607672919030050%26sid%3Dliteratum%253Aachs%26aulast%3DKotnova%26aufirst%3DA.%2BP.%26aulast%3DLyanova%26aufirst%3DB.%2BM.%26aulast%3DDukhanina%26aufirst%3DE.%2BA.%26aulast%3DPortseva%26aufirst%3DT.%2BN.%26aulast%3DIlyin%26aufirst%3DY.%2BV.%26aulast%3DGeorgieva%26aufirst%3DS.%2BG.%26aulast%3DStepchenko%26aufirst%3DA.%2BG.%26aulast%3DPankratova%26aufirst%3DE.%2BV.%26atitle%3DThapsigargin%252C%2520inhibitor%2520of%2520sarco-endoplasmic%2520Ca2%252B-ATPase%252C%2520effectively%2520suppresses%2520the%2520expression%2520of%2520S100A4%2520protein%2520in%2520human%2520breast%2520cancer%2520cell%2520line%26jtitle%3DDokl.%2520Biochem.%2520Biophys.%26date%3D2019%26volume%3D486%26spage%3D181%26epage%3D183%26doi%3D10.1134%2FS1607672919030050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1975</span>– <span class="NLM_lpage">1980</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.8833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.8833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30008891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ohtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=1975-1980&author=F.+Huangauthor=P.+Wangauthor=X.+Wang&title=Thapsigargin+induces+apoptosis+of+prostate+cancer+through+cofilin-1+and+paxillin&doi=10.3892%2Fol.2018.8833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin</span></div><div class="casAuthors">Huang Fengyu; Huang Fengyu; Wang Peitao; Wang Xinsheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1975-1980</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">It is widely considered that endoplasmic reticulum stress may rapidly induce apoptosis.  The aim of the present study was to investigate the effect of thapsigargin on the induction of apoptosis in prostate cancer cells, and to explore its possible mechanism.  A Cell Counting Kit-8 was selected to determine the effect of thapsigargin (0, 1, 10 and 100 nM) on the proliferation of PC3 cells.  Cell proliferation of the prostate cancer cells was effectively inhibited by treatment with thapsigargin, and thapsigargin significantly increased the rate of apoptosis and caspase-3/9 activities in prostate cancer cells.  The protein expression of phosphorylated (p)-RAC-α serine threonine-protein kinase, p-mechanistic target of rapamycin, F-actin and paxillin were significantly decreased, and cofilin-1 protein expression was significantly increased by treatment with thapsigargin in prostate cancer cells.  Overall, the data of the present study revealed that thapsigargin induced apoptosis in prostate cancer cells through cofilin-1 and paxillin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfpOBgcGQpVZVVjGoY74BafW6udTcc2ea9g9NlC0ZfS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ohtg%253D%253D&md5=d2e1f06c0465572c47a844587a61c383</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.8833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.8833%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DThapsigargin%2520induces%2520apoptosis%2520of%2520prostate%2520cancer%2520through%2520cofilin-1%2520and%2520paxillin%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D1975%26epage%3D1980%26doi%3D10.3892%2Fol.2018.8833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin-induced sequential expression of proteins related to autophagy and apoptosis in human breast cancer MCF-7 cells</span>. <i>Bull. Korean Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3469</span>– <span class="NLM_lpage">3472</span>, <span class="refDoi"> DOI: 10.5012/bkcs.2011.32.9.3469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5012%2Fbkcs.2011.32.9.3469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2ntLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=3469-3472&author=M.+Parkauthor=S.+H.+Kim&title=Thapsigargin-induced+sequential+expression+of+proteins+related+to+autophagy+and+apoptosis+in+human+breast+cancer+MCF-7+cells&doi=10.5012%2Fbkcs.2011.32.9.3469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin-induced sequential expression of proteins related to autophagy and apoptosis in human breast cancer MCF-7 cells</span></div><div class="casAuthors">Park, Mikyung; Kim, Seong Hwan</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3469-3472</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">The thapsigargin induced sequential expression of autophagy and apoptosis related mols. in human breast cancer MCF-7 cells were evaluated.  Before evaluating that, the effect of thapsigargin on the viability of MCF-7 cells was assessed.  Results show the endogenous levels of Beclin-I and ATG5 that are autophagy promoting proteins, were decreased by thapsigargin.  Indeed, the gradual down-regulation of autophagy-related mols. has been suggested to facilitate apoptosis.  Esp., the cleavage or down-regulation of Beclin-I and ATG5 has been suggested to facilitate switch to apoptosis by unmasking a caspase-dependent apoptosis.  The sequential expression regulation of autophagy and apoptosis-related mols. is the crosstalk between autophagic and apoptotic signaling in the process of cell death in human breast cancer MCF-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDgivRTNKGprVg90H21EOLACvtfcHk0ljEOwOD24-jdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2ntLrI&md5=d9bad1ef34abdf232849b79d80492a8b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2011.32.9.3469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2011.32.9.3469%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DThapsigargin-induced%2520sequential%2520expression%2520of%2520proteins%2520related%2520to%2520autophagy%2520and%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520MCF-7%2520cells%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2011%26volume%3D32%26spage%3D3469%26epage%3D3472%26doi%3D10.5012%2Fbkcs.2011.32.9.3469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35196</span>, <span class="refDoi"> DOI: 10.1038/srep35196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep35196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27731378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yisr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35196&author=Z.+Maauthor=C.+Fanauthor=Y.+Yangauthor=S.+Diauthor=W.+Huauthor=T.+Liauthor=Y.+Zhuauthor=J.+Hanauthor=Z.+Xinauthor=G.+Wuauthor=J.+Zhaoauthor=X.+Liauthor=X.+Yan&title=Thapsigargin+sensitizes+human+esophageal+cancer+to+TRAIL-induced+apoptosis+via+AMPK+activation&doi=10.1038%2Fsrep35196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation</span></div><div class="casAuthors">Ma, Zhiqiang; Fan, Chongxi; Yang, Yang; Di, Shouyin; Hu, Wei; Li, Tian; Zhu, Yifang; Han, Jing; Xin, Zhenlong; Wu, Guiling; Zhao, Jing; Li, Xiaofei; Yan, Xiaolong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35196</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent for esophageal squamous cell carcinoma (ESCC).  Forced expression of CHOP, one of the key downstream transcription factors during endoplasmic reticulum (ER) stress, upregulates the death receptor 5 (DR5) levels and promotes oxidative stress and cell death.  In this study, we show that ER stress mediated by thapsigargin promoted CHOP and DR5 synthesis thus sensitizing TRAIL treatment, which induced ESCC cells apoptosis.  These effects were reversed by DR5 siRNA in vitro and CHOP siRNA both in vitro and in vivo.  Besides, chem. inhibition of AMPK by Compd. C and AMPK siRNA weakened the anti-cancer effect of thapsigargin and TRAIL co-treatment.  Therefore, our findings suggest ER stress effectively sensitizes human ESCC to TRAIL-mediated apoptosis via the TRAIL-DR5-AMPK signaling pathway, and that activation of ER stress may be beneficial for improving the efficacy of TRAIL-based anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIVQKNV1HCYrVg90H21EOLACvtfcHk0ljEOwOD24-jdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yisr%252FK&md5=a405ca11f1e4b1bae31c3465f87dfde2</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fsrep35196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35196%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DDi%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DX.%26atitle%3DThapsigargin%2520sensitizes%2520human%2520esophageal%2520cancer%2520to%2520TRAIL-induced%2520apoptosis%2520via%2520AMPK%2520activation%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35196%26doi%3D10.1038%2Fsrep35196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Körbel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linxweiler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wemmert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, M.</span></span> <span> </span><span class="NLM_article-title">Treatment of <i>SEC62</i> over-expressing tumors by thapsigargin and trifluoperazine</span>. <i>Biomol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1515/bmc-2018-0006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1515%2Fbmc-2018-0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29779013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MfltVaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=53-63&author=C.+K%C3%B6rbelauthor=M.+Linxweilerauthor=F.+Bochenauthor=S.+Wemmertauthor=B.+Schickauthor=M.+Meyerauthor=H.+Maurerauthor=M.+D.+Mengerauthor=R.+Zimmermannauthor=M.+Greiner&title=Treatment+of+SEC62+over-expressing+tumors+by+thapsigargin+and+trifluoperazine&doi=10.1515%2Fbmc-2018-0006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine</span></div><div class="casAuthors">Korbel Christina; Menger Michael D; Linxweiler Maximilian; Bochen Florian; Wemmert Silke; Schick Bernhard; Meyer Markus; Maurer Hans; Zimmermann Richard; Greiner Markus</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular concepts</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment with analogues of the SERCA-inhibitor Thapsigargin is a promising new approach for a wide variety of cancer entities.  However, our previous studies on various tumor cells suggested resistance of SEC62 over-expressing tumors to this treatment.  Therefore, we proposed the novel concept that e.g. lung-, prostate-, and thyroid-cancer patients should be tested for SEC62 over-expression, and developed a novel therapeutic strategy for a combinatorial treatment of SEC62 over-expressing tumors.  The latter was based on the observations that treatment of SEC62 over-expressing tumor cells with SEC62-targeting siRNAs showed less resistance to Thapsigargin as well as a reduction in migratory potential and that the siRNA effects can be mimicked by the Calmodulin antagonist Trifluoperazine.  Therefore, the combinatorial treatment of SEC62 over-expressing tumors was proposed to involve Thapsigargin and Trifluoperazine.  Here, we addressed the impact of Thapsigargin and Trifluoperazine in separate and combined treatments of heterotopic tumors, induced by inoculation of human hypopharyngeal squamous cell carcinoma (FaDu)-cells into the mouse flank.  Seeding of the tumor cells and/or their growth rate were significantly reduced by all three treatments, suggesting Trifluoperazine is a small molecule to be considered for future therapeutic strategies for patients, suffering from Sec62-overproducing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJdtqO1XyHUIhLSh9fo81bfW6udTcc2eYudEI2InD98Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfltVaisQ%253D%253D&md5=8117a801c83a2abe6e06de080abe3707</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1515%2Fbmc-2018-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc-2018-0006%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6rbel%26aufirst%3DC.%26aulast%3DLinxweiler%26aufirst%3DM.%26aulast%3DBochen%26aufirst%3DF.%26aulast%3DWemmert%26aufirst%3DS.%26aulast%3DSchick%26aufirst%3DB.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DMaurer%26aufirst%3DH.%26aulast%3DMenger%26aufirst%3DM.%2BD.%26aulast%3DZimmermann%26aufirst%3DR.%26aulast%3DGreiner%26aufirst%3DM.%26atitle%3DTreatment%2520of%2520SEC62%2520over-expressing%2520tumors%2520by%2520thapsigargin%2520and%2520trifluoperazine%26jtitle%3DBiomol.%2520Concepts%26date%3D2018%26volume%3D9%26spage%3D53%26epage%3D63%26doi%3D10.1515%2Fbmc-2018-0006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-G.</span></span> <span> </span><span class="NLM_article-title">Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12670894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFaisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1483-1489&author=H.+Yamaguchiauthor=K.+Bhallaauthor=H.-G.+Wang&title=Bax+plays+a+pivotal+role+in+thapsigargin-induced+apoptosis+of+human+colon+cancer+HCT116+cells+by+controlling+Smac%2FDiablo+and+Omi%2FHtrA2+release+from+mitochondria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Bax Plays a Pivotal Role in Thapsigargin-induced Apoptosis of Human Colon Cancer HCT116 Cells by Controlling Smac/Diablo and Omi/HtrA2 Release from Mitochondria</span></div><div class="casAuthors">Yamaguchi, Hirohito; Bhalla, Kapil; Wang, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1483-1489</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bax is a crucial mediator of the mitochondrial pathway for apoptosis, and loss of this proapoptotic Bcl-2 family protein contributes to drug resistance in human cancers.  We report here that the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (THG) induces apoptosis of human colon cancer HCT116 cells through a Bax-dependent signaling pathway controlling the cytosolic release of mitochondrial apoptogenic mols.  Treating HCT116 cells with THG results in caspase-8 activation; Bid cleavage; Bax conformational change and mitochondrial translocation; the release of cytochrome c, Smac/Diablo, and Omi/HtrA2 into the cytosol; caspase-3 activation; and apoptosis.  In contrast, knockout of Bax completely abrogates the full processing/activation of caspase-3 but has no effect on the processing of caspase-8 and the initial cleavage of caspase-3 to p24 fragment after THG treatment.  The caspase-8-specific inhibitor z-IETD-fmk, as well as pan-caspase inhibitor z-VAD-fmk, but not the calpain inhibitor E-64d, prevents Bid cleavage, Bax conformational change, and subsequent caspase-3 processing and apoptosis.  Caspase-8 processing is dependent on de novo protein synthesis; DR5 expression is strongly up-regulated by THG treatment.  Moreover, the absence of Bax blocks THG-induced Omi and Smac release from mitochondria, and expression of cytosolic Omi (GFP-IETD-Omi) or Smac (GFP-IETD-Smac) restores the sensitivity of Bax-knockout HCT116 cells to apoptosis in response to THG treatment.  Taken together, our results indicate that Bax-dependent Smac and Omi release plays an essential role in caspase-3 activation and apoptosis induced by THG in human colon cancer HCT116 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSFriq19w3d7Vg90H21EOLACvtfcHk0lj1F2NIUE-rhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFaisbg%253D&md5=6599315a7d74998b09cc9b590878b58c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.-G.%26atitle%3DBax%2520plays%2520a%2520pivotal%2520role%2520in%2520thapsigargin-induced%2520apoptosis%2520of%2520human%2520colon%2520cancer%2520HCT116%2520cells%2520by%2520controlling%2520Smac%252FDiablo%2520and%2520Omi%252FHtrA2%2520release%2520from%2520mitochondria%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D1483%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inigo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Hsp60 and IL-8 axis promotes apoptosis resistance in cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1038/s41416-019-0617-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41416-019-0617-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31673102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFemsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2019&pages=934-943&author=S.+Kumarauthor=J.+O%E2%80%99Malleyauthor=A.+K.+Chaudharyauthor=J.+R.+Inigoauthor=N.+Yadavauthor=R.+Kumarauthor=D.+Chandra&title=Hsp60+and+IL-8+axis+promotes+apoptosis+resistance+in+cancer&doi=10.1038%2Fs41416-019-0617-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp60 and IL-8 axis promotes apoptosis resistance in cancer</span></div><div class="casAuthors">Kumar, Sandeep; O'Malley, Jordan; Chaudhary, Ajay Kumar; Inigo, Joseph R.; Yadav, Neelu; Kumar, Rahul; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">934-943</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Interleukin-8 (IL-8) and heat shock protein 60 (Hsp60) play crucial roles in cell survival and maintenance of cellular homoeostasis.  However, cross talks between these two proteins are not defined.  IL-8 expression in tumor tissue sections was analyzed by immunohistochem.  IL-8 expression and release in cancer cells was quantified using ELISA (ELISA).  Apoptosis was quantified using caspase activity and Annexin-V/PI staining.  We obsd. IL-8 release from cancer cells in response to histone deacetylase inhibitor, apicidin (Api), and non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase, thapsigargin (TG).  IL-8 release was increased upon TG-treatment.  TG-induced IL-8 expression was reduced in the presence of Api in Bax-dependent manner.  Increased apoptosis was assocd. with decreased IL-8 expression in response to combined treatment of TG and Api.  TG and Api combination induced caspase-8 and caspase-9 dependent apoptosis.  Hsp60 knockdown abrogated IL-8 expression induced by Api, TG, and their combination.  The level of TGF-β, an upstream regulator of IL-8, was decreased upon Hsp60-silencing.  Knocking down Hsp60 decreased IL-8 expression and its release in prostate cancer cell xenograft tumors in SCID mice.  This study describes the underlying mechanism assocd. with apoptosis resistance mediated via Hsp60-IL-8 axis in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0xlaXpnUUrVg90H21EOLACvtfcHk0lg2Cc8banEuVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFemsLrL&md5=d2817bd4eb1e6f0d25987babbd4359b5</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fs41416-019-0617-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-019-0617-0%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DJ.%26aulast%3DChaudhary%26aufirst%3DA.%2BK.%26aulast%3DInigo%26aufirst%3DJ.%2BR.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DHsp60%2520and%2520IL-8%2520axis%2520promotes%2520apoptosis%2520resistance%2520in%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2019%26volume%3D121%26spage%3D934%26epage%3D943%26doi%3D10.1038%2Fs41416-019-0617-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilja, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span> <span> </span><span class="NLM_article-title">Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer</span>. <i>J. Natl. Cancer. Inst.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1093/jnci/95.13.990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fjnci%2F95.13.990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12837835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=990-1000&author=S.+R.+Denmeadeauthor=C.+M.+Jakobsenauthor=S.+Janssenauthor=S.+R.+Khanauthor=E.+S.+Garrettauthor=H.+Liljaauthor=S.+B.+Christensenauthor=J.+T.+Isaacs&title=Prostate-specific+antigen-activated+thapsigargin+prodrug+as+targeted+therapy+for+prostate+cancer&doi=10.1093%2Fjnci%2F95.13.990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer</span></div><div class="casAuthors">Denmeade, Samuel R.; Jakobsen, Carsten M.; Janssen, Samuel; Khan, Saeed R.; Garrett, Elizabeth S.; Lilja, Hans; Christensen, S. Brogger; Isaacs, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">990-1000</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Std. anti-proliferative chemotherapy is relatively ineffective against slowly proliferating androgen-independent prostate cancer cells within metastatic sites.  In contrast, the lipophilic cytotoxin thapsigargin, which causes apoptosis by disrupting intracellular free Ca2+ levels, is effective against both proliferative and quiescent (i.e., G0-arrested) cells.  However, thapsigargin's mechanism of action indicates that it is unlikely to be selective for cancer cells or prostate cells.  We coupled a chem. modified form of thapsigargin, L12ADT, to a peptide carrier that is a substrate for the prostate-specific antigen (PSA) protease to produce a sol., cell-impermeant latent prodrug that is specifically activated extracellularly within metastatic prostate cancer sites by PSA.  We analyzed the kinetics of PSA hydrolysis of the prodrug, the in vitro cytotoxicity of the prodrug against PSA-producing LNCaP human prostate cancer and PSA non-producing HCT-116 human colon cancer cells, and the in vivo pharmacokinetics of the prodrug in mice.  We also analyzed antitumor efficacy of the prodrug in nude mice xenograft models of prostate cancer (using LNCaP cells) and renal carcinoma (using human SN12C cells).  The L12ADT peptide prodrug was hydrolyzed efficiently by PSA, was selectively toxic to PSA-producing prostate cancer cells in vitro, and was stable in human plasma.  A single dose of 7 mg/kg resulted in a peak serum prodrug concn. of 15.4±1.1 μM and a half-life of approx. 2.8 h.  Over 24 h, less than 0.5% of free L12ADT was obsd. in plasma.  Levels of prodrug and liberated L12ADT in prostate cancer xenograft tumors were approx. eightfold and sixfold, resp., higher than the in vitro LD50s.  Prostate cancer xenograft tumors in mice treated with prodrug by i.v. administration were growth-inhibited without substantial host toxicity.  Continuous s.c. prodrug administration in mice produced complete growth inhibition of established PSA-producing prostate cancer xenograft tumors but had no effect on PSA non-producing renal carcinoma xenograft tumors.  Further development of PSA-activated thapsigargin prodrugs as therapy for metastatic prostate cancer is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF5KzcmdurTrVg90H21EOLACvtfcHk0lg2Cc8banEuVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D&md5=1d4d04fa16cf7ce8989727164379d5cc</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.13.990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.13.990%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DJakobsen%26aufirst%3DC.%2BM.%26aulast%3DJanssen%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DGarrett%26aufirst%3DE.%2BS.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DProstate-specific%2520antigen-activated%2520thapsigargin%2520prodrug%2520as%2520targeted%2520therapy%2520for%2520prostate%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D2003%26volume%3D95%26spage%3D990%26epage%3D1000%26doi%3D10.1093%2Fjnci%2F95.13.990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vander
Griend, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalrymple, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span> <span> </span><span class="NLM_article-title">Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1349</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-1136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1535-7163.MCT-08-1136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19417145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1340-1349&author=D.+J.+Vander%0AGriendauthor=L.+Antonyauthor=S.+L.+Dalrympleauthor=Y.+Xuauthor=S.+B.+Christensenauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacs&title=Amino+acid+containing+thapsigargin+analogues+deplete+androgen+receptor+protein+via+synthesis+inhibition+and+induce+the+death+of+prostate+cancer+cells&doi=10.1158%2F1535-7163.MCT-08-1136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells</span></div><div class="casAuthors">Vander Griend, Donald J.; Antony, Lizamma; Dalrymple, Susan L.; Xu, Yi; Christensen, S. Brogger; Denmeade, Samuel R.; Isaacs, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1340-1349</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There are quant. and/or qual. mechanisms allowing androgen receptor (AR) growth signaling in androgen ablation refractory prostate cancer cells.  Regardless of the mechanism, agents that deplete AR protein expression prevent such AR growth signaling.  Thapsigargin (TG) is a highly cell-penetrant sequiterpene-lactone that once inside cells inhibits (IC50, 10 nmol/L) critically important housekeeping SERCA 2b calcium pumps in the endoplasmic reticulum.  Using a series of five genetically diverse androgen ablation refractory human prostate cancer lines (LNCaP, LAPC-4, VCaP, MDA-PCa-2b, and CWR22Rv1), TG inhibition of SERCA pumps consistently results in depletion of the endoplasmic reticulum Ca+2 coupled with μmol/L elevation in the intracellular free Ca+2 initiating a mol. cascade that: (a) inhibits Cap-dependent AR protein synthesis resulting in 90% depletion of AR protein by 24 h of TG exposure, (b) arrests the cells in G0, and (c) induces their apoptotic death.  Unfortunately, due to its highly lipophilic nature, TG is not deliverable as a systemic agent without host toxicity.  Therefore, TG analogs contg. amino acids were developed, which retain ability to deplete AR protein and induce cell death and which can be covalently linked to peptide carriers producing water sol. prodrugs for systemic delivery.  Specific amino acid sequences are used to restrict the liberation of cytotoxic amino acid contg. TG analogs from the peptide prodrug by prostate-specific proteases, such as prostate-specific antigen and prostate-specific membrane antigen, or cancer-specific proteases, such as fibroblast activation protein, so that toxicity of these prodrugs is selectively targeted to metastatic sites of prostate cancer.  Based on these results, these prodrugs are undergoing clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwb0BEOf1jSbVg90H21EOLACvtfcHk0lg2Cc8banEuVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7w%253D&md5=9e8e00d66561ea1bb25359cc65699e14</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1136%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BGriend%26aufirst%3DD.%2BJ.%26aulast%3DAntony%26aufirst%3DL.%26aulast%3DDalrymple%26aufirst%3DS.%2BL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DAmino%2520acid%2520containing%2520thapsigargin%2520analogues%2520deplete%2520androgen%2520receptor%2520protein%2520via%2520synthesis%2520inhibition%2520and%2520induce%2520the%2520death%2520of%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1340%26epage%3D1349%26doi%3D10.1158%2F1535-7163.MCT-08-1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzyk, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of enzyme-activated thapsigargin prodrugs by solid-phase synthesis</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1463</span>, <span class="refDoi"> DOI: 10.3390/molecules23061463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules23061463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGgtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1463&author=T.+Zimmermannauthor=S.+B.+Christensenauthor=H.+Franzyk&title=Preparation+of+enzyme-activated+thapsigargin+prodrugs+by+solid-phase+synthesis&doi=10.3390%2Fmolecules23061463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of enzyme-activated thapsigargin prodrugs by solid-phase synthesis</span></div><div class="casAuthors">Zimmermann, Tomas; Christensen, Soren Brogger; Franzyk, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1463/1-1463/13</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Since cells in solid tumors divide less rapidly than cells in the bone marrow or cells of the immune system, mitotic inhibitors often cause severe side effects when used for treatment of diseases like prostate cancer and breast cancer.  One approach to overcome this problem involves attempts at developing drugs based on general cytotoxins, like calicheamicin and thapsigargin, which kill cells at all phases of the cell cycle.  However, such toxins can only be used when efficient targeting to the malignant tissue is possible.  In the case of thapsigargin, selectivity for tumor-assocd. cells is achieved by conjugating the drug to a peptide that is only cleaved in the vicinity of tumors to release the cytotoxic drug or an analog with retained activity.  Solid-phase synthesis protocols were developed for prepn. of three already validated prodrugs of thapsigargin: one prodrug cleavable by human kallikrein 2, one prodrug cleavable by prostate-specific antigen, and one prodrug cleavable by prostate-specific membrane antigen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdfvtNACIoqLVg90H21EOLACvtfcHk0li0NOvvm7G5_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGgtL3P&md5=7df6ce174bb356b57fa0f6bc09488b4a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23061463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23061463%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DFranzyk%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520enzyme-activated%2520thapsigargin%2520prodrugs%2520by%2520solid-phase%2520synthesis%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D1463%26doi%3D10.3390%2Fmolecules23061463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarantopoulas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosgrove, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetnar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgood, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carducci, M.</span></span> <span> </span><span class="NLM_article-title">Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: Results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumors</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1038/bjc.2016.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fbjc.2016.72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27115568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFOmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2016&pages=986-994&author=D.+Mahalingamauthor=G.+Wildingauthor=S.+Denmeadeauthor=J.+Sarantopoulasauthor=D.+Cosgroveauthor=J.+Cetnarauthor=N.+Azadauthor=J.+Bruceauthor=M.+Kurmanauthor=V.+E.+Allgoodauthor=M.+Carducci&title=Mipsagargin%2C+a+novel+thapsigargin-based+PSMA-activated+prodrug%3A+Results+of+a+first-in-man+phase+I+clinical+trial+in+patients+with+refractory%2C+advanced+or+metastatic+solid+tumors&doi=10.1038%2Fbjc.2016.72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours</span></div><div class="casAuthors">Mahalingam, D.; Wilding, G.; Denmeade, S.; Sarantopoulas, J.; Cosgrove, D.; Cetnar, J.; Azad, N.; Bruce, J.; Kurman, M.; Allgood, V. E.; Carducci, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">986-994</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Mipsagargin (G-202; (8-O-(12-aminododecanoyl)-8-O-debutanoyl thapsigargin)-Asp-γ-Glu-γ-Glu-γ-GluGluOH)) is a novel thapsigargin-based targeted prodrug that is activated by PSMA-mediated cleavage of an inert masking peptide.  The active moiety is an inhibitor of the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump protein that is necessary for cellular viability.  We evaluated the safety of mipsagargin in patients with advanced solid tumors and established a recommended phase II dosing (RP2D) regimen.  Methods: Patients with advanced solid tumors received mipsagargin by i.v. infusion on days 1, 2 and 3 of 28-day cycles and were allowed to continue participation in the absence of disease progression or unacceptable toxicity.  The dosing began at 1.2 mg m-2 and was escalated using a modified Fibonacci schema to det. maximally tolerated dose (MTD) with an expansion cohort at the RP2D.  Plasma was analyzed for mipsagargin pharmacokinetics and response was assessed using RECIST criteria.  Results: A total of 44 patients were treated at doses ranging from 1.2 to 88 mg m-2, including 28 patients in the dose escalation phase and 16 patients in an expansion cohort.  One dose-limiting toxicity (DLT; Grade 3 rash) was obsd. in the dose escalation portion of the study.  At 88 mg m-2, observations of Grade 2 infusion-related reaction (IRR, 2 patients) and Grade 2 creatinine elevation (1 patient) led to declaration of 66.8 mg m-2 as the recommended phase II dose (RP2D).  Across the study, the most common treatment-related adverse events (AEs) were fatigue, rash, nausea, pyrexia and IRR.  Two patients developed treatment-related Grade 3 acute renal failure that was reversible during the treatment-free portion of the cycle.  To help ameliorate the IRR and creatinine elevations, a RP2D of 40 mg m-2 on day 1 and 66.8 mg m-2 on days 2 and 3 with prophylactic premedications and hydration on each day of infusion was established.  Clin. response was not obsd., but prolonged disease stabilization was obsd. in a subset of patients.  Conclusions: Mipsagargin demonstrated an acceptable tolerability and favorable pharmacokinetic profile in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG66Gw8dy-PLVg90H21EOLACvtfcHk0li0NOvvm7G5_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFOmtbY%253D&md5=dac90827cd0be1017afcb48ea6d6279b</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2016.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2016.72%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DDenmeade%26aufirst%3DS.%26aulast%3DSarantopoulas%26aufirst%3DJ.%26aulast%3DCosgrove%26aufirst%3DD.%26aulast%3DCetnar%26aufirst%3DJ.%26aulast%3DAzad%26aufirst%3DN.%26aulast%3DBruce%26aufirst%3DJ.%26aulast%3DKurman%26aufirst%3DM.%26aulast%3DAllgood%26aufirst%3DV.%2BE.%26aulast%3DCarducci%26aufirst%3DM.%26atitle%3DMipsagargin%252C%2520a%2520novel%2520thapsigargin-based%2520PSMA-activated%2520prodrug%253A%2520Results%2520of%2520a%2520first-in-man%2520phase%2520I%2520clinical%2520trial%2520in%2520patients%2520with%2520refractory%252C%2520advanced%2520or%2520metastatic%2520solid%2520tumors%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2016%26volume%3D114%26spage%3D986%26epage%3D994%26doi%3D10.1038%2Fbjc.2016.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peguero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarantopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgood, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubb, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, L.</span></span> <span> </span><span class="NLM_article-title">A phase II, multicenter, single-arm study of mipsagargin (G-202) as a second-line therapy following sorafenib for adult patients with progressive advanced hepatocellular carcinoma</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">833</span>, <span class="refDoi"> DOI: 10.3390/cancers11060833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fcancers11060833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtlCku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=833&author=D.+Mahalingamauthor=J.+Pegueroauthor=P.+Cenauthor=S.+P.+Aroraauthor=J.+Sarantopoulosauthor=J.+Roweauthor=V.+Allgoodauthor=B.+Tubbauthor=L.+Campos&title=A+phase+II%2C+multicenter%2C+single-arm+study+of+mipsagargin+%28G-202%29+as+a+second-line+therapy+following+sorafenib+for+adult+patients+with+progressive+advanced+hepatocellular+carcinoma&doi=10.3390%2Fcancers11060833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II, multicenter, single-arm study of mipsagargin (G-202) as a second-line therapy following sorafenib for adult patients with progressive advanced hepatocellular carcinoma</span></div><div class="casAuthors">Mahalingam, Devalingam; Peguero, Julio; Cen, Putao; Arora, Sukeshi P.; Sarantopoulos, John; Rowe, Julie; Allgood, Victoria; Tubb, Benjamin; Campos, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">833</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Background: Mipsagargin (G-202) is a thapsigargin-based prodrug with cytotoxic activity masked by a peptide that is cleaved by prostate-specific membrane antigen (PSMA), a protease expressed in prostate cancer cells and the endothelium of tumor vasculature.  It was hypothesized that PSMA-mediated activation of mipsagargin would result in disruption of the tumor vasculature, leading to a decrease in blood flow, and in direct cytotoxic effects on tumor cells, resulting in anti-tumor activity.  Method: In this open-label, Phase II study, mipsagargin was administered i.v. on Days 1, 2, and 3 of a 28-day cycle to patients with hepatocellular carcinoma (HCC) who progressed on or after treatment with sorafenib or intolerant of sorafenib.  Assessments included time to disease progression (TTP), response rate, progression-free survival (PFS), overall survival (OS), and safety.  Blood flow metrics in hepatic lesions were evaluated using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).  Results: Of 25 treated patients, 19 were evaluable for efficacy.  None had an objective response, 12 (63.2%) had a best response of stable disease, and 12 (63.2%) showed radiol. progression; seven patients (36.8%) were censored.  The median TTP was 134.0 days, median PFS was 129.0 days, and median OS was 205.0 days.  Of five patients with DCE-MRI data for 11 HCC lesions, all demonstrated a reduced Ktrans (mean, 52%).  The most common treatment-emergent AEs were Grade 1-2 and consisted of increased blood creatinine (68.0%), fatigue (56.0%), and nausea (44.0%).  Conclusions: Mipsagargin is relatively well tolerated and promotes prolonged disease stabilization in patients with advanced HCC that had progressed on prior treatment with sorafenib.  A significant decrease in Ktrans upon treatment suggests mipsagargin reduces blood flow in hepatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39z-l_72PlrVg90H21EOLACvtfcHk0li0NOvvm7G5_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtlCku7k%253D&md5=0199cc69daa5fb862752e9f1e0a1157e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3390%2Fcancers11060833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers11060833%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DPeguero%26aufirst%3DJ.%26aulast%3DCen%26aufirst%3DP.%26aulast%3DArora%26aufirst%3DS.%2BP.%26aulast%3DSarantopoulos%26aufirst%3DJ.%26aulast%3DRowe%26aufirst%3DJ.%26aulast%3DAllgood%26aufirst%3DV.%26aulast%3DTubb%26aufirst%3DB.%26aulast%3DCampos%26aufirst%3DL.%26atitle%3DA%2520phase%2520II%252C%2520multicenter%252C%2520single-arm%2520study%2520of%2520mipsagargin%2520%2528G-202%2529%2520as%2520a%2520second-line%2520therapy%2520following%2520sorafenib%2520for%2520adult%2520patients%2520with%2520progressive%2520advanced%2520hepatocellular%2520carcinoma%26jtitle%3DCancers%26date%3D2019%26volume%3D11%26spage%3D833%26doi%3D10.3390%2Fcancers11060833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyong, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragasa, C. Y.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic labdane diterpenoids from <i>Andrographis paniculata</i> (Burm.f.) Nees</span>. <i>Asian J. Pharm. Clin. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.22159/ajpcr.2017.v10i12.19194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.22159%2Fajpcr.2017.v10i12.19194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1egurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=99-104&author=M.+C.+S.+Tanauthor=G.+G.+Oyongauthor=C.-C.+Shenauthor=C.+Y.+Ragasa&title=Cytotoxic+labdane+diterpenoids+from+Andrographis+paniculata+%28Burm.f.%29+Nees&doi=10.22159%2Fajpcr.2017.v10i12.19194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic labdane diterpenoids from Andrographispaniculata (Burm.f.) Nees</span></div><div class="casAuthors">Tan, Maria Carmen S.; Oyong, Glenn G.; Shen, Chien Chang; Ragasa, Consolacion Y.</div><div class="citationInfo"><span class="NLM_cas:title">Asian Journal of Pharmaceutical and Clinical Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">99-104</span>CODEN:
                <span class="NLM_cas:coden">AJPCBB</span>;
        ISSN:<span class="NLM_cas:issn">0974-2441</span>.
    
            (<span class="NLM_cas:orgname">Asian Journal of Pharmaceutical and Clinical Research</span>)
        </div><div class="casAbstract">The primary objective of this study was to probe the cytotoxic capacity of the labdane diterpenoids andrographolide (1), 14-deoxyandrographolide (2), 14-deoxy-12-hydroxyandrographolide (3), and neoandrographolide (4) on mutant and wild-type immortalized cell lines.  Breast adenocarcinoma (MCF-7), colon carcinomas (HCT-116 and HT-29), small cell lung carcinoma (H69PR), human acute monocytic leukemia (THP-1), and wild-type primary normal human dermal fibroblasts - neonatal cells (HDFn) were incubated with 1-4, and the degree of cytotoxicity was analyzed by employing the in vitro PrestoBlue cell viability assay.  Working solns. of 1-4 were prepd. in complete cell culture medium to a final non-toxic DMSO concn. of 0.2%.  The plates were incubated at 37°C with 5% CO2 in a 98% humidified incubator throughout the assay.  Nonlinear regression and statistical analyses were done to extrapolate the half maximal inhibitory concn. 50% (IC50).  One-way ANOVA (p<0.05) and multiple comparison, Tukey's post hoc test (p<0.05), were used to compare different pairs of data sets.  Results were considered statistically significant at p<0.05.  The highest cytotoxicity index was exhibited by the H69PR and 1 trials which displayed the lowest IC50 value of 3.66μg/mL, followed by HT-29 treated with 2, HCT-116 and 1 trials, and H69PR treated with 4 (IC50 = 3.81, 3.82, and 4.19μg/mL, resp.).  Only 1 and 4 were detrimental toward MCF-7, while 1, 3, and 4 were degenerative against H69PR.  Tukey's post hoc multiple comparison indicated no significant difference in the cytotoxicity of 1-4 on HCT-116 cells which afforded IC50 values ranging from 3.82 to 5.12μg/mL.  Evaluation of the two colon carcinoma cell lines showed that HCT-116 was categorically more susceptible to cellular damage caused by treatments with 1-4 than was HT-29.  Cytotoxicity was not detected in THP-1 and HDFn cells (IC50>100μg/mL).  Diterpenoids 1-4 isolated from the dichloromethane ext. of the leaves of A. paniculata exhibited different cytotoxic activities against MCF-7, HCT-116, HT-29, and H69PR.  All constituents had comparable action on HCT-116 cells but were not found to be cytotoxic to normal HDFn cells and mutant THP-1 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8XqkWsuGUorVg90H21EOLACvtfcHk0lh2YWGBHbATBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1egurvO&md5=ce8002bb5eb9c492a24e6129d101d1ff</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.22159%2Fajpcr.2017.v10i12.19194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.22159%252Fajpcr.2017.v10i12.19194%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DM.%2BC.%2BS.%26aulast%3DOyong%26aufirst%3DG.%2BG.%26aulast%3DShen%26aufirst%3DC.-C.%26aulast%3DRagasa%26aufirst%3DC.%2BY.%26atitle%3DCytotoxic%2520labdane%2520diterpenoids%2520from%2520Andrographis%2520paniculata%2520%2528Burm.f.%2529%2520Nees%26jtitle%3DAsian%2520J.%2520Pharm.%2520Clin.%2520Res.%26date%3D2017%26volume%3D10%26spage%3D99%26epage%3D104%26doi%3D10.22159%2Fajpcr.2017.v10i12.19194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chantrapromma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boonnak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitakpornpreecha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordthong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidan Kumar, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fun, H. K.</span></span> <span> </span><span class="NLM_article-title">Absolute configuration of andrographolide and its proliferation of osteoblast cell lines</span>. <i>Crystallogr. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1134/S1063774518030069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1134%2FS1063774518030069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKnt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2018&pages=412-417&author=S.+Chantraprommaauthor=N.+Boonnakauthor=T.+Pitakpornpreechaauthor=T.+Yordthongauthor=C.+S.+Chidan+Kumarauthor=H.+K.+Fun&title=Absolute+configuration+of+andrographolide+and+its+proliferation+of+osteoblast+cell+lines&doi=10.1134%2FS1063774518030069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute Configuration of Andrographolide and Its Proliferation of Osteoblast Cell Lines</span></div><div class="casAuthors">Chantrapromma, S.; Boonnak, N.; Pitakpornpreecha, T.; Yordthong, T.; Chidan Kumar, C. S.; Fun, H. K.</div><div class="citationInfo"><span class="NLM_cas:title">Crystallography Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-417</span>CODEN:
                <span class="NLM_cas:coden">CYSTE3</span>;
        ISSN:<span class="NLM_cas:issn">1063-7745</span>.
    
            (<span class="NLM_cas:orgname">Pleiades Publishing, Ltd.</span>)
        </div><div class="casAbstract">Andrographolide, C20H30O5, is a labdane diterpenoid which was isolated from the leave of Andrographis paniculata.  Its crystal structure is detd. by single crystal X-ray diffraction: monoclinic, sp. gr.P21, Z = 2.  Abs. configuration is detd. by the refinement of the Flack parameter to 0.21(19).  In the crystal, mols. are linked by O-H···O hydrogen bonds and C-H···O interactions into two dimensional network parallel to the (001) plane.  Its proliferation of osteoblast cell lines is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkugwYhgDVO7Vg90H21EOLACvtfcHk0lh2YWGBHbATBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKnt7fE&md5=79f2a488d71288570078ea010b3f7d9f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1134%2FS1063774518030069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS1063774518030069%26sid%3Dliteratum%253Aachs%26aulast%3DChantrapromma%26aufirst%3DS.%26aulast%3DBoonnak%26aufirst%3DN.%26aulast%3DPitakpornpreecha%26aufirst%3DT.%26aulast%3DYordthong%26aufirst%3DT.%26aulast%3DChidan%2BKumar%26aufirst%3DC.%2BS.%26aulast%3DFun%26aufirst%3DH.%2BK.%26atitle%3DAbsolute%2520configuration%2520of%2520andrographolide%2520and%2520its%2520proliferation%2520of%2520osteoblast%2520cell%2520lines%26jtitle%3DCrystallogr.%2520Rep.%26date%3D2018%26volume%3D63%26spage%3D412%26epage%3D417%26doi%3D10.1134%2FS1063774518030069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravi, S. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Găman, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Găman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro
e Sousa, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Moura Dantas, S. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolim, H. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Carvalho Melo-Cavalcante, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mubarak, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarla, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilpi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanasov, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, M. A.</span></span> <span> </span><span class="NLM_article-title">Andrographolide, a diterpene lactone from <i>Andrographis paniculata</i> and its therapeutic promises in cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>420</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.01.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.canlet.2018.01.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29408515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2018&pages=129-145&author=M.+T.+Islamauthor=E.+S.+Aliauthor=S.+J.+Uddinauthor=M.+A.+Islamauthor=S.+Shawauthor=I.+N.+Khanauthor=S.+S.+S.+Saraviauthor=S.+Ahmadauthor=S.+Rehmanauthor=V.+K.+Guptaauthor=M.-A.+G%C4%83manauthor=A.+M.+G%C4%83manauthor=S.+Yeleauthor=A.+K.+Dasauthor=J.+M.+de+Castro%0Ae+Sousaauthor=S.+M.+M.+de+Moura+Dantasauthor=H.+M.+L.+Rolimauthor=A.+A.+de%0ACarvalho+Melo-Cavalcanteauthor=M.+S.+Mubarakauthor=N.+S.+Yarlaauthor=J.+A.+Shilpiauthor=S.+K.+Mishraauthor=A.+G.+Atanasovauthor=M.+A.+Kamal&title=Andrographolide%2C+a+diterpene+lactone+from+Andrographis+paniculata+and+its+therapeutic+promises+in+cancer&doi=10.1016%2Fj.canlet.2018.01.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer</span></div><div class="casAuthors">Islam, Muhammad Torequl; Ali, Eunus S.; Uddin, Shaikh Jamal; Islam, Md. Amirul; Shaw, Subrata; Khan, Ishaq N.; Saravi, Seyed Soheil Saeedi; Ahmad, Saheem; Rehman, Shahnawaz; Gupta, Vijai Kumar; Gaman, Mihnea-Alexandru; Gaman, Amelia Maria; Yele, Santosh; Das, Asish Kumar; Marcelo de Castro e Sousa, Joao; Dantas, Sandra Maria Mendes de Moura; Rolim, Hercilia Maria Lins; Melo-Cavalcante, Ana Amelia de Carvalho; Mubarak, Mohammad S.; Yarla, Nagendra Sastry; Shilpi, Jamil A.; Mishra, Siddhartha Kumar; Atanasov, Atanas G.; Kamal, Mohammad Amjad</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-145</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The diterpene lactone andrographolide, isolated from Andrographis paniculata, has been proven to possess several important protective biol. activities, including antioxidant, anti-inflammatory, immunomodulatory, antiseptic, antimicrobial, cytotoxic, hypolipidemic, cardioprotective, hepatoprotective, and neuroprotective effects.  In addn., it has been reported to play a therapeutic role in the treatment of major human diseases, such as Parkinson's disease, rheumatoid arthritis, and colitis.  This systematic review aims to highlight andrographolide as a promising agent in cancer treatment.  To this purpose, a no. of databases were used to search for the cytotoxic/anticancer effects of andrographolide in pre-clin. and clin. studies.  Among 1703 identified literature articles, 139 were included in this review; 109 were investigated as non-clin., whereas 24, 3, and 3 were pre-clin., clin., and non-pre-clin. trials, resp.  Among the model systems, cultured cell lines appeared as the most frequently (79.14%) used, followed by in vivo models using rodents, among others.  Furthermore, andrographolide was found to exert cytotoxic/anticancer effects on almost all types of cell lines with the underlying mechanisms involving oxidative stress, cell cycle arrest, anti-inflammatory and immune system mediated effects, apoptosis, necrosis, autophagy, inhibition of cell adhesion, proliferation, migration, invasion, anti-angiogenic activity, and other misc. actions.  After careful consideration of the relevant evidence, we suggest that andrographolide can be one of the potential agents in the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdZoMT1XD3nLVg90H21EOLACvtfcHk0lh2YWGBHbATBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyjt7c%253D&md5=ee59fdcc7c95d5eb9610a03360f7c68e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.01.074%26sid%3Dliteratum%253Aachs%26aulast%3DIslam%26aufirst%3DM.%2BT.%26aulast%3DAli%26aufirst%3DE.%2BS.%26aulast%3DUddin%26aufirst%3DS.%2BJ.%26aulast%3DIslam%26aufirst%3DM.%2BA.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DI.%2BN.%26aulast%3DSaravi%26aufirst%3DS.%2BS.%2BS.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DRehman%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DV.%2BK.%26aulast%3DG%25C4%2583man%26aufirst%3DM.-A.%26aulast%3DG%25C4%2583man%26aufirst%3DA.%2BM.%26aulast%3DYele%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DA.%2BK.%26aulast%3Dde%2BCastro%2Be%2BSousa%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BMoura%2BDantas%26aufirst%3DS.%2BM.%2BM.%26aulast%3DRolim%26aufirst%3DH.%2BM.%2BL.%26aulast%3Dde%2BCarvalho%2BMelo-Cavalcante%26aufirst%3DA.%2BA.%26aulast%3DMubarak%26aufirst%3DM.%2BS.%26aulast%3DYarla%26aufirst%3DN.%2BS.%26aulast%3DShilpi%26aufirst%3DJ.%2BA.%26aulast%3DMishra%26aufirst%3DS.%2BK.%26aulast%3DAtanasov%26aufirst%3DA.%2BG.%26aulast%3DKamal%26aufirst%3DM.%2BA.%26atitle%3DAndrographolide%252C%2520a%2520diterpene%2520lactone%2520from%2520Andrographis%2520paniculata%2520and%2520its%2520therapeutic%2520promises%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D420%26spage%3D129%26epage%3D145%26doi%3D10.1016%2Fj.canlet.2018.01.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheriyamundath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madassery, J.</span></span> <span> </span><span class="NLM_article-title">Exploring the mechanisms of cytotoxic and anti-inflammatory property of andrographolide and its derivatives</span>. <i>Pharmacogn. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.4103/phrev.phrev_47_17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.4103%2Fphrev.phrev_47_17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFKnt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=56-65&author=R.+Raghavanauthor=S.+Cheriyamundathauthor=J.+Madassery&title=Exploring+the+mechanisms+of+cytotoxic+and+anti-inflammatory+property+of+andrographolide+and+its+derivatives&doi=10.4103%2Fphrev.phrev_47_17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the mechanisms of cytotoxic and anti-inflammatory property of andrographolide and its derivatives</span></div><div class="casAuthors">Raghavan, Rahul; Cheriyamundath, Sanith; Madassery, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacognosy Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">56-61</span>CODEN:
                <span class="NLM_cas:coden">PRHEEV</span>;
        ISSN:<span class="NLM_cas:issn">0973-7847</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications</span>)
        </div><div class="casAbstract">A review.  This review explores the mechanisms of cytotoxic and anti-inflammatory properties of andrographolide and derivs. of andrographolide in various cell lines.  In vitro and in vivo studies that shed light on the mol. mechanisms of cytotoxicity and anti-inflammatory property of andrographolide and its derivs. are reviewed here.  Cytotoxic effect of andrographolide on cancer cell lines are mainly due to the induction of reactive oxygen species, activation of c-Jun N-terminal kinase, inhibition of autophagy, and induction of apoptosis.  Anti-inflammatory effect of andrographolide is predominantly due to the covalent inhibition of nuclear factor kappa B transcription factor and thereby inhibition of various targets genes such as tumor necrosis factor-alpha, interleukin-6, macrophage inflammatory protein-2, and nitric oxide synthase.  Andrographolide is known to directly bind Ras protein; therefore, inhibition of growth factor-activated downstream pathways such as ERK1/2 pathway might be due to the direct inhibition of Ras functions.  Inhibition of Ras pathway by antagonizing Ras protein might be a key event contributing to both cytotoxicity and anti-inflammatory functions of andrographolide.  Evidence from literature study showed that derivs. of andrographolide such as neoandrographolide and 14-deoxy-11,12-didehydroandrographolides are potent anti-inflammatory agents with less cytotoxicity.  Unfavorable chem. modifications such as sulfation and glucuronidation inside the body and fast removal from plasma are the major factors known to hinder the bioavailability of andrographolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmITlo_1iT7Vg90H21EOLACvtfcHk0ljkxa13UqBULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFKnt73F&md5=7d5e7f21e6dea91f6869eb88bd4e207e</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.4103%2Fphrev.phrev_47_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Fphrev.phrev_47_17%26sid%3Dliteratum%253Aachs%26aulast%3DRaghavan%26aufirst%3DR.%26aulast%3DCheriyamundath%26aufirst%3DS.%26aulast%3DMadassery%26aufirst%3DJ.%26atitle%3DExploring%2520the%2520mechanisms%2520of%2520cytotoxic%2520and%2520anti-inflammatory%2520property%2520of%2520andrographolide%2520and%2520its%2520derivatives%26jtitle%3DPharmacogn.%2520Rev.%26date%3D2018%26volume%3D12%26spage%3D56%26epage%3D65%26doi%3D10.4103%2Fphrev.phrev_47_17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batsaikhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Application of electric cell-substrate impedance sensing to investigate the cytotoxic effects of andrographolide on U87 MG glioblastoma cell migration and apoptosis</span>. <i>Sensors</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2275</span>, <span class="refDoi"> DOI: 10.3390/s19102275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fs19102275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFOntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=2275&author=S.-P.+Chiuauthor=B.+Batsaikhanauthor=H.-M.+Huangauthor=J.-Y.+Wang&title=Application+of+electric+cell-substrate+impedance+sensing+to+investigate+the+cytotoxic+effects+of+andrographolide+on+U87+MG+glioblastoma+cell+migration+and+apoptosis&doi=10.3390%2Fs19102275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Application of electric cell-substrate impedance sensing to investigate the cytotoxic effects of andrographolide on U-87 MG glioblastoma cell migration and apoptosis</span></div><div class="casAuthors">Chiu, Sheng-Po; Batsaikhan, Buyandelger; Huang, Huei-Mei; Wang, Jia-Yi</div><div class="citationInfo"><span class="NLM_cas:title">Sensors</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2275</span>CODEN:
                <span class="NLM_cas:coden">SENSC9</span>;
        ISSN:<span class="NLM_cas:issn">1424-8220</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults.  In recent studies, the efficacy of suberoylanilide hydroxamic acid (SAHA) has been investigated for GBM.  We explored the effects of two exploratory compds., the histone deacetylase SAHA and the natural product andrographolide, on Uppsala 87 Malignant Glioma (U-87 MG) cell migration and viability in comparison with the clin. used therapeutic agent temozolomide (TMZ).  We used the elec. cell-substrate impedance sensing (ECIS) system to monitor the migration of U-87 MG cells after treatment with various concns. of these compds.  Moreover, we used the Alamar blue assay and western blotting to observe the concn.-dependent changes in the viability and apoptosis of U-87 MG cells.  Our results demonstrated that both SAHA and andrographolide (10-300 μM) significantly inhibited GBM cell migration in a concn.-dependent manner, and 10 μM SAHA and 56 μM andrographolide demonstrated remarkable inhibitory effects on U-87 MG migration.  Western blotting indicated that compared with TMZ, both SAHA and andrographolide induced higher expression levels of apoptosis-related proteins, such as caspase-3, BAX, and PARP in U-87 MG cells.  Furthermore, all three drugs downregulated the expression of the antiapoptotic protein Bcl-2.  In conclusion, SAHA and andrographolide showed exceptional results in inhibiting cell migration and motility.  The ECIS wound healing assay is a powerful technique to identify and screen potential therapeutic agents that can inhibit cancer cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQPToNFXGohLVg90H21EOLACvtfcHk0ljkxa13UqBULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOntL0%253D&md5=8e9e64199c73079d0595c4c45add8b8c</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.3390%2Fs19102275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fs19102275%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DS.-P.%26aulast%3DBatsaikhan%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DH.-M.%26aulast%3DWang%26aufirst%3DJ.-Y.%26atitle%3DApplication%2520of%2520electric%2520cell-substrate%2520impedance%2520sensing%2520to%2520investigate%2520the%2520cytotoxic%2520effects%2520of%2520andrographolide%2520on%2520U87%2520MG%2520glioblastoma%2520cell%2520migration%2520and%2520apoptosis%26jtitle%3DSensors%26date%3D2019%26volume%3D19%26spage%3D2275%26doi%3D10.3390%2Fs19102275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhukhan, G. C.</span></span> <span> </span><span class="NLM_article-title">Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells</span>. <i>Environ. Toxicol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.etap.2019.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.etap.2019.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30889542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltVWisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2019&pages=120-132&author=K.+D.+Chowdhuryauthor=A.+Sarkarauthor=S.+Chatterjeeauthor=D.+Patraauthor=D.+Senguptaauthor=S.+Banerjeeauthor=P.+Chakrabortyauthor=G.+C.+Sadhukhan&title=Cathepsin+B+mediated+scramblase+activation+triggers+cytotoxicity+and+cell+cycle+arrest+by+andrographolide+to+overcome+cellular+resistance+in+cisplatin+resistant+human+hepatocellular+carcinoma+HepG2+cells&doi=10.1016%2Fj.etap.2019.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells</span></div><div class="casAuthors">Chowdhury, Kaustav Dutta; Sarkar, Avik; Chatterjee, Sujan; Patra, Debajyoti; Sengupta, Dipanwita; Banerjee, Soumi; Chakraborty, Pratip; Sadhukhan, Gobinda Chandra</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-132</span>CODEN:
                <span class="NLM_cas:coden">ETOPFR</span>;
        ISSN:<span class="NLM_cas:issn">1382-6689</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide regimen in single or in combination with anticancer drugs is a promising new strategy to reverse chemoresistance in heaptocellular carcinoma.  Apoptosis inducing factor (AIF) may regulate a complementary, cooperative or redundant pathway, along with caspase cascades.  Despite these findings, mechanisms underlying caspase-dependent and-independent signaling pathways in andrographolide -induced apoptosis in cisplatin-resistant human hepatocellular carcinoma cell line (HepG2CR) remain unclear.  Andrographolide treatment effectively reduced NF-κB nuclear localization by modulating protein kinase A- protein phosphatase 2 A- Iκβ kinase (PKA/PP2 A/IKK) axis that in turn maintains initiator caspase8 activity.  Lysosomal distribution of tBid stimulates cytosolic cathepsin B resulting accumulation of truncated-AIF with induction in scramblase mediated phosphatidylserine exposure in HepG2CR cells.  Andrographolide treatment thereby switch on subG1 phase arrest by modulating cellular check points (cyclin A, B, cyclin dependent kinase-1) cueing to the apoptosis event.  Collectively, this study suggested antineoplastic potential of andrographolide through PKA/PP2 A/IKK pathway in HepG2CR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolOZFEA90qJbVg90H21EOLACvtfcHk0ljkxa13UqBULg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltVWisrk%253D&md5=61bd3e62c6b709683a253f873eb1fc2f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.etap.2019.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.etap.2019.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DK.%2BD.%26aulast%3DSarkar%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DPatra%26aufirst%3DD.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DChakraborty%26aufirst%3DP.%26aulast%3DSadhukhan%26aufirst%3DG.%2BC.%26atitle%3DCathepsin%2520B%2520mediated%2520scramblase%2520activation%2520triggers%2520cytotoxicity%2520and%2520cell%2520cycle%2520arrest%2520by%2520andrographolide%2520to%2520overcome%2520cellular%2520resistance%2520in%2520cisplatin%2520resistant%2520human%2520hepatocellular%2520carcinoma%2520HepG2%2520cells%26jtitle%3DEnviron.%2520Toxicol.%2520Pharmacol.%26date%3D2019%26volume%3D68%26spage%3D120%26epage%3D132%26doi%3D10.1016%2Fj.etap.2019.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">106206</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2020.106206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.intimp.2020.106206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32018066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFCrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2020&pages=106206&author=W.+Liuauthor=T.+Fanauthor=M.+Liauthor=G.+Zhangauthor=W.+Guoauthor=X.+Yangauthor=C.+Jiangauthor=X.+Liauthor=X.+Xuauthor=A.+Tangauthor=K.+Liuauthor=L.+Liuauthor=L.+Kongauthor=Q.+Xuauthor=Y.+Sun&title=Andrographolide+potentiates+PD-1+blockade+immunotherapy+by+inhibiting+COX2-mediated+PGE2+release&doi=10.1016%2Fj.intimp.2020.106206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release</span></div><div class="casAuthors">Liu, Wen; Fan, Ting; Li, Manru; Zhang, Guohui; Guo, Wenjie; Yang, Xiaoling; Jiang, Chunhong; Li, Xiang; Xu, Xiangyu; Tang, Anshu; Liu, Keqin; Liu, Lixuan; Kong, Lingdong; Xu, Qiang; Sun, Yang</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">106206</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer immunotherapy has now become a first line therapy for several kinds of tumors.  However, the clin. performance of immnuocheckpoint blockade therapy is usually limited by low response rate or side effects including cytokine storm.  Andrographolide, a natural diterpenoid from Andrographis paniculata, has been used in Asia for treatment of bronchitis, paristhmitis and bacillary dysentery for its unique anti-inflammatory effect.  However, its effect on anti-tumor immunity remains elusive.  In this study, we found that andrographolide in combination with anti-PD-1 antibody showed a higher therapeutic benefit than individual therapy in murine xenograft model of CT26 colon cancer.  Consequently, andrographolide and anti-PD-1 antibody co-treatment boosted the function of CD4+ and CD8+ T cells evidenced by considerable tissue infiltration, elevated IFN-gamma secretion and enhanced expression of cytotoxic T-cell related mols. including FasL, perforin and Granzyme B, which significantly decreases the tumor load.  Mechanistically, andrographolide treatment inhibited COX2 activity and PGE2 release both in vivo and in vitro, which augments anti-tumor efficiency of anti-PD-1 therapy.  Finally, we confirmed that COX2 level in human colon cancer sample pos. correlated with tumor-promoting factors.  Our study here provides a potential combination strategy for immunotherapy against colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCRK0tchVyHLVg90H21EOLACvtfcHk0lh3LaIT8E-ncA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFCrtbY%253D&md5=bbdc8187cf8d7ea63573ad6714a2be1e</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2020.106206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2020.106206%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DAndrographolide%2520potentiates%2520PD-1%2520blockade%2520immunotherapy%2520by%2520inhibiting%2520COX2-mediated%2520PGE2%2520release%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2020%26volume%3D81%26spage%3D106206%26doi%3D10.1016%2Fj.intimp.2020.106206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q.</span></span> <span> </span><span class="NLM_article-title">Andrographolide attenuates bupivacaine-induced cytotoxicity in SH-SY5Y cells through preserving Akt/mTOR activity</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1659</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S201122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2147%2FDDDT.S201122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31190744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVyrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=1659-1666&author=H.+Zhangauthor=W.+Wangauthor=Q.+Du&title=Andrographolide+attenuates+bupivacaine-induced+cytotoxicity+in+SH-SY5Y+cells+through+preserving+Akt%2FmTOR+activity&doi=10.2147%2FDDDT.S201122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide attenuates bupivacaine-induced cytotoxicity in SH-SY5Y cells through preserving Akt/mTOR activity</span></div><div class="casAuthors">Zhang, Huiyuan; Wang, Weiwei; Du, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1659-1666</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Bupivacaine (Bup) is the most commonly used local anesthetic.  However, Bup induces cytotoxicity, esp. in older patients.  Recent reports have indicated that andrographolide (Andro) exhibits protective effects on human neurons.  Nevertheless, whether Andro can inhibit Bup-induced cytotoxicity remains unclear.  As such, we investigated the effect of Andro on Bup-induced cytotoxicity of SH-SY5Y cells in the present study.  Methods: Western blotting was used to examine expression of Bax, Bcl2, active caspase 3, p-Akt, and p-mTOR in SH-SY5Y cells.  In addn., ELISA was used to detect levels of total glutathione and reactive oxygen species in cells.  Results: We found that Andro attenuated Bup-induced cytotoxicity of SH-SY5Y cells.  In addn., Andro inhibited Bup-induced apoptosis via downregulating the expression of Bax and active caspase 3 and upregulating the proteins Bcl2, p-Akt, and p-mTOR in SH-SY5Y cells.  Moreover, Andro alleviated Bup-induced oxidative damage in SH-SY5Y cells via downregulating the level of reactive oxygen species and upregulating of the level of total glutathione.  More significantly, inhibition of Akt abolished the protective effect of Andro in Bup-treated SH-SY5Y cells.  Conclusion: Our findings indicated that Andro played a neuroprotective role via preserving Akt/mTOR activity and increasing antioxidative status in Bup-treated SH-SY5Y cells.  Therefore, Andro may be a potential agent for the treatment of human cytotoxicity induced by Bup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB6oiypAHl97Vg90H21EOLACvtfcHk0lh3LaIT8E-ncA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVyrs7w%253D&md5=89f574314ee958d1d630e60f8ca8c930</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S201122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S201122%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DQ.%26atitle%3DAndrographolide%2520attenuates%2520bupivacaine-induced%2520cytotoxicity%2520in%2520SH-SY5Y%2520cells%2520through%2520preserving%2520Akt%252FmTOR%2520activity%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2019%26volume%3D13%26spage%3D1659%26epage%3D1666%26doi%3D10.2147%2FDDDT.S201122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laksmiani, N. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynaldi, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widiastari, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugraha, I. P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suyadnya, I. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharani, R. A. I. K.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic activity of andrographolide in colon cancer through inhibition COX-2 by in silico study</span>. <i>J. Phys.: Conf. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1040</i></span>,  <span class="NLM_fpage">012009</span>, <span class="refDoi"> DOI: 10.1088/1742-6596/1040/1/012009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1088%2F1742-6596%2F1040%2F1%2F012009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1GrurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1040&publication_year=2018&pages=012009&author=N.+P.+L.+Laksmianiauthor=K.+R.+Reynaldiauthor=M.+I.+Widiastariauthor=I.+P.+W.+Nugrahaauthor=I.+M.+K.+Suyadnyaauthor=R.+A.+I.+K.+Maharani&title=Cytotoxic+activity+of+andrographolide+in+colon+cancer+through+inhibition+COX-2+by+in+silico+study&doi=10.1088%2F1742-6596%2F1040%2F1%2F012009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic activity of andrographolide in colon cancer through inhibition cox-2 by in silico study</span></div><div class="casAuthors">Laksmiani, N. P. L.; Reynaldi, K. R.; Widiastari, M. I.; Nugraha, I. P. W.; Suyadnya, I. M. K.; Maharani, R. A. I. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physics: Conference Series</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1040</span>
        (<span class="NLM_cas:issue">International Conference on Mathematics and Natural Sciences (IConMNS 2017)</span>),
    <span class="NLM_cas:pages">012009/1-012009/6</span>CODEN:
                <span class="NLM_cas:coden">JPCSDZ</span>;
        ISSN:<span class="NLM_cas:issn">1742-6588</span>.
    
            (<span class="NLM_cas:orgname">IOP Publishing Ltd.</span>)
        </div><div class="casAbstract">Colon cancer is a cancer with characteristics of cyclooxygenase (COX-2) protein overexpression.  Increased COX-2 expression may inhibit regulation of apoptotic mechanism.  Andrographolide was known has activity as an anticancer.  The aimed of this study was detd. the mechanism and affinity of andrographolide with COX-2 protein as anti-colon cancer using mol. docking.  In silico assay used mol. docking method with Chimera 1.10.1 (use for protein prepn. COX-2), Hyperchem 8 (use for optimization 3D structure of andrographolide), and Autodock 4.2 programs (use for mol. docking).The results in mol. docking was a binding energy value of and hydrogen bonds.  Data were compared with native ligand, celecoxib, and meloxicam.  The binding energy values between COX-2 protein with andrographolide, native ligand, celecoxib, and meloxicam were resp. - 8.66; -9.94; -10.12; and -7.68 kcal/mol.  This indicate that andrographolide had a stronger affinity and more stable than meloxicam for COX-2 protein with hydrogen bonds on Arg120 amino acid.  Based on the results obtained, andrographolide had an anti-colon cancer activity caused it can bind to the protein COX-2.  The mechanism of andrographolide as anti-colon cancer by inhibited the overexpression of COX-2 in order to increase apoptotic regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMY069hErUoLVg90H21EOLACvtfcHk0lh3LaIT8E-ncA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1GrurjO&md5=7048a46de349707b64cb0223d7ea11a9</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1088%2F1742-6596%2F1040%2F1%2F012009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F1742-6596%252F1040%252F1%252F012009%26sid%3Dliteratum%253Aachs%26aulast%3DLaksmiani%26aufirst%3DN.%2BP.%2BL.%26aulast%3DReynaldi%26aufirst%3DK.%2BR.%26aulast%3DWidiastari%26aufirst%3DM.%2BI.%26aulast%3DNugraha%26aufirst%3DI.%2BP.%2BW.%26aulast%3DSuyadnya%26aufirst%3DI.%2BM.%2BK.%26aulast%3DMaharani%26aufirst%3DR.%2BA.%2BI.%2BK.%26atitle%3DCytotoxic%2520activity%2520of%2520andrographolide%2520in%2520colon%2520cancer%2520through%2520inhibition%2520COX-2%2520by%2520in%2520silico%2520study%26jtitle%3DJ.%2520Phys.%253A%2520Conf.%2520Ser.%26date%3D2018%26volume%3D1040%26spage%3D012009%26doi%3D10.1088%2F1742-6596%2F1040%2F1%2F012009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, D.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.-H.</span></span> <span> </span><span class="NLM_article-title">Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4305</span>– <span class="NLM_lpage">4310</span>, <span class="refDoi"> DOI: 10.3892/ol.2017.6669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2017.6669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28943944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FhvFSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=4305-4310&author=R.+Zhangauthor=J.+Zhaoauthor=J.+Xuauthor=D.-X.+Jiaoauthor=J.+Wangauthor=Z.-Q.+Gongauthor=J.-H.+Jia&title=Andrographolide+suppresses+proliferation+of+human+colon+cancer+SW620+cells+through+the+TLR4%2FNF-%CE%BAB%2FMMP-9+signaling+pathway&doi=10.3892%2Fol.2017.6669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway</span></div><div class="casAuthors">Zhang Rui; Zhao Jian; Xu Jian; Jiao De-Xin; Wang Jian; Gong Zhi-Qiang; Jia Jian-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4305-4310</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Modern pharmacological research has revealed that andrographolide has various functions, including anti-bacterial, anti-inflammatory and anti-viral effects, immunoregulation, treating cardiovascular and cerebrovascular diseases, and prevention and treatment of alcoholic liver injury.  The present study investigated whether andrographolide suppresses the proliferation of human colon cancer cell through the Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB/matrix metalloproteinase-9 (MMP-9) signaling pathway.  The MTT assay and lactate dehydrogenase assay were used to evaluate the anticancer effects of andrographolide on cell proliferation and cytotoxicity in human colon cancer SW620 cells.  Flow cytometry was used to analyze the anticancer effects of andrographolide on apoptosis by Annexin V-fluorescein isothiocyanate/propidium iodide kit.  The effects of andrographolide on the activity of caspase-3/9 were measured using ELISA.  Western blot analysis was also used to analyze the protein expression of TLR4, myeloid differentiation primary response gene 88 (MyD88), NF-κB-p65 and MMP-9.  In the present study, it was found that andrographolide suppressed the cell proliferation, augmented cytotoxicity, evoked cell apoptosis and activated caspase-3/9 activities in human colon cancer SW620 cells.  The results revealed that the anti-proliferation effects of andrographolide on the SW620 cells was associated with the inhibition of TLR4, MyD88, NF-κB-p65 and MMP-9 signaling activation.  The results suggest that andrographolide is a promising drug for treatment of human colon cancer via suppression of the TLR4/NF-κB/MMP-9 signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR02yiRS-GsP-2mnZh2OgS0fW6udTcc2ebQNLSwp7mVgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FhvFSkug%253D%253D&md5=b221e65f55391e9e3cbae594553c7531</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.6669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.6669%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJiao%26aufirst%3DD.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DZ.-Q.%26aulast%3DJia%26aufirst%3DJ.-H.%26atitle%3DAndrographolide%2520suppresses%2520proliferation%2520of%2520human%2520colon%2520cancer%2520SW620%2520cells%2520through%2520the%2520TLR4%252FNF-%25CE%25BAB%252FMMP-9%2520signaling%2520pathway%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D14%26spage%3D4305%26epage%3D4310%26doi%3D10.3892%2Fol.2017.6669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farooqui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, I. A.</span></span> <span> </span><span class="NLM_article-title">Andrographolide exhibits anticancer potential against human colon cancer cells by inducing cell cycle arrest and programmed cell death via augmentation of intracellular reactive oxygen species level</span>. <i>Nutr. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1080/01635581.2018.1470649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F01635581.2018.1470649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29781715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVSmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=787-803&author=I.+Khanauthor=F.+Khanauthor=A.+Farooquiauthor=I.+A.+Ansari&title=Andrographolide+exhibits+anticancer+potential+against+human+colon+cancer+cells+by+inducing+cell+cycle+arrest+and+programmed+cell+death+via+augmentation+of+intracellular+reactive+oxygen+species+level&doi=10.1080%2F01635581.2018.1470649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide Exhibits Anticancer Potential Against Human Colon Cancer Cells by Inducing Cell Cycle Arrest and Programmed Cell Death via Augmentation of Intracellular Reactive Oxygen Species Level</span></div><div class="casAuthors">Khan, Imran; Khan, Fahad; Farooqui, Arshi; Ansari, Irfan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition and Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">787-803</span>CODEN:
                <span class="NLM_cas:coden">NUCADQ</span>;
        ISSN:<span class="NLM_cas:issn">0163-5581</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Andrographolide, a diterpenoid lactone and a major constituent of Andrographis paniculata Nees, exhibits remarkable anticancer activity.  However, the effect of andrographolide on colon cancer has not been completely elucidated yet.  Thus, we investigated the chemopreventive potential of andrographolide in colon cancer HT-29 cells.  The cytotoxic potential of andrographolide on HT-29 cells was detd. by MTT assay, trypan blue exclusion assay, colony formation assay, and morphol. anal.; and apoptotic property by DAPI and Hoechst staining, FITC-Annexin V assay, DNA fragmentation assay and caspase-3 activity assay.  To elucidate andrographolide action, intracellular reactive oxygen species (ROS) level was detd. by DCFDA dye; change in mitochondrial potential by Rhodamine123 and Mito Tracker Red CMXRos dye; and cell cycle modulatory property by flow cytometric anal.  Results of the study have shown that andrographolide decreased cell viability of HT-29 cells in a dose- and time-dependent manner.  Furthermore, andrographolide induced apoptosis in HT-29 cells which seemed to be linked with augmented intracellular ROS level and disruption of mitochondrial membrane potential.  Interestingly, andrographolide caused significant cell cycle arrest in G2/M phase at lower doses, but, in G0/G1 phase at higher doses.  In summary, our results indicated that andrographolide exhibited antiproliferative and apoptotic properties against colon cancer HT-29 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouVBjv135YGLVg90H21EOLACvtfcHk0lisYiFbDNBLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVSmsLY%253D&md5=9b5649b33b9938315e97cccff237e064</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1080%2F01635581.2018.1470649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01635581.2018.1470649%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DI.%26aulast%3DKhan%26aufirst%3DF.%26aulast%3DFarooqui%26aufirst%3DA.%26aulast%3DAnsari%26aufirst%3DI.%2BA.%26atitle%3DAndrographolide%2520exhibits%2520anticancer%2520potential%2520against%2520human%2520colon%2520cancer%2520cells%2520by%2520inducing%2520cell%2520cycle%2520arrest%2520and%2520programmed%2520cell%2520death%2520via%2520augmentation%2520of%2520intracellular%2520reactive%2520oxygen%2520species%2520level%26jtitle%3DNutr.%2520Cancer%26date%3D2018%26volume%3D70%26spage%3D787%26epage%3D803%26doi%3D10.1080%2F01635581.2018.1470649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, E.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor activities of andrographolide, a diterpene from <i>Andrographis paniculata</i>, by inducing apoptosis and inhibiting VEGF level</span>. <i>J. Asian Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1080/10286020801948334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F10286020801948334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=18464090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BD1czgtFelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=467-473&author=F.+Zhaoauthor=E.-Q.+Heauthor=L.+Wangauthor=K.+Liu&title=Anti-tumor+activities+of+andrographolide%2C+a+diterpene+from+Andrographis+paniculata%2C+by+inducing+apoptosis+and+inhibiting+VEGF+level&doi=10.1080%2F10286020801948334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level</span></div><div class="casAuthors">Zhao Feng; He En-Qi; Wang Lu; Liu Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asian natural products research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">467-73</span>
        ISSN:<span class="NLM_cas:issn">1028-6020</span>.
    </div><div class="casAbstract">Andrographolide (1), a diterpenoid lactone isolated from a traditional herb (Andrographis paniculata), is known to possess potent anti-inflammatory activity.  In this study, we investigated the anti-tumor effect of 1 on various cancer cell lines in vitro.  It induced apoptosis of prostate cancer (PC-3) cells (the most sensitive cell line among the cell lines screened) via the activation of caspase 3, up-regulation of bax, and down-regulation of bcl-2.  Furthermore, its inhibitory activity on the level of vascular endothelial growth factor was also verified by ELISA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCx7OqSDDPrK__Jf7-eMvJfW6udTcc2ebQNLSwp7mVgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czgtFelsA%253D%253D&md5=4ff43270d0c74e851d01abc8726fe76d</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1080%2F10286020801948334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10286020801948334%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DE.-Q.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DK.%26atitle%3DAnti-tumor%2520activities%2520of%2520andrographolide%252C%2520a%2520diterpene%2520from%2520Andrographis%2520paniculata%252C%2520by%2520inducing%2520apoptosis%2520and%2520inhibiting%2520VEGF%2520level%26jtitle%3DJ.%2520Asian%2520Nat.%2520Prod.%2520Res.%26date%3D2008%26volume%3D10%26spage%3D467%26epage%3D473%26doi%3D10.1080%2F10286020801948334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Liposomal codelivery of doxorubicin and andrographolide inhibits breast cancer growth and metastasis</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1618</span>– <span class="NLM_lpage">1626</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.7b01164</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.7b01164" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Gisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=1618-1626&author=X.+Kangauthor=Z.+Zhengauthor=Z.+Liuauthor=H.+Wangauthor=Y.+Zhaoauthor=W.+Zhangauthor=M.+Shiauthor=Y.+Heauthor=Y.+Caoauthor=Q.+Xuauthor=C.+Pengauthor=Y.+Huang&title=Liposomal+codelivery+of+doxorubicin+and+andrographolide+inhibits+breast+cancer+growth+and+metastasis&doi=10.1021%2Facs.molpharmaceut.7b01164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Liposomal codelivery of doxorubicin and andrographolide inhibits breast cancer growth and metastasis</span></div><div class="casAuthors">Kang, Xuejia; Zheng, Zening; Liu, Zehua; Wang, Huiyuan; Zhao, Yuge; Zhang, Wenyuan; Shi, Mingjie; He, Yang; Cao, Yang; Xu, Qin; Peng, Chengyuan; Huang, Yongzhuo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1618-1626</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Effective treatment of metastatic (stage IV) breast cancers remains a formidable challenge.  To address this issue, a cell-penetrating peptide-assisted liposomal system was developed for codelivery of doxorubicin and andrographolide.  This nanomedicine-based combination therapy showed the ability to inhibit the in vitro migration and invasion of 4T1 cells through the wound healing and transwell invasion assays.  Furthermore, this delivery system exhibited the enhanced accumulation in the tumor tissues and deep intratumoral penetration.  The synergistic effect of doxorubicin and andrographolide led to an evident inhibition of tumor growth in an orthotopic breast tumor mouse model and efficient prevention of lung metastasis.  The therapeutic mechanism was assocd. with the anti-angiogenesis effect.  In conclusion, this nanomedicine-based combination therapy provides a potential method for overcoming metastatic breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorz_Ha-XfrzrVg90H21EOLACvtfcHk0ljek8PBLFc3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Gisr4%253D&md5=d02eb075785a357a29a7ac2719117eb1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.7b01164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.7b01164%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DLiposomal%2520codelivery%2520of%2520doxorubicin%2520and%2520andrographolide%2520inhibits%2520breast%2520cancer%2520growth%2520and%2520metastasis%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2018%26volume%3D15%26spage%3D1618%26epage%3D1626%26doi%3D10.1021%2Facs.molpharmaceut.7b01164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graverini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazzini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nardiello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casamenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini-Giampietro, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilia, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergonzi, M. C.</span></span> <span> </span><span class="NLM_article-title">Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: In vitro and in vivo evaluation</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/j.colsurfb.2017.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.colsurfb.2017.10.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29096375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleksrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2018&pages=302-313&author=G.+Graveriniauthor=V.+Piazziniauthor=E.+Landucciauthor=D.+Pantanoauthor=P.+Nardielloauthor=F.+Casamentiauthor=D.+E.+Pellegrini-Giampietroauthor=A.+R.+Biliaauthor=M.+C.+Bergonzi&title=Solid+lipid+nanoparticles+for+delivery+of+andrographolide+across+the+blood-brain+barrier%3A+In+vitro+and+in+vivo+evaluation&doi=10.1016%2Fj.colsurfb.2017.10.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation</span></div><div class="casAuthors">Graverini, Giulia; Piazzini, Vieri; Landucci, Elisa; Pantano, Daniela; Nardiello, Pamela; Casamenti, Fiorella; Pellegrini-Giampietro, Domenico E.; Bilia, Anna Rita; Bergonzi, Maria Camilla</div><div class="citationInfo"><span class="NLM_cas:title">Colloids and Surfaces, B: Biointerfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">302-313</span>CODEN:
                <span class="NLM_cas:coden">CSBBEQ</span>;
        ISSN:<span class="NLM_cas:issn">0927-7765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide is a major diterpenoid of Andrographis paniculata and possesses several biol. activities, including protection against oxidative stress mediated neurotoxicity, inflammation-mediated neurodegeneration, and cerebral ischemia.  However, this mol. shows low bioavailability, poor water soly., and high chem. and metabolic instability.  The present study reports prepn. of solid lipid nanoparticles (SLN) to deliver andrographolide (AG) into the brain.  SLN were prepd. using Compritol 888 ATO as solid lipid and Brij 78 as surfactant and applying emulsion/evapn./solidifying method as preparative procedure.  Nanoparticles have a spherical shape, small dimensions, and narrow size distribution.  Encapsulation efficiency of AG-loaded SLN was found to be 92%.  Nanoparticles showed excellent phys. and chem. stability during storage at 4 °C for one month.  The lyophilized product was also stable at 25 °C during the same period.  SLN remained unchanged also in the presence of human serum albumin and plasma.  In vitro release at pH 7.4 was also studied.  The release of AG was prolonged and sustained when the compd. was entrapped in SLN.  The ability of SLN to cross the blood-brain barrier (BBB) was evaluated first in vitro by applying a permeation test with artificial membrane (parallel artificial membrane permeability assay, PAMPA) to predict passive and transcellular permeability through the BBB, and then by using hCMEC/D3 cells, a well-established in vitro BBB model.  In vitro results proved that nanoparticles improved permeability of AG compared to free AG.  Fluorescent nanoparticles were then prepd. for in vivo tests in healthy rats.  After i.v. administration, fluorescent SLN were detected in brain parenchyma outside the vascular bed, confirming their ability to overcome the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_pi9tWQpaRbVg90H21EOLACvtfcHk0ljek8PBLFc3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleksrbO&md5=6bb1fbb9e409b21b63bacba0bf0c4651</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2017.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2017.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DGraverini%26aufirst%3DG.%26aulast%3DPiazzini%26aufirst%3DV.%26aulast%3DLanducci%26aufirst%3DE.%26aulast%3DPantano%26aufirst%3DD.%26aulast%3DNardiello%26aufirst%3DP.%26aulast%3DCasamenti%26aufirst%3DF.%26aulast%3DPellegrini-Giampietro%26aufirst%3DD.%2BE.%26aulast%3DBilia%26aufirst%3DA.%2BR.%26aulast%3DBergonzi%26aufirst%3DM.%2BC.%26atitle%3DSolid%2520lipid%2520nanoparticles%2520for%2520delivery%2520of%2520andrographolide%2520across%2520the%2520blood-brain%2520barrier%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2018%26volume%3D161%26spage%3D302%26epage%3D313%26doi%3D10.1016%2Fj.colsurfb.2017.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span> <span> </span><span class="NLM_article-title">Andrographolide-loaded silk fibroin nanoparticles</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">34726</span>– <span class="NLM_lpage">34732</span>, <span class="refDoi"> DOI: 10.1039/C8RA04156C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC8RA04156C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=34726-34732&author=Z.+Xuauthor=J.+Renauthor=Q.+Jingauthor=F.+Renauthor=M.+Huangauthor=W.+Dingauthor=B.+Zeng&title=Andrographolide-loaded+silk+fibroin+nanoparticles&doi=10.1039%2FC8RA04156C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC8RA04156C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8RA04156C%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DZeng%26aufirst%3DB.%26atitle%3DAndrographolide-loaded%2520silk%2520fibroin%2520nanoparticles%26jtitle%3DRSC%2520Adv.%26date%3D2018%26volume%3D8%26spage%3D34726%26epage%3D34732%26doi%3D10.1039%2FC8RA04156C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nallamolu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayanti, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitneni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoon, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesharwani, P.</span></span> <span> </span><span class="NLM_article-title">Self-micro emulsifying drug delivery system “SMEDDS” for efficient oral delivery of andrographolide</span>. <i>Drug Delivery Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.2174/2210303109666190723145209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F2210303109666190723145209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs12ru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=38-53&author=S.+Nallamoluauthor=V.+R.+Jayantiauthor=M.+Chitneniauthor=L.+Y.+Khoonauthor=P.+Kesharwani&title=Self-micro+emulsifying+drug+delivery+system+%E2%80%9CSMEDDS%E2%80%9D+for+efficient+oral+delivery+of+andrographolide&doi=10.2174%2F2210303109666190723145209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Self-micro Emulsifying Drug Delivery System "SMEDDS" for Efficient Oral Delivery of Andrographolide</span></div><div class="casAuthors">Nallamolu, Sivaram; Jayanti, Vijaya R.; Chitneni, Mallikarjun; Khoon, Liew Y.; Kesharwani, Prashant</div><div class="citationInfo"><span class="NLM_cas:title">Drug Delivery Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-53</span>CODEN:
                <span class="NLM_cas:coden">DDLRAQ</span>;
        ISSN:<span class="NLM_cas:issn">2210-3031</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Objective: Andrographolide has potent anticancer and antimicrobial activity; however, its clin. application has been limited due to its poor water soly. as well as lack of appropriate formulation.  The objective of this investigation was to formulate Self-Micro Emulsifying Drug Delivery System (SMEDDS) of andrographolide and explore its oral drug delivery aptitudes.  Methods: Andrographolide SMEDDS was optimized by ternary phase approach and studied for various in vitro characteristics: Particle size, electron microscopy, polydispersity index, surface charge, diln. effect, pH stability, freeze-thaw effect, dissoln. profile and stability studies.  Further, antimicrobial and cytotoxic performance of andrographolide SMEDDS were evaluated in MCF-7 breast cancer cell lines and methicillin-resistant microorganisms, resp.  Results: An optimized SMEDDS formulation of andrographolide was successfully prepd. and evaluated for its drug delivery potential.  The soly. of andrographolide in the developed SMEDDS formulation was increased significantly, and the drug loading was enough for making this drug clin. applicable.  The andrographolide SMEDDS formulation competitively inhibited the growth of microorganisms and showed enhanced anti-microbial activity against MRSA microorganisms.  Conclusions: The SMEDDS strategy represents one of the best approaches to deliver andrographolide via oral route, while resolving its soly. limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnba7c5nnp-bVg90H21EOLACvtfcHk0ljek8PBLFc3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs12ru74%253D&md5=1abb6639d775cc60e2010a53f0f424cc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F2210303109666190723145209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2210303109666190723145209%26sid%3Dliteratum%253Aachs%26aulast%3DNallamolu%26aufirst%3DS.%26aulast%3DJayanti%26aufirst%3DV.%2BR.%26aulast%3DChitneni%26aufirst%3DM.%26aulast%3DKhoon%26aufirst%3DL.%2BY.%26aulast%3DKesharwani%26aufirst%3DP.%26atitle%3DSelf-micro%2520emulsifying%2520drug%2520delivery%2520system%2520%25E2%2580%259CSMEDDS%25E2%2580%259D%2520for%2520efficient%2520oral%2520delivery%2520of%2520andrographolide%26jtitle%3DDrug%2520Delivery%2520Lett.%26date%3D2020%26volume%3D10%26spage%3D38%26epage%3D53%26doi%3D10.2174%2F2210303109666190723145209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandanur, S. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golakoti, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anticancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5781</span>– <span class="NLM_lpage">5786</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2015.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26561364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5781-5786&author=S.+G.+S.+Kandanurauthor=N.+R.+Golakotiauthor=S.+Nanduri&title=Synthesis+and+in+vitro+cytotoxicity+of+novel+C-12+substituted-14-deoxy-andrographolide+derivatives+as+potent+anticancer+agents&doi=10.1016%2Fj.bmcl.2015.10.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anti-cancer agents</span></div><div class="casAuthors">Kandanur, Sai Giridhar Sarma; Golakoti, Nageswara Rao; Nanduri, Srinivas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5781-5786</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide, the major labdane diterpenoid from Andrographis paniculata has been reported to be cytotoxic against various cancer cells in vitro.  Our research efforts led to the discovery of novel 12-phenylthio and 12-aryl amino-14-deoxyandrographolide derivs. with potent cytotoxic activity, 12-benzylamino-14-deoxyandrographolide analogs showing broad range of cytotoxic activity against most of the cell lines and 12-alkylamino-14-deoxyandrographolide derivs. being selective to few cell lines (PC-3 and HOP-92), when the selected analogs were evaluated against 60 human cancer cell line panel at National Cancer Institute (N.C.I.), USA.  The SAR (structure activity relationship) studies demonstrated potent activity for the compds. contg. the following functionalities at C-12: substituted aryl amino/phenylthio > benzylamine > alkyl amine.  The significant cytotoxic activity obsd. for the phenylthio and acetylsulfamoylphenylamino compds. suggest that these could serve as templates for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLTZAEDh1R-7Vg90H21EOLACvtfcHk0ljGc91HJtLjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsLrO&md5=15732c729efd55cbf3d1249be0156e93</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DKandanur%26aufirst%3DS.%2BG.%2BS.%26aulast%3DGolakoti%26aufirst%3DN.%2BR.%26aulast%3DNanduri%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520cytotoxicity%2520of%2520novel%2520C-12%2520substituted-14-deoxy-andrographolide%2520derivatives%2520as%2520potent%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5781%26epage%3D5786%26doi%3D10.1016%2Fj.bmcl.2015.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandanur, S. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golakoti, N. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new C-12(α/β)-(<i>N</i>-) sulfamoyl-phenylamino-14-deoxy-andrographolide derivatives as potent anticancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2854</span>– <span class="NLM_lpage">2862</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2017.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28527822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFyjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2854-2862&author=S.+G.+S.+Kandanurauthor=S.+Nanduriauthor=N.+R.+Golakoti&title=Synthesis+and+biological+evaluation+of+new+C-12%28%CE%B1%2F%CE%B2%29-%28N-%29+sulfamoyl-phenylamino-14-deoxy-andrographolide+derivatives+as+potent+anticancer+agents&doi=10.1016%2Fj.bmcl.2017.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new C-12(α/β)-(N-) sulfamoyl-phenylamino-14-deoxy-andrographolide derivatives as potent anti-cancer agents</span></div><div class="casAuthors">Kandanur, Sai Giridhar Sarma; Nanduri, Srinivas; Golakoti, Nageswara Rao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2854-2862</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide, the major diterpenoidal constituent of Andrographis paniculata (Acanthaceae) and its derivs. have been reported to possess plethora of biol. properties including potent anti-cancer activity.  In this work, synthesis and in-vitro anti-cancer evaluation of new C-12-substituted aryl amino 14-deoxy-andrographolide derivs. are reported.  The substitutions include various sulfonamide moieties -SO2-NH-R1.  The new derivs. exhibited improved cytotoxicity (GI50, TGI and LC50) compared to andrographolide (I) and the corresponding 3,14,19-O-triacetyl andrographolide when evaluated against 60 NCI cell line panel.  Compds. II and III are found to be non-toxic to normal human dermal fibroblasts (NHDF) cells compared to ref. drug THZ-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosAQ7YKkT-pLVg90H21EOLACvtfcHk0ljGc91HJtLjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFyjtLk%253D&md5=46b5cb322c22c1a0c5128c9f4e511ecb</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DKandanur%26aufirst%3DS.%2BG.%2BS.%26aulast%3DNanduri%26aufirst%3DS.%26aulast%3DGolakoti%26aufirst%3DN.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520C-12%2528%25CE%25B1%252F%25CE%25B2%2529-%2528N-%2529%2520sulfamoyl-phenylamino-14-deoxy-andrographolide%2520derivatives%2520as%2520potent%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2854%26epage%3D2862%26doi%3D10.1016%2Fj.bmcl.2017.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Könst, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarski, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cencic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusupova, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusupov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderwal, C. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1140</span>– <span class="NLM_lpage">1149</span>, <span class="refDoi"> DOI: 10.1038/nchem.2800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fnchem.2800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29064494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1140-1149&author=Z.+A.+K%C3%B6nstauthor=A.+R.+Szklarskiauthor=S.+Pellegrinoauthor=S.+E.+Michalakauthor=M.+Meyerauthor=C.+Zanetteauthor=R.+Cencicauthor=S.+Namauthor=V.+K.+Vooraauthor=D.+A.+Horneauthor=J.+Pelletierauthor=D.+L.+Mobleyauthor=G.+Yusupovaauthor=M.+Yusupovauthor=C.+D.+Vanderwal&title=Synthesis+facilitates+an+understanding+of+the+structural+basis+for+translation+inhibition+by+the+lissoclimides&doi=10.1038%2Fnchem.2800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides</span></div><div class="casAuthors">Konst, Zef A.; Szklarski, Anne R.; Pellegrino, Simone; Michalak, Sharon E.; Meyer, Melanie; Zanette, Camila; Cencic, Regina; Nam, Sangkil; Voora, Vamsee K.; Horne, David A.; Pelletier, Jerry; Mobley, David L.; Yusupova, Gulnara; Yusupov, Marat; Vanderwal, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1149</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The lissoclimides are unusual succinimide-contg. labdane diterpenoids that were reported to be potent cytotoxins.  Our short semisynthesis and analog-oriented synthesis approaches provide a series of lissoclimide natural products and analogs that expand the structure-activity relationships (SARs) in this family.  The semisynthesis approach yielded significant quantities of chlorolissoclimide (CL) to permit an evaluation against the National Cancer Institute's 60-cell line panel and allowed us to obtain an X-ray co-crystal structure of the synthetic secondary metabolite with the eukaryotic 80S ribosome.  Although it shares a binding site with other imide-based natural product translation inhibitors, CL engages in a particularly interesting and novel face-on halogen-π interaction between the ligand's alkyl chloride and a guanine residue.  Our analog-oriented synthesis provides many more lissoclimide compds., which were tested against aggressive human cancer cell lines and for protein synthesis inhibitory activity.  Finally, computational modeling was used to explain the SARs of certain key compds. and set the stage for the structure-guided design of better translation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIoB2VqvwCs7Vg90H21EOLACvtfcHk0ljGc91HJtLjmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsLvI&md5=ed22ec4ac3b662938800cd7e01670c89</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2800%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6nst%26aufirst%3DZ.%2BA.%26aulast%3DSzklarski%26aufirst%3DA.%2BR.%26aulast%3DPellegrino%26aufirst%3DS.%26aulast%3DMichalak%26aufirst%3DS.%2BE.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DZanette%26aufirst%3DC.%26aulast%3DCencic%26aufirst%3DR.%26aulast%3DNam%26aufirst%3DS.%26aulast%3DVoora%26aufirst%3DV.%2BK.%26aulast%3DHorne%26aufirst%3DD.%2BA.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DYusupova%26aufirst%3DG.%26aulast%3DYusupov%26aufirst%3DM.%26aulast%3DVanderwal%26aufirst%3DC.%2BD.%26atitle%3DSynthesis%2520facilitates%2520an%2520understanding%2520of%2520the%2520structural%2520basis%2520for%2520translation%2520inhibition%2520by%2520the%2520lissoclimides%26jtitle%3DNat.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1140%26epage%3D1149%26doi%3D10.1038%2Fnchem.2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.-L.</span></span> <span> </span><span class="NLM_article-title">Development of a bifunctional andrographolide-based chemical probe for pharmacological study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152770</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0152770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1371%2Fjournal.pone.0152770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27035713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFeht7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=Y.-H.+Hsuauthor=Y.-L.+Hsuauthor=S.-H.+Liuauthor=H.-C.+Liaoauthor=P.-X.+Leeauthor=C.-H.+Linauthor=L.-C.+Loauthor=S.-L.+Fu&title=Development+of+a+bifunctional+andrographolide-based+chemical+probe+for+pharmacological+study&doi=10.1371%2Fjournal.pone.0152770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a bifunctional andrographolide-based chemical probe for pharmacological study</span></div><div class="casAuthors">Hsu, Ya-Hsin; Hsu, Yu-Ling; Liu, Sheng-Hung; Liao, Hsin-Chia; Lee, Po-Xuan; Lin, Chao-Hsiung; Lo, Lee-Chiang; Fu, Shu-Ling</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152770/1-e0152770/13</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Andrographolide (ANDRO) is a lactone diterpenoid compd. present in the medicinal plant Andrographis paniculata which is clin. applied for multiple human diseases in Asia and Europe.  The pharmacol. activities of andrographolide have been widely demonstrated, including anti-inflammation, anti-cancer and hepatoprotection.  However, the pharmacol. mechanism of andrographolide remains unclear.  Therefore, further characterization on the kinetics and mol. targets of andrographolide is essential.  In this study, we described the synthesis and characterization of a novel fluorescent andrographolide deriv. (ANDRO-NBD).  ANDRO-NBD exhibited a comparable anti-cancer spectrum to andrographolide: ANDRO-NBD was cytotoxic to various types of cancer cells and suppressed the migration activity of melanoma cells; ANDRO-NBD treatment induced the cleavage of heat shock protein 90 (Hsp90) and the downregulation of its client oncoproteins, v-Src and Bcr-abl.  Notably, ANDRO-NBD showed superior inhibitory effects to andrographolide in all anticancer assays we have performed.  In addn., ANDRO-NBD was further used as a fluorescent probe to investigate the uptake kinetics, cellular distribution and mol. targets of andrographolide.  Our data revealed that ANDRO-NBD entered cells rapidly and its fluorescent signal could be detected in nucleus, cytoplasm, mitochondria, and lysosome.  Moreover, we demonstrated that ANDRO-NBD was covalently bound to several putative target proteins of andrographolide, including NF-ΚB and hnRNPK.  In summary, we developed a fluorescent andrographolide probe with comparable bioactivity to andrographolide, which serves as a powerful tool to explore the pharmacol. mechanism of andrographolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSPOzo2QI_crVg90H21EOLACvtfcHk0ljKbBuCyskDNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFeht7nF&md5=ab3e3eb720384287dcf30eac786160db</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152770%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DY.-H.%26aulast%3DHsu%26aufirst%3DY.-L.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DLiao%26aufirst%3DH.-C.%26aulast%3DLee%26aufirst%3DP.-X.%26aulast%3DLin%26aufirst%3DC.-H.%26aulast%3DLo%26aufirst%3DL.-C.%26aulast%3DFu%26aufirst%3DS.-L.%26atitle%3DDevelopment%2520of%2520a%2520bifunctional%2520andrographolide-based%2520chemical%2520probe%2520for%2520pharmacological%2520study%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Solís, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch-Morell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Rosende, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Mingarro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanahuja, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagrasa, V.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective potential of <i>Ginkgo biloba</i> in retinal diseases</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1292</span>– <span class="NLM_lpage">1303</span>, <span class="refDoi"> DOI: 10.1055/a-0947-5712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fa-0947-5712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31266069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSis7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=1292-1303&author=I.+Mart%C3%ADnez-Sol%C3%ADsauthor=N.+Aceroauthor=F.+Bosch-Morellauthor=E.+Castilloauthor=M.+E.+Gonz%C3%A1lez-Rosendeauthor=D.+Mu%C3%B1oz-Mingarroauthor=T.+Ortegaauthor=M.+A.+Sanahujaauthor=V.+Villagrasa&title=Neuroprotective+potential+of+Ginkgo+biloba+in+retinal+diseases&doi=10.1055%2Fa-0947-5712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective Potential of Ginkgo biloba in Retinal Diseases</span></div><div class="casAuthors">Martinez-Solis, Isabel; Acero, Nuria; Bosch-Morell, Francisco; Castillo, Encarna; Gonzalez-Rosende, Maria Eugenia; Munoz-Mingarro, Dolores; Ortega, Teresa; Sanahuja, Maria Amparo; Villagrasa, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1292-1303</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  Like other tissues of the central nervous system, the retina is susceptible to damage by oxidative processes that result in several neurodegenerative disease such as age-related macular degeneration, diabetic retinopathy, glaucoma, ischemic retinal disease, retinal disease produced by light oxidn., and detached retina, among other diseases.  The use of antioxidant substances is a soln. to some health problems caused by oxidative stress, because they regulate redox homeostasis and reduce oxidative stress.  This is important for neurodegeneration linked to oxidn. processes.  In line with this, Ginkgo bilobais a medicinal plant with excellent antioxidant properties whose effects have been demonstrated in several degenerative processes, including retinal diseases assocd. with neurodegeneration.  This review describes the current literature on the role of ginkgo in retinal diseases assocd. with neurodegeneration.  The information leads to the conclusion that G. bilobaexts. might be a good option to improve certain neurodegenerative retinal diseases, but more research is needed to det. the safety and efficacy of G. bilobain these retinal degenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4u6laJ3EwrVg90H21EOLACvtfcHk0ljKbBuCyskDNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSis7fF&md5=3da6ae0d5b3e18835bf80f343c95fe1c</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1055%2Fa-0947-5712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fa-0947-5712%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Sol%25C3%25ADs%26aufirst%3DI.%26aulast%3DAcero%26aufirst%3DN.%26aulast%3DBosch-Morell%26aufirst%3DF.%26aulast%3DCastillo%26aufirst%3DE.%26aulast%3DGonz%25C3%25A1lez-Rosende%26aufirst%3DM.%2BE.%26aulast%3DMu%25C3%25B1oz-Mingarro%26aufirst%3DD.%26aulast%3DOrtega%26aufirst%3DT.%26aulast%3DSanahuja%26aufirst%3DM.%2BA.%26aulast%3DVillagrasa%26aufirst%3DV.%26atitle%3DNeuroprotective%2520potential%2520of%2520Ginkgo%2520biloba%2520in%2520retinal%2520diseases%26jtitle%3DPlanta%2520Med.%26date%3D2019%26volume%3D85%26spage%3D1292%26epage%3D1303%26doi%3D10.1055%2Fa-0947-5712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeFeudis, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drieu, K.</span></span> <span> </span><span class="NLM_article-title"><i>Ginkgo biloba</i> extracts and cancer: A research area in its infancy</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1046/j.1472-8206.2003.00156.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1046%2Fj.1472-8206.2003.00156.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12914542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=405-417&author=F.+V.+DeFeudisauthor=V.+Papadopoulosauthor=K.+Drieu&title=Ginkgo+biloba+extracts+and+cancer%3A+A+research+area+in+its+infancy&doi=10.1046%2Fj.1472-8206.2003.00156.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgo biloba extracts and cancer: A research area in its infancy</span></div><div class="casAuthors">DeFeudis, Francis V.; Papadopoulos, Vassilios; Drieu, Katy</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-417</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent studies conducted with various mol., cellular and whole animal models have revealed that leaf exts. of Ginkgo biloba may have anticancer (chemopreventive) properties that are related to their antioxidant, anti-angiogenic and gene-regulatory actions.  The antioxidant and assocd. anti-lipoperoxidative effects of Ginkgo exts. appear to involve both their flavonoid and terpenoid constituents.  The anti-angiogenic activity of the exts. may involve their antioxidant activity and their ability to inhibit both inducible and endothelial forms of nitric oxide synthase.  With regard to gene expression, a Ginkgo ext. and one of its terpenoid constituents, ginkgolide B, inhibited the proliferation of a highly aggressive human breast cancer cell line and xenografts of this cell line in nude mice.  CDNA microarray analyses have shown that exposure of human breast cancer cells to a Ginkgo ext. altered the expression of genes that are involved in the regulation of cell proliferation, cell differentiation or apoptosis, and that exposure of human bladder cancer cells to a Ginkgo ext. produced an adaptive transcriptional response that augments antioxidant status and inhibits DNA damage.  In humans, Ginkgo exts. inhibit the formation of radiation-induced (chromosome-damaging) clastogenic factors and UV light-induced oxidative stress - effects that may also be assocd. with anticancer activity.  Flavonoid and terpenoid constituents of Ginkgo exts. may act in a complementary manner to inhibit several carcinogenesis-related processes, and therefore the total exts. may be required for producing optimal effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo68m-fuu1vL7Vg90H21EOLACvtfcHk0ljKbBuCyskDNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFCnt7w%253D&md5=57591dba05ae3385be6c52e1f6aaf231</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-8206.2003.00156.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-8206.2003.00156.x%26sid%3Dliteratum%253Aachs%26aulast%3DDeFeudis%26aufirst%3DF.%2BV.%26aulast%3DPapadopoulos%26aufirst%3DV.%26aulast%3DDrieu%26aufirst%3DK.%26atitle%3DGinkgo%2520biloba%2520extracts%2520and%2520cancer%253A%2520A%2520research%2520area%2520in%2520its%2520infancy%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2003%26volume%3D17%26spage%3D405%26epage%3D417%26doi%3D10.1046%2Fj.1472-8206.2003.00156.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J. C. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. C.</span></span> <span> </span><span class="NLM_article-title">Effects of <i>Ginkgo biloba</i> extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.3748/wjg.v10.i1.37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3748%2Fwjg.v10.i1.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=14695765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FhsFeisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=37-41&author=J.+C.+J+Chaoauthor=C.+C.+Chu&title=Effects+of+Ginkgo+biloba+extract+on+cell+proliferation+and+cytotoxicity+in+human+hepatocellular+carcinoma+cells&doi=10.3748%2Fwjg.v10.i1.37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Chao Jane C J; Chu Chia Chou</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    </div><div class="casAbstract">AIM:  To study the effect of Ginkgo biloba extract (EGb 761) containing 22-27% flavonoids (ginkgo-flavone glycosides) and 5-7% terpenoids (ginkgolides and bilobalides) on cell proliferation and cytotoxicity in human hepatocellular carcinoma (HCC) cells.  METHODS:  Human HCC cell lines (HepG2 and Hep3B) were incubated with various concentrations (0-1 000 mg/L) of EGb 761 solution.  After 24 h incubation, cell proliferation and cytotoxicity were determined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and lactate dehydrogenase (LDH) release, respectively.  After 48 h incubation, the expression of proliferating cell nuclear antigen (PCNA) and p53 protein was measured by Western blotting.  RESULTS:  The results showed that EGb 761 (50-1 000 mg/L) significantly suppressed cell proliferation and increased LDH release (P<0.05) in HepG2 and Hep3B cells compared with the control group.  The cell proliferation of HepG2 and Hep3B cells treated with EGb 761 (1 000 mg/L) was 45% and 39% of the control group (P<0.05), respectively.  LDH release of HepG2 cells without and with EGb 761 (1 000 mg/L) treatment was 6.7% and 37.7%, respectively, and that of Hep3B cells without and with EGb 761 (1 000 mg/L) treatment was 7.2% and 40.3%, respectively.  The expression of PCNA and p53 protein in HepG2 cells treated with EGb 761 (1 000 mg/L) was 85% and 174% of the control group, respectively.  CONCLUSION:  Ginkgo biloba extract significantly can suppress proliferation and increase cytotoxicity in HepG2 and Hep3B cells.  Additionally, Ginkgo biloba extract can decrease PCNA and increase p53 expression in HepG2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvqPfetQrfSzEC-75aqa5AfW6udTcc2ebSBOCPsev1fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FhsFeisg%253D%253D&md5=6ef5502009eca99bced971836552edde</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v10.i1.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v10.i1.37%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DJ.%2BC.%2BJ%26aulast%3DChu%26aufirst%3DC.%2BC.%26atitle%3DEffects%2520of%2520Ginkgo%2520biloba%2520extract%2520on%2520cell%2520proliferation%2520and%2520cytotoxicity%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2004%26volume%3D10%26spage%3D37%26epage%3D41%26doi%3D10.3748%2Fwjg.v10.i1.37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aponte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.-C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitonis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, D. W.</span></span> <span> </span><span class="NLM_article-title"><i>Ginkgo biloba</i> and ovarian cancer prevention: Epidemiological and biological evidence</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>251</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2006.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.canlet.2006.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=17194528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVyjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2007&pages=43-52&author=B.+Yeauthor=M.+Aponteauthor=Y.+Daiauthor=L.+Liauthor=M.-C.+D.+Hoauthor=A.+Vitonisauthor=D.+Edwardsauthor=T.-N.+Huangauthor=D.+W.+Cramer&title=Ginkgo+biloba+and+ovarian+cancer+prevention%3A+Epidemiological+and+biological+evidence&doi=10.1016%2Fj.canlet.2006.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence</span></div><div class="casAuthors">Ye, Bin; Aponte, Margarita; Dai, Yan; Li, Lily; Ho, Ming-Chih D.; Vitonis, Allison; Edwards, Dale; Huang, Tai-Nang; Cramer, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is considerable interest in herbal therapies for cancer prevention but often with little scientific evidence to support their use.  In this study, we examd. epidemiol. data regarding effects of commonly used herbal supplements on risk for ovarian cancer and sought supporting biol. evidence. 4.2% of 721 controls compared to 1.6% of 668 cases regularly used Ginkgo biloba for an estd. relative risk (and 95% confidence interval) of 0.41 (0.20, 0.84) (p = 0.01); and the effect was most apparent in women with non-mucinous types of ovarian cancer, RR = 0.33 (0.15, 0.74) (p = 0.007).  In vitro expts. with normal and ovarian cancer cells showed that Ginkgo ext. and its components, quercetin and ginkgolide A and B, have significant anti-proliferative effects (∼40%) in serous ovarian cancer cells, but little effect in mucinous (RMUG-L) cells.  For the ginkgolides, the inhibitory effect appeared to be cell cycle blockage at G0/G1 to S phase.  This combined epidemiol. and biol. data provide supportive evidence for further studies of the chemopreventive or therapeutic effects of Ginkgo and ginkgolides on ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqICjc6C26GRrVg90H21EOLACvtfcHk0liZM-6o-wwxvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVyjsrg%253D&md5=ff94c8948961b706c0d9c91734ba2f9e</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DB.%26aulast%3DAponte%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DM.-C.%2BD.%26aulast%3DVitonis%26aufirst%3DA.%26aulast%3DEdwards%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DT.-N.%26aulast%3DCramer%26aufirst%3DD.%2BW.%26atitle%3DGinkgo%2520biloba%2520and%2520ovarian%2520cancer%2520prevention%253A%2520Epidemiological%2520and%2520biological%2520evidence%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D251%26spage%3D43%26epage%3D52%26doi%3D10.1016%2Fj.canlet.2006.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takad, S.</span></span> <span> </span><span class="NLM_article-title">Ginkgolides</span>. <i>J. Chem. Soc. C</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_fpage">2201</span>– <span class="NLM_lpage">2206</span>, <span class="refDoi"> DOI: 10.1039/j39670002201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fj39670002201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF1cXjt1E%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1967&pages=2201-2206&author=K.+Okabeauthor=K.+Yamadaauthor=S.+Yamamuraauthor=S.+Takad&title=Ginkgolides&doi=10.1039%2Fj39670002201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolides</span></div><div class="casAuthors">Okabe, Kei; Yamada, Kiyoyuki; Yamamura, Shosuke; Takada, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2201-6</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">Three bitter principles, ginkgolides A, B, and C, were isolated from the leaves of Ginkgo biloba.  Since the structure of ginkgolide A was established by x-ray anal. of its p-bromobenzoate, structures of the other 2 were deduced by comparison of the N.M.R. spectra.  The structures of ginkgolides A and B were correlated by chem. methods.  Owing to its complex structure, ginkgolide A gave an unusual oxidn. product, the structure of which was detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBlUMr7LYhiLVg90H21EOLACvtfcHk0liZM-6o-wwxvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXjt1E%253D&md5=9f11e20289ed4cd4dad6b432c23be5a7</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2Fj39670002201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39670002201%26sid%3Dliteratum%253Aachs%26aulast%3DOkabe%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DS.%26aulast%3DTakad%26aufirst%3DS.%26atitle%3DGinkgolides%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1967%26spage%3D2201%26epage%3D2206%26doi%3D10.1039%2Fj39670002201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, P.</span></span> <span> </span><span class="NLM_article-title">Structure of ginkgolide B (BN 52021) monohydrate, a highly specific PAF/acether receptor antagonist isolated from <i>Ginkgo biboba</i> L</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>C42</i></span>,  <span class="NLM_fpage">1759</span>– <span class="NLM_lpage">1762</span>, <span class="refDoi"> DOI: 10.1107/S0108270186090662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270186090662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL2sXlvFyltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C42&publication_year=1986&pages=1759-1762&author=L.+Dupontauthor=O.+Didebergauthor=G.+Germainauthor=P.+Braquet&title=Structure+of+ginkgolide+B+%28BN+52021%29+monohydrate%2C+a+highly+specific+PAF%2Facether+receptor+antagonist+isolated+from+Ginkgo+biboba+L&doi=10.1107%2FS0108270186090662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of ginkgolide B (BN 52021) monohydrate, a highly specific PAF/acether receptor antagonist isolated from Ginkgo biboba L</span></div><div class="casAuthors">Dupont, L.; Dideberg, O.; Germain, G.; Braquet, P.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C:  Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">C42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1759-62</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    </div><div class="casAbstract">X-ray anal. of ginkgolide B (I) monohydrate, isolated from Ginkgo biboba, confirmed that the cohesion of the crystal is the result of van der Waals interactions and H bonds involving H2O mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmAmJ7QkOzTrVg90H21EOLACvtfcHk0ljH6d4_Xk4DNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlvFyltbg%253D&md5=02201ce1a13318c49f51fe541b4ef0b0</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1107%2FS0108270186090662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270186090662%26sid%3Dliteratum%253Aachs%26aulast%3DDupont%26aufirst%3DL.%26aulast%3DDideberg%26aufirst%3DO.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DBraquet%26aufirst%3DP.%26atitle%3DStructure%2520of%2520ginkgolide%2520B%2520%2528BN%252052021%2529%2520monohydrate%252C%2520a%2520highly%2520specific%2520PAF%252Facether%2520receptor%2520antagonist%2520isolated%2520from%2520Ginkgo%2520biboba%2520L%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D1986%26volume%3DC42%26spage%3D1759%26epage%3D1762%26doi%3D10.1107%2FS0108270186090662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sbit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, P.</span></span> <span> </span><span class="NLM_article-title">Structure of ginkgolide A (BN52020) monohydrate and ginkgolide C (BN52022).ethanol.1.5hydrate, isolated from <i>Ginkgo biloba</i> L</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>C43</i></span>,  <span class="NLM_fpage">2377</span>– <span class="NLM_lpage">2381</span>, <span class="refDoi"> DOI: 10.1107/S0108270187087699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270187087699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL1cXkvFegt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C43&publication_year=1987&pages=2377-2381&author=M.+Sbitauthor=L.+Dupontauthor=O.+Didebergauthor=P.+Braquet&title=Structure+of+ginkgolide+A+%28BN52020%29+monohydrate+and+ginkgolide+C+%28BN52022%29.ethanol.1.5hydrate%2C+isolated+from+Ginkgo+biloba+L&doi=10.1107%2FS0108270187087699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of ginkgolide A (BN52020) monohydrate and ginkgolide C (BN52022).ethanol.1.5hydrate, isolated from Ginkgo biloba L</span></div><div class="casAuthors">Sbit, M.; Dupont, L.; Dideberg, O.; Braquet, P.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C:  Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">C43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2377-81</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    </div><div class="casAbstract">In ginkgolides A and C (I; R = R1 = H; R = R1 = OH, resp.) conformations of the rings are very similar to those in ginkgolide B (I; R = H, R1 = OH), except for rings A and F of I (R = R1 = H) where there is no OH substitution in the 2-position: the intramol. OH···O H-bond occurring in ginkgolides B and I (R = R1 = OH) is no longer possible in I (R = R1 = H).  The cohesion of the crystals results from van der Waals interactions and O-H···O hydrogen H-bonds involving H2O and (I; R = R1 = OH) mols.  In I (R = R1 = H), there is a short intermol. O···O contact of 2.859 (6) Å between a lactone ring and a ketone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWaqabXY6QObVg90H21EOLACvtfcHk0ljH6d4_Xk4DNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvFegt7c%253D&md5=0157f304be34ea170babbe7fd691b0c1</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1107%2FS0108270187087699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270187087699%26sid%3Dliteratum%253Aachs%26aulast%3DSbit%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DL.%26aulast%3DDideberg%26aufirst%3DO.%26aulast%3DBraquet%26aufirst%3DP.%26atitle%3DStructure%2520of%2520ginkgolide%2520A%2520%2528BN52020%2529%2520monohydrate%2520and%2520ginkgolide%2520C%2520%2528BN52022%2529.ethanol.1.5hydrate%252C%2520isolated%2520from%2520Ginkgo%2520biloba%2520L%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D1987%26volume%3DC43%26spage%3D2377%26epage%3D2381%26doi%3D10.1107%2FS0108270187087699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fronczek, F. R.</span></span> <span> </span><span class="NLM_article-title">Three ginkgolide hydrates from <i>Ginkgo biloba</i> L.: Ginkgolide A monohydrate, ginkgolide C sesquihydrate, and ginkgolide J dihydrate, all determined at 120 K</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">o195</span>– <span class="NLM_lpage">o198</span>, <span class="refDoi"> DOI: 10.1107/S0108270102000689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270102000689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=11807243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFKlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=o195-o198&author=J.+Zhaoauthor=I.+Muhammadauthor=D.+C.+Dunbarauthor=I.+A.+Khanauthor=N.+H.+Fischerauthor=F.+R.+Fronczek&title=Three+ginkgolide+hydrates+from+Ginkgo+biloba+L.%3A+Ginkgolide+A+monohydrate%2C+ginkgolide+C+sesquihydrate%2C+and+ginkgolide+J+dihydrate%2C+all+determined+at+120+K&doi=10.1107%2FS0108270102000689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Three ginkgolide hydrates from Ginkgo biloba L.: ginkgolide A monohydrate, ginkgolide C sesquihydrate and ginkgolide J dihydrate, all determined at 120 K</span></div><div class="casAuthors">Zhao, Jianping; Muhammad, Ilias; Dunbar, D. Chuck; Khan, Ikhlas A.; Fischer, Nikolaus H.; Fronczek, Frank R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Crystal Structure Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">C58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">o195-o198</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A low-temp. structure of ginkgolide A monohydrate, (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)-3-(1,1-dimethylethyl)-hexahydro-4,7b-dihydroxy-8-methyl-9H-1,7a-epoxymethano-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione monohydrate, C20H24O9·H2O, obtained from Mo Kα data, is a factor of three more precise than the previous room-temp. detn.  A refinement of the ginkgolide A monohydrate structure with Cu Kα data has allowed the assignment of the abs. configuration of compds.  Ginkgolide C sesquihydrate, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11S,11aR)-3-(1,1-dimethylethyl)-hexahydro-2,4,7b,11-tetrahydroxy-8-methyl-9H-1,7a-epoxymethano-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione sesquihydrate, C20H24O11·1.5H2O, has two independent diterpene mols., both of which exhibit intramol. H bonding between OH groups.  Ginkgolide J dihydrate, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)-3-(1,1-dimethylethyl)-hexahydro-2,4,7b-trihydroxy-8-methyl-9H-1,7a-epoxymethano-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione dihydrate, C20H24O10·2H2O, has the same basic skeleton as the other ginkgolides, with its three OH groups having the same configurations as those in ginkgolide C.  The conformations of the six five-membered rings are quite similar across ginkgolides A-C and J, except for the A and F rings of ginkgolide A.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppXh4ndDY9W7Vg90H21EOLACvtfcHk0ljH6d4_Xk4DNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFKlur8%253D&md5=e233442d0008d829c80fd84205498d7e</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1107%2FS0108270102000689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270102000689%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMuhammad%26aufirst%3DI.%26aulast%3DDunbar%26aufirst%3DD.%2BC.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DFischer%26aufirst%3DN.%2BH.%26aulast%3DFronczek%26aufirst%3DF.%2BR.%26atitle%3DThree%2520ginkgolide%2520hydrates%2520from%2520Ginkgo%2520biloba%2520L.%253A%2520Ginkgolide%2520A%2520monohydrate%252C%2520ginkgolide%2520C%2520sesquihydrate%252C%2520and%2520ginkgolide%2520J%2520dihydrate%252C%2520all%2520determined%2520at%2520120%2520K%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D2002%26volume%3D58%26spage%3Do195%26epage%3Do198%26doi%3D10.1107%2FS0108270102000689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnewyn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgain, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drieu, K.</span></span> <span> </span><span class="NLM_article-title">BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from <i>Ginkgo biloba</i> L</span>. <i>Ketsueki to Myakkan</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.2491/jjsth1970.16.558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2491%2Fjjsth1970.16.558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL28XksFyqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1985&pages=558-572&author=P.+G.+Braquetauthor=B.+Spinnewynauthor=M.+Braquetauthor=R.+H.+Bourgainauthor=J.+E.+Taylorauthor=A.+Etienneauthor=K.+Drieu&title=BN+52021+and+related+compounds%3A+A+new+series+of+highly+specific+PAF-acether+receptor+antagonists+isolated+from+Ginkgo+biloba+L&doi=10.2491%2Fjjsth1970.16.558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">BN 52021 and related compounds:  a new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L</span></div><div class="casAuthors">Braquet, Pierre G.; Spinnewyn, Brigitte; Braquet, Monique; Bourgain, Rene H.; Taylor, John E.; Etienne, Annie; Drieu, Kathy</div><div class="citationInfo"><span class="NLM_cas:title">Ketsueki to Myakkan</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">558-72</span>CODEN:
                <span class="NLM_cas:coden">KTMYA3</span>;
        ISSN:<span class="NLM_cas:issn">0386-9717</span>.
    </div><div class="casAbstract">The ginkgolides BN 52020 (ginkgolide A), BN 52021 (ginkgolide B), and BN 52022 (ginkgolide C) specifically inhibited the binding of platelet-activating factor (PAF) to the PAF receptor on isolated rabbit platelet membranes and inhibited PAF-dependent in vitro platelet aggregation.  BN 52021 was the most active ginkgolide, with IC50s of ∼10-7 M.  After oral administration to rabbits, BN 52021 inhibited PAF-dependent platelet aggregation.  After oral administration to rats, BN 52021 inhibited thrombus formation induced by elec. stimulation of the carotid artery.  BN 52021 inhibited PAF-dependent human polymorphonuclear leukocyte aggregation in vitro.  The ginkgolides did not significantly affect arachidonic acid metab. and did not bind to neurotransmitter receptors.  The use of BN 52021 and related compds. as pharmacol. tools for studying PAF biol. activities is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI8Hhb_uBBubVg90H21EOLACvtfcHk0liyu6df5H4VhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFyqt7c%253D&md5=253d63324ac881efe352547215ebe973</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.2491%2Fjjsth1970.16.558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2491%252Fjjsth1970.16.558%26sid%3Dliteratum%253Aachs%26aulast%3DBraquet%26aufirst%3DP.%2BG.%26aulast%3DSpinnewyn%26aufirst%3DB.%26aulast%3DBraquet%26aufirst%3DM.%26aulast%3DBourgain%26aufirst%3DR.%2BH.%26aulast%3DTaylor%26aufirst%3DJ.%2BE.%26aulast%3DEtienne%26aufirst%3DA.%26aulast%3DDrieu%26aufirst%3DK.%26atitle%3DBN%252052021%2520and%2520related%2520compounds%253A%2520A%2520new%2520series%2520of%2520highly%2520specific%2520PAF-acether%2520receptor%2520antagonists%2520isolated%2520from%2520Ginkgo%2520biloba%2520L%26jtitle%3DKetsueki%2520to%2520Myakkan%26date%3D1985%26volume%3D16%26spage%3D558%26epage%3D572%26doi%3D10.2491%2Fjjsth1970.16.558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strømgaard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, K.</span></span> <span> </span><span class="NLM_article-title">Ginkgolide derivatives for photolabeling studies: Preparation and pharmacological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4038</span>– <span class="NLM_lpage">4046</span>, <span class="refDoi"> DOI: 10.1021/jm020147w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020147w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4038-4046&author=K.+Str%C3%B8mgaardauthor=D.+R.+Saitoauthor=H.+Shindouauthor=S.+Ishiiauthor=T.+Shimizuauthor=K.+Nakanishi&title=Ginkgolide+derivatives+for+photolabeling+studies%3A+Preparation+and+pharmacological+evaluation&doi=10.1021%2Fjm020147w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolide Derivatives for Photolabeling Studies: Preparation and Pharmacological Evaluation</span></div><div class="casAuthors">Stromgaard, Kristian; Saito, D. Roland; Shindou, Hideo; Ishii, Satoshi; Shimizu, Takao; Nakanishi, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4038-4046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The terpene trilactones (TTLs), ginkgolides, e.g. ginkgolide B (I), and bilobalide (II), are structurally unique constituents of Ginkgo biloba exts., which exhibit various neuromodulatory properties.  Although the TTLs are believed to be responsible for some of these effects, the specific interactions with targets in the central nervous system remain to be elucidated on a mol. level.  Ginkgolides are known antagonists of the platelet-activating factor (PAF) receptor.  Herein, we describe the first examn. of the binding of native TTLs and their derivs. to the cloned PAF receptor, confirming that of the TTLs, ginkgolide B is the most potent PAF receptor antagonist.  Ginkgolide derivs. carrying photoactivatable and fluorescent groups for the purpose of performing photolabeling have been prepd. and evaluated using the cloned PAF receptor.  These studies have shown that ginkgolide derivs. with arom. photoactivatable substituents are potent PAF receptor antagonists with Ki values of 0.09-0.79 μM and hence excellent ligands for clarifying the binding of ginkgolides to PAF receptor by photolabeling studies.  Ginkgolide derivs. incorporating both fluorescent and photoactivatable groups still retained binding affinity to the PAF receptor and hence should be promising ligands for photolabeling and subsequent sequencing studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuySJkf2zsrVg90H21EOLACvtfcHk0liTPPPFXx92eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslKjt74%253D&md5=a21b4002c990299b21b417929d95acde</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm020147w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020147w%26sid%3Dliteratum%253Aachs%26aulast%3DStr%25C3%25B8mgaard%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DD.%2BR.%26aulast%3DShindou%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DK.%26atitle%3DGinkgolide%2520derivatives%2520for%2520photolabeling%2520studies%253A%2520Preparation%2520and%2520pharmacological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4038%26epage%3D4046%26doi%3D10.1021%2Fjm020147w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.-W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2156</span>, <span class="refDoi"> DOI: 10.3390/molecules24112156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules24112156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Smt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=2156&author=J.+Cuiauthor=L.+A.+Huauthor=W.+Shiauthor=G.+Cuiauthor=X.+Zhangauthor=Q.-W.+Zhang&title=Design%2C+synthesis%2C+and+anti-platelet+aggregation+activity+study+of+ginkgolide-1%2C2%2C3-triazole+derivatives&doi=10.3390%2Fmolecules24112156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives</span></div><div class="casAuthors">Cui, Jian; Hu, Le-An; Shi, Wei; Cui, Guozhen; Zhang, Xumu; Zhang, Qing-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2156pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">An azide-alkyne Huisgen cycloaddn. reaction was used to introduce a triazole nucleus into the target ginkgolide mols.  A series of ginkgolide-1,2,3-triazole conjugates with varied functional groups including benzyl, Ph and heterocycle moieties I (R = 2-chlorophenyl, 3-pyridinyl, 2-methylbenzyl, etc.; R1 = H, OH; R2 = H, OH) was thus synthesized.  Many of the designed derivs. showed potent antiplatelet aggregation activities with IC50 values of 5~ 21 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGj4ATEa_oNbVg90H21EOLACvtfcHk0lgkEj35c63ZEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Smt7fI&md5=873bb9e5a788745548ea5c17df8dc641</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24112156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24112156%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%2BA.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.-W.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520anti-platelet%2520aggregation%2520activity%2520study%2520of%2520ginkgolide-1%252C2%252C3-triazole%2520derivatives%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D2156%26doi%3D10.3390%2Fmolecules24112156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jancar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chammas, R.</span></span> <span> </span><span class="NLM_article-title">PAF receptor and tumor growth</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.2174/1389450115666140903111812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1389450115666140903111812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25182608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=982-987&author=S.+Jancarauthor=R.+Chammas&title=PAF+receptor+and+tumor+growth&doi=10.2174%2F1389450115666140903111812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">PAF Receptor and Tumor Growth</span></div><div class="casAuthors">Jancar, Sonia; Chammas, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">982-987</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The receptor for the lipid mediator PAF (PAFR) is a G-protein coupled receptor expressed in several cell types.  Besides PAF, a series of oxidized phospholipids can also bind to PAFR.  Dying cells also express PAFR-ligands and, in both situations, scavenger receptors are involved as well.  There is evidence that the scavenger receptor CD36 and PAFR assoc. in the macrophages membrane and signal in conjunction to induce a regulatory phenotype.  In the tumor microenvironment, apoptotic cells are abundant due to hypoxia, and PAF-like phospholipids are generated.  Engagement of PAFR expressed by tumor macrophages and dendritic cells induces a regulatory/tolerogenic phenotype and subverts the innate and adaptive immune response to the tumor.  During cancer therapies, PAFR-ligands can be generated, further aggravating the immune suppression.  Moreover, some tumor cells express PAFR and its activation by PAFR-ligands generated during chemotherapy induce anti-apoptotic factors, which protect the tumor cells from death induced by these treatments.  It is proposed that PAFR antagonists, administered in combination with chemotherapy, may represent a promising strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICPd0OAd6FbVg90H21EOLACvtfcHk0lgE5NpRWjvHTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnurzN&md5=24274facbb9a7043b51e0628e51eb766</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.2174%2F1389450115666140903111812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666140903111812%26sid%3Dliteratum%253Aachs%26aulast%3DJancar%26aufirst%3DS.%26aulast%3DChammas%26aufirst%3DR.%26atitle%3DPAF%2520receptor%2520and%2520tumor%2520growth%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26spage%3D982%26epage%3D987%26doi%3D10.2174%2F1389450115666140903111812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span> <span> </span><span class="NLM_article-title">The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: A novel target for combination therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fbjc.2014.323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24921917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=515-524&author=Y.+Yuauthor=X.+Zhangauthor=S.+Hongauthor=M.+Zhangauthor=Q.+Caiauthor=M.+Zhangauthor=W.+Jiangauthor=C.+Xu&title=The+expression+of+platelet-activating+factor+receptor+modulates+the+cisplatin+sensitivity+of+ovarian+cancer+cells%3A+A+novel+target+for+combination+therapy&doi=10.1038%2Fbjc.2014.323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy</span></div><div class="casAuthors">Yu, Y.; Zhang, X.; Hong, S.; Zhang, M.; Cai, Q.; Zhang, M.; Jiang, W.; Xu, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-524</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Ovarian cancer has the highest mortality rate of the gynaecol. cancers.  Although cisplatin (CDDP) is an effective treatment for ovarian cancer, recurrence is frequent and leads to death.  The objective was to explore the role and possible mechanisms of platelet-activating factor receptor (PAFR) signalling in CDDP-treated ovarian cancer cells.  Methods: The upregulation of PAFR in CDDP-treated ovarian cancer cells was obsd. using realtime PCR and Western blot.  The potential role of PAFR in modulating the CDDP sensitivity was assessed using a pharmacol. inhibitor and siRNA knockdown.  The PAFR-activated signalling pathways involved in cell responses to CDDP were assessed.  Results: Cisplatin induced increased PAFR expression in two ovarian cancer cell lines.  The upregulation of PAFR by CDDP correlated with the time-dependent accumulation of NF-κB and HIF-1α in the nucleus.  The inhibition of PAFR sensitized the ovarian cancer cells to CDDP.  The PI3K and ERK pathways lie downstream of activated PAFR in CDDP-treated cells and their inhibition enhanced CDDP sensitivity.  Finally, co-treatment with a PAFR antagonist (Ginkgolide B) and CDDP markedly reduced tumor growth in an in vivo model of ovarian cancer.  Conclusions: Together, these findings suggest that PAFR is a novel and promising therapeutic target for sensitizing ovarian cancer cells to CDDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7niV2H8ZO7Vg90H21EOLACvtfcHk0lg6PyuNkSZ9YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCmsLY%253D&md5=79128ca940eb77057fa0ff51ef7f14a2</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.323%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DThe%2520expression%2520of%2520platelet-activating%2520factor%2520receptor%2520modulates%2520the%2520cisplatin%2520sensitivity%2520of%2520ovarian%2520cancer%2520cells%253A%2520A%2520novel%2520target%2520for%2520combination%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D515%26epage%3D524%26doi%3D10.1038%2Fbjc.2014.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span> <span> </span><span class="NLM_article-title">Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: The role of platelet-activating factor</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">999</span>, <span class="refDoi"> DOI: 10.1186/s12885-018-4918-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs12885-018-4918-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30340558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1OgurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=999&author=T.+Gaoauthor=Y.+Yuauthor=Q.+Congauthor=Y.+Wangauthor=M.+Sunauthor=L.+Yaoauthor=C.+Xuauthor=W.+Jiang&title=Human+mesenchymal+stem+cells+in+the+tumour+microenvironment+promote+ovarian+cancer+progression%3A+The+role+of+platelet-activating+factor&doi=10.1186%2Fs12885-018-4918-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor</span></div><div class="casAuthors">Gao, Tong; Yu, Yi; Cong, Qing; Wang, Yisheng; Sun, Mingming; Yao, Liangqing; Xu, Congjian; Jiang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">999</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The tumor microenvironment conferred by mesenchymal stem cells (MSCs) plays a key role in tumor development and progression.  We previously detd. that platelet-activating factor receptor (PAFR) was overexpressed in ovarian cancer cells (OCCs) and that PAF can promote ovarian cancer progression via PAF/PAFR-mediated inflammatory signalling pathways.  Evidence suggests that MSCs can secrete high concns. of PAF.  Here, we investigated the role of PAF/PAFR signalling in the microenvironment mediated by MSCs and OCCs and its effect on cancer progression.  Methods: The PAF concns. in the culture media of MSCs, OCCs and co-cultured MSCs and OCCs were detd. by ELISA.  The effects of MSCs on OCCs in vitro were assessed on cells treated with conditioned medium (CM).  The expression and phosphorylation of key proteins in the PAF/PAFR signalling pathway were evaluated.  In vivo, MSCs/RFP and SKOV3 cells were co-administered at different proportions to nude mice by interscapular injection.  Mice in the WEB2086 group were i.p. injected with the PAFR antagonist WEB2086 at a dose of 1 mg/kg.d for the duration of the animal expts.  Tumor progression was obsd., and the wt. and survival time of mice were measured.  The PAF concn. in peripheral and tumor site blood was detd. by ELISA.  Results: High concns. of PAF were detected in CM from MSCs and MSCs co-cultured with OCCs.  Both types of medium promoted non-mucinous OCC proliferation and migration but had no effect on mucinous-type OCCs.  These effects could be blocked by PAFR inhibitors.  The expression and phosphorylation of key proteins in the PAF/PAFR pathway significantly increased upon treatment with PAF and MSC-CM.  In vivo, the tumor vol. was larger following co-injection of SKOV3 cells and MSCs/RFP than following injection of SKOV3 cells alone.  The tumor-promoting effect of MSCs/RFP was blocked by the PAFR antagonist WEB2086.  Serum PAF concns. significantly increased in co-injected mice.  Conclusion: Our results suggest that the tumor-promoting effect of MSCs on OCCs via their cross-talk in the tumor microenvironment was, at least in part, mediated by the PAF/PAFR pathway, suggesting a new target for the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzpGOjJddqvbVg90H21EOLACvtfcHk0ljD6i8hRfzRug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1OgurzK&md5=858609e0ad9b74a09837ed8142811ba4</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1186%2Fs12885-018-4918-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-018-4918-0%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DCong%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%26atitle%3DHuman%2520mesenchymal%2520stem%2520cells%2520in%2520the%2520tumour%2520microenvironment%2520promote%2520ovarian%2520cancer%2520progression%253A%2520The%2520role%2520of%2520platelet-activating%2520factor%26jtitle%3DBMC%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D999%26doi%3D10.1186%2Fs12885-018-4918-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.-C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological action and mechanisms of ginkgolide B</span>. <i>Chin. Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1097/00029330-200705020-00013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2F00029330-200705020-00013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=17543184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFehtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=922-928&author=S.-H.+Xiaauthor=D.-C.+Fang&title=Pharmacological+action+and+mechanisms+of+ginkgolide+B&doi=10.1097%2F00029330-200705020-00013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological action and mechanisms of ginkgolide B</span></div><div class="casAuthors">Xia, Shi-hai; Fang, Dian-chun</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Medical Journal (Beijing, China, English Edition)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">922-928</span>CODEN:
                <span class="NLM_cas:coden">CMJODS</span>;
        ISSN:<span class="NLM_cas:issn">0366-6999</span>.
    
            (<span class="NLM_cas:orgname">Chinese Medical Association</span>)
        </div><div class="casAbstract">Objective: To review the recent research progress in pharmacol. actions and mechanisms of ginkgolide B.  Data sources: Information included in this article was identified by searching of PUBMED (1987-2006) online resources using the key terms "ginkgolide B", "platelet activating factor", and "pharmacol.".  Study selection Mainly original milestone articles and crit. reviews written by major pioneer investigators of the field were selected.  Results: The key issues related to the pharmacol. actions and mechanisms of ginkgolide B were summarized.  The ginkgolide B possesses a no. of beneficial effects such as anti-inflammatory, anti-allergic, antioxidant, and neuroprotective effects.  Meantime, their mechanisms were discussed.  Conclusions: The Ginkgolide B is the most potent antagonist of platelet activating factor (PAF) and exhibits therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99Qo1awOBz7Vg90H21EOLACvtfcHk0ljFvZ3r12bUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFehtb4%253D&md5=716d7c4ba120af0e161515d5bafb4432</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1097%2F00029330-200705020-00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00029330-200705020-00013%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DS.-H.%26aulast%3DFang%26aufirst%3DD.-C.%26atitle%3DPharmacological%2520action%2520and%2520mechanisms%2520of%2520ginkgolide%2520B%26jtitle%3DChin.%2520Med.%2520J.%26date%3D2007%26volume%3D120%26spage%3D922%26epage%3D928%26doi%3D10.1097%2F00029330-200705020-00013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span> <span> </span><span class="NLM_article-title">Ginkgolide B inhibits human bladder cancer cell migration and invasion through microRNA-223–3p</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1794</span>, <span class="refDoi"> DOI: 10.1159/000447878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1159%2F000447878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27744452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVemtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1787-1794&author=Y.+Zhiauthor=J.+Panauthor=W.+Shenauthor=P.+Heauthor=J.+Zhengauthor=X.+Zhouauthor=G.+Luauthor=Z.+Chenauthor=Z.+Zhou&title=Ginkgolide+B+inhibits+human+bladder+cancer+cell+migration+and+invasion+through+microRNA-223%E2%80%933p&doi=10.1159%2F000447878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p</span></div><div class="casAuthors">Zhi, Yi; Pan, Jinhong; Shen, Wenhao; He, Peng; Zheng, Ji; Zhou, Xiaozhou; Lu, Gensheng; Chen, Zhiwen; Zhou, Zhansong</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1787-1794</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Ginkgolide B (GB) is currently used as an anticancer drug for treatment of some malignant cancers.  However, whether it may have therapeutic effects on bladder cancer remains unknown.  Here, we studied the effects of GB on bladder cancer cells.  Methods: Bladder cells were treated with different doses of GB, and the effects on ZEB1 and microRNA-223-3p (miR-223-3p) were analyzed by RT-qPCR and/or Western blot.  Prediction of a regulatory relationship between miR-93 and 3'-UTR of Beclin-1 mRNA was performed by a bioinformatics algorithm and confirmed by a dual luciferase reporter assay.  Results: We found that GB dose-dependently decreased ZEB1 protein, but not mRNA, in bladder cancer cells, resulting in suppression of cell invasion.  Moreover, in bladder cancer cells, GB dose-dependently decreased the levels of miR-223-3p, which suppressed the protein translation of ZEB1 through binding to 3'-UTR of ZEB1 mRNA.  Overexpression of miR-223-3p decreased ZEB1 protein, while depletion of miR-223-3p increased ZEB1 protein in bladder cancer cells.  Conclusion: GB inhibits bladder cancer cell invasiveness through suppressing ZEB1 protein translation via upregulating miR-223-3p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaKxN21rHiPrVg90H21EOLACvtfcHk0ljFvZ3r12bUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVemtr%252FM&md5=3373e5b6fda5fb7ab561d9f3bbd0542a</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1159%2F000447878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000447878%26sid%3Dliteratum%253Aachs%26aulast%3DZhi%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.%26atitle%3DGinkgolide%2520B%2520inhibits%2520human%2520bladder%2520cancer%2520cell%2520migration%2520and%2520invasion%2520through%2520microRNA-223%25E2%2580%25933p%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2016%26volume%3D39%26spage%3D1787%26epage%3D1794%26doi%3D10.1159%2F000447878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-κB pathway</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.10.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.10.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30399592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2hsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=563-572&author=C.+Louauthor=H.+Luauthor=Z.+Maauthor=C.+Liuauthor=Y.+Zhang&title=Ginkgolide+B+enhances+gemcitabine+sensitivity+in+pancreatic+cancer+cell+lines+via+inhibiting+PAFR%2FNF-%CE%BAB+pathway&doi=10.1016%2Fj.biopha.2018.10.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-κB pathway</span></div><div class="casAuthors">Lou, Changjie; Lu, Haibo; Ma, Zhigang; Liu, Chao; Zhang, Yanqiao</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">563-572</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Gemcitabine resistance will occur by time after the initial response in pancreatic cancer.  Ginkgolide B (GB), a major terpene lactone component of Ginkgo biloba leaves, is a highly selective and competitive inhibitor for platelet-activating factor (PAF) receptor.  In the present study, we evaluated the effect of GB on gemcitabine sensitivity in pancreatic cancer cell lines in vitro and in vivo.  Cell viability assay, flow cytometry, dual luciferase reporter assay and tumor xenograft model were used to evaluate cell proliferation, apoptosis, nuclear factor kappa b (NF-κB) activity in vitro and tumor growth in vivo.  Western blot, immunohistochem. (IHC) and immunofluorescence were used to shown different protein expression levels.  We found the half maximal inhibitory concn. (IC50) of gemcitabine was significantly downregulated by GB in a dose-dependent manner.  Furthermore, GB could suppress cell proliferation, increase cell apoptosis and repress tumor growth when combined with gemcitabine, but had no effect when treated alone.  Gemcitabine could upregulate PAFR and phosphorylated NF-κB/p65 expression, and increase NF-κB activity, but this was largely suppressed in combination with GB.  GB could suppress PAFR expression in a dose-dependent manner.  Knockout of PAFR significantly decreased phosphorylated NF-κB/p65 expression, inhibited NF-κB activity, increased gemcitabine sensitivity and cell apoptosis.  Besides, GB had no influence on gemcitabine IC50 in IκBα-SR stably expressed BxPC-3 and CAPAN1.  Our results suggested that GB could enhance gemcitabine sensitivity in pancreatic cancer cell lines by suppressing PAFR/NF-κB pathway.  Thus GB may have therapeutic potential when used in combination with gemcitabine in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJAPLb9wHybVg90H21EOLACvtfcHk0ljFE1HXRVrbnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2hsrnJ&md5=13319f7a3a52236b3a65b0d6aa57b9fb</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.10.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.10.084%26sid%3Dliteratum%253Aachs%26aulast%3DLou%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DGinkgolide%2520B%2520enhances%2520gemcitabine%2520sensitivity%2520in%2520pancreatic%2520cancer%2520cell%2520lines%2520via%2520inhibiting%2520PAFR%252FNF-%25CE%25BAB%2520pathway%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D109%26spage%3D563%26epage%3D572%26doi%3D10.1016%2Fj.biopha.2018.10.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span> <span> </span><span class="NLM_article-title">miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2016.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.cbi.2016.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26768586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=2016&pages=72-81&author=W.+Maauthor=J.+Liauthor=J.+Huauthor=Y.+Chengauthor=J.+Wangauthor=X.+Zhangauthor=M.+Xu&title=miR214-regulated+p53-NOX4%2Fp66shc+pathway+plays+a+crucial+role+in+the+protective+effect+of+ginkgolide+B+against+cisplatin-induced+cytotoxicity+in+HEI-OC1+cells&doi=10.1016%2Fj.cbi.2016.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells</span></div><div class="casAuthors">Ma, Weijun; Li, Jianping; Hu, Juan; Cheng, Ying; Wang, Junli; Zhang, Xiaotong; Xu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The chemotherapeutic agent, cisplatin, is widely used for the treatment of several neoplastic diseases.  The concomitant cytotoxicity in cochlear cells severely limits the max. dose of cisplatin.  Our previous study has shown that Ginkgolide B (GB) could protect against cisplatin-induced ototoxicity.  In the present study, we aimed to elucidate the probable mechanism underlying GB-mediated protective effects against cisplatin-induced cytotoxicity.  The results showed that, in HEI-OC1 auditory cells, both NOX4 and p66shc expression was increased by cisplatin.  GB significantly reduced NOX4 and p66shc expression and superoxide generation.  Over-expression of NOX4 or p66shc suppressed the inhibitory effects of GB on superoxide generation and the protective effects of GB on loss of cell viability and apoptosis assocd. with cisplatin.  Moreover, p53 expression was increased by cisplatin.  GB significantly decreased p53 expression and p53-binding of the promoters of NOX4 and p66shc.  Over-expression of p53 suppressed the inhibitory effects of GB on NOX4 and p66shc expression and superoxide generation and the protective effects of GB on loss of cell viability and apoptosis assocd. with cisplatin.  Furthermore, miR214 expression was decreased by cisplatin.  GB significantly increased miR214 expression and inhibition of miR214 suppressed the inhibitory effects of GB on p53, NOX4 and p66shc expression and superoxide generation and the protective effects of GB against cisplatin-induced cytotoxicity.  We demonstrate that GB decreases superoxide generation and the subsequent apoptosis through redn. of p53-mediated NOX4/p66shc pathway via up-regulation of miR214, resulting in attenuation of cisplatin-induced cytotoxicity.  Our findings have gained an insight into the mol. mechanism of GB-exhibited inhibitory effect on cisplatin-induced cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7A0wUm5qV-7Vg90H21EOLACvtfcHk0ljFE1HXRVrbnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslylug%253D%253D&md5=3354bcde3ce51bfee54df54aa918a5a1</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26atitle%3DmiR214-regulated%2520p53-NOX4%252Fp66shc%2520pathway%2520plays%2520a%2520crucial%2520role%2520in%2520the%2520protective%2520effect%2520of%2520ginkgolide%2520B%2520against%2520cisplatin-induced%2520cytotoxicity%2520in%2520HEI-OC1%2520cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D245%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.cbi.2016.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dungdung, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N.</span></span> <span> </span><span class="NLM_article-title">Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.2217/nnm.13.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2217%2Fnnm.13.56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23742256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVeksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=441-456&author=S.+Ghoshauthor=S.+R.+Dungdungauthor=S.+T.+Choudhuryauthor=S.+Chakrabortyauthor=N.+Das&title=Mitochondria+protection+with+ginkgolide+B-loaded+polymeric+nanocapsules+prevents+diethylnitrosamine-induced+hepatocarcinoma+in+rats&doi=10.2217%2Fnnm.13.56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats</span></div><div class="casAuthors">Ghosh, Swarupa; Dungdung, Sandhya Rekha; Choudhury, Somsubhra Thakur; Chakraborty, Somsuta; Das, Nirmalendu</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-456</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1743-5889</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: Hepatocellular carcinoma (HCC) has no successful pharmacotherapeutic remedy.  The aim of this study was to ascertain whether ginkgolide B (GB)-loaded polymeric nanocapsules can prevent diethylnitrosamine (DEN)-induced HCC in rats.  Materials & methods: GB was fabricated in two types of nanocapsules of which one was polyethylene glycol coated (N1GB) and the other was uncoated (N2GB).  These nanocapsules were orally gavaged during DEN-induced HCC development in rats.  Results: Nanocapsulation of GB enabled aq. suspension and slow time-dependent release of the compd.  Anticarcinogenic potential of N2GB was reflected by its ability in the management of DEN-induced reactive oxygen species generation, mitochondrial dysfunction, p53, NF-κB, inducible nitric oxide synthase, COX-2 and VEGF expressions, and induction of apoptosis in cancer cells in the rat liver.  Conclusion: Pos. zeta-potential on N2GB surface might have offered higher hepatic accumulation of GB, esp. at the electron-dense organelle mitochondria.  Mitochondria protection against DEN-induced oxidative damage ensured HCC prevention.  Original submitted 27 June 2012; Revised submitted 4 Dec. 2012; Published online 7 June 2013.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodSLwS_VVnGrVg90H21EOLACvtfcHk0li_xAWLqQTpPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVeksro%253D&md5=3572076c22e0f347b3480b5a374dad01</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.2217%2Fnnm.13.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fnnm.13.56%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DDungdung%26aufirst%3DS.%2BR.%26aulast%3DChoudhury%26aufirst%3DS.%2BT.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DN.%26atitle%3DMitochondria%2520protection%2520with%2520ginkgolide%2520B-loaded%2520polymeric%2520nanocapsules%2520prevents%2520diethylnitrosamine-induced%2520hepatocarcinoma%2520in%2520rats%26jtitle%3DNanomedicine%26date%3D2014%26volume%3D9%26spage%3D441%26epage%3D456%26doi%3D10.2217%2Fnnm.13.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, P.</span></span> <span> </span><span class="NLM_article-title">PAF receptor antagonist ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25755731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC2MnislOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=432-440&author=L.+Sunauthor=Z.+Heauthor=J.+Keauthor=S.+Liauthor=X.+Wuauthor=L.+Lianauthor=X.+Heauthor=X.+Heauthor=J.+Huauthor=Y.+Zouauthor=X.+Wuauthor=P.+Lan&title=PAF+receptor+antagonist+ginkgolide+B+inhibits+tumourigenesis+and+angiogenesis+in+colitis-associated+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer</span></div><div class="casAuthors">Sun Lei; He Zhen; Ke Jia; Li Senmao; Wu Xianrui; Lian Lei; He Xiaowen; He Xiaosheng; Hu Jiancong; Zou Yifeng; Wu Xiaojian; Lan Ping</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">432-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Platelet activating factor (PAF), a potent pro-inflammatory phospholipid, has been found to trigger tumor growth and angiogenesis through its G-protein coupled receptor (PAFR).  This study was aimed to investigate the potential role of PAF in azoxymethane (AOM)/dextran sulfate sodium (DSS) induced colitis-associated cancer (CAC), using PAFR antagonist Ginkgolide B (GKB).  We found GKB up-regulated serum level of PAF-AH activity.  As assessed by disease activity index (DAI), histological injury scores, leukocytes infiltration, and expression of pro-inflammatory cytokines, GKB ameliorated colonic inflammation and decreased tumor number and load in mice.  GKB also decreased expression of vascular endothelial growth factor (VEGF) and microvessel density (MVD) in tumor.  These results suggest that PAFR antagonist might be a potential therapeutic strategy for CAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnmBqw7L9yvxgd2Wuil24tfW6udTcc2ebHMGHaVH5O7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnislOmsQ%253D%253D&md5=9b4af2e39c941727dd3db2128b5e2c0d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DKe%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLian%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DP.%26atitle%3DPAF%2520receptor%2520antagonist%2520ginkgolide%2520B%2520inhibits%2520tumourigenesis%2520and%2520angiogenesis%2520in%2520colitis-associated%2520cancer%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2015%26volume%3D8%26spage%3D432%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, Y.</span></span> <span> </span><span class="NLM_article-title">Two new diterpenoids, jolkinolides A and B, obtained from <i>Euphorbia jolkini</i> Boiss. (Euphorbiaceae)</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1390</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)84635-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0040-4039%2801%2984635-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1972&pages=1387-1390&author=D.+Uemuraauthor=Y.+Hirata&title=Two+new+diterpenoids%2C+jolkinolides+A+and+B%2C+obtained+from+Euphorbia+jolkini+Boiss.+%28Euphorbiaceae%29&doi=10.1016%2FS0040-4039%2801%2984635-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2984635-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252984635-9%26sid%3Dliteratum%253Aachs%26aulast%3DUemura%26aufirst%3DD.%26aulast%3DHirata%26aufirst%3DY.%26atitle%3DTwo%2520new%2520diterpenoids%252C%2520jolkinolides%2520A%2520and%2520B%252C%2520obtained%2520from%2520Euphorbia%2520jolkini%2520Boiss.%2520%2528Euphorbiaceae%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1972%26volume%3D13%26spage%3D1387%26epage%3D1390%26doi%3D10.1016%2FS0040-4039%2801%2984635-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.-K.</span></span> <span> </span><span class="NLM_article-title"><i>ent</i>-Abietane diterpenoids and their probable biogenetic precursors from the roots of <i>Euphorbia fischeriana</i></span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">55859</span>– <span class="NLM_lpage">55865</span>, <span class="refDoi"> DOI: 10.1039/C7RA11982H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC7RA11982H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFertrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=55859-55865&author=J.+Zhangauthor=J.+Heauthor=X.-X.+Wangauthor=Y.-X.+Shiauthor=N.+Zhangauthor=B.-Z.+Maauthor=W.-K.+Zhangauthor=J.-K.+Xu&title=ent-Abietane+diterpenoids+and+their+probable+biogenetic+precursors+from+the+roots+of+Euphorbia+fischeriana&doi=10.1039%2FC7RA11982H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-abietane diterpenoids and their probable biogenetic precursors from the roots of Euphorbia fischeriana</span></div><div class="casAuthors">Zhang, Jia; He, Jun; Wang, Xiao-Xue; Shi, Ying-Xue; Zhang, Nuan; Ma, Bing-Zhi; Zhang, Wei-Ku; Xu, Jie-Kun</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">88</span>),
    <span class="NLM_cas:pages">55859-55865</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Five new ent-abietane diterpenoids (1-5), along with nine known analogs (6-14), were isolated from the roots of Euphorbia fischeriana.  Their structures and abs. configurations were detd. by the anal. of extensive spectroscopic data (UV, IR, HRESIMS, NMR) and the comparison of the exptl. and calcd. electronic CD (ECD).  Among the isolates, it's notable that the ent-abietane diterpenoids bearing an addnl. five-membered lactone ring might be derived from the proposed precursors of fischeriabietane B (2) and C (3), and their plausible biosynthetic relationship was detailed discussed.  All the isolates were evaluated for cytotoxicity against three human cancer cell lines (Panc-28, Bel-7402, and HT-29), 2 and 3 exhibited moderate cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOlBwaTOzVw7Vg90H21EOLACvtfcHk0lgvQa0YAUC49Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFertrzM&md5=e58473b265aa6eaac508bb8559f6f7c9</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1039%2FC7RA11982H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA11982H%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.-X.%26aulast%3DShi%26aufirst%3DY.-X.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DB.-Z.%26aulast%3DZhang%26aufirst%3DW.-K.%26aulast%3DXu%26aufirst%3DJ.-K.%26atitle%3Dent-Abietane%2520diterpenoids%2520and%2520their%2520probable%2520biogenetic%2520precursors%2520from%2520the%2520roots%2520of%2520Euphorbia%2520fischeriana%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D55859%26epage%3D55865%26doi%3D10.1039%2FC7RA11982H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal and molecular structure of jolkinolide B, a novel oxidolactone diterpene</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)92614-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0040-4039%2801%2992614-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1977&pages=283-284&author=D.+Uemuraauthor=C.+Katayamaauthor=Y.+Hirata&title=Crystal+and+molecular+structure+of+jolkinolide+B%2C+a+novel+oxidolactone+diterpene&doi=10.1016%2FS0040-4039%2801%2992614-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2992614-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252992614-0%26sid%3Dliteratum%253Aachs%26aulast%3DUemura%26aufirst%3DD.%26aulast%3DKatayama%26aufirst%3DC.%26aulast%3DHirata%26aufirst%3DY.%26atitle%3DCrystal%2520and%2520molecular%2520structure%2520of%2520jolkinolide%2520B%252C%2520a%2520novel%2520oxidolactone%2520diterpene%26jtitle%3DTetrahedron%2520Lett.%26date%3D1977%26volume%3D18%26spage%3D283%26epage%3D284%26doi%3D10.1016%2FS0040-4039%2801%2992614-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Anticancer activities of diterpenoids derived from <i>Euphorbia fischeriana</i> Steud</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">387</span>, <span class="refDoi"> DOI: 10.3390/molecules23020387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules23020387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Kjt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=387&author=B.+Jianauthor=H.+Zhangauthor=C.+Hanauthor=J.+Liu&title=Anticancer+activities+of+diterpenoids+derived+from+Euphorbia+fischeriana+Steud&doi=10.3390%2Fmolecules23020387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer activities of diterpenoids derived from Euphorbia fischeriana Steud</span></div><div class="casAuthors">Jian, Baiyu; Zhang, Hao; Han, Cuicui; Liu, Jicheng</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387/1-387/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Euphorbia fischeriana Steud is an essential oriental folk medicine used for healing cancer, edema and tuberculosis.  Recently, its anticancer activitity has attracted more attention.  A vol. of research has indicated that diterpenoids are the major anticancer active constituents from this medicinal herb.  In this review, we aimed to provide a summary of the promising anticancer diterpenoids from this plant; many diterpenoids mentioned in this article are newly discovered diterpenoids.  According to the carbon skeleton and substituents, they can be classified into eight subtypes: ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurane, and lathyrane.  Futhermore, their key anticancer mechanisms and protein targets of these compds. will be discussed.  These natural diterpenoids could provide a reservoir for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs6-P9l074MrVg90H21EOLACvtfcHk0ljGf8WwKhOyrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Kjt73O&md5=012e0b6fcf61062a15fba7c7c935d870</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020387%26sid%3Dliteratum%253Aachs%26aulast%3DJian%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DAnticancer%2520activities%2520of%2520diterpenoids%2520derived%2520from%2520Euphorbia%2520fischeriana%2520Steud%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D387%26doi%3D10.3390%2Fmolecules23020387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-C.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide A and jolkinolide B inhibit proliferation of A549 cells and activity of human umbilical vein endothelial cells</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.12659/MSM.902704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.12659%2FMSM.902704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28087861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2rs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=223-237&author=L.+Shenauthor=S.-Q.+Zhangauthor=L.+Liuauthor=Y.+Sunauthor=Y.-X.+Wuauthor=L.-P.+Xieauthor=J.-C.+Liu&title=Jolkinolide+A+and+jolkinolide+B+inhibit+proliferation+of+A549+cells+and+activity+of+human+umbilical+vein+endothelial+cells&doi=10.12659%2FMSM.902704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide A and Jolkinolide B inhibit proliferation of A549 cells and activity of human umbilical vein endothelial cells</span></div><div class="casAuthors">Shen, Lei; Zhang, Shan-Qiang; Liu, Lei; Sun, Yu; Wu, Yu-Xuan; Xie, Li-Ping; Liu, Ji-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">223-237</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1643-3750</span>.
    
            (<span class="NLM_cas:orgname">International Scientific Information, Inc.</span>)
        </div><div class="casAbstract">Background: Jolkinolide A (JA) and Jolkinolide B (JB) are diterpenoids extd. from the roots of Euphorbia fischeriana Steud and have been shown to have anti-tumor activity.  However, their effects on the ability of tumor cells to invade blood vessels and metastasize remain largely unknown.  Investigations into the effects of JA and JB on the angiogenesis of tumor tissues may facilitate the identification of new natural drugs with anti-tumor growth and metastasis activities.  Material/Methods: We used different concns. of JA and JB (20 μg/mL, 40 μg/mL, 60 μg/mL, 80 μg/mL, and 100 μg/mL) to stimulate A549 cells and then studied the effects on the growth and metastasis of lung cancers.  In addn., we used conditional media from A549 cells (A549-CM) stimulated by either JA or JB in different concns. to culture human umbilical vein endothelial cells (HUVECs).  Results: We found that both JA and JB significantly inhibited the Akt-STAT3-mTOR signaling pathway and reduced the expression of VEGF in A549 cells, but JB exhibited more significant inhibitory effects than JA.  The JB-stimulated A549 cell conditional media had a greater inhibitory effect on the proliferation and migration of HUVECs than did the conditional media of JA-stimulated A549 cells.  This effect gradually increased with increasing concns. of either type of Jolkinolide.  Conclusions: Our results suggest that JA and JB inhibited VEGF expression in A549 cells through the inhibition of the Akt-STAT3-mTOR signaling pathway, and directly inhibited the proliferation and migration of HUVECs.  These findings are of great significance for the development of new plant-derived chemotherapy agents for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprSy_6_yWYx7Vg90H21EOLACvtfcHk0lh32Bbxj6RG8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2rs7%252FO&md5=ae51790aae73f79867b9f71d0fc9c50b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.12659%2FMSM.902704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.902704%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.-Q.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.-X.%26aulast%3DXie%26aufirst%3DL.-P.%26aulast%3DLiu%26aufirst%3DJ.-C.%26atitle%3DJolkinolide%2520A%2520and%2520jolkinolide%2520B%2520inhibit%2520proliferation%2520of%2520A549%2520cells%2520and%2520activity%2520of%2520human%2520umbilical%2520vein%2520endothelial%2520cells%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2017%26volume%3D23%26spage%3D223%26epage%3D237%26doi%3D10.12659%2FMSM.902704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">The effects of jolkinolide B on HepG2 cells as revealed by <sup>1</sup>H-NMR-based metabolic profiling</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>842</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejphar.2018.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30355510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCktLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=842&publication_year=2019&pages=10-19&author=Y.+Yanauthor=Y.+Wangauthor=X.+Wangauthor=D.+Liuauthor=X.+Wuauthor=C.+Xuauthor=C.+Chenauthor=Z.+Li&title=The+effects+of+jolkinolide+B+on+HepG2+cells+as+revealed+by+1H-NMR-based+metabolic+profiling&doi=10.1016%2Fj.ejphar.2018.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of jolkinolide B on HepG2 cells as revealed by 1H-NMR-based metabolic profiling</span></div><div class="casAuthors">Yan, Yujing; Wang, Yingfeng; Wang, Xia; Liu, Dewen; Wu, Xiuyuan; Xu, Can; Chen, Chang; Li, Zhongfeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">842</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-19</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Jolkinolide B (JB), which is isolated from the dried root of Euphorbia fischeriana Steud., has been reported to possess various therapeutic effects, such as treatment of edema and abdominal distention and protection against acute lung injury, and it has also been reported to have anti-inflammatory even antitumor properties.  In the current work, a cellular metabolomics evaluation based on the NMR (NMR) approach was applied to investigate the mechanism of JB in HepG2 cells.  In addn., biol. assays such as the MTT assay, DAPI staining and the Annexin V-FITC/PI assay were implemented to evaluate cell viability and apoptosis in JB-treated cells.  Subsequently, we used multivariate statistical analyses, such as principal component anal. (PCA) and orthogonal projection to latent structure with discriminant anal. (OPLS-DA) to identify metabolic biomarkers.  In total, 36 metabolites in the cell ext. samples and 30 metabolites in the cell culture media samples were clearly identified to be altered after the treatment.  Variations in the specific metabolites suggested that HepG2 cells that were exposed to JB displayed the disordered effects in multiple metabolic pathways, such as the tricarboxylic acid cycle, amino acid metab., GSH synthesis and pyruvate metab.  NMR-based cell metabolomics provided a holistic method for the identification of JB's antitumor mechanisms and the exploration of its potential applications in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsq1oeOWaaALVg90H21EOLACvtfcHk0ljE4czs1k6VvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCktLrE&md5=f3b276a5abd725a3af711e2028a92fdc</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DThe%2520effects%2520of%2520jolkinolide%2520B%2520on%2520HepG2%2520cells%2520as%2520revealed%2520by%25201H-NMR-based%2520metabolic%2520profiling%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D842%26spage%3D10%26epage%3D19%26doi%3D10.1016%2Fj.ejphar.2018.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span> <span> </span><span class="NLM_article-title">Antimetastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1117</span>– <span class="NLM_lpage">1122</span>, <span class="refDoi"> DOI: 10.3892/ol.2015.3310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2015.3310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26622636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1117-1122&author=C.+Sunauthor=H.+Cuiauthor=H.+Yangauthor=X.+Duauthor=L.+Yueauthor=J.+Liuauthor=Y.+Lin&title=Antimetastatic+effect+of+jolkinolide+B+and+the+mechanism+of+activity+in+breast+cancer+MDA-MB-231+cells&doi=10.3892%2Fol.2015.3310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-metastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells</span></div><div class="casAuthors">Sun, Chao; Cui, Fiongxia; Yang, Hongyan; Du, Xiaohut; Yue, Liling; Liu, Jicheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Tumor metastasis is the main cause of mortality in cancer patients.  However, no effective therapies are currently available to prevent metastasis.  Cell adhesion to the extracellular matrix (ECM) is crucial in cancer progression and metastasis.  Thus, suppression of cell adhesion may be an effective therapeutic strategy for the prevention of metastasis.  In the present study, the anti-adhesion and anti-invasion effects of jolkinolide B, a diterpenoid compd. from Enphorbia fischeriana Steud, that were exerted through suppression of β1-integrin expression and phosphorylation of focal adhesion kinase (FAK) were examd. in human breast cancer MDA-MB-231 cells.  Jolkinolide B inhibited the adhesion of MDA-MB-231 cells to fibroneetin but not to poly-L-lysine.  In addn., olkinolidc B inhibited extracellular signal-regulated kinase (ERK) phosphorylation.  U0126, an ERK inhibitor, also suppressed the invasion and adhesion of MDA-MB-231 cells.  Overall, the present data demonstrated that jolkinolidc B is a novel inhibitor of FAK-mediated signaling pathways that is involved in decreasing cell adhe-sion and invasion.  M itogert-activated protein kinase/ERK kinase may play a crit. role in these effects, indicating that jolkinolide B possesses therapeutic potential for the treatment of breast cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJapX9PAs0jbVg90H21EOLACvtfcHk0lg_nyzZcuPgfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOis70%253D&md5=d0867879826ee80c66241d781ad8b909</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.3892%2Fol.2015.3310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2015.3310%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26atitle%3DAntimetastatic%2520effect%2520of%2520jolkinolide%2520B%2520and%2520the%2520mechanism%2520of%2520activity%2520in%2520breast%2520cancer%2520MDA-MB-231%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2015%26volume%3D10%26spage%3D1117%26epage%3D1122%26doi%3D10.3892%2Fol.2015.3310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">36114</span>, <span class="refDoi"> DOI: 10.1038/srep36114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep36114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27796318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSitL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36114&author=C.+Gaoauthor=X.+Yanauthor=B.+Wangauthor=L.+Yuauthor=J.+Hanauthor=D.+Liauthor=Q.+Zheng&title=Jolkinolide+B+induces+apoptosis+and+inhibits+tumor+growth+in+mouse+melanoma+B16F10+cells+by+altering+glycolysis&doi=10.1038%2Fsrep36114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis</span></div><div class="casAuthors">Gao, Caixia; Yan, Xinyan; Wang, Bo; Yu, Lina; Han, Jichun; Li, Defang; Zheng, Qiusheng</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36114</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most cancer cells preferentially rely on glycolysis to produce the energy (ATP, ATP) for growth and proliferation.  Emerging evidence demonstrates that the apoptosis in cancer cells could be closely assocd. with the inhibition of glycolysis.  In this study, we have found that jolkinolide B (JB), a bioactive diterpenoid extd. from the root of Euphorbia fischeriana Steud, induced tumor cells apoptosis and decreased the prodn. of ATP and lactic acid in mouse melanoma B16F10 cells.  Furthermore, we found that JB downregulated the mRNA expression of glucose transporter genes (Glut1, Glut3 and Glut4) and glycolysis-related kinase genes (Hk2 and Ldha) in B16F10 cells.  Moreover, treatment with JB upregulated the mRNA expression of pro-apoptosis genes (Bax), downregulated the mRNA expression of anti-apoptosis genes (Bcl-2, Caspase-3 and Caspase-9), decreased the potential of mitochondrial membrane and increased reactive oxygen species (ROS) levels in B16F10 cells.  Finally, intragastric administration of JB suppressed tumor growth and induced tumor apoptosis in mouse xenograft model of murine melanoma B16F10 cells.  Taken together, these results suggest that JB could induce apoptosis through the mitochondrial pathway and inhibit tumor growth.  The inhibition of glycolysis could play a crucial role in the induction of apoptosis in JB-treated B16F10 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE_uUACM62rrVg90H21EOLACvtfcHk0lhzv2S1Mtbq4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSitL3K&md5=f0cc0c3765ae207bceaca7fad195170d</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1038%2Fsrep36114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36114%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DQ.%26atitle%3DJolkinolide%2520B%2520induces%2520apoptosis%2520and%2520inhibits%2520tumor%2520growth%2520in%2520mouse%2520melanoma%2520B16F10%2520cells%2520by%2520altering%2520glycolysis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36114%26doi%3D10.1038%2Fsrep36114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B from <i>Euphorbia fischeriana</i> Steud. induces apoptosis in human leukemic cell via JAK2/STAT3 pathways</span>. <i>Int. J. Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.5414/CP201807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5414%2FCP201807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23253949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC3s3jtlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=170-178&author=J.-H.+Wangauthor=K.+Zhangauthor=H.-Y.+Niuauthor=L.-H.+Shuauthor=D.-M.+Yueauthor=D.-Y.+Liauthor=P.+He&title=Jolkinolide+B+from+Euphorbia+fischeriana+Steud.+induces+apoptosis+in+human+leukemic+cell+via+JAK2%2FSTAT3+pathways&doi=10.5414%2FCP201807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways</span></div><div class="casAuthors">Wang Jia-He; Zhang Ke; Niu Hui-Yan; Shu Lin-Hua; Yue Dong-Mei; Li Dong- Yang; He Ping</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-8</span>
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    </div><div class="casAbstract">Jolkinolide B from the roots of Euphorbia fischeriana Steud exhibits significant antitumor activities against several tumor lines.  Previous study has shown that Jolkinolide B could induce apoptosis in human leukemia cells.  However, the exact mechanism and signaling pathway involved in Jolkinolide B-induced apoptosis have not been fully elucidated.  In the present study, we found that Jolkinolide B reduced cell viability and induced apoptosis in dose- and time-dependent manner in human leukemic HL-60 and THP-1 cells.  The induction of apoptosis was accompanied by the downregulation of JAK2/STAT3.  Our results also suggest that expression of Bcl-2 and mitochondrial cytochrome c was dosedependently reduced following Jolkinolide B-treated THP-1 and HL-60 cells, whereas Jolkinolide B up-regulated the expression of Bax and cytosolic cytochrome c.  Moreover, we observed that Jolkinolide B treatment resulted in activation of caspase-3, -8, and -9.  JSI-124, a STAT-3 inhibitor, was able to block the negative effect of Jolkinolide B on cell apoptosis.  Taken together, our study for the first time suggests that Jolkinolide B is able to enhance apoptosis of human leukemic HL-60 and THP-1 cells, at least in part, through downregulation of JAK2/STAT3 and bcl-2, and upregulation of Bax and cytosolic cytochrome c.  Moreover, the triggering of caspase-3, -8, and -9 activation mediated apoptotic induction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScp4np4qQVT5w7prLlxLOzfW6udTcc2eYvW92Xd4ssN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3jtlGiuw%253D%253D&md5=0712eb5c0a1158ac6c8ad603377be5f7</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.5414%2FCP201807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5414%252FCP201807%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.-H.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DNiu%26aufirst%3DH.-Y.%26aulast%3DShu%26aufirst%3DL.-H.%26aulast%3DYue%26aufirst%3DD.-M.%26aulast%3DLi%26aufirst%3DD.-Y.%26aulast%3DHe%26aufirst%3DP.%26atitle%3DJolkinolide%2520B%2520from%2520Euphorbia%2520fischeriana%2520Steud.%2520induces%2520apoptosis%2520in%2520human%2520leukemic%2520cell%2520via%2520JAK2%252FSTAT3%2520pathways%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmacol.%2520Ther.%26date%3D2013%26volume%3D51%26spage%3D170%26epage%3D178%26doi%3D10.5414%2FCP201807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-C.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.3892/or.2012.2113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2For.2012.2113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23129237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksl2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=212-218&author=H.-Y.+Xuauthor=Z.-W.+Chenauthor=J.-C.+Houauthor=F.-X.+Duauthor=J.-C.+Liu&title=Jolkinolide+B+induces+apoptosis+in+MCF-7+cells+through+inhibition+of+the+PI3K%2FAkt%2FmTOR+signaling+pathway&doi=10.3892%2For.2012.2113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway</span></div><div class="casAuthors">Xu, Hui-Yu; Chen, Zhi-Wei; Hou, Jin-Cai; Du, Feng-Xia; Liu, Ji-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">The aim of this study was to explore the mol. mechanisms of jolkinolide B (JB), which is extd. from the root of Euphorbia fischeriana Steud.  In this study, we found that JB, a diterpenoid from the traditional Chinese medicinal herb, strongly inhibited the PI3K/Akt/mTOR signaling pathway.  Furthermore, we evaluated the effects of JB on the proliferation and apoptosis of MCF-7 human breast cancer cells.  Our results showed significant induction of apoptosis in MCF-7 cells incubated with JB.  The viability of the MCF-7 cells was assessed by MTT assay.  Flow cytometry was used to detect apoptosis and cell cycle anal.  Transmission electron microscopy (TEM) anal. was used to observe cell morphol.  MCF-7 cells were s.c. inoculated into nude mice to study the in vivo antitumor effects of JB.  The growth of MCF-7 cells was inhibited and arrested in the S phase by JB.  The data showed significantly decreased tumor vol. and wt. in nude mice inoculated with MCF-7 cells.  In addn., treatment with JB was able to induce downregulation of cyclinDl, cyclinE, mTOR, p-PI3K and p-Akt, and upregulation of PTEN and p-eIF4E.  Collectively, JB-induced apoptosis of MCF-7 cells occurs through the PI3K/Akt/mTOR signaling pathway.  Furthermore, the PI3K/Akt signaling cascade plays a role in the induction of apoptosis in JB-treated cells.  These observations suggest that JB may have therapeutic applications in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Xm8_l4YBarVg90H21EOLACvtfcHk0liJt4XklYz72w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksl2hsw%253D%253D&md5=3163200098761a007b502b9c3aca8905</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.3892%2For.2012.2113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2012.2113%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.-Y.%26aulast%3DChen%26aufirst%3DZ.-W.%26aulast%3DHou%26aufirst%3DJ.-C.%26aulast%3DDu%26aufirst%3DF.-X.%26aulast%3DLiu%26aufirst%3DJ.-C.%26atitle%3DJolkinolide%2520B%2520induces%2520apoptosis%2520in%2520MCF-7%2520cells%2520through%2520inhibition%2520of%2520the%2520PI3K%252FAkt%252FmTOR%2520signaling%2520pathway%26jtitle%3DOncol.%2520Rep.%26date%3D2013%26volume%3D29%26spage%3D212%26epage%3D218%26doi%3D10.3892%2For.2012.2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.-Y.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca<sup>2+</sup>-mitochondria dependent pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">91223</span>– <span class="NLM_lpage">91237</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.20077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29207638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1M3otFyktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=91223-91237&author=J.+Zhangauthor=Y.+Wangauthor=Y.+Zhouauthor=Q.-Y.+He&title=Jolkinolide+B+induces+apoptosis+of+colorectal+carcinoma+through+ROS-ER+stress-Ca2%2B-mitochondria+dependent+pathway&doi=10.18632%2Foncotarget.20077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca(2+)-mitochondria dependent pathway</span></div><div class="casAuthors">Zhang Jing; Wang Yang; Zhou Ye; He Qing-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">91223-91237</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal carcinoma (CRC) remains one of the leading causes of death in cancer-related diseases.  In this study, we aimed to investigate the anticancer effect of Jolkinolide B (JB), a bioactive diterpenoid component isolated from the dried roots of Euphorbia fischeriana Steud, on CRC cells and its underlying mechanisms.  We found that JB suppressed the cell viability and colony formation of CRC cells, HT29 and SW620.  Annexin V/PI assay revealed that JB induced apoptosis in CRC cells, which was further confirmed by the increased expression of cleaved-caspase3 and cleaved-PARP. iTRAQ-based quantitative proteomics was performed to identify JB-regulated proteins in CRC cells.  Gene Ontology (GO) analysis revealed that these JB-regulated proteins were mainly involved in ER stress response, which was evidenced by the expression of ER stress marker proteins, HSP90, Bip and PDI.  Moreover, we found that JB provoked the generation of reactive oxygen species (ROS), and that inhibition of the ROS generation with N-acetyl L-cysteine could reverse the JB-induced apoptosis.  Confocal microscopy and flow cytometry showed that JB treatment enhanced intracellular and mitochondrial Ca(2+) level and JC-1 assay revealed a loss of mitochondrial membrane potential in CRC after JB treatment.  The mitochondrial Ca(2+) uptake and depolarization can be blocked by Ruthenium Red (RuRed), an inhibitor of mitochondrial Ca(2+) uniporter.  Taken together, we demonstrated that JB exerts its anticancer effect by ER stress-Ca(2+)-mitochondria signaling, suggesting the promising chemotherapeutic potential of JB for the treatment of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnMJHvdBDxTkH3Rlp_k91zfW6udTcc2eaStVzDwlIkjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3otFyktg%253D%253D&md5=ac311c7c382e4e21b0a8b3b98bf0bfa7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20077%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DQ.-Y.%26atitle%3DJolkinolide%2520B%2520induces%2520apoptosis%2520of%2520colorectal%2520carcinoma%2520through%2520ROS-ER%2520stress-Ca2%252B-mitochondria%2520dependent%2520pathway%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D91223%26epage%3D91237%26doi%3D10.18632%2Foncotarget.20077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">4967</span>– <span class="NLM_lpage">4974</span>, <span class="refDoi"> DOI: 10.1002/jcb.26742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjcb.26742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29384225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=4967-4974&author=X.+Gaoauthor=H.+Han&title=Jolkinolide+B+inhibits+glycolysis+by+downregulating+hexokinase+2+expression+through+inactivating+the+Akt%2FmTOR+pathway+in+non-small+cell+lung+cancer+cells&doi=10.1002%2Fjcb.26742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells</span></div><div class="casAuthors">Gao, Xiang; Han, Han</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4967-4974</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Jolkinolide B (JB), a bioactive compd. isolated from herbal medicine, has been found to inhibit tumor growth by altering glycolysis.  However, whether glycolysis is influenced by JB in non-small cell lung cancer (NSCLC) cells and the mechanism remain unknown.  The aim of the present study was to evaluate the effect of JB on the glycolysis in NSCLC cells and the underlying mol. mechanism.  The results showed that JB treatment inhibited cell viability of A549 and H1299 cells in a concn.-dependent manner.  JB reduced the glucose consumption, lactate prodn., and HK2 expression.  The expressions of p-Akt and p-mTOR were also decreased by JB treatment.  Knockdown of HK2 reduced glucose consumption and lactate prodn.  Inhibition of the Akt/mTOR pathway decreased HK2 expression and inhibited glycolysis.  In conclusion, the results indicated that JB inhibits glycolysis by down-regulating HK2 expression through inactivating the Akt/mTOR pathway in NSCLC cells, suggesting that JB might be a potential therapeutic agent for the treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLZlhhbSksW7Vg90H21EOLACvtfcHk0ljXwYjH09Z6BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWru7k%253D&md5=3e3a56f04a97efb0f8280460d2b30e3b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26742%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DH.%26atitle%3DJolkinolide%2520B%2520inhibits%2520glycolysis%2520by%2520downregulating%2520hexokinase%25202%2520expression%2520through%2520inactivating%2520the%2520Akt%252FmTOR%2520pathway%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D119%26spage%3D4967%26epage%3D4974%26doi%3D10.1002%2Fjcb.26742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Euphonoids A-G, cytotoxic diterpenoids from <i>Euphorbia fischeriana</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">112064</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2019.112064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2019.112064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31325614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2019&pages=112064&author=X.-L.+Yanauthor=J.-S.+Zhangauthor=J.-L.+Huangauthor=Y.+Zhangauthor=J.-Q.+Chenauthor=G.-H.+Tangauthor=S.+Yin&title=Euphonoids+A-G%2C+cytotoxic+diterpenoids+from+Euphorbia+fischeriana&doi=10.1016%2Fj.phytochem.2019.112064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Euphonoids A-G, cytotoxic diterpenoids from Euphorbia fischeriana</span></div><div class="casAuthors">Yan, Xue-Long; Zhang, Jun-Sheng; Huang, Jia-Luo; Zhang, Yao; Chen, Jia-Qi; Tang, Gui-Hua; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112064</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Seven previously undescribed polycyclic diterpenoids, euphonoids A-G, including four ent-abietanes, two ent-atisanes, and one ent-kaurene, along with 26 known analogs were isolated from the roots of Euphorbia fischeriana.  The structures of the undescribed compds. were elucidated by spectroscopic anal., ECD calcns., and single crystal X-ray diffraction.  Besides, the structure of a previously reported ent-abietane diterpenoid, fischeriabietane A, was revised.  All the isolates were screened for the cytotoxicities against five cancer cell lines.  Euphonoid A(I), fischeriabietane A, 11-oxo-ebracteolatanolide B, caudicifolin, jolkinolide B, and methyl-8,11-3-dihydroxy-12-oxo-ent-abietadi-13,15(17)-ene-16-oate showed significant inhibitory activities against human prostate cancer C4-2B and C4-2B/ENZR cell lines, with IC50 values being less than 10 μM.  The brief structure-activity relationships (SARs) of these diterpenoids were also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmhm6LsBkMALVg90H21EOLACvtfcHk0lgoABglHzBNCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtb3L&md5=3bc0fd85816e6cfa2c1ed56031bcab5e</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2019.112064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2019.112064%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.-L.%26aulast%3DZhang%26aufirst%3DJ.-S.%26aulast%3DHuang%26aufirst%3DJ.-L.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.-Q.%26aulast%3DTang%26aufirst%3DG.-H.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DEuphonoids%2520A-G%252C%2520cytotoxic%2520diterpenoids%2520from%2520Euphorbia%2520fischeriana%26jtitle%3DPhytochemistry%26date%3D2019%26volume%3D166%26spage%3D112064%26doi%3D10.1016%2Fj.phytochem.2019.112064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, G.-W.</span></span> <span> </span><span class="NLM_article-title">Diterpenoids from the roots of <i>Euphorbia fischeriana</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1021/np0600088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np0600088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=967-970&author=Y.-B.+Wangauthor=R.+Huangauthor=H.-B.+Wangauthor=H.-Z.+Jinauthor=L.-G.+Louauthor=G.-W.+Qin&title=Diterpenoids+from+the+roots+of+Euphorbia+fischeriana&doi=10.1021%2Fnp0600088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Diterpenoids from the Roots of Euphorbia fischeriana</span></div><div class="casAuthors">Wang, Yu-Bo; Huang, Rong; Wang, Hong-Bing; Jin, Hui-Zi; Lou, Li-Guang; Qin, Guo-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">967-970</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">From the dried roots of Euphorbia fischeriana, 7 new diterpenoids, 3α,17-dihydroxy-ent-pimara-8(14),15-diene (1), 7β,11β,12β-trihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide (2), 17-acetoxyjolkinolide B (3), 13β-hydroxy-ent-abiet-8(14)-en-7-one (4), 12-deoxyphorbaldehyde-13-acetate (5) 12-deoxyphorbaldehyde-13-hexadecacetate (6), and 12-deoxyphorbol-13-(9Z)-octadecanoate-20-acetate (7), and 2 known compds., 12-deoxyphorbol-13-decanoate (8) and prostratin (9), were isolated.  The structures of the new compds. were elucidated on the basis of spectroscopic anal.  The structure of compd. 1 was confirmed by single-crystal X-ray crystallog.  Compds. 3 and 8 exhibited potent cytotoxic activity to Ramos B cells with IC50 values of 0.023 and 0.0051 μg/mL, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrusZB34QGnQbVg90H21EOLACvtfcHk0lg6fat7aF9ktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSnsLs%253D&md5=7f3d672c2606e54a8aeabba287624255</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fnp0600088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp0600088%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-B.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.-B.%26aulast%3DJin%26aufirst%3DH.-Z.%26aulast%3DLou%26aufirst%3DL.-G.%26aulast%3DQin%26aufirst%3DG.-W.%26atitle%3DDiterpenoids%2520from%2520the%2520roots%2520of%2520Euphorbia%2520fischeriana%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2006%26volume%3D69%26spage%3D967%26epage%3D970%26doi%3D10.1021%2Fnp0600088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H. H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, Z.-D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic diterpenoids from the roots of <i>Euphorbia ebracteolata</i></span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1055/s-2005-864102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fs-2005-864102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=15856412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFKrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2005&pages=349-354&author=H.-M.+Shiauthor=I.+D.+Williamsauthor=H.+H.-Y.+Sungauthor=H.-X.+Zhuauthor=N.+Y.+Ipauthor=Z.-D.+Min&title=Cytotoxic+diterpenoids+from+the+roots+of+Euphorbia+ebracteolata&doi=10.1055%2Fs-2005-864102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic diterpenoids from the roots of Euphorbia ebracteolata</span></div><div class="casAuthors">Shi, Hai-Ming; Williams, Ian D.; Sung, Herman H.-Y.; Zhu, Hua-Xu; Ip, Nancy Y.; Min, Zhi-Da</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Three new diterpenoids, yuexiandajisu D (1), E (2) and F were isolated from the roots of Euphorbia ebracteolata, along with eight known diterpenoids, jolkinolide B (4), jolkinolide A, ent-11α-hydroxyabieta-8(14),13(15)-dien-16,12α-olide (6), ent-(13S)-hydroxyatis-16-ene-3,14-dione, ent-3β,(13S)-dihydroxyatis-16-en-14-one, ent-3-oxokaurane-16α,17-diol, ent-16α,17-dihydroxyatisan-3-one and ent-atisane-3β,16α,17-triol.  The structures of all compds. were deduced using spectroscopic methods and confirmed for 1 and 2 by single-crystal x-ray diffraction.  A biogenetic pathway for the formation of 1 and 2 is proposed briefly.  Cytotoxic activities were evaluated against ANA-1, B 16 and Jurkat tumor cells.  Jolkinolide B (4) displayed modest activity on ANA-1, B 16 and Jurkat tumor cells with IC50 values 4.46×10-2, 4.48×10-2, 6.47×10-2 μM, and ent-11α-hydroxyabieta-8(14), 13(15)-dien-16,12α-olide (6) showed significant activity against ANA-1 and Jurkat cells with IC50 values 7.12×10-3 and 1.79×10-2 μM.  Compd. 1 was found to be slightly active against ANA-1 cells with an IC50 value 2.88×10-1 μM.  Structure-activity relationships of isolated compds. are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3wl36G1yevbVg90H21EOLACvtfcHk0lg6fat7aF9ktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFKrsbY%253D&md5=9ec32a892333c65856fa82976c3f507c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1055%2Fs-2005-864102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2005-864102%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DH.-M.%26aulast%3DWilliams%26aufirst%3DI.%2BD.%26aulast%3DSung%26aufirst%3DH.%2BH.-Y.%26aulast%3DZhu%26aufirst%3DH.-X.%26aulast%3DIp%26aufirst%3DN.%2BY.%26aulast%3DMin%26aufirst%3DZ.-D.%26atitle%3DCytotoxic%2520diterpenoids%2520from%2520the%2520roots%2520of%2520Euphorbia%2520ebracteolata%26jtitle%3DPlanta%2520Med.%26date%3D2005%26volume%3D71%26spage%3D349%26epage%3D354%26doi%3D10.1055%2Fs-2005-864102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mangisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tembu, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nthambeleni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langat, M. K.</span></span> <span> </span><span class="NLM_article-title"><i>ent</i>-Abietane diterpenoids from <i>Suregada zanzibariensis</i> Baill. (Euphorbiaceae), their cytotoxic and anticancer properties</span>. <i>Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3240</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1080/14786419.2018.1470628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F14786419.2018.1470628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29741101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptFCmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=3240-3247&author=M.+Mangisaauthor=V.+J.+Tembuauthor=G.+Foucheauthor=R.+Nthambeleniauthor=X.+Peterauthor=M.+K.+Langat&title=ent-Abietane+diterpenoids+from+Suregada+zanzibariensis+Baill.+%28Euphorbiaceae%29%2C+their+cytotoxic+and+anticancer+properties&doi=10.1080%2F14786419.2018.1470628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-abietane diterpenoids from Suregada zanzibariensis Baill. (Euphorbiaceae), their cytotoxic and anticancer properties</span></div><div class="casAuthors">Mangisa, Mandisa; Tembu, Vuyelwa J.; Fouche, Gerda; Nthambeleni, Rudzani; Peter, Xolani; Langat, Moses K.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3240-3247</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The stem bark ext. of Suregada zanzibariensis afforded a previously undescribed ent-abietane diterpenoid trivially named mangiolide (1) and a known jolkinolide B (2) via anticancer bioassay-guided fractionation.  The CH2Cl2:MeOH ext. of S. zanzibariensis was initially analyzed for its anticancer properties against three cancer cell lines, renal (TK10), melanoma (UACC62), and breast (MCF7) and was found to be potent at low μg/mL ranges.  Compd. (1), 6α-acetoxy-14-keto-ent-abieta-7(8),13(15)-diene-16,12-olide (mangiolide) inhibited the growth of renal (TK10) with a GIC50 of 0.02 μg/mL; a GIC50 of 0.03 μg/mL for melanoma (UACC62) and a GIC50 of 0.05 μg/mL for breast (MCF7) cancer cell lines.  Compd. (2), 8,13-diepoxy-13,15-ent-abietene-16,12-olide (jolkinolide B) inhibited the growth (GIC50) of the cell lines at 3.31 μg/mL for renal (TK10), 0.94 μg/mL for melanoma (UACC62) and 2.99 μg/mL for the breast (MCF7).  The structures were established on the basis of their spectroscopic anal. and the abs. stereostructures assigned using electronic CD (ECD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUFKcj0oWxH7Vg90H21EOLACvtfcHk0lgXcAya-mmxfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptFCmsbg%253D&md5=86a162097e0f608cc9783d99764d1224</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1080%2F14786419.2018.1470628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786419.2018.1470628%26sid%3Dliteratum%253Aachs%26aulast%3DMangisa%26aufirst%3DM.%26aulast%3DTembu%26aufirst%3DV.%2BJ.%26aulast%3DFouche%26aufirst%3DG.%26aulast%3DNthambeleni%26aufirst%3DR.%26aulast%3DPeter%26aufirst%3DX.%26aulast%3DLangat%26aufirst%3DM.%2BK.%26atitle%3Dent-Abietane%2520diterpenoids%2520from%2520Suregada%2520zanzibariensis%2520Baill.%2520%2528Euphorbiaceae%2529%252C%2520their%2520cytotoxic%2520and%2520anticancer%2520properties%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2019%26volume%3D33%26spage%3D3240%26epage%3D3247%26doi%3D10.1080%2F14786419.2018.1470628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span> <span> </span><span class="NLM_article-title">17-Hydroxyjolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">7302</span>– <span class="NLM_lpage">7310</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-0462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F0008-5472.CAN-09-0462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19706767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7302-7310&author=Y.+Wangauthor=X.+Maauthor=S.+Yanauthor=S.+Shenauthor=H.+Zhuauthor=Y.+Guauthor=H.+Wangauthor=G.+Qinauthor=Q.+Yu&title=17-Hydroxyjolkinolide+B+inhibits+signal+transducers+and+activators+of+transcription+3+signaling+by+covalently+cross-linking+Janus+kinases+and+induces+apoptosis+of+human+cancer+cells&doi=10.1158%2F0008-5472.CAN-09-0462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">17-Hydroxy-jolkinolide B Inhibits Signal Transducers and Activators of Transcription 3 Signaling by Covalently Cross-Linking Janus Kinases and Induces Apoptosis of Human Cancer Cells</span></div><div class="casAuthors">Wang, Ying; Ma, Xiuquan; Yan, Shousheng; Shen, Shensi; Zhu, Huiling; Gu, Yuan; Wang, Hongbing; Qin, Guowei; Yu, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7302-7310</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive activation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway occurs frequently in cancer cells and contributes to oncogenesis.  Among the members of STAT family, STAT3 plays a pivotal role in the development and progression of human tumors.  The STAT3-mediated signaling pathway has been recognized as a promising anticancer target.  Here, we show that 17-Hydroxy-jolkinolide B (HJB), a diterpenoid from the Chinese medicinal herb Euphorbia fischeriana Steud, strongly inhibits interleukin (IL)-6-induced as well as constitutive STAT3 activation.  Furthermore, we show that HJB directly targets the JAK family kinases, JAK1, JAK2, and TYK2, by inducing dimerization of the JAKs via crosslinking.  Addn. of DTT or glutathione prevents the JAK crosslinking and blocks the inhibitory effects of HJB on IL-6-induced STAT3 activation, suggesting that HJB may react with cystein residues of JAKs to form covalent bonds that inactivate JAKs.  Liq. chromatog./mass spectrometry anal. confirmed that each HJB reacted with two thiols.  The effect of HJB on the JAK/STAT3 pathway is specific as HJB has no effect on platelet-derived growth factor, epidermal growth factor, or insulin-like growth factor I signaling pathways.  Finally, we show that HJB inhibits growth and induces apoptosis of tumor cells, particularly those tumor cells with constitutively activated STAT3.  We propose that the natural compd. HJB is a promising anticancer drug candidate as a potent STAT3 signaling inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpns_2dXS-p4bVg90H21EOLACvtfcHk0lh0IcNkVH6A4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7rO&md5=29eb6931e70cc6c7b2616c8aa58ce287</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-0462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-0462%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3D17-Hydroxyjolkinolide%2520B%2520inhibits%2520signal%2520transducers%2520and%2520activators%2520of%2520transcription%25203%2520signaling%2520by%2520covalently%2520cross-linking%2520Janus%2520kinases%2520and%2520induces%2520apoptosis%2520of%2520human%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D7302%26epage%3D7310%26doi%3D10.1158%2F0008-5472.CAN-09-0462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, G.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span> <span> </span><span class="NLM_article-title">17-Acetoxyjolkinolide B irreversibly inhibits IκB kinase and induces apoptosis of cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1523</span>– <span class="NLM_lpage">1532</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1535-7163.MCT-08-0263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=18566223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVSktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1523-1532&author=S.-S.+Yanauthor=Y.+Liauthor=Y.+Wangauthor=S.-S.+Shenauthor=Y.+Guauthor=H.-B.+Wangauthor=G.-W.+Qinauthor=Q.+Yu&title=17-Acetoxyjolkinolide+B+irreversibly+inhibits+I%CE%BAB+kinase+and+induces+apoptosis+of+cancer+cells&doi=10.1158%2F1535-7163.MCT-08-0263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">17-Acetoxyjolkinolide B irreversibly inhibits IκB kinase and induces apoptosis of tumor cells</span></div><div class="casAuthors">Yan, Shou-Sheng; Li, Ying; Wang, Ying; Shen, Shen-Si; Gu, Yuan; Wang, Hong-Bing; Qin, Guo-Wei; Yu, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1523-1532</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nuclear factor-κB (NF-κB) is critically important for tumor cell survival, growth, angiogenesis, and metastasis.  One of the key events in the NF-κB signaling is the activation of inhibitor of NF-κB kinase (IKK) in response to stimuli of various cytokines.  We have identified 17-acetoxyjolkinolide B (17-AJB) from a traditional Chinese medicinal herb Euphorbia fischeriana Steud as a novel small-mol. inhibitor of IKK.  17-AJB effectively inhibited tumor necrosis factor-α-induced NF-κB activation and induced apoptosis of tumor cells.  17-AJB had no effect on binding of tumor necrosis factor-α to its receptor or on binding of NF-κB to DNA.  It inhibited NF-κB nuclear translocation.  Detailed anal. revealed that the direct target of 17-AJB was IKK.  17-AJB kept IKK in its phosphorylated form irreversibly.  This irreversible modification of IKK inactivated its kinase activity, leading to its failure to activate NF-κB.  The effect of 17-AJB on IKK was specific.  It had no effect on other kinases such as p38, p44/42, and JNK.  In addn., 17-AJB induced apoptosis in tumor cells.  The effects of 17-AJB on apoptosis correlated with inhibition of expression of the NF-κB-regulated genes.  Taken together, our data suggest that 17-AJB is a novel type NF-κB pathway inhibitor.  Its unique interaction mechanism with IKK may render it a strong apoptosis inducer of tumor cells and a novel type anticancer drug candidate. [Mol Cancer Ther 2008;7(6):1523-32].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDk1JrGK0qfbVg90H21EOLACvtfcHk0lj9KqOYwYHQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVSktLs%253D&md5=cf9f32601c3193cca747326f180bd0a1</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0263%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.-S.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DS.-S.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.-B.%26aulast%3DQin%26aufirst%3DG.-W.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3D17-Acetoxyjolkinolide%2520B%2520irreversibly%2520inhibits%2520I%25CE%25BAB%2520kinase%2520and%2520induces%2520apoptosis%2520of%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1523%26epage%3D1532%26doi%3D10.1158%2F1535-7163.MCT-08-0263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shriwas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span> <span> </span><span class="NLM_article-title">Plant-derived glucose transport inhibitors with potential antitumor activity</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1002/ptr.6587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fptr.6587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31823431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2020&pages=1027-1040&author=P.+Shriwasauthor=X.+Chenauthor=A.+D.+Kinghornauthor=Y.+Ren&title=Plant-derived+glucose+transport+inhibitors+with+potential+antitumor+activity&doi=10.1002%2Fptr.6587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Plant-derived glucose transport inhibitors with potential antitumor activity</span></div><div class="casAuthors">Shriwas, Pratik; Chen, Xiaozhuo; Kinghorn, A. Douglas; Ren, Yulin</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1027-1040</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Glucose, a key nutrient utilized by human cells to provide cellular energy and a carbon source for biomass synthesis, is internalized in cells via glucose transporters that regulate glucose homeostasis throughout the human body.  Glucose transporters have been used as important targets for the discovery of new drugs to treat cancer, diabetes, and heart disease, owing to their abnormal expression during these disease conditions.  Thus far, several glucose transport inhibitors have been used in clin. trials, and increasing nos. of natural products have been characterized as potential anticancer agents targeting glucose transport.  The present review focuses on natural product glucose transport inhibitors of plant origin, including alkaloids, flavonoids and other phenolic compds., and isoprenoids, with their potential antitumor properties also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpggQdy9_urVg90H21EOLACvtfcHk0lj9KqOYwYHQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFKntLg%253D&md5=97fa2d7593242669420fa98e96716b39</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1002%2Fptr.6587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.6587%26sid%3Dliteratum%253Aachs%26aulast%3DShriwas%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DRen%26aufirst%3DY.%26atitle%3DPlant-derived%2520glucose%2520transport%2520inhibitors%2520with%2520potential%2520antitumor%2520activity%26jtitle%3DPhytother.%2520Res.%26date%3D2020%26volume%3D34%26spage%3D1027%26epage%3D1040%26doi%3D10.1002%2Fptr.6587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, R.</span></span> <span> </span><span class="NLM_article-title">Structures of nagilactones E and F and biological activity of nagilactones as plant growth regulator</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1246/cl.1972.759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1246%2Fcl.1972.759" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1972&pages=759-762&author=Y.+Hayashiauthor=J.+Yokoiauthor=Y.+Watanabeauthor=T.+Sakanauthor=Y.+Masudaauthor=R.+Yamamoto&title=Structures+of+nagilactones+E+and+F+and+biological+activity+of+nagilactones+as+plant+growth+regulator&doi=10.1246%2Fcl.1972.759"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1246%2Fcl.1972.759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.1972.759%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DYokoi%26aufirst%3DJ.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DSakan%26aufirst%3DT.%26aulast%3DMasuda%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DR.%26atitle%3DStructures%2520of%2520nagilactones%2520E%2520and%2520F%2520and%2520biological%2520activity%2520of%2520nagilactones%2520as%2520plant%2520growth%2520regulator%26jtitle%3DChem.%2520Lett.%26date%3D1972%26volume%3D1%26spage%3D759%26epage%3D762%26doi%3D10.1246%2Fcl.1972.759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic bisnor- and norditerpene dilactones having 7α,8α-epoxy-9,11-enolide substructure from <i>Podocarpus macrophyllus</i> D. DON</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1248/cpb.57.668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fcpb.57.668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19571410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=668-679&author=K.+Satoauthor=Y.+Inabaauthor=H.-S.+Parkauthor=T.+Akiyamaauthor=T.+Koyamaauthor=H.+Fukayaauthor=Y.+Aoyagiauthor=K.+Takeya&title=Cytotoxic+bisnor-+and+norditerpene+dilactones+having+7%CE%B1%2C8%CE%B1-epoxy-9%2C11-enolide+substructure+from+Podocarpus+macrophyllus+D.+DON&doi=10.1248%2Fcpb.57.668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic bisnor- and norditerpene dilactones having 7α,8α-epoxy-9,11-enolide substructure from Podocarpus macrophyllus D. DON</span></div><div class="casAuthors">Sato, Kimihiko; Inaba, Yasunori; Park, Hyun-Sun; Akiyama, Toshiyuki; Koyama, Tetsuo; Fukaya, Haruhiko; Aoyagi, Yutaka; Takeya, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">668-679</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Fourteen new bisnor- and norditerpene dilactones, makilactones E-R, having a 7α:8α-epoxy-9,11-enolide substructure, were isolated from a methanolic ext. of the root and the bark of Podocarpus macrophyllus D. DON (Podocarpaceae) with thirteen known bisnor- and norditerpenoids, and the structures of those new bisnor- and norditerpenoids were detd. on the basis of their spectroscopic studies.  Of the thirteen known ones isolated, the structures of two, i.e., podolactone B and inumakilactone B, were revised on the basis of x-ray crystallog. anal. and spectroscopic anal.  Many of the compds. of this type isolated in this study showed potent cytotoxic activities against P388 murine leukemia cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVfZl54pd0rVg90H21EOLACvtfcHk0lhHwhFsWMFxoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGhurzO&md5=ce08c024ce02bb6fd5d110ffba46669c</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1248%2Fcpb.57.668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.57.668%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DH.-S.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DT.%26aulast%3DFukaya%26aufirst%3DH.%26aulast%3DAoyagi%26aufirst%3DY.%26aulast%3DTakeya%26aufirst%3DK.%26atitle%3DCytotoxic%2520bisnor-%2520and%2520norditerpene%2520dilactones%2520having%25207%25CE%25B1%252C8%25CE%25B1-epoxy-9%252C11-enolide%2520substructure%2520from%2520Podocarpus%2520macrophyllus%2520D.%2520DON%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2009%26volume%3D57%26spage%3D668%26epage%3D679%26doi%3D10.1248%2Fcpb.57.668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.-S.</span></span> <span> </span><span class="NLM_article-title">Two new anti-proliferative C<sub>18</sub>-norditerpenes from the roots of <i>Podocarpus macrophyllus</i></span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>, <span class="NLM_elocation-id">e1800043</span> <span class="refDoi"> DOI: 10.1002/cbdv.201800043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fcbdv.201800043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29573148" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&author=Y.-Y.+Qiauthor=J.+Suauthor=Z.-J.+Zhangauthor=L.-W.+Liauthor=M.+Fanauthor=Y.+Zhuauthor=X.-D.+Wuauthor=Q.-S.+Zhao&title=Two+new+anti-proliferative+C18-norditerpenes+from+the+roots+of+Podocarpus+macrophyllus&doi=10.1002%2Fcbdv.201800043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201800043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201800043%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DY.-Y.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.-J.%26aulast%3DLi%26aufirst%3DL.-W.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.-D.%26aulast%3DZhao%26aufirst%3DQ.-S.%26atitle%3DTwo%2520new%2520anti-proliferative%2520C18-norditerpenes%2520from%2520the%2520roots%2520of%2520Podocarpus%2520macrophyllus%26jtitle%3DChem.%2520Biodiversity%26date%3D2018%26volume%3D15%26doi%3D10.1002%2Fcbdv.201800043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span> <span> </span><span class="NLM_article-title">Norditerpenoids and dinorditerpenoids from the seeds of <i>Podocarpus nagi</i> as cytotoxic agents and autophagy inducers</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2117</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b00347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b00347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2jtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=2110-2117&author=Z.-L.+Fengauthor=L.-L.+Zhangauthor=Y.-D.+Zhengauthor=Q.-Y.+Liuauthor=J.-X.+Liuauthor=L.+Fengauthor=L.+Huangauthor=Q.-W.+Zhangauthor=J.-J.+Luauthor=L.-G.+Lin&title=Norditerpenoids+and+dinorditerpenoids+from+the+seeds+of+Podocarpus+nagi+as+cytotoxic+agents+and+autophagy+inducers&doi=10.1021%2Facs.jnatprod.7b00347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Norditerpenoids and Dinorditerpenoids from the Seeds of Podocarpus nagi as Cytotoxic Agents and Autophagy Inducers</span></div><div class="casAuthors">Feng, Zhe-Ling; Zhang, Le-Le; Zheng, Yuan-Dong; Liu, Qian-Yu; Liu, Jing-Xin; Feng, Lu; Huang, Li; Zhang, Qing-Wen; Lu, Jin-Jian; Lin, Li-Gen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2110-2117</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Nine new norditerpenoids and dinorditerpenoids, 2-oxonagilactone A, 7β-hydroxynagilactone D, nagilactones K and L (I), 3β-hydroxynagilactone L, 2β-hydroxynagilactone L (II), 3-epi-15-hydroxynagilactone D, 1α-chloro-2β,3β,15-trihydroxynagilactone L, and 15-hydroxynagilactone L, were isolated from the seeds of Podocarpus nagi, along with eight known analogs.  The structures of the new compds. were established based on detailed NMR and HRESIMS anal., as well as from their ECD spectra.  The abs. configuration of the known compd. 1-deoxy-2α-hydroxynagilactone A was confirmed by single-crystal X-ray diffraction.  All of the isolates were tested for their cytotoxic activities against cancer cells.  The results indicated that compds. I and II, as well as several known compds., displayed cytotoxicity against A2780 and HEY cancer cells.  Among the new compds., II showed IC50 values of less than 2.5 μM against the two cell lines used.  Furthermore, compd. II induced autophagic flux in A2780 cells, as evidenced by an enhanced expression level of the autophagy marker phosphatidylethanolamine-modified microtubule-assocd. protein light-chain 3 (LC3-II) and increased mRFP-GFP-LC3 puncta.  Also, compd. II activated the c-Jun N-terminal kinase (JNK) pathway, while pretreatment with the JNK inhibitor SP600125 decreased compd. II-induced autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-68I7dtwcf7Vg90H21EOLACvtfcHk0lj2vxZ2Gvfmqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2jtr3I&md5=c8fe5362ec33be06710b0ed760761cf1</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b00347%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DZ.-L.%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DZheng%26aufirst%3DY.-D.%26aulast%3DLiu%26aufirst%3DQ.-Y.%26aulast%3DLiu%26aufirst%3DJ.-X.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.-W.%26aulast%3DLu%26aufirst%3DJ.-J.%26aulast%3DLin%26aufirst%3DL.-G.%26atitle%3DNorditerpenoids%2520and%2520dinorditerpenoids%2520from%2520the%2520seeds%2520of%2520Podocarpus%2520nagi%2520as%2520cytotoxic%2520agents%2520and%2520autophagy%2520inducers%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D2110%26epage%3D2117%26doi%3D10.1021%2Facs.jnatprod.7b00347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Downregulation of cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>830</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejphar.2018.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29680228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlOrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=830&publication_year=2018&pages=17-25&author=L.-L.+Zhangauthor=Z.-L.+Fengauthor=M.-X.+Suauthor=X.-M.+Jiangauthor=X.+Chenauthor=Y.+Wangauthor=A.+Liauthor=L.-G.+Linauthor=J.-J.+Lu&title=Downregulation+of+cyclin+B1+mediates+nagilactone+E-induced+G2+phase+cell+cycle+arrest+in+non-small+cell+lung+cancer+cells&doi=10.1016%2Fj.ejphar.2018.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells</span></div><div class="casAuthors">Zhang, Le-Le; Feng, Zhe-Ling; Su, Min-Xia; Jiang, Xiao-Ming; Chen, Xiuping; Wang, Yitao; Li, Ao; Lin, Li-Gen; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">830</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-25</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) is one of the most common forms and leading causes of cancer-related mortality worldwide, and discovery of new effective drugs still remains imperative to improve the survival rate.  Nagilactone E (NLE) is a natural product isolated from Podocarpus nagi seeds, which has been used as raw materials for edible oil and industrial oil extn.  This study aimed to investigate the anticancer potential of NLE against NSCLC A549 and NCI-H1975 cells.  MTT assay revealed that NLE inhibited the proliferation of A549 and NCI-H1975 cells with IC50s of 5.18±0.49 and 3.57±0.29μM, resp.  NLE treatment inhibited clone formation in both cancer cell lines.  Cell cycle anal. indicated that NLE treatment effectively induced G2 phase cell cycle arrest in A549 and NCI-H1975 cells.  NLE downregulated the phosphorylation of cdc2 (Tyr15) and cdc25C (Ser216) as well as the expression level of the protein kinase Wee1 in concn.- and time-dependent manners.  In addn., NLE treatment decreased the protein level of Cyclin B1 as well as its nuclear localization, which might decrease the activity of the Cyclin B1/cdc2 complex and induce G2 phase arrest.  Long-term NLE treatment also induced caspase-dependent cell apoptosis, as evidenced by increase in Annexin V pos. cells and the cleavage of PARP.  To sum, NLE inhibited proliferation, induced G2 phase arrest, and triggered caspase-dependent apoptosis in NSCLC cells, suggesting it to be a potential leading compd. for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e30sb8oV57Vg90H21EOLACvtfcHk0lh3Qisajo0Vag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlOrtrc%253D&md5=18299c46f235b29de1620ea1d37af219</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DFeng%26aufirst%3DZ.-L.%26aulast%3DSu%26aufirst%3DM.-X.%26aulast%3DJiang%26aufirst%3DX.-M.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-G.%26aulast%3DLu%26aufirst%3DJ.-J.%26atitle%3DDownregulation%2520of%2520cyclin%2520B1%2520mediates%2520nagilactone%2520E-induced%2520G2%2520phase%2520cell%2520cycle%2520arrest%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D830%26spage%3D17%26epage%3D25%26doi%3D10.1016%2Fj.ejphar.2018.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration, and invasion in non-small cell lung cancer cells</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2018.09.222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phymed.2018.09.222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30599910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCiu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=32-39&author=L.-L.+Zhangauthor=X.-M.+Jiangauthor=M.-Y.+Huangauthor=Z.-L.+Fengauthor=X.+Chenauthor=Y.+Wangauthor=H.+Liauthor=A.+Liauthor=L.-G.+Linauthor=J.-J.+Lu&title=Nagilactone+E+suppresses+TGF-%CE%B21-induced+epithelial-mesenchymal+transition%2C+migration%2C+and+invasion+in+non-small+cell+lung+cancer+cells&doi=10.1016%2Fj.phymed.2018.09.222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells</span></div><div class="casAuthors">Zhang, Le-Le; Jiang, Xiao-Ming; Huang, Mu-Yang; Feng, Zhe-Ling; Chen, Xiuping; Wang, Yitao; Li, Hua; Li, Ao; Lin, Li-Gen; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-39</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death around the world.  Epithelial-mesenchymal transition (EMT) has been documented to increase motility and invasiveness of cancer cells, which promotes cancer metastasis.  This study aims to investigate the inhibitory effects and mechanisms of the dinorditerpenoids and norditerpenoids isolated from the seeds of Podocarpus nagi against transforming growth factor (TGF)-β1-induced EMT.  A series of dinorditerpenoids and norditerpenoids were isolated from the seeds of P. nagi.  Western blot and quant. real-time PCR assays were performed to det. the expression levels of relative proteins and mRNA, along with immunofluorescence, Smad-binding element (SBE)-luciferase and chromatin immunopptn. (ChIP) assays for the mechanism study.  Transwell assays were conducted to det. the effect of the compds. on cell migration and invasion.  Nagilactone E (NLE) showed the superior inhibitory effect against TGF-β1-induced EMT.  NLE treatment dramatically inhibited TGF-β1-induced expression of EMT markers in A549 cells.  Mechanism study indicated that NLE markedly suppressed TGF-β1-induced Smad2 and Smad3 activation and nuclear translocation.  SBE-luciferase and ChIP assays showed that NLE inhibited the combining of Smad3 to SBE in the promoters of the cell signaling factors.  NLE co-treatment attenuated TGF-β1-induced up-regulation of the protein and mRNA levels of TGF-β receptor TβRI.  Furthermore, NLE inhibited TGF-β1-stimulated cell migration and invasion, as well as up-regulation of the key signaling proteins related with migration and invasion.  NLE inhibited TGF-β/Smad signaling pathway, thereafter suppressed TGF-β1-induced EMT, migration and invasion in NSCLC A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQArBZLm-girVg90H21EOLACvtfcHk0ljdLtBmsepSEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCiu7zE&md5=743ab953a037e6cfe7db0602607943a5</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2018.09.222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2018.09.222%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DJiang%26aufirst%3DX.-M.%26aulast%3DHuang%26aufirst%3DM.-Y.%26aulast%3DFeng%26aufirst%3DZ.-L.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-G.%26aulast%3DLu%26aufirst%3DJ.-J.%26atitle%3DNagilactone%2520E%2520suppresses%2520TGF-%25CE%25B21-induced%2520epithelial-mesenchymal%2520transition%252C%2520migration%252C%2520and%2520invasion%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DPhytomedicine%26date%3D2019%26volume%3D52%26spage%3D32%26epage%3D39%26doi%3D10.1016%2Fj.phymed.2018.09.222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/s41401-019-0332-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41401-019-0332-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32047261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivVCntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2020&pages=698-705&author=L.-L.+Zhangauthor=J.+Guoauthor=X.-M.+Jiangauthor=X.-P.+Chenauthor=Y.-T.+Wangauthor=A.+Liauthor=L.-G.+Linauthor=H.+Liauthor=J.-J.+Lu&title=Identification+of+nagilactone+E+as+a+protein+synthesis+inhibitor+with+anticancer+activity&doi=10.1038%2Fs41401-019-0332-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity</span></div><div class="casAuthors">Zhang, Le-le; Guo, Jing; Jiang, Xiao-ming; Chen, Xiu-ping; Wang, Yi-tao; Li, Ao; Lin, Li-gen; Li, Hua; Lu, Jin-jian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Norditerpenoids and dinorditerpenoids represent diterpenoids widely distributed in the genus Podocarpus with notable chem. structures and biol. activities.  We previously reported that nagilactone E (NLE), a dinorditerpenoid isolated from Podocarpus nagi, possessed anticancer effects against lung cancer cells in vitro.  In this study we investigated the in vivo effect of NLE against lung cancer as well as the underlying mechanisms.  We administered NLE (10 mg·kg-1·d-1, i.p.) to CB-17/SCID mice bearing human lung cancer cell line A549 xenograft for 3 wk.  We found that NLE administration significantly suppressed the tumor growth without obvious adverse effects.  Thereafter, RNA sequencing (RNA-seq) anal. was performed to study the mechanisms of NLE.  The effects of NLE on A549 cells have been illustrated by GO and pathway enrichment analyses.  CMap dataset anal. supported NLE to be a potential protein synthesis inhibitor.  The inhibitory effect of NLE on synthesis of total de novo protein was confirmed in Click-iT assay.  Using the pcDNA3-RLUC-POLIRES-FLUC luciferase assay we further demonstrated that NLE inhibited both cap-dependent and cap-independent translation.  Finally, mol. docking revealed the low-energy binding conformations of NLE and its potential target RIOK2.  In conclusion, NLE is a protein synthesis inhibitor with anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjqfNwVQCb7LVg90H21EOLACvtfcHk0lh8izUzMuSG2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivVCntrk%253D&md5=e2b86e9113d0397f9cb79ae46e3b8586</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fs41401-019-0332-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41401-019-0332-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.-M.%26aulast%3DChen%26aufirst%3DX.-P.%26aulast%3DWang%26aufirst%3DY.-T.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-G.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.-J.%26atitle%3DIdentification%2520of%2520nagilactone%2520E%2520as%2520a%2520protein%2520synthesis%2520inhibitor%2520with%2520anticancer%2520activity%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2020%26volume%3D41%26spage%3D698%26epage%3D705%26doi%3D10.1038%2Fs41401-019-0332-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, C.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span> <span> </span><span class="NLM_article-title">7α,8α-Epoxynagilactones and their glucosides from the twigs of <i>Podocarpus nagi</i>: Isolation, structures, and cytotoxic activities</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2018.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fitote.2018.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29355751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2018&pages=174-183&author=Y.-D.+Zhengauthor=G.+Baiauthor=C.+Tangauthor=C.-Q.+Keauthor=S.+Yaoauthor=L.-J.+Tongauthor=F.+Fengauthor=Y.+Liauthor=J.+Dingauthor=H.+Xieauthor=Y.+Ye&title=7%CE%B1%2C8%CE%B1-Epoxynagilactones+and+their+glucosides+from+the+twigs+of+Podocarpus+nagi%3A+Isolation%2C+structures%2C+and+cytotoxic+activities&doi=10.1016%2Fj.fitote.2018.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">7α,8α-Epoxynagilactones and their glucosides from the twigs of Podocarpus nagi: Isolation, structures, and cytotoxic activities</span></div><div class="casAuthors">Zheng, Yuan-Dong; Bai, Gang; Tang, Chunping; Ke, Chang-Qiang; Yao, Sheng; Tong, Lin-Jiang; Feng, Fang; Li, Yan; Ding, Jian; Xie, Hua; Ye, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-183</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A phytochem. investigation of twigs of Podocarpus nagi resulted in the identification of eight new type B nagilactones (1-8), all bearing a 7α,8α-epoxy-9(11)-enolide substructure, along with two known analogs (9-10).  Their structures were detd. on the basis of spectroscopic anal., including HRESIMS, IR and NMR expts., and X-ray crystallog. anal.  In vitro cytotoxic assay exhibited that compds. 1, 2, 9 and 10 could induce antiproliferation against three different types of human cancer cells while compds. 3 and 5 were inactive.  Notably, the IC50 value of compd. 1 is 0.208 μM for A431 human epidermoid carcinoma cells, reaching the same level as the pos. control combretastatin A-4 (0.104 μM).  Furthermore, compd. 1 performed a strong inhibition of cancer cells by triggering apoptosis and arresting the cell cycle at G1 phase.  These results unfold potential anticancer therapeutic applications of type B nagilactones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmaqjyL11AR7Vg90H21EOLACvtfcHk0lj2CIyJx7eN-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsrs%253D&md5=b45cc49e338a9eb0f49ba632bc63a13f</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2018.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2018.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.-D.%26aulast%3DBai%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKe%26aufirst%3DC.-Q.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DL.-J.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DY.%26atitle%3D7%25CE%25B1%252C8%25CE%25B1-Epoxynagilactones%2520and%2520their%2520glucosides%2520from%2520the%2520twigs%2520of%2520Podocarpus%2520nagi%253A%2520Isolation%252C%2520structures%252C%2520and%2520cytotoxic%2520activities%26jtitle%3DFitoterapia%26date%3D2018%26volume%3D125%26spage%3D174%26epage%3D183%26doi%3D10.1016%2Fj.fitote.2018.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span> <span> </span><span class="NLM_article-title">New cytotoxic nor- and bisnorditerpene dilactones, makilactones A-D, from <i>Podocarpus macrophyllus</i> D. Don</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1462</span>, <span class="refDoi"> DOI: 10.3987/COM-08-11624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3987%2FCOM-08-11624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFais7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=1453-1462&author=K.+Satoauthor=K.+Sugawaraauthor=H.+Takeuchiauthor=H.-S.+Parkauthor=T.+Akiyamaauthor=T.+Koyamaauthor=H.+Fukayaauthor=Y.+Aoyagiauthor=K.+Takeya&title=New+cytotoxic+nor-+and+bisnorditerpene+dilactones%2C+makilactones+A-D%2C+from+Podocarpus+macrophyllus+D.+Don&doi=10.3987%2FCOM-08-11624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">New cytotoxic nor- and bisnorditerpene dilactones, makilactones A-D, from Podocarpus macrophyllus D. Don</span></div><div class="casAuthors">Sato, Kimihiko; Sugawara, Keito; Takeuchi, Hirono; Park, Hyun-Sun; Akiyama, Toshiyuki; Koyama, Tetsuo; Fukaya, Haruhiko; Aoyagi, Yutaka; Takeya, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1453-1462</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">Four new nor- and bisnorditerpene dilactones, makilactones A-D, were isolated from a MeOH ext. of bark and root of Podocarpus macrophyllus D. Don (Podocarpaceae) with three known diterpene dilactones.  The structures of the new nor- and bisnorditerpene dilactones having a 7:8,9:11-dienolide moiety were detd. by the spectroscopic studies, including 1D and 2D NMR spectral anal., and single crystal X-Ray crystallog. anal.  Two of the presently isolated compds. were shown to be very strongly cytotoxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqld6qvelYB17Vg90H21EOLACvtfcHk0lgWfqPZ65pgPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFais7w%253D&md5=3505c0e33bdcaaf13973c29fb4df32a0</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.3987%2FCOM-08-11624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-08-11624%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DH.-S.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DT.%26aulast%3DFukaya%26aufirst%3DH.%26aulast%3DAoyagi%26aufirst%3DY.%26aulast%3DTakeya%26aufirst%3DK.%26atitle%3DNew%2520cytotoxic%2520nor-%2520and%2520bisnorditerpene%2520dilactones%252C%2520makilactones%2520A-D%252C%2520from%2520Podocarpus%2520macrophyllus%2520D.%2520Don%26jtitle%3DHeterocycles%26date%3D2009%26volume%3D78%26spage%3D1453%26epage%3D1462%26doi%3D10.3987%2FCOM-08-11624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicklow, D. T.</span></span> <span> </span><span class="NLM_article-title">Isolation and identification of two new biologically active norditerpene dilactones from <i>Aspergillus wentii</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(80)83075-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0031-9422%2880%2983075-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL3MXkslGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=1157-1161&author=J.+W.+Dornerauthor=R.+J.+Coleauthor=J.+P.+Springerauthor=R.+H.+Coxauthor=H.+Cutlerauthor=D.+T.+Wicklow&title=Isolation+and+identification+of+two+new+biologically+active+norditerpene+dilactones+from+Aspergillus+wentii&doi=10.1016%2F0031-9422%2880%2983075-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and identification of two new biologically active norditerpene dilactones from Aspergillus wentii</span></div><div class="casAuthors">Dorner, Joe W.; Cole, Richard J.; Springer, James P.; Cox, Richard H.; Cutler, Horace; Wicklow, Donald T.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1157-61</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    </div><div class="casAbstract">Culture exts. of A. wentii yielded 2 new biol.-active norditerpenoid lactones, named wentilactone A (I; R2 = O) and B (I; R = H).  The structure of wentilactone A was detd. by single crystal x-ray diffraction and CD, and that of wentilactone B by NMR.  Both inhibited wheat coleptile growth and wentilactone A had an LD50 of 7.0 mg/kg when administered orally to 1 day-old chickens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozHIe2H1KgJbVg90H21EOLACvtfcHk0lj3aQmkZILsOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslGguw%253D%253D&md5=68df04d65d0270bf474892b7c7921a35</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2880%2983075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252880%252983075-5%26sid%3Dliteratum%253Aachs%26aulast%3DDorner%26aufirst%3DJ.%2BW.%26aulast%3DCole%26aufirst%3DR.%2BJ.%26aulast%3DSpringer%26aufirst%3DJ.%2BP.%26aulast%3DCox%26aufirst%3DR.%2BH.%26aulast%3DCutler%26aufirst%3DH.%26aulast%3DWicklow%26aufirst%3DD.%2BT.%26atitle%3DIsolation%2520and%2520identification%2520of%2520two%2520new%2520biologically%2520active%2520norditerpene%2520dilactones%2520from%2520Aspergillus%2520wentii%26jtitle%3DPhytochemistry%26date%3D1980%26volume%3D19%26spage%3D1157%26epage%3D1161%26doi%3D10.1016%2F0031-9422%2880%2983075-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.-G.</span></span> <span> </span><span class="NLM_article-title">Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus <i>Aspergillus wentii</i> EN-48</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1021/np2006742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np2006742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=148-152&author=H.-F.+Sunauthor=X.-M.+Liauthor=L.+Mengauthor=C.-M.+Cuiauthor=S.-S.+Gaoauthor=C.-S.+Liauthor=C.-G.+Huangauthor=B.-G.+Wang&title=Asperolides+A-C%2C+tetranorlabdane+diterpenoids+from+the+marine+alga-derived+endophytic+fungus+Aspergillus+wentii+EN-48&doi=10.1021%2Fnp2006742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus Aspergillus wentii EN-48</span></div><div class="casAuthors">Sun, Hao-Fen; Li, Xiao-Ming; Meng, Li; Cui, Chuan-Ming; Gao, Shu-Shan; Li, Chun-Shun; Huang, Cai-Guo; Wang, Bin-Gui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Bioassay-guided fractionation of the culture ext. of Aspergillus wentii EN-48, an endophytic fungus isolated from an unidentified marine brown algal species of the genus Sargassum, led to the isolation of three new tetranorlabdane diterpenoids, asperolides A-C (1-3), and five related derivs. (4-8).  The structures of these compds. were established on the basis of spectroscopic interpretation, and compd. 1 was confirmed by X-ray crystallog. anal.  The abs. configuration of 1 was detd. by application of the modified Mosher's method.  An X-ray structure for wentilactone B (6) is also reported.  Compds. 1-8 were evaluated for cytotoxic and antibacterial activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofgKQoOoOXfbVg90H21EOLACvtfcHk0ljJPRmlL0e5NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWjsrg%253D&md5=33c831d97deb5b820ea2acc77df5df18</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fnp2006742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp2006742%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.-F.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DC.-M.%26aulast%3DGao%26aufirst%3DS.-S.%26aulast%3DLi%26aufirst%3DC.-S.%26aulast%3DHuang%26aufirst%3DC.-G.%26aulast%3DWang%26aufirst%3DB.-G.%26atitle%3DAsperolides%2520A-C%252C%2520tetranorlabdane%2520diterpenoids%2520from%2520the%2520marine%2520alga-derived%2520endophytic%2520fungus%2520Aspergillus%2520wentii%2520EN-48%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D148%26epage%3D152%26doi%3D10.1021%2Fnp2006742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e952</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fcddis.2013.484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24309939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=C.+Lvauthor=Y.+Hongauthor=L.+Miaoauthor=C.+Liauthor=G.+Xuauthor=S.+Weiauthor=B.+Wangauthor=C.+Huangauthor=B.+Jiao&title=Wentilactone+A+as+a+novel+potential+antitumor+agent+induces+apoptosis+and+G2%2FM+arrest+of+human+lung+carcinoma+cells%2C+and+is+mediated+by+HRas-GTP+accumulation+to+excessively+activate+the+Ras%2FRaf%2FERK%2Fp53-p21+pathway&doi=10.1038%2Fcddis.2013.484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway</span></div><div class="casAuthors">Lv, C.; Hong, Y.; Miao, L.; Li, C.; Xu, G.; Wei, S.; Wang, B.; Huang, C.; Jiao, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">e952</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy remains the common therapeutic for patients with lung cancer.  Novel, selective antitumor agents are pressingly needed.  This study is the first to investigate a different, however, effective antitumor drug candidate Wentilactone A (WA) for its development as a novel agent.  In NCI-H460 and NCI-H446 cell lines, WA triggered G2/M phase arrest and mitochondrial-related apoptosis, accompanying the accumulation of reactive oxygen species (ROS).  It also induced activation of mitogen-activated protein kinase and p53 and increased expression of p21.  When we pre-treated cells with ERK, JNK, p38, p53 inhibitor or NAC followed by WA treatment, only ERK and p53 inhibitors blocked WA-induced apoptosis and G2/M arrest.  We further obsd. Ras (HRas, KRas and NRas) and Raf activation, and found that WA treatment increased HRas-Raf activation.  Knockdown of HRas by using small interfering RNA (siRNA) abolished WA-induced apoptosis and G2/M arrest.  HRas siRNA also halted Raf, ERK, p53 activation and p21 accumulation.  Mol. docking anal. suggested that WA could bind to HRas-GTP, causing accumulation of Ras-GTP and excessive activation of Raf/ERK/p53-p21.  The direct binding affinity was confirmed by surface plasmon resonance (SPR).  In vivo, WA suppressed tumor growth without adverse toxicity and presented the same mechanism as that in vitro.  Taken together, these findings suggest WA as a promising novel, potent and selective antitumor drug candidate for lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLAvfEEmYMwLVg90H21EOLACvtfcHk0ljJPRmlL0e5NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL&md5=f93de635f1df60ed2b44eacd80ede458</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.484%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DC.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DWentilactone%2520A%2520as%2520a%2520novel%2520potential%2520antitumor%2520agent%2520induces%2520apoptosis%2520and%2520G2%252FM%2520arrest%2520of%2520human%2520lung%2520carcinoma%2520cells%252C%2520and%2520is%2520mediated%2520by%2520HRas-GTP%2520accumulation%2520to%2520excessively%2520activate%2520the%2520Ras%252FRaf%252FERK%252Fp53-p21%2520pathway%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.-G.</span></span> <span> </span><span class="NLM_article-title">Tetranorlabdane diterpenoids from the deep sea sediment-derived fungus <i>Aspergillus wentii</i> SD-310</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1055/s-0042-102965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fs-0042-102965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27257768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpt1Khs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2016&pages=877-881&author=X.-D.+Liauthor=X.+Liauthor=X.-M.+Liauthor=G.-M.+Xuauthor=P.+Zhangauthor=L.-H.+Mengauthor=B.-G.+Wang&title=Tetranorlabdane+diterpenoids+from+the+deep+sea+sediment-derived+fungus+Aspergillus+wentii+SD-310&doi=10.1055%2Fs-0042-102965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Tetranorlabdane Diterpenoids from the Deep Sea Sediment-Derived Fungus Aspergillus wentii SD-310</span></div><div class="casAuthors">Li, Xiao-Dong; Li, Xin; Li, Xiao-Ming; Xu, Gang-Ming; Zhang, Peng; Meng, Ling-Hong; Wang, Bin-Gui</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">9/10</span>),
    <span class="NLM_cas:pages">877-881</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Two new tetranorlabdane diterpenoids, asperolides D (I) and E (II), along with 6 related known congeners, were isolated and identified from the culture ext. of the deep sea sediment-derived fungus Aspergillus wentii SD-310.  The structures of these compds. were established on the basis of spectroscopic interpretation, and the skeleton and abs. configurations of I and II were detd. by X-ray crystallog. anal.  I and II were evaluated for their cytotoxic activity against 7 tumor cell lines and antibacterial activity against 2 human and 8 aquatic pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNsI5Zgyu2SLVg90H21EOLACvtfcHk0litRYKh9FA6lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpt1Khs7Y%253D&md5=5d805a45d72fd6ef7de87ec6e1f9638e</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1055%2Fs-0042-102965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0042-102965%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.-D.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DXu%26aufirst%3DG.-M.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMeng%26aufirst%3DL.-H.%26aulast%3DWang%26aufirst%3DB.-G.%26atitle%3DTetranorlabdane%2520diterpenoids%2520from%2520the%2520deep%2520sea%2520sediment-derived%2520fungus%2520Aspergillus%2520wentii%2520SD-310%26jtitle%3DPlanta%2520Med.%26date%3D2016%26volume%3D82%26spage%3D877%26epage%3D881%26doi%3D10.1055%2Fs-0042-102965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrero, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrador, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quilez
del Moral, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdivia, M. V.</span></span> <span> </span><span class="NLM_article-title">A convenient synthesis of A-ring-functionalized podolactones. Revision of the structure of wentilactone B</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1379</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.1021/ol0257070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0257070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1WgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=1379-1382&author=A.+F.+Barreroauthor=M.+M.+Herradorauthor=J.+F.+Quilez%0Adel+Moralauthor=M.+V.+Valdivia&title=A+convenient+synthesis+of+A-ring-functionalized+podolactones.+Revision+of+the+structure+of+wentilactone+B&doi=10.1021%2Fol0257070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Synthesis of A-Ring-Functionalized Podolactones. Revision of the Structure of Wentilactone B</span></div><div class="casAuthors">Barrero, Alejandro F.; Herrador, Maria M.; Quilez del Moral, Jose F.; Valdivia, Monica V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1379-1382</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new route to podolactones functionalized in the A ring has been achieved.  Two key steps were employed in this synthesis, the construction of the bicyclic skeleton via a Mn(III)-mediated radical cyclization and the transformation of this bicyclic intermediate into the tetracyclic podolactone skeleton through a Pd (II)-mediated bislactonization of the corresponding conjugate diene.  The reported synthesis of 3β-hydroxy-13,14,15,16-tetranorlabda-7,9(11)-dien-(19,6β),(12,17)-diolide (I) let the authors reassign the structure of wentilactone B, for which structure I was wrongly reported.  The hydroxyl group should be in the 2α-position in Wentilactone B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog4LSs01YaA7Vg90H21EOLACvtfcHk0liT7EZ-5KWvYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1WgsLY%253D&md5=69f98549487ed201881fb042be28650e</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fol0257070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0257070%26sid%3Dliteratum%253Aachs%26aulast%3DBarrero%26aufirst%3DA.%2BF.%26aulast%3DHerrador%26aufirst%3DM.%2BM.%26aulast%3DQuilez%2Bdel%2BMoral%26aufirst%3DJ.%2BF.%26aulast%3DValdivia%26aufirst%3DM.%2BV.%26atitle%3DA%2520convenient%2520synthesis%2520of%2520A-ring-functionalized%2520podolactones.%2520Revision%2520of%2520the%2520structure%2520of%2520wentilactone%2520B%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D1379%26epage%3D1382%26doi%3D10.1021%2Fol0257070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Wentilactone B from <i>Aspergillus wentii</i> induces apoptosis and inhibits proliferation and migration of human hepatoma SMMC-7721 cells</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1964</span>– <span class="NLM_lpage">1971</span>, <span class="refDoi"> DOI: 10.1248/bpb.b12-00368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fbpb.b12-00368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22972522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=1964-1971&author=Z.+Zhangauthor=L.+Miaoauthor=W.+Sunauthor=B.+Jiaoauthor=B.+Wangauthor=L.+Yaoauthor=C.+Huang&title=Wentilactone+B+from+Aspergillus+wentii+induces+apoptosis+and+inhibits+proliferation+and+migration+of+human+hepatoma+SMMC-7721+cells&doi=10.1248%2Fbpb.b12-00368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone B from Aspergillus wentii induces apoptosis and inhibits proliferation and migration of human hepatoma SMMC-7721 cells</span></div><div class="casAuthors">Zhang, Zhenwei; Miao, Lei; Sun, Weizhang; Jiao, Binghua; Wang, Bingui; Yao, Li; Huang, Caiguo</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1964-1971</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Wentilactone B (EN-48-57) is one of the six derivs. sepd. from Aspergillus wentii (EN-48).  Of these derivs., Wentilactone B exerted a more significant antibacterial and cytotoxic activity in several tumor cell lines.  The present study demonstrates that Wentilactone B could efficiently induce SMMC-7721 cells apoptosis, but not normal hepatic cells, as measured by an inverted microscope, 4',6-diamidino-2-phenylindole staining and flow cytometry.  In addn., Wentilactone B could inhibit the metastasis of SMMC-7721 cells, which was detected by colony formation, scratch migration and a transwell assay, and could induce a series of intracellular events, including the down-regulation of CD44 and epidermal growth factor receptor proteins.  In conclusion, Wentilactone B inhibited the growth of SMMC-7721 cells by triggering apoptosis and inhibiting metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCm5tf98lmSbVg90H21EOLACvtfcHk0ljqJo0c5gp63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OisLc%253D&md5=c136620ad14b204502d2b924ca42e9d3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b12-00368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b12-00368%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DJiao%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DWentilactone%2520B%2520from%2520Aspergillus%2520wentii%2520induces%2520apoptosis%2520and%2520inhibits%2520proliferation%2520and%2520migration%2520of%2520human%2520hepatoma%2520SMMC-7721%2520cells%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D35%26spage%3D1964%26epage%3D1971%26doi%3D10.1248%2Fbpb.b12-00368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e657</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fcddis.2013.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23744357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=Z.+Zhangauthor=L.+Miaoauthor=C.+Lvauthor=H.+Sunauthor=S.+Weiauthor=B.+Wangauthor=C.+Huangauthor=B.+Jiao&title=Wentilactone+B+induces+G2%2FM+phase+arrest+and+apoptosis+via+the+Ras%2FRaf%2FMAPK+signaling+pathway+in+human+hepatoma+SMMC-7721+cells&doi=10.1038%2Fcddis.2013.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells</span></div><div class="casAuthors">Zhang, Z.; Miao, L.; Lv, C.; Sun, H.; Wei, S.; Wang, B.; Huang, C.; Jiao, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">e657</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is generally acknowledged as the most common primary malignant tumor, and it is known to be resistant to conventional chemotherapy.  Wentilactone B (WB), a tetranorditerpenoid deriv. extd. from the marine algae-derived endophytic fungus Aspergillus wentii EN-48, has been shown to trigger apoptosis and inhibit metastasis in HCC cell lines.  However, the mechanisms of its antitumor activity remain to be elucidated.  We report here that WB could significantly induce cell cycle arrest at G2 phase and mitochondrial-related apoptosis, accompanying the accumulation of reactive oxygen species (ROS).  Addnl., treatment with WB induced phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), but not p38 MAP kinase.  Among the pathway inhibitors examd., only SP600125 (JNK inhibitor) markedly reversed WB-induced apoptosis, and only U0126 (ERK inhibitor) significantly blocked WB-triggered G2 phase arrest.  We also found that WB treatment increased both Ras and Raf activation, and transfection of cells with dominant-neg. Ras (RasN17) abolished WB-induced apoptosis and G2 phase arrest in SMMC-7721 cells.  Furthermore, the results of inverse docking (INVDOCK) anal. suggested that WB could bind to Ras-GTP, and the direct binding affinity was also confirmed by surface plasmon resonance (SPR).  Finally, in vivo, WB suppressed tumor growth in mouse xenograft models.  Taken together, these results indicate that WB induced G2/M phase arrest and apoptosis in human hepatoma SMMC-7721 cells via the Ras/Raf/ERK and Ras/Raf/JNK signaling pathways, and this agent may be a potentially useful compd. for developing anticancer agents for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmCgMcUzW6bVg90H21EOLACvtfcHk0ljqJo0c5gp63w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7bN&md5=3a7fba508cce7f99e5d43c4671611a8d</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.182%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DLv%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DWentilactone%2520B%2520induces%2520G2%252FM%2520phase%2520arrest%2520and%2520apoptosis%2520via%2520the%2520Ras%252FRaf%252FMAPK%2520signaling%2520pathway%2520in%2520human%2520hepatoma%2520SMMC-7721%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.3390/md11020316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmd11020316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23434831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1aksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=316-331&author=C.+Lvauthor=W.+Sunauthor=H.+Sunauthor=S.+Weiauthor=R.+Chenauthor=B.+Wangauthor=C.+Huang&title=Asperolide+A%2C+a+marine-derived+tetranorditerpenoid%2C+induces+G2%2FM+arrest+in+human+NCI-H460+lung+carcinoma+cells%2C+is+mediated+by+p53-p21+stabilization+and+modulated+by+Ras%2FRaf%2FMEK%2FERK+signaling+pathway&doi=10.3390%2Fmd11020316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway</span></div><div class="casAuthors">Lv, Cuiting; Sun, Wenxia; Sun, Haofen; Wei, Shanjian; Chen, Ruohua; Wang, Bingui; Huang, Caiguo</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">316-331</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">Here we first demonstrate that asperolide A, a very recently reported marine-derived tetranorditerpenoid, leads to the inhibition of NCI-H460 lung carcinoma cell proliferation by G2/M arrest with the activation of the Ras/Raf/MEK/ERK signaling and p53-dependent p21 pathway.  Treatment with 35 μM asperolide A (2 × IC50) resulted in a significant increase in the proportion of G2/M phase cells, about a 2.9-fold increase during 48 h.  Immunoblot assays demonstrated time-dependent inhibition of G2/M regulatory proteins.  Moreover, asperolide A significantly activated MAP kinases (ERK1/2, JNK and p38 MAP kinase) by phosphorylation, and only the inhibition of ERK activation by PD98059 reversed downregulation of G2/M regulatory proteins CDC2, and suppressed upregulation of p21 and p-p53 levels.  Transfection of cells with dominant-neg. Ras (RasN17) mutant genes up-regulated asperolide A-induced the decrease of cyclin B1 and CDC2, suppressed Raf, ERK activity and p53-p21 expression, and at last, abolished G2/M arrest.  This study indicates that asperolide A-induced G2/M arrest in human NCI-H460 lung carcinoma cells relys on the participation of the Ras/Raf/MEK/ERK signaling pathway in p53-p21 stabilization.  An in vivo study with asperolide A illustrated a marked inhibition of tumor growth, and little toxicity compared to Cisplatin therapy.  Overall, these findings provide potential effectiveness and a theor. basis for the therapeutic use of asperolide A in the treatment of malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5tisdlpSCjrVg90H21EOLACvtfcHk0liEWCYVWKTriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1aksLs%253D&md5=1b4c45712f1040e7938e405a35e6f51d</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3390%2Fmd11020316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd11020316%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DAsperolide%2520A%252C%2520a%2520marine-derived%2520tetranorditerpenoid%252C%2520induces%2520G2%252FM%2520arrest%2520in%2520human%2520NCI-H460%2520lung%2520carcinoma%2520cells%252C%2520is%2520mediated%2520by%2520p53-p21%2520stabilization%2520and%2520modulated%2520by%2520Ras%252FRaf%252FMEK%252FERK%2520signaling%2520pathway%26jtitle%3DMar.%2520Drugs%26date%3D2013%26volume%3D11%26spage%3D316%26epage%3D331%26doi%3D10.3390%2Fmd11020316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaRonde-LeBlanc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodawer, A.</span></span> <span> </span><span class="NLM_article-title">A family portrait of the RIO kinases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">37297</span>– <span class="NLM_lpage">37300</span>, <span class="refDoi"> DOI: 10.1074/jbc.R500013200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.R500013200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=16183636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2isr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=37297-37300&author=N.+LaRonde-LeBlancauthor=A.+Wlodawer&title=A+family+portrait+of+the+RIO+kinases&doi=10.1074%2Fjbc.R500013200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">A family portrait of the RIO kinases</span></div><div class="casAuthors">LaRonde-LeBlanc, Nicole; Wlodawer, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">37297-37300</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  The RIO family of atypical serine protein kinases was first characterized only recently.  It consists of enzymes that contain a unique domain with a characteristic kinase sequence motif and usually some addnl. domains.  At least 2 RIO proteins, Rio1 and Rio2, are present in organisms varying from Archaea to humans, with a third Rio3 subfamily present only in multicellular eukaryotes.  Yeast Rio1 and Rio2 proteins have been implicated in the processing of 20 S pre-rRNA and are necessary for survival of the cells.  Crystal structures of Archaeoglobus fulgidus Rio1 and Rio2 have shown that whereas the overall fold of these enzymes resembles typical protein kinases, some of the structural domains, particularly those involved in peptide substrate binding, are not present.  The mode of binding of nucleotides also differs from that found in typical protein kinases.  Although it has been shown that both Rio1 and Rio2 have the enzymic activity of kinases and are capable of autophosphorylation, the biol. substrates of RIO proteins and their full biol. role still remain to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEw2a7RXg-9rVg90H21EOLACvtfcHk0liEWCYVWKTriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2isr%252FO&md5=cd4d7b8d5be167df4dea5ee338ad9289</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R500013200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R500013200%26sid%3Dliteratum%253Aachs%26aulast%3DLaRonde-LeBlanc%26aufirst%3DN.%26aulast%3DWlodawer%26aufirst%3DA.%26atitle%3DA%2520family%2520portrait%2520of%2520the%2520RIO%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D37297%26epage%3D37300%26doi%3D10.1074%2Fjbc.R500013200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-S.</span></span> <span> </span><span class="NLM_article-title">High expression of RIOK2 and NOB1 predict human non-small cell lung cancer outcomes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">28666</span>, <span class="refDoi"> DOI: 10.1038/srep28666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep28666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27346559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKhsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=28666&author=K.+Liuauthor=H.-L.+Chenauthor=S.+Wangauthor=M.-M.+Guauthor=X.-M.+Chenauthor=S.-L.+Zhangauthor=K.-J.+Yuauthor=Q.-S.+You&title=High+expression+of+RIOK2+and+NOB1+predict+human+non-small+cell+lung+cancer+outcomes&doi=10.1038%2Fsrep28666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes</span></div><div class="casAuthors">Liu, Kun; Chen, Hong-Lin; Wang, Shuo; Gu, Ming-Ming; Chen, Xin-Ming; Zhang, Shuang-Long; Yu, Kang-Jun; You, Qing-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28666</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide.  However, there is a shortage of suitable diagnostic markers for early stages of NSCLC, and therapeutic targets are limited.  Right open reading frame (Rio) kinase 2 (RIOK2) and Nin one binding (NOB1) protein are important accessory factors in ribosome assembly and are highly expressed in malignant tumors; moreover, they interact with each other.  However, the RIOK2 expression profile and its clin. significance as well as NOB1's mechanism in NSCLC remain unknown.  In this study, NSCLC cell lines and 15 NSCLC tumor tissues (paired with adjacent normal lung tissues) were collected for a real-time quant. PCR (RT-qPCR) anal.  In addn., 153 NSCLC cases and 27 normal lung tissues were used in an immunohistochem. anal. to evaluate the RIOK2 and NOB1 expression profiles, their clinicopathol. factors in NSCLC and their correlations with prognoses.  RIOK2 and NOB1 were highly expressed in NSCLC cells and tissues, and their expression profiles were significantly assocd. with the Tumor Node Metastasis (TNM) clin. stage, lymph node metastasis, and differentiation.  RIOK2 expression was correlated with NOB1.  The results suggested that simultaneously detg. the expression of RIOK2 and NOB1 will improve the diagnostic rate in early stages of NSCLC.  Moreover, RIOK2 and NOB1 might be potential targets for NSCLC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYCGUvnqqnXrVg90H21EOLACvtfcHk0liEWCYVWKTriw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKhsrfJ&md5=b55f1aa2cdccd1b3d7414b0e9f911f33</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fsrep28666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep28666%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.-L.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DM.-M.%26aulast%3DChen%26aufirst%3DX.-M.%26aulast%3DZhang%26aufirst%3DS.-L.%26aulast%3DYu%26aufirst%3DK.-J.%26aulast%3DYou%26aufirst%3DQ.-S.%26atitle%3DHigh%2520expression%2520of%2520RIOK2%2520and%2520NOB1%2520predict%2520human%2520non-small%2520cell%2520lung%2520cancer%2520outcomes%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D28666%26doi%3D10.1038%2Fsrep28666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span> <span> </span><span class="NLM_article-title">3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from <i>Podocarpus nagi</i>, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1578</span>– <span class="NLM_lpage">1586</span>, <span class="refDoi"> DOI: 10.1038/s41401-019-0254-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41401-019-0254-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31201357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3M3mvFKrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=1578-1586&author=H.+Shanauthor=S.+Yaoauthor=Y.+Yeauthor=Q.+Yu&title=3-Deoxy-2%CE%B2%2C16-dihydroxynagilactone+E%2C+a+natural+compound+from+Podocarpus+nagi%2C+preferentially+inhibits+JAK2%2FSTAT3+signaling+by+allosterically+interacting+with+the+regulatory+domain+of+JAK2+and+induces+apoptosis+of+cancer+cells&doi=10.1038%2Fs41401-019-0254-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells</span></div><div class="casAuthors">Shan Hui; Yu Qiang; Shan Hui; Yao Sheng; Ye Yang; Yu Qiang; Yao Sheng; Ye Yang</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1578-1586</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways, especially the JAK2/STAT3 pathway, play vital roles in the development of many malignancies.  Overactivation of STAT3 promotes cancer cell survival and proliferation.  Therefore, the JAK2/STAT3-signaling pathway has been considered a promising target for cancer therapy.  In this study, we identified a natural compound 3-deoxy-2β,16-dihydroxynagilactone E (B6) from the traditional Chinese medicinal plant Podocarpus nagi as a potent inhibitor of STAT3 signaling.  B6 preferentially inhibited the phosphorylation of STAT3 by interacting with and inactivating JAK2, the main upstream kinase of STAT3.  B6 dose-dependently inhibited IL-6-induced STAT3 signaling with an IC50 of 0.2 μM.  In contrast to other JAK2 inhibitors, B6 did not interact with the catalytic domain but instead with the FERM-SH2 domain of JAK2.  This interaction was JAK-specific since B6 had little effect on other tyrosine kinases.  Furthermore, B6 potently inhibited the growth and induced apoptosis of MDA-MB-231 and MDA-MB-468 breast cancer cells with overactivated STAT3.  Taken together, our study uncovers a novel compound and a novel mechanism for the regulation of JAK2 and offers a new therapeutic approach for the treatment of cancers with overactivated JAK2/STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE2A638uprkzEwO064Z95rfW6udTcc2eb2eWjngNfNkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3mvFKrsw%253D%253D&md5=38a6d5f9c33d931428139dea248a1e08</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fs41401-019-0254-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41401-019-0254-4%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3D3-Deoxy-2%25CE%25B2%252C16-dihydroxynagilactone%2520E%252C%2520a%2520natural%2520compound%2520from%2520Podocarpus%2520nagi%252C%2520preferentially%2520inhibits%2520JAK2%252FSTAT3%2520signaling%2520by%2520allosterically%2520interacting%2520with%2520the%2520regulatory%2520domain%2520of%2520JAK2%2520and%2520induces%2520apoptosis%2520of%2520cancer%2520cells%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2019%26volume%3D40%26spage%3D1578%26epage%3D1586%26doi%3D10.1038%2Fs41401-019-0254-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupchan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Court, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dailey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, R. F.</span></span> <span> </span><span class="NLM_article-title">Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from <i>Tripterygium wilfordii</i></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">7194</span>– <span class="NLM_lpage">7195</span>, <span class="refDoi"> DOI: 10.1021/ja00775a078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00775a078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE38XlsFagtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1972&pages=7194-7195&author=S.+M.+Kupchanauthor=W.+A.+Courtauthor=R.+G.+Daileyauthor=C.+J.+Gilmoreauthor=R.+F.+Bryan&title=Triptolide+and+tripdiolide%2C+novel+antileukemic+diterpenoid+triepoxides+from+Tripterygium+wilfordii&doi=10.1021%2Fja00775a078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor inhibitors.  LXXIV.  Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii</span></div><div class="casAuthors">Kupchan, S. Morris; Court, William A.; Dailey, Richard G., Jr.; Gilmore, Christopher J.; Bryan, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7194-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The isolation and structural elucidation by direct x-ray analysis of triptolide (I, R = H) and tripdiolide (I, R = OH), novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii, are reported.  These compounds and the companion cytotoxic ketone triptonide (II) appear to be the first reported natural products containing the 18(4 → 3)abeo-abietane skeleton and the first recognized diterpenoid triepoxides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN9AmLhh4YsrVg90H21EOLACvtfcHk0liEPd6AVa6Ugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XlsFagtbY%253D&md5=5f49ab816f300041630eaec53c680496</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fja00775a078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00775a078%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DCourt%26aufirst%3DW.%2BA.%26aulast%3DDailey%26aufirst%3DR.%2BG.%26aulast%3DGilmore%26aufirst%3DC.%2BJ.%26aulast%3DBryan%26aufirst%3DR.%2BF.%26atitle%3DTriptolide%2520and%2520tripdiolide%252C%2520novel%2520antileukemic%2520diterpenoid%2520triepoxides%2520from%2520Tripterygium%2520wilfordii%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1972%26volume%3D94%26spage%3D7194%26epage%3D7195%26doi%3D10.1021%2Fja00775a078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, R. F.</span></span> <span> </span><span class="NLM_article-title">Crystal and molecular structures and absolute configuration of triptolide and tripdiolide, two antileukemic diterpenoid triepoxides</span>. <i>J. Chem. Soc., Perkin Trans. 2</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.1039/p29730000816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fp29730000816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE3sXhs1Gmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=816-819&author=C.+J.+Gilmoreauthor=R.+F.+Bryan&title=Crystal+and+molecular+structures+and+absolute+configuration+of+triptolide+and+tripdiolide%2C+two+antileukemic+diterpenoid+triepoxides&doi=10.1039%2Fp29730000816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal and molecular structures and absolute configuration of triptolide and tripdiolide, two antileukemic diterpenoid triepoxides</span></div><div class="casAuthors">Gilmore, Christopher J.; Bryan, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Perkin Transactions 2:  Physical Organic Chemistry (1972-1999)</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">816-19</span>CODEN:
                <span class="NLM_cas:coden">JCPKBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9580</span>.
    </div><div class="casAbstract">The crystal and mol. structure and abs. configuration of triptolide (I) and tripdiolide (II) were detd. by 3-dimensional x-ray anal. and refined by least squares to R = 0.086 (1044 independent reflections) and 0.082 (1399 independent reflections), resp.  Crystals of I are monoclinic, space group P21, with a 13.420, b 6.256, c 11.593 Å, β 118.09°, d.(obsd.) = 1.40, and d. (calcd.) = 1.39 for Z = 2.  The mol. II is isostructural with I, with a 13.680, b 6.253, Å, and β 119.05°.  Tripdiolide is 2-hydroxytriptolide; each mol. has an 18(4→3)abeo-abietane skeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpg-W6rm_W7bVg90H21EOLACvtfcHk0liEPd6AVa6Ugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhs1Gmu7k%253D&md5=664e097317ce32f61a0916511cbc650d</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1039%2Fp29730000816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp29730000816%26sid%3Dliteratum%253Aachs%26aulast%3DGilmore%26aufirst%3DC.%2BJ.%26aulast%3DBryan%26aufirst%3DR.%2BF.%26atitle%3DCrystal%2520and%2520molecular%2520structures%2520and%2520absolute%2520configuration%2520of%2520triptolide%2520and%2520tripdiolide%252C%2520two%2520antileukemic%2520diterpenoid%2520triepoxides%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25202%26date%3D1973%26spage%3D816%26epage%3D819%26doi%3D10.1039%2Fp29730000816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziaei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halaby, R.</span></span> <span> </span><span class="NLM_article-title">Immunosuppressive, anti-inflammatory and anticancer properties of triptolide: A mini review</span>. <i>Avicenna J. Phytomed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27222828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1yiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=149-164&author=S.+Ziaeiauthor=R.+Halaby&title=Immunosuppressive%2C+anti-inflammatory+and+anticancer+properties+of+triptolide%3A+A+mini+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: a mini review</span></div><div class="casAuthors">Ziaei, Samira; Halaby, Reginald</div><div class="citationInfo"><span class="NLM_cas:title">Avicenna Journal of Phytomedicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-164</span>CODEN:
                <span class="NLM_cas:coden">AJPVAX</span>;
        ISSN:<span class="NLM_cas:issn">2228-7949</span>.
    
            (<span class="NLM_cas:orgname">Mashhad University of Medical Sciences</span>)
        </div><div class="casAbstract">Objective: Triptolide, the active component of Tripterygium wilfordii Hook F has been used to treat autoimmune and inflammatory conditions for over two hundred years in traditional Chinese medicine.  However, the processes through which triptolide exerts immunosuppression and anti-inflammation are not understood well.  In this review, we discuss the autoimmune disorders and inflammatory conditions that are currently treated with triptolide.  Triptolide also possesses anti-tumorigenic effects.  We discuss the toxicity of various triptolide derivs. and offer suggestions to improve its safety.  This study also examines the clin. trials that have investigated the efficacy of triptolide.  Our aim is to examine the mechanisms that are responsible for the immunosuppressive, anti-inflammatory, and anti-cancer effects of triptolide.  Materials and Methods: The present review provides a comprehensive summary of the literature with respect to the immunosuppressive, anti-inflammatory, and anti-cancer properties of triptolide.  Results: Triptolide possesses immunosuppressive, anti-inflammatory, and anti-cancer effects.  Conclusion: Triptolide can be used alone or in combination with existing therapeutic modalities as novel treatments for autoimmune disorders, cancers, and for immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGY5Jk7UBbLVg90H21EOLACvtfcHk0lj7m6pND4sLrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1yiur4%253D&md5=f617220e3c6b4406157ec388b1a04d6a</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZiaei%26aufirst%3DS.%26aulast%3DHalaby%26aufirst%3DR.%26atitle%3DImmunosuppressive%252C%2520anti-inflammatory%2520and%2520anticancer%2520properties%2520of%2520triptolide%253A%2520A%2520mini%2520review%26jtitle%3DAvicenna%2520J.%2520Phytomed.%26date%3D2016%26volume%3D6%26spage%3D149%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span> <span> </span><span class="NLM_article-title">Triptolide: A new star for treating human malignancies</span>. <i>J. Cancer Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">S271</span>– <span class="NLM_lpage">S275</span>, <span class="refDoi"> DOI: 10.4103/0973-1482.235340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.4103%2F0973-1482.235340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29970675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVCqt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=S271-S275&author=P.+Yanauthor=X.+Sun&title=Triptolide%3A+A+new+star+for+treating+human+malignancies&doi=10.4103%2F0973-1482.235340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide: a new star for treating human malignancies</span></div><div class="casAuthors">Yan, Ping; Sun, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Therapeutics (Mumbai, India)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9Suppl.2</span>),
    <span class="NLM_cas:pages">S271-S275</span>CODEN:
                <span class="NLM_cas:coden">JCRTBK</span>;
        ISSN:<span class="NLM_cas:issn">1998-4138</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications</span>)
        </div><div class="casAbstract">A review.  In recent years, cancer has become the most common human disease worldwide, and great attentions have been paid to clarifying the carcinogenesis and identifying new effective antitumor therapy.  Although great progress has been made in this research field, human malignant diseases could still not be radically cured.  Thunder god vine is a herbal medicine, which has proved to exert efficient antitumor activity in various human cancers such as lung cancer, pancreatic cancer, and colon cancer.  In vivo and in vitro expts. showed that thunder god vine ext. triptolide could inhibit tumor cell proliferation, cell migration, and cell invasion.  Here, we overviewed the functional role of triptolide in human malignancies and its promising therapeutic potential in treating such deadly diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIbGkILzOCLVg90H21EOLACvtfcHk0lj7m6pND4sLrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVCqt7rE&md5=26d75f56db3f011898227fc075139892</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.4103%2F0973-1482.235340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0973-1482.235340%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DTriptolide%253A%2520A%2520new%2520star%2520for%2520treating%2520human%2520malignancies%26jtitle%3DJ.%2520Cancer%2520Res.%2520Ther.%26date%3D2018%26volume%3D14%26spage%3DS271%26epage%3DS275%26doi%3D10.4103%2F0973-1482.235340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span> <span> </span><span class="NLM_article-title">Triptolide mediated amelioration of breast cancer via modulation of molecular pathways</span>. <i>Pharmacogn. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">838</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.5530/pj.2017.6.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5530%2Fpj.2017.6.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVyrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=838-845&author=S.+Sarkarauthor=S.+Paul&title=Triptolide+mediated+amelioration+of+breast+cancer+via+modulation+of+molecular+pathways&doi=10.5530%2Fpj.2017.6.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide mediated amelioration of breast cancer via modulation of molecular pathways</span></div><div class="casAuthors">Sarkar, Swadesh; Paul, Santanu</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacognosy Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">838-845</span>CODEN:
                <span class="NLM_cas:coden">PJHOD4</span>;
        ISSN:<span class="NLM_cas:issn">0975-3575</span>.
    
            (<span class="NLM_cas:orgname">Pharmacognosy Network Worldwide</span>)
        </div><div class="casAbstract">A review.  Triptolide is the main bioactive mol. isolated from a root ext. of Tripterigium wilfordii Hook F. of Celastraceae family.  Chem., it is a diterpenoid triepoxide mol. and its chem. formula is C20 H24 O6.  Its five-membered unsatd. lactone ring (D-ring) is crucial for anti-tumor potential and carbonyl group at C-18 position is essential to exert important influence on the interaction between triptolide and the targeted protein(s).  It is bio-synthesized from deoxy-D-xylullose-5-phosphate (DOXP) pathway in the cell.  Triptolide can induce apoptosis in a no. of breast cancer cells by up-regulating different pro-apoptotic and down-regulating different anti-apoptotic mols.  In vitro expts. indicate that it can down regulate several cell cycle related genes and induces S-phase cell cycle arrest.  Triptolide treatment can also modulate the expression of different cell signaling mols., e.g.  ERK, NF-κB, FAK, VEGF, β-catenin, AKT etc.  In vivo expts. indicate that triptolide can effectively reduce breast tumor growth in the mouse model.  Apart from the single drug treatment, triptolide can effectively be applied in combination therapy.  Application of Triptolide with other chemotherapeutic drugs, very efficiently check the proliferation of tumor cells which reduces the effective concn. of the com. available drugs thus reducing their toxic side-effects.  Although triptolide is very effective against a no. of diseases, its higher degree of multi-organ toxicity limits its use of further clin. trial.  Therefore, to reduce the toxic effects, a no. of strategies have been developed which increase its water soly. and at the same time decrease the toxic effect.  In this review article, we have addressed how triptolide participates in the antitumor processes in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIzXpdrNVH4bVg90H21EOLACvtfcHk0lj7m6pND4sLrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVyrsrk%253D&md5=eae18d4029ba750a5a1fcf3eddc1ebb1</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.5530%2Fpj.2017.6.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5530%252Fpj.2017.6.131%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DPaul%26aufirst%3DS.%26atitle%3DTriptolide%2520mediated%2520amelioration%2520of%2520breast%2520cancer%2520via%2520modulation%2520of%2520molecular%2520pathways%26jtitle%3DPharmacogn.%2520J.%26date%3D2017%26volume%3D9%26spage%3D838%26epage%3D845%26doi%3D10.5530%2Fpj.2017.6.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.-P.</span></span> <span> </span><span class="NLM_article-title">Effect of the natural product triptolide on pancreatic cancer: A systematic review of preclinical studies</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">490</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2017.00490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28890697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2nsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=490&author=C.+Zhangauthor=X.-J.+Heauthor=L.+Liauthor=C.+Luauthor=A.-P.+Lu&title=Effect+of+the+natural+product+triptolide+on+pancreatic+cancer%3A+A+systematic+review+of+preclinical+studies&doi=10.3389%2Ffphar.2017.00490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the natural product triptolide on pancreatic cancer: a systematic review of preclinical studies</span></div><div class="casAuthors">Zhang, Chi; He, Xiao-Juan; Li, Li; Lu, Cheng; Lu, Ai-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">490/1-490/9</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Objective: Triptolide (TL), a natural product isolated from Tripterygium wilfordii Hook F (TwHF), shows potent anticancer effects in vitro and in vivo.  We aimed to summary the biochem. mechanisms through which TL has been shown to induce apoptosis, autophagy and inhibit angiogenesis in pancreatic cancer (PC).  Methods: We undertook a systematic review of preclin. evidence.  We searched electronic databases.  The potential mechanisms and the underlying signaling pathways have been accumulated as well.  Results: We screened 116 abstrs. for eligibility and included 17 preclin. studies in the anal.  Details of the animals and cell lines were provided in 16 studies (94.1%).  Six studies (75.0%) randomly assigned animals to treatment or control groups and only 1 study (12.5%) reported on blinding.  The majority of the TL's research field has focused on its pro-apoptotic effects through downregulation of inhibitory pathways and upregulation of apoptotic pathways.  The studies have shown that TL is effective both in vitro and in vivo against PC cells.  Conclusion: This study provides a systematic summary of TL's anti-pancreatic cancer profile and the underlying mechanisms of with special emphasis on the apoptosis, autophagy, angiogenesis and related mol. pathways.  Improved study quality in terms of treatment allocation methods reporting, randomization and blinding will accelerate needed progress toward trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogQmeUm7qocbVg90H21EOLACvtfcHk0lj7m6pND4sLrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2nsLjN&md5=8471d6cf8fe988119e15ce3bb0c106fa</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00490%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DX.-J.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DA.-P.%26atitle%3DEffect%2520of%2520the%2520natural%2520product%2520triptolide%2520on%2520pancreatic%2520cancer%253A%2520A%2520systematic%2520review%2520of%2520preclinical%2520studies%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D490%26doi%3D10.3389%2Ffphar.2017.00490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">112079</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2020.112079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32028140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVWgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2020&pages=112079&author=Y.+Zangauthor=F.+Laiauthor=J.+Fuauthor=C.+Liauthor=J.+Maauthor=C.+Chenauthor=K.+Liuauthor=T.+Zhangauthor=X.+Chenauthor=D.+Zhang&title=Novel+nitric+oxide-releasing+derivatives+of+triptolide+as+antitumor+and+anti-inflammatory+agents%3A+Design%2C+synthesis%2C+biological+evaluation%2C+and+nitric+oxide+release+studies&doi=10.1016%2Fj.ejmech.2020.112079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies</span></div><div class="casAuthors">Zang, Yingda; Lai, Fangfang; Fu, Junmin; Li, Chuangjun; Ma, Jie; Chen, Chengjuan; Liu, Ke; Zhang, Tiantai; Chen, Xiaoguang; Zhang, Dongming</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112079pp.</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel triptolide/furoxans hybrids and, e.g., I, was designed and synthesized as analogs of triptolide, which is a naturally derived compd. isolated from the thunder god vine (Tripterygium wilfordii Hook. F).  Some of these synthesized compds. exhibited antiproliferative activities in the nanomolar range.  Among them, I exhibited both good antiproliferative activity and NO-releasing ability and the acute toxicity of I decreased more than 160 times (LD50 = 160.9 mg/kg) than triptolide.  Moreover, I significantly inhibited the growth of melanoma at a low dose (0.3 mg/kg) and showed strong anti-inflammatory activity in vitro and in vivo.  These results indicate that I could be a promising candidate for further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXROlmczxhA7Vg90H21EOLACvtfcHk0lh35m9fFmOCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVWgsbg%253D&md5=6c1140d3bca33e778e70fad252afea3b</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112079%26sid%3Dliteratum%253Aachs%26aulast%3DZang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DNovel%2520nitric%2520oxide-releasing%2520derivatives%2520of%2520triptolide%2520as%2520antitumor%2520and%2520anti-inflammatory%2520agents%253A%2520Design%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520nitric%2520oxide%2520release%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D190%26spage%3D112079%26doi%3D10.1016%2Fj.ejmech.2020.112079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel C14-hydroxy substituted triptolide derivatives as potential selective antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5115</span>– <span class="NLM_lpage">5123</span>, <span class="refDoi"> DOI: 10.1021/jm900342g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900342g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVKnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5115-5123&author=Z.+Liauthor=Z.-L.+Zhouauthor=Z.-H.+Miaoauthor=L.-P.+Linauthor=H.-J.+Fengauthor=L.-J.+Tongauthor=J.+Dingauthor=Y.-C.+Li&title=Design+and+synthesis+of+novel+C14-hydroxy+substituted+triptolide+derivatives+as+potential+selective+antitumor+agents&doi=10.1021%2Fjm900342g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel C14-Hydroxyl Substituted Triptolide Derivatives as Potential Selective Antitumor Agents</span></div><div class="casAuthors">Li, Zheng; Zhou, Zhao-Li; Miao, Ze-Hong; Lin, Li-Ping; Feng, Hui-Jin; Tong, Lin-Jiang; Ding, Jian; Li, Yuan-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5115-5123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It has long been considered that the free β hydroxyl group at C14 of triptolide is essential to its potent anticancer activity.  In this study, we synthesized novel derivs. of triptolide with a hydroxyl group substituted by epoxy groups (e.g. I) or a five-membered ring (e.g. II).  The epoxy compds. showed significant in vitro anticancer activity although less potent than triptolide.  Although with an α oxygen configuration at the C14 position, (14S)-14,21-epoxytriptolide (I) exhibited the highest potency among all these derivs., clearly challenging the traditional viewpoint on the necessity of C14β-hydroxyl group of triptolide.  Further studies revealed that while displaying broad spectrum in vitro anticancer activity, compd. I demonstrated prominent selective in vivo anticancer activity, particularly against human ovarian SK-OV-3 and prostate PC-3 cancers with obviously lower toxicity than triptolide.  Noticeably, compd. I was also highly effective against multidrug resistant cancer cells.  Therefore, our study gives new insights into the structure-activity relationship of triptolide and also produces a promising anticancer drug candidate with unique anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7BKNGzgX73LVg90H21EOLACvtfcHk0lh35m9fFmOCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVKnt7w%253D&md5=3eae112da83726b8d3562c79e2ad36d3</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm900342g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900342g%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.-L.%26aulast%3DMiao%26aufirst%3DZ.-H.%26aulast%3DLin%26aufirst%3DL.-P.%26aulast%3DFeng%26aufirst%3DH.-J.%26aulast%3DTong%26aufirst%3DL.-J.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-C.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520C14-hydroxy%2520substituted%2520triptolide%2520derivatives%2520as%2520potential%2520selective%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5115%26epage%3D5123%26doi%3D10.1021%2Fjm900342g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangwan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudeja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawra, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazar, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A. K.</span></span> <span> </span><span class="NLM_article-title">A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">156ra139</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3004334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1126%2Fscitranslmed.3004334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23076356" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&author=R.+Chughauthor=V.+Sangwanauthor=S.+P.+Patilauthor=V.+Dudejaauthor=R.+K.+Dawraauthor=S.+Banerjeeauthor=R.+J.+Schumacherauthor=B.+R.+Blazarauthor=G.+I.+Georgauthor=S.+M.+Vickersauthor=A.+K.+Saluja&title=A+preclinical+evaluation+of+Minnelide+as+a+therapeutic+agent+against+pancreatic+cancer&doi=10.1126%2Fscitranslmed.3004334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004334%26sid%3Dliteratum%253Aachs%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DSangwan%26aufirst%3DV.%26aulast%3DPatil%26aufirst%3DS.%2BP.%26aulast%3DDudeja%26aufirst%3DV.%26aulast%3DDawra%26aufirst%3DR.%2BK.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSchumacher%26aufirst%3DR.%2BJ.%26aulast%3DBlazar%26aufirst%3DB.%2BR.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DVickers%26aufirst%3DS.%2BM.%26aulast%3DSaluja%26aufirst%3DA.%2BK.%26atitle%3DA%2520preclinical%2520evaluation%2520of%2520Minnelide%2520as%2520a%2520therapeutic%2520agent%2520against%2520pancreatic%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26doi%3D10.1126%2Fscitranslmed.3004334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acikgoz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oktem, G.</span></span> <span> </span><span class="NLM_article-title">Triptolide inhibits CD133+/CD44<sup>+</sup> colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial-mesenchymal transition via downregulating expressions of snail, slug, and twist</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">3313</span>– <span class="NLM_lpage">3324</span>, <span class="refDoi"> DOI: 10.1002/jcb.29602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjcb.29602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31904143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivFWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2020&pages=3313-3324&author=E.+Acikgozauthor=C.+Tatarauthor=G.+Oktem&title=Triptolide+inhibits+CD133%2B%2FCD44%2B+colon+cancer+stem+cell+growth+and+migration+through+triggering+apoptosis+and+represses+epithelial-mesenchymal+transition+via+downregulating+expressions+of+snail%2C+slug%2C+and+twist&doi=10.1002%2Fjcb.29602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide inhibits CD133+/CD44+ colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial-mesenchymal transition via downregulating expressions of snail, slug, and twist</span></div><div class="casAuthors">Acikgoz, Eda; Tatar, Cansu; Oktem, Gulperi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">3313-3324</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In cancer studies, there is an increasing interest in close friendship between epithelial-mesenchymal transition (EMT) and CSCs.  Triptolide (TPL) isolated from Chinese herb Tripterygium wilfordii has important effects on the prevention of migration and metastasis as well as cytotoxic effect against cancer cells.  The potential lethal efficacy of TPL on CSCs that is highly resistant to the drug is an unsolved mystery.  Fundamentally, the present study basically aims to find answers to two questions (a) is it possible to target colon CSCs with TPL and (b) what are the mechanisms underlying TPL's potential to eliminate CSCs.  Cytotoxic effects of TPL on CSCs were evaluated by WST-1 and Muse count and viability assays.  Apoptosis assay and cell-cycle anal. were performed to investigate the inhibitory effect of TPL.  Moreover, the effects of TPL on spheroid formation capacity, migration, and EMT processes, which are assocd. with CSC phenotype, were also investigated.  The results revealed that TPL triggered cell death and apoptosis and altered cell cycle distribution.  Moreover, TPL significantly reduced the snail slug and twist expressions assocd. with EMT.  TPL has been shown to be effective in colon CSCs by in vitro expts., and it might be a highly effective agent against colon cancer has been implicated in need of supporting in vivo and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6iTKf59UGrbVg90H21EOLACvtfcHk0lh35m9fFmOCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivFWhug%253D%253D&md5=bee7a1ab5c24675744913663abbdc26c</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1002%2Fjcb.29602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.29602%26sid%3Dliteratum%253Aachs%26aulast%3DAcikgoz%26aufirst%3DE.%26aulast%3DTatar%26aufirst%3DC.%26aulast%3DOktem%26aufirst%3DG.%26atitle%3DTriptolide%2520inhibits%2520CD133%252B%252FCD44%252B%2520colon%2520cancer%2520stem%2520cell%2520growth%2520and%2520migration%2520through%2520triggering%2520apoptosis%2520and%2520represses%2520epithelial-mesenchymal%2520transition%2520via%2520downregulating%2520expressions%2520of%2520snail%252C%2520slug%252C%2520and%2520twist%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2020%26volume%3D121%26spage%3D3313%26epage%3D3324%26doi%3D10.1002%2Fjcb.29602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span> <span> </span><span class="NLM_article-title">Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">892</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1248/bpb.b18-00818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fbpb.b18-00818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30956264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ejtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=892-899&author=W.+Jiangauthor=M.+Chenauthor=C.+Xiaoauthor=W.+Yangauthor=Q.+Qinauthor=Q.+Tanauthor=Z.+Liangauthor=X.+Liaoauthor=A.+Maoauthor=C.+Wei&title=Triptolide+suppresses+growth+of+breast+cancer+by+targeting+HMGB1+in+vitro+and+in+vivo&doi=10.1248%2Fbpb.b18-00818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo</span></div><div class="casAuthors">Jiang, Wei; Chen, Maojian; Xiao, Chanchan; Yang, Weiping; Qin, Qinghong; Tan, Qixing; Liang, Zhijie; Liao, Xiaoli; Mao, Anyun; Wei, Changyuan</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-899</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Triptolide has been indicated potent anti-cancer effect involving multiple mol. targets and signaling pathways.  High-mobility group box 1 (HMGB1) is a highly conserved DNA-binding protein taking part in breast cancer development.  The therapeutic effect of triptolide on HMGB1 has not been reported.  Thus, our study aims to clarify the role of HMGB1 in triptolide-induced anti-growth effect on breast cancer in vitro and in vivo.  We demonstrated that triptolide significantly suppressed growth of breast cancer cells by inhibition of cell viability, clonogenic ability.  Further studies evidenced that triptolide treatment not only inhibited HMGB1 mRNA expression, but also decreased supernatant level of HMGB1 in vitro.  In line with these observations, exogenous recombinant HMGB1 (rHMGB1) promoted cell proliferation of breast cancer, and triptolide reversed the rHMGB1-promoted proliferative effect.  As well, triptolide enhanced the anti-proliferative activity of Et pyruvate (EP) (HMGB1 inhibitor).  Furthermore, downstream correlation factors (Toll-like receptor 4 (TLR4) and phosphorylated-nuclear factor-kappaB (NF-κB) p65) of HMGB1 were significantly decreased in vitro after triptolide treatment.  Consistantly, we confirmed that tumor growth was significantly inhibited after triptolide treatment in vivo.  Meanwhile, immunohistochem. analyses showed that triptolide treatment significantly decreased the level of cytoplasmic HMGB1 and TLR4 expression, whereas the expression of NF-κB p65 was relatively higher in cytoplasm, and conversely lower in nucleus as compared to the control group.  Collectively, these results demonstrate that triptolide suppresses the growth of breast cancer cells via redn. of HMGB1 expression in vitro and in vivo, which may provide new insights into the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_9wbxp4AuUbVg90H21EOLACvtfcHk0lhY49b0EJVd_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ejtbrF&md5=0b9d22960a4a900f9c5d8b1b2a579127</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b18-00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b18-00818%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26atitle%3DTriptolide%2520suppresses%2520growth%2520of%2520breast%2520cancer%2520by%2520targeting%2520HMGB1%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2019%26volume%3D42%26spage%3D892%26epage%3D899%26doi%3D10.1248%2Fbpb.b18-00818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span> <span> </span><span class="NLM_article-title">Antitumor properties of triptolide: Phenotype regulation of macrophage differentiation</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1080/15384047.2019.1679555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F15384047.2019.1679555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31663424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVymsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=178-188&author=H.+Liauthor=L.+Liauthor=H.+Meiauthor=G.+Panauthor=X.+Wangauthor=X.+Huangauthor=T.+Wangauthor=Z.+Jiangauthor=L.+Zhangauthor=L.+Sun&title=Antitumor+properties+of+triptolide%3A+Phenotype+regulation+of+macrophage+differentiation&doi=10.1080%2F15384047.2019.1679555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor properties of triptolide: phenotype regulation of macrophage differentiation</span></div><div class="casAuthors">Li, Han; Li, Liping; Mei, Huifang; Pan, Guofeng; Wang, Xinzhi; Huang, Xin; Wang, Tao; Jiang, Zhenzhou; Zhang, Luyong; Sun, Lixin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-188</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAMs), which generally exhibit an M2-like phenotype, play a crit. role in tumor development.  Triptolide exerts a unique bioactive spectrum of anticancer activities.  The aim of this study was to det. whether triptolide has any effect on the activation of TAMs and the prodn. of tumor-promoting mediators.  ICR-1 mice with azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon tumors and BALB/c mice co-inoculated with 4T1 cells and M2-polarized RAW264.7 cells were used to examine whether the inhibitory effect of triptolide on tumor progression was mediated by the targeting of TAMs.  Real-time PCR, Western blot, immunofluorescence staining, and flow cytometry assays were performed to det. the expression of cell surface markers and cytokine prodn.  The results showed that triptolide inhibited macrophage differentiation toward the M2 phenotype and abolished M2 macrophage-mediated tumor progression.  Furthermore, triptolide inhibited the expression of M2 markers, such as CD206, Arginase 1, and CD204, and inhibited the secretion of anti-inflammatory cytokines.  Thus our study indicated that triptolide selectively inhibited the functions of M2-polarized macrophages and TAMs, and this inhibitory effect of triptolide on TAM viability, differentiation, and cytokine prodn. might elucidate the major mechanisms underlying its antitumor activity.  Our findings provide important information for the potential clin. application of triptolide in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf6Cvb4eI_PrVg90H21EOLACvtfcHk0ljEHdo7Qrg72w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVymsLnK&md5=8a3cd713df7dfdef26e17a6cc2828ebc</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1080%2F15384047.2019.1679555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2019.1679555%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DAntitumor%2520properties%2520of%2520triptolide%253A%2520Phenotype%2520regulation%2520of%2520macrophage%2520differentiation%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2020%26volume%3D21%26spage%3D178%26epage%3D188%26doi%3D10.1080%2F15384047.2019.1679555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2FCAD.0000000000000894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31972592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVOitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=483-491&author=H.+Huauthor=S.+Zhuauthor=Y.+Tongauthor=G.+Huangauthor=B.+Tanauthor=L.+Yang&title=Antitumor+activity+of+triptolide+in+SKOV3+cells+and+SKOV3%2FDDP+in+vivo+and+in+vitro&doi=10.1097%2FCAD.0000000000000894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro</span></div><div class="casAuthors">Hu, Hui; Zhu, Sihong; Tong, Yan; Huang, Genhua; Tan, Buzhen; Yang, Lilan</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">483-491</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">1473-5741</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">This study was designed to investigate the antitumor activity of triptolide in ovarian cancer inoculated with SKOV3 and SKOV3/cisplatin (DDP) cells, and to assess the mechanisms.  In-vivo and in-vitro expts. were designed to evaluate the effects of triptolide on the tumor growth of SKOV3 and SKOV3/DDP cells.  The expts. were divided into four groups: a SKOV3 group, a SKOV3 + TP treatment group, a SKOV3/DDP group and a SKOV3/DDP + TP treatment group.  The expression of Sorcin, vascular endothelial growth factor and matrix metalloproteinase-2 were detected by western blotting and immunohistochem.  Tumor cell apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling.  In-vitro expts. showed that compared with SKOV3 control group, the level of colony-stimulating factor 1 and expression of Sorcin in SKOV3/DDP was significantly higher.  Interestingly, triptolide treatment could reduce colony-stimulating factor 1 level and expression of Sorcin in both SKOV3 and SKOV3/DDP cell lines.  In-vivo expts. showed that tissue necrosis area in SKOV3 + TP and SKOV3/DDP + TP was larger than SKOV3 and SKOV3/DDP group, resp.  Triptolide treatment induced apoptosis in both SKOV3 and SKOV3/DDP cells.  Compared with SKOV3 group, the size of tumors was large, and the expression of MMP-2, Sorcin and vascular endothelial growth factor was higher in SKOV3/DDP group.  Triptolide treatment reduced the size of tumors, and the expression of MMP-2, Sorcin and vascular endothelial growth factor in SKOV3/DDP as well as in SKOV3 tumors.  In conclusion, triptolide has antitumor activity in both SKOV3 and SKOV3/DDP cells likely through inducing apoptosis and regulating MMP-2, Sorcin and vascular endothelial growth factor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6HzDfNPF9bVg90H21EOLACvtfcHk0li5FbZBGHbmlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVOitbk%253D&md5=9cd3eee10b0dff6cec4b62778d5cf4d6</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000894%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DAntitumor%2520activity%2520of%2520triptolide%2520in%2520SKOV3%2520cells%2520and%2520SKOV3%252FDDP%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2020%26volume%3D31%26spage%3D483%26epage%3D491%26doi%3D10.1097%2FCAD.0000000000000894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span> <span> </span><span class="NLM_article-title">Broad targeting of triptolide to resistance and sensitization for cancer therapy</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.05.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.05.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29807227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKrsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2018&pages=771-780&author=Z.-Y.+Houauthor=X.-P.+Tongauthor=Y.-B.+Pengauthor=B.-K.+Zhangauthor=M.+Yan&title=Broad+targeting+of+triptolide+to+resistance+and+sensitization+for+cancer+therapy&doi=10.1016%2Fj.biopha.2018.05.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Broad targeting of triptolide to resistance and sensitization for cancer therapy</span></div><div class="casAuthors">Hou, Zhen-yan; Tong, Xiao-pei; Peng, Yong-bo; Zhang, Bi-kui; Yan, Miao</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">771-780</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cancer cell resistance to current anticancer therapeutics as well as the side effects are still obstacles to successful cancer therapy.  Hence, the development of novel anticancer agents or therapeutics is of vital significance, and esp. rational adjuvant therapies contg. low-cost natural products with multiple targets have attracted great interests.  Triptolide, the main biocomponent of Tripterygium wilfordii Hook F, is restricted in clin. applications mainly due to its severe systemic toxicities, although it has shown strong antitumor activities in preclin. studies.  Mounting evidence suggests that triptolide at low doses as an adjuvant therapeutic agent circumvents resistance to current anticancer therapies, enhances the anticancer effectiveness, and relieves toxicities of both triptolide and anticancer therapies.  Furthermore, several unique antitumor targets of triptolide make it superior to other therapeutics.  The mol. mechanisms of triptolide-induced anti-resistance and sensitization effects include changes in ATP-binding cassette transporters, induction of apoptosis pathways, increase in tumor suppressors and decrease in oncogenic factors, and interactions with the RNA polymerase II complex; targeting cancer stem cells and tumor-microenvironment-mediated resistance are also involved.  Besides, some synthetic derivs. and novel delivery systems of triptolide are also developed to enhance the water-soly. and reduce the toxicity, which will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFS4QDU8X8SLVg90H21EOLACvtfcHk0lgwstvvzqTwdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKrsr3I&md5=8af39d9462510672fcf26fc6f4854764</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.05.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.05.088%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DZ.-Y.%26aulast%3DTong%26aufirst%3DX.-P.%26aulast%3DPeng%26aufirst%3DY.-B.%26aulast%3DZhang%26aufirst%3DB.-K.%26aulast%3DYan%26aufirst%3DM.%26atitle%3DBroad%2520targeting%2520of%2520triptolide%2520to%2520resistance%2520and%2520sensitization%2520for%2520cancer%2520therapy%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D104%26spage%3D771%26epage%3D780%26doi%3D10.1016%2Fj.biopha.2018.05.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of Akt</span>. <i>J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3020</span>, <span class="refDoi"> DOI: 10.7150/jca.30669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.7150%2Fjca.30669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31281478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjsFeisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3012-3020&author=G.+Huangauthor=H.+Huauthor=Y.+Zhangauthor=Y.+Zhuauthor=J.+Liuauthor=B.+Tanauthor=T.+Chen&title=Triptolide+sensitizes+cisplatin-resistant+human+epithelial+ovarian+cancer+by+inhibiting+the+phosphorylation+of+Akt&doi=10.7150%2Fjca.30669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT</span></div><div class="casAuthors">Huang, Genhua; Hu, Hui; Zhang, Yao; Zhu, Yinfang; Liu, Junli; Tan, Buzhen; Chen, Tingtao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer (Wyoming, Australia)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3012-3020</span>CODEN:
                <span class="NLM_cas:coden">JCWAAL</span>;
        ISSN:<span class="NLM_cas:issn">1837-9664</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher Pty Ltd.</span>)
        </div><div class="casAbstract">Advanced and chemotherapy-resistant ovarian cancer causes high mortality of ovarian cancer, and it is important to find safe and effective drugs to reduce the chemotherapeutic resistance of ovarian cancer.  In our study, we attempted to clarify the resistance mechanisms of SKOV3/DDP cells in vitro and evaluated the sensitization to triptolide (TPL) in vivo.  Our results indicated that the overexpression of AKT and p-AKT greatly enhanced the cisplatin (DDP) tolerance of SKOV3/DDP, and the combination of DDP + TPL had a significant tumor inhibition effect compared to DDP treatment (p<0.05), via reducing the expressions of p-PI3K, p-Akt, Survivin, VEGF and MMP-2, and the increase of Caspase-3.  Collectively, these results suggest that the synergistic anticancer effect of TPL and DDP warrants their potential clin. applications in further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPnq8ZacJHtLVg90H21EOLACvtfcHk0lgwstvvzqTwdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjsFeisbg%253D&md5=78f2948afec439099fead01a328cb468</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.7150%2Fjca.30669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fjca.30669%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DTriptolide%2520sensitizes%2520cisplatin-resistant%2520human%2520epithelial%2520ovarian%2520cancer%2520by%2520inhibiting%2520the%2520phosphorylation%2520of%2520Akt%26jtitle%3DJ.%2520Cancer%26date%3D2019%26volume%3D10%26spage%3D3012%26epage%3D3020%26doi%3D10.7150%2Fjca.30669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.-F.</span></span> <span> </span><span class="NLM_article-title">Triptolide enhances the sensitivity of pancreatic cancer Panc-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3750</span>– <span class="NLM_lpage">3760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31312385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktF2mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=3750-3760&author=J.-X.+Maauthor=Y.-L.+Sunauthor=Y.+Yuauthor=J.+Zhangauthor=H.-Y.+Wuauthor=X.-F.+Yu&title=Triptolide+enhances+the+sensitivity+of+pancreatic+cancer+Panc-1+cells+to+gemcitabine+by+inhibiting+TLR4%2FNF-%CE%BAB+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling</span></div><div class="casAuthors">Ma, Jian-Xia; Sun, Yun-Liang; Yu, Yang; Zhang, Jian; Wu, Hong-Yu; Yu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Translational Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3750-3760</span>CODEN:
                <span class="NLM_cas:coden">AJTRA7</span>;
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Background: This study aimed to investigate roles of Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling in triptolide (TPL)-induced sensitivity of pancreatic cancer cells to gemcitabine (GEM).  Methods: In vitro, pancreatic cancer PANC-1 cells were treated with lipopolysaccharide (LPS) to activate TLR4, TLR4-siRNA, GEM alone, or GEM plus TPL.  In vivo, nude mice bearing PANC-1 cell xenografts were treated with GEM, TPL, or both.  Cell proliferation was detected by MTT assay and Ki-67 staining.  Apoptosis was assessed by flow cytometry and TUNEL assay.  A double luciferase reporter gene was used to detect NF-κB activity.  Results: The sensitivity of PANC-1 cells to GEM was reduced by LPS but enhanced by TLR4-siRNA.  TPL inhibited expression of TLR4/NF-κB signaling components, which was reversed by LPS.  The TPL+GEM group showed more apoptosis than the LPS+TPL+GEM group.  Moreover, the activity of NF-κB and the expression of TLR4, p-p65 Survivin, CyclinD1 and Bcl-2 in the TPL+GEM group were lower than in the LPS+TPL+GEM group, whereas Bax expression was higher.  The vol. of transplanted tumors in the TPL+GEM group was lower than that in the TPL or GEM group.  Phospho-p65, Survivin, CyclinD1 and Bcl-2 expression in transplanted tumors was lower in TPL+GEM group than in either single drug group.  The Ki-67 staining score of the TPL+GEM group was lower and tumor cells apoptosis rate was increased when compared with TPL or GEM alone.  Conclusions: TPL enhances the sensitivity of pancreatic cancer PANC-1 cells to GEM by inhibiting TLR4/NF-κB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLlxtqP30Fo7Vg90H21EOLACvtfcHk0liObq-NrxnsUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktF2mtL4%253D&md5=965b664622a41414f31735bca66d19cc</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.-X.%26aulast%3DSun%26aufirst%3DY.-L.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.-Y.%26aulast%3DYu%26aufirst%3DX.-F.%26atitle%3DTriptolide%2520enhances%2520the%2520sensitivity%2520of%2520pancreatic%2520cancer%2520Panc-1%2520cells%2520to%2520gemcitabine%2520by%2520inhibiting%2520TLR4%252FNF-%25CE%25BAB%2520signaling%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2019%26volume%3D11%26spage%3D3750%26epage%3D3760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span> <span> </span><span class="NLM_article-title">Combined treatment with triptolide and tyrosine kinase inhibitors synergistically enhances apoptosis in non-small cell lung cancer H1975 cells but not H1299 cells through EGFR/Akt pathway</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1248/cpb.c19-00300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fcpb.c19-00300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31142691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1Sgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2019&pages=864-871&author=X.+Tongauthor=P.+Jiangauthor=Y.+Liauthor=L.+Guoauthor=H.-M.+Zhangauthor=B.-K.+Zhangauthor=M.+Yan&title=Combined+treatment+with+triptolide+and+tyrosine+kinase+inhibitors+synergistically+enhances+apoptosis+in+non-small+cell+lung+cancer+H1975+cells+but+not+H1299+cells+through+EGFR%2FAkt+pathway&doi=10.1248%2Fcpb.c19-00300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Combined treatment with triptolide and tyrosine kinase inhibitors synergistically enhances apoptosis in non-small cell lung cancer H1975 Cells but Not H1299 cells through EGFR/Akt pathway</span></div><div class="casAuthors">Tong, Xiaopei; Jiang, Pei; Li, Yao; Guo, Lin; Zhang, Hui-min; Zhang, Bi-kui; Yan, Miao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">864-871</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Lung cancer is one of the most common malignant cancers in the world.  Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is a second- or third-line therapy for mutated non-small cell lung cancer (NSCLC).  It usually becomes drug resistance after a period of treatment.  Triptolide (TPL) is an epoxy diterpenoid lactone compd. extd. from Tripterygium wilfordii Hook.F. and many studies demonstrated that TPL has a synergistic effect when combined with chemotherapy drugs.  In this research, we plan to evaluate the combined effect of TPL and EGFR-TKIs (Gefitinib, Erlotinib, and Icotinib) and investigate the possible mechanisms.  3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted to detect the cell viabilities, combined effect was evaluated by Combination Index.  Mol. docking study was used to predict the binding ability of TPL.  The expression of proteins was detected by Western blot.  MTT results showed TPL had synergistic effect with three EGFR-TKIs at different concns. on H1975 cells but not on H1299 cells.  Mol. docking study demonstrated that TPL with T790M/L858R EGFR can form a more stable compd. than that with wild type EGFR.  Western blot results showed TPL inhibited the EGFR/Akt pathway and increased the expression of Bax and the ratio of Bax and Bcl-2 in H1975 cells.  In conclusion, TPL had synergistic effect with three EGFR-TKIs on H1975 cells but not on H1299 cells, which may be due to the binding ability of TPL and different-type EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriO-06ez4bdbVg90H21EOLACvtfcHk0lgImBBV-Jje0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1Sgt74%253D&md5=c7a9405c5e376ddd0f4b86c38953dc97</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c19-00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c19-00300%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.-M.%26aulast%3DZhang%26aufirst%3DB.-K.%26aulast%3DYan%26aufirst%3DM.%26atitle%3DCombined%2520treatment%2520with%2520triptolide%2520and%2520tyrosine%2520kinase%2520inhibitors%2520synergistically%2520enhances%2520apoptosis%2520in%2520non-small%2520cell%2520lung%2520cancer%2520H1975%2520cells%2520but%2520not%2520H1299%2520cells%2520through%2520EGFR%252FAkt%2520pathway%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2019%26volume%3D67%26spage%3D864%26epage%3D871%26doi%3D10.1248%2Fcpb.c19-00300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">A mechanistic overview of triptolide and celastrol, natural products from <i>Tripterygium wilfordii</i> Hook f</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">104</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2018.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29491837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=104&author=S.-R.+Chenauthor=Y.+Daiauthor=J.+Zhaoauthor=L.+Linauthor=Y.+Wangauthor=Y.+Wang&title=A+mechanistic+overview+of+triptolide+and+celastrol%2C+natural+products+from+Tripterygium+wilfordii+Hook+f&doi=10.3389%2Ffphar.2018.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F</span></div><div class="casAuthors">Chen, Shao-Ru; Dai, Yan; Zhao, Jing; Lin, Ligen; Wang, Yitao; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104/1-104/13</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Tripterygium wilfordii Hook F.  These compds. exhibit similar pharmacol. activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities.  Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases.  However, toxicity restricts the further development of triptolide and celastrol.  In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol.  We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivs.  Furthermore, we propose the use of structural derivs., targeted therapy, and combination treatment as possible solns. to reduce toxicity and increase therapeutic window of these potent natural products from T. wilfordii Hook F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6S3u2q0YLLVg90H21EOLACvtfcHk0lhPOh54K0Ih3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE&md5=826675620f132aa76d9b07f466fb9631</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00104%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.-R.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DA%2520mechanistic%2520overview%2520of%2520triptolide%2520and%2520celastrol%252C%2520natural%2520products%2520from%2520Tripterygium%2520wilfordii%2520Hook%2520f%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D104%26doi%3D10.3389%2Ffphar.2018.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span> <span> </span><span class="NLM_article-title">The study of cellular mechanism of triptolide in the treatment of cancer, bone loss and cardiovascular disease and triptolide’s toxicity</span>. <i>Curr. Stem Cell Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.2174/1574888X14666190301155810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1574888X14666190301155810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30834841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFOmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=18-23&author=Y.+Wangauthor=B.+Wangauthor=X.+Yang&title=The+study+of+cellular+mechanism+of+triptolide+in+the+treatment+of+cancer%2C+bone+loss+and+cardiovascular+disease+and+triptolide%E2%80%99s+toxicity&doi=10.2174%2F1574888X14666190301155810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity</span></div><div class="casAuthors">Wang, Youhan; Wang, Biao; Yang, Xiaobin</div><div class="citationInfo"><span class="NLM_cas:title">Current Stem Cell Research & Therapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-23</span>CODEN:
                <span class="NLM_cas:coden">CSCRC9</span>;
        ISSN:<span class="NLM_cas:issn">1574-888X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Triptolide (TPL), the active component of Tripterygium wilfordii Hook F (Twhf) has been used to treat cancer and bone loss conditions for over two hundred years in traditional Chinese medicine (TCM).  In this paper, we reviewed the specific mol. mechanisms in the treatment of cancer, bone loss and cardiovascular disease.  In addn., we analyze the toxicity of TPL and collect some optimized derivs. extd. from TPL.  Although pos. results were obtained in most cell culture and animal studies, further studies are needed to substantiate the beneficial effects of TPL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWl6y3K_gArVg90H21EOLACvtfcHk0ljbE2BTz_01-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFOmuro%253D&md5=128311100568176f9043e0dcc00c4408</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.2174%2F1574888X14666190301155810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1574888X14666190301155810%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DThe%2520study%2520of%2520cellular%2520mechanism%2520of%2520triptolide%2520in%2520the%2520treatment%2520of%2520cancer%252C%2520bone%2520loss%2520and%2520cardiovascular%2520disease%2520and%2520triptolide%25E2%2580%2599s%2520toxicity%26jtitle%3DCurr.%2520Stem%2520Cell%2520Res.%2520Ther.%26date%3D2020%26volume%3D15%26spage%3D18%26epage%3D23%26doi%3D10.2174%2F1574888X14666190301155810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, H.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.-H.</span></span> <span> </span><span class="NLM_article-title">Triptolide, a potential autophagy modulator</span>. <i>Chin. J. Integr. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1007/s11655-018-2847-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs11655-018-2847-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30178091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1GltLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=233-240&author=Y.-M.+Weiauthor=Y.-H.+Wangauthor=H.-Q.+Xueauthor=Z.-H.+Luanauthor=B.-W.+Liuauthor=J.-H.+Ren&title=Triptolide%2C+a+potential+autophagy+modulator&doi=10.1007%2Fs11655-018-2847-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide, A Potential Autophagy Modulator</span></div><div class="casAuthors">Wei, Yan-ming; Wang, Yong-hui; Xue, Hui-qing; Luan, Zhi-hua; Liu, Bi-wang; Ren, Jin-hong</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Journal of Integrative Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">CJIMBS</span>;
        ISSN:<span class="NLM_cas:issn">1672-0415</span>.
    
            (<span class="NLM_cas:orgname">Chinese Journal of Integrated Traditional and Western Medicine Press</span>)
        </div><div class="casAbstract">As a major active component extd. from traditional Chinese herb Tripterygium wilfordii Hook F, triptolide exhibits multiple pharmacol. effects.  Autophagy is an evolutionary conserved intracellular catabolic process involved in cytoplasmic materials degrdn.  Autophagic dysfunction contributes to the pathologies of many human diseases, which makes it a promising therapeutic target.  Recent studies have shown that triptolide exerts neuroprotection, anti-tumor activities, organ toxicity, and podocyte protection by modulating autophagy.  This article highlights the current information on triptolide-modulated autophagy, analyzes the possible pathways involved, and describes the crosstalk between autophagy and apoptosis modulated by triptolide, in hope of providing implications for the roles of autophagy in pharmacol. effects of triptolide and expanding its novel usage as an autophagy modulator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocYlKVAczheLVg90H21EOLACvtfcHk0liKJKQOYs9vOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1GltLvK&md5=ec124ba08736c597c7e66d81d743e9d3</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1007%2Fs11655-018-2847-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11655-018-2847-z%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.-M.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DXue%26aufirst%3DH.-Q.%26aulast%3DLuan%26aufirst%3DZ.-H.%26aulast%3DLiu%26aufirst%3DB.-W.%26aulast%3DRen%26aufirst%3DJ.-H.%26atitle%3DTriptolide%252C%2520a%2520potential%2520autophagy%2520modulator%26jtitle%3DChin.%2520J.%2520Integr.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D233%26epage%3D240%26doi%3D10.1007%2Fs11655-018-2847-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belgum, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evenson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etchison, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jay-Dixon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Cunha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratzke, R. A.</span></span> <span> </span><span class="NLM_article-title">Triptolide and its prodrug Minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.18632/genesandcancer.55</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Fgenesandcancer.55" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26000097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFGjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=144-152&author=B.+A.+Jacobsonauthor=E.+Z.+Chenauthor=S.+Tangauthor=H.+S.+Belgumauthor=J.+A.+McCauleyauthor=K.+A.+Evensonauthor=R.+G.+Etchisonauthor=J.+Jay-Dixonauthor=M.+R.+Patelauthor=A.+Razaauthor=A.+K.+Salujaauthor=J.+D%E2%80%99Cunhaauthor=R.+A.+Kratzke&title=Triptolide+and+its+prodrug+Minnelide+suppress+Hsp70+and+inhibit+in+vivo+growth+in+a+xenograft+model+of+mesothelioma&doi=10.18632%2Fgenesandcancer.55"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma</span></div><div class="casAuthors">Jacobson, Blake A.; Chen, Esther Z.; Tang, Shaogeng; Belgum, Holly Sedgwick; McCauley, Joel A.; Evenson, Kristen A.; Etchison, Ryan G.; Jay-Dixon, Joe; Patel, Manish R.; Raza, Ahmad; Ashok; Saluja, K.; D'Cunha, Jonathan; Kratzke, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">Malignant mesothelioma is a devastating disease with a poor prognosis for which there is a clear need for more successful therapeutic approaches.  Triptolide, a diterpenoid triepoxide, is a highly effective agent against several cancer types in animal models.  Owing to triptolide's poor soly. in water, a water-sol. analog, minnelide, was synthesized.  Minnelide is a prodrug of triptolide and is activated by exposure to phosphatases that are found in all body tissues, including blood.  Mesothelioma cells were treated in vitro with minnelide or its parent compd., triptolide.  Minnelide and triptolide were both found to significantly reduce mesothelioma cell viability and induce apoptosis.  The level of Hsp70, a protein that promotes cancer cell survival, was measured in mesothelioma cells before and after treatment with triptolide.  Hsp70 levels were decreased in a dose-dependent manner.  In addn., triptolide sensitized cells to gemcitabine and pemetrexed as measured by cell viability.  Mice bearing mesothelioma flank tumors were treated with daily injections (28 d) of minnelide or saline soln. and xenograft tumor growth recorded.  Mice displayed significantly reduced tumor burden.  These findings support the clin. evaluation of minnelide therapy for mesothelioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8cHIQIeCxj7Vg90H21EOLACvtfcHk0lgPRJY1I6Zpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFGjtb0%253D&md5=b27d6acde77f59190442c0798536be0b</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.55%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DE.%2BZ.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DBelgum%26aufirst%3DH.%2BS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DEvenson%26aufirst%3DK.%2BA.%26aulast%3DEtchison%26aufirst%3DR.%2BG.%26aulast%3DJay-Dixon%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DRaza%26aufirst%3DA.%26aulast%3DSaluja%26aufirst%3DA.%2BK.%26aulast%3DD%25E2%2580%2599Cunha%26aufirst%3DJ.%26aulast%3DKratzke%26aufirst%3DR.%2BA.%26atitle%3DTriptolide%2520and%2520its%2520prodrug%2520Minnelide%2520suppress%2520Hsp70%2520and%2520inhibit%2520in%2520vivo%2520growth%2520in%2520a%2520xenograft%2520model%2520of%2520mesothelioma%26jtitle%3DGenes%2520Cancer%26date%3D2015%26volume%3D6%26spage%3D144%26epage%3D152%26doi%3D10.18632%2Fgenesandcancer.55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Triptolide-targeted delivery methods</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.12.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2018.12.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30605832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtl2nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2019&pages=342-351&author=H.+Xuauthor=B.+Liu&title=Triptolide-targeted+delivery+methods&doi=10.1016%2Fj.ejmech.2018.12.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide-targeted delivery methods</span></div><div class="casAuthors">Xu, Hongtao; Liu, Bo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">342-351</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Triptolide, a complex triepoxide diterpene natural product, has attracted considerable interest in the medicinal society due to its multiple biol. activities.  However, poor water soly., narrow therapeutic window and multi-organ toxicity have greatly hindered its clin. application.  In order to improve its clin. potential, either structural modification or the development of novel targeted delivery systems for triptolide have been executed worldwide in the past decades.  In this review, we systematically summarized strategies that have been utilized to develop triptolide-targeted delivery methods, including direct conjugation of triptolide to selected ligands such as sugar, short peptide, oligonucleotide, antibody and most importantly encapsulation of triptolide with well-designed nano-vehicle.  Thanks to the potent multiple biol. activities of triptolide, either direct conjugation of triptolide to selected ligands or encapsulation of triptolide with nanocarriers could provide better anti-inflammatory or anticancer activity.  Thus, these targeted delivery strategies could be taken as a starting point for future utilization of triptolide and also other NPs in exptl. clin. therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEBECpNsurDLVg90H21EOLACvtfcHk0ljU8RE5m2ZCUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtl2nsA%253D%253D&md5=f0d3e5d5f8ff684e0966319146893ec9</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.12.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.12.058%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DTriptolide-targeted%2520delivery%2520methods%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D164%26spage%3D342%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2018.12.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">119907</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2020.119907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biomaterials.2020.119907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32120315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2020&pages=119907&author=J.+Fengauthor=M.+Xuauthor=J.+Wangauthor=S.+Zhouauthor=Y.+Liuauthor=S.+Liuauthor=Y.+Huangauthor=Y.+Chenauthor=L.+Chenauthor=Q.+Songauthor=J.+Gongauthor=H.+Luauthor=X.+Gaoauthor=J.+Chen&title=Sequential+delivery+of+nanoformulated+%CE%B1-mangostin+and+triptolide+overcomes+permeation+obstacles+and+improves+therapeutic+effects+in+pancreatic+cancer&doi=10.1016%2Fj.biomaterials.2020.119907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer</span></div><div class="casAuthors">Feng, Jingxian; Xu, Minjun; Wang, Jiahao; Zhou, Songlei; Liu, Yipu; Liu, Shanshan; Huang, Yukun; Chen, Yu; Chen, Liang; Song, Qingxiang; Gong, Jingru; Lu, Huiping; Gao, Xiaoling; Chen, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119907</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease exhibiting the poorest prognosis among solid tumors.  The efficacy of conventional therapies has been hindered largely due to the insufficient chemotherapeutic delivery to the dense desmoplastic tumor stroma, and the extremely high or toxic dose needed for chemotherapy.  Traditional Chinese Medicine (TCM) contains effective components that can effectively regulate tumor microenvironment and kill tumor cells, providing promising alternatives to PDAC chemotherapy.  In this study, two active drug monomers of TCM were screened out and a sequentially targeting delivery regimen was developed to realize the optimized combinational therapy.  Transforming growth factor-β (TGF-β) plays an indispensable role in promoting cancer-assocd. fibroblasts (CAFs) activation and proliferation, and CAFs have caused major phys. barriers for chemotherapeutic drug delivery.  Herein, CAFs-targeting biodegradable polymer nanoparticle (CRE-NP(α-M)) coated with CREKA peptide and loaded with TCM α-mangostin (α-M) was developed to modulate tumor microenvironment by interfering of TGF-β/Smad signaling pathway.  Low pH-triggered micelle modified with CRPPR peptide and loaded with another TCM triptolide was constructed to increase the therapeutic effect of triptolide at the tumor sites and reduced its damage to main organs.  As expected, CRE-NP(α-M) effectively inactived CAFs, reduced extracellular matrix prodn., promoted tumor vascular normalization and enhanced blood perfusion at the tumor site.  The sequentially targeting drug delivery regimen, CRP-MC(Trip) following CRE-NP(α-M) pretreatment, exhibited strong tumor growth inhibition effect in the orthotopic tumor model.  Hence, sequentially targeting delivery of nanoformulated TCM offers an efficient approach to overcome the permeation obstacles and improve the effect of chemotherapy on PDAC, and provides a novel option to treat desmoplastic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwE-jLfqRsbVg90H21EOLACvtfcHk0lgePfAwG5fC_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKiu78%253D&md5=d527aba9251de3ede0edfee52f7f1ab6</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2020.119907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2020.119907%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DSequential%2520delivery%2520of%2520nanoformulated%2520%25CE%25B1-mangostin%2520and%2520triptolide%2520overcomes%2520permeation%2520obstacles%2520and%2520improves%2520therapeutic%2520effects%2520in%2520pancreatic%2520cancer%26jtitle%3DBiomaterials%26date%3D2020%26volume%3D241%26spage%3D119907%26doi%3D10.1016%2Fj.biomaterials.2020.119907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Toxicity of triptolide and the molecular mechanisms involved</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2017.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28402922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlajtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=531-541&author=C.+Xiauthor=S.+Pengauthor=Z.+Wuauthor=Q.+Zhouauthor=J.+Zhou&title=Toxicity+of+triptolide+and+the+molecular+mechanisms+involved&doi=10.1016%2Fj.biopha.2017.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of triptolide and the molecular mechanisms involved</span></div><div class="casAuthors">Xi, Chen; Peng, Shaojun; Wu, Zhengping; Zhou, Qingping; Zhou, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Triptolide (TP), a major active and toxic ingredient isolated from the traditional Chinese herb Tripterygium wilfordii Hook f.  (TWHF). A widespread application of TP raises the question on the safety of its use in clin. settings.  The metab. of TP is mediated by hepatic cytochrome P450s, and a strong correlation exists between TP toxicity and CPY3A.  Toxicity of TP and the mol. mechanisms of its toxic effects have been studied in recent years.  Studies have demonstrated that TP exposure results in injury of various organs, including the liver, kidney, testes, ovary, and heart in animals and even in humans, according to clin. case reports.  Moreover, on the cellular level, TP has been reported to be assocd. with diverse toxic effects, encompassing membrane damage, mitochondrial disruption, metab. dysfunction, endoplasmic reticulum stress, oxidative stress, apoptosis and autophagy.  This review presents an overview of the current findings related to TP toxicity with an emphasis on biol. targets and the mol. mechanisms that may be involved, thus providing a systematic understanding of the mechanisms by which TP affects cells and tissues in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpUqHdCyNcXLVg90H21EOLACvtfcHk0liIJiAoVTSpuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlajtbY%253D&md5=70ac9625b43840691c406c57c896b679</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DToxicity%2520of%2520triptolide%2520and%2520the%2520molecular%2520mechanisms%2520involved%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D90%26spage%3D531%26epage%3D541%26doi%3D10.1016%2Fj.biopha.2017.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">A review of the total syntheses of triptolide</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1984</span>– <span class="NLM_lpage">1995</span>, <span class="refDoi"> DOI: 10.3762/bjoc.15.194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3762%2Fbjoc.15.194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31501665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCnsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1984-1995&author=X.+Zhangauthor=Z.+Xiaoauthor=H.+Xu&title=A+review+of+the+total+syntheses+of+triptolide&doi=10.3762%2Fbjoc.15.194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the total syntheses of triptolide</span></div><div class="casAuthors">Zhang, Xiang; Xiao, Zaozao; Xu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1984-1995</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  Triptolide is a complex triepoxide diterpene natural product that has attracted considerable interest in the org. chem. and medicinal chem. societies due to its intriguing structural features and multiple promising biol. activities.  In this review, progress in the total syntheses of triptolide were systematically summarized.  We hope to gain a better understanding of the field and provide constructive suggestions for future studies of triptolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngIB78Vc4F7Vg90H21EOLACvtfcHk0liIJiAoVTSpuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCnsLfI&md5=36b95b1783a368094c813f5729b392de</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.15.194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.15.194%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DA%2520review%2520of%2520the%2520total%2520syntheses%2520of%2520triptolide%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2019%26volume%3D15%26spage%3D1984%26epage%3D1995%26doi%3D10.3762%2Fbjoc.15.194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.-H.</span></span> <span> </span><span class="NLM_article-title">Triptolide: Structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1039/c2np00088a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fc2np00088a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22270059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=457-475&author=Z.-L.+Zhouauthor=Y.-X.+Yangauthor=J.+Dingauthor=Y.-C.+Liauthor=Z.-H.+Miao&title=Triptolide%3A+Structural+modifications%2C+structure-activity+relationships%2C+bioactivities%2C+clinical+development+and+mechanisms&doi=10.1039%2Fc2np00088a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms</span></div><div class="casAuthors">Zhou, Zhao-Li; Yang, Ya-Xi; Ding, Jian; Li, Yuan-Chao; Miao, Ze-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-475</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1972 to 2011Triptolide, a principal bioactive ingredient of Tripterygium wilfordii Hook F, has attracted extensive exploration due to its unique structure of a diterpenoid triepoxide and multiple biol. activities.  This review will focus on the structural modifications, structure-activity relationships, pharmacol., and clin. development of triptolide in the last forty years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8SUmelewlLVg90H21EOLACvtfcHk0lh0cBl9dU07cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wktbg%253D&md5=8dfd5b37b76fc5f4ea39fc5fc055a9fd</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1039%2Fc2np00088a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2np00088a%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.-L.%26aulast%3DYang%26aufirst%3DY.-X.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-C.%26aulast%3DMiao%26aufirst%3DZ.-H.%26atitle%3DTriptolide%253A%2520Structural%2520modifications%252C%2520structure-activity%2520relationships%252C%2520bioactivities%252C%2520clinical%2520development%2520and%2520mechanisms%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2012%26volume%3D29%26spage%3D457%26epage%3D475%26doi%3D10.1039%2Fc2np00088a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Triptolide: Medicinal chemistry, chemical biology and clinical progress</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.05.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31121546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFektLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=378-392&author=W.+Houauthor=B.+Liuauthor=H.+Xu&title=Triptolide%3A+Medicinal+chemistry%2C+chemical+biology+and+clinical+progress&doi=10.1016%2Fj.ejmech.2019.05.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide: Medicinal chemistry, chemical biology and clinical progress</span></div><div class="casAuthors">Hou, Wei; Liu, Bo; Xu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">378-392</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the past decades, triptolide has attracted considerable interests in the org. and medicinal chem. society owing to its intriguing structure features and promising multiple pharmacol. activities.  However, its limited water soly. and oral bioavailability, imprecise mechanism of action and sever toxicity, scares from nature and difficulty in the synthesis have greatly hindered its clin. potential.  Hence, to circumvent such problems, a lot of elegant total synthesis have been developed.  With the advancement of the total synthesis, various triptolide derivs. have been synthesized and tested in the search for more drug-like derivs. for potential anticancer agents, anti-inflammatory agents, immunosuppressive agents and anti-Alzheimer's agents, etc.  Meanwhile, through designing and synthesizing of various of bioactive probes, some mol. targets that are responsible for the multiple pharmacol. activities as well as toxicity of triptolide have been identified.  It is no doubt will help the future development of new drug-like triptolide derivs.  In order to gain a comprehensive and deep understanding of the area and provides suggestions for triptolide's further studies, i. the medicinal chem. advancement, ii. bioactive probes-based cellular target identification and iii. clin. progress of triptolide derivs. are reviewed in this article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8KlHBuZ6B8rVg90H21EOLACvtfcHk0lh0cBl9dU07cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFektLg%253D&md5=0b29f1ef204d8ef7cf228033c1f4b97d</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.032%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DTriptolide%253A%2520Medicinal%2520chemistry%252C%2520chemical%2520biology%2520and%2520clinical%2520progress%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D176%26spage%3D378%26epage%3D392%26doi%3D10.1016%2Fj.ejmech.2019.05.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velagapudi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borazanci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span> <span> </span><span class="NLM_article-title">Triptolide and its derivatives as cancer therapies</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2019.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tips.2019.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30975442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvVWnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=327-341&author=P.+Noelauthor=D.+D.+Von+Hoffauthor=A.+K.+Salujaauthor=M.+Velagapudiauthor=E.+Borazanciauthor=H.+Han&title=Triptolide+and+its+derivatives+as+cancer+therapies&doi=10.1016%2Fj.tips.2019.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide and Its Derivatives as Cancer Therapies</span></div><div class="casAuthors">Noel, Pawan; Von Hoff, Daniel D.; Saluja, Ashok K.; Velagapudi, Mohana; Borazanci, Erkut; Han, Haiyong</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">327-341</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triptolide, a compd. isolated from a Chinese medicinal herb, possesses potent antitumor, immunosuppressive, and anti-inflammatory properties, but is clin. limited due to its poor soly., bioavailability, and toxicity.  Recently, Minnelide, a water-sol. prodrug of triptolide, was shown to have potent antitumor activity in various preclin. cancer models.  Minnelide is currently in Phase II clin. trials for treatment of advanced pancreatic cancer, which has fueled increased interest in this promising agent.  Here, we review the recent advances in the biol. activity of triptolide and its analogs, their mechanisms of actions, and their clin. developments.  A special emphasis is given to proteins and pathways within the tumor and stromal compartments that are targeted by triptolide and its analogs as well as the ongoing clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQTbU52HqAs7Vg90H21EOLACvtfcHk0lh0cBl9dU07cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvVWnsr0%253D&md5=beae1702494160ce5b03c97701afaead</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2019.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2019.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DNoel%26aufirst%3DP.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DSaluja%26aufirst%3DA.%2BK.%26aulast%3DVelagapudi%26aufirst%3DM.%26aulast%3DBorazanci%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DH.%26atitle%3DTriptolide%2520and%2520its%2520derivatives%2520as%2520cancer%2520therapies%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2019%26volume%3D40%26spage%3D327%26epage%3D341%26doi%3D10.1016%2Fj.tips.2019.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Divergent total synthesis of triptolide, triptonide, tripdiolide, 16-hydroxytriptolide, and their analogues</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">10110</span>– <span class="NLM_lpage">10122</span>, <span class="refDoi"> DOI: 10.1021/jo501744j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo501744j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=10110-10122&author=H.+Xuauthor=H.+Tangauthor=H.+Fengauthor=Y.+Li&title=Divergent+total+synthesis+of+triptolide%2C+triptonide%2C+tripdiolide%2C+16-hydroxytriptolide%2C+and+their+analogues&doi=10.1021%2Fjo501744j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent Total Synthesis of Triptolide, Triptonide, Tripdiolide, 16-Hydroxytriptolide, and Their Analogues</span></div><div class="casAuthors">Xu, Hongtao; Tang, Huanyu; Feng, Huijin; Li, Yuanchao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">10110-10122</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A divergent route was developed for the formal total synthesis of triptolide (I), triptonide (II), and tripdiolide (III), as well as a total synthesis of 16-hydroxytriptolide (IV) and their analogs in an enantioselective form.  Common advanced intermediate V was concisely assembled by employing an indium(III)-catalyzed cationic polycyclization reaction and a palladium-catalyzed carbonylation-lactone formation reaction as key steps.  This advanced intermediate was readily converted to the above natural products by using palladium-catalyzed cross-coupling or the Claisen rearrangement reaction as key steps.  Addnl., preliminary structure-cytotoxic activity relationship studies of C13 suggested that it might be a new modification site that could still retain the cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowZEc7oeXfirVg90H21EOLACvtfcHk0lhc0jBSIj68Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahsrfP&md5=6c9520a816b1ba388ef8fff8ef6fdc1a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Fjo501744j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo501744j%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DDivergent%2520total%2520synthesis%2520of%2520triptolide%252C%2520triptonide%252C%2520tripdiolide%252C%252016-hydroxytriptolide%252C%2520and%2520their%2520analogues%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D10110%26epage%3D10122%26doi%3D10.1021%2Fjo501744j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.-M.</span></span> <span> </span><span class="NLM_article-title">Bioactive 18(4→3)-<i>abeo</i>-abietanoid derivatives from the leaves of <i>Tripterygium wilfordii</i></span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30046</span>– <span class="NLM_lpage">30052</span>, <span class="refDoi"> DOI: 10.1039/C5RA02174J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC5RA02174J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=30046-30052&author=C.+Wangauthor=C.-J.+Liauthor=J.+Maauthor=J.-Z.+Yangauthor=X.-G.+Chenauthor=L.+Liauthor=D.-M.+Zhang&title=Bioactive+18%284%E2%86%923%29-abeo-abietanoid+derivatives+from+the+leaves+of+Tripterygium+wilfordii&doi=10.1039%2FC5RA02174J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1039%2FC5RA02174J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA02174J%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.-J.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.-Z.%26aulast%3DChen%26aufirst%3DX.-G.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DD.-M.%26atitle%3DBioactive%252018%25284%25E2%2586%25923%2529-abeo-abietanoid%2520derivatives%2520from%2520the%2520leaves%2520of%2520Tripterygium%2520wilfordii%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D30046%26epage%3D30052%26doi%3D10.1039%2FC5RA02174J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span> <span> </span><span class="NLM_article-title">Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1284</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.1002/pros.23834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fpros.23834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31212374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSnt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=1284-1293&author=F.+Dongauthor=P.+Yangauthor=R.+Wangauthor=W.+Sunauthor=Y.+Zhangauthor=A.+Wangauthor=M.+Chenauthor=L.+Chenauthor=C.+Zhangauthor=M.+Jiang&title=Triptonide+acts+as+a+novel+antiprostate+cancer+agent+mainly+through+inhibition+of+mTOR+signaling+pathway&doi=10.1002%2Fpros.23834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway</span></div><div class="casAuthors">Dong, Fulu; Yang, Ping; Wang, Rui; Sun, Wenxing; Zhang, Yonghui; Wang, Aiting; Chen, Miaomiao; Chen, Lu; Zhang, Chong; Jiang, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1284-1293</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The increasing incidence of prostate cancer (PCa) indicates an urgent need for the development of new effective drugs in PCa therapy.  Triptonide has been reported to have a strong inhibition activity in cancers through screening of Chinese herbal medicine.  This study aims to investigate the effects of triptonide on anti-PCa activity and its mechanisms.  Three human advanced PCa cell lines PC3, DU145, and LNCap, and a human normal prostate epithelial cell line RWPE were treated with a range (0, 1.25, 2.5, 5, 10, 20, 40, 80, 160, and 320 nM) of triptonide concns. for 72 h resp.  Then, cell viability was assessed by cell counting kit-8.  PCa cells were treated with different doses (0-20 nM) of triptonide for 72 h.  Cell cycle and apoptosis were assessed by flow cytometry assays.  Nude mice bearing human PCa xenografts were i.p. injected daily with either triptonide (10 mg/kg/d) or phosphate-buffered saline as a control for 35 days.  RNA-sequencing (RNA-seq) was performed by an Illumina Hiseq Sequencing platform and confirmed by a real-time polymerase chain reaction.  Gene Ontol., Kyoto Encyclopedia of Genes and Genomes pathway anal., and ingenuity pathway anal. were used to analyze RNA-seq results.  Results : Triptonide effectively inhibits the proliferation of human PCa cells PC3, DU145, and LNCap in vitro with their IC50 values as 11.961, 10.259, and 12.012 nM, resp.  Triptonide (10 mg/kg) potently inhibits the growth of PCa cell xenografts in vivo at an inhibition rate of over 97.95%.  Treatment with triptonide (5 nM) significantly promotes cell apoptosis and retaining cell-cycle arrest in the G2/M phase.  RNA-seq data revealed that total of 936 genes were upregulated or downregulated in triptonide treated.  Moreover, the phosphorylation of mechanistic target of rapamycin (mTOR) and the downstream protein p70S6K were both inhibited, most obviously in PCa cells.  Our findings suggest that triptonide can efficaciously suppress PCa growth in vitro and in vivo via inhibiting the phosphorylation of mTOR and the activities of related downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLxC5w0Ff4zbVg90H21EOLACvtfcHk0lhc0jBSIj68Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSnt7vF&md5=32c40f80cb4cbef255dd3aa219743dc3</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fpros.23834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.23834%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DM.%26atitle%3DTriptonide%2520acts%2520as%2520a%2520novel%2520antiprostate%2520cancer%2520agent%2520mainly%2520through%2520inhibition%2520of%2520mTOR%2520signaling%2520pathway%26jtitle%3DProstate%26date%3D2019%26volume%3D79%26spage%3D1284%26epage%3D1293%26doi%3D10.1002%2Fpros.23834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span> <span> </span><span class="NLM_article-title">Triptonide effectively inhibits Wnt/β-catenin signaling via C-terminal transactivation domain of β-catenin</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32779</span>, <span class="refDoi"> DOI: 10.1038/srep32779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep32779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27596363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVymtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=32779&author=J.+Chinisonauthor=J.+S.+Aguilarauthor=A.+Avalosauthor=Y.+Huangauthor=Z.+Wangauthor=D.+J.+Cameronauthor=J.+Hao&title=Triptonide+effectively+inhibits+Wnt%2F%CE%B2-catenin+signaling+via+C-terminal+transactivation+domain+of+%CE%B2-catenin&doi=10.1038%2Fsrep32779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin</span></div><div class="casAuthors">Chinison, Jessica; Aguilar, Jose S.; Avalos, Alan; Huang, Ying; Wang, Zhijun; Cameron, D. Joshua; Hao, Jijun</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32779</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Abnormal activation of canonical Wnt/β-catenin signaling is implicated in many diseases including cancer.  As a result, therapeutic agents that disrupt this signaling pathway have been highly sought after.  Triptonide is a key bioactive small mol. identified in a traditional Chinese medicine named Tripterygium wilfordii Hook F., and it has a broad spectrum of biol. functions.  Here we show that triptonide can effectively inhibit canonical Wnt/β-catenin signaling by targeting the downstream C-terminal transcription domain of β-catenin or a nuclear component assocd. with β-catenin.  In addn., triptonide treatment robustly rescued the zebrafish "eyeless" phenotype induced by GSK-3β antagonist 6-bromoindirubin-30-oxime (BIO) for Wnt signaling activation during embryonic gastrulation.  Finally, triptonide effectively induced apoptosis of Wnt-dependent cancer cells, supporting the therapeutic potential of triptonide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdkCjTBzKXnbVg90H21EOLACvtfcHk0lhc0jBSIj68Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVymtrzF&md5=887266067801cb37ed38a51f4875de18</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fsrep32779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32779%26sid%3Dliteratum%253Aachs%26aulast%3DChinison%26aufirst%3DJ.%26aulast%3DAguilar%26aufirst%3DJ.%2BS.%26aulast%3DAvalos%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCameron%26aufirst%3DD.%2BJ.%26aulast%3DHao%26aufirst%3DJ.%26atitle%3DTriptonide%2520effectively%2520inhibits%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520via%2520C-terminal%2520transactivation%2520domain%2520of%2520%25CE%25B2-catenin%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D32779%26doi%3D10.1038%2Fsrep32779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">114870</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2019.114870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.taap.2019.114870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31866380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2020&pages=114870&author=S.+Xiangauthor=Z.+Zhaoauthor=T.+Zhangauthor=B.+Zhangauthor=M.+Mengauthor=Z.+Caoauthor=Q.+Zhou&title=Triptonide+effectively+suppresses+gastric+tumor+growth+and+metastasis+through+inhibition+of+the+oncogenic+Notch1+and+NF-%CE%BAB+signaling+pathways&doi=10.1016%2Fj.taap.2019.114870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways</span></div><div class="casAuthors">Xiang, Shufen; Zhao, Zhe; Zhang, Tong; Zhang, Bin; Meng, Mei; Cao, Zhifei; Zhou, Quansheng</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114870</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Gastric cancer ranks as the third leading cause of cancer-related death worldwide.  The uncontrolled tumor growth and robust metastasis are key factors to cause the cancer patient death.  Mechanistically, aberrant activation of Notch and NF-κB signaling pathways plays pivotal roles in the initiation and metastasis of gastric cancer.  Despite great efforts have been made in recent decades, the effective drug against the advanced and metastatic gastric cancer is still lacking in the clin. setting.  In this study, we found that triptonide, a small mol. (MW358) purified from the traditional Chinese medicinal herb Tripterygium wilfordii Hook F, effectively suppressed tumor growth and metastasis in xenograft mice without obvious toxicity at the doses we tested, resulting in potent anti-gastric cancer effect with low toxicity.  Triptonide markedly inhibited human metastatic gastric cancer cell migration, invasion, proliferation, and tumorigenicity.  Mol. mechanistic studies revealed that triptonide significantly reduced Notch1 protein levels in metastatic gastric cancer cells through degrading the oncogenic protein Notch1 via the ubiquitin-proteasome pathway.  Consequently, the levels of Notch1 downstream proteins RBPJ, IKKα, IKKβ were significantly diminished, and nuclear factor-kappa B (NF-κB) phosphorylation was significantly reduced.  Together, triptonide effectively suppresses gastric cancer growth and metastasis via inhibition of the oncogenic Notch1 and NF-κB signaling pathways.  Our findings provide a new strategy and drug candidate for treatment of the advanced and metastatic gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw4qxIF3bacrVg90H21EOLACvtfcHk0lg4__lue-8Aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFygsg%253D%253D&md5=ca48e3d0998eac94819ec7ddf1c3ee61</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2019.114870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2019.114870%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DTriptonide%2520effectively%2520suppresses%2520gastric%2520tumor%2520growth%2520and%2520metastasis%2520through%2520inhibition%2520of%2520the%2520oncogenic%2520Notch1%2520and%2520NF-%25CE%25BAB%2520signaling%2520pathways%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2020%26volume%3D388%26spage%3D114870%26doi%3D10.1016%2Fj.taap.2019.114870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2019.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bcp.2019.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31075266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1GntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2019&pages=70-81&author=B.+Zhangauthor=M.+Mengauthor=S.+Xiangauthor=Z.+Caoauthor=X.+Xuauthor=Z.+Zhaoauthor=T.+Zhangauthor=B.+Chenauthor=P.+Yangauthor=Y.+Liauthor=Q.+Zhou&title=Selective+activation+of+tumor-suppressive+MAPKP+signaling+pathway+by+triptonide+effectively+inhibits+pancreatic+cancer+cell+tumorigenicity+and+tumor+growth&doi=10.1016%2Fj.bcp.2019.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth</span></div><div class="casAuthors">Zhang, Bin; Meng, Mei; Xiang, Shufen; Cao, Zhifei; Xu, Xingdong; Zhao, Zhe; Zhang, Tong; Chen, Bowen; Yang, Ping; Li, Ye; Zhou, Quansheng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-81</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK, 1K) family members ERK, JNK, and p38 play a divergent role in either promoting tumorigenesis or tumor-suppression.  Activation of ERK and JNK promotes tumorigenesis; whereas, escalation of p38 inhibits carcinogenesis.  As these three MAPK members are controlled by the common up-stream MAPK signaling proteins which consist of MAPK kinases (2K) and MAPK kinase kinases (3K), how to selectively actuate tumor-suppressive p38, not concurrently stimulate tumorigenic ERK and JNK, in cancer cells is a challenge for cancer researchers, and a new opportunity for novel anti-cancer drug discovery.  Using human pancreatic cancer cells and xenograft mice as models, we found that a small mol. triptonide first discerningly activated the up-stream MAPK kinase kinase MEKK4, not the other two 3K members ASK1 and GADD45; and then selectively actuated the middle stream MAPK kinase MKK4, not the other two 2K members MKK3 and MKK6; and followed by activation of the MAPK member p38, not the other two members ERK and JNK.  These data suggest that triptonide is a selective MEKK4-MKK4-p38 axis agonist.  Consequently, selective activation of the MEKK4-MKK4-p38 signaling axis by triptonide activated tumor suppressor p21 and inhibited CDK3 expression, resulting in cancer cell cycle arrest at G2/M phase and marked inhibition of pancreatic cancer cell tumorigenic capability in vitro and tumor growth in xenograft mice.  Our findings support the notion that selective activation of tumor-suppressive MEKK4-MKK4-p38-p21 signaling pathway by triptonide is a new approach for pancreatic cancer therapy, providing a new drug candidate for development of novel anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrza99hIqu7Vg90H21EOLACvtfcHk0lg4__lue-8Aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1GntL4%253D&md5=77f274a98ba2ae251c57b55ba58a6794</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2019.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2019.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DSelective%2520activation%2520of%2520tumor-suppressive%2520MAPKP%2520signaling%2520pathway%2520by%2520triptonide%2520effectively%2520inhibits%2520pancreatic%2520cancer%2520cell%2520tumorigenicity%2520and%2520tumor%2520growth%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2019%26volume%3D166%26spage%3D70%26epage%3D81%26doi%3D10.1016%2Fj.bcp.2019.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2017.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.toxlet.2017.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28666825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1SgtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2017&pages=9-17&author=P.+Yangauthor=F.+Dongauthor=Q.+Zhou&title=Triptonide+acts+as+a+novel+potent+anti-lymphoma+agent+with+low+toxicity+mainly+through+inhibition+of+proto-oncogene+Lyn+transcription+and+suppression+of+Lyn+signal+pathway&doi=10.1016%2Fj.toxlet.2017.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway</span></div><div class="casAuthors">Yang, Ping; Dong, Fulu; Zhou, Quansheng</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Lyn is a proto-oncogene overexpressed and constitutively activated in lymphoma, and plays an important role in lymphoma initiation and malignant progression.  Hence, the oncogenic Lyn has recently been targeted for novel anti-lymphoma drug discovery; however, the effective Lyn-targeted drug for lymphoma treatment with low toxicity is absent in the clin. setting.  The goal of this study is to explore powerful and low toxic Lyn-targeted anti-lymphoma agent.  Here we show that triptonide, a small mol. purified from the herb Tripterygium wilfordii Hook F, potently inhibits the proliferation of human B-lymphoma Raji and T-lymphoma Jurkat cells with IC50 of 5.7 nM and 4.8 nM, resp.  Strikingly, triptonide at a dose of 5 mg/kg/day almost completely inhibited the lymphoma growth in human lymphoma cells-xenografted mice without obvious side effects, particularly; the tumors in 6 mice among the 8 xenografted mice were completely eradicated in vivo.  Cell biol. studies showed that triptonide at the doses of 2.5-10 nM notably suppressed B-lymphoma cell colony-forming capability, and that triptonide at the dose of 20 nM promoted apoptosis through activation of PARP and caspase 3, but redn. of BCL2 protein levels in the lymphoma cells.  Mol. studies revealed that triptonide markedly inhibited oncogenic Lyn transcription through suppressing the promoter activity of the gene, and that it remarkably reduced both total and phosphorylated Lyn proteins, and diminished Lyn downstream ERK and ATK signal pathways.  Addnl., triptonide significantly enhanced p38 phosphorylation.  Together, triptonide exerts potent anti-lymphoma effect with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn downstream ERK and ATK signal pathways, providing an attractive drug candidate for development of novel anti-lymphoma therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquk-zD0yxLS7Vg90H21EOLACvtfcHk0lg4__lue-8Aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1SgtbjJ&md5=27bfd9567711ac0676b546c1ad0f61ca</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2017.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2017.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DTriptonide%2520acts%2520as%2520a%2520novel%2520potent%2520anti-lymphoma%2520agent%2520with%2520low%2520toxicity%2520mainly%2520through%2520inhibition%2520of%2520proto-oncogene%2520Lyn%2520transcription%2520and%2520suppression%2520of%2520Lyn%2520signal%2520pathway%26jtitle%3DToxicol.%2520Lett.%26date%3D2017%26volume%3D278%26spage%3D9%26epage%3D17%26doi%3D10.1016%2Fj.toxlet.2017.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span> <span> </span><span class="NLM_article-title">NQO1-selective activated prodrug of triptolide: Synthesis and antihepatocellular carcinoma activity evaluation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1253</span>– <span class="NLM_lpage">1257</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCmsb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1253-1257&author=M.+Liuauthor=W.+Songauthor=X.+Duauthor=J.+Suauthor=K.+Dongauthor=Y.+Chenauthor=Z.+Peng&title=NQO1-selective+activated+prodrug+of+triptolide%3A+Synthesis+and+antihepatocellular+carcinoma+activity+evaluation&doi=10.1021%2Facsmedchemlett.8b00404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1-Selective Activated Prodrug of Triptolide: Synthesis and Antihepatocellular Carcinoma Activity Evaluation</span></div><div class="casAuthors">Liu, Meilin; Song, Wei; Du, Xi; Su, Jingtian; Dong, Kang; Chen, Yong; Peng, Zhihong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1253-1257</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis.  Due to its poor response to conventional chemotherapy drugs, the prognosis for its survival is the worst.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is an attractive anticancer target due to its overexpression in HCC.  Although triptolide (TP) possesses potent antitumor activity, its clin. practice is greatly limited due to its general toxicities and narrow therapeutic window.  Herein, we develop an NQO1-selective activated TP analog, named CX-23, which exhibited antiproliferation of HepG2 over normal hepatocytes in vitro.  In vivo study shows that CX-23 can not only prevent the hepatocellular carcinoma progression but also migrate the liver and kidney toxicity.  These findings indicate that NQO1 may serve as a targeted delivery system to release an antitumor reagent and that CX-23 may be a promising lead for developing targeted antihepatocellular carcinoma drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFDSyyainbZrVg90H21EOLACvtfcHk0lj_Wf9wXUon7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCmsb7P&md5=2994e57fa6e8dbb828caa7dfc0e0444b</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00404%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DZ.%26atitle%3DNQO1-selective%2520activated%2520prodrug%2520of%2520triptolide%253A%2520Synthesis%2520and%2520antihepatocellular%2520carcinoma%2520activity%2520evaluation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D1253%26epage%3D1257%26doi%3D10.1021%2Facsmedchemlett.8b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuellar, R. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazar, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryanarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurvich, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span> <span> </span><span class="NLM_article-title">Phosphonooxymethyl prodrug of triptolide: Synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9334</span>– <span class="NLM_lpage">9344</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9334-9344&author=S.+Patilauthor=L.+G.+Lisauthor=R.+J.+Schumacherauthor=B.+J.+Norrisauthor=M.+L.+Morganauthor=R.+A.+D.+Cuellarauthor=B.+R.+Blazarauthor=R.+Suryanarayananauthor=V.+J.+Gurvichauthor=G.+I.+Georg&title=Phosphonooxymethyl+prodrug+of+triptolide%3A+Synthesis%2C+physicochemical+characterization%2C+and+efficacy+in+human+colon+adenocarcinoma+and+ovarian+cancer+xenografts&doi=10.1021%2Facs.jmedchem.5b01329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts</span></div><div class="casAuthors">Patil, Satish; Lis, Lev G.; Schumacher, Robert J.; Norris, Beverly J.; Morgan, Monique L.; Cuellar, Rebecca A. D.; Blazar, Bruce R.; Suryanarayanan, Raj; Gurvich, Vadim J.; Georg, Gunda I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9334-9344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A disodium phosphonooxymethyl prodrug of the antitumor agent triptolide was prepd. from the natural product in three steps (39% yield) and displayed excellent aq. soly. at pH 7.4 (61 mg/mL) compared to the natural product (17 μg/mL).  The estd. shelf life (t90) for hydrolysis of the prodrug at 4 °C and pH 7.4 was found to be two years.  In a mouse model of human colon adenocarcinoma (HT-29), the prodrug administered i.p. was effective in reducing or eliminating xenograft tumors at dose levels as low as 0.3 mg/kg when given daily and at 0.9 mg/kg when given less frequently.  When given via i.p. and oral routes at daily doses of 0.6 and 0.9 mg/kg, the prodrug was also effective and well tolerated in a mouse model of human ovarian cancer (A2780).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq61-SWUZUAnLVg90H21EOLACvtfcHk0lj_Wf9wXUon7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtb%252FL&md5=814a39327c1d30b60720b0dd85fcc708</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01329%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DLis%26aufirst%3DL.%2BG.%26aulast%3DSchumacher%26aufirst%3DR.%2BJ.%26aulast%3DNorris%26aufirst%3DB.%2BJ.%26aulast%3DMorgan%26aufirst%3DM.%2BL.%26aulast%3DCuellar%26aufirst%3DR.%2BA.%2BD.%26aulast%3DBlazar%26aufirst%3DB.%2BR.%26aulast%3DSuryanarayanan%26aufirst%3DR.%26aulast%3DGurvich%26aufirst%3DV.%2BJ.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26atitle%3DPhosphonooxymethyl%2520prodrug%2520of%2520triptolide%253A%2520Synthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520efficacy%2520in%2520human%2520colon%2520adenocarcinoma%2520and%2520ovarian%2520cancer%2520xenografts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9334%26epage%3D9344%26doi%3D10.1021%2Facs.jmedchem.5b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span> <span> </span><span class="NLM_article-title">Minnelide, a novel drug for pancreatic and liver cancer</span>. <i>Pancreatology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">S39</span>– <span class="NLM_lpage">S43</span>, <span class="refDoi"> DOI: 10.1016/j.pan.2015.05.472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.pan.2015.05.472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26122306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=S39-S43&author=S.+Banerjeeauthor=A.+Saluja&title=Minnelide%2C+a+novel+drug+for+pancreatic+and+liver+cancer&doi=10.1016%2Fj.pan.2015.05.472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Minnelide, a novel drug for pancreatic and liver cancer</span></div><div class="casAuthors">Banerjee, Sulagna; Saluja, Ashok</div><div class="citationInfo"><span class="NLM_cas:title">Pancreatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4_Suppl.</span>),
    <span class="NLM_cas:pages">S39-S43</span>CODEN:
                <span class="NLM_cas:coden">PANCC2</span>;
        ISSN:<span class="NLM_cas:issn">1424-3903</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is the 10th leading cause of all new cancer cases for men and the fourth leading cause of death across genders, having very poor prognosis and survival rates.  The current std. of care Gemcitabine fails to add any survival benefit for this disease (www.cancer.gov).  Though the incidence of pancreatic cancer is found to be higher in developed countries, the aggressive biol. of the cancer, its high rate of recurrence and chemo-resistance make it a formidable disease in all parts of the globe.  Hepatocellular carcinoma (HCC) or liver cancer, on the other hand affects almost 750,000 people world wide with 84% of the cases coming from underdeveloped or developing countriesOur studies show that Minnelide, a water sol. pro-drug of triptolide (active compd. from a chinese herb) is very effective against a no. of malignant diseases.The current study discusses the efficacy of this compd. in pancreatic and liver cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNsPsgBGeKrVg90H21EOLACvtfcHk0lj_Wf9wXUon7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtr3E&md5=e8ecae949972a413ba371a22b5f1a668</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.pan.2015.05.472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pan.2015.05.472%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSaluja%26aufirst%3DA.%26atitle%3DMinnelide%252C%2520a%2520novel%2520drug%2520for%2520pancreatic%2520and%2520liver%2520cancer%26jtitle%3DPancreatology%26date%3D2015%26volume%3D15%26spage%3DS39%26epage%3DS43%26doi%3D10.1016%2Fj.pan.2015.05.472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caicedo-Granados, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yueh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangwan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span> <span> </span><span class="NLM_article-title">Wild-type p53 reactivation by small-molecule Minnelide<sup>TM</sup> in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma</span>. <i>Oral Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1156</span>, <span class="refDoi"> DOI: 10.1016/j.oraloncology.2014.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.oraloncology.2014.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25311433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslansrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=1149-1156&author=E.+Caicedo-Granadosauthor=R.+Linauthor=C.+Fujisawaauthor=B.+Yuehauthor=V.+Sangwanauthor=A.+Saluja&title=Wild-type+p53+reactivation+by+small-molecule+MinnelideTM+in+human+papillomavirus+%28HPV%29-positive+head+and+neck+squamous+cell+carcinoma&doi=10.1016%2Fj.oraloncology.2014.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Wild-type p53 reactivation by small-molecule Minnelide in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma</span></div><div class="casAuthors">Caicedo-Granados, Emiro; Lin, Rui; Fujisawa, Caitlin; Yueh, Bevan; Sangwan, Veena; Saluja, Ashok</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1149-1156</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The incidence of high-risk human papillomavirus (HR-HPV) head and neck squamous cell carcinoma (HNSCC) continues to increase, particularly oropharyngeal squamous cell carcinoma (OPSCC) cases.  The inactivation of the p53 tumor suppressor gene promotes a chain of mol. events, including cell cycle progression and apoptosis resistance.  Reactivation of wild-type p53 function is an intriguing therapeutic strategy.  The aim of this study was to investigate whether a novel compd. derived from diterpene triepoxide (Minnelide) can reactivate wild-type p53 function in HPV-pos. HNSCC.  For all of our in vitro expts., we used 2 HPV-pos. HNSCC cell lines, University of Michigan squamous cell carcinoma (UM-SCC) 47 and 93-VU-147, and 2 HPV-pos. human cervical cancer cell lines, SiHa and CaSki.  Cells were treated with different concns. of triptolide and analyzed for p53 activation.  Mice bearing UM-SCC 47 s.c. xenografts and HPV-pos. patient-derived tumor xenografts were treated with Minnelide and evaluated for tumor growth and p53 activation.  In HPV-pos. HNSCC, Minnelide reactivated p53 by suppressing E6 oncoprotein.  Activation of apoptosis followed, both in vitro and in vivo.  In 2 preclin. HNSCC animal models (a s.c. xenograft model and a patient-derived tumor xenograft model), Minnelide reactivated p53 function and significantly decreased tumor progression and tumor vol.  Triptolide and Minnelide caused cell death in vitro and in vivo in HPV-pos. HNSCC by reactivating wild-type p53 and thus inducing apoptosis.  In addn., in 2 HPV-pos. HNSCC animal models, Minnelide decreased tumor progression and induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRShEAlNh2rVg90H21EOLACvtfcHk0lj_Wf9wXUon7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslansrzL&md5=4de2fc267c5e715d6d294d6d9f45e43d</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2014.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2014.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DCaicedo-Granados%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DFujisawa%26aufirst%3DC.%26aulast%3DYueh%26aufirst%3DB.%26aulast%3DSangwan%26aufirst%3DV.%26aulast%3DSaluja%26aufirst%3DA.%26atitle%3DWild-type%2520p53%2520reactivation%2520by%2520small-molecule%2520MinnelideTM%2520in%2520human%2520papillomavirus%2520%2528HPV%2529-positive%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DOral%2520Oncol.%26date%3D2014%26volume%3D50%26spage%3D1149%26epage%3D1156%26doi%3D10.1016%2Fj.oraloncology.2014.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousalova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangwan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evenson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratzke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Cunha, J.</span></span> <span> </span><span class="NLM_article-title">Minnelide: A novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e77411</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0077411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1371%2Fjournal.pone.0077411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24143232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kiu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=I.+Rousalovaauthor=S.+Banerjeeauthor=V.+Sangwanauthor=K.+Evensonauthor=J.+A.+McCauleyauthor=R.+Kratzkeauthor=S.+M.+Vickersauthor=A.+Salujaauthor=J.+D%E2%80%99Cunha&title=Minnelide%3A+A+novel+therapeutic+that+promotes+apoptosis+in+non-small+cell+lung+carcinoma+in+vivo&doi=10.1371%2Fjournal.pone.0077411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo</span></div><div class="casAuthors">Rousalova, Ilona; Banerjee, Sulagna; Sangwan, Veena; Evenson, Kristen; McCauley, Joel A.; Kratzke, Robert; Vickers, Selwyn M.; Saluja, Ashok; D'Cunha, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e77411</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent.  The precise mechanisms of its cytotoxic effects remain unclear.  Methods: Cell viability was studied using CCK8 assay.  Cell proliferation was measured real-time on cultured cells using Elec. Cell Substrate Impedence Sensing (ECIS).  Apoptosis was assayed by Caspase activity on cultured lung cancer cells and TUNEL staining on tissue sections.  Expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA, APAF-1) was estd. by qRTPCR.  Effect of Minnelide on proliferative cells in the tissue was estd. by Ki-67 staining of animal tissue sections.  Results: In this study, we investigated in vitro and in vivo antitumor effects of triptolide/Minnelide in non-small cell lung carcinoma (NSCLC).  Triptolide/Minnelide exhibited anti-proliferative effects and induced apoptosis in NSCLC cell lines and NSCLC mouse models.  Triptolide/Minnelide significantly down-regulated the expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA) and up-regulated pro-apoptotic APAF-1 gene, in part, via attenuating the NF-κB signaling activity.  Conclusion: In conclusion, our results provide supporting mechanistic evidence for Minnelide as a potential in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUoTk9jzQPEbVg90H21EOLACvtfcHk0liM33ybcqtiWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kiu7rO&md5=0194c45ca4713a9c8b6d14d6b25c74e2</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0077411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0077411%26sid%3Dliteratum%253Aachs%26aulast%3DRousalova%26aufirst%3DI.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSangwan%26aufirst%3DV.%26aulast%3DEvenson%26aufirst%3DK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DKratzke%26aufirst%3DR.%26aulast%3DVickers%26aufirst%3DS.%2BM.%26aulast%3DSaluja%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Cunha%26aufirst%3DJ.%26atitle%3DMinnelide%253A%2520A%2520novel%2520therapeutic%2520that%2520promotes%2520apoptosis%2520in%2520non-small%2520cell%2520lung%2520carcinoma%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0077411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnettler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2014.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ygyno.2014.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25172764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOhtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2014&pages=318-324&author=C.+Rivardauthor=M.+Gellerauthor=E.+Schnettlerauthor=M.+Salujaauthor=R.+I.+Vogelauthor=A.+Salujaauthor=S.+Ramakrishnan&title=Inhibition+of+epithelial+ovarian+cancer+by+Minnelide%2C+a+water-soluble+pro-drug&doi=10.1016%2Fj.ygyno.2014.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug</span></div><div class="casAuthors">Rivard, Colleen; Geller, Melissa; Schnettler, Erica; Saluja, Manju; Vogel, Rachel Isaksson; Saluja, Ashok; Ramakrishnan, Sundaram</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-324</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Minnelide is a water-sol. pro-drug of triptolide, a natural product.  The goal of this study was to evaluate the effectiveness of Minnelide on ovarian cancer growth in vitro and in vivo.The effect of Minnelide on ovarian cancer cell proliferation was detd. by real time elec. impedance measurements.  Multiple mouse models with C200 and A2780 epithelial ovarian cancer cell lines were used to assess the efficacy of Minnelide in inhibiting ovarian cancer growth.  Minnelide decreased cell viability of both platinum sensitive and resistant epithelial ovarian cancer cells in vitro.  Minnelide with carboplatin showed additive effects in vitro.  Minnelide monotherapy increased the survival of mice bearing established ovarian tumors.  Minnelide, in combination with carboplatin and paclitaxel, improved overall survival of mice.  Minnelide is a promising pro-drug for the treatment of ovarian cancer, esp. when combined with std. chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptH8M-A73V_bVg90H21EOLACvtfcHk0liM33ybcqtiWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOhtrzM&md5=0ead311ba5e7f2cbfc5d5a80be6d4fd3</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2014.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2014.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DGeller%26aufirst%3DM.%26aulast%3DSchnettler%26aufirst%3DE.%26aulast%3DSaluja%26aufirst%3DM.%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DSaluja%26aufirst%3DA.%26aulast%3DRamakrishnan%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520epithelial%2520ovarian%2520cancer%2520by%2520Minnelide%252C%2520a%2520water-soluble%2520pro-drug%26jtitle%3DGynecol.%2520Oncol.%26date%3D2014%26volume%3D135%26spage%3D318%26epage%3D324%26doi%3D10.1016%2Fj.ygyno.2014.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isharwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlass, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehm, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudeja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konety, B.</span></span> <span> </span><span class="NLM_article-title">Minnelide inhibits androgen dependent, castration resistant prostate cancer growth by decreasing expression of androgen receptor full length and splice variants</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1002/pros.23298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fpros.23298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28144973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVSktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=584-596&author=S.+Isharwalauthor=S.+Modiauthor=N.+Aroraauthor=C.+Uhlrichauthor=B.+Giriauthor=U.+Barlassauthor=A.+Soubraauthor=R.+Chughauthor=S.+M.+Dehmauthor=V.+Dudejaauthor=A.+Salujaauthor=S.+Banerjeeauthor=B.+Konety&title=Minnelide+inhibits+androgen+dependent%2C+castration+resistant+prostate+cancer+growth+by+decreasing+expression+of+androgen+receptor+full+length+and+splice+variants&doi=10.1002%2Fpros.23298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants</span></div><div class="casAuthors">Isharwal, Sumit; Modi, Shrey; Arora, Nivedita; Uhlrich, Charles, III; Giri, Bhuwan; Barlass, Usman; Soubra, Ayman; Chugh, Rohit; Dehm, Scott M.; Dudeja, Vikas; Saluja, Ashok; Banerjee, Sulagna; Konety, Badrinath</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">584-596</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BACKGROUND : With almost 30,000 deaths per yr, prostate cancer is the second-leading cause of cancer-related death in men.  Androgen Deprivation Therapy (ADT) has been the corner stone of prostate cancer treatment for decades.  However, despite an initial response of prostate cancer to ADT, this eventually fails and the tumors recur, resulting in Castration Resistant Prostate Cancer (CRPC).  Triptolide, a diterpene triepoxide, has been tested for its anti-tumor properties in a no. of cancers for over a decade.  Owing to its poor soly. in aq. medium, its clin. application had been limited.  To circumvent this problem, we have synthesized a water-sol. pro-drug of triptolide, Minnelide, that is currently being evaluated in a Phase 1 clin. trial against gastrointestinal tumors.  In the current study, we assessed the therapeutic potential of Minnelide and its active compd. triptolide against androgen dependent prostate cancer both in vitro as well as in vivo.  METHODS : Cell viability was measured by a MTT based assay after treating prostate cancer cells with multiple doses of triptolide.  Apoptotic cell death was measured using a caspase 3/7 activity.  Androgen Receptor (AR) promoter-binding activity was evaluated by using luciferase reporter assay.  For evaluating the effect in vivo, 22Rv1 cells were implanted s.c. in animals, following which, treatment was started with 0.21 mg/kg Minnelide.  RESULTS : Our study showed that treatment with triptolide induced apoptotic cell death in CRPC cells.  Triptolide treatment inhibited AR transcriptional activity and decreased the expression of AR and its splice variants both at the mRNA and the protein level.  Our studies show that triptolide inhibits nuclear translocation of Sp1, resulting in its decreased transcriptional activity leading to downregulation of AR and its splice variants in prostate cancer cells.  In vivo, Minnelide (0.21 mg/kg) regressed s.c. tumors derived from CRPC 22RV1 at our study endpoint.  Our animal studies further confirmed that Minnelide was more efficacious than the std. of care therapies, Docetaxel and Enzalutamide.  CONCLUSION : Our study indicates that Minnelide is very effective as a therapeutic option against CRPC at a dose that is currently tolerated by patients in the ongoing clin. trials.  Prostate 77: 584-596, 2017. 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZEe8dozgQkbVg90H21EOLACvtfcHk0lhyvL_DzTA63g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVSktbo%253D&md5=53edfa527fb3cdfa07579a4cce489137</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1002%2Fpros.23298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.23298%26sid%3Dliteratum%253Aachs%26aulast%3DIsharwal%26aufirst%3DS.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DArora%26aufirst%3DN.%26aulast%3DUhlrich%26aufirst%3DC.%26aulast%3DGiri%26aufirst%3DB.%26aulast%3DBarlass%26aufirst%3DU.%26aulast%3DSoubra%26aufirst%3DA.%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DDehm%26aufirst%3DS.%2BM.%26aulast%3DDudeja%26aufirst%3DV.%26aulast%3DSaluja%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DKonety%26aufirst%3DB.%26atitle%3DMinnelide%2520inhibits%2520androgen%2520dependent%252C%2520castration%2520resistant%2520prostate%2520cancer%2520growth%2520by%2520decreasing%2520expression%2520of%2520androgen%2520receptor%2520full%2520length%2520and%2520splice%2520variants%26jtitle%3DProstate%26date%3D2017%26volume%3D77%26spage%3D584%26epage%3D596%26doi%3D10.1002%2Fpros.23298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavania, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudeja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">163</span>, <span class="refDoi"> DOI: 10.1186/s12967-019-1901-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs12967-019-1901-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31109340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3M7nvVWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=163&author=B.+Giriauthor=V.+K.+Guptaauthor=B.+Yaffeauthor=S.+Modiauthor=P.+Royauthor=V.+Sethiauthor=S.+P.+Lavaniaauthor=S.+M.+Vickersauthor=V.+Dudejaauthor=S.+Banerjeeauthor=J.+Wattsauthor=A.+Saluja&title=Pre-clinical+evaluation+of+Minnelide+as+a+therapy+for+acute+myeloid+leukemia&doi=10.1186%2Fs12967-019-1901-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia</span></div><div class="casAuthors">Giri Bhuwan; Gupta Vineet K; Yaffe Brianna; Modi Shrey; Roy Pooja; Sethi Vrishketan; Lavania Shweta P; Vickers Selwyn M; Dudeja Vikas; Banerjee Sulagna; Watts Justin; Saluja Ashok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is an urgent need for novel and effective treatment options for acute myeloid leukemia (AML).  Triptolide, a diterpenoid tri-epoxide compound isolated from the herb Tripterygium wilfordii and its water-soluble pro-drug-Minnelide have shown promising anti-cancer activity.  A recent clinical trial for patients with solid tumors confirmed the safety and efficacy at biologically equivalent doses of 0.2 mg/kg/day and lower.  METHODS:  Cell viability of multiple AML cell lines as well as patient apheresis samples were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) based assay.  Apoptosis was evaluated by estimating the amount of cleaved caspase.  AML cell line (THP1-Luc) was implanted in immunocompromised mice and treated with indicated doses of Minnelide.  Leukemic burden before and after treatment was evaluated by imaging in an In Vivo Imaging System (IVIS).  RESULTS:  In the current study, we show that Minnelide, at doses below maximum tolerated dose (MTD) demonstrates leukemic clearance of both primary AML blasts and luciferase expressing THP-1 cells in mice.  In vitro, multiple primary AML apheresis samples and AML cell lines (THP-1, KG1, Kasumi-1, HL-60) were sensitive to triptolide mediated cell death and apoptosis in low doses.  Treatment with triptolide led to a significant decrease in the colony forming ability of AML cell lines as well as in the expression of stem cell markers.  Additionally, it resulted in the cell cycle arrest in the G1/S phase with significant downregulation of c-Myc, a major transcriptional regulator mediating cancer cell growth and stemness.  CONCLUSION:  Our results suggest that Minnelide, with confirmed safety and activity in the clinic, exerts a potent anti-leukemic effect in multiple models of AML at doses easily achievable in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfBOJKnz1vQ3WEEzDrymxmfW6udTcc2eaZwxP5YER-Y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7nvVWnsw%253D%253D&md5=9ea8c7dc6a7759c334550960fbbb7945</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1186%2Fs12967-019-1901-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12967-019-1901-8%26sid%3Dliteratum%253Aachs%26aulast%3DGiri%26aufirst%3DB.%26aulast%3DGupta%26aufirst%3DV.%2BK.%26aulast%3DYaffe%26aufirst%3DB.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DP.%26aulast%3DSethi%26aufirst%3DV.%26aulast%3DLavania%26aufirst%3DS.%2BP.%26aulast%3DVickers%26aufirst%3DS.%2BM.%26aulast%3DDudeja%26aufirst%3DV.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DWatts%26aufirst%3DJ.%26aulast%3DSaluja%26aufirst%3DA.%26atitle%3DPre-clinical%2520evaluation%2520of%2520Minnelide%2520as%2520a%2520therapy%2520for%2520acute%2520myeloid%2520leukemia%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2019%26volume%3D17%26spage%3D163%26doi%3D10.1186%2Fs12967-019-1901-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, R.-Y</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris-Natschke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1039/b810774m</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fb810774m" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19779642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOiu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=1321-1344&author=R.-Y+Kuoauthor=K.+Qianauthor=S.+L.+Morris-Natschkeauthor=K.-H.+Lee&title=Plant-derived+triterpenoids+and+analogues+as+antitumor+and+anti-HIV+agents&doi=10.1039%2Fb810774m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents</span></div><div class="casAuthors">Kuo, Reen-Yen; Qian, Keduo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1321-1344</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This article reviews the antitumor and anti-HIV activities of naturally occurring triterpenoids, including the lupane, ursane, oleanane, lanostane, dammarane, and misc. scaffolds.  Structure-activity relationships of selected natural compds. and their synthetic derivs. are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4100e-8N2XrVg90H21EOLACvtfcHk0lin7Nul68Vryg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOiu7rF&md5=91e86d89ca40cc6eb306efe2980a5604</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1039%2Fb810774m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb810774m%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DR.-Y%26aulast%3DQian%26aufirst%3DK.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DPlant-derived%2520triterpenoids%2520and%2520analogues%2520as%2520antitumor%2520and%2520anti-HIV%2520agents%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2009%26volume%3D26%26spage%3D1321%26epage%3D1344%26doi%3D10.1039%2Fb810774m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Anti-cancer effects of pristimerin and the mechanisms: A critical review</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">746</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2019.00746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31354475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVaqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=746&author=J.-J.+Liauthor=Y.-Y.+Yanauthor=H.-M.+Sunauthor=Y.+Liuauthor=C.-Y.+Suauthor=H.-B.+Chenauthor=J.-Y.+Zhang&title=Anti-cancer+effects+of+pristimerin+and+the+mechanisms%3A+A+critical+review&doi=10.3389%2Ffphar.2019.00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer effects of pristimerin and the mechanisms: a critical review</span></div><div class="casAuthors">Li, Jia-jun; Yan, Yan-yan; Sun, Hong-mei; Liu, Yun; Su, Chao-yue; Chen, Hu-biao; Zhang, Jian-ye</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">746</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">As a quinonemethide triterpenoid extd. from species of the Celastraceae and Hippocrateaceae, pristimerin has been shown potent anti-cancer effects.  Specifically, it was found that pristimerin can affect many tumor-related processes, such as apoptosis, autophagy, migration and invasion, vasculogenesis, and drug resistance.  Various mol. targets or signaling pathways are also involved, such as cyclins, reactive oxygen species (ROS), microRNA, nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and PI3K/AKT/mammalian target of rapamycin (mTOR) pathways.  In this review, we will focus on the research about pristimerin-induced anti-cancer activities to achieve a deeper understanding of the targets and mechanisms, which offer evidences suggesting that pristimerin can be a potent anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnBBPFj49ALrVg90H21EOLACvtfcHk0lhv9Nb1e8o0mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVaqs70%253D&md5=a5659c3c2ef602d3a04116c604ded75b</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00746%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-J.%26aulast%3DYan%26aufirst%3DY.-Y.%26aulast%3DSun%26aufirst%3DH.-M.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DC.-Y.%26aulast%3DChen%26aufirst%3DH.-B.%26aulast%3DZhang%26aufirst%3DJ.-Y.%26atitle%3DAnti-cancer%2520effects%2520of%2520pristimerin%2520and%2520the%2520mechanisms%253A%2520A%2520critical%2520review%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D746%26doi%3D10.3389%2Ffphar.2019.00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Relationship between structural characteristics and plant sources along with pharmacology research of quassinoids</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1248/cpb.c18-00958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fcpb.c18-00958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31257321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlahsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2019&pages=654-665&author=Z.+Liauthor=J.-Y.+Ruanauthor=F.+Sunauthor=J.-J.+Yanauthor=J.-L.+Wangauthor=Z.-X.+Zhangauthor=Y.+Zhangauthor=T.+Wang&title=Relationship+between+structural+characteristics+and+plant+sources+along+with+pharmacology+research+of+quassinoids&doi=10.1248%2Fcpb.c18-00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between structural characteristics and plant sources along with pharmacology research of quassinoids</span></div><div class="casAuthors">Li, Zheng; Ruan, Jing-ya; Sun, Fan; Yan, Jie-jing; Wang, Jian-li; Zhang, Zi-xin; Zhang, Yi; Wang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">654-665</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Quassinoids, one kind of triterpenoids with multiple bioactivities such as anti-cancer, anti-malarial, anti-oxidative, anti-microbial, anti-diabetic, anti-viral, and anti-inflammatory effects, have drawn much attention in recent years.  Between 2004 and 2018, the structural characteristics and plant sources of 190 quassinoids were reported.  Herein, the structure-activity relationships (SARs) of quassinoids along with the anti-cancer mechanisms of four representative quassinoids, eurycomanone, bruceine D, dehydrobruceine B, and brusatol are discussed.  This review might be useful for further research and development of quassinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7eHd47uLRrVg90H21EOLACvtfcHk0lhv9Nb1e8o0mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlahsrrN&md5=2ad8054a65ae8dd8d386b0f5b5a57629</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c18-00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c18-00958%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRuan%26aufirst%3DJ.-Y.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.-J.%26aulast%3DWang%26aufirst%3DJ.-L.%26aulast%3DZhang%26aufirst%3DZ.-X.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DRelationship%2520between%2520structural%2520characteristics%2520and%2520plant%2520sources%2520along%2520with%2520pharmacology%2520research%2520of%2520quassinoids%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2019%26volume%3D67%26spage%3D654%26epage%3D665%26doi%3D10.1248%2Fcpb.c18-00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Unprecedented quassinoids from <i>Eurycoma longifolia</i>: Biogenetic evidence and antifeedant effects</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1683</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.0c00244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.0c00244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2020&pages=1674-1683&author=W.-Q.+Yangauthor=X.-H.+Shaoauthor=F.+Dengauthor=L.-J.+Huauthor=Y.+Xiongauthor=X.-J.+Huangauthor=C.-L.+Fanauthor=R.-W.+Jiangauthor=W.-C.+Yeauthor=Y.+Wang&title=Unprecedented+quassinoids+from+Eurycoma+longifolia%3A+Biogenetic+evidence+and+antifeedant+effects&doi=10.1021%2Facs.jnatprod.0c00244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Quassinoids from Eurycoma longifolia: Biogenetic Evidence and Antifeedant Effects</span></div><div class="casAuthors">Yang, Wei-Qun; Shao, Xue-Hua; Deng, Fang; Hu, Li-Jun; Xiong, Yu; Huang, Xiao-Jun; Fan, Chun-Lin; Jiang, Ren-Wang; Ye, Wen-Cai; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1674-1683</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Six new quassinoids (I-6) were isolated from the roots of Eurycoma longifolia, and their structures with abs. configurations were detd. unambiguously by spectroscopic analyses and single-crystal X-ray crystallog. expts.  Compds. 1 and 2 are the first members of a new class of quassinoids with an unusual C26 carbon skeleton.  Compd. 6 features a C20 cage-like scaffold with an unprecedented densely functionalized 2,5-dioxatricyclo[5.2.2.04,8]undecane core.  The discovery of the two C26 quassinoids I and 2 has provided firm evidence for the better understanding the biogenetic process from C30 triterpenoid precursors to quassinoids.  Compd. 5 exhibited significant antifeedant activity on the diamondback moth (DBM) larvae and excellent systemic absorption and accumulated properties in Brassica chinensis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS60zxv4ZAK7Vg90H21EOLACvtfcHk0ljYcsJlElt8Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlertLs%253D&md5=0786ac7ab862ba86dc7a53684162bf7c</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.0c00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.0c00244%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.-Q.%26aulast%3DShao%26aufirst%3DX.-H.%26aulast%3DDeng%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DL.-J.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.-J.%26aulast%3DFan%26aufirst%3DC.-L.%26aulast%3DJiang%26aufirst%3DR.-W.%26aulast%3DYe%26aufirst%3DW.-C.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DUnprecedented%2520quassinoids%2520from%2520Eurycoma%2520longifolia%253A%2520Biogenetic%2520evidence%2520and%2520antifeedant%2520effects%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2020%26volume%3D83%26spage%3D1674%26epage%3D1683%26doi%3D10.1021%2Facs.jnatprod.0c00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupchan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigel, C. W.</span></span> <span> </span><span class="NLM_article-title">Bruceantin, a new potent antileukemic simaroubolide from <i>Brucea antidysenterica</i></span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1021/jo00941a049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00941a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE3sXnt1ertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=178-179&author=S.+M.+Kupchanauthor=R.+W.+Brittonauthor=M.+F.+Zieglerauthor=C.+W.+Sigel&title=Bruceantin%2C+a+new+potent+antileukemic+simaroubolide+from+Brucea+antidysenterica&doi=10.1021%2Fjo00941a049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica</span></div><div class="casAuthors">Kupchan, S. Morris; Britton, Ronald W.; Ziegler, Myra F.; Sigel, Carl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">178-9</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Bruceantin (I) and bruceantarin (II) are antileukemic simaroubolides from B. antidysenterica, a plant used in Ethiopia in the treatment of cancer.  Hydrogenation of I gave dihydrobruceantin (III), and mild alk. hydrolysis of III gave bruceolide (IV).  Hydrolysis of I and esterification of the steam distillable acid with diazoethane gave Et trans-3,4-dimethyl-2-pentenoate.  Mild alk. hydrolysis of II gave BzOH and IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu0_QiNsD2LVg90H21EOLACvtfcHk0ljQLN5zeN9u4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXnt1ertA%253D%253D&md5=e930a286c2f5a0e5a9e04c06d744fdaf</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjo00941a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00941a049%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DBritton%26aufirst%3DR.%2BW.%26aulast%3DZiegler%26aufirst%3DM.%2BF.%26aulast%3DSigel%26aufirst%3DC.%2BW.%26atitle%3DBruceantin%252C%2520a%2520new%2520potent%2520antileukemic%2520simaroubolide%2520from%2520Brucea%2520antidysenterica%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D178%26epage%3D179%26doi%3D10.1021%2Fjo00941a049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.-Y.</span></span> <span> </span><span class="NLM_article-title">Bruceine A</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">o854</span>– <span class="NLM_lpage">o855</span>, <span class="refDoi"> DOI: 10.1107/S1600536810007646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS1600536810007646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21580678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=o854-o855&author=X.-H.+Fengauthor=Y.-N.+Zhangauthor=W.-Z.+Heauthor=L.+Zhangauthor=H.-Y.+Jiang&title=Bruceine+A&doi=10.1107%2FS1600536810007646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine A</span></div><div class="casAuthors">Feng, Xue Huan; Zhang, Yan Ning; He, Wei Zhi; Zhang, Lan; Jiang, Hong Yun</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Structure Reports Online</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">o854-o855</span>CODEN:
                <span class="NLM_cas:coden">ACSEBH</span>;
        ISSN:<span class="NLM_cas:issn">1600-5368</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The title compd., C26H34O11, known as bruceine A, is a natural quassinoid extd. from the dried fruits of Brucea javanica.  Its structure consists of five fused rings including an oxygen-contg. heterocyclic ring and a lactone ring.  Two intramol. O-H...O links help to establish the mol. conformation.  In the crystal, O-H...O hydrogen bonds connect the mols.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-hUh6kCSD4bVg90H21EOLACvtfcHk0lhP_ag1U1Hmaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCmtr8%253D&md5=9b55ad929fc888a095e632a2133cc9c2</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1107%2FS1600536810007646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536810007646%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.-H.%26aulast%3DZhang%26aufirst%3DY.-N.%26aulast%3DHe%26aufirst%3DW.-Z.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DH.-Y.%26atitle%3DBruceine%2520A%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2010%26volume%3D66%26spage%3Do854%26epage%3Do855%26doi%3D10.1107%2FS1600536810007646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.-W.</span></span> <span> </span><span class="NLM_article-title">Brusatol</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">o1592</span>– <span class="NLM_lpage">o1593</span>, <span class="refDoi"> DOI: 10.1107/S1600536812018582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS1600536812018582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22719401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XotFansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=o1592-o1593&author=S.-Z.+Huauthor=L.+Jinauthor=T.+Yuauthor=H.-Y.+Tianauthor=R.-W.+Jiang&title=Brusatol&doi=10.1107%2FS1600536812018582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol</span></div><div class="casAuthors">Hu, Shu-Zhi; Jin, Lu; Yu, Tong; Tian, Hai-Yan; Jiang, Ren-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Structure Reports Online</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">o1592-o1593</span>CODEN:
                <span class="NLM_cas:coden">ACSEBH</span>;
        ISSN:<span class="NLM_cas:issn">1600-5368</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The title compd., C26H32O11, is composed of an α,β-unsatd. cyclohexanone ring (A), two cyclohexane rings (B and C), a six-membered lactone ring (D) and THF ring (E).  Ring A exists in a half-chair conformation with a C atom displaced by 0.679 (2) Å from the mean plane through the remaining five atoms.  Ring B exists in a normal chair conformation.  Both rings C and D exist in a twisted-chair conformation due to the O-atom bridge and the carbonyl group in rings C and D, resp.  Ring E shows an envelope conformation with a C atom displaced by 0.761 (1) Å from the mean plane through the remaining five atoms.  The ring junctions are A/B trans, B/C trans, C/D cis and D/E cis.  An intramol. O-H···O hydrogen bond occurs.  In the crystal, O-H···O hydrogen bonds involving the hydroxy, lactone and ester groups and C-H···O interactions are obsd.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDV9MwYGgfkrVg90H21EOLACvtfcHk0lhP_ag1U1Hmaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotFansLc%253D&md5=107870c921cef39208eda087ad9e105b</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1107%2FS1600536812018582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536812018582%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.-Z.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DH.-Y.%26aulast%3DJiang%26aufirst%3DR.-W.%26atitle%3DBrusatol%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2012%26volume%3D68%26spage%3Do1592%26epage%3Do1593%26doi%3D10.1107%2FS1600536812018582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of bruceantin: An old drug with new promise</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1021/np030304+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np030304%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSisLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=269-272&author=M.+Cuendetauthor=J.+M.+Pezzuto&title=Antitumor+activity+of+bruceantin%3A+An+old+drug+with+new+promise&doi=10.1021%2Fnp030304%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Bruceantin: An Old Drug with New Promise</span></div><div class="casAuthors">Cuendet, Muriel; Pezzuto, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-272</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bruceantin was first isolated from Brucea antidysenterica, a tree used in Ethiopia for the treatment of cancer, and activity was obsd. against B16 melanoma, colon 38, and L1210 and P388 leukemia in mice.  Phase I and II clin. trials were then initiated, but no objective tumor regressions were obsd. and clin. development was terminated.  Recently, the activity of bruceantin has been studied with a no. of leukemia, lymphoma, and myeloma cell lines.  Cell differentiation was induced and c-MYC was down-regulated, suggesting a mechanistic correlation between c-MYC down-regulation and induction of cell differentiation or cell death.  Treatment of HL-60 and RPMI 8226 cell lines induced apoptosis, and this involved the caspase and mitochondrial pathways.  Moreover, an in vivo study using RPMI 8226 human-SCID xenografts demonstrated that bruceantin induced regression in early as well as advanced tumors, and these significant antitumor responses were facilitated in the absence of overt toxicity.  Apoptosis was significantly elevated in tumors derived from animals treated with bruceantin.  In sum, bruceantin interferes with the growth of leukemia, lymphoma, and myeloma cells in culture and xenograft models.  Responses of this type suggest bruceantin should be reinvestigated for clin. efficacy against hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGg5prtWifNrVg90H21EOLACvtfcHk0liel9lsZATYQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSisLvK&md5=11fe566d8f2665cf16fb18033f3e7820</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Fnp030304%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp030304%252B%26sid%3Dliteratum%253Aachs%26aulast%3DCuendet%26aufirst%3DM.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DAntitumor%2520activity%2520of%2520bruceantin%253A%2520An%2520old%2520drug%2520with%2520new%2520promise%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D269%26epage%3D272%26doi%3D10.1021%2Fnp030304%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mata-Greenwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daeuble, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grieco, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McChesney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Novel esters of glaucarubolone as inducers of terminal differentiation of promyelocytic HL-60 cells and inhibitors of 7,12-dimethylbenz[<i>a</i>]anthracene-induced preneoplastic lesion formation in mouse mammary organ culture</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1513</span>, <span class="refDoi"> DOI: 10.1021/np010212p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np010212p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1yks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2001&pages=1509-1513&author=E.+Mata-Greenwoodauthor=J.+F.+Daeubleauthor=P.+A.+Griecoauthor=J.+Douauthor=J.+D.+McChesneyauthor=R.+G.+Mehtaauthor=A.+D.+Kinghornauthor=J.+M.+Pezzuto&title=Novel+esters+of+glaucarubolone+as+inducers+of+terminal+differentiation+of+promyelocytic+HL-60+cells+and+inhibitors+of+7%2C12-dimethylbenz%5Ba%5Danthracene-induced+preneoplastic+lesion+formation+in+mouse+mammary+organ+culture&doi=10.1021%2Fnp010212p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Esters of Glaucarubolone as Inducers of Terminal Differentiation of Promyelocytic HL-60 Cells and Inhibitors of 7,12-Dimethylbenz[a]anthracene-Induced Preneoplastic Lesion Formation in Mouse Mammary Organ Culture</span></div><div class="casAuthors">Mata-Greenwood, Eugenia; Daeuble, John F.; Grieco, Paul A.; Dou, Jinhui; McChesney, James D.; Mehta, Rajendra G.; Kinghorn, A. Douglas; Pezzuto, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1509-1513</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to discover new chemotherapeutic/chemopreventive agents from natural sources, brusatol was found to induce HL-60 cellular differentiation, accompanied by strong antiproliferative and cytotoxic effects.  A series of 48 natural and semisynthetic quassinoids was designed to effect both antiproliferative and differentiation-inducing properties.  Compds. were assessed in vitro using the HL-60 promyelocytic cell model.  Changes in activity due to structural modification of the core structure glaucarubolone were consistent with activities reported in other cell systems. However, the following were novel SAR findings:(1) semisynthetic analogs with a hydroxylated ring at the β-position of the ester side chain at C-15 were able to induce cellular differentiation at concns. lower than those inducing cell growth arrest, and (2) quassinoids inhibiting DNA synthesis with greater efficacy than reducing cellular viability possessed alkyl substitutions at the α-position of the C-15 ester side chain.  Analogs from this latter group and brusatol and bruceantin inhibited dimethylbenz(a)anthracene-induced preneoplastic lesion formation in a mouse mammary organ culture.  The novel finding of 1 and glaucarubolone analogs as potent inducers of differentiation leads to potential novel applications in the field of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDnNEsGu8kkbVg90H21EOLACvtfcHk0liel9lsZATYQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1yks78%253D&md5=525aac789770b3306c94d655e580f81a</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1021%2Fnp010212p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp010212p%26sid%3Dliteratum%253Aachs%26aulast%3DMata-Greenwood%26aufirst%3DE.%26aulast%3DDaeuble%26aufirst%3DJ.%2BF.%26aulast%3DGrieco%26aufirst%3DP.%2BA.%26aulast%3DDou%26aufirst%3DJ.%26aulast%3DMcChesney%26aufirst%3DJ.%2BD.%26aulast%3DMehta%26aufirst%3DR.%2BG.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DNovel%2520esters%2520of%2520glaucarubolone%2520as%2520inducers%2520of%2520terminal%2520differentiation%2520of%2520promyelocytic%2520HL-60%2520cells%2520and%2520inhibitors%2520of%25207%252C12-dimethylbenz%255Ba%255Danthracene-induced%2520preneoplastic%2520lesion%2520formation%2520in%2520mouse%2520mammary%2520organ%2520culture%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2001%26volume%3D64%26spage%3D1509%26epage%3D1513%26doi%3D10.1021%2Fnp010212p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache
de Blanco, E. J.</span></span> <span> </span><span class="NLM_article-title">NF-κB inhibitors from <i>Brucea javanica</i> exhibiting intracellular effects on reactive oxygen species</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">3295</span>– <span class="NLM_lpage">3300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20944100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGksbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=3295-3300&author=J.-A.+Kimauthor=E.+K.+Lauauthor=L.+Panauthor=E.+J.+Carcache%0Ade+Blanco&title=NF-%CE%BAB+inhibitors+from+Brucea+javanica+exhibiting+intracellular+effects+on+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species</span></div><div class="casAuthors">Kim, Jeong-Ah; Lau, Edward K.; Pan, Li; Carcache De Blanco, Esperanza J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3295-3300</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Brucea javanica was studied to identify nuclear factor kappaB (NF-κB) inhibitors exhibiting reactive oxygen species (ROS) intracellular amplification.  Eight compds. were evaluated for selective cytotoxicity using HT-29, HeLa, and HL-60 cells, and in a NF-κB assay.  Active compds. were then tested using ROS and mitochondria transmembrane potential (MTP) assays.  NF-κB and nuclear factor activated T-cell (NFAT) translocation were also assessed using their resp. whole cell assays.  Bruceajavanone B, bruceantin, bruceine A, (-)-hydnocarpin, and chrysoeriol exhibited cytotoxic potential and NF-κB p65 inhibition.  Chrysoeriol exhibited selective cytotoxicity against leukemia cells with greater potency and also showed an ability to up-regulate NFAT transcriptional pathways through the amplification of intracellular ROS, in the presence of H2O2, to a greater degree than bruceantin and bruceine.  Chrysoeriol selectively kills leukemic cells and potentiates the amplification of ROS levels.  Therefore, chrysoeriol could serve as a potential chemotherapeutic modifier for leukemia chemotherapy since leukemia cells have a higher susceptibility to elevated ROS levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xOp8CB0jB7Vg90H21EOLACvtfcHk0liJ4YOEXQ50Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGksbvM&md5=62923b2b3ef20fc56b2632f234f89769</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.-A.%26aulast%3DLau%26aufirst%3DE.%2BK.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26atitle%3DNF-%25CE%25BAB%2520inhibitors%2520from%2520Brucea%2520javanica%2520exhibiting%2520intracellular%2520effects%2520on%2520reactive%2520oxygen%2520species%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D3295%26epage%3D3300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xirou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syrigos, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, J. C.</span></span> <span> </span><span class="NLM_article-title">Targeting colon cancer with the novel STAT3 inhibitor bruceantinol</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1038/s41388-018-0547-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41388-018-0547-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30348989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFynsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=1676-1687&author=N.+Weiauthor=J.+Liauthor=C.+Fangauthor=J.+Changauthor=V.+Xirouauthor=N.+K.+Syrigosauthor=B.+J.+Marksauthor=E.+Chuauthor=J.+C.+Schmitz&title=Targeting+colon+cancer+with+the+novel+STAT3+inhibitor+bruceantinol&doi=10.1038%2Fs41388-018-0547-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting colon cancer with the novel STAT3 inhibitor bruceantinol</span></div><div class="casAuthors">Wei, Ning; Li, Jun; Fang, Cheng; Chang, Jin; Xirou, Vasiliki; Syrigos, Nick K.; Marks, Benjamin J.; Chu, Edward; Schmitz, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1676-1687</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">STAT3, a transcriptional mediator of oncogenic signaling, is constitutively active in ∼70% of human cancers.  The development of STAT3 inhibitors remains an active area of research as no inhibitors have yet to be approved for the treatment of human cancer.  Herein, we revealed that bruceantinol (BOL) is a novel STAT3 inhibitor demonstrating potent antitumor activity in in vitro and in vivo human colorectal cancer (CRC) models.  BOL strongly inhibited STAT3 DNA-binding ability (IC50 = 2.4 pM), blocked the constitutive and IL-6-induced STAT3 activation in a dose- and time-dependent manner, and suppressed transcription of STAT3 target genes encoding anti-apoptosis factors (MCL-1, PTTG1, and survivin) and cell-cycle regulators (c-Myc).  Structure-activity relationship studies demonstrated that the C15 side chain on BOL affected its ability to bind STAT3.  Administration of 4 mg/kg BOL significantly inhibited CRC tumor xenografts [p < 0.001], but no effect was obsd. in a STAT3-/- tumor model.  Addnl. studies showed that BOL effectively sensitized MEK inhibitors through repression of p-STAT3 and MCL-1 induction, known resistance mechanisms of MEK inhibition.  Taken together, our findings suggest BOL is a novel therapeutic STAT3 inhibitor that can be used either alone or in combination with MEK inhibitors for the treatment of human CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszhsdy_chYLVg90H21EOLACvtfcHk0libFuX77G5C4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFynsbrP&md5=401a8a656f44cde28fdb629f765ce53a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0547-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0547-y%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXirou%26aufirst%3DV.%26aulast%3DSyrigos%26aufirst%3DN.%2BK.%26aulast%3DMarks%26aufirst%3DB.%2BJ.%26aulast%3DChu%26aufirst%3DE.%26aulast%3DSchmitz%26aufirst%3DJ.%2BC.%26atitle%3DTargeting%2520colon%2520cancer%2520with%2520the%2520novel%2520STAT3%2520inhibitor%2520bruceantinol%26jtitle%3DOncogene%26date%3D2019%26volume%3D38%26spage%3D1676%26epage%3D1687%26doi%3D10.1038%2Fs41388-018-0547-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Issa, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpentier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span> <span> </span><span class="NLM_article-title">Bruceantin inhibits multiple myeloma cancer stem cell proliferation</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1080/15384047.2016.1210737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F15384047.2016.1210737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27434731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=966-975&author=M.+E.+Issaauthor=S.+Berndtauthor=G.+Carpentierauthor=J.+M.+Pezzutoauthor=M.+Cuendet&title=Bruceantin+inhibits+multiple+myeloma+cancer+stem+cell+proliferation&doi=10.1080%2F15384047.2016.1210737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceantin inhibits multiple myeloma cancer stem cell proliferation</span></div><div class="casAuthors">Issa, Mark E.; Berndt, Sarah; Carpentier, Gilles; Pezzuto, John M.; Cuendet, Muriel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">966-975</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) continues to claim the lives of a majority of patients.  MM cancer stem cells (CSCs) have been demonstrated to sustain tumor growth.  Due to their ability to self-renew and to express detoxifying enzymes and efflux transporters, MM-CSCs are rendered highly resistant to conventional therapies.  Therefore, managing MM-CSCs characteristics could have profound clin. implications.  Bruceantin (BCT) is a natural product previously demonstrated to inhibit the growth of MM in RPMI 8226 cells-inoculated mouse xenograft models, and to cause regression in already established tumors.  The objectives of the present study were to test the inhibitory effects of BCT on MM-CSCs growth derived from a human primary tumor, and to explore a mechanism of action underlying these effects.  BCT exhibited potent antiproliferative activity in MM-CSCs starting at 25 nM.  BCT induced cell cycle arrest, cell death and apoptosis in MM-CSCs as well as inhibited cell migration and angiogenesis in vitro.  Using a qPCR screen, it was found that the gene expression of a no. of Notch pathway members was altered.  Pretreatment of MM-CSCs with the γ-secretase inhibitor RO4929097, a Notch pathway inhibitor, reversed BCT-induced effects on MM-CSCs proliferation.  In this study, BCT was shown to be an effective agent in controlling the proliferation, viability and migration of MM-CSCs as well as angiogenesis in vitro.  The effect on MM-CSCs proliferation may be mediated by the Notch pathway.  These results warrant further investigation of BCT in a broader set of human-derived MM-CSCs and with in vivo models representative of MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoKtzhqnt5m7Vg90H21EOLACvtfcHk0lhI3srkCEqPBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVaksL7F&md5=0d8d036d277d4e396456ad522a8f0d8a</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1080%2F15384047.2016.1210737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2016.1210737%26sid%3Dliteratum%253Aachs%26aulast%3DIssa%26aufirst%3DM.%2BE.%26aulast%3DBerndt%26aufirst%3DS.%26aulast%3DCarpentier%26aufirst%3DG.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DCuendet%26aufirst%3DM.%26atitle%3DBruceantin%2520inhibits%2520multiple%2520myeloma%2520cancer%2520stem%2520cell%2520proliferation%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2016%26volume%3D17%26spage%3D966%26epage%3D975%26doi%3D10.1080%2F15384047.2016.1210737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukamiya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastow, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukainaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloids</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4963</span>– <span class="NLM_lpage">4968</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.06.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmc.2004.06.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=15336275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFSnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4963-4968&author=C.+Murakamiauthor=N.+Fukamiyaauthor=S.+Tamuraauthor=M.+Okanoauthor=K.+F.+Bastowauthor=H.+Tokudaauthor=T.+Mukainakaauthor=H.+Nishinoauthor=K.-H.+Lee&title=Multidrug-resistant+cancer+cell+susceptibility+to+cytotoxic+quassinoids%2C+and+cancer+chemopreventive+effects+of+quassinoids+and+canthin+alkaloids&doi=10.1016%2Fj.bmc.2004.06.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloids</span></div><div class="casAuthors">Murakami, Chihiro; Fukamiya, Narihiko; Tamura, Sadaaki; Okano, Masayoshi; Bastow, Kenneth F.; Tokuda, Harukuni; Mukainaka, Teruo; Nishino, Hoyoky; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4963-4968</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Twenty-three quassinoids, which were isolated previously from Simaroubaceous plants, were evaluated for cytotoxicity against three multidrug-resistant cancer cell lines, KB-VIN, KB-7d, and KB-CPT.  Nine compds. showed significant cytotoxicity in all three cell lines.  Six compds. demonstrated significant activity against the KB-7d and KB-CPT cell lines, and three compds. revealed notable activity only against KB-7d cells.  Structure-activity relationships were drawn based on these data.  In addn., six quassinoid derivs. and four canthin alkaloids, which were isolated from Brucea antidysenterica, were examd. for their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA) induced Epstein-Barr virus early antigen (EBV-EA) activation as cancer chemopreventive agents.  All of these compds. demonstrated significant inhibitory effects against EBV-EA activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxG2hy88XoB7Vg90H21EOLACvtfcHk0lhI3srkCEqPBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFSnu74%253D&md5=da8f6d6e7b2f09a09d6d90187fc4f8f5</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.06.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.06.045%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DC.%26aulast%3DFukamiya%26aufirst%3DN.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DOkano%26aufirst%3DM.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTokuda%26aufirst%3DH.%26aulast%3DMukainaka%26aufirst%3DT.%26aulast%3DNishino%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DMultidrug-resistant%2520cancer%2520cell%2520susceptibility%2520to%2520cytotoxic%2520quassinoids%252C%2520and%2520cancer%2520chemopreventive%2520effects%2520of%2520quassinoids%2520and%2520canthin%2520alkaloids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4963%26epage%3D4968%26doi%3D10.1016%2Fj.bmc.2004.06.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantvit, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedayat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McChesney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Multiple myeloma regression mediated by bruceantin</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-0362-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1078-0432.CCR-0362-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=14871997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1170-1179&author=M.+Cuendetauthor=K.+Christovauthor=D.+D.+Lantvitauthor=Y.+Dengauthor=S.+Hedayatauthor=L.+Helsonauthor=J.+D.+McChesneyauthor=J.+M.+Pezzuto&title=Multiple+myeloma+regression+mediated+by+bruceantin&doi=10.1158%2F1078-0432.CCR-0362-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple myeloma regression mediated by bruceantin</span></div><div class="casAuthors">Cuendet, Muriel; Christov, Konstantin; Lantvit, Daniel D.; Deng, Yunfan; Hedayat, Samad; Helson, Lawrence; McChesney, James D.; Pezzuto, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1170-1179</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bruceantin has been shown to induce cell differentiation in a no. of leukemia and lymphoma cell lines.  It also down-regulated c-MYC, suggesting a correlation of down-regulation with induction of cell differentiation or cell death.  In the present study, we focused on multiple myeloma, using the RPMI 8226 cell line as a model.  The effects of bruceantin on c-MYC levels and apoptosis were examd. by immunoblotting, 4',6-diamidino-2-phenylindole staining, evaluation of caspase-like activity, and 3,3'-dihexyloxacarbocyanine iodide staining.  The potential of bruceantin to inhibit primary tumor growth was assessed with RPMI 8226 xenografts in SCID mice, and apoptosis in the tumors was evaluated by the terminal deoxynucleotidyl transferase-mediated nick end labeling assay.  c-MYC was strongly down-regulated in cultured RPMI 8226 cells by treatment with bruceantin for 24 h.  With U266 and H929 cells, bruceantin did not regulate c-MYC in this manner.  Apoptosis was induced in the three cell lines.  In RPMI 8226 cells, apoptosis occurred through proteolytic processing of procaspases and degrdn. of poly(ADP-ribose) polymerase.  The mitochondrial pathway was also involved.  Because RPMI 8226 cells were the most sensitive, they were used in a xenograft model.  Bruceantin treatment (2.5-5 mg/kg) resulted in a significant regression of tumors without overt toxicity.  Apoptosis was significantly elevated in tumors derived from animals treated with bruceantin (37%) as compared with the control tumors (14%).  Bruceantin interferes with the growth of RPMI 8226 cells in cell culture and xenograft models.  These results suggest that bruceantin should be reinvestigated for clin. efficacy against multiple myeloma and other hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKXCPN79etW7Vg90H21EOLACvtfcHk0lhKLdjXKWxwdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCnsrs%253D&md5=c4521936bb6aa5447048dcc73a119ebe</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-0362-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-0362-3%26sid%3Dliteratum%253Aachs%26aulast%3DCuendet%26aufirst%3DM.%26aulast%3DChristov%26aufirst%3DK.%26aulast%3DLantvit%26aufirst%3DD.%2BD.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DHedayat%26aufirst%3DS.%26aulast%3DHelson%26aufirst%3DL.%26aulast%3DMcChesney%26aufirst%3DJ.%2BD.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DMultiple%2520myeloma%2520regression%2520mediated%2520by%2520bruceantin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D1170%26epage%3D1179%26doi%3D10.1158%2F1078-0432.CCR-0362-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, D. H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedikian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodey, G. P.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacology of bruceantin by radioimmunoassay</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1007/BF00257747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2FBF00257747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=7160053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADyaL3s7ivFyitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1982&pages=169-172&author=K.+L.+L.+Fongauthor=D.+H.+W.+Hoauthor=R.+S.+Benjaminauthor=N.+S.+Brownauthor=A.+Bedikianauthor=B.+S.+Yapauthor=C.+L.+Wisemanauthor=W.+Kramerauthor=G.+P.+Bodey&title=Clinical+pharmacology+of+bruceantin+by+radioimmunoassay&doi=10.1007%2FBF00257747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of bruceantin by radioimmunoassay</span></div><div class="casAuthors">Fong K L; Ho D H; Benjamin R S; Brown N S; Bedikian A; Yap B S; Wiseman C L; Kramer W; Bodey G P</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-72</span>
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">During the phase I clinical trial of a new antitumor agent, bruceantin, the pharmacology was studied in 18 cancer patients.  The drug was infused intravenously (IV) for 3 h at doses ranging from 1 to 3.6 mg/m2 per day for 5 days.  The plasma drug disappearance curves were biphasic, with a fast initial half-life of less than 15 min.  The second half-life (t1/2 beta) varied from 0.7 to 38 h among different patients and was not dose-related.  The difference between the t1/2 beta on day 1 and that on day 5 was not significant.  In patients with normal liver function, the mean plasma concentration at the end of infusion was 22 ng/ml, and the value of the area under the concentration X time curve (AUC) was 111 (ng/ml)h.  In contrast, in patients with abnormal liver function the corresponding values were 115 ng/ml and 830 (ng/ml)h, respectively.  In addition, these patients had a slower elimination half-life of 10.9 h and a decreased total clearance of 157 ml/min/m2, as compared with 2.6 h and 671 ml/min/m2, respectively, for the normal group.  All these differences were statistically significant.  Patients with abnormal liver function developed more severe toxicity, including fever, severe nausea, vomiting, and hypotension.  Two patients with severe hepatic dysfunction received a reduced dose and developed no toxicity.  These results demonstrated the importance of the effects of liver dysfunction on drug disposition and showed that the dosage should be reduced in patients with hepatic dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT378_1soZJrQyMywPm6HgQfW6udTcc2ea7mhMr--FB7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7ivFyitw%253D%253D&md5=f9fc85add70c492667273c844f50a97c</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1007%2FBF00257747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00257747%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DK.%2BL.%2BL.%26aulast%3DHo%26aufirst%3DD.%2BH.%2BW.%26aulast%3DBenjamin%26aufirst%3DR.%2BS.%26aulast%3DBrown%26aufirst%3DN.%2BS.%26aulast%3DBedikian%26aufirst%3DA.%26aulast%3DYap%26aufirst%3DB.%2BS.%26aulast%3DWiseman%26aufirst%3DC.%2BL.%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DBodey%26aufirst%3DG.%2BP.%26atitle%3DClinical%2520pharmacology%2520of%2520bruceantin%2520by%2520radioimmunoassay%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1982%26volume%3D9%26spage%3D169%26epage%3D172%26doi%3D10.1007%2FBF00257747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arseneau, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuperminc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckdeschel, J. C.</span></span> <span> </span><span class="NLM_article-title">A Phase II study of bruceantin (NSC-165, 563) in advanced malignant melanoma</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1007/BF00208896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2FBF00208896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=6678872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADyaL2c3ovVegtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1983&pages=239-242&author=J.+C.+Arseneauauthor=J.+M.+Wolterauthor=M.+Kupermincauthor=J.+C.+Ruckdeschel&title=A+Phase+II+study+of+bruceantin+%28NSC-165%2C+563%29+in+advanced+malignant+melanoma&doi=10.1007%2FBF00208896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma</span></div><div class="casAuthors">Arseneau J C; Wolter J M; Kuperminc M; Ruckdeschel J C</div><div class="citationInfo"><span class="NLM_cas:title">Investigational new drugs</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-42</span>
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    </div><div class="casAbstract">The Eastern Cooperative Oncology Group (ECOG) conducted a Phase II trial of Bruceantin in malignant melanoma.  Twenty-two patients, thirteen without prior cytotoxic chemotherapy, were entered.  All patients were evaluable for response and toxicity.  Dose limiting toxicity was found to be hypotension during Bruceantin infusion.  Other prominent side effects were nausea, vomiting, anorexia, fever, chills, and weakness.  Only minor hematologic toxicity was encountered.  Two partial responses, both in previously treated patients were observed (response rate -9%).  Bruceantin has only limited activity against malignant melanoma and is unlikely to contribute to systemic therapy of this disease, either as a single agent or in combinations of cytotoxic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWCXJG6Nn05evW160gIxP_fW6udTcc2eaHWZICUxLZfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c3ovVegtQ%253D%253D&md5=73a9ba5a7e025c2d1142a11b64dd2458</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1007%2FBF00208896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00208896%26sid%3Dliteratum%253Aachs%26aulast%3DArseneau%26aufirst%3DJ.%2BC.%26aulast%3DWolter%26aufirst%3DJ.%2BM.%26aulast%3DKuperminc%26aufirst%3DM.%26aulast%3DRuckdeschel%26aufirst%3DJ.%2BC.%26atitle%3DA%2520Phase%2520II%2520study%2520of%2520bruceantin%2520%2528NSC-165%252C%2520563%2529%2520in%2520advanced%2520malignant%2520melanoma%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1983%26volume%3D1%26spage%3D239%26epage%3D242%26doi%3D10.1007%2FBF00208896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupchan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacadie, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigel, C. W.</span></span> <span> </span><span class="NLM_article-title">The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from <i>Brucea antidysenterica</i></span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1021/jo00893a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00893a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE2MXhtFaitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=648-654&author=S.+M.+Kupchanauthor=R.+W.+Brittonauthor=J.+A.+Lacadieauthor=M.+F.+Zieglerauthor=C.+W.+Sigel&title=The+isolation+and+structural+elucidation+of+bruceantin+and+bruceantinol%2C+new+potent+antileukemic+quassinoids+from+Brucea+antidysenterica&doi=10.1021%2Fjo00893a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor inhibitors.  100.  Isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica</span></div><div class="casAuthors">Kupchan, S. Morris; Britton, Ronald W.; Lacadie, John A.; Ziegler, Myra F.; Sigel, Carl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">648-54</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Bruceantin and bruceantinol, two new potent antileukemic quassinoids isolated from B. antidysenterica, had structures I and II, resp., according to chem. degrdn. products, mass, ir, uv, and NMR spectra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkWjLvDcZdqbVg90H21EOLACvtfcHk0lg9qEhY47VQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhtFaitbg%253D&md5=cc5991382386962bd342f186b7aa2a46</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1021%2Fjo00893a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00893a023%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DBritton%26aufirst%3DR.%2BW.%26aulast%3DLacadie%26aufirst%3DJ.%2BA.%26aulast%3DZiegler%26aufirst%3DM.%2BF.%26aulast%3DSigel%26aufirst%3DC.%2BW.%26atitle%3DThe%2520isolation%2520and%2520structural%2520elucidation%2520of%2520bruceantin%2520and%2520bruceantinol%252C%2520new%2520potent%2520antileukemic%2520quassinoids%2520from%2520Brucea%2520antidysenterica%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D648%26epage%3D654%26doi%3D10.1021%2Fjo00893a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z. X.</span></span> <span> </span><span class="NLM_article-title">Seven quassinoids from Fructus Bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1796</span>– <span class="NLM_lpage">1800</span>, <span class="refDoi"> DOI: 10.1002/ptr.3477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fptr.3477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21480411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2mt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1796-1800&author=M.+Zhaoauthor=S.+T.+Lauauthor=P.+S.+Leungauthor=C.+T.+Cheauthor=Z.+X.+Lin&title=Seven+quassinoids+from+Fructus+Bruceae+with+cytotoxic+effects+on+pancreatic+adenocarcinoma+cell+lines&doi=10.1002%2Fptr.3477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Seven Quassinoids from Fructus Bruceae with Cytotoxic Effects on Pancreatic Adenocarcinoma Cell Lines</span></div><div class="casAuthors">Zhao, M.; Lau, S. T.; Leung, P. S.; Che, C. T.; Lin, Z. X.</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1796-1800</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Our previous studies showed that the alc. ext. of the fruit of Brucea javanica (Fructus Bruceae) possessed significant cytotoxicity in pancreatic adenocarcinoma cell lines.  A bioassay-guided fractionation and purifn. resulted in the isolation and characterization of seven quassinoids including brusatol, bruceine D, bruceine H, yadanzioside A, yadanzioside G, javanicoside C and bruceantinoside A.  Among them, brusatol exhibited the most potent in vitro antipancreatic cancer action, with IC50 values of 0.36 μm and 0.10 μm on PANC-1 and SW1990 cell lines, resp.  This is the first report on the antipancreatic adenocarcinoma activity of brusatol.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpehpJB-Uxw2bVg90H21EOLACvtfcHk0lgTiD0REsz7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2mt7bM&md5=9ae61809b31245333ac3105fae9e3d12</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1002%2Fptr.3477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.3477%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DS.%2BT.%26aulast%3DLeung%26aufirst%3DP.%2BS.%26aulast%3DChe%26aufirst%3DC.%2BT.%26aulast%3DLin%26aufirst%3DZ.%2BX.%26atitle%3DSeven%2520quassinoids%2520from%2520Fructus%2520Bruceae%2520with%2520cytotoxic%2520effects%2520on%2520pancreatic%2520adenocarcinoma%2520cell%2520lines%26jtitle%3DPhytother.%2520Res.%26date%3D2011%26volume%3D25%26spage%3D1796%26epage%3D1800%26doi%3D10.1002%2Fptr.3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsuyanagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span> <span> </span><span class="NLM_article-title">A structure-activity relationship study of brusatol, an antitumor quassinoid</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4262</span>– <span class="NLM_lpage">4271</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.01.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tet.2006.01.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslCgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=4262-4271&author=Y.+Hitotsuyanagiauthor=I.+H.+Kimauthor=T.+Hasudaauthor=Y.+Yamauchiauthor=K.+Takeya&title=A+structure-activity+relationship+study+of+brusatol%2C+an+antitumor+quassinoid&doi=10.1016%2Fj.tet.2006.01.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-activity relationship study of brusatol, an antitumor quassinoid</span></div><div class="casAuthors">Hitotsuyanagi, Yukio; Kim, Ik Hwi; Hasuda, Tomoyo; Yamauchi, Yuka; Takeya, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4262-4271</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Analogs of brusatol were prepd. and examd. for their cytotoxic activity by using P-388 murine leukemia cells.  The following structure-activity relationships were noted: (i) an enone carbonyl oxygen or an enolic oxygen at C-2 is essential, but an oxygen at C-3 not essential for the activity; (ii) the C-11 β-hydroxyl group is important for the activity; and (iii) the length of the ester alkoxy side chain at C-21 seems to have a slight effect on the activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUEJ9xvZVpurVg90H21EOLACvtfcHk0lgTiD0REsz7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslCgsLk%253D&md5=c7642024afc2ee2e25468ff56f4c2b9b</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.01.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.01.083%26sid%3Dliteratum%253Aachs%26aulast%3DHitotsuyanagi%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DHasuda%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTakeya%26aufirst%3DK.%26atitle%3DA%2520structure-activity%2520relationship%2520study%2520of%2520brusatol%252C%2520an%2520antitumor%2520quassinoid%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D4262%26epage%3D4271%26doi%3D10.1016%2Fj.tet.2006.01.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colburn, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncharova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, C. J.</span></span> <span> </span><span class="NLM_article-title">Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1021/np800732n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np800732n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=503-506&author=J.+A.+Beutlerauthor=M.-I.+Kangauthor=F.+Robertauthor=J.+A.+Clementauthor=J.+Pelletierauthor=N.+H.+Colburnauthor=T.+C.+McKeeauthor=E.+Goncharovaauthor=J.+B.+McMahonauthor=C.+J.+Henrich&title=Quassinoid+inhibition+of+AP-1+function+does+not+correlate+with+cytotoxicity+or+protein+synthesis+inhibition&doi=10.1021%2Fnp800732n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Quassinoid Inhibition of AP-1 Function Does Not Correlate with Cytotoxicity or Protein Synthesis Inhibition</span></div><div class="casAuthors">Beutler, John A.; Kang, Moon-Il; Robert, Francis; Clement, Jason A.; Pelletier, Jerry; Colburn, Nancy H.; McKee, Tawnya C.; Goncharova, Ekaterina; McMahon, James B.; Henrich, Curtis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-506</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Several quassinoids were identified in a high-throughput screening assay as inhibitors of the transcription factor AP-1.  Further biol. characterization revealed that while their effect was not specific to AP-1, protein synthesis inhibition and cell growth assays were inconsistent with a mechanism of simple protein synthesis inhibition.  Numerous plant exts. from the plant family Simaroubaceae were also identified in the same screen; bioassay-guided fractionation of one ext. (Ailanthus triphylla) yielded two known quassinoids, ailanthinone (3) and glaucarubinone (4), which were also identified in the pure compd. screening procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUuSj7boFqX7Vg90H21EOLACvtfcHk0lgTiD0REsz7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKhsrk%253D&md5=a1e162c90f056c605a48c438d53a1289</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1021%2Fnp800732n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp800732n%26sid%3Dliteratum%253Aachs%26aulast%3DBeutler%26aufirst%3DJ.%2BA.%26aulast%3DKang%26aufirst%3DM.-I.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DClement%26aufirst%3DJ.%2BA.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DColburn%26aufirst%3DN.%2BH.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DGoncharova%26aufirst%3DE.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DHenrich%26aufirst%3DC.%2BJ.%26atitle%3DQuassinoid%2520inhibition%2520of%2520AP-1%2520function%2520does%2520not%2520correlate%2520with%2520cytotoxicity%2520or%2520protein%2520synthesis%2520inhibition%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2009%26volume%3D72%26spage%3D503%26epage%3D506%26doi%3D10.1021%2Fnp800732n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.-W.</span></span> <span> </span><span class="NLM_article-title">Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from <i>Brucea javanica</i></span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fitote.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26071073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=66-72&author=Q.-M.+Yeauthor=L.-L.+Baiauthor=S.-Z.+Huauthor=H.-Y.+Tianauthor=L.-J.+Ruanauthor=Y.-F.+Tanauthor=L.-P.+Huauthor=W.-C.+Yeauthor=D.-M.+Zhangauthor=R.-W.+Jiang&title=Isolation%2C+chemotaxonomic+significance+and+cytotoxic+effects+of+quassinoids+from+Brucea+javanica&doi=10.1016%2Fj.fitote.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from Brucea javanica</span></div><div class="casAuthors">Ye, Qing-Mei; Bai, Liang-Liang; Hu, Shu-Zhi; Tian, Hai-Yan; Ruan, Li-Jun; Tan, Ya-Fang; Hu, Li-Ping; Ye, Wen-Cai; Zhang, Dong-Mei; Jiang, Ren-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new quassinoid, bruceene A (1) along with seventeen known quassinoids (2-18) was isolated from the fruits of Brucea javanica.  The structure of 1 was elucidated by extensive spectroscopic methods, and was further confirmed by single-crystal X-ray diffraction anal.  Isolation of similar quassinoids 1-3 as those in genus Ailanthus from genus Brucea, indicated the close chemotaxonomic relationship between these two genera, which further supported the phylogenetic study by DNA anal.  Compds. 5, 7, 10 and 12 with a 3-hydroxy-3-en-2-one moiety showed potent inhibitory activities against the MCF-7 and MDA-MB-231 cells with IC50 values in the ranges 0.063-0.182 μM and 0.081-0.238 μM, resp.; while glycosidation at 3-OH significantly decreased the cytotoxicity.  It was also found that the most potent compd. 7 induced apoptosis in MCF-7 cells via the intrinsic mitochondrial apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMiNdcjrP2rVg90H21EOLACvtfcHk0liK2vSsjXV9dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsLvF&md5=6802fefdd32d687010f7e6ad2b9f0496</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DQ.-M.%26aulast%3DBai%26aufirst%3DL.-L.%26aulast%3DHu%26aufirst%3DS.-Z.%26aulast%3DTian%26aufirst%3DH.-Y.%26aulast%3DRuan%26aufirst%3DL.-J.%26aulast%3DTan%26aufirst%3DY.-F.%26aulast%3DHu%26aufirst%3DL.-P.%26aulast%3DYe%26aufirst%3DW.-C.%26aulast%3DZhang%26aufirst%3DD.-M.%26aulast%3DJiang%26aufirst%3DR.-W.%26atitle%3DIsolation%252C%2520chemotaxonomic%2520significance%2520and%2520cytotoxic%2520effects%2520of%2520quassinoids%2520from%2520Brucea%2520javanica%26jtitle%3DFitoterapia%26date%3D2015%26volume%3D105%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.fitote.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.-B.</span></span> <span> </span><span class="NLM_article-title">Bioactive quassinoids from the seeds of <i>Brucea javanica</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">688</span>, <span class="refDoi"> DOI: 10.1021/np200920c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200920c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=683-688&author=J.-H.+Liuauthor=N.+Zhaoauthor=G.-J.+Zhangauthor=S.-S.+Yuauthor=L.-J.+Wuauthor=J.+Quauthor=S.-G.+Maauthor=X.-G.+Chenauthor=T.-Q.+Zhangauthor=J.+Baiauthor=H.+Chenauthor=Z.-F.+Fangauthor=F.+Zhaoauthor=W.-B.+Tang&title=Bioactive+quassinoids+from+the+seeds+of+Brucea+javanica&doi=10.1021%2Fnp200920c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive Quassinoids from the Seeds of Brucea javanica</span></div><div class="casAuthors">Liu, Jun-Hong; Zhao, Nan; Zhang, Gui-Jie; Yu, Shi-Shan; Wu, Li-Jun; Qu, Jing; Ma, Shuang-Gang; Chen, Xiao-Guang; Zhang, Tian-Qi; Bai, Jian; Chen, Hui; Fang, Zhen-Feng; Zhao, Fen; Tang, Wei-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-688</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Six new quassinoids (1-6) and eight known compds. of this type (7-14) were isolated from the seeds of Brucea javanica.  Their structures were elucidated by anal. of their spectroscopic data and from chem. evidence.  Compds. 1-5 were found to be unusual quassinoids with a 2,3-seco A ring.  The configurations at C-4 in 4 and 5 were detd. by a difference CD method.  In in vitro bioassays, 8 and 10 showed inhibitory activities for nitric oxide prodn. in LPS-activated macrophages, with IC50 values of 1.9 and 5.0 μM, resp., while compds. 6, 8-11, 13, and 14 exhibited cytotoxicity against five human tumor cell lines (HCT-8, HepG2, BGC-823, A549, and SKVO3), having IC50 values in the range 0.12-9.3 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpscuGrN_hUhLVg90H21EOLACvtfcHk0liK2vSsjXV9dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlsb0%253D&md5=57570fff8393668cb169f8f91586ef08</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Fnp200920c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200920c%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.-H.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DG.-J.%26aulast%3DYu%26aufirst%3DS.-S.%26aulast%3DWu%26aufirst%3DL.-J.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DS.-G.%26aulast%3DChen%26aufirst%3DX.-G.%26aulast%3DZhang%26aufirst%3DT.-Q.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DZ.-F.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DW.-B.%26atitle%3DBioactive%2520quassinoids%2520from%2520the%2520seeds%2520of%2520Brucea%2520javanica%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D683%26epage%3D688%26doi%3D10.1021%2Fnp200920c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukamiya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Bruceanols D, E, and F. Three new cytotoxic quassinoids from <i>Brucea antidysenterica</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2091</span>– <span class="NLM_lpage">2097</span>, <span class="refDoi"> DOI: 10.1021/np50102a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50102a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVWqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=2091-2097&author=K.+Imamuraauthor=N.+Fukamiyaauthor=M.+Okanoauthor=K.+Tagaharaauthor=K.-H.+Lee&title=Bruceanols+D%2C+E%2C+and+F.+Three+new+cytotoxic+quassinoids+from+Brucea+antidysenterica&doi=10.1021%2Fnp50102a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceanols D, E, and F. Three new cytotoxic quassinoids from Brucea antidysenterica</span></div><div class="casAuthors">Imamura, Kazunori; Fukamya, Narihiko; Okano, Masayoshi; Tagahara, Kiyoshi; Lee, Kuo Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2091-7</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">Three new quassinoids, bruceanols D (I), E (II), and F (III), were isolated from Brucea antidysenterica, and their structures were elucidated by spectral evidence and chem. transformation.  All of these compds. exhibited cytotoxicity against five human tumor cell lines, malignant melanoma (RPMI-7951), lung carcinoma (A-549), ileocecal adenocarcinoma (HCT-8), epidermoid carcinoma of the nasopharynx (KB), and medulloblastoma (TE-671), and against murine lymphocytic leukemia (P-388).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0gvxol3jBrVg90H21EOLACvtfcHk0lg_obCXDKpUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVWqurk%253D&md5=361bdbfd8fdaca1ffb406f6132d172ac</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1021%2Fnp50102a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50102a010%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DK.%26aulast%3DFukamiya%26aufirst%3DN.%26aulast%3DOkano%26aufirst%3DM.%26aulast%3DTagahara%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DBruceanols%2520D%252C%2520E%252C%2520and%2520F.%2520Three%2520new%2520cytotoxic%2520quassinoids%2520from%2520Brucea%2520antidysenterica%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1993%26volume%3D56%26spage%3D2091%26epage%3D2097%26doi%3D10.1021%2Fnp50102a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aarthi, R.</span></span> <span> </span><span class="NLM_article-title">Brusatol—As potent chemotherapeutic regimen and its role on reversing EMT transition</span>. <i>J. Pharm. Sci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1753</span>– <span class="NLM_lpage">1762</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFGrtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1753-1762&author=R.+Aarthi&title=Brusatol%E2%80%94As+potent+chemotherapeutic+regimen+and+its+role+on+reversing+EMT+transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol - as potent chemotherapeutic regimen and its role on reversing EMT transition</span></div><div class="casAuthors">Aarthi, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences and Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1753-1762</span>CODEN:
                <span class="NLM_cas:coden">JPSRC9</span>;
        ISSN:<span class="NLM_cas:issn">0975-1459</span>.
    
            (<span class="NLM_cas:orgname">Pharmainfo Publisher</span>)
        </div><div class="casAbstract">A review.  Cancer is highly resistant to chemotherapeutic agents and their prognosis after resistance is found to be poor.  The development of new therapeutic entities is badly needed for this deadly malignancy.  In this review article, we elaborately given information about brusatol, a natural quassinoid isolated from a Chinese herbal medicine named Bruceae Fructus, that it possess potent cytotoxic effect against different types of cell lines.  Its anti-cancer effects has been demonstrated through different cell lines and its cytoxicity studies has been discussed briefly.  In this review we also summarise possible mechanism for brusatol and its action on EMT reversal process.  This article is expected to widen the knowledge of brusatol as potent chemotherapeutic agent and also indicating that brusatol is a promising adjunct to the current chemotherapeutic regimen for any mostly any type of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEI7JjwtKELVg90H21EOLACvtfcHk0lg_obCXDKpUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFGrtL3I&md5=42503808b27ef6db12e088787d2251e2</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAarthi%26aufirst%3DR.%26atitle%3DBrusatol%25E2%2580%2594As%2520potent%2520chemotherapeutic%2520regimen%2520and%2520its%2520role%2520on%2520reversing%2520EMT%2520transition%26jtitle%3DJ.%2520Pharm.%2520Sci.%2520Res.%26date%3D2019%26volume%3D11%26spage%3D1753%26epage%3D1762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Clair, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol overcomes chemoresistance through inhibition of protein translation</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1002/mc.22609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fmc.22609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28019675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=1493-1500&author=B.+Harderauthor=W.+Tianauthor=J.+J.+La+Clairauthor=A.-C.+Tanauthor=A.+Ooiauthor=E.+Chapmanauthor=D.+D.+Zhang&title=Brusatol+overcomes+chemoresistance+through+inhibition+of+protein+translation&doi=10.1002%2Fmc.22609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol overcomes chemoresistance through inhibition of protein translation</span></div><div class="casAuthors">Harder, Bryan; Tian, Wang; La Clair, James J.; Tan, Aik-Choon; Ooi, Aikseng; Chapman, Eli; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1493-1500</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The NRF2 pathway activates a cell survival response when cells are exposed to xenobiotics or are under oxidative stress.  Therapeutic activation of NRF2 can also be used prior to insult as a means of disease prevention.  However, prolonged expression of NRF2 has been shown to protect cancer cells by inducing the metab. and efflux of chemotherapeutics, leading to both intrinsic and acquired chemoresistance to cancer drugs.  This effect has been termed the "dark side" of NRF2.  In an effort to combat this chemoresistance, our group discovered the first NRF2 inhibitor, the natural product brusatol, however the mechanism of inhibition was previously unknown.  In this report, we show that brusatol's mode of action is not through direct inhibition of the NRF2 pathway, but through the inhibition of both cap-dependent and cap-independent protein translation, which has an impact on many short-lived proteins, including NRF2.  Therefore, there is still a need to develop a new generation of specific NRF2 inhibitors with limited toxicity and off-target effects that could be used as adjuvant therapies to sensitize cancers with high expression of NRF2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEXTD-im3kLVg90H21EOLACvtfcHk0lg_obCXDKpUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D&md5=ce13967747c43025a1287dce903f9831</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1002%2Fmc.22609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22609%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DW.%26aulast%3DLa%2BClair%26aufirst%3DJ.%2BJ.%26aulast%3DTan%26aufirst%3DA.-C.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520overcomes%2520chemoresistance%2520through%2520inhibition%2520of%2520protein%2520translation%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D1493%26epage%3D1500%26doi%3D10.1002%2Fmc.22609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Comprehensive antitumor effect of brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">973</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.06.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30021391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1SrtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2018&pages=962-973&author=R.+Yeauthor=N.+Daiauthor=Q.+Heauthor=P.+Guoauthor=Y.+Xiangauthor=Q.+Zhangauthor=Z.+Hongauthor=Q.+Zhang&title=Comprehensive+antitumor+effect+of+brusatol+through+inhibition+of+cell+viability+and+promotion+of+apoptosis+caused+by+autophagy+via+the+PI3K%2FAkt%2FmTOR+pathway+in+hepatocellular+carcinoma&doi=10.1016%2Fj.biopha.2018.06.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma</span></div><div class="casAuthors">Ye, Ruifan; Dai, Ninggao; He, Qikuan; Guo, Pengyi; Xiang, Yukai; Zhang, Qiong; Hong, Zhong; Zhang, Qiyu</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">962-973</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Brusatol, a natural quassinoid isolated from a traditional Chinese herbal medicine known as Bruceae Fructus, has recently been reported to possess powerful cytotoxic effects against various cancer cell lines, highlighting its potential as an anti-cancer drug.  However, the precise mol. mechanisms by which Brusatol exerts its anti-cancer effects remain poorly understood in hepatocellular carcinoma (HCC).  In this study, we demonstrated that Brusatol inhibited cell viability, proliferation and induced apoptosis in liver cancer lines.  Furthermore, Brusatol could activate autophagy in diverse liver cell lines, and the autophagy inhibitor chloroquine (CQ) reversed Brusatol-induced apoptosis in Bel7404 cells.  In addn., we found that Brusatol inhibited PI3K/Akt/mTOR.  Brusatol may also inhibit invasion, migration and the epithelial-mesenchymal transition (EMT).  In a human liver xenograft tumor model in nude mice, immunohistochem. showed that Brusatol significantly inhibited tumor invasion and proliferation.  Taken together, these results revealed that Brusatol effectively inhibited proliferation and induced apoptosis in HCC through autophagy induction, probably via the PI3K/Akt/mTOR pathway, and inhibited tumor invasion and migration in vivo and in vitro.  All above indicated that Brusatol is an encouraging anti-tumor drug candidate or a supplement to the current chemotherapeutic systematic plan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHOAO_iQE007Vg90H21EOLACvtfcHk0ljdin_1AeUemw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1SrtbzK&md5=91d36771e396f20d8a4a93459605a1a5</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DR.%26aulast%3DDai%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DComprehensive%2520antitumor%2520effect%2520of%2520brusatol%2520through%2520inhibition%2520of%2520cell%2520viability%2520and%2520promotion%2520of%2520apoptosis%2520caused%2520by%2520autophagy%2520via%2520the%2520PI3K%252FAkt%252FmTOR%2520pathway%2520in%2520hepatocellular%2520carcinoma%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D105%26spage%3D962%26epage%3D973%26doi%3D10.1016%2Fj.biopha.2018.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span> <span> </span><span class="NLM_article-title">Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway</span>. <i>Oxid. Med. Cell. Longev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">2360427</span>, <span class="refDoi"> DOI: 10.1155/2018/2360427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1155%2F2018%2F2360427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29849873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MbitVOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=2360427&author=Y.+Xiangauthor=W.+Yeauthor=C.+Huangauthor=D.+Yuauthor=H.+Chenauthor=T.+Dengauthor=F.+Zhangauthor=B.+Louauthor=J.+Zhangauthor=K.+Shiauthor=B.+Chenauthor=M.+Zhou&title=Brusatol+enhances+the+chemotherapy+efficacy+of+gemcitabine+in+pancreatic+cancer+via+the+Nrf2+signalling+pathway&doi=10.1155%2F2018%2F2360427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway</span></div><div class="casAuthors">Xiang Yukai; Ye Wen; Huang Chaohao; Yu Dinglai; Chen Hao; Deng Tuo; Zhang Fan; Lou Bin; Zhang Jie; Chen Bicheng; Zhou Mengtao; Shi Keqing; Chen Bicheng; Zhou Mengtao</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2360427</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although gemcitabine is the standard chemotherapy treatment for advanced pancreatic cancer, its benefits are quite limited due to prevalent chemoresistance, and the mechanism underlying gemcitabine chemoresistance remains unclear.  Currently, Nrf2 has been deemed as a significant contributor to gemcitabine chemoresistance in pancreatic cancer.  Brusatol is a unique inhibitor of the Nrf2 pathway, and in previous studies, we determined that brusatol exhibits the effects of growth inhibition and proapoptosis in pancreatic cancer cells.  Due to these data, we speculate that brusatol can reverse gemcitabine-induced Nrf2 activation and propose that it can enhance gemcitabine efficacy in treating pancreatic cancer.  In this study, we first proved that brusatol can effectively inhibit the Nrf2 signalling pathway and increase ROS accumulation in pancreatic cancer cells.  Next, we demonstrated that brusatol can abrogate gemcitabine-induced Nrf2 activation in pancreatic cancer cells.  In addition, we discovered that brusatol potentiates gemcitabine-induced growth inhibition and apoptosis in human pancreatic cancer cells.  In nude mice with PANC-1 xenografts, treatment with a combination of brusatol and gemcitabine considerably reduced in vivo tumour growth compared with control treatment or treatment with either brusatol or gemcitabine alone.  Immunohistochemical staining also showed that Nrf2 expression levels were reduced in brusatol-treated xenograft tumour tissues.  In summary, our results suggest that brusatol is capable of enhancing the antitumour effects of gemcitabine in both pancreatic cancer cells and PANC-1 xenografts via suppressing the Nrf2 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZFYd2xluH2H6CEoQgWY10fW6udTcc2ea2lkMq8bo6aLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbitVOltA%253D%253D&md5=6b1f2f14a29032a63ab0c6f435ddb0b1</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1155%2F2018%2F2360427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F2360427%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLou%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DM.%26atitle%3DBrusatol%2520enhances%2520the%2520chemotherapy%2520efficacy%2520of%2520gemcitabine%2520in%2520pancreatic%2520cancer%2520via%2520the%2520Nrf2%2520signalling%2520pathway%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longev.%26date%3D2018%26spage%3D2360427%26doi%3D10.1155%2F2018%2F2360427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toppin, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.1073/pnas.1014275108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1073%2Fpnas.1014275108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21205897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=1433-1438&author=D.+Renauthor=N.+F.+Villeneuveauthor=T.+Jiangauthor=T.+Wuauthor=A.+Lauauthor=H.+A.+Toppinauthor=D.+D.+Zhang&title=Brusatol+enhances+the+efficacy+of+chemotherapy+by+inhibiting+the+Nrf2-mediated+defense+mechanism&doi=10.1073%2Fpnas.1014275108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism</span></div><div class="casAuthors">Ren, Dongmei; Villeneuve, Nicole F.; Jiang, Tao; Wu, Tongde; Lau, Alexandria; Toppin, Henry A.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1433-1438, S1433/1-S1433/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The major obstacle in cancer treatment is the resistance of cancer cells to therapies.  Nrf2 is a transcription factor that regulates a cellular defense response and is ubiquitously expressed at low basal levels in normal tissues due to Keap1-dependent ubiquitination and proteasomal degrdn.  Recently, Nrf2 has emerged as an important contributor to chemoresistance.  High constitutive expression of Nrf2 was found in many types of cancers, creating an environment conducive for cancer cell survival.  Here, we report the identification of brusatol as a unique inhibitor of the Nrf2 pathway that sensitizes a broad spectrum of cancer cells and A549 xenografts to cisplatin and other chemotherapeutic drugs.  Mechanistically, brusatol selectively reduces the protein level of Nrf2 through enhanced ubiquitination and degrdn. of Nrf2.  Consequently, expression of Nrf2-downstream genes is reduced and the Nrf2-dependent protective response is suppressed.  In A549 xenografts, brusatol and cisplatin cotreatment induced apoptosis, reduced cell proliferation, and inhibited tumor growth more substantially when compared with cisplatin treatment alone.  Addnl., A549-K xenografts, in which Nrf2 is expressed at very low levels due to ectopic expression of Keap1, do not respond to brusatol treatment, demonstrating that brusatol-mediated sensitization to cisplatin is Nrf2 dependent.  Moreover, a decrease in drug detoxification and impairment in drug removal may be the primary mechanisms by which brusatol enhances the efficacy of chemotherapeutic drugs.  Taken together, these results clearly demonstrate the effectiveness of using brusatol to combat chemoresistance and suggest that brusatol can be developed into an adjuvant chemotherapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruj8dASN0Mv7Vg90H21EOLACvtfcHk0ljNxGH3StcceQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D&md5=6d2cad037bc5db9e922d100338d6fdf9</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014275108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014275108%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DD.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DToppin%26aufirst%3DH.%2BA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520enhances%2520the%2520efficacy%2520of%2520chemotherapy%2520by%2520inhibiting%2520the%2520Nrf2-mediated%2520defense%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D1433%26epage%3D1438%26doi%3D10.1073%2Fpnas.1014275108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo de la Vega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1002/mc.22745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fmc.22745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28976703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=182-192&author=S.+Taoauthor=M.+Rojo+de+la+Vegaauthor=E.+Chapmanauthor=A.+Ooiauthor=D.+D.+Zhang&title=The+effects+of+NRF2+modulation+on+the+initiation+and+progression+of+chemically+and+genetically+induced+lung+cancer&doi=10.1002%2Fmc.22745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer</span></div><div class="casAuthors">Tao, Shasha; Rojo de la Vega, Montserrat; Chapman, Eli; Ooi, Aikseng; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-192</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Targeting the transcription factor NRF2 has been recognized as a feasible strategy for cancer prevention and treatment, but many of the mechanistic details underlying its role in cancer development and progression are lacking.  Therefore, careful mechanistic studies of the NRF2 pathway in cancer initiation and progression are needed to identify which therapeutic avenue-activation or inhibition-is appropriate in a given context.  Moreover, while numerous reports confirm the protective effect of NRF2 activation against chem. carcinogenesis little is known of its role in cancer arising from spontaneous mutations.  Here, we tested the effects of NRF2 modulation (activation by sulforaphane or inhibition by brusatol) in lung carcinogenesis using a chem. (vinyl carbamate) model in A/J mice and a genetic (conditional KrasG12D oncogene expression, to simulate spontaneous oncogene mutation) model in C57BL/6J mice.  Mice were treated with NRF2 modulators before carcinogen exposure or KrasG12D expression to test the role of NRF2 in cancer initiation, or treated after tumor development to test the role of NRF2 in cancer progression.  Lung tissues were analyzed to det. tumor burden, as well as status of NRF2 and KRAS pathways.  Addnl., proliferation, apoptosis, and oxidative DNA damage were assessed.  Overall, NRF2 activation prevents initiation of chem. induced cancer, but promotes progression of pre-existing tumors regardless of chem. or genetic etiol.  Once tumors are initiated, NRF2 inhibition is effective against the progression of chem. and spontaneously induced tumors.  These results have important implications for NRF2-targeted cancer prevention and intervention strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop5OpWFapg6LVg90H21EOLACvtfcHk0ljNxGH3StcceQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jF&md5=443bd2d5de35e912bce26279ff4a17ce</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1002%2Fmc.22745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22745%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DS.%26aulast%3DRojo%2Bde%2Bla%2BVega%26aufirst%3DM.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DThe%2520effects%2520of%2520NRF2%2520modulation%2520on%2520the%2520initiation%2520and%2520progression%2520of%2520chemically%2520and%2520genetically%2520induced%2520lung%2520cancer%26jtitle%3DMol.%2520Carcinog.%26date%3D2018%26volume%3D57%26spage%3D182%26epage%3D192%26doi%3D10.1002%2Fmc.22745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebinuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teratani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukasawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, H.</span></span> <span> </span><span class="NLM_article-title">Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">680</span>, <span class="refDoi"> DOI: 10.1186/s12885-018-4588-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs12885-018-4588-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29940898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2ntb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=680&author=Y.+Murakamiauthor=K.+Sugiyamaauthor=H.+Ebinumaauthor=N.+Nakamotoauthor=K.+Ojiroauthor=P.-S.+Chuauthor=N.+Tanikiauthor=Y.+Saitoauthor=T.+Terataniauthor=Y.+Kodaauthor=T.+Suzukiauthor=K.+Saitoauthor=M.+Fukasawaauthor=M.+Ikedaauthor=N.+Katoauthor=T.+Kanaiauthor=H.+Saito&title=Dual+effects+of+the+Nrf2+inhibitor+for+inhibition+of+hepatitis+C+virus+and+hepatic+cancer+cells&doi=10.1186%2Fs12885-018-4588-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells</span></div><div class="casAuthors">Murakami, Yuko; Sugiyama, Kazuo; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Ojiro, Keisuke; Chu, Po-sung; Taniki, Nobuhito; Saito, Yoshimasa; Teratani, Toshiaki; Koda, Yuzo; Suzuki, Takahiro; Saito, Kyoko; Fukasawa, Masayoshi; Ikeda, Masanori; Kato, Nobuyuki; Kanai, Takanori; Saito, Hidetsugu</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">680/1-680/14</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: We previously showed that knockdown of nuclear factor E2-related factor 2 (Nrf2) resulted in suppression of hepatitis C virus (HCV) infection.  In this study, whether brusatol, an Nrf2 inhibitor, has dual anti-HCV and anticancer effects was explored.  Methods: The anti-HCV effect of brusatol was investigated by analyzing HCV RNA and proteins in a hepatic cell line persistently-infected with HCV, HPI cells, and by analyzing HCV replication in a replicon-replicating hepatic cell line, OR6 cells.  Then, dual anti-HCV and anticancer effects of brusatol and enhancement of the effects by the combination of brusatol with anticancer drugs including sorafenib, which has been reported to have the dual effects, were then investigated.  Results: Brusatol suppressed the persistent HCV infection at both the RNA and protein levels in assocn. with a redn. in Nrf2 protein in the HPI cells.  Anal. of the OR6 cells treated with brusatol indicated that brusatol inhibited HCV persistence by inhibiting HCV replication.  Combination of brusatol with an anticancer drug not only enhanced the anticancer effect but also, in the case of the combination with sorafenib, strongly suppressed HCV infection.  Conclusions: Brusatol has dual anti-HCV and anticancer effects and can enhance the comparable effects of sorafenib.  There is therefore the potential for combination therapy of brusatol and sorafenib for HCV-related hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNxzqbe0LjlrVg90H21EOLACvtfcHk0liLoDdFqCN0gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2ntb%252FM&md5=ccebdcb846d88c82a56c2d603d165203</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1186%2Fs12885-018-4588-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-018-4588-y%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DK.%26aulast%3DEbinuma%26aufirst%3DH.%26aulast%3DNakamoto%26aufirst%3DN.%26aulast%3DOjiro%26aufirst%3DK.%26aulast%3DChu%26aufirst%3DP.-S.%26aulast%3DTaniki%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DTeratani%26aufirst%3DT.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DFukasawa%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKanai%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DH.%26atitle%3DDual%2520effects%2520of%2520the%2520Nrf2%2520inhibitor%2520for%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520and%2520hepatic%2520cancer%2520cells%26jtitle%3DBMC%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D680%26doi%3D10.1186%2Fs12885-018-4588-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span> <span> </span><span class="NLM_article-title">Brusatol inhibits amyloid-β-induced neurotoxicity in U-251 cells via regulating the Nrf2/HO-1 pathway</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">10556</span>– <span class="NLM_lpage">10563</span>, <span class="refDoi"> DOI: 10.1002/jcb.28341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjcb.28341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30629288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFWksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2019&pages=10556-10563&author=X.+Liuauthor=H.+W.+Xuauthor=Y.+Q.+Zhangauthor=P.+Wangauthor=W.+Gao&title=Brusatol+inhibits+amyloid-%CE%B2-induced+neurotoxicity+in+U-251+cells+via+regulating+the+Nrf2%2FHO-1+pathway&doi=10.1002%2Fjcb.28341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol inhibits amyloid-β-induced neurotoxicity in U-251 cells via regulating the Nrf2/HO-1 pathway</span></div><div class="casAuthors">Liu, Xin; Xu, Hua Wen; Zhang, Yue Qi; Wang, Peng; Gao, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">10556-10563</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) has been reported to cause oxidative damage of neurons leading to neurotoxicity in a variety of diseases and cancers.  As an anticancer drug, brusatol (BR) has been shown to have potent cytotoxic effects on various cancer cell lines.  In this study, the effect and mechanism of BR on Aβ-induced neurotoxicity was investigated in U-251 glioma cells.  Using the MTT assay, the results suggest that BR ameliorated cell injury induced by Aβ in U-251 cells.  After running Hoechst and Western blot assays, BR prevented cell apoptosis induced by Aβ in U-251 cells.  In addn., BR inhibited the increased reactive oxygen species and mitochondrial membrane potential levels induced by Aβ in U-251 cells using the DCFH-DA and Rh123 method.  Furthermore, BR induced the Nrf2/HO-1 pathway by inhibiting the PI3K/AKT/mTOR pathway to inhibit neurotoxicity elicited by Aβ.  These results suggest that brustasol is a valuable potential antitumor drug available for chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQQ-Nl4jrLbVg90H21EOLACvtfcHk0liLoDdFqCN0gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFWksw%253D%253D&md5=6c6a91bfca6019f694519a410134557e</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fjcb.28341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.28341%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DW.%26atitle%3DBrusatol%2520inhibits%2520amyloid-%25CE%25B2-induced%2520neurotoxicity%2520in%2520U-251%2520cells%2520via%2520regulating%2520the%2520Nrf2%252FHO-1%2520pathway%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2019%26volume%3D120%26spage%3D10556%26epage%3D10563%26doi%3D10.1002%2Fjcb.28341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muench, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedoris, K.</span></span> <span> </span><span class="NLM_article-title">c-Myc and cancer metabolism</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5546</span>– <span class="NLM_lpage">5553</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1078-0432.CCR-12-0977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23071356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFahu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=5546-5553&author=D.+M.+Millerauthor=S.+D.+Thomasauthor=A.+Islamauthor=D.+Muenchauthor=K.+Sedoris&title=c-Myc+and+cancer+metabolism&doi=10.1158%2F1078-0432.CCR-12-0977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">c-Myc and Cancer Metabolism</span></div><div class="casAuthors">Miller, Donald M.; Thomas, Shelia D.; Islam, Ashraful; Muench, David; Sedoris, Kara</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5546-5553</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The processes of cellular growth regulation and cellular metab. are closely interrelated.  The c-Myc oncogene is a "master regulator" which controls many aspects of both of these processes.  The metabolic changes which occur in transformed cells, many of which are driven by c-Myc overexpression, are necessary to support the increased need for nucleic acids, proteins, and lipids necessary for rapid cellular proliferation.  At the same time, c-Myc overexpression results in coordinated changes in level of expression of gene families which result in increased cellular proliferation.  This interesting duality of c-Myc effects places it in the mainstream of transformational changes and gives it a very important role in regulating the "transformed phenotype".  The effects induced by c-Myc can occur either as a "primary oncogene" which is activated by amplification or translocation or as a downstream effect of other activated oncogenes.  In either case, it appears that c-Myc plays a central role in sustaining the changes which occur with transformation.  Although efforts to use c-Myc as a therapeutic target have been quite frustrating, it appears that this may change in the next few years.  Clin Cancer Res; 18(20); 5546-53. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5OkM1yBQI7LVg90H21EOLACvtfcHk0lhFZKF-AWSDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFahu73K&md5=8e1a95beadc8ab07cb8f8c00877c8e4c</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0977%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DThomas%26aufirst%3DS.%2BD.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DMuench%26aufirst%3DD.%26aulast%3DSedoris%26aufirst%3DK.%26atitle%3Dc-Myc%2520and%2520cancer%2520metabolism%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D5546%26epage%3D5553%26doi%3D10.1158%2F1078-0432.CCR-12-0977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span> <span> </span><span class="NLM_article-title">Brusatol-mediated inhibition of c-Myc increases HIF-1α degradation and causes cell death in colorectal cancer under hypoxia</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3415</span>– <span class="NLM_lpage">3431</span>, <span class="refDoi"> DOI: 10.7150/thno.20861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.7150%2Fthno.20861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28912885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFaitrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=3415-3431&author=E.-T.+Ohauthor=C.+W.+Kimauthor=H.+G.+Kimauthor=J.-S.+Leeauthor=H.+J.+Park&title=Brusatol-mediated+inhibition+of+c-Myc+increases+HIF-1%CE%B1+degradation+and+causes+cell+death+in+colorectal+cancer+under+hypoxia&doi=10.7150%2Fthno.20861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol-mediated inhibition of c-Myc increases HIF-1α degradation and causes cell death in colorectal cancer under hypoxia</span></div><div class="casAuthors">Oh, Eun-Taex; Kim, Chan Woo; Kim, Ha Gyeong; Lee, Jae-Seon; Park, Heon Joo</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3415-3431</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">HIF-1 (hypoxia-inducible factor-1) regulates the expression of ∼100 genes involved in angiogenesis, metastasis, tumor growth, chemoresistance and radioresistance, underscoring the growing interest in targeting HIF-1 for cancer control.  In the present study, we investigated the mol. mechanisms underlying brusatol-induced HIF-1α degrdn. and cell death in colorectal cancer under hypoxia (0.5% O2).  Under hypoxia, pretreatment of cancer cells with brusatol increased HIF-1α degrdn. and cancer cell death in a dose-dependent manner.  This effect was mediated by activation of prolyl hydroxylases (PHDs), as evidenced by the block of brusatol-induced HIF-1α degrdn. and cancer cell death by both pharmacol. inhibition and siRNA-mediated knockdown of PHDs.  In addn., a ferrous iron chelator (2,2'-bypyridyl) blocked brusatol-induced degrdn. of HIF-1α and cancer cell death in hypoxia by inhibiting PHD activation.  We further found that brusatol inhibited c-Myc expression, and showed that overexpression of c-Myc prevented brusatol-induced degrdn. of HIF-1α and cancer cell death by increasing mitochondrial ROS prodn. and subsequent ROS-mediated transition of ferrous iron to ferric iron.  Consistent with these results, treatment of tumor-bearing mice with brusatol significantly suppressed tumor growth by promoting PHD-mediated HIF-1α degrdn.  Collectively, our results suggest that brusatol-mediated inhibition of c-Myc/ROS signaling pathway increases HIF-1α degrdn. by promoting PHD activity and induces cell death in colorectal cancer under hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiEo_Rs0pDbVg90H21EOLACvtfcHk0lhFZKF-AWSDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFaitrjE&md5=9726b8ee8a4d94ebae21477cfb622301</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.7150%2Fthno.20861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.20861%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DE.-T.%26aulast%3DKim%26aufirst%3DC.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BG.%26aulast%3DLee%26aufirst%3DJ.-S.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26atitle%3DBrusatol-mediated%2520inhibition%2520of%2520c-Myc%2520increases%2520HIF-1%25CE%25B1%2520degradation%2520and%2520causes%2520cell%2520death%2520in%2520colorectal%2520cancer%2520under%2520hypoxia%26jtitle%3DTheranostics%26date%3D2017%26volume%3D7%26spage%3D3415%26epage%3D3431%26doi%3D10.7150%2Fthno.20861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mata-Greenwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-<i>myc</i></span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2284</span>, <span class="refDoi"> DOI: 10.1038/sj.leu.2402696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsj.leu.2402696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12399973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFWksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=2275-2284&author=E.+Mata-Greenwoodauthor=M.+Cuendetauthor=D.+Sherauthor=D.+Gustinauthor=W.+Stockauthor=J.+M.+Pezzuto&title=Brusatol-mediated+induction+of+leukemic+cell+differentiation+and+G1+arrest+is+associated+with+down-regulation+of+c-myc&doi=10.1038%2Fsj.leu.2402696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-myc</span></div><div class="casAuthors">Mata-Greenwood, E.; Cuendet, M.; Sher, D.; Gustin, D.; Stock, W.; Pezzuto, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2275-2284</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Employing the natural product quassinoid brusatol, we currently report cellular and mol. events leading to cell death or terminal differentiation in a panel of leukemic cells.  Brusatol and bruceantin exerted significant cytotoxic effects with several leukemic cell lines, but not with K562 or normal lymphocytic cells.  Cell lines that were less sensitive to the cytotoxic effects of brusatol responded primarily through induction of terminal differentiation.  The differentiated phenotype in cell lines derived from acute or chronic myeloid leukemias (HL-60, K562, Kasumi-1, NB4, U937, BV173) was characterized for producing superoxide and non-specific esterase, and some with up-regulation of CD13 (cluster of differentiation) and down-regulation of CD15.  Chronic myeloid leukemic cell lines, K562 and BV173, and acute lymphoblastic cell lines, SUPB13 and RS4;11, were induced to differentiate along the erythrocytic pathway.  Withdrawal studies showed that brusatol treatment for 48 h was sufficient to induce commitment towards terminal differentiation in HL-60, K562 and SUPB13.  Reh cells did not undergo maturation.  Anal. of c-MYC protein expression revealed that brusatol or bruceantin down-regulated expression to undetectable levels in cell lines that were most sensitive, based on cell death or terminal differentiation.  Generally, c-myc RNA was reduced, but to a lower extent than c-MYC protein levels, indicating c-myc expression was regulated by quassinoids at the post-transcriptional level.  Thus, regulation of c-myc expression may represent a crit. event that leads to terminal differentiation.  Since these responses are facilitated at clin. achievable concns., quassinoids may be of value for the management of hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVGNe1HlRDxLVg90H21EOLACvtfcHk0lhFZKF-AWSDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFWksbk%253D&md5=a385718ad7aeff2514da34a9080436d8</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2402696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2402696%26sid%3Dliteratum%253Aachs%26aulast%3DMata-Greenwood%26aufirst%3DE.%26aulast%3DCuendet%26aufirst%3DM.%26aulast%3DSher%26aufirst%3DD.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DStock%26aufirst%3DW.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DBrusatol-mediated%2520induction%2520of%2520leukemic%2520cell%2520differentiation%2520and%2520G1%2520arrest%2520is%2520associated%2520with%2520down-regulation%2520of%2520c-myc%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D2275%26epage%3D2284%26doi%3D10.1038%2Fsj.leu.2402696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangappa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basappa</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangappa, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. S.</span></span> <span> </span><span class="NLM_article-title">Brusatol, a Nrf2 inhibitor targets STAT3 signaling cascade in head and neck squamous cell carcinoma</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">550</span>, <span class="refDoi"> DOI: 10.3390/biom9100550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fbiom9100550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=550&author=J.+H.+Leeauthor=S.+Rangappaauthor=C.+D.+Mohanauthor=+Basappaauthor=G.+Sethiauthor=Z.-X.+Linauthor=K.+S.+Rangappaauthor=K.+S.+Ahn&title=Brusatol%2C+a+Nrf2+inhibitor+targets+STAT3+signaling+cascade+in+head+and+neck+squamous+cell+carcinoma&doi=10.3390%2Fbiom9100550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol, a Nrf2 inhibitor targets STAT3 signaling cascade in head and neck squamous cell carcinoma</span></div><div class="casAuthors">Lee, Jong Hyun; Rangappa, Shobith; Mohan, Chakrabhavi Dhananjaya; Basappa; Sethi, Gautam; Lin, Zhi-Xiu; Rangappa, Kanchugarakoppal S.; Ahn, Kwang Seok</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">550/1-550/17</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">STAT3 is a latent transcription factor that plays a vital role in the transmission of extracellular signal from receptors to the nucleus.  It has been regarded as a master transcription factor due to its role in the regulation of a broad spectrum of genes, which can contribute to oncogenesis.  Persistent activation of STAT3 and deregulation of its signaling has been obsd. in various human cancers including head and neck squamous cell carcinoma (HNSCC).  In the present work, we identified brusatol (BT) as a potential blocker of STAT3 signaling pathway in diverse HNSCC cells.  The data from the cell-based expts. suggested that BT-induced cytotoxicity and abrogated the activation of STAT3 and that of upstream kinases such as JAK1, JAK2, and Src.  It reduced the levels of nuclear STAT3 and its DNA binding ability.  BT treatment increased annexin-V-pos. cells, promoted procaspase-3 and PARP cleavage, and downregulated the mRNA and protein expression of diverse proteins (Bcl-2, Bcl-xl, survivin) in HNSCC cells.  Taken together, brusatol can function as a promising inhibitor targeting STAT3 signaling pathway in HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9EhjQdheKO7Vg90H21EOLACvtfcHk0liIglkGF4hNKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKi&md5=48f99e54863ec4e1ef7481acafd31bb7</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.3390%2Fbiom9100550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9100550%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DRangappa%26aufirst%3DS.%26aulast%3DMohan%26aufirst%3DC.%2BD.%26aulast%3DBasappa%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DZ.-X.%26aulast%3DRangappa%26aufirst%3DK.%2BS.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26atitle%3DBrusatol%252C%2520a%2520Nrf2%2520inhibitor%2520targets%2520STAT3%2520signaling%2520cascade%2520in%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26spage%3D550%26doi%3D10.3390%2Fbiom9100550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span> <span> </span><span class="NLM_article-title">Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κB/STAT3/Bcl-2 signaling pathway</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>487</i></span>,  <span class="NLM_fpage">820</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2017.04.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bbrc.2017.04.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28455228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFertLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2017&pages=820-826&author=Y.+Xiangauthor=W.+Yeauthor=C.+Huangauthor=B.+Louauthor=J.+Zhangauthor=D.+Yuauthor=X.+Huangauthor=B.+Chenauthor=M.+Zhou&title=Brusatol+inhibits+growth+and+induces+apoptosis+in+pancreatic+cancer+cells+via+JNK%2Fp38+MAPK%2FNF-%CE%BAB%2FSTAT3%2FBcl-2+signaling+pathway&doi=10.1016%2Fj.bbrc.2017.04.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway</span></div><div class="casAuthors">Xiang, Yukai; Ye, Wen; Huang, Chaohao; Lou, Bin; Zhang, Jie; Yu, Dinglai; Huang, Xince; Chen, Bicheng; Zhou, Mengtao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">820-826</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Brusatol, isolated from brucea, has been proved to exhibit anticancer influence on various kind of human malignancies.  However, the role that brusatol plays in pancreatic cancer is seldom known by the public.  Through researches brusatol was proved to inhibit growth and induce apoptosis in both PATU-8988 and PANC-1 cells by decreasing the expression level of Bcl-2 and increasing the expression levels of Bax, Cleaved Caspase-3.  Then we found the activation of the JNK, p38 MAPK and inactivation of the NF-κb, Stat3 are related with the potential pro-apoptotic signaling pathways.  However, SP600125 could not only abrogated the JNK activation caused by brusatol, but also reverse the p38 activation and the decrease of Bcl-2 as SB203580 did.  Besides, SP600125 and SB203580 also reversed the inactivation of NF-κb and Stat3.  Furthermore, BAY 11-7082 and S3I-201 indeed had the similar effect as brusatol had on the expression of Phospho-Stat3 and Bcl-2.  To sum up, we came to a conclusion that in pancreatic cancer, brusatol do inhibit growth and induce apoptosis.  And we inferred that brusatol illustrates anticancer attribution via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9B-JuNQOjrVg90H21EOLACvtfcHk0liIglkGF4hNKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFertLo%253D&md5=9c2446c2290cf6fcbafc3c59e21510e2</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.04.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.04.133%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DLou%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DM.%26atitle%3DBrusatol%2520inhibits%2520growth%2520and%2520induces%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%2520via%2520JNK%252Fp38%2520MAPK%252FNF-%25CE%25BAB%252FSTAT3%252FBcl-2%2520signaling%2520pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D487%26spage%3D820%26epage%3D826%26doi%3D10.1016%2Fj.bbrc.2017.04.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.-N.</span></span> <span> </span><span class="NLM_article-title">Bruceine D suppresses viability, metastasis and EMT of human breast cancer MDA-MB-231 cells</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">7285</span>– <span class="NLM_lpage">7291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=7285-7291&author=C.+Luoauthor=S.-P.+Fangauthor=Y.+Wangauthor=C.+Weiauthor=Y.-X.+Chenauthor=Z.-N.+Ji&title=Bruceine+D+suppresses+viability%2C+metastasis+and+EMT+of+human+breast+cancer+MDA-MB-231+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D suppresses viability, metastasis and EMT of human breast cancer MDA-MB-231 cells</span></div><div class="casAuthors">Luo, Can; Fang, Shang-Ping; Wang, Yu.; Wei, Cheng; Chen, Yu-Xin; Ji, Zhao-Ning</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7285-7291</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Bruceine D (BD), a major quassinoid extd. from the Chinese medicinal herb Brucea javanica, has been demonstrated to exert anticancer effects on various tumor cells.  However, the anti-metastatic effect of BD has not been reported.  The present study was designed to investigate the anti-metastatic effect of BD on MDA-MB-231 cells.  The effects of BD on cell viability, migration and invasion were examd. by MTT assay, wound healing assay and transwell assay, resp.  The effect of BD on epithelial-mesenchymal transition (EMT)-assocd. proteins, including E-cadherin and vimentin was tested by Western blot.  At the same time, we detected the expression of β-catenin, which is a key mol. target for promoting cell metastasis.  The results showed that BD inhibited the viability of MDA-MB-231 cells in a dose and time-dependent manner, and it also reduced cell migration and invasion in a dose-dependent manner.  Western blot showed that BD reversed EMT through suppressing vimentin but enhancing E-cadherin expression.  Furthermore, BD obviously decreased the expression of β-catenin in a dose-dependent manner.  Taken together, all these results suggest that BD suppresses viability, metastasis and EMT of human breast cancer MDA-MB-231 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM-jDVlY-FvrVg90H21EOLACvtfcHk0lhFr2V4EKZ1bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVamsrw%253D&md5=f9c55ef8b7644f0ab5ced3002d7b3958</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DS.-P.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.-X.%26aulast%3DJi%26aufirst%3DZ.-N.%26atitle%3DBruceine%2520D%2520suppresses%2520viability%252C%2520metastasis%2520and%2520EMT%2520of%2520human%2520breast%2520cancer%2520MDA-MB-231%2520cells%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2019%26volume%3D12%26spage%3D7285%26epage%3D7291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span> <span> </span><span class="NLM_article-title">Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">126</span>, <span class="refDoi"> DOI: 10.1038/s41419-020-2317-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41419-020-2317-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32071301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=126&author=J.+Fanauthor=D.+Renauthor=J.+Wangauthor=X.+Liuauthor=H.+Zhangauthor=M.+Wuauthor=G.+Yang&title=Bruceine+D+induces+lung+cancer+cell+apoptosis+and+autophagy+via+the+ROS%2FMAPK+signaling+pathway+in+vitro+and+in+vivo&doi=10.1038%2Fs41419-020-2317-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo</span></div><div class="casAuthors">Fan, Jiangjiang; Ren, Dongmei; Wang, Jinxia; Liu, Xiaoqing; Zhang, Huaran; Wu, Mingsheng; Yang, Guotao</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Worldwide, lung cancer remains a leading cause of cancer mortality.  Bruceine D (BD) has been shown to induce pancreatic cancer cell death via several different mechanisms.  In this study, we demonstrated that BD inhibited lung cancer cell proliferation.  Apoptosis and autophagy were the most important mechanisms involved in BD-induced lung cancer cell death, and complete autophagic flux was obsd. in A549 and NCI-H292 cells.  In addn., BD significantly improved intracellular reactive oxygen species (ROS) levels.  BD-mediated cell apoptosis and autophagy were almost inhibited in cells pretreated with N-acetylcysteine (NAC), an ROS scavenger.  Furthermore, MAPK signaling pathway activation contributed to BD-induced cell proliferation inhibition and NAC could eliminate p-ERK and p-JNK upregulation.  Finally, an in vivo study indicated that BD inhibited the growth of lung cancer xenografts.  Overall, BD is a promising candidate for the treatment of lung cancer owing to its multiple mechanisms and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoadQk2e9T51bVg90H21EOLACvtfcHk0lhFr2V4EKZ1bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFGltrg%253D&md5=2274b7d5d2acfefab929f5bf7fc1999e</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1038%2Fs41419-020-2317-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-020-2317-3%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DG.%26atitle%3DBruceine%2520D%2520induces%2520lung%2520cancer%2520cell%2520apoptosis%2520and%2520autophagy%2520via%2520the%2520ROS%252FMAPK%2520signaling%2520pathway%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2020%26volume%3D11%26spage%3D126%26doi%3D10.1038%2Fs41419-020-2317-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.-X.</span></span> <span> </span><span class="NLM_article-title">Brucein D, a naturally occurring tetracyclic triterpene quassinoid, induces apoptosis in pancreatic cancer through ROS-associated PI3K/Akt signaling pathway</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">936</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2017.00936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29311937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOhurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=936&author=Z.-Q.+Laiauthor=S.-P.+Ipauthor=H.-J.+Liaoauthor=Z.+Luauthor=J.-H.+Xieauthor=Z.-R.+Suauthor=Y.-L.+Chenauthor=Y.-F.+Xianauthor=P.-S.+Leungauthor=Z.-X.+Lin&title=Brucein+D%2C+a+naturally+occurring+tetracyclic+triterpene+quassinoid%2C+induces+apoptosis+in+pancreatic+cancer+through+ROS-associated+PI3K%2FAkt+signaling+pathway&doi=10.3389%2Ffphar.2017.00936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Brucein D, a naturally occurring tetracyclic triterpene quassinoid, induces apoptosis in pancreatic cancer through ros-associated PI3K/Akt signaling pathway</span></div><div class="casAuthors">Lai, Zheng-Quan; Ip, Siu-Po; Liao, Hui-Jun; Lu, Zheng; Xie, Jian-Hui; Su, Zi-Ren; Chen, Yun-Long; Xian, Yan-Fang; Leung, Po-Sing; Lin, Zhi-Xiu</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">936/1-936/15</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Brucein D (BD), a major active quassinoid in Brucea javanica, has exhibited pronounced anticancer activities.  However, the biol. mechanisms have not been fully explored.  In this study, BD exhibited more potent cytotoxic effect on pancreatic cancer (PanCa) cell lines, while exerted weaker cytotoxic effects on GES-1 cells (non-tumorigenic).  BD was shown to elicit apoptosis through inducing both the intrinsic and extrinsic mitochondria-mediated caspase activations.  Furthermore, the BD-induced apoptotic effects were dependent on the accumulated reactive oxygen species (ROS) and inactivation of PI3K/Akt signaling pathway.  Pretreatment with tempol completely prevented the cellular apoptosis induced by BD, and recovered the inactivation of AKT, which suggested ROS essentially involved in BD-elicited apoptosis and down-regulation of PI3K/Akt pathway.  In addn., the results obtained from orthotopic xenograft in nude mice were congruent with those of the in vitro investigations.  These results support the notion that BD held good potential to be further developed into an effective pharmaceutical agent for the treatment of PanCa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8cAwRR8p7vbVg90H21EOLACvtfcHk0ljcC7tAeXd4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOhurzE&md5=e1d4b1335239532741573bc33d4f9d4c</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00936%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DZ.-Q.%26aulast%3DIp%26aufirst%3DS.-P.%26aulast%3DLiao%26aufirst%3DH.-J.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DJ.-H.%26aulast%3DSu%26aufirst%3DZ.-R.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DXian%26aufirst%3DY.-F.%26aulast%3DLeung%26aufirst%3DP.-S.%26aulast%3DLin%26aufirst%3DZ.-X.%26atitle%3DBrucein%2520D%252C%2520a%2520naturally%2520occurring%2520tetracyclic%2520triterpene%2520quassinoid%252C%2520induces%2520apoptosis%2520in%2520pancreatic%2520cancer%2520through%2520ROS-associated%2520PI3K%252FAkt%2520signaling%2520pathway%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D936%26doi%3D10.3389%2Ffphar.2017.00936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span> <span> </span><span class="NLM_article-title">Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway</span>. <i>Cancer Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7345</span>– <span class="NLM_lpage">7358</span>, <span class="refDoi"> DOI: 10.1002/cam4.2612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fcam4.2612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31631559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVeju7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=7345-7358&author=S.+Wangauthor=H.+Huauthor=B.+Zhongauthor=D.+Shiauthor=X.+Qingauthor=C.+Chengauthor=X.+Dengauthor=Z.+Zhangauthor=Z.+Shao&title=Bruceine+D+inhibits+tumor+growth+and+stem+cell-like+traits+of+osteosarcoma+through+inhibition+of+STAT3+signaling+pathway&doi=10.1002%2Fcam4.2612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway</span></div><div class="casAuthors">Wang, Shangyu; Hu, Hongzhi; Zhong, Binlong; Shi, Deyao; Qing, Xiangcheng; Cheng, Cheng; Deng, Xiangyu; Zhang, Zhicai; Shao, Zengwu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7345-7358</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">This study aims to explore the anti-osteosarcoma effects of Bruceine D (BD), a natural compd. derived from Brucea javanica, and investigate its underlying mechanisms.  Results demonstrated that BD could significantly inhibit cell proliferation and migration, induce cell cycle arrest, and promote apoptosis in osteosarcoma cells.  Besides, BD could also suppress the sphere-forming and self-renewal ability of OSCs.  Mechanistically, the inhibitory role of BD on osteosarcoma cell growth and migration including OSC stemness was partially executed through the inhibition of STAT3 signaling pathway.  More importantly, BD showed significant anti-osteosarcoma activity without obvious side effects in vivo.  Collectively, the results of this study demonstrated that BD exerts a strong inhibitory effect on tumor growth and stem cell like traits of osteosarcoma which may be partially due to STAT3 inhibition, suggesting that BD maybe a promising therapeutic candidate against osteosarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrczm6gDjS0YLVg90H21EOLACvtfcHk0ljcC7tAeXd4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVeju7zF&md5=9e47465e820c9d0b11e7779fcb39d050</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1002%2Fcam4.2612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.2612%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DQing%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DShao%26aufirst%3DZ.%26atitle%3DBruceine%2520D%2520inhibits%2520tumor%2520growth%2520and%2520stem%2520cell-like%2520traits%2520of%2520osteosarcoma%2520through%2520inhibition%2520of%2520STAT3%2520signaling%2520pathway%26jtitle%3DCancer%2520Med.%26date%3D2019%26volume%3D8%26spage%3D7345%26epage%3D7358%26doi%3D10.1002%2Fcam4.2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N.</span></span> <span> </span><span class="NLM_article-title">Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">109089</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31226632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1WjsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2019&pages=109089&author=B.+Tanauthor=Y.+Huangauthor=L.+Lanauthor=B.+Zhangauthor=L.+Yeauthor=W.+Yanauthor=F.+Wangauthor=N.+Lin&title=Bruceine+D+induces+apoptosis+in+human+non-small+cell+lung+cancer+cells+through+regulating+JNK+pathway&doi=10.1016%2Fj.biopha.2019.109089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway</span></div><div class="casAuthors">Tan, Biqin; Huang, Yuyu; Lan, Lihua; Zhang, Bo; Ye, Lijun; Yan, Wei; Wang, Fei; Lin, Nengming</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109089</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Bruceine D (BD) is the quassinoids isolated from the traditional Chinese herbal medicine Brucea javanica's fruit, which exhibits anti-cancer activity.  Here, we demonstrated that BD inhibited human non-small cell lung cancer (NSCLC) cell lines in vitro that were attributed to the induction of cell apoptosis.  Human NSCLC H460 and A549 cell lines were treated with BD, and cell viability was conducted with CCK-8 assay.  Cell clone formation was obsd. by clone formation assay.  Cell apoptosis was measured using DAPI staining and flow cytometry.  Protein levels was analyzed by western blot.  The results showed BD inhibited the cell viability of H460 and A549 cells in a dose-dependent manner with IC50 values of 0.5 and 0.6μmol/L, resp., at 48 h of treatment.  Treatment with BD (0.125-1.0μmol/L) dose-dependently promoted chromatin condensation, Annexin V-pos. cell population and caspase-dependent apoptosis in H460 and A549 cells.  Mechanistically, BD stimulated the phosphorylation of JNK.  Furthermore, the anti-cancer effects of BD were alleviated effectively by a specific JNK inhibitor SP600125 in NSCLC cells.  In conclusion, the results demonstrated that BD exerted anti-cancer activity against NSCLC cells through JNK activation, which suggests its potent usefulness for prevention and treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiYyGYZXLHE7Vg90H21EOLACvtfcHk0lipnepZginqfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1WjsrnM&md5=90b3b2f8722c6546c51d0aad57992d89</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109089%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DN.%26atitle%3DBruceine%2520D%2520induces%2520apoptosis%2520in%2520human%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520through%2520regulating%2520JNK%2520pathway%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D117%26spage%3D109089%26doi%3D10.1016%2Fj.biopha.2019.109089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, R.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.-C.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic quassinoids from <i>Ailanthus altissima</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2012.11.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23290052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=654-657&author=Y.+Wangauthor=W.-J.+Wangauthor=C.+Suauthor=D.-M.+Zhangauthor=L.-P.+Xuauthor=R.-R.+Heauthor=L.+Wangauthor=J.+Zhangauthor=X.-Q.+Zhangauthor=W.-C.+Ye&title=Cytotoxic+quassinoids+from+Ailanthus+altissima&doi=10.1016%2Fj.bmcl.2012.11.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic quassinoids from Ailanthus altissima</span></div><div class="casAuthors">Wang, Yan; Wang, Wen-Jing; Su, Chang; Zhang, Dong-Mei; Xu, Li-Peng; He, Rong-Rong; Wang, Lei; Zhang, Jian; Zhang, Xiao-Qi; Ye, Wen-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">654-657</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two new quassinoids, altissinol A (I) and B (II), together with 12 known quassinoids, were isolated from the 95% ethanol ext. of the barks of Ailanthus altissima.  The structures of I and II were detd. on the basis of the spectroscopic methods including UV, IR, HR-ESI-MS, 1D and 2D NMR.  The cytotoxic potential of all isolates were evaluated in vitro against three human hepatoma cell lines.  Quassinoids 1-7 displayed potent cytotoxic activities against human hepatoma Hep3B and HepG2 cell lines.  Compds. 2, 3, and 5 exhibited cytotoxic activity against multidrug resistance HepG2/ADM cell line with IC50 value 4.3-fold more sensitive to Doxorubicin (DOX).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpqD4qm-d7brVg90H21EOLACvtfcHk0lipnepZginqfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ehsA%253D%253D&md5=9bdfad721cd538e2fa1e4d3c6e3f400d</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.116%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.-J.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DD.-M.%26aulast%3DXu%26aufirst%3DL.-P.%26aulast%3DHe%26aufirst%3DR.-R.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.-Q.%26aulast%3DYe%26aufirst%3DW.-C.%26atitle%3DCytotoxic%2520quassinoids%2520from%2520Ailanthus%2520altissima%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D654%26epage%3D657%26doi%3D10.1016%2Fj.bmcl.2012.11.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozeki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsuyanagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mello Alves, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic quassinoids from <i>Simaba cedron</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1021/np980023f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np980023f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK1cXjs1Giuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=776-780&author=A.+Ozekiauthor=Y.+Hitotsuyanagiauthor=E.+Hashimotoauthor=H.+Itokawaauthor=K.+Takeyaauthor=S.+de+Mello+Alves&title=Cytotoxic+quassinoids+from+Simaba+cedron&doi=10.1021%2Fnp980023f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Quassinoids from Simaba cedron</span></div><div class="casAuthors">Ozeki, Akira; Hitotsuyanagi, Yukio; Hashimoto, Eriko; Itokawa, Hideji; Takeya, Koichi; de Alves, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">776-780</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four new quassinoids, cedronolactones A-D (1-4), together with nine known compds., simalikalactone D (5), chaparrinone (6), chaparrin (7), glaucarubolone (8), glaucarubol (9), samaderine Z (10), guanepolide (11), ailanquassin A (12), and polyandrol (13), were isolated from the wood of Simaba cedron.  The chem. structures of 1-4 were elucidated on the basis of their chem. and spectral properties.  Cedronolactone A (1) was shown to exhibit a significant in vitro cytotoxicity (IC50 0.0074 μg/mL) against P-388 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr21s4T0xcui7Vg90H21EOLACvtfcHk0lipnepZginqfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjs1Giuro%253D&md5=af1ebe45aae3634e7fe6bc4cbe5e3467</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1021%2Fnp980023f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp980023f%26sid%3Dliteratum%253Aachs%26aulast%3DOzeki%26aufirst%3DA.%26aulast%3DHitotsuyanagi%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DE.%26aulast%3DItokawa%26aufirst%3DH.%26aulast%3DTakeya%26aufirst%3DK.%26aulast%3Dde%2BMello%2BAlves%26aufirst%3DS.%26atitle%3DCytotoxic%2520quassinoids%2520from%2520Simaba%2520cedron%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1998%26volume%3D61%26spage%3D776%26epage%3D780%26doi%3D10.1021%2Fnp980023f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, D.</span></span> <span> </span><span class="NLM_article-title">Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cell growth, migration and invasion</span>. <i>Exp. Mol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.yexmp.2019.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.yexmp.2019.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31002772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvF2hs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2019&pages=114-120&author=Y.+Zhangauthor=C.+Zhangauthor=D.+Min&title=Ailanthone+up-regulates+miR-449a+to+restrain+acute+myeloid+leukemia+cell+growth%2C+migration+and+invasion&doi=10.1016%2Fj.yexmp.2019.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cells growth, migration and invasion</span></div><div class="casAuthors">Zhang, Yang; Zhang, Chunzhi; Min, Dejin</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Pathology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-120</span>CODEN:
                <span class="NLM_cas:coden">EXMPA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4800</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ailanthone (AIL) is a quassinoid isolated from traditional Chinese herbal medicine Ailanthus altissima.  The anti-tumor activities of AIL have been reported in various solid tumors.  This study aimed to reveal the in vitro effect of AIL on acute myeloid leukemia (AML) cells.  The effects of AIL on five AML cell lines (KG1, HL60, U-937, THP-1 and OCI-AML2) as well as myeloid progenitor cells were evaluated by performing CCK-8 assay, flow cytometry, Transwell assay and Western blotting.  KG1 and HL60 cells were transfected with miR-449a inhibitor or its neg. control, and then were treated by AIL.  The above mentioned assays were performed again to study the involvement of miR-449a in AIL's function.  AIL dose-dependently inhibited the viability of AML cells and myeloid progenitor cells.  The IC50 value of AIL towards KG1 and HL60 cells was 0.58 and 0.57μM, resp.  AIL with concn. of 0.5μM significantly induced the apoptosis of AML cells rather than myeloid progenitor cells.  Meanwhile, 0.5μM AIL significantly reduced migration and invasion of AML cells.  MiR-449a was highly expressed in response to the treatment of 0.5μM AIL.  Besides this, the anti-tumor activities of AIL in AML cells were attenuated by miR-449a silence.  Further, the blockage of Notch and PI3K/AKT signaling pathways induced by AIL was reversed by miR-449a silence.  AIL restrained AML cells growth, migration and invasion through up-regulation of miR-449a, and deactivation of Notch and PI3K/AKT signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3sSrOuOxgbrVg90H21EOLACvtfcHk0lhj8PkwOIB8KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvF2hs7w%253D&md5=861f23badd7c32fa4fd8d6b1bd7dd77d</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2Fj.yexmp.2019.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexmp.2019.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMin%26aufirst%3DD.%26atitle%3DAilanthone%2520up-regulates%2520miR-449a%2520to%2520restrain%2520acute%2520myeloid%2520leukemia%2520cell%2520growth%252C%2520migration%2520and%2520invasion%26jtitle%3DExp.%2520Mol.%2520Pathol.%26date%3D2019%26volume%3D108%26spage%3D114%26epage%3D120%26doi%3D10.1016%2Fj.yexmp.2019.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of the <i>Ailanthus altissima</i> bark phytochemical ailanthone against breast cancer MCF-7 cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6022</span>– <span class="NLM_lpage">6028</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.8039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.8039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29552229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MnisValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=6022-6028&author=R.+Wangauthor=Y.+Luauthor=H.+Liauthor=L.+Sunauthor=N.+Yangauthor=M.+Zhaoauthor=M.+Zhangauthor=Q.+Shi&title=Antitumor+activity+of+the+Ailanthus+altissima+bark+phytochemical+ailanthone+against+breast+cancer+MCF-7+cells&doi=10.3892%2Fol.2018.8039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF-7 cells</span></div><div class="casAuthors">Wang Ruxing; Zhang Manli; Shi Qingwen; Wang Ruxing; Lu Yanjie; Li Hong; Sun Lixin; Yang Ning; Zhao Mingzhen</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">6022-6028</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Ailanthone is isolated from the bark of Ailanthus altissima (Mill.) Swingle (Simaroubaceae).  The mechanism that underlies the activity of ailanthone on MCF-7 cells was investigated by MTT assay.  Breast cancer MCF-7 cells were treated with 0.5, 1.0, 2.0, 4.0 and 8.0 μg/ml ailanthone for 24, 48 and 72 h.  The inhibition of proliferation induced by treatment with ailanthone was assessed by MTT assay.  Apoptosis and cell cycle distribution in MCF-7 cells with the same doses of ailanthone for 48 h were determined by flow cytometry.  Expression of apoptosis-associated genes and proteins were analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis, respectively.  The results revealed that ailanthone inhibited MCF-7 cell proliferation.  Flow cytometry assay demonstrated that ailanthone induced apoptosis and G0/G1 cell cycle arrest in MCF-7 cells.  Western blotting and RT-PCR assays demonstrated that upregulation of pro-apoptotic caspase-3 and Bcl-associated X, and downregulation of anti-apoptotic apoptosis regulator B-cell lymphoma-2 in MCF-7 cells may be associated with the induction of apoptosis and inhibition of proliferation.  To the best of our knowledge, the present study is the first to investigate the antitumor activity of ailanthone from A. altissima on MCF-7 cells and to attempt to elucidate the underlying mechanism.  The present study revealed the presence of ailanthone-mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrppWwtIoRB91QT_1O5WBYfW6udTcc2eaO97_Xz4CM17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnisValuw%253D%253D&md5=236fb6d2e38d8cbf4a4bffdf57934255</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.8039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.8039%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DQ.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520Ailanthus%2520altissima%2520bark%2520phytochemical%2520ailanthone%2520against%2520breast%2520cancer%2520MCF-7%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D15%26spage%3D6022%26epage%3D6028%26doi%3D10.3892%2Fol.2018.8039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span> <span> </span><span class="NLM_article-title">Ailanthone induces G<sub>2</sub>/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6821</span>– <span class="NLM_lpage">6827</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fmmr.2017.7491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28901518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFWjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=6821-6827&author=Y.+Chenauthor=L.+Zhuauthor=X.+Yangauthor=C.+Weiauthor=C.+Chenauthor=Y.+Heauthor=Z.+Ji&title=Ailanthone+induces+G2%2FM+cell+cycle+arrest+and+apoptosis+of+SGC-7901+human+gastric+cancer+cells&doi=10.3892%2Fmmr.2017.7491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells</span></div><div class="casAuthors">Chen, Yuxin; Zhu, Ling; Yang, Xi; Wei, Cheng; Chen, Chuanrong; He, Yang; Ji, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">6821-6827</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Ailanthone is a major quassinoid extd. from the Chinese medicinal herb Ailanthus altissima, which has been reported to exert antiproliferative effects on various cancer cells.  The present study aimed to investigate the antitumor effects of ailanthone on SGC-7901 cells, and to analyze its underlying mol. mechanisms.  Following treatment with ailanthone, Cell Counting kit-8 was used to detect the cytotoxic effects of ailanthone on SGC-7901 cells in vitro.  The typical apoptotic morphol. of SGC-7901 cells was obsd. by Hoechst 33258 staining.  Cell cycle progression and apoptosis were measured by flow cytometry, and the protein and mRNA expression levels of Bcl-2 and Bax were analyzed by western blot anal. and reverse transcription-quant. polymerase chain reaction (RT-qPCR) resp., in SGC-7901 cells.  The results of the present study indicated that ailanthone inhibited the proliferation of SGC-7901 cells in a dose- and time-dependent manner in vitro, and also demonstrated that ailanthone induced G2/M phase cell cycle arrest and apoptosis of SGC-7901 cells.  Furthermore, anal. of the underlying mol. mechanisms revealed that ailanthone downregulated the expression levels of Bcl-2, whereas the expression levels of Bax were upregulated at the protein and mRNA levels.  In conclusion, ailanthone may inhibit the proliferation of SGC-7901 cells by inducing G2/M phase cell cycle arrest and apoptosis via altering the protein and mRNA expression levels of Bcl-2 and Bax in SGC-7901 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKCdQO4XZC0bVg90H21EOLACvtfcHk0ljx_mtD5BOMEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFWjsLw%253D&md5=908f0c1c39c4e593396f51c3dc4d10ed</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7491%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DZ.%26atitle%3DAilanthone%2520induces%2520G2%252FM%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520of%2520SGC-7901%2520human%2520gastric%2520cancer%2520cells%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D16%26spage%3D6821%26epage%3D6827%26doi%3D10.3892%2Fmmr.2017.7491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">16185</span>, <span class="refDoi"> DOI: 10.1038/srep16185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep16185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26525771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOnsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=16185&author=Z.+Zhuoauthor=J.+Huauthor=X.+Yangauthor=M.+Chenauthor=X.+Leiauthor=L.+Dengauthor=N.+Yaoauthor=Q.+Pengauthor=Z.+Chenauthor=W.+Yeauthor=D.+Zhang&title=Ailanthone+inhibits+Huh7+cancer+cell+growth+via+cell+cycle+arrest+and+apoptosis+in+vitro+and+in+vivo&doi=10.1038%2Fsrep16185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo</span></div><div class="casAuthors">Zhuo, Zhenjian; Hu, Jianyang; Yang, Xiaolin; Chen, Minfen; Lei, Xueping; Deng, Lijuan; Yao, Nan; Peng, Qunlong; Chen, Zhesheng; Ye, Wencai; Zhang, Dongmei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16185</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">While searching for natural anti-hepatocellular carcinoma (HCC) components in Ailanthus altissima, we discovered that ailanthone had potent antineoplastic activity against HCC.  However, the mol. mechanisms underlying the antitumor effect of ailanthone on HCC have not been examd.  In this study, the antitumor activity and the underlying mechanisms of ailanthone were evaluated in vitro and in vivo.  Mechanistic studies showed that ailanthone induced G0/G1-phase cell cycle arrest, as indicated by decreased expression of cyclins and CDKs and increased expression of p21 and p27.  Our results demonstrated that ailanthone triggered DNA damage characterized by activation of the ATM/ATR pathway.  Moreover, ailanthone-induced cell death was assocd. with apoptosis, as evidenced by an increased ratio of cells in the subG1 phase and by PARP cleavage and caspase activation.  Ailanthone-induced apoptosis was mitochondrion-mediated and involved the PI3K/AKT signaling pathway in Huh7 cells.  In vivo studies demonstrated that ailanthone inhibited the growth and angiogenesis of tumor xenografts without significant secondary adverse effects, indicating its safety for treating HCC.  In conclusion, our study is the first to report the efficacy of ailanthone against Huh7 cells and to elucidate its underlying mol. mechanisms.  These findings suggest that ailanthone is a potential agent for the treatment of liver cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosWKOMLHZXqrVg90H21EOLACvtfcHk0ljx_mtD5BOMEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOnsL%252FM&md5=a7712888d89d84bdbc66ffe8249246d3</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1038%2Fsrep16185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep16185%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DAilanthone%2520inhibits%2520Huh7%2520cancer%2520cell%2520growth%2520via%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D16185%26doi%3D10.1038%2Fsrep16185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span> <span> </span><span class="NLM_article-title">Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3569</span>– <span class="NLM_lpage">3576</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.9101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.9101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30127963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3c3gtFaisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=3569-3576&author=C.+Weiauthor=C.+Chenauthor=Y.+Chengauthor=L.+Zhuauthor=Y.+Wangauthor=C.+Luoauthor=Y.+Heauthor=Z.+Yangauthor=Z.+Ji&title=Ailanthone+induces+autophagic+and+apoptotic+cell+death+in+human+promyelocytic+leukemia+HL-60+cells&doi=10.3892%2Fol.2018.9101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells</span></div><div class="casAuthors">Wei Cheng; He Yang; Yang Zhiming; Ji Zhaoning; Chen Chuanrong; Cheng Yuxin; Zhu Lin; Wang Yu; Luo Can</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3569-3576</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Ailanthone, which is extracted from the traditional Chinese medicinal plant Ailanthus altissima, has been thoroughly demonstrated to have anti-tumor, anti-HIV, anti-inflammatory, anti-malarial, anti-allergic and anti-microbial activities.  However, the anti-proliferative effects of ailanthone on HL-60 cells and potential mechanisms underlying those effects have not been reported.  In the present study, we demonstrated the potent cytotoxicity of ailanthone against HL-60 cells.  Annexin V-APC/7-ADD staining assay indicated that ailanthone increased the number of apoptotic cells in a dose-dependent manner.  PI staining showed that ailanthone increased the percentage of G0/G1-phase cells in a dose-dependent manner.  Acridine orange staining suggested that ailanthone induced the formation of acidic vesicular organelles in HL-60 cells and pretreatment with BaF-A1 could attenuate this process.  Western blotting showed that ailanthone up-regulated the protein expression levels of beclin-1 and LC3-II and down-regulated those of LC3-I and p62 in a dose-dependent manner.  Use of BaF-A1 showed that the anti-proliferative effects of ailanthone on HL-60 cells may be partly attributable to the induction of autophagy-mediated apoptosis by MTT assay and annexin V-APC/7-ADD staining assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIKBh_sM1AHpNiNltV31zlfW6udTcc2ea0VDlinkvDfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3gtFaisg%253D%253D&md5=9930c1e9089dae05f5812d20b0d3801d</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.9101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.9101%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DZ.%26atitle%3DAilanthone%2520induces%2520autophagic%2520and%2520apoptotic%2520cell%2520death%2520in%2520human%2520promyelocytic%2520leukemia%2520HL-60%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D3569%26epage%3D3576%26doi%3D10.3892%2Fol.2018.9101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, T.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of novel ailanthone derivatives in vitro and in vivo</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">579</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=3178149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL1MXjtlCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1988&pages=573-579&author=T.+Katoauthor=Y.+Suzumuraauthor=M.+Fukushimaauthor=T.+Hondaauthor=T.+Nakanishiauthor=T.+Noguchi&title=Antitumor+activity+of+novel+ailanthone+derivatives+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of novel ailanthone derivatives in vitro and in vivo</span></div><div class="casAuthors">Kato, Taketoshi; Suzumura, Yasuko; Fukushima, Masanori; Honda, Tadashi; Nakanishi, Toshihiro; Noguchi, Teruhisa</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-9</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    </div><div class="casAbstract">The antitumor activities of 2 ailanthone derivs. SUN 2071 (I) and SUN 0237 (II) were studied.  The cytotoxic activity of II was close to that of bruceantin and vincristine.  I was shown to be a potent inhibitor of protein synthesis in L1210 cultured cells.  When administered i.p. to i.p.-inoculated P388 leukemia mice, daily treatment with I and II increased the lifespan.  These increases were comparable to those achieved with vincristine.  The therapeutic ratio of I was also close to that of vincristine.  However, the compds. were ineffective when administered as a single injection.  Daily i.p. treatment with I demonstrated significant tumor growth inhibition in mice inoculated s.c. with colon-38 and moderate activity against i.p. L1210 leukemia and i.p. B16 melanoma.  The compds. were ineffective when tested against the Lewis lung carcinoma and colon-26.  In a preliminary toxicol. study, I at a therapeutic dose in daily consecutive i.p. injection produced leukopenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_VS2Y53DVU7Vg90H21EOLACvtfcHk0lgcSL55sJO89Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXjtlCjuw%253D%253D&md5=90d9ce05f9ead64c88d0645287725942</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DSuzumura%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520novel%2520ailanthone%2520derivatives%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAnticancer%2520Res.%26date%3D1988%26volume%3D8%26spage%3D573%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span>; <span class="NLM_string-name">Chama, M. A.</span>; <span class="NLM_string-name">Addae-Mensah, I.</span>; <span class="NLM_string-name">Waibel, R.</span></span> <span> </span><span class="NLM_article-title">The Dichapetalins - Unique Cytotoxic Constituents of the Dichapetalaceae</span>; In  <i>Phytochemicals as Nutraceuticals: Global Approaches to Their Role in Nutrition and Health</i>; Ed. <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V.</span></span>; <span class="NLM_publisher-name">InTech</span>: <span class="NLM_publisher-loc">Shanghai</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5772%2F27224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=245-254&author=D.+Osei-Safo&author=M.+A.+Chama&author=I.+Addae-Mensah&author=R.+Waibelauthor=V.+Rao&title=Phytochemicals+as+Nutraceuticals%3A+Global+Approaches+to+Their+Role+in+Nutrition+and+Health"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.5772%2F27224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F27224%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Safo%26aufirst%3DD.%26atitle%3DThe%2520Dichapetalins%2520-%2520Unique%2520Cytotoxic%2520Constituents%2520of%2520the%2520Dichapetalaceae%26btitle%3DPhytochemicals%2520as%2520Nutraceuticals%253A%2520Global%2520Approaches%2520to%2520Their%2520Role%2520in%2520Nutrition%2520and%2520Health%26aulast%3DRao%26aufirst%3DV.%26pub%3DInTech%26date%3D2012%26spage%3D245%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asunka, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, I. V.</span></span> <span> </span><span class="NLM_article-title">Dichapetalin A, a novel plant constituent from <i>Dichapetalum madagascariense</i> with potential antineoplastic activity</span>. <i>Nat. Prod. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1080/10575639508043195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F10575639508043195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XltlGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=93-100&author=H.+Achenbachauthor=S.+A.+Asunkaauthor=R.+Waibelauthor=I.+Addae-Mensahauthor=I.+V.+Oppong&title=Dichapetalin+A%2C+a+novel+plant+constituent+from+Dichapetalum+madagascariense+with+potential+antineoplastic+activity&doi=10.1080%2F10575639508043195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalin A, a novel plant constituent from Dichapetalum madagascariense with potential antineoplastic activity</span></div><div class="casAuthors">Achenbach, H.; Asunka, S. A.; Waibel, R.; Addae-Mensah, I.; Oppong, I. V.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">NPLEEF</span>;
        ISSN:<span class="NLM_cas:issn">1057-5634</span>.
    
            (<span class="NLM_cas:orgname">Harwood</span>)
        </div><div class="casAbstract">From the roots of Dichapetalum madagascariense (Dichapetalaceae) dichapetalin A (I), a plant constituent with a new basic skeleton, has been isolated.  Its structure was elucidated by spectroscopic methods.  In-vitro expts. revealed a strong and selective cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlQ2Ebt__DCbVg90H21EOLACvtfcHk0lgcSL55sJO89Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlGqsLo%253D&md5=af533530a1ed001c4d6080e7a4b65a07</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1080%2F10575639508043195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10575639508043195%26sid%3Dliteratum%253Aachs%26aulast%3DAchenbach%26aufirst%3DH.%26aulast%3DAsunka%26aufirst%3DS.%2BA.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DOppong%26aufirst%3DI.%2BV.%26atitle%3DDichapetalin%2520A%252C%2520a%2520novel%2520plant%2520constituent%2520from%2520Dichapetalum%2520madagascariense%2520with%2520potential%2520antineoplastic%2520activity%26jtitle%3DNat.%2520Prod.%2520Lett.%26date%3D1995%26volume%3D7%26spage%3D93%26epage%3D100%26doi%3D10.1080%2F10575639508043195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weckert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, H.</span></span> <span> </span><span class="NLM_article-title">The absolute configuration of dichapetalin A</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(96)00349-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0031-9422%2896%2900349-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XlvF2gu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1996&pages=657-660&author=E.+Weckertauthor=G.+Matternauthor=I.+Addae-Mensahauthor=R.+Waibelauthor=H.+Achenbach&title=The+absolute+configuration+of+dichapetalin+A&doi=10.1016%2F0031-9422%2896%2900349-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">The absolute configuration of dichapetalin A</span></div><div class="casAuthors">Weckert, Edgar; Mattern, Guenter; Addae-Mensah, Ivan; Waibel, Reiner; Achenbach, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">657-660</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The abs. configuration of dichapetalin A (I), [(4α,6'α,7α,17α,20S,23R,24E)-2',3',5',6'-tetrahydro-7,23,26-trihydroxy-6'-phenyl-13,30-cyclo-29-nordammara-2,11,24-trieno[4,3-c]pyran-21-oic acid γ-lactone], the major cytotoxic constituent from Dichapetalum madagascariense has been established to be 4R,5R,7R,8R,9R,10S,13R,14S,17S,20S,23R,6'S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJntI69Zco9LVg90H21EOLACvtfcHk0lgkvIQ0EulHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvF2gu7k%253D&md5=0f3d2a0e914ebece24d6d5365000da97</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2896%2900349-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252896%252900349-4%26sid%3Dliteratum%253Aachs%26aulast%3DWeckert%26aufirst%3DE.%26aulast%3DMattern%26aufirst%3DG.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAchenbach%26aufirst%3DH.%26atitle%3DThe%2520absolute%2520configuration%2520of%2520dichapetalin%2520A%26jtitle%3DPhytochemistry%26date%3D1996%26volume%3D43%26spage%3D657%26epage%3D660%26doi%3D10.1016%2F0031-9422%2896%2900349-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asunka, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, H.</span></span> <span> </span><span class="NLM_article-title">The dichapetalins - a new class of triterpenoids</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(96)00350-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0031-9422%2896%2900350-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XlvF2gu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1996&pages=649-656&author=I.+Addae-Mensahauthor=R.+Waibelauthor=S.+A.+Asunkaauthor=I.+V.+Oppongauthor=H.+Achenbach&title=The+dichapetalins+-+a+new+class+of+triterpenoids&doi=10.1016%2F0031-9422%2896%2900350-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">The dichapetalins-a new class of triterpenoids</span></div><div class="casAuthors">Addae-Mensah, Ivan; Waibel, Reiner; Asunka, Stephen A.; Oppong, Isaac V.; Achenbach, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-656</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The isolation and structure elucidation by spectroscopic methods of dichapetalins B-H from the roots of Dichapetalum madagascariense are described.  These compds. constitute a novel class of triterpenoids.  Previously isolated dichapetalin A shows a strong and selective cytotoxic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOVUNIU0LFj7Vg90H21EOLACvtfcHk0lgkvIQ0EulHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvF2gu7s%253D&md5=5dc500e5615923f2d3b69e398fe4649c</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2896%2900350-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252896%252900350-0%26sid%3Dliteratum%253Aachs%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAsunka%26aufirst%3DS.%2BA.%26aulast%3DOppong%26aufirst%3DI.%2BV.%26aulast%3DAchenbach%26aufirst%3DH.%26atitle%3DThe%2520dichapetalins%2520-%2520a%2520new%2520class%2520of%2520triterpenoids%26jtitle%3DPhytochemistry%26date%3D1996%26volume%3D43%26spage%3D649%26epage%3D656%26doi%3D10.1016%2F0031-9422%2896%2900350-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussagues, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcourt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poughon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalo Mutiso, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ausseil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimondo, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massiot, G.</span></span> <span> </span><span class="NLM_article-title">Dichapetalins from <i>Dichapetalum</i> species and their cytotoxic properties</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2013.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2013.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23618620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVGntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=184-191&author=C.+Longauthor=Y.+Aussaguesauthor=N.+Molinierauthor=L.+Marcourtauthor=L.+Vendierauthor=A.+Samsonauthor=V.+Poughonauthor=P.+B.+Chalo+Mutisoauthor=F.+Ausseilauthor=F.+Sautelauthor=P.+B.+Arimondoauthor=G.+Massiot&title=Dichapetalins+from+Dichapetalum+species+and+their+cytotoxic+properties&doi=10.1016%2Fj.phytochem.2013.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalins from Dichapetalum species and their cytotoxic properties</span></div><div class="casAuthors">Long, Christophe; Aussagues, Yannick; Molinier, Nicolas; Marcourt, Laurence; Vendier, Laure; Samson, Arnaud; Poughon, Valerie; Chalo Mutiso, Patrick B.; Ausseil, Frederic; Sautel, Francois; Arimondo, Paola B.; Massiot, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">184-191</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Six dichapetalins named dichapetalins N-S were isolated from Dichapetalum mombuttense, Dichapetalum zenkeri and Dichapetalum leucosia.  They were accompanied in the same plants by the known dichapetalins A, B, C, I, L and M.  The structures of the compds. were elucidated by 1D and 2D NMR expts. and mass spectrometry.  They all possessed the dammarane skeleton substituted at position C-3 by a C6-C2 unit forming a 2-phenylpyran moiety.  All contained a lactone ring in the side chain except dichapetalins O, Q and R, in which this ring was replaced by a lactol.  Dichapetalin Q and R were also the first dichapetalins bearing a tertiary Me and a double bond instead of the cyclopropane of the dammaranes.  All these compds. were assayed against cancer cell lines HCT116 and WM 266-4 and displayed cytotoxic and anti-proliferative activities in the 10-6 to 10-8 M range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolD3Uk1gkc-LVg90H21EOLACvtfcHk0lhxUFpKpvCnLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVGntrs%253D&md5=036c3c30814c5778e96822d1a6baa936</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2013.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2013.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DC.%26aulast%3DAussagues%26aufirst%3DY.%26aulast%3DMolinier%26aufirst%3DN.%26aulast%3DMarcourt%26aufirst%3DL.%26aulast%3DVendier%26aufirst%3DL.%26aulast%3DSamson%26aufirst%3DA.%26aulast%3DPoughon%26aufirst%3DV.%26aulast%3DChalo%2BMutiso%26aufirst%3DP.%2BB.%26aulast%3DAusseil%26aufirst%3DF.%26aulast%3DSautel%26aufirst%3DF.%26aulast%3DArimondo%26aufirst%3DP.%2BB.%26aulast%3DMassiot%26aufirst%3DG.%26atitle%3DDichapetalins%2520from%2520Dichapetalum%2520species%2520and%2520their%2520cytotoxic%2520properties%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D94%26spage%3D184%26epage%3D191%26doi%3D10.1016%2Fj.phytochem.2013.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madulid, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveros, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orjala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordell, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic constituents from the stem bark of <i>Dichapetalum gelonioides</i> collected in the Philippines</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1021/np058083q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np058083q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWmu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=332-337&author=L.+Fangauthor=A.+Itoauthor=H.-B.+Chaiauthor=Q.+Miauthor=W.+P.+Jonesauthor=D.+R.+Madulidauthor=M.+B.+Oliverosauthor=Q.+Gaoauthor=J.+Orjalaauthor=N.+R.+Farnsworthauthor=D.+D.+Soejartoauthor=G.+A.+Cordellauthor=S.+M.+Swansonauthor=J.+M.+Pezzutoauthor=A.+D.+Kinghorn&title=Cytotoxic+constituents+from+the+stem+bark+of+Dichapetalum+gelonioides+collected+in+the+Philippines&doi=10.1021%2Fnp058083q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Constituents from the Stem Bark of Dichapetalum gelonioides Collected in the Philippines</span></div><div class="casAuthors">Fang, Liqiong; Ito, Aiko; Chai, Hee-Byung; Mi, Qiuwen; Jones, William P.; Madulid, Domingo R.; Oliveros, Mildred B.; Gao, Qi; Orjala, Jimmy; Farnsworth, Norman R.; Soejarto, Djaja D.; Cordell, Geoffrey A.; Swanson, Steven M.; Pezzuto, John M.; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">332-337</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Fractionation of an Et acetate-sol. ext. of the stem bark of Dichapetalum gelonioides, collected in the Philippines, using the LNCaP (hormone-dependent human prostate) cell line as a monitor, led to the purifn. of three dichapetalin-type triterpenoids [dichapetalins A (1), I (2), and J (3)], along with two dolabrane norditerpenoids (6, 7), and the addnl. triterpenoids zeylanol (8), 28-hydroxyzeylanol (9), and betulinic acid.  Since compds. 1-3 exhibited promising selectivity against the SW626 (human ovarian cancer) cell line, a re-collection of the plant material was carried out, to obtain more of these compds. for addnl. biol. testing.  Two further phenylpyranotriterpenoids [dichapetalins K (4) and L (5)] were isolated from the re-collected plant material.  The structures of the new compds. 2-5 and 9 were detd. on the basis of spectroscopic data interpretation, and the relative configuration of 6 was confirmed using X-ray crystallog.  Compds. 4-6 and the Me ester, 6a, exhibited broad cytotoxic activity when tested against a panel of human tumor cell lines.  Dichapetalin A (1) was not active when evaluated in an in vivo hollow fiber assay in the dose range 1-6 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTeU7vOBs7l7Vg90H21EOLACvtfcHk0lhxUFpKpvCnLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWmu7zM&md5=258501544419568de5e342dda723eca8</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Fnp058083q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp058083q%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DMi%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DW.%2BP.%26aulast%3DMadulid%26aufirst%3DD.%2BR.%26aulast%3DOliveros%26aufirst%3DM.%2BB.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DOrjala%26aufirst%3DJ.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DCordell%26aufirst%3DG.%2BA.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCytotoxic%2520constituents%2520from%2520the%2520stem%2520bark%2520of%2520Dichapetalum%2520gelonioides%2520collected%2520in%2520the%2520Philippines%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2006%26volume%3D69%26spage%3D332%26epage%3D337%26doi%3D10.1021%2Fnp058083q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziwornu, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appiah-Opong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chama, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuffour, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amewu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span> <span> </span><span class="NLM_article-title">Constituents of the roots of <i>Dichapetalum pallidum</i> and their anti-proliferative activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">532</span>, <span class="refDoi"> DOI: 10.3390/molecules22040532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules22040532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGqsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=532&author=D.+Osei-Safoauthor=G.+A.+Dziwornuauthor=R.+Appiah-Opongauthor=M.+A.+Chamaauthor=I.+Tuffourauthor=R.+Waibelauthor=R.+Amewuauthor=I.+Addae-Mensah&title=Constituents+of+the+roots+of+Dichapetalum+pallidum+and+their+anti-proliferative+activity&doi=10.3390%2Fmolecules22040532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Constituents of the roots of Dichapetalum pallidum and their anti-proliferative activity</span></div><div class="casAuthors">Osei-Safo, Dorcas; Dziwornu, Godwin Akpeko; Appiah-Opong, Regina; Chama, Mary Anti; Tuffour, Isaac; Waibel, Reiner; Amewu, Richard; Addae-Mensah, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">532/1-532/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">As part of our search for bioactive compds. from the Dichapetalaceae, repeated chromatog. purifn. of the roots of a hitherto unexamd. species, Dichapetalum pallidum, led to the isolation of the newly occurring 7-hydroxydichapetalin P (1) and the known dichapetalins A (2) and X (3).  Also isolated were the known compds. friedelin-2,3-lactone (4), friedelan-3-one (6), friedelan-3β-ol (7) and pomolic (8), as well as the dipeptide aurantiamide acetate (5).  The compds. were characterized by direct interpretation of their IR, 1D NMR and 2D NMR spectral data and by comparison of their physico-chem. data, including their chromatog. profiles, with the literature and authentic samples in our compd. library for the genus Dichapetalum.  The compds. were assayed for their anti-proliferative activities against the human T-lymphocytic leukemia (Jurkat), acute promyelocytic leukemia (HL-60) and T-lymphoblast-like leukemia (CEM) cell lines.  Overall, dichapetalin X showed the strongest (3.14 μM) and broadest cytotoxic activities against all the leukemic cell lines tested, exhibiting even stronger activities than the std. compd., curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXYp5G-ekZoLVg90H21EOLACvtfcHk0lhPDvxCkF-MmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGqsrrE&md5=89aca8b55a0dad1f417f6a05f81dba9a</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22040532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22040532%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Safo%26aufirst%3DD.%26aulast%3DDziwornu%26aufirst%3DG.%2BA.%26aulast%3DAppiah-Opong%26aufirst%3DR.%26aulast%3DChama%26aufirst%3DM.%2BA.%26aulast%3DTuffour%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAmewu%26aufirst%3DR.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26atitle%3DConstituents%2520of%2520the%2520roots%2520of%2520Dichapetalum%2520pallidum%2520and%2520their%2520anti-proliferative%2520activity%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D532%26doi%3D10.3390%2Fmolecules22040532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagasabai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninh, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalowich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and natural killer cell stimulatory constituents of <i>Phyllanthus songboiensis</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2014.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2014.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25596805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2015&pages=132-140&author=Y.+Renauthor=C.+Yuanauthor=Y.+Dengauthor=R.+Kanagasabaiauthor=T.+N.+Ninhauthor=V.+T.+Tuauthor=H.-B.+Chaiauthor=D.+D.+Soejartoauthor=J.+R.+Fuchsauthor=J.+C.+Yalowichauthor=J.+Yuauthor=A.+D.+Kinghorn&title=Cytotoxic+and+natural+killer+cell+stimulatory+constituents+of+Phyllanthus+songboiensis&doi=10.1016%2Fj.phytochem.2014.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis</span></div><div class="casAuthors">Ren, Yulin; Yuan, Chunhua; Deng, Youcai; Kanagasabai, Ragu; Ninh, Tran Ngoc; Tu, Vuong Tan; Chai, Hee-Byung; Soejarto, Djaja D.; Fuchs, James R.; Yalowich, Jack C.; Yu, Jianhua; Douglas Kinghorn, A.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-140</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A dichapetalin-type triterpenoid and a dibenzylbutyrolactone-type lignan, together with five known lignans, a known arom. diterpenoid, and a known acylated phytosterol, were isolated from the aerial parts of Phyllanthus songboiensis, collected in Vietnam.  Their structures were detd. by interpretation of the spectroscopic data, and the inhibitory activity toward HT-29 human colon cancer cells of all isolates was evaluated by a cytotoxicity assay.  The known arylnaphthalene lignan, (+)-acutissimalignan A, was highly cytotoxic toward HT-29 cells, with an IC50 value of 19 nM, but this compd. was inactive as a DNA topoisomerase IIα (topo IIα) poison.  The known phytosterol, (-)-β-sitosterol-3-O-β-D-(6-O-palmitoyl)glucopyranoside, was found to stimulate natural killer (NK) cells at a concn. of 10 μM in the presence of interleukin 12 (IL-12).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHuti1QSS3rVg90H21EOLACvtfcHk0lhPDvxCkF-MmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVGhsQ%253D%253D&md5=f11415045ccf37238a5f2a1a59e00b05</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2014.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2014.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DKanagasabai%26aufirst%3DR.%26aulast%3DNinh%26aufirst%3DT.%2BN.%26aulast%3DTu%26aufirst%3DV.%2BT.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DYalowich%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCytotoxic%2520and%2520natural%2520killer%2520cell%2520stimulatory%2520constituents%2520of%2520Phyllanthus%2520songboiensis%26jtitle%3DPhytochemistry%26date%3D2015%26volume%3D111%26spage%3D132%26epage%3D140%26doi%3D10.1016%2Fj.phytochem.2014.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref263"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref263'); return false;" data-citation="" class="refNumLink">263</a></strong><div class="NLM_citation" id="cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chama, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziwornu, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otchere, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span> <span> </span><span class="NLM_article-title">Isolation, characterization, and anthelminthic activities of a novel dichapetalin and other constituents of <i>Dichapetalum filicaule</i></span>. <i>Pharm. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.3109/13880209.2015.1059861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3109%2F13880209.2015.1059861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26118692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVynu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=1179-1188&author=M.+A.+Chamaauthor=G.+A.+Dziwornuauthor=R.+Waibelauthor=D.+Osei-Safoauthor=I.+Addae-Mensahauthor=J.+Otchereauthor=M.+Wilson&title=Isolation%2C+characterization%2C+and+anthelminthic+activities+of+a+novel+dichapetalin+and+other+constituents+of+Dichapetalum+filicaule&doi=10.3109%2F13880209.2015.1059861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, characterization, and anthelminthic activities of a novel dichapetalin and other constituents of Dichapetalum filicaule</span></div><div class="casAuthors">Chama, Mary Anti; Dziwornu, Godwin Akpeko; Waibel, Reiner; Osei-Safo, Dorcas; Addae-Mensah, Ivan; Otchere, Joseph; Wilson, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Biology (Abingdon, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1179-1188</span>CODEN:
                <span class="NLM_cas:coden">PHBIFC</span>;
        ISSN:<span class="NLM_cas:issn">1388-0209</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Context: Dichapetalum filicaule Breteler (Dichapetalaceae) is a rare species occurring only in Cote d'Ivoire and Ghana.  Although research on several species of the genus has produced interesting bioactive compds., particularly the Dichapetalins, a novel class of triterpenoids with antineoplastic properties, there is virtually no information on the ethnobotanical uses and chem. constituents of D. filicaule.  Objective: The phytochem. and anthelminthic activities of the constituents of D. filicaule were investigated.  Materials and methods: Chem. constituents of the petroleum ether, chloroform-acetone, and methanol root exts. of D. filicaule were isolated by column chromatog. and characterized by their physico-chem. properties, 1-D and 2-D NMR spectroscopy and mass spectrometry.  In vitro anthelminthic activity of the exts. and compds. against the human hookworm, Necator americanus, Stiles 1902 (Nematoda: Ancylostomatidae) was detd. within a concn. range of 2500-250 μg/mL using the Egg Hatch Inhibition (EHI) Assay.  The hookworm species were identified using a published polymerase chain reaction (PCR) method.  Results: A new dichapetalin, dichapetalin X (), together with the known dichapetalin A (), pomolic acid (), glycerol monostearate (), D:A-friedooleanan-3β-ol (), and D:A-friedooleanan-3-one () were isolated.  Compds. , , and exhibited EHI with IC50 values of 523.2, 162.4, and 306.0 μg/mL, resp., against the hookworm.  The pos. control albendazole gave an IC50 value of 93.27 μg/mL.  Discussion and conclusion: This is the first report of the phytochem. investigation of D. filicaule.  The study has yielded a new dichapetalin and also demonstrated the potential anthelminthic properties of the constituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtqhqXMZK3H7Vg90H21EOLACvtfcHk0lgpyDiVEBjNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVynu7fP&md5=bc03e95c4fd3a3f5b59629c2231f6afe</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.3109%2F13880209.2015.1059861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F13880209.2015.1059861%26sid%3Dliteratum%253Aachs%26aulast%3DChama%26aufirst%3DM.%2BA.%26aulast%3DDziwornu%26aufirst%3DG.%2BA.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DOsei-Safo%26aufirst%3DD.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DOtchere%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DM.%26atitle%3DIsolation%252C%2520characterization%252C%2520and%2520anthelminthic%2520activities%2520of%2520a%2520novel%2520dichapetalin%2520and%2520other%2520constituents%2520of%2520Dichapetalum%2520filicaule%26jtitle%3DPharm.%2520Biol.%26date%3D2016%26volume%3D54%26spage%3D1179%26epage%3D1188%26doi%3D10.3109%2F13880209.2015.1059861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref264"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref264'); return false;" data-citation="" class="refNumLink">264</a></strong><div class="NLM_citation" id="cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chama, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asomaning, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, I. V.</span></span> <span> </span><span class="NLM_article-title">Dichapetalin M from <i>Dichapetalum madagascariensis</i></span>. <i>Phytochem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/j.phytol.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytol.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsF2qtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=147-150&author=D.+Osei-Safoauthor=M.+A.+Chamaauthor=I.+Addae-Mensahauthor=R.+Waibelauthor=W.+A.+Asomaningauthor=I.+V.+Oppong&title=Dichapetalin+M+from+Dichapetalum+madagascariensis&doi=10.1016%2Fj.phytol.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalin M from Dichapetalum madagascariensis</span></div><div class="casAuthors">Osei-Safo, Dorcas; Chama, Mary A.; Addae-Mensah, Ivan; Waibel, Reiner; Asomaning, William A.; Oppong, Isaac V.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-150</span>CODEN:
                <span class="NLM_cas:coden">PLHEBK</span>;
        ISSN:<span class="NLM_cas:issn">1874-3900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The roots of Dichapetalum madagascariensis have yielded the new dichapetalin M, together with the previously reported dichapetalin A.  This brings to nine, the total no. of dichapetalins so far isolated from the roots of the plant, and to thirteen, the total no. of dichapetalins isolated from the Dichapetalaceae.  Dichapetalin M exhibited greater toxicity towards brine shrimp larvae than dichapetalin A, which has demonstrated cell inhibition against various cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNHmg0oE-UTrVg90H21EOLACvtfcHk0lgpyDiVEBjNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsF2qtL8%253D&md5=c4c1db359cd9080b9677963479200660</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1016%2Fj.phytol.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytol.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Safo%26aufirst%3DD.%26aulast%3DChama%26aufirst%3DM.%2BA.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAsomaning%26aufirst%3DW.%2BA.%26aulast%3DOppong%26aufirst%3DI.%2BV.%26atitle%3DDichapetalin%2520M%2520from%2520Dichapetalum%2520madagascariensis%26jtitle%3DPhytochem.%2520Lett.%26date%3D2008%26volume%3D1%26spage%3D147%26epage%3D150%26doi%3D10.1016%2Fj.phytol.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref265"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref265'); return false;" data-citation="" class="refNumLink">265</a></strong><div class="NLM_citation" id="cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jing, S.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-H.</span></span> <span> </span><span class="NLM_article-title">Biologically active dichapetalins from <i>Dichapetalum gelonioides</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1021/np400971r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400971r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=882-893&author=S.-X.+Jingauthor=S.-H.+Luoauthor=C.-H.+Liauthor=J.+Huaauthor=Y.-L.+Wangauthor=X.-M.+Niuauthor=X.-N.+Liauthor=Y.+Liuauthor=C.-S.+Huangauthor=Y.+Wangauthor=S.-H.+Li&title=Biologically+active+dichapetalins+from+Dichapetalum+gelonioides&doi=10.1021%2Fnp400971r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Biologically active dichapetalins from Dichapetalum gelonioides</span></div><div class="casAuthors">Jing, Shu-Xi; Luo, Shi-Hong; Li, Chun-Huan; Hua, Juan; Wang, Yan-Li; Niu, Xue-Mei; Li, Xiao-Nian; Liu, Yan; Huang, Chun-Shuai; Wang, Ying; Li, Sheng-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">882-893</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A phytochem. investigation of the toxic tropical plant Dichapetalum gelonioides led to the isolation and identification of 14 new dichapetalins (1-14) and the known dichapetalins A (15) and K (16).  The structures of the new compds. were detd. by analyses of their NMR, MS, electronic CD, and X-ray diffraction data.  The esterification at C-25 by 4-hydroxyphenylpropanoic acid and the hydroxylation at C-2' are unique in this unusual class of natural products.  In addn. to the known cytotoxicity, an array of biol. activities, including antifeedant, nematicidal, antifungal, and NO and AChE inhibitory activities, were obsd. for this class of compds.  These findings suggested that dichapetalin hybrid triterpenoids as a class have broad biol. active cellular functions, including defense against insect herbivores and pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojE8l1aJuPA7Vg90H21EOLACvtfcHk0lgpyDiVEBjNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqtrw%253D&md5=32550cd0a89c4c2a5b10e33836833f6a</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1021%2Fnp400971r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400971r%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DS.-X.%26aulast%3DLuo%26aufirst%3DS.-H.%26aulast%3DLi%26aufirst%3DC.-H.%26aulast%3DHua%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-L.%26aulast%3DNiu%26aufirst%3DX.-M.%26aulast%3DLi%26aufirst%3DX.-N.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DC.-S.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-H.%26atitle%3DBiologically%2520active%2520dichapetalins%2520from%2520Dichapetalum%2520gelonioides%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D882%26epage%3D893%26doi%3D10.1021%2Fnp400971r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref266"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref266'); return false;" data-citation="" class="refNumLink">266</a></strong><div class="NLM_citation" id="cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuchinda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornsakulkarn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohmakotr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongsaeree, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabpai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoosook, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasisit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napaswad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sophasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutrakul, V.</span></span> <span> </span><span class="NLM_article-title">Dichapetalin-type triterpenoids and lignans from the aerial parts of <i>Phyllanthus acutissima</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/np7007347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np7007347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitValsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=655-663&author=P.+Tuchindaauthor=J.+Kornsakulkarnauthor=M.+Pohmakotrauthor=P.+Kongsaereeauthor=S.+Prabpaiauthor=C.+Yoosookauthor=J.+Kasisitauthor=C.+Napaswadauthor=S.+Sophasanauthor=V.+Reutrakul&title=Dichapetalin-type+triterpenoids+and+lignans+from+the+aerial+parts+of+Phyllanthus+acutissima&doi=10.1021%2Fnp7007347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalin-Type Triterpenoids and Lignans from the Aerial Parts of Phyllanthus acutissima</span></div><div class="casAuthors">Tuchinda, Patoomratana; Kornsakulkarn, Jittra; Pohmakotr, Manat; Kongsaeree, Palangpon; Prabpai, Samran; Yoosook, Chalobon; Kasisit, Jitra; Napaswad, Chanita; Sophasan, Samaisukh; Reutrakul, Vichai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-663</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Chem. investigation of the aerial parts of Phyllanthus acutissima resulted in the isolation of five new dichapetalin-type triterpenoids, acutissimatriterpenes A(I)-E, and two new lignans, acutissimalignans A (II) and B, along with two known lignans and three known ellagic acid derivs.  The structures of 1-7 were detd. mainly on the basis of spectroscopic methods.  The compds. obtained were evaluated for cytotoxic and anti-HIV-1 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYzX18v_w1LVg90H21EOLACvtfcHk0lgXANrNn8J5ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitValsr4%253D&md5=f5a09a15d3c0afb8c035e7cda201f38f</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1021%2Fnp7007347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp7007347%26sid%3Dliteratum%253Aachs%26aulast%3DTuchinda%26aufirst%3DP.%26aulast%3DKornsakulkarn%26aufirst%3DJ.%26aulast%3DPohmakotr%26aufirst%3DM.%26aulast%3DKongsaeree%26aufirst%3DP.%26aulast%3DPrabpai%26aufirst%3DS.%26aulast%3DYoosook%26aufirst%3DC.%26aulast%3DKasisit%26aufirst%3DJ.%26aulast%3DNapaswad%26aufirst%3DC.%26aulast%3DSophasan%26aufirst%3DS.%26aulast%3DReutrakul%26aufirst%3DV.%26atitle%3DDichapetalin-type%2520triterpenoids%2520and%2520lignans%2520from%2520the%2520aerial%2520parts%2520of%2520Phyllanthus%2520acutissima%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26spage%3D655%26epage%3D663%26doi%3D10.1021%2Fnp7007347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref267"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref267'); return false;" data-citation="" class="refNumLink">267</a></strong><div class="NLM_citation" id="cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tundis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loizzo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menichini, F.</span></span> <span> </span><span class="NLM_article-title">An overview on chemical aspects and potential health benefits of limonoids and their derivatives</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1080/10408398.2011.581400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F10408398.2011.581400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24188270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaitb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=225-250&author=R.+Tundisauthor=M.+R.+Loizzoauthor=F.+Menichini&title=An+overview+on+chemical+aspects+and+potential+health+benefits+of+limonoids+and+their+derivatives&doi=10.1080%2F10408398.2011.581400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview on Chemical Aspects and Potential Health Benefits of Limonoids and Their Derivatives</span></div><div class="casAuthors">Tundis, Rosa; Loizzo, Monica Rosa; Menichini, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-250</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Limonoids are heavily oxygenated, modified triterpenes dominant in Meliaceae and Rutaceae plant families.  The term limonoid' is derived from limonin, which was first identified as the bitter constituent of Citrus seeds in 1841.  This group of secondary metabolites exhibits a wide range of biol. properties, including anticancer, antibacterial, antifungal, antimalarial, and antiviral activities.  Significant progress on the role of limonoids as promising candidates for cancer chemoprevention and/or therapy has been achieved in particular in recent years.  The aim of this review article is to discuss the recent developments on limonoids chem. aspects and biol. activities with the relationship between structure and activity, supporting the new possibilities for the medicinal and/or nutraceutical use of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzFIz5DA-A37Vg90H21EOLACvtfcHk0lgXANrNn8J5ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaitb%252FE&md5=418bea3e794c8a1b46303cd7536dc638</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1080%2F10408398.2011.581400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408398.2011.581400%26sid%3Dliteratum%253Aachs%26aulast%3DTundis%26aufirst%3DR.%26aulast%3DLoizzo%26aufirst%3DM.%2BR.%26aulast%3DMenichini%26aufirst%3DF.%26atitle%3DAn%2520overview%2520on%2520chemical%2520aspects%2520and%2520potential%2520health%2520benefits%2520of%2520limonoids%2520and%2520their%2520derivatives%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2014%26volume%3D54%26spage%3D225%26epage%3D250%26doi%3D10.1080%2F10408398.2011.581400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref268"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref268'); return false;" data-citation="" class="refNumLink">268</a></strong><div class="NLM_citation" id="cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, M.</span></span> <span> </span><span class="NLM_article-title">Structure of limonin</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>C46</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1107/S0108270189007225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270189007225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK3cXkslyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C46&publication_year=1990&pages=425-427&author=K.+Takahashiauthor=M.+Obayashiauthor=M.+Nakatani&title=Structure+of+limonin&doi=10.1107%2FS0108270189007225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of limonin</span></div><div class="casAuthors">Takahashi, K.; Obayashi, M.; Nakatani, M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C:  Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">C46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">425-7</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    </div><div class="casAbstract">The mol. structure of limonin, the bitter principle of citrus fruits, was detd. by x-ray diffraction methods.  The structure was essentially the same as epilimonol iodoacetate, the heavy-atom deriv. of limonin.  A structure energy calcn. (MMP2) for limonin yields the same structure as that of the x-ray anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuhmlnCcjZGrVg90H21EOLACvtfcHk0lj6BRluuiJq9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslyksLc%253D&md5=39fb184a82a79c13d201b983268d8670</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1107%2FS0108270189007225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270189007225%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DObayashi%26aufirst%3DM.%26aulast%3DNakatani%26aufirst%3DM.%26atitle%3DStructure%2520of%2520limonin%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D1990%26volume%3DC46%26spage%3D425%26epage%3D427%26doi%3D10.1107%2FS0108270189007225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref269"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref269'); return false;" data-citation="" class="refNumLink">269</a></strong><div class="NLM_citation" id="cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, D. G.</span></span> <span> </span><span class="NLM_article-title">The structure of limonin: X-ray analysis of epilimonol iodoacetate</span>. <i>J. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_fpage">4183</span>– <span class="NLM_lpage">4200</span>, <span class="refDoi"> DOI: 10.1039/jr9610004183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fjr9610004183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF38XisV2rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1961&pages=4183-4200&author=S.+Arnottauthor=A.+W.+Davieauthor=J.+M.+Robertsonauthor=G.+A.+Simauthor=D.+G.+Watson&title=The+structure+of+limonin%3A+X-ray+analysis+of+epilimonol+iodoacetate&doi=10.1039%2Fjr9610004183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of limonin. X-ray analysis of epilimonol iodoacetate</span></div><div class="casAuthors">Arnott, S.; Davie, A. W.; Robertson, J. Monteath; Sim, G. A.; Watson, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4183-200</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">The structure of limonin (I) was detd. from study of the title deriv., whose crystals were monoclinic, space group C22-P21, with 4 mols./unit cell.  The asym. crystal unit had 2 mols.  Full 3-dimensional analysis gave the structure of I as shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolsoxl-t0kErVg90H21EOLACvtfcHk0lj6BRluuiJq9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38XisV2rug%253D%253D&md5=306db50c219d92a0d4f92c2ae7c26af9</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1039%2Fjr9610004183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9610004183%26sid%3Dliteratum%253Aachs%26aulast%3DArnott%26aufirst%3DS.%26aulast%3DDavie%26aufirst%3DA.%2BW.%26aulast%3DRobertson%26aufirst%3DJ.%2BM.%26aulast%3DSim%26aufirst%3DG.%2BA.%26aulast%3DWatson%26aufirst%3DD.%2BG.%26atitle%3DThe%2520structure%2520of%2520limonin%253A%2520X-ray%2520analysis%2520of%2520epilimonol%2520iodoacetate%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1961%26spage%3D4183%26epage%3D4200%26doi%3D10.1039%2Fjr9610004183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref270"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref270'); return false;" data-citation="" class="refNumLink">270</a></strong><div class="NLM_citation" id="cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, O. H.</span></span> <span> </span><span class="NLM_article-title">The bitter principles of citrus fruit. I. Isolation of nomilin, a new bitter principle from the seeds of oranges and lemons</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1948</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1021/ja01182a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01182a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaH1cXhsVenug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1948&pages=545-549&author=O.+H.+Emerson&title=The+bitter+principles+of+citrus+fruit.+I.+Isolation+of+nomilin%2C+a+new+bitter+principle+from+the+seeds+of+oranges+and+lemons&doi=10.1021%2Fja01182a034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Bitter principles in citrus fruit. I. Isolation of nomilin, a new bitter principle from the seeds of oranges and lemons</span></div><div class="casAuthors">Emerson, Oliver H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1948</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Immature navel oranges (140 lb.) yielded 5 gallons of juice from which 1.58 g. limonin (I) was isolated.  I forms a complex with 1 mol. CH2Cl2, which is lost in the air.  Valencia orange seeds (22 lb.) yield 40 g. I.  The CH2Cl2EtOH mother liquors from I give a mixt. of I and nomilin (II), C28H34O9, from which iso-PrOH exts. II, m. 278-9° (decompn.), [α]D23 -95.7° (298.9 mg. in 25 ml. Me2CO); the yield from 37 lb. orange seeds is 14 g.  I and II can be isolated also from lemon seed.  II contains 1 OH group that reacts with MeMgI but not readily with Ac2O.  II (237 mg.) and 40 ml. 0.1 N NaOH, heated 30 min. on the steam bath, give 88% nomilic acid (III), C26H32O8, m. 208-9°; AcOH is also formed.  In contrast to I, II does not yield appreciable quantities of Me2CO on fusion with KOH.  I and NH2OH yield an oxime, m. 260-70° (decompn.); the product from II could not be crystd.  The absorption spectra of I, II, and III in EtOH are given.  The intensification of the absorption and the shift toward the visible suggest a greater degree of conjugation in III than exists in I or II.  The absorption spectra of I and II are very similar.  The alc. mother liquor of I from 22 lb. of orange seeds yields 500 mg. of a compd. (C9H12O4)x(?), m. 315° (decompn.).  The nonbitter precursor of I in navel orange juice behaves like the diacid obtained by opening both lactone rings but it is possible that the precursor may be a lactone acid or a compd. of the diacid or lactone acid such as a glycoside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2I97uJbp6bVg90H21EOLACvtfcHk0lj6BRluuiJq9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH1cXhsVenug%253D%253D&md5=530146f6724d78d9322daaaa8e3b9714</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1021%2Fja01182a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01182a034%26sid%3Dliteratum%253Aachs%26aulast%3DEmerson%26aufirst%3DO.%2BH.%26atitle%3DThe%2520bitter%2520principles%2520of%2520citrus%2520fruit.%2520I.%2520Isolation%2520of%2520nomilin%252C%2520a%2520new%2520bitter%2520principle%2520from%2520the%2520seeds%2520of%2520oranges%2520and%2520lemons%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1948%26volume%3D70%26spage%3D545%26epage%3D549%26doi%3D10.1021%2Fja01182a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref271"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref271'); return false;" data-citation="" class="refNumLink">271</a></strong><div class="NLM_citation" id="cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, H. L.</span></span> <span> </span><span class="NLM_article-title">The identity of obaculactone, evodin and dictamnolactone with limonin</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1940</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1307</span>– <span class="NLM_lpage">1309</span>, <span class="refDoi"> DOI: 10.1021/ja01862a509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01862a509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaH3cXktFWqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1940&pages=1307-1309&author=M.+S.+Schechterauthor=H.+L.+Haller&title=The+identity+of+obaculactone%2C+evodin+and+dictamnolactone+with+limonin&doi=10.1021%2Fja01862a509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Identity of obaculactone, evodin and dictamnolactone with limonin</span></div><div class="casAuthors">Schechter, Milton S.; Haller, H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1940</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1307-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Obaculactone (C. A. 25, 4870), evodin (J. Pharm. Soc. Japan No. 248, 979(1902)), dictamnolactone (C. A. 17, 2583), limonin and citrolimonin (C. A. 30, 5586.5) are the same compd., for which the name limonin is proposed, since it was given this name by Bernay (Ann. 40, 317(1841)).  Values for nα and nγ 1.563 and 1.582; nβ is indeterminate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXMegGGRgTJbVg90H21EOLACvtfcHk0lhlZ0LNWUhI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH3cXktFWqsQ%253D%253D&md5=196793d7285f0484f6afc471bc617c4a</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1021%2Fja01862a509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01862a509%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DM.%2BS.%26aulast%3DHaller%26aufirst%3DH.%2BL.%26atitle%3DThe%2520identity%2520of%2520obaculactone%252C%2520evodin%2520and%2520dictamnolactone%2520with%2520limonin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1940%26volume%3D62%26spage%3D1307%26epage%3D1309%26doi%3D10.1021%2Fja01862a509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref272"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref272'); return false;" data-citation="" class="refNumLink">272</a></strong><div class="NLM_citation" id="cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells</span>. <i>Food Funct.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1039/C2FO30209H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC2FO30209H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23117440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=258-265&author=J.+Kimauthor=G.+K.+Jayaprakashaauthor=B.+S.+Patil&title=Limonoids+and+their+anti-proliferative+and+anti-aromatase+properties+in+human+breast+cancer+cells&doi=10.1039%2FC2FO30209H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells</span></div><div class="casAuthors">Kim, Jinhee; Jayaprakasha, Guddadarangavvanahally K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Food & Function</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">258-265</span>CODEN:
                <span class="NLM_cas:coden">FFOUAI</span>;
        ISSN:<span class="NLM_cas:issn">2042-6496</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Lemons are a widely used citrus crop and have shown several potential health benefits.  In the present study, the mechanism and effectiveness of the anti-cancer and anti-aromatase properties of limonoids were investigated for the first time.  Defatted lemon (Citrus lemon L. Burm) seed powder was extd. with Et acetate (EtOAc) and methanol (MeOH) for 16 h each, successively.  These exts. were fractionated using 1D (silica) and 2D (ion exchange and SP-70 columns) column chromatog. to obtain nine limonoids.  The compds. were identified by TLC, HPLC, and LC-MS techniques.  A panel of 9 purified limonoids, including limonin, nomilin, obacunone, limonexic acid (LNA), isolimonexic acid (ILNA), nomilinic acid glucoside (NAG), deacetyl nomilinic acid glucoside (DNAG), limonin glucoside (LG) and obacunone glucoside (OG) as well as 4 modified compds. such as limonin methoxime (LM), limonin oxime (LO), defuran limonin (DL), and defuran nomilin (DN), were screened for their cytotoxicity on estrogen receptor (ER)-pos. (MCF-7) or ER-neg. (MDA-MB-231) human breast cancer cells.  We further tested the mechanism of the anti-proliferative activity of limonoids using an in vitro aromatase enzyme assay and western blot with anti-caspase-7.  Among the tested limonoids, 11 limonoids exhibited cytotoxicity on MCF-7 whereas 8 limonoids showed cytotoxicity against the MDA-MB-231 cell lines.  Although most of the limonoids showed anti-aromatase activity, the inhibition of proliferation was not related to the anti-aromatase activity.  On the other hand, the anti-proliferative activity was significantly correlated with caspase-7 activation by limonoids.  Our findings indicated that the citrus limonoids may have potential for the prevention of estrogen-responsive breast cancer (MCF-7) via caspase-7 dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjjTcA3X49u7Vg90H21EOLACvtfcHk0lhlZ0LNWUhI5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCitLY%253D&md5=eb49eab14311108ca08a7620cf081cdc</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1039%2FC2FO30209H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2FO30209H%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DLimonoids%2520and%2520their%2520anti-proliferative%2520and%2520anti-aromatase%2520properties%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DFood%2520Funct.%26date%3D2013%26volume%3D4%26spage%3D258%26epage%3D265%26doi%3D10.1039%2FC2FO30209H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref273"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref273'); return false;" data-citation="" class="refNumLink">273</a></strong><div class="NLM_citation" id="cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span> <span> </span><span class="NLM_article-title">Limonin: A review of its pharmacology, toxicity, and pharmacokinetics</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3679</span>, <span class="refDoi"> DOI: 10.3390/molecules24203679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules24203679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1yisb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=3679&author=S.+Fanauthor=C.+Zhangauthor=T.+Luoauthor=J.+Wangauthor=Y.+Tangauthor=Z.+Chenauthor=L.+Yu&title=Limonin%3A+A+review+of+its+pharmacology%2C+toxicity%2C+and+pharmacokinetics&doi=10.3390%2Fmolecules24203679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin: a review of its pharmacology, toxicity, and pharmacokinetics</span></div><div class="casAuthors">Fan, Shunming; Zhang, Chunling; Luo, Ting; Wang, Jiaqi; Tang, Yu; Chen, Zhimin; Yu, Lingying</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3679</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Limonin is a natural tetracyclic triterpenoid compd., which widely exists in Euodia rutaecarpa (Juss.) Benth., Phellodendron chinense Schneid., and Coptis chinensis Franch.  Its extensive pharmacol. effects have attracted considerable attention in recent years.  However, there is no systematic review focusing on the pharmacol., toxicity, and pharmacokinetics of limonin.  Therefore, this review aimed to provide the latest information on the pharmacol., toxicity, and pharmacokinetics of limonin, exploring the therapeutic potential of this compd. and looking for ways to improve efficacy and bioavailability.  Limonin has a wide spectrum of pharmacol. effects, including anti-cancer, anti-inflammatory and analgesic, anti-bacterial and anti-virus, anti-oxidn., liver protection properties.  However, limonin has also been shown to lead to hepatotoxicity, renal toxicity, and genetic damage.  Moreover, limonin also has complex impacts on hepatic metabolic enzyme.  Pharmacokinetic studies have demonstrated that limonin has poor bioavailability, and the redn., hydrolysis, and methylation are the main metabolic pathways of limonin.  We also found that the position and group of the substituents of limonin are key in affecting pharmacol. activity and bioavailability.  However, some issues still exist, such as the mechanism of antioxidant activity of limonin not being clear.  In addn., there are few studies on the toxicity mechanism of limonin, and the effects of limonin concn. on pharmacol. effects and toxicity are not clear, and no researchers have reported any ways in which to reduce the toxicity of limonin.  Therefore, future research directions include the mechanism of antioxidant activity of limonin, how the concn. of limonin affects pharmacol. effects and toxicity, finding ways to reduce the toxicity of limonin, and structural modification of limonin-one of the key methods necessary to enhance pharmacol. activity and bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxkWT-IgwobVg90H21EOLACvtfcHk0lhI_ZgGmVuj2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1yisb7F&md5=ec2dfffc3c877217118416c991fa7729</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24203679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24203679%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26atitle%3DLimonin%253A%2520A%2520review%2520of%2520its%2520pharmacology%252C%2520toxicity%252C%2520and%2520pharmacokinetics%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D3679%26doi%3D10.3390%2Fmolecules24203679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref274"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref274'); return false;" data-citation="" class="refNumLink">274</a></strong><div class="NLM_citation" id="cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guthrie, N.</span>; <span class="NLM_string-name">Morley, K.</span>; <span class="NLM_string-name">Hasegawa, S.</span>; <span class="NLM_string-name">Manners, G. D.</span>; <span class="NLM_string-name">Vandenberg, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Human Breast Cancer Cells by Citrus Limonoids</span>. In  <i>Citrus Limonoids: Functional Chemicals in Agriculture and Food</i>; ACS Symposium Series  <span class="NLM_volume">758</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berhow, M. A.</span>, <span class="NLM_string-name">Hasegawa, S.</span>, <span class="NLM_string-name">Manners, G. D.</span></span>, Eds.; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2000</span>; pp  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=164-174&author=N.+Guthrie&author=K.+Morley&author=S.+Hasegawa&author=G.+D.+Manners&author=T.+Vandenbergauthor=M.+A.+Berhow&author=S.+Hasegawa&author=G.+D.+Manners&title=Inhibition+of+Human+Breast+Cancer+Cells+by+Citrus+Limonoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGuthrie%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520Human%2520Breast%2520Cancer%2520Cells%2520by%2520Citrus%2520Limonoids%26jtitle%3DCitrus%2520Limonoids%253A%2520Functional%2520Chemicals%2520in%2520Agriculture%2520and%2520Food%26volume%3D758%26aulast%3DBerhow%26aufirst%3DM.%2BA.%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2000%26spage%3D164%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref275"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref275'); return false;" data-citation="" class="refNumLink">275</a></strong><div class="NLM_citation" id="cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, K. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetti, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Characterization of <i>Citrus aurantifolia</i> bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis</span>. <i>Microchem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.microc.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.microc.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCktLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=108-117&author=J.+R.+Patilauthor=G.+K.+Jayaprakashaauthor=K.+N.+C.+Murthyauthor=M.+B.+Chettiauthor=B.+S.+Patil&title=Characterization+of+Citrus+aurantifolia+bioactive+compounds+and+their+inhibition+of+human+pancreatic+cancer+cells+through+apoptosis&doi=10.1016%2Fj.microc.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Citrus aurantifolia bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis</span></div><div class="casAuthors">Patil, Jaiprakash R.; Jayaprakasha, G. K.; Murthy, K. N. Chidambara; Chetti, Mahadev B.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Microchemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">MICJAN</span>;
        ISSN:<span class="NLM_cas:issn">0026-265X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the current study, we have isolated and purified 5 putative compds. from lime (Citrus aurantifolia Swingle) seeds using Soxhlet extn. and chromatog. sepn.  The purity and structures of the isolated compds. were identified by TLC, HPLC, and mass spectra as limonin, limonexic acid (LNA), isolimonexic acid (ILNA), β-sitosterol glucoside (SG), and limonin glucoside (LG).  These putative compds. exhibited significant inhibition of Panc-28 cells with IC50 values in the range of 18-42 μM in MTT assay after incubation for 72 h, which was confirmed by viable cell count.  Further, induction of apoptosis was confirmed through annexin-FITC staining of the cells and expression of apoptosis related proteins was also studied to understand the mechanism.  Expression of apoptosis related protein showed apoptosis through induction of p53 by, p21 dependent manner and cytochrome-c mediated caspases driven intrinsic pathway.  Expression of apoptosis favoring proteins in cells treated with isolated compds. were in the order of ILNA > LNA > SG > Limonin > LG based on the expression ratio of bax/bcl2.  These results were further supported through fluorescent probed microscopic images.  To the best of our knowledge, this is the 1st report on isolation and identification of LNA, SG, and LG from lime and their mechanism of inhibition of human pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiA-V2fXOIr7Vg90H21EOLACvtfcHk0lhI_ZgGmVuj2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCktLnP&md5=ec485f65e52b4a45fa026ef0e0d97186</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1016%2Fj.microc.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.microc.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DJ.%2BR.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DMurthy%26aufirst%3DK.%2BN.%2BC.%26aulast%3DChetti%26aufirst%3DM.%2BB.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DCharacterization%2520of%2520Citrus%2520aurantifolia%2520bioactive%2520compounds%2520and%2520their%2520inhibition%2520of%2520human%2520pancreatic%2520cancer%2520cells%2520through%2520apoptosis%26jtitle%3DMicrochem.%2520J.%26date%3D2010%26volume%3D94%26spage%3D108%26epage%3D117%26doi%3D10.1016%2Fj.microc.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref276"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref276'); return false;" data-citation="" class="refNumLink">276</a></strong><div class="NLM_citation" id="cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, D. H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, J. D.</span></span> <span> </span><span class="NLM_article-title">Evaluation of limonoids against the murine P-388 lymphocytic leukemia cell line</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1021/np50027a015</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50027a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL3sXkvFyrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1983&pages=379-390&author=G.+R.+Pettitauthor=D.+H.+R.+Bartonauthor=C.+L.+Heraldauthor=J.+Polonskyauthor=J.+M.+Schmidtauthor=J.+D.+Connolly&title=Evaluation+of+limonoids+against+the+murine+P-388+lymphocytic+leukemia+cell+line&doi=10.1021%2Fnp50027a015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of limonoids against the murine P388 lymphocytic leukemia cell line</span></div><div class="casAuthors">Pettit, George R.; Barton, Derek H. R.; Herald, Cherry L.; Polonsky, Judith; Schmidt, Jean M.; Connolly, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-90</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">A structure/activity study of selected limonoids from 2 plant families (Meliaceae and Rutaceae) of the Rutales order against the murine P-388 lymphocytic leukemia system (PS system) was undertaken.  The presence of both a 19→28 lactol and a 14, 15β-epoxide group was important for pronounced inhibition of the PS in vitro cell line.  Substitution of an A-ring α,B-unsatd. ketone (3-oxo-1-ene) for the lactol led to diminished activity, while redn. of the olefin caused complete loss of activity.  At the dose levels employed, even very good PS in vitro inhibition was not translated into PS in vivo antineoplastic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6E5sfhoDp9LVg90H21EOLACvtfcHk0ljD327nEwpF5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXkvFyrsrk%253D&md5=657e7f6f124cf03ef97f44df3d6c1a02</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1021%2Fnp50027a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50027a015%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DBarton%26aufirst%3DD.%2BH.%2BR.%26aulast%3DHerald%26aufirst%3DC.%2BL.%26aulast%3DPolonsky%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DConnolly%26aufirst%3DJ.%2BD.%26atitle%3DEvaluation%2520of%2520limonoids%2520against%2520the%2520murine%2520P-388%2520lymphocytic%2520leukemia%2520cell%2520line%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1983%26volume%3D46%26spage%3D379%26epage%3D390%26doi%3D10.1021%2Fnp50027a015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref277"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref277'); return false;" data-citation="" class="refNumLink">277</a></strong><div class="NLM_citation" id="cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span> <span> </span><span class="NLM_article-title">By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3793</span>– <span class="NLM_lpage">3802</span>, <span class="refDoi"> DOI: 10.2147/OTT.S165220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2147%2FOTT.S165220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30013360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FoslWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=3793-3802&author=J.+Yaoauthor=J.+Liuauthor=W.+Zhao&title=By+blocking+hexokinase-2+phosphorylation%2C+limonin+suppresses+tumor+glycolysis+and+induces+cell+apoptosis+in+hepatocellular+carcinoma&doi=10.2147%2FOTT.S165220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</span></div><div class="casAuthors">Yao Junliang; Liu Jingtian; Zhao Wensheng</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3793-3803</span>
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    </div><div class="casAbstract">Introduction:  The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC).  Methods:  Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro.  The glucose consumption and lactate production after limonin treatment was determined.  The effect of limonin on hexokinase-2 (HK-2) activity was assessed and the mitochondrial location of HK-2 was studied by immunoprecipitation.  Cell apoptosis and protein expression were detected by flow cytometry and western blotting respectively.  Protein overexpression by plasmid transfection was adopted to investigate the molecular mechanisms.  Results:  HCC proliferation and colony formation were inhibited by limonin in vitro.  With the suppression of HK-2 activity, the glycolytic level in HCC cells was substantially reduced, which was evidenced by the decrease of glucose consumption and lactate production.  The phosphorylation of HK-2 was substantially inhibited by limonin, which resulted in the disassociation of HK-2 from mitochondria.  Due to the reduction of HK-2 in mitochondria, increasing Bax were shifted to the mitochondria and gave rise to the release of cytochrome C, which induced HCC cells to subject to mitochondria-mediated apoptosis.  Mechanism investigations revealed that the decrease of HK-2 phosphorylation was mainly due to the inhibition of Akt activity.  In Akt exogenously overexpressed HCC cells, limonin-mediated cell proliferation inhibition, glycolysis suppression and apoptosis induction were significantly impaired.  Conclusion:  Limonin inhibited the tumor glycolysis in hepatocellular carcinoma by suppressing HK-2 activity, and the suppression of HK-2 was closely related to the decrease of Akt activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6y4MGPcVf7VVwdslNBF-tfW6udTcc2ebv3ZYpwS84lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FoslWqtg%253D%253D&md5=e92b4a93567ff6f743576fa48b58806d</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.2147%2FOTT.S165220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S165220%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DW.%26atitle%3DBy%2520blocking%2520hexokinase-2%2520phosphorylation%252C%2520limonin%2520suppresses%2520tumor%2520glycolysis%2520and%2520induces%2520cell%2520apoptosis%2520in%2520hepatocellular%2520carcinoma%26jtitle%3DOncoTargets%2520Ther.%26date%3D2018%26volume%3D11%26spage%3D3793%26epage%3D3802%26doi%3D10.2147%2FOTT.S165220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref278"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref278'); return false;" data-citation="" class="refNumLink">278</a></strong><div class="NLM_citation" id="cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span> <span> </span><span class="NLM_article-title">Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">108699</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.108699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.108699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30970511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFWgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2019&pages=108699&author=Z.+Suauthor=C.+Wangauthor=D.+Changauthor=X.+Zhuauthor=C.+Saiauthor=J.+Pei&title=Limonin+attenuates+the+stemness+of+breast+cancer+cells+via+suppressing+MIR216A+methylation&doi=10.1016%2Fj.biopha.2019.108699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation</span></div><div class="casAuthors">Su, Zhou; Wang, Caihong; Chang, Deyu; Zhu, Xiuna; Sai, Chunmei; Pei, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108699</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Limonin has been shown to exert anti-inflammatory effects, however, its roles in tumor progression remain unclear.  This work aims to investigate the roles and related mechanism of limonin in the stemness of breast cancer cells.  Here, we found that limonin attenuated the stemness of breast cancer cells in a concn.-dependent manner, evident by the decreasing the capacity of cell spheroid formation, expression of stemness markers and ALDH1 activity, whereas had no toxicity on non-tumorigenic cells.  Addnl., limonin enhanced adriamycin sensitivity of breast cancer cells and attenuated adriamycin resistance in adriamycin-resistant breast cancer cells.  Mechanistically, limonin decreased MIR216A methylation level and thus increased miR-216a-3p expression.  Furthermore, miR-216a-3p could directly bind to WNT3A and thus inactivated Wnt/β-catenin pathway.  Therefore, our results indicate that limonin could attenuate the stemness and chemoresistance via inhibiting MIR216A methylation and subsequently suppressing Wnt/β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCKFNkwHXX1LVg90H21EOLACvtfcHk0lhwrzFCk8DtjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFWgtbk%253D&md5=17ea86d396399bd0b7a3e37858906079</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.108699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.108699%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSai%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DJ.%26atitle%3DLimonin%2520attenuates%2520the%2520stemness%2520of%2520breast%2520cancer%2520cells%2520via%2520suppressing%2520MIR216A%2520methylation%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D112%26spage%3D108699%26doi%3D10.1016%2Fj.biopha.2019.108699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref279"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref279'); return false;" data-citation="" class="refNumLink">279</a></strong><div class="NLM_citation" id="cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span> <span> </span><span class="NLM_article-title">Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2019.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fct.2019.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30738134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFOru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2019&pages=621-628&author=W.+Zhaoauthor=M.+Wuauthor=L.+Cuiauthor=W.+Du&title=Limonin+attenuates+the+stemness+of+cervical+carcinoma+cells+by+promoting+YAP+nuclear-cytoplasmic+translocation&doi=10.1016%2Fj.fct.2019.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit279R"><div class="casContent"><span class="casTitleNuber">279</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation</span></div><div class="casAuthors">Zhao, Wei; Wu, Mingyuan; Cui, Lijuan; Du, Wenxia</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This work aimed to investigate the role and related mechanism of limonin in regulating the stemness of cervical carcinoma (CC) cells.  In the present study, we constructed adriamycin-resistant CC cells and found that they exhibited greater stemness than parental cells.  Addnl., limonin attenuated the stemness of CC cells that were resistant or sensitive to adriamycin, as evidenced by the decreases in spheroid formation capacity, stemness markers expression and ALDH1 activity, whereas limonin did not affect the viability of normal cervical epithelial cells.  Furthermore, limonin enhanced adriamycin sensitivity and attenuated adriamycin resistance in CC cells.  Mechanistically, the nuclear-cytoplasmic translocation of YAP, not TAZ, was promoted by limonin in CC cells.  Addnl., YAP overexpression attenuated the inhibitory effects of limonin on CC cell stemness.  Therefore, limonin can attenuate the stemness, and thus the chemoresistance, of CC cells by promoting the nuclear-cytoplasmic translocation of YAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq91ca_57X1-7Vg90H21EOLACvtfcHk0ljJewqFg2BGAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFOru7Y%253D&md5=651327ba5f10b78e74353b56ba37f87a</span></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2019.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2019.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DW.%26atitle%3DLimonin%2520attenuates%2520the%2520stemness%2520of%2520cervical%2520carcinoma%2520cells%2520by%2520promoting%2520YAP%2520nuclear-cytoplasmic%2520translocation%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2019%26volume%3D125%26spage%3D621%26epage%3D628%26doi%3D10.1016%2Fj.fct.2019.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref280"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref280'); return false;" data-citation="" class="refNumLink">280</a></strong><div class="NLM_citation" id="cit280"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">109051</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31177062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1SqtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2019&pages=109051&author=Z.+Tangauthor=Y.+Tangauthor=L.+Liauthor=T.+Liuauthor=J.+Yang&title=Limonin+provokes+hepatocellular+carcinoma+cells+with+stemness+entry+into+cycle+via+activating+PI3K%2FAkt+signaling&doi=10.1016%2Fj.biopha.2019.109051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit280R"><div class="casContent"><span class="casTitleNuber">280</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling</span></div><div class="casAuthors">Tang, Zhenyong; Tang, Yuntian; Li, Lei; Liu, Tianqi; Yang, Jianrong</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109051</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The inhibitory roles of limonin have been revealed in various tumors.  However, the roles and related mechanism of limonin in hepatocellular carcinoma (HCC) progression are still confused.  Here, we collected non-adherent spheroids formed by HCC cells and found that the proportion of spheroids in G0 phase was remarkably higher than that in HCC cells.  Addnl., limonin increased EdU incorporation without affecting apoptosis in spheroids.  Notably, upon limonin treatment, the proportion of spheroids in G0 was decreased and S/G2/M increased.  Furthermore, we found that limonin attenuated the stemness of HCC cells, characterized as the decreased ALDH1 activity, stemness marker expression and spheroid formation ability.  Moreover, an integrated transcriptional anal. based on RNA-sequencing data was employed to gain mechanistic insight into limonin functioning, and we found that the most significant pathways identified centered on PI3K/Akt signaling. qRT-PCR and western blot obtained the consistent results.  Overall, these data suggest that limonin attenuates the stemness of HCC cells by reducing cellular quiescence through activating PI3K/Akt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfK9UGoHNBWLVg90H21EOLACvtfcHk0ljJewqFg2BGAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1SqtbrE&md5=12441cab1a60bbeaa6a13fd3867dffbf</span></div><a href="/servlet/linkout?suffix=cit280&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109051%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DLimonin%2520provokes%2520hepatocellular%2520carcinoma%2520cells%2520with%2520stemness%2520entry%2520into%2520cycle%2520via%2520activating%2520PI3K%252FAkt%2520signaling%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D117%26spage%3D109051%26doi%3D10.1016%2Fj.biopha.2019.109051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref281"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref281'); return false;" data-citation="" class="refNumLink">281</a></strong><div class="NLM_citation" id="cit281"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span> <span> </span><span class="NLM_article-title">Limonin enhances the radiosensitivity of nasopharyngeal carcinoma cells via attenuating STAT3-induced cell stemness</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">109366</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31545261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1CntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2019&pages=109366&author=L.+Gaoauthor=J.-Z.+Sangauthor=H.+Cao&title=Limonin+enhances+the+radiosensitivity+of+nasopharyngeal+carcinoma+cells+via+attenuating+STAT3-induced+cell+stemness&doi=10.1016%2Fj.biopha.2019.109366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit281R"><div class="casContent"><span class="casTitleNuber">281</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin enhances the radiosensitivity of nasopharyngeal carcinoma cells via attenuating Stat3-induced cell stemness</span></div><div class="casAuthors">Gao, Ling; Sang, Jian-zhong; Cao, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109366</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The inhibitory effects of limonin have been disclosed in various tumors, however, its roles in nasopharyngeal carcinoma (NPC) progression are never been revealed.  In the current work, we collected NPC cells with a higher stemness compared with bulk cells through isolating the side population (SP) cells.  It was found that limonin exhibited a stronger inhibitory effect on SP cells than that in bulk cells, which was evident by a lower IC50 value.  Addnl., limonin attenuated the stemness and migration ability of SP cells with the higher stemness, characterized as decreasing the spheroid formation ability, expression of stemness markers and migration ability.  Moreover, the proportion of SP cells in G0 phase was remarkably higher than that in bulk cells.  Notably, upon limonin treatment, the proportion of SP cells in G0 was decreased and S/G2/M increased.  Furthermore, limonin enhanced the radiosensitivity of NPC cells.  The mechanistic studies based on RNA-sequencing anal. revealed that limonin inhibited the gene transcription driven by Stat3 (signal transducer and activator of transcription 3) and an activator of Stat3 (Colivelin or IL-6) rescued the inhibitory effects of limonin.  Therefore, these results demonstrate that limonin could reduce the stemness of NPC cells and thus the radiosensitivity through suppressing Stat3 transcriptional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70K4Yht1bULVg90H21EOLACvtfcHk0lh2CRWItJhZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1CntLrK&md5=db91f97f42b0d3a1109af97257dd3c83</span></div><a href="/servlet/linkout?suffix=cit281&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109366%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DSang%26aufirst%3DJ.-Z.%26aulast%3DCao%26aufirst%3DH.%26atitle%3DLimonin%2520enhances%2520the%2520radiosensitivity%2520of%2520nasopharyngeal%2520carcinoma%2520cells%2520via%2520attenuating%2520STAT3-induced%2520cell%2520stemness%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D118%26spage%3D109366%26doi%3D10.1016%2Fj.biopha.2019.109366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref282"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref282'); return false;" data-citation="" class="refNumLink">282</a></strong><div class="NLM_citation" id="cit282"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Anticancer effect of limonin against benzo[<i>a</i>]pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>, <span class="NLM_elocation-id">e22374</span> <span class="refDoi"> DOI: 10.1002/jbt.22374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjbt.22374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31702096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFaktLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&author=C.+Gongauthor=L.+Qiauthor=Y.+Huoauthor=S.+Zhangauthor=X.+Ningauthor=L.+Baiauthor=Z.+Wang&title=Anticancer+effect+of+limonin+against+benzo%5Ba%5Dpyrene-induced+lung+carcinogenesis+in+Swiss+albino+mice+and+the+inhibition+of+A549+cell+proliferation+through+apoptotic+pathway&doi=10.1002%2Fjbt.22374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit282R"><div class="casContent"><span class="casTitleNuber">282</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer effect of Limonin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway</span></div><div class="casAuthors">Gong, Cuike; Qi, Lei; Huo, Yanxia; Zhang, Shiran; Ning, Xuecong; Bai, Linlin; Wang, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Molecular Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e22374</span>CODEN:
                <span class="NLM_cas:coden">JBMTFQ</span>;
        ISSN:<span class="NLM_cas:issn">1095-6670</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The main purpose of the current study is to reveal the anticancer action of limonin against benzo(a)pyrene [B(a)P]-treated lung carcinogenesis in Swiss albino mice and A549 lung cancer cells.  B(a)P was orally supplemented (50 mg/kg body wt.) twice a week for four weeks induction of lung cancer in mice.  The lung wt., body wt., incidence of tumor, lipid peroxidn., carcinoembryonic antigen (CEA), enzymic and nonenzymic antioxidants (superoxide dismutase, GPx, glutathione, glutathione reductase, catalase, and glutathione S-transferase), serum marker enzymes (aryl hydroxylase, lactate dehydrogenase, 5'-nucleotidases, and -glutamyl transpeptidase), and inflammatory mediators (interleukin-1beta, interleukin-6, and tumor necrosis factor-a) were estd.  Moreover, a histopathol. study of lung tissues was supported by the biochem. anal.  B(a)P-induced mice showed increased lipid peroxidn., CEA, serum marker enzymes and inflammatory cytokines levels with simultaneously decreased in the nonenzymic and enzymic antioxidants levels.  Furthermore, our in vitro study also supported the anticancer effect of the treatment of limonin-enhanced apoptosis by loss of cell viability, improved ROS prodn., apoptotic morphol. changes, and apoptosis protein expression were analyzed.  Overall, these results suggest the anticancer potential of limonin against B(a)P-induced lung cancer in Swiss albino mice and A549 lung cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjqKevTf757Vg90H21EOLACvtfcHk0ljLzYx6aGumug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFaktLnN&md5=a496b77d50a24e69b47f17c6d494652c</span></div><a href="/servlet/linkout?suffix=cit282&amp;dbid=16384&amp;doi=10.1002%2Fjbt.22374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.22374%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAnticancer%2520effect%2520of%2520limonin%2520against%2520benzo%255Ba%255Dpyrene-induced%2520lung%2520carcinogenesis%2520in%2520Swiss%2520albino%2520mice%2520and%2520the%2520inhibition%2520of%2520A549%2520cell%2520proliferation%2520through%2520apoptotic%2520pathway%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2019%26volume%3D33%26doi%3D10.1002%2Fjbt.22374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref283"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref283'); return false;" data-citation="" class="refNumLink">283</a></strong><div class="NLM_citation" id="cit283"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity</span>. <i>Tissue Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">101346</span>, <span class="refDoi"> DOI: 10.1016/j.tice.2020.101346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tice.2020.101346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32746992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslSiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2020&pages=101346&author=G.+Yangauthor=Z.+Liauthor=L.+Chen&title=Limonin+suppresses+the+progression+of+oral+tongue+squamous+cell+carcinoma+via+inhibiting+YAP+transcriptional+regulatory+activity&doi=10.1016%2Fj.tice.2020.101346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit283R"><div class="casContent"><span class="casTitleNuber">283</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity</span></div><div class="casAuthors">Yang, Guangsheng; Li, Zhi; Chen, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Tissue & Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101346</span>CODEN:
                <span class="NLM_cas:coden">TICEBI</span>;
        ISSN:<span class="NLM_cas:issn">0040-8166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The suppressive roles of limonin have been established in various tumors.  However, its roles in oral tongue squamous cell carcinoma (OTSCC) progression are still confusing.  This work aims to explore limonin-mediated effects on OTSCC progression.  CCK8 anal. was performed to evaluate limonin-mediated effects on OTSCC cell viability.  Wound healing and transwell invasion anal. were constructed to examine the effects of limonin on OTSCC cell migration and invasion capacity.  RT-qPCR, western blot and luciferase reporter assays were used to explore the underlying mechanisms contributing to limonin-mediated effects on OTSCC progression.  It was found that limonin significantly suppressed the viability of OTSCC cells.  Addnl., limonin reduced the migration and invasion ability of OTSCC cells.  Mechanistically, limonin suppresses OTSCC progression by promoting the nuclear to cytoplasm translocation of YAP, decreasing YAP protein expression and subsequently decreasing YAP transcriptional regulatory activity, this is responsible for limonin-mediated suppression on OTSCC progression.  Thus, this work suggests that limonin suppresses OTSCC progression through inhibiting YAP transcriptional regulatory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aMHTZq7OWbVg90H21EOLACvtfcHk0ljLzYx6aGumug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslSiu74%253D&md5=fdd887439426fce48dffe7a62deecdbc</span></div><a href="/servlet/linkout?suffix=cit283&amp;dbid=16384&amp;doi=10.1016%2Fj.tice.2020.101346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tice.2020.101346%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DLimonin%2520suppresses%2520the%2520progression%2520of%2520oral%2520tongue%2520squamous%2520cell%2520carcinoma%2520via%2520inhibiting%2520YAP%2520transcriptional%2520regulatory%2520activity%26jtitle%3DTissue%2520Cell%26date%3D2020%26volume%3D65%26spage%3D101346%26doi%3D10.1016%2Fj.tice.2020.101346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref284"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref284'); return false;" data-citation="" class="refNumLink">284</a></strong><div class="NLM_citation" id="cit284"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, G. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidallon, M. L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salamanez, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, E. B.</span></span> <span> </span><span class="NLM_article-title">Nanodelivery system based on zein-alginate complexes enhances in vitro chemopreventive activity and bioavailability of pomelo [<i>Citrus maxima</i> (Burm.) Merr.] seed limonoids</span>. <i>J. Drug Delivery Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">101296</span>, <span class="refDoi"> DOI: 10.1016/j.jddst.2019.101296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.jddst.2019.101296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCksbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2019&pages=101296&author=G.+F.+M.+Bautistaauthor=M.+L.+P.+Vidallonauthor=K.+C.+Salamanezauthor=E.+B.+Rodriguez&title=Nanodelivery+system+based+on+zein-alginate+complexes+enhances+in+vitro+chemopreventive+activity+and+bioavailability+of+pomelo+%5BCitrus+maxima+%28Burm.%29+Merr.%5D+seed+limonoids&doi=10.1016%2Fj.jddst.2019.101296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit284R"><div class="casContent"><span class="casTitleNuber">284</span><div class="casTitle"><span class="NLM_cas:atitle">Nanodelivery system based on zein-alginate complexes enhances in vitro chemopreventive activity and bioavailability of pomelo [Citrus maxima (Burm.) Merr.] seed limonoids</span></div><div class="casAuthors">Bautista, Gio Ferson M.; Vidallon, Mark Louis P.; Salamanez, Kevin C.; Rodriguez, Evelyn B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Delivery Science and Technology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101296</span>CODEN:
                <span class="NLM_cas:coden">JDDSAL</span>;
        ISSN:<span class="NLM_cas:issn">1773-2247</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Limonin and nomilin, the major limonoid components of pomelo [Citrus maxima (Burm.) Merr.] seeds, have been reported to be potential cancer chemopreventive agents, but their low aq. soly. and limited bioavailability impede their applications as nutraceuticals.  In this study, a zein-alginate encapsulation system was utilized to produce highly dispersible limonin and nomilin nanoparticles (172.7 ± 7.4 and 273.3 ± 2.3 nm dia., resp.) with high encapsulation efficiencies and high stabilities at both ambient and refrigerated storage conditions.  In vitro release studies showed that the nanodelivery system can delay and minimize the release of the limonoids in simulated gastric fluid (SGF) and preferentially release these compds. in simulated intestinal fluid (SIF).  Furthermore, zein-alginate encapsulated limonin and nomilin exhibited significantly improved glutathione S-transferase (GST)-inducing activity, free radical-scavenging activity, and anti-angiogenic activity.  These results demonstrate that the zein-alginate complexes can serve as effective oral delivery system for limonin and nomilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-j2j3j1Ih1bVg90H21EOLACvtfcHk0lhu8-KaSmgdSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCksbzL&md5=e69e4f5a979626e6693d5053aea7eb41</span></div><a href="/servlet/linkout?suffix=cit284&amp;dbid=16384&amp;doi=10.1016%2Fj.jddst.2019.101296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jddst.2019.101296%26sid%3Dliteratum%253Aachs%26aulast%3DBautista%26aufirst%3DG.%2BF.%2BM.%26aulast%3DVidallon%26aufirst%3DM.%2BL.%2BP.%26aulast%3DSalamanez%26aufirst%3DK.%2BC.%26aulast%3DRodriguez%26aufirst%3DE.%2BB.%26atitle%3DNanodelivery%2520system%2520based%2520on%2520zein-alginate%2520complexes%2520enhances%2520in%2520vitro%2520chemopreventive%2520activity%2520and%2520bioavailability%2520of%2520pomelo%2520%255BCitrus%2520maxima%2520%2528Burm.%2529%2520Merr.%255D%2520seed%2520limonoids%26jtitle%3DJ.%2520Drug%2520Delivery%2520Sci.%2520Technol.%26date%3D2019%26volume%3D54%26spage%3D101296%26doi%3D10.1016%2Fj.jddst.2019.101296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref285"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref285'); return false;" data-citation="" class="refNumLink">285</a></strong><div class="NLM_citation" id="cit285"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkata, K. C. N.</span>; <span class="NLM_string-name">Rathinavelu, A.</span>; <span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Limonoids: Structure-Activity Relationship Studies and Anticancer Properties</span>. In  <i>Studies in Natural Products Chemistry</i>, Vol.  <span class="NLM_volume">59</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atta-ur-Rahman</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam, The Netherlands</span>, <span class="NLM_year">2018</span>; pp  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">399</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=375-399&author=K.+C.+N.+Venkata&author=A.+Rathinavelu&author=A.+Bishayeeauthor=+Atta-ur-Rahman&title=Studies+in+Natural+Products+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit285&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVenkata%26aufirst%3DK.%2BC.%2BN.%26atitle%3DLimonoids%253A%2520Structure-Activity%2520Relationship%2520Studies%2520and%2520Anticancer%2520Properties%26btitle%3DStudies%2520in%2520Natural%2520Products%2520Chemistry%26volume%3D59%26aulast%3DAtta-ur-Rahman%26pub%3DElsevier%26date%3D2018%26spage%3D375%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref286"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref286'); return false;" data-citation="" class="refNumLink">286</a></strong><div class="NLM_citation" id="cit286"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratheeshkumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raphael, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuttan, G.</span></span> <span> </span><span class="NLM_article-title">Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells</span>. <i>Integr. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1177/1534735411403307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref286/cit286&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1177%2F1534735411403307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref286/cit286&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21665879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref286/cit286&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2qu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=48-60&author=P.+Pratheeshkumarauthor=T.+J.+Raphaelauthor=G.+Kuttan&title=Nomilin+inhibits+metastasis+via+induction+of+apoptosis+and+regulates+the+activation+of+transcription+factors+and+the+cytokine+profile+in+B16F-10+cells&doi=10.1177%2F1534735411403307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit286R"><div class="casContent"><span class="casTitleNuber">286</span><div class="casTitle"><span class="NLM_cas:atitle">Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells</span></div><div class="casAuthors">Pratheeshkumar, Poyil; Raphael, Tharakan J.; Kuttan, Girija</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Cancer Therapies</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">ICTNAY</span>;
        ISSN:<span class="NLM_cas:issn">1534-7354</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Nomilin is a triterpenoid present in common edible citrus fruits with putative anticancer properties.  In this study, the authors investigated the antimetastatic potential of nomilin and its possible mechanism of action.  Metastasis was induced in C57BL/6 mice through the lateral tail vein using highly metastatic B16F-10 melanoma cells.  Administration of nomilin inhibited tumor nodule formation in the lungs (68%) and markedly increased the survival rate of the metastatic tumor-bearing animals.  These results correlated with the biochem. parameters and histopathol. anal.  Nomilin showed an inhibition of tumor cell invasion and activation of matrix metalloproteinases.  Treatment with nomilin induced apoptotic response, characterized by an increase in the sub-G1 fraction of cells with chromatin condensation and membrane blebbing, a typical ladder of DNA fragmentation, and detection of apoptotic cells by TUNEL assay.  Nomilin treatment also exhibited a downregulated Bcl-2 and cyclin-D1 expression and upregulated p53, Bax, caspase-9, caspase-3, p21, and p27 gene expression in B16F-10 cells.  Proinflammatory cytokine prodn. and gene expression were found to be downregulated in nomilin-treated cells.  The study also reveals that nomilin could inhibit the activation and nuclear translocation of antiapoptotic transcription factors such as nuclear factor (NF)-κB, CREB, and ATF-2 in B16F-10 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUwpDsCKpoxrVg90H21EOLACvtfcHk0lgE3msMPQx-qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2qu70%253D&md5=15bacfd6fcb1ab8057a908b5520a484d</span></div><a href="/servlet/linkout?suffix=cit286&amp;dbid=16384&amp;doi=10.1177%2F1534735411403307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1534735411403307%26sid%3Dliteratum%253Aachs%26aulast%3DPratheeshkumar%26aufirst%3DP.%26aulast%3DRaphael%26aufirst%3DT.%2BJ.%26aulast%3DKuttan%26aufirst%3DG.%26atitle%3DNomilin%2520inhibits%2520metastasis%2520via%2520induction%2520of%2520apoptosis%2520and%2520regulates%2520the%2520activation%2520of%2520transcription%2520factors%2520and%2520the%2520cytokine%2520profile%2520in%2520B16F-10%2520cells%26jtitle%3DIntegr.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D48%26epage%3D60%26doi%3D10.1177%2F1534735411403307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref287"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref287'); return false;" data-citation="" class="refNumLink">287</a></strong><div class="NLM_citation" id="cit287"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratheeshkumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuttan, G.</span></span> <span> </span><span class="NLM_article-title">Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>668</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2011.07.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref287/cit287&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejphar.2011.07.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref287/cit287&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21839074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref287/cit287&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Gru7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=668&publication_year=2011&pages=450-458&author=P.+Pratheeshkumarauthor=G.+Kuttan&title=Nomilin+inhibits+tumor-specific+angiogenesis+by+downregulating+VEGF%2C+NO+and+proinflammatory+cytokine+profile+and+also+by+inhibiting+the+activation+of+MMP-2+and+MMP-9&doi=10.1016%2Fj.ejphar.2011.07.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit287R"><div class="casContent"><span class="casTitleNuber">287</span><div class="casTitle"><span class="NLM_cas:atitle">Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9</span></div><div class="casAuthors">Pratheeshkumar, Poyil; Kuttan, Girija</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">668</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-458</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Angiogenesis is a crucial step in the growth and metastasis of cancers.  Antiangiogenic activity of nomilin was studied using in vivo as well as in vitro models.  Nomilin significantly inhibited tumor directed capillary formation.  Serum proinflammatory cytokines such as IL-1β, IL-6, TNF-α and GM-CSF and also serum NO levels were significantly reduced by the treatment of nomilin.  Administration of nomilin significantly reduced the serum level of VEGF, a proangiogenic factor and increased the antiangiogenic factors IL-2 and TIMP-1.  In vitro studies using rat aortic ring assay showed that administration of nomilin at non-toxic concns. significantly inhibited microvessel sprouting.  Studies using human umbilical vein endothelial cells clearly demonstrated that administration of nomilin significantly retarded endothelial cell proliferation, migration, invasion and tube formation.  These data clearly demonstrate the antiangiogenic potential of nomilin by downregulating the activation of MMPs, prodn. of VEGF, NO and proinflammatory cytokines as well as upregulating IL-2 and TIMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXhXvQ6aWCKbVg90H21EOLACvtfcHk0lgE3msMPQx-qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Gru7%252FM&md5=d61ee0df4d9498a69c1fbb249ae5d6ad</span></div><a href="/servlet/linkout?suffix=cit287&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.07.029%26sid%3Dliteratum%253Aachs%26aulast%3DPratheeshkumar%26aufirst%3DP.%26aulast%3DKuttan%26aufirst%3DG.%26atitle%3DNomilin%2520inhibits%2520tumor-specific%2520angiogenesis%2520by%2520downregulating%2520VEGF%252C%2520NO%2520and%2520proinflammatory%2520cytokine%2520profile%2520and%2520also%2520by%2520inhibiting%2520the%2520activation%2520of%2520MMP-2%2520and%2520MMP-9%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D668%26spage%3D450%26epage%3D458%26doi%3D10.1016%2Fj.ejphar.2011.07.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref288"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref288'); return false;" data-citation="" class="refNumLink">288</a></strong><div class="NLM_citation" id="cit288"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chidambara Murthy, K.N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G.K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S</span></span> <span> </span><span class="NLM_article-title">Obacunone and obacunone glucoside inhibit human colon cancer (SW480) cells by the induction of apoptosis</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1625</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2011.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fct.2011.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21515332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFWit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=1616-1625&author=K.N.+Chidambara+Murthyauthor=G.K.+Jayaprakashaauthor=B.+S+Patil&title=Obacunone+and+obacunone+glucoside+inhibit+human+colon+cancer+%28SW480%29+cells+by+the+induction+of+apoptosis&doi=10.1016%2Fj.fct.2011.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit288R"><div class="casContent"><span class="casTitleNuber">288</span><div class="casTitle"><span class="NLM_cas:atitle">Obacunone and obacunone glucoside inhibit human colon cancer (SW480) cells by the induction of apoptosis</span></div><div class="casAuthors">Chidambara Murthy, K. N.; Jayaprakasha, G. K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1616-1625</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Objectives: The study was aimed to purify obacunone and obacunone glucoside (OG) from seeds of Marsh White grapefruit and understand the mode of cytotoxicity of limonoids on colon cancer (SW480) cells.  Methodol.: Both limonoids were purified using chromatog. techniques.  The structures and purity of limonoids were confirmed by NMR and HPLC anal., resp.  Results: Obacunone and OG inhibited SW480 cell proliferation with IC50 values of 97 and 109.7 μM resp., at 24 h.  Sequence of events such as decreased ratio of bcl2/bax gene transcription, activation of caspase-3, fragmentation of DNA in cells treated with obacunone and OG demonstrated induction of apoptosis by limonoids.  Addnl., higher induction of cytochrome-c in cytosol suggests the activation of intrinsic apoptosis by limonoids.  Involvement of apoptosis was also confirmed through expression of bax, bcl2, pro-caspase-3 and caspase-9.  Both the limonoids activated p21 and arrested cells at G1 and G2/M phase.  Additive activity of proliferation inhibition and activation of caspase-3 by limonoids was obsd. when combined with camptothecin, demonstrating the induction of apoptosis.  In conclusion, both limonoids induced apoptosis by activation of intrinsic apoptosis pathway and activation of p21 leading to arresting cells at G2/M phase of the cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd1RqmGUFcALVg90H21EOLACvtfcHk0lhTRsbNfEz8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFWit7k%253D&md5=fc03204765dd5840add53b9d84ab863c</span></div><a href="/servlet/linkout?suffix=cit288&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2011.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2011.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DChidambara%2BMurthy%26aufirst%3DK.N.%26aulast%3DJayaprakasha%26aufirst%3DG.K.%26aulast%3DPatil%26aufirst%3DB.%2BS%26atitle%3DObacunone%2520and%2520obacunone%2520glucoside%2520inhibit%2520human%2520colon%2520cancer%2520%2528SW480%2529%2520cells%2520by%2520the%2520induction%2520of%2520apoptosis%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2011%26volume%3D49%26spage%3D1616%26epage%3D1625%26doi%3D10.1016%2Fj.fct.2011.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref289"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref289'); return false;" data-citation="" class="refNumLink">289</a></strong><div class="NLM_citation" id="cit289"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, K. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2015.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tox.2015.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25592883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVKjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2015&pages=88-97&author=K.+N.+C.+Murthyauthor=G.+K.+Jayaprakashaauthor=B.+S.+Patil&title=Cytotoxicity+of+obacunone+and+obacunone+glucoside+in+human+prostate+cancer+cells+involves+Akt-mediated+programmed+cell+death&doi=10.1016%2Fj.tox.2015.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit289R"><div class="casContent"><span class="casTitleNuber">289</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death</span></div><div class="casAuthors">Murthy, Kotamballi N. Chidambara; Jayaprakasha, Guddadarangavvanahally K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-97</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Obacunone and obacunone glucoside (OG) are naturally occurring triterpenoids commonly found in citrus and other plants of the Rutaceae family.  The current study reports the mechanism of cytotoxicity of citrus-derived obacunone and OG on human androgen-dependent prostate cancer LNCaP cells.  Both limonoids exhibited time- and dose-dependent inhibition of cell proliferation, with more than 60% inhibition of cell viability at 100 μM, after 24 and 48 h.  Anal. of fragmentation of DNA, activity of caspase-3, and cytosolic cytochrome-c in the cells treated with limonoids provided evidence for activation of programmed cell death by limonoids.  Treatment of LNCaP cells with obacunone and OG resulted in dose-dependent changes in expression of proteins responsible for the induction of programmed cell death through the intrinsic pathway and down-regulation of Akt, a key mol. in cell signaling pathways.  In addn., obacunone and OG also neg. regulated an inflammation-assocd. transcription factor, androgen receptor, and prostate-specific antigen, and activated proteins related to the cell cycle, confirming the ability of limonoids to induce cytotoxicity through multiple pathways.  The results of this study provided, for the first time, an evidence of the cytotoxicity of obacunone and OG in androgen-dependent human prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN3z4SJsXHabVg90H21EOLACvtfcHk0lhTRsbNfEz8yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVKjuw%253D%253D&md5=7db8ddf31439b5ceb25c2f937a0cbd69</span></div><a href="/servlet/linkout?suffix=cit289&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2015.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2015.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DMurthy%26aufirst%3DK.%2BN.%2BC.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DCytotoxicity%2520of%2520obacunone%2520and%2520obacunone%2520glucoside%2520in%2520human%2520prostate%2520cancer%2520cells%2520involves%2520Akt-mediated%2520programmed%2520cell%2520death%26jtitle%3DToxicology%26date%3D2015%26volume%3D329%26spage%3D88%26epage%3D97%26doi%3D10.1016%2Fj.tox.2015.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref290"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref290'); return false;" data-citation="" class="refNumLink">290</a></strong><div class="NLM_citation" id="cit290"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2014.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biochi.2014.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24927687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFChsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=36-44&author=J.+Kimauthor=G.+K.+Jayaprakashaauthor=B.+S.+Patil&title=Obacunone+exhibits+anti-proliferative+and+anti-aromatase+activity+in+vitro+by+inhibiting+the+p38+MAPK+signaling+pathway+in+MCF-7+human+breast+adenocarcinoma+cells&doi=10.1016%2Fj.biochi.2014.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit290R"><div class="casContent"><span class="casTitleNuber">290</span><div class="casTitle"><span class="NLM_cas:atitle">Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells</span></div><div class="casAuthors">Kim, Jinhee; Jayaprakasha, G. K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Overexpression of the aromatase enzyme CYP19 has been implicated in the onset of estrogen-dependent breast carcinogenesis.  Obacunone, a natural compd. present in citrus fruits, has been demonstrated for various biol. activities including anti-cancer and anti-inflammatory properties.  In the present study, we have isolated obacunone and obacunone glucoside (OG) from lemon seeds, then fractionated these compds. using chromatog. techniques and characterized them by HPLC, LC-MS, and 2D NMR spectral anal.  To investigate the mechanism of anti-cancer and anti-aromatase activities of limonoids, their cytotoxic effect was tested on human breast cancer (MCF-7) and non-malignant (MCF-12F) breast cells.  MTT assays confirmed that obacunone was strongly inhibited MCF-7 cell proliferation without affecting non-malignant breast cells.  Treatment with obacunone increased apoptosis by up-regulating expression of the pro-apoptotic protein Bax and down-regulating the anti-apoptotic protein Bcl2, as well as inducing G1 cell cycle arrest.  In addn., obacunone significantly inhibited aromatase activity in an in vitro enzyme assay.  Exposure of MCF-7 breast cancer cells to obacunone down-regulated expression of inflammatory mols. including nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2).  Furthermore, we found that obacunone inhibited COX-2 and NF-κB by activation of the p38 mitogen-activated protein kinase (MAPK).  Finally, the uptake level of obacunone into MCF-7 cells was measured by HPLC and its structure was confirmed by LC-HR-MS.  This study demonstrated that obacunone may have the potential to prevent estrogen-responsive breast cancer through inhibition of the aromatase enzyme and inflammatory pathways, as well as activation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY-nGOxUd5UbVg90H21EOLACvtfcHk0lgCFdjvdN5IUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFChsrvK&md5=52e0d5fcf70afb71ce9468642651e5fe</span></div><a href="/servlet/linkout?suffix=cit290&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2014.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2014.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DObacunone%2520exhibits%2520anti-proliferative%2520and%2520anti-aromatase%2520activity%2520in%2520vitro%2520by%2520inhibiting%2520the%2520p38%2520MAPK%2520signaling%2520pathway%2520in%2520MCF-7%2520human%2520breast%2520adenocarcinoma%2520cells%26jtitle%3DBiochimie%26date%3D2014%26volume%3D105%26spage%3D36%26epage%3D44%26doi%3D10.1016%2Fj.biochi.2014.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref291"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref291'); return false;" data-citation="" class="refNumLink">291</a></strong><div class="NLM_citation" id="cit291"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akisanya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsall, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. A. H.</span></span> <span> </span><span class="NLM_article-title">West African timbers. III. Petroleum extracts from the genus <i>Entandrophragma</i></span>. <i>J. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_fpage">3827</span>– <span class="NLM_lpage">3829</span>, <span class="refDoi"> DOI: 10.1039/jr9600003827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref291/cit291&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fjr9600003827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref291/cit291&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF3MXhvVWjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1960&pages=3827-3829&author=A.+Akisanyaauthor=C.+W.+L.+Bevanauthor=J.+Hirstauthor=T.+G.+Halsallauthor=D.+A.+H.+Taylor&title=West+African+timbers.+III.+Petroleum+extracts+from+the+genus+Entandrophragma&doi=10.1039%2Fjr9600003827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit291R"><div class="casContent"><span class="casTitleNuber">291</span><div class="casTitle"><span class="NLM_cas:atitle">West African timbers. III. Petroleum extracts from the genus Entandrophragma</span></div><div class="casAuthors">Akisanya, A.; Bevan, C. W. L.; Hirst, J.; Halsall, T. G.; Taylor, D. A. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3827-9</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">cf. CA 54, 3601c.  As part of a phytochem. survey of the family Meliaceae, heartwood timber of the 4 species of the West African genus Entandrophragma was examd.  Ligroine extn. of all gave β-sitosterol (I); 4 new (and apparently related) substances were isolated.  The distribution of these within the genus was described.  The finely ground heartwood (36 kg.) of E. angolense (Type A) percolated 24 hrs. with refluxing ligroine, the ext. filtered and evapd., and the 110 g. of residue dissolved in 10 ml./g. MeOH and stored at 0° gave a powder, m. 75-132°.  Repeated crystns. gave 19 g. I, m. 137° (MeOH).  Concn. of the mother liquor gave 44 g. gedunin, needles, m. 218° (MeOH), [α]20D -44° (CHCl3).  Similar extn. of Type B wood gave a solid which yielded Me angolensate, m. 197° (MeOH), [α]20D -43° (CHCl3).  E. candoleii (43 kg. of finely ground timber) extd. as above gave 70 g. of a yellow gum.  Maceration with ligroine gave a white solid, which gave 5 g. I as flakes; acetate m. 126°, [α]18D -40.6°; formate m. 104.5°.  Oxidn. of I with CrO3 in Me2CO gave stigmast-4-ene-3,6-dione, m. 166°, [α]18D -38.9° (CHCl3).  Chromatography of the mother liquors on Al2O3 gave no further product.  E. cylindricum [finely ground heartwood (13.2 kg.)] extd. as above and the 220 g. of thick oil crystd. gave 25 g. entandrophragmin, prisms, m. 241° (aq. MeOH), [α]20D -4°.  Chromatography of the mother liquors gave more of this substance and a small amt. of I.  Powd. heartwood (12 kg.) of E. utile gave 43 g. of an ext. which (partly crystd.) gave 7 g. utilin, m. 278° (alc.), [α]20D -355.5° (CHCl3).  Chromatography of the mother liquors on Al2O3 gave 4 g. entandrophragmin, m. 241°.  The heartwood further extd. with Me2CO and the ext. chromatographed and eluted with C6H6 gave 0.05% Me angolensate, m. 197°.  Entandrophragmin, utilin, and gedunin, but not Me angolensate, gave similar results on pyrolysis.  The substance (0.5 g.) was pyrolyzed at 360° to yield high and low boiling fractions.  The latter gave a brick red dinitrophenylhydrazone, which was chromatographed in CHCl3 to give (from entandrophragmin) a product, m. 230-2° (AcOH).  Furan-3-carboxaldehyde prepd. from the 3-carboxylic acid gave a similar deriv.  A small amt. of MeCHO 2,4-dinitrophenylhydrazone was also isolated.  Similar results were obtained on hydrolysis (in alkali) of entandrophragmin, utilin, and gedunin, but not of Me angolensate.  The substance (200 mg.) in 5 cc. alc. was treated with 5 ml. 2N NaOH; after steam distn. it also yielded a furan-3-carboxaldehyde deriv.  Me angolensate (1 g.) refluxed 16 hrs. with 2.5 g. KOH in 25 ml. alc. and the soln. dild. with 400 ml. H2O, extd. with Et2O, and the ext. evapd. gave a trace of I; acidification of the aq. layer gave angolensic acid, needles, m. 272° (aq. MeOH).  CH2N2 gave Me angolensate.  Gedunin (2.9 g.) in 200 ml. MeOH hydrogenated at atm. pressure over Pd-C, the soln. filtered and evapd., and the residue crystd. gave dihydrogedunin, m. 240° (MeOH), m. 240°, [α]20D -8° (MeOH).  Ultraviolet and infrared spectra were given for the above compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQriQiWgc0LVg90H21EOLACvtfcHk0lh5P35eyJGq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXhvVWjsw%253D%253D&md5=9a6334a33333c8ab244eb1675677eeb0</span></div><a href="/servlet/linkout?suffix=cit291&amp;dbid=16384&amp;doi=10.1039%2Fjr9600003827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9600003827%26sid%3Dliteratum%253Aachs%26aulast%3DAkisanya%26aufirst%3DA.%26aulast%3DBevan%26aufirst%3DC.%2BW.%2BL.%26aulast%3DHirst%26aufirst%3DJ.%26aulast%3DHalsall%26aufirst%3DT.%2BG.%26aulast%3DTaylor%26aufirst%3DD.%2BA.%2BH.%26atitle%3DWest%2520African%2520timbers.%2520III.%2520Petroleum%2520extracts%2520from%2520the%2520genus%2520Entandrophragma%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1960%26spage%3D3827%26epage%3D3829%26doi%3D10.1039%2Fjr9600003827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref292"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref292'); return false;" data-citation="" class="refNumLink">292</a></strong><div class="NLM_citation" id="cit292"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. M.</span></span> <span> </span><span class="NLM_article-title">The structure of gedunin</span>. <i>Proc. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_fpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref292/cit292&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF38Xks1Sitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1962&pages=222&author=S.+A.+Sutherlandauthor=G.+A.+Simauthor=J.+M.+Robertson&title=The+structure+of+gedunin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit292R"><div class="casContent"><span class="casTitleNuber">292</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of gedunin</span></div><div class="casAuthors">Sutherland, S. A.; Sim, G. A.; Robertson, J. Monteath</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Chemical Society, London</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">222</span>CODEN:
                <span class="NLM_cas:coden">PCSLAW</span>;
        ISSN:<span class="NLM_cas:issn">0369-8718</span>.
    </div><div class="casAbstract">The constitution and relative stereochemistry of dihydrogedun-3β-yl iodoacetate is established by x-ray analysis as I, thus establishing structure of gedunin as II.  I crystd. in the orthorhombic system, space group P212121 with four mols. of C30H39IO8 in a unit cell of dimensions a 21.52, b 10.57, c 12.96 ± A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptrhGcZNT0prVg90H21EOLACvtfcHk0ljH8zgTjZCfPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xks1Sitrc%253D&md5=141e31062d93d35be67d4282eabf38eb</span></div><a href="/servlet/linkout?suffix=cit292&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DS.%2BA.%26aulast%3DSim%26aufirst%3DG.%2BA.%26aulast%3DRobertson%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520structure%2520of%2520gedunin%26jtitle%3DProc.%2520Chem.%2520Soc.%26date%3D1962%26spage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref293"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref293'); return false;" data-citation="" class="refNumLink">293</a></strong><div class="NLM_citation" id="cit293"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akihisa, T.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and apoptosis-inducing activities of limonoids from the seeds of <i>Azadirachta indica</i> (Neem)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1021/np100783k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np100783k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=866-870&author=T.+Kikuchiauthor=K.+Ishiiauthor=T.+Notoauthor=A.+Takahashiauthor=K.+Tabataauthor=T.+Suzukiauthor=T.+Akihisa&title=Cytotoxic+and+apoptosis-inducing+activities+of+limonoids+from+the+seeds+of+Azadirachta+indica+%28Neem%29&doi=10.1021%2Fnp100783k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit293R"><div class="casContent"><span class="casTitleNuber">293</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and Apoptosis-Inducing Activities of Limonoids from the Seeds of Azadirachta indica (Neem)</span></div><div class="casAuthors">Kikuchi, Takashi; Ishii, Koichi; Noto, Taisuke; Takahashi, Akitomo; Tabata, Keiichi; Suzuki, Takashi; Akihisa, Toshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">866-870</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Thirty-five limonoids, including 15 of the azadiradione type (1-15), five of the gedunin type (16-20), four of the azadirachtin type (21-24), nine of the nimbin type (25-33), and two degraded limonoids (34, 35), isolated from Azadirachta indica seed exts., were evaluated for their cytotoxic activities against five human cancer cell lines.  Seven compds. (3, 6, 7, 16, 18, 28, and 29) exhibited cytotoxic activity against one or more cell lines.  Among these compds., 7-deacetyl-7-benzoylepoxyazadiradione (7), 7-deacetyl-7-benzoylgeduin (18), and 28-deoxonimbolide (28) exhibited potent cytotoxic activity against HL60 leukemia cells with IC50 values in the range 2.7-3.1 μM.  Compds. 7, 18, and 28 induced early apoptosis in HL60 cells, obsd. by flow cytometry.  Western blot anal. showed that compds. 7, 18, and 28 activated caspases-3, -8, and -9 in HL60 cells.  This suggested that compds. 7, 18, and 28 induced apoptotic cell death in HL60 cells via both the mitochondrial- and the death receptor-mediated pathways.  Furthermore, compd. 7 was shown to possess high selective cytotoxicity for leukemia cells since it exhibited only weak cytotoxicity against a normal lymphocyte cell line (RPMI 1788).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT-evtXVsQArVg90H21EOLACvtfcHk0li4OmwXceJptg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjt7o%253D&md5=caec0cc3149a22b138ad23ea1165fa84</span></div><a href="/servlet/linkout?suffix=cit293&amp;dbid=16384&amp;doi=10.1021%2Fnp100783k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100783k%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26aulast%3DNoto%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DTabata%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DAkihisa%26aufirst%3DT.%26atitle%3DCytotoxic%2520and%2520apoptosis-inducing%2520activities%2520of%2520limonoids%2520from%2520the%2520seeds%2520of%2520Azadirachta%2520indica%2520%2528Neem%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D866%26epage%3D870%26doi%3D10.1021%2Fnp100783k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref294"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref294'); return false;" data-citation="" class="refNumLink">294</a></strong><div class="NLM_citation" id="cit294"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, G. E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Gedunin, a novel Hsp90 inhibitor: Semisynthesis of derivatives and preliminary structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6502</span>, <span class="refDoi"> DOI: 10.1021/jm8007486</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8007486" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKlurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6495-6502&author=G.+E.+L.+Brandtauthor=M.+D.+Schmidtauthor=T.+E.+Prisinzanoauthor=B.+S.+J.+Blagg&title=Gedunin%2C+a+novel+Hsp90+inhibitor%3A+Semisynthesis+of+derivatives+and+preliminary+structure-activity+relationships&doi=10.1021%2Fjm8007486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit294R"><div class="casContent"><span class="casTitleNuber">294</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin, a Novel Hsp90 Inhibitor: Semisynthesis of Derivatives and Preliminary Structure-Activity Relationships</span></div><div class="casAuthors">Brandt, Gary E. L.; Schmidt, Matthew D.; Prisinzano, Thomas E.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6495-6502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gedunin, a tetranortriterpenoid isolated from the Indian neem tree (Azadirachta indica), was recently shown to manifest anticancer activity via inhibition of the 90 kDa heat shock protein (Hsp90) folding machinery and to induce the degrdn. of Hsp90-dependent client proteins similar to other Hsp90 inhibitors.  The mechanism of action by which gedunin induces client protein degrdn. remains undetd., however, prior studies have demonstrated that it does not bind competitively vs. ATP.  In an effort to further probe the mechanism of action, 19 semisynthetic derivs. of gedunin were prepd. and their antiproliferative activity against MCF-7 and SkBr3 breast cancer cells detd.  Although no compd. was found to exhibit antiproliferative activity more effective than the natural product, functionalities crit. for antiproliferative activity have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTdQv-gkImM7Vg90H21EOLACvtfcHk0ljZOy-vwAyIHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKlurrI&md5=d54c7fe7c950be8ad291c0dc67561fa5</span></div><a href="/servlet/linkout?suffix=cit294&amp;dbid=16384&amp;doi=10.1021%2Fjm8007486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007486%26sid%3Dliteratum%253Aachs%26aulast%3DBrandt%26aufirst%3DG.%2BE.%2BL.%26aulast%3DSchmidt%26aufirst%3DM.%2BD.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DGedunin%252C%2520a%2520novel%2520Hsp90%2520inhibitor%253A%2520Semisynthesis%2520of%2520derivatives%2520and%2520preliminary%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6495%26epage%3D6502%26doi%3D10.1021%2Fjm8007486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref295"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref295'); return false;" data-citation="" class="refNumLink">295</a></strong><div class="NLM_citation" id="cit295"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kishore
T, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganugula, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gade, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Gedunin abrogates aldose reductase, PI3K/Akt/mTOR, and NF-κB signaling pathways to inhibit angiogenesis in a hamster model of oral carcinogenesis</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2083</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1007/s13277-015-4003-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs13277-015-4003-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOqurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=2083-2093&author=K.+K.+Kishore%0ATauthor=R.+Ganugulaauthor=D.+R.+Gadeauthor=G.+B.+Reddyauthor=S.+Nagini&title=Gedunin+abrogates+aldose+reductase%2C+PI3K%2FAkt%2FmTOR%2C+and+NF-%CE%BAB+signaling+pathways+to+inhibit+angiogenesis+in+a+hamster+model+of+oral+carcinogenesis&doi=10.1007%2Fs13277-015-4003-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit295R"><div class="casContent"><span class="casTitleNuber">295</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin abrogates aldose reductase, PI3K/Akt/mToR, and NF-κB signaling pathways to inhibit angiogenesis in a hamster model of oral carcinogenesis</span></div><div class="casAuthors">Kishore T, Kranthi Kiran; Ganugula, Raghu; Gade, Deepak Reddy; Reddy, Geereddy Bhanuprakash; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2083-2093</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aberrant activation of oncogenic signaling pathways plays a central role in tumor development and progression.  The aim of this present study was to investigate the chemopreventive effects of the neem limonoid gedunin in the hamster model of oral cancer based on its ability to modulate aldose reductase (AR), phosphatidyl inositol-3-kinase (PI3K)/Akt, and nuclear factor kappa B (NF-κB) pathways to block angiogenesis.  Administration of gedunin suppressed the development of HBP carcinomas by inhibiting PI3K/Akt and NF-κB pathways through the inactivation of Akt and inhibitory kappa B kinase (IKK), resp.  Immunoblot and mol. docking interactions revealed that inhibition of these signaling pathways may be mediated via inactivation of AR by gedunin.  Gedunin blocked angiogenesis by downregulating the expression of miR-21 and the pro-angiogenic factors vascular endothelial growth factor and hypoxia inducible factor-1 alpha (HIF-1α).  In conclusion, the results of the present study provide compelling evidence that gedunin prevents progression of hamster buccal pouch (HBP) carcinomas via inhibition of the kinases Akt, IKK, and AR, and the oncogenic transcription factors NF-κB and HIF-1α to block angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKS7QK2BvbbbVg90H21EOLACvtfcHk0lj8TY1sXj-Y3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOqurvP&md5=cd1a476a99942d3540abb50dc6129cb4</span></div><a href="/servlet/linkout?suffix=cit295&amp;dbid=16384&amp;doi=10.1007%2Fs13277-015-4003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-015-4003-0%26sid%3Dliteratum%253Aachs%26aulast%3DKishore%2BT%26aufirst%3DK.%2BK.%26aulast%3DGanugula%26aufirst%3DR.%26aulast%3DGade%26aufirst%3DD.%2BR.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DGedunin%2520abrogates%2520aldose%2520reductase%252C%2520PI3K%252FAkt%252FmTOR%252C%2520and%2520NF-%25CE%25BAB%2520signaling%2520pathways%2520to%2520inhibit%2520angiogenesis%2520in%2520a%2520hamster%2520model%2520of%2520oral%2520carcinogenesis%26jtitle%3DTumor%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D2083%26epage%3D2093%26doi%3D10.1007%2Fs13277-015-4003-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref296"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref296'); return false;" data-citation="" class="refNumLink">296</a></strong><div class="NLM_citation" id="cit296"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasanain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span> <span> </span><span class="NLM_article-title">Gedunin isolated from the mangrove plant <i>Xylocarpus granatum</i> exerts its anti-proliferative activity in ovarian cancer cells through G2/M-phase arrest and oxidative stress-mediated intrinsic apoptosis</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1007/s10495-020-01605-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs10495-020-01605-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32399945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpt1Kgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=481-499&author=R.+Sahaiauthor=A.+Bhattacharjeeauthor=V.+N.+Shuklaauthor=P.+Yadavauthor=M.+Hasanainauthor=J.+Sarkarauthor=T.+Narenderauthor=K.+Mitra&title=Gedunin+isolated+from+the+mangrove+plant+Xylocarpus+granatum+exerts+its+anti-proliferative+activity+in+ovarian+cancer+cells+through+G2%2FM-phase+arrest+and+oxidative+stress-mediated+intrinsic+apoptosis&doi=10.1007%2Fs10495-020-01605-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit296R"><div class="casContent"><span class="casTitleNuber">296</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin isolated from the mangrove plant Xylocarpus granatum exerts its anti-proliferative activity in ovarian cancer cells through G2/M-phase arrest and oxidative stress-mediated intrinsic apoptosis</span></div><div class="casAuthors">Sahai, Rohit; Bhattacharjee, Arindam; Shukla, Vishwa Nath; Yadav, Pragya; Hasanain, Mohammad; Sarkar, Jayanta; Narender, T.; Mitra, Kalyan</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">481-499</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Here, we describe the mol. mechanisms underlying the in vitro anti proliferative activity of gedunin (isolated from the mangrove plant Xylocarpus granatum) in human ovarian cancer cells.  We obsd. that gedunin triggered severe ROS generation leading to DNA damage and cell cycle arrest in G2/M phase thus inhibiting cell proliferation.  ROS upregulation also led to mitochondrial stress and membrane depolarization, which eventually resulted in mitochondria-mediated apoptosis following cytochrome C release, caspase 9, 3 activation, and PARP cleavage.  Moreover, an upregulation in stress kinases like phospho-ERK 1/2, phospho-p38 and phospho-JNK was also obsd. in gedunin treated cells.  Free radical scavenger N-Acetyl-L-Cysteine (NAC) reversed all these effects resulting in increased cell survival, abrogation of cell cycle arrest, rescue of mitochondrial membrane potential and suppression of apoptotic markers.  Interestingly, gedunin is also an inhibitor of the evolutionarily conserved mol. chaperone Heat Shock Protein 90 (hsp90) responsible for maintaining cellular homeostasis.  Targeting this chaperone could be an attractive strategy for developing cancer therapeutics since many oncogenic proteins are also client proteins of hsp90.  Collectively, our findings provide insights into the mol. mechanism of action of gedunin, which may aid drug development efforts against ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEWpWXaD9Uh7Vg90H21EOLACvtfcHk0lj8TY1sXj-Y3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpt1Kgurs%253D&md5=f2411a5d92f4961293ccd4dc4ff8e23e</span></div><a href="/servlet/linkout?suffix=cit296&amp;dbid=16384&amp;doi=10.1007%2Fs10495-020-01605-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-020-01605-5%26sid%3Dliteratum%253Aachs%26aulast%3DSahai%26aufirst%3DR.%26aulast%3DBhattacharjee%26aufirst%3DA.%26aulast%3DShukla%26aufirst%3DV.%2BN.%26aulast%3DYadav%26aufirst%3DP.%26aulast%3DHasanain%26aufirst%3DM.%26aulast%3DSarkar%26aufirst%3DJ.%26aulast%3DNarender%26aufirst%3DT.%26aulast%3DMitra%26aufirst%3DK.%26atitle%3DGedunin%2520isolated%2520from%2520the%2520mangrove%2520plant%2520Xylocarpus%2520granatum%2520exerts%2520its%2520anti-proliferative%2520activity%2520in%2520ovarian%2520cancer%2520cells%2520through%2520G2%252FM-phase%2520arrest%2520and%2520oxidative%2520stress-mediated%2520intrinsic%2520apoptosis%26jtitle%3DApoptosis%26date%3D2020%26volume%3D25%26spage%3D481%26epage%3D499%26doi%3D10.1007%2Fs10495-020-01605-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref297"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref297'); return false;" data-citation="" class="refNumLink">297</a></strong><div class="NLM_citation" id="cit297"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patwardhan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadli, A.</span></span> <span> </span><span class="NLM_article-title">Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">7313</span>– <span class="NLM_lpage">7325</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.427328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M112.427328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23355466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslegsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=7313-7325&author=C.+A.+Patwardhanauthor=A.+Fauqauthor=L.+B.+Petersonauthor=C.+Millerauthor=B.+S.+J.+Blaggauthor=A.+Chadli&title=Gedunin+inactivates+the+co-chaperone+p23+protein+causing+cancer+cell+death+by+apoptosis&doi=10.1074%2Fjbc.M112.427328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit297R"><div class="casContent"><span class="casTitleNuber">297</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis</span></div><div class="casAuthors">Patwardhan, Chaitanya A.; Fauq, Abdul; Peterson, Laura B.; Miller, Charles; Blagg, Brian S. J.; Chadli, Ahmed</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7313-7325</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pharmacol. inhibition of Hsp90 is an exciting option for cancer therapy.  The clin. efficacy of Hsp90 inhibitors is, however, less than expected.  Binding of the co-chaperone p23 to Hsp90 and induced overexpression of anti-apoptotic proteins Hsp70 and Hsp27 are thought to contribute to this outcome.  Herein, we report that the natural product gedunin may provide a new alternative to inactivate the Hsp90 machine.  We show that gedunin directly binds to p23 and inactivates it, without overexpression of Hsp27 and relatively modest induction of Hsp70.  Using mol. docking and mutational anal., we mapped the gedunin-binding site on p23.  Functional anal. shows that gedunin inhibits the p23 chaperoning activity, blocks its cellular interaction with Hsp90, and interferes with p23-mediated gene regulation.  Cell treatment with gedunin leads to cancer cell death by apoptosis through inactivation of p23 and activation of caspase 7, which cleaves p23 at the C terminus.  These results provide important insight into the mol. mechanism of action of this promising lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU7vrMB7OXCrVg90H21EOLACvtfcHk0lhhSoh2lFE16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslegsrY%253D&md5=23e5c129df95e868f9491de26f1b4677</span></div><a href="/servlet/linkout?suffix=cit297&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.427328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.427328%26sid%3Dliteratum%253Aachs%26aulast%3DPatwardhan%26aufirst%3DC.%2BA.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DChadli%26aufirst%3DA.%26atitle%3DGedunin%2520inactivates%2520the%2520co-chaperone%2520p23%2520protein%2520causing%2520cancer%2520cell%2520death%2520by%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D7313%26epage%3D7325%26doi%3D10.1074%2Fjbc.M112.427328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref298"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref298'); return false;" data-citation="" class="refNumLink">298</a></strong><div class="NLM_citation" id="cit298"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandy, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alabi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanaswamy, R.</span></span> <span> </span><span class="NLM_article-title">Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">10891</span>– <span class="NLM_lpage">10904</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.8055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26988754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC28fht1Omsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=10891-10904&author=R.+Subramaniauthor=E.+Gonzalezauthor=S.+B.+Nandyauthor=A.+Arumugamauthor=F.+Camachoauthor=J.+Medelauthor=D.+Alabiauthor=R.+Lakshmanaswamy&title=Gedunin+inhibits+pancreatic+cancer+by+altering+sonic+hedgehog+signaling+pathway&doi=10.18632%2Foncotarget.8055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit298R"><div class="casContent"><span class="casTitleNuber">298</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway</span></div><div class="casAuthors">Subramani Ramadevi; Nandy Sushmita Bose; Arumugam Arunkumar; Lakshmanaswamy Rajkumar; Gonzalez Elizabeth; Camacho Fernando; Medel Joshua; Alabi Damilola; Lakshmanaswamy Rajkumar</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">10891-10904</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The lack of efficient treatment options for pancreatic cancer highlights the critical need for the development of novel and effective chemotherapeutic agents.  The medicinal properties found in plants have been used to treat many different illnesses including cancers.  This study focuses on the anticancer effects of gedunin, a natural compound isolated from Azadirachta indica.  METHODS:  Anti-proliferative effect of gedunin on pancreatic cancer cells was assessed using MTS assay.  We used matrigel invasion assay, scratch assay, and soft agar colony formation assay to measure the anti-metastatic potential of gedunin.  Immunoblotting was performed to analyze the effect of gedunin on the expression of key proteins involved in pancreatic cancer growth and metastasis.  Gedunin induced apoptosis was measured using flow cytometric analysis.  To further validate, xenograft studies with HPAC cells were performed.  RESULTS:  Gedunin treatment is highly effective in inducing death of pancreatic cancer cells via intrinsic and extrinsic mediated apoptosis.  Our data further indicates that gedunin inhibited metastasis of pancreatic cancer cells by decreasing their EMT, invasive, migratory and colony formation capabilities.  Gedunin treatment also inhibited sonic hedgehog signaling pathways.  Further, experiments with recombinant sonic hedgehog protein and Gli inhibitor (Gant-61) demonstrated that gedunin induces its anti-metastatic effect through inhibition of sonic hedgehog signaling.  The anti-cancer effect of gedunin was further validated using xenograft mouse model.  CONCLUSION:  Overall, our data suggests that gedunin could serve as a potent anticancer agent against pancreatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqYlHGuiBnVX6oPH0mYWL1fW6udTcc2eYC9Njm-cQek7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fht1Omsw%253D%253D&md5=838e085eef92530d468c038d3a894a98</span></div><a href="/servlet/linkout?suffix=cit298&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8055%26sid%3Dliteratum%253Aachs%26aulast%3DSubramani%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DNandy%26aufirst%3DS.%2BB.%26aulast%3DArumugam%26aufirst%3DA.%26aulast%3DCamacho%26aufirst%3DF.%26aulast%3DMedel%26aufirst%3DJ.%26aulast%3DAlabi%26aufirst%3DD.%26aulast%3DLakshmanaswamy%26aufirst%3DR.%26atitle%3DGedunin%2520inhibits%2520pancreatic%2520cancer%2520by%2520altering%2520sonic%2520hedgehog%2520signaling%2520pathway%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D10891%26epage%3D10904%26doi%3D10.18632%2Foncotarget.8055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref299"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref299'); return false;" data-citation="" class="refNumLink">299</a></strong><div class="NLM_citation" id="cit299"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siva, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkanna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poornima, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divya Reddy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boustie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usha Rani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh Babu, K.</span></span> <span> </span><span class="NLM_article-title">New seco-limonoids from <i>Cipadessa baccifera</i>: Isolation, structure determination, synthesis and their antiproliferative activities</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2017.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fitote.2017.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28065696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Ogsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=34-40&author=B.+Sivaauthor=A.+Venkannaauthor=B.+Poornimaauthor=S.+Divya+Reddyauthor=J.+Boustieauthor=S.+Bastienauthor=N.+Jainauthor=P.+Usha+Raniauthor=K.+Suresh+Babu&title=New+seco-limonoids+from+Cipadessa+baccifera%3A+Isolation%2C+structure+determination%2C+synthesis+and+their+antiproliferative+activities&doi=10.1016%2Fj.fitote.2017.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit299R"><div class="casContent"><span class="casTitleNuber">299</span><div class="casTitle"><span class="NLM_cas:atitle">New seco-limonoids from Cipadessa baccifera: Isolation, structure determination, synthesis and their antiproliferative activities</span></div><div class="casAuthors">Siva, Bandi; Venkanna, Arramshetti; Poornima, Borra; Divya Reddy, Solipeta; Boustie, Joel; Bastien, Schnell; Jain, Nishant; Usha Rani, Pathipati; Suresh Babu, Katragadda</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-40</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A comprehensive reinvestigation of chem. constituents from CHCl3-sol. ext. of Cipadessa baccifera led to the isolation of two new limonoids 1, 2 together with six known compds. 3-8.  Their structures were established on the basis of extensive anal. of spectroscopic (IR, MS, 2D NMR) data.  Further, a series of cipaferen G (3) derivs. were efficiently synthesized utilizing Yamaguchi esterification (2, 4, 6-trichlorobenzoyl chloride, Et3N, THF, DMAP, toluene) at the C-3 position of the limonoids core, which is being reported for the first time.  The anti-proliferative activity of the isolates and the synthetic analogs were studied against HeLa, PANC 1, HepG2, SKNSH, MDA-MB-231 and IMR32 cancer cells using the sulforodamine B assay.  Among the tested compds., 13d and 13h manifested potent activity against IMR32, HepG2 cell lines with GI50 0.013 and 0.01 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraz0jU3UW0GrVg90H21EOLACvtfcHk0lii4fvS8N-dVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Ogsg%253D%253D&md5=1c43c961fca04b5bc00fa9a28a4a03d8</span></div><a href="/servlet/linkout?suffix=cit299&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2017.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2017.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DSiva%26aufirst%3DB.%26aulast%3DVenkanna%26aufirst%3DA.%26aulast%3DPoornima%26aufirst%3DB.%26aulast%3DDivya%2BReddy%26aufirst%3DS.%26aulast%3DBoustie%26aufirst%3DJ.%26aulast%3DBastien%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DUsha%2BRani%26aufirst%3DP.%26aulast%3DSuresh%2BBabu%26aufirst%3DK.%26atitle%3DNew%2520seco-limonoids%2520from%2520Cipadessa%2520baccifera%253A%2520Isolation%252C%2520structure%2520determination%252C%2520synthesis%2520and%2520their%2520antiproliferative%2520activities%26jtitle%3DFitoterapia%26date%3D2017%26volume%3D117%26spage%3D34%26epage%3D40%26doi%3D10.1016%2Fj.fitote.2017.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref300"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref300'); return false;" data-citation="" class="refNumLink">300</a></strong><div class="NLM_citation" id="cit300"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekong, D. E. U.</span></span> <span> </span><span class="NLM_article-title">Chemistry of the meliacins (limonoids). The structure of nimbolide, a new meliacin from <i>Azadirachta indica</i></span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_fpage">808</span>, <span class="refDoi"> DOI: 10.1039/C1967000808A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC1967000808A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF1cXitFyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1967&pages=808&author=D.+E.+U.+Ekong&title=Chemistry+of+the+meliacins+%28limonoids%29.+The+structure+of+nimbolide%2C+a+new+meliacin+from+Azadirachta+indica&doi=10.1039%2FC1967000808A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit300R"><div class="casContent"><span class="casTitleNuber">300</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of the meliacins (Limonoids).  Structure of nimbolide, a new meliacin from Azadirachta indica</span></div><div class="casAuthors">Ekong, Donald E. U.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (London)</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">808</span>CODEN:
                <span class="NLM_cas:coden">CCOMA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-241X</span>.
    </div><div class="casAbstract">Extn. of fresh leaves of Nigerian samples of A. indica yielded a new meliacin, nimbolide (I), m. 245-7°, [α]D 206°.  The structure was assigned on the basis of N.M.R. and ir data.  Partial hydrogenation of I gave a dihydro deriv. which was hydrolyzed with dil. alkali to give deacetyldihydronimbic acid, m. 192-4°, [α]D 217° (pyridine) reported earlier (Sengupta, et al., CA 55: 4574e).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJ1CsTD0T3LVg90H21EOLACvtfcHk0lii4fvS8N-dVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXitFyltQ%253D%253D&md5=3d4acd5eabb55b76b343a4b0f5ae0f96</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.1039%2FC1967000808A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1967000808A%26sid%3Dliteratum%253Aachs%26aulast%3DEkong%26aufirst%3DD.%2BE.%2BU.%26atitle%3DChemistry%2520of%2520the%2520meliacins%2520%2528limonoids%2529.%2520The%2520structure%2520of%2520nimbolide%252C%2520a%2520new%2520meliacin%2520from%2520Azadirachta%2520indica%26jtitle%3DChem.%2520Commun.%26date%3D1967%26spage%3D808%26doi%3D10.1039%2FC1967000808A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref301"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref301'); return false;" data-citation="" class="refNumLink">301</a></strong><div class="NLM_citation" id="cit301"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raj, J. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, G.</span></span> <span> </span><span class="NLM_article-title">The isomeric compounds nimbolide and isonimbolide</span>. <i>Acta Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>C61</i></span>,  <span class="NLM_fpage">o70</span>– <span class="NLM_lpage">o72</span>, <span class="refDoi"> DOI: 10.1107/S0108270104031385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270104031385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C61&publication_year=2005&pages=o70-o72&author=K.+A.+Solomonauthor=R.+Malathiauthor=S.+S.+Rajanauthor=G.+Anithaauthor=J.+J.+L.+Rajauthor=S.+Narasimhanauthor=G.+Sureshauthor=G.+Gopalakrishnan&title=The+isomeric+compounds+nimbolide+and+isonimbolide&doi=10.1107%2FS0108270104031385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit301R"><div class="casContent"><span class="casTitleNuber">301</span><div class="casTitle"><span class="NLM_cas:atitle">The isomeric compounds nimbolide and isonimbolide</span></div><div class="casAuthors">Malathi, R.; Anitha, G.; Solomon, K. Anand; Suresh, G.; Rajan, S. S.; Narasimhan, S.; Raj, J. Josepha Lourdu; Gopalakrishnan, Geetha</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Crystal Structure Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">C61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">o70-o72</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Nimbolide [systematic name: (4α,5α,6α,7α,15β,17α)-7,15:21,23-diepoxy-6-hydroxy-4,8-dimethyl-1-oxo-18,24-dinor-11,12-secochola-2,13,20,22-tetraene-4,11-dicarboxylic acid γ-lactone Me ester], C27H30O7, was isolated from the leaves of Azadirachta indica, and its isomer, isonimbolide [systematic name: (4α,5α,6α,7α,15α)-7,15:21,23-diepoxy-6-hydroxy-4,8-dimethyl-1-oxo-18,24-dinor-11,12-secochola-2,16,20,22-tetraene-4,11-dicarboxylic acid γ-lactone Me ester], was prepd. from a novel rearrangement reaction of nimbolide, using B trifluoride etherate and Bu4NBr.  The reaction conditions are probably responsible for the ether cleavage, double-bond rearrangement and reformation of the ether linkage.  As a result, there are conformational changes in two cyclopentane rings and the side-chain -CH2COOMe group.  In isonimbolide, an R44(24) H-bond motif is obsd.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRhAvCkE9rx7Vg90H21EOLACvtfcHk0lhTGUzp5kHG7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslWhsg%253D%253D&md5=5877bf3e1a96c15a4970d66a71463b84</span></div><a href="/servlet/linkout?suffix=cit301&amp;dbid=16384&amp;doi=10.1107%2FS0108270104031385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270104031385%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DK.%2BA.%26aulast%3DMalathi%26aufirst%3DR.%26aulast%3DRajan%26aufirst%3DS.%2BS.%26aulast%3DAnitha%26aufirst%3DG.%26aulast%3DRaj%26aufirst%3DJ.%2BJ.%2BL.%26aulast%3DNarasimhan%26aufirst%3DS.%26aulast%3DSuresh%26aufirst%3DG.%26aulast%3DGopalakrishnan%26aufirst%3DG.%26atitle%3DThe%2520isomeric%2520compounds%2520nimbolide%2520and%2520isonimbolide%26jtitle%3DActa%2520Crystallogr.%26date%3D2005%26volume%3DC61%26spage%3Do70%26epage%3Do72%26doi%3D10.1107%2FS0108270104031385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref302"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref302'); return false;" data-citation="" class="refNumLink">302</a></strong><div class="NLM_citation" id="cit302"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodduluru, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasala, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barua, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistla, R.</span></span> <span> </span><span class="NLM_article-title">Chemopreventive and therapeutic effects of nimbolide in cancer: The underlying mechanisms</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1026</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2014.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tiv.2014.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24759803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVSjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1026-1035&author=L.+N.+Bodduluruauthor=E.+R.+Kasalaauthor=N.+Thotaauthor=C.+C.+Baruaauthor=R.+Sistla&title=Chemopreventive+and+therapeutic+effects+of+nimbolide+in+cancer%3A+The+underlying+mechanisms&doi=10.1016%2Fj.tiv.2014.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit302R"><div class="casContent"><span class="casTitleNuber">302</span><div class="casTitle"><span class="NLM_cas:atitle">Chemopreventive and therapeutic effects of nimbolide in cancer: The underlying mechanisms</span></div><div class="casAuthors">Bodduluru, Lakshmi Narendra; Kasala, Eshvendar Reddy; Thota, Nagaraju; Barua, Chandana C.; Sistla, Ramakrishna</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1026-1035</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer chemoprevention is a strategy taken to block, reverse or retard the multistep process of carcinogenesis, including the blockage of its vital morphogenetic milestones viz. normal-preneoplasia-neoplasia-metastasis.  Naturally occurring phytochems. are becoming increasingly popular over synthetic drugs for several reasons, including safety, efficacy and easy availability.  Nimbolide, a triterpene derived from the leaves and flowers of neem, is widely used in traditional medical practices for treating various human ailments.  The neem limonoid exhibits multiple pharmacol. effects among which its anticancer activity is the most promising.  The preclin. and mechanistic studies carried over the decades have shown that nimbolide inhibits tumorigenesis and metastasis without any toxicity and unwanted side effects.  Nimbolide exhibits anticancer activity through selective modulation of multiple cell signaling pathways linked to inflammation, survival, growth, invasion, angiogenesis and metastasis.  The present review highlights the current knowledge on mol. targets that contribute to the obsd. anticancer activity of nimbolide related to (i) inhibition of carcinogenic activation and induction of antioxidant and carcinogen detoxification enzymes, (ii) induction of growth arrest and apoptosis; and (iii) suppression of proinflammatory signaling pathways related to cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw6LNFCh0SfrVg90H21EOLACvtfcHk0lgvIuUC1mefzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVSjurw%253D&md5=2960e01d6a1432bcc1f7dfd44565b773</span></div><a href="/servlet/linkout?suffix=cit302&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2014.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBodduluru%26aufirst%3DL.%2BN.%26aulast%3DKasala%26aufirst%3DE.%2BR.%26aulast%3DThota%26aufirst%3DN.%26aulast%3DBarua%26aufirst%3DC.%2BC.%26aulast%3DSistla%26aufirst%3DR.%26atitle%3DChemopreventive%2520and%2520therapeutic%2520effects%2520of%2520nimbolide%2520in%2520cancer%253A%2520The%2520underlying%2520mechanisms%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2014%26volume%3D28%26spage%3D1026%26epage%3D1035%26doi%3D10.1016%2Fj.tiv.2014.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref303"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref303'); return false;" data-citation="" class="refNumLink">303</a></strong><div class="NLM_citation" id="cit303"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, D. D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuya, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. L.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span> <span> </span><span class="NLM_article-title">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">44790</span>– <span class="NLM_lpage">44802</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.8316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27027349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=44790-44802&author=L.+Wangauthor=D.+D.+K.+Phanauthor=J.+Zhangauthor=P.-S.+Ongauthor=W.+L.+Thuyaauthor=R.+Sooauthor=A.+L.-A.+Wongauthor=W.+P.+Yongauthor=S.+C.+Leeauthor=P.+C.-L.+Hoauthor=G.+Sethiauthor=B.+C.+Goh&title=Anticancer+properties+of+nimbolide+and+pharmacokinetic+considerations+to+accelerate+its+development&doi=10.18632%2Foncotarget.8316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit303R"><div class="casContent"><span class="casTitleNuber">303</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span></div><div class="casAuthors">Wang Lingzhi; Phan Do Dang Khoa; Thuya Win Lwin; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher; Wang Lingzhi; Zhang Jingwen; Sethi Gautam; Goh Boon Cher; Phan Do Dang Khoa; Ong Pei-Shi; Thuya Win Lwin; Ho Paul Chi-Lui; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">44790-44802</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nimbolide is one of the main components in the leaf extract of Azadirachta indica (A. indica).  Accumulating evidence from various in vitro and in vivo studies indicates that nimbolide possesses potent anticancer activity against several types of cancer and also shows potential chemopreventive activity in animal models.  The main mechanisms of action of nimbolide include anti-proliferation, induction of apoptosis, inhibition of metastasis and angiogenesis, and modulation of carcinogen-metabolizing enzymes.  Although multiple pharmacodynamic (PD) studies have been carried out, nimbolide is still at the infant stage in the drug development pipeline due to the lack of systematic pharmacokinetic (PK) studies and long-term toxicological studies.  Preclinical PK and toxicological studies are vital in determining the dosage range to support the safety of nimbolide for first-in-human clinical trials.  In this review, we will provide a comprehensive summary for the current status of nimbolide as an anticancer and chemopreventive lead compound, and highlight the importance of systematic preclinical PK and toxicological studies in accelerating the process of application of nimbolide as a therapeutic agent against various malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi_DV2txfJVny-c-E1v-fmfW6udTcc2ebXkzm94Jn1i7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D&md5=67bb5ca109816b6a367c1ed03239fe76</span></div><a href="/servlet/linkout?suffix=cit303&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8316%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPhan%26aufirst%3DD.%2BD.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DOng%26aufirst%3DP.-S.%26aulast%3DThuya%26aufirst%3DW.%2BL.%26aulast%3DSoo%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DA.%2BL.-A.%26aulast%3DYong%26aufirst%3DW.%2BP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DP.%2BC.-L.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26atitle%3DAnticancer%2520properties%2520of%2520nimbolide%2520and%2520pharmacokinetic%2520considerations%2520to%2520accelerate%2520its%2520development%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D44790%26epage%3D44802%26doi%3D10.18632%2Foncotarget.8316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref304"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref304'); return false;" data-citation="" class="refNumLink">304</a></strong><div class="NLM_citation" id="cit304"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kigodi, P. G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebtaranonth, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordell, G. A.</span></span> <span> </span><span class="NLM_article-title">Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from <i>Azadirachta indica</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1246</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1021/np50066a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50066a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref304/cit304&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK3cXhsFGhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1989&pages=1246-1251&author=P.+G.+K.+Kigodiauthor=G.+Blaskoauthor=Y.+Thebtaranonthauthor=J.+M.+Pezzutoauthor=G.+A.+Cordell&title=Spectroscopic+and+biological+investigation+of+nimbolide+and+28-deoxonimbolide+from+Azadirachta+indica&doi=10.1021%2Fnp50066a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit304R"><div class="casContent"><span class="casTitleNuber">304</span><div class="casTitle"><span class="NLM_cas:atitle">Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from Azadirachta indica</span></div><div class="casAuthors">Kigodi, Phillip G. K.; Blasko, Gabor; Thebtaranonth, Yodhathai; Pezzuto, John M.; Cordell, Geoffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1246-51</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">The reisolation of nimbolide (I) from A. indica of Tanzanian origin and the isolation and structure elucidation of a new limonoid, 28-deoxonimbolide (II), from the same plant source are reported.  For the first time, unambiguous 1H- and 13C-NMR assignments of compds. I and II are presented, as well as their in vitro cytotoxic activity against human tumor cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEWxq_WLQotrVg90H21EOLACvtfcHk0liSwjigwTuI2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhsFGhsLo%253D&md5=c0eceb9758deea1521533579e9167363</span></div><a href="/servlet/linkout?suffix=cit304&amp;dbid=16384&amp;doi=10.1021%2Fnp50066a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50066a008%26sid%3Dliteratum%253Aachs%26aulast%3DKigodi%26aufirst%3DP.%2BG.%2BK.%26aulast%3DBlasko%26aufirst%3DG.%26aulast%3DThebtaranonth%26aufirst%3DY.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DCordell%26aufirst%3DG.%2BA.%26atitle%3DSpectroscopic%2520and%2520biological%2520investigation%2520of%2520nimbolide%2520and%252028-deoxonimbolide%2520from%2520Azadirachta%2520indica%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1989%26volume%3D52%26spage%3D1246%26epage%3D1251%26doi%3D10.1021%2Fnp50066a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref305"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref305'); return false;" data-citation="" class="refNumLink">305</a></strong><div class="NLM_citation" id="cit305"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunadharini, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senthilkumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banudevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2012.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.toxlet.2012.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23089555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2012&pages=131-142&author=P.+Elumalaiauthor=D.+N.+Gunadhariniauthor=K.+Senthilkumarauthor=S.+Banudeviauthor=R.+Arunkumarauthor=C.+S.+Bensonauthor=G.+Sharmilaauthor=J.+Arunakaran&title=Induction+of+apoptosis+in+human+breast+cancer+cells+by+nimbolide+through+extrinsic+and+intrinsic+pathway&doi=10.1016%2Fj.toxlet.2012.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit305R"><div class="casContent"><span class="casTitleNuber">305</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span></div><div class="casAuthors">Elumalai, P.; Gunadharini, D. N.; Senthilkumar, K.; Banudevi, S.; Arunkumar, R.; Benson, C. S.; Sharmila, G.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">We aimed to investigate the cytotoxic effects of nimbolide, a limonoid present in leaves and flowers of the neem tree (Azadirachta indica) on human breast cancer cells.  The mol. mechanisms involved in the apoptotic activity exerted by nimbolide were studied on the estrogen dependent (MCF-7) and estrogen independent (MDA-MB-231) human breast cancer cell lines.  The growth inhibitory effect of nimbolide was assessed by MTT assay.  Apoptosis induction by nimbolide treatment was detd. by JC-1 mitochondrial membrane potential staining, cytochrome c release, caspase activation, cleavage of PARP and AO/EtBr dual staining.  The modulation of apoptotic proteins (intrinsic pathway: Bax, bad, Bcl-2, Bcl-xL, Mcl-1, XIAP-1 and caspase-3, 9; extrinsic pathway: TRAIL, FasL, FADDR and Caspase-8) were studied by western blot and real time PCR anal.  Treatment with nimbolide resulted in dose and time-dependent inhibition of growth of MCF-7 and MDA-MB-231 cells.  The occurrence of apoptosis in these cells was indicated by JC-1 staining, modulation of both intrinsic and extrinsic apoptotic signaling mols. expression and further apoptosis was confirmed by AO/EtBr dual staining.  These events were assocd. with: increased levels of proapoptotic proteins Bax, Bad, Fas-L, TRAIL, FADDR, cytochrome c and reduced levels of the anti-apoptotic proteins Bcl-2, Bcl-xL, Mcl-1 and XIAP-1.  Nimbolide induces the cleavage of pro-caspase-8, pro-caspase-3 and PARP.  The above data suggest that nimbolide induces apoptosis by both the intrinsic and extrinsic pathways.  With evidence of above data it is suggested that nimbolide exhibit anticancer effect through its apoptosis-inducing property.  Thus, nimbolide raises new hope for its use in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu-R8QusMprVg90H21EOLACvtfcHk0liSwjigwTuI2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ&md5=39fb463162d9c9fb21e707b2af5b2b1a</span></div><a href="/servlet/linkout?suffix=cit305&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2012.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DGunadharini%26aufirst%3DD.%2BN.%26aulast%3DSenthilkumar%26aufirst%3DK.%26aulast%3DBanudevi%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DBenson%26aufirst%3DC.%2BS.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520nimbolide%2520through%2520extrinsic%2520and%2520intrinsic%2520pathway%26jtitle%3DToxicol.%2520Lett.%26date%3D2012%26volume%3D215%26spage%3D131%26epage%3D142%26doi%3D10.1016%2Fj.toxlet.2012.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref306"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref306'); return false;" data-citation="" class="refNumLink">306</a></strong><div class="NLM_citation" id="cit306"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span> <span> </span><span class="NLM_article-title">In-vitro morphological assessment of apoptosis induced by nimbolide; a limonoid from <i>Azadirachta indica</i> (neem tree)</span>. <i>Iran. J. Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.22037/ijpr.2019.2391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.22037%2Fijpr.2019.2391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31531067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslWjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=846-859&author=M.+Kashifauthor=Y.+Hwangauthor=W.-J.+Kimauthor=G.+Kim&title=In-vitro+morphological+assessment+of+apoptosis+induced+by+nimbolide%3B+a+limonoid+from+Azadirachta+indica+%28neem+tree%29&doi=10.22037%2Fijpr.2019.2391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit306R"><div class="casContent"><span class="casTitleNuber">306</span><div class="casTitle"><span class="NLM_cas:atitle">In-vitro morphological assessment of apoptosis induced by nimbolide; a limonoid from Azadirachta Indica (Neem Tree)</span></div><div class="casAuthors">Kashif, Muhammad; Hwang, Yawon; Kim, Wun-Jae; Kim, Gonhyung</div><div class="citationInfo"><span class="NLM_cas:title">Iranian Journal of Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">IJPRC9</span>;
        ISSN:<span class="NLM_cas:issn">1726-6890</span>.
    
            (<span class="NLM_cas:orgname">Shaheed Beheshti University of Medical Sciences and Health Services, School of Pharmacy</span>)
        </div><div class="casAbstract">The present study was designed to investigate the in-vitro morphol. assessment of apoptotic effect caused by nimbolide on the selected cancer cell lines (DU-145, PC-3, A-549) and normal cell lines (NIH3T3, CCD-18Co).  The cells were grown in 6 well tissue culture plates after treatment with different concns. of nimbolide and untreated control cells.  Apoptotic and necrotic cells were measured using Hoechst 33342 and propidium iodide dual staining through a fluorescent microscope and also by staining with annexin V and propidium iodide through flow cytometric anal.  The activity of caspase 3, 8, and 9 was measured by caspases colorimetric assay kits.  The no. of apoptotic and necrotic cells were significantly higher in all selected cancer cell lines treated with nimbolide as compared with untreated control cells, whereas in normal cell lines no significant difference was obsd. between nimbolide treated and untreated cells.  The activity of caspase 3, 8, and 9 was also significantly higher in all cancer cell lines treated with nimbolide as compared with untreated control cells while it did not change significantly in normal cell lines as compared with untreated control.  The results of the present study suggested that nimbolide induced apoptosis only in cancer cells without affecting the normal cells and one of the apoptosis inducing mechanism is through the activation of caspases signaling pathways.  Therefore, nimbolide may be a novel promising candidate as an anticancer drug in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-Y7uLRJX5rVg90H21EOLACvtfcHk0ljojar5ywDO7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslWjs74%253D&md5=b847513080499ac9c6b989307aab881b</span></div><a href="/servlet/linkout?suffix=cit306&amp;dbid=16384&amp;doi=10.22037%2Fijpr.2019.2391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.22037%252Fijpr.2019.2391%26sid%3Dliteratum%253Aachs%26aulast%3DKashif%26aufirst%3DM.%26aulast%3DHwang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DW.-J.%26aulast%3DKim%26aufirst%3DG.%26atitle%3DIn-vitro%2520morphological%2520assessment%2520of%2520apoptosis%2520induced%2520by%2520nimbolide%253B%2520a%2520limonoid%2520from%2520Azadirachta%2520indica%2520%2528neem%2520tree%2529%26jtitle%3DIran.%2520J.%2520Pharm.%2520Res.%26date%3D2019%26volume%3D18%26spage%3D846%26epage%3D859%26doi%3D10.22037%2Fijpr.2019.2391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref307"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref307'); return false;" data-citation="" class="refNumLink">307</a></strong><div class="NLM_citation" id="cit307"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inigo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref307/cit307&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.canlet.2017.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref307/cit307&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29107110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref307/cit307&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2018&pages=82-93&author=S.+Kumarauthor=J.+R.+Inigoauthor=R.+Kumarauthor=A.+K.+Chaudharyauthor=J.+O%E2%80%99Malleyauthor=S.+Balachandarauthor=J.+Wangauthor=K.+Attwoodauthor=N.+Yadavauthor=S.+Hochwaldauthor=X.+Wangauthor=D.+Chandra&title=Nimbolide+reduces+CD44+positive+cell+population+and+induces+mitochondrial+apoptosis+in+pancreatic+cancer+cells&doi=10.1016%2Fj.canlet.2017.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit307R"><div class="casContent"><span class="casTitleNuber">307</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span></div><div class="casAuthors">Kumar, Sandeep; Inigo, Joseph R.; Kumar, Rahul; Chaudhary, Ajay K.; O'Malley, Jordan; Balachandar, Srimmitha; Wang, Jianmin; Attwood, Kristopher; Yadav, Neelu; Hochwald, Steven; Wang, Xinjiang; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive disease and current treatment regimens fail to effectively cure PDAC.  Development of resistance to current therapy is one of the key reasons for this outcome.  Nimbolide (NL), a triterpenoid obtained from Azadirachta indica, exhibits anticancer properties in various cancer including PDAC cells.  However, the underlying mechanism of this anticancer agent in PDAC cells remains undefined.  We show that NL exerts a higher level of apoptotic cell death compared to the first-line agent gemcitabine for PDAC, as well as other anticancer agents including sorafenib and curcumin.  The anticancer efficacy of NL was further evidenced by a redn. in the CD44+ as well as cancer stem-like cell (CSC) population, as it causes decreased sphere formation.  Mechanistically, the anticancer efficacy of NL assocs. with reduced mutant p53 as well as increased mitochondrial activity in the form of increased mitochondrial reactive oxygen species and mitochondrial mass.  Together, this study highlights the therapeutic potential of NL in mutant p53 expressing pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWaM4J0Gt34LVg90H21EOLACvtfcHk0ljojar5ywDO7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I&md5=200e394249c261cc9bce68f32d88cc2c</span></div><a href="/servlet/linkout?suffix=cit307&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DInigo%26aufirst%3DJ.%2BR.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DChaudhary%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DJ.%26aulast%3DBalachandar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAttwood%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DHochwald%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DNimbolide%2520reduces%2520CD44%2520positive%2520cell%2520population%2520and%2520induces%2520mitochondrial%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D413%26spage%3D82%26epage%3D93%26doi%3D10.1016%2Fj.canlet.2017.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref308"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref308'); return false;" data-citation="" class="refNumLink">308</a></strong><div class="NLM_citation" id="cit308"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethumadhavan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4465</span>– <span class="NLM_lpage">4476</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref308/cit308&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1078-0432.CCR-13-0080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref308/cit308&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23766363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref308/cit308&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4465-4476&author=S.+C.+Guptaauthor=S.+Prasadauthor=D.+R.+Sethumadhavanauthor=M.+S.+Nairauthor=Y.-Y.+Moauthor=B.+B.+Aggarwal&title=Nimbolide%2C+a+limonoid+triterpene%2C+inhibits+growth+of+human+colorectal+cancer+xenografts+by+suppressing+the+proinflammatory+microenvironment&doi=10.1158%2F1078-0432.CCR-13-0080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit308R"><div class="casContent"><span class="casTitleNuber">308</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment</span></div><div class="casAuthors">Gupta, Subash C.; Prasad, Sahdeo; Sethumadhavan, Dhanya R.; Nair, Mangalam S.; Mo, Yin-Yuan; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4465-4476</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Extensive research over the past decade has revealed that the proinflammatory microenvironment plays a crit. role in the development of colorectal cancer.  Whether nimbolide, a limonoid triterpene, can inhibit the growth of colorectal cancer was investigated in the present study.  Exptl. Design: The effect of nimbolide on proliferation of colorectal cancer cell lines was examd. by MTT assay, apoptosis by caspase activation and poly-ADP ribose polymerase cleavage, NF-κB activation by DNA-binding assay, and protein expression by Western blotting.  The effect of nimbolide on the tumor growth in vivo was examd. in colorectal cancer xenografts in a nude mouse model.  Results: Nimbolide inhibited proliferation, induced apoptosis, and suppressed NF-κB activation and NF-κB-regulated tumorigenic proteins in colorectal cancer cells.  The suppression of NF-κB activation by nimbolide was caused by sequential inhibition of IκB kinase (IKK) activation, IκBα phosphorylation, and p65 nuclear translocation.  Furthermore, the effect of nimbolide on IKK activity was found to be direct.  In vivo, nimbolide (at 5 and 20 mg/kg body wt.), injected i.p. after tumor inoculation, significantly decreased the vol. of colorectal cancer xenografts.  The limonoid-treated xenografts exhibited significant downregulation in the expression of proteins involved in tumor cell survival (Bcl-2, Bcl-xL, c-IAP-1, survivin, and Mcl-1), proliferation (c-Myc and cyclin D1), invasion (MMP-9, ICAM-1), metastasis (CXCR4), and angiogenesis (VEGF).  The limonoid was found to be bioavailable in the blood plasma and tumor tissues of treated mice.  Conclusions: Our studies provide evidence that nimbolide can suppress the growth of human colorectal cancer through modulation of the proinflammatory microenvironment.  Clin Cancer Res; 19(16); 4465-76. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30IQjfm0ztrVg90H21EOLACvtfcHk0ljojar5ywDO7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP&md5=3d2f0873757d724a55912403c5647464</span></div><a href="/servlet/linkout?suffix=cit308&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0080%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DSethumadhavan%26aufirst%3DD.%2BR.%26aulast%3DNair%26aufirst%3DM.%2BS.%26aulast%3DMo%26aufirst%3DY.-Y.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DNimbolide%252C%2520a%2520limonoid%2520triterpene%252C%2520inhibits%2520growth%2520of%2520human%2520colorectal%2520cancer%2520xenografts%2520by%2520suppressing%2520the%2520proinflammatory%2520microenvironment%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4465%26epage%3D4476%26doi%3D10.1158%2F1078-0432.CCR-13-0080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref309"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref309'); return false;" data-citation="" class="refNumLink">309</a></strong><div class="NLM_citation" id="cit309"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsueh, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.-H.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1002/tox.22576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref309/cit309&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Ftox.22576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref309/cit309&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29962003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref309/cit309&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=913-922&author=K.-C.+Hsuehauthor=C.-L.+Linauthor=J.-N.+Tungauthor=S.-F.+Yangauthor=Y.-H.+Hsieh&title=Nimbolide+induced+apoptosis+by+activating+ERK-mediated+inhibition+of+c-IAP1+expression+in+human+hepatocellular+carcinoma+cells&doi=10.1002%2Ftox.22576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit309R"><div class="casContent"><span class="casTitleNuber">309</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Hsueh, Kuan-Chun; Lin, Chia-Liang; Tung, Jai-Nien; Yang, Shun-Fa; Hsieh, Yi-Hsien</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Nimbolide is one of the major compds. from the leaves and flowers of the neem tree and exhibits antitumor properties on various cancer cells.  However, no report has shown that nimbolide induces apoptosis in vitro and in vivo in human hepatocellular carcinoma cells.  Our results indicated that it inhibited cell growth in Huh-7 and PLC/PRF/5 cells.  We also found that nimbolide induced cell death through the induction of G2/M phase arrest and mitochondrial dysfunction, accompanied by the increased expression of cleaved caspase-7, caspase-9, caspase-3, caspase-PARP, and Bax and decreased expression of Mcl-1 and Bcl-2.  A human apoptosis antibody array anal. demonstrated that inhibition of the apoptosis family proteins (XIAP, c-IAP1, and c-IAP2) was one of the major targets of nimbolide.  Addnl., nimbolide sustained activation of ERK expression.  Moreover, pretreatment with U0126 (MEK inhibitor) markedly abolished nimbolide-inhibited cell viability, induced cell apoptosis, ERK phosphorylation, cleaved caspase-9, caspase-3, cleaved-PARP activation, and increased c-IAP1 expression in Huh-7 cells.  An in vivo study showed that nimbolide significantly reduced Huh-7 tumor growth and wt. in a xenograft mouse model.  This study indicated the antitumor potential of nimbolide in human hepatocellular carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolM-4DfaR-WrVg90H21EOLACvtfcHk0lj2Gey8orfiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL&md5=31599c2e87b293209bd66ec7c9f970b5</span></div><a href="/servlet/linkout?suffix=cit309&amp;dbid=16384&amp;doi=10.1002%2Ftox.22576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftox.22576%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DK.-C.%26aulast%3DLin%26aufirst%3DC.-L.%26aulast%3DTung%26aufirst%3DJ.-N.%26aulast%3DYang%26aufirst%3DS.-F.%26aulast%3DHsieh%26aufirst%3DY.-H.%26atitle%3DNimbolide%2520induced%2520apoptosis%2520by%2520activating%2520ERK-mediated%2520inhibition%2520of%2520c-IAP1%2520expression%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2018%26volume%3D33%26spage%3D913%26epage%3D922%26doi%3D10.1002%2Ftox.22576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref310"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref310'); return false;" data-citation="" class="refNumLink">310</a></strong><div class="NLM_citation" id="cit310"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutia, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manavathi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1087</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-1126-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref310/cit310&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41419-018-1126-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref310/cit310&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30352996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref310/cit310&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1087&author=J.+Sophiaauthor=J.+Kowshikauthor=A.+Dwivediauthor=S.+K.+Bhutiaauthor=B.+Manavathiauthor=R.+Mishraauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+inhibits+cytoprotective+autophagy+to+activate+apoptosis+via+modulation+of+the+PI3K%2FAkt%2FGSK-3%CE%B2+signalling+pathway+in+oral+cancer&doi=10.1038%2Fs41419-018-1126-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit310R"><div class="casContent"><span class="casTitleNuber">310</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer</span></div><div class="casAuthors">Sophia Josephraj; Kowshik Jaganathan; Nagini Siddavaram; Dwivedi Anju; Manavathi Bramanandam; Bhutia Sujit K; Mishra Rajakishore</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1087</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects.  The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3β and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells.  Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis.  Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs.  Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy.  Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis.  Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3β(Tyr216), the active form of GSK-3β that inhibits autophagy.  Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide.  Analysis of key markers of apoptosis and autophagy as well as p-Akt(Ser473) during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors.  In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3β as well as the ncRNAs miR-126 and HOTAIR.  Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUFUIs6wFK5xJfW6udTcc2eak4Kknfq41PLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D&md5=dca3631d9b3de9fa6c58e5c843002d63</span></div><a href="/servlet/linkout?suffix=cit310&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-1126-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-1126-4%26sid%3Dliteratum%253Aachs%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DDwivedi%26aufirst%3DA.%26aulast%3DBhutia%26aufirst%3DS.%2BK.%26aulast%3DManavathi%26aufirst%3DB.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520inhibits%2520cytoprotective%2520autophagy%2520to%2520activate%2520apoptosis%2520via%2520modulation%2520of%2520the%2520PI3K%252FAkt%252FGSK-3%25CE%25B2%2520signalling%2520pathway%2520in%2520oral%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D1087%26doi%3D10.1038%2Fs41419-018-1126-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref311"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref311'); return false;" data-citation="" class="refNumLink">311</a></strong><div class="NLM_citation" id="cit311"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondi, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottumukkala, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2018.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref311/cit311&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tiv.2018.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref311/cit311&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29778718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref311/cit311&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=114-128&author=V.+Pooladandaauthor=S.+Bandiauthor=S.+R.+Mondiauthor=K.+M.+Gottumukkalaauthor=C.+Godugu&title=Nimbolide+epigenetically+regulates+autophagy+and+apoptosis+in+breast+cancer&doi=10.1016%2Fj.tiv.2018.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit311R"><div class="casContent"><span class="casTitleNuber">311</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span></div><div class="casAuthors">Pooladanda, Venkatesh; Bandi, Soumya; Mondi, Sandhya Rani; Gottumukkala, Krishna Mohan; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-128</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Autophagy is a crit. regulator of cellular homeostasis and its dysregulation often results in various disease manifestations, including cancer.  Nimbolide, an active chem. constituent of neem (Azadirachta indica) exhibits potent anticancer effects.  Although, nimbolide mediated apoptosis activation in breast cancer cells is well known.  Nevertheless, its role in autophagy induction mechanism and epigenetic alteration is not explored previously.  The authors' current study intended to bridge the gaps in the existing research by exploring the potential of nimbolide in inducing autophagy, which could counter regulate the transformations in breast cancer.  In the authors' studies, nimbolide significantly inhibited the cell proliferation of MDA-MB-231 and MCF-7 cells with IC50 values of 1.97 and 5.04 μM, resp.  Nimbolide markedly arrested the cell cycle progression and cell survival with loss of mitochondrial membrane potential by reducing Bcl-2 concomitantly inducing Bax and caspases protein expression with modulation of HDAC-2 and H3K27Ac expression.  Consequently, characteristic autophagolysosome accumulation was obsd. by acridine orange, monodansylcadaverine (MDC) and Lysotracker Red staining.  Moreover, nimbolide induced autophagy signaling by increasing Beclin 1 and LC3B along with decreased p62 and mTOR protein expression.  Thus, the authors' findings imply that nimbolide induces autophagy mediated apoptotic cell death in breast cancer with epigenetic modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEtzXopBYiOLVg90H21EOLACvtfcHk0lj2Gey8orfiLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM&md5=0585d8ebe91341dec1d41a27416e657b</span></div><a href="/servlet/linkout?suffix=cit311&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2018.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2018.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DBandi%26aufirst%3DS.%26aulast%3DMondi%26aufirst%3DS.%2BR.%26aulast%3DGottumukkala%26aufirst%3DK.%2BM.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520epigenetically%2520regulates%2520autophagy%2520and%2520apoptosis%2520in%2520breast%2520cancer%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2018%26volume%3D51%26spage%3D114%26epage%3D128%26doi%3D10.1016%2Fj.tiv.2018.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref312"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref312'); return false;" data-citation="" class="refNumLink">312</a></strong><div class="NLM_citation" id="cit312"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somagoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talluri, M. V. N. K.</span></span> <span> </span><span class="NLM_article-title">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1092</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2018.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref312/cit312&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.jchromb.2018.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref312/cit312&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29908468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref312/cit312&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1092&publication_year=2018&pages=191-198&author=S.+M.+Bairaauthor=A.+Khuranaauthor=J.+Somagoniauthor=R.+Srinivasauthor=C.+Goduguauthor=M.+V.+N.+K.+Talluri&title=First+report+on+the+pharmacokinetic+profile+of+nimbolide%2C+a+novel+anticancer+agent+in+oral+and+intravenous+administrated+rats+by+LC%2FMS+method&doi=10.1016%2Fj.jchromb.2018.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit312R"><div class="casContent"><span class="casTitleNuber">312</span><div class="casTitle"><span class="NLM_cas:atitle">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span></div><div class="casAuthors">Baira, Shandilya Mahamuni; Khurana, Amit; Somagoni, Jaganmohan; Srinivas, R.; Godugu, Chandraiah; Talluri, M. V. N. Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1092</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide is a novel, natural compd. with promising potential as a drug candidate for anticancer activity.  It is isolated from the Indian traditional medicinal plant Azadirachta indica popularly known as neem.  The present study was undertaken to explore the oral bioavailability and pharmacokinetic characteristics of nimbolide in rats using the LC/QTOF/MS method.  A simple protein pptn. method using acetonitrile was employed for extg. nimbolide from rat plasma.  The chromatog. sepn. of nimbolide and the internal std. (regorafenib) was attained on an Aquity BEH C18 column (100×2.1mm, 2.7μm), using ACN and 0.1% of formic acid in water as mobile phase components in a gradient elution mode at a flow rate of 0.45mL/min over a short run time of 4min.  A mass detection was carried out using target ions of [M+H]+ at m/z 467.2074 for nimbolide and m/z 483.0847 for the internal std.  The LC/MS method was validated and all the parameters were found well within the specified limits.  The calibration curve was constructed in the range of 1-1000ng/mL.  The method shows good accuracy (91.66-97.12%) and precision (intra 2.21-6.92% CV and inter-day 2.56-4.62% CV).  This developed LC/MS method was effectively applied to the pharmacokinetic study of nimbolide upon oral and i.v. administration in rats.  In concordance with its physicochem. properties and high lipophilicity, we found that it shows poor oral absorption at different doses (10, 30 and 50mg/kg).  As expected, higher plasma levels were obsd. upon i.v. (10mg/kg) administration.  This method can be extended for evaluation of drug interaction and drug metab. in rats as well as in humans.  Moreover, our rapid and sensitive method may cater the need to accelerate the preclin. formulation development and lead optimization for future drug development of this potent anticancer agent.  Further, our oral bioavailability studies demonstrated that nimbolide possesses poor oral absorption, which could be the probable reason for the delay in therapeutic translation of this promising agent for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoozrI6BEnwjbVg90H21EOLACvtfcHk0lhBgRwjgxCoXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E&md5=a59323ce4452b99ecc9e7b5bbbd102db</span></div><a href="/servlet/linkout?suffix=cit312&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2018.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBaira%26aufirst%3DS.%2BM.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DSomagoni%26aufirst%3DJ.%26aulast%3DSrinivas%26aufirst%3DR.%26aulast%3DGodugu%26aufirst%3DC.%26aulast%3DTalluri%26aufirst%3DM.%2BV.%2BN.%2BK.%26atitle%3DFirst%2520report%2520on%2520the%2520pharmacokinetic%2520profile%2520of%2520nimbolide%252C%2520a%2520novel%2520anticancer%2520agent%2520in%2520oral%2520and%2520intravenous%2520administrated%2520rats%2520by%2520LC%252FMS%2520method%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2018%26volume%3D1092%26spage%3D191%26epage%3D198%26doi%3D10.1016%2Fj.jchromb.2018.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref313"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref313'); return false;" data-citation="" class="refNumLink">313</a></strong><div class="NLM_citation" id="cit313"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polonsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varon, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnoux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of amoorastatin</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">7731</span>– <span class="NLM_lpage">7733</span>, <span class="refDoi"> DOI: 10.1021/ja00492a051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00492a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref313/cit313&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE1MXlsFWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1978&pages=7731-7733&author=J.+Polonskyauthor=Z.+Varonauthor=B.+Arnouxauthor=C.+Pascardauthor=G.+R.+Pettitauthor=J.+M.+Schmidt&title=Isolation+and+structure+of+amoorastatin&doi=10.1021%2Fja00492a051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit313R"><div class="casContent"><span class="casTitleNuber">313</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents.  61.  Isolation and structure of amoorastatin</span></div><div class="casAuthors">Polonsky, Judith; Varon, Zoia; Arnoux, Bernadette; Pascard, Claudine; Pettit, George R.; Schmidt, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7731-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The structure of antineoplastic amoorastatin (I), isolated from seeds of Aphanamixis grandifolia, was detd. by mass spectroscopy, 1H-NMR comparison with aphanastatin, and x-ray crystal structure detn. of the (28R)-epimer of I.  Rings A and B of I have the chair conformation, ring C is in a boat conformation and ring D has an envelope-shape with C-17 out-of-plane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIiP9CWVZlorVg90H21EOLACvtfcHk0lhBgRwjgxCoXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXlsFWgtQ%253D%253D&md5=8aee9aaa815a601ba45c19537a8e5fd3</span></div><a href="/servlet/linkout?suffix=cit313&amp;dbid=16384&amp;doi=10.1021%2Fja00492a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00492a051%26sid%3Dliteratum%253Aachs%26aulast%3DPolonsky%26aufirst%3DJ.%26aulast%3DVaron%26aufirst%3DZ.%26aulast%3DArnoux%26aufirst%3DB.%26aulast%3DPascard%26aufirst%3DC.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DIsolation%2520and%2520structure%2520of%2520amoorastatin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1978%26volume%3D100%26spage%3D7731%26epage%3D7733%26doi%3D10.1021%2Fja00492a051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref314"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref314'); return false;" data-citation="" class="refNumLink">314</a></strong><div class="NLM_citation" id="cit314"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polonsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varon, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marazano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnoux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotsuki, H.</span></span> <span> </span><span class="NLM_article-title">The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatin</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1007/BF01949897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref314/cit314&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2FBF01949897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref314/cit314&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=477905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref314/cit314&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE1MXlsFChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1979&pages=987-989&author=J.+Polonskyauthor=Z.+Varonauthor=C.+Marazanoauthor=B.+Arnouxauthor=G.+R.+Pettitauthor=J.+M.+Schmidauthor=M.+Ochiauthor=H.+Kotsuki&title=The+structure+of+amoorastatone+and+the+cytotoxic+limonoid+12-hydroxyamoorastatin&doi=10.1007%2FBF01949897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit314R"><div class="casContent"><span class="casTitleNuber">314</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatin</span></div><div class="casAuthors">Polonsky, Judith; Varon, Zoia; Marazano, C.; Arnoux, Bernadette; Pettit, G. R.; Schmid, J. M.; Ochi, M.; Kotsuki, H.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">987-9</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">Two new limonoid terpenes were isolated from aq. exts. of seeds from Aphanamixis grandifolia and were identified as 12-hydroxyamoorastatin (I) and amoorastatone (II) by mass spectra and NMR data.  Unequivocal evidence for the structural assignment of I was obtained by chem. conversion to sendanin.  I significantly inhibited growth of murine P388 lymphocytic leukemia cell lines, whereas II was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTpkW87bq4I7Vg90H21EOLACvtfcHk0lhBgRwjgxCoXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXlsFChtbg%253D&md5=4570922bf69cfde7531102db32bb0fca</span></div><a href="/servlet/linkout?suffix=cit314&amp;dbid=16384&amp;doi=10.1007%2FBF01949897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01949897%26sid%3Dliteratum%253Aachs%26aulast%3DPolonsky%26aufirst%3DJ.%26aulast%3DVaron%26aufirst%3DZ.%26aulast%3DMarazano%26aufirst%3DC.%26aulast%3DArnoux%26aufirst%3DB.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSchmid%26aufirst%3DJ.%2BM.%26aulast%3DOchi%26aufirst%3DM.%26aulast%3DKotsuki%26aufirst%3DH.%26atitle%3DThe%2520structure%2520of%2520amoorastatone%2520and%2520the%2520cytotoxic%2520limonoid%252012-hydroxyamoorastatin%26jtitle%3DExperientia%26date%3D1979%26volume%3D35%26spage%3D987%26epage%3D989%26doi%3D10.1007%2FBF01949897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref315"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref315'); return false;" data-citation="" class="refNumLink">315</a></strong><div class="NLM_citation" id="cit315"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-O.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic limonoids from <i>Melia azedarach</i> var. <i>japonica</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1496</span>, <span class="refDoi"> DOI: 10.1016/S0031-9422(00)89749-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref315/cit315&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0031-9422%2800%2989749-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref315/cit315&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK2cXmslKks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=1493-1496&author=J.-W.+Ahnauthor=S.-U.+Choiauthor=C.-O.+Lee&title=Cytotoxic+limonoids+from+Melia+azedarach+var.+japonica&doi=10.1016%2FS0031-9422%2800%2989749-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit315R"><div class="casContent"><span class="casTitleNuber">315</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic limonoids from Melia azedarach var. Japonica</span></div><div class="casAuthors">Ahn, Jong-Woong; Choi, Sang-Un; Lee, Chong-Ock</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1493-6</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    </div><div class="casAbstract">Bioassay-guided chem. investigation of the stem bark of Melia azedarach var. Japonica has led to the isolation of a new limonoid 12-hydroxyamoorastatone (I) along with two known limonoids 12-hydroxyamoorastatin and 12-acetoxyamoorastatin.  The structure of the new compd. followed from spectral data and the stereochem. was detd. by NOE expt. on the di-p-bromobenzoate.  All three compds. exhibited significant cytotoxicities against five human tumor cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr16v03KOp3trVg90H21EOLACvtfcHk0ljTZhxvuW26Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslKks7w%253D&md5=bcd0e3b9944d71092c82417fe5d673af</span></div><a href="/servlet/linkout?suffix=cit315&amp;dbid=16384&amp;doi=10.1016%2FS0031-9422%2800%2989749-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0031-9422%252800%252989749-6%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.-W.%26aulast%3DChoi%26aufirst%3DS.-U.%26aulast%3DLee%26aufirst%3DC.-O.%26atitle%3DCytotoxic%2520limonoids%2520from%2520Melia%2520azedarach%2520var.%2520japonica%26jtitle%3DPhytochemistry%26date%3D1994%26volume%3D36%26spage%3D1493%26epage%3D1496%26doi%3D10.1016%2FS0031-9422%2800%2989749-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref316"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref316'); return false;" data-citation="" class="refNumLink">316</a></strong><div class="NLM_citation" id="cit316"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lone, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khuroo, M. A.</span></span> <span> </span><span class="NLM_article-title">Arglabin: From isolation to antitumor evaluation</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2015.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref316/cit316&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.cbi.2015.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref316/cit316&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26327249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref316/cit316&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKgsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=2015&pages=180-198&author=S.+H.+Loneauthor=K.+A.+Bhatauthor=M.+A.+Khuroo&title=Arglabin%3A+From+isolation+to+antitumor+evaluation&doi=10.1016%2Fj.cbi.2015.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit316R"><div class="casContent"><span class="casTitleNuber">316</span><div class="casTitle"><span class="NLM_cas:atitle">Arglabin: From isolation to antitumor evaluation</span></div><div class="casAuthors">Lone, Shabir H.; Bhat, Khursheed A.; Khuroo, Mohd. A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">240</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-198</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Arglabin belongs to guaianolide class of sesquiterpene lactones, isolated from Artemisia species.  The mol. bears a 5,7,5-tricyclic ring system having five contiguous stereo centers in which the two five membered rings are trans-annulated.  Arglabin shows promising antitumor activity against different tumor cell lines.  The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors.  It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase).  The present review is an attempt to summarize the chem. and biol. of this mol. since its isolation in 1982.  It embodies the isolation, structure elucidation, stereo chem. description, structural classification, chem. synthesis, structural modifications and antitumor evaluation reported till date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovYOZoJ8Ws7bVg90H21EOLACvtfcHk0ljTZhxvuW26Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKgsrjI&md5=63f6cbfb4f7bf750c47c4879a0f74818</span></div><a href="/servlet/linkout?suffix=cit316&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2015.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2015.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DLone%26aufirst%3DS.%2BH.%26aulast%3DBhat%26aufirst%3DK.%2BA.%26aulast%3DKhuroo%26aufirst%3DM.%2BA.%26atitle%3DArglabin%253A%2520From%2520isolation%2520to%2520antitumor%2520evaluation%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D240%26spage%3D180%26epage%3D198%26doi%3D10.1016%2Fj.cbi.2015.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref317"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref317'); return false;" data-citation="" class="refNumLink">317</a></strong><div class="NLM_citation" id="cit317"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Natural product micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00241</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00241" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref317/cit317&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFSguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4155-4164&author=J.+Liauthor=S.+Liauthor=J.+Guoauthor=Q.+Liauthor=J.+Longauthor=C.+Maauthor=Y.+Dingauthor=C.+Yanauthor=L.+Liauthor=Z.+Wuauthor=H.+Zhuauthor=K.+K.+Liauthor=L.+Wenauthor=Q.+Zhangauthor=Q.+Xueauthor=C.+Zhaoauthor=N.+Liuauthor=I.+Ivanovauthor=M.+Luoauthor=R.+Xiauthor=H.+Longauthor=P.+G.+Wangauthor=Y.+Chen&title=Natural+product+micheliolide+%28MCL%29+irreversibly+activates+pyruvate+kinase+M2+and+suppresses+leukemia&doi=10.1021%2Facs.jmedchem.8b00241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit317R"><div class="casContent"><span class="casTitleNuber">317</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia</span></div><div class="casAuthors">Li, Jing; Li, Shanshan; Guo, Jianshuang; Li, Qiuying; Long, Jing; Ma, Cheng; Ding, Yahui; Yan, Chunli; Li, Liangwei; Wu, Zhigang; Zhu, He; Li, Keqin Kathy; Wen, Liuqing; Zhang, Quan; Xue, Qingqing; Zhao, Caili; Liu, Ning; Ivanov, Ivaylo; Luo, Ming; Xi, Rimo; Long, Haibo; Wang, Peng George; Chen, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4155-4164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metabolic reprogramming of cancer cells is essential for tumorigenesis in which pyruvate kinase M2 (PKM2), the low activity isoform of pyruvate kinase, plays a crit. role.  Herein, we describe the identification of a nature-product-derived micheliolide (MCL) that selectively activates PKM2 through the covalent binding at residue cysteine424 (C424), which is not contained in PKM1.  This interaction promotes more tetramer formation, inhibits the lysine433 (K433) acetylation, and influences the translocation of PKM2 into the nucleus.  In addn., the pro-drug dimethylaminomicheliolide (DMAMCL) with similar properties as MCL significantly suppresses the growth of leukemia cells and tumorigenesis in a zebrafish xenograft model.  Cell-based assay with knock down PKM2 expression verifies that the effects of MCL are dependent on PKM2 expression.  DMAMCL is currently in clin. trials in Australia.  Our discovery may provide a valuable pharmacol. mechanism for clin. treatment and benefit the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlWteclCMHbVg90H21EOLACvtfcHk0ljTZhxvuW26Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFSguro%253D&md5=8742015134a65572dee296a5e88fa861</span></div><a href="/servlet/linkout?suffix=cit317&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00241%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DK.%2BK.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DI.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DXi%26aufirst%3DR.%26aulast%3DLong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%2BG.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DNatural%2520product%2520micheliolide%2520%2528MCL%2529%2520irreversibly%2520activates%2520pyruvate%2520kinase%2520M2%2520and%2520suppresses%2520leukemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4155%26epage%3D4164%26doi%3D10.1021%2Facs.jmedchem.8b00241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref318"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref318'); return false;" data-citation="" class="refNumLink">318</a></strong><div class="NLM_citation" id="cit318"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref318/cit318&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.04.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref318/cit318&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31082765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref318/cit318&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVCqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2019&pages=215-233&author=J.+Wangauthor=S.+Suauthor=S.+Zhangauthor=S.+Zhaiauthor=R.+Shengauthor=W.+Wuauthor=R.+Guo&title=Structure-activity+relationship+and+synthetic+methodologies+of+%CE%B1-santonin+derivatives+with+diverse+bioactivities%3A+A+mini-review&doi=10.1016%2Fj.ejmech.2019.04.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit318R"><div class="casContent"><span class="casTitleNuber">318</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review</span></div><div class="casAuthors">Wang, Jiangming; Su, Siyuan; Zhang, Shangzhe; Zhai, Shiyang; Sheng, Ruilong; Wu, Wenhui; Guo, Ruihua</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215-233</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  α-Santonin, a sesquiterpene lactone isolated from Artemisia Santonica, possesses diverse bioactivities including antioxidant, anti-inflammation, immunosuppressive, anti-roundworm, anti-malaria, etc.  However, its bioactivities are not satisfactory and need to be further optimized.  Thus, many α-santonin derivs. were synthesized on the basis of rings A, B and C for the discovery of new analogs with prominent bioactivities.  Herein, we reviewed and discussed the related synthetic methodologies, diverse bioactivities and structure-activity relationships (SAR) of α-santonin derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplIAEQHiQBpLVg90H21EOLACvtfcHk0ljHRh12vUpd2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVCqsL8%253D&md5=0b4ce66c103b72d06964bcd16ef11ea9</span></div><a href="/servlet/linkout?suffix=cit318&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.066%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhai%26aufirst%3DS.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520and%2520synthetic%2520methodologies%2520of%2520%25CE%25B1-santonin%2520derivatives%2520with%2520diverse%2520bioactivities%253A%2520A%2520mini-review%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D175%26spage%3D215%26epage%3D233%26doi%3D10.1016%2Fj.ejmech.2019.04.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref319"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref319'); return false;" data-citation="" class="refNumLink">319</a></strong><div class="NLM_citation" id="cit319"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arantes, F. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, L. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltha, C. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidencio, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, J. W. M.</span></span> <span> </span><span class="NLM_article-title">A quantum chemical and chemometric study of sesquiterpene lactones with cytotoxicity against tumor cells</span>. <i>J. Chemom.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1002/cem.1385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref319/cit319&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fcem.1385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref319/cit319&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=401-407&author=F.+F.+P.+Arantesauthor=L.+C.+A.+Barbosaauthor=C.+R.+A.+Malthaauthor=A.+J.+Demunerauthor=P.+H.+Fidencioauthor=J.+W.+M.+Carneiro&title=A+quantum+chemical+and+chemometric+study+of+sesquiterpene+lactones+with+cytotoxicity+against+tumor+cells&doi=10.1002%2Fcem.1385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit319R"><div class="casContent"><span class="casTitleNuber">319</span><div class="casTitle"><span class="NLM_cas:atitle">A quantum chemical and chemometric study of sesquiterpene lactones with cytotoxicity against tumor cells</span></div><div class="casAuthors">Arantes, Francisco F. P.; Barbosa, Luiz C. A.; Maltha, Celia R. A.; Demuner, Antonio J.; Fidencio, Paulo H.; Carneiro, Jose Walkimar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemometrics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">401-407</span>CODEN:
                <span class="NLM_cas:coden">JOCHEU</span>;
        ISSN:<span class="NLM_cas:issn">0886-9383</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The semi-empirical MO method PM6 was employed to calc. a set of mol. descriptors of 20 sesquiterpene lactones (SQLs) with cytotoxicity against HL-60 (leukemia) tumor cells.  The principal component anal. (PCA) and hierarchical cluster anal. (HCA) methods were used to obtain possible relationships between the calcd. descriptors and the biol. activity of the lactones.  Four descriptors were identified as responsible for the sepn. between the active and inactive compds.: EHOMO (HOMO energy); Q11 (net at. charge on C11); Q12 (net at. charge on C12) and Q13 (net at. charge on C13).  These results indicated that the presence of the α-methylene-γ-lactone group has a significant role in the mechanism by which SQLs exert their biol. activities.In order to deepen our knowledge about the structure-activity relationship of sesquiterpene lactones (SQLs), a quantum chem. and chemometric study of sesquiterpene lactones with cytotoxicity was performed against HL-60 (leukemia) tumor cells.  The anal. of the mol. descriptors identified as responsible for the sepn. between the active and inactive compds. indicated that the presence of the α-methylene-γ-lactone functionality has a significant role in the mechanism by which SQLs exert their biol. activities.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcXa-osTwBiLVg90H21EOLACvtfcHk0ljHRh12vUpd2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsb7J&md5=80fb49c33e6e5eb9e17383c76baad6f8</span></div><a href="/servlet/linkout?suffix=cit319&amp;dbid=16384&amp;doi=10.1002%2Fcem.1385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcem.1385%26sid%3Dliteratum%253Aachs%26aulast%3DArantes%26aufirst%3DF.%2BF.%2BP.%26aulast%3DBarbosa%26aufirst%3DL.%2BC.%2BA.%26aulast%3DMaltha%26aufirst%3DC.%2BR.%2BA.%26aulast%3DDemuner%26aufirst%3DA.%2BJ.%26aulast%3DFidencio%26aufirst%3DP.%2BH.%26aulast%3DCarneiro%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DA%2520quantum%2520chemical%2520and%2520chemometric%2520study%2520of%2520sesquiterpene%2520lactones%2520with%2520cytotoxicity%2520against%2520tumor%2520cells%26jtitle%3DJ.%2520Chemom.%26date%3D2011%26volume%3D25%26spage%3D401%26epage%3D407%26doi%3D10.1002%2Fcem.1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref320"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref320'); return false;" data-citation="" class="refNumLink">320</a></strong><div class="NLM_citation" id="cit320"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zibelman, M.</span></span> <span> </span><span class="NLM_article-title">Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.2217/fon-2017-0585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref320/cit320&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2217%2Ffon-2017-0585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref320/cit320&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29848096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref320/cit320&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1CqurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1409-1421&author=F.+Anariauthor=C.+Ramamurthyauthor=M.+Zibelman&title=Impact+of+tumor+microenvironment+composition+on+therapeutic+responses+and+clinical+outcomes+in+cancer&doi=10.2217%2Ffon-2017-0585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit320R"><div class="casContent"><span class="casTitleNuber">320</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer</span></div><div class="casAuthors">Anari, Fern; Ramamurthy, Chethan; Zibelman, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1409-1421</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1744-8301</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment (TME) plays an important role in cancer growth and progression.  Paradoxically, the TME is capable of acting as both a potential barrier and facilitator of tumor proliferation by affecting various processes including local growth resistance, immune system interactions, and the formation of distant metastases.  This important interaction between cancer cells and their local environment, composed of immune cells, angiogenic cells, lymphatic endothelial cells and cancer-assocd. fibroblasts is paramount to det. a cancer cell's ability to grow and ultimately metastasize.  It is essential to understand this complex interplay in order to define treatment modalities to target the TME as part of anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDb7jUyAWCr7Vg90H21EOLACvtfcHk0ljHRh12vUpd2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1CqurvL&md5=8f607c4860c49bbcc2ead24edd7e4f85</span></div><a href="/servlet/linkout?suffix=cit320&amp;dbid=16384&amp;doi=10.2217%2Ffon-2017-0585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon-2017-0585%26sid%3Dliteratum%253Aachs%26aulast%3DAnari%26aufirst%3DF.%26aulast%3DRamamurthy%26aufirst%3DC.%26aulast%3DZibelman%26aufirst%3DM.%26atitle%3DImpact%2520of%2520tumor%2520microenvironment%2520composition%2520on%2520therapeutic%2520responses%2520and%2520clinical%2520outcomes%2520in%2520cancer%26jtitle%3DFuture%2520Oncol.%26date%3D2018%26volume%3D14%26spage%3D1409%26epage%3D1421%26doi%3D10.2217%2Ffon-2017-0585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref321"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref321'); return false;" data-citation="" class="refNumLink">321</a></strong><div class="NLM_citation" id="cit321"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amorim, M. H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil da Costa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastos, M. M. S. M.</span></span> <span> </span><span class="NLM_article-title">Sesquiterpene lactones: Adverse health effects and toxicity mechanisms</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.3109/10408444.2013.813905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref321/cit321&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3109%2F10408444.2013.813905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref321/cit321&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23875764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref321/cit321&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOisbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=559-579&author=M.+H.+R.+Amorimauthor=R.+M.+Gil+da+Costaauthor=C.+Lopesauthor=M.+M.+S.+M.+Bastos&title=Sesquiterpene+lactones%3A+Adverse+health+effects+and+toxicity+mechanisms&doi=10.3109%2F10408444.2013.813905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit321R"><div class="casContent"><span class="casTitleNuber">321</span><div class="casTitle"><span class="NLM_cas:atitle">Sesquiterpene lactones: Adverse health effects and toxicity mechanisms</span></div><div class="casAuthors">Amorim, M. Helena R.; Gil da Costa, Rui M.; Lopes, Carlos; Bastos, Margarida M. S. M.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">559-579</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Sesquiterpene lactones (STLs) present a wide range of biol. activities, mostly based on their alkylating capabilities, which underlie their therapeutic potential.  These compds. are the active constituents of a variety of plants, frequently used as herbal remedies.  STLs such as artemisinin and its derivs. are in use as first-line antimalarials while others, such as parthenolide, have recently reached cancer clin. trials.  However, the toxicol. profile of these compds. must be thoroughly characterized, since the same properties that make STL useful medicines can also cause severe toxicity.  STL-contg. plants have long been known to induce a contact dermatitis in exposed farm workers, and also to cause several toxic syndromes in farm animals.  More recently, concerns are been raised regarding the genotoxic potential of these compds. and the embryotoxicity of artemisinins.  A growing no. of STLs are being reported to be mutagenic in different in vitro and in vivo assays.  As yet no systematic studies have been published, but the genotoxicity of STLs seems to depend not so much on direct DNA alkylation as on oxidative DNA damage and other partially elucidated mechanisms.  As the medicinal use of these compds. increases, further studies of their toxic potential are needed, esp. those focusing on the structural determinants of genotoxicity and embryotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3GuCv-r4fCrVg90H21EOLACvtfcHk0lgDIewLsXOHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOisbvP&md5=96dad6ddbf16d32cd5f5be26da290601</span></div><a href="/servlet/linkout?suffix=cit321&amp;dbid=16384&amp;doi=10.3109%2F10408444.2013.813905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10408444.2013.813905%26sid%3Dliteratum%253Aachs%26aulast%3DAmorim%26aufirst%3DM.%2BH.%2BR.%26aulast%3DGil%2Bda%2BCosta%26aufirst%3DR.%2BM.%26aulast%3DLopes%26aufirst%3DC.%26aulast%3DBastos%26aufirst%3DM.%2BM.%2BS.%2BM.%26atitle%3DSesquiterpene%2520lactones%253A%2520Adverse%2520health%2520effects%2520and%2520toxicity%2520mechanisms%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2013%26volume%3D43%26spage%3D559%26epage%3D579%26doi%3D10.3109%2F10408444.2013.813905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref322"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref322'); return false;" data-citation="" class="refNumLink">322</a></strong><div class="NLM_citation" id="cit322"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Studies on the genetic toxicity of <i>Evodia rutaecarpa</i> and its main components</span>. <i>Shijie Zhongyiyao</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref322/cit322&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSisr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=145-150&author=Q.+Xiaauthor=Y.+Liuauthor=R.+Yangauthor=Q.+Liuauthor=Y.+Zhuoauthor=H.+Li&title=Studies+on+the+genetic+toxicity+of+Evodia+rutaecarpa+and+its+main+components"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit322R"><div class="casContent"><span class="casTitleNuber">322</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the genetic toxicity of Evodia rutaecarpa and its main components</span></div><div class="casAuthors">Xia, Qiyue; Liu, Yanping; Yang, Runfang; Liu, Qiangqiang; Zhuo, Yanqiang; Li, Hongxia</div><div class="citationInfo"><span class="NLM_cas:title">Shijie Zhongyiyao</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-150, 154</span>CODEN:
                <span class="NLM_cas:coden">SZHHAN</span>;
        ISSN:<span class="NLM_cas:issn">1673-7202</span>.
    
            (<span class="NLM_cas:orgname">Shijie Zhongyiyao Bianjibu</span>)
        </div><div class="casAbstract">Objective: To investigate the genetic toxicity of Evodia rutaecarpa and its main components, including evodiamine, rutaecarpin and limonin, in order to provide useful data for developing toxic Traditional Chinese Medicine.  Methods: Ames test, CHL chromosome aberration assay and micronucleus assay of bone marrow cell in mice were used to test evodiamine, rutaecarpin, limonin and Evodia rutaecarpa.  Strains TA97, TA98, TA100, TA102 and TA1535 were used in the Ames test.  There were five dose groups resp. for evodiamine, rutaecarpin and limonin as follows: 0.0005, 0.005 mg/plate, 0.05 mg/plate, 0.5 mg/plate, 5 mg/plate.  As a result, the results of the Ames assay were neg. for various groups of evodiamine, rutaecarpin and limonin.  In CHL chromosome aberration assay, the doses of evodiamine, rutaecarpin and limonin were 0.005 mg/mL, 0.05 mg/mL and 0.5 mg/mL resp.  Exposure time was 4 h and 24 h.  Results: The result of the Evodiamine was neg.  Aberration rate of 24 h exposure Rutaecarpin chromosome increased significantly compared with that of neg. control group (P < 0.05).  Aberration rate of Limonin chromosome 0.05 and 0.5 mg/mL groups increased in 4 h and 24 h exposure compared with neg. control group (P < 0.05), the 0.005 mg/mL group was not significantly different compared with neg. control group (P > 0.05).  In vivo micronucleus test with Evodia rutaecarpa alc. ext., there were 3 dosing groups: 0.88, 3.52, 10.55 g raw drug/kg, 4 days, once every day.  The results were neg.  Conclusion: no genetic toxicity was obsd. in Evodia rutaecarpa alc. ext.  However, rutaecarpin and limonin shows some genotoxicity in vivo test, which requires further research to confirm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ3vYCVub2fLVg90H21EOLACvtfcHk0lgDIewLsXOHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSisr3O&md5=4c6f5eddc84cb992fb3d09ec9130f4da</span></div><a href="/servlet/linkout?suffix=cit322&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DStudies%2520on%2520the%2520genetic%2520toxicity%2520of%2520Evodia%2520rutaecarpa%2520and%2520its%2520main%2520components%26jtitle%3DShijie%2520Zhongyiyao%26date%3D2014%26volume%3D9%26spage%3D145%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref323"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref323'); return false;" data-citation="" class="refNumLink">323</a></strong><div class="NLM_citation" id="cit323"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orjala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberlies, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroll, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairchild, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vite, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarjoura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cope, F. O.</span></span> <span> </span><span class="NLM_article-title">Discovery of anticancer agents of diverse natural origin</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1063</span>, <span class="refDoi"> DOI: 10.1351/PAC-CON-08-10-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref323/cit323&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1351%2FPAC-CON-08-10-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref323/cit323&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20046887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref323/cit323&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFaitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2009&pages=1051-1063&author=A.+D.+Kinghornauthor=E.+J.+Carcache+de+Blancoauthor=H.-B.+Chaiauthor=J.+Orjalaauthor=N.+R.+Farnsworthauthor=D.+D.+Soejartoauthor=N.+H.+Oberliesauthor=M.+C.+Waniauthor=D.+J.+Krollauthor=C.+J.+Pearceauthor=S.+M.+Swansonauthor=R.+A.+Kramerauthor=W.+C.+Roseauthor=C.+R.+Fairchildauthor=G.+D.+Viteauthor=S.+Emanuelauthor=D.+Jarjouraauthor=F.+O.+Cope&title=Discovery+of+anticancer+agents+of+diverse+natural+origin&doi=10.1351%2FPAC-CON-08-10-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit323R"><div class="casContent"><span class="casTitleNuber">323</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of anticancer agents of diverse natural origin</span></div><div class="casAuthors">Kinghorn, A. Douglas; Carcache de Blanco, Esperanza J.; Chai, Hee-Byung; Orjala, Jimmy; Farnsworth, Norman R.; Soejarto, D. Doel; Oberlies, Nicholas H.; Wani, Mansukh C.; Kroll, David J.; Pearce, Cedric J.; Swanson, Steven M.; Kramer, Robert A.; Rose, William C.; Fairchild, Craig R.; Vite, Gregory D.; Emanuel, Stuart; Jarjoura, David; Cope, Frederick O.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1051-1063</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">International Union of Pure and Applied Chemistry</span>)
        </div><div class="casAbstract">A review.  A collaborative multidisciplinary research project is described in which new natural product anticancer drug leads are obtained from a diverse group of organisms, constituted by tropical plants, aquatic cyanobacteria, and filamentous fungi.  Information is provided on how these organisms are collected and processed.  The types of bioassays are indicated in which crude exts. of these acquisitions are tested.  Progress made in the isolation of lead bioactive secondary metabolites from three tropical plants is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7FFiQ0aKOfLVg90H21EOLACvtfcHk0lgDIewLsXOHUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFaitrw%253D&md5=ab5d31b1fbd29c38fc29e3502f25743e</span></div><a href="/servlet/linkout?suffix=cit323&amp;dbid=16384&amp;doi=10.1351%2FPAC-CON-08-10-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252FPAC-CON-08-10-16%26sid%3Dliteratum%253Aachs%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DOrjala%26aufirst%3DJ.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DOberlies%26aufirst%3DN.%2BH.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DKroll%26aufirst%3DD.%2BJ.%26aulast%3DPearce%26aufirst%3DC.%2BJ.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DKramer%26aufirst%3DR.%2BA.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DFairchild%26aufirst%3DC.%2BR.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DJarjoura%26aufirst%3DD.%26aulast%3DCope%26aufirst%3DF.%2BO.%26atitle%3DDiscovery%2520of%2520anticancer%2520agents%2520of%2520diverse%2520natural%2520origin%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2009%26volume%3D81%26spage%3D1051%26epage%3D1063%26doi%3D10.1351%2FPAC-CON-08-10-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref324"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref324'); return false;" data-citation="" class="refNumLink">324</a></strong><div class="NLM_citation" id="cit324"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.</span></span> <span> </span><span class="NLM_article-title">The relevance of higher plants in lead compound discovery programs</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1555</span>, <span class="refDoi"> DOI: 10.1021/np200391c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200391c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref324/cit324&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1agtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=1539-1555&author=A.+D.+Kinghornauthor=L.+Panauthor=J.+N.+Fletcherauthor=H.+Chai&title=The+relevance+of+higher+plants+in+lead+compound+discovery+programs&doi=10.1021%2Fnp200391c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit324R"><div class="casContent"><span class="casTitleNuber">324</span><div class="casTitle"><span class="NLM_cas:atitle">The Relevance of Higher Plants in Lead Compound Discovery Programs</span></div><div class="casAuthors">Kinghorn, A. Douglas; Pan, Li; Fletcher, Joshua N.; Chai, Heebyung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1555</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Along with compds. from terrestrial microorganisms, the constituents of higher plants have provided a substantial no. of the natural product-derived drugs used currently in Western medicine.  Interest in the elucidation of new structures of the secondary metabolite constituents of plants has remained high among the natural products community over the first decade of the 21st century, particularly of species that are used in systems of traditional medicine or are utilized as botanical dietary supplements.  In this review, progress made in the senior author's lab. in research work on naturally occurring sweeteners and other taste-modifying substances and on potential anticancer agents from tropical plants will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokz6AuD5kj_rVg90H21EOLACvtfcHk0lhNXdmxhfjb9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1agtbw%253D&md5=d665f1818fba55a3c48c2990c013aa0a</span></div><a href="/servlet/linkout?suffix=cit324&amp;dbid=16384&amp;doi=10.1021%2Fnp200391c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200391c%26sid%3Dliteratum%253Aachs%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DFletcher%26aufirst%3DJ.%2BN.%26aulast%3DChai%26aufirst%3DH.%26atitle%3DThe%2520relevance%2520of%2520higher%2520plants%2520in%2520lead%2520compound%2520discovery%2520programs%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D1539%26epage%3D1555%26doi%3D10.1021%2Fnp200391c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref325"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref325'); return false;" data-citation="" class="refNumLink">325</a></strong><div class="NLM_citation" id="cit325"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakotondraibe, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orjala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberlies, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of anticancer agents of diverse natural origin</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5623</span>– <span class="NLM_lpage">5638</span>, <span class="refDoi"> DOI: 10.21873/anticanres.11146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref325/cit325&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.21873%2Fanticanres.11146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref325/cit325&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27793884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref325/cit325&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFahtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=5623-5638&author=A.+D.+Kinghornauthor=E.+J.+Carcache+de+Blancoauthor=D.+M.+Lucasauthor=H.+L.+Rakotondraibeauthor=J.+Orjalaauthor=D.+D.+Soejartoauthor=N.+H.+Oberliesauthor=C.+J.+Pearceauthor=M.+C.+Waniauthor=B.+R.+Stockwellauthor=J.+E.+Burdetteauthor=S.+M.+Swansonauthor=J.+R.+Fuchsauthor=M.+A.+Phelpsauthor=L.+Xuauthor=X.+Zhangauthor=Y.+Y.+Shen&title=Discovery+of+anticancer+agents+of+diverse+natural+origin&doi=10.21873%2Fanticanres.11146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit325R"><div class="casContent"><span class="casTitleNuber">325</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of anticancer agents of diverse natural origin</span></div><div class="casAuthors">Kinghorn, A. Douglas; Carcache De Blanco, Esperanza J.; Lucas, David M.; Liva, Rakotondraibe H.; Orjala, Jimmy; Soejarto, D. Doel; Oberlies, Nicholas H.; Pearce, Cedric J.; Wani, Mansukh C.; Stockwell, Brent R.; Burdette, Joanna E.; Swanson, Steven M.; Fuchs, James R.; Phelps, Mitchell A.; Xu, Lihui; Zhang, Xiaoli; Shen, Young Yongchun</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5623-5638</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Recent progress is described in an ongoing collaborative multidisciplinary research project directed towards the purifn., structural characterization, chem. modification, and biol. evaluation of new potential natural product anticancer agents obtained from a diverse group of organisms, comprising tropical plants, aquatic and terrestrial cyanobacteria, and filamentous fungi.  Information is provided on how these organisms are collected and processed.  The types of bioassays are indicated in which initial exts., chromatog. fractions, and purified isolated compds. of these acquisitions are tested.  Several promising biol. active lead compds. from each major organism class investigated are described, and these may be seen to be representative of a very wide chem. diversity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocy2oPvcIlEbVg90H21EOLACvtfcHk0lhNXdmxhfjb9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFahtro%253D&md5=e8812bd05ef88b7947b92e2815fcfbee</span></div><a href="/servlet/linkout?suffix=cit325&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.11146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.11146%26sid%3Dliteratum%253Aachs%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DLucas%26aufirst%3DD.%2BM.%26aulast%3DRakotondraibe%26aufirst%3DH.%2BL.%26aulast%3DOrjala%26aufirst%3DJ.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DOberlies%26aufirst%3DN.%2BH.%26aulast%3DPearce%26aufirst%3DC.%2BJ.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DBurdette%26aufirst%3DJ.%2BE.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DPhelps%26aufirst%3DM.%2BA.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%2BY.%26atitle%3DDiscovery%2520of%2520anticancer%2520agents%2520of%2520diverse%2520natural%2520origin%26jtitle%3DAnticancer%2520Res.%26date%3D2016%26volume%3D36%26spage%3D5623%26epage%3D5638%26doi%3D10.21873%2Fanticanres.11146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262'],'ref263':['cit263'],'ref264':['cit264'],'ref265':['cit265'],'ref266':['cit266'],'ref267':['cit267'],'ref268':['cit268'],'ref269':['cit269'],'ref270':['cit270'],'ref271':['cit271'],'ref272':['cit272'],'ref273':['cit273'],'ref274':['cit274'],'ref275':['cit275'],'ref276':['cit276'],'ref277':['cit277'],'ref278':['cit278'],'ref279':['cit279'],'ref280':['cit280'],'ref281':['cit281'],'ref282':['cit282'],'ref283':['cit283'],'ref284':['cit284'],'ref285':['cit285'],'ref286':['cit286'],'ref287':['cit287'],'ref288':['cit288'],'ref289':['cit289'],'ref290':['cit290'],'ref291':['cit291'],'ref292':['cit292'],'ref293':['cit293'],'ref294':['cit294'],'ref295':['cit295'],'ref296':['cit296'],'ref297':['cit297'],'ref298':['cit298'],'ref299':['cit299'],'ref300':['cit300'],'ref301':['cit301'],'ref302':['cit302'],'ref303':['cit303'],'ref304':['cit304'],'ref305':['cit305'],'ref306':['cit306'],'ref307':['cit307'],'ref308':['cit308'],'ref309':['cit309'],'ref310':['cit310'],'ref311':['cit311'],'ref312':['cit312'],'ref313':['cit313'],'ref314':['cit314'],'ref315':['cit315'],'ref316':['cit316'],'ref317':['cit317'],'ref318':['cit318'],'ref319':['cit319'],'ref320':['cit320'],'ref321':['cit321'],'ref322':['cit322'],'ref323':['cit323'],'ref324':['cit324'],'ref325':['cit325']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karin  Jöhrer</span>, <span class="hlFld-ContribAuthor ">Serhat Sezai  Ҫiҫek</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Myeloma Inhibitory Activity of Plant Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (11)
                                     , 2678. <a href="https://doi.org/10.3390/cancers13112678" title="DOI URL">https://doi.org/10.3390/cancers13112678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13112678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13112678%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DMultiple%252BMyeloma%252BInhibitory%252BActivity%252Bof%252BPlant%252BNatural%252BProducts%26aulast%3DJ%25C3%25B6hrer%26aufirst%3DKarin%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D11%26spage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicja K.  Surowiak</span>, <span class="hlFld-ContribAuthor ">Lucyna  Balcerzak</span>, <span class="hlFld-ContribAuthor ">Stanisław  Lochyński</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Strub</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Activity of Selected Natural and Synthetic Terpenoid Lactones. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (9)
                                     , 5036. <a href="https://doi.org/10.3390/ijms22095036" title="DOI URL">https://doi.org/10.3390/ijms22095036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22095036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22095036%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBiological%252BActivity%252Bof%252BSelected%252BNatural%252Band%252BSynthetic%252BTerpenoid%252BLactones%26aulast%3DSurowiak%26aufirst%3DAlicja%2BK.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D9%26spage%3D5036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of artemisinin (ART, <b>1</b>) and its derivatives <b>1a</b>–<b>1e</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>MCF-7 and <sup><i>b</i></sup>MDA-MB-231 breast, <sup><i>c</i></sup>C33A cervical, and <sup><i>d</i></sup>SMMC-7721 liver cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cellular signaling for the mediation of cytotoxicity of artemisinin (<b>1</b>) and actions against human cancer cells of five synthetic derivatives (<b>1a</b>–<b>1e</b>) of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key SAR conclusions for the synthetic modification of artemisinin (<b>1</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of parthenolide (PTL, <b>2</b>) and its analogues <b>2a</b>–<b>2f</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HepG2 liver cancer, <sup><i>b</i></sup>MCF-7 breast cancer, <sup><i>c</i></sup>MOLM-13, <sup><i>d</i></sup>EOL-1, and <sup><i>e</i></sup>AML leukemia, <sup><i>f</i></sup>HCT116 and <sup><i>j</i></sup>HT-29 colon cancer, <sup><i>g</i></sup>Panc-1 pancreatic, <sup><i>h</i></sup>A549 nonsmall cell lung, and <sup><i>i</i></sup>Bel-7402 human hepatocellular carcinoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of parthenolide dimeric derivatives <b>2g</b> and <b>2h</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>PKM2 protein and <sup><i>b</i></sup>U118 human glioma cells and the <sup><i>c</i></sup>dose used in an animal model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Key SAR conclusions for the synthetic modification of parthenolide (PTL, <b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of thapsigargin (TPG, <b>3</b>) and an analogue (<b>3a</b>) and a prodrug (<b>3b</b>) and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>EL4 murine lymphoma, <sup><i>b</i></sup>S180 sarcoma, <sup><i>c</i></sup>MCF-7 human breast cancer, <sup><i>d</i></sup>TSU-Pr1, and <sup><i>e</i></sup>LNCaP human prostate cancer cells, and <sup><i>f</i></sup>inhibition of SERCA pump.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Key SAR conclusions for the synthetic modification of thapsigargin (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of andrographolide (AGL, <b>4</b>) and its analogues <b>4a</b>–<b>4g</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>A2058 melanoma, <sup><i>b</i></sup>HCT116 colon cancer, <sup><i>c</i></sup>HL-60 leukemia, <sup><i>d</i></sup>HT-29 colon cancer, <sup><i>e</i></sup>MCF-7 and <sup><i>f</i></sup>MDA-MB-231 breast cancer, and <sup><i>h</i></sup>CCRF-CEM leukemia cells and <sup><i>g</i></sup>P-388 murine leukemia cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Key SAR conclusions for the synthetic modification of andrographolide (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of ginkgolide B (GKL B, <b>5</b>) and its analogues <b>5a</b>–<b>5e</b> and IC<sub>50</sub> (μM) values for the inhibition of PAF-induced platelet aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Key SAR conclusions for the synthetic modification of ginkgolide B (<b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of jolkinolide B (JKL B, <b>6</b>) and its analogues <b>6a</b>–<b>6f</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>C4–2B human prostate cancer, <sup><i>b</i></sup>HCT-15 human colon cancer, <sup><i>c</i></sup>MCF-7 and <sup><i>d</i></sup>MDA-MB-231 human breast cancer, <sup><i>e</i></sup>UACC62 human melanoma, <sup><i>f</i></sup>Bel-7402 human lung cancer, <sup><i>g</i></sup>HT-29 human colon cancer, <sup><i>h</i></sup>Panc-28 human pancreatic cancer, and <sup><i>i</i></sup>Ramos B human Burkitt’s lymphoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Key SAR conclusions for the synthetic modification of jolkinolide B (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of nagilactone E (NGL E, <b>7</b>) and its analogues <b>7a</b>–<b>7g</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>A549 and <sup><i>b</i></sup>NCI-H1975 human nonsmall cell lung cancer, <sup><i>c</i></sup>P-388 murine leukemia, <sup><i>d</i></sup>A431 human epidermoid carcinoma, <sup><i>e</i></sup>AGS human gastric cancer, <sup><i>f</i></sup>HeLa human cervical cancer, <sup><i>g</i></sup>HepG2 human hepatoma, <sup><i>h</i></sup>MDA-MB-231 human breast cancer, <sup><i>i</i></sup>Panc-1 human pancreatic cancer, <sup><i>j</i></sup>U87 human glioma, and <sup><i>k</i></sup>A2780 and <sup><i>l</i></sup>HEY human ovarian carcinoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of nagilactone E analogues <b>7h</b>–<b>7r</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>AGS human gastric cancer, <sup><i>b</i></sup>HeLa human cervical cancer, <sup><i>c</i></sup>HepG2 human hepatoma, <sup><i>d</i></sup>MDA-MB-231 human breast cancer, <sup><i>e</i></sup>P-388 murine leukemia, <sup><i>f</i></sup>Panc-1 human pancreatic cancer, <sup><i>g</i></sup>NCI H460 human large-cell and <sup><i>k</i></sup>NCI H446 human small-cell lung cancer, <sup><i>h</i></sup>SMMC-7721 human hepatocarcinoma, <sup>i</sup>SW1990 human pancreatic cancer, and <sup><i>j</i></sup>MCF-7 human breast cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Key SAR conclusions for the synthetic modification of nagilactone E (<b>7</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of triptolide (TPL, <b>8</b>) and its analogues <b>8a</b>–<b>8h</b> and IC<sub>50</sub> (μM) values for <sup><i>a</i></sup>B16F10 mouse melanoma, <sup><i>b</i></sup>BGC-823 human gastric cancer, <sup><i>c</i></sup>HCT116 human colon cancer, <sup><i>d</i></sup>HepG2 human hepatoma, <sup><i>e</i></sup>NCI-H1650 human bronchoalveolar carcinoma, <sup><i>f</i></sup>Panc-1 human pancreatic cancer, and <sup><i>g</i></sup>PC3 and <sup><i>h</i></sup>DU-145 human prostate cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Key SAR conclusions for the synthetic modification of triptolide (<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures of bruceantin (BRC, <b>9</b>) and its analogues <b>9a</b>–<b>9i</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HL-60 leukemia, <sup><i>b</i></sup>HT-29, <sup><i>d</i></sup>HCT116, and <sup><i>i</i></sup>HCT-8 colon cancer, <sup><i>c</i></sup>HeLa cervical cancer, <sup><i>e</i></sup>Panc-1 and <sup><i>f</i></sup>SW1990 pancreatic cancer, <sup><i>g</i></sup>MCF-7 and <sup><i>h</i></sup>MDA-MB-231 breast cancer, <sup><i>j</i></sup>HepG2 hepatoma, <sup><i>k</i></sup>BGC-823 gastric cancer, and <sup><i>l</i></sup>A549 lung cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of bruceantin analogues <b>9j</b>–<b>9u</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HCT-8 colon cancer, <sup><i>b</i></sup>HepG2 and <sup><i>k</i></sup>Hep3B hepatoma, <sup><i>c</i></sup>BGC-823 gastric cancer, <sup><i>d</i></sup>A549 lung cancer, <sup><i>e</i></sup>Panc-1 and <sup><i>f</i></sup>SW1990 pancreatic cancer, <sup><i>g</i></sup>MCF-7 and <sup><i>h</i></sup>MDA-MB-231 breast cancer, <sup><i>i</i></sup>KB human oral epidermoid cancer, <sup><i>j</i></sup>P-388 murine leukemia, <sup><i>l</i></sup>HL-60 leukemia, and <sup><i>m</i></sup>L1210 murine leukemia cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Key SAR conclusions for the synthetic modification of bruceantin (<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structures of dichapetalin A (DCT A, <b>10</b>) and its analogues <b>10a</b>–<b>10g</b> and IC<sub>50</sub> values for <sup><i>a</i></sup>CEM human T-lymphoblast-like leukemia, <sup><i>b</i></sup>HCT116 and <sup><i>i</i></sup>HT-29 human colon cancer, <sup><i>c</i></sup>HL-60 human acute promyelocytic leukemia, <sup><i>d</i></sup>Jurkat human T-lymphocytic leukemia, <sup><i>e</i></sup>LNCaP human prostate cancer, <sup><i>f</i></sup>Lu-1 human lung cancer, <sup><i>g</i></sup>SW626 human ovarian cancer, and <sup><i>h</i></sup>WM 266–4 human melanoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of dichapetalin A analogues <b>10h</b>–<b>10m</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HCT116 colon cancer and <sup><i>b</i></sup>WM 266–4 human melanoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of dichapetalin A analogues <b>10n</b>–<b>10v</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>HCT116, <sup><i>i</i></sup>SW480, and <sup><i>j</i></sup>Col-2 colon cancer, <sup><i>b</i></sup>WM 266-4 melanoma, <sup><i>c</i></sup>CEM T-lymphoblast-like leukemia, <sup><i>d</i></sup>HL-60 acute promyelocytic leukemia, <sup><i>e</i></sup>Jurkat T-lymphocytic leukemia, <sup><i>f</i></sup>A549 non-small-cell lung cancer, <sup><i>g</i></sup>MCF-7 breast cancer, <sup><i>h</i></sup>SMMC-7721 human hepatocarcinoma, <sup><i>k</i></sup>KB oral epidermoid carcinoma cells, and <sup><i>l</i></sup>P-388 murine leukemia cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Key SAR conclusions for the synthetic modification of dichapetalin A (<b>10</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of limonin (LMN, <b>11</b>) and its analogues <b>11a</b>–<b>11h</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>MCF-7 breast cancer, <sup><i>b</i></sup>MDA-MB-435 melanoma, <sup><i>c</i></sup>Panc-28 pancreatic cancer, and <sup><i>d</i></sup>SW480 colon cancer cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Cellular signaling pathways for the mediation of cytotoxicity of limonin (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of limonin analogues <b>11i</b>–<b>11n</b> and IC<sub>50</sub> (μM) values for human <sup><i>a</i></sup>A549 lung cancer, <sup><i>b</i></sup>MCF-7 and <sup><i>d</i></sup>SK-BR-3 breast cancer, <sup><i>c</i></sup>HL-60 leukemia, <sup><i>e</i></sup>HeLa cervical, <sup><i>f</i></sup>HepG2 hepatoma, and <sup><i>g</i></sup>IMR32 neuroblastoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structures of limonin analogues <b>11o</b>–<b>11v</b> and IC<sub>50</sub> values (μM) for <sup><i>a</i></sup>Col-2 and <sup><i>g</i></sup>HCT15 human colon cancer, <sup><i>b</i></sup>KB human oral epidermoid carcinoma, <sup><i>c</i></sup>MCF-7 and <sup><i>d</i></sup>MDA-MB-231 human breast cancer, <sup><i>e</i></sup>P-388 murine leukemia, and human <sup><i>f</i></sup>A549 lung cancer, <sup><i>h</i></sup>SK-MEL-2 melanoma, <sup><i>i</i></sup>SK-OV-3 ovarian cancer, and <sup><i>j</i></sup>XF-498 glioblastoma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/medium/jm0c01449_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Key SAR conclusions for the synthetic modification of limonin (LMN, <b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01449/20201218/images/large/jm0c01449_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01449&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 325 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: The next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+The+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lgYkRna8UnQSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520The%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loeb, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeb, L. A.</span></span> <span> </span><span class="NLM_article-title">Significance of multiple mutations in cancer</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1093/carcin/21.3.379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fcarcin%2F21.3.379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10688858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitVeisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=379-385&author=K.+R.+Loebauthor=L.+A.+Loeb&title=Significance+of+multiple+mutations+in+cancer&doi=10.1093%2Fcarcin%2F21.3.379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of multiple mutations in cancer</span></div><div class="casAuthors">Loeb, Keith R.; Loeb, Lawrence A.</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review, with 71 refs.  There is increasing evidence that in eukaryotic cells, DNA undergoes continuous damage, repair, and resynthesis.  A homeostatic equil. exists in which extensive DNA damage is counterbalanced by multiple pathways for DNA repair.  In normal cells, most DNA damage is repaired without error.  However, in tumor cells this equil. may be skewed, resulting in the accumulation of multiple mutations.  Among genes mutated are those that function in guaranteeing the stability of the genome.  Loss of this stability results in a mutator phenotype.  Evidence for a mutator phenotype in human cancers includes the frequent occurrence of gene amplification, microsatellite instability, chromosomal aberrations, and aneuploidy.  Current expts. have centered on two mechanisms for the generation of genomic instability, one focused on mutations in mismatch repair genes resulting in microsatellite instability and one focused on mutations in genes that are required for chromosomal segregation resulting in chromosomal aberrations.  This dichotomy may reflect only the ease by which these manifestations can be identified.  Underlying both pathways may be a more general phenomenon involving the selection for mutator genes during tumor progression.  During carcinogenesis there is selection for cells harboring mutations that can overcome adverse conditions that limit tumor growth.  These mutations are produced by direct DNA damage as well as secondarily as a result of mutations in genes that cause a mutator phenotype.  Thus, as tumor progression selects for cells with specific mutations, it also selects for cancer cells harboring mutations in genes that normally function in maintaining genetic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPFdsQN8bQWLVg90H21EOLACvtfcHk0lgYkRna8UnQSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitVeisrg%253D&md5=45e1a6ce6cf4ea9b3ce4641d0031d97b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F21.3.379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F21.3.379%26sid%3Dliteratum%253Aachs%26aulast%3DLoeb%26aufirst%3DK.%2BR.%26aulast%3DLoeb%26aufirst%3DL.%2BA.%26atitle%3DSignificance%2520of%2520multiple%2520mutations%2520in%2520cancer%26jtitle%3DCarcinogenesis%26date%3D2000%26volume%3D21%26spage%3D379%26epage%3D385%26doi%3D10.1093%2Fcarcin%2F21.3.379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. A.</span></span> <span> </span><span class="NLM_article-title">Natural product and natural product derived drugs in clinical trials</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1039/C4NP00064A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC4NP00064A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25204227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1612-1661&author=M.+S.+Butlerauthor=A.+A.+B.+Robertsonauthor=M.+A.+Cooper&title=Natural+product+and+natural+product+derived+drugs+in+clinical+trials&doi=10.1039%2FC4NP00064A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product and natural product derived drugs in clinical trials</span></div><div class="casAuthors">Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1612-1661</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 2008-2013.  Previous review: 2008, 25, 475There are a significant no. of natural product (NP) drugs in development.  We review the 100 NP and NP-derived compds. and 33 Antibody Drug Conjugates (ADCs) with a NP-derived cytotoxic component being evaluated in clin. trials or in registration at the end of 2013. 38 of these compds. and 33 ADCs are being investigated as potential oncol. treatments, 26 as anti-infectives, 19 for the treatment of cardiovascular and metabolic diseases, 11 for inflammatory and related diseases and 6 for neurol.  There was a spread of the NP and NP-derived compds. through the different development phases (17 in phase I, 52 in phase II, 23 in phase III and 8 NDA and/or MAA filed), while there were 23 ADCs in phase I and 10 in phase II. 50 of these 100 compds. were either NPs or semi-synthetic (SS) NPs, which indicated the original NP still plays an important role.  NP and NP-derived compds. for which clin. trials have been halted or discontinued since 2008 are listed in the Supplementary Information.  The 25 NP and NP-derived drugs launched since 2008 are also reviewed, and late stage development candidates and new NP drug pharmacophores analyzed.  The short term prospect for new NP and NP-derived drug approvals is bright, with 31 compds. in phase III or in registration, which should ensure a steady stream of approvals for at least the next five years.  However, there could be future issues for new drug types as only five new drug pharmacophores discovered in the last 15 years are currently being evaluated in clin. trials.  The next few years will be crit. for NP-driven lead discovery, and a concerted effort is required to identify new biol. active pharmacophores and to progress these and existing compds. through pre-clin. drug development into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ZulhKpZ6PbVg90H21EOLACvtfcHk0lhePMJ49mMd5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFeju7fF&md5=05f9fafdbe8dd7c1407fb7b4afab0587</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2FC4NP00064A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00064A%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BS.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%2BB.%26aulast%3DCooper%26aufirst%3DM.%2BA.%26atitle%3DNatural%2520product%2520and%2520natural%2520product%2520derived%2520drugs%2520in%2520clinical%2520trials%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D1612%26epage%3D1661%26doi%3D10.1039%2FC4NP00064A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b01285</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b01285" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2020&pages=770-803&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+nearly+four+decades+from+01%2F1981+to+09%2F2019&doi=10.1021%2Facs.jnatprod.9b01285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">770-803</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016.  For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the first of Jan. 1981 to the 30th of Sept. 2019 for all diseases worldwide and from ∼1946 (earliest so far identified) to the 30th of Sept. 2019 for all approved antitumor drugs worldwide.  As in earlier reviews, only the first approval of any drug is counted, irresp. of how many "biosimilars" or added approvals were subsequently identified.  As in the 2012 and 2016 reviews, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions, and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from 1946 to 1980, of the 75 small mols., 40, or 53.3%, are N or ND.  In the 1981 to date time frame the equiv. figures for the N* compds. of the 185 small mols. are 62, or 33.5%, though to these can be added the 58 S* and S*/NMs, bringing the figure to 64.9%.  In other areas, the influence of natural product structures is quite marked with, as expected from prior information, the anti-infective area being dependent on natural products and their structures, though as can be seen in the review there are still disease areas (shown in Table 2) for which there are no drugs derived from natural products.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are still able to identify only two de novo combinatorial compds. (one of which is a little speculative) approved as drugs in this 39-yr time frame, though there is also one drug that was developed using the "fragment-binding methodol." and approved in 2012.  We have also added a discussion of candidate drug entities currently in clin. trials as "warheads" and some very interesting preliminary reports on sources of novel antibiotics from Nature due to the abs. requirement for new agents to combat plasmid-borne resistance genes now in the general populace.  We continue to draw the attention of readers to the recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated"; thus we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9vVZR4nleEbVg90H21EOLACvtfcHk0lhZ1C8LJA9btQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXks1Cmsrw%253D&md5=2c10c2aef98042d8bd772b6280b51d2b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b01285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b01285%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520nearly%2520four%2520decades%2520from%252001%252F1981%2520to%252009%252F2019%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2020%26volume%3D83%26spage%3D770%26epage%3D803%26doi%3D10.1021%2Facs.jnatprod.9b01285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco Carcache, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addo, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Current status and contemporary approaches to the discovery of antitumor agents from higher plants</span>. <i>Biotechnol. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">107337</span>, <span class="refDoi"> DOI: 10.1016/j.biotechadv.2019.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biotechadv.2019.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30633954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1emtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=107337&author=G.+Agarwalauthor=P.+J.+Blanco+Carcacheauthor=E.+M.+Addoauthor=A.+D.+Kinghorn&title=Current+status+and+contemporary+approaches+to+the+discovery+of+antitumor+agents+from+higher+plants&doi=10.1016%2Fj.biotechadv.2019.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Current status and contemporary approaches to the discovery of antitumor agents from higher plants</span></div><div class="casAuthors">Agarwal, Garima; Carcache, Peter J. Blanco; Addo, Ermias Mekuria; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Advances</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107337</span>CODEN:
                <span class="NLM_cas:coden">BIADDD</span>;
        ISSN:<span class="NLM_cas:issn">0734-9750</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Higher plant constituents have afforded clin. available anticancer drugs.  These include both chem. unmodified small mols. and their synthetic derivs. currently used or those in clin. trials as antineoplastic agents, and an updated summary is provided.  In addn., botanical dietary supplements, exemplified by mangosteen and noni constituents, are also covered as potential cancer chemotherapeutic agents.  Approaches to metabolite purifn., rapid dereplication, and biol. evaluation including anal. hyphenated techniques, mol. networking, and advanced cellular and animal models are discussed.  Further, enhanced and targeted drug delivery systems for phytochems., including micelles, nanoparticles and antibody drug conjugates (ADCs) are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUDKtoINxG87Vg90H21EOLACvtfcHk0lhZ1C8LJA9btQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1emtrc%253D&md5=094832aae5d9e3f20d6ac048bce98611</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biotechadv.2019.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biotechadv.2019.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DG.%26aulast%3DBlanco%2BCarcache%26aufirst%3DP.%2BJ.%26aulast%3DAddo%26aufirst%3DE.%2BM.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCurrent%2520status%2520and%2520contemporary%2520approaches%2520to%2520the%2520discovery%2520of%2520antitumor%2520agents%2520from%2520higher%2520plants%26jtitle%3DBiotechnol.%2520Adv.%26date%3D2020%26volume%3D38%26spage%3D107337%26doi%3D10.1016%2Fj.biotechadv.2019.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frank, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">The methylerythritol phosphate pathway to isoprenoids</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">5675</span>– <span class="NLM_lpage">5703</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00537</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=5675-5703&author=A.+Frankauthor=M.+Groll&title=The+methylerythritol+phosphate+pathway+to+isoprenoids&doi=10.1021%2Facs.chemrev.6b00537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Methylerythritol Phosphate Pathway to Isoprenoids</span></div><div class="casAuthors">Frank, Annika; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5675-5703</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Isoprenoids constitute one of the most diverse classes of natural products.  As a compd. class they are essential to basic metabolic processes including cell wall biosynthesis, post-translational protein modifications, and signaling.  In addn., isoprenoid secondary metabolites are highly valuable natural products with a wide range of biotechnol. applications.  The biosynthesis of their 2 universal building blocks, isopentenyl diphosphate and dimethylallyl diphosphate, was thought to proceed exclusively by way of mevalonate as a key intermediate until a novel pathway involving methylerithritol phosphate (MEP) was discovered in the early 1990s.  Here, the authors describe the 7 enzymes of the MEP pathway, their discovery, 3-dimensional structures and mechanisms.  The latter include examples of remarkable enzyme catalysis including an unusual cytidilation reaction and the use of Fe-S cluster cofactors in reductive ring opening and OH group elimination.  Furthermore, isoprenoid biosynthesis shows a characteristic species distribution.  A brief overview highlights the MEP pathway's potential as a selective drug target, absent in humans but essential to the survival of many important bacterial and apicomplexan pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI7TRNfELYI7Vg90H21EOLACvtfcHk0lhZ1C8LJA9btQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnF&md5=4e64297438c0ea4ddbcb6d170febaefc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00537%26sid%3Dliteratum%253Aachs%26aulast%3DFrank%26aufirst%3DA.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DThe%2520methylerythritol%2520phosphate%2520pathway%2520to%2520isoprenoids%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D5675%26epage%3D5703%26doi%3D10.1021%2Facs.chemrev.6b00537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarkowská, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, M.</span></span> <span> </span><span class="NLM_article-title">Isoprenoid-derived plant signaling molecules: Biosynthesis and biological importance</span>. <i>Planta</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>247</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1007/s00425-018-2878-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs00425-018-2878-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29532163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksVegtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=2018&pages=1051-1066&author=D.+Tarkowsk%C3%A1author=M.+Strnad&title=Isoprenoid-derived+plant+signaling+molecules%3A+Biosynthesis+and+biological+importance&doi=10.1007%2Fs00425-018-2878-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Isoprenoid-derived plant signaling molecules: biosynthesis and biological importance</span></div><div class="casAuthors">Tarkowska, Danuse; Strnad, Miroslav</div><div class="citationInfo"><span class="NLM_cas:title">Planta</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1051-1066</span>CODEN:
                <span class="NLM_cas:coden">PLANAB</span>;
        ISSN:<span class="NLM_cas:issn">0032-0935</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Main conclusion: The present review summarizes current knowledge of the biosynthesis and biol. importance of isoprenoid-derived plant signaling compds.  Cellular organisms use chem. signals for intercellular communication to coordinate their growth, development, and responses to environmental cues.  The skeletons of majority of plant signaling mols., mediators of plant intercellular 'broadcasting', are built from C5 units of isoprene and therefore belong to a huge and diverse group of natural substances called isoprenoids (terpenoids).  They fill many important roles in nature.  This review summarizes current knowledge of the biosynthesis and biol. importance of a group of isoprenoid-derived plant signaling compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1JRPGm7TzTLVg90H21EOLACvtfcHk0lhHzo0QYAK-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksVegtLs%253D&md5=2c6e74552af2065511dd5207da227de3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00425-018-2878-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00425-018-2878-x%26sid%3Dliteratum%253Aachs%26aulast%3DTarkowsk%25C3%25A1%26aufirst%3DD.%26aulast%3DStrnad%26aufirst%3DM.%26atitle%3DIsoprenoid-derived%2520plant%2520signaling%2520molecules%253A%2520Biosynthesis%2520and%2520biological%2520importance%26jtitle%3DPlanta%26date%3D2018%26volume%3D247%26spage%3D1051%26epage%3D1066%26doi%3D10.1007%2Fs00425-018-2878-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajikumar, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phon, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephanopoulos, G.</span></span> <span> </span><span class="NLM_article-title">Terpenoids: Opportunities for biosynthesis of natural product drugs using engineered microorganisms</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1021/mp700151b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp700151b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsFGjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=167-190&author=P.+K.+Ajikumarauthor=K.+Tyoauthor=S.+Carlsenauthor=O.+Muchaauthor=T.+H.+Phonauthor=G.+Stephanopoulos&title=Terpenoids%3A+Opportunities+for+biosynthesis+of+natural+product+drugs+using+engineered+microorganisms&doi=10.1021%2Fmp700151b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms</span></div><div class="casAuthors">Ajikumar, Parayil Kumaran; Tyo, Keith; Carlsen, Simon; Mucha, Oliver; Phon, Too Heng; Stephanopoulos, Gregory</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-190</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Terpenoids represent a diverse class of mols. that provide a wealth of opportunities to address many human health and societal issues.  The expansive array of structures and functionalities that have been evolved in nature provide an excellent pool of mols. for use in human therapeutics.  While this class of mols. has members with therapeutic properties including anticancer, antiparasitic, antimicrobial, antiallergenic, antispasmodic, antihyperglycemic, anti-inflammatory, and immunomodulatory properties, supply limitations prevent the large scale use of some mols.  Many of these mols. are only found in ppm levels in nature thus requiring massive harvesting to obtain sufficient amts. of the drug.  Synthetic biol. and metabolic engineering provide innovative approaches to increase the prodn. of the desired mol. in the native organism, and most importantly, transfer the biosynthetic pathways to other hosts.  Microbial systems are well studied, and genetic manipulations allow the optimization of microbial metabs. for the prodn. of common terpenoid precursors.  Using a host of tools, unprecedented advancements in the large scale prodn. of terpenoids have been achieved in recent years.  Identification of limiting steps and pathway regulation, coupled with design strategies to minimize terpenoid byproducts with a high flux to the desired biosynthetic pathways, have yielded greater than 100-fold improvements in the prodn. of a range of terpenoids.  This review focuses on the biodiversity of terpenoids, the biosynthetic pathways involved, and engineering efforts to maximize the prodn. through these pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7OFP275GvZ7Vg90H21EOLACvtfcHk0lhHzo0QYAK-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsFGjur4%253D&md5=0c7e294fa82c77e790ff46257c92a8c6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fmp700151b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp700151b%26sid%3Dliteratum%253Aachs%26aulast%3DAjikumar%26aufirst%3DP.%2BK.%26aulast%3DTyo%26aufirst%3DK.%26aulast%3DCarlsen%26aufirst%3DS.%26aulast%3DMucha%26aufirst%3DO.%26aulast%3DPhon%26aufirst%3DT.%2BH.%26aulast%3DStephanopoulos%26aufirst%3DG.%26atitle%3DTerpenoids%253A%2520Opportunities%2520for%2520biosynthesis%2520of%2520natural%2520product%2520drugs%2520using%2520engineered%2520microorganisms%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2008%26volume%3D5%26spage%3D167%26epage%3D190%26doi%3D10.1021%2Fmp700151b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paduch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandefer-Szerszeń, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trytek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiedurek, J.</span></span> <span> </span><span class="NLM_article-title">Terpenes: Substances useful in human healthcare</span>. <i>Arch. Immunol. Ther. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1007/s00005-007-0039-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs00005-007-0039-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=18219762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGqsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=315-327&author=R.+Paduchauthor=M.+Kandefer-Szersze%C5%84author=M.+Trytekauthor=J.+Fiedurek&title=Terpenes%3A+Substances+useful+in+human+healthcare&doi=10.1007%2Fs00005-007-0039-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenes: substances useful in human healthcare</span></div><div class="casAuthors">Paduch, Roman; Kandefer-Szerzen, Martyna; Trytek, Mariusz; Fiedurek, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Archivum Immunologiae et Therapiae Experimentalis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">315-327</span>CODEN:
                <span class="NLM_cas:coden">AITEAT</span>;
        ISSN:<span class="NLM_cas:issn">0004-069X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Terpenes are naturally occurring substances produced by a wide variety of plants and animals.  A broad range of the biol. properties of terpenoids is described, including cancer chemopreventive effects, antimicrobial, antifungal, antiviral, anti-hyperglycemic, anti-inflammatory, and antiparasitic activities.  Terpenes are also presented as skin penetration enhancers and agents involved in the prevention and therapy of several inflammatory diseases.  Moreover, a potential mechanism of their action against pathogens and their influence on skin permeability are discussed.  The major conclusion is that larger-scale use of terpenoids in modern medicine should be taken into consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPWXrsN016JbVg90H21EOLACvtfcHk0lhHzo0QYAK-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGqsLzM&md5=15f8d9199ac8af186c17a627cd593e24</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00005-007-0039-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00005-007-0039-1%26sid%3Dliteratum%253Aachs%26aulast%3DPaduch%26aufirst%3DR.%26aulast%3DKandefer-Szersze%25C5%2584%26aufirst%3DM.%26aulast%3DTrytek%26aufirst%3DM.%26aulast%3DFiedurek%26aufirst%3DJ.%26atitle%3DTerpenes%253A%2520Substances%2520useful%2520in%2520human%2520healthcare%26jtitle%3DArch.%2520Immunol.%2520Ther.%2520Exp.%26date%3D2007%26volume%3D55%26spage%3D315%26epage%3D327%26doi%3D10.1007%2Fs00005-007-0039-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estévez, F.</span></span> <span> </span><span class="NLM_article-title">Recent advances on cytotoxic sesquiterpene lactones</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4355</span>– <span class="NLM_lpage">4361</span>, <span class="refDoi"> DOI: 10.2174/1381612825666190119114323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1381612825666190119114323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=4355-4361&author=J.+Quintanaauthor=F.+Est%C3%A9vez&title=Recent+advances+on+cytotoxic+sesquiterpene+lactones&doi=10.2174%2F1381612825666190119114323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F1381612825666190119114323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612825666190119114323%26sid%3Dliteratum%253Aachs%26aulast%3DQuintana%26aufirst%3DJ.%26aulast%3DEst%25C3%25A9vez%26aufirst%3DF.%26atitle%3DRecent%2520advances%2520on%2520cytotoxic%2520sesquiterpene%2520lactones%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2019%26volume%3D24%26spage%3D4355%26epage%3D4361%26doi%3D10.2174%2F1381612825666190119114323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Development of anticancer agents from plant-derived sesquiterpene lactones</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2420</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160510123255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F0929867323666160510123255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27160533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=2397-2420&author=Y.+Renauthor=J.+Yuauthor=A.+D.+Kinghorn&title=Development+of+anticancer+agents+from+plant-derived+sesquiterpene+lactones&doi=10.2174%2F0929867323666160510123255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones</span></div><div class="casAuthors">Ren, Yulin; Yu, Jianhua; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2397-2420</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Sesquiterpene lactones are of considerable interest due to their potent bioactivities, including cancer cell cytotoxicity and antineoplastic efficacy in in vivo studies.  Among these compds., artesunate, dimethylaminoparthenolide, and L12ADT peptide prodrug, a deriv. of thapsigargin, are being evaluated in the current cancer clin. or preclin. trials.  Based on the structures of several antitumor sesquiterpene lactones, a no. of analogs showing greater potency have been either isolated as natural products or partially synthesized, and some potential anticancer agents that have emerged from this group of lead compds. have been investigated extensively.  The present review focuses on artemisinin, parthenolide, thapsigargin, and their naturally occurring or synthetic analogs showing potential anticancer activity.  This provides an overview of the advances in the development of these types of sesquiterpene lactones as potential anticancer agents, including their structural characterization, synthesis and synthetic modification, and antitumor potential, with the mechanism of action and structure-activity relationships also discussed.  It is hoped that this will be helpful in stimulating the further interest in developing sesquiterpene lactones and their derivs. as new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_1PsbdXAYcbVg90H21EOLACvtfcHk0liu2EITqiMFvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7jF&md5=fd2a8464d69d9bec4f3fdd4d065c3c41</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160510123255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160510123255%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DDevelopment%2520of%2520anticancer%2520agents%2520from%2520plant-derived%2520sesquiterpene%2520lactones%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D2397%26epage%3D2420%26doi%3D10.2174%2F0929867323666160510123255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Potential anticancer agents characterized from selected tropical plants</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.9b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.9b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFyjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2019&pages=657-679&author=Y.+Renauthor=E.+J.+Carcache+de+Blancoauthor=J.+R.+Fuchsauthor=D.+D.+Soejartoauthor=J.+E.+Burdetteauthor=S.+M.+Swansonauthor=A.+D.+Kinghorn&title=Potential+anticancer+agents+characterized+from+selected+tropical+plants&doi=10.1021%2Facs.jnatprod.9b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potential Anticancer Agents Characterized from Selected Tropical Plants</span></div><div class="casAuthors">Ren, Yulin; de Blanco, Esperanza J. Carcache; Fuchs, James R.; Soejarto, Djaja D.; Burdette, Joanna E.; Swanson, Steven M.; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">657-679</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Higher plants are well known for their value in affording clin. useful anticancer agents, with such compds. acting against cancer cells by a range of mechanisms of action.  There remains a strong interest in the discovery and development of plant secondary metabolites as addnl. cancer chemotherapeutic lead compds.  In the present review, progress on the discovery of plant-derived compds. of the biflavonoid, lignan, sesquiterpene, steroid, and xanthone structural types is presented.  Several potential anticancer leads of these types have been characterized from tropical plants collected in three countries as part of our ongoing collaborative multi-institutional project.  Preliminary structure-activity relationships and work on in vivo testing and cellular mechanisms of action are also discussed.  In addn., the relevant work reported by other groups on the same compd. classes is included herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6wQ6YEZLhGLVg90H21EOLACvtfcHk0liu2EITqiMFvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFyjs7s%253D&md5=24dbd8b58989ad4a3c24549923f542ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.9b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.9b00018%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DBurdette%26aufirst%3DJ.%2BE.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DPotential%2520anticancer%2520agents%2520characterized%2520from%2520selected%2520tropical%2520plants%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2019%26volume%3D82%26spage%3D657%26epage%3D679%26doi%3D10.1021%2Facs.jnatprod.9b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Natural product triterpenoids and their semi-synthetic derivatives with potential anticancer activity</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">814</span>, <span class="refDoi"> DOI: 10.1055/a-0832-2383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fa-0832-2383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30658371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=802-814&author=Y.+Renauthor=A.+D.+Kinghorn&title=Natural+product+triterpenoids+and+their+semi-synthetic+derivatives+with+potential+anticancer+activity&doi=10.1055%2Fa-0832-2383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity *</span></div><div class="casAuthors">Ren, Yulin; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11/12</span>),
    <span class="NLM_cas:pages">802-814</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Triterpenoids are distributed widely in higher plants and are of interest because of their structural diversity and broad range of bioactivities.  In particular, there is a very large literature on the propensity of a variety of triterpenoids to act as potential anticancer agents.  In the present review, the anticancer potential is summarized for naturally occurring triterpenoids and their semi-synthetic derivs., including examples of lupane-, oleanane-, ursane-, and cucurbitane-type pentacyclic triterpenoids, along with dammarane-type tetracyclic triterpenes including ginsenosides and their sapogenins and dichapetalins, which have been characterized as antitumor leads from higher plants.  Preliminary structure-activity relationships and reported mechanisms of the antineoplastic-related activity are included.  Prior studies for triterpenoids of plant origin are supportive of addnl. work being conducted on the more detailed biol. and mechanistic evaluation for the progression of this type of natural products as possible cancer chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp13aTkQV1DCbVg90H21EOLACvtfcHk0liu2EITqiMFvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVSisbY%253D&md5=9e8d63dcd2b07d651a231d3e7284b23b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1055%2Fa-0832-2383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fa-0832-2383%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DNatural%2520product%2520triterpenoids%2520and%2520their%2520semi-synthetic%2520derivatives%2520with%2520potential%2520anticancer%2520activity%26jtitle%3DPlanta%2520Med.%26date%3D2019%26volume%3D85%26spage%3D802%26epage%3D814%26doi%3D10.1055%2Fa-0832-2383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghantous, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gali-Muhtasib, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saliba, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwiche, N.</span></span> <span> </span><span class="NLM_article-title">What made sesquiterpene lactones reach cancer clinical trials?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">678</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.drudis.2010.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20541036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=668-678&author=A.+Ghantousauthor=H.+Gali-Muhtasibauthor=H.+Vuorelaauthor=N.+A.+Salibaauthor=N.+Darwiche&title=What+made+sesquiterpene+lactones+reach+cancer+clinical+trials%3F&doi=10.1016%2Fj.drudis.2010.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">What made sesquiterpene lactones reach cancer clinical trials?</span></div><div class="casAuthors">Ghantous, Akram; Gali-Muhtasib, Hala; Vuorela, Heikki; Saliba, Najat A.; Darwiche, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">668-678</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sesquiterpene lactones (SLs) are plant-derived compds. often used in traditional medicine against inflammation and cancer.  This review focuses on the chem. and biol. properties of SLs that lead to enhanced anticancer and anti-inflammatory effects.  The chem. properties comprise alkylating center reactivity, lipophilicity, and mol. geometry and electronic features.  SLs in clin. trials are artemisinin, thapsigargin and parthenolide and many of their synthetic derivs.  These drugs are selective toward tumor and cancer stem cells by targeting specific signaling pathways, which make them lead compds. in cancer clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSvY2k51WSrbVg90H21EOLACvtfcHk0lhUzDQHSPuK5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3K&md5=8e7baa64e3c226c50ac5ccc740cb79b4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DGhantous%26aufirst%3DA.%26aulast%3DGali-Muhtasib%26aufirst%3DH.%26aulast%3DVuorela%26aufirst%3DH.%26aulast%3DSaliba%26aufirst%3DN.%2BA.%26aulast%3DDarwiche%26aufirst%3DN.%26atitle%3DWhat%2520made%2520sesquiterpene%2520lactones%2520reach%2520cancer%2520clinical%2520trials%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D668%26epage%3D678%26doi%3D10.1016%2Fj.drudis.2010.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slezakova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda-Kucerova, J.</span></span> <span> </span><span class="NLM_article-title">Anticancer activity of artemisinin and its derivatives</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">5995</span>– <span class="NLM_lpage">6003</span>, <span class="refDoi"> DOI: 10.21873/anticanres.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.21873%2Fanticanres.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29061778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVGqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=5995-6003&author=S.+Slezakovaauthor=J.+Ruda-Kucerova&title=Anticancer+activity+of+artemisinin+and+its+derivatives&doi=10.21873%2Fanticanres.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activity of Artemisinin and its derivatives</span></div><div class="casAuthors">Slezakova, Silvia; Ruda-Kucerova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5995-6003</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Artemisinin is an ext. from the plant Artemisia annua.  With its semi-synthetic derivs., they form a group of well-known and efficacious antimalarial drugs.  Recent studies have documented the potential anticancer effect of artemisinin and its derivs. (ARTs).  This review summarizes results of preclin. studies, documenting mechanisms of anticancer actions of ARTs and clin. studies focused mainly on efficacy, safely and dose-ranging of ARTs as anticancer chemotherapeutics.  The main mechanisms of action of ARTs is the prodn. of reactive oxygen species, inhibition of cell cycle in G0/G1 phase, induction of apoptosis and inhibition of angiogenesis.  Safety studies have shown no evident toxicity and low incidence of adverse effects.  ARTs potential to inhibit growth of solid tumors suggests their application in a neoadjuvant therapy.  Dihydroartemisinin and artesunate exhibit chemosensitizing effects in vivo in breast, lung, pancreas and glioma cancer cells, proposing the use of ARTs also in combination anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqffAzRp6rrh7Vg90H21EOLACvtfcHk0lirh0PcxspXGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVGqtb4%253D&md5=a266986154a4528708994039c2e646b9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.12046%26sid%3Dliteratum%253Aachs%26aulast%3DSlezakova%26aufirst%3DS.%26aulast%3DRuda-Kucerova%26aufirst%3DJ.%26atitle%3DAnticancer%2520activity%2520of%2520artemisinin%2520and%2520its%2520derivatives%26jtitle%3DAnticancer%2520Res.%26date%3D2017%26volume%3D37%26spage%3D5995%26epage%3D6003%26doi%3D10.21873%2Fanticanres.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangguan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B.</span></span> <span> </span><span class="NLM_article-title">Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">3367</span>– <span class="NLM_lpage">3383</span>, <span class="refDoi"> DOI: 10.1007/s00204-019-02579-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs00204-019-02579-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31563988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKrsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2019&pages=3367-3383&author=Y.+Liauthor=J.+Luauthor=Q.+Chenauthor=S.+Hanauthor=H.+Shaoauthor=P.+Chenauthor=Q.+Jinauthor=M.+Yangauthor=F.+Shangguanauthor=M.+Feiauthor=L.+Wangauthor=Y.+Liuauthor=N.+Liuauthor=B.+Lu&title=Artemisinin+suppresses+hepatocellular+carcinoma+cell+growth%2C+migration+and+invasion+by+targeting+cellular+bioenergetics+and+Hippo-YAP+signaling&doi=10.1007%2Fs00204-019-02579-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling</span></div><div class="casAuthors">Li, Yujie; Lu, Jing; Chen, Qin; Han, Shengnan; Shao, Hua; Chen, Pingyi; Jin, Qiumei; Yang, Mingyue; Shangguan, Fugen; Fei, Mingming; Wang, Lu; Liu, Yongzhang; Liu, Naxin; Lu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3367-3383</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The primary liver cancer (PLC) is one of the leading causes of cancer-related death worldwide.  The predominant form of PLC is hepatocellular carcinoma (HCC), which accounts for about 85% of all PLC.  Artemisinin (ART) was clin. used as anti-malarial agents.  Recently, it was demonstrated to inhibit cell growth and migration in multiple cancer types.  However, the mol. mechanism underlying these anti-cancer activity remains largely unknown.  Herein, it is discovered that ART dramatically suppresses HCC cell growth in vitro through arresting cell cycle progression, and represses cell migration and invasion via regulating N-cadherin-Snail-E-cadherin axis.  In addn., the disruption of cellular bioenergetics contributed to ART-caused cell growth, migration and invasion inhibition.  Moreover, ART (100 mg/kg, i.p.) substantially inhibits HCC xenograft growth in vivo.  Importantly, Hippo-YAP signal transduction is remarkably inactivated in HCC cells upon ART administration.  Collectively, these data reveal a novel mechanism of ART in regulating HCC cell growth, migration, and invasion, which indicates that ART could be considered as a potential drug for the treatment of HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMWiMTVFvWwLVg90H21EOLACvtfcHk0lirh0PcxspXGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKrsrbE&md5=c44498fd3c31746c9de221b9bf502267</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00204-019-02579-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-019-02579-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DShangguan%26aufirst%3DF.%26aulast%3DFei%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DB.%26atitle%3DArtemisinin%2520suppresses%2520hepatocellular%2520carcinoma%2520cell%2520growth%252C%2520migration%2520and%2520invasion%2520by%2520targeting%2520cellular%2520bioenergetics%2520and%2520Hippo-YAP%2520signaling%26jtitle%3DArch.%2520Toxicol.%26date%3D2019%26volume%3D93%26spage%3D3367%26epage%3D3383%26doi%3D10.1007%2Fs00204-019-02579-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, D.</span></span> <span> </span><span class="NLM_article-title">Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1227</span>– <span class="NLM_lpage">1235</span>, <span class="refDoi"> DOI: 10.1093/abbs/gmy125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fabbs%2Fgmy125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30395153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlWksLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1227-1235&author=B.+Liauthor=S.+Buauthor=J.+Sunauthor=Y.+Guoauthor=D.+Lai&title=Artemisinin+derivatives+inhibit+epithelial+ovarian+cancer+cells+via+autophagy-mediated+cell+cycle+arrest&doi=10.1093%2Fabbs%2Fgmy125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest</span></div><div class="casAuthors">Li, Boning; Bu, Shixia; Sun, Junyan; Guo, Ying; Lai, Dongmei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1227-1235</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1745-7270</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Epithelial ovarian cancer (EOC) is the most fatal gynecol. malignancy due to its late diagnosis and lack of curative therapy.  The antimalaria compd. artemisinin and its derivs., such as artesunate (ART) and dihydroartemisinin (DHA), have proven to be potent anticancer drugs and act through various anticancer mechanisms.  To identify novel targets of artemisinin derivs. in EOC cells, we investigated the effects of ART and DHA on SKOV3 and primary EOC cell growth via CCK-8 assay.  Both ART and DHA inhibited EOC cell growth.  A cell cycle distribution anal. showed that ART and DHA caused G2/M cell cycle arrest.  Moreover, ART and DHA induced autophagy in EOC cells, whereas autophagy inhibitors reversed the cell growth inhibition and cell cycle arrest induced by ART and DHA.  Western blot anal. showed that ART and DHA also suppressed the cell cycle-related NF-κB-signaling pathway in EOC cells.  These data suggest that artemisinin derivs. induce autophagy, block the cell cycle, and inhibit cell growth in EOC cells.  Our research provides new targets for artemisinin derivs. for EOC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruIljEG6whuLVg90H21EOLACvtfcHk0ljrfuxw3khSVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlWksLrJ&md5=bc325f54d554ea566ada39a924088062</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fabbs%2Fgmy125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fabbs%252Fgmy125%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DBu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DD.%26atitle%3DArtemisinin%2520derivatives%2520inhibit%2520epithelial%2520ovarian%2520cancer%2520cells%2520via%2520autophagy-mediated%2520cell%2520cycle%2520arrest%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2018%26volume%3D50%26spage%3D1227%26epage%3D1235%26doi%3D10.1093%2Fabbs%2Fgmy125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisanti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosentini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laganà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberio, G. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berruti, A.</span></span> <span> </span><span class="NLM_article-title">Antineoplastic activity of artemisinin in adrenocortical carcinoma</span>. <i>Endocrine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1007/s12020-019-02077-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs12020-019-02077-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31493273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsleltbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2019&pages=425-427&author=L.+Loriniauthor=S.+Grisantiauthor=R.+Ambrosiniauthor=D.+Cosentiniauthor=M.+Lagan%C3%A0author=L.+Grazioliauthor=G.+A.+M.+Tiberioauthor=S.+Sigalaauthor=A.+Berruti&title=Antineoplastic+activity+of+artemisinin+in+adrenocortical+carcinoma&doi=10.1007%2Fs12020-019-02077-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic activity of artemisinin in adrenocortical carcinoma</span></div><div class="casAuthors">Lorini, Luigi; Grisanti, Salvatore; Ambrosini, Roberta; Cosentini, Deborah; Lagana, Marta; Grazioli, Luigi; Tiberio, Guido A. M.; Sigala, Sandra; Berruti, Alfredo</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">425-427</span>CODEN:
                <span class="NLM_cas:coden">EOCRE5</span>;
        ISSN:<span class="NLM_cas:issn">1355-008X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomoiVZOsxFpbVg90H21EOLACvtfcHk0ljrfuxw3khSVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsleltbbE&md5=908082ba7c421c6dbd3bccb2799416a7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs12020-019-02077-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12020-019-02077-7%26sid%3Dliteratum%253Aachs%26aulast%3DLorini%26aufirst%3DL.%26aulast%3DGrisanti%26aufirst%3DS.%26aulast%3DAmbrosini%26aufirst%3DR.%26aulast%3DCosentini%26aufirst%3DD.%26aulast%3DLagan%25C3%25A0%26aufirst%3DM.%26aulast%3DGrazioli%26aufirst%3DL.%26aulast%3DTiberio%26aufirst%3DG.%2BA.%2BM.%26aulast%3DSigala%26aufirst%3DS.%26aulast%3DBerruti%26aufirst%3DA.%26atitle%3DAntineoplastic%2520activity%2520of%2520artemisinin%2520in%2520adrenocortical%2520carcinoma%26jtitle%3DEndocrine%26date%3D2019%26volume%3D66%26spage%3D425%26epage%3D427%26doi%3D10.1007%2Fs12020-019-02077-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Akt enhances the anticancer effects of artemisinin in clear cell renal cell carcinoma</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">109383</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31545251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ylu73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2019&pages=109383&author=C.+Yuauthor=P.+Sunauthor=Y.+Zhouauthor=B.+Shenauthor=M.+Zhouauthor=L.+Wuauthor=M.+Kong&title=Inhibition+of+Akt+enhances+the+anticancer+effects+of+artemisinin+in+clear+cell+renal+cell+carcinoma&doi=10.1016%2Fj.biopha.2019.109383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma</span></div><div class="casAuthors">Yu, Congcong; Sun, Peiyu; Zhou, Yuehong; Shen, Bin; Zhou, Meihua; Wu, Lingzhi; Kong, Min</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109383</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Given studies have shown that Artemisinin (ART) reduces cancer cell proliferation, migration, invasion, tumorigenesis and metastasis.  In this study, we evaluated the roles of ART in clear cell renal cell carcinoma (ccRCC) progression.  We measured the eff ;ects of ART on cancer cell proliferation, colony formation, migration, invasion and tumorigenesis.  CCK-8 assay demonstrated that ART inhibited cell growth with IC50 values 31.30 ± 0.73 μM in UMRC-2 and 23.97 ± 0.92 μM in CAKI-2, resp.  Colony formation assay shown that ART inhibited cell colony formation.  Transwell migration and invasion assay shown that ART inhibited RCC migration and invasion.  Realtime-qPCR assay shown that ART decreased the mRNA levels of proliferation related genes c-Myc, cyclin D1 and PCNA, and reduced the mRNA levels of mesenchymal genes N-cadherin, Vimentin and Snail, but increased the mRNA levels of epithelial marker E-cadherin.  Moreover, ART inhibited AKT signaling pathway.  In the presence of AKT inhibitor VIII, a pan-AKT inhibitor, ART reduced more cell proliferation, migration and invasion than in the absence of AKT inhibitor VIII, suggesting combination of ART and AKT inhibitor enhanced the anti-cancer effects of ART.  Furthermore, the in vivo xenograft tumor model results suggested that ART decreased tumor size and wt., and suppressed AKT signaling.  Taken together, our results indicated that ART inhibited ccRCC cell proliferation, colony formation, migration, invasion and tumorigenesis.  Combination of ART and AKT inhibitor enhanced the anti-cancer cell proliferation, migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrad5ePyjzRS7Vg90H21EOLACvtfcHk0ljUrLytkGrzGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ylu73I&md5=c02ed450ce89bd1034262c597eee56d0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109383%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520Akt%2520enhances%2520the%2520anticancer%2520effects%2520of%2520artemisinin%2520in%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D118%26spage%3D109383%26doi%3D10.1016%2Fj.biopha.2019.109383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Interactions between artemisinin derivatives and P-glycoprotein</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">152998</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2019.152998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phymed.2019.152998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31301971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlGgu73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2019&pages=152998&author=Y.+Wangauthor=Y.+Liauthor=D.+Shangauthor=T.+Efferth&title=Interactions+between+artemisinin+derivatives+and+P-glycoprotein&doi=10.1016%2Fj.phymed.2019.152998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between artemisinin derivatives and P-glycoprotein</span></div><div class="casAuthors">Wang, Yulin; Li, Yongjie; Shang, Dong; Efferth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152998</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Artemisinin was isolated and identified in 1972, which was the starting point for a new era in antimalarial drug therapy.  Furthermore, numerous studies have demonstrated that artemisinin and its derivs. exhibit considerable anticancer activity both in vitro, in vivo, and even in clin. Phase I/II trials.  P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) is one of the most serious causes of chemotherapy failure in cancer treatment.  Interestingly, many artemisinin derivs. exhibit excellent ability to overcome P-gp mediated MDR and even show collateral sensitivity against MDR cancer cells.  Furthermore, some artemisinin derivs. show P-gp-mediated MDR reversal activity.  Therefore, the interaction between P-gp and artemisinin derivs. is important to develop novel combination treatment protocols with artemisinin derivs. and established anticancer drugs that are P-gp substrates.  This systematic review provides an updated overview on the interaction between artemisinin derivs. and P-gp and the effect of artemisinin derivs. on the P-gp expression level.  Artemisinin derivs. exhibit multi-specific interactions with P-gp.  The currently used artemisinin derivs. are not transported by P-gp.  However, some of novel synthesized artemisinin derivs. exhibit P-gp substrate properties.  Furthermore, many artemisinin derivs. act as P-gp inhibitors, which exhibit the potential to reverse MDR towards clin. used anticancer drugs.  Therefore, studies on the interaction between artemisinin derivs. and P-gp provide important information for the development of novel anti-cancer artemisinin derivs. to reverse P-gp mediated MDR and for the design of rational artemisinin-based combination therapies against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGfzWFlwF97Vg90H21EOLACvtfcHk0ljUrLytkGrzGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlGgu73M&md5=ebc13b2395efa5573f05e925c9c709b1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2019.152998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2019.152998%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShang%26aufirst%3DD.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DInteractions%2520between%2520artemisinin%2520derivatives%2520and%2520P-glycoprotein%26jtitle%3DPhytomedicine%26date%3D2019%26volume%3D60%26spage%3D152998%26doi%3D10.1016%2Fj.phymed.2019.152998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Artemisinin and its derivatives prevent <i>Helicobacter pylori</i>-induced gastric carcinogenesis via inhibition of NF-κB signaling</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">152968</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2019.152968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phymed.2019.152968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31280140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlCiu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=152968&author=T.+Suauthor=F.+Liauthor=J.+Guanauthor=L.+Liuauthor=P.+Huangauthor=Y.+Wangauthor=X.+Qiauthor=Z.+Liuauthor=L.+Luauthor=D.+Wang&title=Artemisinin+and+its+derivatives+prevent+Helicobacter+pylori-induced+gastric+carcinogenesis+via+inhibition+of+NF-%CE%BAB+signaling&doi=10.1016%2Fj.phymed.2019.152968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling</span></div><div class="casAuthors">Su, Tao; Li, Fangyuan; Guan, Jiaji; Liu, Linxin; Huang, Ping; Wang, Ying; Qi, Xiaoxiao; Liu, Zhongqiu; Lu, Linlin; Wang, Dawei</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152968</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Gastric cancer has a high morbidity and is a leading cause of cancer-related mortality worldwide.  Helicobacter pylori (H. pylori) infection is commonly found in the early stage of gastric cancer pathogenesis, which induces chronic gastritis.  Artemisinin (ART) and its derivs. (ARTS, artesunate and DHA, dihydroartemisinin), a new class of potent antimalarials, have been reported to exert both preventive and anti-gastric cancer effects.  However, the underlying mechanisms of the chemopreventive effects of ART and its derivs. in H. pylori infection induced-gastric cancer are not fully elucidated.  We investigated the effects of H. pylori infection in gastric cancer; and the preventive mechanisms of ART, ARTS and DHA.The H. pylori growth was detd. by the broth macro-diln. method, and its adhesion to gastric cancer cells was evaluated by using the urease assay.  The protein and mRNA levels, reactive oxygen species (ROS) prodn., as well as the prodn. of inflammatory cytokines were evaluated by Western blot, real-time PCR, flow cytometry and ELISA, resp.  Moreover, an in vivo MNU (N-methyl-N-nitroso-urea) and H. pylori-induced gastric adenocarcinoma mouse model was established for the investigation of the cancer preventive effects of ART and its derivaties, and the underlying mechanisms of action.  ART, DHA and ARTS inhibited the growth of H. pylori and gastric cancer cells,suppressed H. pylori adhesion to the gastric cancer cells, and reduced the H. pylori-enhanced ROS prodn.  Moreover, ART, DHA and ARTS significantly reduced tumor incidence, no. of tumor nodules and tumor size in the mouse model.  Among these three compds., DHA exerted the most potent chemopreventive effect.  Mechanistic studies showed that ART and its derivs. potently inhibited the NF-κB activation.  ART, DHA and ARTS have potent preventive effects in H. pylori-induced gastric carcinogenesis.  These effects are, at least in part, attributed to the inhibition of NF-κB signaling pathway.  Our findings provide a mol. justification of using ART and its derivs. for the prevention and treatment of gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOvjm1jfKkQ7Vg90H21EOLACvtfcHk0ljcgmHlSzyZkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlCiu7rK&md5=47586cd8b58d1aa4d7ddb6beff13294c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2019.152968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2019.152968%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DArtemisinin%2520and%2520its%2520derivatives%2520prevent%2520Helicobacter%2520pylori-induced%2520gastric%2520carcinogenesis%2520via%2520inhibition%2520of%2520NF-%25CE%25BAB%2520signaling%26jtitle%3DPhytomedicine%26date%3D2019%26volume%3D63%26spage%3D152968%26doi%3D10.1016%2Fj.phymed.2019.152968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houh, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, D.</span></span> <span> </span><span class="NLM_article-title">The effects of artemisinin on the cytolytic activity of natural killer (NK) cells</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1600</span>, <span class="refDoi"> DOI: 10.3390/ijms18071600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fijms18071600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVehsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1600&author=Y.+K.+Houhauthor=K.+E.+Kimauthor=S.+Parkauthor=D.+Y.+Hurauthor=S.+Kimauthor=D.+Kimauthor=S.+I.+Bangauthor=Y.+Yangauthor=H.+J.+Parkauthor=D.+Cho&title=The+effects+of+artemisinin+on+the+cytolytic+activity+of+natural+killer+%28NK%29+cells&doi=10.3390%2Fijms18071600"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of artemisinin on the cytolytic activity of natural killer (NK) cells</span></div><div class="casAuthors">Houh, Youn Kyung; Kim, Kyung Eun; Park, Sunyoung; Hur, Dae Young; Kim, Seonghan; Kim, Daejin; Bang, Sa Ik; Yang, Yoolhee; Park, Hyun Jeong; Cho, Daeho</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1600/1-1600/11</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Artemisinin, a chem. compd. used for the treatment of malaria, has been known to show anti-cancer activity.  However, the effect of this chem. on natural killer (NK) cells, which are involved in tumor killing, remains unknown.  Here, we demonstrate that artemisinin exerts a potent anti-cancer effect by activating NK cells.  NK-92MI cells pre-treated with artemisinin were subjected to a cytotoxicity assay using K562 cells.  The results showed that artemisinin significantly enhances the cytolytic activity of NK cells in a dose-dependent manner.  Addnl., the artemisinin-enhanced cytotoxic effect of NK-92MI cells on tumor cells was accompanied by the stimulation of granule exocytosis, as evidenced by the detection of CD107a expression in NK cells.  Moreover, this enhancement of cytotoxicity by artemisinin was also obsd. in human primary NK cells from peripheral blood.  Our results suggest that artemisinin enhances human NK cell cytotoxicity and degranulation.  This is the first evidence that artemisinin exerts antitumor activity by enhancing NK cytotoxicity.  Therefore, these results provide a deeper understanding of the action of artemisinin and will contribute to the development and application of this class of compds. in cancer treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGJDQHHVQswLVg90H21EOLACvtfcHk0liYBHoRVlsWNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVehsrvE&md5=3b303aa59a015d3d681ec0e4eef97f7a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fijms18071600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18071600%26sid%3Dliteratum%253Aachs%26aulast%3DHouh%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BE.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DHur%26aufirst%3DD.%2BY.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBang%26aufirst%3DS.%2BI.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DD.%26atitle%3DThe%2520effects%2520of%2520artemisinin%2520on%2520the%2520cytolytic%2520activity%2520of%2520natural%2520killer%2520%2528NK%2529%2520cells%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1600%26doi%3D10.3390%2Fijms18071600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.-J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2019.01.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.intimp.2019.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30798159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1Sitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2019&pages=110-116&author=Y.+Caoauthor=Y.-H.+Fengauthor=L.-W.+Gaoauthor=X.-Y.+Liauthor=Q.-X.+Jinauthor=Y.-Y.+Wangauthor=Y.-Y.+Xuauthor=F.+Jinauthor=S.-L.+Luauthor=M.-J.+Wei&title=Artemisinin+enhances+the+anti-tumor+immune+response+in+4T1+breast+cancer+cells+in+vitro+and+in+vivo&doi=10.1016%2Fj.intimp.2019.01.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo</span></div><div class="casAuthors">Cao, Yu; Feng, Yong-Hui; Gao, Li-Wei; Li, Xiao-Ying; Jin, Quan-Xiu; Wang, Yu-Ying; Xu, Ying-Ying; Jin, Feng; Lu, Shi-Long; Wei, Min-Jie</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-116</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Breast cancer is a prominent cause of death among women worldwide.  Recent studies have demonstrated that artemisinin (ART) displays anti-tumor activity.  Using a mouse breast cancer model, we investigated the effects of ART in vitro and in vivo to det. how it influences the anti-tumor immune response.  We measured the proliferation and apoptosis of 4T1 cells in vitro after ART treatment by MTT assay and FACS.  To examine the effects of ART in vivo, tumor vols. and survival rates were measured in 4T1 tumor-bearing mice.  FACS was used to det. the frequencies of Tregs, MDSCs, CD4+ IFN-γ+ T cells, and CTLs in the tumors and spleens of the mice. mRNA levels of the transcription factors T-bet and FOXP3 and cytokines IFN-γ, TNF-α, TGF-β, and IL-10 were also detd. by real-time RT-PCR.  ELISA was used to measure TGF-β protein levels in the cell culture supernatants.  ART supplementation significantly increased 4T1 cell apoptosis and decreased TGF-β levels in vitro.  ART also impeded tumor growth in 4T1 TB mice and extended their survival.  MDSC and Treg frequencies significantly decreased in the 4T1 TB mice after ART treatment while CD4+ IFN-γ+ T cells and CTLs significantly increased.  ART significantly increased T-bet, IFN-γ, and TNF-α mRNA levels within the tumor and significantly decreased TGF-β mRNA levels.  ART supplementation hindered 4T1 tumor growth in vivo by promoting T cell activation and quelling immunosuppression from Tregs and MDSCs in the tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc0qbJfSGPhrVg90H21EOLACvtfcHk0liYBHoRVlsWNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1Sitb0%253D&md5=9e3a8a96b7b3de5f78422e6b5dfa8473</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2019.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2019.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DY.-H.%26aulast%3DGao%26aufirst%3DL.-W.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DJin%26aufirst%3DQ.-X.%26aulast%3DWang%26aufirst%3DY.-Y.%26aulast%3DXu%26aufirst%3DY.-Y.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DS.-L.%26aulast%3DWei%26aufirst%3DM.-J.%26atitle%3DArtemisinin%2520enhances%2520the%2520anti-tumor%2520immune%2520response%2520in%25204T1%2520breast%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2019%26volume%3D70%26spage%3D110%26epage%3D116%26doi%3D10.1016%2Fj.intimp.2019.01.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steely, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willoughby, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aivaliotis, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, G. L.</span></span> <span> </span><span class="NLM_article-title">Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1031</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2FCAD.0000000000000547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28708672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOrsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1018-1031&author=A.+M.+Steelyauthor=J.+A.+Willoughbyauthor=S.+N.+Sundarauthor=V.+I.+Aivaliotisauthor=G.+L.+Firestone&title=Artemisinin+disrupts+androgen+responsiveness+of+human+prostate+cancer+cells+by+stimulating+the+26S+proteasome-mediated+degradation+of+the+androgen+receptor+protein&doi=10.1097%2FCAD.0000000000000547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein</span></div><div class="casAuthors">Steely, Andrea M.; Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Aivaliotis, Vasiliki I.; Firestone, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1018-1031</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Androgen receptor (AR) expression and activity is highly linked to the development and progression of prostate cancer and is a target of therapeutic strategies for this disease.  We investigated whether the antimalarial drug artemisinin, which is a sesquiterpene lactone isolated from the sweet wormwood plant Artemisia annua, could alter AR expression and responsiveness in cultured human prostate cancer cell lines.  Artemisinin treatment induced the 26S proteasome-mediated degrdn. of the receptor protein, without altering AR transcript levels, in androgen-responsive LNCaP prostate cancer cells or PC-3 prostate cancer cells expressing exogenous wild-type AR.  Furthermore, artemisinin stimulated AR ubiquitination and AR receptor interactions with the E3 ubiquitin ligase MDM2 in LNCaP cells.  The artemisinin-induced loss of AR protein prevented androgen-responsive cell proliferation and ablated total AR transcriptional activity.  The serine/threonine protein kinase AKT-1 was shown to be highly assocd. with artemisinin-induced proteasome-mediated degrdn. of AR protein.  Artemisinin treatment activated AKT-1 enzymic activity, enhanced receptor assocn. with AKT-1, and induced AR serine phosphorylation.  Treatment of LNCaP cells with the PI3-kinase inhibitor LY294002, which inhibits the PI3-kinase-dependent activation of AKT-1, prevented the artemisinin-induced AR degrdn.  Furthermore, in transfected receptor-neg. PC-3 cells, artemisinin failed to stimulate the degrdn. of an altered receptor protein (S215A/S792A) with mutations in its two consensus AKT-1 serine phosphorylation sites.  Taken together, our results indicate that artemisinin induces the degrdn. of AR protein and disrupts androgen responsiveness of human prostate cancer cells, suggesting that this natural compd. represents a new potential therapeutic mol. that selectively targets AR levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumQe65M9qS7Vg90H21EOLACvtfcHk0ljdaBhC6ICqzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOrsLjK&md5=2d9a855334c5b253ca8a57ce88aec05a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000547%26sid%3Dliteratum%253Aachs%26aulast%3DSteely%26aufirst%3DA.%2BM.%26aulast%3DWilloughby%26aufirst%3DJ.%2BA.%26aulast%3DSundar%26aufirst%3DS.%2BN.%26aulast%3DAivaliotis%26aufirst%3DV.%2BI.%26aulast%3DFirestone%26aufirst%3DG.%2BL.%26atitle%3DArtemisinin%2520disrupts%2520androgen%2520responsiveness%2520of%2520human%2520prostate%2520cancer%2520cells%2520by%2520stimulating%2520the%252026S%2520proteasome-mediated%2520degradation%2520of%2520the%2520androgen%2520receptor%2520protein%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2017%26volume%3D28%26spage%3D1018%26epage%3D1031%26doi%3D10.1097%2FCAD.0000000000000547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, N.</span></span> <span> </span><span class="NLM_article-title">Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">282</span>, <span class="refDoi"> DOI: 10.1186/s13046-018-0960-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs13046-018-0960-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30477536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlWhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=282&author=Y.+Yaoauthor=Q.+Guoauthor=Y.+Caoauthor=Y.+Qiuauthor=R.+Tanauthor=Z.+Yuauthor=Y.+Zhouauthor=N.+Lu&title=Artemisinin+derivatives+inactivate+cancer-associated+fibroblasts+through+suppressing+TGF-%CE%B2+signaling+in+breast+cancer&doi=10.1186%2Fs13046-018-0960-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer</span></div><div class="casAuthors">Yao, Yuyuan; Guo, Qinglong; Cao, Yue; Qiu, Yangmin; Tan, Renxiang; Yu, Zhou; Zhou, Yuxin; Lu, Na</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cancer-assocd. fibroblasts (CAFs) are activated fibroblasts assocd. with cancer.  They have an important role in tumor growth and metastasis.  Artemisinin (ART) is a sesquiterpene lactone extd. from Chinese herb qinghao, and artemether (ARM), artesunate (ARS) and dihydroartemisinin (DHA) were synthesized derivs. of artemisinin, which also have anti-malarial and anti-cancer effects such as artemisinin.  Methods: In this study, we investigated the in-vitro and in-vivo effects of artemisinin derivs. on inactivating cancer-assocd. fibroblasts and uncovered its underlying mechanism.  Results: We demonstrated that ARS and DHA could revert L-929-CAFs and CAFs from activated to inactivated state in vitro.  Mech., ARS and DHA could suppress TGF-β signaling to inhibit activation of L-929-CAFs and CAFs, and decreased interaction between tumor and tumor microenvironment.  The results showed that ARS and DHA could suppress CAFs-induced breast cancer growth and metastasis in the orthotopic model.  Conformably, ARS and DHA suppressed TGF-β signaling to inactivate cancer-assocd. fibroblasts and inhibit cancer metastasis in vivo.  Conclusions: Artemisinin derivs. are potential therapeutic agents for the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFnvHdNlDnr7Vg90H21EOLACvtfcHk0ljdaBhC6ICqzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlWhtbc%253D&md5=4e77b1f170c94f476ae66d5304cbf19d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs13046-018-0960-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-018-0960-7%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DN.%26atitle%3DArtemisinin%2520derivatives%2520inactivate%2520cancer-associated%2520fibroblasts%2520through%2520suppressing%2520TGF-%25CE%25B2%2520signaling%2520in%2520breast%2520cancer%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D37%26spage%3D282%26doi%3D10.1186%2Fs13046-018-0960-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-based smart nanomedicines with self-supply of ferrous ion to enhance oxidative stress for specific and efficient cancer treatment</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">29490</span>– <span class="NLM_lpage">29497</span>, <span class="refDoi"> DOI: 10.1021/acsami.9b07390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.9b07390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGhs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=29490-29497&author=Y.+Luoauthor=X.+Sunauthor=L.+Huangauthor=J.+Yanauthor=B.-Y.+Yuauthor=J.+Tian&title=Artemisinin-based+smart+nanomedicines+with+self-supply+of+ferrous+ion+to+enhance+oxidative+stress+for+specific+and+efficient+cancer+treatment&doi=10.1021%2Facsami.9b07390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-Based Smart Nanomedicines with Self-Supply of Ferrous Ion to Enhance Oxidative Stress for Specific and Efficient Cancer Treatment</span></div><div class="casAuthors">Luo, Yingping; Sun, Xian; Huang, Liwei; Yan, Jin; Yu, Bo-Yang; Tian, Jiangwei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29490-29497</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Though abundant researches report that artemisinin could inhibit cancer cell growth via generating toxic reactive oxygen species (ROS), the therapeutic efficiency of artemisinin for cancer treatment is still limited owing to the insufficient intracellular ferrous ion and defensive effect of intracellular glutathione.  Herein, we report a cathepsin B-controllable smart nanomedicine based on the structural and pharmacodynamic characteristics of artemisinin, which employed transferrin-peptide-modified mesoporous silica to codeliver artemisinin and buthionine-sulfoximine, a glutathione scavenger, into cancer cells.  As a gatekeeper, the transferrin-peptide can not only target the cancer cells but also supply the extra ferrous iron to catalyze artemisinin to produce excessive ROS to kill cancer cells efficiently.  Once the designed nanomedicine attack into lysosome of tumor cells, the cargos of nanomedicine can be released in the presence of cathepsin B to immediately activate self-amplification of oxidative stress by simultaneously elevating the levels of ROS and weakening the levels of glutathione.  We anticipate that this rational design strategy provides innovative opportunities for artemisinin in the clin. application of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTGCIAJkDUq7Vg90H21EOLACvtfcHk0lhYsdUHLCLpBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGhs7rK&md5=95e2be587783d314dcba6abb4f0da81b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsami.9b07390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.9b07390%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DB.-Y.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DArtemisinin-based%2520smart%2520nanomedicines%2520with%2520self-supply%2520of%2520ferrous%2520ion%2520to%2520enhance%2520oxidative%2520stress%2520for%2520specific%2520and%2520efficient%2520cancer%2520treatment%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2019%26volume%3D11%26spage%3D29490%26epage%3D29497%26doi%3D10.1021%2Facsami.9b07390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capci Karagöz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsogoeva, S. B.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-derived dimers: Potent antimalarial and anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7360</span>– <span class="NLM_lpage">7388</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01380</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01380" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC28fjtlKhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7360-7388&author=T.+Fr%C3%B6hlichauthor=A.+Capci+Karag%C3%B6zauthor=C.+Reiterauthor=S.+B.+Tsogoeva&title=Artemisinin-derived+dimers%3A+Potent+antimalarial+and+anticancer+agents&doi=10.1021%2Facs.jmedchem.5b01380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents</span></div><div class="casAuthors">Frohlich Tony; Capci Karagoz Aysun; Reiter Christoph; Tsogoeva Svetlana B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7360-88</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The development of new efficient therapeutics for the treatment of malaria and cancer is an important endeavor.  Over the past 15 years, much attention has been paid to the synthesis of dimeric structures, which combine two units of artemisinin, as lead compounds of interest.  A wide variety of atemisinin-derived dimers containing different linkers demonstrate improved properties compared to their parent compounds (e.g., circumventing multidrug resistance), making the dimerization concept highly compelling for development of efficient antimalarial and anticancer drugs.  The present Perspective highlights recent developments on different types of artemisinin-derived dimers and their structural and functional features.  Particular emphasis is put on the respective in vitro and in vivo studies, exploring the role of the length and nature of linkers on the activities of the dimers, and considering the future prospects of the dimerization concept for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5J9u1WsTDZK_dlEzl_fBafW6udTcc2ebB-KW2kzh5Ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fjtlKhsA%253D%253D&md5=0bc32b707e395961bf4a61a2c0665061</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01380%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DT.%26aulast%3DCapci%2BKarag%25C3%25B6z%26aufirst%3DA.%26aulast%3DReiter%26aufirst%3DC.%26aulast%3DTsogoeva%26aufirst%3DS.%2BB.%26atitle%3DArtemisinin-derived%2520dimers%253A%2520Potent%2520antimalarial%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7360%26epage%3D7388%26doi%3D10.1021%2Facs.jmedchem.5b01380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships</span>. <i>Arch. Pharm. Chem. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>352</i></span>, <span class="NLM_elocation-id">e1900240</span> <span class="refDoi"> DOI: 10.1002/ardp.201900240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fardp.201900240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2019&author=B.+Zhang&title=Artemisinin-derived+dimers+as+potential+anticancer+agents%3A+Current+developments%2C+action+mechanisms%2C+and+structure-activity+relationships&doi=10.1002%2Fardp.201900240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fardp.201900240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201900240%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DArtemisinin-derived%2520dimers%2520as%2520potential%2520anticancer%2520agents%253A%2520Current%2520developments%252C%2520action%2520mechanisms%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DArch.%2520Pharm.%2520Chem.%2520Life%2520Sci.%26date%3D2019%26volume%3D352%26doi%3D10.1002%2Fardp.201900240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. K.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1021/jm020119d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020119d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1SgtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=987-994&author=M.+Jungauthor=S.+Leeauthor=J.+Hamauthor=K.+Leeauthor=H.+Kimauthor=S.+K.+Kim&title=Antitumor+activity+of+novel+deoxoartemisinin+monomers%2C+dimers%2C+and+trimer&doi=10.1021%2Fjm020119d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Novel Deoxoartemisinin Monomers, Dimers, and Trimer</span></div><div class="casAuthors">Jung, Mankil; Lee, Sangmin; Ham, Jungyeob; Lee, Kyunghoon; Kim, Hanjo; Kim, Soo Kie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">987-994</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first primary amines and bromoalkyl analogs of deoxoartemisinin with nonacetal functionality at C-12 are prepd. as versatile intermediates for the synthesis of various derivs.  Eight C-12 nonacetal type dimers and one trimer of deoxoartemisinin were prepd. using novel chem.  Dimers, and trimer I, were esp. potent and selective at inhibiting the growth of certain human cancer cell lines and were comparable to that of clin. used anticancer drugs.  The linker with one amide- or one sulfur-centered two ethylene groups of the dimers is essential for high anticancer activity.  Trimer I shows very potent activity against most of the human cancer cell lines tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOlkHJl0xdGLVg90H21EOLACvtfcHk0lhyGUxJJzFJmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1SgtLc%253D&md5=02e082b1cd0fec1aab1247597e8a621a</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm020119d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020119d%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DHam%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DS.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520novel%2520deoxoartemisinin%2520monomers%252C%2520dimers%252C%2520and%2520trimer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D987%26epage%3D994%26doi%3D10.1021%2Fjm020119d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.-X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.02.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.02.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30852384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks12it78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=21-28&author=J.-Y.+Yuauthor=X.-Q.+Liauthor=M.-X.+Wei&title=Synthesis+and+biological+activities+of+artemisinin-piperazine-dithiocarbamate+derivatives&doi=10.1016%2Fj.ejmech.2019.02.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives</span></div><div class="casAuthors">Yu, Jia-Ying; Li, Xue-Qiang; Wei, Meng-Xue</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-28</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Twelve derivs. of artemisinin-piperazine-dithiocarbamate, I (R = CH2Ph, CH2C6H4Me-4, n-pentyl, CH2CO2CH2Ph, etc.), have been synthesized, and some of them show good in vitro cytotoxic activity.  Compd. I (R = CH2C6H4CN-4) (II) exhibits the best inhibitory activity against SMMC-7721 cell lines with an IC50 of 0.0025 ± 0.04 μM for 72 h, but the toxicity was lower against LO2 cell lines with an IC50 of 0.18 ± 0.04 μM for 72 h.  The results indicate that compd. II is more cytotoxic towards cancer cell lines than towards benign cell lines compared with vincristine in vitro.  And compd. II also has good inhibitory activity against colon, breast and prostate cancer cells.  Meanwhile, we have also proposed the six-member ring mechanism of DMSO in catalyzing the esterification of hydroxyl and acyl chloride.  Instead of using the hydroxyl, we can obtain the nucleophilic substitution prodn. simply and efficiently without a Lewis acid, which has not been reported previously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWlRfgzrd8crVg90H21EOLACvtfcHk0lhyGUxJJzFJmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks12it78%253D&md5=58a2aebce79f86c7f42ab4882b38cb42</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.02.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.02.071%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.-Y.%26aulast%3DLi%26aufirst%3DX.-Q.%26aulast%3DWei%26aufirst%3DM.-X.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520artemisinin-piperazine-dithiocarbamate%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D169%26spage%3D21%26epage%3D28%26doi%3D10.1016%2Fj.ejmech.2019.02.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khair, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yergeri, M. C.</span></span> <span> </span><span class="NLM_article-title">Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3323</span>– <span class="NLM_lpage">3338</span>, <span class="refDoi"> DOI: 10.2174/1381612825666190902155957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1381612825666190902155957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31475891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1OitLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=3323-3338&author=M.+S.+Kumarauthor=T.+T.+Yadavauthor=R.+R.+Khairauthor=G.+J.+Petersauthor=M.+C.+Yergeri&title=Combination+therapies+of+artemisinin+and+its+derivatives+as+a+viable+approach+for+future+cancer+treatment&doi=10.2174%2F1381612825666190902155957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment</span></div><div class="casAuthors">Kumar, Maushmi S.; Yadav, Tanuja T.; Khair, Rohan R.; Peters, Godefridus J.; Yergeri, Mayur C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3323-3338</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: Many anticancer drugs have been developed for clin. usage till now, but the major problem is the development of drug-resistance over a period of time in the treatment of cancer.  Anticancer drugs produce huge adverse effects, ultimately leading to death of the patient.  Researchers have been focusing on the development of novel mols. with higher efficacy and lower toxicity; the anti-malarial drug artemisinin and its derivs. have exhibited cytotoxic effects.  Methods: We have done extensive literature search for artemisinin for its new role as anti-cancer agent for future treatment.  Last two decades papers were referred for deep understanding to strengthen its role.  Result: Literature shows changes at 9, 10 position in the artemisinin structure produces anticancer activity.  Artemisinin shows anticancer activity in leukemia, hepatocellular carcinoma, colorectal and breast cancer cell lines.  Artemisinin and its derivs. have been studied as combination therapy with several synthetic compds., RNA interfaces, recombinant proteins and antibodies etc., for synergizing the effect of these drugs.  They produce an anticancer effect by causing cell cycle arrest, regulating signaling in apoptosis, angiogenesis and cytotoxicity activity on the steroid receptors.  Many novel formulations of artemisinin are being developed in the form of carbon nanotubes, polymer-coated drug particles, etc., for delivering artemisinin, since it has poor water/ oil soly. and is chem. unstable.  Conclusion: We have summarize the combination therapies of artemisinin and its derivs. with other anticancer drugs and also focussed on recent developments of different drug delivery systems in the last 10 years.  Various reports and clin. trials of artemisinin type drugs indicated selective cytotoxicity along with minimal toxicity thus projecting them as promising anti-cancer agents in future cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_yzgpTIPj07Vg90H21EOLACvtfcHk0lgepQJ8cYpJmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1OitLzF&md5=a508563e0a15e928dbbdea976bd9f138</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1381612825666190902155957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612825666190902155957%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DM.%2BS.%26aulast%3DYadav%26aufirst%3DT.%2BT.%26aulast%3DKhair%26aufirst%3DR.%2BR.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26aulast%3DYergeri%26aufirst%3DM.%2BC.%26atitle%3DCombination%2520therapies%2520of%2520artemisinin%2520and%2520its%2520derivatives%2520as%2520a%2520viable%2520approach%2520for%2520future%2520cancer%2520treatment%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2019%26volume%3D25%26spage%3D3323%26epage%3D3338%26doi%3D10.2174%2F1381612825666190902155957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fröhlich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wölfling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mernyák, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulmány, Á. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minorics, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupkó, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidenberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marschall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsogoeva, S. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of artemisinin-estrogen hybrids highly active against HCMV, <i>P. falciparum</i>, and cervical and breast cancer</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3crgtFKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1128-1133&author=T.+Fr%C3%B6hlichauthor=A.+Kissauthor=J.+W%C3%B6lflingauthor=E.+Merny%C3%A1kauthor=%C3%81.+E.+Kulm%C3%A1nyauthor=R.+Minoricsauthor=I.+Zupk%C3%B3author=M.+Leidenbergerauthor=O.+Friedrichauthor=B.+Kappesauthor=F.+Hahnauthor=M.+Marschallauthor=G.+Schneiderauthor=S.+B.+Tsogoeva&title=Synthesis+of+artemisinin-estrogen+hybrids+highly+active+against+HCMV%2C+P.+falciparum%2C+and+cervical+and+breast+cancer&doi=10.1021%2Facsmedchemlett.8b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer</span></div><div class="casAuthors">Frohlich Tony; Tsogoeva Svetlana B; Kiss Anita; Wolfling Janos; Mernyak Erzsebet; Schneider Gyula; Kulmany Agnes E; Minorics Renata; Zupko Istvan; Leidenberger Maria; Friedrich Oliver; Kappes Barbara; Hahn Friedrich; Marschall Manfred</div><div class="citationInfo"><span class="NLM_cas:title">ACS medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1128-1133</span>
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    </div><div class="casAbstract">Artemisinin-estrogen hybrids were for the first time both synthesized and investigated for their in vitro biological activity against malaria parasites (Plasmodium falciparum 3D7), human cytomegalovirus (HCMV), and a panel of human malignant cells of gynecological origin containing breast (MCF7, MDA-MB-231, MDA-MB-361, T47D) and cervical tumor cell lines (HeLa, SiHa, C33A).  In terms of antimalarial efficacy, hybrid 8 (EC50 = 3.8 nM) was about two times more active than its parent compound artesunic acid (7) (EC50 = 8.9 nM) as well as the standard drug chloroquine (EC50 = 9.8 nM) and was, therefore, comparable to the clinically used dihydroartemisinin (6) (EC50 = 2.4 nM).  Furthermore, hybrids 9-12 showed a strong antiviral effect with EC50 values in the submicromolar range (0.22-0.38 μM) and thus possess profoundly stronger anti-HCMV activity (approximately factor 25) than the parent compound artesunic acid (7) (EC50 = 5.41 μM).  These compounds also exerted a higher in vitro anti-HCMV efficacy than ganciclovir used as the standard of current antiviral treatment.  In addition, hybrids 8-12 elicited substantially more pronounced growth inhibiting action on all cancer cell lines than their parent compounds and the reference drug cisplatin.  The most potent agent, hybrid 12, exhibited submicromolar EC50 values (0.15-0.93 μM) against breast cancer and C33A cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIymkYCXITsudfST00W0BcfW6udTcc2eabp_d9JGf7ULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crgtFKiug%253D%253D&md5=01eb9e5d37e598cd409b75b63c5733eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00381%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DT.%26aulast%3DKiss%26aufirst%3DA.%26aulast%3DW%25C3%25B6lfling%26aufirst%3DJ.%26aulast%3DMerny%25C3%25A1k%26aufirst%3DE.%26aulast%3DKulm%25C3%25A1ny%26aufirst%3D%25C3%2581.%2BE.%26aulast%3DMinorics%26aufirst%3DR.%26aulast%3DZupk%25C3%25B3%26aufirst%3DI.%26aulast%3DLeidenberger%26aufirst%3DM.%26aulast%3DFriedrich%26aufirst%3DO.%26aulast%3DKappes%26aufirst%3DB.%26aulast%3DHahn%26aufirst%3DF.%26aulast%3DMarschall%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DTsogoeva%26aufirst%3DS.%2BB.%26atitle%3DSynthesis%2520of%2520artemisinin-estrogen%2520hybrids%2520highly%2520active%2520against%2520HCMV%252C%2520P.%2520falciparum%252C%2520and%2520cervical%2520and%2520breast%2520cancer%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D1128%26epage%3D1133%26doi%3D10.1021%2Facsmedchemlett.8b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2018.09.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30278333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVegsr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=149-165&author=X.+Liuauthor=Y.+Zhangauthor=W.+Huangauthor=J.+Luoauthor=Y.+Liauthor=W.+Tanauthor=A.+Zhang&title=Development+of+high+potent+and+selective+Bcl-2+inhibitors+bearing+the+structural+elements+of+natural+product+artemisinin&doi=10.1016%2Fj.ejmech.2018.09.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin</span></div><div class="casAuthors">Liu, Xiaohua; Zhang, Yu; Huang, Wenjing; Luo, Jia; Li, Yang; Tan, Wenfu; Zhang, Ao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">149-165</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">By taking advantage of the apoptosis-inducing capacity of artemisinin derivs., the authors developed several series of compds. by merging the basic structural elements of the natural product artemisinin into the P2 interaction pocket of the clin. prescribed Bcl-2 inhibitor venetoclax.  Most of the new compds. displayed improved biochem. potency against Bcl-2 and high selectivity over Bcl-xL.  Specifically, compds. I and II were found to be the most potent with IC50 values less than 2.0 nM.  Unfortunately, these compds. only showed moderate antiproliferative effects against Bcl-2 dependent cells.  Though further structural optimization is needed to improve the cellular absorptive permeability, the current approach represents an alternative strategy to develop novel Bcl-2 inhibitors with greater selectivity over Bcl-xL, which is related to the off-target adverse effects of venetoclax.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYsHA4drQdRLVg90H21EOLACvtfcHk0lhtRPLeaJC8Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVegsr3L&md5=39caef7357b62af6112f4d0940a3cda3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.059%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520high%2520potent%2520and%2520selective%2520Bcl-2%2520inhibitors%2520bearing%2520the%2520structural%2520elements%2520of%2520natural%2520product%2520artemisinin%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D159%26spage%3D149%26epage%3D165%26doi%3D10.1016%2Fj.ejmech.2018.09.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trimble, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plesa, M.</span></span> <span> </span><span class="NLM_article-title">A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2019.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ygyno.2019.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32005582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVensLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2020&pages=188-194&author=C.+L.+Trimbleauthor=K.+Levinsonauthor=L.+Maldonadoauthor=M.+J.+Donovanauthor=K.+T.+Clarkauthor=J.+Fuauthor=M.+E.+Shayauthor=M.+E.+Sauterauthor=S.+A.+Sandersauthor=P.+S.+Frantzauthor=M.+Plesa&title=A+first-in-human+proof-of-concept+trial+of+intravaginal+artesunate+to+treat+cervical+intraepithelial+neoplasia+2%2F3+%28CIN2%2F3%29&doi=10.1016%2Fj.ygyno.2019.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)</span></div><div class="casAuthors">Trimble, Cornelia L.; Levinson, Kimberly; Maldonado, Leonel; Donovan, Michael J.; Clark, Katharine T.; Fu, Jie; Shay, Maria E.; Sauter, Mary Elizabeth; Sanders, Stephanie A.; Frantz, Peter S.; Plesa, Mihaela</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">188-194</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Most treatment options for cervical intraepithelial neoplasia 2/3 (CIN2/3) are either excisional or ablative, and require sequential visits to health care providers.  Artesunate, a compd. that is WHO-approved for treatment of acute malaria, also has cytotoxic effect on squamous cells transformed by HPV.  We conducted a first-in-human Phase I dose-escalation study to assess the safety and efficacy of self-administered artesunate vaginal inserts in biopsy-confirmed CIN2/3.  Safety analyses were based on patients who received at least one dose, and were assessed by the severity, frequency, and duration of reported adverse events.  Tolerability was assessed as the percentage of subjects able to complete their designated dosing regimen.  Modified intention-to-treat analyses for efficacy and viral clearance were based on patients who received at least one dose for whom endpoint data were available.  Efficacy was defined as histol. regression to CIN1 or less.  Viral clearance was defined as absence of HPV genotoype (s) detected at baseline.  A total of 28 patients received 1, 2, or 3 five-day treatment cycles at study weeks 0, 2, and 4, resp., prior to a planned, std.-of-care resection at study week 15.  Reported adverse events were mild, and self-limited.  In the modified intention-to-treat anal., histol. regression was obsd. in 19/28 (67.9%) subjects.  Clearance of HPV genotypes detected at baseline occurred in 9 of the 19 (47.4%) subjects whose lesions underwent histol. regression.  Self-administered vaginal artesunate inserts were safe and well-tolerated, at clin. EDs to treat CIN2/3.  These findings support proceeding with Phase II clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCb58aUZG-grVg90H21EOLACvtfcHk0li4jg2EvZyIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVensLw%253D&md5=b0a84c1d666d2cf98e482ff930ce1c69</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2019.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2019.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DTrimble%26aufirst%3DC.%2BL.%26aulast%3DLevinson%26aufirst%3DK.%26aulast%3DMaldonado%26aufirst%3DL.%26aulast%3DDonovan%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DK.%2BT.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DShay%26aufirst%3DM.%2BE.%26aulast%3DSauter%26aufirst%3DM.%2BE.%26aulast%3DSanders%26aufirst%3DS.%2BA.%26aulast%3DFrantz%26aufirst%3DP.%2BS.%26aulast%3DPlesa%26aufirst%3DM.%26atitle%3DA%2520first-in-human%2520proof-of-concept%2520trial%2520of%2520intravaginal%2520artesunate%2520to%2520treat%2520cervical%2520intraepithelial%2520neoplasia%25202%252F3%2520%2528CIN2%252F3%2529%26jtitle%3DGynecol.%2520Oncol.%26date%3D2020%26volume%3D157%26spage%3D188%26epage%3D194%26doi%3D10.1016%2Fj.ygyno.2019.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghantous, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinjab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herceg, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darwiche, N.</span></span> <span> </span><span class="NLM_article-title">Parthenolide: From plant shoots to cancer roots</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">905</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.drudis.2013.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23688583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=894-905&author=A.+Ghantousauthor=A.+Sinjabauthor=Z.+Hercegauthor=N.+Darwiche&title=Parthenolide%3A+From+plant+shoots+to+cancer+roots&doi=10.1016%2Fj.drudis.2013.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide: from plant shoots to cancer roots</span></div><div class="casAuthors">Ghantous, Akram; Sinjab, Ansam; Herceg, Zdenko; Darwiche, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">894-905</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Parthenolide (PTL), a sesquiterpene lactone (SL) originally purified from the shoots of feverfew (Tanacetum parthenium), has shown potent anticancer and anti-inflammatory activities.  It is currently being tested in cancer clin. trials.  Structure-activity relationship (SAR) studies of parthenolide revealed key chem. properties required for biol. activities and epigenetic mechanisms, and led to the derivatization of an orally bioavailable analog, dimethylamino-parthenolide (DMAPT).  Parthenolide is the first small mol. found to be selective against cancer stem cells (CSC), which it achieves by targeting specific signaling pathways and killing cancer from its roots.  In this review, we highlight the exciting journey of parthenolide, from plant shoots to cancer roots.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSNnHqQJd2UrVg90H21EOLACvtfcHk0lhs5lE7-W4SAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFGjtbw%253D&md5=e87a1ab300093f8953879ee931d3cd42</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DGhantous%26aufirst%3DA.%26aulast%3DSinjab%26aufirst%3DA.%26aulast%3DHerceg%26aufirst%3DZ.%26aulast%3DDarwiche%26aufirst%3DN.%26atitle%3DParthenolide%253A%2520From%2520plant%2520shoots%2520to%2520cancer%2520roots%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D894%26epage%3D905%26doi%3D10.1016%2Fj.drudis.2013.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freund, R. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobrecht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, H.-D.</span></span> <span> </span><span class="NLM_article-title">Advances in chemistry and bioactivity of parthenolide</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1039/C9NP00049F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC9NP00049F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31763637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ajurbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2020&pages=541-565&author=R.+R.+A.+Freundauthor=P.+Gobrechtauthor=D.+Fischerauthor=H.-D.+Arndt&title=Advances+in+chemistry+and+bioactivity+of+parthenolide&doi=10.1039%2FC9NP00049F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in chemistry and bioactivity of parthenolide</span></div><div class="casAuthors">Freund, Robert R. A.; Gobrecht, Philipp; Fischer, Dietmar; Arndt, Hans-Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-565</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Review covering up to 07/2019(-)-Parthenolide is a germacrane sesquiterpene lactone, available in ample amts. from the traditional medical plant feverfew (Tanacetum parthenium).  Acting as a covalently reactive compd., it displays anti-inflammatory, redox-modulating, and epigenetic activities, as well as selective cytotoxicity towards cancer stem and progenitor cells.  Furthermore, parthenolide was found to modulate microtubule dynamics by interfering with the detyrosination of α-tubulin, a specific posttranslational modification of the cytoskeleton.  This review interfaces recently achieved parthenolide syntheses with strategies for bioactivity-based derivatization.  Furthermore, chem. probe development from parthenolide is discussed, leading to a qualified summary of reported biol. activities and implicated or identified targets.  Special emphasis is given to parthenolide-induced microtubule modulation and the recently characterized tubulin carboxypeptidase enzymes involved in nerve (re)growth, cardiac muscle cell function, and metastasis development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFup1MnWZMV7Vg90H21EOLACvtfcHk0lhs5lE7-W4SAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ajurbM&md5=53d831765248cbc9b8f94f7a56572350</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC9NP00049F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9NP00049F%26sid%3Dliteratum%253Aachs%26aulast%3DFreund%26aufirst%3DR.%2BR.%2BA.%26aulast%3DGobrecht%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DArndt%26aufirst%3DH.-D.%26atitle%3DAdvances%2520in%2520chemistry%2520and%2520bioactivity%2520of%2520parthenolide%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2020%26volume%3D37%26spage%3D541%26epage%3D565%26doi%3D10.1039%2FC9NP00049F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnischky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span> <span> </span><span class="NLM_article-title">The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">4163</span>– <span class="NLM_lpage">4169</span>, <span class="refDoi"> DOI: 10.1182/blood-2004-10-4135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1182%2Fblood-2004-10-4135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=15687234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks12ju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=4163-4169&author=M.+L.+Guzmanauthor=R.+M.+Rossiauthor=L.+Karnischkyauthor=X.+Liauthor=D.+R.+Petersonauthor=D.+S.+Howardauthor=C.+T.+Jordan&title=The+sesquiterpene+lactone+parthenolide+induces+apoptosis+of+human+acute+myelogenous+leukemia+stem+and+progenitor+cells&doi=10.1182%2Fblood-2004-10-4135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells</span></div><div class="casAuthors">Guzman, Monica L.; Rossi, Randall M.; Karnischky, Lilliana; Li, Xiaojie; Peterson, Derick R.; Howard, Dianna S.; Jordan, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4163-4169</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Recent studies have described malignant stem cells as central to the initiation, growth, and potential relapse of acute and chronic myelogenous leukemia (AML and CML).  Because of their important role in pathogenesis, rare and biol. distinct leukemia stem cells (LSCs) represent a crit. target for therapeutic intervention.  However, to date, very few agents have been shown to directly target the LSC population.  The present studies demonstrate that parthenolide (PTL), a naturally occurring small mol., induces robust apoptosis in primary human AML cells and blast crisis CML (bcCML) cells while sparing normal hematopoietic cells.  Furthermore, anal. of progenitor cells using in vitro colony assays, as well as stem cells using the nonobese diabetic/severe combined immunodeficient (NOD/SCID) xenograft model, show that PTL also preferentially targets AML progenitor and stem cell populations.  Notably, in comparison to the std. chemotherapy drug cytosine arabinoside (Ara-C), PTL is much more specific to leukemia cells.  The mol. mechanism of PTL-mediated apoptosis is strongly assocd. with inhibition of nuclear factor κ B (NF-κB), proapoptotic activation of p53, and increased reactive oxygen species (ROS).  On the basis of these findings, we propose that the activity of PTL triggers LSC-specific apoptosis and as such represents a potentially important new class of drugs for LSC-targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBTKT6XR3lUbVg90H21EOLACvtfcHk0ljPfp-PUQGzuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks12ju74%253D&md5=4436e10afc798d6c233808acc3f0c0a2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-10-4135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-10-4135%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DRossi%26aufirst%3DR.%2BM.%26aulast%3DKarnischky%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPeterson%26aufirst%3DD.%2BR.%26aulast%3DHoward%26aufirst%3DD.%2BS.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26atitle%3DThe%2520sesquiterpene%2520lactone%2520parthenolide%2520induces%2520apoptosis%2520of%2520human%2520acute%2520myelogenous%2520leukemia%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D4163%26epage%3D4169%26doi%3D10.1182%2Fblood-2004-10-4135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span> <span> </span><span class="NLM_article-title">Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.2147/OTT.S117250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2147%2FOTT.S117250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28176967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCisr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=453-461&author=W.+Liuauthor=X.+Wangauthor=J.+Sunauthor=Y.+Yangauthor=W.+Liauthor=J.+Song&title=Parthenolide+suppresses+pancreatic+cell+growth+by+autophagy-mediated+apoptosis&doi=10.2147%2FOTT.S117250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis</span></div><div class="casAuthors">Liu, Weifeng; Wang, Xinshuai; Sun, Junjun; Yang, Yanhui; Li, Wensheng; Song, Junxin</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">453-461</span>CODEN:
                <span class="NLM_cas:coden">OTNHAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Pancreatic cancer is an aggressive malignancy and is unresponsive to conventional chemotherapies.  Parthenolide, a sesquiterpene lactone isolated from feverfew, has exhibited potent anticancer effects against various cancers.  The purpose of this report was to investigate the effect and underlying mechanism of parthenolide in human pancreatic cancer Panc-1 and BxPC3 cells.  The results demonstrated that parthenolide suppressed the growth and induced apoptosis of Panc-1 and BxPC3 pancreatic cancer cells with the half maximal inhibitory concn. (IC♂♂) ranging between 7 and 9 μM after 24 h of treatment.  Significant autophagy was induced by parthenolide treatment in pancreatic cancer cells.  Parthenolide treatment concn.-dependently increased the percentage of autophagic cells and significantly increased the expression levels of p62/SQSTM1, Beclin 1, and LC3II in Panc-1 cells.  Punctate LC3II staining confirmed autophagy.  Furthermore, inhibiting autophagy by chloroquine, 3-methyladenine, or LC3II siRNA significantly blocked parthenolide-induced apoptosis, suggesting that parthenolide induced apoptosis through autophagy in this study.  In conclusion, these studies established that parthenolide inhibits pancreatic cell growth by autophagy-mediated apoptosis.  Data of the present study suggest that parthenolide can serve as a potential chemotherapeutic agent for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsjs7XQNtJ4rVg90H21EOLACvtfcHk0ljttlkvr6mRjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCisr7P&md5=4d4553c3fb9de779968d21af546d2786</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2147%2FOTT.S117250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S117250%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DJ.%26atitle%3DParthenolide%2520suppresses%2520pancreatic%2520cell%2520growth%2520by%2520autophagy-mediated%2520apoptosis%26jtitle%3DOncoTargets%2520Ther.%26date%3D2017%26volume%3D10%26spage%3D453%26epage%3D461%26doi%3D10.2147%2FOTT.S117250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">3572</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.7739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.7739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29467878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MrktVGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=3572-3579&author=H.+Liauthor=H.+Luauthor=M.+Lvauthor=Q.+Wangauthor=Y.+Sun&title=Parthenolide+facilitates+apoptosis+and+reverses+drug-resistance+of+human+gastric+carcinoma+cells+by+inhibiting+the+STAT3+signaling+pathway&doi=10.3892%2Fol.2018.7739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway</span></div><div class="casAuthors">Li Hua; Sun Yuping; Li Hua; Lu Hang; Lv Meng; Wang Qingsheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3572-3579</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">In the present study, SGC-7901/DDP cells were treated with different concentrations of parthenolide (PN) (2.5-15 μmol/l), cisplatin (DDP) (1.25-15 μg/ml) and PN+DDP.  The proliferation inhibition rates were measured using an MTT assay, and the synergies of PN and DDP were analyzed.  The effect of PN and DDP on SGC-7901/DDP cell proliferation demonstrated a time- and concentration-dependent association, and a synergy between PN and DDP was identified.  DAPI staining and flow cytometry results indicated that 15 μmol/l PN significantly induced SGC-7901/DDP apoptosis and G1 phase arrest compared with the untreated control group.  Western blotting analysis results indicated that among the apoptosis-associated proteins, there were dose-dependent increases in the protein expression of apoptosis regulator BAX, cellular tumor antigen p53, cleaved caspase-3 and cleaved capase-9, and decreases in apoptosis regulator Bcl-2 and Bcl-xL protein expression levels.  Among the cell cycle-associated proteins, cyclin D1 expression was significantly decreased, cyclin-dependent kinase inhibitor 1 expression was significantly increased, and signal transducer and activator of transcription 3 (STAT3) activation was inhibited.  Scratch and Transwell assay results revealed that PN significantly inhibited SGC-7901/DDP cell migration, and invasion.  The present study demonstrated that PN induces SGC-7901/DDP apoptosis, inhibits SGC-7901/DDP proliferation, migration and invasion, and enhances the drug sensitivity of the cells to DDP.  The underlying mechanisms may be associated with inhibition of the STAT3 signaling pathway and regulation of the downstream apoptotic protein and cyclin expression levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrmXdAiWRkMdFxYDaSSP8XfW6udTcc2eZqgPQiRB4Airntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrktVGmtA%253D%253D&md5=efb23320870893f96ff5e3515333e01b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.7739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.7739%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLv%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DParthenolide%2520facilitates%2520apoptosis%2520and%2520reverses%2520drug-resistance%2520of%2520human%2520gastric%2520carcinoma%2520cells%2520by%2520inhibiting%2520the%2520STAT3%2520signaling%2520pathway%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D15%26spage%3D3572%26epage%3D3579%26doi%3D10.3892%2Fol.2018.7739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span> <span> </span><span class="NLM_article-title">Collateral sensitivity of parthenolide via NF-κB and HIF-α inhibition and epigenetic changes in drug-resistant cancer cell lines</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">542</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2019.00542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31164821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVGksbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=542&author=M.+Dawoodauthor=E.+Ookoauthor=T.+Efferth&title=Collateral+sensitivity+of+parthenolide+via+NF-%CE%BAB+and+HIF-%CE%B1+inhibition+and+epigenetic+changes+in+drug-resistant+cancer+cell+lines&doi=10.3389%2Ffphar.2019.00542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Collateral sensitivity of parthenolide via NF-κB and HIF-α Inhibition and epigenetic changes in drug-resistant cancer cell lines</span></div><div class="casAuthors">Dawood, Mona; Ooko, Edna; Efferth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">542</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Parthenolide (PT) is a sesquiterpene lactone isolated from Tanacetum parthenium.  In this study, PT showed varying cytotoxic effects against different solid tumor cell lines.  HCT116 (p53+/+) colon carcinoma cells and their parental HCT116 knockout p53 (p53-/-) cell lines showed a resistance degree of 2.36.  On the other hand, wild-type U87.MG cells or cells transfected with a deletion-activated EGFR cDNA (U87.MGΔEGFR) exhibited slight sensitivity toward PT.  Multidrug-resistant MDA-MB-231-BCRP cells were even more sensitive toward PT than sensitive MDA-MB-231-pcDNA cells with a resistance degree of 0.07 (collateral sensitivity).  To the best of our knowledge, hypersensitivity (collateral sensitivity) in MDA-MB-231-BCRP cell line is reported in this study for the first time.  We attempted to identify the mechanism of collateral sensitivity.  Firstly, we found that PT bound to IKK preventing I κBα degrdn. and eventually inhibition of the nuclear factor kappa B (NF-κB) pathway.  Down-regulation of hypoxia inducing factor 1-alpha (HIF-1α) in MDA-MB-231-BCRP resistant cells may be a second mechanism, since it is a target gene of NF-κB.  Moreover, PT also showed epigenetic effect by inhibition of HDAC activity as shown using both mol. docking and HDAC activity assay.  Based on COMPARE and hierarchical cluster analyses, we found gene expression profiles that predicted sensitivity or resistance of 47 tumor cell lines toward PT.  Interestingly, pathway analyses of gene expression profiles revealed NF-κB and HIF signaling as top networks of these genes, cellular functions and canonical pathways influencing the activity of PT against tumor cells.  In conclusion, PT exerted profound cytotoxic activity against various cancer cell lines mainly against BCRP-overexpressing tumor cells, suggesting PT as novel candidate for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrowSGH63_cSrVg90H21EOLACvtfcHk0ljiP4LcaJMapA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVGksbzO&md5=ba66ef72b6a031ba2b027649302b4d66</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00542%26sid%3Dliteratum%253Aachs%26aulast%3DDawood%26aufirst%3DM.%26aulast%3DOoko%26aufirst%3DE.%26aulast%3DEfferth%26aufirst%3DT.%26atitle%3DCollateral%2520sensitivity%2520of%2520parthenolide%2520via%2520NF-%25CE%25BAB%2520and%2520HIF-%25CE%25B1%2520inhibition%2520and%2520epigenetic%2520changes%2520in%2520drug-resistant%2520cancer%2520cell%2520lines%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D542%26doi%3D10.3389%2Ffphar.2019.00542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-W.</span></span> <span> </span><span class="NLM_article-title">Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1809</span>– <span class="NLM_lpage">1820</span>, <span class="refDoi"> DOI: 10.3892/ijo.2017.4166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fijo.2017.4166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29075793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyqtLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2017&pages=1809-1820&author=S.+L.+Kimauthor=Y.+R.+Parkauthor=S.+T.+Leeauthor=S.-W.+Kim&title=Parthenolide+suppresses+hypoxia-inducible+factor-1%CE%B1+signaling+and+hypoxia+induced+epithelial-mesenchymal+transition+in+colorectal+cancer&doi=10.3892%2Fijo.2017.4166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer</span></div><div class="casAuthors">Kim, Se Lim; Park, Young Ran; Lee, Soo Teik; Kim, Sang-Wook</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1809-1820</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Activation of hypoxia-inducible factor 1α (HIF-1α) is frequently obsd. in solid tumors and it has been assocd. with various pathophysiol. processes, including epithelial-mesenchymal transition (EMT).  Previously, we reported that parthenolide (PT), an inhibitor of nuclear factor-κB (NF-κB), is a promising anticancer agent because it promotes apoptosis of human colorectal cancer (CRC).  Here, we investigated a new mol. mechanism by which PT acts on HIF-1α and hypoxia contributing to EMT by NF-κB inhibition.  Cell viability, DNA binding activity, vascular cell tube formation and cell motility were studied after treatment of PT in hypoxic or normoxic condition.  Moreover, effects of PT on hypoxia signaling and hypoxia-induced EMT signaling were investigated.  We also examd. the inhibitory effect of PT on CRC progression in xenografts.  We demonstrated that PT markedly inhibits hypoxia dependent HIF-1α activity and angiogenesis by preventing NF-κB activation.  We also report that PT decreases the level of proteins assocd. with glucose metab., angiogenesis, development and survival that are regulated by HIF-1α.  Furthermore, we verified that PT protects the morphol. change from epithelial to mesenchymal state, inhibits matrix metalloproteinase (MMP) enzyme activity and decreases cell motility involved in the regulation of the hypoxia-induced EMT markers.  In addn., PT inhibits growth in CRC xenograft models and regulates NF-κB, HIF-1α and EMT specific marker in tissue specimens.  Our data demonstrated that PT can inhibit HIF-1α signaling and hypoxia-induced EMT, suggesting a novel mol. mechanism for HIF-1α mediated cancer progression and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI01oAq9n1NLVg90H21EOLACvtfcHk0liGhn-ZVK5Hlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyqtLzM&md5=b0ecfec45fd349a3a4c9e0190e81cc81</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3892%2Fijo.2017.4166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2017.4166%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BL.%26aulast%3DPark%26aufirst%3DY.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BT.%26aulast%3DKim%26aufirst%3DS.-W.%26atitle%3DParthenolide%2520suppresses%2520hypoxia-inducible%2520factor-1%25CE%25B1%2520signaling%2520and%2520hypoxia%2520induced%2520epithelial-mesenchymal%2520transition%2520in%2520colorectal%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2017%26volume%3D51%26spage%3D1809%26epage%3D1820%26doi%3D10.3892%2Fijo.2017.4166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talib, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Kury, L. T.</span></span> <span> </span><span class="NLM_article-title">Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing p53-dependent apoptosis and inhibiting VEGF expression</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1495</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.08.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.08.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30257366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1ClsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2018&pages=1488-1495&author=W.+H.+Talibauthor=L.+T.+Al+Kury&title=Parthenolide+inhibits+tumor-promoting+effects+of+nicotine+in+lung+cancer+by+inducing+p53-dependent+apoptosis+and+inhibiting+VEGF+expression&doi=10.1016%2Fj.biopha.2018.08.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression</span></div><div class="casAuthors">Talib, Wamidh H.; Al Kury, Lina T.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1488-1495</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The correlation between cigarette smoking and the onset of non-small cell lung cancer is well documented.  Enhanced proliferation, angiogenesis induction, and resistance to apoptosis were reported as direct results assocd. with exposure to nicotine (the active ingredient of cigarettes).  Parthenolide is a sesquiterpene lactone with anticancer activity against different cancer types.  In this study, we tested the ability of parthenolide to inhibit the proliferating effect of nicotine in lung cancer cell lines.  MTT assay was used to measure cell survival of A549 and H526 cells treated with nicotine, parthenolide, and their combination.  Angiogenesis inhibition was measured using VEGF detection kit and apoptosis induction was evaluated by measuring caspase-3 activity.  Real time PCR assay was used to detect the change in expression of several genes assocd. with cell proliferation and apoptosis (CASP3, CASP7, CASP8, CASP9, P53, GADD45, BAX, BIM, Bcl-2, TOPO I, and TOPO II).  Parthenolide inhibited lung cancer cells in a concn.-dependent manner and decreased the proliferation stimulating effect of nicotine.  Caspase-3 activity and VEGF assays evidenced an apoptosis-inducing and VEGF- inhibiting effects of parthenolide.  The real time PCR assay demonstrated that parthenolide down-regulated the expression of Bcl-2 and up-regulated the expression of E2F1, P53, GADD45, BAX, BIM, and CASP 3,7,8,9, which indicates an activation of P53- dependent apoptosis pathway in response to parthenolide.  Furthermore, this pathway remained active in the presence of nicotine suggesting the ability of parthenolide to exclude the anti-apoptotic effect of nicotine.  Our results indicate that parthenolide inhibits nicotine proliferating effect on lung cancer.  The anticancer effect of parthenolide is mediated by angiogenesis inhibition and activation of P53- dependent apoptosis.  Parthenolide is a promising natural product for inhibiting and treating nicotine-assocd. lung cancer.  However, further studied on more lung cancer cell lines and on protein level are needed to fully understand its mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCAq1pjtnml7Vg90H21EOLACvtfcHk0lgAru4nf425Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1ClsL3M&md5=0129c491458ddb8c6742248c2f093cae</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.08.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.08.139%26sid%3Dliteratum%253Aachs%26aulast%3DTalib%26aufirst%3DW.%2BH.%26aulast%3DAl%2BKury%26aufirst%3DL.%2BT.%26atitle%3DParthenolide%2520inhibits%2520tumor-promoting%2520effects%2520of%2520nicotine%2520in%2520lung%2520cancer%2520by%2520inducing%2520p53-dependent%2520apoptosis%2520and%2520inhibiting%2520VEGF%2520expression%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D107%26spage%3D1488%26epage%3D1495%26doi%3D10.1016%2Fj.biopha.2018.08.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtola, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petri, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altobelli, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeulenaere, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olzmann, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maimone, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span> <span> </span><span class="NLM_article-title">Parthenolide covalently targets and inhibits focal adhesion kinase in breast cancer cells</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.chembiol.2019.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31080076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlOrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=1027-1035&author=C.+A.+Berdanauthor=R.+Hoauthor=H.+S.+Lehtolaauthor=M.+Toauthor=X.+Huauthor=T.+R.+Huffmanauthor=Y.+Petriauthor=C.+R.+Altobelliauthor=S.+G.+Demeulenaereauthor=J.+A.+Olzmannauthor=T.+J.+Maimoneauthor=D.+K.+Nomura&title=Parthenolide+covalently+targets+and+inhibits+focal+adhesion+kinase+in+breast+cancer+cells&doi=10.1016%2Fj.chembiol.2019.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells</span></div><div class="casAuthors">Berdan, Charles A.; Ho, Raymond; Lehtola, Haley S.; To, Milton; Hu, Xirui; Huffman, Tucker R.; Petri, Yana; Altobelli, Chad R.; Demeulenaere, Sasha G.; Olzmann, James A.; Maimone, Thomas J.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1027-1035.e22</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Parthenolide, a natural product from the feverfew plant and member of the large family of sesquiterpene lactones, exerts multiple biol. and therapeutic activities including anti-inflammatory and anti-cancer effects.  Here, we further study the parthenolide mechanism of action using activity-based protein profiling-based chemoproteomic platforms to map addnl. covalent targets engaged by parthenolide in human breast cancer cells.  We find that parthenolide, as well as other related exocyclic methylene lactone-contg. sesquiterpenes, covalently modify cysteine 427 of focal adhesion kinase 1 (FAK1), leading to impairment of FAK1-dependent signaling pathways and breast cancer cell proliferation, survival, and motility.  These studies reveal a functional target exploited by members of a large family of anti-cancer natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBoLxdD_DwkLVg90H21EOLACvtfcHk0lgAru4nf425Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlOrsLw%253D&md5=fd9e4ca4129156abd553d0cfe5f41c74</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DBerdan%26aufirst%3DC.%2BA.%26aulast%3DHo%26aufirst%3DR.%26aulast%3DLehtola%26aufirst%3DH.%2BS.%26aulast%3DTo%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHuffman%26aufirst%3DT.%2BR.%26aulast%3DPetri%26aufirst%3DY.%26aulast%3DAltobelli%26aufirst%3DC.%2BR.%26aulast%3DDemeulenaere%26aufirst%3DS.%2BG.%26aulast%3DOlzmann%26aufirst%3DJ.%2BA.%26aulast%3DMaimone%26aufirst%3DT.%2BJ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DParthenolide%2520covalently%2520targets%2520and%2520inhibits%2520focal%2520adhesion%2520kinase%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26spage%3D1027%26epage%3D1035%26doi%3D10.1016%2Fj.chembiol.2019.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">5335</span>– <span class="NLM_lpage">5344</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.819300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M117.819300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29462785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFWqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=5335-5344&author=X.+Zhuauthor=C.+Yuanauthor=C.+Tianauthor=C.+Liauthor=F.+Nieauthor=X.+Songauthor=R.+Zengauthor=D.+Wuauthor=X.+Haoauthor=L.+Li&title=The+plant+sesquiterpene+lactone+parthenolide+inhibits+Wnt%2F%CE%B2-catenin+signaling+by+blocking+synthesis+of+the+transcriptional+regulators+TCF4%2FLEF1&doi=10.1074%2Fjbc.M117.819300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The plant sesquiterpene lactone parthenolide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1</span></div><div class="casAuthors">Zhu, Xiaoliang; Yuan, Chunmao; Tian, Chenyang; Li, Chen; Nie, Fen; Song, Xiaomin; Zeng, Rong; Wu, Dianqing; Hao, Xiaojiang; Li, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5335-5344</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Wnt/β-catenin pathway is essential for embryonic development and homeostasis, but excessive activation of this pathway is frequently obsd. in various human diseases, including cancer.  Current therapeutic drugs targeting the Wnt pathway often lack sufficient efficacy, and new compds. targeting this pathway are therefore greatly needed.  Here the authors report that the plant-derived natural product parthenolide (PTL), a sesquiterpene lactone, inhibits Wnt signaling.  The authors found that PTL dose-dependently inhibits Wnt3a- and CHIR99021-induced transcriptional activity assessed with the T-cell factor (TCF)/lymphoid enhancer factor (LEF) firefly luciferase (TOPFlash) assay in HEK293 cells.  Further investigations revealed that PTL decreases the levels of the transcription factors TCF4/LEF1 without affecting β-catenin stability or subcellular distribution.  Moreover, this effect of PTL on TCF4/LEF1 was related to protein synthesis rather than to proteasome-mediated degrdn.  Of note, siRNA-mediated knockdown of RPL10, a ribosome protein PTL binds, substantially decreased TCF4/LEF1 protein levels and also Wnt3a-induced TOPFlash activities, suggesting a potential mechanism by which PTL may repress Wnt/β-catenin signaling.  In summary, PTL binds RPL10 and thereby potently inhibits the Wnt/β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvFi8Wxv3O8LVg90H21EOLACvtfcHk0lho9Elp5VGwCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFWqtrg%253D&md5=09d3b5085074968f14b601fa22fe4d85</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.819300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.819300%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DNie%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DThe%2520plant%2520sesquiterpene%2520lactone%2520parthenolide%2520inhibits%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520by%2520blocking%2520synthesis%2520of%2520the%2520transcriptional%2520regulators%2520TCF4%252FLEF1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D5335%26epage%3D5344%26doi%3D10.1074%2Fjbc.M117.819300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taleghani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasseri, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iranshahi, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of dual-action parthenolide prodrugs as potent anticancer agents</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bioorg.2017.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28215600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVymsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2017&pages=128-134&author=A.+Taleghaniauthor=M.+A.+Nasseriauthor=M.+Iranshahi&title=Synthesis+of+dual-action+parthenolide+prodrugs+as+potent+anticancer+agents&doi=10.1016%2Fj.bioorg.2017.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of dual-action parthenolide prodrugs as potent anticancer agents</span></div><div class="casAuthors">Taleghani, Akram; Nasseri, Mohammad Ali; Iranshahi, Mehrdad</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer stem cells are responsible for the failure of a large no. of cancer treatments and the re-emergence of cancer in patients.  Parthenolide is a potent anticancer sesquiterpene lactone that is also able to kill cancer stem cells.  The main problem with this compd. is its poor soly. in water.  To solve this problem, medicinal chemists have tried to prep. amino-derivs. of parthenolide, however, most amino-derivs. have less potency than that of parthenolide.  In this paper, the authors proposed a new approach to synthesize parthenolide derivs. with better soly. and higher potency.  The authors prepd. novel parthenolide derivs. through the aza-Michael addn. of nitrogen-contg. anticancer drug mols. (cytarabine and melphalan) to the α-methylene-γ-lactone group of parthenolide.  Different types of catalysts were used to catalyze the aza-Michael addn.  Among all the used catalysts, 1,8-diazabicyclo [5.4.0] undec-7-ene (DBU) was found to have the highest catalytic activity.  In addn., the authors examd. the effects of parthenolide-anticancer drug hybrids on the growth and proliferation of three cancer cell lines (MCF-7, LNcaP, Hep G2) and CHO.  The parthenolide prodrugs showed potent cytotoxic property with IC50 values ranging from 0.2 to 5.2 μM, higher than those of parthenolide and anticancer drugs (cytarabine and melphalan).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX51FkClDO2rVg90H21EOLACvtfcHk0lho9Elp5VGwCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVymsLk%253D&md5=91997aec756d570d2f13ded547f1efd9</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DTaleghani%26aufirst%3DA.%26aulast%3DNasseri%26aufirst%3DM.%2BA.%26aulast%3DIranshahi%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520dual-action%2520parthenolide%2520prodrugs%2520as%2520potent%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Chem.%26date%3D2017%26volume%3D71%26spage%3D128%26epage%3D134%26doi%3D10.1016%2Fj.bioorg.2017.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span> <span> </span><span class="NLM_article-title">Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4346</span>– <span class="NLM_lpage">4349</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2009.05.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19505822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4346-4349&author=S.+Neelakantanauthor=S.+Nasimauthor=M.+L.+Guzmanauthor=C.+T.+Jordanauthor=P.+A.+Crooks&title=Aminoparthenolides+as+novel+anti-leukemic+agents%3A+Discovery+of+the+NF-%CE%BAB+inhibitor%2C+DMAPT+%28LC-1%29&doi=10.1016%2Fj.bmcl.2009.05.092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)</span></div><div class="casAuthors">Neelakantan, Sundar; Nasim, Shama; Guzman, Monica L.; Jordan, Craig T.; Crooks, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4346-4349</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of aminoparthenolide analogs were synthesized and evaluated for their anti-leukemic activity.  Eight compds. exhibited good anti-leukemic activity with LD50's in the low μM range (1.5-3.0 μM).  Compds. I, II and III were the most potent compds. in the series, causing greater than 90% cell death at 10 μM concn. against primary AML cells in culture, with LD50 values of 1.7, 1.8 and 1.6 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzFsAppmWkqbVg90H21EOLACvtfcHk0lglMEpUMZdWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGmu7w%253D&md5=aff3db6b1997e882d2474e120a1419fa</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.092%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DNasim%26aufirst%3DS.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26atitle%3DAminoparthenolides%2520as%2520novel%2520anti-leukemic%2520agents%253A%2520Discovery%2520of%2520the%2520NF-%25CE%25BAB%2520inhibitor%252C%2520DMAPT%2520%2528LC-1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4346%26epage%3D4349%26doi%3D10.1016%2Fj.bmcl.2009.05.092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumanchi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakshatri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C. J.</span></span> <span> </span><span class="NLM_article-title">A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NF-κB and generating reactive oxygen species</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1002/pros.21141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fpros.21141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20209491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1074-1086&author=R.+Shanmugamauthor=P.+Kusumanchiauthor=L.+Chengauthor=P.+Crooksauthor=S.+Neelakantanauthor=W.+Matthewsauthor=H.+Nakshatriauthor=C.+J.+Sweeney&title=A+water-soluble+parthenolide+analogue+suppresses+in+vivo+prostate+cancer+growth+by+targeting+NF-%CE%BAB+and+generating+reactive+oxygen+species&doi=10.1002%2Fpros.21141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFκB and generating reactive oxygen species</span></div><div class="casAuthors">Shanmugam, Rajasubramaniam; Kusumanchi, Praveen; Cheng, Liang; Crooks, Peter; Neelakantan, Sundar; Matthews, William; Nakshatri, Harikrishna; Sweeney, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1086</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">BACKGROUND: To characterize the mol. changes assocd. with DMAPT-induced prostate cancer cell death and its in vivo activity.  METHODS: CWR22Rv1 and PC-3 were subjected to flow cytometry, electrophoretic mobility shift assays, and Western blot studies to measure DMAPT's ability to generate reactive oxygen species (ROS), inhibit NFκB DNA binding, and cause changes in anti-apoptotic proteins.  N-acetyl cysteine (NAC) and short hairpin RNA (shRNA) were used to det. the contribution of ROS and JNK2 activation, resp.  The BrdU incorporation assay was used to measure proliferation and trypan blue studies assessed cell viability after DMAPT treatment.  The in vivo activity of DMAPT as a single agent and in combination with bicalutamide or docetaxel was assessed in a s.c. xenograft model with athymic nude female mice.  RESULTS: DMAPT generated ROS with subsequent JNK activation and inhibited NFκB DNA binding and expression of NFκB-regulated anti-apoptotic proteins.  DMAPT increased necrotic and apoptotic cell death in a cell-type-dependent manner and both types of cell death were blocked by NAC.  Addnl., shRNA JNK2 partially blocked the anti-proliferative activity of DMAPT.  DMAPT inhibited CWR22Rv1 and PC-3 cellular proliferation by 100% with 10 and 20 μM resp. and in vivo, DMAPT was more effective at inhibiting growth than bicalutamide (CWR22v1) and docetaxel (PC-3).  CONCLUSIONS: DMAPT promotes cell death by both generating ROS and inhibition of NFκB.  Its in vivo activity supports the conduct of clin. trials in patients with castrate-resistant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hRizuVUKjrVg90H21EOLACvtfcHk0lglMEpUMZdWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFSisbY%253D&md5=8a43622d28067a05fedf13656cc7d16a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fpros.21141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21141%26sid%3Dliteratum%253Aachs%26aulast%3DShanmugam%26aufirst%3DR.%26aulast%3DKusumanchi%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCrooks%26aufirst%3DP.%26aulast%3DNeelakantan%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DW.%26aulast%3DNakshatri%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26atitle%3DA%2520water-soluble%2520parthenolide%2520analogue%2520suppresses%2520in%2520vivo%2520prostate%2520cancer%2520growth%2520by%2520targeting%2520NF-%25CE%25BAB%2520and%2520generating%2520reactive%2520oxygen%2520species%26jtitle%3DProstate%26date%3D2010%26volume%3D70%26spage%3D1074%26epage%3D1086%26doi%3D10.1002%2Fpros.21141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span> <span> </span><span class="NLM_article-title">Cooperative down-regulation of ribosomal protein L10 and NF-κB signaling pathway is responsible for the anti-proliferative effects by DMAPT in pancreatic cancer cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">35009</span>– <span class="NLM_lpage">35018</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.16557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.16557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28388532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1cvlsleisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=35009-35018&author=C.+Shiauthor=Y.+Wangauthor=Y.+Guoauthor=Y.+Chenauthor=N.+Liu&title=Cooperative+down-regulation+of+ribosomal+protein+L10+and+NF-%CE%BAB+signaling+pathway+is+responsible+for+the+anti-proliferative+effects+by+DMAPT+in+pancreatic+cancer+cells&doi=10.18632%2Foncotarget.16557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cooperative down-regulation of ribosomal protein L10 and NF-κB signaling pathway is responsible for the anti-proliferative effects by DMAPT in pancreatic cancer cells</span></div><div class="casAuthors">Shi Chen; Wang Yang; Guo Yuna; Chen Yijun; Liu Nan</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">35009-35018</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dimethylaminoparthenolide (DMAPT), a water-soluble analogue of natural product parthenolide, possesses anti-inflammatory and anti-tumor activities.  Despite that the anti-inflammatory mechanism of DMAPT has been well studied, specific target(s) for DMPAT and its anti-tumor mechanism remain poorly understood.  In this study, to assess the anti-proliferative effects of DMAPT in pancreatic cancer cell lines and exploit its anti-tumor mechanism, serial affinity chromatograph was implemented to probe potential targets for DMAPT, revealing that ribosomal protein L10 (RPL10) is a specific binding protein of DMAPT in PANC-1 cells.  DMAPT could decrease the expression of RPL10 accompanying its anti-proliferative effects.  Mechanistically, in both PANC-1 cells and MiaPaca-2 cells, reduced expression of RPL10 triggered by DMAPT binding decreased the expression of either p65 or IKKγ through the direct binding between RPL10 and p65 or IKKγ.  Together, the present study strongly implies that RPL10 is a novel target with therapeutic potential for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpzTbGs5iFh4HWj6b1v8uTfW6udTcc2eZ-H9tEx0cwBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvlsleisA%253D%253D&md5=c7be90b05bc4607af14c9557cec6b576</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.16557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.16557%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26atitle%3DCooperative%2520down-regulation%2520of%2520ribosomal%2520protein%2520L10%2520and%2520NF-%25CE%25BAB%2520signaling%2520pathway%2520is%2520responsible%2520for%2520the%2520anti-proliferative%2520effects%2520by%2520DMAPT%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D35009%26epage%3D35018%26doi%3D10.18632%2Foncotarget.16557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estabrook, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin-Sinex, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgmann, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhaemers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, M. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2249</span>– <span class="NLM_lpage">2258</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.freeradbiomed.2011.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22019440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2249-2258&author=N.+C.+Estabrookauthor=H.+Chin-Sinexauthor=A.+J.+Borgmannauthor=R.+M.+Dhaemersauthor=R.+H.+Shapiroauthor=D.+Gilleyauthor=N.+Hudaauthor=P.+Crooksauthor=C.+Sweeneyauthor=M.+S.+Mendonca&title=Inhibition+of+NF-%CE%BAB+and+DNA+double-strand+break+repair+by+DMAPT+sensitizes+non-small-cell+lung+cancers+to+X-rays&doi=10.1016%2Fj.freeradbiomed.2011.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays</span></div><div class="casAuthors">Estabrook, Neil C.; Chin-Sinex, Helen; Borgmann, Anthony J.; Dhaemers, Ryan M.; Shapiro, Ronald H.; Gilley, David; Huda, Nazmul; Crooks, Peter; Sweeney, Christopher; Mendonca, Marc S.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2249-2258</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated the efficacy and mechanism of dimethylaminoparthenolide (DMAPT), an NF-κB inhibitor, to sensitize human lung cancer cells to X-ray killing in vitro and in vivo.  We tested whether DMAPT increased the effectiveness of single and fractionated X-ray treatment through inhibition of NF-κB and/or DNA double-strand break (DSB) repair.  Treatment with DMAPT decreased plating efficiency, inhibited constitutive and radiation-induced NF-κB binding activity, and enhanced radiation-induced cell killing by dose modification factors of 1.8 and 1.4 in vitro.  X-ray fractionation demonstrated that DMAPT inhibited split-dose recovery/repair, and neutral DNA comet assays confirmed that DMAPT altered the fast and slow components of X-ray-induced DNA DSB repair.  Knockdown of the NF-κB family member p65 by siRNA increased radiation sensitivity and completely inhibited split-dose recovery in a manner very similar to DMAPT treatment.  The data suggest a link between inhibition of NF-κB and inhibition of DSB repair by DMAPT that leads to enhancement of X-ray-induced cell killing in vitro in non-small-cell lung cancer cells.  Studies of A549 tumor xenografts in nude mice demonstrated that DMAPT enhanced X-ray-induced tumor growth delay in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3oigOlBYJyrVg90H21EOLACvtfcHk0lgjHxzBzOGSUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegu73J&md5=518eafc7d7dc05d1eb3f84061b8520ef</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DEstabrook%26aufirst%3DN.%2BC.%26aulast%3DChin-Sinex%26aufirst%3DH.%26aulast%3DBorgmann%26aufirst%3DA.%2BJ.%26aulast%3DDhaemers%26aufirst%3DR.%2BM.%26aulast%3DShapiro%26aufirst%3DR.%2BH.%26aulast%3DGilley%26aufirst%3DD.%26aulast%3DHuda%26aufirst%3DN.%26aulast%3DCrooks%26aufirst%3DP.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DMendonca%26aufirst%3DM.%2BS.%26atitle%3DInhibition%2520of%2520NF-%25CE%25BAB%2520and%2520DNA%2520double-strand%2520break%2520repair%2520by%2520DMAPT%2520sensitizes%2520non-small-cell%2520lung%2520cancers%2520to%2520X-rays%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D51%26spage%3D2249%26epage%3D2258%26doi%3D10.1016%2Fj.freeradbiomed.2011.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deraska, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reavis, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaro, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, D.</span></span> <span> </span><span class="NLM_article-title">NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1038/s41420-017-0008-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41420-017-0008-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29531807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1Mngtl2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=10&author=P.+V.+Deraskaauthor=C.+O%E2%80%99Learyauthor=H.+D.+Reavisauthor=S.+Labeauthor=T.-K.+Dinhauthor=J.-B.+Lazaroauthor=C.+Sweeneyauthor=A.+D.+D%E2%80%99Andreaauthor=D.+Kozono&title=NF-%CE%BAB+inhibition+by+dimethylaminoparthenolide+radiosensitizes+non-small-cell+lung+carcinoma+by+blocking+DNA+double-strand+break+repair&doi=10.1038%2Fs41420-017-0008-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair</span></div><div class="casAuthors">Deraska Peter V; O'Leary Colin; Reavis Hunter D; Labe Shelby; Dinh Tru-Khang; Lazaro Jean-Bernard; D'Andrea Alan D; Kozono David; Lazaro Jean-Bernard; D'Andrea Alan D; Sweeney Christopher; D'Andrea Alan D</div><div class="citationInfo"><span class="NLM_cas:title">Cell death discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn">2058-7716</span>.
    </div><div class="casAbstract">Despite optimal chemotherapy, radiotherapy (RT), and/or surgery, non-small-cell lung carcinoma (NSCLC) remains the leading cause of cancer-related death in the US and worldwide.  Thoracic RT, a mainstay in the treatment of locally advanced NSCLC, is often restricted in efficacy by a therapeutic index limited by sensitivity of tissues surrounding the malignancy.  Therefore, radiosensitizers that can improve the therapeutic index are a vital unmet need.  Inhibition of the NF-κB pathway is a proposed mechanism of radiosensitization.  Here we demonstrate that inhibition of the canonical NF-κB pathway by dimethylaminoparthenolide (DMAPT) radiosensitizes NSCLC by blocking DNA double-strand break (DSB) repair.  NF-κB inhibition results in significant impairment of both homologous recombination (HR) and non-homologous end joining (NHEJ), as well as reductions in ionizing radiation (IR)-induced DNA repair biomarkers.  NF-κB inhibition by DMAPT shows preclinical potential for further investigation as a NSCLC radiosensitizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaynErFKLIgBOk4JA3soTqfW6udTcc2eY1K31QdgloSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mngtl2hsw%253D%253D&md5=53b3ea584371bb13768877d45b6bece3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fs41420-017-0008-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41420-017-0008-3%26sid%3Dliteratum%253Aachs%26aulast%3DDeraska%26aufirst%3DP.%2BV.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DC.%26aulast%3DReavis%26aufirst%3DH.%2BD.%26aulast%3DLabe%26aufirst%3DS.%26aulast%3DDinh%26aufirst%3DT.-K.%26aulast%3DLazaro%26aufirst%3DJ.-B.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%2BD.%26aulast%3DKozono%26aufirst%3DD.%26atitle%3DNF-%25CE%25BAB%2520inhibition%2520by%2520dimethylaminoparthenolide%2520radiosensitizes%2520non-small-cell%2520lung%2520carcinoma%2520by%2520blocking%2520DNA%2520double-strand%2520break%2520repair%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2018%26volume%3D4%26spage%3D10%26doi%3D10.1038%2Fs41420-017-0008-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morel, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ormsby, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, P. J.</span></span> <span> </span><span class="NLM_article-title">Parthenolide selectively sensitizes prostate tumor tissue to radiotherapy while protecting healthy tissues in vivo</span>. <i>Radiat. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1667/RR14710.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1667%2FRR14710.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28398879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWru77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2017&pages=501-512&author=K.+L.+Morelauthor=R.+J.+Ormsbyauthor=E.+Bezakauthor=C.+J.+Sweeneyauthor=P.+J.+Sykes&title=Parthenolide+selectively+sensitizes+prostate+tumor+tissue+to+radiotherapy+while+protecting+healthy+tissues+in+vivo&doi=10.1667%2FRR14710.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Parthenolide selectively sensitizes prostate tumor tissue to radiotherapy while protecting healthy tissues in vivo</span></div><div class="casAuthors">Morel, Katherine L.; Ormsby, Rebecca J.; Bezak, Eva; Sweeney, Christopher J.; Sykes, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Radiation Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-512</span>CODEN:
                <span class="NLM_cas:coden">RAREAE</span>;
        ISSN:<span class="NLM_cas:issn">1938-5404</span>.
    
            (<span class="NLM_cas:orgname">Radiation Research Society</span>)
        </div><div class="casAbstract">Radiotherapy is widely used in cancer treatment, however the benefits can be limited by radiation-induced damage to neighboring normal tissues.  Parthenolide (PTL) exhibits antiinflammatory and anti-tumor properties and selectively induces radiosensitivity in prostate cancer cell lines, while protecting primary prostate epithelial cell lines from radiation- induced damage.  Low doses of radiation have also been shown to protect from subsequent high-dose-radiation induced apoptosis as well as DNA damage.  These properties of PTL and low-dose radiation could be used to improve radiotherapy by killing more tumor cells and less normal cells.  Sixteen-week-old male Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) and C57BL/6J mice were treated with PTL (40 mg/kg), dimethylaminoparthenolide (DMAPT, a PTL analog with increased bioavailability) (100 mg/kg), or vehicle control three times over one week prior to combinations of low (10 mGy) and high (6 Gy) doses of whole-body X-irradn.  Tissues were analyzed for apoptosis at a range of time points up to 72 h postirradn.  Both PTL and DMAPT protected normal tissues, but not prostate tumor tissues, from a significant proportion of highdose- radiation-induced apoptosis.  DMAPT provided superior protection compared to PTL in normal dorsolateral prostate (71.7% redn., P = 0.026), spleen (48.2% redn., P = 0.0001) and colorectal tissue (38.0% redn., P = 0.0002), and doubled radiation-induced apoptosis in TRAMP prostate tumor tissue (101.3% increase, P = 0.039).  Both drugs induced the greatest radiosensitivity in TRAMP prostate tissue in areas with higher grade prostatic intraepithelial neoplasia (PIN) lesions.  A 10 mGy dose delivered 3 h prior to a 6 Gy dose induced a radioadaptive apoptosis response in normal C57Bl/6J prostate (28.4% redn., P = 0.045) and normal TRAMP spleen (13.6% redn., P = 0.047), however the low-dose-adaptive radioprotection did not significantly add to the PTL/DMAPT-induced protection in normal tissues, nor did it affect tumor kill.  These results support the use of the more bioavailable DMAPT and lowdose radiation, alone or in combination as useful radioprotectors of normal tissues to alleviate radiotherapy-induced side-effects in patients.  The enhanced radiosensitization in prostate tissues displaying high-grade PIN suggests that DMAPT also holds promise for targeted therapy of advanced prostate cancer, which may go on to become metastatic.  The redox mechanisms involved in the differential radioprotection obsd. here suggest that increased radiotherapy efficacy by DMAPT is more broadly applicable to a range of cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr4IwWEbNYN7Vg90H21EOLACvtfcHk0lhwssaXjr0d0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWru77N&md5=0b29eefce3e477485fa84c2566873038</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1667%2FRR14710.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1667%252FRR14710.1%26sid%3Dliteratum%253Aachs%26aulast%3DMorel%26aufirst%3DK.%2BL.%26aulast%3DOrmsby%26aufirst%3DR.%2BJ.%26aulast%3DBezak%26aufirst%3DE.%26aulast%3DSweeney%26aufirst%3DC.%2BJ.%26aulast%3DSykes%26aufirst%3DP.%2BJ.%26atitle%3DParthenolide%2520selectively%2520sensitizes%2520prostate%2520tumor%2520tissue%2520to%2520radiotherapy%2520while%2520protecting%2520healthy%2520tissues%2520in%2520vivo%26jtitle%3DRadiat.%2520Res.%26date%3D2017%26volume%3D187%26spage%3D501%26epage%3D512%26doi%3D10.1667%2FRR14710.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minhajuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alessandro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemkov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adane, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollyea, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, C. T.</span></span> <span> </span><span class="NLM_article-title">Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">21984</span>– <span class="NLM_lpage">22000</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.750653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M116.750653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27573247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=21984-22000&author=S.+Peiauthor=M.+Minhajuddinauthor=A.+D%E2%80%99Alessandroauthor=T.+Nemkovauthor=B.+M.+Stevensauthor=B.+Adaneauthor=N.+Khanauthor=F.+K.+Hagenauthor=V.+K.+Yadavauthor=S.+Deauthor=J.+M.+Ashtonauthor=K.+C.+Hansenauthor=J.+A.+Gutmanauthor=D.+A.+Pollyeaauthor=P.+A.+Crooksauthor=C.+Smithauthor=C.+T.+Jordan&title=Rational+design+of+a+parthenolide-based+drug+regimen+that+selectively+eradicates+acute+myelogenous+leukemia+stem+cells&doi=10.1074%2Fjbc.M116.750653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells</span></div><div class="casAuthors">Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo; Nemkov, Travis; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Hagen, Fred K.; Yadav, Vinod K.; De, Subhajyoti; Ashton, John M.; Hansen, Kirk C.; Gutman, Jonathan A.; Pollyea, Daniel A.; Crooks, Peter A.; Smith, Clayton; Jordan, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">21984-22000</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Although multidrug approaches to cancer therapy are common, few strategies are based on rigorous scientific principles.  Rather, drug combinations are largely dictated by empirical or clin. parameters.  In the present study we developed a strategy for rational design of a regimen that selectively targets human acute myelogenous leukemia (AML) stem cells.  As a starting point, we used parthenolide, an agent shown to target crit. mechanisms of redox balance in primary AML cells.  Next, using proteomic, genomic, and metabolomic methods, we detd. that treatment with parthenolide leads to induction of compensatory mechanisms that include up-regulated NADPH prodn. via the pentose phosphate pathway as well as activation of the Nrf2-mediated oxidative stress response pathway.  Using this knowledge we identified 2-deoxyglucose and temsirolimus as agents that can be added to a parthenolide regimen as a means to inhibit such compensatory events and thereby further enhance eradication of AML cells.  We demonstrate that the parthenolide, 2-deoxyglucose, temsirolimus (termed PDT) regimen is a potent means of targeting AML stem cells but has little to no effect on normal stem cells.  Taken together our findings illustrate a comprehensive approach to designing combination anticancer drug regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofi19JgIu4zbVg90H21EOLACvtfcHk0liyb1-ulpMAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgsbbI&md5=f428d714f3a7a2745809ffdc86d4b55c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.750653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.750653%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DS.%26aulast%3DMinhajuddin%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DA.%26aulast%3DNemkov%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DB.%2BM.%26aulast%3DAdane%26aufirst%3DB.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DHagen%26aufirst%3DF.%2BK.%26aulast%3DYadav%26aufirst%3DV.%2BK.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DAshton%26aufirst%3DJ.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BC.%26aulast%3DGutman%26aufirst%3DJ.%2BA.%26aulast%3DPollyea%26aufirst%3DD.%2BA.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DJordan%26aufirst%3DC.%2BT.%26atitle%3DRational%2520design%2520of%2520a%2520parthenolide-based%2520drug%2520regimen%2520that%2520selectively%2520eradicates%2520acute%2520myelogenous%2520leukemia%2520stem%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D21984%26epage%3D22000%26doi%3D10.1074%2Fjbc.M116.750653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.2217/nnm-2018-0479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2217%2Fnnm-2018-0479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31868113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVers7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=41-54&author=X.+Jinauthor=Q.+Yangauthor=N.+Caiauthor=Z.+Zhang&title=A+cocktail+of+betulinic+acid%2C+parthenolide%2C+honokiol+and+ginsenoside+Rh2+in+liposome+systems+for+lung+cancer+treatment&doi=10.2217%2Fnnm-2018-0479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment</span></div><div class="casAuthors">Jin, Xin; Yang, Qing; Cai, Ning; Zhang, Zhenhai</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1748-6963</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: Lung cancer has a very high incidence rate, and thus, there is an urgent need for novel and effective therapies.  Materials & methods: In this study, we proposed a potential treatment option by combining four natural products in liposome systems.  Results: In vitro studies indicated that the combination of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 exhibited a synergistic action.  When these four natural products were loaded into liposome systems, we obsd. an increased effect.  The relative action was also obsd. in vivo.  The cisplatin group presented obvious kidney damage, whereas both cocktail therapy and cocktail liposome therapy were safer.  Conclusion: Therefore, we propose cocktail liposome systems may provide a more efficient and safer treatment for lung cancer.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGoz1jvPVWLLVg90H21EOLACvtfcHk0liyb1-ulpMAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVers7zK&md5=8f9a483a2f403bfff01b7fb900e04dc5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2217%2Fnnm-2018-0479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fnnm-2018-0479%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DCai%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DA%2520cocktail%2520of%2520betulinic%2520acid%252C%2520parthenolide%252C%2520honokiol%2520and%2520ginsenoside%2520Rh2%2520in%2520liposome%2520systems%2520for%2520lung%2520cancer%2520treatment%26jtitle%3DNanomedicine%26date%3D2020%26volume%3D15%26spage%3D41%26epage%3D54%26doi%3D10.2217%2Fnnm-2018-0479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anticancer activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.06.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2018.06.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30006167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlSltLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=216-229&author=Y.+Dingauthor=H.+Guoauthor=W.+Geauthor=X.+Chenauthor=S.+Liauthor=M.+Wangauthor=Y.+Chenauthor=Q.+Zhang&title=Copper%28I%29+oxide+nanoparticles+catalyzed+click+chemistry+based+synthesis+of+melampomagnolide+B-triazole+conjugates+and+their+anticancer+activities&doi=10.1016%2Fj.ejmech.2018.06.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities</span></div><div class="casAuthors">Ding, Yahui; Guo, Hongyu; Ge, Weizhi; Chen, Xinyi; Li, Shengzu; Wang, Mengmeng; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of thirty-one melampomagnolide B-triazole conjugates was synthesized via copper(I) oxide nanoparticles-catalyzed click chem.  These conjugates were evaluated for their anti-cancer activities against a panel of five human cancer cell lines.  The most active compd., I, showed high activity against HCT116 cell line with IC50 value of 0.43 μM, which demonstrated 11.5-fold improvement compared to that of the parent compd. melampomagnolide B (IC50 = 4.93 μM).  Compd. I showed significant efficacy for inducing apoptosis, inhibiting proliferation and migration of HCT116 cells.  The preliminary mol. mechanism of I was also investigated.  On the base of these results, compd. I might be considered as a promising candidate for further evaluation as a potential anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2kad9CTfb0rVg90H21EOLACvtfcHk0lgUCyF7LLwtDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlSltLnP&md5=fa0597b84688c64a2dcd6930bf69091a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.06.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.06.058%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DCopper%2528I%2529%2520oxide%2520nanoparticles%2520catalyzed%2520click%2520chemistry%2520based%2520synthesis%2520of%2520melampomagnolide%2520B-triazole%2520conjugates%2520and%2520their%2520anticancer%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D216%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2018.06.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.01.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30739826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivFygtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2019&pages=445-469&author=W.+Geauthor=X.+Haoauthor=F.+Hanauthor=Z.+Liuauthor=T.+Wangauthor=M.+Wangauthor=N.+Chenauthor=Y.+Dingauthor=Y.+Chenauthor=Q.+Zhang&title=Synthesis+and+structure-activity+relationship+studies+of+parthenolide+derivatives+as+potential+anti-triple+negative+breast+cancer+agents&doi=10.1016%2Fj.ejmech.2019.01.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents</span></div><div class="casAuthors">Ge, Weizhi; Hao, Xin; Han, Fangzhi; Liu, Zhongquan; Wang, Tianpeng; Wang, Mengmeng; Chen, Ning; Ding, Yahui; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">445-469</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is the most aggressive cancers with a high recurrence rate and rapidly acquired drug resistance among various breast cancer subtypes.  There is no specific drug for treatment of TNBC.  Discovery of therapeutic agents with unique modes of actions is urgently needed.  In this study, a series of seventy parthenolide derivs. was designed, synthesized, and evaluated for their anti-TNBC activities.  Compd. I exhibited the most potent activity against different breast cancer cells with IC50 values ranging from 0.20 μM to 0.27 μM, which demonstrated 11.6- to 18.6-fold improvement comparing to that of the parent compd. parthenolide with IC50 values of 2.68-4.63 μM.  It is worth to note that I was more active than the pos. control drug ADR.  Moreover, compd. I could induce apoptosis of SUM-159 cells through mitochondria pathway and cause G1 phase arrest of SUM-159 cells.  These findings indicate that compd. I deserves further studies as a lead compd. for ultimate discovery of effective anti-TNBC drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW97WDAuIPtLVg90H21EOLACvtfcHk0ljjnmNAz5BBWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivFygtL8%253D&md5=32965e2aa3657b697c4d23f2cf7b63ce</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DW.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520of%2520parthenolide%2520derivatives%2520as%2520potential%2520anti-triple%2520negative%2520breast%2520cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D166%26spage%3D445%26epage%3D469%26doi%3D10.1016%2Fj.ejmech.2019.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">111706</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.111706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31553932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVams7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2019&pages=111706&author=Y.+Dingauthor=S.+Liauthor=W.+Geauthor=Z.+Liuauthor=X.+Zhangauthor=M.+Wangauthor=T.+Chenauthor=Y.+Chenauthor=Q.+Zhang&title=Design+and+synthesis+of+parthenolide+and+5-fluorouracil+conjugates+as+potential+anticancer+agents+against+drug+resistant+hepatocellular+carcinoma&doi=10.1016%2Fj.ejmech.2019.111706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma</span></div><div class="casAuthors">Ding, Yahui; Li, Shengzu; Ge, Weizhi; Liu, Zhongquan; Zhang, Xuhai; Wang, Mengmeng; Chen, Tianyang; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111706</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of twenty-three parthenolide-5-fluorouracil (5-FU) conjugates were synthesized and evaluated for their anti-cancer activities against human hepatocellular carcinoma cell line Bel-7402 and 5-fluorouracil-resistant human hepatocellular carcinoma cell line Bel-7402/5-FU.  The preliminary structure-activity relationships were discussed.  The most active compd., I, showed high activity against Bel-7402/5-FU cell line with IC50 value of 2.25 μM, which demonstrated 5.8-fold improvement compared to that of the parent compd. parthenolide (IC50 = 12.98 μM).  The investigation of preliminary mol. mechanism of I revealed that I could reverse drug resistance by inhibiting MDR1, ABCC1 and ABCG2 to increase the intracellular drug accumulation and induce apoptosis of Bel-7402/5-FU cells through mitochondria mediated pathway.  On the basis of these results, compd. I deserves to be further investigated as a potential anti-HCC lead compd. for ultimate discovery of parthenolide-based anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIpi4bMKVa8LVg90H21EOLACvtfcHk0lj_NxWset1dAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVams7rM&md5=acfcb009bf87ed110f49c4f2a4df22f3</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111706%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520parthenolide%2520and%25205-fluorouracil%2520conjugates%2520as%2520potential%2520anticancer%2520agents%2520against%2520drug%2520resistant%2520hepatocellular%2520carcinoma%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D183%26spage%3D111706%26doi%3D10.1016%2Fj.ejmech.2019.111706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz
Acuña, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejía, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallucci, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and NF-κB inhibitory sesquiterpene lactones from <i>Piptocoma rufescens</i></span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2671</span>– <span class="NLM_lpage">2678</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2012.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tet.2012.01.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22685350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2ruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=2671-2678&author=Y.+Renauthor=U.+Mu%C3%B1oz%0AAcu%C3%B1aauthor=F.+Jim%C3%A9nezauthor=R.+Garc%C3%ADaauthor=M.+Mej%C3%ADaauthor=H.-B.+Chaiauthor=J.+C.+Gallucciauthor=N.+R.+Farnsworthauthor=D.+D.+Soejartoauthor=E.+J.+Carcache+de+Blancoauthor=A.+D.+Kinghorn&title=Cytotoxic+and+NF-%CE%BAB+inhibitory+sesquiterpene+lactones+from+Piptocoma+rufescens&doi=10.1016%2Fj.tet.2012.01.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens</span></div><div class="casAuthors">Ren, Yulin; Acuna, Ulyana Munoz; Jimenez, Francisco; Garcia, Ricardo; Mejia, Melciades; Chai, Heebyung; Gallucci, Judith C.; Farnsworth, Norman R.; Soejarto, Djaja D.; Carcache de Blanco, Esperanza J.; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2671-2678</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Six new (1-6) and eight known germacranolide-type sesquiterpene lactones, along with several known phenylpropanol coumarates and methylated flavonoids, were isolated from the leaves of Piptocoma rufescens, collected in the Dominican Republic.  The new compds. were identified by anal. of their spectroscopic data, with the mol. structure of 3 being established by single-crystal x-ray diffraction.  The abs. configurations of the sesquiterpene lactones isolated were detd. from their CD and NOESY NMR spectra, together with the anal. of Mosher ester reactions.  Bioassay screening results showed the majority of the sesquiterpene lactones isolated (1-13) to be highly cytotoxic toward the HT-29 human colon cancer cell line, with the most potent compd. being 15-deoxygoyazensolide (10, IC50, 0.26 μM).  In addn., several of the sesquiterpene lactones exhibited NF-κB (p65) inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcHiA3AQ7oobVg90H21EOLACvtfcHk0lgshwlK2gPaaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2ruro%253D&md5=aa4ac9de414ad67710e7ebd97eb488ee</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2012.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2012.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DMu%25C3%25B1oz%2BAcu%25C3%25B1a%26aufirst%3DU.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DF.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DR.%26aulast%3DMej%25C3%25ADa%26aufirst%3DM.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DGallucci%26aufirst%3DJ.%2BC.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCytotoxic%2520and%2520NF-%25CE%25BAB%2520inhibitory%2520sesquiterpene%2520lactones%2520from%2520Piptocoma%2520rufescens%26jtitle%3DTetrahedron%26date%3D2012%26volume%3D68%26spage%3D2671%26epage%3D2678%26doi%3D10.1016%2Fj.tet.2012.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallucci, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Crystal structures and human leukemia cell apoptosis inducible activities of parthenolide analogues isolated from <i>Piptocoma rufescens</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b01079</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b01079" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Squ7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2018&pages=554-561&author=Y.+Renauthor=J.+C.+Gallucciauthor=X.+Liauthor=L.+Chenauthor=J.+Yuauthor=A.+D.+Kinghorn&title=Crystal+structures+and+human+leukemia+cell+apoptosis+inducible+activities+of+parthenolide+analogues+isolated+from+Piptocoma+rufescens&doi=10.1021%2Facs.jnatprod.7b01079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures and human leukemia cell apoptosis inducible activities of parthenolide analogues isolated from Piptocoma rufescens</span></div><div class="casAuthors">Ren, Yulin; Gallucci, Judith C.; Li, Xinxin; Chen, Lichao; Yu, Jianhua; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-561</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">The mol. structures of 3 parthenolide analogs, (-)-goyazensolide (1), (-)-15-deoxygoyazensolide (2), and (-)-ereglomerulide (3), isolated from the leaves of P. rufescens in a previous study were detd. by x-ray anal., and the abs. configuration of 1 was confirmed crystallog. using Cu Kα radiation at low temp.  Compds. 1-3, (+)-rufesolide A (4), and com. parthenolide (5) were found to be growth inhibitory toward MOLM-13 and EOL-1 human acute myeloid leukemia cells using PKC412 (midostaurin) as the pos. control, with compds. 1-3 being more active than compd. 5.  Also, compds. 1-4 exhibited synergistic effects when tested with PKC412, but 5 did not show this type of activity.  At a concn. lower than 2.0 μM, both 1 and 2 induced approx. 50% of the cells to become apoptotic at a late stage of the cell cycle, but no similar apoptotic effects were obsd. for 3, 4, or 5.  Leukemia cell apoptosis was induced by these compds. through the activation of caspase-3 and the inhibition of NF-κB, as indicated by immunoblotting anal., and compds. 1 and 2 seemed to be promising leads for development as potential antileukemic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEqlP6yzLvrVg90H21EOLACvtfcHk0li90gJIawDnig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Squ7Y%253D&md5=8e081b76c039d188ab12ea0dfda3f705</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b01079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b01079%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGallucci%26aufirst%3DJ.%2BC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCrystal%2520structures%2520and%2520human%2520leukemia%2520cell%2520apoptosis%2520inducible%2520activities%2520of%2520parthenolide%2520analogues%2520isolated%2520from%2520Piptocoma%2520rufescens%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2018%26volume%3D81%26spage%3D554%26epage%3D561%26doi%3D10.1021%2Facs.jnatprod.7b01079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Acuña, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantvit, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span> <span> </span><span class="NLM_article-title">Goyazensolide induces apoptosis in cancer cells <i>in vitro</i> and <i>in vivo</i></span>. <i>Int. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.3923/ijcr.2013.36.53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3923%2Fijcr.2013.36.53" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25621077" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=36-53&author=U.+Mu%C3%B1oz-Acu%C3%B1aauthor=Q.+Shenauthor=Y.+Renauthor=D.+D.+Lantvitauthor=J.+A.+Wittwerauthor=A.+D.+Kinghornauthor=S.+M.+Swansonauthor=E.+J.+Carcache+de+Blanco&title=Goyazensolide+induces+apoptosis+in+cancer+cells+in+vitro+and+in+vivo&doi=10.3923%2Fijcr.2013.36.53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3923%2Fijcr.2013.36.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3923%252Fijcr.2013.36.53%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Acu%25C3%25B1a%26aufirst%3DU.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DLantvit%26aufirst%3DD.%2BD.%26aulast%3DWittwer%26aufirst%3DJ.%2BA.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26atitle%3DGoyazensolide%2520induces%2520apoptosis%2520in%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DInt.%2520J.%2520Cancer%2520Res.%26date%3D2013%26volume%3D9%26spage%3D36%26epage%3D53%26doi%3D10.3923%2Fijcr.2013.36.53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spear, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oblinger, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welling, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, L.-S.</span></span> <span> </span><span class="NLM_article-title">Natural compounds as potential treatments of <i>NF2</i>-deficient schwannoma and meningioma: Cucurbitacin D and goyazensolide</span>. <i>Otol. Neurotol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1527</span>, <span class="refDoi"> DOI: 10.1097/MAO.0b013e3182956169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2FMAO.0b013e3182956169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23928514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC3sfotVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1519-1527&author=S.+A.+Spearauthor=S.+S.+Burnsauthor=J.+L.+Oblingerauthor=Y.+Renauthor=L.+Panauthor=A.+D.+Kinghornauthor=D.+B.+Wellingauthor=L.-S.+Chang&title=Natural+compounds+as+potential+treatments+of+NF2-deficient+schwannoma+and+meningioma%3A+Cucurbitacin+D+and+goyazensolide&doi=10.1097%2FMAO.0b013e3182956169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide</span></div><div class="casAuthors">Spear Samuel A; Burns Sarah S; Oblinger Janet L; Ren Yulin; Pan Li; Kinghorn A Douglas; Welling D Bradley; Chang Long-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1519-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">HYPOTHESIS:  Cucurbitacin D and goyazensolide, 2 plant-derived natural compounds, possess potent growth-inhibitory activity in schwannoma and meningioma cells.  BACKGROUND:  Currently, no FDA-approved drugs are available for neurofibromatosis type 2 (NF2)-associated schwannomas and meningiomas.  Selected natural compounds with antineoplastic activity, such as cucurbitacin D and goyazensolide, may be developed as potential treatments for these tumors.  METHODS:  The Nf2-deficient mouse schwannoma Sch10545 and human benign meningioma Ben-Men-1 cells were treated with various concentrations of cucurbitacin D and goyazensolide.  The effect on cell proliferation was determined using resazurin assays.  Flow cytometry was used to assess the cell cycle profiles.  Western blot analysis was performed to investigate the expression of various signaling molecules related to the cell cycle and the AKT pathway.  RESULTS:  Cucurbitacin D inhibited proliferation of Sch10545 cells (IC50 ∼ 0.75 μM) and Ben-Men-1 cells (IC50 ∼0.2 μM).  Goyazensolide also reduced cell proliferation of Sch10545 cells (IC50 ∼0.9 μM) and Ben-Men-1 cells (IC50 ∼1 μM).  The G2/M population increased in both Sch10545 and Ben-Men-1 cells treated with cucurbitacin D or goyazensolide around the IC50.  Cucurbitacin and goyazensolide substantially reduced the levels of cyclins E and A in treated Sch10545 and Ben-Men-1 cells.  Cucurbitacin D also inhibited cyclin B, phospho-AKT and phospho-PRAS40 expression.  In addition, goyazensolide reduced the levels of phospho-AKT and NFκB and increased the expression of pro-apoptotic Bim in Sch10545 and Ben-Men-1 cells.  CONCLUSION:  Both cucurbitacin D and goyazensolide effectively inhibit proliferation of NF2-deficient schwannoma and meningioma cells, suggesting that these natural compounds should be further evaluated as potential treatments for NF2-related tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9VuHkT8Q0Hdy3lHz94U-GfW6udTcc2eank55e8e0VpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfotVantQ%253D%253D&md5=afbaa511e84ba0b5496d13b23d35307c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1097%2FMAO.0b013e3182956169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMAO.0b013e3182956169%26sid%3Dliteratum%253Aachs%26aulast%3DSpear%26aufirst%3DS.%2BA.%26aulast%3DBurns%26aufirst%3DS.%2BS.%26aulast%3DOblinger%26aufirst%3DJ.%2BL.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DWelling%26aufirst%3DD.%2BB.%26aulast%3DChang%26aufirst%3DL.-S.%26atitle%3DNatural%2520compounds%2520as%2520potential%2520treatments%2520of%2520NF2-deficient%2520schwannoma%2520and%2520meningioma%253A%2520Cucurbitacin%2520D%2520and%2520goyazensolide%26jtitle%3DOtol.%2520Neurotol.%26date%3D2013%26volume%3D34%26spage%3D1519%26epage%3D1527%26doi%3D10.1097%2FMAO.0b013e3182956169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Identification of parthenolide dimers as activators of pyruvate kinase M2 in xenografts of glioblastoma multiforme in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1597</span>– <span class="NLM_lpage">1611</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs12ks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=1597-1611&author=Y.+Dingauthor=Q.+Xueauthor=S.+Liuauthor=K.+Huauthor=D.+Wangauthor=T.+Wangauthor=Y.+Liauthor=H.+Guoauthor=X.+Haoauthor=W.+Geauthor=Y.+Zhangauthor=A.+Liauthor=J.+Liauthor=Y.+Chenauthor=Q.+Zhang&title=Identification+of+parthenolide+dimers+as+activators+of+pyruvate+kinase+M2+in+xenografts+of+glioblastoma+multiforme+in+vivo&doi=10.1021%2Facs.jmedchem.9b01328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo</span></div><div class="casAuthors">Ding, Yahui; Xue, Qingqing; Liu, Shuo; Hu, Kai; Wang, Da; Wang, Tianpeng; Li, Ye; Guo, Hongyu; Hao, Xin; Ge, Weizhi; Zhang, Yan; Li, Ang; Li, Jing; Chen, Yue; Zhang, Quan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1597-1611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we detail the discovery of a series of parthenolide dimers as activators of PKM2 and evaluation of their anti-GBM activities.  The most promising compd. 5 showed high potency to activate PKM2 with an AC50 value of 15 nM, inhibited proliferation and metastasis, and induced apoptosis of GBM cells.  Compd. 5 could promote tetramer formation of PKM2 and reduce nucleus translocation of PKM2 in GBM cells without influence on the expression of total PKM2, thereby inhibiting the STAT3 signal pathway in vitro and in vivo.  PKM2 knockdown assay demonstrated that the anti-GBM effect of 5 mainly depended on the expression of PKM2 in vitro and in vivo.  Compd. 16, a prodrug of 5, markedly suppressed U118 tumor xenograft growth and reduced the wt. of tumor.  On the basis of these investigations, we propose that 16 might be considered as a promising lead compd. for discovery of anti-GBM drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGSzLzH8RIxrVg90H21EOLACvtfcHk0ljRU3Qec7w3mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs12ks70%253D&md5=e4596295089acdb58caae08e05c48ad4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01328%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DIdentification%2520of%2520parthenolide%2520dimers%2520as%2520activators%2520of%2520pyruvate%2520kinase%2520M2%2520in%2520xenografts%2520of%2520glioblastoma%2520multiforme%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D1597%26epage%3D1611%26doi%3D10.1021%2Facs.jmedchem.9b01328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doan, N. T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span> <span> </span><span class="NLM_article-title">Targeting thapsigargin towards tumors</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.steroids.2014.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.steroids.2014.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25065587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Kru7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=2-7&author=N.+T.+Q.+Doanauthor=E.+S.+Paulsenauthor=P.+Sehgalauthor=J.+V.+M%C3%B8llerauthor=P.+Nissenauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacsauthor=C.+A.+Dionneauthor=S.+B.+Christensen&title=Targeting+thapsigargin+towards+tumors&doi=10.1016%2Fj.steroids.2014.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting thapsigargin towards tumors</span></div><div class="casAuthors">Doan, Nhu Thi Quynh; Paulsen, Eleonora Sandholdt; Sehgal, Pankaj; Moeller, Jesper Vuust; Nissen, Poul; Denmeade, Samuel R.; Isaacs, John T.; Dionne, Craig A.; Christensen, Soeren Broegger</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2-7</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The skin irritating principle from Thapsia garganica was isolated, named thapsigargin and the structure elucidated.  By inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) thapsigargin provokes apoptosis in almost all cells.  By conjugating thapsigargin to peptides, which are only substrates for either prostate specific antigen (PSA) or prostate specific membrane antigen (PSMA) prodrugs were created, which selectively affect prostate cancer cells or neovascular tissue in tumors.  One of the prodrug is currently tested in clin. phase II.  The prodrug under clin. trial has been named mipsagargin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo3XRhn7mC3LVg90H21EOLACvtfcHk0ljdlNDp3-FgMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Kru7fM&md5=40b2f353210ebe88da3b061a310417f6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2014.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2014.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DDoan%26aufirst%3DN.%2BT.%2BQ.%26aulast%3DPaulsen%26aufirst%3DE.%2BS.%26aulast%3DSehgal%26aufirst%3DP.%26aulast%3DM%25C3%25B8ller%26aufirst%3DJ.%2BV.%26aulast%3DNissen%26aufirst%3DP.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26atitle%3DTargeting%2520thapsigargin%2520towards%2520tumors%26jtitle%3DSteroids%26date%3D2015%26volume%3D97%26spage%3D2%26epage%3D7%26doi%3D10.1016%2Fj.steroids.2014.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quynh
Doan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, origin, chemistry, structure-activity relationships and prodrug development</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5501</span>– <span class="NLM_lpage">5517</span>, <span class="refDoi"> DOI: 10.2174/1381612821666151002112824</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1381612821666151002112824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26429715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGktbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=5501-5517&author=N.+Quynh%0ADoanauthor=S.+Christensen&title=Thapsigargin%2C+origin%2C+chemistry%2C+structure-activity+relationships+and+prodrug+development&doi=10.2174%2F1381612821666151002112824"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development</span></div><div class="casAuthors">Quynh Doan, Nhu Thi; Christensen, Soren Brogger</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">5501-5517</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Thapsigargin was originally isolated from the roots of the Mediterranean umbelliferous plant Thapsia garganica in order to characterize the skin irritant principle.  Characteristic chem. properties and semi-syntheses are reviewed.  The biol. activity was related to the subnanomolar affinity for the sarco/endoplasmic reticulum calcium ATPase.  Prolonged inhibition of the pump afforded collapse of the calcium homeostasis and eventually apoptosis.  Structure-activity relationships enabled design of an equipotent analog contg. a linker.  Conjugation of the analog contg. the linker with peptides, which only are substrates for either prostate specific antigen (PSA) or prostate specific membrane antigen (PSMA) enabled design of prodrugs targeting a no. of cancer diseases including prostate cancer (G115) and hepatocellular carcinoma (G202).  Prodrug G202 has under the name of mipsagargin in phase II clin. trials shown promising properties against hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFZdSp5MJs6LVg90H21EOLACvtfcHk0lgwykEZvjWswA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGktbjO&md5=8e85c0e7b3f0eaf4dd6aebcf070e5428</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F1381612821666151002112824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612821666151002112824%26sid%3Dliteratum%253Aachs%26aulast%3DQuynh%2BDoan%26aufirst%3DN.%26aulast%3DChristensen%26aufirst%3DS.%26atitle%3DThapsigargin%252C%2520origin%252C%2520chemistry%252C%2520structure-activity%2520relationships%2520and%2520prodrug%2520development%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2015%26volume%3D21%26spage%3D5501%26epage%3D5517%26doi%3D10.2174%2F1381612821666151002112824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajaj, S. O.</span></span> <span> </span><span class="NLM_article-title">Promising anticancer drug thapsigargin: A perspective toward the total synthesis</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1080/00397911.2017.1386789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F00397911.2017.1386789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyjurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=1-13&author=S.+Deyauthor=S.+O.+Bajaj&title=Promising+anticancer+drug+thapsigargin%3A+A+perspective+toward+the+total+synthesis&doi=10.1080%2F00397911.2017.1386789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Promising anticancer drug thapsigargin: A perspective toward the total synthesis</span></div><div class="casAuthors">Dey, Supriya; Bajaj, Sumit O.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The guaianolide ring contg. sesquiterpene thapsigargin is found in the roots and fruits of Mediterranean plant Thapsia garganica.  It is known for its activity as a potent antagonist for Ca2+-ATPase (sarco-endoplasmic reticulum Ca2+-ATPase) inhibition.  Recently, a prodrug mipsagargin is being investigated to target the blood vessel of the cancer cells for the treatment of tumors.  The limited natural supply (low isolation and only localized growth (Mediterranean area)) from the natural sources strongly urges for the development of chem. synthetic strategies to access these natural products.  This review pertain the various strategies used so far in the thapsigargin's synthesis, focusing on major contributions in the total synthesis till date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4DfiF8pHXR7Vg90H21EOLACvtfcHk0li07AOrKnSq_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyjurzK&md5=62e37c8353a72e9dc8f2ffb0628013e2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F00397911.2017.1386789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911.2017.1386789%26sid%3Dliteratum%253Aachs%26aulast%3DDey%26aufirst%3DS.%26aulast%3DBajaj%26aufirst%3DS.%2BO.%26atitle%3DPromising%2520anticancer%2520drug%2520thapsigargin%253A%2520A%2520perspective%2520toward%2520the%2520total%2520synthesis%26jtitle%3DSynth.%2520Commun.%26date%3D2018%26volume%3D48%26spage%3D1%26epage%3D13%26doi%3D10.1080%2F00397911.2017.1386789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophersen, C.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, constitution of a sesquiterpene lactone histamine liberator from <i>Thapsia garganica</i></span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3829</span>– <span class="NLM_lpage">3830</span>, <span class="refDoi"> DOI: 10.1016/0040-4039(80)80191-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0040-4039%2880%2980191-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL3MXhvFantb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1980&pages=3829-3830&author=S.+B.+Christensenauthor=U.+Rasmussenauthor=C.+Christophersen&title=Thapsigargin%2C+constitution+of+a+sesquiterpene+lactone+histamine+liberator+from+Thapsia+garganica&doi=10.1016%2F0040-4039%2880%2980191-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin.  Constitution of a sesquiterpene lactone histamine liberator from Thapsia garganica</span></div><div class="casAuthors">Christensen, S. Broegger; Rasmussen, Ulla; Christophersen, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">3829-30</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The structure of thapsigargin (I), the major skin irritating constituent previously isolated from the root of T. garganica , was detd. by spectroscopic and chem. means.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8vMrtk06etrVg90H21EOLACvtfcHk0ljumkLXqbAAVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXhvFantb4%253D&md5=59c358a0499e1276735a7de45f3cca95</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2880%2980191-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252880%252980191-2%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DRasmussen%26aufirst%3DU.%26aulast%3DChristophersen%26aufirst%3DC.%26atitle%3DThapsigargin%252C%2520constitution%2520of%2520a%2520sesquiterpene%2520lactone%2520histamine%2520liberator%2520from%2520Thapsia%2520garganica%26jtitle%3DTetrahedron%2520Lett.%26date%3D1980%26volume%3D21%26spage%3D3829%26epage%3D3830%26doi%3D10.1016%2F0040-4039%2880%2980191-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lowry, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennings, H.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, a weak skin tumor promoter, alters the growth and differentiation of mouse keratinocytes in culture</span>. <i>Carcinogenesis</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1093/carcin/17.4.699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fcarcin%2F17.4.699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=8625480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XislCgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=699-706&author=D.+T.+Lowryauthor=L.+Liauthor=H.+Hennings&title=Thapsigargin%2C+a+weak+skin+tumor+promoter%2C+alters+the+growth+and+differentiation+of+mouse+keratinocytes+in+culture&doi=10.1093%2Fcarcin%2F17.4.699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, a weak skin tumor promoter, alters the growth and differentiation of mouse keratinocytes in culture</span></div><div class="casAuthors">Lowry, David T.; Li, Luowei; Hennings, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Carcinogenesis</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">699-706</span>CODEN:
                <span class="NLM_cas:coden">CRNGDP</span>;
        ISSN:<span class="NLM_cas:issn">0143-3334</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Thapsigargin (Tg), applied twice weekly to the backs of CD-1 mice initiated with 7,12-dimethylbenz[a]anthracene, promoted papillomas on the skin of ∼50% of the mice.  Tg alone induced papillomas in 10% of the mice.  Although Tg and 12-O-tetradecanoylphorbol 13-acetate (TPA) are synergistic in a keratinocyte co-culture assay for promotion, skin tumor promotion by TPA was inhibited by co-treatment with Tg.  Treatment of cultured keratinocytes with non-toxin doses of Tg increased the level of intracellular free Ca2+ and delayed Ca2+-induced stratification.  Tg blocked expression of the spinous layer differentiation marker keratin 1 (K1), while inducing cornification, a marker of differentiation in the granular layer/stratum corneum.  In medium with 1.4 mM Ca2+, Tg prolonged keratinocyte proliferation and selected foci of monolayer cells.  A Tg-independent cell line, TK-1, was developed from a single dish in which foci continued to expand after Tg removal.  Grafting TK-1 cells on to the backs of nude mice as part of a reconstituted skin resulted in the development of dysplastic papillomas with a high rate of progression to squamous cell carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6zElTwqC_d7Vg90H21EOLACvtfcHk0lg9EgypB8nF0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCgsLg%253D&md5=93f63c740c8eeee5f09ee4d9ed858e13</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2F17.4.699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252F17.4.699%26sid%3Dliteratum%253Aachs%26aulast%3DLowry%26aufirst%3DD.%2BT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHennings%26aufirst%3DH.%26atitle%3DThapsigargin%252C%2520a%2520weak%2520skin%2520tumor%2520promoter%252C%2520alters%2520the%2520growth%2520and%2520differentiation%2520of%2520mouse%2520keratinocytes%2520in%2520culture%26jtitle%3DCarcinogenesis%26date%3D1996%26volume%3D17%26spage%3D699%26epage%3D706%26doi%3D10.1093%2Fcarcin%2F17.4.699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søhoel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brøgger Christensen, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from <i>Thapsia garganica</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">2651</span>– <span class="NLM_lpage">2658</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2006.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2006.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=17098264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1CnsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=2651-2658&author=H.+Liuauthor=K.+G.+Jensenauthor=L.+M.+Tranauthor=M.+Chenauthor=L.+Zhaiauthor=C.+E.+Olsenauthor=H.+S%C3%B8hoelauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacsauthor=S.+Br%C3%B8gger+Christensen&title=Cytotoxic+phenylpropanoids+and+an+additional+thapsigargin+analogue+isolated+from+Thapsia+garganica&doi=10.1016%2Fj.phytochem.2006.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from Thapsia garganica</span></div><div class="casAuthors">Liu, Huizhen; Jensen, Kent Gunnertoft; Tran, Linh My; Chen, Ming; Zhai, Lin; Olsen, Carl Erik; Sohoel, Helmer; Denmeade, Samuel R.; Isaacs, John T.; Brogger Christensen, S.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2651-2658</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Four phenylpropanoids and a thapsigargin analog have been isolated from the fruits of Thapsia garganica.  A spectroscopic method for elucidating the relative stereochem. at the two pairs of stereogenic centers in the phenylpropanoids has been developed.  The phenylpropanoids were found to be potent cytotoxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC8lAHS1QQHLVg90H21EOLACvtfcHk0lg9EgypB8nF0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1CnsbnJ&md5=911f4a4fcd2af52aecadc7d1d33d308c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2006.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2006.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJensen%26aufirst%3DK.%2BG.%26aulast%3DTran%26aufirst%3DL.%2BM.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DZhai%26aufirst%3DL.%26aulast%3DOlsen%26aufirst%3DC.%2BE.%26aulast%3DS%25C3%25B8hoel%26aufirst%3DH.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DBr%25C3%25B8gger%2BChristensen%26aufirst%3DS.%26atitle%3DCytotoxic%2520phenylpropanoids%2520and%2520an%2520additional%2520thapsigargin%2520analogue%2520isolated%2520from%2520Thapsia%2520garganica%26jtitle%3DPhytochemistry%26date%3D2006%26volume%3D67%26spage%3D2651%26epage%3D2658%26doi%3D10.1016%2Fj.phytochem.2006.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brøgger
Christensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kromann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tombal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin analogs for targeting programmed death of androgen-independent prostate cancer cells</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(99)00074-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0968-0896%2899%2900074-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10465403" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1273-1280&author=S.+Br%C3%B8gger%0AChristensenauthor=A.+Andersenauthor=H.+Kromannauthor=M.+Treimanauthor=B.+Tombalauthor=S.+Denmeadeauthor=J.+T.+Isaacs&title=Thapsigargin+analogs+for+targeting+programmed+death+of+androgen-independent+prostate+cancer+cells&doi=10.1016%2FS0968-0896%2899%2900074-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2899%2900074-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252899%252900074-7%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25B8gger%2BChristensen%26aufirst%3DS.%26aulast%3DAndersen%26aufirst%3DA.%26aulast%3DKromann%26aufirst%3DH.%26aulast%3DTreiman%26aufirst%3DM.%26aulast%3DTombal%26aufirst%3DB.%26aulast%3DDenmeade%26aufirst%3DS.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DThapsigargin%2520analogs%2520for%2520targeting%2520programmed%2520death%2520of%2520androgen-independent%2520prostate%2520cancer%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D1273%26epage%3D1280%26doi%3D10.1016%2FS0968-0896%2899%2900074-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thastrup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drøbak, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanley, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, A. P.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, a tumor promoter, discharges intracellular Ca<sup>2+</sup> stores by specific inhibition of the endoplasmic reticulum Ca<sup>2+</sup>-ATPase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">2466</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1073/pnas.87.7.2466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1073%2Fpnas.87.7.2466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=2138778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK3cXhvFemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=2466-2470&author=O.+Thastrupauthor=P.+J.+Cullenauthor=B.+K.+Dr%C3%B8bakauthor=M.+R.+Hanleyauthor=A.+P.+Dawson&title=Thapsigargin%2C+a+tumor+promoter%2C+discharges+intracellular+Ca2%2B+stores+by+specific+inhibition+of+the+endoplasmic+reticulum+Ca2%2B-ATPase&doi=10.1073%2Fpnas.87.7.2466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, a tumor promoter, discharges intracellular calcium stores by specific inhibition of the endoplasmic reticulum calcium ATPase</span></div><div class="casAuthors">Thastrup, Ole; Cullen, Peter J.; Drobak, Bjorn K.; Hanley, Michael R.; Dawson, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2466-70</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Thapsigargin (I), a tumor-promoting sesquiterpene lactone, discharges intracellular Ca2+ in rat hepatocytes, as it does in many vertebrate cell types.  It appears to act intracellularly, as incubation of isolated rat liver microsomes with I induces a rapid, dose-dependent release of stored Ca2+.  The I-releasable pool of microsomal Ca2+ includes the pools sensitive to inositol 1,4,5-trisphosphate and GTP.  I pretreatment of microsomes blocks subsequent loading with 45Ca2+, suggesting that its target is the ATP-dependent Ca2+ pump of endoplasmic reticulum.  This hypothesis is strongly supported by the demonstration that I causes a rapid inhibition of the Ca2+-activated ATPase activity of rat liver microsomes, with an identical dose dependence to that seen in whole cell or isolated microsome Ca2+ discharge.  The inhibition of the endoplasmic reticulum isoform of the Ca2+-ATPase is highly selective, as I has little or no effect on the Ca2+-ATPases of hepatocyte or erythrocyte plasma membrane or of cardiac or skeletal muscle sarcoplasmic reticulum.  These results suggest that I increases the concn. of cytosolic free Ca2+ in sensitive cells by an acute and highly specific arrest of the endoplasmic reticulum Ca2+ pump, followed by a rapid Ca2+ leak from at least two pharmacol. distinct Ca2+ stores.  The implications of this mechanism of action for the application of I in the anal. of Ca2+ hemostasis and possible forms of Ca2+ control are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwq70TgjRICrVg90H21EOLACvtfcHk0lh7ffdPziy6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhvFemurk%253D&md5=03282a990f01740f93da56eb8397a242</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1073%2Fpnas.87.7.2466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.87.7.2466%26sid%3Dliteratum%253Aachs%26aulast%3DThastrup%26aufirst%3DO.%26aulast%3DCullen%26aufirst%3DP.%2BJ.%26aulast%3DDr%25C3%25B8bak%26aufirst%3DB.%2BK.%26aulast%3DHanley%26aufirst%3DM.%2BR.%26aulast%3DDawson%26aufirst%3DA.%2BP.%26atitle%3DThapsigargin%252C%2520a%2520tumor%2520promoter%252C%2520discharges%2520intracellular%2520Ca2%252B%2520stores%2520by%2520specific%2520inhibition%2520of%2520the%2520endoplasmic%2520reticulum%2520Ca2%252B-ATPase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1990%26volume%3D87%26spage%3D2466%26epage%3D2470%26doi%3D10.1073%2Fpnas.87.7.2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olesen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praetorius, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engedal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, J. V.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the sarco/endoplasmic reticulum (ER) Ca<sup>2+</sup>-ATPase by thapsigargin analogs induces cell death via ER Ca<sup>2+</sup> depletion and the unfolded protein response</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">19656</span>– <span class="NLM_lpage">19673</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.796920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M117.796920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28972171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=19656-19673&author=P.+Sehgalauthor=P.+Szalaiauthor=C.+Olesenauthor=H.+A.+Praetoriusauthor=P.+Nissenauthor=S.+B.+Christensenauthor=N.+Engedalauthor=J.+V.+M%C3%B8ller&title=Inhibition+of+the+sarco%2Fendoplasmic+reticulum+%28ER%29+Ca2%2B-ATPase+by+thapsigargin+analogs+induces+cell+death+via+ER+Ca2%2B+depletion+and+the+unfolded+protein+response&doi=10.1074%2Fjbc.M117.796920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response</span></div><div class="casAuthors">Sehgal, Pankaj; Szalai, Paula; Olesen, Claus; Praetorius, Helle A.; Nissen, Poul; Christensen, Soeren Broegger; Engedal, Nikolai; Moeller, Jesper V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19656-19673</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Calcium (Ca2+) is a fundamental regulator of cell signaling and function.  Thapsigargin (Tg) blocks the sarco/endoplasmic reticulum (ER) Ca2+-ATPase (SERCA), disrupts Ca2+ homeostasis, and causes cell death.  However, the exact mechanisms whereby SERCA inhibition induces cell death are incompletely understood.  Here, the authors report that low (0.1 μm) concns. of Tg and Tg analogs with various long-chain substitutions at the O-8 position extensively inhibit SERCA1a-mediated Ca2+ transport.  The authors also found that, in both prostate and breast cancer cells, exposure to Tg or Tg analogs for 1 day caused extensive drainage of the ER Ca2+ stores.  This Ca2+ depletion was followed by markedly reduced cell proliferation rates and morphol. changes that developed over 2-4 days and culminated in cell death.  Interestingly, these changes were not accompanied by bulk increases in cytosolic Ca2+ levels.  Moreover, knockdown of two key store-operated Ca2+ entry (SOCE) components, Orai1 and STIM1, did not reduce Tg cytotoxicity, indicating that SOCE and Ca2+ entry are not crit. for Tg-induced cell death.  However, the authors obsd. a correlation between the abilities of Tg and Tg analogs to deplete ER Ca2+ stores and their detrimental effects on cell viability.  Furthermore, caspase activation and cell death were assocd. with a sustained unfolded protein response.  The authors conclude that ER Ca2+ drainage and sustained unfolded protein response activation are key for initiation of apoptosis at low concns. of Tg and Tg analogs, whereas high cytosolic Ca2+ levels and SOCE are not required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZR89n8X7wgbVg90H21EOLACvtfcHk0lh7ffdPziy6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsr3O&md5=720c1b7e01c47d5d62586ff3a800831a</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.796920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.796920%26sid%3Dliteratum%253Aachs%26aulast%3DSehgal%26aufirst%3DP.%26aulast%3DSzalai%26aufirst%3DP.%26aulast%3DOlesen%26aufirst%3DC.%26aulast%3DPraetorius%26aufirst%3DH.%2BA.%26aulast%3DNissen%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DEngedal%26aufirst%3DN.%26aulast%3DM%25C3%25B8ller%26aufirst%3DJ.%2BV.%26atitle%3DInhibition%2520of%2520the%2520sarco%252Fendoplasmic%2520reticulum%2520%2528ER%2529%2520Ca2%252B-ATPase%2520by%2520thapsigargin%2520analogs%2520induces%2520cell%2520death%2520via%2520ER%2520Ca2%252B%2520depletion%2520and%2520the%2520unfolded%2520protein%2520response%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D19656%26epage%3D19673%26doi%3D10.1074%2Fjbc.M117.796920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taverner, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobus, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champion, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paton, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei-Rossmann, J.</span></span> <span> </span><span class="NLM_article-title">Calcium influx caused by ER stress inducers enhances oncolytic adenovirus enadenotucirev replication and killing through PKCα activation</span>. <i>Mol. Ther. Oncolytics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.omto.2019.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.omto.2019.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31890865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVKqs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=117-130&author=W.+K.+Tavernerauthor=E.+J.+Jacobusauthor=J.+Christiansonauthor=B.+Championauthor=A.+W.+Patonauthor=J.+C.+Patonauthor=W.+Suauthor=R.+Cawoodauthor=L.+W.+Seymourauthor=J.+Lei-Rossmann&title=Calcium+influx+caused+by+ER+stress+inducers+enhances+oncolytic+adenovirus+enadenotucirev+replication+and+killing+through+PKC%CE%B1+activation&doi=10.1016%2Fj.omto.2019.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation</span></div><div class="casAuthors">Taverner, William K.; Jacobus, Egon J.; Christianson, John; Champion, Brian; Paton, Adrienne W.; Paton, James C.; Su, Weiheng; Cawood, Ryan; Seymour, Len W.; Lei-Rossmann, Janet</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy--Oncolytics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-130</span>CODEN:
                <span class="NLM_cas:coden">MTOHDL</span>;
        ISSN:<span class="NLM_cas:issn">2372-7705</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oncolytic viruses represent an emerging approach to cancer therapy.  However, better understanding of their interaction with the host cancer cell and approaches to enhance their efficacy are needed.  Here, we investigate the effect of chem. induced endoplasmic reticulum (ER) stress on the activity of the chimeric group B adenovirus Enadenotucirev, its closely related parental virus Ad11p, and the archetypal group C oncolytic adenovirus Ad5.  We show that treatment of colorectal and ovarian cancer cell lines with thapsigargin or ionomycin caused an influx of Ca2+, leading to an upregulation in E1A transcript and protein levels.  Increased E1A protein levels, in turn, increased levels of expression of the E2B viral DNA polymerase, genome replication, late viral protein expression, infectious virus particle prodn., and cell killing during Enadenotucirev and Ad11p, but not Ad5, infection.  This effect was not due to the induction of ER stress, but rather the influx of extracellular Ca2+ and consequent increase in protein kinase C activity.  These results underscore the importance of Ca2+ homeostasis during adenoviral infection, indicate a signaling pathway between protein kinase C and E1A, and raise the possibility of using Ca2+ flux-modulating agents in the manuf. and potentiation of oncolytic virotherapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8zYKRLDcoqLVg90H21EOLACvtfcHk0ljObv1aj91WyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVKqs7rK&md5=0325fedb1dccfdd3620e0fe4f9a8cc35</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.omto.2019.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.omto.2019.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DTaverner%26aufirst%3DW.%2BK.%26aulast%3DJacobus%26aufirst%3DE.%2BJ.%26aulast%3DChristianson%26aufirst%3DJ.%26aulast%3DChampion%26aufirst%3DB.%26aulast%3DPaton%26aufirst%3DA.%2BW.%26aulast%3DPaton%26aufirst%3DJ.%2BC.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DCawood%26aufirst%3DR.%26aulast%3DSeymour%26aufirst%3DL.%2BW.%26aulast%3DLei-Rossmann%26aufirst%3DJ.%26atitle%3DCalcium%2520influx%2520caused%2520by%2520ER%2520stress%2520inducers%2520enhances%2520oncolytic%2520adenovirus%2520enadenotucirev%2520replication%2520and%2520killing%2520through%2520PKC%25CE%25B1%2520activation%26jtitle%3DMol.%2520Ther.%2520Oncolytics%26date%3D2019%26volume%3D15%26spage%3D117%26epage%3D130%26doi%3D10.1016%2Fj.omto.2019.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotnova, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyanova, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukhanina, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portseva, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilyin, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgieva, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepchenko, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pankratova, E. V.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin, inhibitor of sarco-endoplasmic Ca<sup>2+</sup>-ATPase, effectively suppresses the expression of S100A4 protein in human breast cancer cell line</span>. <i>Dokl. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>486</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1134/S1607672919030050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1134%2FS1607672919030050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31367816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFShu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2019&pages=181-183&author=A.+P.+Kotnovaauthor=B.+M.+Lyanovaauthor=E.+A.+Dukhaninaauthor=T.+N.+Portsevaauthor=Y.+V.+Ilyinauthor=S.+G.+Georgievaauthor=A.+G.+Stepchenkoauthor=E.+V.+Pankratova&title=Thapsigargin%2C+inhibitor+of+sarco-endoplasmic+Ca2%2B-ATPase%2C+effectively+suppresses+the+expression+of+S100A4+protein+in+human+breast+cancer+cell+line&doi=10.1134%2FS1607672919030050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin, inhibitor of sarco-endoplasmic calcium-ATPase, effectively suppresses expression of S100A4 protein in human breast cancer cell line</span></div><div class="casAuthors">Kotnova, A. P.; Lyanova, B. M.; Dukhanina, E. A.; Portseva, T. N.; Ilyin, Yu. V.; Georgieva, S. G.; Stepchenko, A. G.; Pankratova, E. V.</div><div class="citationInfo"><span class="NLM_cas:title">Doklady Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-183</span>CODEN:
                <span class="NLM_cas:coden">DBBOAL</span>;
        ISSN:<span class="NLM_cas:issn">1607-6729</span>.
    
            (<span class="NLM_cas:orgname">Pleiades Publishing, Ltd.</span>)
        </div><div class="casAbstract">Abstr.: Thapsigargin (SERCA ATPase inhibitor) inhibited the S100A4 metastatic marker expression in MDA-MB231 breast cancer cells.  We found that S100A4 gene transcription is regulated by Ca2+ signaling pathways.  We found that the synthesis of S100A4 mRNA and S100A4 protein in MDA-MB231 cells was effectively suppressed by thapsigargin at a concn. of 0.4-4μM with retaining cell viability.  We assume that the change in the gene transcription in response to disturbance of Ca2+ homeostasis is directly involved in the remodeling of Ca2+ signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHIIPoKGX8brVg90H21EOLACvtfcHk0lglZOlpIoH2Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFShu7vJ&md5=244401ad35e38a2e08de14585b06167b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1134%2FS1607672919030050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS1607672919030050%26sid%3Dliteratum%253Aachs%26aulast%3DKotnova%26aufirst%3DA.%2BP.%26aulast%3DLyanova%26aufirst%3DB.%2BM.%26aulast%3DDukhanina%26aufirst%3DE.%2BA.%26aulast%3DPortseva%26aufirst%3DT.%2BN.%26aulast%3DIlyin%26aufirst%3DY.%2BV.%26aulast%3DGeorgieva%26aufirst%3DS.%2BG.%26aulast%3DStepchenko%26aufirst%3DA.%2BG.%26aulast%3DPankratova%26aufirst%3DE.%2BV.%26atitle%3DThapsigargin%252C%2520inhibitor%2520of%2520sarco-endoplasmic%2520Ca2%252B-ATPase%252C%2520effectively%2520suppresses%2520the%2520expression%2520of%2520S100A4%2520protein%2520in%2520human%2520breast%2520cancer%2520cell%2520line%26jtitle%3DDokl.%2520Biochem.%2520Biophys.%26date%3D2019%26volume%3D486%26spage%3D181%26epage%3D183%26doi%3D10.1134%2FS1607672919030050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1975</span>– <span class="NLM_lpage">1980</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.8833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.8833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30008891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ohtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=1975-1980&author=F.+Huangauthor=P.+Wangauthor=X.+Wang&title=Thapsigargin+induces+apoptosis+of+prostate+cancer+through+cofilin-1+and+paxillin&doi=10.3892%2Fol.2018.8833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin</span></div><div class="casAuthors">Huang Fengyu; Huang Fengyu; Wang Peitao; Wang Xinsheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1975-1980</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">It is widely considered that endoplasmic reticulum stress may rapidly induce apoptosis.  The aim of the present study was to investigate the effect of thapsigargin on the induction of apoptosis in prostate cancer cells, and to explore its possible mechanism.  A Cell Counting Kit-8 was selected to determine the effect of thapsigargin (0, 1, 10 and 100 nM) on the proliferation of PC3 cells.  Cell proliferation of the prostate cancer cells was effectively inhibited by treatment with thapsigargin, and thapsigargin significantly increased the rate of apoptosis and caspase-3/9 activities in prostate cancer cells.  The protein expression of phosphorylated (p)-RAC-α serine threonine-protein kinase, p-mechanistic target of rapamycin, F-actin and paxillin were significantly decreased, and cofilin-1 protein expression was significantly increased by treatment with thapsigargin in prostate cancer cells.  Overall, the data of the present study revealed that thapsigargin induced apoptosis in prostate cancer cells through cofilin-1 and paxillin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfpOBgcGQpVZVVjGoY74BafW6udTcc2eYhZL-z9oyZG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fot1Ohtg%253D%253D&md5=d2e1f06c0465572c47a844587a61c383</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.8833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.8833%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DThapsigargin%2520induces%2520apoptosis%2520of%2520prostate%2520cancer%2520through%2520cofilin-1%2520and%2520paxillin%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D1975%26epage%3D1980%26doi%3D10.3892%2Fol.2018.8833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin-induced sequential expression of proteins related to autophagy and apoptosis in human breast cancer MCF-7 cells</span>. <i>Bull. Korean Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">3469</span>– <span class="NLM_lpage">3472</span>, <span class="refDoi"> DOI: 10.5012/bkcs.2011.32.9.3469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5012%2Fbkcs.2011.32.9.3469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2ntLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=3469-3472&author=M.+Parkauthor=S.+H.+Kim&title=Thapsigargin-induced+sequential+expression+of+proteins+related+to+autophagy+and+apoptosis+in+human+breast+cancer+MCF-7+cells&doi=10.5012%2Fbkcs.2011.32.9.3469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin-induced sequential expression of proteins related to autophagy and apoptosis in human breast cancer MCF-7 cells</span></div><div class="casAuthors">Park, Mikyung; Kim, Seong Hwan</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3469-3472</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">The thapsigargin induced sequential expression of autophagy and apoptosis related mols. in human breast cancer MCF-7 cells were evaluated.  Before evaluating that, the effect of thapsigargin on the viability of MCF-7 cells was assessed.  Results show the endogenous levels of Beclin-I and ATG5 that are autophagy promoting proteins, were decreased by thapsigargin.  Indeed, the gradual down-regulation of autophagy-related mols. has been suggested to facilitate apoptosis.  Esp., the cleavage or down-regulation of Beclin-I and ATG5 has been suggested to facilitate switch to apoptosis by unmasking a caspase-dependent apoptosis.  The sequential expression regulation of autophagy and apoptosis-related mols. is the crosstalk between autophagic and apoptotic signaling in the process of cell death in human breast cancer MCF-7 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDgivRTNKGprVg90H21EOLACvtfcHk0ljgVI2vI5RGmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2ntLrI&md5=d9bad1ef34abdf232849b79d80492a8b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2011.32.9.3469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2011.32.9.3469%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26atitle%3DThapsigargin-induced%2520sequential%2520expression%2520of%2520proteins%2520related%2520to%2520autophagy%2520and%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520MCF-7%2520cells%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2011%26volume%3D32%26spage%3D3469%26epage%3D3472%26doi%3D10.5012%2Fbkcs.2011.32.9.3469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span> <span> </span><span class="NLM_article-title">Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">35196</span>, <span class="refDoi"> DOI: 10.1038/srep35196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep35196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27731378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yisr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=35196&author=Z.+Maauthor=C.+Fanauthor=Y.+Yangauthor=S.+Diauthor=W.+Huauthor=T.+Liauthor=Y.+Zhuauthor=J.+Hanauthor=Z.+Xinauthor=G.+Wuauthor=J.+Zhaoauthor=X.+Liauthor=X.+Yan&title=Thapsigargin+sensitizes+human+esophageal+cancer+to+TRAIL-induced+apoptosis+via+AMPK+activation&doi=10.1038%2Fsrep35196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation</span></div><div class="casAuthors">Ma, Zhiqiang; Fan, Chongxi; Yang, Yang; Di, Shouyin; Hu, Wei; Li, Tian; Zhu, Yifang; Han, Jing; Xin, Zhenlong; Wu, Guiling; Zhao, Jing; Li, Xiaofei; Yan, Xiaolong</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35196</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent for esophageal squamous cell carcinoma (ESCC).  Forced expression of CHOP, one of the key downstream transcription factors during endoplasmic reticulum (ER) stress, upregulates the death receptor 5 (DR5) levels and promotes oxidative stress and cell death.  In this study, we show that ER stress mediated by thapsigargin promoted CHOP and DR5 synthesis thus sensitizing TRAIL treatment, which induced ESCC cells apoptosis.  These effects were reversed by DR5 siRNA in vitro and CHOP siRNA both in vitro and in vivo.  Besides, chem. inhibition of AMPK by Compd. C and AMPK siRNA weakened the anti-cancer effect of thapsigargin and TRAIL co-treatment.  Therefore, our findings suggest ER stress effectively sensitizes human ESCC to TRAIL-mediated apoptosis via the TRAIL-DR5-AMPK signaling pathway, and that activation of ER stress may be beneficial for improving the efficacy of TRAIL-based anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIVQKNV1HCYrVg90H21EOLACvtfcHk0lh6r-Q2SUJHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yisr%252FK&md5=a405ca11f1e4b1bae31c3465f87dfde2</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fsrep35196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep35196%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DDi%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DX.%26atitle%3DThapsigargin%2520sensitizes%2520human%2520esophageal%2520cancer%2520to%2520TRAIL-induced%2520apoptosis%2520via%2520AMPK%2520activation%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D35196%26doi%3D10.1038%2Fsrep35196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Körbel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linxweiler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wemmert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, M.</span></span> <span> </span><span class="NLM_article-title">Treatment of <i>SEC62</i> over-expressing tumors by thapsigargin and trifluoperazine</span>. <i>Biomol. Concepts</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1515/bmc-2018-0006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1515%2Fbmc-2018-0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29779013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MfltVaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=53-63&author=C.+K%C3%B6rbelauthor=M.+Linxweilerauthor=F.+Bochenauthor=S.+Wemmertauthor=B.+Schickauthor=M.+Meyerauthor=H.+Maurerauthor=M.+D.+Mengerauthor=R.+Zimmermannauthor=M.+Greiner&title=Treatment+of+SEC62+over-expressing+tumors+by+thapsigargin+and+trifluoperazine&doi=10.1515%2Fbmc-2018-0006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine</span></div><div class="casAuthors">Korbel Christina; Menger Michael D; Linxweiler Maximilian; Bochen Florian; Wemmert Silke; Schick Bernhard; Meyer Markus; Maurer Hans; Zimmermann Richard; Greiner Markus</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular concepts</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Treatment with analogues of the SERCA-inhibitor Thapsigargin is a promising new approach for a wide variety of cancer entities.  However, our previous studies on various tumor cells suggested resistance of SEC62 over-expressing tumors to this treatment.  Therefore, we proposed the novel concept that e.g. lung-, prostate-, and thyroid-cancer patients should be tested for SEC62 over-expression, and developed a novel therapeutic strategy for a combinatorial treatment of SEC62 over-expressing tumors.  The latter was based on the observations that treatment of SEC62 over-expressing tumor cells with SEC62-targeting siRNAs showed less resistance to Thapsigargin as well as a reduction in migratory potential and that the siRNA effects can be mimicked by the Calmodulin antagonist Trifluoperazine.  Therefore, the combinatorial treatment of SEC62 over-expressing tumors was proposed to involve Thapsigargin and Trifluoperazine.  Here, we addressed the impact of Thapsigargin and Trifluoperazine in separate and combined treatments of heterotopic tumors, induced by inoculation of human hypopharyngeal squamous cell carcinoma (FaDu)-cells into the mouse flank.  Seeding of the tumor cells and/or their growth rate were significantly reduced by all three treatments, suggesting Trifluoperazine is a small molecule to be considered for future therapeutic strategies for patients, suffering from Sec62-overproducing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJdtqO1XyHUIhLSh9fo81bfW6udTcc2ebteRXiq5HWw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfltVaisQ%253D%253D&md5=8117a801c83a2abe6e06de080abe3707</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1515%2Fbmc-2018-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc-2018-0006%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6rbel%26aufirst%3DC.%26aulast%3DLinxweiler%26aufirst%3DM.%26aulast%3DBochen%26aufirst%3DF.%26aulast%3DWemmert%26aufirst%3DS.%26aulast%3DSchick%26aufirst%3DB.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DMaurer%26aufirst%3DH.%26aulast%3DMenger%26aufirst%3DM.%2BD.%26aulast%3DZimmermann%26aufirst%3DR.%26aulast%3DGreiner%26aufirst%3DM.%26atitle%3DTreatment%2520of%2520SEC62%2520over-expressing%2520tumors%2520by%2520thapsigargin%2520and%2520trifluoperazine%26jtitle%3DBiomol.%2520Concepts%26date%3D2018%26volume%3D9%26spage%3D53%26epage%3D63%26doi%3D10.1515%2Fbmc-2018-0006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-G.</span></span> <span> </span><span class="NLM_article-title">Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12670894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisFaisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1483-1489&author=H.+Yamaguchiauthor=K.+Bhallaauthor=H.-G.+Wang&title=Bax+plays+a+pivotal+role+in+thapsigargin-induced+apoptosis+of+human+colon+cancer+HCT116+cells+by+controlling+Smac%2FDiablo+and+Omi%2FHtrA2+release+from+mitochondria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Bax Plays a Pivotal Role in Thapsigargin-induced Apoptosis of Human Colon Cancer HCT116 Cells by Controlling Smac/Diablo and Omi/HtrA2 Release from Mitochondria</span></div><div class="casAuthors">Yamaguchi, Hirohito; Bhalla, Kapil; Wang, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1483-1489</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bax is a crucial mediator of the mitochondrial pathway for apoptosis, and loss of this proapoptotic Bcl-2 family protein contributes to drug resistance in human cancers.  We report here that the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (THG) induces apoptosis of human colon cancer HCT116 cells through a Bax-dependent signaling pathway controlling the cytosolic release of mitochondrial apoptogenic mols.  Treating HCT116 cells with THG results in caspase-8 activation; Bid cleavage; Bax conformational change and mitochondrial translocation; the release of cytochrome c, Smac/Diablo, and Omi/HtrA2 into the cytosol; caspase-3 activation; and apoptosis.  In contrast, knockout of Bax completely abrogates the full processing/activation of caspase-3 but has no effect on the processing of caspase-8 and the initial cleavage of caspase-3 to p24 fragment after THG treatment.  The caspase-8-specific inhibitor z-IETD-fmk, as well as pan-caspase inhibitor z-VAD-fmk, but not the calpain inhibitor E-64d, prevents Bid cleavage, Bax conformational change, and subsequent caspase-3 processing and apoptosis.  Caspase-8 processing is dependent on de novo protein synthesis; DR5 expression is strongly up-regulated by THG treatment.  Moreover, the absence of Bax blocks THG-induced Omi and Smac release from mitochondria, and expression of cytosolic Omi (GFP-IETD-Omi) or Smac (GFP-IETD-Smac) restores the sensitivity of Bax-knockout HCT116 cells to apoptosis in response to THG treatment.  Taken together, our results indicate that Bax-dependent Smac and Omi release plays an essential role in caspase-3 activation and apoptosis induced by THG in human colon cancer HCT116 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSFriq19w3d7Vg90H21EOLACvtfcHk0liwovob3VnWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisFaisbg%253D&md5=6599315a7d74998b09cc9b590878b58c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DH.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DH.-G.%26atitle%3DBax%2520plays%2520a%2520pivotal%2520role%2520in%2520thapsigargin-induced%2520apoptosis%2520of%2520human%2520colon%2520cancer%2520HCT116%2520cells%2520by%2520controlling%2520Smac%252FDiablo%2520and%2520Omi%252FHtrA2%2520release%2520from%2520mitochondria%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D1483%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inigo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Hsp60 and IL-8 axis promotes apoptosis resistance in cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1038/s41416-019-0617-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41416-019-0617-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31673102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFemsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2019&pages=934-943&author=S.+Kumarauthor=J.+O%E2%80%99Malleyauthor=A.+K.+Chaudharyauthor=J.+R.+Inigoauthor=N.+Yadavauthor=R.+Kumarauthor=D.+Chandra&title=Hsp60+and+IL-8+axis+promotes+apoptosis+resistance+in+cancer&doi=10.1038%2Fs41416-019-0617-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp60 and IL-8 axis promotes apoptosis resistance in cancer</span></div><div class="casAuthors">Kumar, Sandeep; O'Malley, Jordan; Chaudhary, Ajay Kumar; Inigo, Joseph R.; Yadav, Neelu; Kumar, Rahul; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">934-943</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Interleukin-8 (IL-8) and heat shock protein 60 (Hsp60) play crucial roles in cell survival and maintenance of cellular homoeostasis.  However, cross talks between these two proteins are not defined.  IL-8 expression in tumor tissue sections was analyzed by immunohistochem.  IL-8 expression and release in cancer cells was quantified using ELISA (ELISA).  Apoptosis was quantified using caspase activity and Annexin-V/PI staining.  We obsd. IL-8 release from cancer cells in response to histone deacetylase inhibitor, apicidin (Api), and non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase, thapsigargin (TG).  IL-8 release was increased upon TG-treatment.  TG-induced IL-8 expression was reduced in the presence of Api in Bax-dependent manner.  Increased apoptosis was assocd. with decreased IL-8 expression in response to combined treatment of TG and Api.  TG and Api combination induced caspase-8 and caspase-9 dependent apoptosis.  Hsp60 knockdown abrogated IL-8 expression induced by Api, TG, and their combination.  The level of TGF-β, an upstream regulator of IL-8, was decreased upon Hsp60-silencing.  Knocking down Hsp60 decreased IL-8 expression and its release in prostate cancer cell xenograft tumors in SCID mice.  This study describes the underlying mechanism assocd. with apoptosis resistance mediated via Hsp60-IL-8 axis in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0xlaXpnUUrVg90H21EOLACvtfcHk0livrTSJbcIG_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFemsLrL&md5=d2817bd4eb1e6f0d25987babbd4359b5</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fs41416-019-0617-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-019-0617-0%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DJ.%26aulast%3DChaudhary%26aufirst%3DA.%2BK.%26aulast%3DInigo%26aufirst%3DJ.%2BR.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DHsp60%2520and%2520IL-8%2520axis%2520promotes%2520apoptosis%2520resistance%2520in%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2019%26volume%3D121%26spage%3D934%26epage%3D943%26doi%3D10.1038%2Fs41416-019-0617-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilja, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span> <span> </span><span class="NLM_article-title">Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer</span>. <i>J. Natl. Cancer. Inst.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1093/jnci/95.13.990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1093%2Fjnci%2F95.13.990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12837835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=990-1000&author=S.+R.+Denmeadeauthor=C.+M.+Jakobsenauthor=S.+Janssenauthor=S.+R.+Khanauthor=E.+S.+Garrettauthor=H.+Liljaauthor=S.+B.+Christensenauthor=J.+T.+Isaacs&title=Prostate-specific+antigen-activated+thapsigargin+prodrug+as+targeted+therapy+for+prostate+cancer&doi=10.1093%2Fjnci%2F95.13.990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer</span></div><div class="casAuthors">Denmeade, Samuel R.; Jakobsen, Carsten M.; Janssen, Samuel; Khan, Saeed R.; Garrett, Elizabeth S.; Lilja, Hans; Christensen, S. Brogger; Isaacs, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">990-1000</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Std. anti-proliferative chemotherapy is relatively ineffective against slowly proliferating androgen-independent prostate cancer cells within metastatic sites.  In contrast, the lipophilic cytotoxin thapsigargin, which causes apoptosis by disrupting intracellular free Ca2+ levels, is effective against both proliferative and quiescent (i.e., G0-arrested) cells.  However, thapsigargin's mechanism of action indicates that it is unlikely to be selective for cancer cells or prostate cells.  We coupled a chem. modified form of thapsigargin, L12ADT, to a peptide carrier that is a substrate for the prostate-specific antigen (PSA) protease to produce a sol., cell-impermeant latent prodrug that is specifically activated extracellularly within metastatic prostate cancer sites by PSA.  We analyzed the kinetics of PSA hydrolysis of the prodrug, the in vitro cytotoxicity of the prodrug against PSA-producing LNCaP human prostate cancer and PSA non-producing HCT-116 human colon cancer cells, and the in vivo pharmacokinetics of the prodrug in mice.  We also analyzed antitumor efficacy of the prodrug in nude mice xenograft models of prostate cancer (using LNCaP cells) and renal carcinoma (using human SN12C cells).  The L12ADT peptide prodrug was hydrolyzed efficiently by PSA, was selectively toxic to PSA-producing prostate cancer cells in vitro, and was stable in human plasma.  A single dose of 7 mg/kg resulted in a peak serum prodrug concn. of 15.4±1.1 μM and a half-life of approx. 2.8 h.  Over 24 h, less than 0.5% of free L12ADT was obsd. in plasma.  Levels of prodrug and liberated L12ADT in prostate cancer xenograft tumors were approx. eightfold and sixfold, resp., higher than the in vitro LD50s.  Prostate cancer xenograft tumors in mice treated with prodrug by i.v. administration were growth-inhibited without substantial host toxicity.  Continuous s.c. prodrug administration in mice produced complete growth inhibition of established PSA-producing prostate cancer xenograft tumors but had no effect on PSA non-producing renal carcinoma xenograft tumors.  Further development of PSA-activated thapsigargin prodrugs as therapy for metastatic prostate cancer is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF5KzcmdurTrVg90H21EOLACvtfcHk0liLCdgYXmfi-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D&md5=1d4d04fa16cf7ce8989727164379d5cc</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.13.990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.13.990%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DJakobsen%26aufirst%3DC.%2BM.%26aulast%3DJanssen%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DGarrett%26aufirst%3DE.%2BS.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DProstate-specific%2520antigen-activated%2520thapsigargin%2520prodrug%2520as%2520targeted%2520therapy%2520for%2520prostate%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer.%2520Inst.%26date%3D2003%26volume%3D95%26spage%3D990%26epage%3D1000%26doi%3D10.1093%2Fjnci%2F95.13.990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vander
Griend, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalrymple, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. T.</span></span> <span> </span><span class="NLM_article-title">Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1340</span>– <span class="NLM_lpage">1349</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-1136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1535-7163.MCT-08-1136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19417145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1340-1349&author=D.+J.+Vander%0AGriendauthor=L.+Antonyauthor=S.+L.+Dalrympleauthor=Y.+Xuauthor=S.+B.+Christensenauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacs&title=Amino+acid+containing+thapsigargin+analogues+deplete+androgen+receptor+protein+via+synthesis+inhibition+and+induce+the+death+of+prostate+cancer+cells&doi=10.1158%2F1535-7163.MCT-08-1136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells</span></div><div class="casAuthors">Vander Griend, Donald J.; Antony, Lizamma; Dalrymple, Susan L.; Xu, Yi; Christensen, S. Brogger; Denmeade, Samuel R.; Isaacs, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1340-1349</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There are quant. and/or qual. mechanisms allowing androgen receptor (AR) growth signaling in androgen ablation refractory prostate cancer cells.  Regardless of the mechanism, agents that deplete AR protein expression prevent such AR growth signaling.  Thapsigargin (TG) is a highly cell-penetrant sequiterpene-lactone that once inside cells inhibits (IC50, 10 nmol/L) critically important housekeeping SERCA 2b calcium pumps in the endoplasmic reticulum.  Using a series of five genetically diverse androgen ablation refractory human prostate cancer lines (LNCaP, LAPC-4, VCaP, MDA-PCa-2b, and CWR22Rv1), TG inhibition of SERCA pumps consistently results in depletion of the endoplasmic reticulum Ca+2 coupled with μmol/L elevation in the intracellular free Ca+2 initiating a mol. cascade that: (a) inhibits Cap-dependent AR protein synthesis resulting in 90% depletion of AR protein by 24 h of TG exposure, (b) arrests the cells in G0, and (c) induces their apoptotic death.  Unfortunately, due to its highly lipophilic nature, TG is not deliverable as a systemic agent without host toxicity.  Therefore, TG analogs contg. amino acids were developed, which retain ability to deplete AR protein and induce cell death and which can be covalently linked to peptide carriers producing water sol. prodrugs for systemic delivery.  Specific amino acid sequences are used to restrict the liberation of cytotoxic amino acid contg. TG analogs from the peptide prodrug by prostate-specific proteases, such as prostate-specific antigen and prostate-specific membrane antigen, or cancer-specific proteases, such as fibroblast activation protein, so that toxicity of these prodrugs is selectively targeted to metastatic sites of prostate cancer.  Based on these results, these prodrugs are undergoing clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwb0BEOf1jSbVg90H21EOLACvtfcHk0lhCi6kB4wijHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlGqt7w%253D&md5=9e8e00d66561ea1bb25359cc65699e14</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1136%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BGriend%26aufirst%3DD.%2BJ.%26aulast%3DAntony%26aufirst%3DL.%26aulast%3DDalrymple%26aufirst%3DS.%2BL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DAmino%2520acid%2520containing%2520thapsigargin%2520analogues%2520deplete%2520androgen%2520receptor%2520protein%2520via%2520synthesis%2520inhibition%2520and%2520induce%2520the%2520death%2520of%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D1340%26epage%3D1349%26doi%3D10.1158%2F1535-7163.MCT-08-1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzyk, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of enzyme-activated thapsigargin prodrugs by solid-phase synthesis</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1463</span>, <span class="refDoi"> DOI: 10.3390/molecules23061463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules23061463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGgtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1463&author=T.+Zimmermannauthor=S.+B.+Christensenauthor=H.+Franzyk&title=Preparation+of+enzyme-activated+thapsigargin+prodrugs+by+solid-phase+synthesis&doi=10.3390%2Fmolecules23061463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of enzyme-activated thapsigargin prodrugs by solid-phase synthesis</span></div><div class="casAuthors">Zimmermann, Tomas; Christensen, Soren Brogger; Franzyk, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1463/1-1463/13</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Since cells in solid tumors divide less rapidly than cells in the bone marrow or cells of the immune system, mitotic inhibitors often cause severe side effects when used for treatment of diseases like prostate cancer and breast cancer.  One approach to overcome this problem involves attempts at developing drugs based on general cytotoxins, like calicheamicin and thapsigargin, which kill cells at all phases of the cell cycle.  However, such toxins can only be used when efficient targeting to the malignant tissue is possible.  In the case of thapsigargin, selectivity for tumor-assocd. cells is achieved by conjugating the drug to a peptide that is only cleaved in the vicinity of tumors to release the cytotoxic drug or an analog with retained activity.  Solid-phase synthesis protocols were developed for prepn. of three already validated prodrugs of thapsigargin: one prodrug cleavable by human kallikrein 2, one prodrug cleavable by prostate-specific antigen, and one prodrug cleavable by prostate-specific membrane antigen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdfvtNACIoqLVg90H21EOLACvtfcHk0lhCi6kB4wijHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGgtL3P&md5=7df6ce174bb356b57fa0f6bc09488b4a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23061463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23061463%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DT.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DFranzyk%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520enzyme-activated%2520thapsigargin%2520prodrugs%2520by%2520solid-phase%2520synthesis%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D1463%26doi%3D10.3390%2Fmolecules23061463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denmeade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarantopoulas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosgrove, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetnar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgood, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carducci, M.</span></span> <span> </span><span class="NLM_article-title">Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: Results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumors</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">986</span>– <span class="NLM_lpage">994</span>, <span class="refDoi"> DOI: 10.1038/bjc.2016.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fbjc.2016.72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27115568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFOmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2016&pages=986-994&author=D.+Mahalingamauthor=G.+Wildingauthor=S.+Denmeadeauthor=J.+Sarantopoulasauthor=D.+Cosgroveauthor=J.+Cetnarauthor=N.+Azadauthor=J.+Bruceauthor=M.+Kurmanauthor=V.+E.+Allgoodauthor=M.+Carducci&title=Mipsagargin%2C+a+novel+thapsigargin-based+PSMA-activated+prodrug%3A+Results+of+a+first-in-man+phase+I+clinical+trial+in+patients+with+refractory%2C+advanced+or+metastatic+solid+tumors&doi=10.1038%2Fbjc.2016.72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours</span></div><div class="casAuthors">Mahalingam, D.; Wilding, G.; Denmeade, S.; Sarantopoulas, J.; Cosgrove, D.; Cetnar, J.; Azad, N.; Bruce, J.; Kurman, M.; Allgood, V. E.; Carducci, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">986-994</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Mipsagargin (G-202; (8-O-(12-aminododecanoyl)-8-O-debutanoyl thapsigargin)-Asp-γ-Glu-γ-Glu-γ-GluGluOH)) is a novel thapsigargin-based targeted prodrug that is activated by PSMA-mediated cleavage of an inert masking peptide.  The active moiety is an inhibitor of the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump protein that is necessary for cellular viability.  We evaluated the safety of mipsagargin in patients with advanced solid tumors and established a recommended phase II dosing (RP2D) regimen.  Methods: Patients with advanced solid tumors received mipsagargin by i.v. infusion on days 1, 2 and 3 of 28-day cycles and were allowed to continue participation in the absence of disease progression or unacceptable toxicity.  The dosing began at 1.2 mg m-2 and was escalated using a modified Fibonacci schema to det. maximally tolerated dose (MTD) with an expansion cohort at the RP2D.  Plasma was analyzed for mipsagargin pharmacokinetics and response was assessed using RECIST criteria.  Results: A total of 44 patients were treated at doses ranging from 1.2 to 88 mg m-2, including 28 patients in the dose escalation phase and 16 patients in an expansion cohort.  One dose-limiting toxicity (DLT; Grade 3 rash) was obsd. in the dose escalation portion of the study.  At 88 mg m-2, observations of Grade 2 infusion-related reaction (IRR, 2 patients) and Grade 2 creatinine elevation (1 patient) led to declaration of 66.8 mg m-2 as the recommended phase II dose (RP2D).  Across the study, the most common treatment-related adverse events (AEs) were fatigue, rash, nausea, pyrexia and IRR.  Two patients developed treatment-related Grade 3 acute renal failure that was reversible during the treatment-free portion of the cycle.  To help ameliorate the IRR and creatinine elevations, a RP2D of 40 mg m-2 on day 1 and 66.8 mg m-2 on days 2 and 3 with prophylactic premedications and hydration on each day of infusion was established.  Clin. response was not obsd., but prolonged disease stabilization was obsd. in a subset of patients.  Conclusions: Mipsagargin demonstrated an acceptable tolerability and favorable pharmacokinetic profile in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG66Gw8dy-PLVg90H21EOLACvtfcHk0lgRB34QoYePQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFOmtbY%253D&md5=dac90827cd0be1017afcb48ea6d6279b</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2016.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2016.72%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DDenmeade%26aufirst%3DS.%26aulast%3DSarantopoulas%26aufirst%3DJ.%26aulast%3DCosgrove%26aufirst%3DD.%26aulast%3DCetnar%26aufirst%3DJ.%26aulast%3DAzad%26aufirst%3DN.%26aulast%3DBruce%26aufirst%3DJ.%26aulast%3DKurman%26aufirst%3DM.%26aulast%3DAllgood%26aufirst%3DV.%2BE.%26aulast%3DCarducci%26aufirst%3DM.%26atitle%3DMipsagargin%252C%2520a%2520novel%2520thapsigargin-based%2520PSMA-activated%2520prodrug%253A%2520Results%2520of%2520a%2520first-in-man%2520phase%2520I%2520clinical%2520trial%2520in%2520patients%2520with%2520refractory%252C%2520advanced%2520or%2520metastatic%2520solid%2520tumors%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2016%26volume%3D114%26spage%3D986%26epage%3D994%26doi%3D10.1038%2Fbjc.2016.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peguero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarantopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgood, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubb, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, L.</span></span> <span> </span><span class="NLM_article-title">A phase II, multicenter, single-arm study of mipsagargin (G-202) as a second-line therapy following sorafenib for adult patients with progressive advanced hepatocellular carcinoma</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">833</span>, <span class="refDoi"> DOI: 10.3390/cancers11060833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fcancers11060833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtlCku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=833&author=D.+Mahalingamauthor=J.+Pegueroauthor=P.+Cenauthor=S.+P.+Aroraauthor=J.+Sarantopoulosauthor=J.+Roweauthor=V.+Allgoodauthor=B.+Tubbauthor=L.+Campos&title=A+phase+II%2C+multicenter%2C+single-arm+study+of+mipsagargin+%28G-202%29+as+a+second-line+therapy+following+sorafenib+for+adult+patients+with+progressive+advanced+hepatocellular+carcinoma&doi=10.3390%2Fcancers11060833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II, multicenter, single-arm study of mipsagargin (G-202) as a second-line therapy following sorafenib for adult patients with progressive advanced hepatocellular carcinoma</span></div><div class="casAuthors">Mahalingam, Devalingam; Peguero, Julio; Cen, Putao; Arora, Sukeshi P.; Sarantopoulos, John; Rowe, Julie; Allgood, Victoria; Tubb, Benjamin; Campos, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">833</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Background: Mipsagargin (G-202) is a thapsigargin-based prodrug with cytotoxic activity masked by a peptide that is cleaved by prostate-specific membrane antigen (PSMA), a protease expressed in prostate cancer cells and the endothelium of tumor vasculature.  It was hypothesized that PSMA-mediated activation of mipsagargin would result in disruption of the tumor vasculature, leading to a decrease in blood flow, and in direct cytotoxic effects on tumor cells, resulting in anti-tumor activity.  Method: In this open-label, Phase II study, mipsagargin was administered i.v. on Days 1, 2, and 3 of a 28-day cycle to patients with hepatocellular carcinoma (HCC) who progressed on or after treatment with sorafenib or intolerant of sorafenib.  Assessments included time to disease progression (TTP), response rate, progression-free survival (PFS), overall survival (OS), and safety.  Blood flow metrics in hepatic lesions were evaluated using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).  Results: Of 25 treated patients, 19 were evaluable for efficacy.  None had an objective response, 12 (63.2%) had a best response of stable disease, and 12 (63.2%) showed radiol. progression; seven patients (36.8%) were censored.  The median TTP was 134.0 days, median PFS was 129.0 days, and median OS was 205.0 days.  Of five patients with DCE-MRI data for 11 HCC lesions, all demonstrated a reduced Ktrans (mean, 52%).  The most common treatment-emergent AEs were Grade 1-2 and consisted of increased blood creatinine (68.0%), fatigue (56.0%), and nausea (44.0%).  Conclusions: Mipsagargin is relatively well tolerated and promotes prolonged disease stabilization in patients with advanced HCC that had progressed on prior treatment with sorafenib.  A significant decrease in Ktrans upon treatment suggests mipsagargin reduces blood flow in hepatic lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39z-l_72PlrVg90H21EOLACvtfcHk0lgRB34QoYePQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtlCku7k%253D&md5=0199cc69daa5fb862752e9f1e0a1157e</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3390%2Fcancers11060833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers11060833%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingam%26aufirst%3DD.%26aulast%3DPeguero%26aufirst%3DJ.%26aulast%3DCen%26aufirst%3DP.%26aulast%3DArora%26aufirst%3DS.%2BP.%26aulast%3DSarantopoulos%26aufirst%3DJ.%26aulast%3DRowe%26aufirst%3DJ.%26aulast%3DAllgood%26aufirst%3DV.%26aulast%3DTubb%26aufirst%3DB.%26aulast%3DCampos%26aufirst%3DL.%26atitle%3DA%2520phase%2520II%252C%2520multicenter%252C%2520single-arm%2520study%2520of%2520mipsagargin%2520%2528G-202%2529%2520as%2520a%2520second-line%2520therapy%2520following%2520sorafenib%2520for%2520adult%2520patients%2520with%2520progressive%2520advanced%2520hepatocellular%2520carcinoma%26jtitle%3DCancers%26date%3D2019%26volume%3D11%26spage%3D833%26doi%3D10.3390%2Fcancers11060833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyong, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragasa, C. Y.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic labdane diterpenoids from <i>Andrographis paniculata</i> (Burm.f.) Nees</span>. <i>Asian J. Pharm. Clin. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.22159/ajpcr.2017.v10i12.19194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.22159%2Fajpcr.2017.v10i12.19194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1egurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=99-104&author=M.+C.+S.+Tanauthor=G.+G.+Oyongauthor=C.-C.+Shenauthor=C.+Y.+Ragasa&title=Cytotoxic+labdane+diterpenoids+from+Andrographis+paniculata+%28Burm.f.%29+Nees&doi=10.22159%2Fajpcr.2017.v10i12.19194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic labdane diterpenoids from Andrographispaniculata (Burm.f.) Nees</span></div><div class="casAuthors">Tan, Maria Carmen S.; Oyong, Glenn G.; Shen, Chien Chang; Ragasa, Consolacion Y.</div><div class="citationInfo"><span class="NLM_cas:title">Asian Journal of Pharmaceutical and Clinical Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">99-104</span>CODEN:
                <span class="NLM_cas:coden">AJPCBB</span>;
        ISSN:<span class="NLM_cas:issn">0974-2441</span>.
    
            (<span class="NLM_cas:orgname">Asian Journal of Pharmaceutical and Clinical Research</span>)
        </div><div class="casAbstract">The primary objective of this study was to probe the cytotoxic capacity of the labdane diterpenoids andrographolide (1), 14-deoxyandrographolide (2), 14-deoxy-12-hydroxyandrographolide (3), and neoandrographolide (4) on mutant and wild-type immortalized cell lines.  Breast adenocarcinoma (MCF-7), colon carcinomas (HCT-116 and HT-29), small cell lung carcinoma (H69PR), human acute monocytic leukemia (THP-1), and wild-type primary normal human dermal fibroblasts - neonatal cells (HDFn) were incubated with 1-4, and the degree of cytotoxicity was analyzed by employing the in vitro PrestoBlue cell viability assay.  Working solns. of 1-4 were prepd. in complete cell culture medium to a final non-toxic DMSO concn. of 0.2%.  The plates were incubated at 37°C with 5% CO2 in a 98% humidified incubator throughout the assay.  Nonlinear regression and statistical analyses were done to extrapolate the half maximal inhibitory concn. 50% (IC50).  One-way ANOVA (p<0.05) and multiple comparison, Tukey's post hoc test (p<0.05), were used to compare different pairs of data sets.  Results were considered statistically significant at p<0.05.  The highest cytotoxicity index was exhibited by the H69PR and 1 trials which displayed the lowest IC50 value of 3.66μg/mL, followed by HT-29 treated with 2, HCT-116 and 1 trials, and H69PR treated with 4 (IC50 = 3.81, 3.82, and 4.19μg/mL, resp.).  Only 1 and 4 were detrimental toward MCF-7, while 1, 3, and 4 were degenerative against H69PR.  Tukey's post hoc multiple comparison indicated no significant difference in the cytotoxicity of 1-4 on HCT-116 cells which afforded IC50 values ranging from 3.82 to 5.12μg/mL.  Evaluation of the two colon carcinoma cell lines showed that HCT-116 was categorically more susceptible to cellular damage caused by treatments with 1-4 than was HT-29.  Cytotoxicity was not detected in THP-1 and HDFn cells (IC50>100μg/mL).  Diterpenoids 1-4 isolated from the dichloromethane ext. of the leaves of A. paniculata exhibited different cytotoxic activities against MCF-7, HCT-116, HT-29, and H69PR.  All constituents had comparable action on HCT-116 cells but were not found to be cytotoxic to normal HDFn cells and mutant THP-1 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8XqkWsuGUorVg90H21EOLACvtfcHk0lgRB34QoYePQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1egurvO&md5=ce8002bb5eb9c492a24e6129d101d1ff</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.22159%2Fajpcr.2017.v10i12.19194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.22159%252Fajpcr.2017.v10i12.19194%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DM.%2BC.%2BS.%26aulast%3DOyong%26aufirst%3DG.%2BG.%26aulast%3DShen%26aufirst%3DC.-C.%26aulast%3DRagasa%26aufirst%3DC.%2BY.%26atitle%3DCytotoxic%2520labdane%2520diterpenoids%2520from%2520Andrographis%2520paniculata%2520%2528Burm.f.%2529%2520Nees%26jtitle%3DAsian%2520J.%2520Pharm.%2520Clin.%2520Res.%26date%3D2017%26volume%3D10%26spage%3D99%26epage%3D104%26doi%3D10.22159%2Fajpcr.2017.v10i12.19194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chantrapromma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boonnak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitakpornpreecha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordthong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidan Kumar, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fun, H. K.</span></span> <span> </span><span class="NLM_article-title">Absolute configuration of andrographolide and its proliferation of osteoblast cell lines</span>. <i>Crystallogr. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1134/S1063774518030069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1134%2FS1063774518030069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKnt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2018&pages=412-417&author=S.+Chantraprommaauthor=N.+Boonnakauthor=T.+Pitakpornpreechaauthor=T.+Yordthongauthor=C.+S.+Chidan+Kumarauthor=H.+K.+Fun&title=Absolute+configuration+of+andrographolide+and+its+proliferation+of+osteoblast+cell+lines&doi=10.1134%2FS1063774518030069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute Configuration of Andrographolide and Its Proliferation of Osteoblast Cell Lines</span></div><div class="casAuthors">Chantrapromma, S.; Boonnak, N.; Pitakpornpreecha, T.; Yordthong, T.; Chidan Kumar, C. S.; Fun, H. K.</div><div class="citationInfo"><span class="NLM_cas:title">Crystallography Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-417</span>CODEN:
                <span class="NLM_cas:coden">CYSTE3</span>;
        ISSN:<span class="NLM_cas:issn">1063-7745</span>.
    
            (<span class="NLM_cas:orgname">Pleiades Publishing, Ltd.</span>)
        </div><div class="casAbstract">Andrographolide, C20H30O5, is a labdane diterpenoid which was isolated from the leave of Andrographis paniculata.  Its crystal structure is detd. by single crystal X-ray diffraction: monoclinic, sp. gr.P21, Z = 2.  Abs. configuration is detd. by the refinement of the Flack parameter to 0.21(19).  In the crystal, mols. are linked by O-H···O hydrogen bonds and C-H···O interactions into two dimensional network parallel to the (001) plane.  Its proliferation of osteoblast cell lines is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkugwYhgDVO7Vg90H21EOLACvtfcHk0liJ3lYkwQS8sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKnt7fE&md5=79f2a488d71288570078ea010b3f7d9f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1134%2FS1063774518030069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1134%252FS1063774518030069%26sid%3Dliteratum%253Aachs%26aulast%3DChantrapromma%26aufirst%3DS.%26aulast%3DBoonnak%26aufirst%3DN.%26aulast%3DPitakpornpreecha%26aufirst%3DT.%26aulast%3DYordthong%26aufirst%3DT.%26aulast%3DChidan%2BKumar%26aufirst%3DC.%2BS.%26aulast%3DFun%26aufirst%3DH.%2BK.%26atitle%3DAbsolute%2520configuration%2520of%2520andrographolide%2520and%2520its%2520proliferation%2520of%2520osteoblast%2520cell%2520lines%26jtitle%3DCrystallogr.%2520Rep.%26date%3D2018%26volume%3D63%26spage%3D412%26epage%3D417%26doi%3D10.1134%2FS1063774518030069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravi, S. S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Găman, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Găman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro
e Sousa, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Moura Dantas, S. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolim, H. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Carvalho Melo-Cavalcante, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mubarak, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarla, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shilpi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanasov, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal, M. A.</span></span> <span> </span><span class="NLM_article-title">Andrographolide, a diterpene lactone from <i>Andrographis paniculata</i> and its therapeutic promises in cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>420</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.01.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.canlet.2018.01.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29408515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXislyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2018&pages=129-145&author=M.+T.+Islamauthor=E.+S.+Aliauthor=S.+J.+Uddinauthor=M.+A.+Islamauthor=S.+Shawauthor=I.+N.+Khanauthor=S.+S.+S.+Saraviauthor=S.+Ahmadauthor=S.+Rehmanauthor=V.+K.+Guptaauthor=M.-A.+G%C4%83manauthor=A.+M.+G%C4%83manauthor=S.+Yeleauthor=A.+K.+Dasauthor=J.+M.+de+Castro%0Ae+Sousaauthor=S.+M.+M.+de+Moura+Dantasauthor=H.+M.+L.+Rolimauthor=A.+A.+de%0ACarvalho+Melo-Cavalcanteauthor=M.+S.+Mubarakauthor=N.+S.+Yarlaauthor=J.+A.+Shilpiauthor=S.+K.+Mishraauthor=A.+G.+Atanasovauthor=M.+A.+Kamal&title=Andrographolide%2C+a+diterpene+lactone+from+Andrographis+paniculata+and+its+therapeutic+promises+in+cancer&doi=10.1016%2Fj.canlet.2018.01.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer</span></div><div class="casAuthors">Islam, Muhammad Torequl; Ali, Eunus S.; Uddin, Shaikh Jamal; Islam, Md. Amirul; Shaw, Subrata; Khan, Ishaq N.; Saravi, Seyed Soheil Saeedi; Ahmad, Saheem; Rehman, Shahnawaz; Gupta, Vijai Kumar; Gaman, Mihnea-Alexandru; Gaman, Amelia Maria; Yele, Santosh; Das, Asish Kumar; Marcelo de Castro e Sousa, Joao; Dantas, Sandra Maria Mendes de Moura; Rolim, Hercilia Maria Lins; Melo-Cavalcante, Ana Amelia de Carvalho; Mubarak, Mohammad S.; Yarla, Nagendra Sastry; Shilpi, Jamil A.; Mishra, Siddhartha Kumar; Atanasov, Atanas G.; Kamal, Mohammad Amjad</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">129-145</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The diterpene lactone andrographolide, isolated from Andrographis paniculata, has been proven to possess several important protective biol. activities, including antioxidant, anti-inflammatory, immunomodulatory, antiseptic, antimicrobial, cytotoxic, hypolipidemic, cardioprotective, hepatoprotective, and neuroprotective effects.  In addn., it has been reported to play a therapeutic role in the treatment of major human diseases, such as Parkinson's disease, rheumatoid arthritis, and colitis.  This systematic review aims to highlight andrographolide as a promising agent in cancer treatment.  To this purpose, a no. of databases were used to search for the cytotoxic/anticancer effects of andrographolide in pre-clin. and clin. studies.  Among 1703 identified literature articles, 139 were included in this review; 109 were investigated as non-clin., whereas 24, 3, and 3 were pre-clin., clin., and non-pre-clin. trials, resp.  Among the model systems, cultured cell lines appeared as the most frequently (79.14%) used, followed by in vivo models using rodents, among others.  Furthermore, andrographolide was found to exert cytotoxic/anticancer effects on almost all types of cell lines with the underlying mechanisms involving oxidative stress, cell cycle arrest, anti-inflammatory and immune system mediated effects, apoptosis, necrosis, autophagy, inhibition of cell adhesion, proliferation, migration, invasion, anti-angiogenic activity, and other misc. actions.  After careful consideration of the relevant evidence, we suggest that andrographolide can be one of the potential agents in the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdZoMT1XD3nLVg90H21EOLACvtfcHk0liJ3lYkwQS8sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXislyjt7c%253D&md5=ee59fdcc7c95d5eb9610a03360f7c68e</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.01.074%26sid%3Dliteratum%253Aachs%26aulast%3DIslam%26aufirst%3DM.%2BT.%26aulast%3DAli%26aufirst%3DE.%2BS.%26aulast%3DUddin%26aufirst%3DS.%2BJ.%26aulast%3DIslam%26aufirst%3DM.%2BA.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DI.%2BN.%26aulast%3DSaravi%26aufirst%3DS.%2BS.%2BS.%26aulast%3DAhmad%26aufirst%3DS.%26aulast%3DRehman%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DV.%2BK.%26aulast%3DG%25C4%2583man%26aufirst%3DM.-A.%26aulast%3DG%25C4%2583man%26aufirst%3DA.%2BM.%26aulast%3DYele%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DA.%2BK.%26aulast%3Dde%2BCastro%2Be%2BSousa%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BMoura%2BDantas%26aufirst%3DS.%2BM.%2BM.%26aulast%3DRolim%26aufirst%3DH.%2BM.%2BL.%26aulast%3Dde%2BCarvalho%2BMelo-Cavalcante%26aufirst%3DA.%2BA.%26aulast%3DMubarak%26aufirst%3DM.%2BS.%26aulast%3DYarla%26aufirst%3DN.%2BS.%26aulast%3DShilpi%26aufirst%3DJ.%2BA.%26aulast%3DMishra%26aufirst%3DS.%2BK.%26aulast%3DAtanasov%26aufirst%3DA.%2BG.%26aulast%3DKamal%26aufirst%3DM.%2BA.%26atitle%3DAndrographolide%252C%2520a%2520diterpene%2520lactone%2520from%2520Andrographis%2520paniculata%2520and%2520its%2520therapeutic%2520promises%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D420%26spage%3D129%26epage%3D145%26doi%3D10.1016%2Fj.canlet.2018.01.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheriyamundath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madassery, J.</span></span> <span> </span><span class="NLM_article-title">Exploring the mechanisms of cytotoxic and anti-inflammatory property of andrographolide and its derivatives</span>. <i>Pharmacogn. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.4103/phrev.phrev_47_17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.4103%2Fphrev.phrev_47_17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFKnt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=56-65&author=R.+Raghavanauthor=S.+Cheriyamundathauthor=J.+Madassery&title=Exploring+the+mechanisms+of+cytotoxic+and+anti-inflammatory+property+of+andrographolide+and+its+derivatives&doi=10.4103%2Fphrev.phrev_47_17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the mechanisms of cytotoxic and anti-inflammatory property of andrographolide and its derivatives</span></div><div class="casAuthors">Raghavan, Rahul; Cheriyamundath, Sanith; Madassery, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacognosy Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">56-61</span>CODEN:
                <span class="NLM_cas:coden">PRHEEV</span>;
        ISSN:<span class="NLM_cas:issn">0973-7847</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications</span>)
        </div><div class="casAbstract">A review.  This review explores the mechanisms of cytotoxic and anti-inflammatory properties of andrographolide and derivs. of andrographolide in various cell lines.  In vitro and in vivo studies that shed light on the mol. mechanisms of cytotoxicity and anti-inflammatory property of andrographolide and its derivs. are reviewed here.  Cytotoxic effect of andrographolide on cancer cell lines are mainly due to the induction of reactive oxygen species, activation of c-Jun N-terminal kinase, inhibition of autophagy, and induction of apoptosis.  Anti-inflammatory effect of andrographolide is predominantly due to the covalent inhibition of nuclear factor kappa B transcription factor and thereby inhibition of various targets genes such as tumor necrosis factor-alpha, interleukin-6, macrophage inflammatory protein-2, and nitric oxide synthase.  Andrographolide is known to directly bind Ras protein; therefore, inhibition of growth factor-activated downstream pathways such as ERK1/2 pathway might be due to the direct inhibition of Ras functions.  Inhibition of Ras pathway by antagonizing Ras protein might be a key event contributing to both cytotoxicity and anti-inflammatory functions of andrographolide.  Evidence from literature study showed that derivs. of andrographolide such as neoandrographolide and 14-deoxy-11,12-didehydroandrographolides are potent anti-inflammatory agents with less cytotoxicity.  Unfavorable chem. modifications such as sulfation and glucuronidation inside the body and fast removal from plasma are the major factors known to hinder the bioavailability of andrographolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmITlo_1iT7Vg90H21EOLACvtfcHk0ljDHBaOvt8mQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFKnt73F&md5=7d5e7f21e6dea91f6869eb88bd4e207e</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.4103%2Fphrev.phrev_47_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Fphrev.phrev_47_17%26sid%3Dliteratum%253Aachs%26aulast%3DRaghavan%26aufirst%3DR.%26aulast%3DCheriyamundath%26aufirst%3DS.%26aulast%3DMadassery%26aufirst%3DJ.%26atitle%3DExploring%2520the%2520mechanisms%2520of%2520cytotoxic%2520and%2520anti-inflammatory%2520property%2520of%2520andrographolide%2520and%2520its%2520derivatives%26jtitle%3DPharmacogn.%2520Rev.%26date%3D2018%26volume%3D12%26spage%3D56%26epage%3D65%26doi%3D10.4103%2Fphrev.phrev_47_17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batsaikhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Application of electric cell-substrate impedance sensing to investigate the cytotoxic effects of andrographolide on U87 MG glioblastoma cell migration and apoptosis</span>. <i>Sensors</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2275</span>, <span class="refDoi"> DOI: 10.3390/s19102275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fs19102275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFOntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2019&pages=2275&author=S.-P.+Chiuauthor=B.+Batsaikhanauthor=H.-M.+Huangauthor=J.-Y.+Wang&title=Application+of+electric+cell-substrate+impedance+sensing+to+investigate+the+cytotoxic+effects+of+andrographolide+on+U87+MG+glioblastoma+cell+migration+and+apoptosis&doi=10.3390%2Fs19102275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Application of electric cell-substrate impedance sensing to investigate the cytotoxic effects of andrographolide on U-87 MG glioblastoma cell migration and apoptosis</span></div><div class="casAuthors">Chiu, Sheng-Po; Batsaikhan, Buyandelger; Huang, Huei-Mei; Wang, Jia-Yi</div><div class="citationInfo"><span class="NLM_cas:title">Sensors</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2275</span>CODEN:
                <span class="NLM_cas:coden">SENSC9</span>;
        ISSN:<span class="NLM_cas:issn">1424-8220</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults.  In recent studies, the efficacy of suberoylanilide hydroxamic acid (SAHA) has been investigated for GBM.  We explored the effects of two exploratory compds., the histone deacetylase SAHA and the natural product andrographolide, on Uppsala 87 Malignant Glioma (U-87 MG) cell migration and viability in comparison with the clin. used therapeutic agent temozolomide (TMZ).  We used the elec. cell-substrate impedance sensing (ECIS) system to monitor the migration of U-87 MG cells after treatment with various concns. of these compds.  Moreover, we used the Alamar blue assay and western blotting to observe the concn.-dependent changes in the viability and apoptosis of U-87 MG cells.  Our results demonstrated that both SAHA and andrographolide (10-300 μM) significantly inhibited GBM cell migration in a concn.-dependent manner, and 10 μM SAHA and 56 μM andrographolide demonstrated remarkable inhibitory effects on U-87 MG migration.  Western blotting indicated that compared with TMZ, both SAHA and andrographolide induced higher expression levels of apoptosis-related proteins, such as caspase-3, BAX, and PARP in U-87 MG cells.  Furthermore, all three drugs downregulated the expression of the antiapoptotic protein Bcl-2.  In conclusion, SAHA and andrographolide showed exceptional results in inhibiting cell migration and motility.  The ECIS wound healing assay is a powerful technique to identify and screen potential therapeutic agents that can inhibit cancer cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQPToNFXGohLVg90H21EOLACvtfcHk0ljDHBaOvt8mQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOntL0%253D&md5=8e9e64199c73079d0595c4c45add8b8c</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.3390%2Fs19102275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fs19102275%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DS.-P.%26aulast%3DBatsaikhan%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DH.-M.%26aulast%3DWang%26aufirst%3DJ.-Y.%26atitle%3DApplication%2520of%2520electric%2520cell-substrate%2520impedance%2520sensing%2520to%2520investigate%2520the%2520cytotoxic%2520effects%2520of%2520andrographolide%2520on%2520U87%2520MG%2520glioblastoma%2520cell%2520migration%2520and%2520apoptosis%26jtitle%3DSensors%26date%3D2019%26volume%3D19%26spage%3D2275%26doi%3D10.3390%2Fs19102275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhukhan, G. C.</span></span> <span> </span><span class="NLM_article-title">Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells</span>. <i>Environ. Toxicol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.etap.2019.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.etap.2019.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30889542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltVWisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2019&pages=120-132&author=K.+D.+Chowdhuryauthor=A.+Sarkarauthor=S.+Chatterjeeauthor=D.+Patraauthor=D.+Senguptaauthor=S.+Banerjeeauthor=P.+Chakrabortyauthor=G.+C.+Sadhukhan&title=Cathepsin+B+mediated+scramblase+activation+triggers+cytotoxicity+and+cell+cycle+arrest+by+andrographolide+to+overcome+cellular+resistance+in+cisplatin+resistant+human+hepatocellular+carcinoma+HepG2+cells&doi=10.1016%2Fj.etap.2019.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells</span></div><div class="casAuthors">Chowdhury, Kaustav Dutta; Sarkar, Avik; Chatterjee, Sujan; Patra, Debajyoti; Sengupta, Dipanwita; Banerjee, Soumi; Chakraborty, Pratip; Sadhukhan, Gobinda Chandra</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology and Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-132</span>CODEN:
                <span class="NLM_cas:coden">ETOPFR</span>;
        ISSN:<span class="NLM_cas:issn">1382-6689</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide regimen in single or in combination with anticancer drugs is a promising new strategy to reverse chemoresistance in heaptocellular carcinoma.  Apoptosis inducing factor (AIF) may regulate a complementary, cooperative or redundant pathway, along with caspase cascades.  Despite these findings, mechanisms underlying caspase-dependent and-independent signaling pathways in andrographolide -induced apoptosis in cisplatin-resistant human hepatocellular carcinoma cell line (HepG2CR) remain unclear.  Andrographolide treatment effectively reduced NF-κB nuclear localization by modulating protein kinase A- protein phosphatase 2 A- Iκβ kinase (PKA/PP2 A/IKK) axis that in turn maintains initiator caspase8 activity.  Lysosomal distribution of tBid stimulates cytosolic cathepsin B resulting accumulation of truncated-AIF with induction in scramblase mediated phosphatidylserine exposure in HepG2CR cells.  Andrographolide treatment thereby switch on subG1 phase arrest by modulating cellular check points (cyclin A, B, cyclin dependent kinase-1) cueing to the apoptosis event.  Collectively, this study suggested antineoplastic potential of andrographolide through PKA/PP2 A/IKK pathway in HepG2CR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolOZFEA90qJbVg90H21EOLACvtfcHk0ljDHBaOvt8mQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltVWisrk%253D&md5=61bd3e62c6b709683a253f873eb1fc2f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.etap.2019.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.etap.2019.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DK.%2BD.%26aulast%3DSarkar%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DPatra%26aufirst%3DD.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DChakraborty%26aufirst%3DP.%26aulast%3DSadhukhan%26aufirst%3DG.%2BC.%26atitle%3DCathepsin%2520B%2520mediated%2520scramblase%2520activation%2520triggers%2520cytotoxicity%2520and%2520cell%2520cycle%2520arrest%2520by%2520andrographolide%2520to%2520overcome%2520cellular%2520resistance%2520in%2520cisplatin%2520resistant%2520human%2520hepatocellular%2520carcinoma%2520HepG2%2520cells%26jtitle%3DEnviron.%2520Toxicol.%2520Pharmacol.%26date%3D2019%26volume%3D68%26spage%3D120%26epage%3D132%26doi%3D10.1016%2Fj.etap.2019.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span> <span> </span><span class="NLM_article-title">Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">106206</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2020.106206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.intimp.2020.106206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32018066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFCrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2020&pages=106206&author=W.+Liuauthor=T.+Fanauthor=M.+Liauthor=G.+Zhangauthor=W.+Guoauthor=X.+Yangauthor=C.+Jiangauthor=X.+Liauthor=X.+Xuauthor=A.+Tangauthor=K.+Liuauthor=L.+Liuauthor=L.+Kongauthor=Q.+Xuauthor=Y.+Sun&title=Andrographolide+potentiates+PD-1+blockade+immunotherapy+by+inhibiting+COX2-mediated+PGE2+release&doi=10.1016%2Fj.intimp.2020.106206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release</span></div><div class="casAuthors">Liu, Wen; Fan, Ting; Li, Manru; Zhang, Guohui; Guo, Wenjie; Yang, Xiaoling; Jiang, Chunhong; Li, Xiang; Xu, Xiangyu; Tang, Anshu; Liu, Keqin; Liu, Lixuan; Kong, Lingdong; Xu, Qiang; Sun, Yang</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">106206</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer immunotherapy has now become a first line therapy for several kinds of tumors.  However, the clin. performance of immnuocheckpoint blockade therapy is usually limited by low response rate or side effects including cytokine storm.  Andrographolide, a natural diterpenoid from Andrographis paniculata, has been used in Asia for treatment of bronchitis, paristhmitis and bacillary dysentery for its unique anti-inflammatory effect.  However, its effect on anti-tumor immunity remains elusive.  In this study, we found that andrographolide in combination with anti-PD-1 antibody showed a higher therapeutic benefit than individual therapy in murine xenograft model of CT26 colon cancer.  Consequently, andrographolide and anti-PD-1 antibody co-treatment boosted the function of CD4+ and CD8+ T cells evidenced by considerable tissue infiltration, elevated IFN-gamma secretion and enhanced expression of cytotoxic T-cell related mols. including FasL, perforin and Granzyme B, which significantly decreases the tumor load.  Mechanistically, andrographolide treatment inhibited COX2 activity and PGE2 release both in vivo and in vitro, which augments anti-tumor efficiency of anti-PD-1 therapy.  Finally, we confirmed that COX2 level in human colon cancer sample pos. correlated with tumor-promoting factors.  Our study here provides a potential combination strategy for immunotherapy against colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCRK0tchVyHLVg90H21EOLACvtfcHk0lhGUSIs7bnGlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFCrtbY%253D&md5=bbdc8187cf8d7ea63573ad6714a2be1e</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2020.106206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2020.106206%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DY.%26atitle%3DAndrographolide%2520potentiates%2520PD-1%2520blockade%2520immunotherapy%2520by%2520inhibiting%2520COX2-mediated%2520PGE2%2520release%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2020%26volume%3D81%26spage%3D106206%26doi%3D10.1016%2Fj.intimp.2020.106206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q.</span></span> <span> </span><span class="NLM_article-title">Andrographolide attenuates bupivacaine-induced cytotoxicity in SH-SY5Y cells through preserving Akt/mTOR activity</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1659</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S201122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2147%2FDDDT.S201122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31190744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVyrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=1659-1666&author=H.+Zhangauthor=W.+Wangauthor=Q.+Du&title=Andrographolide+attenuates+bupivacaine-induced+cytotoxicity+in+SH-SY5Y+cells+through+preserving+Akt%2FmTOR+activity&doi=10.2147%2FDDDT.S201122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide attenuates bupivacaine-induced cytotoxicity in SH-SY5Y cells through preserving Akt/mTOR activity</span></div><div class="casAuthors">Zhang, Huiyuan; Wang, Weiwei; Du, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1659-1666</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Bupivacaine (Bup) is the most commonly used local anesthetic.  However, Bup induces cytotoxicity, esp. in older patients.  Recent reports have indicated that andrographolide (Andro) exhibits protective effects on human neurons.  Nevertheless, whether Andro can inhibit Bup-induced cytotoxicity remains unclear.  As such, we investigated the effect of Andro on Bup-induced cytotoxicity of SH-SY5Y cells in the present study.  Methods: Western blotting was used to examine expression of Bax, Bcl2, active caspase 3, p-Akt, and p-mTOR in SH-SY5Y cells.  In addn., ELISA was used to detect levels of total glutathione and reactive oxygen species in cells.  Results: We found that Andro attenuated Bup-induced cytotoxicity of SH-SY5Y cells.  In addn., Andro inhibited Bup-induced apoptosis via downregulating the expression of Bax and active caspase 3 and upregulating the proteins Bcl2, p-Akt, and p-mTOR in SH-SY5Y cells.  Moreover, Andro alleviated Bup-induced oxidative damage in SH-SY5Y cells via downregulating the level of reactive oxygen species and upregulating of the level of total glutathione.  More significantly, inhibition of Akt abolished the protective effect of Andro in Bup-treated SH-SY5Y cells.  Conclusion: Our findings indicated that Andro played a neuroprotective role via preserving Akt/mTOR activity and increasing antioxidative status in Bup-treated SH-SY5Y cells.  Therefore, Andro may be a potential agent for the treatment of human cytotoxicity induced by Bup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB6oiypAHl97Vg90H21EOLACvtfcHk0lhGUSIs7bnGlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVyrs7w%253D&md5=89f574314ee958d1d630e60f8ca8c930</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S201122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S201122%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DQ.%26atitle%3DAndrographolide%2520attenuates%2520bupivacaine-induced%2520cytotoxicity%2520in%2520SH-SY5Y%2520cells%2520through%2520preserving%2520Akt%252FmTOR%2520activity%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2019%26volume%3D13%26spage%3D1659%26epage%3D1666%26doi%3D10.2147%2FDDDT.S201122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laksmiani, N. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynaldi, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widiastari, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugraha, I. P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suyadnya, I. M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharani, R. A. I. K.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic activity of andrographolide in colon cancer through inhibition COX-2 by in silico study</span>. <i>J. Phys.: Conf. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1040</i></span>,  <span class="NLM_fpage">012009</span>, <span class="refDoi"> DOI: 10.1088/1742-6596/1040/1/012009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1088%2F1742-6596%2F1040%2F1%2F012009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1GrurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1040&publication_year=2018&pages=012009&author=N.+P.+L.+Laksmianiauthor=K.+R.+Reynaldiauthor=M.+I.+Widiastariauthor=I.+P.+W.+Nugrahaauthor=I.+M.+K.+Suyadnyaauthor=R.+A.+I.+K.+Maharani&title=Cytotoxic+activity+of+andrographolide+in+colon+cancer+through+inhibition+COX-2+by+in+silico+study&doi=10.1088%2F1742-6596%2F1040%2F1%2F012009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic activity of andrographolide in colon cancer through inhibition cox-2 by in silico study</span></div><div class="casAuthors">Laksmiani, N. P. L.; Reynaldi, K. R.; Widiastari, M. I.; Nugraha, I. P. W.; Suyadnya, I. M. K.; Maharani, R. A. I. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physics: Conference Series</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1040</span>
        (<span class="NLM_cas:issue">International Conference on Mathematics and Natural Sciences (IConMNS 2017)</span>),
    <span class="NLM_cas:pages">012009/1-012009/6</span>CODEN:
                <span class="NLM_cas:coden">JPCSDZ</span>;
        ISSN:<span class="NLM_cas:issn">1742-6588</span>.
    
            (<span class="NLM_cas:orgname">IOP Publishing Ltd.</span>)
        </div><div class="casAbstract">Colon cancer is a cancer with characteristics of cyclooxygenase (COX-2) protein overexpression.  Increased COX-2 expression may inhibit regulation of apoptotic mechanism.  Andrographolide was known has activity as an anticancer.  The aimed of this study was detd. the mechanism and affinity of andrographolide with COX-2 protein as anti-colon cancer using mol. docking.  In silico assay used mol. docking method with Chimera 1.10.1 (use for protein prepn. COX-2), Hyperchem 8 (use for optimization 3D structure of andrographolide), and Autodock 4.2 programs (use for mol. docking).The results in mol. docking was a binding energy value of and hydrogen bonds.  Data were compared with native ligand, celecoxib, and meloxicam.  The binding energy values between COX-2 protein with andrographolide, native ligand, celecoxib, and meloxicam were resp. - 8.66; -9.94; -10.12; and -7.68 kcal/mol.  This indicate that andrographolide had a stronger affinity and more stable than meloxicam for COX-2 protein with hydrogen bonds on Arg120 amino acid.  Based on the results obtained, andrographolide had an anti-colon cancer activity caused it can bind to the protein COX-2.  The mechanism of andrographolide as anti-colon cancer by inhibited the overexpression of COX-2 in order to increase apoptotic regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMY069hErUoLVg90H21EOLACvtfcHk0lhGUSIs7bnGlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1GrurjO&md5=7048a46de349707b64cb0223d7ea11a9</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1088%2F1742-6596%2F1040%2F1%2F012009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F1742-6596%252F1040%252F1%252F012009%26sid%3Dliteratum%253Aachs%26aulast%3DLaksmiani%26aufirst%3DN.%2BP.%2BL.%26aulast%3DReynaldi%26aufirst%3DK.%2BR.%26aulast%3DWidiastari%26aufirst%3DM.%2BI.%26aulast%3DNugraha%26aufirst%3DI.%2BP.%2BW.%26aulast%3DSuyadnya%26aufirst%3DI.%2BM.%2BK.%26aulast%3DMaharani%26aufirst%3DR.%2BA.%2BI.%2BK.%26atitle%3DCytotoxic%2520activity%2520of%2520andrographolide%2520in%2520colon%2520cancer%2520through%2520inhibition%2520COX-2%2520by%2520in%2520silico%2520study%26jtitle%3DJ.%2520Phys.%253A%2520Conf.%2520Ser.%26date%3D2018%26volume%3D1040%26spage%3D012009%26doi%3D10.1088%2F1742-6596%2F1040%2F1%2F012009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, D.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.-H.</span></span> <span> </span><span class="NLM_article-title">Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4305</span>– <span class="NLM_lpage">4310</span>, <span class="refDoi"> DOI: 10.3892/ol.2017.6669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2017.6669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28943944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252FhvFSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=4305-4310&author=R.+Zhangauthor=J.+Zhaoauthor=J.+Xuauthor=D.-X.+Jiaoauthor=J.+Wangauthor=Z.-Q.+Gongauthor=J.-H.+Jia&title=Andrographolide+suppresses+proliferation+of+human+colon+cancer+SW620+cells+through+the+TLR4%2FNF-%CE%BAB%2FMMP-9+signaling+pathway&doi=10.3892%2Fol.2017.6669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9 signaling pathway</span></div><div class="casAuthors">Zhang Rui; Zhao Jian; Xu Jian; Jiao De-Xin; Wang Jian; Gong Zhi-Qiang; Jia Jian-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">4305-4310</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Modern pharmacological research has revealed that andrographolide has various functions, including anti-bacterial, anti-inflammatory and anti-viral effects, immunoregulation, treating cardiovascular and cerebrovascular diseases, and prevention and treatment of alcoholic liver injury.  The present study investigated whether andrographolide suppresses the proliferation of human colon cancer cell through the Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB/matrix metalloproteinase-9 (MMP-9) signaling pathway.  The MTT assay and lactate dehydrogenase assay were used to evaluate the anticancer effects of andrographolide on cell proliferation and cytotoxicity in human colon cancer SW620 cells.  Flow cytometry was used to analyze the anticancer effects of andrographolide on apoptosis by Annexin V-fluorescein isothiocyanate/propidium iodide kit.  The effects of andrographolide on the activity of caspase-3/9 were measured using ELISA.  Western blot analysis was also used to analyze the protein expression of TLR4, myeloid differentiation primary response gene 88 (MyD88), NF-κB-p65 and MMP-9.  In the present study, it was found that andrographolide suppressed the cell proliferation, augmented cytotoxicity, evoked cell apoptosis and activated caspase-3/9 activities in human colon cancer SW620 cells.  The results revealed that the anti-proliferation effects of andrographolide on the SW620 cells was associated with the inhibition of TLR4, MyD88, NF-κB-p65 and MMP-9 signaling activation.  The results suggest that andrographolide is a promising drug for treatment of human colon cancer via suppression of the TLR4/NF-κB/MMP-9 signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR02yiRS-GsP-2mnZh2OgS0fW6udTcc2eZahrpjaBFmO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252FhvFSkug%253D%253D&md5=b221e65f55391e9e3cbae594553c7531</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.6669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.6669%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJiao%26aufirst%3DD.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DZ.-Q.%26aulast%3DJia%26aufirst%3DJ.-H.%26atitle%3DAndrographolide%2520suppresses%2520proliferation%2520of%2520human%2520colon%2520cancer%2520SW620%2520cells%2520through%2520the%2520TLR4%252FNF-%25CE%25BAB%252FMMP-9%2520signaling%2520pathway%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D14%26spage%3D4305%26epage%3D4310%26doi%3D10.3892%2Fol.2017.6669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farooqui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansari, I. A.</span></span> <span> </span><span class="NLM_article-title">Andrographolide exhibits anticancer potential against human colon cancer cells by inducing cell cycle arrest and programmed cell death via augmentation of intracellular reactive oxygen species level</span>. <i>Nutr. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1080/01635581.2018.1470649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F01635581.2018.1470649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29781715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVSmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=787-803&author=I.+Khanauthor=F.+Khanauthor=A.+Farooquiauthor=I.+A.+Ansari&title=Andrographolide+exhibits+anticancer+potential+against+human+colon+cancer+cells+by+inducing+cell+cycle+arrest+and+programmed+cell+death+via+augmentation+of+intracellular+reactive+oxygen+species+level&doi=10.1080%2F01635581.2018.1470649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide Exhibits Anticancer Potential Against Human Colon Cancer Cells by Inducing Cell Cycle Arrest and Programmed Cell Death via Augmentation of Intracellular Reactive Oxygen Species Level</span></div><div class="casAuthors">Khan, Imran; Khan, Fahad; Farooqui, Arshi; Ansari, Irfan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrition and Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">787-803</span>CODEN:
                <span class="NLM_cas:coden">NUCADQ</span>;
        ISSN:<span class="NLM_cas:issn">0163-5581</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Andrographolide, a diterpenoid lactone and a major constituent of Andrographis paniculata Nees, exhibits remarkable anticancer activity.  However, the effect of andrographolide on colon cancer has not been completely elucidated yet.  Thus, we investigated the chemopreventive potential of andrographolide in colon cancer HT-29 cells.  The cytotoxic potential of andrographolide on HT-29 cells was detd. by MTT assay, trypan blue exclusion assay, colony formation assay, and morphol. anal.; and apoptotic property by DAPI and Hoechst staining, FITC-Annexin V assay, DNA fragmentation assay and caspase-3 activity assay.  To elucidate andrographolide action, intracellular reactive oxygen species (ROS) level was detd. by DCFDA dye; change in mitochondrial potential by Rhodamine123 and Mito Tracker Red CMXRos dye; and cell cycle modulatory property by flow cytometric anal.  Results of the study have shown that andrographolide decreased cell viability of HT-29 cells in a dose- and time-dependent manner.  Furthermore, andrographolide induced apoptosis in HT-29 cells which seemed to be linked with augmented intracellular ROS level and disruption of mitochondrial membrane potential.  Interestingly, andrographolide caused significant cell cycle arrest in G2/M phase at lower doses, but, in G0/G1 phase at higher doses.  In summary, our results indicated that andrographolide exhibited antiproliferative and apoptotic properties against colon cancer HT-29 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouVBjv135YGLVg90H21EOLACvtfcHk0ljYZxk6g2dt_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVSmsLY%253D&md5=9b5649b33b9938315e97cccff237e064</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1080%2F01635581.2018.1470649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01635581.2018.1470649%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DI.%26aulast%3DKhan%26aufirst%3DF.%26aulast%3DFarooqui%26aufirst%3DA.%26aulast%3DAnsari%26aufirst%3DI.%2BA.%26atitle%3DAndrographolide%2520exhibits%2520anticancer%2520potential%2520against%2520human%2520colon%2520cancer%2520cells%2520by%2520inducing%2520cell%2520cycle%2520arrest%2520and%2520programmed%2520cell%2520death%2520via%2520augmentation%2520of%2520intracellular%2520reactive%2520oxygen%2520species%2520level%26jtitle%3DNutr.%2520Cancer%26date%3D2018%26volume%3D70%26spage%3D787%26epage%3D803%26doi%3D10.1080%2F01635581.2018.1470649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, E.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span> <span> </span><span class="NLM_article-title">Anti-tumor activities of andrographolide, a diterpene from <i>Andrographis paniculata</i>, by inducing apoptosis and inhibiting VEGF level</span>. <i>J. Asian Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1080/10286020801948334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F10286020801948334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=18464090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BD1czgtFelsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=467-473&author=F.+Zhaoauthor=E.-Q.+Heauthor=L.+Wangauthor=K.+Liu&title=Anti-tumor+activities+of+andrographolide%2C+a+diterpene+from+Andrographis+paniculata%2C+by+inducing+apoptosis+and+inhibiting+VEGF+level&doi=10.1080%2F10286020801948334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level</span></div><div class="casAuthors">Zhao Feng; He En-Qi; Wang Lu; Liu Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asian natural products research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">467-73</span>
        ISSN:<span class="NLM_cas:issn">1028-6020</span>.
    </div><div class="casAbstract">Andrographolide (1), a diterpenoid lactone isolated from a traditional herb (Andrographis paniculata), is known to possess potent anti-inflammatory activity.  In this study, we investigated the anti-tumor effect of 1 on various cancer cell lines in vitro.  It induced apoptosis of prostate cancer (PC-3) cells (the most sensitive cell line among the cell lines screened) via the activation of caspase 3, up-regulation of bax, and down-regulation of bcl-2.  Furthermore, its inhibitory activity on the level of vascular endothelial growth factor was also verified by ELISA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCx7OqSDDPrK__Jf7-eMvJfW6udTcc2eY8PMcecfPfFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czgtFelsA%253D%253D&md5=4ff43270d0c74e851d01abc8726fe76d</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1080%2F10286020801948334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10286020801948334%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DE.-Q.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DK.%26atitle%3DAnti-tumor%2520activities%2520of%2520andrographolide%252C%2520a%2520diterpene%2520from%2520Andrographis%2520paniculata%252C%2520by%2520inducing%2520apoptosis%2520and%2520inhibiting%2520VEGF%2520level%26jtitle%3DJ.%2520Asian%2520Nat.%2520Prod.%2520Res.%26date%3D2008%26volume%3D10%26spage%3D467%26epage%3D473%26doi%3D10.1080%2F10286020801948334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Liposomal codelivery of doxorubicin and andrographolide inhibits breast cancer growth and metastasis</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1618</span>– <span class="NLM_lpage">1626</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.7b01164</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.7b01164" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Gisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=1618-1626&author=X.+Kangauthor=Z.+Zhengauthor=Z.+Liuauthor=H.+Wangauthor=Y.+Zhaoauthor=W.+Zhangauthor=M.+Shiauthor=Y.+Heauthor=Y.+Caoauthor=Q.+Xuauthor=C.+Pengauthor=Y.+Huang&title=Liposomal+codelivery+of+doxorubicin+and+andrographolide+inhibits+breast+cancer+growth+and+metastasis&doi=10.1021%2Facs.molpharmaceut.7b01164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Liposomal codelivery of doxorubicin and andrographolide inhibits breast cancer growth and metastasis</span></div><div class="casAuthors">Kang, Xuejia; Zheng, Zening; Liu, Zehua; Wang, Huiyuan; Zhao, Yuge; Zhang, Wenyuan; Shi, Mingjie; He, Yang; Cao, Yang; Xu, Qin; Peng, Chengyuan; Huang, Yongzhuo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1618-1626</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Effective treatment of metastatic (stage IV) breast cancers remains a formidable challenge.  To address this issue, a cell-penetrating peptide-assisted liposomal system was developed for codelivery of doxorubicin and andrographolide.  This nanomedicine-based combination therapy showed the ability to inhibit the in vitro migration and invasion of 4T1 cells through the wound healing and transwell invasion assays.  Furthermore, this delivery system exhibited the enhanced accumulation in the tumor tissues and deep intratumoral penetration.  The synergistic effect of doxorubicin and andrographolide led to an evident inhibition of tumor growth in an orthotopic breast tumor mouse model and efficient prevention of lung metastasis.  The therapeutic mechanism was assocd. with the anti-angiogenesis effect.  In conclusion, this nanomedicine-based combination therapy provides a potential method for overcoming metastatic breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorz_Ha-XfrzrVg90H21EOLACvtfcHk0lgx42gItXYudw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Gisr4%253D&md5=d02eb075785a357a29a7ac2719117eb1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.7b01164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.7b01164%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DLiposomal%2520codelivery%2520of%2520doxorubicin%2520and%2520andrographolide%2520inhibits%2520breast%2520cancer%2520growth%2520and%2520metastasis%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2018%26volume%3D15%26spage%3D1618%26epage%3D1626%26doi%3D10.1021%2Facs.molpharmaceut.7b01164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graverini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazzini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landucci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nardiello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casamenti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini-Giampietro, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilia, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergonzi, M. C.</span></span> <span> </span><span class="NLM_article-title">Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: In vitro and in vivo evaluation</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/j.colsurfb.2017.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.colsurfb.2017.10.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29096375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleksrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2018&pages=302-313&author=G.+Graveriniauthor=V.+Piazziniauthor=E.+Landucciauthor=D.+Pantanoauthor=P.+Nardielloauthor=F.+Casamentiauthor=D.+E.+Pellegrini-Giampietroauthor=A.+R.+Biliaauthor=M.+C.+Bergonzi&title=Solid+lipid+nanoparticles+for+delivery+of+andrographolide+across+the+blood-brain+barrier%3A+In+vitro+and+in+vivo+evaluation&doi=10.1016%2Fj.colsurfb.2017.10.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation</span></div><div class="casAuthors">Graverini, Giulia; Piazzini, Vieri; Landucci, Elisa; Pantano, Daniela; Nardiello, Pamela; Casamenti, Fiorella; Pellegrini-Giampietro, Domenico E.; Bilia, Anna Rita; Bergonzi, Maria Camilla</div><div class="citationInfo"><span class="NLM_cas:title">Colloids and Surfaces, B: Biointerfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">302-313</span>CODEN:
                <span class="NLM_cas:coden">CSBBEQ</span>;
        ISSN:<span class="NLM_cas:issn">0927-7765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide is a major diterpenoid of Andrographis paniculata and possesses several biol. activities, including protection against oxidative stress mediated neurotoxicity, inflammation-mediated neurodegeneration, and cerebral ischemia.  However, this mol. shows low bioavailability, poor water soly., and high chem. and metabolic instability.  The present study reports prepn. of solid lipid nanoparticles (SLN) to deliver andrographolide (AG) into the brain.  SLN were prepd. using Compritol 888 ATO as solid lipid and Brij 78 as surfactant and applying emulsion/evapn./solidifying method as preparative procedure.  Nanoparticles have a spherical shape, small dimensions, and narrow size distribution.  Encapsulation efficiency of AG-loaded SLN was found to be 92%.  Nanoparticles showed excellent phys. and chem. stability during storage at 4 °C for one month.  The lyophilized product was also stable at 25 °C during the same period.  SLN remained unchanged also in the presence of human serum albumin and plasma.  In vitro release at pH 7.4 was also studied.  The release of AG was prolonged and sustained when the compd. was entrapped in SLN.  The ability of SLN to cross the blood-brain barrier (BBB) was evaluated first in vitro by applying a permeation test with artificial membrane (parallel artificial membrane permeability assay, PAMPA) to predict passive and transcellular permeability through the BBB, and then by using hCMEC/D3 cells, a well-established in vitro BBB model.  In vitro results proved that nanoparticles improved permeability of AG compared to free AG.  Fluorescent nanoparticles were then prepd. for in vivo tests in healthy rats.  After i.v. administration, fluorescent SLN were detected in brain parenchyma outside the vascular bed, confirming their ability to overcome the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_pi9tWQpaRbVg90H21EOLACvtfcHk0liTyxq3j4tIlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleksrbO&md5=6bb1fbb9e409b21b63bacba0bf0c4651</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2017.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2017.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DGraverini%26aufirst%3DG.%26aulast%3DPiazzini%26aufirst%3DV.%26aulast%3DLanducci%26aufirst%3DE.%26aulast%3DPantano%26aufirst%3DD.%26aulast%3DNardiello%26aufirst%3DP.%26aulast%3DCasamenti%26aufirst%3DF.%26aulast%3DPellegrini-Giampietro%26aufirst%3DD.%2BE.%26aulast%3DBilia%26aufirst%3DA.%2BR.%26aulast%3DBergonzi%26aufirst%3DM.%2BC.%26atitle%3DSolid%2520lipid%2520nanoparticles%2520for%2520delivery%2520of%2520andrographolide%2520across%2520the%2520blood-brain%2520barrier%253A%2520In%2520vitro%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2018%26volume%3D161%26spage%3D302%26epage%3D313%26doi%3D10.1016%2Fj.colsurfb.2017.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span> <span> </span><span class="NLM_article-title">Andrographolide-loaded silk fibroin nanoparticles</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">34726</span>– <span class="NLM_lpage">34732</span>, <span class="refDoi"> DOI: 10.1039/C8RA04156C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC8RA04156C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=34726-34732&author=Z.+Xuauthor=J.+Renauthor=Q.+Jingauthor=F.+Renauthor=M.+Huangauthor=W.+Dingauthor=B.+Zeng&title=Andrographolide-loaded+silk+fibroin+nanoparticles&doi=10.1039%2FC8RA04156C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC8RA04156C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8RA04156C%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DJing%26aufirst%3DQ.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DZeng%26aufirst%3DB.%26atitle%3DAndrographolide-loaded%2520silk%2520fibroin%2520nanoparticles%26jtitle%3DRSC%2520Adv.%26date%3D2018%26volume%3D8%26spage%3D34726%26epage%3D34732%26doi%3D10.1039%2FC8RA04156C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nallamolu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayanti, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitneni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoon, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesharwani, P.</span></span> <span> </span><span class="NLM_article-title">Self-micro emulsifying drug delivery system “SMEDDS” for efficient oral delivery of andrographolide</span>. <i>Drug Delivery Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.2174/2210303109666190723145209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F2210303109666190723145209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs12ru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=38-53&author=S.+Nallamoluauthor=V.+R.+Jayantiauthor=M.+Chitneniauthor=L.+Y.+Khoonauthor=P.+Kesharwani&title=Self-micro+emulsifying+drug+delivery+system+%E2%80%9CSMEDDS%E2%80%9D+for+efficient+oral+delivery+of+andrographolide&doi=10.2174%2F2210303109666190723145209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Self-micro Emulsifying Drug Delivery System "SMEDDS" for Efficient Oral Delivery of Andrographolide</span></div><div class="casAuthors">Nallamolu, Sivaram; Jayanti, Vijaya R.; Chitneni, Mallikarjun; Khoon, Liew Y.; Kesharwani, Prashant</div><div class="citationInfo"><span class="NLM_cas:title">Drug Delivery Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-53</span>CODEN:
                <span class="NLM_cas:coden">DDLRAQ</span>;
        ISSN:<span class="NLM_cas:issn">2210-3031</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Objective: Andrographolide has potent anticancer and antimicrobial activity; however, its clin. application has been limited due to its poor water soly. as well as lack of appropriate formulation.  The objective of this investigation was to formulate Self-Micro Emulsifying Drug Delivery System (SMEDDS) of andrographolide and explore its oral drug delivery aptitudes.  Methods: Andrographolide SMEDDS was optimized by ternary phase approach and studied for various in vitro characteristics: Particle size, electron microscopy, polydispersity index, surface charge, diln. effect, pH stability, freeze-thaw effect, dissoln. profile and stability studies.  Further, antimicrobial and cytotoxic performance of andrographolide SMEDDS were evaluated in MCF-7 breast cancer cell lines and methicillin-resistant microorganisms, resp.  Results: An optimized SMEDDS formulation of andrographolide was successfully prepd. and evaluated for its drug delivery potential.  The soly. of andrographolide in the developed SMEDDS formulation was increased significantly, and the drug loading was enough for making this drug clin. applicable.  The andrographolide SMEDDS formulation competitively inhibited the growth of microorganisms and showed enhanced anti-microbial activity against MRSA microorganisms.  Conclusions: The SMEDDS strategy represents one of the best approaches to deliver andrographolide via oral route, while resolving its soly. limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnba7c5nnp-bVg90H21EOLACvtfcHk0lgvnoq_Wp_Wfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs12ru74%253D&md5=1abb6639d775cc60e2010a53f0f424cc</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.2174%2F2210303109666190723145209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2210303109666190723145209%26sid%3Dliteratum%253Aachs%26aulast%3DNallamolu%26aufirst%3DS.%26aulast%3DJayanti%26aufirst%3DV.%2BR.%26aulast%3DChitneni%26aufirst%3DM.%26aulast%3DKhoon%26aufirst%3DL.%2BY.%26aulast%3DKesharwani%26aufirst%3DP.%26atitle%3DSelf-micro%2520emulsifying%2520drug%2520delivery%2520system%2520%25E2%2580%259CSMEDDS%25E2%2580%259D%2520for%2520efficient%2520oral%2520delivery%2520of%2520andrographolide%26jtitle%3DDrug%2520Delivery%2520Lett.%26date%3D2020%26volume%3D10%26spage%3D38%26epage%3D53%26doi%3D10.2174%2F2210303109666190723145209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandanur, S. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golakoti, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anticancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5781</span>– <span class="NLM_lpage">5786</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2015.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26561364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5781-5786&author=S.+G.+S.+Kandanurauthor=N.+R.+Golakotiauthor=S.+Nanduri&title=Synthesis+and+in+vitro+cytotoxicity+of+novel+C-12+substituted-14-deoxy-andrographolide+derivatives+as+potent+anticancer+agents&doi=10.1016%2Fj.bmcl.2015.10.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anti-cancer agents</span></div><div class="casAuthors">Kandanur, Sai Giridhar Sarma; Golakoti, Nageswara Rao; Nanduri, Srinivas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5781-5786</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide, the major labdane diterpenoid from Andrographis paniculata has been reported to be cytotoxic against various cancer cells in vitro.  Our research efforts led to the discovery of novel 12-phenylthio and 12-aryl amino-14-deoxyandrographolide derivs. with potent cytotoxic activity, 12-benzylamino-14-deoxyandrographolide analogs showing broad range of cytotoxic activity against most of the cell lines and 12-alkylamino-14-deoxyandrographolide derivs. being selective to few cell lines (PC-3 and HOP-92), when the selected analogs were evaluated against 60 human cancer cell line panel at National Cancer Institute (N.C.I.), USA.  The SAR (structure activity relationship) studies demonstrated potent activity for the compds. contg. the following functionalities at C-12: substituted aryl amino/phenylthio > benzylamine > alkyl amine.  The significant cytotoxic activity obsd. for the phenylthio and acetylsulfamoylphenylamino compds. suggest that these could serve as templates for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLTZAEDh1R-7Vg90H21EOLACvtfcHk0lgvnoq_Wp_Wfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2gsLrO&md5=15732c729efd55cbf3d1249be0156e93</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DKandanur%26aufirst%3DS.%2BG.%2BS.%26aulast%3DGolakoti%26aufirst%3DN.%2BR.%26aulast%3DNanduri%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520cytotoxicity%2520of%2520novel%2520C-12%2520substituted-14-deoxy-andrographolide%2520derivatives%2520as%2520potent%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5781%26epage%3D5786%26doi%3D10.1016%2Fj.bmcl.2015.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandanur, S. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golakoti, N. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new C-12(α/β)-(<i>N</i>-) sulfamoyl-phenylamino-14-deoxy-andrographolide derivatives as potent anticancer agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2854</span>– <span class="NLM_lpage">2862</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2017.04.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28527822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFyjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2854-2862&author=S.+G.+S.+Kandanurauthor=S.+Nanduriauthor=N.+R.+Golakoti&title=Synthesis+and+biological+evaluation+of+new+C-12%28%CE%B1%2F%CE%B2%29-%28N-%29+sulfamoyl-phenylamino-14-deoxy-andrographolide+derivatives+as+potent+anticancer+agents&doi=10.1016%2Fj.bmcl.2017.04.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new C-12(α/β)-(N-) sulfamoyl-phenylamino-14-deoxy-andrographolide derivatives as potent anti-cancer agents</span></div><div class="casAuthors">Kandanur, Sai Giridhar Sarma; Nanduri, Srinivas; Golakoti, Nageswara Rao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2854-2862</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Andrographolide, the major diterpenoidal constituent of Andrographis paniculata (Acanthaceae) and its derivs. have been reported to possess plethora of biol. properties including potent anti-cancer activity.  In this work, synthesis and in-vitro anti-cancer evaluation of new C-12-substituted aryl amino 14-deoxy-andrographolide derivs. are reported.  The substitutions include various sulfonamide moieties -SO2-NH-R1.  The new derivs. exhibited improved cytotoxicity (GI50, TGI and LC50) compared to andrographolide (I) and the corresponding 3,14,19-O-triacetyl andrographolide when evaluated against 60 NCI cell line panel.  Compds. II and III are found to be non-toxic to normal human dermal fibroblasts (NHDF) cells compared to ref. drug THZ-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosAQ7YKkT-pLVg90H21EOLACvtfcHk0lgpvNZcHjnuTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFyjtLk%253D&md5=46b5cb322c22c1a0c5128c9f4e511ecb</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.033%26sid%3Dliteratum%253Aachs%26aulast%3DKandanur%26aufirst%3DS.%2BG.%2BS.%26aulast%3DNanduri%26aufirst%3DS.%26aulast%3DGolakoti%26aufirst%3DN.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520C-12%2528%25CE%25B1%252F%25CE%25B2%2529-%2528N-%2529%2520sulfamoyl-phenylamino-14-deoxy-andrographolide%2520derivatives%2520as%2520potent%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2854%26epage%3D2862%26doi%3D10.1016%2Fj.bmcl.2017.04.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Könst, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarski, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalak, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cencic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voora, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horne, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusupova, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusupov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderwal, C. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1140</span>– <span class="NLM_lpage">1149</span>, <span class="refDoi"> DOI: 10.1038/nchem.2800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fnchem.2800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29064494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1140-1149&author=Z.+A.+K%C3%B6nstauthor=A.+R.+Szklarskiauthor=S.+Pellegrinoauthor=S.+E.+Michalakauthor=M.+Meyerauthor=C.+Zanetteauthor=R.+Cencicauthor=S.+Namauthor=V.+K.+Vooraauthor=D.+A.+Horneauthor=J.+Pelletierauthor=D.+L.+Mobleyauthor=G.+Yusupovaauthor=M.+Yusupovauthor=C.+D.+Vanderwal&title=Synthesis+facilitates+an+understanding+of+the+structural+basis+for+translation+inhibition+by+the+lissoclimides&doi=10.1038%2Fnchem.2800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides</span></div><div class="casAuthors">Konst, Zef A.; Szklarski, Anne R.; Pellegrino, Simone; Michalak, Sharon E.; Meyer, Melanie; Zanette, Camila; Cencic, Regina; Nam, Sangkil; Voora, Vamsee K.; Horne, David A.; Pelletier, Jerry; Mobley, David L.; Yusupova, Gulnara; Yusupov, Marat; Vanderwal, Christopher D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1140-1149</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The lissoclimides are unusual succinimide-contg. labdane diterpenoids that were reported to be potent cytotoxins.  Our short semisynthesis and analog-oriented synthesis approaches provide a series of lissoclimide natural products and analogs that expand the structure-activity relationships (SARs) in this family.  The semisynthesis approach yielded significant quantities of chlorolissoclimide (CL) to permit an evaluation against the National Cancer Institute's 60-cell line panel and allowed us to obtain an X-ray co-crystal structure of the synthetic secondary metabolite with the eukaryotic 80S ribosome.  Although it shares a binding site with other imide-based natural product translation inhibitors, CL engages in a particularly interesting and novel face-on halogen-π interaction between the ligand's alkyl chloride and a guanine residue.  Our analog-oriented synthesis provides many more lissoclimide compds., which were tested against aggressive human cancer cell lines and for protein synthesis inhibitory activity.  Finally, computational modeling was used to explain the SARs of certain key compds. and set the stage for the structure-guided design of better translation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIoB2VqvwCs7Vg90H21EOLACvtfcHk0lgpvNZcHjnuTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsLvI&md5=ed22ec4ac3b662938800cd7e01670c89</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2800%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6nst%26aufirst%3DZ.%2BA.%26aulast%3DSzklarski%26aufirst%3DA.%2BR.%26aulast%3DPellegrino%26aufirst%3DS.%26aulast%3DMichalak%26aufirst%3DS.%2BE.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DZanette%26aufirst%3DC.%26aulast%3DCencic%26aufirst%3DR.%26aulast%3DNam%26aufirst%3DS.%26aulast%3DVoora%26aufirst%3DV.%2BK.%26aulast%3DHorne%26aufirst%3DD.%2BA.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DYusupova%26aufirst%3DG.%26aulast%3DYusupov%26aufirst%3DM.%26aulast%3DVanderwal%26aufirst%3DC.%2BD.%26atitle%3DSynthesis%2520facilitates%2520an%2520understanding%2520of%2520the%2520structural%2520basis%2520for%2520translation%2520inhibition%2520by%2520the%2520lissoclimides%26jtitle%3DNat.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1140%26epage%3D1149%26doi%3D10.1038%2Fnchem.2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.-L.</span></span> <span> </span><span class="NLM_article-title">Development of a bifunctional andrographolide-based chemical probe for pharmacological study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152770</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0152770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1371%2Fjournal.pone.0152770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27035713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFeht7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=Y.-H.+Hsuauthor=Y.-L.+Hsuauthor=S.-H.+Liuauthor=H.-C.+Liaoauthor=P.-X.+Leeauthor=C.-H.+Linauthor=L.-C.+Loauthor=S.-L.+Fu&title=Development+of+a+bifunctional+andrographolide-based+chemical+probe+for+pharmacological+study&doi=10.1371%2Fjournal.pone.0152770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a bifunctional andrographolide-based chemical probe for pharmacological study</span></div><div class="casAuthors">Hsu, Ya-Hsin; Hsu, Yu-Ling; Liu, Sheng-Hung; Liao, Hsin-Chia; Lee, Po-Xuan; Lin, Chao-Hsiung; Lo, Lee-Chiang; Fu, Shu-Ling</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152770/1-e0152770/13</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Andrographolide (ANDRO) is a lactone diterpenoid compd. present in the medicinal plant Andrographis paniculata which is clin. applied for multiple human diseases in Asia and Europe.  The pharmacol. activities of andrographolide have been widely demonstrated, including anti-inflammation, anti-cancer and hepatoprotection.  However, the pharmacol. mechanism of andrographolide remains unclear.  Therefore, further characterization on the kinetics and mol. targets of andrographolide is essential.  In this study, we described the synthesis and characterization of a novel fluorescent andrographolide deriv. (ANDRO-NBD).  ANDRO-NBD exhibited a comparable anti-cancer spectrum to andrographolide: ANDRO-NBD was cytotoxic to various types of cancer cells and suppressed the migration activity of melanoma cells; ANDRO-NBD treatment induced the cleavage of heat shock protein 90 (Hsp90) and the downregulation of its client oncoproteins, v-Src and Bcr-abl.  Notably, ANDRO-NBD showed superior inhibitory effects to andrographolide in all anticancer assays we have performed.  In addn., ANDRO-NBD was further used as a fluorescent probe to investigate the uptake kinetics, cellular distribution and mol. targets of andrographolide.  Our data revealed that ANDRO-NBD entered cells rapidly and its fluorescent signal could be detected in nucleus, cytoplasm, mitochondria, and lysosome.  Moreover, we demonstrated that ANDRO-NBD was covalently bound to several putative target proteins of andrographolide, including NF-ΚB and hnRNPK.  In summary, we developed a fluorescent andrographolide probe with comparable bioactivity to andrographolide, which serves as a powerful tool to explore the pharmacol. mechanism of andrographolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSPOzo2QI_crVg90H21EOLACvtfcHk0lilqz5sWM6dFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFeht7nF&md5=ab3e3eb720384287dcf30eac786160db</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152770%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DY.-H.%26aulast%3DHsu%26aufirst%3DY.-L.%26aulast%3DLiu%26aufirst%3DS.-H.%26aulast%3DLiao%26aufirst%3DH.-C.%26aulast%3DLee%26aufirst%3DP.-X.%26aulast%3DLin%26aufirst%3DC.-H.%26aulast%3DLo%26aufirst%3DL.-C.%26aulast%3DFu%26aufirst%3DS.-L.%26atitle%3DDevelopment%2520of%2520a%2520bifunctional%2520andrographolide-based%2520chemical%2520probe%2520for%2520pharmacological%2520study%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Solís, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acero, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch-Morell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Rosende, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Mingarro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanahuja, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagrasa, V.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective potential of <i>Ginkgo biloba</i> in retinal diseases</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">1292</span>– <span class="NLM_lpage">1303</span>, <span class="refDoi"> DOI: 10.1055/a-0947-5712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fa-0947-5712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31266069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSis7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=1292-1303&author=I.+Mart%C3%ADnez-Sol%C3%ADsauthor=N.+Aceroauthor=F.+Bosch-Morellauthor=E.+Castilloauthor=M.+E.+Gonz%C3%A1lez-Rosendeauthor=D.+Mu%C3%B1oz-Mingarroauthor=T.+Ortegaauthor=M.+A.+Sanahujaauthor=V.+Villagrasa&title=Neuroprotective+potential+of+Ginkgo+biloba+in+retinal+diseases&doi=10.1055%2Fa-0947-5712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective Potential of Ginkgo biloba in Retinal Diseases</span></div><div class="casAuthors">Martinez-Solis, Isabel; Acero, Nuria; Bosch-Morell, Francisco; Castillo, Encarna; Gonzalez-Rosende, Maria Eugenia; Munoz-Mingarro, Dolores; Ortega, Teresa; Sanahuja, Maria Amparo; Villagrasa, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1292-1303</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  Like other tissues of the central nervous system, the retina is susceptible to damage by oxidative processes that result in several neurodegenerative disease such as age-related macular degeneration, diabetic retinopathy, glaucoma, ischemic retinal disease, retinal disease produced by light oxidn., and detached retina, among other diseases.  The use of antioxidant substances is a soln. to some health problems caused by oxidative stress, because they regulate redox homeostasis and reduce oxidative stress.  This is important for neurodegeneration linked to oxidn. processes.  In line with this, Ginkgo bilobais a medicinal plant with excellent antioxidant properties whose effects have been demonstrated in several degenerative processes, including retinal diseases assocd. with neurodegeneration.  This review describes the current literature on the role of ginkgo in retinal diseases assocd. with neurodegeneration.  The information leads to the conclusion that G. bilobaexts. might be a good option to improve certain neurodegenerative retinal diseases, but more research is needed to det. the safety and efficacy of G. bilobain these retinal degenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4u6laJ3EwrVg90H21EOLACvtfcHk0lilqz5sWM6dFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSis7fF&md5=3da6ae0d5b3e18835bf80f343c95fe1c</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1055%2Fa-0947-5712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fa-0947-5712%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Sol%25C3%25ADs%26aufirst%3DI.%26aulast%3DAcero%26aufirst%3DN.%26aulast%3DBosch-Morell%26aufirst%3DF.%26aulast%3DCastillo%26aufirst%3DE.%26aulast%3DGonz%25C3%25A1lez-Rosende%26aufirst%3DM.%2BE.%26aulast%3DMu%25C3%25B1oz-Mingarro%26aufirst%3DD.%26aulast%3DOrtega%26aufirst%3DT.%26aulast%3DSanahuja%26aufirst%3DM.%2BA.%26aulast%3DVillagrasa%26aufirst%3DV.%26atitle%3DNeuroprotective%2520potential%2520of%2520Ginkgo%2520biloba%2520in%2520retinal%2520diseases%26jtitle%3DPlanta%2520Med.%26date%3D2019%26volume%3D85%26spage%3D1292%26epage%3D1303%26doi%3D10.1055%2Fa-0947-5712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeFeudis, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drieu, K.</span></span> <span> </span><span class="NLM_article-title"><i>Ginkgo biloba</i> extracts and cancer: A research area in its infancy</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1046/j.1472-8206.2003.00156.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1046%2Fj.1472-8206.2003.00156.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12914542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFCnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=405-417&author=F.+V.+DeFeudisauthor=V.+Papadopoulosauthor=K.+Drieu&title=Ginkgo+biloba+extracts+and+cancer%3A+A+research+area+in+its+infancy&doi=10.1046%2Fj.1472-8206.2003.00156.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgo biloba extracts and cancer: A research area in its infancy</span></div><div class="casAuthors">DeFeudis, Francis V.; Papadopoulos, Vassilios; Drieu, Katy</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">405-417</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent studies conducted with various mol., cellular and whole animal models have revealed that leaf exts. of Ginkgo biloba may have anticancer (chemopreventive) properties that are related to their antioxidant, anti-angiogenic and gene-regulatory actions.  The antioxidant and assocd. anti-lipoperoxidative effects of Ginkgo exts. appear to involve both their flavonoid and terpenoid constituents.  The anti-angiogenic activity of the exts. may involve their antioxidant activity and their ability to inhibit both inducible and endothelial forms of nitric oxide synthase.  With regard to gene expression, a Ginkgo ext. and one of its terpenoid constituents, ginkgolide B, inhibited the proliferation of a highly aggressive human breast cancer cell line and xenografts of this cell line in nude mice.  CDNA microarray analyses have shown that exposure of human breast cancer cells to a Ginkgo ext. altered the expression of genes that are involved in the regulation of cell proliferation, cell differentiation or apoptosis, and that exposure of human bladder cancer cells to a Ginkgo ext. produced an adaptive transcriptional response that augments antioxidant status and inhibits DNA damage.  In humans, Ginkgo exts. inhibit the formation of radiation-induced (chromosome-damaging) clastogenic factors and UV light-induced oxidative stress - effects that may also be assocd. with anticancer activity.  Flavonoid and terpenoid constituents of Ginkgo exts. may act in a complementary manner to inhibit several carcinogenesis-related processes, and therefore the total exts. may be required for producing optimal effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo68m-fuu1vL7Vg90H21EOLACvtfcHk0lilqz5sWM6dFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFCnt7w%253D&md5=57591dba05ae3385be6c52e1f6aaf231</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-8206.2003.00156.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-8206.2003.00156.x%26sid%3Dliteratum%253Aachs%26aulast%3DDeFeudis%26aufirst%3DF.%2BV.%26aulast%3DPapadopoulos%26aufirst%3DV.%26aulast%3DDrieu%26aufirst%3DK.%26atitle%3DGinkgo%2520biloba%2520extracts%2520and%2520cancer%253A%2520A%2520research%2520area%2520in%2520its%2520infancy%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2003%26volume%3D17%26spage%3D405%26epage%3D417%26doi%3D10.1046%2Fj.1472-8206.2003.00156.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J. C. J</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. C.</span></span> <span> </span><span class="NLM_article-title">Effects of <i>Ginkgo biloba</i> extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.3748/wjg.v10.i1.37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3748%2Fwjg.v10.i1.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=14695765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FhsFeisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=37-41&author=J.+C.+J+Chaoauthor=C.+C.+Chu&title=Effects+of+Ginkgo+biloba+extract+on+cell+proliferation+and+cytotoxicity+in+human+hepatocellular+carcinoma+cells&doi=10.3748%2Fwjg.v10.i1.37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Chao Jane C J; Chu Chia Chou</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-41</span>
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    </div><div class="casAbstract">AIM:  To study the effect of Ginkgo biloba extract (EGb 761) containing 22-27% flavonoids (ginkgo-flavone glycosides) and 5-7% terpenoids (ginkgolides and bilobalides) on cell proliferation and cytotoxicity in human hepatocellular carcinoma (HCC) cells.  METHODS:  Human HCC cell lines (HepG2 and Hep3B) were incubated with various concentrations (0-1 000 mg/L) of EGb 761 solution.  After 24 h incubation, cell proliferation and cytotoxicity were determined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and lactate dehydrogenase (LDH) release, respectively.  After 48 h incubation, the expression of proliferating cell nuclear antigen (PCNA) and p53 protein was measured by Western blotting.  RESULTS:  The results showed that EGb 761 (50-1 000 mg/L) significantly suppressed cell proliferation and increased LDH release (P<0.05) in HepG2 and Hep3B cells compared with the control group.  The cell proliferation of HepG2 and Hep3B cells treated with EGb 761 (1 000 mg/L) was 45% and 39% of the control group (P<0.05), respectively.  LDH release of HepG2 cells without and with EGb 761 (1 000 mg/L) treatment was 6.7% and 37.7%, respectively, and that of Hep3B cells without and with EGb 761 (1 000 mg/L) treatment was 7.2% and 40.3%, respectively.  The expression of PCNA and p53 protein in HepG2 cells treated with EGb 761 (1 000 mg/L) was 85% and 174% of the control group, respectively.  CONCLUSION:  Ginkgo biloba extract significantly can suppress proliferation and increase cytotoxicity in HepG2 and Hep3B cells.  Additionally, Ginkgo biloba extract can decrease PCNA and increase p53 expression in HepG2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvqPfetQrfSzEC-75aqa5AfW6udTcc2eZj1Iw_mhfusrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FhsFeisg%253D%253D&md5=6ef5502009eca99bced971836552edde</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v10.i1.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v10.i1.37%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DJ.%2BC.%2BJ%26aulast%3DChu%26aufirst%3DC.%2BC.%26atitle%3DEffects%2520of%2520Ginkgo%2520biloba%2520extract%2520on%2520cell%2520proliferation%2520and%2520cytotoxicity%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2004%26volume%3D10%26spage%3D37%26epage%3D41%26doi%3D10.3748%2Fwjg.v10.i1.37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aponte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.-C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitonis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, D. W.</span></span> <span> </span><span class="NLM_article-title"><i>Ginkgo biloba</i> and ovarian cancer prevention: Epidemiological and biological evidence</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>251</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2006.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.canlet.2006.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=17194528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksVyjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2007&pages=43-52&author=B.+Yeauthor=M.+Aponteauthor=Y.+Daiauthor=L.+Liauthor=M.-C.+D.+Hoauthor=A.+Vitonisauthor=D.+Edwardsauthor=T.-N.+Huangauthor=D.+W.+Cramer&title=Ginkgo+biloba+and+ovarian+cancer+prevention%3A+Epidemiological+and+biological+evidence&doi=10.1016%2Fj.canlet.2006.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence</span></div><div class="casAuthors">Ye, Bin; Aponte, Margarita; Dai, Yan; Li, Lily; Ho, Ming-Chih D.; Vitonis, Allison; Edwards, Dale; Huang, Tai-Nang; Cramer, Daniel W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is considerable interest in herbal therapies for cancer prevention but often with little scientific evidence to support their use.  In this study, we examd. epidemiol. data regarding effects of commonly used herbal supplements on risk for ovarian cancer and sought supporting biol. evidence. 4.2% of 721 controls compared to 1.6% of 668 cases regularly used Ginkgo biloba for an estd. relative risk (and 95% confidence interval) of 0.41 (0.20, 0.84) (p = 0.01); and the effect was most apparent in women with non-mucinous types of ovarian cancer, RR = 0.33 (0.15, 0.74) (p = 0.007).  In vitro expts. with normal and ovarian cancer cells showed that Ginkgo ext. and its components, quercetin and ginkgolide A and B, have significant anti-proliferative effects (∼40%) in serous ovarian cancer cells, but little effect in mucinous (RMUG-L) cells.  For the ginkgolides, the inhibitory effect appeared to be cell cycle blockage at G0/G1 to S phase.  This combined epidemiol. and biol. data provide supportive evidence for further studies of the chemopreventive or therapeutic effects of Ginkgo and ginkgolides on ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqICjc6C26GRrVg90H21EOLACvtfcHk0liD7_6PguHIcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksVyjsrg%253D&md5=ff94c8948961b706c0d9c91734ba2f9e</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DB.%26aulast%3DAponte%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DM.-C.%2BD.%26aulast%3DVitonis%26aufirst%3DA.%26aulast%3DEdwards%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DT.-N.%26aulast%3DCramer%26aufirst%3DD.%2BW.%26atitle%3DGinkgo%2520biloba%2520and%2520ovarian%2520cancer%2520prevention%253A%2520Epidemiological%2520and%2520biological%2520evidence%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D251%26spage%3D43%26epage%3D52%26doi%3D10.1016%2Fj.canlet.2006.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takad, S.</span></span> <span> </span><span class="NLM_article-title">Ginkgolides</span>. <i>J. Chem. Soc. C</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_fpage">2201</span>– <span class="NLM_lpage">2206</span>, <span class="refDoi"> DOI: 10.1039/j39670002201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fj39670002201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF1cXjt1E%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1967&pages=2201-2206&author=K.+Okabeauthor=K.+Yamadaauthor=S.+Yamamuraauthor=S.+Takad&title=Ginkgolides&doi=10.1039%2Fj39670002201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolides</span></div><div class="casAuthors">Okabe, Kei; Yamada, Kiyoyuki; Yamamura, Shosuke; Takada, Susumu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2201-6</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">Three bitter principles, ginkgolides A, B, and C, were isolated from the leaves of Ginkgo biloba.  Since the structure of ginkgolide A was established by x-ray anal. of its p-bromobenzoate, structures of the other 2 were deduced by comparison of the N.M.R. spectra.  The structures of ginkgolides A and B were correlated by chem. methods.  Owing to its complex structure, ginkgolide A gave an unusual oxidn. product, the structure of which was detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBlUMr7LYhiLVg90H21EOLACvtfcHk0liD7_6PguHIcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXjt1E%253D&md5=9f11e20289ed4cd4dad6b432c23be5a7</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2Fj39670002201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39670002201%26sid%3Dliteratum%253Aachs%26aulast%3DOkabe%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DS.%26aulast%3DTakad%26aufirst%3DS.%26atitle%3DGinkgolides%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1967%26spage%3D2201%26epage%3D2206%26doi%3D10.1039%2Fj39670002201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, P.</span></span> <span> </span><span class="NLM_article-title">Structure of ginkgolide B (BN 52021) monohydrate, a highly specific PAF/acether receptor antagonist isolated from <i>Ginkgo biboba</i> L</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>C42</i></span>,  <span class="NLM_fpage">1759</span>– <span class="NLM_lpage">1762</span>, <span class="refDoi"> DOI: 10.1107/S0108270186090662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270186090662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL2sXlvFyltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C42&publication_year=1986&pages=1759-1762&author=L.+Dupontauthor=O.+Didebergauthor=G.+Germainauthor=P.+Braquet&title=Structure+of+ginkgolide+B+%28BN+52021%29+monohydrate%2C+a+highly+specific+PAF%2Facether+receptor+antagonist+isolated+from+Ginkgo+biboba+L&doi=10.1107%2FS0108270186090662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of ginkgolide B (BN 52021) monohydrate, a highly specific PAF/acether receptor antagonist isolated from Ginkgo biboba L</span></div><div class="casAuthors">Dupont, L.; Dideberg, O.; Germain, G.; Braquet, P.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C:  Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">C42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1759-62</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    </div><div class="casAbstract">X-ray anal. of ginkgolide B (I) monohydrate, isolated from Ginkgo biboba, confirmed that the cohesion of the crystal is the result of van der Waals interactions and H bonds involving H2O mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmAmJ7QkOzTrVg90H21EOLACvtfcHk0ljlZcOZyKxy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlvFyltbg%253D&md5=02201ce1a13318c49f51fe541b4ef0b0</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1107%2FS0108270186090662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270186090662%26sid%3Dliteratum%253Aachs%26aulast%3DDupont%26aufirst%3DL.%26aulast%3DDideberg%26aufirst%3DO.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DBraquet%26aufirst%3DP.%26atitle%3DStructure%2520of%2520ginkgolide%2520B%2520%2528BN%252052021%2529%2520monohydrate%252C%2520a%2520highly%2520specific%2520PAF%252Facether%2520receptor%2520antagonist%2520isolated%2520from%2520Ginkgo%2520biboba%2520L%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D1986%26volume%3DC42%26spage%3D1759%26epage%3D1762%26doi%3D10.1107%2FS0108270186090662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sbit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dideberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, P.</span></span> <span> </span><span class="NLM_article-title">Structure of ginkgolide A (BN52020) monohydrate and ginkgolide C (BN52022).ethanol.1.5hydrate, isolated from <i>Ginkgo biloba</i> L</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>C43</i></span>,  <span class="NLM_fpage">2377</span>– <span class="NLM_lpage">2381</span>, <span class="refDoi"> DOI: 10.1107/S0108270187087699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270187087699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL1cXkvFegt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C43&publication_year=1987&pages=2377-2381&author=M.+Sbitauthor=L.+Dupontauthor=O.+Didebergauthor=P.+Braquet&title=Structure+of+ginkgolide+A+%28BN52020%29+monohydrate+and+ginkgolide+C+%28BN52022%29.ethanol.1.5hydrate%2C+isolated+from+Ginkgo+biloba+L&doi=10.1107%2FS0108270187087699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of ginkgolide A (BN52020) monohydrate and ginkgolide C (BN52022).ethanol.1.5hydrate, isolated from Ginkgo biloba L</span></div><div class="casAuthors">Sbit, M.; Dupont, L.; Dideberg, O.; Braquet, P.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C:  Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">C43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2377-81</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    </div><div class="casAbstract">In ginkgolides A and C (I; R = R1 = H; R = R1 = OH, resp.) conformations of the rings are very similar to those in ginkgolide B (I; R = H, R1 = OH), except for rings A and F of I (R = R1 = H) where there is no OH substitution in the 2-position: the intramol. OH···O H-bond occurring in ginkgolides B and I (R = R1 = OH) is no longer possible in I (R = R1 = H).  The cohesion of the crystals results from van der Waals interactions and O-H···O hydrogen H-bonds involving H2O and (I; R = R1 = OH) mols.  In I (R = R1 = H), there is a short intermol. O···O contact of 2.859 (6) Å between a lactone ring and a ketone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWaqabXY6QObVg90H21EOLACvtfcHk0ljlZcOZyKxy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvFegt7c%253D&md5=0157f304be34ea170babbe7fd691b0c1</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1107%2FS0108270187087699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270187087699%26sid%3Dliteratum%253Aachs%26aulast%3DSbit%26aufirst%3DM.%26aulast%3DDupont%26aufirst%3DL.%26aulast%3DDideberg%26aufirst%3DO.%26aulast%3DBraquet%26aufirst%3DP.%26atitle%3DStructure%2520of%2520ginkgolide%2520A%2520%2528BN52020%2529%2520monohydrate%2520and%2520ginkgolide%2520C%2520%2528BN52022%2529.ethanol.1.5hydrate%252C%2520isolated%2520from%2520Ginkgo%2520biloba%2520L%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D1987%26volume%3DC43%26spage%3D2377%26epage%3D2381%26doi%3D10.1107%2FS0108270187087699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fronczek, F. R.</span></span> <span> </span><span class="NLM_article-title">Three ginkgolide hydrates from <i>Ginkgo biloba</i> L.: Ginkgolide A monohydrate, ginkgolide C sesquihydrate, and ginkgolide J dihydrate, all determined at 120 K</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">o195</span>– <span class="NLM_lpage">o198</span>, <span class="refDoi"> DOI: 10.1107/S0108270102000689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270102000689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=11807243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFKlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=o195-o198&author=J.+Zhaoauthor=I.+Muhammadauthor=D.+C.+Dunbarauthor=I.+A.+Khanauthor=N.+H.+Fischerauthor=F.+R.+Fronczek&title=Three+ginkgolide+hydrates+from+Ginkgo+biloba+L.%3A+Ginkgolide+A+monohydrate%2C+ginkgolide+C+sesquihydrate%2C+and+ginkgolide+J+dihydrate%2C+all+determined+at+120+K&doi=10.1107%2FS0108270102000689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Three ginkgolide hydrates from Ginkgo biloba L.: ginkgolide A monohydrate, ginkgolide C sesquihydrate and ginkgolide J dihydrate, all determined at 120 K</span></div><div class="casAuthors">Zhao, Jianping; Muhammad, Ilias; Dunbar, D. Chuck; Khan, Ikhlas A.; Fischer, Nikolaus H.; Fronczek, Frank R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Crystal Structure Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">C58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">o195-o198</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">A low-temp. structure of ginkgolide A monohydrate, (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)-3-(1,1-dimethylethyl)-hexahydro-4,7b-dihydroxy-8-methyl-9H-1,7a-epoxymethano-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione monohydrate, C20H24O9·H2O, obtained from Mo Kα data, is a factor of three more precise than the previous room-temp. detn.  A refinement of the ginkgolide A monohydrate structure with Cu Kα data has allowed the assignment of the abs. configuration of compds.  Ginkgolide C sesquihydrate, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11S,11aR)-3-(1,1-dimethylethyl)-hexahydro-2,4,7b,11-tetrahydroxy-8-methyl-9H-1,7a-epoxymethano-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione sesquihydrate, C20H24O11·1.5H2O, has two independent diterpene mols., both of which exhibit intramol. H bonding between OH groups.  Ginkgolide J dihydrate, (1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)-3-(1,1-dimethylethyl)-hexahydro-2,4,7b-trihydroxy-8-methyl-9H-1,7a-epoxymethano-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione dihydrate, C20H24O10·2H2O, has the same basic skeleton as the other ginkgolides, with its three OH groups having the same configurations as those in ginkgolide C.  The conformations of the six five-membered rings are quite similar across ginkgolides A-C and J, except for the A and F rings of ginkgolide A.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppXh4ndDY9W7Vg90H21EOLACvtfcHk0ljlZcOZyKxy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFKlur8%253D&md5=e233442d0008d829c80fd84205498d7e</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1107%2FS0108270102000689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270102000689%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMuhammad%26aufirst%3DI.%26aulast%3DDunbar%26aufirst%3DD.%2BC.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DFischer%26aufirst%3DN.%2BH.%26aulast%3DFronczek%26aufirst%3DF.%2BR.%26atitle%3DThree%2520ginkgolide%2520hydrates%2520from%2520Ginkgo%2520biloba%2520L.%253A%2520Ginkgolide%2520A%2520monohydrate%252C%2520ginkgolide%2520C%2520sesquihydrate%252C%2520and%2520ginkgolide%2520J%2520dihydrate%252C%2520all%2520determined%2520at%2520120%2520K%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D2002%26volume%3D58%26spage%3Do195%26epage%3Do198%26doi%3D10.1107%2FS0108270102000689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnewyn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braquet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgain, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etienne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drieu, K.</span></span> <span> </span><span class="NLM_article-title">BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from <i>Ginkgo biloba</i> L</span>. <i>Ketsueki to Myakkan</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.2491/jjsth1970.16.558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2491%2Fjjsth1970.16.558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL28XksFyqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1985&pages=558-572&author=P.+G.+Braquetauthor=B.+Spinnewynauthor=M.+Braquetauthor=R.+H.+Bourgainauthor=J.+E.+Taylorauthor=A.+Etienneauthor=K.+Drieu&title=BN+52021+and+related+compounds%3A+A+new+series+of+highly+specific+PAF-acether+receptor+antagonists+isolated+from+Ginkgo+biloba+L&doi=10.2491%2Fjjsth1970.16.558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">BN 52021 and related compounds:  a new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L</span></div><div class="casAuthors">Braquet, Pierre G.; Spinnewyn, Brigitte; Braquet, Monique; Bourgain, Rene H.; Taylor, John E.; Etienne, Annie; Drieu, Kathy</div><div class="citationInfo"><span class="NLM_cas:title">Ketsueki to Myakkan</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">558-72</span>CODEN:
                <span class="NLM_cas:coden">KTMYA3</span>;
        ISSN:<span class="NLM_cas:issn">0386-9717</span>.
    </div><div class="casAbstract">The ginkgolides BN 52020 (ginkgolide A), BN 52021 (ginkgolide B), and BN 52022 (ginkgolide C) specifically inhibited the binding of platelet-activating factor (PAF) to the PAF receptor on isolated rabbit platelet membranes and inhibited PAF-dependent in vitro platelet aggregation.  BN 52021 was the most active ginkgolide, with IC50s of ∼10-7 M.  After oral administration to rabbits, BN 52021 inhibited PAF-dependent platelet aggregation.  After oral administration to rats, BN 52021 inhibited thrombus formation induced by elec. stimulation of the carotid artery.  BN 52021 inhibited PAF-dependent human polymorphonuclear leukocyte aggregation in vitro.  The ginkgolides did not significantly affect arachidonic acid metab. and did not bind to neurotransmitter receptors.  The use of BN 52021 and related compds. as pharmacol. tools for studying PAF biol. activities is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI8Hhb_uBBubVg90H21EOLACvtfcHk0ljwsg_5bchujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFyqt7c%253D&md5=253d63324ac881efe352547215ebe973</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.2491%2Fjjsth1970.16.558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2491%252Fjjsth1970.16.558%26sid%3Dliteratum%253Aachs%26aulast%3DBraquet%26aufirst%3DP.%2BG.%26aulast%3DSpinnewyn%26aufirst%3DB.%26aulast%3DBraquet%26aufirst%3DM.%26aulast%3DBourgain%26aufirst%3DR.%2BH.%26aulast%3DTaylor%26aufirst%3DJ.%2BE.%26aulast%3DEtienne%26aufirst%3DA.%26aulast%3DDrieu%26aufirst%3DK.%26atitle%3DBN%252052021%2520and%2520related%2520compounds%253A%2520A%2520new%2520series%2520of%2520highly%2520specific%2520PAF-acether%2520receptor%2520antagonists%2520isolated%2520from%2520Ginkgo%2520biloba%2520L%26jtitle%3DKetsueki%2520to%2520Myakkan%26date%3D1985%26volume%3D16%26spage%3D558%26epage%3D572%26doi%3D10.2491%2Fjjsth1970.16.558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strømgaard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, K.</span></span> <span> </span><span class="NLM_article-title">Ginkgolide derivatives for photolabeling studies: Preparation and pharmacological evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4038</span>– <span class="NLM_lpage">4046</span>, <span class="refDoi"> DOI: 10.1021/jm020147w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020147w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4038-4046&author=K.+Str%C3%B8mgaardauthor=D.+R.+Saitoauthor=H.+Shindouauthor=S.+Ishiiauthor=T.+Shimizuauthor=K.+Nakanishi&title=Ginkgolide+derivatives+for+photolabeling+studies%3A+Preparation+and+pharmacological+evaluation&doi=10.1021%2Fjm020147w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolide Derivatives for Photolabeling Studies: Preparation and Pharmacological Evaluation</span></div><div class="casAuthors">Stromgaard, Kristian; Saito, D. Roland; Shindou, Hideo; Ishii, Satoshi; Shimizu, Takao; Nakanishi, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4038-4046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The terpene trilactones (TTLs), ginkgolides, e.g. ginkgolide B (I), and bilobalide (II), are structurally unique constituents of Ginkgo biloba exts., which exhibit various neuromodulatory properties.  Although the TTLs are believed to be responsible for some of these effects, the specific interactions with targets in the central nervous system remain to be elucidated on a mol. level.  Ginkgolides are known antagonists of the platelet-activating factor (PAF) receptor.  Herein, we describe the first examn. of the binding of native TTLs and their derivs. to the cloned PAF receptor, confirming that of the TTLs, ginkgolide B is the most potent PAF receptor antagonist.  Ginkgolide derivs. carrying photoactivatable and fluorescent groups for the purpose of performing photolabeling have been prepd. and evaluated using the cloned PAF receptor.  These studies have shown that ginkgolide derivs. with arom. photoactivatable substituents are potent PAF receptor antagonists with Ki values of 0.09-0.79 μM and hence excellent ligands for clarifying the binding of ginkgolides to PAF receptor by photolabeling studies.  Ginkgolide derivs. incorporating both fluorescent and photoactivatable groups still retained binding affinity to the PAF receptor and hence should be promising ligands for photolabeling and subsequent sequencing studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuySJkf2zsrVg90H21EOLACvtfcHk0ljwsg_5bchujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslKjt74%253D&md5=a21b4002c990299b21b417929d95acde</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm020147w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020147w%26sid%3Dliteratum%253Aachs%26aulast%3DStr%25C3%25B8mgaard%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DD.%2BR.%26aulast%3DShindou%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DK.%26atitle%3DGinkgolide%2520derivatives%2520for%2520photolabeling%2520studies%253A%2520Preparation%2520and%2520pharmacological%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4038%26epage%3D4046%26doi%3D10.1021%2Fjm020147w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.-W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2156</span>, <span class="refDoi"> DOI: 10.3390/molecules24112156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules24112156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1Smt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=2156&author=J.+Cuiauthor=L.+A.+Huauthor=W.+Shiauthor=G.+Cuiauthor=X.+Zhangauthor=Q.-W.+Zhang&title=Design%2C+synthesis%2C+and+anti-platelet+aggregation+activity+study+of+ginkgolide-1%2C2%2C3-triazole+derivatives&doi=10.3390%2Fmolecules24112156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and anti-platelet aggregation activity study of ginkgolide-1,2,3-triazole derivatives</span></div><div class="casAuthors">Cui, Jian; Hu, Le-An; Shi, Wei; Cui, Guozhen; Zhang, Xumu; Zhang, Qing-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2156pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">An azide-alkyne Huisgen cycloaddn. reaction was used to introduce a triazole nucleus into the target ginkgolide mols.  A series of ginkgolide-1,2,3-triazole conjugates with varied functional groups including benzyl, Ph and heterocycle moieties I (R = 2-chlorophenyl, 3-pyridinyl, 2-methylbenzyl, etc.; R1 = H, OH; R2 = H, OH) was thus synthesized.  Many of the designed derivs. showed potent antiplatelet aggregation activities with IC50 values of 5~ 21 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGj4ATEa_oNbVg90H21EOLACvtfcHk0ljwsg_5bchujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1Smt7fI&md5=873bb9e5a788745548ea5c17df8dc641</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24112156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24112156%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%2BA.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.-W.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520anti-platelet%2520aggregation%2520activity%2520study%2520of%2520ginkgolide-1%252C2%252C3-triazole%2520derivatives%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D2156%26doi%3D10.3390%2Fmolecules24112156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jancar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chammas, R.</span></span> <span> </span><span class="NLM_article-title">PAF receptor and tumor growth</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.2174/1389450115666140903111812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1389450115666140903111812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25182608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=982-987&author=S.+Jancarauthor=R.+Chammas&title=PAF+receptor+and+tumor+growth&doi=10.2174%2F1389450115666140903111812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">PAF Receptor and Tumor Growth</span></div><div class="casAuthors">Jancar, Sonia; Chammas, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">982-987</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The receptor for the lipid mediator PAF (PAFR) is a G-protein coupled receptor expressed in several cell types.  Besides PAF, a series of oxidized phospholipids can also bind to PAFR.  Dying cells also express PAFR-ligands and, in both situations, scavenger receptors are involved as well.  There is evidence that the scavenger receptor CD36 and PAFR assoc. in the macrophages membrane and signal in conjunction to induce a regulatory phenotype.  In the tumor microenvironment, apoptotic cells are abundant due to hypoxia, and PAF-like phospholipids are generated.  Engagement of PAFR expressed by tumor macrophages and dendritic cells induces a regulatory/tolerogenic phenotype and subverts the innate and adaptive immune response to the tumor.  During cancer therapies, PAFR-ligands can be generated, further aggravating the immune suppression.  Moreover, some tumor cells express PAFR and its activation by PAFR-ligands generated during chemotherapy induce anti-apoptotic factors, which protect the tumor cells from death induced by these treatments.  It is proposed that PAFR antagonists, administered in combination with chemotherapy, may represent a promising strategy for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICPd0OAd6FbVg90H21EOLACvtfcHk0lhvduSbxOYjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnurzN&md5=24274facbb9a7043b51e0628e51eb766</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.2174%2F1389450115666140903111812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666140903111812%26sid%3Dliteratum%253Aachs%26aulast%3DJancar%26aufirst%3DS.%26aulast%3DChammas%26aufirst%3DR.%26atitle%3DPAF%2520receptor%2520and%2520tumor%2520growth%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26spage%3D982%26epage%3D987%26doi%3D10.2174%2F1389450115666140903111812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span> <span> </span><span class="NLM_article-title">The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: A novel target for combination therapy</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/bjc.2014.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fbjc.2014.323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24921917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=515-524&author=Y.+Yuauthor=X.+Zhangauthor=S.+Hongauthor=M.+Zhangauthor=Q.+Caiauthor=M.+Zhangauthor=W.+Jiangauthor=C.+Xu&title=The+expression+of+platelet-activating+factor+receptor+modulates+the+cisplatin+sensitivity+of+ovarian+cancer+cells%3A+A+novel+target+for+combination+therapy&doi=10.1038%2Fbjc.2014.323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy</span></div><div class="casAuthors">Yu, Y.; Zhang, X.; Hong, S.; Zhang, M.; Cai, Q.; Zhang, M.; Jiang, W.; Xu, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-524</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Ovarian cancer has the highest mortality rate of the gynaecol. cancers.  Although cisplatin (CDDP) is an effective treatment for ovarian cancer, recurrence is frequent and leads to death.  The objective was to explore the role and possible mechanisms of platelet-activating factor receptor (PAFR) signalling in CDDP-treated ovarian cancer cells.  Methods: The upregulation of PAFR in CDDP-treated ovarian cancer cells was obsd. using realtime PCR and Western blot.  The potential role of PAFR in modulating the CDDP sensitivity was assessed using a pharmacol. inhibitor and siRNA knockdown.  The PAFR-activated signalling pathways involved in cell responses to CDDP were assessed.  Results: Cisplatin induced increased PAFR expression in two ovarian cancer cell lines.  The upregulation of PAFR by CDDP correlated with the time-dependent accumulation of NF-κB and HIF-1α in the nucleus.  The inhibition of PAFR sensitized the ovarian cancer cells to CDDP.  The PI3K and ERK pathways lie downstream of activated PAFR in CDDP-treated cells and their inhibition enhanced CDDP sensitivity.  Finally, co-treatment with a PAFR antagonist (Ginkgolide B) and CDDP markedly reduced tumor growth in an in vivo model of ovarian cancer.  Conclusions: Together, these findings suggest that PAFR is a novel and promising therapeutic target for sensitizing ovarian cancer cells to CDDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7niV2H8ZO7Vg90H21EOLACvtfcHk0lhvduSbxOYjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCmsLY%253D&md5=79128ca940eb77057fa0ff51ef7f14a2</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.323%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DThe%2520expression%2520of%2520platelet-activating%2520factor%2520receptor%2520modulates%2520the%2520cisplatin%2520sensitivity%2520of%2520ovarian%2520cancer%2520cells%253A%2520A%2520novel%2520target%2520for%2520combination%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D515%26epage%3D524%26doi%3D10.1038%2Fbjc.2014.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span> <span> </span><span class="NLM_article-title">Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: The role of platelet-activating factor</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">999</span>, <span class="refDoi"> DOI: 10.1186/s12885-018-4918-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs12885-018-4918-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30340558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1OgurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=999&author=T.+Gaoauthor=Y.+Yuauthor=Q.+Congauthor=Y.+Wangauthor=M.+Sunauthor=L.+Yaoauthor=C.+Xuauthor=W.+Jiang&title=Human+mesenchymal+stem+cells+in+the+tumour+microenvironment+promote+ovarian+cancer+progression%3A+The+role+of+platelet-activating+factor&doi=10.1186%2Fs12885-018-4918-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor</span></div><div class="casAuthors">Gao, Tong; Yu, Yi; Cong, Qing; Wang, Yisheng; Sun, Mingming; Yao, Liangqing; Xu, Congjian; Jiang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">999</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The tumor microenvironment conferred by mesenchymal stem cells (MSCs) plays a key role in tumor development and progression.  We previously detd. that platelet-activating factor receptor (PAFR) was overexpressed in ovarian cancer cells (OCCs) and that PAF can promote ovarian cancer progression via PAF/PAFR-mediated inflammatory signalling pathways.  Evidence suggests that MSCs can secrete high concns. of PAF.  Here, we investigated the role of PAF/PAFR signalling in the microenvironment mediated by MSCs and OCCs and its effect on cancer progression.  Methods: The PAF concns. in the culture media of MSCs, OCCs and co-cultured MSCs and OCCs were detd. by ELISA.  The effects of MSCs on OCCs in vitro were assessed on cells treated with conditioned medium (CM).  The expression and phosphorylation of key proteins in the PAF/PAFR signalling pathway were evaluated.  In vivo, MSCs/RFP and SKOV3 cells were co-administered at different proportions to nude mice by interscapular injection.  Mice in the WEB2086 group were i.p. injected with the PAFR antagonist WEB2086 at a dose of 1 mg/kg.d for the duration of the animal expts.  Tumor progression was obsd., and the wt. and survival time of mice were measured.  The PAF concn. in peripheral and tumor site blood was detd. by ELISA.  Results: High concns. of PAF were detected in CM from MSCs and MSCs co-cultured with OCCs.  Both types of medium promoted non-mucinous OCC proliferation and migration but had no effect on mucinous-type OCCs.  These effects could be blocked by PAFR inhibitors.  The expression and phosphorylation of key proteins in the PAF/PAFR pathway significantly increased upon treatment with PAF and MSC-CM.  In vivo, the tumor vol. was larger following co-injection of SKOV3 cells and MSCs/RFP than following injection of SKOV3 cells alone.  The tumor-promoting effect of MSCs/RFP was blocked by the PAFR antagonist WEB2086.  Serum PAF concns. significantly increased in co-injected mice.  Conclusion: Our results suggest that the tumor-promoting effect of MSCs on OCCs via their cross-talk in the tumor microenvironment was, at least in part, mediated by the PAF/PAFR pathway, suggesting a new target for the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzpGOjJddqvbVg90H21EOLACvtfcHk0lhvduSbxOYjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1OgurzK&md5=858609e0ad9b74a09837ed8142811ba4</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1186%2Fs12885-018-4918-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-018-4918-0%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DCong%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DW.%26atitle%3DHuman%2520mesenchymal%2520stem%2520cells%2520in%2520the%2520tumour%2520microenvironment%2520promote%2520ovarian%2520cancer%2520progression%253A%2520The%2520role%2520of%2520platelet-activating%2520factor%26jtitle%3DBMC%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D999%26doi%3D10.1186%2Fs12885-018-4918-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.-C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological action and mechanisms of ginkgolide B</span>. <i>Chin. Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">928</span>, <span class="refDoi"> DOI: 10.1097/00029330-200705020-00013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2F00029330-200705020-00013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=17543184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFehtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=922-928&author=S.-H.+Xiaauthor=D.-C.+Fang&title=Pharmacological+action+and+mechanisms+of+ginkgolide+B&doi=10.1097%2F00029330-200705020-00013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological action and mechanisms of ginkgolide B</span></div><div class="casAuthors">Xia, Shi-hai; Fang, Dian-chun</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Medical Journal (Beijing, China, English Edition)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">922-928</span>CODEN:
                <span class="NLM_cas:coden">CMJODS</span>;
        ISSN:<span class="NLM_cas:issn">0366-6999</span>.
    
            (<span class="NLM_cas:orgname">Chinese Medical Association</span>)
        </div><div class="casAbstract">Objective: To review the recent research progress in pharmacol. actions and mechanisms of ginkgolide B.  Data sources: Information included in this article was identified by searching of PUBMED (1987-2006) online resources using the key terms "ginkgolide B", "platelet activating factor", and "pharmacol.".  Study selection Mainly original milestone articles and crit. reviews written by major pioneer investigators of the field were selected.  Results: The key issues related to the pharmacol. actions and mechanisms of ginkgolide B were summarized.  The ginkgolide B possesses a no. of beneficial effects such as anti-inflammatory, anti-allergic, antioxidant, and neuroprotective effects.  Meantime, their mechanisms were discussed.  Conclusions: The Ginkgolide B is the most potent antagonist of platelet activating factor (PAF) and exhibits therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99Qo1awOBz7Vg90H21EOLACvtfcHk0lg5SQ42PutI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFehtb4%253D&md5=716d7c4ba120af0e161515d5bafb4432</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1097%2F00029330-200705020-00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00029330-200705020-00013%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DS.-H.%26aulast%3DFang%26aufirst%3DD.-C.%26atitle%3DPharmacological%2520action%2520and%2520mechanisms%2520of%2520ginkgolide%2520B%26jtitle%3DChin.%2520Med.%2520J.%26date%3D2007%26volume%3D120%26spage%3D922%26epage%3D928%26doi%3D10.1097%2F00029330-200705020-00013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span> <span> </span><span class="NLM_article-title">Ginkgolide B inhibits human bladder cancer cell migration and invasion through microRNA-223–3p</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1794</span>, <span class="refDoi"> DOI: 10.1159/000447878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1159%2F000447878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27744452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVemtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1787-1794&author=Y.+Zhiauthor=J.+Panauthor=W.+Shenauthor=P.+Heauthor=J.+Zhengauthor=X.+Zhouauthor=G.+Luauthor=Z.+Chenauthor=Z.+Zhou&title=Ginkgolide+B+inhibits+human+bladder+cancer+cell+migration+and+invasion+through+microRNA-223%E2%80%933p&doi=10.1159%2F000447878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p</span></div><div class="casAuthors">Zhi, Yi; Pan, Jinhong; Shen, Wenhao; He, Peng; Zheng, Ji; Zhou, Xiaozhou; Lu, Gensheng; Chen, Zhiwen; Zhou, Zhansong</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1787-1794</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Ginkgolide B (GB) is currently used as an anticancer drug for treatment of some malignant cancers.  However, whether it may have therapeutic effects on bladder cancer remains unknown.  Here, we studied the effects of GB on bladder cancer cells.  Methods: Bladder cells were treated with different doses of GB, and the effects on ZEB1 and microRNA-223-3p (miR-223-3p) were analyzed by RT-qPCR and/or Western blot.  Prediction of a regulatory relationship between miR-93 and 3'-UTR of Beclin-1 mRNA was performed by a bioinformatics algorithm and confirmed by a dual luciferase reporter assay.  Results: We found that GB dose-dependently decreased ZEB1 protein, but not mRNA, in bladder cancer cells, resulting in suppression of cell invasion.  Moreover, in bladder cancer cells, GB dose-dependently decreased the levels of miR-223-3p, which suppressed the protein translation of ZEB1 through binding to 3'-UTR of ZEB1 mRNA.  Overexpression of miR-223-3p decreased ZEB1 protein, while depletion of miR-223-3p increased ZEB1 protein in bladder cancer cells.  Conclusion: GB inhibits bladder cancer cell invasiveness through suppressing ZEB1 protein translation via upregulating miR-223-3p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaKxN21rHiPrVg90H21EOLACvtfcHk0lg5SQ42PutI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVemtr%252FM&md5=3373e5b6fda5fb7ab561d9f3bbd0542a</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1159%2F000447878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000447878%26sid%3Dliteratum%253Aachs%26aulast%3DZhi%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.%26atitle%3DGinkgolide%2520B%2520inhibits%2520human%2520bladder%2520cancer%2520cell%2520migration%2520and%2520invasion%2520through%2520microRNA-223%25E2%2580%25933p%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2016%26volume%3D39%26spage%3D1787%26epage%3D1794%26doi%3D10.1159%2F000447878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-κB pathway</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.10.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.10.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30399592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2hsrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=563-572&author=C.+Louauthor=H.+Luauthor=Z.+Maauthor=C.+Liuauthor=Y.+Zhang&title=Ginkgolide+B+enhances+gemcitabine+sensitivity+in+pancreatic+cancer+cell+lines+via+inhibiting+PAFR%2FNF-%CE%BAB+pathway&doi=10.1016%2Fj.biopha.2018.10.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-κB pathway</span></div><div class="casAuthors">Lou, Changjie; Lu, Haibo; Ma, Zhigang; Liu, Chao; Zhang, Yanqiao</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">563-572</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Gemcitabine resistance will occur by time after the initial response in pancreatic cancer.  Ginkgolide B (GB), a major terpene lactone component of Ginkgo biloba leaves, is a highly selective and competitive inhibitor for platelet-activating factor (PAF) receptor.  In the present study, we evaluated the effect of GB on gemcitabine sensitivity in pancreatic cancer cell lines in vitro and in vivo.  Cell viability assay, flow cytometry, dual luciferase reporter assay and tumor xenograft model were used to evaluate cell proliferation, apoptosis, nuclear factor kappa b (NF-κB) activity in vitro and tumor growth in vivo.  Western blot, immunohistochem. (IHC) and immunofluorescence were used to shown different protein expression levels.  We found the half maximal inhibitory concn. (IC50) of gemcitabine was significantly downregulated by GB in a dose-dependent manner.  Furthermore, GB could suppress cell proliferation, increase cell apoptosis and repress tumor growth when combined with gemcitabine, but had no effect when treated alone.  Gemcitabine could upregulate PAFR and phosphorylated NF-κB/p65 expression, and increase NF-κB activity, but this was largely suppressed in combination with GB.  GB could suppress PAFR expression in a dose-dependent manner.  Knockout of PAFR significantly decreased phosphorylated NF-κB/p65 expression, inhibited NF-κB activity, increased gemcitabine sensitivity and cell apoptosis.  Besides, GB had no influence on gemcitabine IC50 in IκBα-SR stably expressed BxPC-3 and CAPAN1.  Our results suggested that GB could enhance gemcitabine sensitivity in pancreatic cancer cell lines by suppressing PAFR/NF-κB pathway.  Thus GB may have therapeutic potential when used in combination with gemcitabine in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJAPLb9wHybVg90H21EOLACvtfcHk0lg5SQ42PutI5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2hsrnJ&md5=13319f7a3a52236b3a65b0d6aa57b9fb</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.10.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.10.084%26sid%3Dliteratum%253Aachs%26aulast%3DLou%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DGinkgolide%2520B%2520enhances%2520gemcitabine%2520sensitivity%2520in%2520pancreatic%2520cancer%2520cell%2520lines%2520via%2520inhibiting%2520PAFR%252FNF-%25CE%25BAB%2520pathway%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D109%26spage%3D563%26epage%3D572%26doi%3D10.1016%2Fj.biopha.2018.10.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span> <span> </span><span class="NLM_article-title">miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>245</i></span>,  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2016.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.cbi.2016.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26768586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=2016&pages=72-81&author=W.+Maauthor=J.+Liauthor=J.+Huauthor=Y.+Chengauthor=J.+Wangauthor=X.+Zhangauthor=M.+Xu&title=miR214-regulated+p53-NOX4%2Fp66shc+pathway+plays+a+crucial+role+in+the+protective+effect+of+ginkgolide+B+against+cisplatin-induced+cytotoxicity+in+HEI-OC1+cells&doi=10.1016%2Fj.cbi.2016.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">miR214-regulated p53-NOX4/p66shc pathway plays a crucial role in the protective effect of Ginkgolide B against cisplatin-induced cytotoxicity in HEI-OC1 cells</span></div><div class="casAuthors">Ma, Weijun; Li, Jianping; Hu, Juan; Cheng, Ying; Wang, Junli; Zhang, Xiaotong; Xu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">245</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The chemotherapeutic agent, cisplatin, is widely used for the treatment of several neoplastic diseases.  The concomitant cytotoxicity in cochlear cells severely limits the max. dose of cisplatin.  Our previous study has shown that Ginkgolide B (GB) could protect against cisplatin-induced ototoxicity.  In the present study, we aimed to elucidate the probable mechanism underlying GB-mediated protective effects against cisplatin-induced cytotoxicity.  The results showed that, in HEI-OC1 auditory cells, both NOX4 and p66shc expression was increased by cisplatin.  GB significantly reduced NOX4 and p66shc expression and superoxide generation.  Over-expression of NOX4 or p66shc suppressed the inhibitory effects of GB on superoxide generation and the protective effects of GB on loss of cell viability and apoptosis assocd. with cisplatin.  Moreover, p53 expression was increased by cisplatin.  GB significantly decreased p53 expression and p53-binding of the promoters of NOX4 and p66shc.  Over-expression of p53 suppressed the inhibitory effects of GB on NOX4 and p66shc expression and superoxide generation and the protective effects of GB on loss of cell viability and apoptosis assocd. with cisplatin.  Furthermore, miR214 expression was decreased by cisplatin.  GB significantly increased miR214 expression and inhibition of miR214 suppressed the inhibitory effects of GB on p53, NOX4 and p66shc expression and superoxide generation and the protective effects of GB against cisplatin-induced cytotoxicity.  We demonstrate that GB decreases superoxide generation and the subsequent apoptosis through redn. of p53-mediated NOX4/p66shc pathway via up-regulation of miR214, resulting in attenuation of cisplatin-induced cytotoxicity.  Our findings have gained an insight into the mol. mechanism of GB-exhibited inhibitory effect on cisplatin-induced cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7A0wUm5qV-7Vg90H21EOLACvtfcHk0lif6i8txtLW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslylug%253D%253D&md5=3354bcde3ce51bfee54df54aa918a5a1</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26atitle%3DmiR214-regulated%2520p53-NOX4%252Fp66shc%2520pathway%2520plays%2520a%2520crucial%2520role%2520in%2520the%2520protective%2520effect%2520of%2520ginkgolide%2520B%2520against%2520cisplatin-induced%2520cytotoxicity%2520in%2520HEI-OC1%2520cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D245%26spage%3D72%26epage%3D81%26doi%3D10.1016%2Fj.cbi.2016.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dungdung, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N.</span></span> <span> </span><span class="NLM_article-title">Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.2217/nnm.13.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2217%2Fnnm.13.56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23742256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVeksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=441-456&author=S.+Ghoshauthor=S.+R.+Dungdungauthor=S.+T.+Choudhuryauthor=S.+Chakrabortyauthor=N.+Das&title=Mitochondria+protection+with+ginkgolide+B-loaded+polymeric+nanocapsules+prevents+diethylnitrosamine-induced+hepatocarcinoma+in+rats&doi=10.2217%2Fnnm.13.56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats</span></div><div class="casAuthors">Ghosh, Swarupa; Dungdung, Sandhya Rekha; Choudhury, Somsubhra Thakur; Chakraborty, Somsuta; Das, Nirmalendu</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-456</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1743-5889</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: Hepatocellular carcinoma (HCC) has no successful pharmacotherapeutic remedy.  The aim of this study was to ascertain whether ginkgolide B (GB)-loaded polymeric nanocapsules can prevent diethylnitrosamine (DEN)-induced HCC in rats.  Materials & methods: GB was fabricated in two types of nanocapsules of which one was polyethylene glycol coated (N1GB) and the other was uncoated (N2GB).  These nanocapsules were orally gavaged during DEN-induced HCC development in rats.  Results: Nanocapsulation of GB enabled aq. suspension and slow time-dependent release of the compd.  Anticarcinogenic potential of N2GB was reflected by its ability in the management of DEN-induced reactive oxygen species generation, mitochondrial dysfunction, p53, NF-κB, inducible nitric oxide synthase, COX-2 and VEGF expressions, and induction of apoptosis in cancer cells in the rat liver.  Conclusion: Pos. zeta-potential on N2GB surface might have offered higher hepatic accumulation of GB, esp. at the electron-dense organelle mitochondria.  Mitochondria protection against DEN-induced oxidative damage ensured HCC prevention.  Original submitted 27 June 2012; Revised submitted 4 Dec. 2012; Published online 7 June 2013.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodSLwS_VVnGrVg90H21EOLACvtfcHk0lif6i8txtLW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVeksro%253D&md5=3572076c22e0f347b3480b5a374dad01</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.2217%2Fnnm.13.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fnnm.13.56%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DDungdung%26aufirst%3DS.%2BR.%26aulast%3DChoudhury%26aufirst%3DS.%2BT.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DN.%26atitle%3DMitochondria%2520protection%2520with%2520ginkgolide%2520B-loaded%2520polymeric%2520nanocapsules%2520prevents%2520diethylnitrosamine-induced%2520hepatocarcinoma%2520in%2520rats%26jtitle%3DNanomedicine%26date%3D2014%26volume%3D9%26spage%3D441%26epage%3D456%26doi%3D10.2217%2Fnnm.13.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, P.</span></span> <span> </span><span class="NLM_article-title">PAF receptor antagonist ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25755731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC2MnislOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=432-440&author=L.+Sunauthor=Z.+Heauthor=J.+Keauthor=S.+Liauthor=X.+Wuauthor=L.+Lianauthor=X.+Heauthor=X.+Heauthor=J.+Huauthor=Y.+Zouauthor=X.+Wuauthor=P.+Lan&title=PAF+receptor+antagonist+ginkgolide+B+inhibits+tumourigenesis+and+angiogenesis+in+colitis-associated+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer</span></div><div class="casAuthors">Sun Lei; He Zhen; Ke Jia; Li Senmao; Wu Xianrui; Lian Lei; He Xiaowen; He Xiaosheng; Hu Jiancong; Zou Yifeng; Wu Xiaojian; Lan Ping</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">432-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Platelet activating factor (PAF), a potent pro-inflammatory phospholipid, has been found to trigger tumor growth and angiogenesis through its G-protein coupled receptor (PAFR).  This study was aimed to investigate the potential role of PAF in azoxymethane (AOM)/dextran sulfate sodium (DSS) induced colitis-associated cancer (CAC), using PAFR antagonist Ginkgolide B (GKB).  We found GKB up-regulated serum level of PAF-AH activity.  As assessed by disease activity index (DAI), histological injury scores, leukocytes infiltration, and expression of pro-inflammatory cytokines, GKB ameliorated colonic inflammation and decreased tumor number and load in mice.  GKB also decreased expression of vascular endothelial growth factor (VEGF) and microvessel density (MVD) in tumor.  These results suggest that PAFR antagonist might be a potential therapeutic strategy for CAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnmBqw7L9yvxgd2Wuil24tfW6udTcc2eY6zAQFaF08RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnislOmsQ%253D%253D&md5=9b4af2e39c941727dd3db2128b5e2c0d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DKe%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLian%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DP.%26atitle%3DPAF%2520receptor%2520antagonist%2520ginkgolide%2520B%2520inhibits%2520tumourigenesis%2520and%2520angiogenesis%2520in%2520colitis-associated%2520cancer%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2015%26volume%3D8%26spage%3D432%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, Y.</span></span> <span> </span><span class="NLM_article-title">Two new diterpenoids, jolkinolides A and B, obtained from <i>Euphorbia jolkini</i> Boiss. (Euphorbiaceae)</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1390</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)84635-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0040-4039%2801%2984635-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1972&pages=1387-1390&author=D.+Uemuraauthor=Y.+Hirata&title=Two+new+diterpenoids%2C+jolkinolides+A+and+B%2C+obtained+from+Euphorbia+jolkini+Boiss.+%28Euphorbiaceae%29&doi=10.1016%2FS0040-4039%2801%2984635-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2984635-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252984635-9%26sid%3Dliteratum%253Aachs%26aulast%3DUemura%26aufirst%3DD.%26aulast%3DHirata%26aufirst%3DY.%26atitle%3DTwo%2520new%2520diterpenoids%252C%2520jolkinolides%2520A%2520and%2520B%252C%2520obtained%2520from%2520Euphorbia%2520jolkini%2520Boiss.%2520%2528Euphorbiaceae%2529%26jtitle%3DTetrahedron%2520Lett.%26date%3D1972%26volume%3D13%26spage%3D1387%26epage%3D1390%26doi%3D10.1016%2FS0040-4039%2801%2984635-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.-K.</span></span> <span> </span><span class="NLM_article-title"><i>ent</i>-Abietane diterpenoids and their probable biogenetic precursors from the roots of <i>Euphorbia fischeriana</i></span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">55859</span>– <span class="NLM_lpage">55865</span>, <span class="refDoi"> DOI: 10.1039/C7RA11982H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC7RA11982H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFertrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=55859-55865&author=J.+Zhangauthor=J.+Heauthor=X.-X.+Wangauthor=Y.-X.+Shiauthor=N.+Zhangauthor=B.-Z.+Maauthor=W.-K.+Zhangauthor=J.-K.+Xu&title=ent-Abietane+diterpenoids+and+their+probable+biogenetic+precursors+from+the+roots+of+Euphorbia+fischeriana&doi=10.1039%2FC7RA11982H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-abietane diterpenoids and their probable biogenetic precursors from the roots of Euphorbia fischeriana</span></div><div class="casAuthors">Zhang, Jia; He, Jun; Wang, Xiao-Xue; Shi, Ying-Xue; Zhang, Nuan; Ma, Bing-Zhi; Zhang, Wei-Ku; Xu, Jie-Kun</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">88</span>),
    <span class="NLM_cas:pages">55859-55865</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Five new ent-abietane diterpenoids (1-5), along with nine known analogs (6-14), were isolated from the roots of Euphorbia fischeriana.  Their structures and abs. configurations were detd. by the anal. of extensive spectroscopic data (UV, IR, HRESIMS, NMR) and the comparison of the exptl. and calcd. electronic CD (ECD).  Among the isolates, it's notable that the ent-abietane diterpenoids bearing an addnl. five-membered lactone ring might be derived from the proposed precursors of fischeriabietane B (2) and C (3), and their plausible biosynthetic relationship was detailed discussed.  All the isolates were evaluated for cytotoxicity against three human cancer cell lines (Panc-28, Bel-7402, and HT-29), 2 and 3 exhibited moderate cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOlBwaTOzVw7Vg90H21EOLACvtfcHk0lh2_K10tFAFyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFertrzM&md5=e58473b265aa6eaac508bb8559f6f7c9</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1039%2FC7RA11982H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA11982H%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.-X.%26aulast%3DShi%26aufirst%3DY.-X.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DB.-Z.%26aulast%3DZhang%26aufirst%3DW.-K.%26aulast%3DXu%26aufirst%3DJ.-K.%26atitle%3Dent-Abietane%2520diterpenoids%2520and%2520their%2520probable%2520biogenetic%2520precursors%2520from%2520the%2520roots%2520of%2520Euphorbia%2520fischeriana%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D55859%26epage%3D55865%26doi%3D10.1039%2FC7RA11982H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uemura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal and molecular structure of jolkinolide B, a novel oxidolactone diterpene</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)92614-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0040-4039%2801%2992614-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1977&pages=283-284&author=D.+Uemuraauthor=C.+Katayamaauthor=Y.+Hirata&title=Crystal+and+molecular+structure+of+jolkinolide+B%2C+a+novel+oxidolactone+diterpene&doi=10.1016%2FS0040-4039%2801%2992614-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2992614-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252992614-0%26sid%3Dliteratum%253Aachs%26aulast%3DUemura%26aufirst%3DD.%26aulast%3DKatayama%26aufirst%3DC.%26aulast%3DHirata%26aufirst%3DY.%26atitle%3DCrystal%2520and%2520molecular%2520structure%2520of%2520jolkinolide%2520B%252C%2520a%2520novel%2520oxidolactone%2520diterpene%26jtitle%3DTetrahedron%2520Lett.%26date%3D1977%26volume%3D18%26spage%3D283%26epage%3D284%26doi%3D10.1016%2FS0040-4039%2801%2992614-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span> <span> </span><span class="NLM_article-title">Anticancer activities of diterpenoids derived from <i>Euphorbia fischeriana</i> Steud</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">387</span>, <span class="refDoi"> DOI: 10.3390/molecules23020387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules23020387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Kjt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=387&author=B.+Jianauthor=H.+Zhangauthor=C.+Hanauthor=J.+Liu&title=Anticancer+activities+of+diterpenoids+derived+from+Euphorbia+fischeriana+Steud&doi=10.3390%2Fmolecules23020387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer activities of diterpenoids derived from Euphorbia fischeriana Steud</span></div><div class="casAuthors">Jian, Baiyu; Zhang, Hao; Han, Cuicui; Liu, Jicheng</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387/1-387/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Euphorbia fischeriana Steud is an essential oriental folk medicine used for healing cancer, edema and tuberculosis.  Recently, its anticancer activitity has attracted more attention.  A vol. of research has indicated that diterpenoids are the major anticancer active constituents from this medicinal herb.  In this review, we aimed to provide a summary of the promising anticancer diterpenoids from this plant; many diterpenoids mentioned in this article are newly discovered diterpenoids.  According to the carbon skeleton and substituents, they can be classified into eight subtypes: ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurane, and lathyrane.  Futhermore, their key anticancer mechanisms and protein targets of these compds. will be discussed.  These natural diterpenoids could provide a reservoir for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs6-P9l074MrVg90H21EOLACvtfcHk0lh2_K10tFAFyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Kjt73O&md5=012e0b6fcf61062a15fba7c7c935d870</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23020387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23020387%26sid%3Dliteratum%253Aachs%26aulast%3DJian%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26atitle%3DAnticancer%2520activities%2520of%2520diterpenoids%2520derived%2520from%2520Euphorbia%2520fischeriana%2520Steud%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D387%26doi%3D10.3390%2Fmolecules23020387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-C.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide A and jolkinolide B inhibit proliferation of A549 cells and activity of human umbilical vein endothelial cells</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.12659/MSM.902704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.12659%2FMSM.902704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28087861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2rs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=223-237&author=L.+Shenauthor=S.-Q.+Zhangauthor=L.+Liuauthor=Y.+Sunauthor=Y.-X.+Wuauthor=L.-P.+Xieauthor=J.-C.+Liu&title=Jolkinolide+A+and+jolkinolide+B+inhibit+proliferation+of+A549+cells+and+activity+of+human+umbilical+vein+endothelial+cells&doi=10.12659%2FMSM.902704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide A and Jolkinolide B inhibit proliferation of A549 cells and activity of human umbilical vein endothelial cells</span></div><div class="casAuthors">Shen, Lei; Zhang, Shan-Qiang; Liu, Lei; Sun, Yu; Wu, Yu-Xuan; Xie, Li-Ping; Liu, Ji-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">223-237</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1643-3750</span>.
    
            (<span class="NLM_cas:orgname">International Scientific Information, Inc.</span>)
        </div><div class="casAbstract">Background: Jolkinolide A (JA) and Jolkinolide B (JB) are diterpenoids extd. from the roots of Euphorbia fischeriana Steud and have been shown to have anti-tumor activity.  However, their effects on the ability of tumor cells to invade blood vessels and metastasize remain largely unknown.  Investigations into the effects of JA and JB on the angiogenesis of tumor tissues may facilitate the identification of new natural drugs with anti-tumor growth and metastasis activities.  Material/Methods: We used different concns. of JA and JB (20 μg/mL, 40 μg/mL, 60 μg/mL, 80 μg/mL, and 100 μg/mL) to stimulate A549 cells and then studied the effects on the growth and metastasis of lung cancers.  In addn., we used conditional media from A549 cells (A549-CM) stimulated by either JA or JB in different concns. to culture human umbilical vein endothelial cells (HUVECs).  Results: We found that both JA and JB significantly inhibited the Akt-STAT3-mTOR signaling pathway and reduced the expression of VEGF in A549 cells, but JB exhibited more significant inhibitory effects than JA.  The JB-stimulated A549 cell conditional media had a greater inhibitory effect on the proliferation and migration of HUVECs than did the conditional media of JA-stimulated A549 cells.  This effect gradually increased with increasing concns. of either type of Jolkinolide.  Conclusions: Our results suggest that JA and JB inhibited VEGF expression in A549 cells through the inhibition of the Akt-STAT3-mTOR signaling pathway, and directly inhibited the proliferation and migration of HUVECs.  These findings are of great significance for the development of new plant-derived chemotherapy agents for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprSy_6_yWYx7Vg90H21EOLACvtfcHk0lj50FzZSq_mew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2rs7%252FO&md5=ae51790aae73f79867b9f71d0fc9c50b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.12659%2FMSM.902704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.902704%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DS.-Q.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.-X.%26aulast%3DXie%26aufirst%3DL.-P.%26aulast%3DLiu%26aufirst%3DJ.-C.%26atitle%3DJolkinolide%2520A%2520and%2520jolkinolide%2520B%2520inhibit%2520proliferation%2520of%2520A549%2520cells%2520and%2520activity%2520of%2520human%2520umbilical%2520vein%2520endothelial%2520cells%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2017%26volume%3D23%26spage%3D223%26epage%3D237%26doi%3D10.12659%2FMSM.902704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">The effects of jolkinolide B on HepG2 cells as revealed by <sup>1</sup>H-NMR-based metabolic profiling</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>842</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejphar.2018.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30355510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCktLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=842&publication_year=2019&pages=10-19&author=Y.+Yanauthor=Y.+Wangauthor=X.+Wangauthor=D.+Liuauthor=X.+Wuauthor=C.+Xuauthor=C.+Chenauthor=Z.+Li&title=The+effects+of+jolkinolide+B+on+HepG2+cells+as+revealed+by+1H-NMR-based+metabolic+profiling&doi=10.1016%2Fj.ejphar.2018.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of jolkinolide B on HepG2 cells as revealed by 1H-NMR-based metabolic profiling</span></div><div class="casAuthors">Yan, Yujing; Wang, Yingfeng; Wang, Xia; Liu, Dewen; Wu, Xiuyuan; Xu, Can; Chen, Chang; Li, Zhongfeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">842</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-19</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Jolkinolide B (JB), which is isolated from the dried root of Euphorbia fischeriana Steud., has been reported to possess various therapeutic effects, such as treatment of edema and abdominal distention and protection against acute lung injury, and it has also been reported to have anti-inflammatory even antitumor properties.  In the current work, a cellular metabolomics evaluation based on the NMR (NMR) approach was applied to investigate the mechanism of JB in HepG2 cells.  In addn., biol. assays such as the MTT assay, DAPI staining and the Annexin V-FITC/PI assay were implemented to evaluate cell viability and apoptosis in JB-treated cells.  Subsequently, we used multivariate statistical analyses, such as principal component anal. (PCA) and orthogonal projection to latent structure with discriminant anal. (OPLS-DA) to identify metabolic biomarkers.  In total, 36 metabolites in the cell ext. samples and 30 metabolites in the cell culture media samples were clearly identified to be altered after the treatment.  Variations in the specific metabolites suggested that HepG2 cells that were exposed to JB displayed the disordered effects in multiple metabolic pathways, such as the tricarboxylic acid cycle, amino acid metab., GSH synthesis and pyruvate metab.  NMR-based cell metabolomics provided a holistic method for the identification of JB's antitumor mechanisms and the exploration of its potential applications in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsq1oeOWaaALVg90H21EOLACvtfcHk0lj50FzZSq_mew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCktLrE&md5=f3b276a5abd725a3af711e2028a92fdc</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DThe%2520effects%2520of%2520jolkinolide%2520B%2520on%2520HepG2%2520cells%2520as%2520revealed%2520by%25201H-NMR-based%2520metabolic%2520profiling%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D842%26spage%3D10%26epage%3D19%26doi%3D10.1016%2Fj.ejphar.2018.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span> <span> </span><span class="NLM_article-title">Antimetastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1117</span>– <span class="NLM_lpage">1122</span>, <span class="refDoi"> DOI: 10.3892/ol.2015.3310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2015.3310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26622636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1117-1122&author=C.+Sunauthor=H.+Cuiauthor=H.+Yangauthor=X.+Duauthor=L.+Yueauthor=J.+Liuauthor=Y.+Lin&title=Antimetastatic+effect+of+jolkinolide+B+and+the+mechanism+of+activity+in+breast+cancer+MDA-MB-231+cells&doi=10.3892%2Fol.2015.3310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-metastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells</span></div><div class="casAuthors">Sun, Chao; Cui, Fiongxia; Yang, Hongyan; Du, Xiaohut; Yue, Liling; Liu, Jicheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Tumor metastasis is the main cause of mortality in cancer patients.  However, no effective therapies are currently available to prevent metastasis.  Cell adhesion to the extracellular matrix (ECM) is crucial in cancer progression and metastasis.  Thus, suppression of cell adhesion may be an effective therapeutic strategy for the prevention of metastasis.  In the present study, the anti-adhesion and anti-invasion effects of jolkinolide B, a diterpenoid compd. from Enphorbia fischeriana Steud, that were exerted through suppression of β1-integrin expression and phosphorylation of focal adhesion kinase (FAK) were examd. in human breast cancer MDA-MB-231 cells.  Jolkinolide B inhibited the adhesion of MDA-MB-231 cells to fibroneetin but not to poly-L-lysine.  In addn., olkinolidc B inhibited extracellular signal-regulated kinase (ERK) phosphorylation.  U0126, an ERK inhibitor, also suppressed the invasion and adhesion of MDA-MB-231 cells.  Overall, the present data demonstrated that jolkinolidc B is a novel inhibitor of FAK-mediated signaling pathways that is involved in decreasing cell adhe-sion and invasion.  M itogert-activated protein kinase/ERK kinase may play a crit. role in these effects, indicating that jolkinolide B possesses therapeutic potential for the treatment of breast cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJapX9PAs0jbVg90H21EOLACvtfcHk0lj50FzZSq_mew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOis70%253D&md5=d0867879826ee80c66241d781ad8b909</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.3892%2Fol.2015.3310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2015.3310%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26atitle%3DAntimetastatic%2520effect%2520of%2520jolkinolide%2520B%2520and%2520the%2520mechanism%2520of%2520activity%2520in%2520breast%2520cancer%2520MDA-MB-231%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2015%26volume%3D10%26spage%3D1117%26epage%3D1122%26doi%3D10.3892%2Fol.2015.3310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">36114</span>, <span class="refDoi"> DOI: 10.1038/srep36114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep36114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27796318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSitL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36114&author=C.+Gaoauthor=X.+Yanauthor=B.+Wangauthor=L.+Yuauthor=J.+Hanauthor=D.+Liauthor=Q.+Zheng&title=Jolkinolide+B+induces+apoptosis+and+inhibits+tumor+growth+in+mouse+melanoma+B16F10+cells+by+altering+glycolysis&doi=10.1038%2Fsrep36114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis</span></div><div class="casAuthors">Gao, Caixia; Yan, Xinyan; Wang, Bo; Yu, Lina; Han, Jichun; Li, Defang; Zheng, Qiusheng</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36114</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Most cancer cells preferentially rely on glycolysis to produce the energy (ATP, ATP) for growth and proliferation.  Emerging evidence demonstrates that the apoptosis in cancer cells could be closely assocd. with the inhibition of glycolysis.  In this study, we have found that jolkinolide B (JB), a bioactive diterpenoid extd. from the root of Euphorbia fischeriana Steud, induced tumor cells apoptosis and decreased the prodn. of ATP and lactic acid in mouse melanoma B16F10 cells.  Furthermore, we found that JB downregulated the mRNA expression of glucose transporter genes (Glut1, Glut3 and Glut4) and glycolysis-related kinase genes (Hk2 and Ldha) in B16F10 cells.  Moreover, treatment with JB upregulated the mRNA expression of pro-apoptosis genes (Bax), downregulated the mRNA expression of anti-apoptosis genes (Bcl-2, Caspase-3 and Caspase-9), decreased the potential of mitochondrial membrane and increased reactive oxygen species (ROS) levels in B16F10 cells.  Finally, intragastric administration of JB suppressed tumor growth and induced tumor apoptosis in mouse xenograft model of murine melanoma B16F10 cells.  Taken together, these results suggest that JB could induce apoptosis through the mitochondrial pathway and inhibit tumor growth.  The inhibition of glycolysis could play a crucial role in the induction of apoptosis in JB-treated B16F10 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE_uUACM62rrVg90H21EOLACvtfcHk0lj-830wiEWqbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSitL3K&md5=f0cc0c3765ae207bceaca7fad195170d</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1038%2Fsrep36114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36114%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DQ.%26atitle%3DJolkinolide%2520B%2520induces%2520apoptosis%2520and%2520inhibits%2520tumor%2520growth%2520in%2520mouse%2520melanoma%2520B16F10%2520cells%2520by%2520altering%2520glycolysis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36114%26doi%3D10.1038%2Fsrep36114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B from <i>Euphorbia fischeriana</i> Steud. induces apoptosis in human leukemic cell via JAK2/STAT3 pathways</span>. <i>Int. J. Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.5414/CP201807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5414%2FCP201807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23253949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC3s3jtlGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2013&pages=170-178&author=J.-H.+Wangauthor=K.+Zhangauthor=H.-Y.+Niuauthor=L.-H.+Shuauthor=D.-M.+Yueauthor=D.-Y.+Liauthor=P.+He&title=Jolkinolide+B+from+Euphorbia+fischeriana+Steud.+induces+apoptosis+in+human+leukemic+cell+via+JAK2%2FSTAT3+pathways&doi=10.5414%2FCP201807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways</span></div><div class="casAuthors">Wang Jia-He; Zhang Ke; Niu Hui-Yan; Shu Lin-Hua; Yue Dong-Mei; Li Dong- Yang; He Ping</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">170-8</span>
        ISSN:<span class="NLM_cas:issn">0946-1965</span>.
    </div><div class="casAbstract">Jolkinolide B from the roots of Euphorbia fischeriana Steud exhibits significant antitumor activities against several tumor lines.  Previous study has shown that Jolkinolide B could induce apoptosis in human leukemia cells.  However, the exact mechanism and signaling pathway involved in Jolkinolide B-induced apoptosis have not been fully elucidated.  In the present study, we found that Jolkinolide B reduced cell viability and induced apoptosis in dose- and time-dependent manner in human leukemic HL-60 and THP-1 cells.  The induction of apoptosis was accompanied by the downregulation of JAK2/STAT3.  Our results also suggest that expression of Bcl-2 and mitochondrial cytochrome c was dosedependently reduced following Jolkinolide B-treated THP-1 and HL-60 cells, whereas Jolkinolide B up-regulated the expression of Bax and cytosolic cytochrome c.  Moreover, we observed that Jolkinolide B treatment resulted in activation of caspase-3, -8, and -9.  JSI-124, a STAT-3 inhibitor, was able to block the negative effect of Jolkinolide B on cell apoptosis.  Taken together, our study for the first time suggests that Jolkinolide B is able to enhance apoptosis of human leukemic HL-60 and THP-1 cells, at least in part, through downregulation of JAK2/STAT3 and bcl-2, and upregulation of Bax and cytosolic cytochrome c.  Moreover, the triggering of caspase-3, -8, and -9 activation mediated apoptotic induction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScp4np4qQVT5w7prLlxLOzfW6udTcc2eavK7lpWw0tkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3jtlGiuw%253D%253D&md5=0712eb5c0a1158ac6c8ad603377be5f7</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.5414%2FCP201807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5414%252FCP201807%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.-H.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DNiu%26aufirst%3DH.-Y.%26aulast%3DShu%26aufirst%3DL.-H.%26aulast%3DYue%26aufirst%3DD.-M.%26aulast%3DLi%26aufirst%3DD.-Y.%26aulast%3DHe%26aufirst%3DP.%26atitle%3DJolkinolide%2520B%2520from%2520Euphorbia%2520fischeriana%2520Steud.%2520induces%2520apoptosis%2520in%2520human%2520leukemic%2520cell%2520via%2520JAK2%252FSTAT3%2520pathways%26jtitle%3DInt.%2520J.%2520Clin.%2520Pharmacol.%2520Ther.%26date%3D2013%26volume%3D51%26spage%3D170%26epage%3D178%26doi%3D10.5414%2FCP201807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-C.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.3892/or.2012.2113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2For.2012.2113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23129237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksl2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=212-218&author=H.-Y.+Xuauthor=Z.-W.+Chenauthor=J.-C.+Houauthor=F.-X.+Duauthor=J.-C.+Liu&title=Jolkinolide+B+induces+apoptosis+in+MCF-7+cells+through+inhibition+of+the+PI3K%2FAkt%2FmTOR+signaling+pathway&doi=10.3892%2For.2012.2113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway</span></div><div class="casAuthors">Xu, Hui-Yu; Chen, Zhi-Wei; Hou, Jin-Cai; Du, Feng-Xia; Liu, Ji-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">The aim of this study was to explore the mol. mechanisms of jolkinolide B (JB), which is extd. from the root of Euphorbia fischeriana Steud.  In this study, we found that JB, a diterpenoid from the traditional Chinese medicinal herb, strongly inhibited the PI3K/Akt/mTOR signaling pathway.  Furthermore, we evaluated the effects of JB on the proliferation and apoptosis of MCF-7 human breast cancer cells.  Our results showed significant induction of apoptosis in MCF-7 cells incubated with JB.  The viability of the MCF-7 cells was assessed by MTT assay.  Flow cytometry was used to detect apoptosis and cell cycle anal.  Transmission electron microscopy (TEM) anal. was used to observe cell morphol.  MCF-7 cells were s.c. inoculated into nude mice to study the in vivo antitumor effects of JB.  The growth of MCF-7 cells was inhibited and arrested in the S phase by JB.  The data showed significantly decreased tumor vol. and wt. in nude mice inoculated with MCF-7 cells.  In addn., treatment with JB was able to induce downregulation of cyclinDl, cyclinE, mTOR, p-PI3K and p-Akt, and upregulation of PTEN and p-eIF4E.  Collectively, JB-induced apoptosis of MCF-7 cells occurs through the PI3K/Akt/mTOR signaling pathway.  Furthermore, the PI3K/Akt signaling cascade plays a role in the induction of apoptosis in JB-treated cells.  These observations suggest that JB may have therapeutic applications in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Xm8_l4YBarVg90H21EOLACvtfcHk0lgPwG_dTSJUwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksl2hsw%253D%253D&md5=3163200098761a007b502b9c3aca8905</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.3892%2For.2012.2113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2012.2113%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.-Y.%26aulast%3DChen%26aufirst%3DZ.-W.%26aulast%3DHou%26aufirst%3DJ.-C.%26aulast%3DDu%26aufirst%3DF.-X.%26aulast%3DLiu%26aufirst%3DJ.-C.%26atitle%3DJolkinolide%2520B%2520induces%2520apoptosis%2520in%2520MCF-7%2520cells%2520through%2520inhibition%2520of%2520the%2520PI3K%252FAkt%252FmTOR%2520signaling%2520pathway%26jtitle%3DOncol.%2520Rep.%26date%3D2013%26volume%3D29%26spage%3D212%26epage%3D218%26doi%3D10.3892%2For.2012.2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.-Y.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca<sup>2+</sup>-mitochondria dependent pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">91223</span>– <span class="NLM_lpage">91237</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.20077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29207638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1M3otFyktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=91223-91237&author=J.+Zhangauthor=Y.+Wangauthor=Y.+Zhouauthor=Q.-Y.+He&title=Jolkinolide+B+induces+apoptosis+of+colorectal+carcinoma+through+ROS-ER+stress-Ca2%2B-mitochondria+dependent+pathway&doi=10.18632%2Foncotarget.20077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca(2+)-mitochondria dependent pathway</span></div><div class="casAuthors">Zhang Jing; Wang Yang; Zhou Ye; He Qing-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">91223-91237</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal carcinoma (CRC) remains one of the leading causes of death in cancer-related diseases.  In this study, we aimed to investigate the anticancer effect of Jolkinolide B (JB), a bioactive diterpenoid component isolated from the dried roots of Euphorbia fischeriana Steud, on CRC cells and its underlying mechanisms.  We found that JB suppressed the cell viability and colony formation of CRC cells, HT29 and SW620.  Annexin V/PI assay revealed that JB induced apoptosis in CRC cells, which was further confirmed by the increased expression of cleaved-caspase3 and cleaved-PARP. iTRAQ-based quantitative proteomics was performed to identify JB-regulated proteins in CRC cells.  Gene Ontology (GO) analysis revealed that these JB-regulated proteins were mainly involved in ER stress response, which was evidenced by the expression of ER stress marker proteins, HSP90, Bip and PDI.  Moreover, we found that JB provoked the generation of reactive oxygen species (ROS), and that inhibition of the ROS generation with N-acetyl L-cysteine could reverse the JB-induced apoptosis.  Confocal microscopy and flow cytometry showed that JB treatment enhanced intracellular and mitochondrial Ca(2+) level and JC-1 assay revealed a loss of mitochondrial membrane potential in CRC after JB treatment.  The mitochondrial Ca(2+) uptake and depolarization can be blocked by Ruthenium Red (RuRed), an inhibitor of mitochondrial Ca(2+) uniporter.  Taken together, we demonstrated that JB exerts its anticancer effect by ER stress-Ca(2+)-mitochondria signaling, suggesting the promising chemotherapeutic potential of JB for the treatment of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnMJHvdBDxTkH3Rlp_k91zfW6udTcc2eY8G2xHfAvjfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3otFyktg%253D%253D&md5=ac311c7c382e4e21b0a8b3b98bf0bfa7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20077%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DQ.-Y.%26atitle%3DJolkinolide%2520B%2520induces%2520apoptosis%2520of%2520colorectal%2520carcinoma%2520through%2520ROS-ER%2520stress-Ca2%252B-mitochondria%2520dependent%2520pathway%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D91223%26epage%3D91237%26doi%3D10.18632%2Foncotarget.20077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span> <span> </span><span class="NLM_article-title">Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">4967</span>– <span class="NLM_lpage">4974</span>, <span class="refDoi"> DOI: 10.1002/jcb.26742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjcb.26742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29384225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFWru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=4967-4974&author=X.+Gaoauthor=H.+Han&title=Jolkinolide+B+inhibits+glycolysis+by+downregulating+hexokinase+2+expression+through+inactivating+the+Akt%2FmTOR+pathway+in+non-small+cell+lung+cancer+cells&doi=10.1002%2Fjcb.26742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells</span></div><div class="casAuthors">Gao, Xiang; Han, Han</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4967-4974</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Jolkinolide B (JB), a bioactive compd. isolated from herbal medicine, has been found to inhibit tumor growth by altering glycolysis.  However, whether glycolysis is influenced by JB in non-small cell lung cancer (NSCLC) cells and the mechanism remain unknown.  The aim of the present study was to evaluate the effect of JB on the glycolysis in NSCLC cells and the underlying mol. mechanism.  The results showed that JB treatment inhibited cell viability of A549 and H1299 cells in a concn.-dependent manner.  JB reduced the glucose consumption, lactate prodn., and HK2 expression.  The expressions of p-Akt and p-mTOR were also decreased by JB treatment.  Knockdown of HK2 reduced glucose consumption and lactate prodn.  Inhibition of the Akt/mTOR pathway decreased HK2 expression and inhibited glycolysis.  In conclusion, the results indicated that JB inhibits glycolysis by down-regulating HK2 expression through inactivating the Akt/mTOR pathway in NSCLC cells, suggesting that JB might be a potential therapeutic agent for the treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLZlhhbSksW7Vg90H21EOLACvtfcHk0liL94eAB2nOvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFWru7k%253D&md5=3e3a56f04a97efb0f8280460d2b30e3b</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26742%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DH.%26atitle%3DJolkinolide%2520B%2520inhibits%2520glycolysis%2520by%2520downregulating%2520hexokinase%25202%2520expression%2520through%2520inactivating%2520the%2520Akt%252FmTOR%2520pathway%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D119%26spage%3D4967%26epage%3D4974%26doi%3D10.1002%2Fjcb.26742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Euphonoids A-G, cytotoxic diterpenoids from <i>Euphorbia fischeriana</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">112064</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2019.112064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2019.112064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31325614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2019&pages=112064&author=X.-L.+Yanauthor=J.-S.+Zhangauthor=J.-L.+Huangauthor=Y.+Zhangauthor=J.-Q.+Chenauthor=G.-H.+Tangauthor=S.+Yin&title=Euphonoids+A-G%2C+cytotoxic+diterpenoids+from+Euphorbia+fischeriana&doi=10.1016%2Fj.phytochem.2019.112064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Euphonoids A-G, cytotoxic diterpenoids from Euphorbia fischeriana</span></div><div class="casAuthors">Yan, Xue-Long; Zhang, Jun-Sheng; Huang, Jia-Luo; Zhang, Yao; Chen, Jia-Qi; Tang, Gui-Hua; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112064</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Seven previously undescribed polycyclic diterpenoids, euphonoids A-G, including four ent-abietanes, two ent-atisanes, and one ent-kaurene, along with 26 known analogs were isolated from the roots of Euphorbia fischeriana.  The structures of the undescribed compds. were elucidated by spectroscopic anal., ECD calcns., and single crystal X-ray diffraction.  Besides, the structure of a previously reported ent-abietane diterpenoid, fischeriabietane A, was revised.  All the isolates were screened for the cytotoxicities against five cancer cell lines.  Euphonoid A(I), fischeriabietane A, 11-oxo-ebracteolatanolide B, caudicifolin, jolkinolide B, and methyl-8,11-3-dihydroxy-12-oxo-ent-abietadi-13,15(17)-ene-16-oate showed significant inhibitory activities against human prostate cancer C4-2B and C4-2B/ENZR cell lines, with IC50 values being less than 10 μM.  The brief structure-activity relationships (SARs) of these diterpenoids were also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmhm6LsBkMALVg90H21EOLACvtfcHk0lhEq-N3KWg3-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtb3L&md5=3bc0fd85816e6cfa2c1ed56031bcab5e</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2019.112064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2019.112064%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DX.-L.%26aulast%3DZhang%26aufirst%3DJ.-S.%26aulast%3DHuang%26aufirst%3DJ.-L.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.-Q.%26aulast%3DTang%26aufirst%3DG.-H.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DEuphonoids%2520A-G%252C%2520cytotoxic%2520diterpenoids%2520from%2520Euphorbia%2520fischeriana%26jtitle%3DPhytochemistry%26date%3D2019%26volume%3D166%26spage%3D112064%26doi%3D10.1016%2Fj.phytochem.2019.112064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, G.-W.</span></span> <span> </span><span class="NLM_article-title">Diterpenoids from the roots of <i>Euphorbia fischeriana</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1021/np0600088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np0600088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=967-970&author=Y.-B.+Wangauthor=R.+Huangauthor=H.-B.+Wangauthor=H.-Z.+Jinauthor=L.-G.+Louauthor=G.-W.+Qin&title=Diterpenoids+from+the+roots+of+Euphorbia+fischeriana&doi=10.1021%2Fnp0600088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Diterpenoids from the Roots of Euphorbia fischeriana</span></div><div class="casAuthors">Wang, Yu-Bo; Huang, Rong; Wang, Hong-Bing; Jin, Hui-Zi; Lou, Li-Guang; Qin, Guo-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">967-970</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">From the dried roots of Euphorbia fischeriana, 7 new diterpenoids, 3α,17-dihydroxy-ent-pimara-8(14),15-diene (1), 7β,11β,12β-trihydroxy-ent-abieta-8(14),13(15)-dien-16,12-olide (2), 17-acetoxyjolkinolide B (3), 13β-hydroxy-ent-abiet-8(14)-en-7-one (4), 12-deoxyphorbaldehyde-13-acetate (5) 12-deoxyphorbaldehyde-13-hexadecacetate (6), and 12-deoxyphorbol-13-(9Z)-octadecanoate-20-acetate (7), and 2 known compds., 12-deoxyphorbol-13-decanoate (8) and prostratin (9), were isolated.  The structures of the new compds. were elucidated on the basis of spectroscopic anal.  The structure of compd. 1 was confirmed by single-crystal X-ray crystallog.  Compds. 3 and 8 exhibited potent cytotoxic activity to Ramos B cells with IC50 values of 0.023 and 0.0051 μg/mL, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrusZB34QGnQbVg90H21EOLACvtfcHk0liEm8oPuHQDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSnsLs%253D&md5=7f3d672c2606e54a8aeabba287624255</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fnp0600088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp0600088%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-B.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.-B.%26aulast%3DJin%26aufirst%3DH.-Z.%26aulast%3DLou%26aufirst%3DL.-G.%26aulast%3DQin%26aufirst%3DG.-W.%26atitle%3DDiterpenoids%2520from%2520the%2520roots%2520of%2520Euphorbia%2520fischeriana%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2006%26volume%3D69%26spage%3D967%26epage%3D970%26doi%3D10.1021%2Fnp0600088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H. H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, Z.-D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic diterpenoids from the roots of <i>Euphorbia ebracteolata</i></span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1055/s-2005-864102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fs-2005-864102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=15856412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFKrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2005&pages=349-354&author=H.-M.+Shiauthor=I.+D.+Williamsauthor=H.+H.-Y.+Sungauthor=H.-X.+Zhuauthor=N.+Y.+Ipauthor=Z.-D.+Min&title=Cytotoxic+diterpenoids+from+the+roots+of+Euphorbia+ebracteolata&doi=10.1055%2Fs-2005-864102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic diterpenoids from the roots of Euphorbia ebracteolata</span></div><div class="casAuthors">Shi, Hai-Ming; Williams, Ian D.; Sung, Herman H.-Y.; Zhu, Hua-Xu; Ip, Nancy Y.; Min, Zhi-Da</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Three new diterpenoids, yuexiandajisu D (1), E (2) and F were isolated from the roots of Euphorbia ebracteolata, along with eight known diterpenoids, jolkinolide B (4), jolkinolide A, ent-11α-hydroxyabieta-8(14),13(15)-dien-16,12α-olide (6), ent-(13S)-hydroxyatis-16-ene-3,14-dione, ent-3β,(13S)-dihydroxyatis-16-en-14-one, ent-3-oxokaurane-16α,17-diol, ent-16α,17-dihydroxyatisan-3-one and ent-atisane-3β,16α,17-triol.  The structures of all compds. were deduced using spectroscopic methods and confirmed for 1 and 2 by single-crystal x-ray diffraction.  A biogenetic pathway for the formation of 1 and 2 is proposed briefly.  Cytotoxic activities were evaluated against ANA-1, B 16 and Jurkat tumor cells.  Jolkinolide B (4) displayed modest activity on ANA-1, B 16 and Jurkat tumor cells with IC50 values 4.46×10-2, 4.48×10-2, 6.47×10-2 μM, and ent-11α-hydroxyabieta-8(14), 13(15)-dien-16,12α-olide (6) showed significant activity against ANA-1 and Jurkat cells with IC50 values 7.12×10-3 and 1.79×10-2 μM.  Compd. 1 was found to be slightly active against ANA-1 cells with an IC50 value 2.88×10-1 μM.  Structure-activity relationships of isolated compds. are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3wl36G1yevbVg90H21EOLACvtfcHk0liEm8oPuHQDvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFKrsbY%253D&md5=9ec32a892333c65856fa82976c3f507c</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1055%2Fs-2005-864102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2005-864102%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DH.-M.%26aulast%3DWilliams%26aufirst%3DI.%2BD.%26aulast%3DSung%26aufirst%3DH.%2BH.-Y.%26aulast%3DZhu%26aufirst%3DH.-X.%26aulast%3DIp%26aufirst%3DN.%2BY.%26aulast%3DMin%26aufirst%3DZ.-D.%26atitle%3DCytotoxic%2520diterpenoids%2520from%2520the%2520roots%2520of%2520Euphorbia%2520ebracteolata%26jtitle%3DPlanta%2520Med.%26date%3D2005%26volume%3D71%26spage%3D349%26epage%3D354%26doi%3D10.1055%2Fs-2005-864102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mangisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tembu, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nthambeleni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langat, M. K.</span></span> <span> </span><span class="NLM_article-title"><i>ent</i>-Abietane diterpenoids from <i>Suregada zanzibariensis</i> Baill. (Euphorbiaceae), their cytotoxic and anticancer properties</span>. <i>Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3240</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1080/14786419.2018.1470628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F14786419.2018.1470628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29741101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptFCmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=3240-3247&author=M.+Mangisaauthor=V.+J.+Tembuauthor=G.+Foucheauthor=R.+Nthambeleniauthor=X.+Peterauthor=M.+K.+Langat&title=ent-Abietane+diterpenoids+from+Suregada+zanzibariensis+Baill.+%28Euphorbiaceae%29%2C+their+cytotoxic+and+anticancer+properties&doi=10.1080%2F14786419.2018.1470628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-abietane diterpenoids from Suregada zanzibariensis Baill. (Euphorbiaceae), their cytotoxic and anticancer properties</span></div><div class="casAuthors">Mangisa, Mandisa; Tembu, Vuyelwa J.; Fouche, Gerda; Nthambeleni, Rudzani; Peter, Xolani; Langat, Moses K.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3240-3247</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The stem bark ext. of Suregada zanzibariensis afforded a previously undescribed ent-abietane diterpenoid trivially named mangiolide (1) and a known jolkinolide B (2) via anticancer bioassay-guided fractionation.  The CH2Cl2:MeOH ext. of S. zanzibariensis was initially analyzed for its anticancer properties against three cancer cell lines, renal (TK10), melanoma (UACC62), and breast (MCF7) and was found to be potent at low μg/mL ranges.  Compd. (1), 6α-acetoxy-14-keto-ent-abieta-7(8),13(15)-diene-16,12-olide (mangiolide) inhibited the growth of renal (TK10) with a GIC50 of 0.02 μg/mL; a GIC50 of 0.03 μg/mL for melanoma (UACC62) and a GIC50 of 0.05 μg/mL for breast (MCF7) cancer cell lines.  Compd. (2), 8,13-diepoxy-13,15-ent-abietene-16,12-olide (jolkinolide B) inhibited the growth (GIC50) of the cell lines at 3.31 μg/mL for renal (TK10), 0.94 μg/mL for melanoma (UACC62) and 2.99 μg/mL for the breast (MCF7).  The structures were established on the basis of their spectroscopic anal. and the abs. stereostructures assigned using electronic CD (ECD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUFKcj0oWxH7Vg90H21EOLACvtfcHk0li8koPz_0ov4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptFCmsbg%253D&md5=86a162097e0f608cc9783d99764d1224</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1080%2F14786419.2018.1470628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786419.2018.1470628%26sid%3Dliteratum%253Aachs%26aulast%3DMangisa%26aufirst%3DM.%26aulast%3DTembu%26aufirst%3DV.%2BJ.%26aulast%3DFouche%26aufirst%3DG.%26aulast%3DNthambeleni%26aufirst%3DR.%26aulast%3DPeter%26aufirst%3DX.%26aulast%3DLangat%26aufirst%3DM.%2BK.%26atitle%3Dent-Abietane%2520diterpenoids%2520from%2520Suregada%2520zanzibariensis%2520Baill.%2520%2528Euphorbiaceae%2529%252C%2520their%2520cytotoxic%2520and%2520anticancer%2520properties%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2019%26volume%3D33%26spage%3D3240%26epage%3D3247%26doi%3D10.1080%2F14786419.2018.1470628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span> <span> </span><span class="NLM_article-title">17-Hydroxyjolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">7302</span>– <span class="NLM_lpage">7310</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-0462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F0008-5472.CAN-09-0462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19706767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=7302-7310&author=Y.+Wangauthor=X.+Maauthor=S.+Yanauthor=S.+Shenauthor=H.+Zhuauthor=Y.+Guauthor=H.+Wangauthor=G.+Qinauthor=Q.+Yu&title=17-Hydroxyjolkinolide+B+inhibits+signal+transducers+and+activators+of+transcription+3+signaling+by+covalently+cross-linking+Janus+kinases+and+induces+apoptosis+of+human+cancer+cells&doi=10.1158%2F0008-5472.CAN-09-0462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">17-Hydroxy-jolkinolide B Inhibits Signal Transducers and Activators of Transcription 3 Signaling by Covalently Cross-Linking Janus Kinases and Induces Apoptosis of Human Cancer Cells</span></div><div class="casAuthors">Wang, Ying; Ma, Xiuquan; Yan, Shousheng; Shen, Shensi; Zhu, Huiling; Gu, Yuan; Wang, Hongbing; Qin, Guowei; Yu, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7302-7310</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutive activation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway occurs frequently in cancer cells and contributes to oncogenesis.  Among the members of STAT family, STAT3 plays a pivotal role in the development and progression of human tumors.  The STAT3-mediated signaling pathway has been recognized as a promising anticancer target.  Here, we show that 17-Hydroxy-jolkinolide B (HJB), a diterpenoid from the Chinese medicinal herb Euphorbia fischeriana Steud, strongly inhibits interleukin (IL)-6-induced as well as constitutive STAT3 activation.  Furthermore, we show that HJB directly targets the JAK family kinases, JAK1, JAK2, and TYK2, by inducing dimerization of the JAKs via crosslinking.  Addn. of DTT or glutathione prevents the JAK crosslinking and blocks the inhibitory effects of HJB on IL-6-induced STAT3 activation, suggesting that HJB may react with cystein residues of JAKs to form covalent bonds that inactivate JAKs.  Liq. chromatog./mass spectrometry anal. confirmed that each HJB reacted with two thiols.  The effect of HJB on the JAK/STAT3 pathway is specific as HJB has no effect on platelet-derived growth factor, epidermal growth factor, or insulin-like growth factor I signaling pathways.  Finally, we show that HJB inhibits growth and induces apoptosis of tumor cells, particularly those tumor cells with constitutively activated STAT3.  We propose that the natural compd. HJB is a promising anticancer drug candidate as a potent STAT3 signaling inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpns_2dXS-p4bVg90H21EOLACvtfcHk0li8koPz_0ov4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaku7rO&md5=29eb6931e70cc6c7b2616c8aa58ce287</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-0462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-0462%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DG.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3D17-Hydroxyjolkinolide%2520B%2520inhibits%2520signal%2520transducers%2520and%2520activators%2520of%2520transcription%25203%2520signaling%2520by%2520covalently%2520cross-linking%2520Janus%2520kinases%2520and%2520induces%2520apoptosis%2520of%2520human%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D7302%26epage%3D7310%26doi%3D10.1158%2F0008-5472.CAN-09-0462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, G.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span> <span> </span><span class="NLM_article-title">17-Acetoxyjolkinolide B irreversibly inhibits IκB kinase and induces apoptosis of cancer cells</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1523</span>– <span class="NLM_lpage">1532</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1535-7163.MCT-08-0263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=18566223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVSktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1523-1532&author=S.-S.+Yanauthor=Y.+Liauthor=Y.+Wangauthor=S.-S.+Shenauthor=Y.+Guauthor=H.-B.+Wangauthor=G.-W.+Qinauthor=Q.+Yu&title=17-Acetoxyjolkinolide+B+irreversibly+inhibits+I%CE%BAB+kinase+and+induces+apoptosis+of+cancer+cells&doi=10.1158%2F1535-7163.MCT-08-0263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">17-Acetoxyjolkinolide B irreversibly inhibits IκB kinase and induces apoptosis of tumor cells</span></div><div class="casAuthors">Yan, Shou-Sheng; Li, Ying; Wang, Ying; Shen, Shen-Si; Gu, Yuan; Wang, Hong-Bing; Qin, Guo-Wei; Yu, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1523-1532</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Nuclear factor-κB (NF-κB) is critically important for tumor cell survival, growth, angiogenesis, and metastasis.  One of the key events in the NF-κB signaling is the activation of inhibitor of NF-κB kinase (IKK) in response to stimuli of various cytokines.  We have identified 17-acetoxyjolkinolide B (17-AJB) from a traditional Chinese medicinal herb Euphorbia fischeriana Steud as a novel small-mol. inhibitor of IKK.  17-AJB effectively inhibited tumor necrosis factor-α-induced NF-κB activation and induced apoptosis of tumor cells.  17-AJB had no effect on binding of tumor necrosis factor-α to its receptor or on binding of NF-κB to DNA.  It inhibited NF-κB nuclear translocation.  Detailed anal. revealed that the direct target of 17-AJB was IKK.  17-AJB kept IKK in its phosphorylated form irreversibly.  This irreversible modification of IKK inactivated its kinase activity, leading to its failure to activate NF-κB.  The effect of 17-AJB on IKK was specific.  It had no effect on other kinases such as p38, p44/42, and JNK.  In addn., 17-AJB induced apoptosis in tumor cells.  The effects of 17-AJB on apoptosis correlated with inhibition of expression of the NF-κB-regulated genes.  Taken together, our data suggest that 17-AJB is a novel type NF-κB pathway inhibitor.  Its unique interaction mechanism with IKK may render it a strong apoptosis inducer of tumor cells and a novel type anticancer drug candidate. [Mol Cancer Ther 2008;7(6):1523-32].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDk1JrGK0qfbVg90H21EOLACvtfcHk0ljfWzJlX5PXBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVSktLs%253D&md5=cf9f32601c3193cca747326f180bd0a1</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0263%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.-S.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DS.-S.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.-B.%26aulast%3DQin%26aufirst%3DG.-W.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3D17-Acetoxyjolkinolide%2520B%2520irreversibly%2520inhibits%2520I%25CE%25BAB%2520kinase%2520and%2520induces%2520apoptosis%2520of%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1523%26epage%3D1532%26doi%3D10.1158%2F1535-7163.MCT-08-0263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shriwas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span> <span> </span><span class="NLM_article-title">Plant-derived glucose transport inhibitors with potential antitumor activity</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1002/ptr.6587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fptr.6587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31823431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2020&pages=1027-1040&author=P.+Shriwasauthor=X.+Chenauthor=A.+D.+Kinghornauthor=Y.+Ren&title=Plant-derived+glucose+transport+inhibitors+with+potential+antitumor+activity&doi=10.1002%2Fptr.6587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Plant-derived glucose transport inhibitors with potential antitumor activity</span></div><div class="casAuthors">Shriwas, Pratik; Chen, Xiaozhuo; Kinghorn, A. Douglas; Ren, Yulin</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1027-1040</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Glucose, a key nutrient utilized by human cells to provide cellular energy and a carbon source for biomass synthesis, is internalized in cells via glucose transporters that regulate glucose homeostasis throughout the human body.  Glucose transporters have been used as important targets for the discovery of new drugs to treat cancer, diabetes, and heart disease, owing to their abnormal expression during these disease conditions.  Thus far, several glucose transport inhibitors have been used in clin. trials, and increasing nos. of natural products have been characterized as potential anticancer agents targeting glucose transport.  The present review focuses on natural product glucose transport inhibitors of plant origin, including alkaloids, flavonoids and other phenolic compds., and isoprenoids, with their potential antitumor properties also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpggQdy9_urVg90H21EOLACvtfcHk0liL0jdfMoxa3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFKntLg%253D&md5=97fa2d7593242669420fa98e96716b39</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1002%2Fptr.6587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.6587%26sid%3Dliteratum%253Aachs%26aulast%3DShriwas%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DRen%26aufirst%3DY.%26atitle%3DPlant-derived%2520glucose%2520transport%2520inhibitors%2520with%2520potential%2520antitumor%2520activity%26jtitle%3DPhytother.%2520Res.%26date%3D2020%26volume%3D34%26spage%3D1027%26epage%3D1040%26doi%3D10.1002%2Fptr.6587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, R.</span></span> <span> </span><span class="NLM_article-title">Structures of nagilactones E and F and biological activity of nagilactones as plant growth regulator</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1246/cl.1972.759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1246%2Fcl.1972.759" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1972&pages=759-762&author=Y.+Hayashiauthor=J.+Yokoiauthor=Y.+Watanabeauthor=T.+Sakanauthor=Y.+Masudaauthor=R.+Yamamoto&title=Structures+of+nagilactones+E+and+F+and+biological+activity+of+nagilactones+as+plant+growth+regulator&doi=10.1246%2Fcl.1972.759"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1246%2Fcl.1972.759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.1972.759%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DYokoi%26aufirst%3DJ.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DSakan%26aufirst%3DT.%26aulast%3DMasuda%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DR.%26atitle%3DStructures%2520of%2520nagilactones%2520E%2520and%2520F%2520and%2520biological%2520activity%2520of%2520nagilactones%2520as%2520plant%2520growth%2520regulator%26jtitle%3DChem.%2520Lett.%26date%3D1972%26volume%3D1%26spage%3D759%26epage%3D762%26doi%3D10.1246%2Fcl.1972.759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic bisnor- and norditerpene dilactones having 7α,8α-epoxy-9,11-enolide substructure from <i>Podocarpus macrophyllus</i> D. DON</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">668</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1248/cpb.57.668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fcpb.57.668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19571410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=668-679&author=K.+Satoauthor=Y.+Inabaauthor=H.-S.+Parkauthor=T.+Akiyamaauthor=T.+Koyamaauthor=H.+Fukayaauthor=Y.+Aoyagiauthor=K.+Takeya&title=Cytotoxic+bisnor-+and+norditerpene+dilactones+having+7%CE%B1%2C8%CE%B1-epoxy-9%2C11-enolide+substructure+from+Podocarpus+macrophyllus+D.+DON&doi=10.1248%2Fcpb.57.668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic bisnor- and norditerpene dilactones having 7α,8α-epoxy-9,11-enolide substructure from Podocarpus macrophyllus D. DON</span></div><div class="casAuthors">Sato, Kimihiko; Inaba, Yasunori; Park, Hyun-Sun; Akiyama, Toshiyuki; Koyama, Tetsuo; Fukaya, Haruhiko; Aoyagi, Yutaka; Takeya, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">668-679</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Fourteen new bisnor- and norditerpene dilactones, makilactones E-R, having a 7α:8α-epoxy-9,11-enolide substructure, were isolated from a methanolic ext. of the root and the bark of Podocarpus macrophyllus D. DON (Podocarpaceae) with thirteen known bisnor- and norditerpenoids, and the structures of those new bisnor- and norditerpenoids were detd. on the basis of their spectroscopic studies.  Of the thirteen known ones isolated, the structures of two, i.e., podolactone B and inumakilactone B, were revised on the basis of x-ray crystallog. anal. and spectroscopic anal.  Many of the compds. of this type isolated in this study showed potent cytotoxic activities against P388 murine leukemia cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVfZl54pd0rVg90H21EOLACvtfcHk0ljAJeJavTiBSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGhurzO&md5=ce08c024ce02bb6fd5d110ffba46669c</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1248%2Fcpb.57.668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.57.668%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DInaba%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DH.-S.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DT.%26aulast%3DFukaya%26aufirst%3DH.%26aulast%3DAoyagi%26aufirst%3DY.%26aulast%3DTakeya%26aufirst%3DK.%26atitle%3DCytotoxic%2520bisnor-%2520and%2520norditerpene%2520dilactones%2520having%25207%25CE%25B1%252C8%25CE%25B1-epoxy-9%252C11-enolide%2520substructure%2520from%2520Podocarpus%2520macrophyllus%2520D.%2520DON%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2009%26volume%3D57%26spage%3D668%26epage%3D679%26doi%3D10.1248%2Fcpb.57.668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.-S.</span></span> <span> </span><span class="NLM_article-title">Two new anti-proliferative C<sub>18</sub>-norditerpenes from the roots of <i>Podocarpus macrophyllus</i></span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>, <span class="NLM_elocation-id">e1800043</span> <span class="refDoi"> DOI: 10.1002/cbdv.201800043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fcbdv.201800043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29573148" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&author=Y.-Y.+Qiauthor=J.+Suauthor=Z.-J.+Zhangauthor=L.-W.+Liauthor=M.+Fanauthor=Y.+Zhuauthor=X.-D.+Wuauthor=Q.-S.+Zhao&title=Two+new+anti-proliferative+C18-norditerpenes+from+the+roots+of+Podocarpus+macrophyllus&doi=10.1002%2Fcbdv.201800043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201800043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201800043%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DY.-Y.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.-J.%26aulast%3DLi%26aufirst%3DL.-W.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.-D.%26aulast%3DZhao%26aufirst%3DQ.-S.%26atitle%3DTwo%2520new%2520anti-proliferative%2520C18-norditerpenes%2520from%2520the%2520roots%2520of%2520Podocarpus%2520macrophyllus%26jtitle%3DChem.%2520Biodiversity%26date%3D2018%26volume%3D15%26doi%3D10.1002%2Fcbdv.201800043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span> <span> </span><span class="NLM_article-title">Norditerpenoids and dinorditerpenoids from the seeds of <i>Podocarpus nagi</i> as cytotoxic agents and autophagy inducers</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2117</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.7b00347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.7b00347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2jtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=2110-2117&author=Z.-L.+Fengauthor=L.-L.+Zhangauthor=Y.-D.+Zhengauthor=Q.-Y.+Liuauthor=J.-X.+Liuauthor=L.+Fengauthor=L.+Huangauthor=Q.-W.+Zhangauthor=J.-J.+Luauthor=L.-G.+Lin&title=Norditerpenoids+and+dinorditerpenoids+from+the+seeds+of+Podocarpus+nagi+as+cytotoxic+agents+and+autophagy+inducers&doi=10.1021%2Facs.jnatprod.7b00347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Norditerpenoids and Dinorditerpenoids from the Seeds of Podocarpus nagi as Cytotoxic Agents and Autophagy Inducers</span></div><div class="casAuthors">Feng, Zhe-Ling; Zhang, Le-Le; Zheng, Yuan-Dong; Liu, Qian-Yu; Liu, Jing-Xin; Feng, Lu; Huang, Li; Zhang, Qing-Wen; Lu, Jin-Jian; Lin, Li-Gen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2110-2117</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Nine new norditerpenoids and dinorditerpenoids, 2-oxonagilactone A, 7β-hydroxynagilactone D, nagilactones K and L (I), 3β-hydroxynagilactone L, 2β-hydroxynagilactone L (II), 3-epi-15-hydroxynagilactone D, 1α-chloro-2β,3β,15-trihydroxynagilactone L, and 15-hydroxynagilactone L, were isolated from the seeds of Podocarpus nagi, along with eight known analogs.  The structures of the new compds. were established based on detailed NMR and HRESIMS anal., as well as from their ECD spectra.  The abs. configuration of the known compd. 1-deoxy-2α-hydroxynagilactone A was confirmed by single-crystal X-ray diffraction.  All of the isolates were tested for their cytotoxic activities against cancer cells.  The results indicated that compds. I and II, as well as several known compds., displayed cytotoxicity against A2780 and HEY cancer cells.  Among the new compds., II showed IC50 values of less than 2.5 μM against the two cell lines used.  Furthermore, compd. II induced autophagic flux in A2780 cells, as evidenced by an enhanced expression level of the autophagy marker phosphatidylethanolamine-modified microtubule-assocd. protein light-chain 3 (LC3-II) and increased mRFP-GFP-LC3 puncta.  Also, compd. II activated the c-Jun N-terminal kinase (JNK) pathway, while pretreatment with the JNK inhibitor SP600125 decreased compd. II-induced autophagy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-68I7dtwcf7Vg90H21EOLACvtfcHk0ljAJeJavTiBSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2jtr3I&md5=c8fe5362ec33be06710b0ed760761cf1</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.7b00347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.7b00347%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DZ.-L.%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DZheng%26aufirst%3DY.-D.%26aulast%3DLiu%26aufirst%3DQ.-Y.%26aulast%3DLiu%26aufirst%3DJ.-X.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.-W.%26aulast%3DLu%26aufirst%3DJ.-J.%26aulast%3DLin%26aufirst%3DL.-G.%26atitle%3DNorditerpenoids%2520and%2520dinorditerpenoids%2520from%2520the%2520seeds%2520of%2520Podocarpus%2520nagi%2520as%2520cytotoxic%2520agents%2520and%2520autophagy%2520inducers%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D2110%26epage%3D2117%26doi%3D10.1021%2Facs.jnatprod.7b00347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Downregulation of cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>830</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2018.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejphar.2018.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29680228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotlOrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=830&publication_year=2018&pages=17-25&author=L.-L.+Zhangauthor=Z.-L.+Fengauthor=M.-X.+Suauthor=X.-M.+Jiangauthor=X.+Chenauthor=Y.+Wangauthor=A.+Liauthor=L.-G.+Linauthor=J.-J.+Lu&title=Downregulation+of+cyclin+B1+mediates+nagilactone+E-induced+G2+phase+cell+cycle+arrest+in+non-small+cell+lung+cancer+cells&doi=10.1016%2Fj.ejphar.2018.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells</span></div><div class="casAuthors">Zhang, Le-Le; Feng, Zhe-Ling; Su, Min-Xia; Jiang, Xiao-Ming; Chen, Xiuping; Wang, Yitao; Li, Ao; Lin, Li-Gen; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">830</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-25</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) is one of the most common forms and leading causes of cancer-related mortality worldwide, and discovery of new effective drugs still remains imperative to improve the survival rate.  Nagilactone E (NLE) is a natural product isolated from Podocarpus nagi seeds, which has been used as raw materials for edible oil and industrial oil extn.  This study aimed to investigate the anticancer potential of NLE against NSCLC A549 and NCI-H1975 cells.  MTT assay revealed that NLE inhibited the proliferation of A549 and NCI-H1975 cells with IC50s of 5.18±0.49 and 3.57±0.29μM, resp.  NLE treatment inhibited clone formation in both cancer cell lines.  Cell cycle anal. indicated that NLE treatment effectively induced G2 phase cell cycle arrest in A549 and NCI-H1975 cells.  NLE downregulated the phosphorylation of cdc2 (Tyr15) and cdc25C (Ser216) as well as the expression level of the protein kinase Wee1 in concn.- and time-dependent manners.  In addn., NLE treatment decreased the protein level of Cyclin B1 as well as its nuclear localization, which might decrease the activity of the Cyclin B1/cdc2 complex and induce G2 phase arrest.  Long-term NLE treatment also induced caspase-dependent cell apoptosis, as evidenced by increase in Annexin V pos. cells and the cleavage of PARP.  To sum, NLE inhibited proliferation, induced G2 phase arrest, and triggered caspase-dependent apoptosis in NSCLC cells, suggesting it to be a potential leading compd. for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e30sb8oV57Vg90H21EOLACvtfcHk0lj8lsSmo1jxNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotlOrtrc%253D&md5=18299c46f235b29de1620ea1d37af219</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2018.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DFeng%26aufirst%3DZ.-L.%26aulast%3DSu%26aufirst%3DM.-X.%26aulast%3DJiang%26aufirst%3DX.-M.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-G.%26aulast%3DLu%26aufirst%3DJ.-J.%26atitle%3DDownregulation%2520of%2520cyclin%2520B1%2520mediates%2520nagilactone%2520E-induced%2520G2%2520phase%2520cell%2520cycle%2520arrest%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D830%26spage%3D17%26epage%3D25%26doi%3D10.1016%2Fj.ejphar.2018.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration, and invasion in non-small cell lung cancer cells</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2018.09.222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phymed.2018.09.222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30599910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCiu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=32-39&author=L.-L.+Zhangauthor=X.-M.+Jiangauthor=M.-Y.+Huangauthor=Z.-L.+Fengauthor=X.+Chenauthor=Y.+Wangauthor=H.+Liauthor=A.+Liauthor=L.-G.+Linauthor=J.-J.+Lu&title=Nagilactone+E+suppresses+TGF-%CE%B21-induced+epithelial-mesenchymal+transition%2C+migration%2C+and+invasion+in+non-small+cell+lung+cancer+cells&doi=10.1016%2Fj.phymed.2018.09.222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells</span></div><div class="casAuthors">Zhang, Le-Le; Jiang, Xiao-Ming; Huang, Mu-Yang; Feng, Zhe-Ling; Chen, Xiuping; Wang, Yitao; Li, Hua; Li, Ao; Lin, Li-Gen; Lu, Jin-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-39</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death around the world.  Epithelial-mesenchymal transition (EMT) has been documented to increase motility and invasiveness of cancer cells, which promotes cancer metastasis.  This study aims to investigate the inhibitory effects and mechanisms of the dinorditerpenoids and norditerpenoids isolated from the seeds of Podocarpus nagi against transforming growth factor (TGF)-β1-induced EMT.  A series of dinorditerpenoids and norditerpenoids were isolated from the seeds of P. nagi.  Western blot and quant. real-time PCR assays were performed to det. the expression levels of relative proteins and mRNA, along with immunofluorescence, Smad-binding element (SBE)-luciferase and chromatin immunopptn. (ChIP) assays for the mechanism study.  Transwell assays were conducted to det. the effect of the compds. on cell migration and invasion.  Nagilactone E (NLE) showed the superior inhibitory effect against TGF-β1-induced EMT.  NLE treatment dramatically inhibited TGF-β1-induced expression of EMT markers in A549 cells.  Mechanism study indicated that NLE markedly suppressed TGF-β1-induced Smad2 and Smad3 activation and nuclear translocation.  SBE-luciferase and ChIP assays showed that NLE inhibited the combining of Smad3 to SBE in the promoters of the cell signaling factors.  NLE co-treatment attenuated TGF-β1-induced up-regulation of the protein and mRNA levels of TGF-β receptor TβRI.  Furthermore, NLE inhibited TGF-β1-stimulated cell migration and invasion, as well as up-regulation of the key signaling proteins related with migration and invasion.  NLE inhibited TGF-β/Smad signaling pathway, thereafter suppressed TGF-β1-induced EMT, migration and invasion in NSCLC A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQArBZLm-girVg90H21EOLACvtfcHk0lj8lsSmo1jxNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCiu7zE&md5=743ab953a037e6cfe7db0602607943a5</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2018.09.222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2018.09.222%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DJiang%26aufirst%3DX.-M.%26aulast%3DHuang%26aufirst%3DM.-Y.%26aulast%3DFeng%26aufirst%3DZ.-L.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-G.%26aulast%3DLu%26aufirst%3DJ.-J.%26atitle%3DNagilactone%2520E%2520suppresses%2520TGF-%25CE%25B21-induced%2520epithelial-mesenchymal%2520transition%252C%2520migration%252C%2520and%2520invasion%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DPhytomedicine%26date%3D2019%26volume%3D52%26spage%3D32%26epage%3D39%26doi%3D10.1016%2Fj.phymed.2018.09.222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/s41401-019-0332-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41401-019-0332-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32047261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivVCntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2020&pages=698-705&author=L.-L.+Zhangauthor=J.+Guoauthor=X.-M.+Jiangauthor=X.-P.+Chenauthor=Y.-T.+Wangauthor=A.+Liauthor=L.-G.+Linauthor=H.+Liauthor=J.-J.+Lu&title=Identification+of+nagilactone+E+as+a+protein+synthesis+inhibitor+with+anticancer+activity&doi=10.1038%2Fs41401-019-0332-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity</span></div><div class="casAuthors">Zhang, Le-le; Guo, Jing; Jiang, Xiao-ming; Chen, Xiu-ping; Wang, Yi-tao; Li, Ao; Lin, Li-gen; Li, Hua; Lu, Jin-jian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Norditerpenoids and dinorditerpenoids represent diterpenoids widely distributed in the genus Podocarpus with notable chem. structures and biol. activities.  We previously reported that nagilactone E (NLE), a dinorditerpenoid isolated from Podocarpus nagi, possessed anticancer effects against lung cancer cells in vitro.  In this study we investigated the in vivo effect of NLE against lung cancer as well as the underlying mechanisms.  We administered NLE (10 mg·kg-1·d-1, i.p.) to CB-17/SCID mice bearing human lung cancer cell line A549 xenograft for 3 wk.  We found that NLE administration significantly suppressed the tumor growth without obvious adverse effects.  Thereafter, RNA sequencing (RNA-seq) anal. was performed to study the mechanisms of NLE.  The effects of NLE on A549 cells have been illustrated by GO and pathway enrichment analyses.  CMap dataset anal. supported NLE to be a potential protein synthesis inhibitor.  The inhibitory effect of NLE on synthesis of total de novo protein was confirmed in Click-iT assay.  Using the pcDNA3-RLUC-POLIRES-FLUC luciferase assay we further demonstrated that NLE inhibited both cap-dependent and cap-independent translation.  Finally, mol. docking revealed the low-energy binding conformations of NLE and its potential target RIOK2.  In conclusion, NLE is a protein synthesis inhibitor with anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjqfNwVQCb7LVg90H21EOLACvtfcHk0lj8lsSmo1jxNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivVCntrk%253D&md5=e2b86e9113d0397f9cb79ae46e3b8586</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1038%2Fs41401-019-0332-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41401-019-0332-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-L.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.-M.%26aulast%3DChen%26aufirst%3DX.-P.%26aulast%3DWang%26aufirst%3DY.-T.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-G.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DJ.-J.%26atitle%3DIdentification%2520of%2520nagilactone%2520E%2520as%2520a%2520protein%2520synthesis%2520inhibitor%2520with%2520anticancer%2520activity%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2020%26volume%3D41%26spage%3D698%26epage%3D705%26doi%3D10.1038%2Fs41401-019-0332-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, C.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span> <span> </span><span class="NLM_article-title">7α,8α-Epoxynagilactones and their glucosides from the twigs of <i>Podocarpus nagi</i>: Isolation, structures, and cytotoxic activities</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2018.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fitote.2018.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29355751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2018&pages=174-183&author=Y.-D.+Zhengauthor=G.+Baiauthor=C.+Tangauthor=C.-Q.+Keauthor=S.+Yaoauthor=L.-J.+Tongauthor=F.+Fengauthor=Y.+Liauthor=J.+Dingauthor=H.+Xieauthor=Y.+Ye&title=7%CE%B1%2C8%CE%B1-Epoxynagilactones+and+their+glucosides+from+the+twigs+of+Podocarpus+nagi%3A+Isolation%2C+structures%2C+and+cytotoxic+activities&doi=10.1016%2Fj.fitote.2018.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">7α,8α-Epoxynagilactones and their glucosides from the twigs of Podocarpus nagi: Isolation, structures, and cytotoxic activities</span></div><div class="casAuthors">Zheng, Yuan-Dong; Bai, Gang; Tang, Chunping; Ke, Chang-Qiang; Yao, Sheng; Tong, Lin-Jiang; Feng, Fang; Li, Yan; Ding, Jian; Xie, Hua; Ye, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-183</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A phytochem. investigation of twigs of Podocarpus nagi resulted in the identification of eight new type B nagilactones (1-8), all bearing a 7α,8α-epoxy-9(11)-enolide substructure, along with two known analogs (9-10).  Their structures were detd. on the basis of spectroscopic anal., including HRESIMS, IR and NMR expts., and X-ray crystallog. anal.  In vitro cytotoxic assay exhibited that compds. 1, 2, 9 and 10 could induce antiproliferation against three different types of human cancer cells while compds. 3 and 5 were inactive.  Notably, the IC50 value of compd. 1 is 0.208 μM for A431 human epidermoid carcinoma cells, reaching the same level as the pos. control combretastatin A-4 (0.104 μM).  Furthermore, compd. 1 performed a strong inhibition of cancer cells by triggering apoptosis and arresting the cell cycle at G1 phase.  These results unfold potential anticancer therapeutic applications of type B nagilactones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmaqjyL11AR7Vg90H21EOLACvtfcHk0liZolarSmKmVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Ogsrs%253D&md5=b45cc49e338a9eb0f49ba632bc63a13f</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2018.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2018.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.-D.%26aulast%3DBai%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKe%26aufirst%3DC.-Q.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DL.-J.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DY.%26atitle%3D7%25CE%25B1%252C8%25CE%25B1-Epoxynagilactones%2520and%2520their%2520glucosides%2520from%2520the%2520twigs%2520of%2520Podocarpus%2520nagi%253A%2520Isolation%252C%2520structures%252C%2520and%2520cytotoxic%2520activities%26jtitle%3DFitoterapia%26date%3D2018%26volume%3D125%26spage%3D174%26epage%3D183%26doi%3D10.1016%2Fj.fitote.2018.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span> <span> </span><span class="NLM_article-title">New cytotoxic nor- and bisnorditerpene dilactones, makilactones A-D, from <i>Podocarpus macrophyllus</i> D. Don</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1462</span>, <span class="refDoi"> DOI: 10.3987/COM-08-11624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3987%2FCOM-08-11624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFais7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=1453-1462&author=K.+Satoauthor=K.+Sugawaraauthor=H.+Takeuchiauthor=H.-S.+Parkauthor=T.+Akiyamaauthor=T.+Koyamaauthor=H.+Fukayaauthor=Y.+Aoyagiauthor=K.+Takeya&title=New+cytotoxic+nor-+and+bisnorditerpene+dilactones%2C+makilactones+A-D%2C+from+Podocarpus+macrophyllus+D.+Don&doi=10.3987%2FCOM-08-11624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">New cytotoxic nor- and bisnorditerpene dilactones, makilactones A-D, from Podocarpus macrophyllus D. Don</span></div><div class="casAuthors">Sato, Kimihiko; Sugawara, Keito; Takeuchi, Hirono; Park, Hyun-Sun; Akiyama, Toshiyuki; Koyama, Tetsuo; Fukaya, Haruhiko; Aoyagi, Yutaka; Takeya, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1453-1462</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">Four new nor- and bisnorditerpene dilactones, makilactones A-D, were isolated from a MeOH ext. of bark and root of Podocarpus macrophyllus D. Don (Podocarpaceae) with three known diterpene dilactones.  The structures of the new nor- and bisnorditerpene dilactones having a 7:8,9:11-dienolide moiety were detd. by the spectroscopic studies, including 1D and 2D NMR spectral anal., and single crystal X-Ray crystallog. anal.  Two of the presently isolated compds. were shown to be very strongly cytotoxic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqld6qvelYB17Vg90H21EOLACvtfcHk0liZolarSmKmVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFais7w%253D&md5=3505c0e33bdcaaf13973c29fb4df32a0</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.3987%2FCOM-08-11624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-08-11624%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DSugawara%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DH.-S.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DT.%26aulast%3DFukaya%26aufirst%3DH.%26aulast%3DAoyagi%26aufirst%3DY.%26aulast%3DTakeya%26aufirst%3DK.%26atitle%3DNew%2520cytotoxic%2520nor-%2520and%2520bisnorditerpene%2520dilactones%252C%2520makilactones%2520A-D%252C%2520from%2520Podocarpus%2520macrophyllus%2520D.%2520Don%26jtitle%3DHeterocycles%26date%3D2009%26volume%3D78%26spage%3D1453%26epage%3D1462%26doi%3D10.3987%2FCOM-08-11624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicklow, D. T.</span></span> <span> </span><span class="NLM_article-title">Isolation and identification of two new biologically active norditerpene dilactones from <i>Aspergillus wentii</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(80)83075-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0031-9422%2880%2983075-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL3MXkslGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=1157-1161&author=J.+W.+Dornerauthor=R.+J.+Coleauthor=J.+P.+Springerauthor=R.+H.+Coxauthor=H.+Cutlerauthor=D.+T.+Wicklow&title=Isolation+and+identification+of+two+new+biologically+active+norditerpene+dilactones+from+Aspergillus+wentii&doi=10.1016%2F0031-9422%2880%2983075-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and identification of two new biologically active norditerpene dilactones from Aspergillus wentii</span></div><div class="casAuthors">Dorner, Joe W.; Cole, Richard J.; Springer, James P.; Cox, Richard H.; Cutler, Horace; Wicklow, Donald T.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1157-61</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    </div><div class="casAbstract">Culture exts. of A. wentii yielded 2 new biol.-active norditerpenoid lactones, named wentilactone A (I; R2 = O) and B (I; R = H).  The structure of wentilactone A was detd. by single crystal x-ray diffraction and CD, and that of wentilactone B by NMR.  Both inhibited wheat coleptile growth and wentilactone A had an LD50 of 7.0 mg/kg when administered orally to 1 day-old chickens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozHIe2H1KgJbVg90H21EOLACvtfcHk0liZolarSmKmVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkslGguw%253D%253D&md5=68df04d65d0270bf474892b7c7921a35</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2880%2983075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252880%252983075-5%26sid%3Dliteratum%253Aachs%26aulast%3DDorner%26aufirst%3DJ.%2BW.%26aulast%3DCole%26aufirst%3DR.%2BJ.%26aulast%3DSpringer%26aufirst%3DJ.%2BP.%26aulast%3DCox%26aufirst%3DR.%2BH.%26aulast%3DCutler%26aufirst%3DH.%26aulast%3DWicklow%26aufirst%3DD.%2BT.%26atitle%3DIsolation%2520and%2520identification%2520of%2520two%2520new%2520biologically%2520active%2520norditerpene%2520dilactones%2520from%2520Aspergillus%2520wentii%26jtitle%3DPhytochemistry%26date%3D1980%26volume%3D19%26spage%3D1157%26epage%3D1161%26doi%3D10.1016%2F0031-9422%2880%2983075-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.-G.</span></span> <span> </span><span class="NLM_article-title">Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus <i>Aspergillus wentii</i> EN-48</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1021/np2006742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np2006742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVWjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=148-152&author=H.-F.+Sunauthor=X.-M.+Liauthor=L.+Mengauthor=C.-M.+Cuiauthor=S.-S.+Gaoauthor=C.-S.+Liauthor=C.-G.+Huangauthor=B.-G.+Wang&title=Asperolides+A-C%2C+tetranorlabdane+diterpenoids+from+the+marine+alga-derived+endophytic+fungus+Aspergillus+wentii+EN-48&doi=10.1021%2Fnp2006742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Asperolides A-C, tetranorlabdane diterpenoids from the marine alga-derived endophytic fungus Aspergillus wentii EN-48</span></div><div class="casAuthors">Sun, Hao-Fen; Li, Xiao-Ming; Meng, Li; Cui, Chuan-Ming; Gao, Shu-Shan; Li, Chun-Shun; Huang, Cai-Guo; Wang, Bin-Gui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Bioassay-guided fractionation of the culture ext. of Aspergillus wentii EN-48, an endophytic fungus isolated from an unidentified marine brown algal species of the genus Sargassum, led to the isolation of three new tetranorlabdane diterpenoids, asperolides A-C (1-3), and five related derivs. (4-8).  The structures of these compds. were established on the basis of spectroscopic interpretation, and compd. 1 was confirmed by X-ray crystallog. anal.  The abs. configuration of 1 was detd. by application of the modified Mosher's method.  An X-ray structure for wentilactone B (6) is also reported.  Compds. 1-8 were evaluated for cytotoxic and antibacterial activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofgKQoOoOXfbVg90H21EOLACvtfcHk0lhKcJI2up9TNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVWjsrg%253D&md5=33c831d97deb5b820ea2acc77df5df18</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fnp2006742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp2006742%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.-F.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DC.-M.%26aulast%3DGao%26aufirst%3DS.-S.%26aulast%3DLi%26aufirst%3DC.-S.%26aulast%3DHuang%26aufirst%3DC.-G.%26aulast%3DWang%26aufirst%3DB.-G.%26atitle%3DAsperolides%2520A-C%252C%2520tetranorlabdane%2520diterpenoids%2520from%2520the%2520marine%2520alga-derived%2520endophytic%2520fungus%2520Aspergillus%2520wentii%2520EN-48%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D148%26epage%3D152%26doi%3D10.1021%2Fnp2006742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e952</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fcddis.2013.484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24309939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=C.+Lvauthor=Y.+Hongauthor=L.+Miaoauthor=C.+Liauthor=G.+Xuauthor=S.+Weiauthor=B.+Wangauthor=C.+Huangauthor=B.+Jiao&title=Wentilactone+A+as+a+novel+potential+antitumor+agent+induces+apoptosis+and+G2%2FM+arrest+of+human+lung+carcinoma+cells%2C+and+is+mediated+by+HRas-GTP+accumulation+to+excessively+activate+the+Ras%2FRaf%2FERK%2Fp53-p21+pathway&doi=10.1038%2Fcddis.2013.484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway</span></div><div class="casAuthors">Lv, C.; Hong, Y.; Miao, L.; Li, C.; Xu, G.; Wei, S.; Wang, B.; Huang, C.; Jiao, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">e952</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy remains the common therapeutic for patients with lung cancer.  Novel, selective antitumor agents are pressingly needed.  This study is the first to investigate a different, however, effective antitumor drug candidate Wentilactone A (WA) for its development as a novel agent.  In NCI-H460 and NCI-H446 cell lines, WA triggered G2/M phase arrest and mitochondrial-related apoptosis, accompanying the accumulation of reactive oxygen species (ROS).  It also induced activation of mitogen-activated protein kinase and p53 and increased expression of p21.  When we pre-treated cells with ERK, JNK, p38, p53 inhibitor or NAC followed by WA treatment, only ERK and p53 inhibitors blocked WA-induced apoptosis and G2/M arrest.  We further obsd. Ras (HRas, KRas and NRas) and Raf activation, and found that WA treatment increased HRas-Raf activation.  Knockdown of HRas by using small interfering RNA (siRNA) abolished WA-induced apoptosis and G2/M arrest.  HRas siRNA also halted Raf, ERK, p53 activation and p21 accumulation.  Mol. docking anal. suggested that WA could bind to HRas-GTP, causing accumulation of Ras-GTP and excessive activation of Raf/ERK/p53-p21.  The direct binding affinity was confirmed by surface plasmon resonance (SPR).  In vivo, WA suppressed tumor growth without adverse toxicity and presented the same mechanism as that in vitro.  Taken together, these findings suggest WA as a promising novel, potent and selective antitumor drug candidate for lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLAvfEEmYMwLVg90H21EOLACvtfcHk0lhKcJI2up9TNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL&md5=f93de635f1df60ed2b44eacd80ede458</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.484%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DC.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DWentilactone%2520A%2520as%2520a%2520novel%2520potential%2520antitumor%2520agent%2520induces%2520apoptosis%2520and%2520G2%252FM%2520arrest%2520of%2520human%2520lung%2520carcinoma%2520cells%252C%2520and%2520is%2520mediated%2520by%2520HRas-GTP%2520accumulation%2520to%2520excessively%2520activate%2520the%2520Ras%252FRaf%252FERK%252Fp53-p21%2520pathway%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.-G.</span></span> <span> </span><span class="NLM_article-title">Tetranorlabdane diterpenoids from the deep sea sediment-derived fungus <i>Aspergillus wentii</i> SD-310</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">881</span>, <span class="refDoi"> DOI: 10.1055/s-0042-102965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1055%2Fs-0042-102965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27257768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpt1Khs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2016&pages=877-881&author=X.-D.+Liauthor=X.+Liauthor=X.-M.+Liauthor=G.-M.+Xuauthor=P.+Zhangauthor=L.-H.+Mengauthor=B.-G.+Wang&title=Tetranorlabdane+diterpenoids+from+the+deep+sea+sediment-derived+fungus+Aspergillus+wentii+SD-310&doi=10.1055%2Fs-0042-102965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Tetranorlabdane Diterpenoids from the Deep Sea Sediment-Derived Fungus Aspergillus wentii SD-310</span></div><div class="casAuthors">Li, Xiao-Dong; Li, Xin; Li, Xiao-Ming; Xu, Gang-Ming; Zhang, Peng; Meng, Ling-Hong; Wang, Bin-Gui</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">9/10</span>),
    <span class="NLM_cas:pages">877-881</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Two new tetranorlabdane diterpenoids, asperolides D (I) and E (II), along with 6 related known congeners, were isolated and identified from the culture ext. of the deep sea sediment-derived fungus Aspergillus wentii SD-310.  The structures of these compds. were established on the basis of spectroscopic interpretation, and the skeleton and abs. configurations of I and II were detd. by X-ray crystallog. anal.  I and II were evaluated for their cytotoxic activity against 7 tumor cell lines and antibacterial activity against 2 human and 8 aquatic pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNsI5Zgyu2SLVg90H21EOLACvtfcHk0lhKcJI2up9TNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpt1Khs7Y%253D&md5=5d805a45d72fd6ef7de87ec6e1f9638e</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1055%2Fs-0042-102965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0042-102965%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.-D.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DXu%26aufirst%3DG.-M.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DMeng%26aufirst%3DL.-H.%26aulast%3DWang%26aufirst%3DB.-G.%26atitle%3DTetranorlabdane%2520diterpenoids%2520from%2520the%2520deep%2520sea%2520sediment-derived%2520fungus%2520Aspergillus%2520wentii%2520SD-310%26jtitle%3DPlanta%2520Med.%26date%3D2016%26volume%3D82%26spage%3D877%26epage%3D881%26doi%3D10.1055%2Fs-0042-102965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrero, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrador, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quilez
del Moral, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdivia, M. V.</span></span> <span> </span><span class="NLM_article-title">A convenient synthesis of A-ring-functionalized podolactones. Revision of the structure of wentilactone B</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1379</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.1021/ol0257070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0257070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1WgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=1379-1382&author=A.+F.+Barreroauthor=M.+M.+Herradorauthor=J.+F.+Quilez%0Adel+Moralauthor=M.+V.+Valdivia&title=A+convenient+synthesis+of+A-ring-functionalized+podolactones.+Revision+of+the+structure+of+wentilactone+B&doi=10.1021%2Fol0257070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A Convenient Synthesis of A-Ring-Functionalized Podolactones. Revision of the Structure of Wentilactone B</span></div><div class="casAuthors">Barrero, Alejandro F.; Herrador, Maria M.; Quilez del Moral, Jose F.; Valdivia, Monica V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1379-1382</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new route to podolactones functionalized in the A ring has been achieved.  Two key steps were employed in this synthesis, the construction of the bicyclic skeleton via a Mn(III)-mediated radical cyclization and the transformation of this bicyclic intermediate into the tetracyclic podolactone skeleton through a Pd (II)-mediated bislactonization of the corresponding conjugate diene.  The reported synthesis of 3β-hydroxy-13,14,15,16-tetranorlabda-7,9(11)-dien-(19,6β),(12,17)-diolide (I) let the authors reassign the structure of wentilactone B, for which structure I was wrongly reported.  The hydroxyl group should be in the 2α-position in Wentilactone B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog4LSs01YaA7Vg90H21EOLACvtfcHk0liBz5mpFowtrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1WgsLY%253D&md5=69f98549487ed201881fb042be28650e</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fol0257070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0257070%26sid%3Dliteratum%253Aachs%26aulast%3DBarrero%26aufirst%3DA.%2BF.%26aulast%3DHerrador%26aufirst%3DM.%2BM.%26aulast%3DQuilez%2Bdel%2BMoral%26aufirst%3DJ.%2BF.%26aulast%3DValdivia%26aufirst%3DM.%2BV.%26atitle%3DA%2520convenient%2520synthesis%2520of%2520A-ring-functionalized%2520podolactones.%2520Revision%2520of%2520the%2520structure%2520of%2520wentilactone%2520B%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D1379%26epage%3D1382%26doi%3D10.1021%2Fol0257070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Wentilactone B from <i>Aspergillus wentii</i> induces apoptosis and inhibits proliferation and migration of human hepatoma SMMC-7721 cells</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1964</span>– <span class="NLM_lpage">1971</span>, <span class="refDoi"> DOI: 10.1248/bpb.b12-00368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fbpb.b12-00368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22972522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1OisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=1964-1971&author=Z.+Zhangauthor=L.+Miaoauthor=W.+Sunauthor=B.+Jiaoauthor=B.+Wangauthor=L.+Yaoauthor=C.+Huang&title=Wentilactone+B+from+Aspergillus+wentii+induces+apoptosis+and+inhibits+proliferation+and+migration+of+human+hepatoma+SMMC-7721+cells&doi=10.1248%2Fbpb.b12-00368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone B from Aspergillus wentii induces apoptosis and inhibits proliferation and migration of human hepatoma SMMC-7721 cells</span></div><div class="casAuthors">Zhang, Zhenwei; Miao, Lei; Sun, Weizhang; Jiao, Binghua; Wang, Bingui; Yao, Li; Huang, Caiguo</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1964-1971</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Wentilactone B (EN-48-57) is one of the six derivs. sepd. from Aspergillus wentii (EN-48).  Of these derivs., Wentilactone B exerted a more significant antibacterial and cytotoxic activity in several tumor cell lines.  The present study demonstrates that Wentilactone B could efficiently induce SMMC-7721 cells apoptosis, but not normal hepatic cells, as measured by an inverted microscope, 4',6-diamidino-2-phenylindole staining and flow cytometry.  In addn., Wentilactone B could inhibit the metastasis of SMMC-7721 cells, which was detected by colony formation, scratch migration and a transwell assay, and could induce a series of intracellular events, including the down-regulation of CD44 and epidermal growth factor receptor proteins.  In conclusion, Wentilactone B inhibited the growth of SMMC-7721 cells by triggering apoptosis and inhibiting metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCm5tf98lmSbVg90H21EOLACvtfcHk0liBz5mpFowtrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1OisLc%253D&md5=c136620ad14b204502d2b924ca42e9d3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b12-00368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b12-00368%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DJiao%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DWentilactone%2520B%2520from%2520Aspergillus%2520wentii%2520induces%2520apoptosis%2520and%2520inhibits%2520proliferation%2520and%2520migration%2520of%2520human%2520hepatoma%2520SMMC-7721%2520cells%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D35%26spage%3D1964%26epage%3D1971%26doi%3D10.1248%2Fbpb.b12-00368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e657</span> <span class="refDoi"> DOI: 10.1038/cddis.2013.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fcddis.2013.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23744357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&author=Z.+Zhangauthor=L.+Miaoauthor=C.+Lvauthor=H.+Sunauthor=S.+Weiauthor=B.+Wangauthor=C.+Huangauthor=B.+Jiao&title=Wentilactone+B+induces+G2%2FM+phase+arrest+and+apoptosis+via+the+Ras%2FRaf%2FMAPK+signaling+pathway+in+human+hepatoma+SMMC-7721+cells&doi=10.1038%2Fcddis.2013.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells</span></div><div class="casAuthors">Zhang, Z.; Miao, L.; Lv, C.; Sun, H.; Wei, S.; Wang, B.; Huang, C.; Jiao, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">e657</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is generally acknowledged as the most common primary malignant tumor, and it is known to be resistant to conventional chemotherapy.  Wentilactone B (WB), a tetranorditerpenoid deriv. extd. from the marine algae-derived endophytic fungus Aspergillus wentii EN-48, has been shown to trigger apoptosis and inhibit metastasis in HCC cell lines.  However, the mechanisms of its antitumor activity remain to be elucidated.  We report here that WB could significantly induce cell cycle arrest at G2 phase and mitochondrial-related apoptosis, accompanying the accumulation of reactive oxygen species (ROS).  Addnl., treatment with WB induced phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), but not p38 MAP kinase.  Among the pathway inhibitors examd., only SP600125 (JNK inhibitor) markedly reversed WB-induced apoptosis, and only U0126 (ERK inhibitor) significantly blocked WB-triggered G2 phase arrest.  We also found that WB treatment increased both Ras and Raf activation, and transfection of cells with dominant-neg. Ras (RasN17) abolished WB-induced apoptosis and G2 phase arrest in SMMC-7721 cells.  Furthermore, the results of inverse docking (INVDOCK) anal. suggested that WB could bind to Ras-GTP, and the direct binding affinity was also confirmed by surface plasmon resonance (SPR).  Finally, in vivo, WB suppressed tumor growth in mouse xenograft models.  Taken together, these results indicate that WB induced G2/M phase arrest and apoptosis in human hepatoma SMMC-7721 cells via the Ras/Raf/ERK and Ras/Raf/JNK signaling pathways, and this agent may be a potentially useful compd. for developing anticancer agents for HCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQmCgMcUzW6bVg90H21EOLACvtfcHk0liBz5mpFowtrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyku7bN&md5=3a7fba508cce7f99e5d43c4671611a8d</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.182%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DLv%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DWentilactone%2520B%2520induces%2520G2%252FM%2520phase%2520arrest%2520and%2520apoptosis%2520via%2520the%2520Ras%252FRaf%252FMAPK%2520signaling%2520pathway%2520in%2520human%2520hepatoma%2520SMMC-7721%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26doi%3D10.1038%2Fcddis.2013.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.3390/md11020316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmd11020316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23434831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1aksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=316-331&author=C.+Lvauthor=W.+Sunauthor=H.+Sunauthor=S.+Weiauthor=R.+Chenauthor=B.+Wangauthor=C.+Huang&title=Asperolide+A%2C+a+marine-derived+tetranorditerpenoid%2C+induces+G2%2FM+arrest+in+human+NCI-H460+lung+carcinoma+cells%2C+is+mediated+by+p53-p21+stabilization+and+modulated+by+Ras%2FRaf%2FMEK%2FERK+signaling+pathway&doi=10.3390%2Fmd11020316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway</span></div><div class="casAuthors">Lv, Cuiting; Sun, Wenxia; Sun, Haofen; Wei, Shanjian; Chen, Ruohua; Wang, Bingui; Huang, Caiguo</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">316-331</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">Here we first demonstrate that asperolide A, a very recently reported marine-derived tetranorditerpenoid, leads to the inhibition of NCI-H460 lung carcinoma cell proliferation by G2/M arrest with the activation of the Ras/Raf/MEK/ERK signaling and p53-dependent p21 pathway.  Treatment with 35 μM asperolide A (2 × IC50) resulted in a significant increase in the proportion of G2/M phase cells, about a 2.9-fold increase during 48 h.  Immunoblot assays demonstrated time-dependent inhibition of G2/M regulatory proteins.  Moreover, asperolide A significantly activated MAP kinases (ERK1/2, JNK and p38 MAP kinase) by phosphorylation, and only the inhibition of ERK activation by PD98059 reversed downregulation of G2/M regulatory proteins CDC2, and suppressed upregulation of p21 and p-p53 levels.  Transfection of cells with dominant-neg. Ras (RasN17) mutant genes up-regulated asperolide A-induced the decrease of cyclin B1 and CDC2, suppressed Raf, ERK activity and p53-p21 expression, and at last, abolished G2/M arrest.  This study indicates that asperolide A-induced G2/M arrest in human NCI-H460 lung carcinoma cells relys on the participation of the Ras/Raf/MEK/ERK signaling pathway in p53-p21 stabilization.  An in vivo study with asperolide A illustrated a marked inhibition of tumor growth, and little toxicity compared to Cisplatin therapy.  Overall, these findings provide potential effectiveness and a theor. basis for the therapeutic use of asperolide A in the treatment of malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5tisdlpSCjrVg90H21EOLACvtfcHk0lhZGbZJSQMgJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1aksLs%253D&md5=1b4c45712f1040e7938e405a35e6f51d</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3390%2Fmd11020316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd11020316%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DAsperolide%2520A%252C%2520a%2520marine-derived%2520tetranorditerpenoid%252C%2520induces%2520G2%252FM%2520arrest%2520in%2520human%2520NCI-H460%2520lung%2520carcinoma%2520cells%252C%2520is%2520mediated%2520by%2520p53-p21%2520stabilization%2520and%2520modulated%2520by%2520Ras%252FRaf%252FMEK%252FERK%2520signaling%2520pathway%26jtitle%3DMar.%2520Drugs%26date%3D2013%26volume%3D11%26spage%3D316%26epage%3D331%26doi%3D10.3390%2Fmd11020316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaRonde-LeBlanc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodawer, A.</span></span> <span> </span><span class="NLM_article-title">A family portrait of the RIO kinases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">37297</span>– <span class="NLM_lpage">37300</span>, <span class="refDoi"> DOI: 10.1074/jbc.R500013200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.R500013200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=16183636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2isr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=37297-37300&author=N.+LaRonde-LeBlancauthor=A.+Wlodawer&title=A+family+portrait+of+the+RIO+kinases&doi=10.1074%2Fjbc.R500013200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">A family portrait of the RIO kinases</span></div><div class="casAuthors">LaRonde-LeBlanc, Nicole; Wlodawer, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">37297-37300</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  The RIO family of atypical serine protein kinases was first characterized only recently.  It consists of enzymes that contain a unique domain with a characteristic kinase sequence motif and usually some addnl. domains.  At least 2 RIO proteins, Rio1 and Rio2, are present in organisms varying from Archaea to humans, with a third Rio3 subfamily present only in multicellular eukaryotes.  Yeast Rio1 and Rio2 proteins have been implicated in the processing of 20 S pre-rRNA and are necessary for survival of the cells.  Crystal structures of Archaeoglobus fulgidus Rio1 and Rio2 have shown that whereas the overall fold of these enzymes resembles typical protein kinases, some of the structural domains, particularly those involved in peptide substrate binding, are not present.  The mode of binding of nucleotides also differs from that found in typical protein kinases.  Although it has been shown that both Rio1 and Rio2 have the enzymic activity of kinases and are capable of autophosphorylation, the biol. substrates of RIO proteins and their full biol. role still remain to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEw2a7RXg-9rVg90H21EOLACvtfcHk0lhZGbZJSQMgJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2isr%252FO&md5=cd4d7b8d5be167df4dea5ee338ad9289</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R500013200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R500013200%26sid%3Dliteratum%253Aachs%26aulast%3DLaRonde-LeBlanc%26aufirst%3DN.%26aulast%3DWlodawer%26aufirst%3DA.%26atitle%3DA%2520family%2520portrait%2520of%2520the%2520RIO%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D37297%26epage%3D37300%26doi%3D10.1074%2Fjbc.R500013200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, M.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.-S.</span></span> <span> </span><span class="NLM_article-title">High expression of RIOK2 and NOB1 predict human non-small cell lung cancer outcomes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">28666</span>, <span class="refDoi"> DOI: 10.1038/srep28666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep28666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27346559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKhsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=28666&author=K.+Liuauthor=H.-L.+Chenauthor=S.+Wangauthor=M.-M.+Guauthor=X.-M.+Chenauthor=S.-L.+Zhangauthor=K.-J.+Yuauthor=Q.-S.+You&title=High+expression+of+RIOK2+and+NOB1+predict+human+non-small+cell+lung+cancer+outcomes&doi=10.1038%2Fsrep28666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes</span></div><div class="casAuthors">Liu, Kun; Chen, Hong-Lin; Wang, Shuo; Gu, Ming-Ming; Chen, Xin-Ming; Zhang, Shuang-Long; Yu, Kang-Jun; You, Qing-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28666</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide.  However, there is a shortage of suitable diagnostic markers for early stages of NSCLC, and therapeutic targets are limited.  Right open reading frame (Rio) kinase 2 (RIOK2) and Nin one binding (NOB1) protein are important accessory factors in ribosome assembly and are highly expressed in malignant tumors; moreover, they interact with each other.  However, the RIOK2 expression profile and its clin. significance as well as NOB1's mechanism in NSCLC remain unknown.  In this study, NSCLC cell lines and 15 NSCLC tumor tissues (paired with adjacent normal lung tissues) were collected for a real-time quant. PCR (RT-qPCR) anal.  In addn., 153 NSCLC cases and 27 normal lung tissues were used in an immunohistochem. anal. to evaluate the RIOK2 and NOB1 expression profiles, their clinicopathol. factors in NSCLC and their correlations with prognoses.  RIOK2 and NOB1 were highly expressed in NSCLC cells and tissues, and their expression profiles were significantly assocd. with the Tumor Node Metastasis (TNM) clin. stage, lymph node metastasis, and differentiation.  RIOK2 expression was correlated with NOB1.  The results suggested that simultaneously detg. the expression of RIOK2 and NOB1 will improve the diagnostic rate in early stages of NSCLC.  Moreover, RIOK2 and NOB1 might be potential targets for NSCLC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYCGUvnqqnXrVg90H21EOLACvtfcHk0lhZGbZJSQMgJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKhsrfJ&md5=b55f1aa2cdccd1b3d7414b0e9f911f33</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fsrep28666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep28666%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.-L.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DM.-M.%26aulast%3DChen%26aufirst%3DX.-M.%26aulast%3DZhang%26aufirst%3DS.-L.%26aulast%3DYu%26aufirst%3DK.-J.%26aulast%3DYou%26aufirst%3DQ.-S.%26atitle%3DHigh%2520expression%2520of%2520RIOK2%2520and%2520NOB1%2520predict%2520human%2520non-small%2520cell%2520lung%2520cancer%2520outcomes%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D28666%26doi%3D10.1038%2Fsrep28666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span> <span> </span><span class="NLM_article-title">3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from <i>Podocarpus nagi</i>, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1578</span>– <span class="NLM_lpage">1586</span>, <span class="refDoi"> DOI: 10.1038/s41401-019-0254-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41401-019-0254-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31201357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3M3mvFKrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=1578-1586&author=H.+Shanauthor=S.+Yaoauthor=Y.+Yeauthor=Q.+Yu&title=3-Deoxy-2%CE%B2%2C16-dihydroxynagilactone+E%2C+a+natural+compound+from+Podocarpus+nagi%2C+preferentially+inhibits+JAK2%2FSTAT3+signaling+by+allosterically+interacting+with+the+regulatory+domain+of+JAK2+and+induces+apoptosis+of+cancer+cells&doi=10.1038%2Fs41401-019-0254-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells</span></div><div class="casAuthors">Shan Hui; Yu Qiang; Shan Hui; Yao Sheng; Ye Yang; Yu Qiang; Yao Sheng; Ye Yang</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1578-1586</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways, especially the JAK2/STAT3 pathway, play vital roles in the development of many malignancies.  Overactivation of STAT3 promotes cancer cell survival and proliferation.  Therefore, the JAK2/STAT3-signaling pathway has been considered a promising target for cancer therapy.  In this study, we identified a natural compound 3-deoxy-2β,16-dihydroxynagilactone E (B6) from the traditional Chinese medicinal plant Podocarpus nagi as a potent inhibitor of STAT3 signaling.  B6 preferentially inhibited the phosphorylation of STAT3 by interacting with and inactivating JAK2, the main upstream kinase of STAT3.  B6 dose-dependently inhibited IL-6-induced STAT3 signaling with an IC50 of 0.2 μM.  In contrast to other JAK2 inhibitors, B6 did not interact with the catalytic domain but instead with the FERM-SH2 domain of JAK2.  This interaction was JAK-specific since B6 had little effect on other tyrosine kinases.  Furthermore, B6 potently inhibited the growth and induced apoptosis of MDA-MB-231 and MDA-MB-468 breast cancer cells with overactivated STAT3.  Taken together, our study uncovers a novel compound and a novel mechanism for the regulation of JAK2 and offers a new therapeutic approach for the treatment of cancers with overactivated JAK2/STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE2A638uprkzEwO064Z95rfW6udTcc2eZNKIGytrac3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3mvFKrsw%253D%253D&md5=38a6d5f9c33d931428139dea248a1e08</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1038%2Fs41401-019-0254-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41401-019-0254-4%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3D3-Deoxy-2%25CE%25B2%252C16-dihydroxynagilactone%2520E%252C%2520a%2520natural%2520compound%2520from%2520Podocarpus%2520nagi%252C%2520preferentially%2520inhibits%2520JAK2%252FSTAT3%2520signaling%2520by%2520allosterically%2520interacting%2520with%2520the%2520regulatory%2520domain%2520of%2520JAK2%2520and%2520induces%2520apoptosis%2520of%2520cancer%2520cells%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2019%26volume%3D40%26spage%3D1578%26epage%3D1586%26doi%3D10.1038%2Fs41401-019-0254-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupchan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Court, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dailey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, R. F.</span></span> <span> </span><span class="NLM_article-title">Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from <i>Tripterygium wilfordii</i></span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">7194</span>– <span class="NLM_lpage">7195</span>, <span class="refDoi"> DOI: 10.1021/ja00775a078</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00775a078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE38XlsFagtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1972&pages=7194-7195&author=S.+M.+Kupchanauthor=W.+A.+Courtauthor=R.+G.+Daileyauthor=C.+J.+Gilmoreauthor=R.+F.+Bryan&title=Triptolide+and+tripdiolide%2C+novel+antileukemic+diterpenoid+triepoxides+from+Tripterygium+wilfordii&doi=10.1021%2Fja00775a078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor inhibitors.  LXXIV.  Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii</span></div><div class="casAuthors">Kupchan, S. Morris; Court, William A.; Dailey, Richard G., Jr.; Gilmore, Christopher J.; Bryan, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7194-5</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The isolation and structural elucidation by direct x-ray analysis of triptolide (I, R = H) and tripdiolide (I, R = OH), novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii, are reported.  These compounds and the companion cytotoxic ketone triptonide (II) appear to be the first reported natural products containing the 18(4 → 3)abeo-abietane skeleton and the first recognized diterpenoid triepoxides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN9AmLhh4YsrVg90H21EOLACvtfcHk0lgsd1BS2kMxDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XlsFagtbY%253D&md5=5f49ab816f300041630eaec53c680496</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fja00775a078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00775a078%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DCourt%26aufirst%3DW.%2BA.%26aulast%3DDailey%26aufirst%3DR.%2BG.%26aulast%3DGilmore%26aufirst%3DC.%2BJ.%26aulast%3DBryan%26aufirst%3DR.%2BF.%26atitle%3DTriptolide%2520and%2520tripdiolide%252C%2520novel%2520antileukemic%2520diterpenoid%2520triepoxides%2520from%2520Tripterygium%2520wilfordii%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1972%26volume%3D94%26spage%3D7194%26epage%3D7195%26doi%3D10.1021%2Fja00775a078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, R. F.</span></span> <span> </span><span class="NLM_article-title">Crystal and molecular structures and absolute configuration of triptolide and tripdiolide, two antileukemic diterpenoid triepoxides</span>. <i>J. Chem. Soc., Perkin Trans. 2</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.1039/p29730000816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fp29730000816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE3sXhs1Gmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=816-819&author=C.+J.+Gilmoreauthor=R.+F.+Bryan&title=Crystal+and+molecular+structures+and+absolute+configuration+of+triptolide+and+tripdiolide%2C+two+antileukemic+diterpenoid+triepoxides&doi=10.1039%2Fp29730000816"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal and molecular structures and absolute configuration of triptolide and tripdiolide, two antileukemic diterpenoid triepoxides</span></div><div class="casAuthors">Gilmore, Christopher J.; Bryan, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Perkin Transactions 2:  Physical Organic Chemistry (1972-1999)</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">816-19</span>CODEN:
                <span class="NLM_cas:coden">JCPKBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9580</span>.
    </div><div class="casAbstract">The crystal and mol. structure and abs. configuration of triptolide (I) and tripdiolide (II) were detd. by 3-dimensional x-ray anal. and refined by least squares to R = 0.086 (1044 independent reflections) and 0.082 (1399 independent reflections), resp.  Crystals of I are monoclinic, space group P21, with a 13.420, b 6.256, c 11.593 Å, β 118.09°, d.(obsd.) = 1.40, and d. (calcd.) = 1.39 for Z = 2.  The mol. II is isostructural with I, with a 13.680, b 6.253, Å, and β 119.05°.  Tripdiolide is 2-hydroxytriptolide; each mol. has an 18(4→3)abeo-abietane skeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpg-W6rm_W7bVg90H21EOLACvtfcHk0lgsd1BS2kMxDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhs1Gmu7k%253D&md5=664e097317ce32f61a0916511cbc650d</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1039%2Fp29730000816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp29730000816%26sid%3Dliteratum%253Aachs%26aulast%3DGilmore%26aufirst%3DC.%2BJ.%26aulast%3DBryan%26aufirst%3DR.%2BF.%26atitle%3DCrystal%2520and%2520molecular%2520structures%2520and%2520absolute%2520configuration%2520of%2520triptolide%2520and%2520tripdiolide%252C%2520two%2520antileukemic%2520diterpenoid%2520triepoxides%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25202%26date%3D1973%26spage%3D816%26epage%3D819%26doi%3D10.1039%2Fp29730000816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziaei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halaby, R.</span></span> <span> </span><span class="NLM_article-title">Immunosuppressive, anti-inflammatory and anticancer properties of triptolide: A mini review</span>. <i>Avicenna J. Phytomed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27222828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXms1yiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=149-164&author=S.+Ziaeiauthor=R.+Halaby&title=Immunosuppressive%2C+anti-inflammatory+and+anticancer+properties+of+triptolide%3A+A+mini+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: a mini review</span></div><div class="casAuthors">Ziaei, Samira; Halaby, Reginald</div><div class="citationInfo"><span class="NLM_cas:title">Avicenna Journal of Phytomedicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-164</span>CODEN:
                <span class="NLM_cas:coden">AJPVAX</span>;
        ISSN:<span class="NLM_cas:issn">2228-7949</span>.
    
            (<span class="NLM_cas:orgname">Mashhad University of Medical Sciences</span>)
        </div><div class="casAbstract">Objective: Triptolide, the active component of Tripterygium wilfordii Hook F has been used to treat autoimmune and inflammatory conditions for over two hundred years in traditional Chinese medicine.  However, the processes through which triptolide exerts immunosuppression and anti-inflammation are not understood well.  In this review, we discuss the autoimmune disorders and inflammatory conditions that are currently treated with triptolide.  Triptolide also possesses anti-tumorigenic effects.  We discuss the toxicity of various triptolide derivs. and offer suggestions to improve its safety.  This study also examines the clin. trials that have investigated the efficacy of triptolide.  Our aim is to examine the mechanisms that are responsible for the immunosuppressive, anti-inflammatory, and anti-cancer effects of triptolide.  Materials and Methods: The present review provides a comprehensive summary of the literature with respect to the immunosuppressive, anti-inflammatory, and anti-cancer properties of triptolide.  Results: Triptolide possesses immunosuppressive, anti-inflammatory, and anti-cancer effects.  Conclusion: Triptolide can be used alone or in combination with existing therapeutic modalities as novel treatments for autoimmune disorders, cancers, and for immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGY5Jk7UBbLVg90H21EOLACvtfcHk0lgsd1BS2kMxDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXms1yiur4%253D&md5=f617220e3c6b4406157ec388b1a04d6a</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZiaei%26aufirst%3DS.%26aulast%3DHalaby%26aufirst%3DR.%26atitle%3DImmunosuppressive%252C%2520anti-inflammatory%2520and%2520anticancer%2520properties%2520of%2520triptolide%253A%2520A%2520mini%2520review%26jtitle%3DAvicenna%2520J.%2520Phytomed.%26date%3D2016%26volume%3D6%26spage%3D149%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span> <span> </span><span class="NLM_article-title">Triptolide: A new star for treating human malignancies</span>. <i>J. Cancer Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">S271</span>– <span class="NLM_lpage">S275</span>, <span class="refDoi"> DOI: 10.4103/0973-1482.235340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.4103%2F0973-1482.235340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29970675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVCqt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=S271-S275&author=P.+Yanauthor=X.+Sun&title=Triptolide%3A+A+new+star+for+treating+human+malignancies&doi=10.4103%2F0973-1482.235340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide: a new star for treating human malignancies</span></div><div class="casAuthors">Yan, Ping; Sun, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Therapeutics (Mumbai, India)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9Suppl.2</span>),
    <span class="NLM_cas:pages">S271-S275</span>CODEN:
                <span class="NLM_cas:coden">JCRTBK</span>;
        ISSN:<span class="NLM_cas:issn">1998-4138</span>.
    
            (<span class="NLM_cas:orgname">Medknow Publications</span>)
        </div><div class="casAbstract">A review.  In recent years, cancer has become the most common human disease worldwide, and great attentions have been paid to clarifying the carcinogenesis and identifying new effective antitumor therapy.  Although great progress has been made in this research field, human malignant diseases could still not be radically cured.  Thunder god vine is a herbal medicine, which has proved to exert efficient antitumor activity in various human cancers such as lung cancer, pancreatic cancer, and colon cancer.  In vivo and in vitro expts. showed that thunder god vine ext. triptolide could inhibit tumor cell proliferation, cell migration, and cell invasion.  Here, we overviewed the functional role of triptolide in human malignancies and its promising therapeutic potential in treating such deadly diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIbGkILzOCLVg90H21EOLACvtfcHk0liE36LafryH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVCqt7rE&md5=26d75f56db3f011898227fc075139892</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.4103%2F0973-1482.235340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0973-1482.235340%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DTriptolide%253A%2520A%2520new%2520star%2520for%2520treating%2520human%2520malignancies%26jtitle%3DJ.%2520Cancer%2520Res.%2520Ther.%26date%3D2018%26volume%3D14%26spage%3DS271%26epage%3DS275%26doi%3D10.4103%2F0973-1482.235340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span> <span> </span><span class="NLM_article-title">Triptolide mediated amelioration of breast cancer via modulation of molecular pathways</span>. <i>Pharmacogn. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">838</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.5530/pj.2017.6.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5530%2Fpj.2017.6.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVyrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=838-845&author=S.+Sarkarauthor=S.+Paul&title=Triptolide+mediated+amelioration+of+breast+cancer+via+modulation+of+molecular+pathways&doi=10.5530%2Fpj.2017.6.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide mediated amelioration of breast cancer via modulation of molecular pathways</span></div><div class="casAuthors">Sarkar, Swadesh; Paul, Santanu</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacognosy Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">838-845</span>CODEN:
                <span class="NLM_cas:coden">PJHOD4</span>;
        ISSN:<span class="NLM_cas:issn">0975-3575</span>.
    
            (<span class="NLM_cas:orgname">Pharmacognosy Network Worldwide</span>)
        </div><div class="casAbstract">A review.  Triptolide is the main bioactive mol. isolated from a root ext. of Tripterigium wilfordii Hook F. of Celastraceae family.  Chem., it is a diterpenoid triepoxide mol. and its chem. formula is C20 H24 O6.  Its five-membered unsatd. lactone ring (D-ring) is crucial for anti-tumor potential and carbonyl group at C-18 position is essential to exert important influence on the interaction between triptolide and the targeted protein(s).  It is bio-synthesized from deoxy-D-xylullose-5-phosphate (DOXP) pathway in the cell.  Triptolide can induce apoptosis in a no. of breast cancer cells by up-regulating different pro-apoptotic and down-regulating different anti-apoptotic mols.  In vitro expts. indicate that it can down regulate several cell cycle related genes and induces S-phase cell cycle arrest.  Triptolide treatment can also modulate the expression of different cell signaling mols., e.g.  ERK, NF-κB, FAK, VEGF, β-catenin, AKT etc.  In vivo expts. indicate that triptolide can effectively reduce breast tumor growth in the mouse model.  Apart from the single drug treatment, triptolide can effectively be applied in combination therapy.  Application of Triptolide with other chemotherapeutic drugs, very efficiently check the proliferation of tumor cells which reduces the effective concn. of the com. available drugs thus reducing their toxic side-effects.  Although triptolide is very effective against a no. of diseases, its higher degree of multi-organ toxicity limits its use of further clin. trial.  Therefore, to reduce the toxic effects, a no. of strategies have been developed which increase its water soly. and at the same time decrease the toxic effect.  In this review article, we have addressed how triptolide participates in the antitumor processes in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIzXpdrNVH4bVg90H21EOLACvtfcHk0liE36LafryH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVyrsrk%253D&md5=eae18d4029ba750a5a1fcf3eddc1ebb1</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.5530%2Fpj.2017.6.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5530%252Fpj.2017.6.131%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DPaul%26aufirst%3DS.%26atitle%3DTriptolide%2520mediated%2520amelioration%2520of%2520breast%2520cancer%2520via%2520modulation%2520of%2520molecular%2520pathways%26jtitle%3DPharmacogn.%2520J.%26date%3D2017%26volume%3D9%26spage%3D838%26epage%3D845%26doi%3D10.5530%2Fpj.2017.6.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.-P.</span></span> <span> </span><span class="NLM_article-title">Effect of the natural product triptolide on pancreatic cancer: A systematic review of preclinical studies</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">490</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2017.00490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28890697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2nsLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=490&author=C.+Zhangauthor=X.-J.+Heauthor=L.+Liauthor=C.+Luauthor=A.-P.+Lu&title=Effect+of+the+natural+product+triptolide+on+pancreatic+cancer%3A+A+systematic+review+of+preclinical+studies&doi=10.3389%2Ffphar.2017.00490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the natural product triptolide on pancreatic cancer: a systematic review of preclinical studies</span></div><div class="casAuthors">Zhang, Chi; He, Xiao-Juan; Li, Li; Lu, Cheng; Lu, Ai-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">490/1-490/9</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Objective: Triptolide (TL), a natural product isolated from Tripterygium wilfordii Hook F (TwHF), shows potent anticancer effects in vitro and in vivo.  We aimed to summary the biochem. mechanisms through which TL has been shown to induce apoptosis, autophagy and inhibit angiogenesis in pancreatic cancer (PC).  Methods: We undertook a systematic review of preclin. evidence.  We searched electronic databases.  The potential mechanisms and the underlying signaling pathways have been accumulated as well.  Results: We screened 116 abstrs. for eligibility and included 17 preclin. studies in the anal.  Details of the animals and cell lines were provided in 16 studies (94.1%).  Six studies (75.0%) randomly assigned animals to treatment or control groups and only 1 study (12.5%) reported on blinding.  The majority of the TL's research field has focused on its pro-apoptotic effects through downregulation of inhibitory pathways and upregulation of apoptotic pathways.  The studies have shown that TL is effective both in vitro and in vivo against PC cells.  Conclusion: This study provides a systematic summary of TL's anti-pancreatic cancer profile and the underlying mechanisms of with special emphasis on the apoptosis, autophagy, angiogenesis and related mol. pathways.  Improved study quality in terms of treatment allocation methods reporting, randomization and blinding will accelerate needed progress toward trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogQmeUm7qocbVg90H21EOLACvtfcHk0liE36LafryH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2nsLjN&md5=8471d6cf8fe988119e15ce3bb0c106fa</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00490%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DX.-J.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DA.-P.%26atitle%3DEffect%2520of%2520the%2520natural%2520product%2520triptolide%2520on%2520pancreatic%2520cancer%253A%2520A%2520systematic%2520review%2520of%2520preclinical%2520studies%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D490%26doi%3D10.3389%2Ffphar.2017.00490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">112079</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2020.112079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32028140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVWgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2020&pages=112079&author=Y.+Zangauthor=F.+Laiauthor=J.+Fuauthor=C.+Liauthor=J.+Maauthor=C.+Chenauthor=K.+Liuauthor=T.+Zhangauthor=X.+Chenauthor=D.+Zhang&title=Novel+nitric+oxide-releasing+derivatives+of+triptolide+as+antitumor+and+anti-inflammatory+agents%3A+Design%2C+synthesis%2C+biological+evaluation%2C+and+nitric+oxide+release+studies&doi=10.1016%2Fj.ejmech.2020.112079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies</span></div><div class="casAuthors">Zang, Yingda; Lai, Fangfang; Fu, Junmin; Li, Chuangjun; Ma, Jie; Chen, Chengjuan; Liu, Ke; Zhang, Tiantai; Chen, Xiaoguang; Zhang, Dongming</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112079pp.</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel triptolide/furoxans hybrids and, e.g., I, was designed and synthesized as analogs of triptolide, which is a naturally derived compd. isolated from the thunder god vine (Tripterygium wilfordii Hook. F).  Some of these synthesized compds. exhibited antiproliferative activities in the nanomolar range.  Among them, I exhibited both good antiproliferative activity and NO-releasing ability and the acute toxicity of I decreased more than 160 times (LD50 = 160.9 mg/kg) than triptolide.  Moreover, I significantly inhibited the growth of melanoma at a low dose (0.3 mg/kg) and showed strong anti-inflammatory activity in vitro and in vivo.  These results indicate that I could be a promising candidate for further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXROlmczxhA7Vg90H21EOLACvtfcHk0ljmYSfd1UGApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVWgsbg%253D&md5=6c1140d3bca33e778e70fad252afea3b</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112079%26sid%3Dliteratum%253Aachs%26aulast%3DZang%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DNovel%2520nitric%2520oxide-releasing%2520derivatives%2520of%2520triptolide%2520as%2520antitumor%2520and%2520anti-inflammatory%2520agents%253A%2520Design%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520nitric%2520oxide%2520release%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D190%26spage%3D112079%26doi%3D10.1016%2Fj.ejmech.2020.112079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel C14-hydroxy substituted triptolide derivatives as potential selective antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5115</span>– <span class="NLM_lpage">5123</span>, <span class="refDoi"> DOI: 10.1021/jm900342g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900342g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVKnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5115-5123&author=Z.+Liauthor=Z.-L.+Zhouauthor=Z.-H.+Miaoauthor=L.-P.+Linauthor=H.-J.+Fengauthor=L.-J.+Tongauthor=J.+Dingauthor=Y.-C.+Li&title=Design+and+synthesis+of+novel+C14-hydroxy+substituted+triptolide+derivatives+as+potential+selective+antitumor+agents&doi=10.1021%2Fjm900342g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel C14-Hydroxyl Substituted Triptolide Derivatives as Potential Selective Antitumor Agents</span></div><div class="casAuthors">Li, Zheng; Zhou, Zhao-Li; Miao, Ze-Hong; Lin, Li-Ping; Feng, Hui-Jin; Tong, Lin-Jiang; Ding, Jian; Li, Yuan-Chao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5115-5123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It has long been considered that the free β hydroxyl group at C14 of triptolide is essential to its potent anticancer activity.  In this study, we synthesized novel derivs. of triptolide with a hydroxyl group substituted by epoxy groups (e.g. I) or a five-membered ring (e.g. II).  The epoxy compds. showed significant in vitro anticancer activity although less potent than triptolide.  Although with an α oxygen configuration at the C14 position, (14S)-14,21-epoxytriptolide (I) exhibited the highest potency among all these derivs., clearly challenging the traditional viewpoint on the necessity of C14β-hydroxyl group of triptolide.  Further studies revealed that while displaying broad spectrum in vitro anticancer activity, compd. I demonstrated prominent selective in vivo anticancer activity, particularly against human ovarian SK-OV-3 and prostate PC-3 cancers with obviously lower toxicity than triptolide.  Noticeably, compd. I was also highly effective against multidrug resistant cancer cells.  Therefore, our study gives new insights into the structure-activity relationship of triptolide and also produces a promising anticancer drug candidate with unique anticancer activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7BKNGzgX73LVg90H21EOLACvtfcHk0ljmYSfd1UGApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVKnt7w%253D&md5=3eae112da83726b8d3562c79e2ad36d3</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm900342g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900342g%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.-L.%26aulast%3DMiao%26aufirst%3DZ.-H.%26aulast%3DLin%26aufirst%3DL.-P.%26aulast%3DFeng%26aufirst%3DH.-J.%26aulast%3DTong%26aufirst%3DL.-J.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-C.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520C14-hydroxy%2520substituted%2520triptolide%2520derivatives%2520as%2520potential%2520selective%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5115%26epage%3D5123%26doi%3D10.1021%2Fjm900342g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangwan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudeja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawra, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazar, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A. K.</span></span> <span> </span><span class="NLM_article-title">A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">156ra139</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.3004334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1126%2Fscitranslmed.3004334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23076356" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&author=R.+Chughauthor=V.+Sangwanauthor=S.+P.+Patilauthor=V.+Dudejaauthor=R.+K.+Dawraauthor=S.+Banerjeeauthor=R.+J.+Schumacherauthor=B.+R.+Blazarauthor=G.+I.+Georgauthor=S.+M.+Vickersauthor=A.+K.+Saluja&title=A+preclinical+evaluation+of+Minnelide+as+a+therapeutic+agent+against+pancreatic+cancer&doi=10.1126%2Fscitranslmed.3004334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004334%26sid%3Dliteratum%253Aachs%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DSangwan%26aufirst%3DV.%26aulast%3DPatil%26aufirst%3DS.%2BP.%26aulast%3DDudeja%26aufirst%3DV.%26aulast%3DDawra%26aufirst%3DR.%2BK.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSchumacher%26aufirst%3DR.%2BJ.%26aulast%3DBlazar%26aufirst%3DB.%2BR.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DVickers%26aufirst%3DS.%2BM.%26aulast%3DSaluja%26aufirst%3DA.%2BK.%26atitle%3DA%2520preclinical%2520evaluation%2520of%2520Minnelide%2520as%2520a%2520therapeutic%2520agent%2520against%2520pancreatic%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26doi%3D10.1126%2Fscitranslmed.3004334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acikgoz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oktem, G.</span></span> <span> </span><span class="NLM_article-title">Triptolide inhibits CD133+/CD44<sup>+</sup> colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial-mesenchymal transition via downregulating expressions of snail, slug, and twist</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">3313</span>– <span class="NLM_lpage">3324</span>, <span class="refDoi"> DOI: 10.1002/jcb.29602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjcb.29602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31904143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivFWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2020&pages=3313-3324&author=E.+Acikgozauthor=C.+Tatarauthor=G.+Oktem&title=Triptolide+inhibits+CD133%2B%2FCD44%2B+colon+cancer+stem+cell+growth+and+migration+through+triggering+apoptosis+and+represses+epithelial-mesenchymal+transition+via+downregulating+expressions+of+snail%2C+slug%2C+and+twist&doi=10.1002%2Fjcb.29602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide inhibits CD133+/CD44+ colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial-mesenchymal transition via downregulating expressions of snail, slug, and twist</span></div><div class="casAuthors">Acikgoz, Eda; Tatar, Cansu; Oktem, Gulperi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">3313-3324</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In cancer studies, there is an increasing interest in close friendship between epithelial-mesenchymal transition (EMT) and CSCs.  Triptolide (TPL) isolated from Chinese herb Tripterygium wilfordii has important effects on the prevention of migration and metastasis as well as cytotoxic effect against cancer cells.  The potential lethal efficacy of TPL on CSCs that is highly resistant to the drug is an unsolved mystery.  Fundamentally, the present study basically aims to find answers to two questions (a) is it possible to target colon CSCs with TPL and (b) what are the mechanisms underlying TPL's potential to eliminate CSCs.  Cytotoxic effects of TPL on CSCs were evaluated by WST-1 and Muse count and viability assays.  Apoptosis assay and cell-cycle anal. were performed to investigate the inhibitory effect of TPL.  Moreover, the effects of TPL on spheroid formation capacity, migration, and EMT processes, which are assocd. with CSC phenotype, were also investigated.  The results revealed that TPL triggered cell death and apoptosis and altered cell cycle distribution.  Moreover, TPL significantly reduced the snail slug and twist expressions assocd. with EMT.  TPL has been shown to be effective in colon CSCs by in vitro expts., and it might be a highly effective agent against colon cancer has been implicated in need of supporting in vivo and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6iTKf59UGrbVg90H21EOLACvtfcHk0ljmYSfd1UGApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivFWhug%253D%253D&md5=bee7a1ab5c24675744913663abbdc26c</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1002%2Fjcb.29602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.29602%26sid%3Dliteratum%253Aachs%26aulast%3DAcikgoz%26aufirst%3DE.%26aulast%3DTatar%26aufirst%3DC.%26aulast%3DOktem%26aufirst%3DG.%26atitle%3DTriptolide%2520inhibits%2520CD133%252B%252FCD44%252B%2520colon%2520cancer%2520stem%2520cell%2520growth%2520and%2520migration%2520through%2520triggering%2520apoptosis%2520and%2520represses%2520epithelial-mesenchymal%2520transition%2520via%2520downregulating%2520expressions%2520of%2520snail%252C%2520slug%252C%2520and%2520twist%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2020%26volume%3D121%26spage%3D3313%26epage%3D3324%26doi%3D10.1002%2Fjcb.29602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span> <span> </span><span class="NLM_article-title">Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">892</span>– <span class="NLM_lpage">899</span>, <span class="refDoi"> DOI: 10.1248/bpb.b18-00818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fbpb.b18-00818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30956264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ejtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2019&pages=892-899&author=W.+Jiangauthor=M.+Chenauthor=C.+Xiaoauthor=W.+Yangauthor=Q.+Qinauthor=Q.+Tanauthor=Z.+Liangauthor=X.+Liaoauthor=A.+Maoauthor=C.+Wei&title=Triptolide+suppresses+growth+of+breast+cancer+by+targeting+HMGB1+in+vitro+and+in+vivo&doi=10.1248%2Fbpb.b18-00818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo</span></div><div class="casAuthors">Jiang, Wei; Chen, Maojian; Xiao, Chanchan; Yang, Weiping; Qin, Qinghong; Tan, Qixing; Liang, Zhijie; Liao, Xiaoli; Mao, Anyun; Wei, Changyuan</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-899</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Triptolide has been indicated potent anti-cancer effect involving multiple mol. targets and signaling pathways.  High-mobility group box 1 (HMGB1) is a highly conserved DNA-binding protein taking part in breast cancer development.  The therapeutic effect of triptolide on HMGB1 has not been reported.  Thus, our study aims to clarify the role of HMGB1 in triptolide-induced anti-growth effect on breast cancer in vitro and in vivo.  We demonstrated that triptolide significantly suppressed growth of breast cancer cells by inhibition of cell viability, clonogenic ability.  Further studies evidenced that triptolide treatment not only inhibited HMGB1 mRNA expression, but also decreased supernatant level of HMGB1 in vitro.  In line with these observations, exogenous recombinant HMGB1 (rHMGB1) promoted cell proliferation of breast cancer, and triptolide reversed the rHMGB1-promoted proliferative effect.  As well, triptolide enhanced the anti-proliferative activity of Et pyruvate (EP) (HMGB1 inhibitor).  Furthermore, downstream correlation factors (Toll-like receptor 4 (TLR4) and phosphorylated-nuclear factor-kappaB (NF-κB) p65) of HMGB1 were significantly decreased in vitro after triptolide treatment.  Consistantly, we confirmed that tumor growth was significantly inhibited after triptolide treatment in vivo.  Meanwhile, immunohistochem. analyses showed that triptolide treatment significantly decreased the level of cytoplasmic HMGB1 and TLR4 expression, whereas the expression of NF-κB p65 was relatively higher in cytoplasm, and conversely lower in nucleus as compared to the control group.  Collectively, these results demonstrate that triptolide suppresses the growth of breast cancer cells via redn. of HMGB1 expression in vitro and in vivo, which may provide new insights into the treatment of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_9wbxp4AuUbVg90H21EOLACvtfcHk0lgjDQjrwUwLEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ejtbrF&md5=0b9d22960a4a900f9c5d8b1b2a579127</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b18-00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b18-00818%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26atitle%3DTriptolide%2520suppresses%2520growth%2520of%2520breast%2520cancer%2520by%2520targeting%2520HMGB1%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2019%26volume%3D42%26spage%3D892%26epage%3D899%26doi%3D10.1248%2Fbpb.b18-00818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span> <span> </span><span class="NLM_article-title">Antitumor properties of triptolide: Phenotype regulation of macrophage differentiation</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1080/15384047.2019.1679555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F15384047.2019.1679555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31663424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVymsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=178-188&author=H.+Liauthor=L.+Liauthor=H.+Meiauthor=G.+Panauthor=X.+Wangauthor=X.+Huangauthor=T.+Wangauthor=Z.+Jiangauthor=L.+Zhangauthor=L.+Sun&title=Antitumor+properties+of+triptolide%3A+Phenotype+regulation+of+macrophage+differentiation&doi=10.1080%2F15384047.2019.1679555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor properties of triptolide: phenotype regulation of macrophage differentiation</span></div><div class="casAuthors">Li, Han; Li, Liping; Mei, Huifang; Pan, Guofeng; Wang, Xinzhi; Huang, Xin; Wang, Tao; Jiang, Zhenzhou; Zhang, Luyong; Sun, Lixin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-188</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAMs), which generally exhibit an M2-like phenotype, play a crit. role in tumor development.  Triptolide exerts a unique bioactive spectrum of anticancer activities.  The aim of this study was to det. whether triptolide has any effect on the activation of TAMs and the prodn. of tumor-promoting mediators.  ICR-1 mice with azoxymethane/dextran sulfate sodium (AOM/DSS)-induced colon tumors and BALB/c mice co-inoculated with 4T1 cells and M2-polarized RAW264.7 cells were used to examine whether the inhibitory effect of triptolide on tumor progression was mediated by the targeting of TAMs.  Real-time PCR, Western blot, immunofluorescence staining, and flow cytometry assays were performed to det. the expression of cell surface markers and cytokine prodn.  The results showed that triptolide inhibited macrophage differentiation toward the M2 phenotype and abolished M2 macrophage-mediated tumor progression.  Furthermore, triptolide inhibited the expression of M2 markers, such as CD206, Arginase 1, and CD204, and inhibited the secretion of anti-inflammatory cytokines.  Thus our study indicated that triptolide selectively inhibited the functions of M2-polarized macrophages and TAMs, and this inhibitory effect of triptolide on TAM viability, differentiation, and cytokine prodn. might elucidate the major mechanisms underlying its antitumor activity.  Our findings provide important information for the potential clin. application of triptolide in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf6Cvb4eI_PrVg90H21EOLACvtfcHk0lgjDQjrwUwLEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVymsLnK&md5=8a3cd713df7dfdef26e17a6cc2828ebc</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1080%2F15384047.2019.1679555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2019.1679555%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DAntitumor%2520properties%2520of%2520triptolide%253A%2520Phenotype%2520regulation%2520of%2520macrophage%2520differentiation%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2020%26volume%3D21%26spage%3D178%26epage%3D188%26doi%3D10.1080%2F15384047.2019.1679555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">491</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1097%2FCAD.0000000000000894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31972592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVOitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=483-491&author=H.+Huauthor=S.+Zhuauthor=Y.+Tongauthor=G.+Huangauthor=B.+Tanauthor=L.+Yang&title=Antitumor+activity+of+triptolide+in+SKOV3+cells+and+SKOV3%2FDDP+in+vivo+and+in+vitro&doi=10.1097%2FCAD.0000000000000894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro</span></div><div class="casAuthors">Hu, Hui; Zhu, Sihong; Tong, Yan; Huang, Genhua; Tan, Buzhen; Yang, Lilan</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">483-491</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">1473-5741</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">This study was designed to investigate the antitumor activity of triptolide in ovarian cancer inoculated with SKOV3 and SKOV3/cisplatin (DDP) cells, and to assess the mechanisms.  In-vivo and in-vitro expts. were designed to evaluate the effects of triptolide on the tumor growth of SKOV3 and SKOV3/DDP cells.  The expts. were divided into four groups: a SKOV3 group, a SKOV3 + TP treatment group, a SKOV3/DDP group and a SKOV3/DDP + TP treatment group.  The expression of Sorcin, vascular endothelial growth factor and matrix metalloproteinase-2 were detected by western blotting and immunohistochem.  Tumor cell apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling.  In-vitro expts. showed that compared with SKOV3 control group, the level of colony-stimulating factor 1 and expression of Sorcin in SKOV3/DDP was significantly higher.  Interestingly, triptolide treatment could reduce colony-stimulating factor 1 level and expression of Sorcin in both SKOV3 and SKOV3/DDP cell lines.  In-vivo expts. showed that tissue necrosis area in SKOV3 + TP and SKOV3/DDP + TP was larger than SKOV3 and SKOV3/DDP group, resp.  Triptolide treatment induced apoptosis in both SKOV3 and SKOV3/DDP cells.  Compared with SKOV3 group, the size of tumors was large, and the expression of MMP-2, Sorcin and vascular endothelial growth factor was higher in SKOV3/DDP group.  Triptolide treatment reduced the size of tumors, and the expression of MMP-2, Sorcin and vascular endothelial growth factor in SKOV3/DDP as well as in SKOV3 tumors.  In conclusion, triptolide has antitumor activity in both SKOV3 and SKOV3/DDP cells likely through inducing apoptosis and regulating MMP-2, Sorcin and vascular endothelial growth factor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6HzDfNPF9bVg90H21EOLACvtfcHk0lgjDQjrwUwLEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVOitbk%253D&md5=9cd3eee10b0dff6cec4b62778d5cf4d6</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000894%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DAntitumor%2520activity%2520of%2520triptolide%2520in%2520SKOV3%2520cells%2520and%2520SKOV3%252FDDP%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2020%26volume%3D31%26spage%3D483%26epage%3D491%26doi%3D10.1097%2FCAD.0000000000000894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span> <span> </span><span class="NLM_article-title">Broad targeting of triptolide to resistance and sensitization for cancer therapy</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.05.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.05.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29807227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKrsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2018&pages=771-780&author=Z.-Y.+Houauthor=X.-P.+Tongauthor=Y.-B.+Pengauthor=B.-K.+Zhangauthor=M.+Yan&title=Broad+targeting+of+triptolide+to+resistance+and+sensitization+for+cancer+therapy&doi=10.1016%2Fj.biopha.2018.05.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Broad targeting of triptolide to resistance and sensitization for cancer therapy</span></div><div class="casAuthors">Hou, Zhen-yan; Tong, Xiao-pei; Peng, Yong-bo; Zhang, Bi-kui; Yan, Miao</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">771-780</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Cancer cell resistance to current anticancer therapeutics as well as the side effects are still obstacles to successful cancer therapy.  Hence, the development of novel anticancer agents or therapeutics is of vital significance, and esp. rational adjuvant therapies contg. low-cost natural products with multiple targets have attracted great interests.  Triptolide, the main biocomponent of Tripterygium wilfordii Hook F, is restricted in clin. applications mainly due to its severe systemic toxicities, although it has shown strong antitumor activities in preclin. studies.  Mounting evidence suggests that triptolide at low doses as an adjuvant therapeutic agent circumvents resistance to current anticancer therapies, enhances the anticancer effectiveness, and relieves toxicities of both triptolide and anticancer therapies.  Furthermore, several unique antitumor targets of triptolide make it superior to other therapeutics.  The mol. mechanisms of triptolide-induced anti-resistance and sensitization effects include changes in ATP-binding cassette transporters, induction of apoptosis pathways, increase in tumor suppressors and decrease in oncogenic factors, and interactions with the RNA polymerase II complex; targeting cancer stem cells and tumor-microenvironment-mediated resistance are also involved.  Besides, some synthetic derivs. and novel delivery systems of triptolide are also developed to enhance the water-soly. and reduce the toxicity, which will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFS4QDU8X8SLVg90H21EOLACvtfcHk0lhh5Spmjx0kEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKrsr3I&md5=8af39d9462510672fcf26fc6f4854764</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.05.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.05.088%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DZ.-Y.%26aulast%3DTong%26aufirst%3DX.-P.%26aulast%3DPeng%26aufirst%3DY.-B.%26aulast%3DZhang%26aufirst%3DB.-K.%26aulast%3DYan%26aufirst%3DM.%26atitle%3DBroad%2520targeting%2520of%2520triptolide%2520to%2520resistance%2520and%2520sensitization%2520for%2520cancer%2520therapy%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D104%26spage%3D771%26epage%3D780%26doi%3D10.1016%2Fj.biopha.2018.05.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of Akt</span>. <i>J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3020</span>, <span class="refDoi"> DOI: 10.7150/jca.30669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.7150%2Fjca.30669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31281478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjsFeisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3012-3020&author=G.+Huangauthor=H.+Huauthor=Y.+Zhangauthor=Y.+Zhuauthor=J.+Liuauthor=B.+Tanauthor=T.+Chen&title=Triptolide+sensitizes+cisplatin-resistant+human+epithelial+ovarian+cancer+by+inhibiting+the+phosphorylation+of+Akt&doi=10.7150%2Fjca.30669"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT</span></div><div class="casAuthors">Huang, Genhua; Hu, Hui; Zhang, Yao; Zhu, Yinfang; Liu, Junli; Tan, Buzhen; Chen, Tingtao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer (Wyoming, Australia)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3012-3020</span>CODEN:
                <span class="NLM_cas:coden">JCWAAL</span>;
        ISSN:<span class="NLM_cas:issn">1837-9664</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher Pty Ltd.</span>)
        </div><div class="casAbstract">Advanced and chemotherapy-resistant ovarian cancer causes high mortality of ovarian cancer, and it is important to find safe and effective drugs to reduce the chemotherapeutic resistance of ovarian cancer.  In our study, we attempted to clarify the resistance mechanisms of SKOV3/DDP cells in vitro and evaluated the sensitization to triptolide (TPL) in vivo.  Our results indicated that the overexpression of AKT and p-AKT greatly enhanced the cisplatin (DDP) tolerance of SKOV3/DDP, and the combination of DDP + TPL had a significant tumor inhibition effect compared to DDP treatment (p<0.05), via reducing the expressions of p-PI3K, p-Akt, Survivin, VEGF and MMP-2, and the increase of Caspase-3.  Collectively, these results suggest that the synergistic anticancer effect of TPL and DDP warrants their potential clin. applications in further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPnq8ZacJHtLVg90H21EOLACvtfcHk0lhh5Spmjx0kEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjsFeisbg%253D&md5=78f2948afec439099fead01a328cb468</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.7150%2Fjca.30669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fjca.30669%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DTriptolide%2520sensitizes%2520cisplatin-resistant%2520human%2520epithelial%2520ovarian%2520cancer%2520by%2520inhibiting%2520the%2520phosphorylation%2520of%2520Akt%26jtitle%3DJ.%2520Cancer%26date%3D2019%26volume%3D10%26spage%3D3012%26epage%3D3020%26doi%3D10.7150%2Fjca.30669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.-F.</span></span> <span> </span><span class="NLM_article-title">Triptolide enhances the sensitivity of pancreatic cancer Panc-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling</span>. <i>Am. J. Transl. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3750</span>– <span class="NLM_lpage">3760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31312385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktF2mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=3750-3760&author=J.-X.+Maauthor=Y.-L.+Sunauthor=Y.+Yuauthor=J.+Zhangauthor=H.-Y.+Wuauthor=X.-F.+Yu&title=Triptolide+enhances+the+sensitivity+of+pancreatic+cancer+Panc-1+cells+to+gemcitabine+by+inhibiting+TLR4%2FNF-%CE%BAB+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling</span></div><div class="casAuthors">Ma, Jian-Xia; Sun, Yun-Liang; Yu, Yang; Zhang, Jian; Wu, Hong-Yu; Yu, Xiao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Translational Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3750-3760</span>CODEN:
                <span class="NLM_cas:coden">AJTRA7</span>;
        ISSN:<span class="NLM_cas:issn">1943-8141</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Background: This study aimed to investigate roles of Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling in triptolide (TPL)-induced sensitivity of pancreatic cancer cells to gemcitabine (GEM).  Methods: In vitro, pancreatic cancer PANC-1 cells were treated with lipopolysaccharide (LPS) to activate TLR4, TLR4-siRNA, GEM alone, or GEM plus TPL.  In vivo, nude mice bearing PANC-1 cell xenografts were treated with GEM, TPL, or both.  Cell proliferation was detected by MTT assay and Ki-67 staining.  Apoptosis was assessed by flow cytometry and TUNEL assay.  A double luciferase reporter gene was used to detect NF-κB activity.  Results: The sensitivity of PANC-1 cells to GEM was reduced by LPS but enhanced by TLR4-siRNA.  TPL inhibited expression of TLR4/NF-κB signaling components, which was reversed by LPS.  The TPL+GEM group showed more apoptosis than the LPS+TPL+GEM group.  Moreover, the activity of NF-κB and the expression of TLR4, p-p65 Survivin, CyclinD1 and Bcl-2 in the TPL+GEM group were lower than in the LPS+TPL+GEM group, whereas Bax expression was higher.  The vol. of transplanted tumors in the TPL+GEM group was lower than that in the TPL or GEM group.  Phospho-p65, Survivin, CyclinD1 and Bcl-2 expression in transplanted tumors was lower in TPL+GEM group than in either single drug group.  The Ki-67 staining score of the TPL+GEM group was lower and tumor cells apoptosis rate was increased when compared with TPL or GEM alone.  Conclusions: TPL enhances the sensitivity of pancreatic cancer PANC-1 cells to GEM by inhibiting TLR4/NF-κB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLlxtqP30Fo7Vg90H21EOLACvtfcHk0lhh5Spmjx0kEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktF2mtL4%253D&md5=965b664622a41414f31735bca66d19cc</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DJ.-X.%26aulast%3DSun%26aufirst%3DY.-L.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.-Y.%26aulast%3DYu%26aufirst%3DX.-F.%26atitle%3DTriptolide%2520enhances%2520the%2520sensitivity%2520of%2520pancreatic%2520cancer%2520Panc-1%2520cells%2520to%2520gemcitabine%2520by%2520inhibiting%2520TLR4%252FNF-%25CE%25BAB%2520signaling%26jtitle%3DAm.%2520J.%2520Transl.%2520Res.%26date%3D2019%26volume%3D11%26spage%3D3750%26epage%3D3760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span> <span> </span><span class="NLM_article-title">Combined treatment with triptolide and tyrosine kinase inhibitors synergistically enhances apoptosis in non-small cell lung cancer H1975 cells but not H1299 cells through EGFR/Akt pathway</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1248/cpb.c19-00300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fcpb.c19-00300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31142691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1Sgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2019&pages=864-871&author=X.+Tongauthor=P.+Jiangauthor=Y.+Liauthor=L.+Guoauthor=H.-M.+Zhangauthor=B.-K.+Zhangauthor=M.+Yan&title=Combined+treatment+with+triptolide+and+tyrosine+kinase+inhibitors+synergistically+enhances+apoptosis+in+non-small+cell+lung+cancer+H1975+cells+but+not+H1299+cells+through+EGFR%2FAkt+pathway&doi=10.1248%2Fcpb.c19-00300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Combined treatment with triptolide and tyrosine kinase inhibitors synergistically enhances apoptosis in non-small cell lung cancer H1975 Cells but Not H1299 cells through EGFR/Akt pathway</span></div><div class="casAuthors">Tong, Xiaopei; Jiang, Pei; Li, Yao; Guo, Lin; Zhang, Hui-min; Zhang, Bi-kui; Yan, Miao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">864-871</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Lung cancer is one of the most common malignant cancers in the world.  Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is a second- or third-line therapy for mutated non-small cell lung cancer (NSCLC).  It usually becomes drug resistance after a period of treatment.  Triptolide (TPL) is an epoxy diterpenoid lactone compd. extd. from Tripterygium wilfordii Hook.F. and many studies demonstrated that TPL has a synergistic effect when combined with chemotherapy drugs.  In this research, we plan to evaluate the combined effect of TPL and EGFR-TKIs (Gefitinib, Erlotinib, and Icotinib) and investigate the possible mechanisms.  3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted to detect the cell viabilities, combined effect was evaluated by Combination Index.  Mol. docking study was used to predict the binding ability of TPL.  The expression of proteins was detected by Western blot.  MTT results showed TPL had synergistic effect with three EGFR-TKIs at different concns. on H1975 cells but not on H1299 cells.  Mol. docking study demonstrated that TPL with T790M/L858R EGFR can form a more stable compd. than that with wild type EGFR.  Western blot results showed TPL inhibited the EGFR/Akt pathway and increased the expression of Bax and the ratio of Bax and Bcl-2 in H1975 cells.  In conclusion, TPL had synergistic effect with three EGFR-TKIs on H1975 cells but not on H1299 cells, which may be due to the binding ability of TPL and different-type EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriO-06ez4bdbVg90H21EOLACvtfcHk0lh_kHiDR7z_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1Sgt74%253D&md5=c7a9405c5e376ddd0f4b86c38953dc97</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c19-00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c19-00300%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.-M.%26aulast%3DZhang%26aufirst%3DB.-K.%26aulast%3DYan%26aufirst%3DM.%26atitle%3DCombined%2520treatment%2520with%2520triptolide%2520and%2520tyrosine%2520kinase%2520inhibitors%2520synergistically%2520enhances%2520apoptosis%2520in%2520non-small%2520cell%2520lung%2520cancer%2520H1975%2520cells%2520but%2520not%2520H1299%2520cells%2520through%2520EGFR%252FAkt%2520pathway%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2019%26volume%3D67%26spage%3D864%26epage%3D871%26doi%3D10.1248%2Fcpb.c19-00300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">A mechanistic overview of triptolide and celastrol, natural products from <i>Tripterygium wilfordii</i> Hook f</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">104</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2018.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29491837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=104&author=S.-R.+Chenauthor=Y.+Daiauthor=J.+Zhaoauthor=L.+Linauthor=Y.+Wangauthor=Y.+Wang&title=A+mechanistic+overview+of+triptolide+and+celastrol%2C+natural+products+from+Tripterygium+wilfordii+Hook+f&doi=10.3389%2Ffphar.2018.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F</span></div><div class="casAuthors">Chen, Shao-Ru; Dai, Yan; Zhao, Jing; Lin, Ligen; Wang, Yitao; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104/1-104/13</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant Tripterygium wilfordii Hook F.  These compds. exhibit similar pharmacol. activities, including anti-cancer, anti-inflammation, anti-obesity, and anti-diabetic activities.  Triptolide and celastrol also provide neuroprotection and prevent cardiovascular and metabolic diseases.  However, toxicity restricts the further development of triptolide and celastrol.  In this review, we comprehensively review therapeutic targets and mechanisms of action, and translational study of triptolide and celastrol.  We systemically discuss the structure-activity-relationship of triptolide, celastrol, and their derivs.  Furthermore, we propose the use of structural derivs., targeted therapy, and combination treatment as possible solns. to reduce toxicity and increase therapeutic window of these potent natural products from T. wilfordii Hook F.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6S3u2q0YLLVg90H21EOLACvtfcHk0lgob7Oi1PyPvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Skt7rE&md5=826675620f132aa76d9b07f466fb9631</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00104%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.-R.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DA%2520mechanistic%2520overview%2520of%2520triptolide%2520and%2520celastrol%252C%2520natural%2520products%2520from%2520Tripterygium%2520wilfordii%2520Hook%2520f%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D104%26doi%3D10.3389%2Ffphar.2018.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span> <span> </span><span class="NLM_article-title">The study of cellular mechanism of triptolide in the treatment of cancer, bone loss and cardiovascular disease and triptolide’s toxicity</span>. <i>Curr. Stem Cell Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.2174/1574888X14666190301155810</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2174%2F1574888X14666190301155810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30834841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFOmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=18-23&author=Y.+Wangauthor=B.+Wangauthor=X.+Yang&title=The+study+of+cellular+mechanism+of+triptolide+in+the+treatment+of+cancer%2C+bone+loss+and+cardiovascular+disease+and+triptolide%E2%80%99s+toxicity&doi=10.2174%2F1574888X14666190301155810"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Study of Cellular Mechanism of Triptolide in the Treatment of Cancer, Bone Loss and Cardiovascular Disease and Triptolide's Toxicity</span></div><div class="casAuthors">Wang, Youhan; Wang, Biao; Yang, Xiaobin</div><div class="citationInfo"><span class="NLM_cas:title">Current Stem Cell Research & Therapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-23</span>CODEN:
                <span class="NLM_cas:coden">CSCRC9</span>;
        ISSN:<span class="NLM_cas:issn">1574-888X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Triptolide (TPL), the active component of Tripterygium wilfordii Hook F (Twhf) has been used to treat cancer and bone loss conditions for over two hundred years in traditional Chinese medicine (TCM).  In this paper, we reviewed the specific mol. mechanisms in the treatment of cancer, bone loss and cardiovascular disease.  In addn., we analyze the toxicity of TPL and collect some optimized derivs. extd. from TPL.  Although pos. results were obtained in most cell culture and animal studies, further studies are needed to substantiate the beneficial effects of TPL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWl6y3K_gArVg90H21EOLACvtfcHk0ljMw2ogtuFarA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFOmuro%253D&md5=128311100568176f9043e0dcc00c4408</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.2174%2F1574888X14666190301155810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1574888X14666190301155810%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DThe%2520study%2520of%2520cellular%2520mechanism%2520of%2520triptolide%2520in%2520the%2520treatment%2520of%2520cancer%252C%2520bone%2520loss%2520and%2520cardiovascular%2520disease%2520and%2520triptolide%25E2%2580%2599s%2520toxicity%26jtitle%3DCurr.%2520Stem%2520Cell%2520Res.%2520Ther.%26date%3D2020%26volume%3D15%26spage%3D18%26epage%3D23%26doi%3D10.2174%2F1574888X14666190301155810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, H.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.-H.</span></span> <span> </span><span class="NLM_article-title">Triptolide, a potential autophagy modulator</span>. <i>Chin. J. Integr. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1007/s11655-018-2847-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs11655-018-2847-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30178091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1GltLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=233-240&author=Y.-M.+Weiauthor=Y.-H.+Wangauthor=H.-Q.+Xueauthor=Z.-H.+Luanauthor=B.-W.+Liuauthor=J.-H.+Ren&title=Triptolide%2C+a+potential+autophagy+modulator&doi=10.1007%2Fs11655-018-2847-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide, A Potential Autophagy Modulator</span></div><div class="casAuthors">Wei, Yan-ming; Wang, Yong-hui; Xue, Hui-qing; Luan, Zhi-hua; Liu, Bi-wang; Ren, Jin-hong</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Journal of Integrative Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">CJIMBS</span>;
        ISSN:<span class="NLM_cas:issn">1672-0415</span>.
    
            (<span class="NLM_cas:orgname">Chinese Journal of Integrated Traditional and Western Medicine Press</span>)
        </div><div class="casAbstract">As a major active component extd. from traditional Chinese herb Tripterygium wilfordii Hook F, triptolide exhibits multiple pharmacol. effects.  Autophagy is an evolutionary conserved intracellular catabolic process involved in cytoplasmic materials degrdn.  Autophagic dysfunction contributes to the pathologies of many human diseases, which makes it a promising therapeutic target.  Recent studies have shown that triptolide exerts neuroprotection, anti-tumor activities, organ toxicity, and podocyte protection by modulating autophagy.  This article highlights the current information on triptolide-modulated autophagy, analyzes the possible pathways involved, and describes the crosstalk between autophagy and apoptosis modulated by triptolide, in hope of providing implications for the roles of autophagy in pharmacol. effects of triptolide and expanding its novel usage as an autophagy modulator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocYlKVAczheLVg90H21EOLACvtfcHk0lj8fO7GDXwxjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1GltLvK&md5=ec124ba08736c597c7e66d81d743e9d3</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1007%2Fs11655-018-2847-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11655-018-2847-z%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DY.-M.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DXue%26aufirst%3DH.-Q.%26aulast%3DLuan%26aufirst%3DZ.-H.%26aulast%3DLiu%26aufirst%3DB.-W.%26aulast%3DRen%26aufirst%3DJ.-H.%26atitle%3DTriptolide%252C%2520a%2520potential%2520autophagy%2520modulator%26jtitle%3DChin.%2520J.%2520Integr.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D233%26epage%3D240%26doi%3D10.1007%2Fs11655-018-2847-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belgum, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evenson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etchison, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jay-Dixon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Cunha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratzke, R. A.</span></span> <span> </span><span class="NLM_article-title">Triptolide and its prodrug Minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.18632/genesandcancer.55</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Fgenesandcancer.55" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26000097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFGjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=144-152&author=B.+A.+Jacobsonauthor=E.+Z.+Chenauthor=S.+Tangauthor=H.+S.+Belgumauthor=J.+A.+McCauleyauthor=K.+A.+Evensonauthor=R.+G.+Etchisonauthor=J.+Jay-Dixonauthor=M.+R.+Patelauthor=A.+Razaauthor=A.+K.+Salujaauthor=J.+D%E2%80%99Cunhaauthor=R.+A.+Kratzke&title=Triptolide+and+its+prodrug+Minnelide+suppress+Hsp70+and+inhibit+in+vivo+growth+in+a+xenograft+model+of+mesothelioma&doi=10.18632%2Fgenesandcancer.55"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma</span></div><div class="casAuthors">Jacobson, Blake A.; Chen, Esther Z.; Tang, Shaogeng; Belgum, Holly Sedgwick; McCauley, Joel A.; Evenson, Kristen A.; Etchison, Ryan G.; Jay-Dixon, Joe; Patel, Manish R.; Raza, Ahmad; Ashok; Saluja, K.; D'Cunha, Jonathan; Kratzke, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">Malignant mesothelioma is a devastating disease with a poor prognosis for which there is a clear need for more successful therapeutic approaches.  Triptolide, a diterpenoid triepoxide, is a highly effective agent against several cancer types in animal models.  Owing to triptolide's poor soly. in water, a water-sol. analog, minnelide, was synthesized.  Minnelide is a prodrug of triptolide and is activated by exposure to phosphatases that are found in all body tissues, including blood.  Mesothelioma cells were treated in vitro with minnelide or its parent compd., triptolide.  Minnelide and triptolide were both found to significantly reduce mesothelioma cell viability and induce apoptosis.  The level of Hsp70, a protein that promotes cancer cell survival, was measured in mesothelioma cells before and after treatment with triptolide.  Hsp70 levels were decreased in a dose-dependent manner.  In addn., triptolide sensitized cells to gemcitabine and pemetrexed as measured by cell viability.  Mice bearing mesothelioma flank tumors were treated with daily injections (28 d) of minnelide or saline soln. and xenograft tumor growth recorded.  Mice displayed significantly reduced tumor burden.  These findings support the clin. evaluation of minnelide therapy for mesothelioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8cHIQIeCxj7Vg90H21EOLACvtfcHk0lj8fO7GDXwxjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFGjtb0%253D&md5=b27d6acde77f59190442c0798536be0b</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.18632%2Fgenesandcancer.55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Fgenesandcancer.55%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DB.%2BA.%26aulast%3DChen%26aufirst%3DE.%2BZ.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DBelgum%26aufirst%3DH.%2BS.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DEvenson%26aufirst%3DK.%2BA.%26aulast%3DEtchison%26aufirst%3DR.%2BG.%26aulast%3DJay-Dixon%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DRaza%26aufirst%3DA.%26aulast%3DSaluja%26aufirst%3DA.%2BK.%26aulast%3DD%25E2%2580%2599Cunha%26aufirst%3DJ.%26aulast%3DKratzke%26aufirst%3DR.%2BA.%26atitle%3DTriptolide%2520and%2520its%2520prodrug%2520Minnelide%2520suppress%2520Hsp70%2520and%2520inhibit%2520in%2520vivo%2520growth%2520in%2520a%2520xenograft%2520model%2520of%2520mesothelioma%26jtitle%3DGenes%2520Cancer%26date%3D2015%26volume%3D6%26spage%3D144%26epage%3D152%26doi%3D10.18632%2Fgenesandcancer.55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Triptolide-targeted delivery methods</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">351</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.12.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2018.12.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30605832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtl2nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2019&pages=342-351&author=H.+Xuauthor=B.+Liu&title=Triptolide-targeted+delivery+methods&doi=10.1016%2Fj.ejmech.2018.12.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide-targeted delivery methods</span></div><div class="casAuthors">Xu, Hongtao; Liu, Bo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">342-351</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Triptolide, a complex triepoxide diterpene natural product, has attracted considerable interest in the medicinal society due to its multiple biol. activities.  However, poor water soly., narrow therapeutic window and multi-organ toxicity have greatly hindered its clin. application.  In order to improve its clin. potential, either structural modification or the development of novel targeted delivery systems for triptolide have been executed worldwide in the past decades.  In this review, we systematically summarized strategies that have been utilized to develop triptolide-targeted delivery methods, including direct conjugation of triptolide to selected ligands such as sugar, short peptide, oligonucleotide, antibody and most importantly encapsulation of triptolide with well-designed nano-vehicle.  Thanks to the potent multiple biol. activities of triptolide, either direct conjugation of triptolide to selected ligands or encapsulation of triptolide with nanocarriers could provide better anti-inflammatory or anticancer activity.  Thus, these targeted delivery strategies could be taken as a starting point for future utilization of triptolide and also other NPs in exptl. clin. therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEBECpNsurDLVg90H21EOLACvtfcHk0lj8fO7GDXwxjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtl2nsA%253D%253D&md5=f0d3e5d5f8ff684e0966319146893ec9</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.12.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.12.058%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DTriptolide-targeted%2520delivery%2520methods%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D164%26spage%3D342%26epage%3D351%26doi%3D10.1016%2Fj.ejmech.2018.12.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>241</i></span>,  <span class="NLM_fpage">119907</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2020.119907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biomaterials.2020.119907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32120315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2020&pages=119907&author=J.+Fengauthor=M.+Xuauthor=J.+Wangauthor=S.+Zhouauthor=Y.+Liuauthor=S.+Liuauthor=Y.+Huangauthor=Y.+Chenauthor=L.+Chenauthor=Q.+Songauthor=J.+Gongauthor=H.+Luauthor=X.+Gaoauthor=J.+Chen&title=Sequential+delivery+of+nanoformulated+%CE%B1-mangostin+and+triptolide+overcomes+permeation+obstacles+and+improves+therapeutic+effects+in+pancreatic+cancer&doi=10.1016%2Fj.biomaterials.2020.119907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer</span></div><div class="casAuthors">Feng, Jingxian; Xu, Minjun; Wang, Jiahao; Zhou, Songlei; Liu, Yipu; Liu, Shanshan; Huang, Yukun; Chen, Yu; Chen, Liang; Song, Qingxiang; Gong, Jingru; Lu, Huiping; Gao, Xiaoling; Chen, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119907</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease exhibiting the poorest prognosis among solid tumors.  The efficacy of conventional therapies has been hindered largely due to the insufficient chemotherapeutic delivery to the dense desmoplastic tumor stroma, and the extremely high or toxic dose needed for chemotherapy.  Traditional Chinese Medicine (TCM) contains effective components that can effectively regulate tumor microenvironment and kill tumor cells, providing promising alternatives to PDAC chemotherapy.  In this study, two active drug monomers of TCM were screened out and a sequentially targeting delivery regimen was developed to realize the optimized combinational therapy.  Transforming growth factor-β (TGF-β) plays an indispensable role in promoting cancer-assocd. fibroblasts (CAFs) activation and proliferation, and CAFs have caused major phys. barriers for chemotherapeutic drug delivery.  Herein, CAFs-targeting biodegradable polymer nanoparticle (CRE-NP(α-M)) coated with CREKA peptide and loaded with TCM α-mangostin (α-M) was developed to modulate tumor microenvironment by interfering of TGF-β/Smad signaling pathway.  Low pH-triggered micelle modified with CRPPR peptide and loaded with another TCM triptolide was constructed to increase the therapeutic effect of triptolide at the tumor sites and reduced its damage to main organs.  As expected, CRE-NP(α-M) effectively inactived CAFs, reduced extracellular matrix prodn., promoted tumor vascular normalization and enhanced blood perfusion at the tumor site.  The sequentially targeting drug delivery regimen, CRP-MC(Trip) following CRE-NP(α-M) pretreatment, exhibited strong tumor growth inhibition effect in the orthotopic tumor model.  Hence, sequentially targeting delivery of nanoformulated TCM offers an efficient approach to overcome the permeation obstacles and improve the effect of chemotherapy on PDAC, and provides a novel option to treat desmoplastic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwE-jLfqRsbVg90H21EOLACvtfcHk0lj0JQmbeA3yyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKiu78%253D&md5=d527aba9251de3ede0edfee52f7f1ab6</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2020.119907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2020.119907%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DSequential%2520delivery%2520of%2520nanoformulated%2520%25CE%25B1-mangostin%2520and%2520triptolide%2520overcomes%2520permeation%2520obstacles%2520and%2520improves%2520therapeutic%2520effects%2520in%2520pancreatic%2520cancer%26jtitle%3DBiomaterials%26date%3D2020%26volume%3D241%26spage%3D119907%26doi%3D10.1016%2Fj.biomaterials.2020.119907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Toxicity of triptolide and the molecular mechanisms involved</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2017.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2017.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28402922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlajtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=531-541&author=C.+Xiauthor=S.+Pengauthor=Z.+Wuauthor=Q.+Zhouauthor=J.+Zhou&title=Toxicity+of+triptolide+and+the+molecular+mechanisms+involved&doi=10.1016%2Fj.biopha.2017.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of triptolide and the molecular mechanisms involved</span></div><div class="casAuthors">Xi, Chen; Peng, Shaojun; Wu, Zhengping; Zhou, Qingping; Zhou, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Triptolide (TP), a major active and toxic ingredient isolated from the traditional Chinese herb Tripterygium wilfordii Hook f.  (TWHF). A widespread application of TP raises the question on the safety of its use in clin. settings.  The metab. of TP is mediated by hepatic cytochrome P450s, and a strong correlation exists between TP toxicity and CPY3A.  Toxicity of TP and the mol. mechanisms of its toxic effects have been studied in recent years.  Studies have demonstrated that TP exposure results in injury of various organs, including the liver, kidney, testes, ovary, and heart in animals and even in humans, according to clin. case reports.  Moreover, on the cellular level, TP has been reported to be assocd. with diverse toxic effects, encompassing membrane damage, mitochondrial disruption, metab. dysfunction, endoplasmic reticulum stress, oxidative stress, apoptosis and autophagy.  This review presents an overview of the current findings related to TP toxicity with an emphasis on biol. targets and the mol. mechanisms that may be involved, thus providing a systematic understanding of the mechanisms by which TP affects cells and tissues in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpUqHdCyNcXLVg90H21EOLACvtfcHk0lj0JQmbeA3yyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlajtbY%253D&md5=70ac9625b43840691c406c57c896b679</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DToxicity%2520of%2520triptolide%2520and%2520the%2520molecular%2520mechanisms%2520involved%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D90%26spage%3D531%26epage%3D541%26doi%3D10.1016%2Fj.biopha.2017.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">A review of the total syntheses of triptolide</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1984</span>– <span class="NLM_lpage">1995</span>, <span class="refDoi"> DOI: 10.3762/bjoc.15.194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3762%2Fbjoc.15.194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31501665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCnsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1984-1995&author=X.+Zhangauthor=Z.+Xiaoauthor=H.+Xu&title=A+review+of+the+total+syntheses+of+triptolide&doi=10.3762%2Fbjoc.15.194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the total syntheses of triptolide</span></div><div class="casAuthors">Zhang, Xiang; Xiao, Zaozao; Xu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1984-1995</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  Triptolide is a complex triepoxide diterpene natural product that has attracted considerable interest in the org. chem. and medicinal chem. societies due to its intriguing structural features and multiple promising biol. activities.  In this review, progress in the total syntheses of triptolide were systematically summarized.  We hope to gain a better understanding of the field and provide constructive suggestions for future studies of triptolide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngIB78Vc4F7Vg90H21EOLACvtfcHk0ljCtuf-rEUuug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCnsLfI&md5=36b95b1783a368094c813f5729b392de</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.15.194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.15.194%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DA%2520review%2520of%2520the%2520total%2520syntheses%2520of%2520triptolide%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2019%26volume%3D15%26spage%3D1984%26epage%3D1995%26doi%3D10.3762%2Fbjoc.15.194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.-H.</span></span> <span> </span><span class="NLM_article-title">Triptolide: Structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1039/c2np00088a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fc2np00088a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22270059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=457-475&author=Z.-L.+Zhouauthor=Y.-X.+Yangauthor=J.+Dingauthor=Y.-C.+Liauthor=Z.-H.+Miao&title=Triptolide%3A+Structural+modifications%2C+structure-activity+relationships%2C+bioactivities%2C+clinical+development+and+mechanisms&doi=10.1039%2Fc2np00088a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms</span></div><div class="casAuthors">Zhou, Zhao-Li; Yang, Ya-Xi; Ding, Jian; Li, Yuan-Chao; Miao, Ze-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-475</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1972 to 2011Triptolide, a principal bioactive ingredient of Tripterygium wilfordii Hook F, has attracted extensive exploration due to its unique structure of a diterpenoid triepoxide and multiple biol. activities.  This review will focus on the structural modifications, structure-activity relationships, pharmacol., and clin. development of triptolide in the last forty years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8SUmelewlLVg90H21EOLACvtfcHk0ljCU50Q22ssng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wktbg%253D&md5=8dfd5b37b76fc5f4ea39fc5fc055a9fd</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1039%2Fc2np00088a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2np00088a%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.-L.%26aulast%3DYang%26aufirst%3DY.-X.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-C.%26aulast%3DMiao%26aufirst%3DZ.-H.%26atitle%3DTriptolide%253A%2520Structural%2520modifications%252C%2520structure-activity%2520relationships%252C%2520bioactivities%252C%2520clinical%2520development%2520and%2520mechanisms%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2012%26volume%3D29%26spage%3D457%26epage%3D475%26doi%3D10.1039%2Fc2np00088a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Triptolide: Medicinal chemistry, chemical biology and clinical progress</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.05.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31121546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFektLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=378-392&author=W.+Houauthor=B.+Liuauthor=H.+Xu&title=Triptolide%3A+Medicinal+chemistry%2C+chemical+biology+and+clinical+progress&doi=10.1016%2Fj.ejmech.2019.05.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide: Medicinal chemistry, chemical biology and clinical progress</span></div><div class="casAuthors">Hou, Wei; Liu, Bo; Xu, Hongtao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">378-392</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the past decades, triptolide has attracted considerable interests in the org. and medicinal chem. society owing to its intriguing structure features and promising multiple pharmacol. activities.  However, its limited water soly. and oral bioavailability, imprecise mechanism of action and sever toxicity, scares from nature and difficulty in the synthesis have greatly hindered its clin. potential.  Hence, to circumvent such problems, a lot of elegant total synthesis have been developed.  With the advancement of the total synthesis, various triptolide derivs. have been synthesized and tested in the search for more drug-like derivs. for potential anticancer agents, anti-inflammatory agents, immunosuppressive agents and anti-Alzheimer's agents, etc.  Meanwhile, through designing and synthesizing of various of bioactive probes, some mol. targets that are responsible for the multiple pharmacol. activities as well as toxicity of triptolide have been identified.  It is no doubt will help the future development of new drug-like triptolide derivs.  In order to gain a comprehensive and deep understanding of the area and provides suggestions for triptolide's further studies, i. the medicinal chem. advancement, ii. bioactive probes-based cellular target identification and iii. clin. progress of triptolide derivs. are reviewed in this article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8KlHBuZ6B8rVg90H21EOLACvtfcHk0ljCU50Q22ssng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFektLg%253D&md5=0b29f1ef204d8ef7cf228033c1f4b97d</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.032%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DTriptolide%253A%2520Medicinal%2520chemistry%252C%2520chemical%2520biology%2520and%2520clinical%2520progress%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D176%26spage%3D378%26epage%3D392%26doi%3D10.1016%2Fj.ejmech.2019.05.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velagapudi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borazanci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span> <span> </span><span class="NLM_article-title">Triptolide and its derivatives as cancer therapies</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2019.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tips.2019.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30975442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvVWnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=327-341&author=P.+Noelauthor=D.+D.+Von+Hoffauthor=A.+K.+Salujaauthor=M.+Velagapudiauthor=E.+Borazanciauthor=H.+Han&title=Triptolide+and+its+derivatives+as+cancer+therapies&doi=10.1016%2Fj.tips.2019.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Triptolide and Its Derivatives as Cancer Therapies</span></div><div class="casAuthors">Noel, Pawan; Von Hoff, Daniel D.; Saluja, Ashok K.; Velagapudi, Mohana; Borazanci, Erkut; Han, Haiyong</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">327-341</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triptolide, a compd. isolated from a Chinese medicinal herb, possesses potent antitumor, immunosuppressive, and anti-inflammatory properties, but is clin. limited due to its poor soly., bioavailability, and toxicity.  Recently, Minnelide, a water-sol. prodrug of triptolide, was shown to have potent antitumor activity in various preclin. cancer models.  Minnelide is currently in Phase II clin. trials for treatment of advanced pancreatic cancer, which has fueled increased interest in this promising agent.  Here, we review the recent advances in the biol. activity of triptolide and its analogs, their mechanisms of actions, and their clin. developments.  A special emphasis is given to proteins and pathways within the tumor and stromal compartments that are targeted by triptolide and its analogs as well as the ongoing clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQTbU52HqAs7Vg90H21EOLACvtfcHk0lhLlNiglemjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvVWnsr0%253D&md5=beae1702494160ce5b03c97701afaead</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2019.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2019.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DNoel%26aufirst%3DP.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DSaluja%26aufirst%3DA.%2BK.%26aulast%3DVelagapudi%26aufirst%3DM.%26aulast%3DBorazanci%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DH.%26atitle%3DTriptolide%2520and%2520its%2520derivatives%2520as%2520cancer%2520therapies%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2019%26volume%3D40%26spage%3D327%26epage%3D341%26doi%3D10.1016%2Fj.tips.2019.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Divergent total synthesis of triptolide, triptonide, tripdiolide, 16-hydroxytriptolide, and their analogues</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">10110</span>– <span class="NLM_lpage">10122</span>, <span class="refDoi"> DOI: 10.1021/jo501744j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo501744j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslahsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=10110-10122&author=H.+Xuauthor=H.+Tangauthor=H.+Fengauthor=Y.+Li&title=Divergent+total+synthesis+of+triptolide%2C+triptonide%2C+tripdiolide%2C+16-hydroxytriptolide%2C+and+their+analogues&doi=10.1021%2Fjo501744j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Divergent Total Synthesis of Triptolide, Triptonide, Tripdiolide, 16-Hydroxytriptolide, and Their Analogues</span></div><div class="casAuthors">Xu, Hongtao; Tang, Huanyu; Feng, Huijin; Li, Yuanchao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">10110-10122</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A divergent route was developed for the formal total synthesis of triptolide (I), triptonide (II), and tripdiolide (III), as well as a total synthesis of 16-hydroxytriptolide (IV) and their analogs in an enantioselective form.  Common advanced intermediate V was concisely assembled by employing an indium(III)-catalyzed cationic polycyclization reaction and a palladium-catalyzed carbonylation-lactone formation reaction as key steps.  This advanced intermediate was readily converted to the above natural products by using palladium-catalyzed cross-coupling or the Claisen rearrangement reaction as key steps.  Addnl., preliminary structure-cytotoxic activity relationship studies of C13 suggested that it might be a new modification site that could still retain the cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowZEc7oeXfirVg90H21EOLACvtfcHk0lhLlNiglemjmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslahsrfP&md5=6c9520a816b1ba388ef8fff8ef6fdc1a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Fjo501744j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo501744j%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DDivergent%2520total%2520synthesis%2520of%2520triptolide%252C%2520triptonide%252C%2520tripdiolide%252C%252016-hydroxytriptolide%252C%2520and%2520their%2520analogues%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D10110%26epage%3D10122%26doi%3D10.1021%2Fjo501744j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.-M.</span></span> <span> </span><span class="NLM_article-title">Bioactive 18(4→3)-<i>abeo</i>-abietanoid derivatives from the leaves of <i>Tripterygium wilfordii</i></span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">30046</span>– <span class="NLM_lpage">30052</span>, <span class="refDoi"> DOI: 10.1039/C5RA02174J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC5RA02174J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=30046-30052&author=C.+Wangauthor=C.-J.+Liauthor=J.+Maauthor=J.-Z.+Yangauthor=X.-G.+Chenauthor=L.+Liauthor=D.-M.+Zhang&title=Bioactive+18%284%E2%86%923%29-abeo-abietanoid+derivatives+from+the+leaves+of+Tripterygium+wilfordii&doi=10.1039%2FC5RA02174J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1039%2FC5RA02174J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA02174J%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.-J.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.-Z.%26aulast%3DChen%26aufirst%3DX.-G.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DD.-M.%26atitle%3DBioactive%252018%25284%25E2%2586%25923%2529-abeo-abietanoid%2520derivatives%2520from%2520the%2520leaves%2520of%2520Tripterygium%2520wilfordii%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D30046%26epage%3D30052%26doi%3D10.1039%2FC5RA02174J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span> <span> </span><span class="NLM_article-title">Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1284</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.1002/pros.23834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fpros.23834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31212374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlSnt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=1284-1293&author=F.+Dongauthor=P.+Yangauthor=R.+Wangauthor=W.+Sunauthor=Y.+Zhangauthor=A.+Wangauthor=M.+Chenauthor=L.+Chenauthor=C.+Zhangauthor=M.+Jiang&title=Triptonide+acts+as+a+novel+antiprostate+cancer+agent+mainly+through+inhibition+of+mTOR+signaling+pathway&doi=10.1002%2Fpros.23834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway</span></div><div class="casAuthors">Dong, Fulu; Yang, Ping; Wang, Rui; Sun, Wenxing; Zhang, Yonghui; Wang, Aiting; Chen, Miaomiao; Chen, Lu; Zhang, Chong; Jiang, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1284-1293</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The increasing incidence of prostate cancer (PCa) indicates an urgent need for the development of new effective drugs in PCa therapy.  Triptonide has been reported to have a strong inhibition activity in cancers through screening of Chinese herbal medicine.  This study aims to investigate the effects of triptonide on anti-PCa activity and its mechanisms.  Three human advanced PCa cell lines PC3, DU145, and LNCap, and a human normal prostate epithelial cell line RWPE were treated with a range (0, 1.25, 2.5, 5, 10, 20, 40, 80, 160, and 320 nM) of triptonide concns. for 72 h resp.  Then, cell viability was assessed by cell counting kit-8.  PCa cells were treated with different doses (0-20 nM) of triptonide for 72 h.  Cell cycle and apoptosis were assessed by flow cytometry assays.  Nude mice bearing human PCa xenografts were i.p. injected daily with either triptonide (10 mg/kg/d) or phosphate-buffered saline as a control for 35 days.  RNA-sequencing (RNA-seq) was performed by an Illumina Hiseq Sequencing platform and confirmed by a real-time polymerase chain reaction.  Gene Ontol., Kyoto Encyclopedia of Genes and Genomes pathway anal., and ingenuity pathway anal. were used to analyze RNA-seq results.  Results : Triptonide effectively inhibits the proliferation of human PCa cells PC3, DU145, and LNCap in vitro with their IC50 values as 11.961, 10.259, and 12.012 nM, resp.  Triptonide (10 mg/kg) potently inhibits the growth of PCa cell xenografts in vivo at an inhibition rate of over 97.95%.  Treatment with triptonide (5 nM) significantly promotes cell apoptosis and retaining cell-cycle arrest in the G2/M phase.  RNA-seq data revealed that total of 936 genes were upregulated or downregulated in triptonide treated.  Moreover, the phosphorylation of mechanistic target of rapamycin (mTOR) and the downstream protein p70S6K were both inhibited, most obviously in PCa cells.  Our findings suggest that triptonide can efficaciously suppress PCa growth in vitro and in vivo via inhibiting the phosphorylation of mTOR and the activities of related downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLxC5w0Ff4zbVg90H21EOLACvtfcHk0liyycuarfanCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlSnt7vF&md5=32c40f80cb4cbef255dd3aa219743dc3</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fpros.23834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.23834%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DM.%26atitle%3DTriptonide%2520acts%2520as%2520a%2520novel%2520antiprostate%2520cancer%2520agent%2520mainly%2520through%2520inhibition%2520of%2520mTOR%2520signaling%2520pathway%26jtitle%3DProstate%26date%3D2019%26volume%3D79%26spage%3D1284%26epage%3D1293%26doi%3D10.1002%2Fpros.23834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span> <span> </span><span class="NLM_article-title">Triptonide effectively inhibits Wnt/β-catenin signaling via C-terminal transactivation domain of β-catenin</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32779</span>, <span class="refDoi"> DOI: 10.1038/srep32779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep32779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27596363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVymtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=32779&author=J.+Chinisonauthor=J.+S.+Aguilarauthor=A.+Avalosauthor=Y.+Huangauthor=Z.+Wangauthor=D.+J.+Cameronauthor=J.+Hao&title=Triptonide+effectively+inhibits+Wnt%2F%CE%B2-catenin+signaling+via+C-terminal+transactivation+domain+of+%CE%B2-catenin&doi=10.1038%2Fsrep32779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin</span></div><div class="casAuthors">Chinison, Jessica; Aguilar, Jose S.; Avalos, Alan; Huang, Ying; Wang, Zhijun; Cameron, D. Joshua; Hao, Jijun</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32779</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Abnormal activation of canonical Wnt/β-catenin signaling is implicated in many diseases including cancer.  As a result, therapeutic agents that disrupt this signaling pathway have been highly sought after.  Triptonide is a key bioactive small mol. identified in a traditional Chinese medicine named Tripterygium wilfordii Hook F., and it has a broad spectrum of biol. functions.  Here we show that triptonide can effectively inhibit canonical Wnt/β-catenin signaling by targeting the downstream C-terminal transcription domain of β-catenin or a nuclear component assocd. with β-catenin.  In addn., triptonide treatment robustly rescued the zebrafish "eyeless" phenotype induced by GSK-3β antagonist 6-bromoindirubin-30-oxime (BIO) for Wnt signaling activation during embryonic gastrulation.  Finally, triptonide effectively induced apoptosis of Wnt-dependent cancer cells, supporting the therapeutic potential of triptonide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdkCjTBzKXnbVg90H21EOLACvtfcHk0lgVrELzjORhkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVymtrzF&md5=887266067801cb37ed38a51f4875de18</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fsrep32779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32779%26sid%3Dliteratum%253Aachs%26aulast%3DChinison%26aufirst%3DJ.%26aulast%3DAguilar%26aufirst%3DJ.%2BS.%26aulast%3DAvalos%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCameron%26aufirst%3DD.%2BJ.%26aulast%3DHao%26aufirst%3DJ.%26atitle%3DTriptonide%2520effectively%2520inhibits%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520via%2520C-terminal%2520transactivation%2520domain%2520of%2520%25CE%25B2-catenin%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D32779%26doi%3D10.1038%2Fsrep32779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">114870</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2019.114870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.taap.2019.114870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31866380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2020&pages=114870&author=S.+Xiangauthor=Z.+Zhaoauthor=T.+Zhangauthor=B.+Zhangauthor=M.+Mengauthor=Z.+Caoauthor=Q.+Zhou&title=Triptonide+effectively+suppresses+gastric+tumor+growth+and+metastasis+through+inhibition+of+the+oncogenic+Notch1+and+NF-%CE%BAB+signaling+pathways&doi=10.1016%2Fj.taap.2019.114870"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways</span></div><div class="casAuthors">Xiang, Shufen; Zhao, Zhe; Zhang, Tong; Zhang, Bin; Meng, Mei; Cao, Zhifei; Zhou, Quansheng</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114870</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Gastric cancer ranks as the third leading cause of cancer-related death worldwide.  The uncontrolled tumor growth and robust metastasis are key factors to cause the cancer patient death.  Mechanistically, aberrant activation of Notch and NF-κB signaling pathways plays pivotal roles in the initiation and metastasis of gastric cancer.  Despite great efforts have been made in recent decades, the effective drug against the advanced and metastatic gastric cancer is still lacking in the clin. setting.  In this study, we found that triptonide, a small mol. (MW358) purified from the traditional Chinese medicinal herb Tripterygium wilfordii Hook F, effectively suppressed tumor growth and metastasis in xenograft mice without obvious toxicity at the doses we tested, resulting in potent anti-gastric cancer effect with low toxicity.  Triptonide markedly inhibited human metastatic gastric cancer cell migration, invasion, proliferation, and tumorigenicity.  Mol. mechanistic studies revealed that triptonide significantly reduced Notch1 protein levels in metastatic gastric cancer cells through degrading the oncogenic protein Notch1 via the ubiquitin-proteasome pathway.  Consequently, the levels of Notch1 downstream proteins RBPJ, IKKα, IKKβ were significantly diminished, and nuclear factor-kappa B (NF-κB) phosphorylation was significantly reduced.  Together, triptonide effectively suppresses gastric cancer growth and metastasis via inhibition of the oncogenic Notch1 and NF-κB signaling pathways.  Our findings provide a new strategy and drug candidate for treatment of the advanced and metastatic gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw4qxIF3bacrVg90H21EOLACvtfcHk0lhYYMPjZmwmCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFygsg%253D%253D&md5=ca48e3d0998eac94819ec7ddf1c3ee61</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2019.114870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2019.114870%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DTriptonide%2520effectively%2520suppresses%2520gastric%2520tumor%2520growth%2520and%2520metastasis%2520through%2520inhibition%2520of%2520the%2520oncogenic%2520Notch1%2520and%2520NF-%25CE%25BAB%2520signaling%2520pathways%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2020%26volume%3D388%26spage%3D114870%26doi%3D10.1016%2Fj.taap.2019.114870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2019.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bcp.2019.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31075266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1GntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2019&pages=70-81&author=B.+Zhangauthor=M.+Mengauthor=S.+Xiangauthor=Z.+Caoauthor=X.+Xuauthor=Z.+Zhaoauthor=T.+Zhangauthor=B.+Chenauthor=P.+Yangauthor=Y.+Liauthor=Q.+Zhou&title=Selective+activation+of+tumor-suppressive+MAPKP+signaling+pathway+by+triptonide+effectively+inhibits+pancreatic+cancer+cell+tumorigenicity+and+tumor+growth&doi=10.1016%2Fj.bcp.2019.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth</span></div><div class="casAuthors">Zhang, Bin; Meng, Mei; Xiang, Shufen; Cao, Zhifei; Xu, Xingdong; Zhao, Zhe; Zhang, Tong; Chen, Bowen; Yang, Ping; Li, Ye; Zhou, Quansheng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-81</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK, 1K) family members ERK, JNK, and p38 play a divergent role in either promoting tumorigenesis or tumor-suppression.  Activation of ERK and JNK promotes tumorigenesis; whereas, escalation of p38 inhibits carcinogenesis.  As these three MAPK members are controlled by the common up-stream MAPK signaling proteins which consist of MAPK kinases (2K) and MAPK kinase kinases (3K), how to selectively actuate tumor-suppressive p38, not concurrently stimulate tumorigenic ERK and JNK, in cancer cells is a challenge for cancer researchers, and a new opportunity for novel anti-cancer drug discovery.  Using human pancreatic cancer cells and xenograft mice as models, we found that a small mol. triptonide first discerningly activated the up-stream MAPK kinase kinase MEKK4, not the other two 3K members ASK1 and GADD45; and then selectively actuated the middle stream MAPK kinase MKK4, not the other two 2K members MKK3 and MKK6; and followed by activation of the MAPK member p38, not the other two members ERK and JNK.  These data suggest that triptonide is a selective MEKK4-MKK4-p38 axis agonist.  Consequently, selective activation of the MEKK4-MKK4-p38 signaling axis by triptonide activated tumor suppressor p21 and inhibited CDK3 expression, resulting in cancer cell cycle arrest at G2/M phase and marked inhibition of pancreatic cancer cell tumorigenic capability in vitro and tumor growth in xenograft mice.  Our findings support the notion that selective activation of tumor-suppressive MEKK4-MKK4-p38-p21 signaling pathway by triptonide is a new approach for pancreatic cancer therapy, providing a new drug candidate for development of novel anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrza99hIqu7Vg90H21EOLACvtfcHk0ljOv_HzLisJKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1GntL4%253D&md5=77f274a98ba2ae251c57b55ba58a6794</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2019.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2019.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMeng%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DSelective%2520activation%2520of%2520tumor-suppressive%2520MAPKP%2520signaling%2520pathway%2520by%2520triptonide%2520effectively%2520inhibits%2520pancreatic%2520cancer%2520cell%2520tumorigenicity%2520and%2520tumor%2520growth%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2019%26volume%3D166%26spage%3D70%26epage%3D81%26doi%3D10.1016%2Fj.bcp.2019.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2017.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.toxlet.2017.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28666825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1SgtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2017&pages=9-17&author=P.+Yangauthor=F.+Dongauthor=Q.+Zhou&title=Triptonide+acts+as+a+novel+potent+anti-lymphoma+agent+with+low+toxicity+mainly+through+inhibition+of+proto-oncogene+Lyn+transcription+and+suppression+of+Lyn+signal+pathway&doi=10.1016%2Fj.toxlet.2017.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway</span></div><div class="casAuthors">Yang, Ping; Dong, Fulu; Zhou, Quansheng</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-17</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Lyn is a proto-oncogene overexpressed and constitutively activated in lymphoma, and plays an important role in lymphoma initiation and malignant progression.  Hence, the oncogenic Lyn has recently been targeted for novel anti-lymphoma drug discovery; however, the effective Lyn-targeted drug for lymphoma treatment with low toxicity is absent in the clin. setting.  The goal of this study is to explore powerful and low toxic Lyn-targeted anti-lymphoma agent.  Here we show that triptonide, a small mol. purified from the herb Tripterygium wilfordii Hook F, potently inhibits the proliferation of human B-lymphoma Raji and T-lymphoma Jurkat cells with IC50 of 5.7 nM and 4.8 nM, resp.  Strikingly, triptonide at a dose of 5 mg/kg/day almost completely inhibited the lymphoma growth in human lymphoma cells-xenografted mice without obvious side effects, particularly; the tumors in 6 mice among the 8 xenografted mice were completely eradicated in vivo.  Cell biol. studies showed that triptonide at the doses of 2.5-10 nM notably suppressed B-lymphoma cell colony-forming capability, and that triptonide at the dose of 20 nM promoted apoptosis through activation of PARP and caspase 3, but redn. of BCL2 protein levels in the lymphoma cells.  Mol. studies revealed that triptonide markedly inhibited oncogenic Lyn transcription through suppressing the promoter activity of the gene, and that it remarkably reduced both total and phosphorylated Lyn proteins, and diminished Lyn downstream ERK and ATK signal pathways.  Addnl., triptonide significantly enhanced p38 phosphorylation.  Together, triptonide exerts potent anti-lymphoma effect with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn downstream ERK and ATK signal pathways, providing an attractive drug candidate for development of novel anti-lymphoma therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquk-zD0yxLS7Vg90H21EOLACvtfcHk0ljGNeUDCyb55A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1SgtbjJ&md5=27bfd9567711ac0676b546c1ad0f61ca</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2017.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2017.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%26aulast%3DDong%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DTriptonide%2520acts%2520as%2520a%2520novel%2520potent%2520anti-lymphoma%2520agent%2520with%2520low%2520toxicity%2520mainly%2520through%2520inhibition%2520of%2520proto-oncogene%2520Lyn%2520transcription%2520and%2520suppression%2520of%2520Lyn%2520signal%2520pathway%26jtitle%3DToxicol.%2520Lett.%26date%3D2017%26volume%3D278%26spage%3D9%26epage%3D17%26doi%3D10.1016%2Fj.toxlet.2017.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span> <span> </span><span class="NLM_article-title">NQO1-selective activated prodrug of triptolide: Synthesis and antihepatocellular carcinoma activity evaluation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1253</span>– <span class="NLM_lpage">1257</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCmsb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1253-1257&author=M.+Liuauthor=W.+Songauthor=X.+Duauthor=J.+Suauthor=K.+Dongauthor=Y.+Chenauthor=Z.+Peng&title=NQO1-selective+activated+prodrug+of+triptolide%3A+Synthesis+and+antihepatocellular+carcinoma+activity+evaluation&doi=10.1021%2Facsmedchemlett.8b00404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1-Selective Activated Prodrug of Triptolide: Synthesis and Antihepatocellular Carcinoma Activity Evaluation</span></div><div class="casAuthors">Liu, Meilin; Song, Wei; Du, Xi; Su, Jingtian; Dong, Kang; Chen, Yong; Peng, Zhihong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1253-1257</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis.  Due to its poor response to conventional chemotherapy drugs, the prognosis for its survival is the worst.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is an attractive anticancer target due to its overexpression in HCC.  Although triptolide (TP) possesses potent antitumor activity, its clin. practice is greatly limited due to its general toxicities and narrow therapeutic window.  Herein, we develop an NQO1-selective activated TP analog, named CX-23, which exhibited antiproliferation of HepG2 over normal hepatocytes in vitro.  In vivo study shows that CX-23 can not only prevent the hepatocellular carcinoma progression but also migrate the liver and kidney toxicity.  These findings indicate that NQO1 may serve as a targeted delivery system to release an antitumor reagent and that CX-23 may be a promising lead for developing targeted antihepatocellular carcinoma drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFDSyyainbZrVg90H21EOLACvtfcHk0lgMv1C7swNfbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCmsb7P&md5=2994e57fa6e8dbb828caa7dfc0e0444b</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00404%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DZ.%26atitle%3DNQO1-selective%2520activated%2520prodrug%2520of%2520triptolide%253A%2520Synthesis%2520and%2520antihepatocellular%2520carcinoma%2520activity%2520evaluation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D1253%26epage%3D1257%26doi%3D10.1021%2Facsmedchemlett.8b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuellar, R. A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazar, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suryanarayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurvich, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span> <span> </span><span class="NLM_article-title">Phosphonooxymethyl prodrug of triptolide: Synthesis, physicochemical characterization, and efficacy in human colon adenocarcinoma and ovarian cancer xenografts</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9334</span>– <span class="NLM_lpage">9344</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9334-9344&author=S.+Patilauthor=L.+G.+Lisauthor=R.+J.+Schumacherauthor=B.+J.+Norrisauthor=M.+L.+Morganauthor=R.+A.+D.+Cuellarauthor=B.+R.+Blazarauthor=R.+Suryanarayananauthor=V.+J.+Gurvichauthor=G.+I.+Georg&title=Phosphonooxymethyl+prodrug+of+triptolide%3A+Synthesis%2C+physicochemical+characterization%2C+and+efficacy+in+human+colon+adenocarcinoma+and+ovarian+cancer+xenografts&doi=10.1021%2Facs.jmedchem.5b01329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts</span></div><div class="casAuthors">Patil, Satish; Lis, Lev G.; Schumacher, Robert J.; Norris, Beverly J.; Morgan, Monique L.; Cuellar, Rebecca A. D.; Blazar, Bruce R.; Suryanarayanan, Raj; Gurvich, Vadim J.; Georg, Gunda I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9334-9344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A disodium phosphonooxymethyl prodrug of the antitumor agent triptolide was prepd. from the natural product in three steps (39% yield) and displayed excellent aq. soly. at pH 7.4 (61 mg/mL) compared to the natural product (17 μg/mL).  The estd. shelf life (t90) for hydrolysis of the prodrug at 4 °C and pH 7.4 was found to be two years.  In a mouse model of human colon adenocarcinoma (HT-29), the prodrug administered i.p. was effective in reducing or eliminating xenograft tumors at dose levels as low as 0.3 mg/kg when given daily and at 0.9 mg/kg when given less frequently.  When given via i.p. and oral routes at daily doses of 0.6 and 0.9 mg/kg, the prodrug was also effective and well tolerated in a mouse model of human ovarian cancer (A2780).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq61-SWUZUAnLVg90H21EOLACvtfcHk0limGDW8YPGYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGjtb%252FL&md5=814a39327c1d30b60720b0dd85fcc708</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01329%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DLis%26aufirst%3DL.%2BG.%26aulast%3DSchumacher%26aufirst%3DR.%2BJ.%26aulast%3DNorris%26aufirst%3DB.%2BJ.%26aulast%3DMorgan%26aufirst%3DM.%2BL.%26aulast%3DCuellar%26aufirst%3DR.%2BA.%2BD.%26aulast%3DBlazar%26aufirst%3DB.%2BR.%26aulast%3DSuryanarayanan%26aufirst%3DR.%26aulast%3DGurvich%26aufirst%3DV.%2BJ.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26atitle%3DPhosphonooxymethyl%2520prodrug%2520of%2520triptolide%253A%2520Synthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520efficacy%2520in%2520human%2520colon%2520adenocarcinoma%2520and%2520ovarian%2520cancer%2520xenografts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9334%26epage%3D9344%26doi%3D10.1021%2Facs.jmedchem.5b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span> <span> </span><span class="NLM_article-title">Minnelide, a novel drug for pancreatic and liver cancer</span>. <i>Pancreatology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">S39</span>– <span class="NLM_lpage">S43</span>, <span class="refDoi"> DOI: 10.1016/j.pan.2015.05.472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.pan.2015.05.472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26122306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=S39-S43&author=S.+Banerjeeauthor=A.+Saluja&title=Minnelide%2C+a+novel+drug+for+pancreatic+and+liver+cancer&doi=10.1016%2Fj.pan.2015.05.472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Minnelide, a novel drug for pancreatic and liver cancer</span></div><div class="casAuthors">Banerjee, Sulagna; Saluja, Ashok</div><div class="citationInfo"><span class="NLM_cas:title">Pancreatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4_Suppl.</span>),
    <span class="NLM_cas:pages">S39-S43</span>CODEN:
                <span class="NLM_cas:coden">PANCC2</span>;
        ISSN:<span class="NLM_cas:issn">1424-3903</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is the 10th leading cause of all new cancer cases for men and the fourth leading cause of death across genders, having very poor prognosis and survival rates.  The current std. of care Gemcitabine fails to add any survival benefit for this disease (www.cancer.gov).  Though the incidence of pancreatic cancer is found to be higher in developed countries, the aggressive biol. of the cancer, its high rate of recurrence and chemo-resistance make it a formidable disease in all parts of the globe.  Hepatocellular carcinoma (HCC) or liver cancer, on the other hand affects almost 750,000 people world wide with 84% of the cases coming from underdeveloped or developing countriesOur studies show that Minnelide, a water sol. pro-drug of triptolide (active compd. from a chinese herb) is very effective against a no. of malignant diseases.The current study discusses the efficacy of this compd. in pancreatic and liver cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNsPsgBGeKrVg90H21EOLACvtfcHk0limGDW8YPGYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKmtr3E&md5=e8ecae949972a413ba371a22b5f1a668</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.pan.2015.05.472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pan.2015.05.472%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSaluja%26aufirst%3DA.%26atitle%3DMinnelide%252C%2520a%2520novel%2520drug%2520for%2520pancreatic%2520and%2520liver%2520cancer%26jtitle%3DPancreatology%26date%3D2015%26volume%3D15%26spage%3DS39%26epage%3DS43%26doi%3D10.1016%2Fj.pan.2015.05.472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caicedo-Granados, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yueh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangwan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span> <span> </span><span class="NLM_article-title">Wild-type p53 reactivation by small-molecule Minnelide<sup>TM</sup> in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma</span>. <i>Oral Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1156</span>, <span class="refDoi"> DOI: 10.1016/j.oraloncology.2014.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.oraloncology.2014.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25311433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslansrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=1149-1156&author=E.+Caicedo-Granadosauthor=R.+Linauthor=C.+Fujisawaauthor=B.+Yuehauthor=V.+Sangwanauthor=A.+Saluja&title=Wild-type+p53+reactivation+by+small-molecule+MinnelideTM+in+human+papillomavirus+%28HPV%29-positive+head+and+neck+squamous+cell+carcinoma&doi=10.1016%2Fj.oraloncology.2014.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Wild-type p53 reactivation by small-molecule Minnelide in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma</span></div><div class="casAuthors">Caicedo-Granados, Emiro; Lin, Rui; Fujisawa, Caitlin; Yueh, Bevan; Sangwan, Veena; Saluja, Ashok</div><div class="citationInfo"><span class="NLM_cas:title">Oral Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1149-1156</span>CODEN:
                <span class="NLM_cas:coden">EJCCER</span>;
        ISSN:<span class="NLM_cas:issn">1368-8375</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The incidence of high-risk human papillomavirus (HR-HPV) head and neck squamous cell carcinoma (HNSCC) continues to increase, particularly oropharyngeal squamous cell carcinoma (OPSCC) cases.  The inactivation of the p53 tumor suppressor gene promotes a chain of mol. events, including cell cycle progression and apoptosis resistance.  Reactivation of wild-type p53 function is an intriguing therapeutic strategy.  The aim of this study was to investigate whether a novel compd. derived from diterpene triepoxide (Minnelide) can reactivate wild-type p53 function in HPV-pos. HNSCC.  For all of our in vitro expts., we used 2 HPV-pos. HNSCC cell lines, University of Michigan squamous cell carcinoma (UM-SCC) 47 and 93-VU-147, and 2 HPV-pos. human cervical cancer cell lines, SiHa and CaSki.  Cells were treated with different concns. of triptolide and analyzed for p53 activation.  Mice bearing UM-SCC 47 s.c. xenografts and HPV-pos. patient-derived tumor xenografts were treated with Minnelide and evaluated for tumor growth and p53 activation.  In HPV-pos. HNSCC, Minnelide reactivated p53 by suppressing E6 oncoprotein.  Activation of apoptosis followed, both in vitro and in vivo.  In 2 preclin. HNSCC animal models (a s.c. xenograft model and a patient-derived tumor xenograft model), Minnelide reactivated p53 function and significantly decreased tumor progression and tumor vol.  Triptolide and Minnelide caused cell death in vitro and in vivo in HPV-pos. HNSCC by reactivating wild-type p53 and thus inducing apoptosis.  In addn., in 2 HPV-pos. HNSCC animal models, Minnelide decreased tumor progression and induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWRShEAlNh2rVg90H21EOLACvtfcHk0ligaJcfeAJyvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslansrzL&md5=4de2fc267c5e715d6d294d6d9f45e43d</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.oraloncology.2014.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.oraloncology.2014.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DCaicedo-Granados%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DFujisawa%26aufirst%3DC.%26aulast%3DYueh%26aufirst%3DB.%26aulast%3DSangwan%26aufirst%3DV.%26aulast%3DSaluja%26aufirst%3DA.%26atitle%3DWild-type%2520p53%2520reactivation%2520by%2520small-molecule%2520MinnelideTM%2520in%2520human%2520papillomavirus%2520%2528HPV%2529-positive%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DOral%2520Oncol.%26date%3D2014%26volume%3D50%26spage%3D1149%26epage%3D1156%26doi%3D10.1016%2Fj.oraloncology.2014.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousalova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangwan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evenson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratzke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Cunha, J.</span></span> <span> </span><span class="NLM_article-title">Minnelide: A novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e77411</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0077411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1371%2Fjournal.pone.0077411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24143232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Kiu7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=I.+Rousalovaauthor=S.+Banerjeeauthor=V.+Sangwanauthor=K.+Evensonauthor=J.+A.+McCauleyauthor=R.+Kratzkeauthor=S.+M.+Vickersauthor=A.+Salujaauthor=J.+D%E2%80%99Cunha&title=Minnelide%3A+A+novel+therapeutic+that+promotes+apoptosis+in+non-small+cell+lung+carcinoma+in+vivo&doi=10.1371%2Fjournal.pone.0077411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo</span></div><div class="casAuthors">Rousalova, Ilona; Banerjee, Sulagna; Sangwan, Veena; Evenson, Kristen; McCauley, Joel A.; Kratzke, Robert; Vickers, Selwyn M.; Saluja, Ashok; D'Cunha, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e77411</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent.  The precise mechanisms of its cytotoxic effects remain unclear.  Methods: Cell viability was studied using CCK8 assay.  Cell proliferation was measured real-time on cultured cells using Elec. Cell Substrate Impedence Sensing (ECIS).  Apoptosis was assayed by Caspase activity on cultured lung cancer cells and TUNEL staining on tissue sections.  Expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA, APAF-1) was estd. by qRTPCR.  Effect of Minnelide on proliferative cells in the tissue was estd. by Ki-67 staining of animal tissue sections.  Results: In this study, we investigated in vitro and in vivo antitumor effects of triptolide/Minnelide in non-small cell lung carcinoma (NSCLC).  Triptolide/Minnelide exhibited anti-proliferative effects and induced apoptosis in NSCLC cell lines and NSCLC mouse models.  Triptolide/Minnelide significantly down-regulated the expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA) and up-regulated pro-apoptotic APAF-1 gene, in part, via attenuating the NF-κB signaling activity.  Conclusion: In conclusion, our results provide supporting mechanistic evidence for Minnelide as a potential in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUoTk9jzQPEbVg90H21EOLACvtfcHk0lg3W4aPlpWIvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Kiu7rO&md5=0194c45ca4713a9c8b6d14d6b25c74e2</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0077411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0077411%26sid%3Dliteratum%253Aachs%26aulast%3DRousalova%26aufirst%3DI.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSangwan%26aufirst%3DV.%26aulast%3DEvenson%26aufirst%3DK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DKratzke%26aufirst%3DR.%26aulast%3DVickers%26aufirst%3DS.%2BM.%26aulast%3DSaluja%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Cunha%26aufirst%3DJ.%26atitle%3DMinnelide%253A%2520A%2520novel%2520therapeutic%2520that%2520promotes%2520apoptosis%2520in%2520non-small%2520cell%2520lung%2520carcinoma%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0077411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnettler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/j.ygyno.2014.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ygyno.2014.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25172764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOhtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2014&pages=318-324&author=C.+Rivardauthor=M.+Gellerauthor=E.+Schnettlerauthor=M.+Salujaauthor=R.+I.+Vogelauthor=A.+Salujaauthor=S.+Ramakrishnan&title=Inhibition+of+epithelial+ovarian+cancer+by+Minnelide%2C+a+water-soluble+pro-drug&doi=10.1016%2Fj.ygyno.2014.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug</span></div><div class="casAuthors">Rivard, Colleen; Geller, Melissa; Schnettler, Erica; Saluja, Manju; Vogel, Rachel Isaksson; Saluja, Ashok; Ramakrishnan, Sundaram</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-324</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Minnelide is a water-sol. pro-drug of triptolide, a natural product.  The goal of this study was to evaluate the effectiveness of Minnelide on ovarian cancer growth in vitro and in vivo.The effect of Minnelide on ovarian cancer cell proliferation was detd. by real time elec. impedance measurements.  Multiple mouse models with C200 and A2780 epithelial ovarian cancer cell lines were used to assess the efficacy of Minnelide in inhibiting ovarian cancer growth.  Minnelide decreased cell viability of both platinum sensitive and resistant epithelial ovarian cancer cells in vitro.  Minnelide with carboplatin showed additive effects in vitro.  Minnelide monotherapy increased the survival of mice bearing established ovarian tumors.  Minnelide, in combination with carboplatin and paclitaxel, improved overall survival of mice.  Minnelide is a promising pro-drug for the treatment of ovarian cancer, esp. when combined with std. chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptH8M-A73V_bVg90H21EOLACvtfcHk0lisnEGhep6Yag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOhtrzM&md5=0ead311ba5e7f2cbfc5d5a80be6d4fd3</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2014.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2014.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DGeller%26aufirst%3DM.%26aulast%3DSchnettler%26aufirst%3DE.%26aulast%3DSaluja%26aufirst%3DM.%26aulast%3DVogel%26aufirst%3DR.%2BI.%26aulast%3DSaluja%26aufirst%3DA.%26aulast%3DRamakrishnan%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520epithelial%2520ovarian%2520cancer%2520by%2520Minnelide%252C%2520a%2520water-soluble%2520pro-drug%26jtitle%3DGynecol.%2520Oncol.%26date%3D2014%26volume%3D135%26spage%3D318%26epage%3D324%26doi%3D10.1016%2Fj.ygyno.2014.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isharwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlass, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehm, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudeja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konety, B.</span></span> <span> </span><span class="NLM_article-title">Minnelide inhibits androgen dependent, castration resistant prostate cancer growth by decreasing expression of androgen receptor full length and splice variants</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1002/pros.23298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fpros.23298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28144973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVSktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=584-596&author=S.+Isharwalauthor=S.+Modiauthor=N.+Aroraauthor=C.+Uhlrichauthor=B.+Giriauthor=U.+Barlassauthor=A.+Soubraauthor=R.+Chughauthor=S.+M.+Dehmauthor=V.+Dudejaauthor=A.+Salujaauthor=S.+Banerjeeauthor=B.+Konety&title=Minnelide+inhibits+androgen+dependent%2C+castration+resistant+prostate+cancer+growth+by+decreasing+expression+of+androgen+receptor+full+length+and+splice+variants&doi=10.1002%2Fpros.23298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants</span></div><div class="casAuthors">Isharwal, Sumit; Modi, Shrey; Arora, Nivedita; Uhlrich, Charles, III; Giri, Bhuwan; Barlass, Usman; Soubra, Ayman; Chugh, Rohit; Dehm, Scott M.; Dudeja, Vikas; Saluja, Ashok; Banerjee, Sulagna; Konety, Badrinath</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">584-596</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BACKGROUND : With almost 30,000 deaths per yr, prostate cancer is the second-leading cause of cancer-related death in men.  Androgen Deprivation Therapy (ADT) has been the corner stone of prostate cancer treatment for decades.  However, despite an initial response of prostate cancer to ADT, this eventually fails and the tumors recur, resulting in Castration Resistant Prostate Cancer (CRPC).  Triptolide, a diterpene triepoxide, has been tested for its anti-tumor properties in a no. of cancers for over a decade.  Owing to its poor soly. in aq. medium, its clin. application had been limited.  To circumvent this problem, we have synthesized a water-sol. pro-drug of triptolide, Minnelide, that is currently being evaluated in a Phase 1 clin. trial against gastrointestinal tumors.  In the current study, we assessed the therapeutic potential of Minnelide and its active compd. triptolide against androgen dependent prostate cancer both in vitro as well as in vivo.  METHODS : Cell viability was measured by a MTT based assay after treating prostate cancer cells with multiple doses of triptolide.  Apoptotic cell death was measured using a caspase 3/7 activity.  Androgen Receptor (AR) promoter-binding activity was evaluated by using luciferase reporter assay.  For evaluating the effect in vivo, 22Rv1 cells were implanted s.c. in animals, following which, treatment was started with 0.21 mg/kg Minnelide.  RESULTS : Our study showed that treatment with triptolide induced apoptotic cell death in CRPC cells.  Triptolide treatment inhibited AR transcriptional activity and decreased the expression of AR and its splice variants both at the mRNA and the protein level.  Our studies show that triptolide inhibits nuclear translocation of Sp1, resulting in its decreased transcriptional activity leading to downregulation of AR and its splice variants in prostate cancer cells.  In vivo, Minnelide (0.21 mg/kg) regressed s.c. tumors derived from CRPC 22RV1 at our study endpoint.  Our animal studies further confirmed that Minnelide was more efficacious than the std. of care therapies, Docetaxel and Enzalutamide.  CONCLUSION : Our study indicates that Minnelide is very effective as a therapeutic option against CRPC at a dose that is currently tolerated by patients in the ongoing clin. trials.  Prostate 77: 584-596, 2017. 2017 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZEe8dozgQkbVg90H21EOLACvtfcHk0lgvR7ZWeOgZwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVSktbo%253D&md5=53edfa527fb3cdfa07579a4cce489137</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1002%2Fpros.23298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.23298%26sid%3Dliteratum%253Aachs%26aulast%3DIsharwal%26aufirst%3DS.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DArora%26aufirst%3DN.%26aulast%3DUhlrich%26aufirst%3DC.%26aulast%3DGiri%26aufirst%3DB.%26aulast%3DBarlass%26aufirst%3DU.%26aulast%3DSoubra%26aufirst%3DA.%26aulast%3DChugh%26aufirst%3DR.%26aulast%3DDehm%26aufirst%3DS.%2BM.%26aulast%3DDudeja%26aufirst%3DV.%26aulast%3DSaluja%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DKonety%26aufirst%3DB.%26atitle%3DMinnelide%2520inhibits%2520androgen%2520dependent%252C%2520castration%2520resistant%2520prostate%2520cancer%2520growth%2520by%2520decreasing%2520expression%2520of%2520androgen%2520receptor%2520full%2520length%2520and%2520splice%2520variants%26jtitle%3DProstate%26date%3D2017%26volume%3D77%26spage%3D584%26epage%3D596%26doi%3D10.1002%2Fpros.23298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavania, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudeja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saluja, A.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">163</span>, <span class="refDoi"> DOI: 10.1186/s12967-019-1901-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs12967-019-1901-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31109340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3M7nvVWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=163&author=B.+Giriauthor=V.+K.+Guptaauthor=B.+Yaffeauthor=S.+Modiauthor=P.+Royauthor=V.+Sethiauthor=S.+P.+Lavaniaauthor=S.+M.+Vickersauthor=V.+Dudejaauthor=S.+Banerjeeauthor=J.+Wattsauthor=A.+Saluja&title=Pre-clinical+evaluation+of+Minnelide+as+a+therapy+for+acute+myeloid+leukemia&doi=10.1186%2Fs12967-019-1901-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia</span></div><div class="casAuthors">Giri Bhuwan; Gupta Vineet K; Yaffe Brianna; Modi Shrey; Roy Pooja; Sethi Vrishketan; Lavania Shweta P; Vickers Selwyn M; Dudeja Vikas; Banerjee Sulagna; Watts Justin; Saluja Ashok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  There is an urgent need for novel and effective treatment options for acute myeloid leukemia (AML).  Triptolide, a diterpenoid tri-epoxide compound isolated from the herb Tripterygium wilfordii and its water-soluble pro-drug-Minnelide have shown promising anti-cancer activity.  A recent clinical trial for patients with solid tumors confirmed the safety and efficacy at biologically equivalent doses of 0.2 mg/kg/day and lower.  METHODS:  Cell viability of multiple AML cell lines as well as patient apheresis samples were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) based assay.  Apoptosis was evaluated by estimating the amount of cleaved caspase.  AML cell line (THP1-Luc) was implanted in immunocompromised mice and treated with indicated doses of Minnelide.  Leukemic burden before and after treatment was evaluated by imaging in an In Vivo Imaging System (IVIS).  RESULTS:  In the current study, we show that Minnelide, at doses below maximum tolerated dose (MTD) demonstrates leukemic clearance of both primary AML blasts and luciferase expressing THP-1 cells in mice.  In vitro, multiple primary AML apheresis samples and AML cell lines (THP-1, KG1, Kasumi-1, HL-60) were sensitive to triptolide mediated cell death and apoptosis in low doses.  Treatment with triptolide led to a significant decrease in the colony forming ability of AML cell lines as well as in the expression of stem cell markers.  Additionally, it resulted in the cell cycle arrest in the G1/S phase with significant downregulation of c-Myc, a major transcriptional regulator mediating cancer cell growth and stemness.  CONCLUSION:  Our results suggest that Minnelide, with confirmed safety and activity in the clinic, exerts a potent anti-leukemic effect in multiple models of AML at doses easily achievable in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfBOJKnz1vQ3WEEzDrymxmfW6udTcc2eb0tAt7n7EKyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7nvVWnsw%253D%253D&md5=9ea8c7dc6a7759c334550960fbbb7945</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1186%2Fs12967-019-1901-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12967-019-1901-8%26sid%3Dliteratum%253Aachs%26aulast%3DGiri%26aufirst%3DB.%26aulast%3DGupta%26aufirst%3DV.%2BK.%26aulast%3DYaffe%26aufirst%3DB.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DP.%26aulast%3DSethi%26aufirst%3DV.%26aulast%3DLavania%26aufirst%3DS.%2BP.%26aulast%3DVickers%26aufirst%3DS.%2BM.%26aulast%3DDudeja%26aufirst%3DV.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DWatts%26aufirst%3DJ.%26aulast%3DSaluja%26aufirst%3DA.%26atitle%3DPre-clinical%2520evaluation%2520of%2520Minnelide%2520as%2520a%2520therapy%2520for%2520acute%2520myeloid%2520leukemia%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2019%26volume%3D17%26spage%3D163%26doi%3D10.1186%2Fs12967-019-1901-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, R.-Y</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris-Natschke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1039/b810774m</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fb810774m" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=19779642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOiu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=1321-1344&author=R.-Y+Kuoauthor=K.+Qianauthor=S.+L.+Morris-Natschkeauthor=K.-H.+Lee&title=Plant-derived+triterpenoids+and+analogues+as+antitumor+and+anti-HIV+agents&doi=10.1039%2Fb810774m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents</span></div><div class="casAuthors">Kuo, Reen-Yen; Qian, Keduo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1321-1344</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This article reviews the antitumor and anti-HIV activities of naturally occurring triterpenoids, including the lupane, ursane, oleanane, lanostane, dammarane, and misc. scaffolds.  Structure-activity relationships of selected natural compds. and their synthetic derivs. are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4100e-8N2XrVg90H21EOLACvtfcHk0liACpqS9OgdMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOiu7rF&md5=91e86d89ca40cc6eb306efe2980a5604</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1039%2Fb810774m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb810774m%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DR.-Y%26aulast%3DQian%26aufirst%3DK.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DPlant-derived%2520triterpenoids%2520and%2520analogues%2520as%2520antitumor%2520and%2520anti-HIV%2520agents%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2009%26volume%3D26%26spage%3D1321%26epage%3D1344%26doi%3D10.1039%2Fb810774m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-Y.</span></span> <span> </span><span class="NLM_article-title">Anti-cancer effects of pristimerin and the mechanisms: A critical review</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">746</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2019.00746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31354475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVaqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=746&author=J.-J.+Liauthor=Y.-Y.+Yanauthor=H.-M.+Sunauthor=Y.+Liuauthor=C.-Y.+Suauthor=H.-B.+Chenauthor=J.-Y.+Zhang&title=Anti-cancer+effects+of+pristimerin+and+the+mechanisms%3A+A+critical+review&doi=10.3389%2Ffphar.2019.00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer effects of pristimerin and the mechanisms: a critical review</span></div><div class="casAuthors">Li, Jia-jun; Yan, Yan-yan; Sun, Hong-mei; Liu, Yun; Su, Chao-yue; Chen, Hu-biao; Zhang, Jian-ye</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">746</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">As a quinonemethide triterpenoid extd. from species of the Celastraceae and Hippocrateaceae, pristimerin has been shown potent anti-cancer effects.  Specifically, it was found that pristimerin can affect many tumor-related processes, such as apoptosis, autophagy, migration and invasion, vasculogenesis, and drug resistance.  Various mol. targets or signaling pathways are also involved, such as cyclins, reactive oxygen species (ROS), microRNA, nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and PI3K/AKT/mammalian target of rapamycin (mTOR) pathways.  In this review, we will focus on the research about pristimerin-induced anti-cancer activities to achieve a deeper understanding of the targets and mechanisms, which offer evidences suggesting that pristimerin can be a potent anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnBBPFj49ALrVg90H21EOLACvtfcHk0ljheOpQxnKkvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVaqs70%253D&md5=a5659c3c2ef602d3a04116c604ded75b</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00746%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.-J.%26aulast%3DYan%26aufirst%3DY.-Y.%26aulast%3DSun%26aufirst%3DH.-M.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DC.-Y.%26aulast%3DChen%26aufirst%3DH.-B.%26aulast%3DZhang%26aufirst%3DJ.-Y.%26atitle%3DAnti-cancer%2520effects%2520of%2520pristimerin%2520and%2520the%2520mechanisms%253A%2520A%2520critical%2520review%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D746%26doi%3D10.3389%2Ffphar.2019.00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span> <span> </span><span class="NLM_article-title">Relationship between structural characteristics and plant sources along with pharmacology research of quassinoids</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1248/cpb.c18-00958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1248%2Fcpb.c18-00958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31257321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlahsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2019&pages=654-665&author=Z.+Liauthor=J.-Y.+Ruanauthor=F.+Sunauthor=J.-J.+Yanauthor=J.-L.+Wangauthor=Z.-X.+Zhangauthor=Y.+Zhangauthor=T.+Wang&title=Relationship+between+structural+characteristics+and+plant+sources+along+with+pharmacology+research+of+quassinoids&doi=10.1248%2Fcpb.c18-00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between structural characteristics and plant sources along with pharmacology research of quassinoids</span></div><div class="casAuthors">Li, Zheng; Ruan, Jing-ya; Sun, Fan; Yan, Jie-jing; Wang, Jian-li; Zhang, Zi-xin; Zhang, Yi; Wang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">654-665</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A review.  Quassinoids, one kind of triterpenoids with multiple bioactivities such as anti-cancer, anti-malarial, anti-oxidative, anti-microbial, anti-diabetic, anti-viral, and anti-inflammatory effects, have drawn much attention in recent years.  Between 2004 and 2018, the structural characteristics and plant sources of 190 quassinoids were reported.  Herein, the structure-activity relationships (SARs) of quassinoids along with the anti-cancer mechanisms of four representative quassinoids, eurycomanone, bruceine D, dehydrobruceine B, and brusatol are discussed.  This review might be useful for further research and development of quassinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi7eHd47uLRrVg90H21EOLACvtfcHk0lhm2rtpuaEhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlahsrrN&md5=2ad8054a65ae8dd8d386b0f5b5a57629</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c18-00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c18-00958%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRuan%26aufirst%3DJ.-Y.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.-J.%26aulast%3DWang%26aufirst%3DJ.-L.%26aulast%3DZhang%26aufirst%3DZ.-X.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DRelationship%2520between%2520structural%2520characteristics%2520and%2520plant%2520sources%2520along%2520with%2520pharmacology%2520research%2520of%2520quassinoids%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2019%26volume%3D67%26spage%3D654%26epage%3D665%26doi%3D10.1248%2Fcpb.c18-00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Unprecedented quassinoids from <i>Eurycoma longifolia</i>: Biogenetic evidence and antifeedant effects</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1683</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.0c00244</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.0c00244" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2020&pages=1674-1683&author=W.-Q.+Yangauthor=X.-H.+Shaoauthor=F.+Dengauthor=L.-J.+Huauthor=Y.+Xiongauthor=X.-J.+Huangauthor=C.-L.+Fanauthor=R.-W.+Jiangauthor=W.-C.+Yeauthor=Y.+Wang&title=Unprecedented+quassinoids+from+Eurycoma+longifolia%3A+Biogenetic+evidence+and+antifeedant+effects&doi=10.1021%2Facs.jnatprod.0c00244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit209R"><div class="casContent"><span class="casTitleNuber">209</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Quassinoids from Eurycoma longifolia: Biogenetic Evidence and Antifeedant Effects</span></div><div class="casAuthors">Yang, Wei-Qun; Shao, Xue-Hua; Deng, Fang; Hu, Li-Jun; Xiong, Yu; Huang, Xiao-Jun; Fan, Chun-Lin; Jiang, Ren-Wang; Ye, Wen-Cai; Wang, Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1674-1683</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Six new quassinoids (I-6) were isolated from the roots of Eurycoma longifolia, and their structures with abs. configurations were detd. unambiguously by spectroscopic analyses and single-crystal X-ray crystallog. expts.  Compds. 1 and 2 are the first members of a new class of quassinoids with an unusual C26 carbon skeleton.  Compd. 6 features a C20 cage-like scaffold with an unprecedented densely functionalized 2,5-dioxatricyclo[5.2.2.04,8]undecane core.  The discovery of the two C26 quassinoids I and 2 has provided firm evidence for the better understanding the biogenetic process from C30 triterpenoid precursors to quassinoids.  Compd. 5 exhibited significant antifeedant activity on the diamondback moth (DBM) larvae and excellent systemic absorption and accumulated properties in Brassica chinensis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS60zxv4ZAK7Vg90H21EOLACvtfcHk0lgJmt2ju50l0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlertLs%253D&md5=0786ac7ab862ba86dc7a53684162bf7c</span></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.0c00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.0c00244%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.-Q.%26aulast%3DShao%26aufirst%3DX.-H.%26aulast%3DDeng%26aufirst%3DF.%26aulast%3DHu%26aufirst%3DL.-J.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.-J.%26aulast%3DFan%26aufirst%3DC.-L.%26aulast%3DJiang%26aufirst%3DR.-W.%26aulast%3DYe%26aufirst%3DW.-C.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DUnprecedented%2520quassinoids%2520from%2520Eurycoma%2520longifolia%253A%2520Biogenetic%2520evidence%2520and%2520antifeedant%2520effects%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2020%26volume%3D83%26spage%3D1674%26epage%3D1683%26doi%3D10.1021%2Facs.jnatprod.0c00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupchan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigel, C. W.</span></span> <span> </span><span class="NLM_article-title">Bruceantin, a new potent antileukemic simaroubolide from <i>Brucea antidysenterica</i></span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1021/jo00941a049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00941a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE3sXnt1ertA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=178-179&author=S.+M.+Kupchanauthor=R.+W.+Brittonauthor=M.+F.+Zieglerauthor=C.+W.+Sigel&title=Bruceantin%2C+a+new+potent+antileukemic+simaroubolide+from+Brucea+antidysenterica&doi=10.1021%2Fjo00941a049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica</span></div><div class="casAuthors">Kupchan, S. Morris; Britton, Ronald W.; Ziegler, Myra F.; Sigel, Carl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">178-9</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Bruceantin (I) and bruceantarin (II) are antileukemic simaroubolides from B. antidysenterica, a plant used in Ethiopia in the treatment of cancer.  Hydrogenation of I gave dihydrobruceantin (III), and mild alk. hydrolysis of III gave bruceolide (IV).  Hydrolysis of I and esterification of the steam distillable acid with diazoethane gave Et trans-3,4-dimethyl-2-pentenoate.  Mild alk. hydrolysis of II gave BzOH and IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqu0_QiNsD2LVg90H21EOLACvtfcHk0li7wu-brxV54g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXnt1ertA%253D%253D&md5=e930a286c2f5a0e5a9e04c06d744fdaf</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1021%2Fjo00941a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00941a049%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DBritton%26aufirst%3DR.%2BW.%26aulast%3DZiegler%26aufirst%3DM.%2BF.%26aulast%3DSigel%26aufirst%3DC.%2BW.%26atitle%3DBruceantin%252C%2520a%2520new%2520potent%2520antileukemic%2520simaroubolide%2520from%2520Brucea%2520antidysenterica%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D178%26epage%3D179%26doi%3D10.1021%2Fjo00941a049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.-Y.</span></span> <span> </span><span class="NLM_article-title">Bruceine A</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">o854</span>– <span class="NLM_lpage">o855</span>, <span class="refDoi"> DOI: 10.1107/S1600536810007646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS1600536810007646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21580678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktlCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=o854-o855&author=X.-H.+Fengauthor=Y.-N.+Zhangauthor=W.-Z.+Heauthor=L.+Zhangauthor=H.-Y.+Jiang&title=Bruceine+A&doi=10.1107%2FS1600536810007646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine A</span></div><div class="casAuthors">Feng, Xue Huan; Zhang, Yan Ning; He, Wei Zhi; Zhang, Lan; Jiang, Hong Yun</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Structure Reports Online</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">o854-o855</span>CODEN:
                <span class="NLM_cas:coden">ACSEBH</span>;
        ISSN:<span class="NLM_cas:issn">1600-5368</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The title compd., C26H34O11, known as bruceine A, is a natural quassinoid extd. from the dried fruits of Brucea javanica.  Its structure consists of five fused rings including an oxygen-contg. heterocyclic ring and a lactone ring.  Two intramol. O-H...O links help to establish the mol. conformation.  In the crystal, O-H...O hydrogen bonds connect the mols.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-hUh6kCSD4bVg90H21EOLACvtfcHk0li7wu-brxV54g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktlCmtr8%253D&md5=9b55ad929fc888a095e632a2133cc9c2</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1107%2FS1600536810007646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536810007646%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.-H.%26aulast%3DZhang%26aufirst%3DY.-N.%26aulast%3DHe%26aufirst%3DW.-Z.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DH.-Y.%26atitle%3DBruceine%2520A%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2010%26volume%3D66%26spage%3Do854%26epage%3Do855%26doi%3D10.1107%2FS1600536810007646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.-W.</span></span> <span> </span><span class="NLM_article-title">Brusatol</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">o1592</span>– <span class="NLM_lpage">o1593</span>, <span class="refDoi"> DOI: 10.1107/S1600536812018582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS1600536812018582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=22719401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XotFansLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=o1592-o1593&author=S.-Z.+Huauthor=L.+Jinauthor=T.+Yuauthor=H.-Y.+Tianauthor=R.-W.+Jiang&title=Brusatol&doi=10.1107%2FS1600536812018582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol</span></div><div class="casAuthors">Hu, Shu-Zhi; Jin, Lu; Yu, Tong; Tian, Hai-Yan; Jiang, Ren-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Structure Reports Online</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">o1592-o1593</span>CODEN:
                <span class="NLM_cas:coden">ACSEBH</span>;
        ISSN:<span class="NLM_cas:issn">1600-5368</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The title compd., C26H32O11, is composed of an α,β-unsatd. cyclohexanone ring (A), two cyclohexane rings (B and C), a six-membered lactone ring (D) and THF ring (E).  Ring A exists in a half-chair conformation with a C atom displaced by 0.679 (2) Å from the mean plane through the remaining five atoms.  Ring B exists in a normal chair conformation.  Both rings C and D exist in a twisted-chair conformation due to the O-atom bridge and the carbonyl group in rings C and D, resp.  Ring E shows an envelope conformation with a C atom displaced by 0.761 (1) Å from the mean plane through the remaining five atoms.  The ring junctions are A/B trans, B/C trans, C/D cis and D/E cis.  An intramol. O-H···O hydrogen bond occurs.  In the crystal, O-H···O hydrogen bonds involving the hydroxy, lactone and ester groups and C-H···O interactions are obsd.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDV9MwYGgfkrVg90H21EOLACvtfcHk0lgnjqAn9Wx1eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotFansLc%253D&md5=107870c921cef39208eda087ad9e105b</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1107%2FS1600536812018582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536812018582%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.-Z.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DH.-Y.%26aulast%3DJiang%26aufirst%3DR.-W.%26atitle%3DBrusatol%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2012%26volume%3D68%26spage%3Do1592%26epage%3Do1593%26doi%3D10.1107%2FS1600536812018582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of bruceantin: An old drug with new promise</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1021/np030304+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np030304%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSisLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=269-272&author=M.+Cuendetauthor=J.+M.+Pezzuto&title=Antitumor+activity+of+bruceantin%3A+An+old+drug+with+new+promise&doi=10.1021%2Fnp030304%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Bruceantin: An Old Drug with New Promise</span></div><div class="casAuthors">Cuendet, Muriel; Pezzuto, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-272</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bruceantin was first isolated from Brucea antidysenterica, a tree used in Ethiopia for the treatment of cancer, and activity was obsd. against B16 melanoma, colon 38, and L1210 and P388 leukemia in mice.  Phase I and II clin. trials were then initiated, but no objective tumor regressions were obsd. and clin. development was terminated.  Recently, the activity of bruceantin has been studied with a no. of leukemia, lymphoma, and myeloma cell lines.  Cell differentiation was induced and c-MYC was down-regulated, suggesting a mechanistic correlation between c-MYC down-regulation and induction of cell differentiation or cell death.  Treatment of HL-60 and RPMI 8226 cell lines induced apoptosis, and this involved the caspase and mitochondrial pathways.  Moreover, an in vivo study using RPMI 8226 human-SCID xenografts demonstrated that bruceantin induced regression in early as well as advanced tumors, and these significant antitumor responses were facilitated in the absence of overt toxicity.  Apoptosis was significantly elevated in tumors derived from animals treated with bruceantin.  In sum, bruceantin interferes with the growth of leukemia, lymphoma, and myeloma cells in culture and xenograft models.  Responses of this type suggest bruceantin should be reinvestigated for clin. efficacy against hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGg5prtWifNrVg90H21EOLACvtfcHk0liMi69IEwuuEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSisLvK&md5=11fe566d8f2665cf16fb18033f3e7820</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1021%2Fnp030304%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp030304%252B%26sid%3Dliteratum%253Aachs%26aulast%3DCuendet%26aufirst%3DM.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DAntitumor%2520activity%2520of%2520bruceantin%253A%2520An%2520old%2520drug%2520with%2520new%2520promise%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D269%26epage%3D272%26doi%3D10.1021%2Fnp030304%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mata-Greenwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daeuble, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grieco, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McChesney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Novel esters of glaucarubolone as inducers of terminal differentiation of promyelocytic HL-60 cells and inhibitors of 7,12-dimethylbenz[<i>a</i>]anthracene-induced preneoplastic lesion formation in mouse mammary organ culture</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">1513</span>, <span class="refDoi"> DOI: 10.1021/np010212p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np010212p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1yks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2001&pages=1509-1513&author=E.+Mata-Greenwoodauthor=J.+F.+Daeubleauthor=P.+A.+Griecoauthor=J.+Douauthor=J.+D.+McChesneyauthor=R.+G.+Mehtaauthor=A.+D.+Kinghornauthor=J.+M.+Pezzuto&title=Novel+esters+of+glaucarubolone+as+inducers+of+terminal+differentiation+of+promyelocytic+HL-60+cells+and+inhibitors+of+7%2C12-dimethylbenz%5Ba%5Danthracene-induced+preneoplastic+lesion+formation+in+mouse+mammary+organ+culture&doi=10.1021%2Fnp010212p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Esters of Glaucarubolone as Inducers of Terminal Differentiation of Promyelocytic HL-60 Cells and Inhibitors of 7,12-Dimethylbenz[a]anthracene-Induced Preneoplastic Lesion Formation in Mouse Mammary Organ Culture</span></div><div class="casAuthors">Mata-Greenwood, Eugenia; Daeuble, John F.; Grieco, Paul A.; Dou, Jinhui; McChesney, James D.; Mehta, Rajendra G.; Kinghorn, A. Douglas; Pezzuto, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1509-1513</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to discover new chemotherapeutic/chemopreventive agents from natural sources, brusatol was found to induce HL-60 cellular differentiation, accompanied by strong antiproliferative and cytotoxic effects.  A series of 48 natural and semisynthetic quassinoids was designed to effect both antiproliferative and differentiation-inducing properties.  Compds. were assessed in vitro using the HL-60 promyelocytic cell model.  Changes in activity due to structural modification of the core structure glaucarubolone were consistent with activities reported in other cell systems. However, the following were novel SAR findings:(1) semisynthetic analogs with a hydroxylated ring at the β-position of the ester side chain at C-15 were able to induce cellular differentiation at concns. lower than those inducing cell growth arrest, and (2) quassinoids inhibiting DNA synthesis with greater efficacy than reducing cellular viability possessed alkyl substitutions at the α-position of the C-15 ester side chain.  Analogs from this latter group and brusatol and bruceantin inhibited dimethylbenz(a)anthracene-induced preneoplastic lesion formation in a mouse mammary organ culture.  The novel finding of 1 and glaucarubolone analogs as potent inducers of differentiation leads to potential novel applications in the field of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDnNEsGu8kkbVg90H21EOLACvtfcHk0lgoGAXOtquatA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1yks78%253D&md5=525aac789770b3306c94d655e580f81a</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1021%2Fnp010212p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp010212p%26sid%3Dliteratum%253Aachs%26aulast%3DMata-Greenwood%26aufirst%3DE.%26aulast%3DDaeuble%26aufirst%3DJ.%2BF.%26aulast%3DGrieco%26aufirst%3DP.%2BA.%26aulast%3DDou%26aufirst%3DJ.%26aulast%3DMcChesney%26aufirst%3DJ.%2BD.%26aulast%3DMehta%26aufirst%3DR.%2BG.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DNovel%2520esters%2520of%2520glaucarubolone%2520as%2520inducers%2520of%2520terminal%2520differentiation%2520of%2520promyelocytic%2520HL-60%2520cells%2520and%2520inhibitors%2520of%25207%252C12-dimethylbenz%255Ba%255Danthracene-induced%2520preneoplastic%2520lesion%2520formation%2520in%2520mouse%2520mammary%2520organ%2520culture%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2001%26volume%3D64%26spage%3D1509%26epage%3D1513%26doi%3D10.1021%2Fnp010212p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache
de Blanco, E. J.</span></span> <span> </span><span class="NLM_article-title">NF-κB inhibitors from <i>Brucea javanica</i> exhibiting intracellular effects on reactive oxygen species</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">3295</span>– <span class="NLM_lpage">3300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20944100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGksbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=3295-3300&author=J.-A.+Kimauthor=E.+K.+Lauauthor=L.+Panauthor=E.+J.+Carcache%0Ade+Blanco&title=NF-%CE%BAB+inhibitors+from+Brucea+javanica+exhibiting+intracellular+effects+on+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species</span></div><div class="casAuthors">Kim, Jeong-Ah; Lau, Edward K.; Pan, Li; Carcache De Blanco, Esperanza J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3295-3300</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Brucea javanica was studied to identify nuclear factor kappaB (NF-κB) inhibitors exhibiting reactive oxygen species (ROS) intracellular amplification.  Eight compds. were evaluated for selective cytotoxicity using HT-29, HeLa, and HL-60 cells, and in a NF-κB assay.  Active compds. were then tested using ROS and mitochondria transmembrane potential (MTP) assays.  NF-κB and nuclear factor activated T-cell (NFAT) translocation were also assessed using their resp. whole cell assays.  Bruceajavanone B, bruceantin, bruceine A, (-)-hydnocarpin, and chrysoeriol exhibited cytotoxic potential and NF-κB p65 inhibition.  Chrysoeriol exhibited selective cytotoxicity against leukemia cells with greater potency and also showed an ability to up-regulate NFAT transcriptional pathways through the amplification of intracellular ROS, in the presence of H2O2, to a greater degree than bruceantin and bruceine.  Chrysoeriol selectively kills leukemic cells and potentiates the amplification of ROS levels.  Therefore, chrysoeriol could serve as a potential chemotherapeutic modifier for leukemia chemotherapy since leukemia cells have a higher susceptibility to elevated ROS levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xOp8CB0jB7Vg90H21EOLACvtfcHk0lgZ_aWWHM05ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGksbvM&md5=62923b2b3ef20fc56b2632f234f89769</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.-A.%26aulast%3DLau%26aufirst%3DE.%2BK.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26atitle%3DNF-%25CE%25BAB%2520inhibitors%2520from%2520Brucea%2520javanica%2520exhibiting%2520intracellular%2520effects%2520on%2520reactive%2520oxygen%2520species%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26spage%3D3295%26epage%3D3300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xirou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syrigos, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, J. C.</span></span> <span> </span><span class="NLM_article-title">Targeting colon cancer with the novel STAT3 inhibitor bruceantinol</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1038/s41388-018-0547-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41388-018-0547-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30348989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFynsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=1676-1687&author=N.+Weiauthor=J.+Liauthor=C.+Fangauthor=J.+Changauthor=V.+Xirouauthor=N.+K.+Syrigosauthor=B.+J.+Marksauthor=E.+Chuauthor=J.+C.+Schmitz&title=Targeting+colon+cancer+with+the+novel+STAT3+inhibitor+bruceantinol&doi=10.1038%2Fs41388-018-0547-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting colon cancer with the novel STAT3 inhibitor bruceantinol</span></div><div class="casAuthors">Wei, Ning; Li, Jun; Fang, Cheng; Chang, Jin; Xirou, Vasiliki; Syrigos, Nick K.; Marks, Benjamin J.; Chu, Edward; Schmitz, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1676-1687</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">STAT3, a transcriptional mediator of oncogenic signaling, is constitutively active in ∼70% of human cancers.  The development of STAT3 inhibitors remains an active area of research as no inhibitors have yet to be approved for the treatment of human cancer.  Herein, we revealed that bruceantinol (BOL) is a novel STAT3 inhibitor demonstrating potent antitumor activity in in vitro and in vivo human colorectal cancer (CRC) models.  BOL strongly inhibited STAT3 DNA-binding ability (IC50 = 2.4 pM), blocked the constitutive and IL-6-induced STAT3 activation in a dose- and time-dependent manner, and suppressed transcription of STAT3 target genes encoding anti-apoptosis factors (MCL-1, PTTG1, and survivin) and cell-cycle regulators (c-Myc).  Structure-activity relationship studies demonstrated that the C15 side chain on BOL affected its ability to bind STAT3.  Administration of 4 mg/kg BOL significantly inhibited CRC tumor xenografts [p < 0.001], but no effect was obsd. in a STAT3-/- tumor model.  Addnl. studies showed that BOL effectively sensitized MEK inhibitors through repression of p-STAT3 and MCL-1 induction, known resistance mechanisms of MEK inhibition.  Taken together, our findings suggest BOL is a novel therapeutic STAT3 inhibitor that can be used either alone or in combination with MEK inhibitors for the treatment of human CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszhsdy_chYLVg90H21EOLACvtfcHk0lixfGPdjcWnlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFynsbrP&md5=401a8a656f44cde28fdb629f765ce53a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0547-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0547-y%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXirou%26aufirst%3DV.%26aulast%3DSyrigos%26aufirst%3DN.%2BK.%26aulast%3DMarks%26aufirst%3DB.%2BJ.%26aulast%3DChu%26aufirst%3DE.%26aulast%3DSchmitz%26aufirst%3DJ.%2BC.%26atitle%3DTargeting%2520colon%2520cancer%2520with%2520the%2520novel%2520STAT3%2520inhibitor%2520bruceantinol%26jtitle%3DOncogene%26date%3D2019%26volume%3D38%26spage%3D1676%26epage%3D1687%26doi%3D10.1038%2Fs41388-018-0547-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Issa, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpentier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span> <span> </span><span class="NLM_article-title">Bruceantin inhibits multiple myeloma cancer stem cell proliferation</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1080/15384047.2016.1210737</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F15384047.2016.1210737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27434731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=966-975&author=M.+E.+Issaauthor=S.+Berndtauthor=G.+Carpentierauthor=J.+M.+Pezzutoauthor=M.+Cuendet&title=Bruceantin+inhibits+multiple+myeloma+cancer+stem+cell+proliferation&doi=10.1080%2F15384047.2016.1210737"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceantin inhibits multiple myeloma cancer stem cell proliferation</span></div><div class="casAuthors">Issa, Mark E.; Berndt, Sarah; Carpentier, Gilles; Pezzuto, John M.; Cuendet, Muriel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">966-975</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1555-8576</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) continues to claim the lives of a majority of patients.  MM cancer stem cells (CSCs) have been demonstrated to sustain tumor growth.  Due to their ability to self-renew and to express detoxifying enzymes and efflux transporters, MM-CSCs are rendered highly resistant to conventional therapies.  Therefore, managing MM-CSCs characteristics could have profound clin. implications.  Bruceantin (BCT) is a natural product previously demonstrated to inhibit the growth of MM in RPMI 8226 cells-inoculated mouse xenograft models, and to cause regression in already established tumors.  The objectives of the present study were to test the inhibitory effects of BCT on MM-CSCs growth derived from a human primary tumor, and to explore a mechanism of action underlying these effects.  BCT exhibited potent antiproliferative activity in MM-CSCs starting at 25 nM.  BCT induced cell cycle arrest, cell death and apoptosis in MM-CSCs as well as inhibited cell migration and angiogenesis in vitro.  Using a qPCR screen, it was found that the gene expression of a no. of Notch pathway members was altered.  Pretreatment of MM-CSCs with the γ-secretase inhibitor RO4929097, a Notch pathway inhibitor, reversed BCT-induced effects on MM-CSCs proliferation.  In this study, BCT was shown to be an effective agent in controlling the proliferation, viability and migration of MM-CSCs as well as angiogenesis in vitro.  The effect on MM-CSCs proliferation may be mediated by the Notch pathway.  These results warrant further investigation of BCT in a broader set of human-derived MM-CSCs and with in vivo models representative of MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoKtzhqnt5m7Vg90H21EOLACvtfcHk0lgnIEMzzFd1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVaksL7F&md5=0d8d036d277d4e396456ad522a8f0d8a</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1080%2F15384047.2016.1210737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384047.2016.1210737%26sid%3Dliteratum%253Aachs%26aulast%3DIssa%26aufirst%3DM.%2BE.%26aulast%3DBerndt%26aufirst%3DS.%26aulast%3DCarpentier%26aufirst%3DG.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DCuendet%26aufirst%3DM.%26atitle%3DBruceantin%2520inhibits%2520multiple%2520myeloma%2520cancer%2520stem%2520cell%2520proliferation%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2016%26volume%3D17%26spage%3D966%26epage%3D975%26doi%3D10.1080%2F15384047.2016.1210737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukamiya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastow, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukainaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloids</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4963</span>– <span class="NLM_lpage">4968</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.06.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmc.2004.06.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=15336275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFSnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=4963-4968&author=C.+Murakamiauthor=N.+Fukamiyaauthor=S.+Tamuraauthor=M.+Okanoauthor=K.+F.+Bastowauthor=H.+Tokudaauthor=T.+Mukainakaauthor=H.+Nishinoauthor=K.-H.+Lee&title=Multidrug-resistant+cancer+cell+susceptibility+to+cytotoxic+quassinoids%2C+and+cancer+chemopreventive+effects+of+quassinoids+and+canthin+alkaloids&doi=10.1016%2Fj.bmc.2004.06.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloids</span></div><div class="casAuthors">Murakami, Chihiro; Fukamiya, Narihiko; Tamura, Sadaaki; Okano, Masayoshi; Bastow, Kenneth F.; Tokuda, Harukuni; Mukainaka, Teruo; Nishino, Hoyoky; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4963-4968</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Twenty-three quassinoids, which were isolated previously from Simaroubaceous plants, were evaluated for cytotoxicity against three multidrug-resistant cancer cell lines, KB-VIN, KB-7d, and KB-CPT.  Nine compds. showed significant cytotoxicity in all three cell lines.  Six compds. demonstrated significant activity against the KB-7d and KB-CPT cell lines, and three compds. revealed notable activity only against KB-7d cells.  Structure-activity relationships were drawn based on these data.  In addn., six quassinoid derivs. and four canthin alkaloids, which were isolated from Brucea antidysenterica, were examd. for their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA) induced Epstein-Barr virus early antigen (EBV-EA) activation as cancer chemopreventive agents.  All of these compds. demonstrated significant inhibitory effects against EBV-EA activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxG2hy88XoB7Vg90H21EOLACvtfcHk0lg802nWoBHp-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFSnu74%253D&md5=da8f6d6e7b2f09a09d6d90187fc4f8f5</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.06.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.06.045%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DC.%26aulast%3DFukamiya%26aufirst%3DN.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DOkano%26aufirst%3DM.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DTokuda%26aufirst%3DH.%26aulast%3DMukainaka%26aufirst%3DT.%26aulast%3DNishino%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DMultidrug-resistant%2520cancer%2520cell%2520susceptibility%2520to%2520cytotoxic%2520quassinoids%252C%2520and%2520cancer%2520chemopreventive%2520effects%2520of%2520quassinoids%2520and%2520canthin%2520alkaloids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D4963%26epage%3D4968%26doi%3D10.1016%2Fj.bmc.2004.06.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantvit, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedayat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McChesney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Multiple myeloma regression mediated by bruceantin</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-0362-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1078-0432.CCR-0362-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=14871997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1170-1179&author=M.+Cuendetauthor=K.+Christovauthor=D.+D.+Lantvitauthor=Y.+Dengauthor=S.+Hedayatauthor=L.+Helsonauthor=J.+D.+McChesneyauthor=J.+M.+Pezzuto&title=Multiple+myeloma+regression+mediated+by+bruceantin&doi=10.1158%2F1078-0432.CCR-0362-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple myeloma regression mediated by bruceantin</span></div><div class="casAuthors">Cuendet, Muriel; Christov, Konstantin; Lantvit, Daniel D.; Deng, Yunfan; Hedayat, Samad; Helson, Lawrence; McChesney, James D.; Pezzuto, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1170-1179</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Bruceantin has been shown to induce cell differentiation in a no. of leukemia and lymphoma cell lines.  It also down-regulated c-MYC, suggesting a correlation of down-regulation with induction of cell differentiation or cell death.  In the present study, we focused on multiple myeloma, using the RPMI 8226 cell line as a model.  The effects of bruceantin on c-MYC levels and apoptosis were examd. by immunoblotting, 4',6-diamidino-2-phenylindole staining, evaluation of caspase-like activity, and 3,3'-dihexyloxacarbocyanine iodide staining.  The potential of bruceantin to inhibit primary tumor growth was assessed with RPMI 8226 xenografts in SCID mice, and apoptosis in the tumors was evaluated by the terminal deoxynucleotidyl transferase-mediated nick end labeling assay.  c-MYC was strongly down-regulated in cultured RPMI 8226 cells by treatment with bruceantin for 24 h.  With U266 and H929 cells, bruceantin did not regulate c-MYC in this manner.  Apoptosis was induced in the three cell lines.  In RPMI 8226 cells, apoptosis occurred through proteolytic processing of procaspases and degrdn. of poly(ADP-ribose) polymerase.  The mitochondrial pathway was also involved.  Because RPMI 8226 cells were the most sensitive, they were used in a xenograft model.  Bruceantin treatment (2.5-5 mg/kg) resulted in a significant regression of tumors without overt toxicity.  Apoptosis was significantly elevated in tumors derived from animals treated with bruceantin (37%) as compared with the control tumors (14%).  Bruceantin interferes with the growth of RPMI 8226 cells in cell culture and xenograft models.  These results suggest that bruceantin should be reinvestigated for clin. efficacy against multiple myeloma and other hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKXCPN79etW7Vg90H21EOLACvtfcHk0lgaC-1M-kVymQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFCnsrs%253D&md5=c4521936bb6aa5447048dcc73a119ebe</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-0362-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-0362-3%26sid%3Dliteratum%253Aachs%26aulast%3DCuendet%26aufirst%3DM.%26aulast%3DChristov%26aufirst%3DK.%26aulast%3DLantvit%26aufirst%3DD.%2BD.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DHedayat%26aufirst%3DS.%26aulast%3DHelson%26aufirst%3DL.%26aulast%3DMcChesney%26aufirst%3DJ.%2BD.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DMultiple%2520myeloma%2520regression%2520mediated%2520by%2520bruceantin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D1170%26epage%3D1179%26doi%3D10.1158%2F1078-0432.CCR-0362-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, K. L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, D. H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedikian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiseman, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodey, G. P.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacology of bruceantin by radioimmunoassay</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1007/BF00257747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2FBF00257747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=7160053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADyaL3s7ivFyitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1982&pages=169-172&author=K.+L.+L.+Fongauthor=D.+H.+W.+Hoauthor=R.+S.+Benjaminauthor=N.+S.+Brownauthor=A.+Bedikianauthor=B.+S.+Yapauthor=C.+L.+Wisemanauthor=W.+Kramerauthor=G.+P.+Bodey&title=Clinical+pharmacology+of+bruceantin+by+radioimmunoassay&doi=10.1007%2FBF00257747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacology of bruceantin by radioimmunoassay</span></div><div class="casAuthors">Fong K L; Ho D H; Benjamin R S; Brown N S; Bedikian A; Yap B S; Wiseman C L; Kramer W; Bodey G P</div><div class="citationInfo"><span class="NLM_cas:title">Cancer chemotherapy and pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-72</span>
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    </div><div class="casAbstract">During the phase I clinical trial of a new antitumor agent, bruceantin, the pharmacology was studied in 18 cancer patients.  The drug was infused intravenously (IV) for 3 h at doses ranging from 1 to 3.6 mg/m2 per day for 5 days.  The plasma drug disappearance curves were biphasic, with a fast initial half-life of less than 15 min.  The second half-life (t1/2 beta) varied from 0.7 to 38 h among different patients and was not dose-related.  The difference between the t1/2 beta on day 1 and that on day 5 was not significant.  In patients with normal liver function, the mean plasma concentration at the end of infusion was 22 ng/ml, and the value of the area under the concentration X time curve (AUC) was 111 (ng/ml)h.  In contrast, in patients with abnormal liver function the corresponding values were 115 ng/ml and 830 (ng/ml)h, respectively.  In addition, these patients had a slower elimination half-life of 10.9 h and a decreased total clearance of 157 ml/min/m2, as compared with 2.6 h and 671 ml/min/m2, respectively, for the normal group.  All these differences were statistically significant.  Patients with abnormal liver function developed more severe toxicity, including fever, severe nausea, vomiting, and hypotension.  Two patients with severe hepatic dysfunction received a reduced dose and developed no toxicity.  These results demonstrated the importance of the effects of liver dysfunction on drug disposition and showed that the dosage should be reduced in patients with hepatic dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT378_1soZJrQyMywPm6HgQfW6udTcc2eZD2XCcdaMm9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7ivFyitw%253D%253D&md5=f9fc85add70c492667273c844f50a97c</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1007%2FBF00257747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00257747%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DK.%2BL.%2BL.%26aulast%3DHo%26aufirst%3DD.%2BH.%2BW.%26aulast%3DBenjamin%26aufirst%3DR.%2BS.%26aulast%3DBrown%26aufirst%3DN.%2BS.%26aulast%3DBedikian%26aufirst%3DA.%26aulast%3DYap%26aufirst%3DB.%2BS.%26aulast%3DWiseman%26aufirst%3DC.%2BL.%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DBodey%26aufirst%3DG.%2BP.%26atitle%3DClinical%2520pharmacology%2520of%2520bruceantin%2520by%2520radioimmunoassay%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D1982%26volume%3D9%26spage%3D169%26epage%3D172%26doi%3D10.1007%2FBF00257747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arseneau, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuperminc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckdeschel, J. C.</span></span> <span> </span><span class="NLM_article-title">A Phase II study of bruceantin (NSC-165, 563) in advanced malignant melanoma</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1007/BF00208896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2FBF00208896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=6678872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADyaL2c3ovVegtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1983&pages=239-242&author=J.+C.+Arseneauauthor=J.+M.+Wolterauthor=M.+Kupermincauthor=J.+C.+Ruckdeschel&title=A+Phase+II+study+of+bruceantin+%28NSC-165%2C+563%29+in+advanced+malignant+melanoma&doi=10.1007%2FBF00208896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma</span></div><div class="casAuthors">Arseneau J C; Wolter J M; Kuperminc M; Ruckdeschel J C</div><div class="citationInfo"><span class="NLM_cas:title">Investigational new drugs</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-42</span>
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    </div><div class="casAbstract">The Eastern Cooperative Oncology Group (ECOG) conducted a Phase II trial of Bruceantin in malignant melanoma.  Twenty-two patients, thirteen without prior cytotoxic chemotherapy, were entered.  All patients were evaluable for response and toxicity.  Dose limiting toxicity was found to be hypotension during Bruceantin infusion.  Other prominent side effects were nausea, vomiting, anorexia, fever, chills, and weakness.  Only minor hematologic toxicity was encountered.  Two partial responses, both in previously treated patients were observed (response rate -9%).  Bruceantin has only limited activity against malignant melanoma and is unlikely to contribute to systemic therapy of this disease, either as a single agent or in combinations of cytotoxic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWCXJG6Nn05evW160gIxP_fW6udTcc2eYfpAAPNfCItrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c3ovVegtQ%253D%253D&md5=73a9ba5a7e025c2d1142a11b64dd2458</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1007%2FBF00208896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00208896%26sid%3Dliteratum%253Aachs%26aulast%3DArseneau%26aufirst%3DJ.%2BC.%26aulast%3DWolter%26aufirst%3DJ.%2BM.%26aulast%3DKuperminc%26aufirst%3DM.%26aulast%3DRuckdeschel%26aufirst%3DJ.%2BC.%26atitle%3DA%2520Phase%2520II%2520study%2520of%2520bruceantin%2520%2528NSC-165%252C%2520563%2529%2520in%2520advanced%2520malignant%2520melanoma%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1983%26volume%3D1%26spage%3D239%26epage%3D242%26doi%3D10.1007%2FBF00208896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupchan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacadie, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigel, C. W.</span></span> <span> </span><span class="NLM_article-title">The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from <i>Brucea antidysenterica</i></span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1021/jo00893a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00893a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE2MXhtFaitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=648-654&author=S.+M.+Kupchanauthor=R.+W.+Brittonauthor=J.+A.+Lacadieauthor=M.+F.+Zieglerauthor=C.+W.+Sigel&title=The+isolation+and+structural+elucidation+of+bruceantin+and+bruceantinol%2C+new+potent+antileukemic+quassinoids+from+Brucea+antidysenterica&doi=10.1021%2Fjo00893a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor inhibitors.  100.  Isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica</span></div><div class="casAuthors">Kupchan, S. Morris; Britton, Ronald W.; Lacadie, John A.; Ziegler, Myra F.; Sigel, Carl W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">648-54</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Bruceantin and bruceantinol, two new potent antileukemic quassinoids isolated from B. antidysenterica, had structures I and II, resp., according to chem. degrdn. products, mass, ir, uv, and NMR spectra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkWjLvDcZdqbVg90H21EOLACvtfcHk0lgVBrSeaMEL5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhtFaitbg%253D&md5=cc5991382386962bd342f186b7aa2a46</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1021%2Fjo00893a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00893a023%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DBritton%26aufirst%3DR.%2BW.%26aulast%3DLacadie%26aufirst%3DJ.%2BA.%26aulast%3DZiegler%26aufirst%3DM.%2BF.%26aulast%3DSigel%26aufirst%3DC.%2BW.%26atitle%3DThe%2520isolation%2520and%2520structural%2520elucidation%2520of%2520bruceantin%2520and%2520bruceantinol%252C%2520new%2520potent%2520antileukemic%2520quassinoids%2520from%2520Brucea%2520antidysenterica%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D648%26epage%3D654%26doi%3D10.1021%2Fjo00893a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z. X.</span></span> <span> </span><span class="NLM_article-title">Seven quassinoids from Fructus Bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1796</span>– <span class="NLM_lpage">1800</span>, <span class="refDoi"> DOI: 10.1002/ptr.3477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fptr.3477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21480411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2mt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1796-1800&author=M.+Zhaoauthor=S.+T.+Lauauthor=P.+S.+Leungauthor=C.+T.+Cheauthor=Z.+X.+Lin&title=Seven+quassinoids+from+Fructus+Bruceae+with+cytotoxic+effects+on+pancreatic+adenocarcinoma+cell+lines&doi=10.1002%2Fptr.3477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Seven Quassinoids from Fructus Bruceae with Cytotoxic Effects on Pancreatic Adenocarcinoma Cell Lines</span></div><div class="casAuthors">Zhao, M.; Lau, S. T.; Leung, P. S.; Che, C. T.; Lin, Z. X.</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1796-1800</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Our previous studies showed that the alc. ext. of the fruit of Brucea javanica (Fructus Bruceae) possessed significant cytotoxicity in pancreatic adenocarcinoma cell lines.  A bioassay-guided fractionation and purifn. resulted in the isolation and characterization of seven quassinoids including brusatol, bruceine D, bruceine H, yadanzioside A, yadanzioside G, javanicoside C and bruceantinoside A.  Among them, brusatol exhibited the most potent in vitro antipancreatic cancer action, with IC50 values of 0.36 μm and 0.10 μm on PANC-1 and SW1990 cell lines, resp.  This is the first report on the antipancreatic adenocarcinoma activity of brusatol.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpehpJB-Uxw2bVg90H21EOLACvtfcHk0ljEnJeiJzk9Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2mt7bM&md5=9ae61809b31245333ac3105fae9e3d12</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1002%2Fptr.3477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.3477%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DS.%2BT.%26aulast%3DLeung%26aufirst%3DP.%2BS.%26aulast%3DChe%26aufirst%3DC.%2BT.%26aulast%3DLin%26aufirst%3DZ.%2BX.%26atitle%3DSeven%2520quassinoids%2520from%2520Fructus%2520Bruceae%2520with%2520cytotoxic%2520effects%2520on%2520pancreatic%2520adenocarcinoma%2520cell%2520lines%26jtitle%3DPhytother.%2520Res.%26date%3D2011%26volume%3D25%26spage%3D1796%26epage%3D1800%26doi%3D10.1002%2Fptr.3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsuyanagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span> <span> </span><span class="NLM_article-title">A structure-activity relationship study of brusatol, an antitumor quassinoid</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4262</span>– <span class="NLM_lpage">4271</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2006.01.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tet.2006.01.083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslCgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=4262-4271&author=Y.+Hitotsuyanagiauthor=I.+H.+Kimauthor=T.+Hasudaauthor=Y.+Yamauchiauthor=K.+Takeya&title=A+structure-activity+relationship+study+of+brusatol%2C+an+antitumor+quassinoid&doi=10.1016%2Fj.tet.2006.01.083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">A structure-activity relationship study of brusatol, an antitumor quassinoid</span></div><div class="casAuthors">Hitotsuyanagi, Yukio; Kim, Ik Hwi; Hasuda, Tomoyo; Yamauchi, Yuka; Takeya, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4262-4271</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Analogs of brusatol were prepd. and examd. for their cytotoxic activity by using P-388 murine leukemia cells.  The following structure-activity relationships were noted: (i) an enone carbonyl oxygen or an enolic oxygen at C-2 is essential, but an oxygen at C-3 not essential for the activity; (ii) the C-11 β-hydroxyl group is important for the activity; and (iii) the length of the ester alkoxy side chain at C-21 seems to have a slight effect on the activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUEJ9xvZVpurVg90H21EOLACvtfcHk0lhGx6x3s263AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslCgsLk%253D&md5=c7642024afc2ee2e25468ff56f4c2b9b</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2006.01.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2006.01.083%26sid%3Dliteratum%253Aachs%26aulast%3DHitotsuyanagi%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DI.%2BH.%26aulast%3DHasuda%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTakeya%26aufirst%3DK.%26atitle%3DA%2520structure-activity%2520relationship%2520study%2520of%2520brusatol%252C%2520an%2520antitumor%2520quassinoid%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D4262%26epage%3D4271%26doi%3D10.1016%2Fj.tet.2006.01.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colburn, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncharova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, C. J.</span></span> <span> </span><span class="NLM_article-title">Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1021/np800732n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np800732n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFKhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=503-506&author=J.+A.+Beutlerauthor=M.-I.+Kangauthor=F.+Robertauthor=J.+A.+Clementauthor=J.+Pelletierauthor=N.+H.+Colburnauthor=T.+C.+McKeeauthor=E.+Goncharovaauthor=J.+B.+McMahonauthor=C.+J.+Henrich&title=Quassinoid+inhibition+of+AP-1+function+does+not+correlate+with+cytotoxicity+or+protein+synthesis+inhibition&doi=10.1021%2Fnp800732n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Quassinoid Inhibition of AP-1 Function Does Not Correlate with Cytotoxicity or Protein Synthesis Inhibition</span></div><div class="casAuthors">Beutler, John A.; Kang, Moon-Il; Robert, Francis; Clement, Jason A.; Pelletier, Jerry; Colburn, Nancy H.; McKee, Tawnya C.; Goncharova, Ekaterina; McMahon, James B.; Henrich, Curtis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-506</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Several quassinoids were identified in a high-throughput screening assay as inhibitors of the transcription factor AP-1.  Further biol. characterization revealed that while their effect was not specific to AP-1, protein synthesis inhibition and cell growth assays were inconsistent with a mechanism of simple protein synthesis inhibition.  Numerous plant exts. from the plant family Simaroubaceae were also identified in the same screen; bioassay-guided fractionation of one ext. (Ailanthus triphylla) yielded two known quassinoids, ailanthinone (3) and glaucarubinone (4), which were also identified in the pure compd. screening procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUuSj7boFqX7Vg90H21EOLACvtfcHk0ljPMYIisNPzCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFKhsrk%253D&md5=a1e162c90f056c605a48c438d53a1289</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1021%2Fnp800732n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp800732n%26sid%3Dliteratum%253Aachs%26aulast%3DBeutler%26aufirst%3DJ.%2BA.%26aulast%3DKang%26aufirst%3DM.-I.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DClement%26aufirst%3DJ.%2BA.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DColburn%26aufirst%3DN.%2BH.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DGoncharova%26aufirst%3DE.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DHenrich%26aufirst%3DC.%2BJ.%26atitle%3DQuassinoid%2520inhibition%2520of%2520AP-1%2520function%2520does%2520not%2520correlate%2520with%2520cytotoxicity%2520or%2520protein%2520synthesis%2520inhibition%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2009%26volume%3D72%26spage%3D503%26epage%3D506%26doi%3D10.1021%2Fnp800732n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.-W.</span></span> <span> </span><span class="NLM_article-title">Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from <i>Brucea javanica</i></span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fitote.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26071073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=66-72&author=Q.-M.+Yeauthor=L.-L.+Baiauthor=S.-Z.+Huauthor=H.-Y.+Tianauthor=L.-J.+Ruanauthor=Y.-F.+Tanauthor=L.-P.+Huauthor=W.-C.+Yeauthor=D.-M.+Zhangauthor=R.-W.+Jiang&title=Isolation%2C+chemotaxonomic+significance+and+cytotoxic+effects+of+quassinoids+from+Brucea+javanica&doi=10.1016%2Fj.fitote.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, chemotaxonomic significance and cytotoxic effects of quassinoids from Brucea javanica</span></div><div class="casAuthors">Ye, Qing-Mei; Bai, Liang-Liang; Hu, Shu-Zhi; Tian, Hai-Yan; Ruan, Li-Jun; Tan, Ya-Fang; Hu, Li-Ping; Ye, Wen-Cai; Zhang, Dong-Mei; Jiang, Ren-Wang</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new quassinoid, bruceene A (1) along with seventeen known quassinoids (2-18) was isolated from the fruits of Brucea javanica.  The structure of 1 was elucidated by extensive spectroscopic methods, and was further confirmed by single-crystal X-ray diffraction anal.  Isolation of similar quassinoids 1-3 as those in genus Ailanthus from genus Brucea, indicated the close chemotaxonomic relationship between these two genera, which further supported the phylogenetic study by DNA anal.  Compds. 5, 7, 10 and 12 with a 3-hydroxy-3-en-2-one moiety showed potent inhibitory activities against the MCF-7 and MDA-MB-231 cells with IC50 values in the ranges 0.063-0.182 μM and 0.081-0.238 μM, resp.; while glycosidation at 3-OH significantly decreased the cytotoxicity.  It was also found that the most potent compd. 7 induced apoptosis in MCF-7 cells via the intrinsic mitochondrial apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMiNdcjrP2rVg90H21EOLACvtfcHk0ljN24roOtT0SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2hsLvF&md5=6802fefdd32d687010f7e6ad2b9f0496</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DQ.-M.%26aulast%3DBai%26aufirst%3DL.-L.%26aulast%3DHu%26aufirst%3DS.-Z.%26aulast%3DTian%26aufirst%3DH.-Y.%26aulast%3DRuan%26aufirst%3DL.-J.%26aulast%3DTan%26aufirst%3DY.-F.%26aulast%3DHu%26aufirst%3DL.-P.%26aulast%3DYe%26aufirst%3DW.-C.%26aulast%3DZhang%26aufirst%3DD.-M.%26aulast%3DJiang%26aufirst%3DR.-W.%26atitle%3DIsolation%252C%2520chemotaxonomic%2520significance%2520and%2520cytotoxic%2520effects%2520of%2520quassinoids%2520from%2520Brucea%2520javanica%26jtitle%3DFitoterapia%26date%3D2015%26volume%3D105%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.fitote.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.-B.</span></span> <span> </span><span class="NLM_article-title">Bioactive quassinoids from the seeds of <i>Brucea javanica</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">688</span>, <span class="refDoi"> DOI: 10.1021/np200920c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200920c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=683-688&author=J.-H.+Liuauthor=N.+Zhaoauthor=G.-J.+Zhangauthor=S.-S.+Yuauthor=L.-J.+Wuauthor=J.+Quauthor=S.-G.+Maauthor=X.-G.+Chenauthor=T.-Q.+Zhangauthor=J.+Baiauthor=H.+Chenauthor=Z.-F.+Fangauthor=F.+Zhaoauthor=W.-B.+Tang&title=Bioactive+quassinoids+from+the+seeds+of+Brucea+javanica&doi=10.1021%2Fnp200920c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive Quassinoids from the Seeds of Brucea javanica</span></div><div class="casAuthors">Liu, Jun-Hong; Zhao, Nan; Zhang, Gui-Jie; Yu, Shi-Shan; Wu, Li-Jun; Qu, Jing; Ma, Shuang-Gang; Chen, Xiao-Guang; Zhang, Tian-Qi; Bai, Jian; Chen, Hui; Fang, Zhen-Feng; Zhao, Fen; Tang, Wei-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-688</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Six new quassinoids (1-6) and eight known compds. of this type (7-14) were isolated from the seeds of Brucea javanica.  Their structures were elucidated by anal. of their spectroscopic data and from chem. evidence.  Compds. 1-5 were found to be unusual quassinoids with a 2,3-seco A ring.  The configurations at C-4 in 4 and 5 were detd. by a difference CD method.  In in vitro bioassays, 8 and 10 showed inhibitory activities for nitric oxide prodn. in LPS-activated macrophages, with IC50 values of 1.9 and 5.0 μM, resp., while compds. 6, 8-11, 13, and 14 exhibited cytotoxicity against five human tumor cell lines (HCT-8, HepG2, BGC-823, A549, and SKVO3), having IC50 values in the range 0.12-9.3 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpscuGrN_hUhLVg90H21EOLACvtfcHk0ljN24roOtT0SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlsb0%253D&md5=57570fff8393668cb169f8f91586ef08</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1021%2Fnp200920c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200920c%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.-H.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DG.-J.%26aulast%3DYu%26aufirst%3DS.-S.%26aulast%3DWu%26aufirst%3DL.-J.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DS.-G.%26aulast%3DChen%26aufirst%3DX.-G.%26aulast%3DZhang%26aufirst%3DT.-Q.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DZ.-F.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DW.-B.%26atitle%3DBioactive%2520quassinoids%2520from%2520the%2520seeds%2520of%2520Brucea%2520javanica%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D683%26epage%3D688%26doi%3D10.1021%2Fnp200920c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukamiya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Bruceanols D, E, and F. Three new cytotoxic quassinoids from <i>Brucea antidysenterica</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2091</span>– <span class="NLM_lpage">2097</span>, <span class="refDoi"> DOI: 10.1021/np50102a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50102a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK2cXhtVWqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1993&pages=2091-2097&author=K.+Imamuraauthor=N.+Fukamiyaauthor=M.+Okanoauthor=K.+Tagaharaauthor=K.-H.+Lee&title=Bruceanols+D%2C+E%2C+and+F.+Three+new+cytotoxic+quassinoids+from+Brucea+antidysenterica&doi=10.1021%2Fnp50102a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceanols D, E, and F. Three new cytotoxic quassinoids from Brucea antidysenterica</span></div><div class="casAuthors">Imamura, Kazunori; Fukamya, Narihiko; Okano, Masayoshi; Tagahara, Kiyoshi; Lee, Kuo Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2091-7</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">Three new quassinoids, bruceanols D (I), E (II), and F (III), were isolated from Brucea antidysenterica, and their structures were elucidated by spectral evidence and chem. transformation.  All of these compds. exhibited cytotoxicity against five human tumor cell lines, malignant melanoma (RPMI-7951), lung carcinoma (A-549), ileocecal adenocarcinoma (HCT-8), epidermoid carcinoma of the nasopharynx (KB), and medulloblastoma (TE-671), and against murine lymphocytic leukemia (P-388).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0gvxol3jBrVg90H21EOLACvtfcHk0ljN24roOtT0SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtVWqurk%253D&md5=361bdbfd8fdaca1ffb406f6132d172ac</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1021%2Fnp50102a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50102a010%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DK.%26aulast%3DFukamiya%26aufirst%3DN.%26aulast%3DOkano%26aufirst%3DM.%26aulast%3DTagahara%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DBruceanols%2520D%252C%2520E%252C%2520and%2520F.%2520Three%2520new%2520cytotoxic%2520quassinoids%2520from%2520Brucea%2520antidysenterica%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1993%26volume%3D56%26spage%3D2091%26epage%3D2097%26doi%3D10.1021%2Fnp50102a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aarthi, R.</span></span> <span> </span><span class="NLM_article-title">Brusatol—As potent chemotherapeutic regimen and its role on reversing EMT transition</span>. <i>J. Pharm. Sci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1753</span>– <span class="NLM_lpage">1762</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFGrtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1753-1762&author=R.+Aarthi&title=Brusatol%E2%80%94As+potent+chemotherapeutic+regimen+and+its+role+on+reversing+EMT+transition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol - as potent chemotherapeutic regimen and its role on reversing EMT transition</span></div><div class="casAuthors">Aarthi, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences and Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1753-1762</span>CODEN:
                <span class="NLM_cas:coden">JPSRC9</span>;
        ISSN:<span class="NLM_cas:issn">0975-1459</span>.
    
            (<span class="NLM_cas:orgname">Pharmainfo Publisher</span>)
        </div><div class="casAbstract">A review.  Cancer is highly resistant to chemotherapeutic agents and their prognosis after resistance is found to be poor.  The development of new therapeutic entities is badly needed for this deadly malignancy.  In this review article, we elaborately given information about brusatol, a natural quassinoid isolated from a Chinese herbal medicine named Bruceae Fructus, that it possess potent cytotoxic effect against different types of cell lines.  Its anti-cancer effects has been demonstrated through different cell lines and its cytoxicity studies has been discussed briefly.  In this review we also summarise possible mechanism for brusatol and its action on EMT reversal process.  This article is expected to widen the knowledge of brusatol as potent chemotherapeutic agent and also indicating that brusatol is a promising adjunct to the current chemotherapeutic regimen for any mostly any type of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEI7JjwtKELVg90H21EOLACvtfcHk0lgPDEovu2-vNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFGrtL3I&md5=42503808b27ef6db12e088787d2251e2</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAarthi%26aufirst%3DR.%26atitle%3DBrusatol%25E2%2580%2594As%2520potent%2520chemotherapeutic%2520regimen%2520and%2520its%2520role%2520on%2520reversing%2520EMT%2520transition%26jtitle%3DJ.%2520Pharm.%2520Sci.%2520Res.%26date%3D2019%26volume%3D11%26spage%3D1753%26epage%3D1762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Clair, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol overcomes chemoresistance through inhibition of protein translation</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1002/mc.22609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fmc.22609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28019675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=1493-1500&author=B.+Harderauthor=W.+Tianauthor=J.+J.+La+Clairauthor=A.-C.+Tanauthor=A.+Ooiauthor=E.+Chapmanauthor=D.+D.+Zhang&title=Brusatol+overcomes+chemoresistance+through+inhibition+of+protein+translation&doi=10.1002%2Fmc.22609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol overcomes chemoresistance through inhibition of protein translation</span></div><div class="casAuthors">Harder, Bryan; Tian, Wang; La Clair, James J.; Tan, Aik-Choon; Ooi, Aikseng; Chapman, Eli; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1493-1500</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The NRF2 pathway activates a cell survival response when cells are exposed to xenobiotics or are under oxidative stress.  Therapeutic activation of NRF2 can also be used prior to insult as a means of disease prevention.  However, prolonged expression of NRF2 has been shown to protect cancer cells by inducing the metab. and efflux of chemotherapeutics, leading to both intrinsic and acquired chemoresistance to cancer drugs.  This effect has been termed the "dark side" of NRF2.  In an effort to combat this chemoresistance, our group discovered the first NRF2 inhibitor, the natural product brusatol, however the mechanism of inhibition was previously unknown.  In this report, we show that brusatol's mode of action is not through direct inhibition of the NRF2 pathway, but through the inhibition of both cap-dependent and cap-independent protein translation, which has an impact on many short-lived proteins, including NRF2.  Therefore, there is still a need to develop a new generation of specific NRF2 inhibitors with limited toxicity and off-target effects that could be used as adjuvant therapies to sensitize cancers with high expression of NRF2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEXTD-im3kLVg90H21EOLACvtfcHk0lgPDEovu2-vNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Wmurw%253D&md5=ce13967747c43025a1287dce903f9831</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1002%2Fmc.22609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22609%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DW.%26aulast%3DLa%2BClair%26aufirst%3DJ.%2BJ.%26aulast%3DTan%26aufirst%3DA.-C.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520overcomes%2520chemoresistance%2520through%2520inhibition%2520of%2520protein%2520translation%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D1493%26epage%3D1500%26doi%3D10.1002%2Fmc.22609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Comprehensive antitumor effect of brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">973</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.06.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2018.06.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30021391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1SrtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2018&pages=962-973&author=R.+Yeauthor=N.+Daiauthor=Q.+Heauthor=P.+Guoauthor=Y.+Xiangauthor=Q.+Zhangauthor=Z.+Hongauthor=Q.+Zhang&title=Comprehensive+antitumor+effect+of+brusatol+through+inhibition+of+cell+viability+and+promotion+of+apoptosis+caused+by+autophagy+via+the+PI3K%2FAkt%2FmTOR+pathway+in+hepatocellular+carcinoma&doi=10.1016%2Fj.biopha.2018.06.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma</span></div><div class="casAuthors">Ye, Ruifan; Dai, Ninggao; He, Qikuan; Guo, Pengyi; Xiang, Yukai; Zhang, Qiong; Hong, Zhong; Zhang, Qiyu</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">962-973</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Brusatol, a natural quassinoid isolated from a traditional Chinese herbal medicine known as Bruceae Fructus, has recently been reported to possess powerful cytotoxic effects against various cancer cell lines, highlighting its potential as an anti-cancer drug.  However, the precise mol. mechanisms by which Brusatol exerts its anti-cancer effects remain poorly understood in hepatocellular carcinoma (HCC).  In this study, we demonstrated that Brusatol inhibited cell viability, proliferation and induced apoptosis in liver cancer lines.  Furthermore, Brusatol could activate autophagy in diverse liver cell lines, and the autophagy inhibitor chloroquine (CQ) reversed Brusatol-induced apoptosis in Bel7404 cells.  In addn., we found that Brusatol inhibited PI3K/Akt/mTOR.  Brusatol may also inhibit invasion, migration and the epithelial-mesenchymal transition (EMT).  In a human liver xenograft tumor model in nude mice, immunohistochem. showed that Brusatol significantly inhibited tumor invasion and proliferation.  Taken together, these results revealed that Brusatol effectively inhibited proliferation and induced apoptosis in HCC through autophagy induction, probably via the PI3K/Akt/mTOR pathway, and inhibited tumor invasion and migration in vivo and in vitro.  All above indicated that Brusatol is an encouraging anti-tumor drug candidate or a supplement to the current chemotherapeutic systematic plan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHOAO_iQE007Vg90H21EOLACvtfcHk0lgPDEovu2-vNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1SrtbzK&md5=91d36771e396f20d8a4a93459605a1a5</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.06.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.06.065%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DR.%26aulast%3DDai%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DComprehensive%2520antitumor%2520effect%2520of%2520brusatol%2520through%2520inhibition%2520of%2520cell%2520viability%2520and%2520promotion%2520of%2520apoptosis%2520caused%2520by%2520autophagy%2520via%2520the%2520PI3K%252FAkt%252FmTOR%2520pathway%2520in%2520hepatocellular%2520carcinoma%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D105%26spage%3D962%26epage%3D973%26doi%3D10.1016%2Fj.biopha.2018.06.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span> <span> </span><span class="NLM_article-title">Brusatol enhances the chemotherapy efficacy of gemcitabine in pancreatic cancer via the Nrf2 signalling pathway</span>. <i>Oxid. Med. Cell. Longev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_fpage">2360427</span>, <span class="refDoi"> DOI: 10.1155/2018/2360427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1155%2F2018%2F2360427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29849873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MbitVOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=2360427&author=Y.+Xiangauthor=W.+Yeauthor=C.+Huangauthor=D.+Yuauthor=H.+Chenauthor=T.+Dengauthor=F.+Zhangauthor=B.+Louauthor=J.+Zhangauthor=K.+Shiauthor=B.+Chenauthor=M.+Zhou&title=Brusatol+enhances+the+chemotherapy+efficacy+of+gemcitabine+in+pancreatic+cancer+via+the+Nrf2+signalling+pathway&doi=10.1155%2F2018%2F2360427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway</span></div><div class="casAuthors">Xiang Yukai; Ye Wen; Huang Chaohao; Yu Dinglai; Chen Hao; Deng Tuo; Zhang Fan; Lou Bin; Zhang Jie; Chen Bicheng; Zhou Mengtao; Shi Keqing; Chen Bicheng; Zhou Mengtao</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2360427</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although gemcitabine is the standard chemotherapy treatment for advanced pancreatic cancer, its benefits are quite limited due to prevalent chemoresistance, and the mechanism underlying gemcitabine chemoresistance remains unclear.  Currently, Nrf2 has been deemed as a significant contributor to gemcitabine chemoresistance in pancreatic cancer.  Brusatol is a unique inhibitor of the Nrf2 pathway, and in previous studies, we determined that brusatol exhibits the effects of growth inhibition and proapoptosis in pancreatic cancer cells.  Due to these data, we speculate that brusatol can reverse gemcitabine-induced Nrf2 activation and propose that it can enhance gemcitabine efficacy in treating pancreatic cancer.  In this study, we first proved that brusatol can effectively inhibit the Nrf2 signalling pathway and increase ROS accumulation in pancreatic cancer cells.  Next, we demonstrated that brusatol can abrogate gemcitabine-induced Nrf2 activation in pancreatic cancer cells.  In addition, we discovered that brusatol potentiates gemcitabine-induced growth inhibition and apoptosis in human pancreatic cancer cells.  In nude mice with PANC-1 xenografts, treatment with a combination of brusatol and gemcitabine considerably reduced in vivo tumour growth compared with control treatment or treatment with either brusatol or gemcitabine alone.  Immunohistochemical staining also showed that Nrf2 expression levels were reduced in brusatol-treated xenograft tumour tissues.  In summary, our results suggest that brusatol is capable of enhancing the antitumour effects of gemcitabine in both pancreatic cancer cells and PANC-1 xenografts via suppressing the Nrf2 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZFYd2xluH2H6CEoQgWY10fW6udTcc2eYtmXkMhsJn6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbitVOltA%253D%253D&md5=6b1f2f14a29032a63ab0c6f435ddb0b1</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1155%2F2018%2F2360427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F2360427%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLou%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DM.%26atitle%3DBrusatol%2520enhances%2520the%2520chemotherapy%2520efficacy%2520of%2520gemcitabine%2520in%2520pancreatic%2520cancer%2520via%2520the%2520Nrf2%2520signalling%2520pathway%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longev.%26date%3D2018%26spage%3D2360427%26doi%3D10.1155%2F2018%2F2360427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeneuve, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toppin, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.1073/pnas.1014275108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1073%2Fpnas.1014275108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21205897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=1433-1438&author=D.+Renauthor=N.+F.+Villeneuveauthor=T.+Jiangauthor=T.+Wuauthor=A.+Lauauthor=H.+A.+Toppinauthor=D.+D.+Zhang&title=Brusatol+enhances+the+efficacy+of+chemotherapy+by+inhibiting+the+Nrf2-mediated+defense+mechanism&doi=10.1073%2Fpnas.1014275108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism</span></div><div class="casAuthors">Ren, Dongmei; Villeneuve, Nicole F.; Jiang, Tao; Wu, Tongde; Lau, Alexandria; Toppin, Henry A.; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1433-1438, S1433/1-S1433/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The major obstacle in cancer treatment is the resistance of cancer cells to therapies.  Nrf2 is a transcription factor that regulates a cellular defense response and is ubiquitously expressed at low basal levels in normal tissues due to Keap1-dependent ubiquitination and proteasomal degrdn.  Recently, Nrf2 has emerged as an important contributor to chemoresistance.  High constitutive expression of Nrf2 was found in many types of cancers, creating an environment conducive for cancer cell survival.  Here, we report the identification of brusatol as a unique inhibitor of the Nrf2 pathway that sensitizes a broad spectrum of cancer cells and A549 xenografts to cisplatin and other chemotherapeutic drugs.  Mechanistically, brusatol selectively reduces the protein level of Nrf2 through enhanced ubiquitination and degrdn. of Nrf2.  Consequently, expression of Nrf2-downstream genes is reduced and the Nrf2-dependent protective response is suppressed.  In A549 xenografts, brusatol and cisplatin cotreatment induced apoptosis, reduced cell proliferation, and inhibited tumor growth more substantially when compared with cisplatin treatment alone.  Addnl., A549-K xenografts, in which Nrf2 is expressed at very low levels due to ectopic expression of Keap1, do not respond to brusatol treatment, demonstrating that brusatol-mediated sensitization to cisplatin is Nrf2 dependent.  Moreover, a decrease in drug detoxification and impairment in drug removal may be the primary mechanisms by which brusatol enhances the efficacy of chemotherapeutic drugs.  Taken together, these results clearly demonstrate the effectiveness of using brusatol to combat chemoresistance and suggest that brusatol can be developed into an adjuvant chemotherapeutic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruj8dASN0Mv7Vg90H21EOLACvtfcHk0lg_Hb4oKmKNVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Smtrs%253D&md5=6d2cad037bc5db9e922d100338d6fdf9</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1014275108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1014275108%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DD.%26aulast%3DVilleneuve%26aufirst%3DN.%2BF.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DToppin%26aufirst%3DH.%2BA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DBrusatol%2520enhances%2520the%2520efficacy%2520of%2520chemotherapy%2520by%2520inhibiting%2520the%2520Nrf2-mediated%2520defense%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D1433%26epage%3D1438%26doi%3D10.1073%2Fpnas.1014275108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo de la Vega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D. D.</span></span> <span> </span><span class="NLM_article-title">The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1002/mc.22745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fmc.22745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28976703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=182-192&author=S.+Taoauthor=M.+Rojo+de+la+Vegaauthor=E.+Chapmanauthor=A.+Ooiauthor=D.+D.+Zhang&title=The+effects+of+NRF2+modulation+on+the+initiation+and+progression+of+chemically+and+genetically+induced+lung+cancer&doi=10.1002%2Fmc.22745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer</span></div><div class="casAuthors">Tao, Shasha; Rojo de la Vega, Montserrat; Chapman, Eli; Ooi, Aikseng; Zhang, Donna D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-192</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Targeting the transcription factor NRF2 has been recognized as a feasible strategy for cancer prevention and treatment, but many of the mechanistic details underlying its role in cancer development and progression are lacking.  Therefore, careful mechanistic studies of the NRF2 pathway in cancer initiation and progression are needed to identify which therapeutic avenue-activation or inhibition-is appropriate in a given context.  Moreover, while numerous reports confirm the protective effect of NRF2 activation against chem. carcinogenesis little is known of its role in cancer arising from spontaneous mutations.  Here, we tested the effects of NRF2 modulation (activation by sulforaphane or inhibition by brusatol) in lung carcinogenesis using a chem. (vinyl carbamate) model in A/J mice and a genetic (conditional KrasG12D oncogene expression, to simulate spontaneous oncogene mutation) model in C57BL/6J mice.  Mice were treated with NRF2 modulators before carcinogen exposure or KrasG12D expression to test the role of NRF2 in cancer initiation, or treated after tumor development to test the role of NRF2 in cancer progression.  Lung tissues were analyzed to det. tumor burden, as well as status of NRF2 and KRAS pathways.  Addnl., proliferation, apoptosis, and oxidative DNA damage were assessed.  Overall, NRF2 activation prevents initiation of chem. induced cancer, but promotes progression of pre-existing tumors regardless of chem. or genetic etiol.  Once tumors are initiated, NRF2 inhibition is effective against the progression of chem. and spontaneously induced tumors.  These results have important implications for NRF2-targeted cancer prevention and intervention strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop5OpWFapg6LVg90H21EOLACvtfcHk0lg_Hb4oKmKNVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jF&md5=443bd2d5de35e912bce26279ff4a17ce</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1002%2Fmc.22745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22745%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DS.%26aulast%3DRojo%2Bde%2Bla%2BVega%26aufirst%3DM.%26aulast%3DChapman%26aufirst%3DE.%26aulast%3DOoi%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%2BD.%26atitle%3DThe%2520effects%2520of%2520NRF2%2520modulation%2520on%2520the%2520initiation%2520and%2520progression%2520of%2520chemically%2520and%2520genetically%2520induced%2520lung%2520cancer%26jtitle%3DMol.%2520Carcinog.%26date%3D2018%26volume%3D57%26spage%3D182%26epage%3D192%26doi%3D10.1002%2Fmc.22745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebinuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teratani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukasawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, H.</span></span> <span> </span><span class="NLM_article-title">Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">680</span>, <span class="refDoi"> DOI: 10.1186/s12885-018-4588-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1186%2Fs12885-018-4588-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29940898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2ntb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=680&author=Y.+Murakamiauthor=K.+Sugiyamaauthor=H.+Ebinumaauthor=N.+Nakamotoauthor=K.+Ojiroauthor=P.-S.+Chuauthor=N.+Tanikiauthor=Y.+Saitoauthor=T.+Terataniauthor=Y.+Kodaauthor=T.+Suzukiauthor=K.+Saitoauthor=M.+Fukasawaauthor=M.+Ikedaauthor=N.+Katoauthor=T.+Kanaiauthor=H.+Saito&title=Dual+effects+of+the+Nrf2+inhibitor+for+inhibition+of+hepatitis+C+virus+and+hepatic+cancer+cells&doi=10.1186%2Fs12885-018-4588-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells</span></div><div class="casAuthors">Murakami, Yuko; Sugiyama, Kazuo; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Ojiro, Keisuke; Chu, Po-sung; Taniki, Nobuhito; Saito, Yoshimasa; Teratani, Toshiaki; Koda, Yuzo; Suzuki, Takahiro; Saito, Kyoko; Fukasawa, Masayoshi; Ikeda, Masanori; Kato, Nobuyuki; Kanai, Takanori; Saito, Hidetsugu</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">680/1-680/14</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: We previously showed that knockdown of nuclear factor E2-related factor 2 (Nrf2) resulted in suppression of hepatitis C virus (HCV) infection.  In this study, whether brusatol, an Nrf2 inhibitor, has dual anti-HCV and anticancer effects was explored.  Methods: The anti-HCV effect of brusatol was investigated by analyzing HCV RNA and proteins in a hepatic cell line persistently-infected with HCV, HPI cells, and by analyzing HCV replication in a replicon-replicating hepatic cell line, OR6 cells.  Then, dual anti-HCV and anticancer effects of brusatol and enhancement of the effects by the combination of brusatol with anticancer drugs including sorafenib, which has been reported to have the dual effects, were then investigated.  Results: Brusatol suppressed the persistent HCV infection at both the RNA and protein levels in assocn. with a redn. in Nrf2 protein in the HPI cells.  Anal. of the OR6 cells treated with brusatol indicated that brusatol inhibited HCV persistence by inhibiting HCV replication.  Combination of brusatol with an anticancer drug not only enhanced the anticancer effect but also, in the case of the combination with sorafenib, strongly suppressed HCV infection.  Conclusions: Brusatol has dual anti-HCV and anticancer effects and can enhance the comparable effects of sorafenib.  There is therefore the potential for combination therapy of brusatol and sorafenib for HCV-related hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNxzqbe0LjlrVg90H21EOLACvtfcHk0lhEnp5bqgtyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2ntb%252FM&md5=ccebdcb846d88c82a56c2d603d165203</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1186%2Fs12885-018-4588-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-018-4588-y%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DK.%26aulast%3DEbinuma%26aufirst%3DH.%26aulast%3DNakamoto%26aufirst%3DN.%26aulast%3DOjiro%26aufirst%3DK.%26aulast%3DChu%26aufirst%3DP.-S.%26aulast%3DTaniki%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DTeratani%26aufirst%3DT.%26aulast%3DKoda%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DFukasawa%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKanai%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DH.%26atitle%3DDual%2520effects%2520of%2520the%2520Nrf2%2520inhibitor%2520for%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520and%2520hepatic%2520cancer%2520cells%26jtitle%3DBMC%2520Cancer%26date%3D2018%26volume%3D18%26spage%3D680%26doi%3D10.1186%2Fs12885-018-4588-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span> <span> </span><span class="NLM_article-title">Brusatol inhibits amyloid-β-induced neurotoxicity in U-251 cells via regulating the Nrf2/HO-1 pathway</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">10556</span>– <span class="NLM_lpage">10563</span>, <span class="refDoi"> DOI: 10.1002/jcb.28341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjcb.28341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30629288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFWksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2019&pages=10556-10563&author=X.+Liuauthor=H.+W.+Xuauthor=Y.+Q.+Zhangauthor=P.+Wangauthor=W.+Gao&title=Brusatol+inhibits+amyloid-%CE%B2-induced+neurotoxicity+in+U-251+cells+via+regulating+the+Nrf2%2FHO-1+pathway&doi=10.1002%2Fjcb.28341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol inhibits amyloid-β-induced neurotoxicity in U-251 cells via regulating the Nrf2/HO-1 pathway</span></div><div class="casAuthors">Liu, Xin; Xu, Hua Wen; Zhang, Yue Qi; Wang, Peng; Gao, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">10556-10563</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) has been reported to cause oxidative damage of neurons leading to neurotoxicity in a variety of diseases and cancers.  As an anticancer drug, brusatol (BR) has been shown to have potent cytotoxic effects on various cancer cell lines.  In this study, the effect and mechanism of BR on Aβ-induced neurotoxicity was investigated in U-251 glioma cells.  Using the MTT assay, the results suggest that BR ameliorated cell injury induced by Aβ in U-251 cells.  After running Hoechst and Western blot assays, BR prevented cell apoptosis induced by Aβ in U-251 cells.  In addn., BR inhibited the increased reactive oxygen species and mitochondrial membrane potential levels induced by Aβ in U-251 cells using the DCFH-DA and Rh123 method.  Furthermore, BR induced the Nrf2/HO-1 pathway by inhibiting the PI3K/AKT/mTOR pathway to inhibit neurotoxicity elicited by Aβ.  These results suggest that brustasol is a valuable potential antitumor drug available for chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQQ-Nl4jrLbVg90H21EOLACvtfcHk0lhEnp5bqgtyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFWksw%253D%253D&md5=6c6a91bfca6019f694519a410134557e</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fjcb.28341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.28341%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DZhang%26aufirst%3DY.%2BQ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DW.%26atitle%3DBrusatol%2520inhibits%2520amyloid-%25CE%25B2-induced%2520neurotoxicity%2520in%2520U-251%2520cells%2520via%2520regulating%2520the%2520Nrf2%252FHO-1%2520pathway%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2019%26volume%3D120%26spage%3D10556%26epage%3D10563%26doi%3D10.1002%2Fjcb.28341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muench, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedoris, K.</span></span> <span> </span><span class="NLM_article-title">c-Myc and cancer metabolism</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5546</span>– <span class="NLM_lpage">5553</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1078-0432.CCR-12-0977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23071356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFahu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=5546-5553&author=D.+M.+Millerauthor=S.+D.+Thomasauthor=A.+Islamauthor=D.+Muenchauthor=K.+Sedoris&title=c-Myc+and+cancer+metabolism&doi=10.1158%2F1078-0432.CCR-12-0977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">c-Myc and Cancer Metabolism</span></div><div class="casAuthors">Miller, Donald M.; Thomas, Shelia D.; Islam, Ashraful; Muench, David; Sedoris, Kara</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5546-5553</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The processes of cellular growth regulation and cellular metab. are closely interrelated.  The c-Myc oncogene is a "master regulator" which controls many aspects of both of these processes.  The metabolic changes which occur in transformed cells, many of which are driven by c-Myc overexpression, are necessary to support the increased need for nucleic acids, proteins, and lipids necessary for rapid cellular proliferation.  At the same time, c-Myc overexpression results in coordinated changes in level of expression of gene families which result in increased cellular proliferation.  This interesting duality of c-Myc effects places it in the mainstream of transformational changes and gives it a very important role in regulating the "transformed phenotype".  The effects induced by c-Myc can occur either as a "primary oncogene" which is activated by amplification or translocation or as a downstream effect of other activated oncogenes.  In either case, it appears that c-Myc plays a central role in sustaining the changes which occur with transformation.  Although efforts to use c-Myc as a therapeutic target have been quite frustrating, it appears that this may change in the next few years.  Clin Cancer Res; 18(20); 5546-53. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5OkM1yBQI7LVg90H21EOLACvtfcHk0lhEnp5bqgtyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFahu73K&md5=8e1a95beadc8ab07cb8f8c00877c8e4c</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0977%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DThomas%26aufirst%3DS.%2BD.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DMuench%26aufirst%3DD.%26aulast%3DSedoris%26aufirst%3DK.%26atitle%3Dc-Myc%2520and%2520cancer%2520metabolism%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D5546%26epage%3D5553%26doi%3D10.1158%2F1078-0432.CCR-12-0977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span> <span> </span><span class="NLM_article-title">Brusatol-mediated inhibition of c-Myc increases HIF-1α degradation and causes cell death in colorectal cancer under hypoxia</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3415</span>– <span class="NLM_lpage">3431</span>, <span class="refDoi"> DOI: 10.7150/thno.20861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.7150%2Fthno.20861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28912885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFaitrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=3415-3431&author=E.-T.+Ohauthor=C.+W.+Kimauthor=H.+G.+Kimauthor=J.-S.+Leeauthor=H.+J.+Park&title=Brusatol-mediated+inhibition+of+c-Myc+increases+HIF-1%CE%B1+degradation+and+causes+cell+death+in+colorectal+cancer+under+hypoxia&doi=10.7150%2Fthno.20861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol-mediated inhibition of c-Myc increases HIF-1α degradation and causes cell death in colorectal cancer under hypoxia</span></div><div class="casAuthors">Oh, Eun-Taex; Kim, Chan Woo; Kim, Ha Gyeong; Lee, Jae-Seon; Park, Heon Joo</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3415-3431</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">HIF-1 (hypoxia-inducible factor-1) regulates the expression of ∼100 genes involved in angiogenesis, metastasis, tumor growth, chemoresistance and radioresistance, underscoring the growing interest in targeting HIF-1 for cancer control.  In the present study, we investigated the mol. mechanisms underlying brusatol-induced HIF-1α degrdn. and cell death in colorectal cancer under hypoxia (0.5% O2).  Under hypoxia, pretreatment of cancer cells with brusatol increased HIF-1α degrdn. and cancer cell death in a dose-dependent manner.  This effect was mediated by activation of prolyl hydroxylases (PHDs), as evidenced by the block of brusatol-induced HIF-1α degrdn. and cancer cell death by both pharmacol. inhibition and siRNA-mediated knockdown of PHDs.  In addn., a ferrous iron chelator (2,2'-bypyridyl) blocked brusatol-induced degrdn. of HIF-1α and cancer cell death in hypoxia by inhibiting PHD activation.  We further found that brusatol inhibited c-Myc expression, and showed that overexpression of c-Myc prevented brusatol-induced degrdn. of HIF-1α and cancer cell death by increasing mitochondrial ROS prodn. and subsequent ROS-mediated transition of ferrous iron to ferric iron.  Consistent with these results, treatment of tumor-bearing mice with brusatol significantly suppressed tumor growth by promoting PHD-mediated HIF-1α degrdn.  Collectively, our results suggest that brusatol-mediated inhibition of c-Myc/ROS signaling pathway increases HIF-1α degrdn. by promoting PHD activity and induces cell death in colorectal cancer under hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiEo_Rs0pDbVg90H21EOLACvtfcHk0liyCa1sU4Ambg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFaitrjE&md5=9726b8ee8a4d94ebae21477cfb622301</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.7150%2Fthno.20861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.20861%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DE.-T.%26aulast%3DKim%26aufirst%3DC.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BG.%26aulast%3DLee%26aufirst%3DJ.-S.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26atitle%3DBrusatol-mediated%2520inhibition%2520of%2520c-Myc%2520increases%2520HIF-1%25CE%25B1%2520degradation%2520and%2520causes%2520cell%2520death%2520in%2520colorectal%2520cancer%2520under%2520hypoxia%26jtitle%3DTheranostics%26date%3D2017%26volume%3D7%26spage%3D3415%26epage%3D3431%26doi%3D10.7150%2Fthno.20861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mata-Greenwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuendet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stock, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span> <span> </span><span class="NLM_article-title">Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-<i>myc</i></span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2284</span>, <span class="refDoi"> DOI: 10.1038/sj.leu.2402696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsj.leu.2402696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=12399973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFWksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=2275-2284&author=E.+Mata-Greenwoodauthor=M.+Cuendetauthor=D.+Sherauthor=D.+Gustinauthor=W.+Stockauthor=J.+M.+Pezzuto&title=Brusatol-mediated+induction+of+leukemic+cell+differentiation+and+G1+arrest+is+associated+with+down-regulation+of+c-myc&doi=10.1038%2Fsj.leu.2402696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-myc</span></div><div class="casAuthors">Mata-Greenwood, E.; Cuendet, M.; Sher, D.; Gustin, D.; Stock, W.; Pezzuto, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2275-2284</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Employing the natural product quassinoid brusatol, we currently report cellular and mol. events leading to cell death or terminal differentiation in a panel of leukemic cells.  Brusatol and bruceantin exerted significant cytotoxic effects with several leukemic cell lines, but not with K562 or normal lymphocytic cells.  Cell lines that were less sensitive to the cytotoxic effects of brusatol responded primarily through induction of terminal differentiation.  The differentiated phenotype in cell lines derived from acute or chronic myeloid leukemias (HL-60, K562, Kasumi-1, NB4, U937, BV173) was characterized for producing superoxide and non-specific esterase, and some with up-regulation of CD13 (cluster of differentiation) and down-regulation of CD15.  Chronic myeloid leukemic cell lines, K562 and BV173, and acute lymphoblastic cell lines, SUPB13 and RS4;11, were induced to differentiate along the erythrocytic pathway.  Withdrawal studies showed that brusatol treatment for 48 h was sufficient to induce commitment towards terminal differentiation in HL-60, K562 and SUPB13.  Reh cells did not undergo maturation.  Anal. of c-MYC protein expression revealed that brusatol or bruceantin down-regulated expression to undetectable levels in cell lines that were most sensitive, based on cell death or terminal differentiation.  Generally, c-myc RNA was reduced, but to a lower extent than c-MYC protein levels, indicating c-myc expression was regulated by quassinoids at the post-transcriptional level.  Thus, regulation of c-myc expression may represent a crit. event that leads to terminal differentiation.  Since these responses are facilitated at clin. achievable concns., quassinoids may be of value for the management of hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVGNe1HlRDxLVg90H21EOLACvtfcHk0liyCa1sU4Ambg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFWksbk%253D&md5=a385718ad7aeff2514da34a9080436d8</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2402696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2402696%26sid%3Dliteratum%253Aachs%26aulast%3DMata-Greenwood%26aufirst%3DE.%26aulast%3DCuendet%26aufirst%3DM.%26aulast%3DSher%26aufirst%3DD.%26aulast%3DGustin%26aufirst%3DD.%26aulast%3DStock%26aufirst%3DW.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26atitle%3DBrusatol-mediated%2520induction%2520of%2520leukemic%2520cell%2520differentiation%2520and%2520G1%2520arrest%2520is%2520associated%2520with%2520down-regulation%2520of%2520c-myc%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D2275%26epage%3D2284%26doi%3D10.1038%2Fsj.leu.2402696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangappa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basappa</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangappa, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. S.</span></span> <span> </span><span class="NLM_article-title">Brusatol, a Nrf2 inhibitor targets STAT3 signaling cascade in head and neck squamous cell carcinoma</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">550</span>, <span class="refDoi"> DOI: 10.3390/biom9100550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fbiom9100550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=550&author=J.+H.+Leeauthor=S.+Rangappaauthor=C.+D.+Mohanauthor=+Basappaauthor=G.+Sethiauthor=Z.-X.+Linauthor=K.+S.+Rangappaauthor=K.+S.+Ahn&title=Brusatol%2C+a+Nrf2+inhibitor+targets+STAT3+signaling+cascade+in+head+and+neck+squamous+cell+carcinoma&doi=10.3390%2Fbiom9100550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol, a Nrf2 inhibitor targets STAT3 signaling cascade in head and neck squamous cell carcinoma</span></div><div class="casAuthors">Lee, Jong Hyun; Rangappa, Shobith; Mohan, Chakrabhavi Dhananjaya; Basappa; Sethi, Gautam; Lin, Zhi-Xiu; Rangappa, Kanchugarakoppal S.; Ahn, Kwang Seok</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">550/1-550/17</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">STAT3 is a latent transcription factor that plays a vital role in the transmission of extracellular signal from receptors to the nucleus.  It has been regarded as a master transcription factor due to its role in the regulation of a broad spectrum of genes, which can contribute to oncogenesis.  Persistent activation of STAT3 and deregulation of its signaling has been obsd. in various human cancers including head and neck squamous cell carcinoma (HNSCC).  In the present work, we identified brusatol (BT) as a potential blocker of STAT3 signaling pathway in diverse HNSCC cells.  The data from the cell-based expts. suggested that BT-induced cytotoxicity and abrogated the activation of STAT3 and that of upstream kinases such as JAK1, JAK2, and Src.  It reduced the levels of nuclear STAT3 and its DNA binding ability.  BT treatment increased annexin-V-pos. cells, promoted procaspase-3 and PARP cleavage, and downregulated the mRNA and protein expression of diverse proteins (Bcl-2, Bcl-xl, survivin) in HNSCC cells.  Taken together, brusatol can function as a promising inhibitor targeting STAT3 signaling pathway in HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9EhjQdheKO7Vg90H21EOLACvtfcHk0liyCa1sU4Ambg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKi&md5=48f99e54863ec4e1ef7481acafd31bb7</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.3390%2Fbiom9100550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9100550%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DRangappa%26aufirst%3DS.%26aulast%3DMohan%26aufirst%3DC.%2BD.%26aulast%3DBasappa%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DZ.-X.%26aulast%3DRangappa%26aufirst%3DK.%2BS.%26aulast%3DAhn%26aufirst%3DK.%2BS.%26atitle%3DBrusatol%252C%2520a%2520Nrf2%2520inhibitor%2520targets%2520STAT3%2520signaling%2520cascade%2520in%2520head%2520and%2520neck%2520squamous%2520cell%2520carcinoma%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26spage%3D550%26doi%3D10.3390%2Fbiom9100550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span> <span> </span><span class="NLM_article-title">Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κB/STAT3/Bcl-2 signaling pathway</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>487</i></span>,  <span class="NLM_fpage">820</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2017.04.133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bbrc.2017.04.133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28455228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFertLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2017&pages=820-826&author=Y.+Xiangauthor=W.+Yeauthor=C.+Huangauthor=B.+Louauthor=J.+Zhangauthor=D.+Yuauthor=X.+Huangauthor=B.+Chenauthor=M.+Zhou&title=Brusatol+inhibits+growth+and+induces+apoptosis+in+pancreatic+cancer+cells+via+JNK%2Fp38+MAPK%2FNF-%CE%BAB%2FSTAT3%2FBcl-2+signaling+pathway&doi=10.1016%2Fj.bbrc.2017.04.133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway</span></div><div class="casAuthors">Xiang, Yukai; Ye, Wen; Huang, Chaohao; Lou, Bin; Zhang, Jie; Yu, Dinglai; Huang, Xince; Chen, Bicheng; Zhou, Mengtao</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">820-826</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Brusatol, isolated from brucea, has been proved to exhibit anticancer influence on various kind of human malignancies.  However, the role that brusatol plays in pancreatic cancer is seldom known by the public.  Through researches brusatol was proved to inhibit growth and induce apoptosis in both PATU-8988 and PANC-1 cells by decreasing the expression level of Bcl-2 and increasing the expression levels of Bax, Cleaved Caspase-3.  Then we found the activation of the JNK, p38 MAPK and inactivation of the NF-κb, Stat3 are related with the potential pro-apoptotic signaling pathways.  However, SP600125 could not only abrogated the JNK activation caused by brusatol, but also reverse the p38 activation and the decrease of Bcl-2 as SB203580 did.  Besides, SP600125 and SB203580 also reversed the inactivation of NF-κb and Stat3.  Furthermore, BAY 11-7082 and S3I-201 indeed had the similar effect as brusatol had on the expression of Phospho-Stat3 and Bcl-2.  To sum up, we came to a conclusion that in pancreatic cancer, brusatol do inhibit growth and induce apoptosis.  And we inferred that brusatol illustrates anticancer attribution via JNK/p38 MAPK/NF-κb/Stat3/Bcl-2 signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy9B-JuNQOjrVg90H21EOLACvtfcHk0lg6KSrmSOQJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFertLo%253D&md5=9c2446c2290cf6fcbafc3c59e21510e2</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.04.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.04.133%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DLou%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DM.%26atitle%3DBrusatol%2520inhibits%2520growth%2520and%2520induces%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%2520via%2520JNK%252Fp38%2520MAPK%252FNF-%25CE%25BAB%252FSTAT3%252FBcl-2%2520signaling%2520pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D487%26spage%3D820%26epage%3D826%26doi%3D10.1016%2Fj.bbrc.2017.04.133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.-N.</span></span> <span> </span><span class="NLM_article-title">Bruceine D suppresses viability, metastasis and EMT of human breast cancer MDA-MB-231 cells</span>. <i>Int. J. Clin. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">7285</span>– <span class="NLM_lpage">7291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=7285-7291&author=C.+Luoauthor=S.-P.+Fangauthor=Y.+Wangauthor=C.+Weiauthor=Y.-X.+Chenauthor=Z.-N.+Ji&title=Bruceine+D+suppresses+viability%2C+metastasis+and+EMT+of+human+breast+cancer+MDA-MB-231+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D suppresses viability, metastasis and EMT of human breast cancer MDA-MB-231 cells</span></div><div class="casAuthors">Luo, Can; Fang, Shang-Ping; Wang, Yu.; Wei, Cheng; Chen, Yu-Xin; Ji, Zhao-Ning</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7285-7291</span>CODEN:
                <span class="NLM_cas:coden">IJCEFA</span>;
        ISSN:<span class="NLM_cas:issn">1940-5901</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Bruceine D (BD), a major quassinoid extd. from the Chinese medicinal herb Brucea javanica, has been demonstrated to exert anticancer effects on various tumor cells.  However, the anti-metastatic effect of BD has not been reported.  The present study was designed to investigate the anti-metastatic effect of BD on MDA-MB-231 cells.  The effects of BD on cell viability, migration and invasion were examd. by MTT assay, wound healing assay and transwell assay, resp.  The effect of BD on epithelial-mesenchymal transition (EMT)-assocd. proteins, including E-cadherin and vimentin was tested by Western blot.  At the same time, we detected the expression of β-catenin, which is a key mol. target for promoting cell metastasis.  The results showed that BD inhibited the viability of MDA-MB-231 cells in a dose and time-dependent manner, and it also reduced cell migration and invasion in a dose-dependent manner.  Western blot showed that BD reversed EMT through suppressing vimentin but enhancing E-cadherin expression.  Furthermore, BD obviously decreased the expression of β-catenin in a dose-dependent manner.  Taken together, all these results suggest that BD suppresses viability, metastasis and EMT of human breast cancer MDA-MB-231 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM-jDVlY-FvrVg90H21EOLACvtfcHk0lg6KSrmSOQJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVamsrw%253D&md5=f9c55ef8b7644f0ab5ced3002d7b3958</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DS.-P.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.-X.%26aulast%3DJi%26aufirst%3DZ.-N.%26atitle%3DBruceine%2520D%2520suppresses%2520viability%252C%2520metastasis%2520and%2520EMT%2520of%2520human%2520breast%2520cancer%2520MDA-MB-231%2520cells%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Med.%26date%3D2019%26volume%3D12%26spage%3D7285%26epage%3D7291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span> <span> </span><span class="NLM_article-title">Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">126</span>, <span class="refDoi"> DOI: 10.1038/s41419-020-2317-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41419-020-2317-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32071301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=126&author=J.+Fanauthor=D.+Renauthor=J.+Wangauthor=X.+Liuauthor=H.+Zhangauthor=M.+Wuauthor=G.+Yang&title=Bruceine+D+induces+lung+cancer+cell+apoptosis+and+autophagy+via+the+ROS%2FMAPK+signaling+pathway+in+vitro+and+in+vivo&doi=10.1038%2Fs41419-020-2317-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo</span></div><div class="casAuthors">Fan, Jiangjiang; Ren, Dongmei; Wang, Jinxia; Liu, Xiaoqing; Zhang, Huaran; Wu, Mingsheng; Yang, Guotao</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Worldwide, lung cancer remains a leading cause of cancer mortality.  Bruceine D (BD) has been shown to induce pancreatic cancer cell death via several different mechanisms.  In this study, we demonstrated that BD inhibited lung cancer cell proliferation.  Apoptosis and autophagy were the most important mechanisms involved in BD-induced lung cancer cell death, and complete autophagic flux was obsd. in A549 and NCI-H292 cells.  In addn., BD significantly improved intracellular reactive oxygen species (ROS) levels.  BD-mediated cell apoptosis and autophagy were almost inhibited in cells pretreated with N-acetylcysteine (NAC), an ROS scavenger.  Furthermore, MAPK signaling pathway activation contributed to BD-induced cell proliferation inhibition and NAC could eliminate p-ERK and p-JNK upregulation.  Finally, an in vivo study indicated that BD inhibited the growth of lung cancer xenografts.  Overall, BD is a promising candidate for the treatment of lung cancer owing to its multiple mechanisms and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoadQk2e9T51bVg90H21EOLACvtfcHk0lg6KSrmSOQJUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFGltrg%253D&md5=2274b7d5d2acfefab929f5bf7fc1999e</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1038%2Fs41419-020-2317-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-020-2317-3%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DG.%26atitle%3DBruceine%2520D%2520induces%2520lung%2520cancer%2520cell%2520apoptosis%2520and%2520autophagy%2520via%2520the%2520ROS%252FMAPK%2520signaling%2520pathway%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2020%26volume%3D11%26spage%3D126%26doi%3D10.1038%2Fs41419-020-2317-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xian, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.-X.</span></span> <span> </span><span class="NLM_article-title">Brucein D, a naturally occurring tetracyclic triterpene quassinoid, induces apoptosis in pancreatic cancer through ROS-associated PI3K/Akt signaling pathway</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">936</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3389%2Ffphar.2017.00936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29311937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOhurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=936&author=Z.-Q.+Laiauthor=S.-P.+Ipauthor=H.-J.+Liaoauthor=Z.+Luauthor=J.-H.+Xieauthor=Z.-R.+Suauthor=Y.-L.+Chenauthor=Y.-F.+Xianauthor=P.-S.+Leungauthor=Z.-X.+Lin&title=Brucein+D%2C+a+naturally+occurring+tetracyclic+triterpene+quassinoid%2C+induces+apoptosis+in+pancreatic+cancer+through+ROS-associated+PI3K%2FAkt+signaling+pathway&doi=10.3389%2Ffphar.2017.00936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">Brucein D, a naturally occurring tetracyclic triterpene quassinoid, induces apoptosis in pancreatic cancer through ros-associated PI3K/Akt signaling pathway</span></div><div class="casAuthors">Lai, Zheng-Quan; Ip, Siu-Po; Liao, Hui-Jun; Lu, Zheng; Xie, Jian-Hui; Su, Zi-Ren; Chen, Yun-Long; Xian, Yan-Fang; Leung, Po-Sing; Lin, Zhi-Xiu</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">936/1-936/15</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Brucein D (BD), a major active quassinoid in Brucea javanica, has exhibited pronounced anticancer activities.  However, the biol. mechanisms have not been fully explored.  In this study, BD exhibited more potent cytotoxic effect on pancreatic cancer (PanCa) cell lines, while exerted weaker cytotoxic effects on GES-1 cells (non-tumorigenic).  BD was shown to elicit apoptosis through inducing both the intrinsic and extrinsic mitochondria-mediated caspase activations.  Furthermore, the BD-induced apoptotic effects were dependent on the accumulated reactive oxygen species (ROS) and inactivation of PI3K/Akt signaling pathway.  Pretreatment with tempol completely prevented the cellular apoptosis induced by BD, and recovered the inactivation of AKT, which suggested ROS essentially involved in BD-elicited apoptosis and down-regulation of PI3K/Akt pathway.  In addn., the results obtained from orthotopic xenograft in nude mice were congruent with those of the in vitro investigations.  These results support the notion that BD held good potential to be further developed into an effective pharmaceutical agent for the treatment of PanCa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8cAwRR8p7vbVg90H21EOLACvtfcHk0lisdiGz3zkjYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOhurzE&md5=e1d4b1335239532741573bc33d4f9d4c</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00936%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DZ.-Q.%26aulast%3DIp%26aufirst%3DS.-P.%26aulast%3DLiao%26aufirst%3DH.-J.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DJ.-H.%26aulast%3DSu%26aufirst%3DZ.-R.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DXian%26aufirst%3DY.-F.%26aulast%3DLeung%26aufirst%3DP.-S.%26aulast%3DLin%26aufirst%3DZ.-X.%26atitle%3DBrucein%2520D%252C%2520a%2520naturally%2520occurring%2520tetracyclic%2520triterpene%2520quassinoid%252C%2520induces%2520apoptosis%2520in%2520pancreatic%2520cancer%2520through%2520ROS-associated%2520PI3K%252FAkt%2520signaling%2520pathway%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D936%26doi%3D10.3389%2Ffphar.2017.00936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span> <span> </span><span class="NLM_article-title">Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway</span>. <i>Cancer Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">7345</span>– <span class="NLM_lpage">7358</span>, <span class="refDoi"> DOI: 10.1002/cam4.2612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fcam4.2612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31631559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVeju7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=7345-7358&author=S.+Wangauthor=H.+Huauthor=B.+Zhongauthor=D.+Shiauthor=X.+Qingauthor=C.+Chengauthor=X.+Dengauthor=Z.+Zhangauthor=Z.+Shao&title=Bruceine+D+inhibits+tumor+growth+and+stem+cell-like+traits+of+osteosarcoma+through+inhibition+of+STAT3+signaling+pathway&doi=10.1002%2Fcam4.2612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway</span></div><div class="casAuthors">Wang, Shangyu; Hu, Hongzhi; Zhong, Binlong; Shi, Deyao; Qing, Xiangcheng; Cheng, Cheng; Deng, Xiangyu; Zhang, Zhicai; Shao, Zengwu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7345-7358</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">This study aims to explore the anti-osteosarcoma effects of Bruceine D (BD), a natural compd. derived from Brucea javanica, and investigate its underlying mechanisms.  Results demonstrated that BD could significantly inhibit cell proliferation and migration, induce cell cycle arrest, and promote apoptosis in osteosarcoma cells.  Besides, BD could also suppress the sphere-forming and self-renewal ability of OSCs.  Mechanistically, the inhibitory role of BD on osteosarcoma cell growth and migration including OSC stemness was partially executed through the inhibition of STAT3 signaling pathway.  More importantly, BD showed significant anti-osteosarcoma activity without obvious side effects in vivo.  Collectively, the results of this study demonstrated that BD exerts a strong inhibitory effect on tumor growth and stem cell like traits of osteosarcoma which may be partially due to STAT3 inhibition, suggesting that BD maybe a promising therapeutic candidate against osteosarcoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrczm6gDjS0YLVg90H21EOLACvtfcHk0lisdiGz3zkjYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVeju7zF&md5=9e47465e820c9d0b11e7779fcb39d050</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1002%2Fcam4.2612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.2612%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DQing%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DShao%26aufirst%3DZ.%26atitle%3DBruceine%2520D%2520inhibits%2520tumor%2520growth%2520and%2520stem%2520cell-like%2520traits%2520of%2520osteosarcoma%2520through%2520inhibition%2520of%2520STAT3%2520signaling%2520pathway%26jtitle%3DCancer%2520Med.%26date%3D2019%26volume%3D8%26spage%3D7345%26epage%3D7358%26doi%3D10.1002%2Fcam4.2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N.</span></span> <span> </span><span class="NLM_article-title">Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">109089</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31226632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1WjsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2019&pages=109089&author=B.+Tanauthor=Y.+Huangauthor=L.+Lanauthor=B.+Zhangauthor=L.+Yeauthor=W.+Yanauthor=F.+Wangauthor=N.+Lin&title=Bruceine+D+induces+apoptosis+in+human+non-small+cell+lung+cancer+cells+through+regulating+JNK+pathway&doi=10.1016%2Fj.biopha.2019.109089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway</span></div><div class="casAuthors">Tan, Biqin; Huang, Yuyu; Lan, Lihua; Zhang, Bo; Ye, Lijun; Yan, Wei; Wang, Fei; Lin, Nengming</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109089</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Bruceine D (BD) is the quassinoids isolated from the traditional Chinese herbal medicine Brucea javanica's fruit, which exhibits anti-cancer activity.  Here, we demonstrated that BD inhibited human non-small cell lung cancer (NSCLC) cell lines in vitro that were attributed to the induction of cell apoptosis.  Human NSCLC H460 and A549 cell lines were treated with BD, and cell viability was conducted with CCK-8 assay.  Cell clone formation was obsd. by clone formation assay.  Cell apoptosis was measured using DAPI staining and flow cytometry.  Protein levels was analyzed by western blot.  The results showed BD inhibited the cell viability of H460 and A549 cells in a dose-dependent manner with IC50 values of 0.5 and 0.6μmol/L, resp., at 48 h of treatment.  Treatment with BD (0.125-1.0μmol/L) dose-dependently promoted chromatin condensation, Annexin V-pos. cell population and caspase-dependent apoptosis in H460 and A549 cells.  Mechanistically, BD stimulated the phosphorylation of JNK.  Furthermore, the anti-cancer effects of BD were alleviated effectively by a specific JNK inhibitor SP600125 in NSCLC cells.  In conclusion, the results demonstrated that BD exerted anti-cancer activity against NSCLC cells through JNK activation, which suggests its potent usefulness for prevention and treatment of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiYyGYZXLHE7Vg90H21EOLACvtfcHk0lhpz_yzRJAd0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1WjsrnM&md5=90b3b2f8722c6546c51d0aad57992d89</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109089%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DN.%26atitle%3DBruceine%2520D%2520induces%2520apoptosis%2520in%2520human%2520non-small%2520cell%2520lung%2520cancer%2520cells%2520through%2520regulating%2520JNK%2520pathway%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D117%26spage%3D109089%26doi%3D10.1016%2Fj.biopha.2019.109089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, R.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.-C.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic quassinoids from <i>Ailanthus altissima</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">654</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.bmcl.2012.11.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23290052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=654-657&author=Y.+Wangauthor=W.-J.+Wangauthor=C.+Suauthor=D.-M.+Zhangauthor=L.-P.+Xuauthor=R.-R.+Heauthor=L.+Wangauthor=J.+Zhangauthor=X.-Q.+Zhangauthor=W.-C.+Ye&title=Cytotoxic+quassinoids+from+Ailanthus+altissima&doi=10.1016%2Fj.bmcl.2012.11.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic quassinoids from Ailanthus altissima</span></div><div class="casAuthors">Wang, Yan; Wang, Wen-Jing; Su, Chang; Zhang, Dong-Mei; Xu, Li-Peng; He, Rong-Rong; Wang, Lei; Zhang, Jian; Zhang, Xiao-Qi; Ye, Wen-Cai</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">654-657</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two new quassinoids, altissinol A (I) and B (II), together with 12 known quassinoids, were isolated from the 95% ethanol ext. of the barks of Ailanthus altissima.  The structures of I and II were detd. on the basis of the spectroscopic methods including UV, IR, HR-ESI-MS, 1D and 2D NMR.  The cytotoxic potential of all isolates were evaluated in vitro against three human hepatoma cell lines.  Quassinoids 1-7 displayed potent cytotoxic activities against human hepatoma Hep3B and HepG2 cell lines.  Compds. 2, 3, and 5 exhibited cytotoxic activity against multidrug resistance HepG2/ADM cell line with IC50 value 4.3-fold more sensitive to Doxorubicin (DOX).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpqD4qm-d7brVg90H21EOLACvtfcHk0lhpz_yzRJAd0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ehsA%253D%253D&md5=9bdfad721cd538e2fa1e4d3c6e3f400d</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.116%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.-J.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DD.-M.%26aulast%3DXu%26aufirst%3DL.-P.%26aulast%3DHe%26aufirst%3DR.-R.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.-Q.%26aulast%3DYe%26aufirst%3DW.-C.%26atitle%3DCytotoxic%2520quassinoids%2520from%2520Ailanthus%2520altissima%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D654%26epage%3D657%26doi%3D10.1016%2Fj.bmcl.2012.11.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozeki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsuyanagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itokawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mello Alves, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic quassinoids from <i>Simaba cedron</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1021/np980023f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np980023f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK1cXjs1Giuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1998&pages=776-780&author=A.+Ozekiauthor=Y.+Hitotsuyanagiauthor=E.+Hashimotoauthor=H.+Itokawaauthor=K.+Takeyaauthor=S.+de+Mello+Alves&title=Cytotoxic+quassinoids+from+Simaba+cedron&doi=10.1021%2Fnp980023f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Quassinoids from Simaba cedron</span></div><div class="casAuthors">Ozeki, Akira; Hitotsuyanagi, Yukio; Hashimoto, Eriko; Itokawa, Hideji; Takeya, Koichi; de Alves, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">776-780</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four new quassinoids, cedronolactones A-D (1-4), together with nine known compds., simalikalactone D (5), chaparrinone (6), chaparrin (7), glaucarubolone (8), glaucarubol (9), samaderine Z (10), guanepolide (11), ailanquassin A (12), and polyandrol (13), were isolated from the wood of Simaba cedron.  The chem. structures of 1-4 were elucidated on the basis of their chem. and spectral properties.  Cedronolactone A (1) was shown to exhibit a significant in vitro cytotoxicity (IC50 0.0074 μg/mL) against P-388 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr21s4T0xcui7Vg90H21EOLACvtfcHk0ljrpyJRuPslfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjs1Giuro%253D&md5=af1ebe45aae3634e7fe6bc4cbe5e3467</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1021%2Fnp980023f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp980023f%26sid%3Dliteratum%253Aachs%26aulast%3DOzeki%26aufirst%3DA.%26aulast%3DHitotsuyanagi%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DE.%26aulast%3DItokawa%26aufirst%3DH.%26aulast%3DTakeya%26aufirst%3DK.%26aulast%3Dde%2BMello%2BAlves%26aufirst%3DS.%26atitle%3DCytotoxic%2520quassinoids%2520from%2520Simaba%2520cedron%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1998%26volume%3D61%26spage%3D776%26epage%3D780%26doi%3D10.1021%2Fnp980023f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, D.</span></span> <span> </span><span class="NLM_article-title">Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cell growth, migration and invasion</span>. <i>Exp. Mol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.yexmp.2019.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.yexmp.2019.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31002772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvF2hs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2019&pages=114-120&author=Y.+Zhangauthor=C.+Zhangauthor=D.+Min&title=Ailanthone+up-regulates+miR-449a+to+restrain+acute+myeloid+leukemia+cell+growth%2C+migration+and+invasion&doi=10.1016%2Fj.yexmp.2019.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cells growth, migration and invasion</span></div><div class="casAuthors">Zhang, Yang; Zhang, Chunzhi; Min, Dejin</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Pathology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-120</span>CODEN:
                <span class="NLM_cas:coden">EXMPA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4800</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Ailanthone (AIL) is a quassinoid isolated from traditional Chinese herbal medicine Ailanthus altissima.  The anti-tumor activities of AIL have been reported in various solid tumors.  This study aimed to reveal the in vitro effect of AIL on acute myeloid leukemia (AML) cells.  The effects of AIL on five AML cell lines (KG1, HL60, U-937, THP-1 and OCI-AML2) as well as myeloid progenitor cells were evaluated by performing CCK-8 assay, flow cytometry, Transwell assay and Western blotting.  KG1 and HL60 cells were transfected with miR-449a inhibitor or its neg. control, and then were treated by AIL.  The above mentioned assays were performed again to study the involvement of miR-449a in AIL's function.  AIL dose-dependently inhibited the viability of AML cells and myeloid progenitor cells.  The IC50 value of AIL towards KG1 and HL60 cells was 0.58 and 0.57μM, resp.  AIL with concn. of 0.5μM significantly induced the apoptosis of AML cells rather than myeloid progenitor cells.  Meanwhile, 0.5μM AIL significantly reduced migration and invasion of AML cells.  MiR-449a was highly expressed in response to the treatment of 0.5μM AIL.  Besides this, the anti-tumor activities of AIL in AML cells were attenuated by miR-449a silence.  Further, the blockage of Notch and PI3K/AKT signaling pathways induced by AIL was reversed by miR-449a silence.  AIL restrained AML cells growth, migration and invasion through up-regulation of miR-449a, and deactivation of Notch and PI3K/AKT signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3sSrOuOxgbrVg90H21EOLACvtfcHk0ljrpyJRuPslfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvF2hs7w%253D&md5=861f23badd7c32fa4fd8d6b1bd7dd77d</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2Fj.yexmp.2019.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexmp.2019.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMin%26aufirst%3DD.%26atitle%3DAilanthone%2520up-regulates%2520miR-449a%2520to%2520restrain%2520acute%2520myeloid%2520leukemia%2520cell%2520growth%252C%2520migration%2520and%2520invasion%26jtitle%3DExp.%2520Mol.%2520Pathol.%26date%3D2019%26volume%3D108%26spage%3D114%26epage%3D120%26doi%3D10.1016%2Fj.yexmp.2019.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of the <i>Ailanthus altissima</i> bark phytochemical ailanthone against breast cancer MCF-7 cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6022</span>– <span class="NLM_lpage">6028</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.8039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.8039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29552229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC1MnisValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=6022-6028&author=R.+Wangauthor=Y.+Luauthor=H.+Liauthor=L.+Sunauthor=N.+Yangauthor=M.+Zhaoauthor=M.+Zhangauthor=Q.+Shi&title=Antitumor+activity+of+the+Ailanthus+altissima+bark+phytochemical+ailanthone+against+breast+cancer+MCF-7+cells&doi=10.3892%2Fol.2018.8039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF-7 cells</span></div><div class="casAuthors">Wang Ruxing; Zhang Manli; Shi Qingwen; Wang Ruxing; Lu Yanjie; Li Hong; Sun Lixin; Yang Ning; Zhao Mingzhen</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">6022-6028</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Ailanthone is isolated from the bark of Ailanthus altissima (Mill.) Swingle (Simaroubaceae).  The mechanism that underlies the activity of ailanthone on MCF-7 cells was investigated by MTT assay.  Breast cancer MCF-7 cells were treated with 0.5, 1.0, 2.0, 4.0 and 8.0 μg/ml ailanthone for 24, 48 and 72 h.  The inhibition of proliferation induced by treatment with ailanthone was assessed by MTT assay.  Apoptosis and cell cycle distribution in MCF-7 cells with the same doses of ailanthone for 48 h were determined by flow cytometry.  Expression of apoptosis-associated genes and proteins were analyzed by reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis, respectively.  The results revealed that ailanthone inhibited MCF-7 cell proliferation.  Flow cytometry assay demonstrated that ailanthone induced apoptosis and G0/G1 cell cycle arrest in MCF-7 cells.  Western blotting and RT-PCR assays demonstrated that upregulation of pro-apoptotic caspase-3 and Bcl-associated X, and downregulation of anti-apoptotic apoptosis regulator B-cell lymphoma-2 in MCF-7 cells may be associated with the induction of apoptosis and inhibition of proliferation.  To the best of our knowledge, the present study is the first to investigate the antitumor activity of ailanthone from A. altissima on MCF-7 cells and to attempt to elucidate the underlying mechanism.  The present study revealed the presence of ailanthone-mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrppWwtIoRB91QT_1O5WBYfW6udTcc2eburjTAQH9Wwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnisValuw%253D%253D&md5=236fb6d2e38d8cbf4a4bffdf57934255</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.8039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.8039%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DQ.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520Ailanthus%2520altissima%2520bark%2520phytochemical%2520ailanthone%2520against%2520breast%2520cancer%2520MCF-7%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D15%26spage%3D6022%26epage%3D6028%26doi%3D10.3892%2Fol.2018.8039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span> <span> </span><span class="NLM_article-title">Ailanthone induces G<sub>2</sub>/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6821</span>– <span class="NLM_lpage">6827</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.7491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fmmr.2017.7491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28901518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFWjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=6821-6827&author=Y.+Chenauthor=L.+Zhuauthor=X.+Yangauthor=C.+Weiauthor=C.+Chenauthor=Y.+Heauthor=Z.+Ji&title=Ailanthone+induces+G2%2FM+cell+cycle+arrest+and+apoptosis+of+SGC-7901+human+gastric+cancer+cells&doi=10.3892%2Fmmr.2017.7491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells</span></div><div class="casAuthors">Chen, Yuxin; Zhu, Ling; Yang, Xi; Wei, Cheng; Chen, Chuanrong; He, Yang; Ji, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">6821-6827</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Ailanthone is a major quassinoid extd. from the Chinese medicinal herb Ailanthus altissima, which has been reported to exert antiproliferative effects on various cancer cells.  The present study aimed to investigate the antitumor effects of ailanthone on SGC-7901 cells, and to analyze its underlying mol. mechanisms.  Following treatment with ailanthone, Cell Counting kit-8 was used to detect the cytotoxic effects of ailanthone on SGC-7901 cells in vitro.  The typical apoptotic morphol. of SGC-7901 cells was obsd. by Hoechst 33258 staining.  Cell cycle progression and apoptosis were measured by flow cytometry, and the protein and mRNA expression levels of Bcl-2 and Bax were analyzed by western blot anal. and reverse transcription-quant. polymerase chain reaction (RT-qPCR) resp., in SGC-7901 cells.  The results of the present study indicated that ailanthone inhibited the proliferation of SGC-7901 cells in a dose- and time-dependent manner in vitro, and also demonstrated that ailanthone induced G2/M phase cell cycle arrest and apoptosis of SGC-7901 cells.  Furthermore, anal. of the underlying mol. mechanisms revealed that ailanthone downregulated the expression levels of Bcl-2, whereas the expression levels of Bax were upregulated at the protein and mRNA levels.  In conclusion, ailanthone may inhibit the proliferation of SGC-7901 cells by inducing G2/M phase cell cycle arrest and apoptosis via altering the protein and mRNA expression levels of Bcl-2 and Bax in SGC-7901 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKCdQO4XZC0bVg90H21EOLACvtfcHk0ljosBqV_LDOjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFWjsLw%253D&md5=908f0c1c39c4e593396f51c3dc4d10ed</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.7491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.7491%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DZ.%26atitle%3DAilanthone%2520induces%2520G2%252FM%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520of%2520SGC-7901%2520human%2520gastric%2520cancer%2520cells%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D16%26spage%3D6821%26epage%3D6827%26doi%3D10.3892%2Fmmr.2017.7491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span> <span> </span><span class="NLM_article-title">Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">16185</span>, <span class="refDoi"> DOI: 10.1038/srep16185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fsrep16185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26525771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOnsL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=16185&author=Z.+Zhuoauthor=J.+Huauthor=X.+Yangauthor=M.+Chenauthor=X.+Leiauthor=L.+Dengauthor=N.+Yaoauthor=Q.+Pengauthor=Z.+Chenauthor=W.+Yeauthor=D.+Zhang&title=Ailanthone+inhibits+Huh7+cancer+cell+growth+via+cell+cycle+arrest+and+apoptosis+in+vitro+and+in+vivo&doi=10.1038%2Fsrep16185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo</span></div><div class="casAuthors">Zhuo, Zhenjian; Hu, Jianyang; Yang, Xiaolin; Chen, Minfen; Lei, Xueping; Deng, Lijuan; Yao, Nan; Peng, Qunlong; Chen, Zhesheng; Ye, Wencai; Zhang, Dongmei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16185</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">While searching for natural anti-hepatocellular carcinoma (HCC) components in Ailanthus altissima, we discovered that ailanthone had potent antineoplastic activity against HCC.  However, the mol. mechanisms underlying the antitumor effect of ailanthone on HCC have not been examd.  In this study, the antitumor activity and the underlying mechanisms of ailanthone were evaluated in vitro and in vivo.  Mechanistic studies showed that ailanthone induced G0/G1-phase cell cycle arrest, as indicated by decreased expression of cyclins and CDKs and increased expression of p21 and p27.  Our results demonstrated that ailanthone triggered DNA damage characterized by activation of the ATM/ATR pathway.  Moreover, ailanthone-induced cell death was assocd. with apoptosis, as evidenced by an increased ratio of cells in the subG1 phase and by PARP cleavage and caspase activation.  Ailanthone-induced apoptosis was mitochondrion-mediated and involved the PI3K/AKT signaling pathway in Huh7 cells.  In vivo studies demonstrated that ailanthone inhibited the growth and angiogenesis of tumor xenografts without significant secondary adverse effects, indicating its safety for treating HCC.  In conclusion, our study is the first to report the efficacy of ailanthone against Huh7 cells and to elucidate its underlying mol. mechanisms.  These findings suggest that ailanthone is a potential agent for the treatment of liver cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosWKOMLHZXqrVg90H21EOLACvtfcHk0lgTZ2MA0Rhekw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOnsL%252FM&md5=a7712888d89d84bdbc66ffe8249246d3</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1038%2Fsrep16185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep16185%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DD.%26atitle%3DAilanthone%2520inhibits%2520Huh7%2520cancer%2520cell%2520growth%2520via%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D16185%26doi%3D10.1038%2Fsrep16185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Z.</span></span> <span> </span><span class="NLM_article-title">Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3569</span>– <span class="NLM_lpage">3576</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.9101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3892%2Fol.2018.9101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30127963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3c3gtFaisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=3569-3576&author=C.+Weiauthor=C.+Chenauthor=Y.+Chengauthor=L.+Zhuauthor=Y.+Wangauthor=C.+Luoauthor=Y.+Heauthor=Z.+Yangauthor=Z.+Ji&title=Ailanthone+induces+autophagic+and+apoptotic+cell+death+in+human+promyelocytic+leukemia+HL-60+cells&doi=10.3892%2Fol.2018.9101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells</span></div><div class="casAuthors">Wei Cheng; He Yang; Yang Zhiming; Ji Zhaoning; Chen Chuanrong; Cheng Yuxin; Zhu Lin; Wang Yu; Luo Can</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3569-3576</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">Ailanthone, which is extracted from the traditional Chinese medicinal plant Ailanthus altissima, has been thoroughly demonstrated to have anti-tumor, anti-HIV, anti-inflammatory, anti-malarial, anti-allergic and anti-microbial activities.  However, the anti-proliferative effects of ailanthone on HL-60 cells and potential mechanisms underlying those effects have not been reported.  In the present study, we demonstrated the potent cytotoxicity of ailanthone against HL-60 cells.  Annexin V-APC/7-ADD staining assay indicated that ailanthone increased the number of apoptotic cells in a dose-dependent manner.  PI staining showed that ailanthone increased the percentage of G0/G1-phase cells in a dose-dependent manner.  Acridine orange staining suggested that ailanthone induced the formation of acidic vesicular organelles in HL-60 cells and pretreatment with BaF-A1 could attenuate this process.  Western blotting showed that ailanthone up-regulated the protein expression levels of beclin-1 and LC3-II and down-regulated those of LC3-I and p62 in a dose-dependent manner.  Use of BaF-A1 showed that the anti-proliferative effects of ailanthone on HL-60 cells may be partly attributable to the induction of autophagy-mediated apoptosis by MTT assay and annexin V-APC/7-ADD staining assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIKBh_sM1AHpNiNltV31zlfW6udTcc2eambeVQRbdAf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3gtFaisg%253D%253D&md5=9930c1e9089dae05f5812d20b0d3801d</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.9101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.9101%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DZ.%26atitle%3DAilanthone%2520induces%2520autophagic%2520and%2520apoptotic%2520cell%2520death%2520in%2520human%2520promyelocytic%2520leukemia%2520HL-60%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D3569%26epage%3D3576%26doi%3D10.3892%2Fol.2018.9101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, T.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of novel ailanthone derivatives in vitro and in vivo</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">579</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=3178149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL1MXjtlCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1988&pages=573-579&author=T.+Katoauthor=Y.+Suzumuraauthor=M.+Fukushimaauthor=T.+Hondaauthor=T.+Nakanishiauthor=T.+Noguchi&title=Antitumor+activity+of+novel+ailanthone+derivatives+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of novel ailanthone derivatives in vitro and in vivo</span></div><div class="casAuthors">Kato, Taketoshi; Suzumura, Yasuko; Fukushima, Masanori; Honda, Tadashi; Nakanishi, Toshihiro; Noguchi, Teruhisa</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">573-9</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    </div><div class="casAbstract">The antitumor activities of 2 ailanthone derivs. SUN 2071 (I) and SUN 0237 (II) were studied.  The cytotoxic activity of II was close to that of bruceantin and vincristine.  I was shown to be a potent inhibitor of protein synthesis in L1210 cultured cells.  When administered i.p. to i.p.-inoculated P388 leukemia mice, daily treatment with I and II increased the lifespan.  These increases were comparable to those achieved with vincristine.  The therapeutic ratio of I was also close to that of vincristine.  However, the compds. were ineffective when administered as a single injection.  Daily i.p. treatment with I demonstrated significant tumor growth inhibition in mice inoculated s.c. with colon-38 and moderate activity against i.p. L1210 leukemia and i.p. B16 melanoma.  The compds. were ineffective when tested against the Lewis lung carcinoma and colon-26.  In a preliminary toxicol. study, I at a therapeutic dose in daily consecutive i.p. injection produced leukopenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_VS2Y53DVU7Vg90H21EOLACvtfcHk0lhi-S8qplLzLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXjtlCjuw%253D%253D&md5=90d9ce05f9ead64c88d0645287725942</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DSuzumura%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DT.%26atitle%3DAntitumor%2520activity%2520of%2520novel%2520ailanthone%2520derivatives%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAnticancer%2520Res.%26date%3D1988%26volume%3D8%26spage%3D573%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span>; <span class="NLM_string-name">Chama, M. A.</span>; <span class="NLM_string-name">Addae-Mensah, I.</span>; <span class="NLM_string-name">Waibel, R.</span></span> <span> </span><span class="NLM_article-title">The Dichapetalins - Unique Cytotoxic Constituents of the Dichapetalaceae</span>; In  <i>Phytochemicals as Nutraceuticals: Global Approaches to Their Role in Nutrition and Health</i>; Ed. <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V.</span></span>; <span class="NLM_publisher-name">InTech</span>: <span class="NLM_publisher-loc">Shanghai</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.5772%2F27224" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=245-254&author=D.+Osei-Safo&author=M.+A.+Chama&author=I.+Addae-Mensah&author=R.+Waibelauthor=V.+Rao&title=Phytochemicals+as+Nutraceuticals%3A+Global+Approaches+to+Their+Role+in+Nutrition+and+Health"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.5772%2F27224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F27224%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Safo%26aufirst%3DD.%26atitle%3DThe%2520Dichapetalins%2520-%2520Unique%2520Cytotoxic%2520Constituents%2520of%2520the%2520Dichapetalaceae%26btitle%3DPhytochemicals%2520as%2520Nutraceuticals%253A%2520Global%2520Approaches%2520to%2520Their%2520Role%2520in%2520Nutrition%2520and%2520Health%26aulast%3DRao%26aufirst%3DV.%26pub%3DInTech%26date%3D2012%26spage%3D245%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asunka, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, I. V.</span></span> <span> </span><span class="NLM_article-title">Dichapetalin A, a novel plant constituent from <i>Dichapetalum madagascariense</i> with potential antineoplastic activity</span>. <i>Nat. Prod. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1080/10575639508043195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F10575639508043195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XltlGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=93-100&author=H.+Achenbachauthor=S.+A.+Asunkaauthor=R.+Waibelauthor=I.+Addae-Mensahauthor=I.+V.+Oppong&title=Dichapetalin+A%2C+a+novel+plant+constituent+from+Dichapetalum+madagascariense+with+potential+antineoplastic+activity&doi=10.1080%2F10575639508043195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit256R"><div class="casContent"><span class="casTitleNuber">256</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalin A, a novel plant constituent from Dichapetalum madagascariense with potential antineoplastic activity</span></div><div class="casAuthors">Achenbach, H.; Asunka, S. A.; Waibel, R.; Addae-Mensah, I.; Oppong, I. V.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-100</span>CODEN:
                <span class="NLM_cas:coden">NPLEEF</span>;
        ISSN:<span class="NLM_cas:issn">1057-5634</span>.
    
            (<span class="NLM_cas:orgname">Harwood</span>)
        </div><div class="casAbstract">From the roots of Dichapetalum madagascariense (Dichapetalaceae) dichapetalin A (I), a plant constituent with a new basic skeleton, has been isolated.  Its structure was elucidated by spectroscopic methods.  In-vitro expts. revealed a strong and selective cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlQ2Ebt__DCbVg90H21EOLACvtfcHk0lisaQ4zc5G4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlGqsLo%253D&md5=af533530a1ed001c4d6080e7a4b65a07</span></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1080%2F10575639508043195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10575639508043195%26sid%3Dliteratum%253Aachs%26aulast%3DAchenbach%26aufirst%3DH.%26aulast%3DAsunka%26aufirst%3DS.%2BA.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DOppong%26aufirst%3DI.%2BV.%26atitle%3DDichapetalin%2520A%252C%2520a%2520novel%2520plant%2520constituent%2520from%2520Dichapetalum%2520madagascariense%2520with%2520potential%2520antineoplastic%2520activity%26jtitle%3DNat.%2520Prod.%2520Lett.%26date%3D1995%26volume%3D7%26spage%3D93%26epage%3D100%26doi%3D10.1080%2F10575639508043195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weckert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, H.</span></span> <span> </span><span class="NLM_article-title">The absolute configuration of dichapetalin A</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(96)00349-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0031-9422%2896%2900349-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XlvF2gu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1996&pages=657-660&author=E.+Weckertauthor=G.+Matternauthor=I.+Addae-Mensahauthor=R.+Waibelauthor=H.+Achenbach&title=The+absolute+configuration+of+dichapetalin+A&doi=10.1016%2F0031-9422%2896%2900349-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">The absolute configuration of dichapetalin A</span></div><div class="casAuthors">Weckert, Edgar; Mattern, Guenter; Addae-Mensah, Ivan; Waibel, Reiner; Achenbach, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">657-660</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The abs. configuration of dichapetalin A (I), [(4α,6'α,7α,17α,20S,23R,24E)-2',3',5',6'-tetrahydro-7,23,26-trihydroxy-6'-phenyl-13,30-cyclo-29-nordammara-2,11,24-trieno[4,3-c]pyran-21-oic acid γ-lactone], the major cytotoxic constituent from Dichapetalum madagascariense has been established to be 4R,5R,7R,8R,9R,10S,13R,14S,17S,20S,23R,6'S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJntI69Zco9LVg90H21EOLACvtfcHk0lisaQ4zc5G4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvF2gu7k%253D&md5=0f3d2a0e914ebece24d6d5365000da97</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2896%2900349-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252896%252900349-4%26sid%3Dliteratum%253Aachs%26aulast%3DWeckert%26aufirst%3DE.%26aulast%3DMattern%26aufirst%3DG.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAchenbach%26aufirst%3DH.%26atitle%3DThe%2520absolute%2520configuration%2520of%2520dichapetalin%2520A%26jtitle%3DPhytochemistry%26date%3D1996%26volume%3D43%26spage%3D657%26epage%3D660%26doi%3D10.1016%2F0031-9422%2896%2900349-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asunka, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, H.</span></span> <span> </span><span class="NLM_article-title">The dichapetalins - a new class of triterpenoids</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1016/0031-9422(96)00350-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2F0031-9422%2896%2900350-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK28XlvF2gu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1996&pages=649-656&author=I.+Addae-Mensahauthor=R.+Waibelauthor=S.+A.+Asunkaauthor=I.+V.+Oppongauthor=H.+Achenbach&title=The+dichapetalins+-+a+new+class+of+triterpenoids&doi=10.1016%2F0031-9422%2896%2900350-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit258R"><div class="casContent"><span class="casTitleNuber">258</span><div class="casTitle"><span class="NLM_cas:atitle">The dichapetalins-a new class of triterpenoids</span></div><div class="casAuthors">Addae-Mensah, Ivan; Waibel, Reiner; Asunka, Stephen A.; Oppong, Isaac V.; Achenbach, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-656</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The isolation and structure elucidation by spectroscopic methods of dichapetalins B-H from the roots of Dichapetalum madagascariense are described.  These compds. constitute a novel class of triterpenoids.  Previously isolated dichapetalin A shows a strong and selective cytotoxic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOVUNIU0LFj7Vg90H21EOLACvtfcHk0lisaQ4zc5G4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvF2gu7s%253D&md5=5dc500e5615923f2d3b69e398fe4649c</span></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1016%2F0031-9422%2896%2900350-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0031-9422%252896%252900350-0%26sid%3Dliteratum%253Aachs%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAsunka%26aufirst%3DS.%2BA.%26aulast%3DOppong%26aufirst%3DI.%2BV.%26aulast%3DAchenbach%26aufirst%3DH.%26atitle%3DThe%2520dichapetalins%2520-%2520a%2520new%2520class%2520of%2520triterpenoids%26jtitle%3DPhytochemistry%26date%3D1996%26volume%3D43%26spage%3D649%26epage%3D656%26doi%3D10.1016%2F0031-9422%2896%2900350-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussagues, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcourt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poughon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalo Mutiso, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ausseil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimondo, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massiot, G.</span></span> <span> </span><span class="NLM_article-title">Dichapetalins from <i>Dichapetalum</i> species and their cytotoxic properties</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2013.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2013.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23618620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVGntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=184-191&author=C.+Longauthor=Y.+Aussaguesauthor=N.+Molinierauthor=L.+Marcourtauthor=L.+Vendierauthor=A.+Samsonauthor=V.+Poughonauthor=P.+B.+Chalo+Mutisoauthor=F.+Ausseilauthor=F.+Sautelauthor=P.+B.+Arimondoauthor=G.+Massiot&title=Dichapetalins+from+Dichapetalum+species+and+their+cytotoxic+properties&doi=10.1016%2Fj.phytochem.2013.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalins from Dichapetalum species and their cytotoxic properties</span></div><div class="casAuthors">Long, Christophe; Aussagues, Yannick; Molinier, Nicolas; Marcourt, Laurence; Vendier, Laure; Samson, Arnaud; Poughon, Valerie; Chalo Mutiso, Patrick B.; Ausseil, Frederic; Sautel, Francois; Arimondo, Paola B.; Massiot, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">184-191</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Six dichapetalins named dichapetalins N-S were isolated from Dichapetalum mombuttense, Dichapetalum zenkeri and Dichapetalum leucosia.  They were accompanied in the same plants by the known dichapetalins A, B, C, I, L and M.  The structures of the compds. were elucidated by 1D and 2D NMR expts. and mass spectrometry.  They all possessed the dammarane skeleton substituted at position C-3 by a C6-C2 unit forming a 2-phenylpyran moiety.  All contained a lactone ring in the side chain except dichapetalins O, Q and R, in which this ring was replaced by a lactol.  Dichapetalin Q and R were also the first dichapetalins bearing a tertiary Me and a double bond instead of the cyclopropane of the dammaranes.  All these compds. were assayed against cancer cell lines HCT116 and WM 266-4 and displayed cytotoxic and anti-proliferative activities in the 10-6 to 10-8 M range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolD3Uk1gkc-LVg90H21EOLACvtfcHk0lg0jqEHT7K0CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVGntrs%253D&md5=036c3c30814c5778e96822d1a6baa936</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2013.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2013.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DC.%26aulast%3DAussagues%26aufirst%3DY.%26aulast%3DMolinier%26aufirst%3DN.%26aulast%3DMarcourt%26aufirst%3DL.%26aulast%3DVendier%26aufirst%3DL.%26aulast%3DSamson%26aufirst%3DA.%26aulast%3DPoughon%26aufirst%3DV.%26aulast%3DChalo%2BMutiso%26aufirst%3DP.%2BB.%26aulast%3DAusseil%26aufirst%3DF.%26aulast%3DSautel%26aufirst%3DF.%26aulast%3DArimondo%26aufirst%3DP.%2BB.%26aulast%3DMassiot%26aufirst%3DG.%26atitle%3DDichapetalins%2520from%2520Dichapetalum%2520species%2520and%2520their%2520cytotoxic%2520properties%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D94%26spage%3D184%26epage%3D191%26doi%3D10.1016%2Fj.phytochem.2013.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madulid, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveros, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orjala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordell, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic constituents from the stem bark of <i>Dichapetalum gelonioides</i> collected in the Philippines</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1021/np058083q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np058083q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref260/cit260&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWmu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=332-337&author=L.+Fangauthor=A.+Itoauthor=H.-B.+Chaiauthor=Q.+Miauthor=W.+P.+Jonesauthor=D.+R.+Madulidauthor=M.+B.+Oliverosauthor=Q.+Gaoauthor=J.+Orjalaauthor=N.+R.+Farnsworthauthor=D.+D.+Soejartoauthor=G.+A.+Cordellauthor=S.+M.+Swansonauthor=J.+M.+Pezzutoauthor=A.+D.+Kinghorn&title=Cytotoxic+constituents+from+the+stem+bark+of+Dichapetalum+gelonioides+collected+in+the+Philippines&doi=10.1021%2Fnp058083q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit260R"><div class="casContent"><span class="casTitleNuber">260</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Constituents from the Stem Bark of Dichapetalum gelonioides Collected in the Philippines</span></div><div class="casAuthors">Fang, Liqiong; Ito, Aiko; Chai, Hee-Byung; Mi, Qiuwen; Jones, William P.; Madulid, Domingo R.; Oliveros, Mildred B.; Gao, Qi; Orjala, Jimmy; Farnsworth, Norman R.; Soejarto, Djaja D.; Cordell, Geoffrey A.; Swanson, Steven M.; Pezzuto, John M.; Kinghorn, A. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">332-337</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Fractionation of an Et acetate-sol. ext. of the stem bark of Dichapetalum gelonioides, collected in the Philippines, using the LNCaP (hormone-dependent human prostate) cell line as a monitor, led to the purifn. of three dichapetalin-type triterpenoids [dichapetalins A (1), I (2), and J (3)], along with two dolabrane norditerpenoids (6, 7), and the addnl. triterpenoids zeylanol (8), 28-hydroxyzeylanol (9), and betulinic acid.  Since compds. 1-3 exhibited promising selectivity against the SW626 (human ovarian cancer) cell line, a re-collection of the plant material was carried out, to obtain more of these compds. for addnl. biol. testing.  Two further phenylpyranotriterpenoids [dichapetalins K (4) and L (5)] were isolated from the re-collected plant material.  The structures of the new compds. 2-5 and 9 were detd. on the basis of spectroscopic data interpretation, and the relative configuration of 6 was confirmed using X-ray crystallog.  Compds. 4-6 and the Me ester, 6a, exhibited broad cytotoxic activity when tested against a panel of human tumor cell lines.  Dichapetalin A (1) was not active when evaluated in an in vivo hollow fiber assay in the dose range 1-6 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTeU7vOBs7l7Vg90H21EOLACvtfcHk0liGm6ayzgCT5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWmu7zM&md5=258501544419568de5e342dda723eca8</span></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Fnp058083q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp058083q%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DMi%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DW.%2BP.%26aulast%3DMadulid%26aufirst%3DD.%2BR.%26aulast%3DOliveros%26aufirst%3DM.%2BB.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DOrjala%26aufirst%3DJ.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DCordell%26aufirst%3DG.%2BA.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCytotoxic%2520constituents%2520from%2520the%2520stem%2520bark%2520of%2520Dichapetalum%2520gelonioides%2520collected%2520in%2520the%2520Philippines%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2006%26volume%3D69%26spage%3D332%26epage%3D337%26doi%3D10.1021%2Fnp058083q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziwornu, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appiah-Opong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chama, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuffour, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amewu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span> <span> </span><span class="NLM_article-title">Constituents of the roots of <i>Dichapetalum pallidum</i> and their anti-proliferative activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">532</span>, <span class="refDoi"> DOI: 10.3390/molecules22040532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules22040532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGqsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=532&author=D.+Osei-Safoauthor=G.+A.+Dziwornuauthor=R.+Appiah-Opongauthor=M.+A.+Chamaauthor=I.+Tuffourauthor=R.+Waibelauthor=R.+Amewuauthor=I.+Addae-Mensah&title=Constituents+of+the+roots+of+Dichapetalum+pallidum+and+their+anti-proliferative+activity&doi=10.3390%2Fmolecules22040532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Constituents of the roots of Dichapetalum pallidum and their anti-proliferative activity</span></div><div class="casAuthors">Osei-Safo, Dorcas; Dziwornu, Godwin Akpeko; Appiah-Opong, Regina; Chama, Mary Anti; Tuffour, Isaac; Waibel, Reiner; Amewu, Richard; Addae-Mensah, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">532/1-532/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">As part of our search for bioactive compds. from the Dichapetalaceae, repeated chromatog. purifn. of the roots of a hitherto unexamd. species, Dichapetalum pallidum, led to the isolation of the newly occurring 7-hydroxydichapetalin P (1) and the known dichapetalins A (2) and X (3).  Also isolated were the known compds. friedelin-2,3-lactone (4), friedelan-3-one (6), friedelan-3β-ol (7) and pomolic (8), as well as the dipeptide aurantiamide acetate (5).  The compds. were characterized by direct interpretation of their IR, 1D NMR and 2D NMR spectral data and by comparison of their physico-chem. data, including their chromatog. profiles, with the literature and authentic samples in our compd. library for the genus Dichapetalum.  The compds. were assayed for their anti-proliferative activities against the human T-lymphocytic leukemia (Jurkat), acute promyelocytic leukemia (HL-60) and T-lymphoblast-like leukemia (CEM) cell lines.  Overall, dichapetalin X showed the strongest (3.14 μM) and broadest cytotoxic activities against all the leukemic cell lines tested, exhibiting even stronger activities than the std. compd., curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXYp5G-ekZoLVg90H21EOLACvtfcHk0liGm6ayzgCT5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGqsrrE&md5=89aca8b55a0dad1f417f6a05f81dba9a</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22040532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22040532%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Safo%26aufirst%3DD.%26aulast%3DDziwornu%26aufirst%3DG.%2BA.%26aulast%3DAppiah-Opong%26aufirst%3DR.%26aulast%3DChama%26aufirst%3DM.%2BA.%26aulast%3DTuffour%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAmewu%26aufirst%3DR.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26atitle%3DConstituents%2520of%2520the%2520roots%2520of%2520Dichapetalum%2520pallidum%2520and%2520their%2520anti-proliferative%2520activity%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D532%26doi%3D10.3390%2Fmolecules22040532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanagasabai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninh, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalowich, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and natural killer cell stimulatory constituents of <i>Phyllanthus songboiensis</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2014.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytochem.2014.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25596805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVGhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2015&pages=132-140&author=Y.+Renauthor=C.+Yuanauthor=Y.+Dengauthor=R.+Kanagasabaiauthor=T.+N.+Ninhauthor=V.+T.+Tuauthor=H.-B.+Chaiauthor=D.+D.+Soejartoauthor=J.+R.+Fuchsauthor=J.+C.+Yalowichauthor=J.+Yuauthor=A.+D.+Kinghorn&title=Cytotoxic+and+natural+killer+cell+stimulatory+constituents+of+Phyllanthus+songboiensis&doi=10.1016%2Fj.phytochem.2014.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis</span></div><div class="casAuthors">Ren, Yulin; Yuan, Chunhua; Deng, Youcai; Kanagasabai, Ragu; Ninh, Tran Ngoc; Tu, Vuong Tan; Chai, Hee-Byung; Soejarto, Djaja D.; Fuchs, James R.; Yalowich, Jack C.; Yu, Jianhua; Douglas Kinghorn, A.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-140</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A dichapetalin-type triterpenoid and a dibenzylbutyrolactone-type lignan, together with five known lignans, a known arom. diterpenoid, and a known acylated phytosterol, were isolated from the aerial parts of Phyllanthus songboiensis, collected in Vietnam.  Their structures were detd. by interpretation of the spectroscopic data, and the inhibitory activity toward HT-29 human colon cancer cells of all isolates was evaluated by a cytotoxicity assay.  The known arylnaphthalene lignan, (+)-acutissimalignan A, was highly cytotoxic toward HT-29 cells, with an IC50 value of 19 nM, but this compd. was inactive as a DNA topoisomerase IIα (topo IIα) poison.  The known phytosterol, (-)-β-sitosterol-3-O-β-D-(6-O-palmitoyl)glucopyranoside, was found to stimulate natural killer (NK) cells at a concn. of 10 μM in the presence of interleukin 12 (IL-12).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHuti1QSS3rVg90H21EOLACvtfcHk0li62o6TiIYuKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVGhsQ%253D%253D&md5=f11415045ccf37238a5f2a1a59e00b05</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2014.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2014.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DKanagasabai%26aufirst%3DR.%26aulast%3DNinh%26aufirst%3DT.%2BN.%26aulast%3DTu%26aufirst%3DV.%2BT.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DYalowich%26aufirst%3DJ.%2BC.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26atitle%3DCytotoxic%2520and%2520natural%2520killer%2520cell%2520stimulatory%2520constituents%2520of%2520Phyllanthus%2520songboiensis%26jtitle%3DPhytochemistry%26date%3D2015%26volume%3D111%26spage%3D132%26epage%3D140%26doi%3D10.1016%2Fj.phytochem.2014.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref263"><div class="reference"><strong class="refLabel"><a href="#ref263" class="rightTabRefNumLink">263</a></strong><div class="NLM_citation" id="rightTab-cit263"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chama, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziwornu, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otchere, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span> <span> </span><span class="NLM_article-title">Isolation, characterization, and anthelminthic activities of a novel dichapetalin and other constituents of <i>Dichapetalum filicaule</i></span>. <i>Pharm. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1188</span>, <span class="refDoi"> DOI: 10.3109/13880209.2015.1059861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3109%2F13880209.2015.1059861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26118692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref263/cit263&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVynu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=1179-1188&author=M.+A.+Chamaauthor=G.+A.+Dziwornuauthor=R.+Waibelauthor=D.+Osei-Safoauthor=I.+Addae-Mensahauthor=J.+Otchereauthor=M.+Wilson&title=Isolation%2C+characterization%2C+and+anthelminthic+activities+of+a+novel+dichapetalin+and+other+constituents+of+Dichapetalum+filicaule&doi=10.3109%2F13880209.2015.1059861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit263R"><div class="casContent"><span class="casTitleNuber">263</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, characterization, and anthelminthic activities of a novel dichapetalin and other constituents of Dichapetalum filicaule</span></div><div class="casAuthors">Chama, Mary Anti; Dziwornu, Godwin Akpeko; Waibel, Reiner; Osei-Safo, Dorcas; Addae-Mensah, Ivan; Otchere, Joseph; Wilson, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Biology (Abingdon, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1179-1188</span>CODEN:
                <span class="NLM_cas:coden">PHBIFC</span>;
        ISSN:<span class="NLM_cas:issn">1388-0209</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Context: Dichapetalum filicaule Breteler (Dichapetalaceae) is a rare species occurring only in Cote d'Ivoire and Ghana.  Although research on several species of the genus has produced interesting bioactive compds., particularly the Dichapetalins, a novel class of triterpenoids with antineoplastic properties, there is virtually no information on the ethnobotanical uses and chem. constituents of D. filicaule.  Objective: The phytochem. and anthelminthic activities of the constituents of D. filicaule were investigated.  Materials and methods: Chem. constituents of the petroleum ether, chloroform-acetone, and methanol root exts. of D. filicaule were isolated by column chromatog. and characterized by their physico-chem. properties, 1-D and 2-D NMR spectroscopy and mass spectrometry.  In vitro anthelminthic activity of the exts. and compds. against the human hookworm, Necator americanus, Stiles 1902 (Nematoda: Ancylostomatidae) was detd. within a concn. range of 2500-250 μg/mL using the Egg Hatch Inhibition (EHI) Assay.  The hookworm species were identified using a published polymerase chain reaction (PCR) method.  Results: A new dichapetalin, dichapetalin X (), together with the known dichapetalin A (), pomolic acid (), glycerol monostearate (), D:A-friedooleanan-3β-ol (), and D:A-friedooleanan-3-one () were isolated.  Compds. , , and exhibited EHI with IC50 values of 523.2, 162.4, and 306.0 μg/mL, resp., against the hookworm.  The pos. control albendazole gave an IC50 value of 93.27 μg/mL.  Discussion and conclusion: This is the first report of the phytochem. investigation of D. filicaule.  The study has yielded a new dichapetalin and also demonstrated the potential anthelminthic properties of the constituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtqhqXMZK3H7Vg90H21EOLACvtfcHk0li62o6TiIYuKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVynu7fP&md5=bc03e95c4fd3a3f5b59629c2231f6afe</span></div><a href="/servlet/linkout?suffix=cit263&amp;dbid=16384&amp;doi=10.3109%2F13880209.2015.1059861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F13880209.2015.1059861%26sid%3Dliteratum%253Aachs%26aulast%3DChama%26aufirst%3DM.%2BA.%26aulast%3DDziwornu%26aufirst%3DG.%2BA.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DOsei-Safo%26aufirst%3DD.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DOtchere%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DM.%26atitle%3DIsolation%252C%2520characterization%252C%2520and%2520anthelminthic%2520activities%2520of%2520a%2520novel%2520dichapetalin%2520and%2520other%2520constituents%2520of%2520Dichapetalum%2520filicaule%26jtitle%3DPharm.%2520Biol.%26date%3D2016%26volume%3D54%26spage%3D1179%26epage%3D1188%26doi%3D10.3109%2F13880209.2015.1059861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref264"><div class="reference"><strong class="refLabel"><a href="#ref264" class="rightTabRefNumLink">264</a></strong><div class="NLM_citation" id="rightTab-cit264"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Safo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chama, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Addae-Mensah, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waibel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asomaning, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, I. V.</span></span> <span> </span><span class="NLM_article-title">Dichapetalin M from <i>Dichapetalum madagascariensis</i></span>. <i>Phytochem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/j.phytol.2008.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.phytol.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref264/cit264&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsF2qtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=147-150&author=D.+Osei-Safoauthor=M.+A.+Chamaauthor=I.+Addae-Mensahauthor=R.+Waibelauthor=W.+A.+Asomaningauthor=I.+V.+Oppong&title=Dichapetalin+M+from+Dichapetalum+madagascariensis&doi=10.1016%2Fj.phytol.2008.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit264R"><div class="casContent"><span class="casTitleNuber">264</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalin M from Dichapetalum madagascariensis</span></div><div class="casAuthors">Osei-Safo, Dorcas; Chama, Mary A.; Addae-Mensah, Ivan; Waibel, Reiner; Asomaning, William A.; Oppong, Isaac V.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">147-150</span>CODEN:
                <span class="NLM_cas:coden">PLHEBK</span>;
        ISSN:<span class="NLM_cas:issn">1874-3900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The roots of Dichapetalum madagascariensis have yielded the new dichapetalin M, together with the previously reported dichapetalin A.  This brings to nine, the total no. of dichapetalins so far isolated from the roots of the plant, and to thirteen, the total no. of dichapetalins isolated from the Dichapetalaceae.  Dichapetalin M exhibited greater toxicity towards brine shrimp larvae than dichapetalin A, which has demonstrated cell inhibition against various cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNHmg0oE-UTrVg90H21EOLACvtfcHk0li62o6TiIYuKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsF2qtL8%253D&md5=c4c1db359cd9080b9677963479200660</span></div><a href="/servlet/linkout?suffix=cit264&amp;dbid=16384&amp;doi=10.1016%2Fj.phytol.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytol.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Safo%26aufirst%3DD.%26aulast%3DChama%26aufirst%3DM.%2BA.%26aulast%3DAddae-Mensah%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAsomaning%26aufirst%3DW.%2BA.%26aulast%3DOppong%26aufirst%3DI.%2BV.%26atitle%3DDichapetalin%2520M%2520from%2520Dichapetalum%2520madagascariensis%26jtitle%3DPhytochem.%2520Lett.%26date%3D2008%26volume%3D1%26spage%3D147%26epage%3D150%26doi%3D10.1016%2Fj.phytol.2008.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref265"><div class="reference"><strong class="refLabel"><a href="#ref265" class="rightTabRefNumLink">265</a></strong><div class="NLM_citation" id="rightTab-cit265"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jing, S.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-H.</span></span> <span> </span><span class="NLM_article-title">Biologically active dichapetalins from <i>Dichapetalum gelonioides</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">882</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1021/np400971r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400971r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref265/cit265&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=882-893&author=S.-X.+Jingauthor=S.-H.+Luoauthor=C.-H.+Liauthor=J.+Huaauthor=Y.-L.+Wangauthor=X.-M.+Niuauthor=X.-N.+Liauthor=Y.+Liuauthor=C.-S.+Huangauthor=Y.+Wangauthor=S.-H.+Li&title=Biologically+active+dichapetalins+from+Dichapetalum+gelonioides&doi=10.1021%2Fnp400971r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit265R"><div class="casContent"><span class="casTitleNuber">265</span><div class="casTitle"><span class="NLM_cas:atitle">Biologically active dichapetalins from Dichapetalum gelonioides</span></div><div class="casAuthors">Jing, Shu-Xi; Luo, Shi-Hong; Li, Chun-Huan; Hua, Juan; Wang, Yan-Li; Niu, Xue-Mei; Li, Xiao-Nian; Liu, Yan; Huang, Chun-Shuai; Wang, Ying; Li, Sheng-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">882-893</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A phytochem. investigation of the toxic tropical plant Dichapetalum gelonioides led to the isolation and identification of 14 new dichapetalins (1-14) and the known dichapetalins A (15) and K (16).  The structures of the new compds. were detd. by analyses of their NMR, MS, electronic CD, and X-ray diffraction data.  The esterification at C-25 by 4-hydroxyphenylpropanoic acid and the hydroxylation at C-2' are unique in this unusual class of natural products.  In addn. to the known cytotoxicity, an array of biol. activities, including antifeedant, nematicidal, antifungal, and NO and AChE inhibitory activities, were obsd. for this class of compds.  These findings suggested that dichapetalin hybrid triterpenoids as a class have broad biol. active cellular functions, including defense against insect herbivores and pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojE8l1aJuPA7Vg90H21EOLACvtfcHk0liW1CaRpbNBwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjs1Gqtrw%253D&md5=32550cd0a89c4c2a5b10e33836833f6a</span></div><a href="/servlet/linkout?suffix=cit265&amp;dbid=16384&amp;doi=10.1021%2Fnp400971r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400971r%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DS.-X.%26aulast%3DLuo%26aufirst%3DS.-H.%26aulast%3DLi%26aufirst%3DC.-H.%26aulast%3DHua%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-L.%26aulast%3DNiu%26aufirst%3DX.-M.%26aulast%3DLi%26aufirst%3DX.-N.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DC.-S.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-H.%26atitle%3DBiologically%2520active%2520dichapetalins%2520from%2520Dichapetalum%2520gelonioides%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26spage%3D882%26epage%3D893%26doi%3D10.1021%2Fnp400971r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref266"><div class="reference"><strong class="refLabel"><a href="#ref266" class="rightTabRefNumLink">266</a></strong><div class="NLM_citation" id="rightTab-cit266"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuchinda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornsakulkarn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohmakotr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongsaeree, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabpai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoosook, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasisit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napaswad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sophasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reutrakul, V.</span></span> <span> </span><span class="NLM_article-title">Dichapetalin-type triterpenoids and lignans from the aerial parts of <i>Phyllanthus acutissima</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1021/np7007347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np7007347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref266/cit266&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitValsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=655-663&author=P.+Tuchindaauthor=J.+Kornsakulkarnauthor=M.+Pohmakotrauthor=P.+Kongsaereeauthor=S.+Prabpaiauthor=C.+Yoosookauthor=J.+Kasisitauthor=C.+Napaswadauthor=S.+Sophasanauthor=V.+Reutrakul&title=Dichapetalin-type+triterpenoids+and+lignans+from+the+aerial+parts+of+Phyllanthus+acutissima&doi=10.1021%2Fnp7007347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit266R"><div class="casContent"><span class="casTitleNuber">266</span><div class="casTitle"><span class="NLM_cas:atitle">Dichapetalin-Type Triterpenoids and Lignans from the Aerial Parts of Phyllanthus acutissima</span></div><div class="casAuthors">Tuchinda, Patoomratana; Kornsakulkarn, Jittra; Pohmakotr, Manat; Kongsaeree, Palangpon; Prabpai, Samran; Yoosook, Chalobon; Kasisit, Jitra; Napaswad, Chanita; Sophasan, Samaisukh; Reutrakul, Vichai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-663</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Chem. investigation of the aerial parts of Phyllanthus acutissima resulted in the isolation of five new dichapetalin-type triterpenoids, acutissimatriterpenes A(I)-E, and two new lignans, acutissimalignans A (II) and B, along with two known lignans and three known ellagic acid derivs.  The structures of 1-7 were detd. mainly on the basis of spectroscopic methods.  The compds. obtained were evaluated for cytotoxic and anti-HIV-1 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYzX18v_w1LVg90H21EOLACvtfcHk0liW1CaRpbNBwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitValsr4%253D&md5=f5a09a15d3c0afb8c035e7cda201f38f</span></div><a href="/servlet/linkout?suffix=cit266&amp;dbid=16384&amp;doi=10.1021%2Fnp7007347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp7007347%26sid%3Dliteratum%253Aachs%26aulast%3DTuchinda%26aufirst%3DP.%26aulast%3DKornsakulkarn%26aufirst%3DJ.%26aulast%3DPohmakotr%26aufirst%3DM.%26aulast%3DKongsaeree%26aufirst%3DP.%26aulast%3DPrabpai%26aufirst%3DS.%26aulast%3DYoosook%26aufirst%3DC.%26aulast%3DKasisit%26aufirst%3DJ.%26aulast%3DNapaswad%26aufirst%3DC.%26aulast%3DSophasan%26aufirst%3DS.%26aulast%3DReutrakul%26aufirst%3DV.%26atitle%3DDichapetalin-type%2520triterpenoids%2520and%2520lignans%2520from%2520the%2520aerial%2520parts%2520of%2520Phyllanthus%2520acutissima%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2008%26volume%3D71%26spage%3D655%26epage%3D663%26doi%3D10.1021%2Fnp7007347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref267"><div class="reference"><strong class="refLabel"><a href="#ref267" class="rightTabRefNumLink">267</a></strong><div class="NLM_citation" id="rightTab-cit267"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tundis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loizzo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menichini, F.</span></span> <span> </span><span class="NLM_article-title">An overview on chemical aspects and potential health benefits of limonoids and their derivatives</span>. <i>Crit. Rev. Food Sci. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1080/10408398.2011.581400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1080%2F10408398.2011.581400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24188270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref267/cit267&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslaitb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=225-250&author=R.+Tundisauthor=M.+R.+Loizzoauthor=F.+Menichini&title=An+overview+on+chemical+aspects+and+potential+health+benefits+of+limonoids+and+their+derivatives&doi=10.1080%2F10408398.2011.581400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit267R"><div class="casContent"><span class="casTitleNuber">267</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview on Chemical Aspects and Potential Health Benefits of Limonoids and Their Derivatives</span></div><div class="casAuthors">Tundis, Rosa; Loizzo, Monica Rosa; Menichini, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Food Science and Nutrition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-250</span>CODEN:
                <span class="NLM_cas:coden">CRFND6</span>;
        ISSN:<span class="NLM_cas:issn">1040-8398</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  Limonoids are heavily oxygenated, modified triterpenes dominant in Meliaceae and Rutaceae plant families.  The term limonoid' is derived from limonin, which was first identified as the bitter constituent of Citrus seeds in 1841.  This group of secondary metabolites exhibits a wide range of biol. properties, including anticancer, antibacterial, antifungal, antimalarial, and antiviral activities.  Significant progress on the role of limonoids as promising candidates for cancer chemoprevention and/or therapy has been achieved in particular in recent years.  The aim of this review article is to discuss the recent developments on limonoids chem. aspects and biol. activities with the relationship between structure and activity, supporting the new possibilities for the medicinal and/or nutraceutical use of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzFIz5DA-A37Vg90H21EOLACvtfcHk0liW1CaRpbNBwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslaitb%252FE&md5=418bea3e794c8a1b46303cd7536dc638</span></div><a href="/servlet/linkout?suffix=cit267&amp;dbid=16384&amp;doi=10.1080%2F10408398.2011.581400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408398.2011.581400%26sid%3Dliteratum%253Aachs%26aulast%3DTundis%26aufirst%3DR.%26aulast%3DLoizzo%26aufirst%3DM.%2BR.%26aulast%3DMenichini%26aufirst%3DF.%26atitle%3DAn%2520overview%2520on%2520chemical%2520aspects%2520and%2520potential%2520health%2520benefits%2520of%2520limonoids%2520and%2520their%2520derivatives%26jtitle%3DCrit.%2520Rev.%2520Food%2520Sci.%2520Nutr.%26date%3D2014%26volume%3D54%26spage%3D225%26epage%3D250%26doi%3D10.1080%2F10408398.2011.581400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref268"><div class="reference"><strong class="refLabel"><a href="#ref268" class="rightTabRefNumLink">268</a></strong><div class="NLM_citation" id="rightTab-cit268"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, M.</span></span> <span> </span><span class="NLM_article-title">Structure of limonin</span>. <i>Acta Crystallogr., Sect. C: Cryst. Struct. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>C46</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1107/S0108270189007225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270189007225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref268/cit268&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK3cXkslyksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C46&publication_year=1990&pages=425-427&author=K.+Takahashiauthor=M.+Obayashiauthor=M.+Nakatani&title=Structure+of+limonin&doi=10.1107%2FS0108270189007225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit268R"><div class="casContent"><span class="casTitleNuber">268</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of limonin</span></div><div class="casAuthors">Takahashi, K.; Obayashi, M.; Nakatani, M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C:  Crystal Structure Communications</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">C46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">425-7</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    </div><div class="casAbstract">The mol. structure of limonin, the bitter principle of citrus fruits, was detd. by x-ray diffraction methods.  The structure was essentially the same as epilimonol iodoacetate, the heavy-atom deriv. of limonin.  A structure energy calcn. (MMP2) for limonin yields the same structure as that of the x-ray anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuhmlnCcjZGrVg90H21EOLACvtfcHk0lg0EzrJpohl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslyksLc%253D&md5=39fb184a82a79c13d201b983268d8670</span></div><a href="/servlet/linkout?suffix=cit268&amp;dbid=16384&amp;doi=10.1107%2FS0108270189007225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270189007225%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DObayashi%26aufirst%3DM.%26aulast%3DNakatani%26aufirst%3DM.%26atitle%3DStructure%2520of%2520limonin%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Cryst.%2520Struct.%2520Commun.%26date%3D1990%26volume%3DC46%26spage%3D425%26epage%3D427%26doi%3D10.1107%2FS0108270189007225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref269"><div class="reference"><strong class="refLabel"><a href="#ref269" class="rightTabRefNumLink">269</a></strong><div class="NLM_citation" id="rightTab-cit269"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, D. G.</span></span> <span> </span><span class="NLM_article-title">The structure of limonin: X-ray analysis of epilimonol iodoacetate</span>. <i>J. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_fpage">4183</span>– <span class="NLM_lpage">4200</span>, <span class="refDoi"> DOI: 10.1039/jr9610004183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fjr9610004183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref269/cit269&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF38XisV2rug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1961&pages=4183-4200&author=S.+Arnottauthor=A.+W.+Davieauthor=J.+M.+Robertsonauthor=G.+A.+Simauthor=D.+G.+Watson&title=The+structure+of+limonin%3A+X-ray+analysis+of+epilimonol+iodoacetate&doi=10.1039%2Fjr9610004183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit269R"><div class="casContent"><span class="casTitleNuber">269</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of limonin. X-ray analysis of epilimonol iodoacetate</span></div><div class="casAuthors">Arnott, S.; Davie, A. W.; Robertson, J. Monteath; Sim, G. A.; Watson, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4183-200</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">The structure of limonin (I) was detd. from study of the title deriv., whose crystals were monoclinic, space group C22-P21, with 4 mols./unit cell.  The asym. crystal unit had 2 mols.  Full 3-dimensional analysis gave the structure of I as shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolsoxl-t0kErVg90H21EOLACvtfcHk0lg0EzrJpohl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38XisV2rug%253D%253D&md5=306db50c219d92a0d4f92c2ae7c26af9</span></div><a href="/servlet/linkout?suffix=cit269&amp;dbid=16384&amp;doi=10.1039%2Fjr9610004183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9610004183%26sid%3Dliteratum%253Aachs%26aulast%3DArnott%26aufirst%3DS.%26aulast%3DDavie%26aufirst%3DA.%2BW.%26aulast%3DRobertson%26aufirst%3DJ.%2BM.%26aulast%3DSim%26aufirst%3DG.%2BA.%26aulast%3DWatson%26aufirst%3DD.%2BG.%26atitle%3DThe%2520structure%2520of%2520limonin%253A%2520X-ray%2520analysis%2520of%2520epilimonol%2520iodoacetate%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1961%26spage%3D4183%26epage%3D4200%26doi%3D10.1039%2Fjr9610004183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref270"><div class="reference"><strong class="refLabel"><a href="#ref270" class="rightTabRefNumLink">270</a></strong><div class="NLM_citation" id="rightTab-cit270"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emerson, O. H.</span></span> <span> </span><span class="NLM_article-title">The bitter principles of citrus fruit. I. Isolation of nomilin, a new bitter principle from the seeds of oranges and lemons</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1948</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1021/ja01182a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01182a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref270/cit270&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaH1cXhsVenug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1948&pages=545-549&author=O.+H.+Emerson&title=The+bitter+principles+of+citrus+fruit.+I.+Isolation+of+nomilin%2C+a+new+bitter+principle+from+the+seeds+of+oranges+and+lemons&doi=10.1021%2Fja01182a034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit270R"><div class="casContent"><span class="casTitleNuber">270</span><div class="casTitle"><span class="NLM_cas:atitle">Bitter principles in citrus fruit. I. Isolation of nomilin, a new bitter principle from the seeds of oranges and lemons</span></div><div class="casAuthors">Emerson, Oliver H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1948</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Immature navel oranges (140 lb.) yielded 5 gallons of juice from which 1.58 g. limonin (I) was isolated.  I forms a complex with 1 mol. CH2Cl2, which is lost in the air.  Valencia orange seeds (22 lb.) yield 40 g. I.  The CH2Cl2EtOH mother liquors from I give a mixt. of I and nomilin (II), C28H34O9, from which iso-PrOH exts. II, m. 278-9° (decompn.), [α]D23 -95.7° (298.9 mg. in 25 ml. Me2CO); the yield from 37 lb. orange seeds is 14 g.  I and II can be isolated also from lemon seed.  II contains 1 OH group that reacts with MeMgI but not readily with Ac2O.  II (237 mg.) and 40 ml. 0.1 N NaOH, heated 30 min. on the steam bath, give 88% nomilic acid (III), C26H32O8, m. 208-9°; AcOH is also formed.  In contrast to I, II does not yield appreciable quantities of Me2CO on fusion with KOH.  I and NH2OH yield an oxime, m. 260-70° (decompn.); the product from II could not be crystd.  The absorption spectra of I, II, and III in EtOH are given.  The intensification of the absorption and the shift toward the visible suggest a greater degree of conjugation in III than exists in I or II.  The absorption spectra of I and II are very similar.  The alc. mother liquor of I from 22 lb. of orange seeds yields 500 mg. of a compd. (C9H12O4)x(?), m. 315° (decompn.).  The nonbitter precursor of I in navel orange juice behaves like the diacid obtained by opening both lactone rings but it is possible that the precursor may be a lactone acid or a compd. of the diacid or lactone acid such as a glycoside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2I97uJbp6bVg90H21EOLACvtfcHk0lg0EzrJpohl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH1cXhsVenug%253D%253D&md5=530146f6724d78d9322daaaa8e3b9714</span></div><a href="/servlet/linkout?suffix=cit270&amp;dbid=16384&amp;doi=10.1021%2Fja01182a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01182a034%26sid%3Dliteratum%253Aachs%26aulast%3DEmerson%26aufirst%3DO.%2BH.%26atitle%3DThe%2520bitter%2520principles%2520of%2520citrus%2520fruit.%2520I.%2520Isolation%2520of%2520nomilin%252C%2520a%2520new%2520bitter%2520principle%2520from%2520the%2520seeds%2520of%2520oranges%2520and%2520lemons%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1948%26volume%3D70%26spage%3D545%26epage%3D549%26doi%3D10.1021%2Fja01182a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref271"><div class="reference"><strong class="refLabel"><a href="#ref271" class="rightTabRefNumLink">271</a></strong><div class="NLM_citation" id="rightTab-cit271"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, H. L.</span></span> <span> </span><span class="NLM_article-title">The identity of obaculactone, evodin and dictamnolactone with limonin</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1940</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1307</span>– <span class="NLM_lpage">1309</span>, <span class="refDoi"> DOI: 10.1021/ja01862a509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01862a509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref271/cit271&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaH3cXktFWqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1940&pages=1307-1309&author=M.+S.+Schechterauthor=H.+L.+Haller&title=The+identity+of+obaculactone%2C+evodin+and+dictamnolactone+with+limonin&doi=10.1021%2Fja01862a509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit271R"><div class="casContent"><span class="casTitleNuber">271</span><div class="casTitle"><span class="NLM_cas:atitle">Identity of obaculactone, evodin and dictamnolactone with limonin</span></div><div class="casAuthors">Schechter, Milton S.; Haller, H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1940</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1307-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Obaculactone (C. A. 25, 4870), evodin (J. Pharm. Soc. Japan No. 248, 979(1902)), dictamnolactone (C. A. 17, 2583), limonin and citrolimonin (C. A. 30, 5586.5) are the same compd., for which the name limonin is proposed, since it was given this name by Bernay (Ann. 40, 317(1841)).  Values for nα and nγ 1.563 and 1.582; nβ is indeterminate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXMegGGRgTJbVg90H21EOLACvtfcHk0lg0EzrJpohl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaH3cXktFWqsQ%253D%253D&md5=196793d7285f0484f6afc471bc617c4a</span></div><a href="/servlet/linkout?suffix=cit271&amp;dbid=16384&amp;doi=10.1021%2Fja01862a509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01862a509%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DM.%2BS.%26aulast%3DHaller%26aufirst%3DH.%2BL.%26atitle%3DThe%2520identity%2520of%2520obaculactone%252C%2520evodin%2520and%2520dictamnolactone%2520with%2520limonin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1940%26volume%3D62%26spage%3D1307%26epage%3D1309%26doi%3D10.1021%2Fja01862a509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref272"><div class="reference"><strong class="refLabel"><a href="#ref272" class="rightTabRefNumLink">272</a></strong><div class="NLM_citation" id="rightTab-cit272"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells</span>. <i>Food Funct.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1039/C2FO30209H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC2FO30209H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23117440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref272/cit272&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=258-265&author=J.+Kimauthor=G.+K.+Jayaprakashaauthor=B.+S.+Patil&title=Limonoids+and+their+anti-proliferative+and+anti-aromatase+properties+in+human+breast+cancer+cells&doi=10.1039%2FC2FO30209H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit272R"><div class="casContent"><span class="casTitleNuber">272</span><div class="casTitle"><span class="NLM_cas:atitle">Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells</span></div><div class="casAuthors">Kim, Jinhee; Jayaprakasha, Guddadarangavvanahally K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Food & Function</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">258-265</span>CODEN:
                <span class="NLM_cas:coden">FFOUAI</span>;
        ISSN:<span class="NLM_cas:issn">2042-6496</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Lemons are a widely used citrus crop and have shown several potential health benefits.  In the present study, the mechanism and effectiveness of the anti-cancer and anti-aromatase properties of limonoids were investigated for the first time.  Defatted lemon (Citrus lemon L. Burm) seed powder was extd. with Et acetate (EtOAc) and methanol (MeOH) for 16 h each, successively.  These exts. were fractionated using 1D (silica) and 2D (ion exchange and SP-70 columns) column chromatog. to obtain nine limonoids.  The compds. were identified by TLC, HPLC, and LC-MS techniques.  A panel of 9 purified limonoids, including limonin, nomilin, obacunone, limonexic acid (LNA), isolimonexic acid (ILNA), nomilinic acid glucoside (NAG), deacetyl nomilinic acid glucoside (DNAG), limonin glucoside (LG) and obacunone glucoside (OG) as well as 4 modified compds. such as limonin methoxime (LM), limonin oxime (LO), defuran limonin (DL), and defuran nomilin (DN), were screened for their cytotoxicity on estrogen receptor (ER)-pos. (MCF-7) or ER-neg. (MDA-MB-231) human breast cancer cells.  We further tested the mechanism of the anti-proliferative activity of limonoids using an in vitro aromatase enzyme assay and western blot with anti-caspase-7.  Among the tested limonoids, 11 limonoids exhibited cytotoxicity on MCF-7 whereas 8 limonoids showed cytotoxicity against the MDA-MB-231 cell lines.  Although most of the limonoids showed anti-aromatase activity, the inhibition of proliferation was not related to the anti-aromatase activity.  On the other hand, the anti-proliferative activity was significantly correlated with caspase-7 activation by limonoids.  Our findings indicated that the citrus limonoids may have potential for the prevention of estrogen-responsive breast cancer (MCF-7) via caspase-7 dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjjTcA3X49u7Vg90H21EOLACvtfcHk0lhzqt_DgmAWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCitLY%253D&md5=eb49eab14311108ca08a7620cf081cdc</span></div><a href="/servlet/linkout?suffix=cit272&amp;dbid=16384&amp;doi=10.1039%2FC2FO30209H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2FO30209H%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DLimonoids%2520and%2520their%2520anti-proliferative%2520and%2520anti-aromatase%2520properties%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DFood%2520Funct.%26date%3D2013%26volume%3D4%26spage%3D258%26epage%3D265%26doi%3D10.1039%2FC2FO30209H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref273"><div class="reference"><strong class="refLabel"><a href="#ref273" class="rightTabRefNumLink">273</a></strong><div class="NLM_citation" id="rightTab-cit273"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span> <span> </span><span class="NLM_article-title">Limonin: A review of its pharmacology, toxicity, and pharmacokinetics</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3679</span>, <span class="refDoi"> DOI: 10.3390/molecules24203679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3390%2Fmolecules24203679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref273/cit273&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1yisb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=3679&author=S.+Fanauthor=C.+Zhangauthor=T.+Luoauthor=J.+Wangauthor=Y.+Tangauthor=Z.+Chenauthor=L.+Yu&title=Limonin%3A+A+review+of+its+pharmacology%2C+toxicity%2C+and+pharmacokinetics&doi=10.3390%2Fmolecules24203679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit273R"><div class="casContent"><span class="casTitleNuber">273</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin: a review of its pharmacology, toxicity, and pharmacokinetics</span></div><div class="casAuthors">Fan, Shunming; Zhang, Chunling; Luo, Ting; Wang, Jiaqi; Tang, Yu; Chen, Zhimin; Yu, Lingying</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3679</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Limonin is a natural tetracyclic triterpenoid compd., which widely exists in Euodia rutaecarpa (Juss.) Benth., Phellodendron chinense Schneid., and Coptis chinensis Franch.  Its extensive pharmacol. effects have attracted considerable attention in recent years.  However, there is no systematic review focusing on the pharmacol., toxicity, and pharmacokinetics of limonin.  Therefore, this review aimed to provide the latest information on the pharmacol., toxicity, and pharmacokinetics of limonin, exploring the therapeutic potential of this compd. and looking for ways to improve efficacy and bioavailability.  Limonin has a wide spectrum of pharmacol. effects, including anti-cancer, anti-inflammatory and analgesic, anti-bacterial and anti-virus, anti-oxidn., liver protection properties.  However, limonin has also been shown to lead to hepatotoxicity, renal toxicity, and genetic damage.  Moreover, limonin also has complex impacts on hepatic metabolic enzyme.  Pharmacokinetic studies have demonstrated that limonin has poor bioavailability, and the redn., hydrolysis, and methylation are the main metabolic pathways of limonin.  We also found that the position and group of the substituents of limonin are key in affecting pharmacol. activity and bioavailability.  However, some issues still exist, such as the mechanism of antioxidant activity of limonin not being clear.  In addn., there are few studies on the toxicity mechanism of limonin, and the effects of limonin concn. on pharmacol. effects and toxicity are not clear, and no researchers have reported any ways in which to reduce the toxicity of limonin.  Therefore, future research directions include the mechanism of antioxidant activity of limonin, how the concn. of limonin affects pharmacol. effects and toxicity, finding ways to reduce the toxicity of limonin, and structural modification of limonin-one of the key methods necessary to enhance pharmacol. activity and bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxkWT-IgwobVg90H21EOLACvtfcHk0lhzqt_DgmAWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1yisb7F&md5=ec2dfffc3c877217118416c991fa7729</span></div><a href="/servlet/linkout?suffix=cit273&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24203679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24203679%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26atitle%3DLimonin%253A%2520A%2520review%2520of%2520its%2520pharmacology%252C%2520toxicity%252C%2520and%2520pharmacokinetics%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D3679%26doi%3D10.3390%2Fmolecules24203679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref274"><div class="reference"><strong class="refLabel"><a href="#ref274" class="rightTabRefNumLink">274</a></strong><div class="NLM_citation" id="rightTab-cit274"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guthrie, N.</span>; <span class="NLM_string-name">Morley, K.</span>; <span class="NLM_string-name">Hasegawa, S.</span>; <span class="NLM_string-name">Manners, G. D.</span>; <span class="NLM_string-name">Vandenberg, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Human Breast Cancer Cells by Citrus Limonoids</span>. In  <i>Citrus Limonoids: Functional Chemicals in Agriculture and Food</i>; ACS Symposium Series  <span class="NLM_volume">758</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berhow, M. A.</span>, <span class="NLM_string-name">Hasegawa, S.</span>, <span class="NLM_string-name">Manners, G. D.</span></span>, Eds.; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2000</span>; pp  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=164-174&author=N.+Guthrie&author=K.+Morley&author=S.+Hasegawa&author=G.+D.+Manners&author=T.+Vandenbergauthor=M.+A.+Berhow&author=S.+Hasegawa&author=G.+D.+Manners&title=Inhibition+of+Human+Breast+Cancer+Cells+by+Citrus+Limonoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit274&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGuthrie%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520Human%2520Breast%2520Cancer%2520Cells%2520by%2520Citrus%2520Limonoids%26jtitle%3DCitrus%2520Limonoids%253A%2520Functional%2520Chemicals%2520in%2520Agriculture%2520and%2520Food%26volume%3D758%26aulast%3DBerhow%26aufirst%3DM.%2BA.%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2000%26spage%3D164%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref275"><div class="reference"><strong class="refLabel"><a href="#ref275" class="rightTabRefNumLink">275</a></strong><div class="NLM_citation" id="rightTab-cit275"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patil, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, K. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chetti, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Characterization of <i>Citrus aurantifolia</i> bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis</span>. <i>Microchem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.microc.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.microc.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref275/cit275&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCktLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=108-117&author=J.+R.+Patilauthor=G.+K.+Jayaprakashaauthor=K.+N.+C.+Murthyauthor=M.+B.+Chettiauthor=B.+S.+Patil&title=Characterization+of+Citrus+aurantifolia+bioactive+compounds+and+their+inhibition+of+human+pancreatic+cancer+cells+through+apoptosis&doi=10.1016%2Fj.microc.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit275R"><div class="casContent"><span class="casTitleNuber">275</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Citrus aurantifolia bioactive compounds and their inhibition of human pancreatic cancer cells through apoptosis</span></div><div class="casAuthors">Patil, Jaiprakash R.; Jayaprakasha, G. K.; Murthy, K. N. Chidambara; Chetti, Mahadev B.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Microchemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">108-117</span>CODEN:
                <span class="NLM_cas:coden">MICJAN</span>;
        ISSN:<span class="NLM_cas:issn">0026-265X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the current study, we have isolated and purified 5 putative compds. from lime (Citrus aurantifolia Swingle) seeds using Soxhlet extn. and chromatog. sepn.  The purity and structures of the isolated compds. were identified by TLC, HPLC, and mass spectra as limonin, limonexic acid (LNA), isolimonexic acid (ILNA), β-sitosterol glucoside (SG), and limonin glucoside (LG).  These putative compds. exhibited significant inhibition of Panc-28 cells with IC50 values in the range of 18-42 μM in MTT assay after incubation for 72 h, which was confirmed by viable cell count.  Further, induction of apoptosis was confirmed through annexin-FITC staining of the cells and expression of apoptosis related proteins was also studied to understand the mechanism.  Expression of apoptosis related protein showed apoptosis through induction of p53 by, p21 dependent manner and cytochrome-c mediated caspases driven intrinsic pathway.  Expression of apoptosis favoring proteins in cells treated with isolated compds. were in the order of ILNA > LNA > SG > Limonin > LG based on the expression ratio of bax/bcl2.  These results were further supported through fluorescent probed microscopic images.  To the best of our knowledge, this is the 1st report on isolation and identification of LNA, SG, and LG from lime and their mechanism of inhibition of human pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiA-V2fXOIr7Vg90H21EOLACvtfcHk0lhzqt_DgmAWNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCktLnP&md5=ec485f65e52b4a45fa026ef0e0d97186</span></div><a href="/servlet/linkout?suffix=cit275&amp;dbid=16384&amp;doi=10.1016%2Fj.microc.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.microc.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DJ.%2BR.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DMurthy%26aufirst%3DK.%2BN.%2BC.%26aulast%3DChetti%26aufirst%3DM.%2BB.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DCharacterization%2520of%2520Citrus%2520aurantifolia%2520bioactive%2520compounds%2520and%2520their%2520inhibition%2520of%2520human%2520pancreatic%2520cancer%2520cells%2520through%2520apoptosis%26jtitle%3DMicrochem.%2520J.%26date%3D2010%26volume%3D94%26spage%3D108%26epage%3D117%26doi%3D10.1016%2Fj.microc.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref276"><div class="reference"><strong class="refLabel"><a href="#ref276" class="rightTabRefNumLink">276</a></strong><div class="NLM_citation" id="rightTab-cit276"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, D. H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herald, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, J. D.</span></span> <span> </span><span class="NLM_article-title">Evaluation of limonoids against the murine P-388 lymphocytic leukemia cell line</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1021/np50027a015</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50027a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref276/cit276&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaL3sXkvFyrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1983&pages=379-390&author=G.+R.+Pettitauthor=D.+H.+R.+Bartonauthor=C.+L.+Heraldauthor=J.+Polonskyauthor=J.+M.+Schmidtauthor=J.+D.+Connolly&title=Evaluation+of+limonoids+against+the+murine+P-388+lymphocytic+leukemia+cell+line&doi=10.1021%2Fnp50027a015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit276R"><div class="casContent"><span class="casTitleNuber">276</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of limonoids against the murine P388 lymphocytic leukemia cell line</span></div><div class="casAuthors">Pettit, George R.; Barton, Derek H. R.; Herald, Cherry L.; Polonsky, Judith; Schmidt, Jean M.; Connolly, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-90</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">A structure/activity study of selected limonoids from 2 plant families (Meliaceae and Rutaceae) of the Rutales order against the murine P-388 lymphocytic leukemia system (PS system) was undertaken.  The presence of both a 19→28 lactol and a 14, 15β-epoxide group was important for pronounced inhibition of the PS in vitro cell line.  Substitution of an A-ring α,B-unsatd. ketone (3-oxo-1-ene) for the lactol led to diminished activity, while redn. of the olefin caused complete loss of activity.  At the dose levels employed, even very good PS in vitro inhibition was not translated into PS in vivo antineoplastic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6E5sfhoDp9LVg90H21EOLACvtfcHk0lgqyYTSiNFCNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXkvFyrsrk%253D&md5=657e7f6f124cf03ef97f44df3d6c1a02</span></div><a href="/servlet/linkout?suffix=cit276&amp;dbid=16384&amp;doi=10.1021%2Fnp50027a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50027a015%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DBarton%26aufirst%3DD.%2BH.%2BR.%26aulast%3DHerald%26aufirst%3DC.%2BL.%26aulast%3DPolonsky%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26aulast%3DConnolly%26aufirst%3DJ.%2BD.%26atitle%3DEvaluation%2520of%2520limonoids%2520against%2520the%2520murine%2520P-388%2520lymphocytic%2520leukemia%2520cell%2520line%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1983%26volume%3D46%26spage%3D379%26epage%3D390%26doi%3D10.1021%2Fnp50027a015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref277"><div class="reference"><strong class="refLabel"><a href="#ref277" class="rightTabRefNumLink">277</a></strong><div class="NLM_citation" id="rightTab-cit277"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span> <span> </span><span class="NLM_article-title">By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3793</span>– <span class="NLM_lpage">3802</span>, <span class="refDoi"> DOI: 10.2147/OTT.S165220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2147%2FOTT.S165220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30013360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref277/cit277&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FoslWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=3793-3802&author=J.+Yaoauthor=J.+Liuauthor=W.+Zhao&title=By+blocking+hexokinase-2+phosphorylation%2C+limonin+suppresses+tumor+glycolysis+and+induces+cell+apoptosis+in+hepatocellular+carcinoma&doi=10.2147%2FOTT.S165220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit277R"><div class="casContent"><span class="casTitleNuber">277</span><div class="casTitle"><span class="NLM_cas:atitle">By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</span></div><div class="casAuthors">Yao Junliang; Liu Jingtian; Zhao Wensheng</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3793-3803</span>
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    </div><div class="casAbstract">Introduction:  The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC).  Methods:  Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro.  The glucose consumption and lactate production after limonin treatment was determined.  The effect of limonin on hexokinase-2 (HK-2) activity was assessed and the mitochondrial location of HK-2 was studied by immunoprecipitation.  Cell apoptosis and protein expression were detected by flow cytometry and western blotting respectively.  Protein overexpression by plasmid transfection was adopted to investigate the molecular mechanisms.  Results:  HCC proliferation and colony formation were inhibited by limonin in vitro.  With the suppression of HK-2 activity, the glycolytic level in HCC cells was substantially reduced, which was evidenced by the decrease of glucose consumption and lactate production.  The phosphorylation of HK-2 was substantially inhibited by limonin, which resulted in the disassociation of HK-2 from mitochondria.  Due to the reduction of HK-2 in mitochondria, increasing Bax were shifted to the mitochondria and gave rise to the release of cytochrome C, which induced HCC cells to subject to mitochondria-mediated apoptosis.  Mechanism investigations revealed that the decrease of HK-2 phosphorylation was mainly due to the inhibition of Akt activity.  In Akt exogenously overexpressed HCC cells, limonin-mediated cell proliferation inhibition, glycolysis suppression and apoptosis induction were significantly impaired.  Conclusion:  Limonin inhibited the tumor glycolysis in hepatocellular carcinoma by suppressing HK-2 activity, and the suppression of HK-2 was closely related to the decrease of Akt activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6y4MGPcVf7VVwdslNBF-tfW6udTcc2eZdjbWjAdq-4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FoslWqtg%253D%253D&md5=e92b4a93567ff6f743576fa48b58806d</span></div><a href="/servlet/linkout?suffix=cit277&amp;dbid=16384&amp;doi=10.2147%2FOTT.S165220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S165220%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DW.%26atitle%3DBy%2520blocking%2520hexokinase-2%2520phosphorylation%252C%2520limonin%2520suppresses%2520tumor%2520glycolysis%2520and%2520induces%2520cell%2520apoptosis%2520in%2520hepatocellular%2520carcinoma%26jtitle%3DOncoTargets%2520Ther.%26date%3D2018%26volume%3D11%26spage%3D3793%26epage%3D3802%26doi%3D10.2147%2FOTT.S165220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref278"><div class="reference"><strong class="refLabel"><a href="#ref278" class="rightTabRefNumLink">278</a></strong><div class="NLM_citation" id="rightTab-cit278"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span> <span> </span><span class="NLM_article-title">Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">108699</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.108699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.108699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30970511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref278/cit278&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFWgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2019&pages=108699&author=Z.+Suauthor=C.+Wangauthor=D.+Changauthor=X.+Zhuauthor=C.+Saiauthor=J.+Pei&title=Limonin+attenuates+the+stemness+of+breast+cancer+cells+via+suppressing+MIR216A+methylation&doi=10.1016%2Fj.biopha.2019.108699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit278R"><div class="casContent"><span class="casTitleNuber">278</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation</span></div><div class="casAuthors">Su, Zhou; Wang, Caihong; Chang, Deyu; Zhu, Xiuna; Sai, Chunmei; Pei, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108699</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Limonin has been shown to exert anti-inflammatory effects, however, its roles in tumor progression remain unclear.  This work aims to investigate the roles and related mechanism of limonin in the stemness of breast cancer cells.  Here, we found that limonin attenuated the stemness of breast cancer cells in a concn.-dependent manner, evident by the decreasing the capacity of cell spheroid formation, expression of stemness markers and ALDH1 activity, whereas had no toxicity on non-tumorigenic cells.  Addnl., limonin enhanced adriamycin sensitivity of breast cancer cells and attenuated adriamycin resistance in adriamycin-resistant breast cancer cells.  Mechanistically, limonin decreased MIR216A methylation level and thus increased miR-216a-3p expression.  Furthermore, miR-216a-3p could directly bind to WNT3A and thus inactivated Wnt/β-catenin pathway.  Therefore, our results indicate that limonin could attenuate the stemness and chemoresistance via inhibiting MIR216A methylation and subsequently suppressing Wnt/β-catenin pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCKFNkwHXX1LVg90H21EOLACvtfcHk0lg_IVoNBt1Fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFWgtbk%253D&md5=17ea86d396399bd0b7a3e37858906079</span></div><a href="/servlet/linkout?suffix=cit278&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.108699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.108699%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSai%26aufirst%3DC.%26aulast%3DPei%26aufirst%3DJ.%26atitle%3DLimonin%2520attenuates%2520the%2520stemness%2520of%2520breast%2520cancer%2520cells%2520via%2520suppressing%2520MIR216A%2520methylation%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D112%26spage%3D108699%26doi%3D10.1016%2Fj.biopha.2019.108699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref279"><div class="reference"><strong class="refLabel"><a href="#ref279" class="rightTabRefNumLink">279</a></strong><div class="NLM_citation" id="rightTab-cit279"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, W.</span></span> <span> </span><span class="NLM_article-title">Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2019.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fct.2019.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30738134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref279/cit279&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFOru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2019&pages=621-628&author=W.+Zhaoauthor=M.+Wuauthor=L.+Cuiauthor=W.+Du&title=Limonin+attenuates+the+stemness+of+cervical+carcinoma+cells+by+promoting+YAP+nuclear-cytoplasmic+translocation&doi=10.1016%2Fj.fct.2019.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit279R"><div class="casContent"><span class="casTitleNuber">279</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation</span></div><div class="casAuthors">Zhao, Wei; Wu, Mingyuan; Cui, Lijuan; Du, Wenxia</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This work aimed to investigate the role and related mechanism of limonin in regulating the stemness of cervical carcinoma (CC) cells.  In the present study, we constructed adriamycin-resistant CC cells and found that they exhibited greater stemness than parental cells.  Addnl., limonin attenuated the stemness of CC cells that were resistant or sensitive to adriamycin, as evidenced by the decreases in spheroid formation capacity, stemness markers expression and ALDH1 activity, whereas limonin did not affect the viability of normal cervical epithelial cells.  Furthermore, limonin enhanced adriamycin sensitivity and attenuated adriamycin resistance in CC cells.  Mechanistically, the nuclear-cytoplasmic translocation of YAP, not TAZ, was promoted by limonin in CC cells.  Addnl., YAP overexpression attenuated the inhibitory effects of limonin on CC cell stemness.  Therefore, limonin can attenuate the stemness, and thus the chemoresistance, of CC cells by promoting the nuclear-cytoplasmic translocation of YAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq91ca_57X1-7Vg90H21EOLACvtfcHk0lj7R_9iV4L0NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFOru7Y%253D&md5=651327ba5f10b78e74353b56ba37f87a</span></div><a href="/servlet/linkout?suffix=cit279&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2019.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2019.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DW.%26atitle%3DLimonin%2520attenuates%2520the%2520stemness%2520of%2520cervical%2520carcinoma%2520cells%2520by%2520promoting%2520YAP%2520nuclear-cytoplasmic%2520translocation%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2019%26volume%3D125%26spage%3D621%26epage%3D628%26doi%3D10.1016%2Fj.fct.2019.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref280"><div class="reference"><strong class="refLabel"><a href="#ref280" class="rightTabRefNumLink">280</a></strong><div class="NLM_citation" id="rightTab-cit280"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">109051</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31177062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref280/cit280&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1SqtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2019&pages=109051&author=Z.+Tangauthor=Y.+Tangauthor=L.+Liauthor=T.+Liuauthor=J.+Yang&title=Limonin+provokes+hepatocellular+carcinoma+cells+with+stemness+entry+into+cycle+via+activating+PI3K%2FAkt+signaling&doi=10.1016%2Fj.biopha.2019.109051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit280R"><div class="casContent"><span class="casTitleNuber">280</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling</span></div><div class="casAuthors">Tang, Zhenyong; Tang, Yuntian; Li, Lei; Liu, Tianqi; Yang, Jianrong</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109051</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The inhibitory roles of limonin have been revealed in various tumors.  However, the roles and related mechanism of limonin in hepatocellular carcinoma (HCC) progression are still confused.  Here, we collected non-adherent spheroids formed by HCC cells and found that the proportion of spheroids in G0 phase was remarkably higher than that in HCC cells.  Addnl., limonin increased EdU incorporation without affecting apoptosis in spheroids.  Notably, upon limonin treatment, the proportion of spheroids in G0 was decreased and S/G2/M increased.  Furthermore, we found that limonin attenuated the stemness of HCC cells, characterized as the decreased ALDH1 activity, stemness marker expression and spheroid formation ability.  Moreover, an integrated transcriptional anal. based on RNA-sequencing data was employed to gain mechanistic insight into limonin functioning, and we found that the most significant pathways identified centered on PI3K/Akt signaling. qRT-PCR and western blot obtained the consistent results.  Overall, these data suggest that limonin attenuates the stemness of HCC cells by reducing cellular quiescence through activating PI3K/Akt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfK9UGoHNBWLVg90H21EOLACvtfcHk0lj7R_9iV4L0NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1SqtbrE&md5=12441cab1a60bbeaa6a13fd3867dffbf</span></div><a href="/servlet/linkout?suffix=cit280&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109051%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DLimonin%2520provokes%2520hepatocellular%2520carcinoma%2520cells%2520with%2520stemness%2520entry%2520into%2520cycle%2520via%2520activating%2520PI3K%252FAkt%2520signaling%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D117%26spage%3D109051%26doi%3D10.1016%2Fj.biopha.2019.109051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref281"><div class="reference"><strong class="refLabel"><a href="#ref281" class="rightTabRefNumLink">281</a></strong><div class="NLM_citation" id="rightTab-cit281"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, J.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span> <span> </span><span class="NLM_article-title">Limonin enhances the radiosensitivity of nasopharyngeal carcinoma cells via attenuating STAT3-induced cell stemness</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">109366</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2019.109366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biopha.2019.109366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31545261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref281/cit281&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1CntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2019&pages=109366&author=L.+Gaoauthor=J.-Z.+Sangauthor=H.+Cao&title=Limonin+enhances+the+radiosensitivity+of+nasopharyngeal+carcinoma+cells+via+attenuating+STAT3-induced+cell+stemness&doi=10.1016%2Fj.biopha.2019.109366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit281R"><div class="casContent"><span class="casTitleNuber">281</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin enhances the radiosensitivity of nasopharyngeal carcinoma cells via attenuating Stat3-induced cell stemness</span></div><div class="casAuthors">Gao, Ling; Sang, Jian-zhong; Cao, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109366</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The inhibitory effects of limonin have been disclosed in various tumors, however, its roles in nasopharyngeal carcinoma (NPC) progression are never been revealed.  In the current work, we collected NPC cells with a higher stemness compared with bulk cells through isolating the side population (SP) cells.  It was found that limonin exhibited a stronger inhibitory effect on SP cells than that in bulk cells, which was evident by a lower IC50 value.  Addnl., limonin attenuated the stemness and migration ability of SP cells with the higher stemness, characterized as decreasing the spheroid formation ability, expression of stemness markers and migration ability.  Moreover, the proportion of SP cells in G0 phase was remarkably higher than that in bulk cells.  Notably, upon limonin treatment, the proportion of SP cells in G0 was decreased and S/G2/M increased.  Furthermore, limonin enhanced the radiosensitivity of NPC cells.  The mechanistic studies based on RNA-sequencing anal. revealed that limonin inhibited the gene transcription driven by Stat3 (signal transducer and activator of transcription 3) and an activator of Stat3 (Colivelin or IL-6) rescued the inhibitory effects of limonin.  Therefore, these results demonstrate that limonin could reduce the stemness of NPC cells and thus the radiosensitivity through suppressing Stat3 transcriptional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp70K4Yht1bULVg90H21EOLACvtfcHk0liV-LvIQbVxwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1CntLrK&md5=db91f97f42b0d3a1109af97257dd3c83</span></div><a href="/servlet/linkout?suffix=cit281&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2019.109366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2019.109366%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DSang%26aufirst%3DJ.-Z.%26aulast%3DCao%26aufirst%3DH.%26atitle%3DLimonin%2520enhances%2520the%2520radiosensitivity%2520of%2520nasopharyngeal%2520carcinoma%2520cells%2520via%2520attenuating%2520STAT3-induced%2520cell%2520stemness%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D118%26spage%3D109366%26doi%3D10.1016%2Fj.biopha.2019.109366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref282"><div class="reference"><strong class="refLabel"><a href="#ref282" class="rightTabRefNumLink">282</a></strong><div class="NLM_citation" id="rightTab-cit282"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Anticancer effect of limonin against benzo[<i>a</i>]pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>, <span class="NLM_elocation-id">e22374</span> <span class="refDoi"> DOI: 10.1002/jbt.22374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fjbt.22374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31702096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref282/cit282&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFaktLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&author=C.+Gongauthor=L.+Qiauthor=Y.+Huoauthor=S.+Zhangauthor=X.+Ningauthor=L.+Baiauthor=Z.+Wang&title=Anticancer+effect+of+limonin+against+benzo%5Ba%5Dpyrene-induced+lung+carcinogenesis+in+Swiss+albino+mice+and+the+inhibition+of+A549+cell+proliferation+through+apoptotic+pathway&doi=10.1002%2Fjbt.22374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit282R"><div class="casContent"><span class="casTitleNuber">282</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer effect of Limonin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway</span></div><div class="casAuthors">Gong, Cuike; Qi, Lei; Huo, Yanxia; Zhang, Shiran; Ning, Xuecong; Bai, Linlin; Wang, Zhihua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemical and Molecular Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e22374</span>CODEN:
                <span class="NLM_cas:coden">JBMTFQ</span>;
        ISSN:<span class="NLM_cas:issn">1095-6670</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The main purpose of the current study is to reveal the anticancer action of limonin against benzo(a)pyrene [B(a)P]-treated lung carcinogenesis in Swiss albino mice and A549 lung cancer cells.  B(a)P was orally supplemented (50 mg/kg body wt.) twice a week for four weeks induction of lung cancer in mice.  The lung wt., body wt., incidence of tumor, lipid peroxidn., carcinoembryonic antigen (CEA), enzymic and nonenzymic antioxidants (superoxide dismutase, GPx, glutathione, glutathione reductase, catalase, and glutathione S-transferase), serum marker enzymes (aryl hydroxylase, lactate dehydrogenase, 5'-nucleotidases, and -glutamyl transpeptidase), and inflammatory mediators (interleukin-1beta, interleukin-6, and tumor necrosis factor-a) were estd.  Moreover, a histopathol. study of lung tissues was supported by the biochem. anal.  B(a)P-induced mice showed increased lipid peroxidn., CEA, serum marker enzymes and inflammatory cytokines levels with simultaneously decreased in the nonenzymic and enzymic antioxidants levels.  Furthermore, our in vitro study also supported the anticancer effect of the treatment of limonin-enhanced apoptosis by loss of cell viability, improved ROS prodn., apoptotic morphol. changes, and apoptosis protein expression were analyzed.  Overall, these results suggest the anticancer potential of limonin against B(a)P-induced lung cancer in Swiss albino mice and A549 lung cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjqKevTf757Vg90H21EOLACvtfcHk0liV-LvIQbVxwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFaktLnN&md5=a496b77d50a24e69b47f17c6d494652c</span></div><a href="/servlet/linkout?suffix=cit282&amp;dbid=16384&amp;doi=10.1002%2Fjbt.22374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.22374%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DC.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAnticancer%2520effect%2520of%2520limonin%2520against%2520benzo%255Ba%255Dpyrene-induced%2520lung%2520carcinogenesis%2520in%2520Swiss%2520albino%2520mice%2520and%2520the%2520inhibition%2520of%2520A549%2520cell%2520proliferation%2520through%2520apoptotic%2520pathway%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2019%26volume%3D33%26doi%3D10.1002%2Fjbt.22374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref283"><div class="reference"><strong class="refLabel"><a href="#ref283" class="rightTabRefNumLink">283</a></strong><div class="NLM_citation" id="rightTab-cit283"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity</span>. <i>Tissue Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">101346</span>, <span class="refDoi"> DOI: 10.1016/j.tice.2020.101346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tice.2020.101346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32746992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref283/cit283&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslSiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2020&pages=101346&author=G.+Yangauthor=Z.+Liauthor=L.+Chen&title=Limonin+suppresses+the+progression+of+oral+tongue+squamous+cell+carcinoma+via+inhibiting+YAP+transcriptional+regulatory+activity&doi=10.1016%2Fj.tice.2020.101346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit283R"><div class="casContent"><span class="casTitleNuber">283</span><div class="casTitle"><span class="NLM_cas:atitle">Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity</span></div><div class="casAuthors">Yang, Guangsheng; Li, Zhi; Chen, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Tissue & Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101346</span>CODEN:
                <span class="NLM_cas:coden">TICEBI</span>;
        ISSN:<span class="NLM_cas:issn">0040-8166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The suppressive roles of limonin have been established in various tumors.  However, its roles in oral tongue squamous cell carcinoma (OTSCC) progression are still confusing.  This work aims to explore limonin-mediated effects on OTSCC progression.  CCK8 anal. was performed to evaluate limonin-mediated effects on OTSCC cell viability.  Wound healing and transwell invasion anal. were constructed to examine the effects of limonin on OTSCC cell migration and invasion capacity.  RT-qPCR, western blot and luciferase reporter assays were used to explore the underlying mechanisms contributing to limonin-mediated effects on OTSCC progression.  It was found that limonin significantly suppressed the viability of OTSCC cells.  Addnl., limonin reduced the migration and invasion ability of OTSCC cells.  Mechanistically, limonin suppresses OTSCC progression by promoting the nuclear to cytoplasm translocation of YAP, decreasing YAP protein expression and subsequently decreasing YAP transcriptional regulatory activity, this is responsible for limonin-mediated suppression on OTSCC progression.  Thus, this work suggests that limonin suppresses OTSCC progression through inhibiting YAP transcriptional regulatory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aMHTZq7OWbVg90H21EOLACvtfcHk0lg2M4-eAYumLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslSiu74%253D&md5=fdd887439426fce48dffe7a62deecdbc</span></div><a href="/servlet/linkout?suffix=cit283&amp;dbid=16384&amp;doi=10.1016%2Fj.tice.2020.101346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tice.2020.101346%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DLimonin%2520suppresses%2520the%2520progression%2520of%2520oral%2520tongue%2520squamous%2520cell%2520carcinoma%2520via%2520inhibiting%2520YAP%2520transcriptional%2520regulatory%2520activity%26jtitle%3DTissue%2520Cell%26date%3D2020%26volume%3D65%26spage%3D101346%26doi%3D10.1016%2Fj.tice.2020.101346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref284"><div class="reference"><strong class="refLabel"><a href="#ref284" class="rightTabRefNumLink">284</a></strong><div class="NLM_citation" id="rightTab-cit284"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bautista, G. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidallon, M. L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salamanez, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, E. B.</span></span> <span> </span><span class="NLM_article-title">Nanodelivery system based on zein-alginate complexes enhances in vitro chemopreventive activity and bioavailability of pomelo [<i>Citrus maxima</i> (Burm.) Merr.] seed limonoids</span>. <i>J. Drug Delivery Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">101296</span>, <span class="refDoi"> DOI: 10.1016/j.jddst.2019.101296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.jddst.2019.101296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref284/cit284&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCksbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2019&pages=101296&author=G.+F.+M.+Bautistaauthor=M.+L.+P.+Vidallonauthor=K.+C.+Salamanezauthor=E.+B.+Rodriguez&title=Nanodelivery+system+based+on+zein-alginate+complexes+enhances+in+vitro+chemopreventive+activity+and+bioavailability+of+pomelo+%5BCitrus+maxima+%28Burm.%29+Merr.%5D+seed+limonoids&doi=10.1016%2Fj.jddst.2019.101296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit284R"><div class="casContent"><span class="casTitleNuber">284</span><div class="casTitle"><span class="NLM_cas:atitle">Nanodelivery system based on zein-alginate complexes enhances in vitro chemopreventive activity and bioavailability of pomelo [Citrus maxima (Burm.) Merr.] seed limonoids</span></div><div class="casAuthors">Bautista, Gio Ferson M.; Vidallon, Mark Louis P.; Salamanez, Kevin C.; Rodriguez, Evelyn B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Delivery Science and Technology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101296</span>CODEN:
                <span class="NLM_cas:coden">JDDSAL</span>;
        ISSN:<span class="NLM_cas:issn">1773-2247</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Limonin and nomilin, the major limonoid components of pomelo [Citrus maxima (Burm.) Merr.] seeds, have been reported to be potential cancer chemopreventive agents, but their low aq. soly. and limited bioavailability impede their applications as nutraceuticals.  In this study, a zein-alginate encapsulation system was utilized to produce highly dispersible limonin and nomilin nanoparticles (172.7 ± 7.4 and 273.3 ± 2.3 nm dia., resp.) with high encapsulation efficiencies and high stabilities at both ambient and refrigerated storage conditions.  In vitro release studies showed that the nanodelivery system can delay and minimize the release of the limonoids in simulated gastric fluid (SGF) and preferentially release these compds. in simulated intestinal fluid (SIF).  Furthermore, zein-alginate encapsulated limonin and nomilin exhibited significantly improved glutathione S-transferase (GST)-inducing activity, free radical-scavenging activity, and anti-angiogenic activity.  These results demonstrate that the zein-alginate complexes can serve as effective oral delivery system for limonin and nomilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-j2j3j1Ih1bVg90H21EOLACvtfcHk0lg2M4-eAYumLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCksbzL&md5=e69e4f5a979626e6693d5053aea7eb41</span></div><a href="/servlet/linkout?suffix=cit284&amp;dbid=16384&amp;doi=10.1016%2Fj.jddst.2019.101296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jddst.2019.101296%26sid%3Dliteratum%253Aachs%26aulast%3DBautista%26aufirst%3DG.%2BF.%2BM.%26aulast%3DVidallon%26aufirst%3DM.%2BL.%2BP.%26aulast%3DSalamanez%26aufirst%3DK.%2BC.%26aulast%3DRodriguez%26aufirst%3DE.%2BB.%26atitle%3DNanodelivery%2520system%2520based%2520on%2520zein-alginate%2520complexes%2520enhances%2520in%2520vitro%2520chemopreventive%2520activity%2520and%2520bioavailability%2520of%2520pomelo%2520%255BCitrus%2520maxima%2520%2528Burm.%2529%2520Merr.%255D%2520seed%2520limonoids%26jtitle%3DJ.%2520Drug%2520Delivery%2520Sci.%2520Technol.%26date%3D2019%26volume%3D54%26spage%3D101296%26doi%3D10.1016%2Fj.jddst.2019.101296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref285"><div class="reference"><strong class="refLabel"><a href="#ref285" class="rightTabRefNumLink">285</a></strong><div class="NLM_citation" id="rightTab-cit285"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkata, K. C. N.</span>; <span class="NLM_string-name">Rathinavelu, A.</span>; <span class="NLM_string-name">Bishayee, A.</span></span> <span> </span><span class="NLM_article-title">Limonoids: Structure-Activity Relationship Studies and Anticancer Properties</span>. In  <i>Studies in Natural Products Chemistry</i>, Vol.  <span class="NLM_volume">59</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atta-ur-Rahman</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam, The Netherlands</span>, <span class="NLM_year">2018</span>; pp  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">399</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&pages=375-399&author=K.+C.+N.+Venkata&author=A.+Rathinavelu&author=A.+Bishayeeauthor=+Atta-ur-Rahman&title=Studies+in+Natural+Products+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit285&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVenkata%26aufirst%3DK.%2BC.%2BN.%26atitle%3DLimonoids%253A%2520Structure-Activity%2520Relationship%2520Studies%2520and%2520Anticancer%2520Properties%26btitle%3DStudies%2520in%2520Natural%2520Products%2520Chemistry%26volume%3D59%26aulast%3DAtta-ur-Rahman%26pub%3DElsevier%26date%3D2018%26spage%3D375%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref286"><div class="reference"><strong class="refLabel"><a href="#ref286" class="rightTabRefNumLink">286</a></strong><div class="NLM_citation" id="rightTab-cit286"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratheeshkumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raphael, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuttan, G.</span></span> <span> </span><span class="NLM_article-title">Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells</span>. <i>Integr. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1177/1534735411403307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref286/cit286&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1177%2F1534735411403307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref286/cit286&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21665879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref286/cit286&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2qu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=48-60&author=P.+Pratheeshkumarauthor=T.+J.+Raphaelauthor=G.+Kuttan&title=Nomilin+inhibits+metastasis+via+induction+of+apoptosis+and+regulates+the+activation+of+transcription+factors+and+the+cytokine+profile+in+B16F-10+cells&doi=10.1177%2F1534735411403307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit286R"><div class="casContent"><span class="casTitleNuber">286</span><div class="casTitle"><span class="NLM_cas:atitle">Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells</span></div><div class="casAuthors">Pratheeshkumar, Poyil; Raphael, Tharakan J.; Kuttan, Girija</div><div class="citationInfo"><span class="NLM_cas:title">Integrative Cancer Therapies</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">ICTNAY</span>;
        ISSN:<span class="NLM_cas:issn">1534-7354</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Nomilin is a triterpenoid present in common edible citrus fruits with putative anticancer properties.  In this study, the authors investigated the antimetastatic potential of nomilin and its possible mechanism of action.  Metastasis was induced in C57BL/6 mice through the lateral tail vein using highly metastatic B16F-10 melanoma cells.  Administration of nomilin inhibited tumor nodule formation in the lungs (68%) and markedly increased the survival rate of the metastatic tumor-bearing animals.  These results correlated with the biochem. parameters and histopathol. anal.  Nomilin showed an inhibition of tumor cell invasion and activation of matrix metalloproteinases.  Treatment with nomilin induced apoptotic response, characterized by an increase in the sub-G1 fraction of cells with chromatin condensation and membrane blebbing, a typical ladder of DNA fragmentation, and detection of apoptotic cells by TUNEL assay.  Nomilin treatment also exhibited a downregulated Bcl-2 and cyclin-D1 expression and upregulated p53, Bax, caspase-9, caspase-3, p21, and p27 gene expression in B16F-10 cells.  Proinflammatory cytokine prodn. and gene expression were found to be downregulated in nomilin-treated cells.  The study also reveals that nomilin could inhibit the activation and nuclear translocation of antiapoptotic transcription factors such as nuclear factor (NF)-κB, CREB, and ATF-2 in B16F-10 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUwpDsCKpoxrVg90H21EOLACvtfcHk0lhzxop6I6b_xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2qu70%253D&md5=15bacfd6fcb1ab8057a908b5520a484d</span></div><a href="/servlet/linkout?suffix=cit286&amp;dbid=16384&amp;doi=10.1177%2F1534735411403307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1534735411403307%26sid%3Dliteratum%253Aachs%26aulast%3DPratheeshkumar%26aufirst%3DP.%26aulast%3DRaphael%26aufirst%3DT.%2BJ.%26aulast%3DKuttan%26aufirst%3DG.%26atitle%3DNomilin%2520inhibits%2520metastasis%2520via%2520induction%2520of%2520apoptosis%2520and%2520regulates%2520the%2520activation%2520of%2520transcription%2520factors%2520and%2520the%2520cytokine%2520profile%2520in%2520B16F-10%2520cells%26jtitle%3DIntegr.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D48%26epage%3D60%26doi%3D10.1177%2F1534735411403307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref287"><div class="reference"><strong class="refLabel"><a href="#ref287" class="rightTabRefNumLink">287</a></strong><div class="NLM_citation" id="rightTab-cit287"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratheeshkumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuttan, G.</span></span> <span> </span><span class="NLM_article-title">Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>668</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2011.07.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref287/cit287&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejphar.2011.07.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref287/cit287&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21839074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref287/cit287&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Gru7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=668&publication_year=2011&pages=450-458&author=P.+Pratheeshkumarauthor=G.+Kuttan&title=Nomilin+inhibits+tumor-specific+angiogenesis+by+downregulating+VEGF%2C+NO+and+proinflammatory+cytokine+profile+and+also+by+inhibiting+the+activation+of+MMP-2+and+MMP-9&doi=10.1016%2Fj.ejphar.2011.07.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit287R"><div class="casContent"><span class="casTitleNuber">287</span><div class="casTitle"><span class="NLM_cas:atitle">Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9</span></div><div class="casAuthors">Pratheeshkumar, Poyil; Kuttan, Girija</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">668</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-458</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Angiogenesis is a crucial step in the growth and metastasis of cancers.  Antiangiogenic activity of nomilin was studied using in vivo as well as in vitro models.  Nomilin significantly inhibited tumor directed capillary formation.  Serum proinflammatory cytokines such as IL-1β, IL-6, TNF-α and GM-CSF and also serum NO levels were significantly reduced by the treatment of nomilin.  Administration of nomilin significantly reduced the serum level of VEGF, a proangiogenic factor and increased the antiangiogenic factors IL-2 and TIMP-1.  In vitro studies using rat aortic ring assay showed that administration of nomilin at non-toxic concns. significantly inhibited microvessel sprouting.  Studies using human umbilical vein endothelial cells clearly demonstrated that administration of nomilin significantly retarded endothelial cell proliferation, migration, invasion and tube formation.  These data clearly demonstrate the antiangiogenic potential of nomilin by downregulating the activation of MMPs, prodn. of VEGF, NO and proinflammatory cytokines as well as upregulating IL-2 and TIMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXhXvQ6aWCKbVg90H21EOLACvtfcHk0lhzxop6I6b_xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Gru7%252FM&md5=d61ee0df4d9498a69c1fbb249ae5d6ad</span></div><a href="/servlet/linkout?suffix=cit287&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.07.029%26sid%3Dliteratum%253Aachs%26aulast%3DPratheeshkumar%26aufirst%3DP.%26aulast%3DKuttan%26aufirst%3DG.%26atitle%3DNomilin%2520inhibits%2520tumor-specific%2520angiogenesis%2520by%2520downregulating%2520VEGF%252C%2520NO%2520and%2520proinflammatory%2520cytokine%2520profile%2520and%2520also%2520by%2520inhibiting%2520the%2520activation%2520of%2520MMP-2%2520and%2520MMP-9%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D668%26spage%3D450%26epage%3D458%26doi%3D10.1016%2Fj.ejphar.2011.07.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref288"><div class="reference"><strong class="refLabel"><a href="#ref288" class="rightTabRefNumLink">288</a></strong><div class="NLM_citation" id="rightTab-cit288"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chidambara Murthy, K.N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G.K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S</span></span> <span> </span><span class="NLM_article-title">Obacunone and obacunone glucoside inhibit human colon cancer (SW480) cells by the induction of apoptosis</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1625</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2011.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fct.2011.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=21515332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref288/cit288&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFWit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=1616-1625&author=K.N.+Chidambara+Murthyauthor=G.K.+Jayaprakashaauthor=B.+S+Patil&title=Obacunone+and+obacunone+glucoside+inhibit+human+colon+cancer+%28SW480%29+cells+by+the+induction+of+apoptosis&doi=10.1016%2Fj.fct.2011.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit288R"><div class="casContent"><span class="casTitleNuber">288</span><div class="casTitle"><span class="NLM_cas:atitle">Obacunone and obacunone glucoside inhibit human colon cancer (SW480) cells by the induction of apoptosis</span></div><div class="casAuthors">Chidambara Murthy, K. N.; Jayaprakasha, G. K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1616-1625</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Objectives: The study was aimed to purify obacunone and obacunone glucoside (OG) from seeds of Marsh White grapefruit and understand the mode of cytotoxicity of limonoids on colon cancer (SW480) cells.  Methodol.: Both limonoids were purified using chromatog. techniques.  The structures and purity of limonoids were confirmed by NMR and HPLC anal., resp.  Results: Obacunone and OG inhibited SW480 cell proliferation with IC50 values of 97 and 109.7 μM resp., at 24 h.  Sequence of events such as decreased ratio of bcl2/bax gene transcription, activation of caspase-3, fragmentation of DNA in cells treated with obacunone and OG demonstrated induction of apoptosis by limonoids.  Addnl., higher induction of cytochrome-c in cytosol suggests the activation of intrinsic apoptosis by limonoids.  Involvement of apoptosis was also confirmed through expression of bax, bcl2, pro-caspase-3 and caspase-9.  Both the limonoids activated p21 and arrested cells at G1 and G2/M phase.  Additive activity of proliferation inhibition and activation of caspase-3 by limonoids was obsd. when combined with camptothecin, demonstrating the induction of apoptosis.  In conclusion, both limonoids induced apoptosis by activation of intrinsic apoptosis pathway and activation of p21 leading to arresting cells at G2/M phase of the cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd1RqmGUFcALVg90H21EOLACvtfcHk0lhmvEY9IyWOtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFWit7k%253D&md5=fc03204765dd5840add53b9d84ab863c</span></div><a href="/servlet/linkout?suffix=cit288&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2011.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2011.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DChidambara%2BMurthy%26aufirst%3DK.N.%26aulast%3DJayaprakasha%26aufirst%3DG.K.%26aulast%3DPatil%26aufirst%3DB.%2BS%26atitle%3DObacunone%2520and%2520obacunone%2520glucoside%2520inhibit%2520human%2520colon%2520cancer%2520%2528SW480%2529%2520cells%2520by%2520the%2520induction%2520of%2520apoptosis%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2011%26volume%3D49%26spage%3D1616%26epage%3D1625%26doi%3D10.1016%2Fj.fct.2011.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref289"><div class="reference"><strong class="refLabel"><a href="#ref289" class="rightTabRefNumLink">289</a></strong><div class="NLM_citation" id="rightTab-cit289"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, K. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death</span>. <i>Toxicology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.tox.2015.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tox.2015.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=25592883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref289/cit289&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVKjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2015&pages=88-97&author=K.+N.+C.+Murthyauthor=G.+K.+Jayaprakashaauthor=B.+S.+Patil&title=Cytotoxicity+of+obacunone+and+obacunone+glucoside+in+human+prostate+cancer+cells+involves+Akt-mediated+programmed+cell+death&doi=10.1016%2Fj.tox.2015.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit289R"><div class="casContent"><span class="casTitleNuber">289</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity of obacunone and obacunone glucoside in human prostate cancer cells involves Akt-mediated programmed cell death</span></div><div class="casAuthors">Murthy, Kotamballi N. Chidambara; Jayaprakasha, Guddadarangavvanahally K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-97</span>CODEN:
                <span class="NLM_cas:coden">TXCYAC</span>;
        ISSN:<span class="NLM_cas:issn">0300-483X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Obacunone and obacunone glucoside (OG) are naturally occurring triterpenoids commonly found in citrus and other plants of the Rutaceae family.  The current study reports the mechanism of cytotoxicity of citrus-derived obacunone and OG on human androgen-dependent prostate cancer LNCaP cells.  Both limonoids exhibited time- and dose-dependent inhibition of cell proliferation, with more than 60% inhibition of cell viability at 100 μM, after 24 and 48 h.  Anal. of fragmentation of DNA, activity of caspase-3, and cytosolic cytochrome-c in the cells treated with limonoids provided evidence for activation of programmed cell death by limonoids.  Treatment of LNCaP cells with obacunone and OG resulted in dose-dependent changes in expression of proteins responsible for the induction of programmed cell death through the intrinsic pathway and down-regulation of Akt, a key mol. in cell signaling pathways.  In addn., obacunone and OG also neg. regulated an inflammation-assocd. transcription factor, androgen receptor, and prostate-specific antigen, and activated proteins related to the cell cycle, confirming the ability of limonoids to induce cytotoxicity through multiple pathways.  The results of this study provided, for the first time, an evidence of the cytotoxicity of obacunone and OG in androgen-dependent human prostate cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN3z4SJsXHabVg90H21EOLACvtfcHk0lhmvEY9IyWOtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVKjuw%253D%253D&md5=7db8ddf31439b5ceb25c2f937a0cbd69</span></div><a href="/servlet/linkout?suffix=cit289&amp;dbid=16384&amp;doi=10.1016%2Fj.tox.2015.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tox.2015.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DMurthy%26aufirst%3DK.%2BN.%2BC.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DCytotoxicity%2520of%2520obacunone%2520and%2520obacunone%2520glucoside%2520in%2520human%2520prostate%2520cancer%2520cells%2520involves%2520Akt-mediated%2520programmed%2520cell%2520death%26jtitle%3DToxicology%26date%3D2015%26volume%3D329%26spage%3D88%26epage%3D97%26doi%3D10.1016%2Fj.tox.2015.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref290"><div class="reference"><strong class="refLabel"><a href="#ref290" class="rightTabRefNumLink">290</a></strong><div class="NLM_citation" id="rightTab-cit290"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaprakasha, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, B. S.</span></span> <span> </span><span class="NLM_article-title">Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2014.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.biochi.2014.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24927687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref290/cit290&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFChsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2014&pages=36-44&author=J.+Kimauthor=G.+K.+Jayaprakashaauthor=B.+S.+Patil&title=Obacunone+exhibits+anti-proliferative+and+anti-aromatase+activity+in+vitro+by+inhibiting+the+p38+MAPK+signaling+pathway+in+MCF-7+human+breast+adenocarcinoma+cells&doi=10.1016%2Fj.biochi.2014.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit290R"><div class="casContent"><span class="casTitleNuber">290</span><div class="casTitle"><span class="NLM_cas:atitle">Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells</span></div><div class="casAuthors">Kim, Jinhee; Jayaprakasha, G. K.; Patil, Bhimanagouda S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Overexpression of the aromatase enzyme CYP19 has been implicated in the onset of estrogen-dependent breast carcinogenesis.  Obacunone, a natural compd. present in citrus fruits, has been demonstrated for various biol. activities including anti-cancer and anti-inflammatory properties.  In the present study, we have isolated obacunone and obacunone glucoside (OG) from lemon seeds, then fractionated these compds. using chromatog. techniques and characterized them by HPLC, LC-MS, and 2D NMR spectral anal.  To investigate the mechanism of anti-cancer and anti-aromatase activities of limonoids, their cytotoxic effect was tested on human breast cancer (MCF-7) and non-malignant (MCF-12F) breast cells.  MTT assays confirmed that obacunone was strongly inhibited MCF-7 cell proliferation without affecting non-malignant breast cells.  Treatment with obacunone increased apoptosis by up-regulating expression of the pro-apoptotic protein Bax and down-regulating the anti-apoptotic protein Bcl2, as well as inducing G1 cell cycle arrest.  In addn., obacunone significantly inhibited aromatase activity in an in vitro enzyme assay.  Exposure of MCF-7 breast cancer cells to obacunone down-regulated expression of inflammatory mols. including nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2).  Furthermore, we found that obacunone inhibited COX-2 and NF-κB by activation of the p38 mitogen-activated protein kinase (MAPK).  Finally, the uptake level of obacunone into MCF-7 cells was measured by HPLC and its structure was confirmed by LC-HR-MS.  This study demonstrated that obacunone may have the potential to prevent estrogen-responsive breast cancer through inhibition of the aromatase enzyme and inflammatory pathways, as well as activation of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY-nGOxUd5UbVg90H21EOLACvtfcHk0lgE9-QAIVwzCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFChsrvK&md5=52e0d5fcf70afb71ce9468642651e5fe</span></div><a href="/servlet/linkout?suffix=cit290&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2014.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2014.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJayaprakasha%26aufirst%3DG.%2BK.%26aulast%3DPatil%26aufirst%3DB.%2BS.%26atitle%3DObacunone%2520exhibits%2520anti-proliferative%2520and%2520anti-aromatase%2520activity%2520in%2520vitro%2520by%2520inhibiting%2520the%2520p38%2520MAPK%2520signaling%2520pathway%2520in%2520MCF-7%2520human%2520breast%2520adenocarcinoma%2520cells%26jtitle%3DBiochimie%26date%3D2014%26volume%3D105%26spage%3D36%26epage%3D44%26doi%3D10.1016%2Fj.biochi.2014.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref291"><div class="reference"><strong class="refLabel"><a href="#ref291" class="rightTabRefNumLink">291</a></strong><div class="NLM_citation" id="rightTab-cit291"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akisanya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halsall, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. A. H.</span></span> <span> </span><span class="NLM_article-title">West African timbers. III. Petroleum extracts from the genus <i>Entandrophragma</i></span>. <i>J. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1960</span>,  <span class="NLM_fpage">3827</span>– <span class="NLM_lpage">3829</span>, <span class="refDoi"> DOI: 10.1039/jr9600003827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref291/cit291&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2Fjr9600003827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref291/cit291&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF3MXhvVWjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1960&pages=3827-3829&author=A.+Akisanyaauthor=C.+W.+L.+Bevanauthor=J.+Hirstauthor=T.+G.+Halsallauthor=D.+A.+H.+Taylor&title=West+African+timbers.+III.+Petroleum+extracts+from+the+genus+Entandrophragma&doi=10.1039%2Fjr9600003827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit291R"><div class="casContent"><span class="casTitleNuber">291</span><div class="casTitle"><span class="NLM_cas:atitle">West African timbers. III. Petroleum extracts from the genus Entandrophragma</span></div><div class="casAuthors">Akisanya, A.; Bevan, C. W. L.; Hirst, J.; Halsall, T. G.; Taylor, D. A. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3827-9</span>CODEN:
                <span class="NLM_cas:coden">JCSOA9</span>;
        ISSN:<span class="NLM_cas:issn">0368-1769</span>.
    </div><div class="casAbstract">cf. CA 54, 3601c.  As part of a phytochem. survey of the family Meliaceae, heartwood timber of the 4 species of the West African genus Entandrophragma was examd.  Ligroine extn. of all gave β-sitosterol (I); 4 new (and apparently related) substances were isolated.  The distribution of these within the genus was described.  The finely ground heartwood (36 kg.) of E. angolense (Type A) percolated 24 hrs. with refluxing ligroine, the ext. filtered and evapd., and the 110 g. of residue dissolved in 10 ml./g. MeOH and stored at 0° gave a powder, m. 75-132°.  Repeated crystns. gave 19 g. I, m. 137° (MeOH).  Concn. of the mother liquor gave 44 g. gedunin, needles, m. 218° (MeOH), [α]20D -44° (CHCl3).  Similar extn. of Type B wood gave a solid which yielded Me angolensate, m. 197° (MeOH), [α]20D -43° (CHCl3).  E. candoleii (43 kg. of finely ground timber) extd. as above gave 70 g. of a yellow gum.  Maceration with ligroine gave a white solid, which gave 5 g. I as flakes; acetate m. 126°, [α]18D -40.6°; formate m. 104.5°.  Oxidn. of I with CrO3 in Me2CO gave stigmast-4-ene-3,6-dione, m. 166°, [α]18D -38.9° (CHCl3).  Chromatography of the mother liquors on Al2O3 gave no further product.  E. cylindricum [finely ground heartwood (13.2 kg.)] extd. as above and the 220 g. of thick oil crystd. gave 25 g. entandrophragmin, prisms, m. 241° (aq. MeOH), [α]20D -4°.  Chromatography of the mother liquors gave more of this substance and a small amt. of I.  Powd. heartwood (12 kg.) of E. utile gave 43 g. of an ext. which (partly crystd.) gave 7 g. utilin, m. 278° (alc.), [α]20D -355.5° (CHCl3).  Chromatography of the mother liquors on Al2O3 gave 4 g. entandrophragmin, m. 241°.  The heartwood further extd. with Me2CO and the ext. chromatographed and eluted with C6H6 gave 0.05% Me angolensate, m. 197°.  Entandrophragmin, utilin, and gedunin, but not Me angolensate, gave similar results on pyrolysis.  The substance (0.5 g.) was pyrolyzed at 360° to yield high and low boiling fractions.  The latter gave a brick red dinitrophenylhydrazone, which was chromatographed in CHCl3 to give (from entandrophragmin) a product, m. 230-2° (AcOH).  Furan-3-carboxaldehyde prepd. from the 3-carboxylic acid gave a similar deriv.  A small amt. of MeCHO 2,4-dinitrophenylhydrazone was also isolated.  Similar results were obtained on hydrolysis (in alkali) of entandrophragmin, utilin, and gedunin, but not of Me angolensate.  The substance (200 mg.) in 5 cc. alc. was treated with 5 ml. 2N NaOH; after steam distn. it also yielded a furan-3-carboxaldehyde deriv.  Me angolensate (1 g.) refluxed 16 hrs. with 2.5 g. KOH in 25 ml. alc. and the soln. dild. with 400 ml. H2O, extd. with Et2O, and the ext. evapd. gave a trace of I; acidification of the aq. layer gave angolensic acid, needles, m. 272° (aq. MeOH).  CH2N2 gave Me angolensate.  Gedunin (2.9 g.) in 200 ml. MeOH hydrogenated at atm. pressure over Pd-C, the soln. filtered and evapd., and the residue crystd. gave dihydrogedunin, m. 240° (MeOH), m. 240°, [α]20D -8° (MeOH).  Ultraviolet and infrared spectra were given for the above compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQriQiWgc0LVg90H21EOLACvtfcHk0lgE9-QAIVwzCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXhvVWjsw%253D%253D&md5=9a6334a33333c8ab244eb1675677eeb0</span></div><a href="/servlet/linkout?suffix=cit291&amp;dbid=16384&amp;doi=10.1039%2Fjr9600003827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9600003827%26sid%3Dliteratum%253Aachs%26aulast%3DAkisanya%26aufirst%3DA.%26aulast%3DBevan%26aufirst%3DC.%2BW.%2BL.%26aulast%3DHirst%26aufirst%3DJ.%26aulast%3DHalsall%26aufirst%3DT.%2BG.%26aulast%3DTaylor%26aufirst%3DD.%2BA.%2BH.%26atitle%3DWest%2520African%2520timbers.%2520III.%2520Petroleum%2520extracts%2520from%2520the%2520genus%2520Entandrophragma%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1960%26spage%3D3827%26epage%3D3829%26doi%3D10.1039%2Fjr9600003827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref292"><div class="reference"><strong class="refLabel"><a href="#ref292" class="rightTabRefNumLink">292</a></strong><div class="NLM_citation" id="rightTab-cit292"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, J. M.</span></span> <span> </span><span class="NLM_article-title">The structure of gedunin</span>. <i>Proc. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_fpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref292/cit292&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF38Xks1Sitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1962&pages=222&author=S.+A.+Sutherlandauthor=G.+A.+Simauthor=J.+M.+Robertson&title=The+structure+of+gedunin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit292R"><div class="casContent"><span class="casTitleNuber">292</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of gedunin</span></div><div class="casAuthors">Sutherland, S. A.; Sim, G. A.; Robertson, J. Monteath</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Chemical Society, London</span>
        (<span class="NLM_cas:date">1962</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">222</span>CODEN:
                <span class="NLM_cas:coden">PCSLAW</span>;
        ISSN:<span class="NLM_cas:issn">0369-8718</span>.
    </div><div class="casAbstract">The constitution and relative stereochemistry of dihydrogedun-3β-yl iodoacetate is established by x-ray analysis as I, thus establishing structure of gedunin as II.  I crystd. in the orthorhombic system, space group P212121 with four mols. of C30H39IO8 in a unit cell of dimensions a 21.52, b 10.57, c 12.96 ± A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptrhGcZNT0prVg90H21EOLACvtfcHk0lgLdy0nFb2FYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xks1Sitrc%253D&md5=141e31062d93d35be67d4282eabf38eb</span></div><a href="/servlet/linkout?suffix=cit292&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutherland%26aufirst%3DS.%2BA.%26aulast%3DSim%26aufirst%3DG.%2BA.%26aulast%3DRobertson%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520structure%2520of%2520gedunin%26jtitle%3DProc.%2520Chem.%2520Soc.%26date%3D1962%26spage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref293"><div class="reference"><strong class="refLabel"><a href="#ref293" class="rightTabRefNumLink">293</a></strong><div class="NLM_citation" id="rightTab-cit293"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akihisa, T.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic and apoptosis-inducing activities of limonoids from the seeds of <i>Azadirachta indica</i> (Neem)</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1021/np100783k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np100783k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref293/cit293&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=866-870&author=T.+Kikuchiauthor=K.+Ishiiauthor=T.+Notoauthor=A.+Takahashiauthor=K.+Tabataauthor=T.+Suzukiauthor=T.+Akihisa&title=Cytotoxic+and+apoptosis-inducing+activities+of+limonoids+from+the+seeds+of+Azadirachta+indica+%28Neem%29&doi=10.1021%2Fnp100783k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit293R"><div class="casContent"><span class="casTitleNuber">293</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic and Apoptosis-Inducing Activities of Limonoids from the Seeds of Azadirachta indica (Neem)</span></div><div class="casAuthors">Kikuchi, Takashi; Ishii, Koichi; Noto, Taisuke; Takahashi, Akitomo; Tabata, Keiichi; Suzuki, Takashi; Akihisa, Toshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">866-870</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Thirty-five limonoids, including 15 of the azadiradione type (1-15), five of the gedunin type (16-20), four of the azadirachtin type (21-24), nine of the nimbin type (25-33), and two degraded limonoids (34, 35), isolated from Azadirachta indica seed exts., were evaluated for their cytotoxic activities against five human cancer cell lines.  Seven compds. (3, 6, 7, 16, 18, 28, and 29) exhibited cytotoxic activity against one or more cell lines.  Among these compds., 7-deacetyl-7-benzoylepoxyazadiradione (7), 7-deacetyl-7-benzoylgeduin (18), and 28-deoxonimbolide (28) exhibited potent cytotoxic activity against HL60 leukemia cells with IC50 values in the range 2.7-3.1 μM.  Compds. 7, 18, and 28 induced early apoptosis in HL60 cells, obsd. by flow cytometry.  Western blot anal. showed that compds. 7, 18, and 28 activated caspases-3, -8, and -9 in HL60 cells.  This suggested that compds. 7, 18, and 28 induced apoptotic cell death in HL60 cells via both the mitochondrial- and the death receptor-mediated pathways.  Furthermore, compd. 7 was shown to possess high selective cytotoxicity for leukemia cells since it exhibited only weak cytotoxicity against a normal lymphocyte cell line (RPMI 1788).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT-evtXVsQArVg90H21EOLACvtfcHk0lgLdy0nFb2FYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjt7o%253D&md5=caec0cc3149a22b138ad23ea1165fa84</span></div><a href="/servlet/linkout?suffix=cit293&amp;dbid=16384&amp;doi=10.1021%2Fnp100783k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100783k%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26aulast%3DNoto%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DTabata%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DAkihisa%26aufirst%3DT.%26atitle%3DCytotoxic%2520and%2520apoptosis-inducing%2520activities%2520of%2520limonoids%2520from%2520the%2520seeds%2520of%2520Azadirachta%2520indica%2520%2528Neem%2529%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D866%26epage%3D870%26doi%3D10.1021%2Fnp100783k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref294"><div class="reference"><strong class="refLabel"><a href="#ref294" class="rightTabRefNumLink">294</a></strong><div class="NLM_citation" id="rightTab-cit294"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, G. E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span> <span> </span><span class="NLM_article-title">Gedunin, a novel Hsp90 inhibitor: Semisynthesis of derivatives and preliminary structure-activity relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6495</span>– <span class="NLM_lpage">6502</span>, <span class="refDoi"> DOI: 10.1021/jm8007486</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8007486" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref294/cit294&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKlurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6495-6502&author=G.+E.+L.+Brandtauthor=M.+D.+Schmidtauthor=T.+E.+Prisinzanoauthor=B.+S.+J.+Blagg&title=Gedunin%2C+a+novel+Hsp90+inhibitor%3A+Semisynthesis+of+derivatives+and+preliminary+structure-activity+relationships&doi=10.1021%2Fjm8007486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit294R"><div class="casContent"><span class="casTitleNuber">294</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin, a Novel Hsp90 Inhibitor: Semisynthesis of Derivatives and Preliminary Structure-Activity Relationships</span></div><div class="casAuthors">Brandt, Gary E. L.; Schmidt, Matthew D.; Prisinzano, Thomas E.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6495-6502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gedunin, a tetranortriterpenoid isolated from the Indian neem tree (Azadirachta indica), was recently shown to manifest anticancer activity via inhibition of the 90 kDa heat shock protein (Hsp90) folding machinery and to induce the degrdn. of Hsp90-dependent client proteins similar to other Hsp90 inhibitors.  The mechanism of action by which gedunin induces client protein degrdn. remains undetd., however, prior studies have demonstrated that it does not bind competitively vs. ATP.  In an effort to further probe the mechanism of action, 19 semisynthetic derivs. of gedunin were prepd. and their antiproliferative activity against MCF-7 and SkBr3 breast cancer cells detd.  Although no compd. was found to exhibit antiproliferative activity more effective than the natural product, functionalities crit. for antiproliferative activity have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTdQv-gkImM7Vg90H21EOLACvtfcHk0lgLdy0nFb2FYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKlurrI&md5=d54c7fe7c950be8ad291c0dc67561fa5</span></div><a href="/servlet/linkout?suffix=cit294&amp;dbid=16384&amp;doi=10.1021%2Fjm8007486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007486%26sid%3Dliteratum%253Aachs%26aulast%3DBrandt%26aufirst%3DG.%2BE.%2BL.%26aulast%3DSchmidt%26aufirst%3DM.%2BD.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DGedunin%252C%2520a%2520novel%2520Hsp90%2520inhibitor%253A%2520Semisynthesis%2520of%2520derivatives%2520and%2520preliminary%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6495%26epage%3D6502%26doi%3D10.1021%2Fjm8007486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref295"><div class="reference"><strong class="refLabel"><a href="#ref295" class="rightTabRefNumLink">295</a></strong><div class="NLM_citation" id="rightTab-cit295"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kishore
T, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganugula, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gade, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Gedunin abrogates aldose reductase, PI3K/Akt/mTOR, and NF-κB signaling pathways to inhibit angiogenesis in a hamster model of oral carcinogenesis</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2083</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1007/s13277-015-4003-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs13277-015-4003-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref295/cit295&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVOqurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=2083-2093&author=K.+K.+Kishore%0ATauthor=R.+Ganugulaauthor=D.+R.+Gadeauthor=G.+B.+Reddyauthor=S.+Nagini&title=Gedunin+abrogates+aldose+reductase%2C+PI3K%2FAkt%2FmTOR%2C+and+NF-%CE%BAB+signaling+pathways+to+inhibit+angiogenesis+in+a+hamster+model+of+oral+carcinogenesis&doi=10.1007%2Fs13277-015-4003-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit295R"><div class="casContent"><span class="casTitleNuber">295</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin abrogates aldose reductase, PI3K/Akt/mToR, and NF-κB signaling pathways to inhibit angiogenesis in a hamster model of oral carcinogenesis</span></div><div class="casAuthors">Kishore T, Kranthi Kiran; Ganugula, Raghu; Gade, Deepak Reddy; Reddy, Geereddy Bhanuprakash; Nagini, Siddavaram</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2083-2093</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aberrant activation of oncogenic signaling pathways plays a central role in tumor development and progression.  The aim of this present study was to investigate the chemopreventive effects of the neem limonoid gedunin in the hamster model of oral cancer based on its ability to modulate aldose reductase (AR), phosphatidyl inositol-3-kinase (PI3K)/Akt, and nuclear factor kappa B (NF-κB) pathways to block angiogenesis.  Administration of gedunin suppressed the development of HBP carcinomas by inhibiting PI3K/Akt and NF-κB pathways through the inactivation of Akt and inhibitory kappa B kinase (IKK), resp.  Immunoblot and mol. docking interactions revealed that inhibition of these signaling pathways may be mediated via inactivation of AR by gedunin.  Gedunin blocked angiogenesis by downregulating the expression of miR-21 and the pro-angiogenic factors vascular endothelial growth factor and hypoxia inducible factor-1 alpha (HIF-1α).  In conclusion, the results of the present study provide compelling evidence that gedunin prevents progression of hamster buccal pouch (HBP) carcinomas via inhibition of the kinases Akt, IKK, and AR, and the oncogenic transcription factors NF-κB and HIF-1α to block angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKS7QK2BvbbbVg90H21EOLACvtfcHk0liKIKSJhJjubQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOqurvP&md5=cd1a476a99942d3540abb50dc6129cb4</span></div><a href="/servlet/linkout?suffix=cit295&amp;dbid=16384&amp;doi=10.1007%2Fs13277-015-4003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-015-4003-0%26sid%3Dliteratum%253Aachs%26aulast%3DKishore%2BT%26aufirst%3DK.%2BK.%26aulast%3DGanugula%26aufirst%3DR.%26aulast%3DGade%26aufirst%3DD.%2BR.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DGedunin%2520abrogates%2520aldose%2520reductase%252C%2520PI3K%252FAkt%252FmTOR%252C%2520and%2520NF-%25CE%25BAB%2520signaling%2520pathways%2520to%2520inhibit%2520angiogenesis%2520in%2520a%2520hamster%2520model%2520of%2520oral%2520carcinogenesis%26jtitle%3DTumor%2520Biol.%26date%3D2016%26volume%3D37%26spage%3D2083%26epage%3D2093%26doi%3D10.1007%2Fs13277-015-4003-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref296"><div class="reference"><strong class="refLabel"><a href="#ref296" class="rightTabRefNumLink">296</a></strong><div class="NLM_citation" id="rightTab-cit296"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasanain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span> <span> </span><span class="NLM_article-title">Gedunin isolated from the mangrove plant <i>Xylocarpus granatum</i> exerts its anti-proliferative activity in ovarian cancer cells through G2/M-phase arrest and oxidative stress-mediated intrinsic apoptosis</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1007/s10495-020-01605-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2Fs10495-020-01605-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=32399945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref296/cit296&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpt1Kgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=481-499&author=R.+Sahaiauthor=A.+Bhattacharjeeauthor=V.+N.+Shuklaauthor=P.+Yadavauthor=M.+Hasanainauthor=J.+Sarkarauthor=T.+Narenderauthor=K.+Mitra&title=Gedunin+isolated+from+the+mangrove+plant+Xylocarpus+granatum+exerts+its+anti-proliferative+activity+in+ovarian+cancer+cells+through+G2%2FM-phase+arrest+and+oxidative+stress-mediated+intrinsic+apoptosis&doi=10.1007%2Fs10495-020-01605-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit296R"><div class="casContent"><span class="casTitleNuber">296</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin isolated from the mangrove plant Xylocarpus granatum exerts its anti-proliferative activity in ovarian cancer cells through G2/M-phase arrest and oxidative stress-mediated intrinsic apoptosis</span></div><div class="casAuthors">Sahai, Rohit; Bhattacharjee, Arindam; Shukla, Vishwa Nath; Yadav, Pragya; Hasanain, Mohammad; Sarkar, Jayanta; Narender, T.; Mitra, Kalyan</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">481-499</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Here, we describe the mol. mechanisms underlying the in vitro anti proliferative activity of gedunin (isolated from the mangrove plant Xylocarpus granatum) in human ovarian cancer cells.  We obsd. that gedunin triggered severe ROS generation leading to DNA damage and cell cycle arrest in G2/M phase thus inhibiting cell proliferation.  ROS upregulation also led to mitochondrial stress and membrane depolarization, which eventually resulted in mitochondria-mediated apoptosis following cytochrome C release, caspase 9, 3 activation, and PARP cleavage.  Moreover, an upregulation in stress kinases like phospho-ERK 1/2, phospho-p38 and phospho-JNK was also obsd. in gedunin treated cells.  Free radical scavenger N-Acetyl-L-Cysteine (NAC) reversed all these effects resulting in increased cell survival, abrogation of cell cycle arrest, rescue of mitochondrial membrane potential and suppression of apoptotic markers.  Interestingly, gedunin is also an inhibitor of the evolutionarily conserved mol. chaperone Heat Shock Protein 90 (hsp90) responsible for maintaining cellular homeostasis.  Targeting this chaperone could be an attractive strategy for developing cancer therapeutics since many oncogenic proteins are also client proteins of hsp90.  Collectively, our findings provide insights into the mol. mechanism of action of gedunin, which may aid drug development efforts against ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEWpWXaD9Uh7Vg90H21EOLACvtfcHk0ljZzvXUKCHIIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpt1Kgurs%253D&md5=f2411a5d92f4961293ccd4dc4ff8e23e</span></div><a href="/servlet/linkout?suffix=cit296&amp;dbid=16384&amp;doi=10.1007%2Fs10495-020-01605-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-020-01605-5%26sid%3Dliteratum%253Aachs%26aulast%3DSahai%26aufirst%3DR.%26aulast%3DBhattacharjee%26aufirst%3DA.%26aulast%3DShukla%26aufirst%3DV.%2BN.%26aulast%3DYadav%26aufirst%3DP.%26aulast%3DHasanain%26aufirst%3DM.%26aulast%3DSarkar%26aufirst%3DJ.%26aulast%3DNarender%26aufirst%3DT.%26aulast%3DMitra%26aufirst%3DK.%26atitle%3DGedunin%2520isolated%2520from%2520the%2520mangrove%2520plant%2520Xylocarpus%2520granatum%2520exerts%2520its%2520anti-proliferative%2520activity%2520in%2520ovarian%2520cancer%2520cells%2520through%2520G2%252FM-phase%2520arrest%2520and%2520oxidative%2520stress-mediated%2520intrinsic%2520apoptosis%26jtitle%3DApoptosis%26date%3D2020%26volume%3D25%26spage%3D481%26epage%3D499%26doi%3D10.1007%2Fs10495-020-01605-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref297"><div class="reference"><strong class="refLabel"><a href="#ref297" class="rightTabRefNumLink">297</a></strong><div class="NLM_citation" id="rightTab-cit297"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patwardhan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauq, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chadli, A.</span></span> <span> </span><span class="NLM_article-title">Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">7313</span>– <span class="NLM_lpage">7325</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.427328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1074%2Fjbc.M112.427328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23355466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref297/cit297&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslegsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=7313-7325&author=C.+A.+Patwardhanauthor=A.+Fauqauthor=L.+B.+Petersonauthor=C.+Millerauthor=B.+S.+J.+Blaggauthor=A.+Chadli&title=Gedunin+inactivates+the+co-chaperone+p23+protein+causing+cancer+cell+death+by+apoptosis&doi=10.1074%2Fjbc.M112.427328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit297R"><div class="casContent"><span class="casTitleNuber">297</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis</span></div><div class="casAuthors">Patwardhan, Chaitanya A.; Fauq, Abdul; Peterson, Laura B.; Miller, Charles; Blagg, Brian S. J.; Chadli, Ahmed</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">7313-7325</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pharmacol. inhibition of Hsp90 is an exciting option for cancer therapy.  The clin. efficacy of Hsp90 inhibitors is, however, less than expected.  Binding of the co-chaperone p23 to Hsp90 and induced overexpression of anti-apoptotic proteins Hsp70 and Hsp27 are thought to contribute to this outcome.  Herein, we report that the natural product gedunin may provide a new alternative to inactivate the Hsp90 machine.  We show that gedunin directly binds to p23 and inactivates it, without overexpression of Hsp27 and relatively modest induction of Hsp70.  Using mol. docking and mutational anal., we mapped the gedunin-binding site on p23.  Functional anal. shows that gedunin inhibits the p23 chaperoning activity, blocks its cellular interaction with Hsp90, and interferes with p23-mediated gene regulation.  Cell treatment with gedunin leads to cancer cell death by apoptosis through inactivation of p23 and activation of caspase 7, which cleaves p23 at the C terminus.  These results provide important insight into the mol. mechanism of action of this promising lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU7vrMB7OXCrVg90H21EOLACvtfcHk0ljZzvXUKCHIIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslegsrY%253D&md5=23e5c129df95e868f9491de26f1b4677</span></div><a href="/servlet/linkout?suffix=cit297&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.427328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.427328%26sid%3Dliteratum%253Aachs%26aulast%3DPatwardhan%26aufirst%3DC.%2BA.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26aulast%3DChadli%26aufirst%3DA.%26atitle%3DGedunin%2520inactivates%2520the%2520co-chaperone%2520p23%2520protein%2520causing%2520cancer%2520cell%2520death%2520by%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D7313%26epage%3D7325%26doi%3D10.1074%2Fjbc.M112.427328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref298"><div class="reference"><strong class="refLabel"><a href="#ref298" class="rightTabRefNumLink">298</a></strong><div class="NLM_citation" id="rightTab-cit298"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandy, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arumugam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alabi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanaswamy, R.</span></span> <span> </span><span class="NLM_article-title">Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">10891</span>– <span class="NLM_lpage">10904</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.8055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26988754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref298/cit298&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC28fht1Omsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=10891-10904&author=R.+Subramaniauthor=E.+Gonzalezauthor=S.+B.+Nandyauthor=A.+Arumugamauthor=F.+Camachoauthor=J.+Medelauthor=D.+Alabiauthor=R.+Lakshmanaswamy&title=Gedunin+inhibits+pancreatic+cancer+by+altering+sonic+hedgehog+signaling+pathway&doi=10.18632%2Foncotarget.8055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit298R"><div class="casContent"><span class="casTitleNuber">298</span><div class="casTitle"><span class="NLM_cas:atitle">Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway</span></div><div class="casAuthors">Subramani Ramadevi; Nandy Sushmita Bose; Arumugam Arunkumar; Lakshmanaswamy Rajkumar; Gonzalez Elizabeth; Camacho Fernando; Medel Joshua; Alabi Damilola; Lakshmanaswamy Rajkumar</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">10891-10904</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The lack of efficient treatment options for pancreatic cancer highlights the critical need for the development of novel and effective chemotherapeutic agents.  The medicinal properties found in plants have been used to treat many different illnesses including cancers.  This study focuses on the anticancer effects of gedunin, a natural compound isolated from Azadirachta indica.  METHODS:  Anti-proliferative effect of gedunin on pancreatic cancer cells was assessed using MTS assay.  We used matrigel invasion assay, scratch assay, and soft agar colony formation assay to measure the anti-metastatic potential of gedunin.  Immunoblotting was performed to analyze the effect of gedunin on the expression of key proteins involved in pancreatic cancer growth and metastasis.  Gedunin induced apoptosis was measured using flow cytometric analysis.  To further validate, xenograft studies with HPAC cells were performed.  RESULTS:  Gedunin treatment is highly effective in inducing death of pancreatic cancer cells via intrinsic and extrinsic mediated apoptosis.  Our data further indicates that gedunin inhibited metastasis of pancreatic cancer cells by decreasing their EMT, invasive, migratory and colony formation capabilities.  Gedunin treatment also inhibited sonic hedgehog signaling pathways.  Further, experiments with recombinant sonic hedgehog protein and Gli inhibitor (Gant-61) demonstrated that gedunin induces its anti-metastatic effect through inhibition of sonic hedgehog signaling.  The anti-cancer effect of gedunin was further validated using xenograft mouse model.  CONCLUSION:  Overall, our data suggests that gedunin could serve as a potent anticancer agent against pancreatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqYlHGuiBnVX6oPH0mYWL1fW6udTcc2ebRj-Cc9T1JNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fht1Omsw%253D%253D&md5=838e085eef92530d468c038d3a894a98</span></div><a href="/servlet/linkout?suffix=cit298&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8055%26sid%3Dliteratum%253Aachs%26aulast%3DSubramani%26aufirst%3DR.%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DNandy%26aufirst%3DS.%2BB.%26aulast%3DArumugam%26aufirst%3DA.%26aulast%3DCamacho%26aufirst%3DF.%26aulast%3DMedel%26aufirst%3DJ.%26aulast%3DAlabi%26aufirst%3DD.%26aulast%3DLakshmanaswamy%26aufirst%3DR.%26atitle%3DGedunin%2520inhibits%2520pancreatic%2520cancer%2520by%2520altering%2520sonic%2520hedgehog%2520signaling%2520pathway%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D10891%26epage%3D10904%26doi%3D10.18632%2Foncotarget.8055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref299"><div class="reference"><strong class="refLabel"><a href="#ref299" class="rightTabRefNumLink">299</a></strong><div class="NLM_citation" id="rightTab-cit299"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siva, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkanna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poornima, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divya Reddy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boustie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usha Rani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh Babu, K.</span></span> <span> </span><span class="NLM_article-title">New seco-limonoids from <i>Cipadessa baccifera</i>: Isolation, structure determination, synthesis and their antiproliferative activities</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2017.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.fitote.2017.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=28065696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref299/cit299&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Ogsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=34-40&author=B.+Sivaauthor=A.+Venkannaauthor=B.+Poornimaauthor=S.+Divya+Reddyauthor=J.+Boustieauthor=S.+Bastienauthor=N.+Jainauthor=P.+Usha+Raniauthor=K.+Suresh+Babu&title=New+seco-limonoids+from+Cipadessa+baccifera%3A+Isolation%2C+structure+determination%2C+synthesis+and+their+antiproliferative+activities&doi=10.1016%2Fj.fitote.2017.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit299R"><div class="casContent"><span class="casTitleNuber">299</span><div class="casTitle"><span class="NLM_cas:atitle">New seco-limonoids from Cipadessa baccifera: Isolation, structure determination, synthesis and their antiproliferative activities</span></div><div class="casAuthors">Siva, Bandi; Venkanna, Arramshetti; Poornima, Borra; Divya Reddy, Solipeta; Boustie, Joel; Bastien, Schnell; Jain, Nishant; Usha Rani, Pathipati; Suresh Babu, Katragadda</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-40</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A comprehensive reinvestigation of chem. constituents from CHCl3-sol. ext. of Cipadessa baccifera led to the isolation of two new limonoids 1, 2 together with six known compds. 3-8.  Their structures were established on the basis of extensive anal. of spectroscopic (IR, MS, 2D NMR) data.  Further, a series of cipaferen G (3) derivs. were efficiently synthesized utilizing Yamaguchi esterification (2, 4, 6-trichlorobenzoyl chloride, Et3N, THF, DMAP, toluene) at the C-3 position of the limonoids core, which is being reported for the first time.  The anti-proliferative activity of the isolates and the synthetic analogs were studied against HeLa, PANC 1, HepG2, SKNSH, MDA-MB-231 and IMR32 cancer cells using the sulforodamine B assay.  Among the tested compds., 13d and 13h manifested potent activity against IMR32, HepG2 cell lines with GI50 0.013 and 0.01 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraz0jU3UW0GrVg90H21EOLACvtfcHk0li2yuL23YaB7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Ogsg%253D%253D&md5=1c43c961fca04b5bc00fa9a28a4a03d8</span></div><a href="/servlet/linkout?suffix=cit299&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2017.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2017.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DSiva%26aufirst%3DB.%26aulast%3DVenkanna%26aufirst%3DA.%26aulast%3DPoornima%26aufirst%3DB.%26aulast%3DDivya%2BReddy%26aufirst%3DS.%26aulast%3DBoustie%26aufirst%3DJ.%26aulast%3DBastien%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DUsha%2BRani%26aufirst%3DP.%26aulast%3DSuresh%2BBabu%26aufirst%3DK.%26atitle%3DNew%2520seco-limonoids%2520from%2520Cipadessa%2520baccifera%253A%2520Isolation%252C%2520structure%2520determination%252C%2520synthesis%2520and%2520their%2520antiproliferative%2520activities%26jtitle%3DFitoterapia%26date%3D2017%26volume%3D117%26spage%3D34%26epage%3D40%26doi%3D10.1016%2Fj.fitote.2017.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref300"><div class="reference"><strong class="refLabel"><a href="#ref300" class="rightTabRefNumLink">300</a></strong><div class="NLM_citation" id="rightTab-cit300"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekong, D. E. U.</span></span> <span> </span><span class="NLM_article-title">Chemistry of the meliacins (limonoids). The structure of nimbolide, a new meliacin from <i>Azadirachta indica</i></span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_fpage">808</span>, <span class="refDoi"> DOI: 10.1039/C1967000808A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1039%2FC1967000808A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaF1cXitFyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1967&pages=808&author=D.+E.+U.+Ekong&title=Chemistry+of+the+meliacins+%28limonoids%29.+The+structure+of+nimbolide%2C+a+new+meliacin+from+Azadirachta+indica&doi=10.1039%2FC1967000808A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit300R"><div class="casContent"><span class="casTitleNuber">300</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of the meliacins (Limonoids).  Structure of nimbolide, a new meliacin from Azadirachta indica</span></div><div class="casAuthors">Ekong, Donald E. U.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (London)</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">808</span>CODEN:
                <span class="NLM_cas:coden">CCOMA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-241X</span>.
    </div><div class="casAbstract">Extn. of fresh leaves of Nigerian samples of A. indica yielded a new meliacin, nimbolide (I), m. 245-7°, [α]D 206°.  The structure was assigned on the basis of N.M.R. and ir data.  Partial hydrogenation of I gave a dihydro deriv. which was hydrolyzed with dil. alkali to give deacetyldihydronimbic acid, m. 192-4°, [α]D 217° (pyridine) reported earlier (Sengupta, et al., CA 55: 4574e).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJ1CsTD0T3LVg90H21EOLACvtfcHk0lgUXiReH7bkAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXitFyltQ%253D%253D&md5=3d4acd5eabb55b76b343a4b0f5ae0f96</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.1039%2FC1967000808A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1967000808A%26sid%3Dliteratum%253Aachs%26aulast%3DEkong%26aufirst%3DD.%2BE.%2BU.%26atitle%3DChemistry%2520of%2520the%2520meliacins%2520%2528limonoids%2529.%2520The%2520structure%2520of%2520nimbolide%252C%2520a%2520new%2520meliacin%2520from%2520Azadirachta%2520indica%26jtitle%3DChem.%2520Commun.%26date%3D1967%26spage%3D808%26doi%3D10.1039%2FC1967000808A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref301"><div class="reference"><strong class="refLabel"><a href="#ref301" class="rightTabRefNumLink">301</a></strong><div class="NLM_citation" id="rightTab-cit301"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malathi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anitha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raj, J. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalakrishnan, G.</span></span> <span> </span><span class="NLM_article-title">The isomeric compounds nimbolide and isonimbolide</span>. <i>Acta Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>C61</i></span>,  <span class="NLM_fpage">o70</span>– <span class="NLM_lpage">o72</span>, <span class="refDoi"> DOI: 10.1107/S0108270104031385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1107%2FS0108270104031385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref301/cit301&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=C61&publication_year=2005&pages=o70-o72&author=K.+A.+Solomonauthor=R.+Malathiauthor=S.+S.+Rajanauthor=G.+Anithaauthor=J.+J.+L.+Rajauthor=S.+Narasimhanauthor=G.+Sureshauthor=G.+Gopalakrishnan&title=The+isomeric+compounds+nimbolide+and+isonimbolide&doi=10.1107%2FS0108270104031385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit301R"><div class="casContent"><span class="casTitleNuber">301</span><div class="casTitle"><span class="NLM_cas:atitle">The isomeric compounds nimbolide and isonimbolide</span></div><div class="casAuthors">Malathi, R.; Anitha, G.; Solomon, K. Anand; Suresh, G.; Rajan, S. S.; Narasimhan, S.; Raj, J. Josepha Lourdu; Gopalakrishnan, Geetha</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Crystal Structure Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">C61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">o70-o72</span>CODEN:
                <span class="NLM_cas:coden">ACSCEE</span>;
        ISSN:<span class="NLM_cas:issn">0108-2701</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Nimbolide [systematic name: (4α,5α,6α,7α,15β,17α)-7,15:21,23-diepoxy-6-hydroxy-4,8-dimethyl-1-oxo-18,24-dinor-11,12-secochola-2,13,20,22-tetraene-4,11-dicarboxylic acid γ-lactone Me ester], C27H30O7, was isolated from the leaves of Azadirachta indica, and its isomer, isonimbolide [systematic name: (4α,5α,6α,7α,15α)-7,15:21,23-diepoxy-6-hydroxy-4,8-dimethyl-1-oxo-18,24-dinor-11,12-secochola-2,16,20,22-tetraene-4,11-dicarboxylic acid γ-lactone Me ester], was prepd. from a novel rearrangement reaction of nimbolide, using B trifluoride etherate and Bu4NBr.  The reaction conditions are probably responsible for the ether cleavage, double-bond rearrangement and reformation of the ether linkage.  As a result, there are conformational changes in two cyclopentane rings and the side-chain -CH2COOMe group.  In isonimbolide, an R44(24) H-bond motif is obsd.  Crystallog. data are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRhAvCkE9rx7Vg90H21EOLACvtfcHk0lgUXiReH7bkAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslWhsg%253D%253D&md5=5877bf3e1a96c15a4970d66a71463b84</span></div><a href="/servlet/linkout?suffix=cit301&amp;dbid=16384&amp;doi=10.1107%2FS0108270104031385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108270104031385%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DK.%2BA.%26aulast%3DMalathi%26aufirst%3DR.%26aulast%3DRajan%26aufirst%3DS.%2BS.%26aulast%3DAnitha%26aufirst%3DG.%26aulast%3DRaj%26aufirst%3DJ.%2BJ.%2BL.%26aulast%3DNarasimhan%26aufirst%3DS.%26aulast%3DSuresh%26aufirst%3DG.%26aulast%3DGopalakrishnan%26aufirst%3DG.%26atitle%3DThe%2520isomeric%2520compounds%2520nimbolide%2520and%2520isonimbolide%26jtitle%3DActa%2520Crystallogr.%26date%3D2005%26volume%3DC61%26spage%3Do70%26epage%3Do72%26doi%3D10.1107%2FS0108270104031385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref302"><div class="reference"><strong class="refLabel"><a href="#ref302" class="rightTabRefNumLink">302</a></strong><div class="NLM_citation" id="rightTab-cit302"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodduluru, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasala, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thota, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barua, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistla, R.</span></span> <span> </span><span class="NLM_article-title">Chemopreventive and therapeutic effects of nimbolide in cancer: The underlying mechanisms</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1026</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2014.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tiv.2014.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=24759803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref302/cit302&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVSjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1026-1035&author=L.+N.+Bodduluruauthor=E.+R.+Kasalaauthor=N.+Thotaauthor=C.+C.+Baruaauthor=R.+Sistla&title=Chemopreventive+and+therapeutic+effects+of+nimbolide+in+cancer%3A+The+underlying+mechanisms&doi=10.1016%2Fj.tiv.2014.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit302R"><div class="casContent"><span class="casTitleNuber">302</span><div class="casTitle"><span class="NLM_cas:atitle">Chemopreventive and therapeutic effects of nimbolide in cancer: The underlying mechanisms</span></div><div class="casAuthors">Bodduluru, Lakshmi Narendra; Kasala, Eshvendar Reddy; Thota, Nagaraju; Barua, Chandana C.; Sistla, Ramakrishna</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1026-1035</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer chemoprevention is a strategy taken to block, reverse or retard the multistep process of carcinogenesis, including the blockage of its vital morphogenetic milestones viz. normal-preneoplasia-neoplasia-metastasis.  Naturally occurring phytochems. are becoming increasingly popular over synthetic drugs for several reasons, including safety, efficacy and easy availability.  Nimbolide, a triterpene derived from the leaves and flowers of neem, is widely used in traditional medical practices for treating various human ailments.  The neem limonoid exhibits multiple pharmacol. effects among which its anticancer activity is the most promising.  The preclin. and mechanistic studies carried over the decades have shown that nimbolide inhibits tumorigenesis and metastasis without any toxicity and unwanted side effects.  Nimbolide exhibits anticancer activity through selective modulation of multiple cell signaling pathways linked to inflammation, survival, growth, invasion, angiogenesis and metastasis.  The present review highlights the current knowledge on mol. targets that contribute to the obsd. anticancer activity of nimbolide related to (i) inhibition of carcinogenic activation and induction of antioxidant and carcinogen detoxification enzymes, (ii) induction of growth arrest and apoptosis; and (iii) suppression of proinflammatory signaling pathways related to cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw6LNFCh0SfrVg90H21EOLACvtfcHk0lho6LippZbUuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVSjurw%253D&md5=2960e01d6a1432bcc1f7dfd44565b773</span></div><a href="/servlet/linkout?suffix=cit302&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2014.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2014.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBodduluru%26aufirst%3DL.%2BN.%26aulast%3DKasala%26aufirst%3DE.%2BR.%26aulast%3DThota%26aufirst%3DN.%26aulast%3DBarua%26aufirst%3DC.%2BC.%26aulast%3DSistla%26aufirst%3DR.%26atitle%3DChemopreventive%2520and%2520therapeutic%2520effects%2520of%2520nimbolide%2520in%2520cancer%253A%2520The%2520underlying%2520mechanisms%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2014%26volume%3D28%26spage%3D1026%26epage%3D1035%26doi%3D10.1016%2Fj.tiv.2014.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref303"><div class="reference"><strong class="refLabel"><a href="#ref303" class="rightTabRefNumLink">303</a></strong><div class="NLM_citation" id="rightTab-cit303"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, D. D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuya, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, A. L.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P. C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, B. C.</span></span> <span> </span><span class="NLM_article-title">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">44790</span>– <span class="NLM_lpage">44802</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.18632%2Foncotarget.8316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27027349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref303/cit303&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=44790-44802&author=L.+Wangauthor=D.+D.+K.+Phanauthor=J.+Zhangauthor=P.-S.+Ongauthor=W.+L.+Thuyaauthor=R.+Sooauthor=A.+L.-A.+Wongauthor=W.+P.+Yongauthor=S.+C.+Leeauthor=P.+C.-L.+Hoauthor=G.+Sethiauthor=B.+C.+Goh&title=Anticancer+properties+of+nimbolide+and+pharmacokinetic+considerations+to+accelerate+its+development&doi=10.18632%2Foncotarget.8316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit303R"><div class="casContent"><span class="casTitleNuber">303</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development</span></div><div class="casAuthors">Wang Lingzhi; Phan Do Dang Khoa; Thuya Win Lwin; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher; Wang Lingzhi; Zhang Jingwen; Sethi Gautam; Goh Boon Cher; Phan Do Dang Khoa; Ong Pei-Shi; Thuya Win Lwin; Ho Paul Chi-Lui; Soo Ross; Wong Andrea Li-Ann; Yong Wei Peng; Lee Soo Chin; Goh Boon Cher</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">44790-44802</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nimbolide is one of the main components in the leaf extract of Azadirachta indica (A. indica).  Accumulating evidence from various in vitro and in vivo studies indicates that nimbolide possesses potent anticancer activity against several types of cancer and also shows potential chemopreventive activity in animal models.  The main mechanisms of action of nimbolide include anti-proliferation, induction of apoptosis, inhibition of metastasis and angiogenesis, and modulation of carcinogen-metabolizing enzymes.  Although multiple pharmacodynamic (PD) studies have been carried out, nimbolide is still at the infant stage in the drug development pipeline due to the lack of systematic pharmacokinetic (PK) studies and long-term toxicological studies.  Preclinical PK and toxicological studies are vital in determining the dosage range to support the safety of nimbolide for first-in-human clinical trials.  In this review, we will provide a comprehensive summary for the current status of nimbolide as an anticancer and chemopreventive lead compound, and highlight the importance of systematic preclinical PK and toxicological studies in accelerating the process of application of nimbolide as a therapeutic agent against various malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi_DV2txfJVny-c-E1v-fmfW6udTcc2eYDOQjbMclhsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fkvVGrsg%253D%253D&md5=67bb5ca109816b6a367c1ed03239fe76</span></div><a href="/servlet/linkout?suffix=cit303&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8316%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPhan%26aufirst%3DD.%2BD.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DOng%26aufirst%3DP.-S.%26aulast%3DThuya%26aufirst%3DW.%2BL.%26aulast%3DSoo%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DA.%2BL.-A.%26aulast%3DYong%26aufirst%3DW.%2BP.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DP.%2BC.-L.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DGoh%26aufirst%3DB.%2BC.%26atitle%3DAnticancer%2520properties%2520of%2520nimbolide%2520and%2520pharmacokinetic%2520considerations%2520to%2520accelerate%2520its%2520development%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D44790%26epage%3D44802%26doi%3D10.18632%2Foncotarget.8316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref304"><div class="reference"><strong class="refLabel"><a href="#ref304" class="rightTabRefNumLink">304</a></strong><div class="NLM_citation" id="rightTab-cit304"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kigodi, P. G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blasko, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebtaranonth, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezzuto, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordell, G. A.</span></span> <span> </span><span class="NLM_article-title">Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from <i>Azadirachta indica</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1246</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1021/np50066a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50066a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref304/cit304&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK3cXhsFGhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1989&pages=1246-1251&author=P.+G.+K.+Kigodiauthor=G.+Blaskoauthor=Y.+Thebtaranonthauthor=J.+M.+Pezzutoauthor=G.+A.+Cordell&title=Spectroscopic+and+biological+investigation+of+nimbolide+and+28-deoxonimbolide+from+Azadirachta+indica&doi=10.1021%2Fnp50066a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit304R"><div class="casContent"><span class="casTitleNuber">304</span><div class="casTitle"><span class="NLM_cas:atitle">Spectroscopic and biological investigation of nimbolide and 28-deoxonimbolide from Azadirachta indica</span></div><div class="casAuthors">Kigodi, Phillip G. K.; Blasko, Gabor; Thebtaranonth, Yodhathai; Pezzuto, John M.; Cordell, Geoffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1246-51</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">The reisolation of nimbolide (I) from A. indica of Tanzanian origin and the isolation and structure elucidation of a new limonoid, 28-deoxonimbolide (II), from the same plant source are reported.  For the first time, unambiguous 1H- and 13C-NMR assignments of compds. I and II are presented, as well as their in vitro cytotoxic activity against human tumor cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEWxq_WLQotrVg90H21EOLACvtfcHk0liq7l-esC7KgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhsFGhsLo%253D&md5=c0eceb9758deea1521533579e9167363</span></div><a href="/servlet/linkout?suffix=cit304&amp;dbid=16384&amp;doi=10.1021%2Fnp50066a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50066a008%26sid%3Dliteratum%253Aachs%26aulast%3DKigodi%26aufirst%3DP.%2BG.%2BK.%26aulast%3DBlasko%26aufirst%3DG.%26aulast%3DThebtaranonth%26aufirst%3DY.%26aulast%3DPezzuto%26aufirst%3DJ.%2BM.%26aulast%3DCordell%26aufirst%3DG.%2BA.%26atitle%3DSpectroscopic%2520and%2520biological%2520investigation%2520of%2520nimbolide%2520and%252028-deoxonimbolide%2520from%2520Azadirachta%2520indica%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1989%26volume%3D52%26spage%3D1246%26epage%3D1251%26doi%3D10.1021%2Fnp50066a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref305"><div class="reference"><strong class="refLabel"><a href="#ref305" class="rightTabRefNumLink">305</a></strong><div class="NLM_citation" id="rightTab-cit305"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elumalai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunadharini, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senthilkumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banudevi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunkumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharmila, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunakaran, J.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2012.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.toxlet.2012.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23089555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref305/cit305&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2012&pages=131-142&author=P.+Elumalaiauthor=D.+N.+Gunadhariniauthor=K.+Senthilkumarauthor=S.+Banudeviauthor=R.+Arunkumarauthor=C.+S.+Bensonauthor=G.+Sharmilaauthor=J.+Arunakaran&title=Induction+of+apoptosis+in+human+breast+cancer+cells+by+nimbolide+through+extrinsic+and+intrinsic+pathway&doi=10.1016%2Fj.toxlet.2012.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit305R"><div class="casContent"><span class="casTitleNuber">305</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway</span></div><div class="casAuthors">Elumalai, P.; Gunadharini, D. N.; Senthilkumar, K.; Banudevi, S.; Arunkumar, R.; Benson, C. S.; Sharmila, G.; Arunakaran, J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-142</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">We aimed to investigate the cytotoxic effects of nimbolide, a limonoid present in leaves and flowers of the neem tree (Azadirachta indica) on human breast cancer cells.  The mol. mechanisms involved in the apoptotic activity exerted by nimbolide were studied on the estrogen dependent (MCF-7) and estrogen independent (MDA-MB-231) human breast cancer cell lines.  The growth inhibitory effect of nimbolide was assessed by MTT assay.  Apoptosis induction by nimbolide treatment was detd. by JC-1 mitochondrial membrane potential staining, cytochrome c release, caspase activation, cleavage of PARP and AO/EtBr dual staining.  The modulation of apoptotic proteins (intrinsic pathway: Bax, bad, Bcl-2, Bcl-xL, Mcl-1, XIAP-1 and caspase-3, 9; extrinsic pathway: TRAIL, FasL, FADDR and Caspase-8) were studied by western blot and real time PCR anal.  Treatment with nimbolide resulted in dose and time-dependent inhibition of growth of MCF-7 and MDA-MB-231 cells.  The occurrence of apoptosis in these cells was indicated by JC-1 staining, modulation of both intrinsic and extrinsic apoptotic signaling mols. expression and further apoptosis was confirmed by AO/EtBr dual staining.  These events were assocd. with: increased levels of proapoptotic proteins Bax, Bad, Fas-L, TRAIL, FADDR, cytochrome c and reduced levels of the anti-apoptotic proteins Bcl-2, Bcl-xL, Mcl-1 and XIAP-1.  Nimbolide induces the cleavage of pro-caspase-8, pro-caspase-3 and PARP.  The above data suggest that nimbolide induces apoptosis by both the intrinsic and extrinsic pathways.  With evidence of above data it is suggested that nimbolide exhibit anticancer effect through its apoptosis-inducing property.  Thus, nimbolide raises new hope for its use in anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu-R8QusMprVg90H21EOLACvtfcHk0liq7l-esC7KgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Gqu7nJ&md5=39fb463162d9c9fb21e707b2af5b2b1a</span></div><a href="/servlet/linkout?suffix=cit305&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2012.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DElumalai%26aufirst%3DP.%26aulast%3DGunadharini%26aufirst%3DD.%2BN.%26aulast%3DSenthilkumar%26aufirst%3DK.%26aulast%3DBanudevi%26aufirst%3DS.%26aulast%3DArunkumar%26aufirst%3DR.%26aulast%3DBenson%26aufirst%3DC.%2BS.%26aulast%3DSharmila%26aufirst%3DG.%26aulast%3DArunakaran%26aufirst%3DJ.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520nimbolide%2520through%2520extrinsic%2520and%2520intrinsic%2520pathway%26jtitle%3DToxicol.%2520Lett.%26date%3D2012%26volume%3D215%26spage%3D131%26epage%3D142%26doi%3D10.1016%2Fj.toxlet.2012.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref306"><div class="reference"><strong class="refLabel"><a href="#ref306" class="rightTabRefNumLink">306</a></strong><div class="NLM_citation" id="rightTab-cit306"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span> <span> </span><span class="NLM_article-title">In-vitro morphological assessment of apoptosis induced by nimbolide; a limonoid from <i>Azadirachta indica</i> (neem tree)</span>. <i>Iran. J. Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.22037/ijpr.2019.2391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.22037%2Fijpr.2019.2391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31531067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref306/cit306&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslWjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=846-859&author=M.+Kashifauthor=Y.+Hwangauthor=W.-J.+Kimauthor=G.+Kim&title=In-vitro+morphological+assessment+of+apoptosis+induced+by+nimbolide%3B+a+limonoid+from+Azadirachta+indica+%28neem+tree%29&doi=10.22037%2Fijpr.2019.2391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit306R"><div class="casContent"><span class="casTitleNuber">306</span><div class="casTitle"><span class="NLM_cas:atitle">In-vitro morphological assessment of apoptosis induced by nimbolide; a limonoid from Azadirachta Indica (Neem Tree)</span></div><div class="casAuthors">Kashif, Muhammad; Hwang, Yawon; Kim, Wun-Jae; Kim, Gonhyung</div><div class="citationInfo"><span class="NLM_cas:title">Iranian Journal of Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">IJPRC9</span>;
        ISSN:<span class="NLM_cas:issn">1726-6890</span>.
    
            (<span class="NLM_cas:orgname">Shaheed Beheshti University of Medical Sciences and Health Services, School of Pharmacy</span>)
        </div><div class="casAbstract">The present study was designed to investigate the in-vitro morphol. assessment of apoptotic effect caused by nimbolide on the selected cancer cell lines (DU-145, PC-3, A-549) and normal cell lines (NIH3T3, CCD-18Co).  The cells were grown in 6 well tissue culture plates after treatment with different concns. of nimbolide and untreated control cells.  Apoptotic and necrotic cells were measured using Hoechst 33342 and propidium iodide dual staining through a fluorescent microscope and also by staining with annexin V and propidium iodide through flow cytometric anal.  The activity of caspase 3, 8, and 9 was measured by caspases colorimetric assay kits.  The no. of apoptotic and necrotic cells were significantly higher in all selected cancer cell lines treated with nimbolide as compared with untreated control cells, whereas in normal cell lines no significant difference was obsd. between nimbolide treated and untreated cells.  The activity of caspase 3, 8, and 9 was also significantly higher in all cancer cell lines treated with nimbolide as compared with untreated control cells while it did not change significantly in normal cell lines as compared with untreated control.  The results of the present study suggested that nimbolide induced apoptosis only in cancer cells without affecting the normal cells and one of the apoptosis inducing mechanism is through the activation of caspases signaling pathways.  Therefore, nimbolide may be a novel promising candidate as an anticancer drug in future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-Y7uLRJX5rVg90H21EOLACvtfcHk0lhCMJb1HrcFRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslWjs74%253D&md5=b847513080499ac9c6b989307aab881b</span></div><a href="/servlet/linkout?suffix=cit306&amp;dbid=16384&amp;doi=10.22037%2Fijpr.2019.2391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.22037%252Fijpr.2019.2391%26sid%3Dliteratum%253Aachs%26aulast%3DKashif%26aufirst%3DM.%26aulast%3DHwang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DW.-J.%26aulast%3DKim%26aufirst%3DG.%26atitle%3DIn-vitro%2520morphological%2520assessment%2520of%2520apoptosis%2520induced%2520by%2520nimbolide%253B%2520a%2520limonoid%2520from%2520Azadirachta%2520indica%2520%2528neem%2520tree%2529%26jtitle%3DIran.%2520J.%2520Pharm.%2520Res.%26date%3D2019%26volume%3D18%26spage%3D846%26epage%3D859%26doi%3D10.22037%2Fijpr.2019.2391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref307"><div class="reference"><strong class="refLabel"><a href="#ref307" class="rightTabRefNumLink">307</a></strong><div class="NLM_citation" id="rightTab-cit307"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inigo, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attwood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span> <span> </span><span class="NLM_article-title">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref307/cit307&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.canlet.2017.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref307/cit307&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29107110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref307/cit307&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2018&pages=82-93&author=S.+Kumarauthor=J.+R.+Inigoauthor=R.+Kumarauthor=A.+K.+Chaudharyauthor=J.+O%E2%80%99Malleyauthor=S.+Balachandarauthor=J.+Wangauthor=K.+Attwoodauthor=N.+Yadavauthor=S.+Hochwaldauthor=X.+Wangauthor=D.+Chandra&title=Nimbolide+reduces+CD44+positive+cell+population+and+induces+mitochondrial+apoptosis+in+pancreatic+cancer+cells&doi=10.1016%2Fj.canlet.2017.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit307R"><div class="casContent"><span class="casTitleNuber">307</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells</span></div><div class="casAuthors">Kumar, Sandeep; Inigo, Joseph R.; Kumar, Rahul; Chaudhary, Ajay K.; O'Malley, Jordan; Balachandar, Srimmitha; Wang, Jianmin; Attwood, Kristopher; Yadav, Neelu; Hochwald, Steven; Wang, Xinjiang; Chandra, Dhyan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive disease and current treatment regimens fail to effectively cure PDAC.  Development of resistance to current therapy is one of the key reasons for this outcome.  Nimbolide (NL), a triterpenoid obtained from Azadirachta indica, exhibits anticancer properties in various cancer including PDAC cells.  However, the underlying mechanism of this anticancer agent in PDAC cells remains undefined.  We show that NL exerts a higher level of apoptotic cell death compared to the first-line agent gemcitabine for PDAC, as well as other anticancer agents including sorafenib and curcumin.  The anticancer efficacy of NL was further evidenced by a redn. in the CD44+ as well as cancer stem-like cell (CSC) population, as it causes decreased sphere formation.  Mechanistically, the anticancer efficacy of NL assocs. with reduced mutant p53 as well as increased mitochondrial activity in the form of increased mitochondrial reactive oxygen species and mitochondrial mass.  Together, this study highlights the therapeutic potential of NL in mutant p53 expressing pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWaM4J0Gt34LVg90H21EOLACvtfcHk0lhh0tg9pt1ZYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2lsL7I&md5=200e394249c261cc9bce68f32d88cc2c</span></div><a href="/servlet/linkout?suffix=cit307&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DInigo%26aufirst%3DJ.%2BR.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DChaudhary%26aufirst%3DA.%2BK.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DJ.%26aulast%3DBalachandar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAttwood%26aufirst%3DK.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DHochwald%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChandra%26aufirst%3DD.%26atitle%3DNimbolide%2520reduces%2520CD44%2520positive%2520cell%2520population%2520and%2520induces%2520mitochondrial%2520apoptosis%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D413%26spage%3D82%26epage%3D93%26doi%3D10.1016%2Fj.canlet.2017.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref308"><div class="reference"><strong class="refLabel"><a href="#ref308" class="rightTabRefNumLink">308</a></strong><div class="NLM_citation" id="rightTab-cit308"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethumadhavan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4465</span>– <span class="NLM_lpage">4476</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-0080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref308/cit308&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1158%2F1078-0432.CCR-13-0080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref308/cit308&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23766363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref308/cit308&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4465-4476&author=S.+C.+Guptaauthor=S.+Prasadauthor=D.+R.+Sethumadhavanauthor=M.+S.+Nairauthor=Y.-Y.+Moauthor=B.+B.+Aggarwal&title=Nimbolide%2C+a+limonoid+triterpene%2C+inhibits+growth+of+human+colorectal+cancer+xenografts+by+suppressing+the+proinflammatory+microenvironment&doi=10.1158%2F1078-0432.CCR-13-0080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit308R"><div class="casContent"><span class="casTitleNuber">308</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment</span></div><div class="casAuthors">Gupta, Subash C.; Prasad, Sahdeo; Sethumadhavan, Dhanya R.; Nair, Mangalam S.; Mo, Yin-Yuan; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4465-4476</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Extensive research over the past decade has revealed that the proinflammatory microenvironment plays a crit. role in the development of colorectal cancer.  Whether nimbolide, a limonoid triterpene, can inhibit the growth of colorectal cancer was investigated in the present study.  Exptl. Design: The effect of nimbolide on proliferation of colorectal cancer cell lines was examd. by MTT assay, apoptosis by caspase activation and poly-ADP ribose polymerase cleavage, NF-κB activation by DNA-binding assay, and protein expression by Western blotting.  The effect of nimbolide on the tumor growth in vivo was examd. in colorectal cancer xenografts in a nude mouse model.  Results: Nimbolide inhibited proliferation, induced apoptosis, and suppressed NF-κB activation and NF-κB-regulated tumorigenic proteins in colorectal cancer cells.  The suppression of NF-κB activation by nimbolide was caused by sequential inhibition of IκB kinase (IKK) activation, IκBα phosphorylation, and p65 nuclear translocation.  Furthermore, the effect of nimbolide on IKK activity was found to be direct.  In vivo, nimbolide (at 5 and 20 mg/kg body wt.), injected i.p. after tumor inoculation, significantly decreased the vol. of colorectal cancer xenografts.  The limonoid-treated xenografts exhibited significant downregulation in the expression of proteins involved in tumor cell survival (Bcl-2, Bcl-xL, c-IAP-1, survivin, and Mcl-1), proliferation (c-Myc and cyclin D1), invasion (MMP-9, ICAM-1), metastasis (CXCR4), and angiogenesis (VEGF).  The limonoid was found to be bioavailable in the blood plasma and tumor tissues of treated mice.  Conclusions: Our studies provide evidence that nimbolide can suppress the growth of human colorectal cancer through modulation of the proinflammatory microenvironment.  Clin Cancer Res; 19(16); 4465-76. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30IQjfm0ztrVg90H21EOLACvtfcHk0lhh0tg9pt1ZYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSitrzP&md5=3d2f0873757d724a55912403c5647464</span></div><a href="/servlet/linkout?suffix=cit308&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-0080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-0080%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DSethumadhavan%26aufirst%3DD.%2BR.%26aulast%3DNair%26aufirst%3DM.%2BS.%26aulast%3DMo%26aufirst%3DY.-Y.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DNimbolide%252C%2520a%2520limonoid%2520triterpene%252C%2520inhibits%2520growth%2520of%2520human%2520colorectal%2520cancer%2520xenografts%2520by%2520suppressing%2520the%2520proinflammatory%2520microenvironment%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4465%26epage%3D4476%26doi%3D10.1158%2F1078-0432.CCR-13-0080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref309"><div class="reference"><strong class="refLabel"><a href="#ref309" class="rightTabRefNumLink">309</a></strong><div class="NLM_citation" id="rightTab-cit309"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsueh, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.-H.</span></span> <span> </span><span class="NLM_article-title">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span>. <i>Environ. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1002/tox.22576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref309/cit309&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Ftox.22576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref309/cit309&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29962003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref309/cit309&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=913-922&author=K.-C.+Hsuehauthor=C.-L.+Linauthor=J.-N.+Tungauthor=S.-F.+Yangauthor=Y.-H.+Hsieh&title=Nimbolide+induced+apoptosis+by+activating+ERK-mediated+inhibition+of+c-IAP1+expression+in+human+hepatocellular+carcinoma+cells&doi=10.1002%2Ftox.22576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit309R"><div class="casContent"><span class="casTitleNuber">309</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Hsueh, Kuan-Chun; Lin, Chia-Liang; Tung, Jai-Nien; Yang, Shun-Fa; Hsieh, Yi-Hsien</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Toxicology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">ETOXFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-4081</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Nimbolide is one of the major compds. from the leaves and flowers of the neem tree and exhibits antitumor properties on various cancer cells.  However, no report has shown that nimbolide induces apoptosis in vitro and in vivo in human hepatocellular carcinoma cells.  Our results indicated that it inhibited cell growth in Huh-7 and PLC/PRF/5 cells.  We also found that nimbolide induced cell death through the induction of G2/M phase arrest and mitochondrial dysfunction, accompanied by the increased expression of cleaved caspase-7, caspase-9, caspase-3, caspase-PARP, and Bax and decreased expression of Mcl-1 and Bcl-2.  A human apoptosis antibody array anal. demonstrated that inhibition of the apoptosis family proteins (XIAP, c-IAP1, and c-IAP2) was one of the major targets of nimbolide.  Addnl., nimbolide sustained activation of ERK expression.  Moreover, pretreatment with U0126 (MEK inhibitor) markedly abolished nimbolide-inhibited cell viability, induced cell apoptosis, ERK phosphorylation, cleaved caspase-9, caspase-3, cleaved-PARP activation, and increased c-IAP1 expression in Huh-7 cells.  An in vivo study showed that nimbolide significantly reduced Huh-7 tumor growth and wt. in a xenograft mouse model.  This study indicated the antitumor potential of nimbolide in human hepatocellular carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolM-4DfaR-WrVg90H21EOLACvtfcHk0liNYAgI8LhKCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1eisLjL&md5=31599c2e87b293209bd66ec7c9f970b5</span></div><a href="/servlet/linkout?suffix=cit309&amp;dbid=16384&amp;doi=10.1002%2Ftox.22576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Ftox.22576%26sid%3Dliteratum%253Aachs%26aulast%3DHsueh%26aufirst%3DK.-C.%26aulast%3DLin%26aufirst%3DC.-L.%26aulast%3DTung%26aufirst%3DJ.-N.%26aulast%3DYang%26aufirst%3DS.-F.%26aulast%3DHsieh%26aufirst%3DY.-H.%26atitle%3DNimbolide%2520induced%2520apoptosis%2520by%2520activating%2520ERK-mediated%2520inhibition%2520of%2520c-IAP1%2520expression%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DEnviron.%2520Toxicol.%26date%3D2018%26volume%3D33%26spage%3D913%26epage%3D922%26doi%3D10.1002%2Ftox.22576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref310"><div class="reference"><strong class="refLabel"><a href="#ref310" class="rightTabRefNumLink">310</a></strong><div class="NLM_citation" id="rightTab-cit310"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sophia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowshik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhutia, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manavathi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagini, S.</span></span> <span> </span><span class="NLM_article-title">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1087</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-1126-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref310/cit310&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1038%2Fs41419-018-1126-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref310/cit310&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=30352996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref310/cit310&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1087&author=J.+Sophiaauthor=J.+Kowshikauthor=A.+Dwivediauthor=S.+K.+Bhutiaauthor=B.+Manavathiauthor=R.+Mishraauthor=S.+Nagini&title=Nimbolide%2C+a+neem+limonoid+inhibits+cytoprotective+autophagy+to+activate+apoptosis+via+modulation+of+the+PI3K%2FAkt%2FGSK-3%CE%B2+signalling+pathway+in+oral+cancer&doi=10.1038%2Fs41419-018-1126-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit310R"><div class="casContent"><span class="casTitleNuber">310</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer</span></div><div class="casAuthors">Sophia Josephraj; Kowshik Jaganathan; Nagini Siddavaram; Dwivedi Anju; Manavathi Bramanandam; Bhutia Sujit K; Mishra Rajakishore</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1087</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects.  The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3β and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells.  Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis.  Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs.  Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy.  Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis.  Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3β(Tyr216), the active form of GSK-3β that inhibits autophagy.  Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide.  Analysis of key markers of apoptosis and autophagy as well as p-Akt(Ser473) during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors.  In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3β as well as the ncRNAs miR-126 and HOTAIR.  Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUFUIs6wFK5xJfW6udTcc2eYxXLV_FD9hMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSltA%253D%253D&md5=dca3631d9b3de9fa6c58e5c843002d63</span></div><a href="/servlet/linkout?suffix=cit310&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-1126-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-1126-4%26sid%3Dliteratum%253Aachs%26aulast%3DSophia%26aufirst%3DJ.%26aulast%3DKowshik%26aufirst%3DJ.%26aulast%3DDwivedi%26aufirst%3DA.%26aulast%3DBhutia%26aufirst%3DS.%2BK.%26aulast%3DManavathi%26aufirst%3DB.%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DNagini%26aufirst%3DS.%26atitle%3DNimbolide%252C%2520a%2520neem%2520limonoid%2520inhibits%2520cytoprotective%2520autophagy%2520to%2520activate%2520apoptosis%2520via%2520modulation%2520of%2520the%2520PI3K%252FAkt%252FGSK-3%25CE%25B2%2520signalling%2520pathway%2520in%2520oral%2520cancer%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D1087%26doi%3D10.1038%2Fs41419-018-1126-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref311"><div class="reference"><strong class="refLabel"><a href="#ref311" class="rightTabRefNumLink">311</a></strong><div class="NLM_citation" id="rightTab-cit311"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooladanda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondi, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottumukkala, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span> <span> </span><span class="NLM_article-title">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2018.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref311/cit311&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.tiv.2018.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref311/cit311&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29778718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref311/cit311&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=114-128&author=V.+Pooladandaauthor=S.+Bandiauthor=S.+R.+Mondiauthor=K.+M.+Gottumukkalaauthor=C.+Godugu&title=Nimbolide+epigenetically+regulates+autophagy+and+apoptosis+in+breast+cancer&doi=10.1016%2Fj.tiv.2018.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit311R"><div class="casContent"><span class="casTitleNuber">311</span><div class="casTitle"><span class="NLM_cas:atitle">Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer</span></div><div class="casAuthors">Pooladanda, Venkatesh; Bandi, Soumya; Mondi, Sandhya Rani; Gottumukkala, Krishna Mohan; Godugu, Chandraiah</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-128</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Autophagy is a crit. regulator of cellular homeostasis and its dysregulation often results in various disease manifestations, including cancer.  Nimbolide, an active chem. constituent of neem (Azadirachta indica) exhibits potent anticancer effects.  Although, nimbolide mediated apoptosis activation in breast cancer cells is well known.  Nevertheless, its role in autophagy induction mechanism and epigenetic alteration is not explored previously.  The authors' current study intended to bridge the gaps in the existing research by exploring the potential of nimbolide in inducing autophagy, which could counter regulate the transformations in breast cancer.  In the authors' studies, nimbolide significantly inhibited the cell proliferation of MDA-MB-231 and MCF-7 cells with IC50 values of 1.97 and 5.04 μM, resp.  Nimbolide markedly arrested the cell cycle progression and cell survival with loss of mitochondrial membrane potential by reducing Bcl-2 concomitantly inducing Bax and caspases protein expression with modulation of HDAC-2 and H3K27Ac expression.  Consequently, characteristic autophagolysosome accumulation was obsd. by acridine orange, monodansylcadaverine (MDC) and Lysotracker Red staining.  Moreover, nimbolide induced autophagy signaling by increasing Beclin 1 and LC3B along with decreased p62 and mTOR protein expression.  Thus, the authors' findings imply that nimbolide induces autophagy mediated apoptotic cell death in breast cancer with epigenetic modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEtzXopBYiOLVg90H21EOLACvtfcHk0liNYAgI8LhKCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVSgu7vM&md5=0585d8ebe91341dec1d41a27416e657b</span></div><a href="/servlet/linkout?suffix=cit311&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2018.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2018.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DPooladanda%26aufirst%3DV.%26aulast%3DBandi%26aufirst%3DS.%26aulast%3DMondi%26aufirst%3DS.%2BR.%26aulast%3DGottumukkala%26aufirst%3DK.%2BM.%26aulast%3DGodugu%26aufirst%3DC.%26atitle%3DNimbolide%2520epigenetically%2520regulates%2520autophagy%2520and%2520apoptosis%2520in%2520breast%2520cancer%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2018%26volume%3D51%26spage%3D114%26epage%3D128%26doi%3D10.1016%2Fj.tiv.2018.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref312"><div class="reference"><strong class="refLabel"><a href="#ref312" class="rightTabRefNumLink">312</a></strong><div class="NLM_citation" id="rightTab-cit312"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somagoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godugu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talluri, M. V. N. K.</span></span> <span> </span><span class="NLM_article-title">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span>. <i>J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1092</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/j.jchromb.2018.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref312/cit312&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.jchromb.2018.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref312/cit312&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29908468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref312/cit312&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1092&publication_year=2018&pages=191-198&author=S.+M.+Bairaauthor=A.+Khuranaauthor=J.+Somagoniauthor=R.+Srinivasauthor=C.+Goduguauthor=M.+V.+N.+K.+Talluri&title=First+report+on+the+pharmacokinetic+profile+of+nimbolide%2C+a+novel+anticancer+agent+in+oral+and+intravenous+administrated+rats+by+LC%2FMS+method&doi=10.1016%2Fj.jchromb.2018.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit312R"><div class="casContent"><span class="casTitleNuber">312</span><div class="casTitle"><span class="NLM_cas:atitle">First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method</span></div><div class="casAuthors">Baira, Shandilya Mahamuni; Khurana, Amit; Somagoni, Jaganmohan; Srinivas, R.; Godugu, Chandraiah; Talluri, M. V. N. Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1092</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nimbolide is a novel, natural compd. with promising potential as a drug candidate for anticancer activity.  It is isolated from the Indian traditional medicinal plant Azadirachta indica popularly known as neem.  The present study was undertaken to explore the oral bioavailability and pharmacokinetic characteristics of nimbolide in rats using the LC/QTOF/MS method.  A simple protein pptn. method using acetonitrile was employed for extg. nimbolide from rat plasma.  The chromatog. sepn. of nimbolide and the internal std. (regorafenib) was attained on an Aquity BEH C18 column (100×2.1mm, 2.7μm), using ACN and 0.1% of formic acid in water as mobile phase components in a gradient elution mode at a flow rate of 0.45mL/min over a short run time of 4min.  A mass detection was carried out using target ions of [M+H]+ at m/z 467.2074 for nimbolide and m/z 483.0847 for the internal std.  The LC/MS method was validated and all the parameters were found well within the specified limits.  The calibration curve was constructed in the range of 1-1000ng/mL.  The method shows good accuracy (91.66-97.12%) and precision (intra 2.21-6.92% CV and inter-day 2.56-4.62% CV).  This developed LC/MS method was effectively applied to the pharmacokinetic study of nimbolide upon oral and i.v. administration in rats.  In concordance with its physicochem. properties and high lipophilicity, we found that it shows poor oral absorption at different doses (10, 30 and 50mg/kg).  As expected, higher plasma levels were obsd. upon i.v. (10mg/kg) administration.  This method can be extended for evaluation of drug interaction and drug metab. in rats as well as in humans.  Moreover, our rapid and sensitive method may cater the need to accelerate the preclin. formulation development and lead optimization for future drug development of this potent anticancer agent.  Further, our oral bioavailability studies demonstrated that nimbolide possesses poor oral absorption, which could be the probable reason for the delay in therapeutic translation of this promising agent for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoozrI6BEnwjbVg90H21EOLACvtfcHk0ljpJhb_Y9opow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCqsb7E&md5=a59323ce4452b99ecc9e7b5bbbd102db</span></div><a href="/servlet/linkout?suffix=cit312&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2018.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBaira%26aufirst%3DS.%2BM.%26aulast%3DKhurana%26aufirst%3DA.%26aulast%3DSomagoni%26aufirst%3DJ.%26aulast%3DSrinivas%26aufirst%3DR.%26aulast%3DGodugu%26aufirst%3DC.%26aulast%3DTalluri%26aufirst%3DM.%2BV.%2BN.%2BK.%26atitle%3DFirst%2520report%2520on%2520the%2520pharmacokinetic%2520profile%2520of%2520nimbolide%252C%2520a%2520novel%2520anticancer%2520agent%2520in%2520oral%2520and%2520intravenous%2520administrated%2520rats%2520by%2520LC%252FMS%2520method%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2018%26volume%3D1092%26spage%3D191%26epage%3D198%26doi%3D10.1016%2Fj.jchromb.2018.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref313"><div class="reference"><strong class="refLabel"><a href="#ref313" class="rightTabRefNumLink">313</a></strong><div class="NLM_citation" id="rightTab-cit313"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polonsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varon, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnoux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of amoorastatin</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">7731</span>– <span class="NLM_lpage">7733</span>, <span class="refDoi"> DOI: 10.1021/ja00492a051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00492a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref313/cit313&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE1MXlsFWgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1978&pages=7731-7733&author=J.+Polonskyauthor=Z.+Varonauthor=B.+Arnouxauthor=C.+Pascardauthor=G.+R.+Pettitauthor=J.+M.+Schmidt&title=Isolation+and+structure+of+amoorastatin&doi=10.1021%2Fja00492a051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit313R"><div class="casContent"><span class="casTitleNuber">313</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic agents.  61.  Isolation and structure of amoorastatin</span></div><div class="casAuthors">Polonsky, Judith; Varon, Zoia; Arnoux, Bernadette; Pascard, Claudine; Pettit, George R.; Schmidt, Jean M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7731-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The structure of antineoplastic amoorastatin (I), isolated from seeds of Aphanamixis grandifolia, was detd. by mass spectroscopy, 1H-NMR comparison with aphanastatin, and x-ray crystal structure detn. of the (28R)-epimer of I.  Rings A and B of I have the chair conformation, ring C is in a boat conformation and ring D has an envelope-shape with C-17 out-of-plane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIiP9CWVZlorVg90H21EOLACvtfcHk0ljpJhb_Y9opow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXlsFWgtQ%253D%253D&md5=8aee9aaa815a601ba45c19537a8e5fd3</span></div><a href="/servlet/linkout?suffix=cit313&amp;dbid=16384&amp;doi=10.1021%2Fja00492a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00492a051%26sid%3Dliteratum%253Aachs%26aulast%3DPolonsky%26aufirst%3DJ.%26aulast%3DVaron%26aufirst%3DZ.%26aulast%3DArnoux%26aufirst%3DB.%26aulast%3DPascard%26aufirst%3DC.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DIsolation%2520and%2520structure%2520of%2520amoorastatin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1978%26volume%3D100%26spage%3D7731%26epage%3D7733%26doi%3D10.1021%2Fja00492a051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref314"><div class="reference"><strong class="refLabel"><a href="#ref314" class="rightTabRefNumLink">314</a></strong><div class="NLM_citation" id="rightTab-cit314"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polonsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varon, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marazano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnoux, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotsuki, H.</span></span> <span> </span><span class="NLM_article-title">The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatin</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1007/BF01949897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref314/cit314&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1007%2FBF01949897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref314/cit314&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=477905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref314/cit314&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaE1MXlsFChtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1979&pages=987-989&author=J.+Polonskyauthor=Z.+Varonauthor=C.+Marazanoauthor=B.+Arnouxauthor=G.+R.+Pettitauthor=J.+M.+Schmidauthor=M.+Ochiauthor=H.+Kotsuki&title=The+structure+of+amoorastatone+and+the+cytotoxic+limonoid+12-hydroxyamoorastatin&doi=10.1007%2FBF01949897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit314R"><div class="casContent"><span class="casTitleNuber">314</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatin</span></div><div class="casAuthors">Polonsky, Judith; Varon, Zoia; Marazano, C.; Arnoux, Bernadette; Pettit, G. R.; Schmid, J. M.; Ochi, M.; Kotsuki, H.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">987-9</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">Two new limonoid terpenes were isolated from aq. exts. of seeds from Aphanamixis grandifolia and were identified as 12-hydroxyamoorastatin (I) and amoorastatone (II) by mass spectra and NMR data.  Unequivocal evidence for the structural assignment of I was obtained by chem. conversion to sendanin.  I significantly inhibited growth of murine P388 lymphocytic leukemia cell lines, whereas II was inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTpkW87bq4I7Vg90H21EOLACvtfcHk0ljpJhb_Y9opow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXlsFChtbg%253D&md5=4570922bf69cfde7531102db32bb0fca</span></div><a href="/servlet/linkout?suffix=cit314&amp;dbid=16384&amp;doi=10.1007%2FBF01949897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01949897%26sid%3Dliteratum%253Aachs%26aulast%3DPolonsky%26aufirst%3DJ.%26aulast%3DVaron%26aufirst%3DZ.%26aulast%3DMarazano%26aufirst%3DC.%26aulast%3DArnoux%26aufirst%3DB.%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DSchmid%26aufirst%3DJ.%2BM.%26aulast%3DOchi%26aufirst%3DM.%26aulast%3DKotsuki%26aufirst%3DH.%26atitle%3DThe%2520structure%2520of%2520amoorastatone%2520and%2520the%2520cytotoxic%2520limonoid%252012-hydroxyamoorastatin%26jtitle%3DExperientia%26date%3D1979%26volume%3D35%26spage%3D987%26epage%3D989%26doi%3D10.1007%2FBF01949897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref315"><div class="reference"><strong class="refLabel"><a href="#ref315" class="rightTabRefNumLink">315</a></strong><div class="NLM_citation" id="rightTab-cit315"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-O.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic limonoids from <i>Melia azedarach</i> var. <i>japonica</i></span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1493</span>– <span class="NLM_lpage">1496</span>, <span class="refDoi"> DOI: 10.1016/S0031-9422(00)89749-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref315/cit315&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2FS0031-9422%2800%2989749-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref315/cit315&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADyaK2cXmslKks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=1493-1496&author=J.-W.+Ahnauthor=S.-U.+Choiauthor=C.-O.+Lee&title=Cytotoxic+limonoids+from+Melia+azedarach+var.+japonica&doi=10.1016%2FS0031-9422%2800%2989749-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit315R"><div class="casContent"><span class="casTitleNuber">315</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic limonoids from Melia azedarach var. Japonica</span></div><div class="casAuthors">Ahn, Jong-Woong; Choi, Sang-Un; Lee, Chong-Ock</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1493-6</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    </div><div class="casAbstract">Bioassay-guided chem. investigation of the stem bark of Melia azedarach var. Japonica has led to the isolation of a new limonoid 12-hydroxyamoorastatone (I) along with two known limonoids 12-hydroxyamoorastatin and 12-acetoxyamoorastatin.  The structure of the new compd. followed from spectral data and the stereochem. was detd. by NOE expt. on the di-p-bromobenzoate.  All three compds. exhibited significant cytotoxicities against five human tumor cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr16v03KOp3trVg90H21EOLACvtfcHk0ljutgsxKZiMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslKks7w%253D&md5=bcd0e3b9944d71092c82417fe5d673af</span></div><a href="/servlet/linkout?suffix=cit315&amp;dbid=16384&amp;doi=10.1016%2FS0031-9422%2800%2989749-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0031-9422%252800%252989749-6%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.-W.%26aulast%3DChoi%26aufirst%3DS.-U.%26aulast%3DLee%26aufirst%3DC.-O.%26atitle%3DCytotoxic%2520limonoids%2520from%2520Melia%2520azedarach%2520var.%2520japonica%26jtitle%3DPhytochemistry%26date%3D1994%26volume%3D36%26spage%3D1493%26epage%3D1496%26doi%3D10.1016%2FS0031-9422%2800%2989749-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref316"><div class="reference"><strong class="refLabel"><a href="#ref316" class="rightTabRefNumLink">316</a></strong><div class="NLM_citation" id="rightTab-cit316"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lone, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khuroo, M. A.</span></span> <span> </span><span class="NLM_article-title">Arglabin: From isolation to antitumor evaluation</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2015.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref316/cit316&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.cbi.2015.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref316/cit316&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=26327249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref316/cit316&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKgsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=2015&pages=180-198&author=S.+H.+Loneauthor=K.+A.+Bhatauthor=M.+A.+Khuroo&title=Arglabin%3A+From+isolation+to+antitumor+evaluation&doi=10.1016%2Fj.cbi.2015.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit316R"><div class="casContent"><span class="casTitleNuber">316</span><div class="casTitle"><span class="NLM_cas:atitle">Arglabin: From isolation to antitumor evaluation</span></div><div class="casAuthors">Lone, Shabir H.; Bhat, Khursheed A.; Khuroo, Mohd. A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">240</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">180-198</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Arglabin belongs to guaianolide class of sesquiterpene lactones, isolated from Artemisia species.  The mol. bears a 5,7,5-tricyclic ring system having five contiguous stereo centers in which the two five membered rings are trans-annulated.  Arglabin shows promising antitumor activity against different tumor cell lines.  The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors.  It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase).  The present review is an attempt to summarize the chem. and biol. of this mol. since its isolation in 1982.  It embodies the isolation, structure elucidation, stereo chem. description, structural classification, chem. synthesis, structural modifications and antitumor evaluation reported till date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovYOZoJ8Ws7bVg90H21EOLACvtfcHk0ljutgsxKZiMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKgsrjI&md5=63f6cbfb4f7bf750c47c4879a0f74818</span></div><a href="/servlet/linkout?suffix=cit316&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2015.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2015.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DLone%26aufirst%3DS.%2BH.%26aulast%3DBhat%26aufirst%3DK.%2BA.%26aulast%3DKhuroo%26aufirst%3DM.%2BA.%26atitle%3DArglabin%253A%2520From%2520isolation%2520to%2520antitumor%2520evaluation%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D240%26spage%3D180%26epage%3D198%26doi%3D10.1016%2Fj.cbi.2015.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref317"><div class="reference"><strong class="refLabel"><a href="#ref317" class="rightTabRefNumLink">317</a></strong><div class="NLM_citation" id="rightTab-cit317"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Natural product micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4155</span>– <span class="NLM_lpage">4164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00241</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00241" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref317/cit317&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFSguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4155-4164&author=J.+Liauthor=S.+Liauthor=J.+Guoauthor=Q.+Liauthor=J.+Longauthor=C.+Maauthor=Y.+Dingauthor=C.+Yanauthor=L.+Liauthor=Z.+Wuauthor=H.+Zhuauthor=K.+K.+Liauthor=L.+Wenauthor=Q.+Zhangauthor=Q.+Xueauthor=C.+Zhaoauthor=N.+Liuauthor=I.+Ivanovauthor=M.+Luoauthor=R.+Xiauthor=H.+Longauthor=P.+G.+Wangauthor=Y.+Chen&title=Natural+product+micheliolide+%28MCL%29+irreversibly+activates+pyruvate+kinase+M2+and+suppresses+leukemia&doi=10.1021%2Facs.jmedchem.8b00241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit317R"><div class="casContent"><span class="casTitleNuber">317</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia</span></div><div class="casAuthors">Li, Jing; Li, Shanshan; Guo, Jianshuang; Li, Qiuying; Long, Jing; Ma, Cheng; Ding, Yahui; Yan, Chunli; Li, Liangwei; Wu, Zhigang; Zhu, He; Li, Keqin Kathy; Wen, Liuqing; Zhang, Quan; Xue, Qingqing; Zhao, Caili; Liu, Ning; Ivanov, Ivaylo; Luo, Ming; Xi, Rimo; Long, Haibo; Wang, Peng George; Chen, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4155-4164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metabolic reprogramming of cancer cells is essential for tumorigenesis in which pyruvate kinase M2 (PKM2), the low activity isoform of pyruvate kinase, plays a crit. role.  Herein, we describe the identification of a nature-product-derived micheliolide (MCL) that selectively activates PKM2 through the covalent binding at residue cysteine424 (C424), which is not contained in PKM1.  This interaction promotes more tetramer formation, inhibits the lysine433 (K433) acetylation, and influences the translocation of PKM2 into the nucleus.  In addn., the pro-drug dimethylaminomicheliolide (DMAMCL) with similar properties as MCL significantly suppresses the growth of leukemia cells and tumorigenesis in a zebrafish xenograft model.  Cell-based assay with knock down PKM2 expression verifies that the effects of MCL are dependent on PKM2 expression.  DMAMCL is currently in clin. trials in Australia.  Our discovery may provide a valuable pharmacol. mechanism for clin. treatment and benefit the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHlWteclCMHbVg90H21EOLACvtfcHk0ljutgsxKZiMxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFSguro%253D&md5=8742015134a65572dee296a5e88fa861</span></div><a href="/servlet/linkout?suffix=cit317&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00241%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DK.%2BK.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DI.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DXi%26aufirst%3DR.%26aulast%3DLong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%2BG.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DNatural%2520product%2520micheliolide%2520%2528MCL%2529%2520irreversibly%2520activates%2520pyruvate%2520kinase%2520M2%2520and%2520suppresses%2520leukemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4155%26epage%3D4164%26doi%3D10.1021%2Facs.jmedchem.8b00241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref318"><div class="reference"><strong class="refLabel"><a href="#ref318" class="rightTabRefNumLink">318</a></strong><div class="NLM_citation" id="rightTab-cit318"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref318/cit318&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1016%2Fj.ejmech.2019.04.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref318/cit318&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=31082765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref318/cit318&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVCqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2019&pages=215-233&author=J.+Wangauthor=S.+Suauthor=S.+Zhangauthor=S.+Zhaiauthor=R.+Shengauthor=W.+Wuauthor=R.+Guo&title=Structure-activity+relationship+and+synthetic+methodologies+of+%CE%B1-santonin+derivatives+with+diverse+bioactivities%3A+A+mini-review&doi=10.1016%2Fj.ejmech.2019.04.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit318R"><div class="casContent"><span class="casTitleNuber">318</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship and synthetic methodologies of α-santonin derivatives with diverse bioactivities: A mini-review</span></div><div class="casAuthors">Wang, Jiangming; Su, Siyuan; Zhang, Shangzhe; Zhai, Shiyang; Sheng, Ruilong; Wu, Wenhui; Guo, Ruihua</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215-233</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  α-Santonin, a sesquiterpene lactone isolated from Artemisia Santonica, possesses diverse bioactivities including antioxidant, anti-inflammation, immunosuppressive, anti-roundworm, anti-malaria, etc.  However, its bioactivities are not satisfactory and need to be further optimized.  Thus, many α-santonin derivs. were synthesized on the basis of rings A, B and C for the discovery of new analogs with prominent bioactivities.  Herein, we reviewed and discussed the related synthetic methodologies, diverse bioactivities and structure-activity relationships (SAR) of α-santonin derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplIAEQHiQBpLVg90H21EOLACvtfcHk0lhbJcsNy-CkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVCqsL8%253D&md5=0b4ce66c103b72d06964bcd16ef11ea9</span></div><a href="/servlet/linkout?suffix=cit318&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.066%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhai%26aufirst%3DS.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DR.%26atitle%3DStructure-activity%2520relationship%2520and%2520synthetic%2520methodologies%2520of%2520%25CE%25B1-santonin%2520derivatives%2520with%2520diverse%2520bioactivities%253A%2520A%2520mini-review%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D175%26spage%3D215%26epage%3D233%26doi%3D10.1016%2Fj.ejmech.2019.04.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref319"><div class="reference"><strong class="refLabel"><a href="#ref319" class="rightTabRefNumLink">319</a></strong><div class="NLM_citation" id="rightTab-cit319"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arantes, F. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, L. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltha, C. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidencio, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, J. W. M.</span></span> <span> </span><span class="NLM_article-title">A quantum chemical and chemometric study of sesquiterpene lactones with cytotoxicity against tumor cells</span>. <i>J. Chemom.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1002/cem.1385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref319/cit319&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1002%2Fcem.1385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref319/cit319&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=401-407&author=F.+F.+P.+Arantesauthor=L.+C.+A.+Barbosaauthor=C.+R.+A.+Malthaauthor=A.+J.+Demunerauthor=P.+H.+Fidencioauthor=J.+W.+M.+Carneiro&title=A+quantum+chemical+and+chemometric+study+of+sesquiterpene+lactones+with+cytotoxicity+against+tumor+cells&doi=10.1002%2Fcem.1385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit319R"><div class="casContent"><span class="casTitleNuber">319</span><div class="casTitle"><span class="NLM_cas:atitle">A quantum chemical and chemometric study of sesquiterpene lactones with cytotoxicity against tumor cells</span></div><div class="casAuthors">Arantes, Francisco F. P.; Barbosa, Luiz C. A.; Maltha, Celia R. A.; Demuner, Antonio J.; Fidencio, Paulo H.; Carneiro, Jose Walkimar M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemometrics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">401-407</span>CODEN:
                <span class="NLM_cas:coden">JOCHEU</span>;
        ISSN:<span class="NLM_cas:issn">0886-9383</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The semi-empirical MO method PM6 was employed to calc. a set of mol. descriptors of 20 sesquiterpene lactones (SQLs) with cytotoxicity against HL-60 (leukemia) tumor cells.  The principal component anal. (PCA) and hierarchical cluster anal. (HCA) methods were used to obtain possible relationships between the calcd. descriptors and the biol. activity of the lactones.  Four descriptors were identified as responsible for the sepn. between the active and inactive compds.: EHOMO (HOMO energy); Q11 (net at. charge on C11); Q12 (net at. charge on C12) and Q13 (net at. charge on C13).  These results indicated that the presence of the α-methylene-γ-lactone group has a significant role in the mechanism by which SQLs exert their biol. activities.In order to deepen our knowledge about the structure-activity relationship of sesquiterpene lactones (SQLs), a quantum chem. and chemometric study of sesquiterpene lactones with cytotoxicity was performed against HL-60 (leukemia) tumor cells.  The anal. of the mol. descriptors identified as responsible for the sepn. between the active and inactive compds. indicated that the presence of the α-methylene-γ-lactone functionality has a significant role in the mechanism by which SQLs exert their biol. activities.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcXa-osTwBiLVg90H21EOLACvtfcHk0lhbJcsNy-CkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOnsb7J&md5=80fb49c33e6e5eb9e17383c76baad6f8</span></div><a href="/servlet/linkout?suffix=cit319&amp;dbid=16384&amp;doi=10.1002%2Fcem.1385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcem.1385%26sid%3Dliteratum%253Aachs%26aulast%3DArantes%26aufirst%3DF.%2BF.%2BP.%26aulast%3DBarbosa%26aufirst%3DL.%2BC.%2BA.%26aulast%3DMaltha%26aufirst%3DC.%2BR.%2BA.%26aulast%3DDemuner%26aufirst%3DA.%2BJ.%26aulast%3DFidencio%26aufirst%3DP.%2BH.%26aulast%3DCarneiro%26aufirst%3DJ.%2BW.%2BM.%26atitle%3DA%2520quantum%2520chemical%2520and%2520chemometric%2520study%2520of%2520sesquiterpene%2520lactones%2520with%2520cytotoxicity%2520against%2520tumor%2520cells%26jtitle%3DJ.%2520Chemom.%26date%3D2011%26volume%3D25%26spage%3D401%26epage%3D407%26doi%3D10.1002%2Fcem.1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref320"><div class="reference"><strong class="refLabel"><a href="#ref320" class="rightTabRefNumLink">320</a></strong><div class="NLM_citation" id="rightTab-cit320"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zibelman, M.</span></span> <span> </span><span class="NLM_article-title">Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1421</span>, <span class="refDoi"> DOI: 10.2217/fon-2017-0585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref320/cit320&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.2217%2Ffon-2017-0585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref320/cit320&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=29848096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref320/cit320&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1CqurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1409-1421&author=F.+Anariauthor=C.+Ramamurthyauthor=M.+Zibelman&title=Impact+of+tumor+microenvironment+composition+on+therapeutic+responses+and+clinical+outcomes+in+cancer&doi=10.2217%2Ffon-2017-0585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit320R"><div class="casContent"><span class="casTitleNuber">320</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer</span></div><div class="casAuthors">Anari, Fern; Ramamurthy, Chethan; Zibelman, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1409-1421</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1744-8301</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  The tumor microenvironment (TME) plays an important role in cancer growth and progression.  Paradoxically, the TME is capable of acting as both a potential barrier and facilitator of tumor proliferation by affecting various processes including local growth resistance, immune system interactions, and the formation of distant metastases.  This important interaction between cancer cells and their local environment, composed of immune cells, angiogenic cells, lymphatic endothelial cells and cancer-assocd. fibroblasts is paramount to det. a cancer cell's ability to grow and ultimately metastasize.  It is essential to understand this complex interplay in order to define treatment modalities to target the TME as part of anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDb7jUyAWCr7Vg90H21EOLACvtfcHk0lhbJcsNy-CkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1CqurvL&md5=8f607c4860c49bbcc2ead24edd7e4f85</span></div><a href="/servlet/linkout?suffix=cit320&amp;dbid=16384&amp;doi=10.2217%2Ffon-2017-0585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon-2017-0585%26sid%3Dliteratum%253Aachs%26aulast%3DAnari%26aufirst%3DF.%26aulast%3DRamamurthy%26aufirst%3DC.%26aulast%3DZibelman%26aufirst%3DM.%26atitle%3DImpact%2520of%2520tumor%2520microenvironment%2520composition%2520on%2520therapeutic%2520responses%2520and%2520clinical%2520outcomes%2520in%2520cancer%26jtitle%3DFuture%2520Oncol.%26date%3D2018%26volume%3D14%26spage%3D1409%26epage%3D1421%26doi%3D10.2217%2Ffon-2017-0585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref321"><div class="reference"><strong class="refLabel"><a href="#ref321" class="rightTabRefNumLink">321</a></strong><div class="NLM_citation" id="rightTab-cit321"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amorim, M. H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil da Costa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastos, M. M. S. M.</span></span> <span> </span><span class="NLM_article-title">Sesquiterpene lactones: Adverse health effects and toxicity mechanisms</span>. <i>Crit. Rev. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.3109/10408444.2013.813905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref321/cit321&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.3109%2F10408444.2013.813905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref321/cit321&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=23875764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref321/cit321&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOisbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=559-579&author=M.+H.+R.+Amorimauthor=R.+M.+Gil+da+Costaauthor=C.+Lopesauthor=M.+M.+S.+M.+Bastos&title=Sesquiterpene+lactones%3A+Adverse+health+effects+and+toxicity+mechanisms&doi=10.3109%2F10408444.2013.813905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit321R"><div class="casContent"><span class="casTitleNuber">321</span><div class="casTitle"><span class="NLM_cas:atitle">Sesquiterpene lactones: Adverse health effects and toxicity mechanisms</span></div><div class="casAuthors">Amorim, M. Helena R.; Gil da Costa, Rui M.; Lopes, Carlos; Bastos, Margarida M. S. M.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">559-579</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Sesquiterpene lactones (STLs) present a wide range of biol. activities, mostly based on their alkylating capabilities, which underlie their therapeutic potential.  These compds. are the active constituents of a variety of plants, frequently used as herbal remedies.  STLs such as artemisinin and its derivs. are in use as first-line antimalarials while others, such as parthenolide, have recently reached cancer clin. trials.  However, the toxicol. profile of these compds. must be thoroughly characterized, since the same properties that make STL useful medicines can also cause severe toxicity.  STL-contg. plants have long been known to induce a contact dermatitis in exposed farm workers, and also to cause several toxic syndromes in farm animals.  More recently, concerns are been raised regarding the genotoxic potential of these compds. and the embryotoxicity of artemisinins.  A growing no. of STLs are being reported to be mutagenic in different in vitro and in vivo assays.  As yet no systematic studies have been published, but the genotoxicity of STLs seems to depend not so much on direct DNA alkylation as on oxidative DNA damage and other partially elucidated mechanisms.  As the medicinal use of these compds. increases, further studies of their toxic potential are needed, esp. those focusing on the structural determinants of genotoxicity and embryotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3GuCv-r4fCrVg90H21EOLACvtfcHk0liuQmAO00ODDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOisbvP&md5=96dad6ddbf16d32cd5f5be26da290601</span></div><a href="/servlet/linkout?suffix=cit321&amp;dbid=16384&amp;doi=10.3109%2F10408444.2013.813905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10408444.2013.813905%26sid%3Dliteratum%253Aachs%26aulast%3DAmorim%26aufirst%3DM.%2BH.%2BR.%26aulast%3DGil%2Bda%2BCosta%26aufirst%3DR.%2BM.%26aulast%3DLopes%26aufirst%3DC.%26aulast%3DBastos%26aufirst%3DM.%2BM.%2BS.%2BM.%26atitle%3DSesquiterpene%2520lactones%253A%2520Adverse%2520health%2520effects%2520and%2520toxicity%2520mechanisms%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2013%26volume%3D43%26spage%3D559%26epage%3D579%26doi%3D10.3109%2F10408444.2013.813905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref322"><div class="reference"><strong class="refLabel"><a href="#ref322" class="rightTabRefNumLink">322</a></strong><div class="NLM_citation" id="rightTab-cit322"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Studies on the genetic toxicity of <i>Evodia rutaecarpa</i> and its main components</span>. <i>Shijie Zhongyiyao</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref322/cit322&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSisr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=145-150&author=Q.+Xiaauthor=Y.+Liuauthor=R.+Yangauthor=Q.+Liuauthor=Y.+Zhuoauthor=H.+Li&title=Studies+on+the+genetic+toxicity+of+Evodia+rutaecarpa+and+its+main+components"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit322R"><div class="casContent"><span class="casTitleNuber">322</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the genetic toxicity of Evodia rutaecarpa and its main components</span></div><div class="casAuthors">Xia, Qiyue; Liu, Yanping; Yang, Runfang; Liu, Qiangqiang; Zhuo, Yanqiang; Li, Hongxia</div><div class="citationInfo"><span class="NLM_cas:title">Shijie Zhongyiyao</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-150, 154</span>CODEN:
                <span class="NLM_cas:coden">SZHHAN</span>;
        ISSN:<span class="NLM_cas:issn">1673-7202</span>.
    
            (<span class="NLM_cas:orgname">Shijie Zhongyiyao Bianjibu</span>)
        </div><div class="casAbstract">Objective: To investigate the genetic toxicity of Evodia rutaecarpa and its main components, including evodiamine, rutaecarpin and limonin, in order to provide useful data for developing toxic Traditional Chinese Medicine.  Methods: Ames test, CHL chromosome aberration assay and micronucleus assay of bone marrow cell in mice were used to test evodiamine, rutaecarpin, limonin and Evodia rutaecarpa.  Strains TA97, TA98, TA100, TA102 and TA1535 were used in the Ames test.  There were five dose groups resp. for evodiamine, rutaecarpin and limonin as follows: 0.0005, 0.005 mg/plate, 0.05 mg/plate, 0.5 mg/plate, 5 mg/plate.  As a result, the results of the Ames assay were neg. for various groups of evodiamine, rutaecarpin and limonin.  In CHL chromosome aberration assay, the doses of evodiamine, rutaecarpin and limonin were 0.005 mg/mL, 0.05 mg/mL and 0.5 mg/mL resp.  Exposure time was 4 h and 24 h.  Results: The result of the Evodiamine was neg.  Aberration rate of 24 h exposure Rutaecarpin chromosome increased significantly compared with that of neg. control group (P < 0.05).  Aberration rate of Limonin chromosome 0.05 and 0.5 mg/mL groups increased in 4 h and 24 h exposure compared with neg. control group (P < 0.05), the 0.005 mg/mL group was not significantly different compared with neg. control group (P > 0.05).  In vivo micronucleus test with Evodia rutaecarpa alc. ext., there were 3 dosing groups: 0.88, 3.52, 10.55 g raw drug/kg, 4 days, once every day.  The results were neg.  Conclusion: no genetic toxicity was obsd. in Evodia rutaecarpa alc. ext.  However, rutaecarpin and limonin shows some genotoxicity in vivo test, which requires further research to confirm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ3vYCVub2fLVg90H21EOLACvtfcHk0liuQmAO00ODDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSisr3O&md5=4c6f5eddc84cb992fb3d09ec9130f4da</span></div><a href="/servlet/linkout?suffix=cit322&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhuo%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DStudies%2520on%2520the%2520genetic%2520toxicity%2520of%2520Evodia%2520rutaecarpa%2520and%2520its%2520main%2520components%26jtitle%3DShijie%2520Zhongyiyao%26date%3D2014%26volume%3D9%26spage%3D145%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref323"><div class="reference"><strong class="refLabel"><a href="#ref323" class="rightTabRefNumLink">323</a></strong><div class="NLM_citation" id="rightTab-cit323"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orjala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farnsworth, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberlies, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroll, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairchild, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vite, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarjoura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cope, F. O.</span></span> <span> </span><span class="NLM_article-title">Discovery of anticancer agents of diverse natural origin</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1063</span>, <span class="refDoi"> DOI: 10.1351/PAC-CON-08-10-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref323/cit323&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.1351%2FPAC-CON-08-10-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref323/cit323&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=20046887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref323/cit323&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFaitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2009&pages=1051-1063&author=A.+D.+Kinghornauthor=E.+J.+Carcache+de+Blancoauthor=H.-B.+Chaiauthor=J.+Orjalaauthor=N.+R.+Farnsworthauthor=D.+D.+Soejartoauthor=N.+H.+Oberliesauthor=M.+C.+Waniauthor=D.+J.+Krollauthor=C.+J.+Pearceauthor=S.+M.+Swansonauthor=R.+A.+Kramerauthor=W.+C.+Roseauthor=C.+R.+Fairchildauthor=G.+D.+Viteauthor=S.+Emanuelauthor=D.+Jarjouraauthor=F.+O.+Cope&title=Discovery+of+anticancer+agents+of+diverse+natural+origin&doi=10.1351%2FPAC-CON-08-10-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit323R"><div class="casContent"><span class="casTitleNuber">323</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of anticancer agents of diverse natural origin</span></div><div class="casAuthors">Kinghorn, A. Douglas; Carcache de Blanco, Esperanza J.; Chai, Hee-Byung; Orjala, Jimmy; Farnsworth, Norman R.; Soejarto, D. Doel; Oberlies, Nicholas H.; Wani, Mansukh C.; Kroll, David J.; Pearce, Cedric J.; Swanson, Steven M.; Kramer, Robert A.; Rose, William C.; Fairchild, Craig R.; Vite, Gregory D.; Emanuel, Stuart; Jarjoura, David; Cope, Frederick O.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1051-1063</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    
            (<span class="NLM_cas:orgname">International Union of Pure and Applied Chemistry</span>)
        </div><div class="casAbstract">A review.  A collaborative multidisciplinary research project is described in which new natural product anticancer drug leads are obtained from a diverse group of organisms, constituted by tropical plants, aquatic cyanobacteria, and filamentous fungi.  Information is provided on how these organisms are collected and processed.  The types of bioassays are indicated in which crude exts. of these acquisitions are tested.  Progress made in the isolation of lead bioactive secondary metabolites from three tropical plants is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7FFiQ0aKOfLVg90H21EOLACvtfcHk0liuQmAO00ODDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFaitrw%253D&md5=ab5d31b1fbd29c38fc29e3502f25743e</span></div><a href="/servlet/linkout?suffix=cit323&amp;dbid=16384&amp;doi=10.1351%2FPAC-CON-08-10-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252FPAC-CON-08-10-16%26sid%3Dliteratum%253Aachs%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DChai%26aufirst%3DH.-B.%26aulast%3DOrjala%26aufirst%3DJ.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DOberlies%26aufirst%3DN.%2BH.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DKroll%26aufirst%3DD.%2BJ.%26aulast%3DPearce%26aufirst%3DC.%2BJ.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DKramer%26aufirst%3DR.%2BA.%26aulast%3DRose%26aufirst%3DW.%2BC.%26aulast%3DFairchild%26aufirst%3DC.%2BR.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DJarjoura%26aufirst%3DD.%26aulast%3DCope%26aufirst%3DF.%2BO.%26atitle%3DDiscovery%2520of%2520anticancer%2520agents%2520of%2520diverse%2520natural%2520origin%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2009%26volume%3D81%26spage%3D1051%26epage%3D1063%26doi%3D10.1351%2FPAC-CON-08-10-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref324"><div class="reference"><strong class="refLabel"><a href="#ref324" class="rightTabRefNumLink">324</a></strong><div class="NLM_citation" id="rightTab-cit324"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, H.</span></span> <span> </span><span class="NLM_article-title">The relevance of higher plants in lead compound discovery programs</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1555</span>, <span class="refDoi"> DOI: 10.1021/np200391c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200391c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref324/cit324&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1agtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=1539-1555&author=A.+D.+Kinghornauthor=L.+Panauthor=J.+N.+Fletcherauthor=H.+Chai&title=The+relevance+of+higher+plants+in+lead+compound+discovery+programs&doi=10.1021%2Fnp200391c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit324R"><div class="casContent"><span class="casTitleNuber">324</span><div class="casTitle"><span class="NLM_cas:atitle">The Relevance of Higher Plants in Lead Compound Discovery Programs</span></div><div class="casAuthors">Kinghorn, A. Douglas; Pan, Li; Fletcher, Joshua N.; Chai, Heebyung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1555</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Along with compds. from terrestrial microorganisms, the constituents of higher plants have provided a substantial no. of the natural product-derived drugs used currently in Western medicine.  Interest in the elucidation of new structures of the secondary metabolite constituents of plants has remained high among the natural products community over the first decade of the 21st century, particularly of species that are used in systems of traditional medicine or are utilized as botanical dietary supplements.  In this review, progress made in the senior author's lab. in research work on naturally occurring sweeteners and other taste-modifying substances and on potential anticancer agents from tropical plants will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokz6AuD5kj_rVg90H21EOLACvtfcHk0lga6atCeAGMZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1agtbw%253D&md5=d665f1818fba55a3c48c2990c013aa0a</span></div><a href="/servlet/linkout?suffix=cit324&amp;dbid=16384&amp;doi=10.1021%2Fnp200391c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200391c%26sid%3Dliteratum%253Aachs%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DFletcher%26aufirst%3DJ.%2BN.%26aulast%3DChai%26aufirst%3DH.%26atitle%3DThe%2520relevance%2520of%2520higher%2520plants%2520in%2520lead%2520compound%2520discovery%2520programs%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D1539%26epage%3D1555%26doi%3D10.1021%2Fnp200391c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref325"><div class="reference"><strong class="refLabel"><a href="#ref325" class="rightTabRefNumLink">325</a></strong><div class="NLM_citation" id="rightTab-cit325"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinghorn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache de Blanco, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakotondraibe, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orjala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soejarto, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberlies, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of anticancer agents of diverse natural origin</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">5623</span>– <span class="NLM_lpage">5638</span>, <span class="refDoi"> DOI: 10.21873/anticanres.11146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref325/cit325&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=10.21873%2Fanticanres.11146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref325/cit325&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=27793884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref325/cit325&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFahtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=5623-5638&author=A.+D.+Kinghornauthor=E.+J.+Carcache+de+Blancoauthor=D.+M.+Lucasauthor=H.+L.+Rakotondraibeauthor=J.+Orjalaauthor=D.+D.+Soejartoauthor=N.+H.+Oberliesauthor=C.+J.+Pearceauthor=M.+C.+Waniauthor=B.+R.+Stockwellauthor=J.+E.+Burdetteauthor=S.+M.+Swansonauthor=J.+R.+Fuchsauthor=M.+A.+Phelpsauthor=L.+Xuauthor=X.+Zhangauthor=Y.+Y.+Shen&title=Discovery+of+anticancer+agents+of+diverse+natural+origin&doi=10.21873%2Fanticanres.11146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit325R"><div class="casContent"><span class="casTitleNuber">325</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of anticancer agents of diverse natural origin</span></div><div class="casAuthors">Kinghorn, A. Douglas; Carcache De Blanco, Esperanza J.; Lucas, David M.; Liva, Rakotondraibe H.; Orjala, Jimmy; Soejarto, D. Doel; Oberlies, Nicholas H.; Pearce, Cedric J.; Wani, Mansukh C.; Stockwell, Brent R.; Burdette, Joanna E.; Swanson, Steven M.; Fuchs, James R.; Phelps, Mitchell A.; Xu, Lihui; Zhang, Xiaoli; Shen, Young Yongchun</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5623-5638</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Recent progress is described in an ongoing collaborative multidisciplinary research project directed towards the purifn., structural characterization, chem. modification, and biol. evaluation of new potential natural product anticancer agents obtained from a diverse group of organisms, comprising tropical plants, aquatic and terrestrial cyanobacteria, and filamentous fungi.  Information is provided on how these organisms are collected and processed.  The types of bioassays are indicated in which initial exts., chromatog. fractions, and purified isolated compds. of these acquisitions are tested.  Several promising biol. active lead compds. from each major organism class investigated are described, and these may be seen to be representative of a very wide chem. diversity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocy2oPvcIlEbVg90H21EOLACvtfcHk0lga6atCeAGMZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFahtro%253D&md5=e8812bd05ef88b7947b92e2815fcfbee</span></div><a href="/servlet/linkout?suffix=cit325&amp;dbid=16384&amp;doi=10.21873%2Fanticanres.11146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.21873%252Fanticanres.11146%26sid%3Dliteratum%253Aachs%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26aulast%3DCarcache%2Bde%2BBlanco%26aufirst%3DE.%2BJ.%26aulast%3DLucas%26aufirst%3DD.%2BM.%26aulast%3DRakotondraibe%26aufirst%3DH.%2BL.%26aulast%3DOrjala%26aufirst%3DJ.%26aulast%3DSoejarto%26aufirst%3DD.%2BD.%26aulast%3DOberlies%26aufirst%3DN.%2BH.%26aulast%3DPearce%26aufirst%3DC.%2BJ.%26aulast%3DWani%26aufirst%3DM.%2BC.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26aulast%3DBurdette%26aufirst%3DJ.%2BE.%26aulast%3DSwanson%26aufirst%3DS.%2BM.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DPhelps%26aufirst%3DM.%2BA.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%2BY.%26atitle%3DDiscovery%2520of%2520anticancer%2520agents%2520of%2520diverse%2520natural%2520origin%26jtitle%3DAnticancer%2520Res.%26date%3D2016%26volume%3D36%26spage%3D5623%26epage%3D5638%26doi%3D10.21873%2Fanticanres.11146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01449&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-24%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01449%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01449" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667984030c63247f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
